data_1jww_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1jww _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.9 p . . . . . 0 CA--C 1.532 0.271 0 N-CA-C 109.838 -0.431 . . . . 10.0 109.838 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -119.2 139.55 51.67 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 127.045 2.138 . . . . 10.0 109.321 -172.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.9 mtmm -104.87 88.75 2.97 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.844 1.658 . . . . 10.0 110.63 -165.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -104.59 152.35 22.53 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.299 1.44 . . . . 10.0 110.497 -168.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -123.54 148.89 45.88 Favored 'General case' 0 CA--C 1.511 -0.545 0 C-N-CA 123.791 0.836 . . . . 10.0 110.199 178.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -138.72 142.3 38.9 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 125.241 1.416 . . . . 10.0 108.205 -175.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -108.86 137.41 46.84 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 107.698 -1.223 . . . . 10.0 107.698 -173.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 5.1 mm -110.22 124.86 67.33 Favored 'Isoleucine or valine' 0 C--N 1.338 0.096 0 C-N-CA 124.52 1.128 . . . . 10.0 110.715 -159.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 . . . . . 0 N--CA 1.45 -0.433 0 N-CA-C 108.942 -0.762 . . . . 10.0 108.942 173.92 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.531 0.236 0 N-CA-C 111.897 0.332 . . . . 10.0 111.897 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.59 -38.26 89.43 Favored 'General case' 0 N--CA 1.446 -0.655 0 O-C-N 121.265 -0.897 . . . . 10.0 110.154 178.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 19.3 mm -41.45 -54.04 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.305 0 C-N-CA 124.349 1.06 . . . . 10.0 111.495 170.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -49.56 -50.28 42.89 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-N 118.355 0.525 . . . . 10.0 110.476 -176.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.53 -46.22 67.01 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.787 -0.57 . . . . 10.0 110.187 -178.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 7.6 mmt180 -55.75 -32.27 63.28 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 113.284 0.846 . . . . 10.0 113.284 177.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.92 -42.58 14.85 Favored 'General case' 0 C--O 1.22 -0.499 0 C-N-CA 123.419 0.688 . . . . 10.0 111.21 172.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -60.28 -18.65 50.69 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 120.933 -1.105 . . . . 10.0 111.359 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.1 mmpt? -51.19 -41.03 59.94 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 113.863 1.06 . . . . 10.0 113.863 164.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 10.8 mt -54.5 129.43 15.61 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.068 0 CA-C-N 119.216 0.916 . . . . 10.0 108.909 175.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 58.0 mp0 -66.94 -46.23 75.38 Favored 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 122.132 -0.355 . . . . 10.0 110.129 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.18 43.91 3.2 Favored Glycine 0 C--N 1.339 0.699 0 O-C-N 121.266 -0.896 . . . . 10.0 111.998 -173.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.4 p -103.8 152.47 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 C-N-CA 124.894 1.278 . . . . 10.0 108.811 -176.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -117.69 -59.75 1.89 Allowed 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.677 -0.861 . . . . 10.0 108.677 168.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 -140.13 160.15 40.59 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 109.29 -0.633 . . . . 10.0 109.29 -178.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -149.2 63.72 6.88 Favored Pre-proline 0 CA--C 1.535 0.374 0 C-N-CA 123.191 0.596 . . . . 10.0 110.804 173.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -78.12 75.58 4.78 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.89 2.393 . . . . 10.0 109.698 -176.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.3 m -70.98 157.41 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 O-C-N 121.744 -0.597 . . . . 10.0 112.024 -177.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -100.93 138.07 38.47 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 110.084 -0.339 . . . . 10.0 110.084 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -120.98 53.66 1.12 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.976 1.31 . . . . 10.0 110.603 -172.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -176.26 -41.31 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 125.727 1.611 . . . . 10.0 108.805 178.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.3 mt -82.24 -15.2 53.94 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.021 1.328 . . . . 10.0 111.44 -172.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 72.91 44.15 0.37 Allowed 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 125.762 1.625 . . . . 10.0 110.377 173.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 39.7 p -140.91 131.71 25.83 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.189 1.396 . . . . 10.0 109.067 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.0 t -99.97 141.94 16.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 107.746 -1.205 . . . . 10.0 107.746 167.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 62.5 m -130.12 124.12 31.97 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 106.576 -1.639 . . . . 10.0 106.576 -176.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 16.5 t -126.63 134.54 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 C-N-CA 123.091 0.556 . . . . 10.0 110.681 -175.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -108.98 94.22 4.93 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 127.043 2.137 . . . . 10.0 106.914 171.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -140.14 163.38 32.89 Favored 'General case' 0 CA--C 1.521 -0.15 0 C-N-CA 123.29 0.636 . . . . 10.0 109.46 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -95.92 132.48 27.01 Favored Pre-proline 0 C--N 1.329 -0.306 0 C-N-CA 123.57 0.748 . . . . 10.0 110.186 177.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -78.81 56.43 5.96 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.081 1.854 . . . . 10.0 109.926 171.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.0 pttt -118.53 -45.74 2.6 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 108.965 -0.754 . . . . 10.0 108.965 170.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.08 -46.29 5.63 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.2 1.0 . . . . 10.0 110.605 -167.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -122.92 -171.34 2.27 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.287 1.035 . . . . 10.0 109.6 175.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 97.2 p -149.46 170.8 17.76 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.297 0.639 . . . . 10.0 110.466 177.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 31.4 m -49.42 -42.11 16.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 123.679 0.792 . . . . 10.0 111.293 172.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 66.9 m -61.23 -42.36 98.47 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 123.454 0.702 . . . . 10.0 111.699 -178.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -62.28 -57.39 11.59 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.265 0.626 . . . . 10.0 109.501 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.1 pp -65.85 -40.87 92.14 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 121.512 0.672 . . . . 10.0 110.373 -173.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -44.32 -47.19 9.54 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 112.675 0.62 . . . . 10.0 112.675 163.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.11 -44.54 96.43 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-N 119.02 0.827 . . . . 10.0 109.512 178.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -52.12 -47.76 65.16 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 110.382 -0.229 . . . . 10.0 110.382 178.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 38.7 t -65.73 -46.17 89.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 N-CA-C 112.776 0.658 . . . . 10.0 112.776 174.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -56.48 -38.67 72.04 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 120.544 -1.347 . . . . 10.0 110.268 178.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.2 tptm -66.65 -35.52 80.36 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.051 1.34 . . . . 10.0 109.83 -178.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 26.4 mt -58.65 -30.15 67.09 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 118.98 -0.533 . . . . 10.0 112.068 169.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 137.39 -39.79 1.58 Allowed Glycine 0 CA--C 1.527 0.804 0 C-N-CA 123.701 0.667 . . . . 10.0 111.716 171.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -97.7 152.44 19.1 Favored 'General case' 0 C--O 1.226 -0.175 0 C-N-CA 125.148 1.379 . . . . 10.0 109.527 -172.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -89.35 153.34 20.94 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.648 0.737 . . . . 10.0 110.849 -170.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 29.1 tp -130.3 148.29 52.11 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.233 1.813 . . . . 10.0 107.383 177.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 9.4 tptp -154.7 152.81 30.37 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 108.912 -0.773 . . . . 10.0 108.912 165.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.6 tp -62.46 154.7 27.64 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 109.488 -0.56 . . . . 10.0 109.488 178.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -108.34 -60.94 1.66 Allowed 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 125.462 1.505 . . . . 10.0 106.961 168.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -174.44 -79.4 0.05 OUTLIER Glycine 0 CA--C 1.521 0.455 0 N-CA-C 110.003 -1.239 . . . . 10.0 110.003 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 . . . . . 0 N--CA 1.452 -0.328 0 C-N-CA 124.384 1.074 . . . . 10.0 108.128 -170.664 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.9 p . . . . . 0 CA--C 1.532 0.271 0 N-CA-C 109.838 -0.431 . . . . 10.0 109.838 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -119.2 139.55 51.67 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 127.045 2.138 . . . . 10.0 109.321 -172.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.9 mtmm -104.87 88.75 2.97 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.844 1.658 . . . . 10.0 110.63 -165.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -104.59 152.35 22.53 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.299 1.44 . . . . 10.0 110.497 -168.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -123.54 148.89 45.88 Favored 'General case' 0 CA--C 1.511 -0.545 0 C-N-CA 123.791 0.836 . . . . 10.0 110.199 178.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -138.72 142.3 38.9 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 125.241 1.416 . . . . 10.0 108.205 -175.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -108.86 137.41 46.84 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 107.698 -1.223 . . . . 10.0 107.698 -173.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 5.1 mm -110.22 124.86 67.33 Favored 'Isoleucine or valine' 0 C--N 1.338 0.096 0 C-N-CA 124.52 1.128 . . . . 10.0 110.715 -159.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 . . . . . 0 N--CA 1.45 -0.433 0 N-CA-C 108.942 -0.762 . . . . 10.0 108.942 173.92 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.531 0.236 0 N-CA-C 111.897 0.332 . . . . 10.0 111.897 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.59 -38.26 89.43 Favored 'General case' 0 N--CA 1.446 -0.655 0 O-C-N 121.265 -0.897 . . . . 10.0 110.154 178.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 19.3 mm -41.45 -54.04 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.305 0 C-N-CA 124.349 1.06 . . . . 10.0 111.495 170.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -49.56 -50.28 42.89 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-N 118.355 0.525 . . . . 10.0 110.476 -176.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.53 -46.22 67.01 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.787 -0.57 . . . . 10.0 110.187 -178.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 7.6 mmt180 -55.75 -32.27 63.28 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 113.284 0.846 . . . . 10.0 113.284 177.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.92 -42.58 14.85 Favored 'General case' 0 C--O 1.22 -0.499 0 C-N-CA 123.419 0.688 . . . . 10.0 111.21 172.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -60.28 -18.65 50.69 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 120.933 -1.105 . . . . 10.0 111.359 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.1 mmpt? -51.19 -41.03 59.94 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 113.863 1.06 . . . . 10.0 113.863 164.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 10.8 mt -54.5 129.43 15.61 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.068 0 CA-C-N 119.216 0.916 . . . . 10.0 108.909 175.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 58.0 mp0 -66.94 -46.23 75.38 Favored 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 122.132 -0.355 . . . . 10.0 110.129 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.18 43.91 3.2 Favored Glycine 0 C--N 1.339 0.699 0 O-C-N 121.266 -0.896 . . . . 10.0 111.998 -173.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.4 p -103.8 152.47 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 C-N-CA 124.894 1.278 . . . . 10.0 108.811 -176.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -117.69 -59.75 1.89 Allowed 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.677 -0.861 . . . . 10.0 108.677 168.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 -140.13 160.15 40.59 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 109.29 -0.633 . . . . 10.0 109.29 -178.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -149.2 63.72 6.88 Favored Pre-proline 0 CA--C 1.535 0.374 0 C-N-CA 123.191 0.596 . . . . 10.0 110.804 173.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -78.12 75.58 4.78 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.89 2.393 . . . . 10.0 109.698 -176.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.3 m -70.98 157.41 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 O-C-N 121.744 -0.597 . . . . 10.0 112.024 -177.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -100.93 138.07 38.47 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 110.084 -0.339 . . . . 10.0 110.084 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -120.98 53.66 1.12 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.976 1.31 . . . . 10.0 110.603 -172.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -176.26 -41.31 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 125.727 1.611 . . . . 10.0 108.805 178.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.3 mt -82.24 -15.2 53.94 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.021 1.328 . . . . 10.0 111.44 -172.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 72.91 44.15 0.37 Allowed 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 125.762 1.625 . . . . 10.0 110.377 173.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 39.7 p -140.91 131.71 25.83 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.189 1.396 . . . . 10.0 109.067 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.0 t -99.97 141.94 16.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 107.746 -1.205 . . . . 10.0 107.746 167.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 62.5 m -130.12 124.12 31.97 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 106.576 -1.639 . . . . 10.0 106.576 -176.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 16.5 t -126.63 134.54 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 C-N-CA 123.091 0.556 . . . . 10.0 110.681 -175.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -108.98 94.22 4.93 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 127.043 2.137 . . . . 10.0 106.914 171.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -140.14 163.38 32.89 Favored 'General case' 0 CA--C 1.521 -0.15 0 C-N-CA 123.29 0.636 . . . . 10.0 109.46 179.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -95.92 132.48 27.01 Favored Pre-proline 0 C--N 1.329 -0.306 0 C-N-CA 123.57 0.748 . . . . 10.0 110.186 177.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -78.81 56.43 5.96 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.081 1.854 . . . . 10.0 109.926 171.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.0 pttt -118.53 -45.74 2.6 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 108.965 -0.754 . . . . 10.0 108.965 170.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.08 -46.29 5.63 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.2 1.0 . . . . 10.0 110.605 -167.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -122.92 -171.34 2.27 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.287 1.035 . . . . 10.0 109.6 175.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 97.2 p -149.46 170.8 17.76 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.297 0.639 . . . . 10.0 110.466 177.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 31.4 m -49.42 -42.11 16.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 123.679 0.792 . . . . 10.0 111.293 172.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 66.9 m -61.23 -42.36 98.47 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 123.454 0.702 . . . . 10.0 111.699 -178.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -62.28 -57.39 11.59 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.265 0.626 . . . . 10.0 109.501 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.1 pp -65.85 -40.87 92.14 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 121.512 0.672 . . . . 10.0 110.373 -173.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -44.32 -47.19 9.54 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 112.675 0.62 . . . . 10.0 112.675 163.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.11 -44.54 96.43 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-N 119.02 0.827 . . . . 10.0 109.512 178.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -52.12 -47.76 65.16 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 110.382 -0.229 . . . . 10.0 110.382 178.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 38.7 t -65.73 -46.17 89.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 N-CA-C 112.776 0.658 . . . . 10.0 112.776 174.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -56.48 -38.67 72.04 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 120.544 -1.347 . . . . 10.0 110.268 178.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.2 tptm -66.65 -35.52 80.36 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.051 1.34 . . . . 10.0 109.83 -178.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 26.4 mt -58.65 -30.15 67.09 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 118.98 -0.533 . . . . 10.0 112.068 169.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 137.39 -39.79 1.58 Allowed Glycine 0 CA--C 1.527 0.804 0 C-N-CA 123.701 0.667 . . . . 10.0 111.716 171.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -97.7 152.44 19.1 Favored 'General case' 0 C--O 1.226 -0.175 0 C-N-CA 125.148 1.379 . . . . 10.0 109.527 -172.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -89.35 153.34 20.94 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.648 0.737 . . . . 10.0 110.849 -170.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 29.1 tp -130.3 148.29 52.11 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.233 1.813 . . . . 10.0 107.383 177.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 9.4 tptp -154.7 152.81 30.37 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 108.912 -0.773 . . . . 10.0 108.912 165.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.6 tp -62.46 154.7 27.64 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 109.488 -0.56 . . . . 10.0 109.488 178.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -108.34 -60.94 1.66 Allowed 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 125.462 1.505 . . . . 10.0 106.961 168.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -174.44 -79.4 0.05 OUTLIER Glycine 0 CA--C 1.521 0.455 0 N-CA-C 110.003 -1.239 . . . . 10.0 110.003 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 . . . . . 0 N--CA 1.452 -0.328 0 C-N-CA 124.384 1.074 . . . . 10.0 108.128 -170.664 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.8 p . . . . . 0 N--CA 1.451 -0.388 0 N-CA-C 107.555 -1.276 . . . . 10.0 107.555 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -121.7 147.69 45.57 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 126.51 1.924 . . . . 10.0 108.143 -166.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -88.69 130.91 35.21 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 107.983 -1.117 . . . . 10.0 107.983 -178.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -145.35 135.9 24.27 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.251 -0.648 . . . . 10.0 109.251 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -122.23 149.42 43.69 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 123.449 0.7 . . . . 10.0 111.614 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -136.28 137.97 41.27 Favored 'General case' 0 N--CA 1.451 -0.409 0 O-C-N 125.134 1.521 . . . . 10.0 110.037 -170.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -93.9 138.09 32.41 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 106.926 -1.509 . . . . 10.0 106.926 178.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 6.9 mm -109.93 132.39 58.3 Favored 'Isoleucine or valine' 0 C--N 1.34 0.168 0 C-N-CA 125.018 1.327 . . . . 10.0 111.496 -165.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 . . . . . 0 N--CA 1.447 -0.618 0 C-N-CA 124.098 0.959 . . . . 10.0 109.649 176.77 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.53 0.178 0 CA-C-O 120.436 0.16 . . . . 10.0 110.976 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 20.7 ttt180 -58.92 -34.8 72.12 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.717 0.807 . . . . 10.0 109.29 -177.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 14.9 mm -52.04 -41.92 33.25 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.466 0 CA-C-O 117.381 -1.295 . . . . 10.0 111.349 171.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 75.0 mt-10 -51.68 -50.11 61.08 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-N 120.78 1.627 . . . . 10.0 110.766 -178.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.2 mtmt -69.64 -45.7 67.87 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.103 0.561 . . . . 10.0 109.789 178.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.4 mmt180 -62.19 -30.92 71.41 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 120.316 -0.554 . . . . 10.0 112.195 -176.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.4 mt -79.07 -50.34 11.21 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 125.238 1.415 . . . . 10.0 110.369 172.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -48.0 -27.3 2.16 Favored 'General case' 0 C--O 1.226 -0.164 0 C-N-CA 124.297 1.039 . . . . 10.0 111.867 178.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -53.06 -47.52 68.39 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 112.337 0.495 . . . . 10.0 112.337 174.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.1 mp -52.83 131.91 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 C-N-CA 124.838 1.255 . . . . 10.0 110.803 -179.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 50.9 mp0 -70.11 -48.05 59.25 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 116.306 -0.406 . . . . 10.0 110.364 -171.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -84.89 39.76 2.97 Favored Glycine 0 CA--C 1.525 0.686 0 O-C-N 121.064 -1.022 . . . . 10.0 111.937 -175.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.6 p -99.92 149.57 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 C-N-CA 124.411 1.084 . . . . 10.0 108.313 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -119.11 -53.69 2.25 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 122.969 0.507 . . . . 10.0 109.819 171.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.1 m-80 -142.6 154.75 44.69 Favored 'General case' 0 C--N 1.339 0.125 0 CA-C-N 118.298 0.499 . . . . 10.0 109.7 -177.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -146.92 62.8 7.77 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 124.101 0.961 . . . . 10.0 111.968 174.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -77.22 73.42 5.5 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.652 2.235 . . . . 10.0 110.048 -178.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.0 m -68.68 155.77 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 O-C-N 121.507 -0.745 . . . . 10.0 111.858 -177.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -99.03 131.51 45.02 Favored 'General case' 0 N--CA 1.458 -0.07 0 N-CA-C 110.204 -0.295 . . . . 10.0 110.204 -176.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -115.38 60.86 0.7 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.919 1.288 . . . . 10.0 110.424 -173.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 168.83 -32.63 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 127.118 2.167 . . . . 10.0 108.708 171.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.0 mt -86.89 -2.74 58.83 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.071 1.349 . . . . 10.0 112.103 -176.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 61.22 43.7 10.66 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 125.303 1.441 . . . . 10.0 111.107 166.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -142.5 129.79 21.05 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.297 1.439 . . . . 10.0 107.983 -176.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.4 t -101.49 132.37 47.47 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 N-CA-C 106.509 -1.663 . . . . 10.0 106.509 172.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 29.2 m -121.63 121.68 37.93 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 125.587 1.555 . . . . 10.0 106.817 -174.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.2 t -125.03 147.63 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 C-N-CA 123.271 0.628 . . . . 10.0 110.27 -176.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -125.24 95.69 4.57 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 127.723 2.409 . . . . 10.0 104.693 174.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -147.95 163.54 36.53 Favored 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 123.448 0.699 . . . . 10.0 109.568 -174.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 18.8 p30 -95.12 131.61 29.72 Favored Pre-proline 0 C--N 1.329 -0.317 0 C-N-CA 122.67 0.388 . . . . 10.0 110.551 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -78.2 60.82 7.57 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 121.537 1.491 . . . . 10.0 108.414 168.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.35 -45.55 0.46 Allowed 'General case' 0 C--N 1.344 0.343 0 O-C-N 121.859 -0.526 . . . . 10.0 110.554 176.232 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -87.66 -36.81 17.23 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 122.896 0.479 . . . . 10.0 110.442 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -137.2 174.88 10.14 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 125.914 1.686 . . . . 10.0 108.275 -179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 59.5 p -131.66 176.14 8.58 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.503 1.121 . . . . 10.0 110.186 174.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 29.7 m -48.99 -39.18 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-N 115.184 -0.916 . . . . 10.0 111.749 168.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 17.6 m -58.48 -40.6 83.19 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.707 0.803 . . . . 10.0 111.648 -178.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -71.32 -52.19 20.16 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.049 0.939 . . . . 10.0 109.686 -175.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.3 pp -64.64 -41.87 95.83 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 120.532 -1.355 . . . . 10.0 110.568 179.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.81 -49.58 15.01 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-O 117.821 -1.085 . . . . 10.0 113.046 163.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -52.99 -46.56 68.36 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 120.712 1.597 . . . . 10.0 109.164 176.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -54.14 -50.04 67.85 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 114.789 -1.096 . . . . 10.0 110.874 -177.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 95.8 t -65.28 -44.73 94.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 112.309 0.485 . . . . 10.0 112.309 173.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -58.79 -47.29 85.26 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 121.107 -0.995 . . . . 10.0 109.952 -175.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.4 tmtm? -56.54 -35.6 68.3 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.899 1.28 . . . . 10.0 111.227 175.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.71 -38.8 67.52 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.612 0.765 . . . . 10.0 110.702 173.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 135.21 -33.05 2.49 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 124.076 0.846 . . . . 10.0 111.767 175.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -94.12 157.84 15.89 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.954 0.902 . . . . 10.0 109.628 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.1 mtmp? -98.14 154.29 17.85 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.677 0.751 . . . . 10.0 110.989 -175.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.8 tp -129.22 148.62 51.17 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.555 1.942 . . . . 10.0 107.219 -177.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.2 tptm -151.67 148.67 28.21 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 119.27 -0.395 . . . . 10.0 111.089 159.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 11.8 tp -63.73 155.15 30.98 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 121.775 0.797 . . . . 10.0 109.702 178.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.5 tttt -119.45 -56.47 2.06 Favored 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 129.282 3.033 . . . . 10.0 107.655 177.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 172.37 -100.07 0.15 Allowed Glycine 0 N--CA 1.442 -0.935 0 N-CA-C 107.152 -2.379 . . . . 10.0 107.152 -176.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 . . . . . 0 N--CA 1.452 -0.327 0 C-N-CA 124.967 1.307 . . . . 10.0 107.94 -165.714 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 19.3 p . . . . . 0 CA--C 1.535 0.382 0 N-CA-C 109.146 -0.687 . . . . 10.0 109.146 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -127.09 135.67 51.08 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 127.524 2.33 . . . . 10.0 108.29 -175.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 58.6 mmtt -83.56 114.56 21.6 Favored 'General case' 0 N--CA 1.448 -0.559 0 O-C-N 124.06 0.85 . . . . 10.0 109.07 171.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -114.98 145.23 42.46 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.807 1.243 . . . . 10.0 109.545 169.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -119.46 150.78 39.65 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.046 0.939 . . . . 10.0 110.639 173.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -140.14 136.68 33.77 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.899 1.28 . . . . 10.0 109.377 -171.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -97.44 134.98 39.97 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 106.981 -1.489 . . . . 10.0 106.981 -177.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.2 mm -108.35 142.01 22.1 Favored 'Isoleucine or valine' 0 C--N 1.342 0.259 0 C-N-CA 124.297 1.039 . . . . 10.0 111.192 -165.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 . . . . . 0 CA--C 1.531 0.25 0 C-N-CA 124.032 0.933 . . . . 10.0 109.375 171.596 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 . . . . . 0 CA--C 1.541 0.63 0 N-CA-C 112.511 0.56 . . . . 10.0 112.511 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.82 -40.7 83.78 Favored 'General case' 0 N--CA 1.45 -0.439 0 O-C-N 120.611 -1.306 . . . . 10.0 109.953 176.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 8.1 mm -41.17 -57.94 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.39 0 N-CA-C 108.993 -0.743 . . . . 10.0 108.993 170.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -49.44 -45.58 46.74 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.075 0.95 . . . . 10.0 111.931 -172.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.6 mmpt? -71.92 -45.26 61.79 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 123.208 0.603 . . . . 10.0 110.272 179.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -62.94 -32.44 73.74 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 120.498 -0.481 . . . . 10.0 111.533 -178.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.4 -39.59 28.07 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.016 1.727 . . . . 10.0 111.668 175.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -49.28 -33.56 13.29 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 119.077 0.853 . . . . 10.0 110.468 171.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -53.83 -37.58 63.74 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 113.178 0.807 . . . . 10.0 113.178 176.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 22.4 mm -60.87 129.46 23.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 123.458 0.703 . . . . 10.0 109.135 178.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -79.64 -37.32 36.29 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 118.623 0.647 . . . . 10.0 111.441 -175.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -77.39 30.24 1.67 Allowed Glycine 0 C--N 1.339 0.718 0 O-C-N 120.391 -1.443 . . . . 10.0 112.619 178.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -102.9 147.22 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 C-N-CA 124.576 1.15 . . . . 10.0 107.96 -176.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -118.19 -47.66 2.56 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 122.661 0.384 . . . . 10.0 110.348 175.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -146.48 144.2 29.49 Favored 'General case' 0 C--O 1.226 -0.181 0 N-CA-C 108.308 -0.997 . . . . 10.0 108.308 -173.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -136.23 60.78 35.49 Favored Pre-proline 0 CA--C 1.539 0.522 0 C-N-CA 123.584 0.753 . . . . 10.0 111.978 176.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -76.34 74.69 4.57 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.948 2.432 . . . . 10.0 110.213 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.3 m -69.11 155.49 7.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 123.36 0.664 . . . . 10.0 112.05 -179.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -94.92 92.07 6.72 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.035 0.445 . . . . 10.0 110.469 -174.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -71.77 43.3 0.09 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 127.364 2.266 . . . . 10.0 114.141 -175.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -176.86 -36.32 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 126.388 1.875 . . . . 10.0 110.577 177.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.6 mt -90.25 3.54 53.26 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 124.519 1.128 . . . . 10.0 112.684 -171.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 64.61 38.31 7.26 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.5 1.12 . . . . 10.0 110.371 165.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -142.22 130.21 21.9 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.278 1.431 . . . . 10.0 107.829 -176.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.4 t -100.46 139.03 22.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 107.578 -1.268 . . . . 10.0 107.578 173.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 27.1 m -127.76 119.4 25.67 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 106.803 -1.554 . . . . 10.0 106.803 -177.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 40.1 t -123.3 138.98 51.39 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 N-CA-C 109.201 -0.666 . . . . 10.0 109.201 -178.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -100.6 109.08 21.13 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 106.485 -1.672 . . . . 10.0 106.485 162.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 14.4 p90 -138.71 165.27 27.41 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 109.465 -0.568 . . . . 10.0 109.465 176.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 15.2 p30 -108.58 128.77 24.97 Favored Pre-proline 0 C--N 1.331 -0.237 0 C-N-CA 123.587 0.755 . . . . 10.0 109.301 177.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -75.59 64.16 6.53 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.449 2.1 . . . . 10.0 109.129 174.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.8 pttt -130.48 -47.54 1.07 Allowed 'General case' 0 CA--C 1.527 0.076 0 N-CA-C 108.967 -0.753 . . . . 10.0 108.967 177.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -89.13 -62.15 1.55 Allowed 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.43 -0.952 . . . . 10.0 108.43 178.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -119.67 163.93 16.66 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 125.9 1.68 . . . . 10.0 109.332 -173.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 34.7 p -118.38 -179.1 3.68 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 122.855 1.312 . . . . 10.0 110.482 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.9 m -44.9 -40.99 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 113.697 -1.592 . . . . 10.0 111.966 163.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.0 t -69.86 -40.16 75.93 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 118.889 -0.577 . . . . 10.0 110.743 -172.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -62.66 -50.68 70.25 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.619 0.723 . . . . 10.0 109.331 -172.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.2 pp -64.33 -46.73 82.21 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.895 -0.503 . . . . 10.0 110.846 178.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.04 -45.88 16.33 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.099 -1.0 . . . . 10.0 113.46 166.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 15.5 tm-20 -62.66 -47.97 81.38 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 119.647 1.112 . . . . 10.0 109.408 177.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -52.73 -47.5 67.33 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 121.372 0.606 . . . . 10.0 109.725 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 80.5 t -66.01 -44.22 92.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 N-CA-C 112.746 0.647 . . . . 10.0 112.746 175.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -54.76 -39.72 68.64 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 120.942 -1.098 . . . . 10.0 110.071 175.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 40.2 tptt -70.73 -37.81 73.53 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 125.431 1.492 . . . . 10.0 110.832 -178.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 12.2 mt -51.36 -26.15 7.23 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 118.792 -0.623 . . . . 10.0 112.49 163.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 129.62 -25.41 4.48 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 124.127 0.87 . . . . 10.0 112.684 165.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 16.8 p90 -115.63 154.58 29.2 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 125.628 1.571 . . . . 10.0 108.437 -172.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.6 156.0 18.45 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.946 0.879 . . . . 10.0 111.545 -167.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 9.9 tp -132.45 146.81 52.22 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 127.033 2.133 . . . . 10.0 106.954 -178.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 9.5 mmtp -146.44 139.45 25.55 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 123.011 0.524 . . . . 10.0 110.616 163.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.8 tt -65.65 157.03 31.07 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 124.32 1.012 . . . . 10.0 109.383 173.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 55.1 tttt -127.44 -65.91 0.91 Allowed 'General case' 0 N--CA 1.437 -1.082 0 C-N-CA 127.445 2.298 . . . . 10.0 108.918 -172.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.35 -86.24 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 107.943 -2.063 . . . . 10.0 107.943 175.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 . . . . . 0 N--CA 1.453 -0.297 0 C-N-CA 124.469 1.108 . . . . 10.0 108.156 -168.13 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 7.2 p . . . . . 0 CA--C 1.53 0.201 0 N-CA-C 108.403 -0.962 . . . . 10.0 108.403 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -117.09 140.9 48.94 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 126.909 2.084 . . . . 10.0 109.089 -174.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 8.3 tptm -97.26 108.69 21.46 Favored 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 124.332 1.053 . . . . 10.0 109.089 -177.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -117.65 151.26 37.58 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 124.903 1.281 . . . . 10.0 109.88 -177.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -126.38 150.45 48.58 Favored 'General case' 0 CA--C 1.515 -0.377 0 C-N-CA 123.468 0.707 . . . . 10.0 111.264 177.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -136.39 140.72 43.42 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.661 1.584 . . . . 10.0 108.553 -169.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -110.32 133.25 53.43 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 108.177 -1.045 . . . . 10.0 108.177 -172.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.8 mm -111.81 136.35 48.22 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.085 0 C-N-CA 124.154 0.982 . . . . 10.0 111.706 -155.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 . . . . . 0 N--CA 1.448 -0.528 0 N-CA-C 108.907 -0.775 . . . . 10.0 108.907 170.363 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 . . . . . 0 N--CA 1.468 0.441 0 N-CA-C 112.394 0.516 . . . . 10.0 112.394 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 23.0 ttm180 -75.67 -39.56 57.36 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 121.188 -0.945 . . . . 10.0 109.018 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 11.0 mm -45.97 -53.02 2.57 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.286 0 CA-C-O 118.523 -0.751 . . . . 10.0 110.037 170.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -44.94 -50.13 10.71 Favored 'General case' 0 C--O 1.224 -0.251 0 C-N-CA 122.918 0.487 . . . . 10.0 111.196 -178.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.5 mptt -68.51 -46.8 68.66 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.419 0.688 . . . . 10.0 110.159 -179.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.45 -36.14 75.39 Favored 'General case' 0 N--CA 1.451 -0.376 0 O-C-N 121.975 -0.453 . . . . 10.0 110.803 -178.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.38 -34.72 36.16 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.902 1.281 . . . . 10.0 111.221 175.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -60.86 -24.1 65.66 Favored 'General case' 0 C--N 1.332 -0.154 0 O-C-N 121.514 -0.741 . . . . 10.0 110.114 174.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -52.0 -40.64 61.29 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 117.893 0.315 . . . . 10.0 111.321 170.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 25.1 mm -57.77 128.67 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 123.585 0.754 . . . . 10.0 109.939 -173.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -69.08 -48.25 63.13 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 120.697 -0.401 . . . . 10.0 110.43 -177.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -80.67 37.85 2.3 Favored Glycine 0 CA--C 1.523 0.579 0 O-C-N 121.186 -0.946 . . . . 10.0 112.759 -174.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.4 p -103.86 147.4 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 C-N-CA 124.289 1.035 . . . . 10.0 108.657 -175.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -104.63 -50.27 3.34 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 107.998 -1.112 . . . . 10.0 107.998 171.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -164.06 160.64 21.87 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.263 -0.643 . . . . 10.0 109.263 -178.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -142.13 65.49 18.85 Favored Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 124.589 1.156 . . . . 10.0 111.358 178.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -75.36 75.54 3.82 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.184 2.589 . . . . 10.0 109.751 178.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.5 m -66.8 156.36 6.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 123.637 0.775 . . . . 10.0 111.808 -178.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -96.07 115.24 27.13 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 121.112 0.482 . . . . 10.0 111.3 -176.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 11.0 p90 -95.0 43.25 1.09 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.351 1.46 . . . . 10.0 112.447 -171.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -172.55 -39.76 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 124.841 1.257 . . . . 10.0 109.562 176.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 12.3 mt -79.04 -12.17 60.02 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.18 0.992 . . . . 10.0 112.019 -175.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 60.34 51.06 5.62 Favored 'General case' 0 C--N 1.334 -0.069 0 C-N-CA 124.915 1.286 . . . . 10.0 109.692 176.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -140.77 133.29 28.55 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 106.514 -1.661 . . . . 10.0 106.514 175.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.0 t -101.85 142.35 16.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 106.533 -1.655 . . . . 10.0 106.533 172.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 29.6 m -130.34 124.02 31.3 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 106.433 -1.692 . . . . 10.0 106.433 -177.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 29.0 t -128.62 137.52 57.09 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 N-CA-C 109.127 -0.694 . . . . 10.0 109.127 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -105.61 105.58 15.69 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 105.668 -1.975 . . . . 10.0 105.668 167.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -145.78 159.91 42.5 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 123.645 0.778 . . . . 10.0 110.541 -176.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -95.98 134.74 23.44 Favored Pre-proline 0 C--N 1.33 -0.263 0 C-N-CA 123.869 0.868 . . . . 10.0 110.813 178.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -80.44 56.27 6.01 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.259 1.973 . . . . 10.0 109.626 170.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.54 -49.95 1.76 Allowed 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 108.411 -0.959 . . . . 10.0 108.411 175.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -87.75 -42.52 12.55 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.525 0.73 . . . . 10.0 110.394 -175.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -137.81 -176.19 4.34 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.848 1.259 . . . . 10.0 109.327 -171.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 78.2 p -151.73 171.86 17.02 Favored 'General case' 0 N--CA 1.455 -0.193 0 O-C-N 122.043 -0.411 . . . . 10.0 110.38 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 88.3 t -42.93 -48.37 1.21 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.166 0 C-N-CA 124.511 1.124 . . . . 10.0 110.582 169.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.9 m -51.01 -42.88 60.68 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.583 1.153 . . . . 10.0 112.73 178.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -70.42 -56.9 5.52 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 124.114 0.965 . . . . 10.0 109.314 -176.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.1 pp -63.83 -40.49 96.73 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 120.786 -1.197 . . . . 10.0 110.816 -177.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -43.84 -52.7 6.56 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-O 118.049 -0.977 . . . . 10.0 112.386 161.106 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.8 -45.38 70.74 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 120.127 1.331 . . . . 10.0 110.573 178.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -53.63 -53.39 52.52 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.134 0.492 . . . . 10.0 110.414 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 59.3 t -64.77 -41.19 91.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-N 116.115 -0.493 . . . . 10.0 112.003 178.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -58.59 -45.99 87.9 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 108.825 -0.806 . . . . 10.0 108.825 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -70.23 -36.22 74.38 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.528 1.131 . . . . 10.0 111.03 -177.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 12.9 mt -52.24 -28.82 20.09 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 112.803 0.668 . . . . 10.0 112.803 165.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 108.22 31.29 3.59 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-N 118.502 0.592 . . . . 10.0 112.741 169.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -152.33 160.33 43.33 Favored 'General case' 0 C--O 1.227 -0.104 0 N-CA-C 106.987 -1.486 . . . . 10.0 106.987 169.009 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -98.99 152.61 19.62 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.581 0.705 . . . . 10.0 110.84 -163.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.5 tp -134.07 146.74 50.59 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 125.7 1.6 . . . . 10.0 108.316 -176.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 12.1 tptp -152.21 154.01 34.95 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 109.445 -0.576 . . . . 10.0 109.445 164.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.3 tp -65.78 155.84 34.97 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 121.401 0.619 . . . . 10.0 109.809 176.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 54.6 tttt -118.16 -55.71 2.22 Favored 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 128.633 2.773 . . . . 10.0 107.242 175.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 173.93 -91.22 0.09 OUTLIER Glycine 0 N--CA 1.444 -0.822 0 N-CA-C 108.175 -1.97 . . . . 10.0 108.175 178.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 . . . . . 0 N--CA 1.45 -0.425 0 C-N-CA 124.506 1.122 . . . . 10.0 108.472 -162.835 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.6 p . . . . . 0 CA--C 1.534 0.331 0 N-CA-C 108.851 -0.796 . . . . 10.0 108.851 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -137.71 140.41 40.72 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 126.465 1.906 . . . . 10.0 107.795 -168.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 18.4 mmtp -82.46 128.34 34.17 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.192 0.597 . . . . 10.0 109.419 178.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -128.99 136.8 50.81 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 125.698 1.599 . . . . 10.0 109.119 176.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -117.28 147.0 42.95 Favored 'General case' 0 CA--C 1.51 -0.587 0 C-N-CA 124.0 0.92 . . . . 10.0 110.198 177.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -141.19 137.26 32.53 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 124.623 1.202 . . . . 10.0 111.241 -172.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -93.65 133.17 37.27 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.737 1.615 . . . . 10.0 108.741 -176.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 7.0 mm -103.56 114.15 42.38 Favored 'Isoleucine or valine' 0 C--N 1.34 0.185 0 C-N-CA 124.038 0.935 . . . . 10.0 110.621 -171.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 . . . . . 0 C--O 1.236 0.361 0 N-CA-C 107.833 -1.173 . . . . 10.0 107.833 170.94 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 . . . . . 0 N--CA 1.468 0.465 0 N-CA-C 112.311 0.486 . . . . 10.0 112.311 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -64.39 -45.25 88.49 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 120.759 -1.213 . . . . 10.0 108.209 179.032 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 9.8 mm -44.68 -47.55 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 C-N-CA 124.328 1.051 . . . . 10.0 111.625 177.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -48.21 -50.63 28.59 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 122.824 0.45 . . . . 10.0 110.868 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -72.77 -46.26 54.29 Favored 'General case' 0 N--CA 1.445 -0.713 0 O-C-N 121.757 -0.589 . . . . 10.0 110.933 -179.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.1 mmp_? -48.92 -42.66 37.87 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.122 0.416 . . . . 10.0 112.122 175.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.405 HD22 ' CD1' ' A' ' 28' ' ' ILE . 0.5 OUTLIER -79.4 -42.35 25.69 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.472 0.709 . . . . 10.0 111.05 178.741 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -55.0 -18.53 5.2 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.406 1.003 . . . . 10.0 112.22 172.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -59.69 -29.07 67.83 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 114.223 1.194 . . . . 10.0 114.223 171.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.405 ' CD1' HD22 ' A' ' 25' ' ' LEU . 11.1 mt -60.58 138.46 21.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 108.227 -1.027 . . . . 10.0 108.227 173.227 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.38 -49.58 32.84 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 109.554 -0.535 . . . . 10.0 109.554 179.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -80.29 42.25 2.55 Favored Glycine 0 CA--C 1.526 0.737 0 O-C-N 120.778 -1.201 . . . . 10.0 112.311 -175.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.6 p -102.05 153.2 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 C-N-CA 125.159 1.383 . . . . 10.0 109.677 -174.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -111.54 -54.62 2.59 Favored 'General case' 0 C--N 1.334 -0.089 0 C-N-CA 123.877 0.871 . . . . 10.0 109.069 171.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 23.1 p30 -162.44 151.71 15.54 Favored 'General case' 0 C--O 1.227 -0.129 0 N-CA-C 108.732 -0.84 . . . . 10.0 108.732 -173.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -133.94 55.94 17.52 Favored Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 124.42 1.088 . . . . 10.0 112.34 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -75.05 79.2 2.73 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 122.884 2.39 . . . . 10.0 110.558 -177.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.4 m -67.47 151.16 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 O-C-N 121.622 -0.674 . . . . 10.0 111.801 -178.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -95.39 88.66 5.18 Favored 'General case' 0 C--O 1.234 0.256 0 O-C-N 122.179 -0.326 . . . . 10.0 110.23 -175.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -72.48 53.52 0.31 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 127.171 2.189 . . . . 10.0 112.727 -178.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -174.65 -40.72 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 126.281 1.832 . . . . 10.0 109.734 174.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 12.4 mt -86.62 -12.39 48.66 Favored 'General case' 0 C--N 1.338 0.093 0 C-N-CA 124.084 0.954 . . . . 10.0 111.797 -171.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 75.4 37.35 0.45 Allowed 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.884 1.274 . . . . 10.0 110.333 170.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 33.3 p -138.35 129.81 27.62 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.242 1.417 . . . . 10.0 108.127 178.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 21.8 t -90.33 131.39 37.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 107.515 -1.291 . . . . 10.0 107.515 167.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 85.6 m -110.54 117.93 34.87 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 106.303 -1.74 . . . . 10.0 106.303 171.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 82.6 t -122.46 141.28 43.48 Favored 'Isoleucine or valine' 0 C--N 1.342 0.248 0 CA-C-N 120.177 1.353 . . . . 10.0 109.79 168.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -100.32 117.02 33.66 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 107.552 -1.277 . . . . 10.0 107.552 164.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -147.87 167.91 23.57 Favored 'General case' 0 C--O 1.226 -0.163 0 N-CA-C 108.861 -0.792 . . . . 10.0 108.861 177.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 24.7 p30 -100.54 135.96 20.05 Favored Pre-proline 0 C--N 1.329 -0.284 0 C-N-CA 123.273 0.629 . . . . 10.0 109.758 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -80.36 54.0 5.02 Favored 'Trans proline' 0 N--CA 1.448 -1.167 0 N-CA-C 108.883 -1.237 . . . . 10.0 108.883 171.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.16 10.19 3.27 Favored 'General case' 0 C--N 1.346 0.443 0 CA-C-N 118.623 0.647 . . . . 10.0 111.834 176.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -142.02 -65.15 0.42 Allowed 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.788 -1.189 . . . . 10.0 107.788 -173.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -114.52 175.51 5.45 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 124.071 0.948 . . . . 10.0 109.359 178.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 92.0 p -127.72 167.57 16.29 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.028 0.931 . . . . 10.0 110.065 177.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 74.2 t -49.06 -52.8 9.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 115.791 -0.641 . . . . 10.0 109.796 167.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.0 m -52.36 -37.13 55.43 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 125.185 1.394 . . . . 10.0 112.579 178.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -71.25 -60.4 2.25 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 109.603 -0.517 . . . . 10.0 109.603 174.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.4 pp -58.81 -46.81 86.76 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 118.348 0.522 . . . . 10.0 111.368 -168.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.18 -35.63 12.11 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 114.549 1.315 . . . . 10.0 114.549 171.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.1 tm-20 -52.54 -35.49 53.61 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 120.466 1.485 . . . . 10.0 110.924 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.63 -52.51 60.53 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 120.057 -0.657 . . . . 10.0 109.922 -178.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 72.7 t -55.24 -47.96 77.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 122.905 0.482 . . . . 10.0 110.884 172.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.88 -55.91 19.76 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 124.906 1.282 . . . . 10.0 109.195 -177.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.8 tptm -57.06 -38.97 74.01 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 126.137 1.775 . . . . 10.0 111.322 177.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.4 mp -60.52 -19.74 58.02 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 113.075 0.768 . . . . 10.0 113.075 172.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 104.74 16.34 17.7 Favored Glycine 0 CA--C 1.528 0.863 0 CA-C-N 118.849 0.749 . . . . 10.0 113.263 168.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -136.0 160.94 37.07 Favored 'General case' 0 C--O 1.227 -0.121 0 N-CA-C 106.776 -1.564 . . . . 10.0 106.776 169.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 10.5 ttmm -105.98 141.16 37.84 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 119.265 0.939 . . . . 10.0 111.405 -168.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 22.9 tp -117.93 145.04 44.95 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 126.117 1.767 . . . . 10.0 107.974 177.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 26.0 mmtt -152.99 153.44 32.93 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 125.721 1.608 . . . . 10.0 108.058 170.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.3 tp -68.34 152.41 45.47 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.398 0.618 . . . . 10.0 109.397 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.94 -57.44 2.04 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 127.51 2.324 . . . . 10.0 105.586 164.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 170.82 -92.56 0.1 OUTLIER Glycine 0 N--CA 1.442 -0.947 0 N-CA-C 105.833 -2.907 . . . . 10.0 105.833 177.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 . . . . . 0 N--CA 1.453 -0.293 0 C-N-CA 122.993 0.517 . . . . 10.0 109.829 -160.756 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 14.9 p . . . . . 0 CA--C 1.536 0.418 0 N-CA-C 108.02 -1.104 . . . . 10.0 108.02 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -140.65 142.25 34.98 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 127.427 2.291 . . . . 10.0 107.917 -167.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -104.91 110.09 22.32 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.54 0.736 . . . . 10.0 109.954 -168.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -108.9 146.14 34.24 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 124.976 1.31 . . . . 10.0 109.833 -175.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -122.63 147.25 46.65 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 123.749 0.82 . . . . 10.0 109.246 173.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -137.0 140.85 42.44 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 125.222 1.576 . . . . 10.0 109.237 -173.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -105.46 133.9 49.45 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.358 1.063 . . . . 10.0 108.261 -175.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.9 mm -109.33 132.33 57.75 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 C-N-CA 123.667 0.787 . . . . 10.0 111.18 -157.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 . . . . . 0 N--CA 1.449 -0.506 0 C-N-CA 123.22 0.608 . . . . 10.0 109.36 172.569 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 . . . . . 0 N--CA 1.468 0.445 0 N-CA-C 112.213 0.449 . . . . 10.0 112.213 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -74.61 -54.14 8.02 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 121.294 -0.879 . . . . 10.0 108.9 173.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.6 mt -48.22 -47.47 13.59 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.445 0 CA-C-O 117.964 -1.017 . . . . 10.0 111.277 -176.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -34.86 -61.88 0.39 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.517 0.727 . . . . 10.0 111.747 174.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.98 -42.25 69.93 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.492 1.117 . . . . 10.0 110.679 -177.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.96 -28.79 62.62 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.651 0.611 . . . . 10.0 112.651 175.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.5 mt -85.3 -42.97 14.13 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 126.188 1.795 . . . . 10.0 109.787 174.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -55.51 -23.95 29.0 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.898 0.879 . . . . 10.0 110.279 177.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -52.85 -41.6 64.41 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 113.794 1.035 . . . . 10.0 113.794 171.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.2 mp -54.58 133.38 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 109.563 -0.532 . . . . 10.0 109.563 176.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -77.98 -42.73 31.79 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 119.505 -0.284 . . . . 10.0 110.483 -178.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -80.63 39.6 2.37 Favored Glycine 0 CA--C 1.527 0.816 0 O-C-N 120.549 -1.344 . . . . 10.0 111.94 178.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.4 p -101.57 149.78 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 C-N-CA 124.973 1.309 . . . . 10.0 108.575 -178.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -109.5 -61.51 1.63 Allowed 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 107.934 -1.136 . . . . 10.0 107.934 170.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 57.8 m-80 -140.54 154.66 46.62 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 107.952 -1.129 . . . . 10.0 107.952 -174.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.47 58.01 2.58 Favored Pre-proline 0 CA--C 1.535 0.371 0 O-C-N 121.965 -0.459 . . . . 10.0 112.113 170.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -75.11 78.23 2.98 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 122.715 2.277 . . . . 10.0 108.756 177.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.4 m -59.12 152.45 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 109.851 -0.426 . . . . 10.0 109.851 174.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 74.3 m-80 -81.07 151.32 28.41 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 118.756 -1.178 . . . . 10.0 109.962 -176.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -123.23 42.91 3.09 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.412 1.485 . . . . 10.0 109.747 -175.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -175.13 -40.22 0.01 OUTLIER 'General case' 0 C--O 1.226 -0.163 0 C-N-CA 125.385 1.474 . . . . 10.0 109.736 170.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.2 mt -75.2 -17.04 60.44 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.884 0.874 . . . . 10.0 112.442 -167.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 65.3 48.69 2.08 Favored 'General case' 0 N--CA 1.46 0.072 0 C-N-CA 125.281 1.432 . . . . 10.0 110.32 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 8.0 p -142.85 133.24 24.81 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.324 1.45 . . . . 10.0 107.969 176.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.0 t -97.63 134.21 36.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 106.869 -1.53 . . . . 10.0 106.869 172.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 85.9 m -121.26 126.22 49.02 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 106.552 -1.647 . . . . 10.0 106.552 178.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.4 t -122.89 149.29 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 C-N-CA 124.323 1.049 . . . . 10.0 108.648 177.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -123.59 107.81 11.93 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 106.054 -1.832 . . . . 10.0 106.054 164.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -145.04 170.67 15.74 Favored 'General case' 0 C--O 1.225 -0.223 0 C-N-CA 124.142 0.977 . . . . 10.0 108.834 -177.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 14.6 p30 -111.85 134.77 21.27 Favored Pre-proline 0 CA--C 1.53 0.196 0 C-N-CA 122.806 0.443 . . . . 10.0 110.397 177.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -77.37 62.47 7.64 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 122.504 2.136 . . . . 10.0 109.867 174.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.1 pttt -123.73 -45.85 2.02 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 123.147 0.579 . . . . 10.0 109.951 172.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -91.49 -60.95 1.75 Allowed 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.385 1.074 . . . . 10.0 108.72 -176.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -119.08 174.34 6.37 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 125.671 1.588 . . . . 10.0 109.321 -175.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 53.3 p -131.66 -177.3 4.36 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.875 1.27 . . . . 10.0 110.167 176.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 35.3 m -48.64 -38.72 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-N 115.03 -0.986 . . . . 10.0 111.946 164.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 68.9 m -62.32 -43.31 99.13 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 122.761 0.424 . . . . 10.0 111.142 -174.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -65.28 -52.97 50.79 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.284 1.034 . . . . 10.0 109.136 -174.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.1 pp -66.97 -43.91 81.82 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 121.983 -0.448 . . . . 10.0 111.274 -178.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -41.66 -51.04 4.14 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-O 118.125 -0.94 . . . . 10.0 112.053 160.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -57.1 -43.92 82.72 Favored 'General case' 0 C--O 1.226 -0.157 0 CA-C-N 119.742 1.155 . . . . 10.0 110.386 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -52.88 -51.82 59.75 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.077 0.465 . . . . 10.0 110.392 176.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 53.9 t -61.85 -46.23 96.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 N-CA-C 112.39 0.515 . . . . 10.0 112.39 176.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -51.45 -51.11 57.74 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.856 1.263 . . . . 10.0 108.428 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.25 -44.26 92.38 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.611 1.565 . . . . 10.0 111.191 177.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -48.35 -39.45 22.16 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.79 0.836 . . . . 10.0 111.308 173.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 125.14 14.25 3.38 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-O 119.575 -0.57 . . . . 10.0 113.273 169.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -138.94 162.52 34.67 Favored 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 107.927 -1.138 . . . . 10.0 107.927 177.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 29.0 mmtt -95.98 151.04 19.8 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.776 0.798 . . . . 10.0 111.328 -172.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.5 tp -132.35 146.33 51.9 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 126.487 1.915 . . . . 10.0 107.886 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 16.5 mmtm -151.64 154.67 36.84 Favored 'General case' 0 N--CA 1.44 -0.947 0 C-N-CA 123.993 0.917 . . . . 10.0 109.011 163.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.6 tp -61.32 159.46 12.39 Favored 'General case' 0 N--CA 1.453 -0.301 0 O-C-N 124.321 1.013 . . . . 10.0 109.393 175.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 32.9 tttt -118.82 -66.34 1.08 Allowed 'General case' 0 N--CA 1.435 -1.216 0 C-N-CA 125.464 1.506 . . . . 10.0 108.276 177.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 161.7 43.63 0.02 OUTLIER Glycine 0 CA--C 1.528 0.865 0 CA-C-O 118.852 -0.971 . . . . 10.0 113.668 175.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 . . . . . 0 CA--C 1.535 0.369 0 C-N-CA 124.976 1.311 . . . . 10.0 112.941 167.662 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.0 p . . . . . 0 N--CA 1.453 -0.285 0 N-CA-C 109.293 -0.632 . . . . 10.0 109.293 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -131.66 150.21 52.23 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 127.472 2.309 . . . . 10.0 107.324 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -109.63 123.46 49.5 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.343 -0.984 . . . . 10.0 108.343 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -130.2 153.55 48.45 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.634 0.774 . . . . 10.0 110.676 176.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -118.7 148.56 42.63 Favored 'General case' 0 CA--C 1.507 -0.7 0 C-N-CA 124.62 1.168 . . . . 10.0 109.481 177.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -135.12 141.0 45.9 Favored 'General case' 0 N--CA 1.447 -0.605 0 O-C-N 124.792 1.308 . . . . 10.0 109.063 -174.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -103.45 131.78 50.26 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.525 1.53 . . . . 10.0 108.827 -174.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -115.44 137.13 50.0 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 C-N-CA 126.111 1.764 . . . . 10.0 110.023 -164.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 . . . . . 0 N--CA 1.454 -0.259 0 N-CA-C 108.21 -1.033 . . . . 10.0 108.21 176.038 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 . . . . . 0 CA--C 1.538 0.51 0 N-CA-C 113.945 1.091 . . . . 10.0 113.945 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.79 -45.89 87.65 Favored 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 120.757 -1.214 . . . . 10.0 108.413 177.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.8 mm -47.4 -48.85 9.47 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.231 0 O-C-N 123.94 0.775 . . . . 10.0 109.856 -177.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -44.03 -54.4 5.49 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.043 0.937 . . . . 10.0 111.526 178.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt -70.73 -45.7 64.4 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.954 0.902 . . . . 10.0 109.459 -177.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 51.7 mmt-85 -55.57 -32.24 62.85 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.147 0.425 . . . . 10.0 112.147 177.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.1 mt -84.39 -35.56 23.06 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.178 1.391 . . . . 10.0 112.26 174.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 32.7 t-20 -55.29 -31.78 61.9 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.685 0.675 . . . . 10.0 110.081 176.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -50.64 -28.89 9.72 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 114.996 1.48 . . . . 10.0 114.996 169.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 6.9 mm -61.71 104.93 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-O 121.71 0.766 . . . . 10.0 109.663 171.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -58.24 -26.08 62.48 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.451 0.537 . . . . 10.0 112.451 -179.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -90.79 18.02 52.34 Favored Glycine 0 CA--C 1.528 0.898 0 O-C-N 121.359 -0.838 . . . . 10.0 112.945 178.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.1 p -79.36 153.98 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 CA-C-N 118.595 1.198 . . . . 10.0 109.514 -179.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -112.94 -59.86 1.96 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.539 -0.912 . . . . 10.0 108.539 163.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 -134.63 155.43 50.5 Favored 'General case' 0 C--N 1.341 0.208 0 N-CA-C 109.254 -0.647 . . . . 10.0 109.254 -178.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -140.36 65.39 27.32 Favored Pre-proline 0 CA--C 1.534 0.355 0 C-N-CA 123.454 0.701 . . . . 10.0 109.825 172.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -78.64 68.7 8.03 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 123.044 2.496 . . . . 10.0 109.539 -176.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.1 m -68.85 155.37 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 O-C-N 122.099 -0.375 . . . . 10.0 111.727 -175.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -97.49 139.04 34.0 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 121.002 0.429 . . . . 10.0 111.407 -177.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -118.24 47.66 1.56 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.702 1.601 . . . . 10.0 110.451 -172.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -176.11 -41.61 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 125.449 1.5 . . . . 10.0 109.557 -177.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 16.6 mt -81.7 -19.02 42.4 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.625 1.17 . . . . 10.0 111.648 -170.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 61.16 50.64 4.8 Favored 'General case' 0 C--N 1.339 0.112 0 C-N-CA 125.892 1.677 . . . . 10.0 109.942 -175.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.4 p -140.07 126.99 20.74 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 107.646 -1.242 . . . . 10.0 107.646 174.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.1 t -97.15 130.62 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 106.769 -1.567 . . . . 10.0 106.769 172.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 58.2 m -110.85 128.38 55.76 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.95 1.7 . . . . 10.0 107.139 176.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.7 t -127.36 137.4 57.87 Favored 'Isoleucine or valine' 0 C--N 1.342 0.253 0 CA-C-N 119.161 0.891 . . . . 10.0 110.709 174.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -107.29 104.6 14.24 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.392 1.477 . . . . 10.0 107.088 164.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 14.7 p90 -143.32 167.02 23.13 Favored 'General case' 0 CA--C 1.52 -0.177 0 C-N-CA 123.936 0.895 . . . . 10.0 109.329 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -107.99 134.05 20.26 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-O 119.109 -0.472 . . . . 10.0 110.804 178.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -77.85 62.29 7.83 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.779 2.319 . . . . 10.0 110.613 176.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.0 pttt -124.42 -47.67 1.85 Allowed 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.706 0.802 . . . . 10.0 109.346 169.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -90.33 -51.84 5.23 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.961 0.905 . . . . 10.0 110.007 -169.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -132.17 174.73 9.9 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.631 1.172 . . . . 10.0 108.333 178.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 82.6 p -137.06 177.49 7.82 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 118.569 0.622 . . . . 10.0 110.757 176.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 49.1 t -42.24 -50.75 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 124.632 1.173 . . . . 10.0 110.902 172.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.1 m -51.56 -38.77 55.9 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.094 0.958 . . . . 10.0 112.414 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -70.11 -58.51 3.72 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.632 0.773 . . . . 10.0 109.178 -174.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.4 pp -63.56 -41.09 98.43 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 121.741 -0.6 . . . . 10.0 111.297 -178.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -43.51 -47.6 7.26 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 118.349 -0.834 . . . . 10.0 111.817 163.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.87 -42.21 98.79 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 119.571 1.078 . . . . 10.0 110.39 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -56.19 -48.59 76.09 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 109.65 -0.5 . . . . 10.0 109.65 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 82.8 t -62.56 -47.45 92.89 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 N-CA-C 112.909 0.707 . . . . 10.0 112.909 173.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -56.13 -37.7 69.81 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.044 -1.035 . . . . 10.0 109.025 -178.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.9 tttp -79.57 -31.51 41.89 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 124.343 1.057 . . . . 10.0 112.011 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 15.3 mt -51.69 -45.19 63.41 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.68 1.127 . . . . 10.0 110.783 163.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 147.89 -39.87 0.99 Allowed Glycine 0 CA--C 1.525 0.713 0 CA-C-N 117.964 0.347 . . . . 10.0 112.78 171.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -89.79 159.55 16.97 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 124.032 0.933 . . . . 10.0 108.738 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 19.7 tttt -91.87 161.23 14.92 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-O 121.137 0.494 . . . . 10.0 110.656 -171.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 23.9 tp -136.13 148.1 48.06 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.189 1.396 . . . . 10.0 108.248 177.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 16.9 mmtm -154.18 159.46 41.4 Favored 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 124.19 0.996 . . . . 10.0 108.587 164.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.8 tp -67.07 152.06 46.48 Favored 'General case' 0 N--CA 1.451 -0.423 0 O-C-N 123.735 0.647 . . . . 10.0 109.351 176.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 13.3 tptm -107.48 -55.2 2.38 Favored 'General case' 0 N--CA 1.438 -1.072 0 C-N-CA 127.168 2.187 . . . . 10.0 105.881 169.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 170.97 -95.96 0.11 Allowed Glycine 0 N--CA 1.444 -0.819 0 N-CA-C 106.204 -2.759 . . . . 10.0 106.204 -179.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 . . . . . 0 N--CA 1.454 -0.253 0 C-N-CA 123.284 0.634 . . . . 10.0 110.447 -165.799 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.448 -0.557 0 N-CA-C 106.713 -1.588 . . . . 10.0 106.713 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -143.49 143.02 31.39 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 126.858 2.063 . . . . 10.0 106.752 -170.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 45.1 mmtt -85.33 145.39 27.53 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.143 -0.688 . . . . 10.0 109.143 175.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -147.06 138.14 23.9 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 107.463 -1.31 . . . . 10.0 107.463 174.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -122.03 149.07 44.02 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 123.796 0.838 . . . . 10.0 110.022 174.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -142.95 141.22 31.38 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 124.804 1.315 . . . . 10.0 110.653 -168.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.44 132.18 43.39 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.985 1.714 . . . . 10.0 108.771 -170.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.7 mm -106.21 121.02 58.17 Favored 'Isoleucine or valine' 0 C--N 1.339 0.145 0 C-N-CA 124.842 1.257 . . . . 10.0 110.821 -170.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 . . . . . 0 N--CA 1.449 -0.505 0 N-CA-C 106.267 -1.753 . . . . 10.0 106.267 175.841 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 . . . . . 0 N--CA 1.466 0.36 0 N-CA-C 112.71 0.633 . . . . 10.0 112.71 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.7 ttm105 -68.58 -43.45 76.49 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 108.528 -0.916 . . . . 10.0 108.528 177.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -56.22 -46.31 81.3 Favored 'Isoleucine or valine' 0 C--N 1.342 0.255 0 CA-C-O 118.772 -0.632 . . . . 10.0 110.211 177.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -44.1 -54.91 5.14 Favored 'General case' 0 C--N 1.342 0.247 0 CA-C-O 121.098 0.475 . . . . 10.0 111.075 178.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.6 mttm -69.53 -42.88 74.07 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 124.298 1.039 . . . . 10.0 110.433 -177.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.23 -36.95 61.62 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 111.893 0.331 . . . . 10.0 111.893 173.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.5 -41.6 32.0 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.727 0.811 . . . . 10.0 110.856 175.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -61.28 -22.13 64.57 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 121.511 -0.743 . . . . 10.0 110.65 -177.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.4 mmpt? -53.68 -39.72 65.37 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 114.202 1.186 . . . . 10.0 114.202 168.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.8 mt -62.86 128.99 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 CA-C-N 118.965 0.802 . . . . 10.0 109.087 -175.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -56.48 -51.16 69.49 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 122.913 0.485 . . . . 10.0 111.824 -177.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -87.26 42.31 3.14 Favored Glycine 0 C--N 1.339 0.71 0 O-C-N 120.916 -1.115 . . . . 10.0 111.666 -172.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.8 p -105.7 151.91 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 C-N-CA 124.506 1.122 . . . . 10.0 108.628 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -117.61 -50.78 2.51 Favored 'General case' 0 C--N 1.334 -0.096 0 C-N-CA 122.946 0.499 . . . . 10.0 110.185 173.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -143.74 145.99 32.81 Favored 'General case' 0 N--CA 1.461 0.087 0 N-CA-C 109.082 -0.71 . . . . 10.0 109.082 -176.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -139.11 56.98 9.79 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 123.537 0.735 . . . . 10.0 112.461 177.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -75.3 78.87 2.87 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 123.321 2.681 . . . . 10.0 111.067 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 43.0 t -65.94 143.78 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 C-N-CA 124.786 1.234 . . . . 10.0 112.039 178.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 -91.01 97.83 11.41 Favored 'General case' 0 C--N 1.341 0.215 0 O-C-N 121.874 -0.516 . . . . 10.0 111.718 -167.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -76.45 53.25 0.84 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.785 1.634 . . . . 10.0 112.86 -177.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 179.19 -33.34 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 125.77 1.628 . . . . 10.0 110.51 168.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.2 mt -88.08 1.53 54.06 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.43 1.092 . . . . 10.0 112.155 -172.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 60.75 39.08 17.73 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 125.543 1.537 . . . . 10.0 110.91 169.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.48 133.97 26.51 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.919 1.287 . . . . 10.0 107.979 -175.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 17.1 t -90.88 142.66 12.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 107.1 -1.444 . . . . 10.0 107.1 167.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 91.6 m -133.98 114.96 13.8 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 125.585 1.554 . . . . 10.0 107.749 -177.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 50.4 t -122.0 156.14 26.55 Favored 'Isoleucine or valine' 0 C--N 1.341 0.235 0 C-N-CA 123.785 0.834 . . . . 10.0 110.607 -177.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.22 107.62 11.4 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 127.764 2.426 . . . . 10.0 105.659 170.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -136.63 165.96 24.66 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 123.395 0.678 . . . . 10.0 111.13 -176.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -99.94 126.84 35.36 Favored Pre-proline 0 CA--C 1.532 0.251 0 C-N-CA 123.73 0.812 . . . . 10.0 110.179 173.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -75.46 65.11 6.48 Favored 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 122.561 2.174 . . . . 10.0 108.569 175.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.32 -50.16 0.25 Allowed 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 107.487 -1.301 . . . . 10.0 107.487 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -106.31 -40.31 5.65 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 123.484 0.714 . . . . 10.0 110.715 173.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.24 150.63 26.06 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 121.539 -0.725 . . . . 10.0 109.993 177.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 44.9 p -147.22 149.31 32.67 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.885 0.85 . . . . 10.0 110.741 171.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 48.9 t -48.62 -51.2 11.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 125.544 1.538 . . . . 10.0 111.559 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.9 m -51.75 -43.01 62.76 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 118.943 -0.551 . . . . 10.0 111.742 178.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -67.71 -54.25 20.94 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.124 -0.695 . . . . 10.0 109.124 -173.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.0 pp -61.66 -45.36 94.36 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 120.695 -0.402 . . . . 10.0 110.212 -178.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.55 -51.93 8.49 Favored 'General case' 0 N--CA 1.45 -0.445 0 O-C-N 121.911 -0.493 . . . . 10.0 111.555 168.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.25 -40.26 95.64 Favored 'General case' 0 C--O 1.226 -0.174 0 CA-C-N 118.53 0.604 . . . . 10.0 110.293 -178.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -52.64 -49.21 65.61 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.393 0.677 . . . . 10.0 109.708 177.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 17.9 t -69.38 -43.83 80.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 116.493 -0.321 . . . . 10.0 111.183 177.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -50.45 -55.31 16.45 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.851 0.86 . . . . 10.0 109.566 178.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.5 ttmt -53.73 -42.45 68.11 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 126.151 1.78 . . . . 10.0 111.035 175.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.9 tp -53.0 -27.12 17.76 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 113.601 0.963 . . . . 10.0 113.601 174.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 140.21 -30.24 2.35 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-N 118.567 0.622 . . . . 10.0 112.671 169.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -127.8 157.97 38.97 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 124.695 1.198 . . . . 10.0 109.03 -173.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.4 ptpt -92.06 155.55 18.0 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 123.101 0.56 . . . . 10.0 111.574 -166.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 11.7 tp -134.37 146.06 49.55 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 126.393 1.877 . . . . 10.0 107.32 -176.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.3 tptp -147.31 137.18 23.02 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 119.232 -0.413 . . . . 10.0 110.602 168.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.5 tt -64.83 154.06 38.24 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.05 -0.722 . . . . 10.0 109.05 178.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 18.8 tttm -119.0 -63.7 1.37 Allowed 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 126.165 1.786 . . . . 10.0 108.371 -178.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.06 -78.75 0.03 OUTLIER Glycine 0 CA--C 1.521 0.452 0 N-CA-C 109.274 -1.53 . . . . 10.0 109.274 173.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 . . . . . 0 N--CA 1.455 -0.218 0 N-CA-C 108.443 -0.947 . . . . 10.0 108.443 -167.32 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.0 p . . . . . 0 N--CA 1.454 -0.26 0 CA-C-O 120.984 0.421 . . . . 10.0 110.216 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -116.69 162.83 17.05 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 126.863 2.065 . . . . 10.0 108.112 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.81 125.64 52.95 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.061 -1.459 . . . . 10.0 107.061 178.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -131.47 145.95 52.01 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.956 1.303 . . . . 10.0 108.474 -178.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -126.19 150.36 48.37 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 118.615 0.643 . . . . 10.0 111.578 177.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -139.74 139.05 36.42 Favored 'General case' 0 C--O 1.234 0.269 0 O-C-N 125.006 1.441 . . . . 10.0 110.079 -166.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.425 ' CG ' ' HZ3' ' A' ' 71' ' ' LYS . 5.3 m-20 -102.79 132.51 48.92 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.491 -0.929 . . . . 10.0 108.491 -171.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 8.7 mm -101.09 122.9 53.73 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 124.143 0.977 . . . . 10.0 109.839 -165.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 . . . . . 0 N--CA 1.451 -0.395 0 N-CA-C 106.861 -1.533 . . . . 10.0 106.861 177.439 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.453 -0.292 0 CA-C-O 120.373 0.13 . . . . 10.0 110.953 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.73 -40.07 75.05 Favored 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 121.645 -0.66 . . . . 10.0 109.752 177.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 9.0 mm -46.15 -50.38 4.61 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.249 0 CA-C-O 117.224 -1.37 . . . . 10.0 112.452 170.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -47.78 -53.41 15.44 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 120.34 1.427 . . . . 10.0 110.838 -176.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.2 tppt? -70.22 -43.59 70.33 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 123.612 0.765 . . . . 10.0 108.951 -176.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 14.2 tpp180 -63.4 -33.94 76.64 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-O 119.658 -0.21 . . . . 10.0 110.81 -175.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -78.68 -38.19 39.89 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 124.71 1.204 . . . . 10.0 110.529 173.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -59.95 -19.06 49.97 Favored 'General case' 0 C--O 1.225 -0.199 0 O-C-N 121.256 -0.903 . . . . 10.0 110.8 177.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.6 ptpt -51.84 -43.63 63.27 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 113.123 0.786 . . . . 10.0 113.123 169.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 5.2 mt -55.97 134.15 19.83 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 N-CA-C 108.635 -0.876 . . . . 10.0 108.635 -176.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -70.85 -47.1 61.13 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 108.705 -0.85 . . . . 10.0 108.705 -177.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -80.84 43.81 2.88 Favored Glycine 0 C--N 1.342 0.875 0 O-C-N 121.068 -1.02 . . . . 10.0 112.111 -176.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.8 p -105.92 152.05 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 C-N-CA 125.298 1.439 . . . . 10.0 109.058 -177.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -115.81 -57.91 2.17 Favored 'General case' 0 CA--C 1.522 -0.127 0 C-N-CA 123.796 0.838 . . . . 10.0 108.873 169.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 64.6 m-80 -143.62 159.24 42.81 Favored 'General case' 0 CA--C 1.526 0.057 0 N-CA-C 109.496 -0.557 . . . . 10.0 109.496 -176.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -141.32 61.34 13.67 Favored Pre-proline 0 CA--C 1.537 0.452 0 C-N-CA 123.884 0.874 . . . . 10.0 111.585 174.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -77.35 71.39 6.4 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 123.09 2.526 . . . . 10.0 110.03 -176.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.5 m -67.02 155.02 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 O-C-N 121.744 -0.598 . . . . 10.0 111.028 -178.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -95.69 155.24 16.83 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 120.98 0.419 . . . . 10.0 109.934 172.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -135.28 48.47 2.25 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 124.954 1.301 . . . . 10.0 109.695 -171.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -175.26 -42.44 0.01 OUTLIER 'General case' 0 C--O 1.224 -0.251 0 C-N-CA 126.09 1.756 . . . . 10.0 108.708 178.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.4 mt -80.66 -15.48 56.46 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 125.436 1.494 . . . . 10.0 112.012 -170.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 71.86 40.29 0.77 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.275 1.43 . . . . 10.0 110.721 174.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.5 p -140.76 123.38 16.12 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.64 1.576 . . . . 10.0 108.969 -178.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.3 t -92.86 145.91 7.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 107.322 -1.362 . . . . 10.0 107.322 168.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 88.3 m -133.75 122.13 22.89 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 105.997 -1.853 . . . . 10.0 105.997 -176.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 29.3 t -122.98 134.42 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-N 118.74 0.7 . . . . 10.0 109.408 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -96.15 104.41 16.37 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 106.833 -1.543 . . . . 10.0 106.833 161.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -145.42 163.72 33.75 Favored 'General case' 0 CA--C 1.521 -0.166 0 C-N-CA 123.558 0.743 . . . . 10.0 109.798 178.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 13.3 p30 -98.5 130.64 27.62 Favored Pre-proline 0 C--N 1.329 -0.307 0 C-N-CA 123.419 0.687 . . . . 10.0 109.492 175.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -79.02 57.56 6.53 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 121.86 1.707 . . . . 10.0 108.967 171.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.34 -46.79 2.03 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.144 -0.687 . . . . 10.0 109.144 174.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -85.75 -61.06 1.84 Allowed 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 109.696 -0.483 . . . . 10.0 109.696 -178.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -107.71 -176.61 3.11 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 124.105 0.962 . . . . 10.0 110.017 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 93.6 p -140.1 169.73 17.15 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.696 1.198 . . . . 10.0 109.622 176.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 84.0 t -48.43 -52.6 8.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 124.408 1.083 . . . . 10.0 109.83 168.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.1 m -55.5 -35.95 66.14 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.631 1.173 . . . . 10.0 112.394 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -71.84 -60.62 2.14 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.703 -0.48 . . . . 10.0 109.703 174.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.0 pp -61.54 -43.72 98.36 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 121.85 -0.531 . . . . 10.0 110.636 -167.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -51.37 -35.49 38.93 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 114.09 1.144 . . . . 10.0 114.09 171.065 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.88 -33.72 67.15 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 119.56 1.073 . . . . 10.0 110.088 176.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.38 -51.1 68.92 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 109.235 -0.654 . . . . 10.0 109.235 -177.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 43.3 t -59.54 -48.0 88.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 124.032 0.933 . . . . 10.0 111.477 173.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -53.09 -47.97 68.15 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 122.209 1.004 . . . . 10.0 109.435 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 32.8 tttp -70.56 -39.8 73.74 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 125.526 1.53 . . . . 10.0 110.897 -177.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 11.8 mt -51.57 -39.34 57.68 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 118.647 -0.692 . . . . 10.0 111.906 169.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 149.64 -21.2 1.17 Allowed Glycine 0 CA--C 1.527 0.798 0 CA-C-N 118.786 0.721 . . . . 10.0 114.698 167.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -118.82 155.43 31.19 Favored 'General case' 0 C--O 1.224 -0.276 0 C-N-CA 124.831 1.253 . . . . 10.0 107.955 -175.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.75 144.75 25.37 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 118.756 0.707 . . . . 10.0 110.331 -168.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 20.2 tp -123.36 145.18 48.96 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 126.157 1.783 . . . . 10.0 107.646 178.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.2 tptp -152.15 151.74 31.42 Favored 'General case' 0 CA--C 1.512 -0.499 0 C-N-CA 124.619 1.168 . . . . 10.0 108.488 171.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.9 tp -66.28 151.51 46.9 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 123.662 0.601 . . . . 10.0 109.66 177.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.425 ' HZ3' ' CG ' ' A' ' 8' ' ' ASP . 0.5 OUTLIER -105.07 -59.01 1.81 Allowed 'General case' 0 N--CA 1.437 -1.087 0 C-N-CA 127.492 2.317 . . . . 10.0 105.674 164.396 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 176.59 -93.65 0.09 OUTLIER Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 108.035 -2.026 . . . . 10.0 108.035 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 . . . . . 0 N--CA 1.453 -0.29 0 C-N-CA 123.601 0.76 . . . . 10.0 109.608 -163.548 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.6 p . . . . . 0 N--CA 1.452 -0.34 0 N-CA-C 106.609 -1.626 . . . . 10.0 106.609 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -126.2 149.91 48.71 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 126.439 1.895 . . . . 10.0 107.478 -168.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.51 131.75 49.02 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 107.883 -1.155 . . . . 10.0 107.883 -176.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -140.27 157.24 45.89 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 123.656 0.782 . . . . 10.0 109.926 178.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -128.31 151.57 49.16 Favored 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 123.542 0.737 . . . . 10.0 110.353 178.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -140.35 146.64 38.69 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.845 1.658 . . . . 10.0 109.184 -170.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -110.15 125.82 53.42 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.311 1.044 . . . . 10.0 109.0 -165.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 8.6 mm -100.36 109.47 25.14 Favored 'Isoleucine or valine' 0 C--N 1.343 0.314 0 CA-C-N 118.907 0.776 . . . . 10.0 112.449 -159.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.499 ' OE1' ' NZ ' ' A' ' 67' ' ' LYS . 52.4 mt-10 . . . . . 0 N--CA 1.45 -0.458 0 N-CA-C 107.934 -1.135 . . . . 10.0 107.934 178.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 . . . . . 0 CA--C 1.534 0.352 0 N-CA-C 113.038 0.755 . . . . 10.0 113.038 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 18.1 ttm180 -72.31 -36.46 68.92 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 120.641 -1.287 . . . . 10.0 109.392 -178.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 9.1 mt -43.95 -53.41 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.44 0 CA-C-O 118.654 -0.689 . . . . 10.0 109.492 168.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -48.98 -47.22 44.3 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.4 0.546 . . . . 10.0 111.811 -175.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.21 -48.45 65.14 Favored 'General case' 0 CA--C 1.531 0.222 0 O-C-N 121.585 -0.697 . . . . 10.0 110.014 177.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.9 mmt180 -56.72 -35.47 68.58 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 112.093 0.405 . . . . 10.0 112.093 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.3 mt -80.3 -44.8 18.97 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.752 1.621 . . . . 10.0 110.896 177.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -54.28 -24.98 21.07 Favored 'General case' 0 C--O 1.227 -0.113 0 CA-C-N 118.319 0.508 . . . . 10.0 111.077 174.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.8 ttmt -58.34 -35.37 71.8 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 112.984 0.735 . . . . 10.0 112.984 173.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.7 mm -60.02 135.13 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 C-N-CA 123.755 0.822 . . . . 10.0 109.85 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -69.05 -54.82 13.1 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 111.998 0.369 . . . . 10.0 111.998 -173.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.67 41.03 2.66 Favored Glycine 0 C--N 1.339 0.711 0 O-C-N 120.916 -1.115 . . . . 10.0 111.928 -173.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.4 p -100.95 150.61 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 C-N-CA 124.562 1.145 . . . . 10.0 108.542 -175.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -111.93 -58.16 2.16 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 108.483 -0.932 . . . . 10.0 108.483 171.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 60.0 m-80 -147.58 156.08 42.46 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.659 -0.867 . . . . 10.0 108.659 -173.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -141.72 56.81 6.3 Favored Pre-proline 0 CA--C 1.536 0.404 0 C-N-CA 123.626 0.771 . . . . 10.0 112.641 175.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -75.43 77.65 3.22 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 122.758 2.306 . . . . 10.0 110.152 -177.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.4 m -57.49 154.04 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 O-C-N 121.83 -0.543 . . . . 10.0 111.632 176.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -93.31 138.2 31.9 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.458 -0.571 . . . . 10.0 109.458 -179.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -117.7 54.56 0.9 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.99 1.316 . . . . 10.0 110.25 -171.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 171.14 -34.12 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 127.039 2.136 . . . . 10.0 109.997 176.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.5 mt -91.3 -1.67 57.59 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.14 1.376 . . . . 10.0 111.978 -171.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 65.44 35.19 7.52 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 124.918 1.287 . . . . 10.0 111.052 165.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -140.44 133.77 29.79 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 125.403 1.481 . . . . 10.0 107.857 -172.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.9 t -94.88 140.65 16.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 106.792 -1.558 . . . . 10.0 106.792 168.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 60.4 m -125.8 119.29 27.49 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 106.108 -1.812 . . . . 10.0 106.108 -178.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.8 t -120.57 142.51 36.15 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.207 0 C-N-CA 122.992 0.517 . . . . 10.0 109.629 -178.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 59.2 tt0 -109.51 110.44 21.54 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 107.184 -1.413 . . . . 10.0 107.184 162.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -151.72 164.93 35.9 Favored 'General case' 0 C--O 1.227 -0.129 0 C-N-CA 123.876 0.871 . . . . 10.0 109.405 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 20.7 p30 -95.53 134.69 23.9 Favored Pre-proline 0 C--N 1.328 -0.365 0 C-N-CA 123.437 0.695 . . . . 10.0 110.681 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -80.77 56.39 6.07 Favored 'Trans proline' 0 N--CA 1.45 -1.077 0 C-N-CA 121.603 1.536 . . . . 10.0 109.193 170.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.55 -39.54 0.51 Allowed 'General case' 0 C--N 1.346 0.439 0 CA-C-N 118.631 0.651 . . . . 10.0 112.54 175.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -95.23 -26.63 15.88 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 122.992 0.517 . . . . 10.0 110.321 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.51 173.22 15.42 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.183 0.993 . . . . 10.0 109.14 -179.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 91.0 p -131.59 169.35 16.25 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.565 1.146 . . . . 10.0 112.258 -177.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 26.4 m -48.75 -43.52 14.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 124.01 0.924 . . . . 10.0 110.679 166.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.85 -36.43 79.1 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.964 1.706 . . . . 10.0 111.642 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -71.55 -61.2 1.86 Allowed 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 108.472 -0.936 . . . . 10.0 108.472 175.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.3 pp -60.19 -42.31 94.8 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 120.042 -0.663 . . . . 10.0 111.545 -169.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -51.24 -37.68 48.36 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 117.305 -1.331 . . . . 10.0 113.879 170.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -51.55 -39.08 57.09 Favored 'General case' 0 C--N 1.346 0.417 0 CA-C-N 120.735 1.607 . . . . 10.0 110.298 173.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.18 -46.14 90.27 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 109.429 -0.582 . . . . 10.0 109.429 -174.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 68.9 t -66.83 -45.87 86.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 123.327 0.651 . . . . 10.0 111.755 172.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -49.9 -54.13 21.54 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 124.67 1.188 . . . . 10.0 108.821 -178.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 46.4 tptt -57.67 -34.78 69.75 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.549 1.54 . . . . 10.0 111.644 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.85 -34.45 65.44 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 124.255 1.022 . . . . 10.0 111.248 174.064 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 125.95 -11.45 7.36 Favored Glycine 0 CA--C 1.529 0.968 0 CA-C-O 119.474 -0.626 . . . . 10.0 113.4 174.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -116.35 151.46 35.87 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 107.149 -1.426 . . . . 10.0 107.149 173.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.499 ' NZ ' ' OE1' ' A' ' 10' ' ' GLU . 13.3 ttpp -95.47 156.4 16.34 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.246 0.546 . . . . 10.0 110.364 -171.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 29.7 tp -128.98 150.44 50.4 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.622 1.569 . . . . 10.0 107.882 -179.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 11.0 tptp -155.14 151.56 28.4 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 108.803 -0.814 . . . . 10.0 108.803 169.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.5 tp -62.74 154.78 28.48 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 121.303 0.573 . . . . 10.0 109.573 177.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 45.6 tttp -117.23 -53.44 2.45 Favored 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 127.769 2.428 . . . . 10.0 107.08 170.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 170.57 -84.38 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.515 0 N-CA-C 109.081 -1.608 . . . . 10.0 109.081 176.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 . . . . . 0 N--CA 1.448 -0.525 0 N-CA-C 108.224 -1.028 . . . . 10.0 108.224 -164.578 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 21.7 p . . . . . 0 N--CA 1.451 -0.393 0 CA-C-O 121.71 0.767 . . . . 10.0 110.103 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -116.47 151.95 35.02 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 125.186 1.394 . . . . 10.0 109.136 -165.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -86.58 129.67 34.78 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.857 1.263 . . . . 10.0 107.719 -171.275 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -134.28 136.34 43.48 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.527 1.131 . . . . 10.0 109.362 174.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -116.11 150.8 36.79 Favored 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 124.622 1.169 . . . . 10.0 108.067 174.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -138.95 138.17 37.07 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 124.493 1.121 . . . . 10.0 109.327 -174.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -102.12 130.59 48.77 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.727 1.611 . . . . 10.0 108.197 -176.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -114.95 153.86 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.068 0 C-N-CA 125.789 1.636 . . . . 10.0 110.895 -165.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 . . . . . 0 N--CA 1.443 -0.811 0 C-N-CA 124.387 1.075 . . . . 10.0 108.23 168.656 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 . . . . . 0 CA--C 1.539 0.523 0 N-CA-C 112.631 0.604 . . . . 10.0 112.631 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.1 ttm180 -78.7 -36.88 42.9 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.307 1.043 . . . . 10.0 108.805 178.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 19.1 mm -43.7 -54.31 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.399 0 CA-C-O 118.462 -0.78 . . . . 10.0 109.854 171.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -44.63 -46.79 10.31 Favored 'General case' 0 C--O 1.224 -0.277 0 C-N-CA 122.998 0.519 . . . . 10.0 111.841 -179.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.54 -46.25 63.95 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 122.971 0.508 . . . . 10.0 110.076 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.09 -33.68 74.9 Favored 'General case' 0 C--O 1.222 -0.342 0 O-C-N 121.987 -0.445 . . . . 10.0 111.808 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.12 -34.84 26.0 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.524 1.53 . . . . 10.0 111.431 177.328 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -58.68 -24.59 61.62 Favored 'General case' 0 C--O 1.226 -0.171 0 O-C-N 121.761 -0.587 . . . . 10.0 109.89 172.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -52.03 -40.12 60.58 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 120.879 -0.328 . . . . 10.0 111.348 171.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 15.9 mm -56.16 127.2 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 C-N-CA 123.203 0.601 . . . . 10.0 109.623 -176.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -70.42 -48.67 54.98 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 121.081 -0.248 . . . . 10.0 110.759 -176.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -84.31 43.43 3.21 Favored Glycine 0 C--N 1.34 0.75 0 O-C-N 120.802 -1.186 . . . . 10.0 111.549 -177.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.3 p -99.4 148.46 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 124.287 1.035 . . . . 10.0 108.582 -178.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -111.02 -57.51 2.23 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 124.106 0.962 . . . . 10.0 108.545 175.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 -143.39 152.46 41.62 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.307 -0.997 . . . . 10.0 108.307 -175.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -138.94 61.57 22.52 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 123.602 0.761 . . . . 10.0 111.072 173.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -78.48 67.76 8.22 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 123.004 2.469 . . . . 10.0 110.018 -175.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.2 m -65.0 155.15 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 O-C-N 121.859 -0.526 . . . . 10.0 110.61 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 75.4 m-80 -93.57 148.98 21.6 Favored 'General case' 0 C--O 1.224 -0.287 0 N-CA-C 108.497 -0.927 . . . . 10.0 108.497 175.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -126.3 47.95 2.2 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 123.643 0.777 . . . . 10.0 110.38 -173.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -174.22 -43.03 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 125.948 1.699 . . . . 10.0 109.614 178.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.0 mt -76.38 -18.47 58.85 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.803 1.241 . . . . 10.0 111.971 -169.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 63.2 54.72 2.01 Favored 'General case' 0 C--N 1.338 0.079 0 C-N-CA 125.752 1.621 . . . . 10.0 110.126 -174.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.2 p -142.29 130.74 22.41 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 107.481 -1.303 . . . . 10.0 107.481 172.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.2 t -105.28 145.41 13.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 106.759 -1.571 . . . . 10.0 106.759 173.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 69.8 m -139.83 123.57 17.42 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 106.25 -1.759 . . . . 10.0 106.25 -169.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 22.2 t -127.42 149.36 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 C-N-CA 123.692 0.797 . . . . 10.0 109.271 179.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 -115.78 112.02 21.38 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 105.895 -1.891 . . . . 10.0 105.895 159.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -146.44 162.81 37.46 Favored 'General case' 0 CA--C 1.52 -0.202 0 C-N-CA 123.403 0.681 . . . . 10.0 109.553 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 20.5 p30 -92.47 130.6 36.78 Favored Pre-proline 0 C--N 1.329 -0.306 0 C-N-CA 122.524 0.33 . . . . 10.0 110.237 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -76.47 61.6 6.82 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 121.554 1.503 . . . . 10.0 108.486 170.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.24 -43.88 0.33 Allowed 'General case' 0 C--N 1.341 0.223 0 O-C-N 122.085 -0.384 . . . . 10.0 109.979 177.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -87.02 -41.96 13.46 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 117.92 0.327 . . . . 10.0 110.865 177.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -133.04 -178.06 4.79 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 124.52 1.128 . . . . 10.0 109.952 -177.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 81.7 p -146.24 167.46 23.45 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.549 0.74 . . . . 10.0 109.579 177.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 64.9 t -43.01 -49.07 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.113 0 C-N-CA 124.836 1.254 . . . . 10.0 111.02 172.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 43.9 m -50.54 -43.4 56.07 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.486 0.714 . . . . 10.0 112.583 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -65.77 -60.21 3.12 Favored 'General case' 0 C--N 1.338 0.09 0 C-N-CA 123.808 0.843 . . . . 10.0 109.055 -177.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.0 pp -61.65 -42.84 99.47 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 120.06 -0.656 . . . . 10.0 110.533 -176.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.11 -53.2 6.63 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 117.823 -1.084 . . . . 10.0 112.16 163.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.32 -48.63 73.86 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 119.96 1.255 . . . . 10.0 110.38 178.398 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -48.28 -54.62 13.05 Favored 'General case' 0 N--CA 1.453 -0.309 0 O-C-N 123.349 0.405 . . . . 10.0 110.642 177.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.1 t -62.9 -44.6 99.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 N-CA-C 112.578 0.585 . . . . 10.0 112.578 176.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.63 -57.49 8.09 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.013 1.325 . . . . 10.0 108.431 178.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.0 tptm -55.6 -38.84 69.96 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 126.455 1.902 . . . . 10.0 111.216 176.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.1 tp -55.05 -27.46 44.8 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.186 0.995 . . . . 10.0 113.047 174.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 131.21 -11.14 5.58 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-O 119.169 -0.795 . . . . 10.0 114.258 168.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -137.91 160.55 38.99 Favored 'General case' 0 CA--C 1.527 0.058 0 CA-C-N 118.667 1.234 . . . . 10.0 108.37 -176.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 41.4 mmtt -88.94 153.62 20.89 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.148 0.499 . . . . 10.0 112.041 -165.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.9 tp -135.23 148.69 49.69 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 125.579 1.552 . . . . 10.0 107.104 176.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.8 mmtt -149.17 154.18 38.77 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 124.523 1.129 . . . . 10.0 108.233 165.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.9 tp -59.76 158.52 10.23 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 109.752 -0.462 . . . . 10.0 109.752 171.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 7.8 tptt -110.38 -74.19 0.66 Allowed 'General case' 0 N--CA 1.434 -1.255 0 C-N-CA 126.832 2.053 . . . . 10.0 106.892 173.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 163.87 44.79 0.02 OUTLIER Glycine 0 CA--C 1.53 0.992 0 CA-C-O 119.491 -0.616 . . . . 10.0 112.537 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 . . . . . 0 CA--C 1.542 0.657 0 C-N-CA 125.059 1.344 . . . . 10.0 113.893 169.255 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.2 p . . . . . 0 N--CA 1.449 -0.489 0 N-CA-C 107.275 -1.38 . . . . 10.0 107.275 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -135.75 146.13 47.33 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 126.543 1.937 . . . . 10.0 106.708 -172.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 28.8 mmtm -81.54 145.73 30.52 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.77 -0.826 . . . . 10.0 108.77 177.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -145.12 141.58 28.92 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.721 1.208 . . . . 10.0 108.212 174.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -122.63 148.82 44.81 Favored 'General case' 0 CA--C 1.51 -0.595 0 C-N-CA 124.413 1.085 . . . . 10.0 108.601 174.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -140.43 138.05 34.42 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 125.101 1.5 . . . . 10.0 109.404 -171.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -103.98 127.82 51.53 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.964 -1.124 . . . . 10.0 107.964 -168.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 10.7 mm -103.56 136.11 38.0 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.114 0 C-N-CA 124.424 1.09 . . . . 10.0 110.804 -160.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 . . . . . 0 N--CA 1.45 -0.473 0 N-CA-C 107.478 -1.305 . . . . 10.0 107.478 169.651 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.531 0.235 0 N-CA-C 112.064 0.394 . . . . 10.0 112.064 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -60.31 -38.4 83.56 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 121.056 -1.027 . . . . 10.0 109.135 -179.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 13.1 mm -52.57 -49.1 46.14 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.477 0 CA-C-O 118.053 -0.975 . . . . 10.0 110.323 176.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -46.42 -50.66 16.42 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.909 0.777 . . . . 10.0 110.56 -177.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.64 -46.37 63.41 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.106 0.562 . . . . 10.0 111.264 178.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.1 mmt180 -58.8 -27.34 64.95 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.743 0.645 . . . . 10.0 112.743 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.0 -39.3 13.04 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.943 1.697 . . . . 10.0 111.404 174.341 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 24.8 t30 -57.47 -25.82 60.3 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 118.703 0.683 . . . . 10.0 110.627 174.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.1 mmpt? -54.4 -37.33 64.94 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 114.3 1.222 . . . . 10.0 114.3 169.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 11.6 mm -54.53 128.82 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 109.084 -0.71 . . . . 10.0 109.084 175.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -68.39 -49.62 58.78 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 109.469 -0.567 . . . . 10.0 109.469 -177.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -82.39 47.31 3.72 Favored Glycine 0 C--N 1.34 0.783 0 O-C-N 120.651 -1.28 . . . . 10.0 112.181 -175.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.5 p -110.23 153.57 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 C-N-CA 125.223 1.409 . . . . 10.0 109.568 -177.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -118.0 -52.01 2.43 Favored 'General case' 0 C--O 1.228 -0.029 0 C-N-CA 122.714 0.406 . . . . 10.0 110.127 169.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -144.57 149.92 36.62 Favored 'General case' 0 CA--C 1.527 0.087 0 N-CA-C 109.075 -0.713 . . . . 10.0 109.075 -173.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -137.58 58.48 16.86 Favored Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 123.691 0.796 . . . . 10.0 112.432 174.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -77.04 77.2 3.87 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 123.125 2.55 . . . . 10.0 110.495 -176.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.7 m -59.71 153.43 4.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 O-C-N 121.741 -0.599 . . . . 10.0 111.398 176.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -97.84 143.6 28.28 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.829 -0.804 . . . . 10.0 108.829 175.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -125.34 43.01 3.15 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.278 1.031 . . . . 10.0 110.953 -166.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -175.6 -40.06 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 125.924 1.69 . . . . 10.0 108.942 -178.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 12.6 mt -76.38 -21.26 56.27 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.346 1.058 . . . . 10.0 111.414 -176.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 63.7 49.48 2.96 Favored 'General case' 0 CA--C 1.527 0.093 0 C-N-CA 125.547 1.539 . . . . 10.0 109.959 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.6 p -137.86 131.67 31.39 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 126.131 1.772 . . . . 10.0 106.854 174.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 17.5 t -93.26 144.21 9.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 106.174 -1.787 . . . . 10.0 106.174 167.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 92.4 m -130.4 123.1 29.09 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 105.453 -2.054 . . . . 10.0 105.453 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 44.5 t -122.26 149.79 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 N-CA-C 108.668 -0.864 . . . . 10.0 108.668 176.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -116.06 108.66 16.48 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 107.113 -1.44 . . . . 10.0 107.113 161.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -146.63 164.63 32.04 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 108.915 -0.772 . . . . 10.0 108.915 -178.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 17.3 p30 -94.81 128.44 39.47 Favored Pre-proline 0 C--N 1.326 -0.421 0 N-CA-C 109.983 -0.377 . . . . 10.0 109.983 174.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -77.55 57.2 5.87 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 121.787 1.658 . . . . 10.0 108.7 168.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.17 -45.66 1.97 Allowed 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.113 -0.699 . . . . 10.0 109.113 177.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -90.11 -58.88 2.35 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 123.2 0.6 . . . . 10.0 109.68 -178.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -111.32 175.13 5.55 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 125.187 1.395 . . . . 10.0 109.565 178.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 59.4 p -129.14 176.65 7.74 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.66 1.184 . . . . 10.0 110.226 175.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 92.3 t -52.43 -39.88 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-N 115.234 -0.893 . . . . 10.0 110.691 168.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.1 m -58.13 -37.34 74.44 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 123.083 0.553 . . . . 10.0 111.882 -177.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -69.36 -58.49 3.94 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 123.999 0.92 . . . . 10.0 109.137 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.1 pp -63.08 -41.22 99.38 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 120.381 -0.528 . . . . 10.0 111.118 -175.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -40.48 -57.93 1.69 Allowed 'General case' 0 C--O 1.22 -0.48 0 O-C-N 121.575 -0.703 . . . . 10.0 111.69 161.024 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.47 -42.3 77.97 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 118.851 0.75 . . . . 10.0 110.35 -177.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -55.35 -47.28 75.98 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.395 -0.82 . . . . 10.0 110.432 179.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 48.0 t -66.02 -41.84 90.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 N-CA-C 111.481 0.178 . . . . 10.0 111.481 171.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -58.21 -45.36 87.79 Favored 'General case' 0 C--N 1.331 -0.201 0 O-C-N 121.181 -0.949 . . . . 10.0 109.181 -172.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 56.5 tttm -64.39 -27.91 69.33 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.32 1.048 . . . . 10.0 112.459 178.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.63 -28.51 60.67 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 119.246 0.93 . . . . 10.0 110.756 168.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 131.26 -48.6 0.96 Allowed Glycine 0 C--N 1.337 0.635 0 N-CA-C 109.477 -1.449 . . . . 10.0 109.477 175.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -86.32 162.62 18.13 Favored 'General case' 0 C--O 1.224 -0.286 0 C-N-CA 125.422 1.489 . . . . 10.0 109.778 -177.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.87 163.7 12.53 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.38 0.609 . . . . 10.0 110.813 -167.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 18.4 tp -139.82 148.6 42.4 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 126.408 1.883 . . . . 10.0 107.561 -175.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.2 tptp -148.18 155.34 41.27 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 118.408 -0.806 . . . . 10.0 108.9 163.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.9 tp -63.83 158.4 22.06 Favored 'General case' 0 C--N 1.339 0.143 0 N-CA-C 108.992 -0.744 . . . . 10.0 108.992 174.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 14.8 tttp -113.77 -69.23 0.87 Allowed 'General case' 0 N--CA 1.436 -1.166 0 C-N-CA 125.739 1.616 . . . . 10.0 107.389 172.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 162.38 49.41 0.02 OUTLIER Glycine 0 CA--C 1.526 0.78 0 CA-C-O 119.666 -0.519 . . . . 10.0 112.35 175.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 . . . . . 0 CA--C 1.53 0.188 0 C-N-CA 124.996 1.319 . . . . 10.0 111.947 178.162 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.4 p . . . . . 0 N--CA 1.45 -0.43 0 N-CA-C 107.309 -1.367 . . . . 10.0 107.309 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -137.75 146.76 44.05 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.414 1.486 . . . . 10.0 108.35 -166.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -91.71 140.14 30.0 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.036 0.534 . . . . 10.0 109.733 -177.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -142.84 148.23 36.72 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.051 1.34 . . . . 10.0 109.315 179.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -123.27 149.37 44.86 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.612 1.165 . . . . 10.0 108.372 174.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -141.04 144.12 34.8 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 124.976 1.422 . . . . 10.0 109.18 -174.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -106.92 132.03 53.32 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.4 1.08 . . . . 10.0 109.801 -169.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.7 mm -110.65 113.93 45.65 Favored 'Isoleucine or valine' 0 C--N 1.34 0.18 0 C-N-CA 125.096 1.358 . . . . 10.0 112.011 -160.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 . . . . . 0 N--CA 1.451 -0.407 0 N-CA-C 108.397 -0.964 . . . . 10.0 108.397 169.686 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 . . . . . 0 N--CA 1.448 -0.558 0 N-CA-C 113.115 0.783 . . . . 10.0 113.115 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.15 -48.44 57.38 Favored 'General case' 0 N--CA 1.451 -0.386 0 O-C-N 120.747 -1.221 . . . . 10.0 108.337 176.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -45.83 -51.55 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 CA-C-O 118.163 -0.922 . . . . 10.0 110.663 175.094 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -43.31 -48.8 6.89 Favored 'General case' 0 C--N 1.341 0.225 0 CA-C-N 118.626 0.648 . . . . 10.0 111.421 178.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.65 -47.04 61.98 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.779 -0.822 . . . . 10.0 108.779 -176.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.56 -38.67 75.17 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.275 -0.42 . . . . 10.0 111.894 -179.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.1 mt -78.96 -41.96 27.95 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.141 1.376 . . . . 10.0 110.576 178.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 15.7 t30 -54.8 -25.05 25.7 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.137 0.575 . . . . 10.0 111.226 173.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.2 ttmt -55.57 -38.38 69.29 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 112.393 0.516 . . . . 10.0 112.393 171.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 21.4 mm -60.01 132.14 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 C-N-CA 124.079 0.951 . . . . 10.0 109.831 -179.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -71.5 -52.63 17.33 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 111.47 0.174 . . . . 10.0 111.47 -174.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -82.95 42.83 3.02 Favored Glycine 0 C--N 1.339 0.71 0 O-C-N 120.753 -1.217 . . . . 10.0 112.026 -176.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.7 p -103.22 148.72 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 C-N-CA 124.385 1.074 . . . . 10.0 108.537 -177.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -110.94 -56.55 2.35 Favored 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 108.965 -0.754 . . . . 10.0 108.965 175.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -147.96 151.53 35.96 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 108.216 -1.031 . . . . 10.0 108.216 -172.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -136.61 65.16 53.96 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 123.77 0.828 . . . . 10.0 110.93 172.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -78.36 68.17 8.05 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.01 2.474 . . . . 10.0 109.447 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.6 m -71.27 158.95 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 C-N-CA 123.058 0.543 . . . . 10.0 111.36 -177.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -100.64 145.6 28.2 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-O 120.936 0.398 . . . . 10.0 110.894 -175.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -121.99 38.78 4.04 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.304 1.442 . . . . 10.0 111.102 -170.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -176.57 -36.68 0.01 OUTLIER 'General case' 0 C--O 1.224 -0.249 0 C-N-CA 125.06 1.344 . . . . 10.0 110.531 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 12.8 mt -82.18 -10.89 59.0 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.9 1.28 . . . . 10.0 112.036 -173.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 71.67 40.45 0.78 Allowed 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 125.661 1.584 . . . . 10.0 110.885 171.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 7.5 p -142.51 133.4 25.65 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.546 1.138 . . . . 10.0 108.975 -175.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.4 t -99.78 139.4 21.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 N-CA-C 106.187 -1.783 . . . . 10.0 106.187 168.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 57.7 m -131.66 118.17 19.66 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 105.218 -2.142 . . . . 10.0 105.218 -174.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.5 t -124.49 140.16 48.59 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.183 0 C-N-CA 122.964 0.506 . . . . 10.0 109.707 -175.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 49.4 tt0 -103.23 111.42 23.8 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 107.39 -1.337 . . . . 10.0 107.39 161.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -145.6 164.46 31.65 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 123.68 0.792 . . . . 10.0 109.782 176.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -96.75 131.56 27.81 Favored Pre-proline 0 C--N 1.33 -0.25 0 C-N-CA 123.067 0.547 . . . . 10.0 110.03 177.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -77.2 61.34 7.25 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 121.302 1.335 . . . . 10.0 108.68 168.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.14 -43.95 0.38 Allowed 'General case' 0 C--N 1.343 0.311 0 O-C-N 121.894 -0.504 . . . . 10.0 110.981 177.082 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.77 -41.12 14.36 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.797 0.839 . . . . 10.0 110.031 178.108 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -144.42 170.06 16.74 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 126.223 1.809 . . . . 10.0 108.772 -170.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 33.0 p -128.71 -179.49 5.1 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 122.608 1.194 . . . . 10.0 110.817 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 99.3 t -46.54 -41.46 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 114.413 -1.267 . . . . 10.0 111.292 163.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 70.6 m -62.0 -40.05 94.33 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 118.46 0.573 . . . . 10.0 111.301 -173.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -68.48 -54.57 16.07 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.814 1.245 . . . . 10.0 108.999 -175.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.0 pp -63.87 -44.07 94.18 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 119.664 -0.814 . . . . 10.0 110.485 -179.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.9 -49.66 10.88 Favored 'General case' 0 C--O 1.221 -0.438 0 CA-C-O 117.823 -1.084 . . . . 10.0 113.212 163.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 14.2 tm-20 -54.82 -46.2 74.52 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 120.715 1.598 . . . . 10.0 109.618 179.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -50.69 -55.37 16.86 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.377 -0.829 . . . . 10.0 109.372 178.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 66.8 t -60.98 -49.97 82.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 112.841 0.682 . . . . 10.0 112.841 177.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -58.34 -33.38 69.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.749 0.785 . . . . 10.0 109.285 -176.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.6 tttp -77.7 -34.11 52.94 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 123.451 0.701 . . . . 10.0 111.583 178.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 67.9 mt -53.09 -42.22 65.71 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.347 0.976 . . . . 10.0 111.148 164.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 143.51 -37.48 1.46 Allowed Glycine 0 C--N 1.337 0.636 0 CA-C-N 118.155 0.434 . . . . 10.0 112.439 168.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 22.3 p90 -85.71 158.55 20.02 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 108.494 -0.928 . . . . 10.0 108.494 176.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 33.6 mttp -100.94 160.84 14.04 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.544 0.688 . . . . 10.0 111.422 -173.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 21.6 tp -136.68 149.49 47.95 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.253 1.821 . . . . 10.0 107.549 -171.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -153.38 152.36 30.97 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 109.011 -0.737 . . . . 10.0 109.011 162.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.7 tp -60.02 156.61 14.43 Favored 'General case' 0 C--O 1.231 0.129 0 O-C-N 123.595 0.56 . . . . 10.0 109.683 175.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -112.1 -70.44 0.81 Allowed 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 125.672 1.589 . . . . 10.0 107.201 172.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 157.4 59.08 0.01 OUTLIER Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.191 -0.763 . . . . 10.0 111.191 -179.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . 0.272 12.4 pt-20 . . . . . 0 CA--C 1.533 0.309 0 C-N-CA 128.098 2.559 . . . . 10.0 114.737 176.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 11.8 p . . . . . 0 N--CA 1.445 -0.687 0 N-CA-C 109.642 -0.503 . . . . 10.0 109.642 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.7 mp0 -101.02 138.33 38.21 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.244 1.817 . . . . 10.0 109.212 177.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.7 tptt -81.87 119.86 24.46 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 108.105 -1.072 . . . . 10.0 108.105 171.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -128.09 153.55 46.69 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.537 1.135 . . . . 10.0 109.575 173.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -128.1 145.24 51.06 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.632 0.773 . . . . 10.0 110.215 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -130.22 133.57 46.64 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 125.236 1.585 . . . . 10.0 111.749 -167.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -85.1 136.11 33.69 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 125.28 1.432 . . . . 10.0 109.781 176.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 5.2 mm -109.42 134.58 51.03 Favored 'Isoleucine or valine' 0 C--N 1.34 0.176 0 C-N-CA 126.543 1.937 . . . . 10.0 109.756 -173.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 . . . . . 0 N--CA 1.446 -0.658 0 N-CA-C 108.28 -1.007 . . . . 10.0 108.28 159.841 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 . . . . . 0 CA--C 1.537 0.443 0 CA-C-O 121.915 0.864 . . . . 10.0 112.491 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 34.5 ttt85 -66.38 -35.41 80.26 Favored 'General case' 0 N--CA 1.45 -0.425 0 O-C-N 120.813 -1.18 . . . . 10.0 109.77 178.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 4.6 mt -52.04 -57.98 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.498 0 N-CA-C 108.861 -0.792 . . . . 10.0 108.861 172.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -45.25 -48.18 12.8 Favored 'General case' 0 C--O 1.221 -0.427 0 O-C-N 123.856 0.723 . . . . 10.0 110.882 -177.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.2 mtmt -68.14 -46.98 69.34 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.934 0.893 . . . . 10.0 110.414 -178.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.3 tpm_? -63.32 -36.59 84.19 Favored 'General case' 0 N--CA 1.45 -0.425 0 O-C-N 121.858 -0.526 . . . . 10.0 110.184 -178.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.06 -34.57 50.34 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.901 1.681 . . . . 10.0 111.457 176.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -64.15 -20.5 66.03 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 118.633 0.651 . . . . 10.0 109.421 175.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -53.97 -41.24 67.64 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 119.941 -0.704 . . . . 10.0 111.156 168.014 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 28.2 mm -58.97 129.96 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 123.667 0.787 . . . . 10.0 109.757 -174.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -73.03 -48.95 31.7 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 116.631 -0.259 . . . . 10.0 110.399 -172.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -82.88 40.9 2.83 Favored Glycine 0 C--N 1.339 0.746 0 O-C-N 120.887 -1.133 . . . . 10.0 111.767 -176.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -104.89 144.73 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 N-CA-C 107.743 -1.206 . . . . 10.0 107.743 179.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -106.67 -55.19 2.36 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.26 -0.644 . . . . 10.0 109.26 171.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -142.89 143.01 31.88 Favored 'General case' 0 C--O 1.226 -0.154 0 N-CA-C 108.824 -0.806 . . . . 10.0 108.824 -174.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -133.68 55.64 16.83 Favored Pre-proline 0 CA--C 1.54 0.585 0 N-CA-C 113.552 0.945 . . . . 10.0 113.552 175.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -77.9 75.58 4.73 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 123.392 2.728 . . . . 10.0 110.39 -177.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.1 m -62.32 153.09 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 123.138 0.575 . . . . 10.0 111.719 178.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -94.35 138.53 32.21 Favored 'General case' 0 N--CA 1.457 -0.116 0 O-C-N 122.082 -0.386 . . . . 10.0 110.06 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -116.01 45.64 1.7 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.676 1.19 . . . . 10.0 111.557 -169.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -175.92 -39.99 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.207 0 C-N-CA 125.232 1.413 . . . . 10.0 109.354 178.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.7 mt -74.92 -20.21 59.8 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.491 1.117 . . . . 10.0 111.427 -174.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 63.39 49.93 3.04 Favored 'General case' 0 C--N 1.339 0.132 0 C-N-CA 125.466 1.506 . . . . 10.0 109.761 -178.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.1 p -140.06 125.85 19.43 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 125.507 1.523 . . . . 10.0 107.446 174.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 32.1 t -91.69 136.46 24.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 107.263 -1.384 . . . . 10.0 107.263 167.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 26.0 m -120.05 124.88 46.94 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 125.592 1.557 . . . . 10.0 107.079 178.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 98.1 t -134.94 146.52 30.43 Favored 'Isoleucine or valine' 0 C--N 1.341 0.232 0 CA-C-N 119.154 0.888 . . . . 10.0 110.524 175.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -105.03 106.64 17.23 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 126.99 2.116 . . . . 10.0 106.162 169.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 26.5 p90 -139.6 154.44 47.59 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 118.926 0.785 . . . . 10.0 110.766 179.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -94.69 128.28 40.36 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 118.589 -0.719 . . . . 10.0 110.079 175.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -76.07 57.87 5.36 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.553 2.169 . . . . 10.0 108.862 169.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.413 ' NZ ' ' OE1' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -124.51 -53.0 1.7 Allowed 'General case' 0 C--N 1.338 0.102 0 N-CA-C 106.508 -1.664 . . . . 10.0 106.508 176.195 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.413 ' OE1' ' NZ ' ' A' ' 50' ' ' LYS . 1.8 tp10 -89.45 -42.49 11.46 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.031 0.532 . . . . 10.0 110.712 -178.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.27 147.63 29.55 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 124.833 1.253 . . . . 10.0 107.965 -172.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 54.1 p -105.81 -171.98 2.01 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.104 0.962 . . . . 10.0 109.864 -179.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.5 p -61.37 -32.72 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 120.323 -0.551 . . . . 10.0 111.006 166.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.2 t -54.76 -43.54 72.84 Favored 'General case' 0 C--O 1.235 0.335 0 O-C-N 121.822 -0.549 . . . . 10.0 109.703 -175.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -64.32 -54.49 32.32 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 125.72 1.608 . . . . 10.0 108.839 -175.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.0 pp -67.78 -42.59 81.45 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.959 -0.463 . . . . 10.0 111.25 -178.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -44.64 -50.62 9.72 Favored 'General case' 0 N--CA 1.449 -0.477 0 O-C-N 121.162 -0.961 . . . . 10.0 111.709 163.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.45 -45.14 92.45 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 118.92 0.782 . . . . 10.0 109.87 179.411 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -51.45 -49.82 60.99 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.031 -0.531 . . . . 10.0 110.182 178.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 58.0 t -68.2 -43.71 84.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 112.209 0.448 . . . . 10.0 112.209 177.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -53.5 -40.99 65.82 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 108.973 -0.751 . . . . 10.0 108.973 176.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.8 tptt -75.01 -36.75 61.92 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.899 1.28 . . . . 10.0 111.324 -179.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 15.5 mt -51.93 -35.03 44.38 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.817 0.735 . . . . 10.0 112.023 167.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.79 24.29 4.99 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 123.192 0.425 . . . . 10.0 112.888 169.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -141.75 160.56 39.93 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 105.276 -2.12 . . . . 10.0 105.276 168.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 62.7 tttt -106.82 144.34 33.61 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 119.548 1.067 . . . . 10.0 111.774 -168.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.0 tp -121.47 147.99 45.03 Favored 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 127.883 2.473 . . . . 10.0 107.622 -176.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.0 mmtt -143.22 170.04 16.5 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 124.407 1.083 . . . . 10.0 108.445 161.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.6 tt -93.31 151.4 19.81 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 123.505 0.722 . . . . 10.0 109.195 178.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 56.9 tttp -116.08 -62.36 1.6 Allowed 'General case' 0 N--CA 1.441 -0.904 0 C-N-CA 125.94 1.696 . . . . 10.0 108.089 -177.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -175.52 -87.93 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 108.455 -1.858 . . . . 10.0 108.455 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 . . . . . 0 N--CA 1.452 -0.353 0 C-N-CA 124.154 0.981 . . . . 10.0 109.177 -171.313 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.3 p . . . . . 0 CA--C 1.534 0.33 0 N-CA-C 107.337 -1.357 . . . . 10.0 107.337 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -139.16 147.74 42.26 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 127.525 2.33 . . . . 10.0 106.747 -167.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 59.7 mmtt -91.93 135.72 33.72 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 123.264 0.625 . . . . 10.0 109.636 -175.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -138.34 140.62 39.57 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.888 -1.152 . . . . 10.0 107.888 173.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -122.3 150.57 42.18 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.631 0.772 . . . . 10.0 110.368 175.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.483 ' CE2' HD11 ' A' ' 57' ' ' LEU . 0.8 OUTLIER -141.95 136.47 30.41 Favored 'General case' 0 N--CA 1.448 -0.566 0 O-C-N 124.925 1.39 . . . . 10.0 110.212 -169.903 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -95.91 135.74 37.26 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.933 1.693 . . . . 10.0 108.993 -175.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 7.2 mm -106.74 116.34 50.26 Favored 'Isoleucine or valine' 0 C--N 1.339 0.15 0 C-N-CA 125.851 1.66 . . . . 10.0 111.463 -165.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 . . . . . 0 N--CA 1.448 -0.548 0 N-CA-C 107.595 -1.261 . . . . 10.0 107.595 170.912 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.539 0.524 0 N-CA-C 112.59 0.589 . . . . 10.0 112.59 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.17 -36.97 66.68 Favored 'General case' 0 N--CA 1.447 -0.619 0 O-C-N 121.005 -1.059 . . . . 10.0 108.795 -178.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 11.6 mm -51.38 -58.2 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 N-CA-C 108.425 -0.954 . . . . 10.0 108.425 168.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -45.75 -41.41 10.71 Favored 'General case' 0 C--O 1.223 -0.311 0 O-C-N 123.604 0.565 . . . . 10.0 111.216 -178.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.29 -54.81 12.76 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 121.634 -0.666 . . . . 10.0 111.735 178.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.428 ' CZ ' ' HA ' ' A' ' 60' ' ' ALA . 4.8 mtp180 -60.99 -39.5 89.91 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 119.454 -0.899 . . . . 10.0 110.81 -178.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.89 -41.79 70.85 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 123.698 0.799 . . . . 10.0 110.74 179.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 44.4 m-20 -54.55 -30.78 55.08 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 118.454 0.57 . . . . 10.0 110.608 171.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -59.19 -31.7 69.24 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 118.377 -0.821 . . . . 10.0 112.776 176.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 18.6 mm -57.89 121.16 4.95 Favored 'Isoleucine or valine' 0 C--N 1.34 0.187 0 CA-C-N 118.933 0.788 . . . . 10.0 109.858 -178.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 50.1 mp0 -57.32 -46.13 83.55 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 123.658 0.783 . . . . 10.0 112.085 -175.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.95 32.61 3.2 Favored Glycine 0 C--N 1.341 0.816 0 CA-C-N 120.323 1.419 . . . . 10.0 112.772 -174.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.7 p -99.41 150.74 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 119.204 1.502 . . . . 10.0 109.327 -176.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -108.79 -59.12 1.92 Allowed 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 108.454 -0.943 . . . . 10.0 108.454 168.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 66.3 m-20 -139.64 152.96 47.19 Favored 'General case' 0 C--N 1.337 0.026 0 N-CA-C 108.775 -0.824 . . . . 10.0 108.775 -174.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -137.1 62.85 41.27 Favored Pre-proline 0 CA--C 1.537 0.462 0 C-N-CA 124.17 0.988 . . . . 10.0 111.687 174.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -75.68 77.1 3.44 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 123.061 2.508 . . . . 10.0 111.511 -177.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 70.6 t -61.96 135.65 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 C-N-CA 125.889 1.676 . . . . 10.0 111.391 176.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -94.85 94.91 8.33 Favored 'General case' 0 C--N 1.346 0.419 0 O-C-N 121.296 -0.878 . . . . 10.0 111.552 -175.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -75.35 49.47 0.47 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.781 2.032 . . . . 10.0 114.055 -173.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -176.84 -37.15 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 124.916 1.287 . . . . 10.0 110.452 176.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.5 mt -84.68 -13.38 51.61 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.057 0.943 . . . . 10.0 111.261 -173.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 74.17 40.54 0.43 Allowed 'General case' 0 C--O 1.228 -0.071 0 C-N-CA 125.213 1.405 . . . . 10.0 110.25 170.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 35.4 p -140.08 131.11 26.25 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 125.028 1.331 . . . . 10.0 107.828 179.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 28.5 t -91.99 144.14 9.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 107.026 -1.472 . . . . 10.0 107.026 165.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 91.3 m -131.67 124.1 29.16 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 105.879 -1.897 . . . . 10.0 105.879 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 42.2 t -126.36 145.21 34.25 Favored 'Isoleucine or valine' 0 C--N 1.339 0.145 0 C-N-CA 123.289 0.635 . . . . 10.0 109.371 177.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -112.85 103.36 11.35 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 105.601 -2.0 . . . . 10.0 105.601 171.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -136.58 159.54 41.51 Favored 'General case' 0 C--O 1.225 -0.218 0 C-N-CA 123.883 0.873 . . . . 10.0 110.755 -175.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 21.2 p30 -94.8 125.78 49.79 Favored Pre-proline 0 C--N 1.331 -0.197 0 C-N-CA 123.481 0.712 . . . . 10.0 109.953 175.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -74.56 65.63 5.63 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 121.766 1.644 . . . . 10.0 108.304 172.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.7 pttt -138.86 -49.77 0.52 Allowed 'General case' 0 C--O 1.227 -0.105 0 N-CA-C 106.967 -1.494 . . . . 10.0 106.967 178.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -106.15 -56.54 2.17 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 124.656 1.182 . . . . 10.0 108.069 174.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.24 139.45 50.06 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 123.391 0.677 . . . . 10.0 109.738 -176.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 20.6 p -130.78 143.51 50.79 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 122.047 0.927 . . . . 10.0 110.518 174.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 30.3 m -45.39 -43.58 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 C-N-CA 125.157 1.383 . . . . 10.0 111.609 176.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.0 m -58.2 -43.13 87.45 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.501 1.121 . . . . 10.0 112.517 -177.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -63.08 -53.19 57.52 Favored 'General case' 0 C--O 1.224 -0.263 0 CA-C-O 122.072 0.939 . . . . 10.0 108.875 -173.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.483 HD11 ' CE2' ' A' ' 7' ' ' PHE 0.267 1.2 pp -65.62 -36.39 83.57 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.082 -1.011 . . . . 10.0 112.621 -177.225 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.93 -64.59 0.48 Allowed 'General case' 0 CA--C 1.534 0.348 0 O-C-N 120.962 -1.087 . . . . 10.0 112.881 156.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.8 tm-20 -52.23 -39.76 60.73 Favored 'General case' 0 CA--C 1.517 -0.301 0 C-N-CA 123.455 0.702 . . . . 10.0 109.572 178.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.428 ' HA ' ' CZ ' ' A' ' 24' ' ' ARG . . . -59.68 -55.01 39.76 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 115.747 -0.661 . . . . 10.0 110.696 -174.275 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 80.4 t -62.46 -42.31 95.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-N 115.666 -0.697 . . . . 10.0 110.909 174.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -55.35 -51.25 67.4 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 121.575 0.702 . . . . 10.0 110.311 -176.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 40.6 tptt -56.65 -39.7 74.17 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 125.765 1.626 . . . . 10.0 111.007 177.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.74 -22.38 35.04 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 113.056 0.762 . . . . 10.0 113.056 174.066 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 108.73 14.71 14.86 Favored Glycine 0 CA--C 1.529 0.952 0 CA-C-N 118.78 0.718 . . . . 10.0 113.161 170.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -143.37 160.27 40.85 Favored 'General case' 0 C--O 1.225 -0.23 0 N-CA-C 106.603 -1.629 . . . . 10.0 106.603 172.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -111.6 144.59 40.6 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 119.064 0.847 . . . . 10.0 111.141 -162.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 23.3 tp -121.38 148.27 44.61 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 125.097 1.359 . . . . 10.0 108.289 -172.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 20.8 mmtt -149.0 139.51 22.52 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 125.446 1.498 . . . . 10.0 110.288 169.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.5 tt -72.1 157.38 37.88 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.633 -0.877 . . . . 10.0 108.633 177.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 64.1 tttt -120.86 -65.26 1.16 Allowed 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 125.585 1.554 . . . . 10.0 108.169 177.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.53 -74.01 0.03 OUTLIER Glycine 0 CA--C 1.522 0.518 0 N-CA-C 110.051 -1.22 . . . . 10.0 110.051 173.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 . . . . . 0 N--CA 1.454 -0.251 0 N-CA-C 106.557 -1.646 . . . . 10.0 106.557 -165.567 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 7.7 p . . . . . 0 N--CA 1.455 -0.195 0 CA-C-O 120.87 0.367 . . . . 10.0 110.33 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -124.51 151.16 44.99 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 127.475 2.31 . . . . 10.0 107.575 -171.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.1 mppt? -93.69 142.67 27.09 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 123.975 0.91 . . . . 10.0 109.6 -176.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -148.19 140.95 24.62 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.027 0.931 . . . . 10.0 109.336 -177.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -117.97 148.75 41.9 Favored 'General case' 0 CA--C 1.508 -0.638 0 C-N-CA 123.361 0.665 . . . . 10.0 110.415 173.577 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -134.47 144.39 48.07 Favored 'General case' 0 N--CA 1.446 -0.632 0 O-C-N 125.407 1.692 . . . . 10.0 108.781 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -109.97 132.42 54.17 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 108.475 -0.935 . . . . 10.0 108.475 -172.028 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.8 mm -113.43 144.16 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 C-N-CA 124.092 0.957 . . . . 10.0 111.811 -157.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 . . . . . 0 N--CA 1.444 -0.76 0 C-N-CA 124.524 1.13 . . . . 10.0 108.123 169.438 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.468 0.43 0 CA-C-O 121.572 0.701 . . . . 10.0 112.001 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 27.1 ttt180 -52.8 -38.14 60.78 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.253 1.021 . . . . 10.0 110.029 -178.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 27.5 mm -59.14 -45.98 92.31 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.538 0 CA-C-O 117.572 -1.204 . . . . 10.0 110.905 174.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -50.12 -50.5 48.35 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 119.606 1.094 . . . . 10.0 109.788 -176.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.7 tmmt? -67.9 -47.81 67.77 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.324 1.05 . . . . 10.0 110.11 179.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.04 -28.95 64.96 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.53 0.567 . . . . 10.0 112.53 177.539 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.09 -43.38 21.86 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.989 1.315 . . . . 10.0 109.347 175.084 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -56.89 -24.59 53.05 Favored 'General case' 0 C--O 1.226 -0.154 0 C-N-CA 123.964 0.905 . . . . 10.0 110.342 178.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.78 -36.51 81.3 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 114.775 1.398 . . . . 10.0 114.775 172.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.9 mp -62.39 129.19 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 120.067 1.303 . . . . 10.0 109.767 176.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -54.5 -51.16 65.98 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 112.433 0.531 . . . . 10.0 112.433 -177.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.85 37.3 2.82 Favored Glycine 0 C--N 1.34 0.774 0 O-C-N 120.563 -1.336 . . . . 10.0 112.317 -171.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.8 p -103.79 155.5 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 CA-C-N 118.362 1.081 . . . . 10.0 108.928 -177.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -120.52 -58.54 1.83 Allowed 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 109.006 -0.739 . . . . 10.0 109.006 170.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 62.2 m-80 -139.08 155.66 47.76 Favored 'General case' 0 CA--C 1.521 -0.172 0 N-CA-C 108.835 -0.802 . . . . 10.0 108.835 -173.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -153.38 58.6 2.37 Favored Pre-proline 0 CA--C 1.533 0.318 0 N-CA-C 112.668 0.618 . . . . 10.0 112.668 173.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -74.45 79.05 2.57 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.659 2.24 . . . . 10.0 109.935 -178.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.5 m -63.47 156.72 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 O-C-N 121.695 -0.628 . . . . 10.0 112.168 -179.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 73.9 m-80 -98.39 122.17 41.24 Favored 'General case' 0 N--CA 1.457 -0.102 0 O-C-N 122.144 -0.348 . . . . 10.0 110.585 -178.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -102.51 42.9 1.11 Allowed 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.954 1.301 . . . . 10.0 111.236 -176.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -163.1 -43.56 0.03 OUTLIER 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 124.176 0.99 . . . . 10.0 109.05 176.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 12.3 mt -76.24 -22.48 55.11 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.827 0.851 . . . . 10.0 111.213 -177.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 62.08 53.83 2.87 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 125.554 1.541 . . . . 10.0 109.509 -175.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 16.9 p -138.1 133.1 33.01 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.955 1.702 . . . . 10.0 107.458 173.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.9 t -100.1 125.46 53.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 107.188 -1.412 . . . . 10.0 107.188 173.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 37.4 m -109.54 115.25 29.57 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 126.397 1.879 . . . . 10.0 107.572 -178.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.7 t -117.1 145.92 22.23 Favored 'Isoleucine or valine' 0 C--N 1.34 0.166 0 CA-C-N 118.971 0.805 . . . . 10.0 110.857 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -115.11 108.07 16.16 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 125.283 1.433 . . . . 10.0 107.748 161.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 26.9 p90 -139.34 162.02 36.02 Favored 'General case' 0 C--O 1.226 -0.134 0 C-N-CA 123.808 0.843 . . . . 10.0 110.253 -178.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 25.1 p30 -95.97 128.48 37.17 Favored Pre-proline 0 C--N 1.332 -0.18 0 C-N-CA 123.397 0.679 . . . . 10.0 110.142 176.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -75.48 61.69 6.09 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 N-CA-C 108.468 -1.397 . . . . 10.0 108.468 171.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.84 -47.14 0.32 Allowed 'General case' 0 C--N 1.346 0.416 0 CA-C-N 118.584 0.629 . . . . 10.0 110.195 176.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -104.59 -40.23 6.1 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.067 0.547 . . . . 10.0 109.898 170.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.32 158.35 17.84 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.377 0.671 . . . . 10.0 110.366 -177.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 97.7 p -148.83 158.74 44.38 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.643 0.735 . . . . 10.0 111.776 172.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.0 m -53.41 -45.78 57.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 124.267 1.027 . . . . 10.0 110.937 173.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 16.0 m -57.66 -43.48 84.99 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.4 1.08 . . . . 10.0 111.722 -178.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -64.2 -57.5 9.33 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.283 1.033 . . . . 10.0 109.262 -178.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.3 pp -65.42 -41.34 93.66 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.123 -0.985 . . . . 10.0 111.058 -176.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -43.03 -52.05 5.45 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-O 118.244 -0.884 . . . . 10.0 112.562 160.595 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.76 -45.95 77.97 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 119.772 1.169 . . . . 10.0 110.082 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -52.7 -54.2 36.85 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.977 -0.556 . . . . 10.0 110.321 178.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 40.6 t -57.85 -47.23 86.68 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 N-CA-C 112.597 0.592 . . . . 10.0 112.597 174.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -53.48 -55.6 23.98 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.754 1.222 . . . . 10.0 109.257 -177.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -59.72 -33.62 71.86 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 126.997 2.119 . . . . 10.0 111.711 178.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.87 -38.0 61.06 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.24 0.616 . . . . 10.0 111.908 168.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 119.25 9.7 8.52 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 124.187 0.898 . . . . 10.0 113.344 176.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -135.76 172.74 12.57 Favored 'General case' 0 C--O 1.225 -0.221 0 N-CA-C 107.076 -1.453 . . . . 10.0 107.076 172.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 33.1 mttt -114.94 157.84 22.83 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 118.853 0.752 . . . . 10.0 111.994 -166.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.2 tp -143.82 145.3 32.25 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.206 1.802 . . . . 10.0 107.254 -170.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 32.2 mmtt -148.84 150.09 32.42 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 124.291 1.036 . . . . 10.0 109.044 164.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.6 tp -63.01 158.62 18.95 Favored 'General case' 0 N--CA 1.456 -0.172 0 O-C-N 123.919 0.762 . . . . 10.0 109.236 175.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 19.1 tttt -124.59 -53.81 1.67 Allowed 'General case' 0 N--CA 1.439 -1.023 0 C-N-CA 127.811 2.444 . . . . 10.0 107.559 -178.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 174.03 -85.56 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 108.098 -2.001 . . . . 10.0 108.098 175.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 . . . . . 0 N--CA 1.453 -0.322 0 C-N-CA 124.38 1.072 . . . . 10.0 108.287 -169.259 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.9 p . . . . . 0 N--CA 1.449 -0.502 0 N-CA-C 108.821 -0.807 . . . . 10.0 108.821 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -141.61 140.78 33.41 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 126.981 2.112 . . . . 10.0 106.833 -170.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -90.84 130.76 36.77 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 123.675 0.79 . . . . 10.0 109.063 177.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -133.12 146.93 52.05 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 125.915 1.686 . . . . 10.0 107.947 -177.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -123.69 150.28 44.47 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.227 0.611 . . . . 10.0 110.249 176.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.403 ' CE2' HD11 ' A' ' 70' ' ' LEU . 2.7 m-85 -138.56 140.9 39.21 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.897 1.279 . . . . 10.0 109.621 -171.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -101.13 134.77 43.65 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 124.836 1.254 . . . . 10.0 108.596 -175.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 6.1 mm -107.6 119.45 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 C-N-CA 124.751 1.221 . . . . 10.0 110.223 -161.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 . . . . . 0 N--CA 1.449 -0.486 0 N-CA-C 108.329 -0.989 . . . . 10.0 108.329 174.025 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.6 m120 . . . . . 0 N--CA 1.464 0.269 0 N-CA-C 113.393 0.886 . . . . 10.0 113.393 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.39 -53.56 18.82 Favored 'General case' 0 C--O 1.234 0.242 0 O-C-N 121.37 -0.831 . . . . 10.0 109.005 171.337 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.4 mm -44.07 -54.85 0.99 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.339 0 O-C-N 123.915 0.759 . . . . 10.0 110.093 179.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -42.53 -50.86 5.26 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.994 0.918 . . . . 10.0 111.702 178.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.39 -47.56 60.29 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 121.453 -0.779 . . . . 10.0 110.794 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -57.64 -36.91 72.47 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.952 0.901 . . . . 10.0 110.765 -177.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.83 -43.97 28.8 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 126.151 1.781 . . . . 10.0 110.741 175.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -52.55 -28.55 21.26 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 118.915 0.779 . . . . 10.0 111.606 172.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.7 tmmt? -62.11 -26.91 68.57 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 112.402 0.519 . . . . 10.0 112.402 177.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 10.0 mm -66.85 133.51 31.3 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.131 0 N-CA-C 108.874 -0.787 . . . . 10.0 108.874 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -64.8 -56.16 15.26 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 120.608 0.242 . . . . 10.0 110.67 -173.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.96 44.71 3.36 Favored Glycine 0 C--N 1.34 0.784 0 O-C-N 120.755 -1.215 . . . . 10.0 112.039 -171.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.6 p -108.15 150.59 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 C-N-CA 124.649 1.18 . . . . 10.0 108.846 -176.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -122.3 -52.29 1.95 Allowed 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.078 0.551 . . . . 10.0 110.285 174.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -138.68 153.89 48.57 Favored 'General case' 0 C--N 1.338 0.097 0 N-CA-C 109.378 -0.601 . . . . 10.0 109.378 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -146.29 61.85 7.45 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 123.484 0.714 . . . . 10.0 111.548 173.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -77.46 73.22 5.66 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.972 2.448 . . . . 10.0 109.599 -179.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.6 m -66.57 151.72 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 O-C-N 121.96 -0.462 . . . . 10.0 111.075 -179.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 -97.68 125.91 42.72 Favored 'General case' 0 N--CA 1.458 -0.068 0 O-C-N 122.193 -0.317 . . . . 10.0 110.413 -175.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -105.4 41.69 1.33 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.074 1.349 . . . . 10.0 111.65 -170.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -171.62 -38.81 0.02 OUTLIER 'General case' 0 C--O 1.225 -0.207 0 C-N-CA 124.958 1.303 . . . . 10.0 110.125 178.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.2 mt -77.37 -17.56 58.11 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.219 1.008 . . . . 10.0 111.616 -175.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 68.56 46.62 0.97 Allowed 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 125.64 1.576 . . . . 10.0 110.136 177.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 12.0 p -141.89 128.86 20.72 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.692 1.197 . . . . 10.0 108.378 177.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.3 t -93.72 135.04 29.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 106.361 -1.718 . . . . 10.0 106.361 169.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 60.6 m -121.05 123.48 42.47 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 105.9 -1.889 . . . . 10.0 105.9 178.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 19.3 t -124.23 149.97 28.66 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.115 0 C-N-CA 123.472 0.709 . . . . 10.0 109.211 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -124.92 102.33 7.49 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 126.647 1.979 . . . . 10.0 105.728 175.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -138.75 166.35 24.63 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 123.883 0.873 . . . . 10.0 110.675 -172.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 19.0 p30 -104.53 127.39 29.09 Favored Pre-proline 0 CA--C 1.532 0.254 0 C-N-CA 123.092 0.557 . . . . 10.0 110.094 177.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -75.59 63.66 6.49 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 122.52 2.147 . . . . 10.0 109.568 176.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 22.3 ttmt -142.74 -58.47 0.44 Allowed 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 106.3 -1.741 . . . . 10.0 106.3 175.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -114.08 1.16 14.53 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.34 1.456 . . . . 10.0 112.632 -173.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -133.23 154.5 50.6 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 125.276 1.43 . . . . 10.0 110.096 171.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 90.8 p -146.74 160.32 42.38 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.363 0.601 . . . . 10.0 111.391 175.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 59.4 t -52.79 -49.87 45.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 124.995 1.318 . . . . 10.0 109.408 173.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -51.11 -47.92 61.85 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 126.37 1.868 . . . . 10.0 111.758 178.337 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -67.83 -54.9 15.37 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.954 0.901 . . . . 10.0 109.899 -174.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.1 pp -66.0 -40.55 91.25 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 120.935 -1.103 . . . . 10.0 111.149 -178.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -43.87 -49.32 8.32 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 120.905 -1.122 . . . . 10.0 112.257 161.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.5 -43.49 79.78 Favored 'General case' 0 C--N 1.339 0.133 0 CA-C-N 119.824 1.193 . . . . 10.0 111.022 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -53.77 -53.26 54.77 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.126 -0.488 . . . . 10.0 110.335 176.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 47.4 t -63.07 -37.35 79.14 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 N-CA-C 112.321 0.489 . . . . 10.0 112.321 177.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -60.53 -55.13 37.1 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 125.091 1.356 . . . . 10.0 108.858 -177.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? -55.12 -41.21 71.41 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.893 0.877 . . . . 10.0 110.611 175.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -49.65 -33.14 14.7 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.33 0.652 . . . . 10.0 112.326 173.342 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 113.82 17.62 7.33 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 124.044 0.83 . . . . 10.0 113.117 169.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.07 167.43 22.1 Favored 'General case' 0 N--CA 1.458 -0.041 0 N-CA-C 107.366 -1.346 . . . . 10.0 107.366 175.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -105.43 144.12 32.65 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 121.536 0.684 . . . . 10.0 111.351 -164.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.4 tp -130.13 145.5 51.71 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.102 1.761 . . . . 10.0 107.9 -178.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 26.0 mmtt -151.77 154.43 36.24 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 124.673 1.189 . . . . 10.0 108.659 167.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.403 HD11 ' CE2' ' A' ' 7' ' ' PHE . 8.7 tp -63.41 155.21 29.66 Favored 'General case' 0 CA--C 1.529 0.167 0 O-C-N 123.702 0.626 . . . . 10.0 110.33 176.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -111.89 -60.01 1.91 Allowed 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 127.508 2.323 . . . . 10.0 106.418 172.315 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -179.07 -84.88 0.06 OUTLIER Glycine 0 CA--C 1.523 0.539 0 N-CA-C 109.625 -1.39 . . . . 10.0 109.625 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 . . . . . 0 N--CA 1.451 -0.385 0 C-N-CA 124.475 1.11 . . . . 10.0 108.116 -169.497 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 13.4 p . . . . . 0 CA--C 1.535 0.375 0 N-CA-C 109.065 -0.716 . . . . 10.0 109.065 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -129.96 149.73 51.56 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 125.901 1.68 . . . . 10.0 109.49 -173.082 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.62 88.69 2.82 Favored 'General case' 0 C--N 1.341 0.215 0 C-N-CA 124.582 1.153 . . . . 10.0 109.606 -167.61 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -86.45 152.47 22.66 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.143 1.377 . . . . 10.0 110.523 -179.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -125.01 149.43 47.76 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.471 1.108 . . . . 10.0 109.341 174.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -140.86 143.64 34.84 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 124.947 1.404 . . . . 10.0 110.794 -172.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -104.91 129.81 53.2 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.677 1.591 . . . . 10.0 108.849 -171.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 6.5 mm -103.62 111.29 32.76 Favored 'Isoleucine or valine' 0 C--N 1.342 0.252 0 C-N-CA 123.852 0.861 . . . . 10.0 111.289 -163.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 . . . . . 0 C--O 1.236 0.346 0 N-CA-C 107.704 -1.221 . . . . 10.0 107.704 175.573 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 . . . . . 0 CA--C 1.536 0.419 0 N-CA-C 112.112 0.412 . . . . 10.0 112.112 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.9 tpt180 -80.86 -48.05 12.94 Favored 'General case' 0 N--CA 1.452 -0.352 0 O-C-N 121.314 -0.866 . . . . 10.0 110.02 168.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 29.0 mm -39.35 -57.65 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.433 0 CA-C-O 118.545 -0.74 . . . . 10.0 110.844 177.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -44.75 -49.23 10.72 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 123.598 0.561 . . . . 10.0 111.499 -175.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.2 ttmt -72.7 -45.44 58.8 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.539 0.736 . . . . 10.0 110.379 -176.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -60.58 -36.36 78.33 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 122.805 0.442 . . . . 10.0 111.673 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.96 -49.01 40.96 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.41 1.084 . . . . 10.0 109.324 171.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -54.51 -19.47 5.87 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.542 -0.723 . . . . 10.0 112.704 177.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -56.25 -35.3 67.26 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.718 1.007 . . . . 10.0 113.718 171.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 11.2 mt -58.22 139.03 18.43 Favored 'Isoleucine or valine' 0 C--N 1.339 0.132 0 CA-C-N 118.59 0.632 . . . . 10.0 109.593 179.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -69.45 -52.66 24.64 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 111.665 0.246 . . . . 10.0 111.665 -176.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -85.07 44.29 3.36 Favored Glycine 0 C--N 1.339 0.749 0 O-C-N 120.705 -1.247 . . . . 10.0 111.224 -175.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.4 p -99.76 152.4 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 C-N-CA 124.62 1.168 . . . . 10.0 108.366 -179.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -112.92 -57.63 2.26 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 108.562 -0.903 . . . . 10.0 108.562 171.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 -148.71 158.13 43.93 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.217 -1.401 . . . . 10.0 107.217 -173.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -148.28 61.15 5.61 Favored Pre-proline 0 CA--C 1.531 0.245 0 O-C-N 121.902 -0.499 . . . . 10.0 111.568 168.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -75.03 83.79 1.77 Allowed 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 122.915 2.41 . . . . 10.0 108.225 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.6 m -54.48 157.3 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 C-N-CA 123.236 0.614 . . . . 10.0 110.527 173.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 -84.52 161.06 20.37 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 107.591 -1.263 . . . . 10.0 107.591 171.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -122.79 29.37 6.86 Favored 'General case' 0 C--N 1.335 -0.051 0 N-CA-C 112.21 0.448 . . . . 10.0 112.21 -169.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -174.55 -37.94 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 122.657 0.383 . . . . 10.0 111.227 -171.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 16.6 mt -72.18 -19.68 61.71 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.327 1.051 . . . . 10.0 111.66 -177.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 67.13 43.65 2.07 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.041 1.336 . . . . 10.0 109.557 -178.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 17.4 p -140.39 123.55 16.71 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.855 1.662 . . . . 10.0 109.167 178.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.6 t -89.76 149.08 4.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 108.226 -1.028 . . . . 10.0 108.226 173.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 85.3 m -130.07 125.94 36.43 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 106.787 -1.56 . . . . 10.0 106.787 179.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 42.1 t -120.13 128.45 75.96 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 C-N-CA 123.452 0.701 . . . . 10.0 109.196 177.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 72.2 tt0 -94.43 106.82 18.8 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 108.085 -1.08 . . . . 10.0 108.085 160.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -144.01 164.79 29.61 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 109.605 -0.517 . . . . 10.0 109.605 175.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 22.3 p30 -93.72 141.41 23.75 Favored Pre-proline 0 C--N 1.328 -0.334 0 N-CA-C 109.522 -0.547 . . . . 10.0 109.522 175.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -85.29 47.92 2.13 Favored 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 121.594 1.529 . . . . 10.0 109.485 170.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.9 -9.64 6.63 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.247 0.93 . . . . 10.0 113.127 177.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -128.56 -51.65 1.26 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.923 1.289 . . . . 10.0 108.68 -167.521 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -122.52 -172.22 2.43 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.767 1.227 . . . . 10.0 109.736 173.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 99.3 p -141.12 169.53 17.44 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.924 1.289 . . . . 10.0 110.959 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 70.0 t -50.1 -49.75 21.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 124.172 0.989 . . . . 10.0 110.491 165.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.2 m -58.47 -36.19 73.33 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 123.841 0.856 . . . . 10.0 111.991 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -69.09 -60.42 2.37 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 109.69 -0.485 . . . . 10.0 109.69 173.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.3 pp -60.07 -47.23 86.75 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 121.051 0.453 . . . . 10.0 110.822 -165.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -48.74 -36.45 16.41 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 114.004 1.113 . . . . 10.0 114.004 172.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -57.35 -33.49 67.81 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 119.08 0.854 . . . . 10.0 110.599 178.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.92 -51.82 66.58 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.544 -0.91 . . . . 10.0 108.544 -178.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 25.1 t -61.15 -45.84 97.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 124.89 1.276 . . . . 10.0 110.484 178.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -56.49 -55.4 34.2 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 124.196 0.998 . . . . 10.0 108.499 -178.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.78 -35.28 74.33 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.083 0.953 . . . . 10.0 111.62 177.01 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.4 mp -55.15 -32.82 62.41 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 118.626 -0.702 . . . . 10.0 112.383 171.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 134.76 -7.06 4.51 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-O 119.394 -0.67 . . . . 10.0 114.366 169.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -135.17 151.26 50.5 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 106.769 -1.567 . . . . 10.0 106.769 -177.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.79 142.28 35.0 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 121.46 0.648 . . . . 10.0 111.09 -161.552 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 16.0 tp -118.34 144.03 46.18 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.583 1.953 . . . . 10.0 107.842 -173.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 4.0 tptp -147.81 154.76 40.89 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.124 0.97 . . . . 10.0 108.669 171.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.7 tp -63.75 157.51 24.11 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 109.267 -0.642 . . . . 10.0 109.267 176.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 30.8 tttp -111.27 -67.19 1.01 Allowed 'General case' 0 N--CA 1.441 -0.89 0 C-N-CA 124.974 1.31 . . . . 10.0 107.932 170.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 162.1 49.75 0.02 OUTLIER Glycine 0 CA--C 1.526 0.762 0 CA-C-N 118.383 0.538 . . . . 10.0 112.914 174.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 . . . . . 0 CA--C 1.532 0.272 0 C-N-CA 124.823 1.249 . . . . 10.0 112.564 -179.329 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 12.8 p . . . . . 0 N--CA 1.448 -0.537 0 N-CA-C 109.824 -0.436 . . . . 10.0 109.824 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -128.86 145.73 51.13 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 126.899 2.08 . . . . 10.0 108.528 -171.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -110.46 100.27 9.13 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.423 1.089 . . . . 10.0 112.559 -163.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -111.7 154.03 25.57 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.054 1.741 . . . . 10.0 110.241 -168.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -129.09 148.28 51.02 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 109.153 -0.684 . . . . 10.0 109.153 -177.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -138.68 138.24 37.58 Favored 'General case' 0 N--CA 1.452 -0.361 0 O-C-N 124.92 1.388 . . . . 10.0 109.281 -171.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -100.89 126.29 47.5 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.399 1.08 . . . . 10.0 108.223 -171.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 6.7 mm -104.62 126.85 59.39 Favored 'Isoleucine or valine' 0 C--N 1.343 0.307 0 C-N-CA 124.654 1.182 . . . . 10.0 111.875 -164.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 . . . . . 0 N--CA 1.449 -0.495 0 N-CA-C 108.459 -0.941 . . . . 10.0 108.459 168.023 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.582 0 N-CA-C 112.923 0.712 . . . . 10.0 112.923 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.3 ttm180 -72.32 -36.8 68.98 Favored 'General case' 0 N--CA 1.447 -0.61 0 O-C-N 121.009 -1.057 . . . . 10.0 109.371 -178.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.6 mt -57.49 -48.17 83.51 Favored 'Isoleucine or valine' 0 C--N 1.344 0.344 0 CA-C-O 118.324 -0.846 . . . . 10.0 108.967 172.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -47.73 -47.04 30.37 Favored 'General case' 0 C--O 1.225 -0.187 0 CA-C-N 118.59 0.632 . . . . 10.0 111.517 -178.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 27.6 ttmt -72.56 -48.87 36.57 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.156 0.582 . . . . 10.0 110.298 -177.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -54.31 -41.19 68.69 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.629 0.603 . . . . 10.0 112.629 176.489 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.5 mt -68.84 -52.4 30.29 Favored 'General case' 0 C--O 1.221 -0.421 0 C-N-CA 124.95 1.3 . . . . 10.0 109.521 173.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 45.9 m-20 -54.02 -19.85 5.44 Favored 'General case' 0 C--O 1.227 -0.118 0 CA-C-N 118.63 0.65 . . . . 10.0 111.964 179.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.6 ttmt -58.74 -26.59 64.12 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 113.72 1.007 . . . . 10.0 113.72 172.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 10.8 mt -54.26 133.93 17.27 Favored 'Isoleucine or valine' 0 C--N 1.341 0.232 0 CA-C-N 119.572 1.078 . . . . 10.0 108.706 173.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -69.56 -47.44 63.65 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.919 -0.488 . . . . 10.0 111.418 179.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -86.61 45.71 3.48 Favored Glycine 0 C--N 1.339 0.714 0 O-C-N 120.637 -1.289 . . . . 10.0 111.2 -174.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -99.32 149.59 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 108.389 -0.967 . . . . 10.0 108.389 -176.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -104.2 -57.43 2.03 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 107.769 -1.197 . . . . 10.0 107.769 165.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 55.4 m-80 -149.28 156.18 41.7 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.409 -0.96 . . . . 10.0 108.409 -171.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -146.45 61.94 7.41 Favored Pre-proline 0 CA--C 1.538 0.517 0 N-CA-C 112.86 0.689 . . . . 10.0 112.86 169.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -79.05 85.74 1.81 Allowed 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 123.23 2.62 . . . . 10.0 109.746 -178.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.0 m -71.84 153.56 7.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 O-C-N 121.495 -0.753 . . . . 10.0 110.901 -178.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -94.02 127.34 39.76 Favored 'General case' 0 C--N 1.339 0.11 0 O-C-N 121.996 -0.44 . . . . 10.0 110.771 -175.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -105.16 59.56 0.68 Allowed 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.437 1.495 . . . . 10.0 110.772 -173.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 173.47 -35.97 0.0 OUTLIER 'General case' 0 C--O 1.226 -0.176 0 C-N-CA 125.411 1.485 . . . . 10.0 109.794 171.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.6 mt -83.33 -14.22 53.4 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.913 0.885 . . . . 10.0 111.087 -172.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 75.92 38.31 0.35 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.735 1.614 . . . . 10.0 110.785 170.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 38.3 p -137.18 131.66 32.83 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.136 1.374 . . . . 10.0 109.327 -177.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.6 t -91.8 142.72 12.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 107.625 -1.25 . . . . 10.0 107.625 167.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 44.7 m -127.2 124.61 39.39 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 106.828 -1.545 . . . . 10.0 106.828 177.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.8 t -124.6 141.24 45.36 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 N-CA-C 109.183 -0.673 . . . . 10.0 109.183 -179.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 55.1 tt0 -115.22 106.82 14.5 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 106.985 -1.487 . . . . 10.0 106.985 166.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -149.96 158.64 44.36 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 123.062 0.545 . . . . 10.0 109.667 -179.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -88.64 128.26 53.3 Favored Pre-proline 0 C--N 1.326 -0.421 0 N-CA-C 109.952 -0.388 . . . . 10.0 109.952 178.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -75.69 60.4 5.92 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.479 2.119 . . . . 10.0 108.939 171.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.5 tttt -130.91 -52.62 1.05 Allowed 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 106.472 -1.677 . . . . 10.0 106.472 173.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -83.85 -43.51 15.28 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.077 0.551 . . . . 10.0 110.475 -170.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -134.12 -173.61 3.31 Favored 'General case' 0 C--N 1.339 0.128 0 C-N-CA 124.904 1.282 . . . . 10.0 109.093 178.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 79.8 p -145.78 166.8 24.84 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.676 0.75 . . . . 10.0 109.864 -177.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 26.8 m -49.79 -41.53 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 115.064 -0.971 . . . . 10.0 111.428 167.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.3 m -56.37 -44.2 79.95 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 123.914 0.885 . . . . 10.0 112.178 177.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -63.22 -56.89 12.83 Favored 'General case' 0 C--N 1.337 0.064 0 N-CA-C 109.203 -0.666 . . . . 10.0 109.203 179.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.2 pp -67.63 -41.22 84.23 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 119.675 -0.81 . . . . 10.0 110.81 -171.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -39.63 -52.47 2.22 Favored 'General case' 0 C--O 1.224 -0.238 0 O-C-N 121.683 -0.635 . . . . 10.0 112.473 159.333 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.45 -43.24 93.2 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 118.62 0.645 . . . . 10.0 109.873 179.4 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -51.87 -46.97 64.69 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 116.062 -0.517 . . . . 10.0 110.224 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 40.6 t -68.34 -47.44 77.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 124.266 1.026 . . . . 10.0 112.58 175.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -58.25 -35.37 71.64 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.406 -0.809 . . . . 10.0 109.126 -176.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.1 -28.79 39.0 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 118.538 -0.744 . . . . 10.0 112.179 179.315 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.2 mt -53.83 -42.65 68.7 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 120.036 1.289 . . . . 10.0 110.797 165.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 139.95 -14.3 3.09 Favored Glycine 0 CA--C 1.527 0.794 0 CA-C-O 119.974 -0.348 . . . . 10.0 113.787 170.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -114.83 159.19 20.92 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 125.54 1.536 . . . . 10.0 107.271 179.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 25.8 mttp -97.24 159.56 14.84 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 121.731 0.777 . . . . 10.0 111.782 -171.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 20.5 tp -137.24 147.28 45.65 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.929 1.691 . . . . 10.0 107.433 -177.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 22.9 tptt -154.41 153.41 31.52 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 108.624 -0.88 . . . . 10.0 108.624 164.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 22.5 mt -61.04 160.21 10.36 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 121.936 0.874 . . . . 10.0 110.856 175.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 12.3 tptt -113.12 -58.0 2.21 Favored 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 128.061 2.544 . . . . 10.0 106.419 173.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -179.88 -84.13 0.06 OUTLIER Glycine 0 CA--C 1.523 0.544 0 N-CA-C 109.617 -1.393 . . . . 10.0 109.617 178.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 . . . . . 0 N--CA 1.45 -0.446 0 N-CA-C 108.304 -0.998 . . . . 10.0 108.304 -169.915 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.4 p . . . . . 0 N--CA 1.451 -0.387 0 N-CA-C 107.263 -1.384 . . . . 10.0 107.263 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -108.68 144.45 36.43 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 126.339 1.855 . . . . 10.0 110.28 179.484 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.0 mmtm -88.47 113.83 24.47 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.701 1.2 . . . . 10.0 109.801 174.034 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -116.64 149.87 39.04 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.678 1.191 . . . . 10.0 110.494 170.922 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -117.03 151.05 37.59 Favored 'General case' 0 CA--C 1.518 -0.257 0 C-N-CA 124.564 1.146 . . . . 10.0 111.423 171.237 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -140.99 137.47 33.04 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.549 1.14 . . . . 10.0 110.143 -175.333 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.513 ' CG ' ' HZ3' ' A' ' 71' ' ' LYS . 6.9 m-20 -95.0 137.84 33.52 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 125.165 1.386 . . . . 10.0 109.11 -176.952 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 7.5 mm -109.47 132.41 57.7 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 C-N-CA 124.84 1.256 . . . . 10.0 110.639 -164.822 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 . . . . . 0 N--CA 1.452 -0.369 0 N-CA-C 108.377 -0.971 . . . . 10.0 108.377 173.197 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.535 0.377 0 N-CA-C 112.44 0.533 . . . . 10.0 112.44 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 15.6 ttt180 -73.49 -47.86 37.85 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 121.65 -0.656 . . . . 10.0 109.291 -179.61 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.3 mt -42.46 -52.51 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 123.1 0.56 . . . . 10.0 110.769 171.125 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -42.83 -58.54 2.32 Favored 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 123.01 0.524 . . . . 10.0 111.025 179.616 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -70.18 -39.59 75.15 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.859 0.863 . . . . 10.0 109.87 -173.885 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.24 -36.46 66.06 Favored 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 122.705 0.402 . . . . 10.0 110.685 175.611 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.49 -36.63 26.27 Favored 'General case' 0 C--O 1.222 -0.376 0 C-N-CA 123.571 0.749 . . . . 10.0 112.554 173.191 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -57.69 -25.73 60.72 Favored 'General case' 0 C--N 1.328 -0.326 0 O-C-N 120.715 -1.24 . . . . 10.0 109.821 179.291 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.5 mmpt? -51.82 -38.45 55.82 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 114.336 1.235 . . . . 10.0 114.336 168.975 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 11.5 mt -57.19 129.43 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 CA-C-N 118.838 0.745 . . . . 10.0 109.253 178.925 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -64.8 -49.53 70.29 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 120.968 -0.293 . . . . 10.0 110.991 -179.942 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -82.91 46.51 3.63 Favored Glycine 0 C--N 1.339 0.717 0 O-C-N 120.998 -1.064 . . . . 10.0 111.5 -175.008 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.3 p -106.7 152.9 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 C-N-CA 124.588 1.155 . . . . 10.0 109.003 -177.716 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -115.23 -51.95 2.69 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.989 -0.745 . . . . 10.0 108.989 168.499 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -151.58 158.86 44.09 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 109.234 -0.654 . . . . 10.0 109.234 -176.68 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -143.18 64.11 13.76 Favored Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 123.918 0.887 . . . . 10.0 111.861 173.088 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -79.22 77.68 4.0 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.178 2.585 . . . . 10.0 109.8 -177.252 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.4 m -71.3 153.16 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 O-C-N 121.775 -0.578 . . . . 10.0 111.385 -176.927 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 74.1 m-80 -87.46 148.05 25.12 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 120.817 -0.353 . . . . 10.0 110.298 177.241 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -124.02 44.8 2.63 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.904 1.281 . . . . 10.0 111.104 -172.306 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -175.8 -40.63 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.216 0 C-N-CA 125.292 1.437 . . . . 10.0 109.596 178.005 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.6 mt -78.15 -18.29 55.77 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.381 1.072 . . . . 10.0 111.834 -172.034 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 66.87 46.38 1.66 Allowed 'General case' 0 C--O 1.231 0.091 0 C-N-CA 125.377 1.471 . . . . 10.0 110.398 179.144 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.9 p -139.03 121.72 16.38 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 125.153 1.381 . . . . 10.0 108.538 176.349 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 17.9 t -88.55 137.56 20.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 107.227 -1.398 . . . . 10.0 107.227 168.505 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 88.8 m -120.09 124.02 44.8 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 106.445 -1.687 . . . . 10.0 106.445 176.659 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 24.7 t -121.56 140.1 46.64 Favored 'Isoleucine or valine' 0 C--N 1.339 0.139 0 CA-C-N 119.114 0.87 . . . . 10.0 110.073 178.755 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -105.19 101.47 11.02 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.458 1.503 . . . . 10.0 107.078 164.389 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -143.19 158.47 43.59 Favored 'General case' 0 CA--C 1.52 -0.21 0 C-N-CA 123.0 0.52 . . . . 10.0 110.627 178.421 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -93.06 129.45 39.46 Favored Pre-proline 0 CA--C 1.531 0.247 0 C-N-CA 123.393 0.677 . . . . 10.0 110.043 176.309 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -78.04 57.15 6.01 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 122.244 1.962 . . . . 10.0 108.86 169.768 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.74 -62.67 1.12 Allowed 'General case' 0 CA--C 1.521 -0.149 0 N-CA-C 106.533 -1.655 . . . . 10.0 106.533 175.822 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -81.84 -32.32 31.24 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 122.468 0.307 . . . . 10.0 110.87 -173.196 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -135.22 -176.48 4.27 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.14 0.976 . . . . 10.0 109.606 177.214 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 86.7 p -140.71 169.73 17.09 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.842 0.857 . . . . 10.0 111.501 -179.853 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 59.4 t -42.53 -48.71 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 125.43 1.492 . . . . 10.0 111.571 160.786 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.5 t -66.82 -34.25 77.4 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.356 -0.384 . . . . 10.0 110.553 -176.0 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -65.77 -60.71 2.61 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.682 -0.859 . . . . 10.0 108.682 173.382 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.9 pp -63.68 -44.91 92.34 Favored 'General case' 0 N--CA 1.447 -0.583 0 O-C-N 121.982 -0.449 . . . . 10.0 111.036 -164.774 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -48.64 -39.56 24.58 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 113.319 0.859 . . . . 10.0 113.319 170.094 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -57.25 -32.94 67.08 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 119.235 0.925 . . . . 10.0 110.646 178.939 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.41 -48.24 81.31 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.792 0.805 . . . . 10.0 109.338 -178.562 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 57.6 t -64.94 -50.57 74.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 124.947 1.299 . . . . 10.0 111.043 174.49 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -50.27 -39.18 44.4 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.354 1.462 . . . . 10.0 109.167 -179.292 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 33.1 tptt -76.59 -40.96 47.98 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 125.303 1.441 . . . . 10.0 110.595 -178.063 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 28.3 mt -53.19 -41.09 64.93 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.712 0.687 . . . . 10.0 111.402 169.056 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 140.4 -30.78 2.3 Favored Glycine 0 C--N 1.338 0.69 0 CA-C-N 118.225 0.466 . . . . 10.0 113.428 166.722 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 15.6 p90 -86.86 160.2 18.82 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 107.797 -1.186 . . . . 10.0 107.797 172.711 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -105.42 150.67 25.05 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 120.859 0.361 . . . . 10.0 110.549 -170.546 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 21.8 tp -123.2 150.47 43.33 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 126.643 1.977 . . . . 10.0 108.234 -176.897 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 19.5 tptt -154.26 140.01 18.05 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 123.145 0.578 . . . . 10.0 110.683 166.018 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.4 tt -70.8 158.27 36.63 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 123.524 0.729 . . . . 10.0 109.786 -178.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.513 ' HZ3' ' CG ' ' A' ' 8' ' ' ASP . 11.8 ttpt -121.74 -67.17 0.98 Allowed 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 126.894 2.078 . . . . 10.0 108.759 178.815 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -165.54 -81.31 0.04 OUTLIER Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.025 -1.23 . . . . 10.0 110.025 176.627 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 . . . . . 0 C--O 1.232 0.151 0 C-N-CA 124.578 1.151 . . . . 10.0 107.937 -169.154 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.447 -0.591 0 N-CA-C 105.908 -1.886 . . . . 10.0 105.908 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -133.98 143.24 48.03 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 126.83 2.052 . . . . 10.0 106.723 -168.345 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 18.3 tptm -89.25 143.33 26.91 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 107.546 -1.279 . . . . 10.0 107.546 -176.273 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -147.44 148.13 30.95 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.416 0.686 . . . . 10.0 109.441 177.66 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -128.09 152.41 48.01 Favored 'General case' 0 CA--C 1.507 -0.675 0 C-N-CA 124.494 1.118 . . . . 10.0 109.156 173.014 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -143.4 131.44 21.75 Favored 'General case' 0 N--CA 1.447 -0.623 0 O-C-N 125.607 1.817 . . . . 10.0 108.638 -170.826 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -93.59 138.41 31.87 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 106.811 -1.551 . . . . 10.0 106.811 -179.57 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 5.3 mm -105.44 141.23 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 124.289 1.036 . . . . 10.0 109.415 -166.251 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 . . . . . 0 N--CA 1.446 -0.662 0 N-CA-C 106.845 -1.539 . . . . 10.0 106.845 172.847 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 . . . . . 0 N--CA 1.464 0.247 0 CA-C-O 120.866 0.365 . . . . 10.0 110.658 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.8 tpp85 -75.09 -44.36 47.75 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 109.098 -0.704 . . . . 10.0 109.098 -178.95 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.4 mm -44.49 -62.08 0.33 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.466 0 C-N-CA 124.063 0.945 . . . . 10.0 108.898 173.663 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -54.61 -34.83 62.67 Favored 'General case' 0 C--O 1.22 -0.483 0 CA-C-N 118.497 0.59 . . . . 10.0 112.203 -175.172 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.04 -43.43 78.74 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 120.715 -1.24 . . . . 10.0 109.376 176.595 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.53 -39.67 85.05 Favored 'General case' 0 C--O 1.224 -0.261 0 O-C-N 122.12 -0.362 . . . . 10.0 111.598 177.997 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.56 -34.62 58.48 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.693 1.197 . . . . 10.0 110.337 -179.426 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -71.14 -7.51 47.14 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 121.671 -0.643 . . . . 10.0 109.537 173.865 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.5 -37.94 82.71 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 118.368 -1.333 . . . . 10.0 109.422 165.92 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 25.6 mm -60.16 123.59 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 123.647 0.779 . . . . 10.0 109.711 -173.729 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -68.32 -48.84 63.81 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 110.001 -0.37 . . . . 10.0 110.001 -179.169 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -82.54 41.06 2.79 Favored Glycine 0 CA--C 1.526 0.747 0 O-C-N 121.326 -0.859 . . . . 10.0 111.937 -175.42 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.3 p -104.46 146.82 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 C-N-CA 124.864 1.266 . . . . 10.0 108.73 -178.266 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -115.94 -52.44 2.61 Favored 'General case' 0 C--N 1.333 -0.109 0 C-N-CA 122.848 0.459 . . . . 10.0 109.838 172.085 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -139.52 143.03 37.25 Favored 'General case' 0 C--N 1.341 0.212 0 N-CA-C 108.803 -0.814 . . . . 10.0 108.803 -176.797 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -130.85 62.74 67.12 Favored Pre-proline 0 CA--C 1.536 0.435 0 C-N-CA 123.39 0.676 . . . . 10.0 110.48 173.188 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -76.26 66.37 7.08 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 123.448 2.765 . . . . 10.0 110.633 -175.931 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.5 t -68.47 145.16 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 C-N-CA 126.123 1.769 . . . . 10.0 110.98 -176.805 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -90.98 145.07 25.02 Favored 'General case' 0 C--N 1.341 0.239 0 C-N-CA 120.315 -0.554 . . . . 10.0 110.582 -179.828 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -122.82 65.47 0.96 Allowed 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 125.309 1.444 . . . . 10.0 109.819 -172.861 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 157.55 -30.9 0.0 OUTLIER 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 127.627 2.371 . . . . 10.0 109.621 169.405 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.6 mt -75.56 -17.62 60.0 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.799 0.839 . . . . 10.0 110.846 -173.821 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 67.07 48.39 1.24 Allowed 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 126.005 1.722 . . . . 10.0 110.653 177.205 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.4 p -143.1 124.77 14.94 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.49 1.516 . . . . 10.0 108.283 176.422 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.0 t -94.2 141.58 14.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 106.884 -1.525 . . . . 10.0 106.884 169.602 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.6 m -129.98 126.05 36.85 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 105.491 -2.04 . . . . 10.0 105.491 -177.889 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 23.9 t -128.37 152.93 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 CA-C-N 118.657 0.662 . . . . 10.0 109.402 178.886 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -130.41 96.94 4.26 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 105.021 -2.215 . . . . 10.0 105.021 176.213 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -148.77 164.66 33.76 Favored 'General case' 0 C--O 1.226 -0.152 0 C-N-CA 123.956 0.903 . . . . 10.0 110.343 -171.569 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -96.09 132.63 26.51 Favored Pre-proline 0 C--N 1.33 -0.24 0 C-N-CA 122.858 0.463 . . . . 10.0 110.501 179.577 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -79.68 55.62 5.71 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 121.721 1.614 . . . . 10.0 109.136 166.991 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.52 -41.49 1.7 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 118.234 0.47 . . . . 10.0 110.364 177.73 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.89 -32.28 11.76 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.688 0.795 . . . . 10.0 111.091 178.332 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -138.22 -174.83 3.91 Favored 'General case' 0 CA--C 1.523 -0.065 0 C-N-CA 124.644 1.178 . . . . 10.0 109.67 -175.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.7 p -148.42 163.25 37.71 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 123.058 0.543 . . . . 10.0 109.896 -178.936 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 55.8 t -38.55 -50.39 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 C-N-CA 125.345 1.458 . . . . 10.0 110.07 163.698 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.3 m -51.4 -44.07 62.1 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 124.552 1.141 . . . . 10.0 113.056 -179.762 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -72.37 -53.59 11.86 Favored 'General case' 0 C--O 1.224 -0.289 0 N-CA-C 109.78 -0.452 . . . . 10.0 109.78 -178.625 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.0 pp -61.05 -39.95 91.79 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 118.247 -1.381 . . . . 10.0 110.738 -177.97 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.86 -57.48 3.74 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-O 117.854 -1.069 . . . . 10.0 112.309 161.54 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 14.6 tm-20 -50.22 -48.49 54.36 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-N 120.332 1.424 . . . . 10.0 110.298 176.392 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -51.63 -54.07 31.76 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 123.555 0.742 . . . . 10.0 109.602 -178.044 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 91.6 t -63.03 -45.12 99.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 115.986 -0.552 . . . . 10.0 111.155 177.818 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.45 -56.86 10.98 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.99 0.9 . . . . 10.0 109.836 178.942 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.9 tptp -49.35 -36.97 23.0 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 127.287 2.235 . . . . 10.0 111.602 175.273 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.4 tp -60.89 -34.38 74.55 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 125.055 1.342 . . . . 10.0 111.705 179.17 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 146.83 -53.0 0.55 Allowed Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.754 -0.538 . . . . 10.0 111.754 176.962 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -98.86 158.83 15.37 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 123.939 0.896 . . . . 10.0 109.859 -176.832 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 8.5 ttpt -92.16 153.18 19.5 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.217 0.532 . . . . 10.0 110.232 -170.46 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 23.9 tp -125.74 151.69 46.33 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.981 1.713 . . . . 10.0 107.932 179.734 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.9 tptp -153.92 147.63 25.29 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 122.775 0.43 . . . . 10.0 110.275 162.919 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.3 tp -59.14 158.48 8.77 Favored 'General case' 0 C--N 1.34 0.155 0 O-C-N 123.485 0.491 . . . . 10.0 109.963 176.561 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.6 tttt -116.26 -71.26 0.75 Allowed 'General case' 0 N--CA 1.436 -1.136 0 C-N-CA 126.849 2.059 . . . . 10.0 108.205 179.472 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 158.88 43.89 0.02 OUTLIER Glycine 0 CA--C 1.529 0.956 0 C-N-CA 123.952 0.787 . . . . 10.0 111.609 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 . . . . . 0 CA--C 1.537 0.452 0 C-N-CA 124.995 1.318 . . . . 10.0 111.962 171.6 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.6 p . . . . . 0 C--O 1.238 0.472 0 CA-C-O 122.606 1.194 . . . . 10.0 112.506 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -82.62 164.19 20.94 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 107.791 -1.188 . . . . 10.0 107.791 176.352 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.65 144.73 31.99 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 106.737 -1.579 . . . . 10.0 106.737 176.611 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -148.24 139.23 23.18 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.424 -0.954 . . . . 10.0 108.424 179.294 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -120.71 148.21 44.26 Favored 'General case' 0 CA--C 1.513 -0.466 0 C-N-CA 123.964 0.906 . . . . 10.0 109.187 175.866 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -139.11 144.2 38.59 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.131 1.372 . . . . 10.0 109.144 -174.834 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -110.14 127.33 54.84 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.67 1.188 . . . . 10.0 107.878 -172.213 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.5 mm -107.25 137.16 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 124.004 0.922 . . . . 10.0 111.301 -160.691 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 . . . . . 0 N--CA 1.455 -0.176 0 C-N-CA 124.554 1.141 . . . . 10.0 108.239 179.816 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 . . . . . 0 N--CA 1.467 0.405 0 CA-C-O 121.167 0.508 . . . . 10.0 111.212 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.65 -41.0 94.08 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 118.077 -0.964 . . . . 10.0 110.383 176.66 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 14.9 mm -47.62 -62.54 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.371 0 N-CA-C 108.367 -0.975 . . . . 10.0 108.367 169.682 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -54.56 -35.82 63.67 Favored 'General case' 0 C--O 1.22 -0.462 0 N-CA-C 112.177 0.436 . . . . 10.0 112.177 -176.281 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.65 -53.56 32.67 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 119.198 0.908 . . . . 10.0 109.783 179.233 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.7 tpt180 -64.27 -35.34 80.51 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 122.225 -0.297 . . . . 10.0 111.253 -178.987 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.51 -44.9 56.63 Favored 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 123.402 0.681 . . . . 10.0 111.319 178.134 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -51.25 -31.27 20.39 Favored 'General case' 0 C--O 1.225 -0.184 0 C-N-CA 123.81 0.844 . . . . 10.0 110.654 172.292 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -60.84 -34.6 74.83 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 118.703 -0.665 . . . . 10.0 112.239 176.956 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 22.4 mm -55.0 133.37 18.54 Favored 'Isoleucine or valine' 0 C--N 1.342 0.261 0 C-N-CA 124.077 0.951 . . . . 10.0 110.854 177.924 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 51.1 mp0 -73.73 -47.03 42.33 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 119.242 -0.408 . . . . 10.0 110.869 -172.955 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.99 36.75 2.52 Favored Glycine 0 C--N 1.343 0.937 0 O-C-N 120.298 -1.501 . . . . 10.0 113.0 -177.669 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.2 p -101.68 149.76 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 124.61 1.164 . . . . 10.0 108.343 -178.042 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -108.15 -57.84 2.06 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 106.572 -1.64 . . . . 10.0 106.572 165.366 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -154.3 167.17 30.84 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 115.644 -0.707 . . . . 10.0 109.371 -169.376 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -157.0 77.05 4.08 Favored Pre-proline 0 N--CA 1.454 -0.24 0 C-N-CA 123.592 0.757 . . . . 10.0 110.841 -179.393 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -75.47 69.53 5.87 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.547 2.164 . . . . 10.0 110.124 -179.13 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.8 m -64.6 157.24 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 C-N-CA 123.518 0.727 . . . . 10.0 110.383 178.056 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -102.35 159.93 14.99 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 119.603 -0.839 . . . . 10.0 111.954 172.218 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -129.76 59.22 1.62 Allowed 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 125.474 1.51 . . . . 10.0 108.743 -172.339 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 171.72 -29.44 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 125.304 1.442 . . . . 10.0 111.335 165.894 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.7 mt -81.86 -7.72 59.63 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 122.714 0.406 . . . . 10.0 111.063 -176.106 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 67.06 41.27 2.68 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 126.025 1.73 . . . . 10.0 110.557 173.895 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -136.86 140.85 42.68 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.928 0.871 . . . . 10.0 109.774 173.579 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.5 t -110.99 138.97 36.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 107.569 -1.271 . . . . 10.0 107.569 174.156 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 90.6 m -124.29 121.56 35.35 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 126.193 1.797 . . . . 10.0 106.293 -176.07 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.4 t -120.02 143.49 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 C-N-CA 124.597 1.159 . . . . 10.0 109.171 -179.944 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -120.66 96.68 5.22 Favored 'General case' 0 N--CA 1.429 -1.519 0 C-N-CA 126.255 1.822 . . . . 10.0 107.067 173.606 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 11.9 p90 -139.35 161.74 36.72 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 124.079 0.952 . . . . 10.0 109.986 -174.806 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -93.7 123.5 59.68 Favored Pre-proline 0 CA--C 1.534 0.358 0 C-N-CA 123.278 0.631 . . . . 10.0 111.011 175.214 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -75.14 67.33 6.07 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.708 2.272 . . . . 10.0 109.039 172.723 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.45 -49.56 0.49 Allowed 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 107.893 -1.151 . . . . 10.0 107.893 177.919 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -82.54 -62.57 1.58 Allowed 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 108.643 -0.873 . . . . 10.0 108.643 177.101 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -110.27 171.79 7.25 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 125.196 1.398 . . . . 10.0 109.701 -176.701 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 24.8 p -125.32 179.61 5.02 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.886 1.274 . . . . 10.0 110.663 172.994 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 26.8 m -51.36 -37.68 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-N 114.846 -1.07 . . . . 10.0 111.93 166.64 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.8 t -69.86 -39.19 76.49 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 119.032 -0.509 . . . . 10.0 110.811 -174.657 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -60.0 -52.58 64.77 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 119.241 0.928 . . . . 10.0 109.261 -176.341 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.2 pp -66.45 -42.91 86.9 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.144 -0.48 . . . . 10.0 110.692 -179.658 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.65 -50.34 13.51 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 121.125 -0.985 . . . . 10.0 112.901 164.255 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -60.71 -43.79 97.38 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 119.748 1.158 . . . . 10.0 109.251 -179.366 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -53.1 -52.08 59.79 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.327 -0.851 . . . . 10.0 109.887 178.718 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 98.3 t -64.22 -43.39 97.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 123.04 0.536 . . . . 10.0 112.287 175.115 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -52.26 -51.76 56.59 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 121.995 0.903 . . . . 10.0 109.262 179.181 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 45.0 tptt -57.89 -30.92 66.24 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.812 1.645 . . . . 10.0 112.273 176.837 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.3 mp -61.54 -30.37 70.6 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.657 0.783 . . . . 10.0 110.812 173.977 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 141.16 -45.7 0.95 Allowed Glycine 0 CA--C 1.526 0.772 0 CA-C-N 118.448 0.567 . . . . 10.0 111.716 171.82 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -99.47 156.2 17.16 Favored 'General case' 0 C--O 1.226 -0.145 0 C-N-CA 124.973 1.309 . . . . 10.0 109.017 -178.67 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 24.1 mtpp -87.97 165.34 15.28 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-O 121.719 0.771 . . . . 10.0 111.191 -173.17 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 11.5 tp -136.04 149.46 48.78 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.141 1.776 . . . . 10.0 107.057 -179.831 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 8.7 mmtp -149.42 153.35 37.2 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 108.857 -0.794 . . . . 10.0 108.857 163.797 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.4 tp -62.04 158.51 16.36 Favored 'General case' 0 N--CA 1.453 -0.291 0 O-C-N 124.25 0.969 . . . . 10.0 109.084 174.905 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 12.1 tttt -114.83 -69.86 0.83 Allowed 'General case' 0 N--CA 1.436 -1.175 0 C-N-CA 126.674 1.989 . . . . 10.0 107.28 177.161 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 162.73 47.21 0.02 OUTLIER Glycine 0 CA--C 1.527 0.808 0 CA-C-O 119.291 -0.727 . . . . 10.0 112.87 175.491 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 . . . . . 0 CA--C 1.536 0.412 0 C-N-CA 125.105 1.362 . . . . 10.0 113.165 171.853 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 20.7 p . . . . . 0 N--CA 1.447 -0.584 0 N-CA-C 107.059 -1.46 . . . . 10.0 107.059 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -114.27 149.51 35.8 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.943 1.297 . . . . 10.0 110.379 -170.247 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.2 mtmm -98.96 77.18 2.17 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 126.266 1.826 . . . . 10.0 110.816 -160.254 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -79.17 153.57 29.95 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.806 1.643 . . . . 10.0 110.586 -173.724 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -129.52 151.51 50.05 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 124.05 0.94 . . . . 10.0 109.155 176.374 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -140.77 133.75 29.22 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 125.262 1.601 . . . . 10.0 109.776 -174.731 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -87.45 134.68 33.56 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 125.953 1.701 . . . . 10.0 107.883 -179.254 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 12.8 mm -106.03 138.71 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 C-N-CA 125.474 1.51 . . . . 10.0 110.636 -166.523 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 . . . . . 0 N--CA 1.443 -0.785 0 N-CA-C 108.546 -0.909 . . . . 10.0 108.546 165.749 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 . . . . . 0 N--CA 1.463 0.182 0 N-CA-C 112.758 0.651 . . . . 10.0 112.758 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.7 ttt180 -70.03 -30.04 67.23 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 121.283 -0.886 . . . . 10.0 109.329 -179.099 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 25.8 mm -55.68 -54.56 24.63 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 CA-C-O 118.431 -0.795 . . . . 10.0 108.972 173.532 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -43.8 -49.72 8.02 Favored 'General case' 0 C--O 1.223 -0.297 0 C-N-CA 123.352 0.661 . . . . 10.0 110.576 -177.895 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.4 mppt? -65.19 -52.24 56.1 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 123.196 0.599 . . . . 10.0 109.818 179.597 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.75 -21.92 66.55 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 112.527 0.566 . . . . 10.0 112.527 -175.506 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.74 -41.28 14.26 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 126.735 2.014 . . . . 10.0 111.44 172.336 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -57.73 -29.07 64.44 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.899 0.88 . . . . 10.0 110.216 175.792 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.2 mmpt? -53.47 -36.03 61.18 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 113.968 1.099 . . . . 10.0 113.968 169.597 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.5 mm -61.08 125.13 16.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 119.108 0.867 . . . . 10.0 109.219 178.576 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 64.2 mt-10 -59.34 -52.9 63.65 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.962 0.727 . . . . 10.0 112.962 -176.547 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.41 43.12 2.85 Favored Glycine 0 C--N 1.339 0.745 0 CA-C-N 120.053 1.297 . . . . 10.0 112.12 -172.78 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.7 p -107.75 153.16 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 C-N-CA 124.783 1.233 . . . . 10.0 108.805 -176.826 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -116.76 -55.13 2.39 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.12 -0.696 . . . . 10.0 109.12 174.615 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -147.32 160.21 42.78 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 108.882 -0.784 . . . . 10.0 108.882 179.596 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.39 61.31 3.9 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 123.647 0.779 . . . . 10.0 112.214 174.29 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -79.42 78.71 3.61 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.826 2.351 . . . . 10.0 109.595 -177.248 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.3 m -58.75 149.65 5.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 123.381 0.672 . . . . 10.0 111.855 -178.276 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -93.59 94.65 8.75 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.979 0.419 . . . . 10.0 111.538 -172.855 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -73.96 53.79 0.49 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 127.084 2.154 . . . . 10.0 112.769 -178.588 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -172.27 -42.88 0.02 OUTLIER 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 125.271 1.428 . . . . 10.0 109.217 170.317 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.3 mt -79.83 -19.69 47.8 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 115.691 -0.686 . . . . 10.0 111.144 -170.996 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 64.54 53.28 1.63 Allowed 'General case' 0 N--CA 1.457 -0.085 0 C-N-CA 124.751 1.22 . . . . 10.0 109.002 -177.199 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 30.3 p -138.04 125.66 22.2 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 106.632 -1.618 . . . . 10.0 106.632 169.849 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.9 t -87.92 145.54 7.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 106.267 -1.753 . . . . 10.0 106.267 166.89 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 96.7 m -128.23 133.49 48.84 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 105.826 -1.916 . . . . 10.0 105.826 178.444 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 26.4 t -136.46 129.31 45.76 Favored 'Isoleucine or valine' 0 C--N 1.339 0.114 0 CA-C-N 118.477 0.581 . . . . 10.0 111.081 176.925 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -92.98 101.02 13.35 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 126.444 1.897 . . . . 10.0 106.265 169.06 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -138.18 159.14 42.83 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 118.411 0.55 . . . . 10.0 111.995 -178.711 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 16.8 p30 -94.87 128.46 39.28 Favored Pre-proline 0 CA--C 1.527 0.06 0 C-N-CA 123.995 0.918 . . . . 10.0 110.656 178.583 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -76.07 56.46 4.87 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 122.425 2.083 . . . . 10.0 109.946 175.511 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.5 ttpt -131.87 -66.34 0.71 Allowed 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 106.628 -1.619 . . . . 10.0 106.628 173.501 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -99.11 -14.86 19.2 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.523 1.129 . . . . 10.0 110.735 -175.378 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -122.06 144.75 48.72 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.24 1.016 . . . . 10.0 110.348 -178.784 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -149.42 147.78 28.68 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.494 0.664 . . . . 10.0 111.291 -173.785 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.4 m -52.41 -42.44 38.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 124.546 1.139 . . . . 10.0 111.314 -178.304 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.2 m -52.72 -44.92 66.68 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.093 1.357 . . . . 10.0 111.974 177.964 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -76.21 -47.3 24.52 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.844 1.258 . . . . 10.0 109.444 -170.636 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.2 pp -65.72 -42.65 90.83 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 119.253 -0.979 . . . . 10.0 109.871 176.455 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.85 -53.17 10.16 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 117.48 -1.248 . . . . 10.0 112.247 163.548 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -50.94 -45.7 60.74 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 120.687 1.585 . . . . 10.0 110.252 178.121 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -55.52 -51.33 67.39 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.135 -0.939 . . . . 10.0 110.211 -178.038 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 21.9 t -65.16 -43.71 95.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-N 116.475 -0.33 . . . . 10.0 111.653 177.021 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.41 -54.25 47.81 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 108.188 -1.041 . . . . 10.0 108.188 -175.884 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -58.09 -38.92 77.32 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.733 1.213 . . . . 10.0 111.107 178.419 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -50.92 -34.09 27.05 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.333 0.653 . . . . 10.0 112.067 172.61 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.75 20.78 6.7 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 123.65 0.643 . . . . 10.0 113.281 172.127 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -142.22 175.05 10.06 Favored 'General case' 0 CA--C 1.522 -0.12 0 N-CA-C 105.627 -1.99 . . . . 10.0 105.627 167.406 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 31.4 tttt -123.08 152.87 40.62 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 119.244 0.929 . . . . 10.0 113.182 -164.867 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 12.7 tp -134.74 148.86 50.35 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 126.815 2.046 . . . . 10.0 107.907 -168.808 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 12.6 tptp -149.94 151.28 33.13 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-O 118.713 -0.661 . . . . 10.0 109.536 161.843 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 11.4 tp -60.45 155.15 18.93 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 109.13 -0.693 . . . . 10.0 109.13 175.617 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 35.8 tttp -112.7 -68.35 0.94 Allowed 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 126.443 1.897 . . . . 10.0 107.815 178.912 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 154.75 51.68 0.01 OUTLIER Glycine 0 CA--C 1.529 0.929 0 CA-C-O 119.527 -0.596 . . . . 10.0 112.726 175.095 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 . . . . . 0 CA--C 1.532 0.282 0 C-N-CA 125.735 1.614 . . . . 10.0 113.584 178.22 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 21.0 p . . . . . 0 N--CA 1.454 -0.253 0 CA-C-O 120.757 0.313 . . . . 10.0 110.533 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -136.83 149.69 47.87 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 127.505 2.322 . . . . 10.0 106.423 -175.689 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.9 mmtm -97.81 132.52 43.35 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 124.43 1.092 . . . . 10.0 110.555 -176.84 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -134.43 140.24 46.12 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.866 1.267 . . . . 10.0 108.88 177.901 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -119.73 145.83 46.18 Favored 'General case' 0 CA--C 1.513 -0.446 0 C-N-CA 123.817 0.847 . . . . 10.0 109.645 173.071 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -137.09 143.33 42.52 Favored 'General case' 0 N--CA 1.448 -0.544 0 O-C-N 125.084 1.49 . . . . 10.0 109.81 -173.221 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -106.63 135.75 47.61 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.273 1.429 . . . . 10.0 108.701 -174.646 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.9 mm -114.86 134.68 57.13 Favored 'Isoleucine or valine' 0 C--N 1.34 0.164 0 C-N-CA 125.203 1.401 . . . . 10.0 110.415 -161.772 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 . . . . . 0 N--CA 1.451 -0.407 0 N-CA-C 109.379 -0.6 . . . . 10.0 109.379 171.911 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 . . . . . 0 CA--C 1.537 0.46 0 CA-C-O 121.135 0.493 . . . . 10.0 112.0 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 11.9 ttm180 -74.6 -40.91 61.28 Favored 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 120.994 -1.066 . . . . 10.0 109.389 178.12 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 39.1 mm -46.23 -52.91 2.9 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 CA-C-O 117.796 -1.097 . . . . 10.0 110.012 170.504 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -43.99 -46.57 8.38 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 119.071 0.85 . . . . 10.0 111.955 -177.016 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -76.79 -39.66 50.75 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 123.737 0.815 . . . . 10.0 110.638 -178.279 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.91 -35.8 77.62 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 122.38 -0.2 . . . . 10.0 111.268 176.847 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.59 -36.28 29.16 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.293 1.837 . . . . 10.0 111.152 176.91 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -53.53 -31.63 47.07 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.265 -0.897 . . . . 10.0 110.88 173.232 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.5 mptt -54.15 -24.9 19.71 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 115.298 1.592 . . . . 10.0 115.298 172.349 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 11.4 mm -61.23 108.2 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 118.708 0.685 . . . . 10.0 109.966 172.381 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -55.37 -33.81 63.75 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.239 0.616 . . . . 10.0 111.945 -177.085 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.85 15.49 57.47 Favored Glycine 0 CA--C 1.528 0.883 0 O-C-N 121.497 -0.752 . . . . 10.0 113.19 -179.058 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.7 p -79.33 154.45 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-N 118.867 1.334 . . . . 10.0 109.943 -179.75 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -114.27 -46.62 2.97 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.541 -0.754 . . . . 10.0 109.716 161.019 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 -144.37 147.91 34.02 Favored 'General case' 0 C--N 1.339 0.12 0 N-CA-C 108.666 -0.864 . . . . 10.0 108.666 -173.389 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -148.48 56.3 2.52 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 118.721 0.692 . . . . 10.0 112.581 172.181 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -74.89 80.62 2.36 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.121 2.547 . . . . 10.0 109.797 178.523 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.6 m -62.3 157.73 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 123.823 0.849 . . . . 10.0 111.47 176.889 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 75.5 m-80 -92.12 116.92 29.36 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 120.23 -0.588 . . . . 10.0 112.18 -173.841 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -90.34 48.28 1.54 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.431 1.492 . . . . 10.0 111.249 -179.335 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -171.99 -39.01 0.02 OUTLIER 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 123.719 0.808 . . . . 10.0 110.579 165.272 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 16.4 mt -77.4 -15.03 59.57 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.794 0.838 . . . . 10.0 111.964 -167.666 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 65.52 47.25 2.28 Favored 'General case' 0 C--O 1.227 -0.081 0 C-N-CA 125.353 1.461 . . . . 10.0 109.824 -179.161 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 17.0 p -140.69 130.84 24.84 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 107.976 -1.12 . . . . 10.0 107.976 176.969 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.8 t -95.81 137.55 23.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 107.021 -1.474 . . . . 10.0 107.021 171.605 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 86.1 m -129.7 115.06 16.78 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 106.357 -1.72 . . . . 10.0 106.357 -174.776 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 32.3 t -115.69 144.05 24.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 C-N-CA 123.379 0.672 . . . . 10.0 109.799 -178.141 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -114.79 107.68 15.76 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 125.499 1.52 . . . . 10.0 107.873 164.836 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -149.13 164.18 35.45 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.736 -0.468 . . . . 10.0 109.736 -178.653 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -94.05 131.31 31.94 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 116.25 -0.432 . . . . 10.0 110.172 175.264 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -77.1 62.17 7.42 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.199 1.933 . . . . 10.0 109.488 169.336 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.83 -48.91 1.13 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.649 0.78 . . . . 10.0 108.994 174.685 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.29 -29.29 18.22 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 122.991 0.516 . . . . 10.0 111.841 -171.766 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.67 169.91 23.62 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.984 1.714 . . . . 10.0 106.82 -169.648 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 59.9 p -135.6 169.88 16.83 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 122.445 1.116 . . . . 10.0 112.649 -178.305 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 35.4 m -48.52 -40.87 11.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 125.189 1.395 . . . . 10.0 111.508 170.997 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 49.8 m -66.57 -35.87 81.26 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 123.509 0.723 . . . . 10.0 111.691 -179.746 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -70.2 -53.05 18.77 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 107.722 -1.214 . . . . 10.0 107.722 179.26 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.7 pp -65.87 -35.82 81.71 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 122.001 -0.437 . . . . 10.0 111.819 -173.317 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.7 ttpp -39.44 -54.63 1.9 Allowed 'General case' 0 C--N 1.341 0.222 0 O-C-N 121.216 -0.928 . . . . 10.0 112.559 159.952 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -54.42 -33.8 60.14 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 121.51 0.671 . . . . 10.0 110.54 -174.239 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.25 -52.33 66.05 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 121.778 0.799 . . . . 10.0 108.86 179.292 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 40.0 t -63.27 -43.11 98.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 115.331 -0.85 . . . . 10.0 110.716 176.617 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -56.88 -51.08 70.47 Favored 'General case' 0 CA--C 1.528 0.114 0 N-CA-C 109.28 -0.637 . . . . 10.0 109.28 -177.201 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -59.32 -35.84 74.55 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.241 1.016 . . . . 10.0 111.77 176.646 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -52.63 -31.21 35.54 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.621 0.769 . . . . 10.0 111.885 171.088 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 119.48 12.92 6.49 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 124.192 0.901 . . . . 10.0 113.124 171.401 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -149.9 161.67 41.83 Favored 'General case' 0 C--O 1.224 -0.245 0 N-CA-C 107.009 -1.478 . . . . 10.0 107.009 179.649 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.8 mttt -104.29 153.7 20.7 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 121.798 0.809 . . . . 10.0 112.002 -165.249 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.1 tp -129.72 145.76 51.52 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 127.298 2.239 . . . . 10.0 107.197 -176.474 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 33.3 mmtt -145.76 151.72 38.42 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 108.379 -0.971 . . . . 10.0 108.379 165.065 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 11.7 tp -63.25 156.46 25.4 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 108.419 -0.956 . . . . 10.0 108.419 173.48 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 24.3 ttpt -113.81 -52.85 2.72 Favored 'General case' 0 N--CA 1.437 -1.119 0 C-N-CA 126.433 1.893 . . . . 10.0 107.199 170.994 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 179.82 -78.95 0.06 OUTLIER Glycine 0 C--N 1.336 0.533 0 N-CA-C 109.736 -1.346 . . . . 10.0 109.736 174.486 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 . . . . . 0 N--CA 1.453 -0.3 0 N-CA-C 107.45 -1.315 . . . . 10.0 107.45 -168.1 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.1 p . . . . . 0 CA--C 1.533 0.309 0 N-CA-C 108.384 -0.969 . . . . 10.0 108.384 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -129.02 145.82 51.16 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 126.364 1.865 . . . . 10.0 109.628 -175.393 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 20.8 mtmt -106.82 92.16 3.97 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.383 1.473 . . . . 10.0 110.282 -165.706 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -97.61 151.67 19.84 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.906 1.682 . . . . 10.0 110.352 -171.822 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -124.43 148.04 47.89 Favored 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 124.24 1.016 . . . . 10.0 109.374 174.765 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -137.7 140.73 40.91 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 124.581 1.176 . . . . 10.0 109.266 -169.773 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -103.37 129.95 50.56 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 125.742 1.617 . . . . 10.0 108.587 -171.661 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.4 mm -110.52 127.16 67.73 Favored 'Isoleucine or valine' 0 C--N 1.34 0.164 0 C-N-CA 123.8 0.84 . . . . 10.0 110.71 -163.711 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 . . . . . 0 N--CA 1.449 -0.483 0 N-CA-C 108.805 -0.813 . . . . 10.0 108.805 169.751 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.534 0.331 0 CA-C-O 121.099 0.476 . . . . 10.0 110.908 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.04 -52.47 65.62 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 107.708 -1.219 . . . . 10.0 107.708 178.657 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.7 mt -46.25 -50.9 4.43 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.435 0 CA-C-O 117.652 -1.166 . . . . 10.0 111.011 -179.51 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -41.56 -57.65 2.18 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 119.147 0.885 . . . . 10.0 111.215 -178.316 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -67.43 -48.07 68.36 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 124.47 1.108 . . . . 10.0 110.566 -179.925 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.1 mmt180 -59.19 -21.7 59.85 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.326 0.861 . . . . 10.0 113.326 179.603 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.1 mt -92.55 -41.12 10.42 Favored 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 126.303 1.841 . . . . 10.0 110.693 171.973 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -52.06 -28.54 17.72 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.703 1.201 . . . . 10.0 110.167 174.6 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -44.81 -44.65 9.6 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 113.72 1.007 . . . . 10.0 113.72 168.411 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 7.3 mm -55.06 128.05 14.68 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 C-N-CA 123.125 0.57 . . . . 10.0 110.573 -179.316 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 20.0 mp0 -65.16 -51.86 58.59 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 122.17 -0.332 . . . . 10.0 111.066 -177.113 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.59 40.41 2.87 Favored Glycine 0 C--N 1.339 0.726 0 O-C-N 120.835 -1.165 . . . . 10.0 111.835 -173.411 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.2 p -99.3 148.64 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 C-N-CA 124.504 1.122 . . . . 10.0 108.571 -176.512 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -111.75 -56.96 2.32 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.1 0.96 . . . . 10.0 108.566 171.67 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -142.55 156.65 45.14 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 109.621 -0.511 . . . . 10.0 109.621 179.437 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -143.36 61.34 9.92 Favored Pre-proline 0 CA--C 1.535 0.4 0 C-N-CA 124.0 0.92 . . . . 10.0 110.721 174.605 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -78.68 71.54 6.86 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 122.76 2.306 . . . . 10.0 109.332 -176.724 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.6 m -64.09 153.51 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 O-C-N 121.728 -0.608 . . . . 10.0 111.002 -178.906 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 -88.23 140.71 29.2 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 120.577 -0.449 . . . . 10.0 110.532 177.256 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -114.89 39.25 2.92 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.277 1.431 . . . . 10.0 111.034 -173.376 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -173.17 -40.94 0.01 OUTLIER 'General case' 0 C--O 1.226 -0.135 0 C-N-CA 124.907 1.283 . . . . 10.0 110.339 178.529 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.5 mt -74.9 -19.43 60.15 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.98 0.912 . . . . 10.0 111.56 -172.434 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 64.44 52.43 1.83 Allowed 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 125.704 1.602 . . . . 10.0 110.343 -178.477 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.8 p -143.94 130.36 19.93 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 125.51 1.524 . . . . 10.0 107.476 175.14 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.9 t -100.47 148.59 6.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 106.829 -1.545 . . . . 10.0 106.829 173.323 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 59.0 m -136.55 126.53 25.97 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 106.403 -1.702 . . . . 10.0 106.403 -176.029 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.4 t -131.83 122.93 50.6 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 CA-C-N 118.48 0.582 . . . . 10.0 111.13 -179.538 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.0 mp0 -89.24 98.17 11.62 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 106.538 -1.652 . . . . 10.0 106.538 165.579 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -141.51 161.77 37.1 Favored 'General case' 0 CA--C 1.516 -0.332 0 C-N-CA 122.979 0.512 . . . . 10.0 110.089 175.661 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 31.3 p30 -92.14 136.26 26.08 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.238 -0.437 . . . . 10.0 110.556 178.439 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -79.85 53.0 4.54 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 121.234 1.289 . . . . 10.0 109.229 170.42 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.84 1.16 2.75 Favored 'General case' 0 C--N 1.347 0.49 0 CA-C-N 118.722 0.692 . . . . 10.0 112.801 177.94 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -138.28 -53.03 0.61 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.374 1.07 . . . . 10.0 108.502 -168.02 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -125.2 -176.41 3.56 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.01 1.324 . . . . 10.0 109.401 173.873 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 85.8 p -135.34 171.44 14.43 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.219 1.008 . . . . 10.0 110.875 174.495 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 77.8 t -48.39 -50.38 12.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 123.45 0.7 . . . . 10.0 110.533 166.787 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 72.2 m -59.78 -33.13 71.3 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.382 0.673 . . . . 10.0 111.526 -178.208 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -70.87 -59.55 2.73 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 108.607 -0.886 . . . . 10.0 108.607 175.482 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.0 pp -61.65 -47.04 87.17 Favored 'General case' 0 N--CA 1.452 -0.374 0 O-C-N 121.607 -0.683 . . . . 10.0 112.058 -170.579 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.3 -29.92 6.68 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 114.588 1.329 . . . . 10.0 114.588 170.428 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.61 -36.29 69.26 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 120.185 1.357 . . . . 10.0 109.993 177.586 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.29 -50.15 75.09 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.595 -0.52 . . . . 10.0 109.595 179.566 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 53.2 t -62.28 -50.17 81.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 123.34 0.656 . . . . 10.0 111.732 175.12 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -53.1 -40.77 64.38 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.684 0.794 . . . . 10.0 109.915 179.906 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.3 tptm -74.01 -38.6 64.02 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 124.498 1.119 . . . . 10.0 110.44 -178.41 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 34.3 mt -54.69 -41.46 70.25 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.278 0.49 . . . . 10.0 111.186 166.849 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 151.24 -51.19 0.52 Allowed Glycine 0 CA--C 1.525 0.68 0 CA-C-N 118.567 0.621 . . . . 10.0 112.445 166.755 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -76.07 157.22 33.18 Favored 'General case' 0 C--O 1.224 -0.25 0 N-CA-C 108.811 -0.811 . . . . 10.0 108.811 177.153 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 31.8 mtpt -103.02 157.75 16.77 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.352 0.596 . . . . 10.0 111.0 -172.663 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 34.2 tp -134.26 147.41 50.65 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.749 1.619 . . . . 10.0 108.419 -174.839 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 10.5 mmtp -152.46 156.01 38.62 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.771 1.628 . . . . 10.0 107.903 174.088 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.8 tp -66.5 159.05 28.07 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 109.771 -0.455 . . . . 10.0 109.771 176.029 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 6.0 tttp -113.76 -57.25 2.31 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 125.458 1.503 . . . . 10.0 108.409 169.651 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -172.72 -79.69 0.05 OUTLIER Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.273 -1.131 . . . . 10.0 110.273 179.962 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 . . . . . 0 N--CA 1.455 -0.2 0 C-N-CA 124.378 1.071 . . . . 10.0 108.435 -176.226 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.5 p . . . . . 0 CA--C 1.533 0.317 0 N-CA-C 108.407 -0.96 . . . . 10.0 108.407 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -134.85 136.53 42.52 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 126.101 1.76 . . . . 10.0 108.03 -170.228 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -102.86 113.63 27.23 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.005 0.922 . . . . 10.0 111.625 -168.415 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -115.64 149.95 37.5 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 127.306 2.243 . . . . 10.0 109.215 -172.32 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -124.24 146.97 48.41 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.493 1.117 . . . . 10.0 108.872 174.086 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -140.57 137.61 33.84 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 124.889 1.368 . . . . 10.0 110.467 -168.168 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.403 ' OD2' ' NZ ' ' A' ' 71' ' ' LYS . 1.2 m-20 -91.27 133.67 35.21 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 126.011 1.724 . . . . 10.0 109.421 -175.915 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.3 mm -113.1 134.38 55.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 125.611 1.565 . . . . 10.0 110.491 -173.959 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 . . . . . 0 N--CA 1.45 -0.441 0 C-N-CA 124.059 0.943 . . . . 10.0 108.645 171.252 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 . . . . . 0 CA--C 1.538 0.506 0 CA-C-O 121.454 0.645 . . . . 10.0 112.422 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.29 -45.96 79.96 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.085 0.954 . . . . 10.0 108.931 179.305 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.0 mt -43.7 -52.48 1.25 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.346 0 CA-C-O 118.362 -0.827 . . . . 10.0 110.532 175.572 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -48.0 -49.02 32.25 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 118.531 0.605 . . . . 10.0 110.873 -177.23 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.61 -47.69 58.85 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 121.627 -0.671 . . . . 10.0 110.533 -179.677 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -54.63 -33.8 61.11 Favored 'General case' 0 C--O 1.225 -0.235 0 C-N-CA 124.008 0.923 . . . . 10.0 112.181 178.305 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.99 -33.63 17.13 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 125.621 1.569 . . . . 10.0 111.392 177.605 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -60.06 -27.17 66.73 Favored 'General case' 0 C--O 1.225 -0.202 0 O-C-N 121.486 -0.759 . . . . 10.0 110.258 174.4 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.2 mmpt? -53.68 -34.26 58.13 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 113.736 1.013 . . . . 10.0 113.736 168.847 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 12.5 mm -56.4 127.92 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 119.126 0.875 . . . . 10.0 109.504 177.354 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -63.59 -56.93 12.07 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.515 -0.311 . . . . 10.0 110.486 -175.836 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.54 49.83 3.72 Favored Glycine 0 C--N 1.341 0.845 0 O-C-N 120.692 -1.255 . . . . 10.0 110.919 -173.042 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -105.71 146.06 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 C-N-CA 124.296 1.039 . . . . 10.0 108.244 -178.151 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -102.17 -52.22 3.2 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 108.375 -0.972 . . . . 10.0 108.375 176.004 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.0 p30 -160.23 149.37 17.41 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.449 -0.945 . . . . 10.0 108.449 -174.905 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -136.26 59.2 25.38 Favored Pre-proline 0 CA--C 1.536 0.424 0 C-N-CA 124.186 0.994 . . . . 10.0 111.54 178.077 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -77.0 74.84 4.82 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.031 2.487 . . . . 10.0 109.626 -178.964 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.0 m -65.28 158.42 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 C-N-CA 123.402 0.681 . . . . 10.0 111.428 179.988 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -96.35 121.71 38.44 Favored 'General case' 0 C--N 1.339 0.136 0 CA-C-O 120.83 0.347 . . . . 10.0 111.71 -176.861 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -96.15 50.16 1.16 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.303 1.441 . . . . 10.0 111.231 179.785 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -175.0 -40.72 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.228 0 C-N-CA 124.162 0.985 . . . . 10.0 109.928 172.533 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.1 mt -81.79 -11.6 58.91 Favored 'General case' 0 C--O 1.226 -0.146 0 C-N-CA 124.294 1.038 . . . . 10.0 112.214 -167.74 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 71.77 36.13 1.27 Allowed 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 125.403 1.481 . . . . 10.0 110.897 173.296 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.8 p -138.95 131.04 28.04 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.019 1.328 . . . . 10.0 108.312 -178.096 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 18.9 t -91.52 149.14 4.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 107.112 -1.44 . . . . 10.0 107.112 167.746 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 68.4 m -137.12 124.3 21.72 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 105.667 -1.975 . . . . 10.0 105.667 -179.553 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 47.9 t -135.98 138.44 47.46 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 CA-C-N 118.454 0.57 . . . . 10.0 109.712 179.278 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -101.95 112.71 25.44 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 107.226 -1.398 . . . . 10.0 107.226 165.145 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -146.99 165.92 28.38 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 123.361 0.664 . . . . 10.0 109.34 179.295 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 31.0 p30 -95.71 128.16 38.8 Favored Pre-proline 0 C--N 1.328 -0.341 0 N-CA-C 110.508 -0.182 . . . . 10.0 110.508 178.494 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -75.65 61.51 6.18 Favored 'Trans proline' 0 N--CA 1.45 -1.032 0 N-CA-C 108.507 -1.382 . . . . 10.0 108.507 169.205 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.31 -44.51 0.37 Allowed 'General case' 0 C--N 1.343 0.295 0 O-C-N 122.122 -0.361 . . . . 10.0 110.379 177.523 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -90.49 -36.61 14.41 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 122.378 0.271 . . . . 10.0 110.333 178.637 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -137.36 -175.58 4.11 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.542 1.137 . . . . 10.0 110.066 -179.707 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 91.5 p -147.05 172.44 13.74 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.295 0.638 . . . . 10.0 111.49 179.872 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 92.0 t -48.79 -45.4 15.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 124.051 0.94 . . . . 10.0 111.081 171.12 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.5 m -60.54 -37.22 80.51 Favored 'General case' 0 C--O 1.234 0.259 0 O-C-N 121.976 -0.452 . . . . 10.0 112.154 -179.689 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -65.71 -60.1 3.24 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 108.091 -1.078 . . . . 10.0 108.091 179.816 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.1 pp -63.48 -40.03 96.02 Favored 'General case' 0 N--CA 1.454 -0.24 0 O-C-N 121.55 -0.719 . . . . 10.0 111.477 -175.774 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.8 ttpp -39.16 -59.14 1.05 Allowed 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 117.627 -1.178 . . . . 10.0 111.004 162.653 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -47.85 -37.84 14.75 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-O 122.064 0.935 . . . . 10.0 110.755 -174.797 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.28 -49.76 76.61 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.041 -0.981 . . . . 10.0 109.784 -178.114 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 77.0 t -68.34 -45.65 82.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 124.536 1.134 . . . . 10.0 111.748 175.487 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -46.18 -44.67 16.2 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 126.576 1.95 . . . . 10.0 108.349 176.11 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -80.63 -34.63 34.84 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.238 1.415 . . . . 10.0 111.349 -176.887 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 18.7 mt -51.97 -43.43 63.56 Favored 'General case' 0 C--N 1.34 0.196 0 CA-C-N 118.871 0.759 . . . . 10.0 111.869 169.033 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 150.81 -35.18 0.93 Allowed Glycine 0 CA--C 1.525 0.666 0 C-N-CA 121.277 -0.487 . . . . 10.0 113.057 172.717 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -99.63 159.13 15.27 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.687 1.195 . . . . 10.0 107.888 -178.52 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.3 ttpt -94.8 155.16 16.93 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.194 0.521 . . . . 10.0 109.871 -176.984 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 24.8 tp -124.9 149.85 47.13 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 126.439 1.896 . . . . 10.0 107.528 179.756 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 34.0 mmtt -149.18 156.88 42.82 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 124.803 1.241 . . . . 10.0 108.332 162.905 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.7 tp -66.09 158.79 27.59 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 109.083 -0.71 . . . . 10.0 109.083 173.963 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.403 ' NZ ' ' OD2' ' A' ' 8' ' ' ASP . 0.0 OUTLIER -113.56 -56.45 2.4 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 125.551 1.54 . . . . 10.0 107.159 166.461 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -176.35 -83.01 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 109.609 -1.396 . . . . 10.0 109.609 179.13 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 . . . . . 0 N--CA 1.454 -0.272 0 C-N-CA 123.544 0.738 . . . . 10.0 109.379 -167.923 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.0 p . . . . . 0 N--CA 1.452 -0.353 0 CA-C-O 120.61 0.243 . . . . 10.0 111.02 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -136.57 151.67 49.63 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 128.434 2.694 . . . . 10.0 107.8 179.548 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 17.0 mmtt -96.86 118.13 32.61 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 108.491 -0.929 . . . . 10.0 108.491 175.796 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -113.68 138.54 50.07 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 124.253 1.021 . . . . 10.0 109.749 172.5 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -113.82 145.79 40.91 Favored 'General case' 0 CA--C 1.51 -0.591 0 C-N-CA 124.589 1.156 . . . . 10.0 110.246 174.97 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -139.17 142.52 37.96 Favored 'General case' 0 N--CA 1.448 -0.575 0 O-C-N 125.036 1.46 . . . . 10.0 110.056 -177.077 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -103.59 134.38 47.02 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 125.882 1.673 . . . . 10.0 108.604 -174.371 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.3 mm -109.58 125.25 66.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 C-N-CA 123.711 0.804 . . . . 10.0 110.422 -162.886 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 . . . . . 0 N--CA 1.452 -0.335 0 N-CA-C 108.476 -0.935 . . . . 10.0 108.476 173.005 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.542 0.642 0 N-CA-C 112.961 0.726 . . . . 10.0 112.961 . . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.0 ttt180 -84.93 -42.02 15.37 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 126.058 1.743 . . . . 10.0 109.604 -172.653 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 18.4 mm -41.66 -57.05 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.323 0 C-N-CA 124.368 1.067 . . . . 10.0 108.66 166.756 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -42.53 -50.62 5.27 Favored 'General case' 0 C--O 1.221 -0.4 0 O-C-N 123.576 0.548 . . . . 10.0 111.399 179.389 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.7 -49.79 56.13 Favored 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 121.875 -0.516 . . . . 10.0 109.631 -176.289 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.9 mmt85 -57.65 -38.65 75.44 Favored 'General case' 0 C--O 1.226 -0.149 0 O-C-N 121.94 -0.475 . . . . 10.0 112.036 -179.437 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.36 -46.35 41.15 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.194 0.997 . . . . 10.0 110.147 177.396 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 53.0 m-20 -54.95 -24.08 22.12 Favored 'General case' 0 C--O 1.226 -0.135 0 C-N-CA 123.319 0.648 . . . . 10.0 111.503 174.941 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.3 ttmt -56.19 -39.53 72.56 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 118.372 0.533 . . . . 10.0 112.225 175.665 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.7 mp -56.74 135.87 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 C-N-CA 123.873 0.869 . . . . 10.0 110.436 179.09 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 55.9 mp0 -70.78 -49.46 46.33 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 116.274 -0.421 . . . . 10.0 110.091 -174.119 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.22 49.01 4.15 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.973 -0.851 . . . . 10.0 110.973 -177.836 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.4 p -110.74 155.54 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 126.009 1.724 . . . . 10.0 109.073 178.03 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -120.34 -56.78 1.97 Allowed 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 110.235 -0.283 . . . . 10.0 110.235 168.648 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -144.97 149.04 34.48 Favored 'General case' 0 C--O 1.226 -0.172 0 N-CA-C 107.992 -1.114 . . . . 10.0 107.992 -171.484 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -142.85 63.73 13.97 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 118.708 0.685 . . . . 10.0 111.201 172.4 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -76.71 74.32 4.91 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.926 2.417 . . . . 10.0 109.38 178.135 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.4 m -66.02 158.27 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 C-N-CA 123.624 0.77 . . . . 10.0 112.082 179.702 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -90.72 101.69 14.44 Favored 'General case' 0 N--CA 1.46 0.069 0 C-N-CA 120.441 -0.504 . . . . 10.0 111.706 -165.982 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -75.55 42.22 0.21 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.249 1.82 . . . . 10.0 113.938 -173.302 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -177.07 -36.3 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.288 1.435 . . . . 10.0 110.64 176.513 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.2 mt -88.67 0.99 55.88 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.635 1.174 . . . . 10.0 112.667 -169.156 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 58.26 45.5 17.11 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 124.789 1.235 . . . . 10.0 110.402 170.955 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -145.39 129.12 17.22 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.694 -1.224 . . . . 10.0 107.694 -178.124 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.5 t -97.55 126.79 50.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 108.277 -1.008 . . . . 10.0 108.277 175.575 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 84.0 m -113.8 112.26 23.1 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.982 1.713 . . . . 10.0 107.457 178.687 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 41.3 t -106.09 141.59 21.01 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.044 0 CA-C-N 118.359 0.527 . . . . 10.0 110.183 177.49 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -108.12 109.77 21.27 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 125.376 1.47 . . . . 10.0 108.016 160.227 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -143.2 169.57 17.37 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.905 -0.776 . . . . 10.0 108.905 177.288 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 7.3 p-10 -115.46 115.34 42.22 Favored Pre-proline 0 CA--C 1.531 0.238 0 C-N-CA 123.722 0.809 . . . . 10.0 110.021 -178.708 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -74.56 72.1 4.46 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.376 2.717 . . . . 10.0 111.015 -175.832 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.88 -39.16 0.63 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.075 0.55 . . . . 10.0 110.934 168.548 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -86.94 -51.07 6.25 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.193 0.451 . . . . 10.0 110.107 176.756 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -123.76 -175.0 3.11 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.784 1.234 . . . . 10.0 110.742 -171.653 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 83.2 p -144.46 167.94 21.3 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.575 0.75 . . . . 10.0 112.677 177.762 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 23.5 m -47.0 -43.19 6.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 124.57 1.148 . . . . 10.0 111.515 164.312 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 68.3 m -68.78 -40.89 79.42 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 122.782 0.433 . . . . 10.0 110.731 -177.095 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -57.78 -59.48 5.15 Favored 'General case' 0 N--CA 1.455 -0.199 0 O-C-N 123.916 0.76 . . . . 10.0 109.297 176.396 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.2 pp -65.05 -39.38 93.23 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 122.165 -0.334 . . . . 10.0 110.933 -171.536 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -43.46 -45.64 6.44 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 118.254 -0.879 . . . . 10.0 113.194 163.812 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -59.92 -40.56 89.25 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 120.236 1.38 . . . . 10.0 111.024 179.802 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -55.44 -49.41 72.49 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 122.106 -0.371 . . . . 10.0 110.104 178.366 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 24.8 t -66.08 -43.44 92.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 N-CA-C 112.815 0.672 . . . . 10.0 112.815 176.207 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -53.19 -44.0 67.59 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.841 0.829 . . . . 10.0 109.081 177.841 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.0 tttp -80.21 -30.59 38.69 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 124.722 1.209 . . . . 10.0 111.591 -175.246 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 15.1 mt -51.38 -35.49 39.01 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.407 1.003 . . . . 10.0 111.507 162.36 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 115.78 28.35 2.73 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 123.041 0.353 . . . . 10.0 112.822 169.066 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -145.67 158.24 43.87 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 107.251 -1.388 . . . . 10.0 107.251 168.443 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.24 130.96 37.82 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.69 -0.485 . . . . 10.0 109.69 -166.146 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 12.1 tp -114.9 146.98 40.55 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 106.265 -1.754 . . . . 10.0 106.265 173.261 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 17.6 tptt -153.09 150.14 28.82 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 109.053 -0.721 . . . . 10.0 109.053 168.458 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.9 tp -62.39 156.6 22.09 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 109.316 -0.624 . . . . 10.0 109.316 178.04 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 42.1 tttt -117.22 -64.24 1.33 Allowed 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 126.326 1.85 . . . . 10.0 107.742 178.905 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 154.06 50.71 0.01 OUTLIER Glycine 0 CA--C 1.527 0.8 0 CA-C-O 119.661 -0.522 . . . . 10.0 112.337 174.967 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 . . . . . 0 CA--C 1.537 0.472 0 C-N-CA 125.267 1.427 . . . . 10.0 111.989 175.014 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.8 p . . . . . 0 CA--C 1.534 0.351 0 N-CA-C 107.195 -1.409 . . . . 10.0 107.195 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -138.39 142.81 39.6 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 129.12 2.968 . . . . 10.0 106.989 -174.227 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 28.9 tttt -111.32 98.69 7.67 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.373 1.069 . . . . 10.0 110.09 -171.504 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -99.92 150.15 22.69 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.834 -1.075 . . . . 10.0 108.844 -175.641 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -122.36 150.17 42.77 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 123.221 0.608 . . . . 10.0 109.919 172.286 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -138.26 137.14 37.2 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 125.452 1.72 . . . . 10.0 108.335 -169.477 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -99.45 139.64 34.81 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 106.328 -1.731 . . . . 10.0 106.328 178.874 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.0 mm -114.32 141.39 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 C-N-CA 124.995 1.318 . . . . 10.0 109.913 -162.779 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 . . . . . 0 N--CA 1.444 -0.729 0 N-CA-C 108.155 -1.054 . . . . 10.0 108.155 176.702 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 . . . . . 0 N--CA 1.464 0.27 0 CA-C-O 120.575 0.226 . . . . 10.0 111.274 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.92 -42.04 41.0 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 118.306 -0.854 . . . . 10.0 111.033 176.202 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 27.2 mm -43.15 -55.1 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.411 0 CA-C-N 118.65 0.659 . . . . 10.0 109.573 174.028 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -43.17 -57.41 2.96 Favored 'General case' 0 C--O 1.222 -0.377 0 C-N-CA 123.244 0.618 . . . . 10.0 111.607 -179.48 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.06 -41.88 63.68 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.392 1.077 . . . . 10.0 109.794 -170.601 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 25.6 tpt180 -53.81 -45.65 70.86 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.328 0.651 . . . . 10.0 109.958 175.358 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.03 -37.72 64.25 Favored 'General case' 0 C--O 1.224 -0.284 0 C-N-CA 123.2 0.6 . . . . 10.0 111.858 176.046 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -51.98 -32.39 33.36 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 123.723 0.809 . . . . 10.0 109.788 175.317 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.7 -33.42 70.16 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.947 1.091 . . . . 10.0 113.947 175.478 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 17.0 mm -57.48 133.21 22.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 108.314 -0.995 . . . . 10.0 108.314 177.465 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -80.29 -41.88 24.12 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 118.486 0.585 . . . . 10.0 110.757 -172.039 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -78.91 39.92 2.05 Favored Glycine 0 C--N 1.339 0.738 0 O-C-N 120.117 -1.614 . . . . 10.0 112.491 176.1 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.4 p -105.68 148.22 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 C-N-CA 124.179 0.991 . . . . 10.0 108.363 -176.594 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -115.54 -56.36 2.35 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.92 -0.77 . . . . 10.0 108.92 174.876 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 64.2 m-80 -147.32 152.76 38.77 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 109.264 -0.643 . . . . 10.0 109.264 -178.546 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -134.81 65.85 67.26 Favored Pre-proline 0 CA--C 1.534 0.341 0 C-N-CA 123.639 0.776 . . . . 10.0 110.015 173.667 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -78.92 67.33 8.57 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.825 2.35 . . . . 10.0 109.078 -178.946 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.0 m -69.59 157.58 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 C-N-CA 122.889 0.476 . . . . 10.0 111.339 -175.89 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -91.51 126.36 36.57 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 121.276 0.56 . . . . 10.0 110.82 -178.675 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -99.61 33.07 2.61 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.962 1.705 . . . . 10.0 112.015 -168.522 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -171.12 -40.71 0.02 OUTLIER 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 124.542 1.137 . . . . 10.0 110.661 179.986 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.1 mt -72.57 -20.06 61.38 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.089 0.956 . . . . 10.0 111.477 -173.31 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 65.17 51.59 1.62 Allowed 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 125.664 1.586 . . . . 10.0 110.424 -178.018 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.1 p -140.1 124.37 17.82 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 125.457 1.503 . . . . 10.0 107.066 173.606 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.9 t -97.2 135.3 31.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 107.773 -1.195 . . . . 10.0 107.773 175.581 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.6 m -120.85 127.84 52.28 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 126.161 1.785 . . . . 10.0 107.418 178.708 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 36.6 t -131.9 128.18 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.123 0 CA-C-N 118.678 0.672 . . . . 10.0 110.093 178.94 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -93.13 102.11 14.41 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 105.314 -2.106 . . . . 10.0 105.314 165.968 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -135.7 176.78 8.37 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.536 1.134 . . . . 10.0 108.612 178.812 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 27.7 p30 -116.96 135.78 23.12 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 118.879 0.763 . . . . 10.0 110.986 175.682 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -79.7 56.84 6.22 Favored 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 121.435 1.424 . . . . 10.0 108.85 167.307 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.8 ptpt -123.88 -39.51 2.38 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 118.133 0.424 . . . . 10.0 111.344 172.828 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -97.99 -61.68 1.35 Allowed 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 107.425 -1.324 . . . . 10.0 107.425 177.48 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -105.62 -174.96 2.66 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 125.047 1.339 . . . . 10.0 111.102 -171.718 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 87.7 p -144.68 164.9 29.59 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 121.673 0.749 . . . . 10.0 109.985 173.692 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.2 m -52.58 -37.47 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 C-N-CA 124.384 1.073 . . . . 10.0 111.154 172.228 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.2 t -62.72 -40.45 97.24 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 122.47 0.308 . . . . 10.0 110.708 177.058 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -65.67 -52.79 48.81 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.891 -0.781 . . . . 10.0 108.891 -175.97 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.0 pp -64.77 -42.47 95.08 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 121.762 -0.586 . . . . 10.0 111.218 -178.482 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -41.54 -55.22 2.94 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-O 117.737 -1.125 . . . . 10.0 111.751 162.345 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 -56.58 -48.28 77.73 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 119.939 1.245 . . . . 10.0 110.353 178.669 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -51.29 -45.31 62.1 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 109.59 -0.522 . . . . 10.0 109.59 -178.665 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 99.5 t -69.39 -46.98 75.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 112.401 0.519 . . . . 10.0 112.401 174.017 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.518 ' CG ' ' HZ2' ' A' ' 67' ' ' LYS . 2.0 t0 -45.59 -42.35 11.04 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.482 1.513 . . . . 10.0 109.522 177.556 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -79.96 -26.2 40.09 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 125.104 1.362 . . . . 10.0 111.329 -173.879 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 67.9 mt -55.96 -41.23 74.39 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 119.489 1.041 . . . . 10.0 110.91 164.559 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 149.03 -40.79 0.88 Allowed Glycine 0 CA--C 1.526 0.755 0 CA-C-N 118.088 0.404 . . . . 10.0 112.531 173.227 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -96.02 157.51 15.86 Favored 'General case' 0 C--N 1.334 -0.099 0 C-N-CA 124.204 1.002 . . . . 10.0 109.351 -177.749 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.518 ' HZ2' ' CG ' ' A' ' 62' ' ' ASP . 63.5 mmtt -92.12 148.61 22.04 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 121.506 0.67 . . . . 10.0 110.341 -170.426 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 10.5 tp -124.46 148.73 47.47 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.115 1.766 . . . . 10.0 106.608 176.675 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.0 tptm -151.48 145.14 24.99 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 117.956 0.344 . . . . 10.0 110.711 165.478 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.4 tt -64.9 159.41 22.81 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-O 121.462 0.649 . . . . 10.0 109.684 178.36 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 27.5 tttt -127.38 -55.54 1.34 Allowed 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 127.701 2.4 . . . . 10.0 107.829 -175.979 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 176.34 -89.91 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 107.92 -2.072 . . . . 10.0 107.92 177.522 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 . . . . . 0 N--CA 1.451 -0.38 0 C-N-CA 123.788 0.835 . . . . 10.0 108.795 -164.295 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.7 p . . . . . 0 N--CA 1.445 -0.694 0 N-CA-C 109.786 -0.45 . . . . 10.0 109.786 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -125.33 145.35 50.07 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 126.581 1.952 . . . . 10.0 108.273 -169.98 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.8 mmtm -87.15 124.45 33.28 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 124.096 0.959 . . . . 10.0 109.675 -175.166 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -125.35 143.11 51.13 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.16 1.784 . . . . 10.0 109.349 176.95 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -121.31 146.75 46.51 Favored 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 123.518 0.727 . . . . 10.0 109.096 172.881 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -133.39 140.27 47.26 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 125.194 1.559 . . . . 10.0 108.522 -173.443 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -96.99 141.79 29.72 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.687 1.995 . . . . 10.0 107.618 -177.471 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.401 ' CD1' ' H ' ' A' ' 43' ' ' VAL . 3.3 mp -132.41 148.5 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 125.236 1.415 . . . . 10.0 110.531 -167.407 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 . . . . . 0 N--CA 1.441 -0.877 0 CA-C-N 112.286 -2.234 . . . . 10.0 106.229 175.613 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 . . . . . 0 N--CA 1.472 0.642 0 N-CA-C 112.334 0.494 . . . . 10.0 112.334 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.81 -40.88 89.9 Favored 'General case' 0 N--CA 1.455 -0.219 0 O-C-N 120.904 -1.122 . . . . 10.0 109.301 176.298 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 20.8 mm -54.13 -49.4 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 108.772 -0.825 . . . . 10.0 108.772 -177.945 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -45.8 -56.42 5.37 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.568 0.747 . . . . 10.0 110.967 -179.895 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.8 mtmt -66.29 -44.6 83.06 Favored 'General case' 0 N--CA 1.453 -0.291 0 O-C-N 121.845 -0.534 . . . . 10.0 111.084 179.583 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.0 tpt85 -56.88 -30.74 64.17 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 111.487 0.18 . . . . 10.0 111.487 178.829 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -84.0 -38.34 21.05 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 125.469 1.508 . . . . 10.0 111.46 174.894 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -60.67 -26.75 67.32 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.779 0.832 . . . . 10.0 109.785 178.845 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.0 mmpt? -50.69 -35.88 33.18 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 114.058 1.133 . . . . 10.0 114.058 168.397 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 13.4 mm -62.84 126.89 22.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 118.63 0.65 . . . . 10.0 109.388 -178.784 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -56.19 -57.53 11.81 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.13 0.419 . . . . 10.0 112.13 -179.673 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -82.57 43.9 3.13 Favored Glycine 0 C--N 1.341 0.838 0 O-C-N 120.259 -1.526 . . . . 10.0 111.988 -170.717 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.5 p -108.07 150.03 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 C-N-CA 124.645 1.178 . . . . 10.0 108.643 -176.965 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -106.86 -58.54 1.92 Allowed 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 109.039 -0.726 . . . . 10.0 109.039 171.81 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -144.97 141.31 28.86 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 106.837 -1.542 . . . . 10.0 106.837 -166.732 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -133.83 59.71 40.94 Favored Pre-proline 0 CA--C 1.535 0.388 0 CA-C-N 118.488 0.586 . . . . 10.0 111.719 172.297 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -77.0 82.26 2.4 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 123.248 2.632 . . . . 10.0 109.215 -178.62 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.9 m -71.53 151.44 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 O-C-N 121.746 -0.596 . . . . 10.0 110.705 -177.793 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -86.32 142.58 28.4 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 120.638 -0.425 . . . . 10.0 110.131 177.345 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -120.88 52.98 1.15 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.269 1.427 . . . . 10.0 110.067 -174.979 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -176.0 -42.7 0.01 OUTLIER 'General case' 0 C--O 1.226 -0.158 0 C-N-CA 125.481 1.512 . . . . 10.0 108.698 178.287 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.8 mt -80.13 -20.96 43.73 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.028 0.931 . . . . 10.0 111.459 -172.599 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 59.04 49.74 9.09 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 126.31 1.844 . . . . 10.0 110.129 -172.336 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 20.7 p -134.74 117.35 15.9 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 125.064 1.345 . . . . 10.0 108.631 173.362 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.401 ' H ' ' CD1' ' A' ' 9' ' ' ILE . 14.4 t -85.34 131.33 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 106.282 -1.747 . . . . 10.0 106.282 171.636 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.2 m -110.81 123.88 50.94 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 105.991 -1.855 . . . . 10.0 105.991 172.295 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 33.6 t -121.92 146.24 27.36 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.274 0 N-CA-C 107.961 -1.126 . . . . 10.0 107.961 171.277 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -112.47 113.35 25.48 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 106.303 -1.74 . . . . 10.0 106.303 166.569 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -142.08 156.82 45.41 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.062 0.545 . . . . 10.0 110.715 -177.099 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 19.6 p30 -93.37 126.05 51.9 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 118.813 -0.613 . . . . 10.0 109.47 177.225 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -74.71 63.42 5.72 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 122.401 2.067 . . . . 10.0 108.922 174.717 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.3 tttt -135.33 -57.03 0.8 Allowed 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 105.331 -2.1 . . . . 10.0 105.331 174.662 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -101.38 -51.12 3.56 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 108.638 -0.875 . . . . 10.0 108.638 -177.797 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -81.59 137.72 35.46 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 123.627 0.771 . . . . 10.0 110.717 -176.851 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.6 p -131.38 145.5 51.85 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.417 1.087 . . . . 10.0 110.945 177.112 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 97.0 t -48.39 -48.05 14.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 C-N-CA 125.243 1.417 . . . . 10.0 110.355 174.776 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.01 -43.79 78.06 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 124.914 1.285 . . . . 10.0 111.432 -179.858 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -64.97 -55.86 16.6 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 121.695 0.76 . . . . 10.0 109.3 -177.249 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.2 pp -65.56 -41.62 92.74 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.162 -0.961 . . . . 10.0 111.307 -176.423 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -43.88 -48.61 8.41 Favored 'General case' 0 N--CA 1.451 -0.4 0 O-C-N 121.51 -0.744 . . . . 10.0 112.291 161.701 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.63 -43.17 84.62 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 119.224 0.92 . . . . 10.0 109.695 -179.377 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -49.67 -56.81 8.75 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 122.741 0.417 . . . . 10.0 110.556 177.057 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 47.4 t -58.45 -50.19 79.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 N-CA-C 113.184 0.809 . . . . 10.0 113.184 174.185 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -59.21 -35.74 74.15 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.317 1.047 . . . . 10.0 109.5 -174.132 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.8 tptt -77.4 -43.83 31.33 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 125.301 1.441 . . . . 10.0 110.52 178.083 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 19.4 mt -51.25 -39.01 55.75 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-N 118.938 0.79 . . . . 10.0 111.569 172.358 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 128.8 3.08 5.56 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-O 119.41 -0.661 . . . . 10.0 113.58 169.29 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -99.45 -160.44 0.8 Allowed 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 107.57 -1.27 . . . . 10.0 107.57 175.768 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 35.0 tttt -139.06 149.12 44.23 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 118.458 0.572 . . . . 10.0 111.238 167.638 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.9 tp -135.62 150.84 49.77 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 127.419 2.288 . . . . 10.0 106.475 -176.046 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.7 tptm -149.76 152.89 35.98 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 108.446 -0.946 . . . . 10.0 108.446 163.642 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.6 tp -63.91 157.46 24.76 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 119.341 0.973 . . . . 10.0 108.883 172.338 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 34.5 tttp -117.03 -56.14 2.28 Favored 'General case' 0 N--CA 1.436 -1.152 0 C-N-CA 126.51 1.924 . . . . 10.0 107.783 170.133 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -179.47 -89.25 0.08 OUTLIER Glycine 0 CA--C 1.523 0.535 0 N-CA-C 109.158 -1.577 . . . . 10.0 109.158 -177.864 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 . . . . . 0 N--CA 1.454 -0.251 0 C-N-CA 123.865 0.866 . . . . 10.0 109.189 -166.666 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 47.6 t . . . . . 0 N--CA 1.469 0.497 0 N-CA-C 107.825 -1.176 . . . . 10.0 107.825 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.9 p -130.62 154.5 47.82 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.826 1.25 . . . . 10.0 109.838 -176.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -119.2 139.55 51.67 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 127.045 2.138 . . . . 10.0 109.321 -172.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.9 mtmm -104.87 88.75 2.97 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.844 1.658 . . . . 10.0 110.63 -165.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -104.59 152.35 22.53 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.299 1.44 . . . . 10.0 110.497 -168.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -123.54 148.89 45.88 Favored 'General case' 0 CA--C 1.511 -0.545 0 C-N-CA 123.791 0.836 . . . . 10.0 110.199 178.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -138.72 142.3 38.9 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 125.241 1.416 . . . . 10.0 108.205 -175.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -108.86 137.41 46.84 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 107.698 -1.223 . . . . 10.0 107.698 -173.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 5.1 mm -110.22 124.86 67.33 Favored 'Isoleucine or valine' 0 C--N 1.338 0.096 0 C-N-CA 124.52 1.128 . . . . 10.0 110.715 -159.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -117.58 102.67 9.36 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.942 -0.762 . . . . 10.0 108.942 173.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 160.15 -84.75 0.12 Allowed Glycine 0 CA--C 1.527 0.792 0 C-N-CA 123.887 0.756 . . . . 10.0 111.858 170.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.14 160.95 15.19 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.441 0.697 . . . . 10.0 110.772 -176.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.6 t -153.02 86.18 1.24 Allowed 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 107.485 -1.302 . . . . 10.0 107.485 170.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 31.6 t -152.48 138.26 17.95 Favored 'General case' 0 C--O 1.227 -0.131 0 N-CA-C 108.564 -0.902 . . . . 10.0 108.564 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -48.73 -53.4 19.09 Favored 'General case' 0 C--O 1.226 -0.173 0 C-N-CA 125.192 1.397 . . . . 10.0 113.738 -172.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.58 -40.76 48.6 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.336 -0.616 . . . . 10.0 109.336 -168.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.2 m -61.7 -52.38 64.53 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.336 -0.616 . . . . 10.0 109.336 176.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -52.33 -40.0 61.36 Favored 'General case' 0 C--O 1.221 -0.428 0 C-N-CA 123.693 0.797 . . . . 10.0 110.205 173.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -51.69 -31.2 25.02 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 121.497 -0.752 . . . . 10.0 111.897 179.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.59 -38.26 89.43 Favored 'General case' 0 N--CA 1.446 -0.655 0 O-C-N 121.265 -0.897 . . . . 10.0 110.154 178.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 19.3 mm -41.45 -54.04 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.305 0 C-N-CA 124.349 1.06 . . . . 10.0 111.495 170.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -49.56 -50.28 42.89 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-N 118.355 0.525 . . . . 10.0 110.476 -176.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.53 -46.22 67.01 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.787 -0.57 . . . . 10.0 110.187 -178.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 7.6 mmt180 -55.75 -32.27 63.28 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 113.284 0.846 . . . . 10.0 113.284 177.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.92 -42.58 14.85 Favored 'General case' 0 C--O 1.22 -0.499 0 C-N-CA 123.419 0.688 . . . . 10.0 111.21 172.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -60.28 -18.65 50.69 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 120.933 -1.105 . . . . 10.0 111.359 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.1 mmpt? -51.19 -41.03 59.94 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 113.863 1.06 . . . . 10.0 113.863 164.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 10.8 mt -54.5 129.43 15.61 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.068 0 CA-C-N 119.216 0.916 . . . . 10.0 108.909 175.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 58.0 mp0 -66.94 -46.23 75.38 Favored 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 122.132 -0.355 . . . . 10.0 110.129 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.18 43.91 3.2 Favored Glycine 0 C--N 1.339 0.699 0 O-C-N 121.266 -0.896 . . . . 10.0 111.998 -173.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.4 p -103.8 152.47 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 C-N-CA 124.894 1.278 . . . . 10.0 108.811 -176.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -117.69 -59.75 1.89 Allowed 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.677 -0.861 . . . . 10.0 108.677 168.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 -140.13 160.15 40.59 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 109.29 -0.633 . . . . 10.0 109.29 -178.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -149.2 63.72 6.88 Favored Pre-proline 0 CA--C 1.535 0.374 0 C-N-CA 123.191 0.596 . . . . 10.0 110.804 173.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -78.12 75.58 4.78 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.89 2.393 . . . . 10.0 109.698 -176.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.3 m -70.98 157.41 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 O-C-N 121.744 -0.597 . . . . 10.0 112.024 -177.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -100.93 138.07 38.47 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 110.084 -0.339 . . . . 10.0 110.084 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -120.98 53.66 1.12 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.976 1.31 . . . . 10.0 110.603 -172.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -176.26 -41.31 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 125.727 1.611 . . . . 10.0 108.805 178.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.3 mt -82.24 -15.2 53.94 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.021 1.328 . . . . 10.0 111.44 -172.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 72.91 44.15 0.37 Allowed 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 125.762 1.625 . . . . 10.0 110.377 173.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 39.7 p -140.91 131.71 25.83 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.189 1.396 . . . . 10.0 109.067 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.0 t -99.97 141.94 16.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 107.746 -1.205 . . . . 10.0 107.746 167.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 62.5 m -130.12 124.12 31.97 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 106.576 -1.639 . . . . 10.0 106.576 -176.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 16.5 t -126.63 134.54 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 C-N-CA 123.091 0.556 . . . . 10.0 110.681 -175.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -108.98 94.22 4.93 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 127.043 2.137 . . . . 10.0 106.914 171.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -140.14 163.38 32.89 Favored 'General case' 0 CA--C 1.521 -0.15 0 C-N-CA 123.29 0.636 . . . . 10.0 109.46 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -95.92 132.48 27.01 Favored Pre-proline 0 C--N 1.329 -0.306 0 C-N-CA 123.57 0.748 . . . . 10.0 110.186 177.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -78.81 56.43 5.96 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.081 1.854 . . . . 10.0 109.926 171.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.0 pttt -118.53 -45.74 2.6 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 108.965 -0.754 . . . . 10.0 108.965 170.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.08 -46.29 5.63 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.2 1.0 . . . . 10.0 110.605 -167.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -122.92 -171.34 2.27 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.287 1.035 . . . . 10.0 109.6 175.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 97.2 p -149.46 170.8 17.76 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.297 0.639 . . . . 10.0 110.466 177.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 31.4 m -49.42 -42.11 16.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 123.679 0.792 . . . . 10.0 111.293 172.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 66.9 m -61.23 -42.36 98.47 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 123.454 0.702 . . . . 10.0 111.699 -178.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -62.28 -57.39 11.59 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.265 0.626 . . . . 10.0 109.501 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.1 pp -65.85 -40.87 92.14 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 121.512 0.672 . . . . 10.0 110.373 -173.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -44.32 -47.19 9.54 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 112.675 0.62 . . . . 10.0 112.675 163.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.11 -44.54 96.43 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-N 119.02 0.827 . . . . 10.0 109.512 178.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -52.12 -47.76 65.16 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 110.382 -0.229 . . . . 10.0 110.382 178.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 38.7 t -65.73 -46.17 89.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 N-CA-C 112.776 0.658 . . . . 10.0 112.776 174.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -56.48 -38.67 72.04 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 120.544 -1.347 . . . . 10.0 110.268 178.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.2 tptm -66.65 -35.52 80.36 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.051 1.34 . . . . 10.0 109.83 -178.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 26.4 mt -58.65 -30.15 67.09 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 118.98 -0.533 . . . . 10.0 112.068 169.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 137.39 -39.79 1.58 Allowed Glycine 0 CA--C 1.527 0.804 0 C-N-CA 123.701 0.667 . . . . 10.0 111.716 171.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -97.7 152.44 19.1 Favored 'General case' 0 C--O 1.226 -0.175 0 C-N-CA 125.148 1.379 . . . . 10.0 109.527 -172.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -89.35 153.34 20.94 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.648 0.737 . . . . 10.0 110.849 -170.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 29.1 tp -130.3 148.29 52.11 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.233 1.813 . . . . 10.0 107.383 177.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 9.4 tptp -154.7 152.81 30.37 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 108.912 -0.773 . . . . 10.0 108.912 165.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.6 tp -62.46 154.7 27.64 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 109.488 -0.56 . . . . 10.0 109.488 178.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -108.34 -60.94 1.66 Allowed 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 125.462 1.505 . . . . 10.0 106.961 168.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -174.44 -79.4 0.05 OUTLIER Glycine 0 CA--C 1.521 0.455 0 N-CA-C 110.003 -1.239 . . . . 10.0 110.003 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -162.49 174.38 12.76 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.384 1.074 . . . . 10.0 108.128 -170.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 23.8 pt20 -45.25 129.95 8.03 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 123.863 0.727 . . . . 10.0 112.123 178.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.403 ' CG ' ' H ' ' A' ' 76' ' ' SER . 8.6 t70 67.27 -176.3 0.2 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.109 1.364 . . . . 10.0 110.69 174.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.403 ' H ' ' CG ' ' A' ' 75' ' ' ASP . 40.3 m -96.47 -23.26 16.66 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.08 1.352 . . . . 10.0 110.975 171.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 15.3 mt -128.24 -119.39 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 123.2 0.6 . . . . 10.0 109.571 -178.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 33.09 64.74 0.27 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 127.259 2.224 . . . . 10.0 113.942 -175.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -65.18 109.91 3.17 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 109.503 -1.439 . . . . 10.0 109.503 171.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.144 0 CA-C-O 116.499 -1.715 . . . . 10.0 107.204 -172.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 47.6 t . . . . . 0 N--CA 1.469 0.497 0 N-CA-C 107.825 -1.176 . . . . 10.0 107.825 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.9 p -130.62 154.5 47.82 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.826 1.25 . . . . 10.0 109.838 -176.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -119.2 139.55 51.67 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 127.045 2.138 . . . . 10.0 109.321 -172.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.9 mtmm -104.87 88.75 2.97 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.844 1.658 . . . . 10.0 110.63 -165.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -104.59 152.35 22.53 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.299 1.44 . . . . 10.0 110.497 -168.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -123.54 148.89 45.88 Favored 'General case' 0 CA--C 1.511 -0.545 0 C-N-CA 123.791 0.836 . . . . 10.0 110.199 178.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -138.72 142.3 38.9 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 125.241 1.416 . . . . 10.0 108.205 -175.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -108.86 137.41 46.84 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 107.698 -1.223 . . . . 10.0 107.698 -173.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 5.1 mm -110.22 124.86 67.33 Favored 'Isoleucine or valine' 0 C--N 1.338 0.096 0 C-N-CA 124.52 1.128 . . . . 10.0 110.715 -159.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -117.58 102.67 9.36 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.942 -0.762 . . . . 10.0 108.942 173.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 160.15 -84.75 0.12 Allowed Glycine 0 CA--C 1.527 0.792 0 C-N-CA 123.887 0.756 . . . . 10.0 111.858 170.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.14 160.95 15.19 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.441 0.697 . . . . 10.0 110.772 -176.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.6 t -153.02 86.18 1.24 Allowed 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 107.485 -1.302 . . . . 10.0 107.485 170.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 31.6 t -152.48 138.26 17.95 Favored 'General case' 0 C--O 1.227 -0.131 0 N-CA-C 108.564 -0.902 . . . . 10.0 108.564 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -48.73 -53.4 19.09 Favored 'General case' 0 C--O 1.226 -0.173 0 C-N-CA 125.192 1.397 . . . . 10.0 113.738 -172.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.58 -40.76 48.6 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.336 -0.616 . . . . 10.0 109.336 -168.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.2 m -61.7 -52.38 64.53 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.336 -0.616 . . . . 10.0 109.336 176.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -52.33 -40.0 61.36 Favored 'General case' 0 C--O 1.221 -0.428 0 C-N-CA 123.693 0.797 . . . . 10.0 110.205 173.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -51.69 -31.2 25.02 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 121.497 -0.752 . . . . 10.0 111.897 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.59 -38.26 89.43 Favored 'General case' 0 N--CA 1.446 -0.655 0 O-C-N 121.265 -0.897 . . . . 10.0 110.154 178.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 19.3 mm -41.45 -54.04 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.305 0 C-N-CA 124.349 1.06 . . . . 10.0 111.495 170.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -49.56 -50.28 42.89 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-N 118.355 0.525 . . . . 10.0 110.476 -176.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.53 -46.22 67.01 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.787 -0.57 . . . . 10.0 110.187 -178.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 7.6 mmt180 -55.75 -32.27 63.28 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 113.284 0.846 . . . . 10.0 113.284 177.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.92 -42.58 14.85 Favored 'General case' 0 C--O 1.22 -0.499 0 C-N-CA 123.419 0.688 . . . . 10.0 111.21 172.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -60.28 -18.65 50.69 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 120.933 -1.105 . . . . 10.0 111.359 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.1 mmpt? -51.19 -41.03 59.94 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 113.863 1.06 . . . . 10.0 113.863 164.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 10.8 mt -54.5 129.43 15.61 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.068 0 CA-C-N 119.216 0.916 . . . . 10.0 108.909 175.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 58.0 mp0 -66.94 -46.23 75.38 Favored 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 122.132 -0.355 . . . . 10.0 110.129 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.18 43.91 3.2 Favored Glycine 0 C--N 1.339 0.699 0 O-C-N 121.266 -0.896 . . . . 10.0 111.998 -173.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.4 p -103.8 152.47 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 C-N-CA 124.894 1.278 . . . . 10.0 108.811 -176.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -117.69 -59.75 1.89 Allowed 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.677 -0.861 . . . . 10.0 108.677 168.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 -140.13 160.15 40.59 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 109.29 -0.633 . . . . 10.0 109.29 -178.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -149.2 63.72 6.88 Favored Pre-proline 0 CA--C 1.535 0.374 0 C-N-CA 123.191 0.596 . . . . 10.0 110.804 173.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -78.12 75.58 4.78 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.89 2.393 . . . . 10.0 109.698 -176.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.3 m -70.98 157.41 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 O-C-N 121.744 -0.597 . . . . 10.0 112.024 -177.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -100.93 138.07 38.47 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 110.084 -0.339 . . . . 10.0 110.084 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -120.98 53.66 1.12 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.976 1.31 . . . . 10.0 110.603 -172.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -176.26 -41.31 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 125.727 1.611 . . . . 10.0 108.805 178.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.3 mt -82.24 -15.2 53.94 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.021 1.328 . . . . 10.0 111.44 -172.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 72.91 44.15 0.37 Allowed 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 125.762 1.625 . . . . 10.0 110.377 173.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 39.7 p -140.91 131.71 25.83 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.189 1.396 . . . . 10.0 109.067 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.0 t -99.97 141.94 16.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 107.746 -1.205 . . . . 10.0 107.746 167.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 62.5 m -130.12 124.12 31.97 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 106.576 -1.639 . . . . 10.0 106.576 -176.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 16.5 t -126.63 134.54 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 C-N-CA 123.091 0.556 . . . . 10.0 110.681 -175.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -108.98 94.22 4.93 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 127.043 2.137 . . . . 10.0 106.914 171.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -140.14 163.38 32.89 Favored 'General case' 0 CA--C 1.521 -0.15 0 C-N-CA 123.29 0.636 . . . . 10.0 109.46 179.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -95.92 132.48 27.01 Favored Pre-proline 0 C--N 1.329 -0.306 0 C-N-CA 123.57 0.748 . . . . 10.0 110.186 177.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -78.81 56.43 5.96 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.081 1.854 . . . . 10.0 109.926 171.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.0 pttt -118.53 -45.74 2.6 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 108.965 -0.754 . . . . 10.0 108.965 170.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.08 -46.29 5.63 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.2 1.0 . . . . 10.0 110.605 -167.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -122.92 -171.34 2.27 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.287 1.035 . . . . 10.0 109.6 175.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 97.2 p -149.46 170.8 17.76 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.297 0.639 . . . . 10.0 110.466 177.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 31.4 m -49.42 -42.11 16.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 123.679 0.792 . . . . 10.0 111.293 172.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 66.9 m -61.23 -42.36 98.47 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 123.454 0.702 . . . . 10.0 111.699 -178.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -62.28 -57.39 11.59 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.265 0.626 . . . . 10.0 109.501 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.1 pp -65.85 -40.87 92.14 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 121.512 0.672 . . . . 10.0 110.373 -173.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -44.32 -47.19 9.54 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 112.675 0.62 . . . . 10.0 112.675 163.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.11 -44.54 96.43 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-N 119.02 0.827 . . . . 10.0 109.512 178.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -52.12 -47.76 65.16 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 110.382 -0.229 . . . . 10.0 110.382 178.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 38.7 t -65.73 -46.17 89.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 N-CA-C 112.776 0.658 . . . . 10.0 112.776 174.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -56.48 -38.67 72.04 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 120.544 -1.347 . . . . 10.0 110.268 178.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.2 tptm -66.65 -35.52 80.36 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.051 1.34 . . . . 10.0 109.83 -178.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 26.4 mt -58.65 -30.15 67.09 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 118.98 -0.533 . . . . 10.0 112.068 169.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 137.39 -39.79 1.58 Allowed Glycine 0 CA--C 1.527 0.804 0 C-N-CA 123.701 0.667 . . . . 10.0 111.716 171.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -97.7 152.44 19.1 Favored 'General case' 0 C--O 1.226 -0.175 0 C-N-CA 125.148 1.379 . . . . 10.0 109.527 -172.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -89.35 153.34 20.94 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.648 0.737 . . . . 10.0 110.849 -170.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 29.1 tp -130.3 148.29 52.11 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.233 1.813 . . . . 10.0 107.383 177.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 9.4 tptp -154.7 152.81 30.37 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 108.912 -0.773 . . . . 10.0 108.912 165.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.6 tp -62.46 154.7 27.64 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 109.488 -0.56 . . . . 10.0 109.488 178.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -108.34 -60.94 1.66 Allowed 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 125.462 1.505 . . . . 10.0 106.961 168.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -174.44 -79.4 0.05 OUTLIER Glycine 0 CA--C 1.521 0.455 0 N-CA-C 110.003 -1.239 . . . . 10.0 110.003 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -162.49 174.38 12.76 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.384 1.074 . . . . 10.0 108.128 -170.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 23.8 pt20 -45.25 129.95 8.03 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 123.863 0.727 . . . . 10.0 112.123 178.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.403 ' CG ' ' H ' ' A' ' 76' ' ' SER . 8.6 t70 67.27 -176.3 0.2 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.109 1.364 . . . . 10.0 110.69 174.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.403 ' H ' ' CG ' ' A' ' 75' ' ' ASP . 40.3 m -96.47 -23.26 16.66 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.08 1.352 . . . . 10.0 110.975 171.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 15.3 mt -128.24 -119.39 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 123.2 0.6 . . . . 10.0 109.571 -178.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 33.09 64.74 0.27 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 127.259 2.224 . . . . 10.0 113.942 -175.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -65.18 109.91 3.17 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 109.503 -1.439 . . . . 10.0 109.503 171.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.144 0 CA-C-O 116.499 -1.715 . . . . 10.0 107.204 -172.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.2 p . . . . . 0 N--CA 1.472 0.652 0 N-CA-C 109.807 -0.442 . . . . 10.0 109.807 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.8 p -142.48 159.09 42.91 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.238 1.415 . . . . 10.0 107.555 178.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -121.7 147.69 45.57 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 126.51 1.924 . . . . 10.0 108.143 -166.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -88.69 130.91 35.21 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 107.983 -1.117 . . . . 10.0 107.983 -178.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -145.35 135.9 24.27 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.251 -0.648 . . . . 10.0 109.251 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -122.23 149.42 43.69 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 123.449 0.7 . . . . 10.0 111.614 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -136.28 137.97 41.27 Favored 'General case' 0 N--CA 1.451 -0.409 0 O-C-N 125.134 1.521 . . . . 10.0 110.037 -170.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -93.9 138.09 32.41 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 106.926 -1.509 . . . . 10.0 106.926 178.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 6.9 mm -109.93 132.39 58.3 Favored 'Isoleucine or valine' 0 C--N 1.34 0.168 0 C-N-CA 125.018 1.327 . . . . 10.0 111.496 -165.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 -124.23 94.18 4.14 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 124.098 0.959 . . . . 10.0 109.649 176.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 162.43 -70.15 0.22 Allowed Glycine 0 CA--C 1.53 0.987 0 CA-C-O 119.33 -0.706 . . . . 10.0 113.089 164.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 23.7 ptp -149.99 136.97 19.46 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.18 0.99 . . . . 10.0 109.72 -173.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.2 p -149.16 30.06 0.78 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.222 1.009 . . . . 10.0 111.066 -156.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 94.6 m -90.4 -65.39 1.02 Allowed 'General case' 0 C--O 1.224 -0.24 0 O-C-N 121.728 -0.607 . . . . 10.0 110.944 -157.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -172.19 -67.92 0.02 OUTLIER 'General case' 0 C--O 1.222 -0.388 0 C-N-CA 123.956 0.902 . . . . 10.0 109.568 -177.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.99 -39.48 66.02 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 109.501 -0.555 . . . . 10.0 109.501 -173.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 13.8 p -60.32 -49.08 79.01 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.776 -0.453 . . . . 10.0 109.776 177.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.26 -43.66 83.2 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.185 0.994 . . . . 10.0 109.445 173.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -55.79 -43.05 76.46 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 122.102 -0.374 . . . . 10.0 110.976 -179.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 20.7 ttt180 -58.92 -34.8 72.12 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.717 0.807 . . . . 10.0 109.29 -177.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 14.9 mm -52.04 -41.92 33.25 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.466 0 CA-C-O 117.381 -1.295 . . . . 10.0 111.349 171.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 75.0 mt-10 -51.68 -50.11 61.08 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-N 120.78 1.627 . . . . 10.0 110.766 -178.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.2 mtmt -69.64 -45.7 67.87 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.103 0.561 . . . . 10.0 109.789 178.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.4 mmt180 -62.19 -30.92 71.41 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 120.316 -0.554 . . . . 10.0 112.195 -176.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.4 mt -79.07 -50.34 11.21 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 125.238 1.415 . . . . 10.0 110.369 172.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -48.0 -27.3 2.16 Favored 'General case' 0 C--O 1.226 -0.164 0 C-N-CA 124.297 1.039 . . . . 10.0 111.867 178.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -53.06 -47.52 68.39 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 112.337 0.495 . . . . 10.0 112.337 174.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.1 mp -52.83 131.91 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 C-N-CA 124.838 1.255 . . . . 10.0 110.803 -179.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 50.9 mp0 -70.11 -48.05 59.25 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 116.306 -0.406 . . . . 10.0 110.364 -171.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -84.89 39.76 2.97 Favored Glycine 0 CA--C 1.525 0.686 0 O-C-N 121.064 -1.022 . . . . 10.0 111.937 -175.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.6 p -99.92 149.57 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 C-N-CA 124.411 1.084 . . . . 10.0 108.313 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -119.11 -53.69 2.25 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 122.969 0.507 . . . . 10.0 109.819 171.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.1 m-80 -142.6 154.75 44.69 Favored 'General case' 0 C--N 1.339 0.125 0 CA-C-N 118.298 0.499 . . . . 10.0 109.7 -177.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -146.92 62.8 7.77 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 124.101 0.961 . . . . 10.0 111.968 174.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -77.22 73.42 5.5 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.652 2.235 . . . . 10.0 110.048 -178.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.0 m -68.68 155.77 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 O-C-N 121.507 -0.745 . . . . 10.0 111.858 -177.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -99.03 131.51 45.02 Favored 'General case' 0 N--CA 1.458 -0.07 0 N-CA-C 110.204 -0.295 . . . . 10.0 110.204 -176.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -115.38 60.86 0.7 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.919 1.288 . . . . 10.0 110.424 -173.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 168.83 -32.63 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 127.118 2.167 . . . . 10.0 108.708 171.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.0 mt -86.89 -2.74 58.83 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.071 1.349 . . . . 10.0 112.103 -176.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 61.22 43.7 10.66 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 125.303 1.441 . . . . 10.0 111.107 166.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -142.5 129.79 21.05 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.297 1.439 . . . . 10.0 107.983 -176.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.4 t -101.49 132.37 47.47 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 N-CA-C 106.509 -1.663 . . . . 10.0 106.509 172.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 29.2 m -121.63 121.68 37.93 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 125.587 1.555 . . . . 10.0 106.817 -174.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.2 t -125.03 147.63 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 C-N-CA 123.271 0.628 . . . . 10.0 110.27 -176.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -125.24 95.69 4.57 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 127.723 2.409 . . . . 10.0 104.693 174.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -147.95 163.54 36.53 Favored 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 123.448 0.699 . . . . 10.0 109.568 -174.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 18.8 p30 -95.12 131.61 29.72 Favored Pre-proline 0 C--N 1.329 -0.317 0 C-N-CA 122.67 0.388 . . . . 10.0 110.551 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -78.2 60.82 7.57 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 121.537 1.491 . . . . 10.0 108.414 168.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.35 -45.55 0.46 Allowed 'General case' 0 C--N 1.344 0.343 0 O-C-N 121.859 -0.526 . . . . 10.0 110.554 176.232 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -87.66 -36.81 17.23 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 122.896 0.479 . . . . 10.0 110.442 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -137.2 174.88 10.14 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 125.914 1.686 . . . . 10.0 108.275 -179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 59.5 p -131.66 176.14 8.58 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.503 1.121 . . . . 10.0 110.186 174.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 29.7 m -48.99 -39.18 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-N 115.184 -0.916 . . . . 10.0 111.749 168.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 17.6 m -58.48 -40.6 83.19 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.707 0.803 . . . . 10.0 111.648 -178.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -71.32 -52.19 20.16 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.049 0.939 . . . . 10.0 109.686 -175.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.3 pp -64.64 -41.87 95.83 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 120.532 -1.355 . . . . 10.0 110.568 179.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.81 -49.58 15.01 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-O 117.821 -1.085 . . . . 10.0 113.046 163.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -52.99 -46.56 68.36 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 120.712 1.597 . . . . 10.0 109.164 176.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -54.14 -50.04 67.85 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 114.789 -1.096 . . . . 10.0 110.874 -177.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 95.8 t -65.28 -44.73 94.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 112.309 0.485 . . . . 10.0 112.309 173.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -58.79 -47.29 85.26 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 121.107 -0.995 . . . . 10.0 109.952 -175.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.4 tmtm? -56.54 -35.6 68.3 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.899 1.28 . . . . 10.0 111.227 175.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.71 -38.8 67.52 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.612 0.765 . . . . 10.0 110.702 173.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 135.21 -33.05 2.49 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 124.076 0.846 . . . . 10.0 111.767 175.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -94.12 157.84 15.89 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.954 0.902 . . . . 10.0 109.628 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.1 mtmp? -98.14 154.29 17.85 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.677 0.751 . . . . 10.0 110.989 -175.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.8 tp -129.22 148.62 51.17 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.555 1.942 . . . . 10.0 107.219 -177.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.2 tptm -151.67 148.67 28.21 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 119.27 -0.395 . . . . 10.0 111.089 159.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 11.8 tp -63.73 155.15 30.98 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 121.775 0.797 . . . . 10.0 109.702 178.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.5 tttt -119.45 -56.47 2.06 Favored 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 129.282 3.033 . . . . 10.0 107.655 177.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 172.37 -100.07 0.15 Allowed Glycine 0 N--CA 1.442 -0.935 0 N-CA-C 107.152 -2.379 . . . . 10.0 107.152 -176.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -157.1 166.4 33.39 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.967 1.307 . . . . 10.0 107.94 -165.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -90.32 156.96 17.9 Favored 'General case' 0 N--CA 1.453 -0.299 0 O-C-N 123.768 0.668 . . . . 10.0 110.265 -175.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -54.06 -33.6 57.89 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.162 0.985 . . . . 10.0 111.478 175.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 13.4 t 73.0 -175.48 0.16 Allowed 'General case' 0 C--N 1.34 0.166 0 C-N-CA 125.735 1.614 . . . . 10.0 110.917 177.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 13.1 pt -127.11 -176.73 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.358 0 N-CA-C 105.417 -2.068 . . . . 10.0 105.417 161.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -78.3 173.79 11.92 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.613 1.965 . . . . 10.0 110.712 175.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -147.52 -84.9 0.05 OUTLIER Glycine 0 CA--C 1.528 0.893 0 C-N-CA 123.701 0.667 . . . . 10.0 112.928 -176.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.235 0 CA-C-O 115.881 -2.009 . . . . 10.0 106.651 -169.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 2.3 p . . . . . 0 N--CA 1.469 0.522 0 CA-C-O 117.384 -1.293 . . . . 10.0 107.614 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 19.3 p -113.35 167.72 10.33 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.921 1.289 . . . . 10.0 109.146 177.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -127.09 135.67 51.08 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 127.524 2.33 . . . . 10.0 108.29 -175.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 58.6 mmtt -83.56 114.56 21.6 Favored 'General case' 0 N--CA 1.448 -0.559 0 O-C-N 124.06 0.85 . . . . 10.0 109.07 171.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -114.98 145.23 42.46 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.807 1.243 . . . . 10.0 109.545 169.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -119.46 150.78 39.65 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.046 0.939 . . . . 10.0 110.639 173.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -140.14 136.68 33.77 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.899 1.28 . . . . 10.0 109.377 -171.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -97.44 134.98 39.97 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 106.981 -1.489 . . . . 10.0 106.981 -177.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.2 mm -108.35 142.01 22.1 Favored 'Isoleucine or valine' 0 C--N 1.342 0.259 0 C-N-CA 124.297 1.039 . . . . 10.0 111.192 -165.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -125.74 84.02 2.23 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.032 0.933 . . . . 10.0 109.375 171.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 160.16 -96.27 0.15 Allowed Glycine 0 CA--C 1.53 0.983 0 CA-C-O 119.892 -0.393 . . . . 10.0 112.753 171.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 5.0 mtt -66.78 74.73 0.11 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.167 1.387 . . . . 10.0 113.082 -172.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.8 p -105.14 45.68 0.95 Allowed 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 126.268 1.827 . . . . 10.0 109.539 -173.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 45.9 t -146.33 59.52 1.22 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.569 0.7 . . . . 10.0 111.099 -173.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 47.54 -77.62 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 127.481 2.313 . . . . 10.0 116.297 167.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.21 -28.62 70.16 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 121.865 0.84 . . . . 10.0 109.596 176.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 20.6 m -60.27 -59.59 5.17 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 123.569 0.747 . . . . 10.0 109.633 168.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -50.69 -38.87 49.41 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.795 1.238 . . . . 10.0 112.203 176.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -55.22 -22.8 19.26 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.406 -0.809 . . . . 10.0 112.511 177.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.82 -40.7 83.78 Favored 'General case' 0 N--CA 1.45 -0.439 0 O-C-N 120.611 -1.306 . . . . 10.0 109.953 176.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 8.1 mm -41.17 -57.94 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.39 0 N-CA-C 108.993 -0.743 . . . . 10.0 108.993 170.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -49.44 -45.58 46.74 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.075 0.95 . . . . 10.0 111.931 -172.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.6 mmpt? -71.92 -45.26 61.79 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 123.208 0.603 . . . . 10.0 110.272 179.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -62.94 -32.44 73.74 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 120.498 -0.481 . . . . 10.0 111.533 -178.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.4 -39.59 28.07 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.016 1.727 . . . . 10.0 111.668 175.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -49.28 -33.56 13.29 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 119.077 0.853 . . . . 10.0 110.468 171.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -53.83 -37.58 63.74 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 113.178 0.807 . . . . 10.0 113.178 176.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 22.4 mm -60.87 129.46 23.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 123.458 0.703 . . . . 10.0 109.135 178.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -79.64 -37.32 36.29 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 118.623 0.647 . . . . 10.0 111.441 -175.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -77.39 30.24 1.67 Allowed Glycine 0 C--N 1.339 0.718 0 O-C-N 120.391 -1.443 . . . . 10.0 112.619 178.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -102.9 147.22 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 C-N-CA 124.576 1.15 . . . . 10.0 107.96 -176.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -118.19 -47.66 2.56 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 122.661 0.384 . . . . 10.0 110.348 175.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -146.48 144.2 29.49 Favored 'General case' 0 C--O 1.226 -0.181 0 N-CA-C 108.308 -0.997 . . . . 10.0 108.308 -173.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -136.23 60.78 35.49 Favored Pre-proline 0 CA--C 1.539 0.522 0 C-N-CA 123.584 0.753 . . . . 10.0 111.978 176.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -76.34 74.69 4.57 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.948 2.432 . . . . 10.0 110.213 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.3 m -69.11 155.49 7.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 123.36 0.664 . . . . 10.0 112.05 -179.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -94.92 92.07 6.72 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.035 0.445 . . . . 10.0 110.469 -174.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -71.77 43.3 0.09 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 127.364 2.266 . . . . 10.0 114.141 -175.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -176.86 -36.32 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 126.388 1.875 . . . . 10.0 110.577 177.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.6 mt -90.25 3.54 53.26 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 124.519 1.128 . . . . 10.0 112.684 -171.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 64.61 38.31 7.26 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.5 1.12 . . . . 10.0 110.371 165.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -142.22 130.21 21.9 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.278 1.431 . . . . 10.0 107.829 -176.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.4 t -100.46 139.03 22.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 107.578 -1.268 . . . . 10.0 107.578 173.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 27.1 m -127.76 119.4 25.67 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 106.803 -1.554 . . . . 10.0 106.803 -177.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 40.1 t -123.3 138.98 51.39 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 N-CA-C 109.201 -0.666 . . . . 10.0 109.201 -178.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -100.6 109.08 21.13 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 106.485 -1.672 . . . . 10.0 106.485 162.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 14.4 p90 -138.71 165.27 27.41 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 109.465 -0.568 . . . . 10.0 109.465 176.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 15.2 p30 -108.58 128.77 24.97 Favored Pre-proline 0 C--N 1.331 -0.237 0 C-N-CA 123.587 0.755 . . . . 10.0 109.301 177.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -75.59 64.16 6.53 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.449 2.1 . . . . 10.0 109.129 174.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.8 pttt -130.48 -47.54 1.07 Allowed 'General case' 0 CA--C 1.527 0.076 0 N-CA-C 108.967 -0.753 . . . . 10.0 108.967 177.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -89.13 -62.15 1.55 Allowed 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.43 -0.952 . . . . 10.0 108.43 178.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -119.67 163.93 16.66 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 125.9 1.68 . . . . 10.0 109.332 -173.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 34.7 p -118.38 -179.1 3.68 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 122.855 1.312 . . . . 10.0 110.482 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.9 m -44.9 -40.99 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 113.697 -1.592 . . . . 10.0 111.966 163.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.0 t -69.86 -40.16 75.93 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 118.889 -0.577 . . . . 10.0 110.743 -172.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -62.66 -50.68 70.25 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.619 0.723 . . . . 10.0 109.331 -172.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.2 pp -64.33 -46.73 82.21 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.895 -0.503 . . . . 10.0 110.846 178.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.04 -45.88 16.33 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.099 -1.0 . . . . 10.0 113.46 166.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 15.5 tm-20 -62.66 -47.97 81.38 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 119.647 1.112 . . . . 10.0 109.408 177.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -52.73 -47.5 67.33 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 121.372 0.606 . . . . 10.0 109.725 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 80.5 t -66.01 -44.22 92.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 N-CA-C 112.746 0.647 . . . . 10.0 112.746 175.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -54.76 -39.72 68.64 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 120.942 -1.098 . . . . 10.0 110.071 175.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 40.2 tptt -70.73 -37.81 73.53 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 125.431 1.492 . . . . 10.0 110.832 -178.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 12.2 mt -51.36 -26.15 7.23 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 118.792 -0.623 . . . . 10.0 112.49 163.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 129.62 -25.41 4.48 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 124.127 0.87 . . . . 10.0 112.684 165.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 16.8 p90 -115.63 154.58 29.2 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 125.628 1.571 . . . . 10.0 108.437 -172.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.6 156.0 18.45 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.946 0.879 . . . . 10.0 111.545 -167.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 9.9 tp -132.45 146.81 52.22 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 127.033 2.133 . . . . 10.0 106.954 -178.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 9.5 mmtp -146.44 139.45 25.55 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 123.011 0.524 . . . . 10.0 110.616 163.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.8 tt -65.65 157.03 31.07 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 124.32 1.012 . . . . 10.0 109.383 173.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 55.1 tttt -127.44 -65.91 0.91 Allowed 'General case' 0 N--CA 1.437 -1.082 0 C-N-CA 127.445 2.298 . . . . 10.0 108.918 -172.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.35 -86.24 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 107.943 -2.063 . . . . 10.0 107.943 175.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -172.89 167.05 5.17 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.469 1.108 . . . . 10.0 108.156 -168.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.13 95.75 4.32 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.601 0.76 . . . . 10.0 110.846 -179.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 51.5 t0 71.32 74.18 0.18 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.116 1.766 . . . . 10.0 110.379 173.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 26.2 p -72.11 92.5 1.34 Allowed 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.672 1.189 . . . . 10.0 110.581 -175.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 9.0 pt -72.83 71.71 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 121.923 0.868 . . . . 10.0 112.978 178.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -56.31 113.78 1.71 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.206 -1.035 . . . . 10.0 108.206 164.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -177.31 -41.76 0.06 OUTLIER Glycine 0 CA--C 1.528 0.882 0 CA-C-N 118.38 0.536 . . . . 10.0 112.858 -174.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 89.3 mtm-85 . . . . . 0 C--O 1.249 1.042 0 N-CA-C 105.184 -2.154 . . . . 10.0 105.184 164.604 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 62.2 t . . . . . 0 N--CA 1.471 0.602 0 N-CA-C 107.914 -1.143 . . . . 10.0 107.914 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 7.2 p -130.11 153.92 48.01 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 125.121 1.368 . . . . 10.0 108.403 -178.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -117.09 140.9 48.94 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 126.909 2.084 . . . . 10.0 109.089 -174.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 8.3 tptm -97.26 108.69 21.46 Favored 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 124.332 1.053 . . . . 10.0 109.089 -177.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -117.65 151.26 37.58 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 124.903 1.281 . . . . 10.0 109.88 -177.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -126.38 150.45 48.58 Favored 'General case' 0 CA--C 1.515 -0.377 0 C-N-CA 123.468 0.707 . . . . 10.0 111.264 177.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -136.39 140.72 43.42 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.661 1.584 . . . . 10.0 108.553 -169.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -110.32 133.25 53.43 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 108.177 -1.045 . . . . 10.0 108.177 -172.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.8 mm -111.81 136.35 48.22 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.085 0 C-N-CA 124.154 0.982 . . . . 10.0 111.706 -155.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -123.41 102.33 7.84 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.907 -0.775 . . . . 10.0 108.907 170.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 147.16 -67.09 0.4 Allowed Glycine 0 C--N 1.341 0.816 0 C-N-CA 123.431 0.538 . . . . 10.0 112.632 165.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 13.3 ptt? -65.13 148.91 50.82 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 117.835 0.817 . . . . 10.0 109.8 -178.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.3 t -160.06 50.48 0.3 Allowed 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 109.435 -0.579 . . . . 10.0 109.435 176.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 35.2 t -162.13 143.23 10.6 Favored 'General case' 0 C--N 1.344 0.347 0 O-C-N 120.387 -1.446 . . . . 10.0 109.404 -179.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.1 -38.72 71.12 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.465 0.706 . . . . 10.0 112.48 -172.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.91 -31.69 72.46 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.429 0.692 . . . . 10.0 109.984 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 88.6 m -76.02 -51.37 12.47 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 108.32 -0.993 . . . . 10.0 108.32 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -46.69 -47.89 20.3 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.567 1.147 . . . . 10.0 110.568 171.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -59.77 -27.55 66.64 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.394 0.516 . . . . 10.0 112.394 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 23.0 ttm180 -75.67 -39.56 57.36 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 121.188 -0.945 . . . . 10.0 109.018 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 11.0 mm -45.97 -53.02 2.57 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.286 0 CA-C-O 118.523 -0.751 . . . . 10.0 110.037 170.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -44.94 -50.13 10.71 Favored 'General case' 0 C--O 1.224 -0.251 0 C-N-CA 122.918 0.487 . . . . 10.0 111.196 -178.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.5 mptt -68.51 -46.8 68.66 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.419 0.688 . . . . 10.0 110.159 -179.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.45 -36.14 75.39 Favored 'General case' 0 N--CA 1.451 -0.376 0 O-C-N 121.975 -0.453 . . . . 10.0 110.803 -178.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.38 -34.72 36.16 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.902 1.281 . . . . 10.0 111.221 175.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -60.86 -24.1 65.66 Favored 'General case' 0 C--N 1.332 -0.154 0 O-C-N 121.514 -0.741 . . . . 10.0 110.114 174.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -52.0 -40.64 61.29 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 117.893 0.315 . . . . 10.0 111.321 170.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 25.1 mm -57.77 128.67 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 123.585 0.754 . . . . 10.0 109.939 -173.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -69.08 -48.25 63.13 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 120.697 -0.401 . . . . 10.0 110.43 -177.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -80.67 37.85 2.3 Favored Glycine 0 CA--C 1.523 0.579 0 O-C-N 121.186 -0.946 . . . . 10.0 112.759 -174.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.4 p -103.86 147.4 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 C-N-CA 124.289 1.035 . . . . 10.0 108.657 -175.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -104.63 -50.27 3.34 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 107.998 -1.112 . . . . 10.0 107.998 171.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -164.06 160.64 21.87 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.263 -0.643 . . . . 10.0 109.263 -178.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -142.13 65.49 18.85 Favored Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 124.589 1.156 . . . . 10.0 111.358 178.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -75.36 75.54 3.82 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.184 2.589 . . . . 10.0 109.751 178.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.5 m -66.8 156.36 6.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 123.637 0.775 . . . . 10.0 111.808 -178.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -96.07 115.24 27.13 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 121.112 0.482 . . . . 10.0 111.3 -176.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 11.0 p90 -95.0 43.25 1.09 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.351 1.46 . . . . 10.0 112.447 -171.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -172.55 -39.76 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 124.841 1.257 . . . . 10.0 109.562 176.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 12.3 mt -79.04 -12.17 60.02 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.18 0.992 . . . . 10.0 112.019 -175.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 60.34 51.06 5.62 Favored 'General case' 0 C--N 1.334 -0.069 0 C-N-CA 124.915 1.286 . . . . 10.0 109.692 176.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -140.77 133.29 28.55 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 106.514 -1.661 . . . . 10.0 106.514 175.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.0 t -101.85 142.35 16.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 106.533 -1.655 . . . . 10.0 106.533 172.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 29.6 m -130.34 124.02 31.3 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 106.433 -1.692 . . . . 10.0 106.433 -177.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 29.0 t -128.62 137.52 57.09 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 N-CA-C 109.127 -0.694 . . . . 10.0 109.127 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -105.61 105.58 15.69 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 105.668 -1.975 . . . . 10.0 105.668 167.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -145.78 159.91 42.5 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 123.645 0.778 . . . . 10.0 110.541 -176.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -95.98 134.74 23.44 Favored Pre-proline 0 C--N 1.33 -0.263 0 C-N-CA 123.869 0.868 . . . . 10.0 110.813 178.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -80.44 56.27 6.01 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.259 1.973 . . . . 10.0 109.626 170.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.54 -49.95 1.76 Allowed 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 108.411 -0.959 . . . . 10.0 108.411 175.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -87.75 -42.52 12.55 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.525 0.73 . . . . 10.0 110.394 -175.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -137.81 -176.19 4.34 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.848 1.259 . . . . 10.0 109.327 -171.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 78.2 p -151.73 171.86 17.02 Favored 'General case' 0 N--CA 1.455 -0.193 0 O-C-N 122.043 -0.411 . . . . 10.0 110.38 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 88.3 t -42.93 -48.37 1.21 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.166 0 C-N-CA 124.511 1.124 . . . . 10.0 110.582 169.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.9 m -51.01 -42.88 60.68 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.583 1.153 . . . . 10.0 112.73 178.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -70.42 -56.9 5.52 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 124.114 0.965 . . . . 10.0 109.314 -176.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.1 pp -63.83 -40.49 96.73 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 120.786 -1.197 . . . . 10.0 110.816 -177.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -43.84 -52.7 6.56 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-O 118.049 -0.977 . . . . 10.0 112.386 161.106 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.8 -45.38 70.74 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 120.127 1.331 . . . . 10.0 110.573 178.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -53.63 -53.39 52.52 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.134 0.492 . . . . 10.0 110.414 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 59.3 t -64.77 -41.19 91.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-N 116.115 -0.493 . . . . 10.0 112.003 178.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -58.59 -45.99 87.9 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 108.825 -0.806 . . . . 10.0 108.825 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -70.23 -36.22 74.38 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.528 1.131 . . . . 10.0 111.03 -177.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 12.9 mt -52.24 -28.82 20.09 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 112.803 0.668 . . . . 10.0 112.803 165.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 108.22 31.29 3.59 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-N 118.502 0.592 . . . . 10.0 112.741 169.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -152.33 160.33 43.33 Favored 'General case' 0 C--O 1.227 -0.104 0 N-CA-C 106.987 -1.486 . . . . 10.0 106.987 169.009 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -98.99 152.61 19.62 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.581 0.705 . . . . 10.0 110.84 -163.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.5 tp -134.07 146.74 50.59 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 125.7 1.6 . . . . 10.0 108.316 -176.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 12.1 tptp -152.21 154.01 34.95 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 109.445 -0.576 . . . . 10.0 109.445 164.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.3 tp -65.78 155.84 34.97 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 121.401 0.619 . . . . 10.0 109.809 176.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 54.6 tttt -118.16 -55.71 2.22 Favored 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 128.633 2.773 . . . . 10.0 107.242 175.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 173.93 -91.22 0.09 OUTLIER Glycine 0 N--CA 1.444 -0.822 0 N-CA-C 108.175 -1.97 . . . . 10.0 108.175 178.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -160.51 170.34 21.12 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 124.506 1.122 . . . . 10.0 108.472 -162.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -54.37 136.1 44.22 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 123.8 0.688 . . . . 10.0 111.355 -177.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -46.61 -58.51 3.75 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.858 0.863 . . . . 10.0 109.413 170.075 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 67.08 170.52 0.25 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.642 1.177 . . . . 10.0 110.873 -176.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 6.1 pt -137.73 -146.38 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 N-CA-C 107.622 -1.251 . . . . 10.0 107.622 174.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 70.56 172.08 0.31 Allowed 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.26 1.424 . . . . 10.0 111.207 -177.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -179.22 166.77 36.47 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 106.185 -2.766 . . . . 10.0 106.185 178.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.253 1.279 0 CA-C-O 115.803 -2.046 . . . . 10.0 105.702 173.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 92.1 t . . . . . 0 N--CA 1.471 0.622 0 N-CA-C 107.641 -1.244 . . . . 10.0 107.641 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.6 p -123.52 169.32 11.53 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.045 1.738 . . . . 10.0 108.851 177.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -137.71 140.41 40.72 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 126.465 1.906 . . . . 10.0 107.795 -168.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 18.4 mmtp -82.46 128.34 34.17 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.192 0.597 . . . . 10.0 109.419 178.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -128.99 136.8 50.81 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 125.698 1.599 . . . . 10.0 109.119 176.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -117.28 147.0 42.95 Favored 'General case' 0 CA--C 1.51 -0.587 0 C-N-CA 124.0 0.92 . . . . 10.0 110.198 177.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -141.19 137.26 32.53 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 124.623 1.202 . . . . 10.0 111.241 -172.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -93.65 133.17 37.27 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.737 1.615 . . . . 10.0 108.741 -176.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 7.0 mm -103.56 114.15 42.38 Favored 'Isoleucine or valine' 0 C--N 1.34 0.185 0 C-N-CA 124.038 0.935 . . . . 10.0 110.621 -171.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -103.87 97.36 7.37 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.833 -1.173 . . . . 10.0 107.833 170.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 149.35 -103.49 0.26 Allowed Glycine 0 CA--C 1.526 0.741 0 C-N-CA 124.202 0.906 . . . . 10.0 111.317 172.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 6.4 mmt -81.94 123.51 28.92 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 118.174 0.987 . . . . 10.0 111.69 -172.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 21.7 p -132.9 58.41 1.77 Allowed 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.263 1.425 . . . . 10.0 108.391 -173.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 97.9 m -129.48 -132.81 0.22 Allowed 'General case' 0 C--N 1.339 0.118 0 N-CA-C 106.665 -1.606 . . . . 10.0 106.665 -175.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -131.02 -49.19 1.02 Allowed 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.282 0.633 . . . . 10.0 111.265 -174.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.63 -45.67 67.97 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 108.683 -0.858 . . . . 10.0 108.683 -174.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 10.0 m -61.56 -53.79 51.63 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.614 -0.721 . . . . 10.0 109.604 177.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -49.05 -46.27 44.06 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.856 0.863 . . . . 10.0 111.106 175.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -58.94 -29.83 67.42 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 121.596 -0.69 . . . . 10.0 112.311 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -64.39 -45.25 88.49 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 120.759 -1.213 . . . . 10.0 108.209 179.032 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 9.8 mm -44.68 -47.55 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 C-N-CA 124.328 1.051 . . . . 10.0 111.625 177.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -48.21 -50.63 28.59 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 122.824 0.45 . . . . 10.0 110.868 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -72.77 -46.26 54.29 Favored 'General case' 0 N--CA 1.445 -0.713 0 O-C-N 121.757 -0.589 . . . . 10.0 110.933 -179.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.1 mmp_? -48.92 -42.66 37.87 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.122 0.416 . . . . 10.0 112.122 175.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.405 HD22 ' CD1' ' A' ' 28' ' ' ILE . 0.5 OUTLIER -79.4 -42.35 25.69 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.472 0.709 . . . . 10.0 111.05 178.741 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -55.0 -18.53 5.2 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.406 1.003 . . . . 10.0 112.22 172.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -59.69 -29.07 67.83 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 114.223 1.194 . . . . 10.0 114.223 171.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.405 ' CD1' HD22 ' A' ' 25' ' ' LEU . 11.1 mt -60.58 138.46 21.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 108.227 -1.027 . . . . 10.0 108.227 173.227 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.38 -49.58 32.84 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 109.554 -0.535 . . . . 10.0 109.554 179.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -80.29 42.25 2.55 Favored Glycine 0 CA--C 1.526 0.737 0 O-C-N 120.778 -1.201 . . . . 10.0 112.311 -175.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.6 p -102.05 153.2 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 C-N-CA 125.159 1.383 . . . . 10.0 109.677 -174.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -111.54 -54.62 2.59 Favored 'General case' 0 C--N 1.334 -0.089 0 C-N-CA 123.877 0.871 . . . . 10.0 109.069 171.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 23.1 p30 -162.44 151.71 15.54 Favored 'General case' 0 C--O 1.227 -0.129 0 N-CA-C 108.732 -0.84 . . . . 10.0 108.732 -173.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -133.94 55.94 17.52 Favored Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 124.42 1.088 . . . . 10.0 112.34 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -75.05 79.2 2.73 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 122.884 2.39 . . . . 10.0 110.558 -177.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.4 m -67.47 151.16 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 O-C-N 121.622 -0.674 . . . . 10.0 111.801 -178.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -95.39 88.66 5.18 Favored 'General case' 0 C--O 1.234 0.256 0 O-C-N 122.179 -0.326 . . . . 10.0 110.23 -175.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -72.48 53.52 0.31 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 127.171 2.189 . . . . 10.0 112.727 -178.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -174.65 -40.72 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 126.281 1.832 . . . . 10.0 109.734 174.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 12.4 mt -86.62 -12.39 48.66 Favored 'General case' 0 C--N 1.338 0.093 0 C-N-CA 124.084 0.954 . . . . 10.0 111.797 -171.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 75.4 37.35 0.45 Allowed 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.884 1.274 . . . . 10.0 110.333 170.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 33.3 p -138.35 129.81 27.62 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.242 1.417 . . . . 10.0 108.127 178.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 21.8 t -90.33 131.39 37.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 107.515 -1.291 . . . . 10.0 107.515 167.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 85.6 m -110.54 117.93 34.87 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 106.303 -1.74 . . . . 10.0 106.303 171.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 82.6 t -122.46 141.28 43.48 Favored 'Isoleucine or valine' 0 C--N 1.342 0.248 0 CA-C-N 120.177 1.353 . . . . 10.0 109.79 168.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -100.32 117.02 33.66 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 107.552 -1.277 . . . . 10.0 107.552 164.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -147.87 167.91 23.57 Favored 'General case' 0 C--O 1.226 -0.163 0 N-CA-C 108.861 -0.792 . . . . 10.0 108.861 177.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 24.7 p30 -100.54 135.96 20.05 Favored Pre-proline 0 C--N 1.329 -0.284 0 C-N-CA 123.273 0.629 . . . . 10.0 109.758 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -80.36 54.0 5.02 Favored 'Trans proline' 0 N--CA 1.448 -1.167 0 N-CA-C 108.883 -1.237 . . . . 10.0 108.883 171.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.16 10.19 3.27 Favored 'General case' 0 C--N 1.346 0.443 0 CA-C-N 118.623 0.647 . . . . 10.0 111.834 176.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -142.02 -65.15 0.42 Allowed 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.788 -1.189 . . . . 10.0 107.788 -173.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -114.52 175.51 5.45 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 124.071 0.948 . . . . 10.0 109.359 178.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 92.0 p -127.72 167.57 16.29 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.028 0.931 . . . . 10.0 110.065 177.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 74.2 t -49.06 -52.8 9.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 115.791 -0.641 . . . . 10.0 109.796 167.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.0 m -52.36 -37.13 55.43 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 125.185 1.394 . . . . 10.0 112.579 178.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -71.25 -60.4 2.25 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 109.603 -0.517 . . . . 10.0 109.603 174.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.4 pp -58.81 -46.81 86.76 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 118.348 0.522 . . . . 10.0 111.368 -168.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.18 -35.63 12.11 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 114.549 1.315 . . . . 10.0 114.549 171.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.1 tm-20 -52.54 -35.49 53.61 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 120.466 1.485 . . . . 10.0 110.924 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.63 -52.51 60.53 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 120.057 -0.657 . . . . 10.0 109.922 -178.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 72.7 t -55.24 -47.96 77.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 122.905 0.482 . . . . 10.0 110.884 172.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.88 -55.91 19.76 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 124.906 1.282 . . . . 10.0 109.195 -177.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.8 tptm -57.06 -38.97 74.01 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 126.137 1.775 . . . . 10.0 111.322 177.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.4 mp -60.52 -19.74 58.02 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 113.075 0.768 . . . . 10.0 113.075 172.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 104.74 16.34 17.7 Favored Glycine 0 CA--C 1.528 0.863 0 CA-C-N 118.849 0.749 . . . . 10.0 113.263 168.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -136.0 160.94 37.07 Favored 'General case' 0 C--O 1.227 -0.121 0 N-CA-C 106.776 -1.564 . . . . 10.0 106.776 169.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 10.5 ttmm -105.98 141.16 37.84 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 119.265 0.939 . . . . 10.0 111.405 -168.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 22.9 tp -117.93 145.04 44.95 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 126.117 1.767 . . . . 10.0 107.974 177.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 26.0 mmtt -152.99 153.44 32.93 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 125.721 1.608 . . . . 10.0 108.058 170.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.3 tp -68.34 152.41 45.47 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.398 0.618 . . . . 10.0 109.397 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.94 -57.44 2.04 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 127.51 2.324 . . . . 10.0 105.586 164.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 170.82 -92.56 0.1 OUTLIER Glycine 0 N--CA 1.442 -0.947 0 N-CA-C 105.833 -2.907 . . . . 10.0 105.833 177.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -166.02 139.7 4.31 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 122.993 0.517 . . . . 10.0 109.829 -160.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -72.52 -47.29 49.62 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.64 1.176 . . . . 10.0 112.596 -177.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 41.4 t0 42.18 78.34 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.769 2.028 . . . . 10.0 113.501 -168.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 6.2 t -77.07 72.65 3.63 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 121.333 -0.854 . . . . 10.0 110.891 -174.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 11.1 pt -71.76 80.21 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-O 121.809 0.814 . . . . 10.0 112.508 179.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -70.63 165.94 21.78 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.657 0.783 . . . . 10.0 111.172 173.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -102.51 97.53 1.56 Allowed Glycine 0 CA--C 1.529 0.927 0 CA-C-O 118.391 -1.227 . . . . 10.0 112.857 -170.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 6.3 tpm_? . . . . . 0 C--O 1.259 1.558 0 C-N-CA 129.552 3.141 . . . . 10.0 109.169 165.539 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 59.5 t . . . . . 0 N--CA 1.47 0.568 0 N-CA-C 108.141 -1.059 . . . . 10.0 108.141 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 14.9 p -133.04 172.4 12.68 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.57 1.548 . . . . 10.0 108.02 179.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -140.65 142.25 34.98 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 127.427 2.291 . . . . 10.0 107.917 -167.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -104.91 110.09 22.32 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.54 0.736 . . . . 10.0 109.954 -168.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -108.9 146.14 34.24 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 124.976 1.31 . . . . 10.0 109.833 -175.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -122.63 147.25 46.65 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 123.749 0.82 . . . . 10.0 109.246 173.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -137.0 140.85 42.44 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 125.222 1.576 . . . . 10.0 109.237 -173.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -105.46 133.9 49.45 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.358 1.063 . . . . 10.0 108.261 -175.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.9 mm -109.33 132.33 57.75 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 C-N-CA 123.667 0.787 . . . . 10.0 111.18 -157.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -123.67 99.73 6.44 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.22 0.608 . . . . 10.0 109.36 172.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 151.49 -61.09 0.4 Allowed Glycine 0 CA--C 1.529 0.922 0 C-N-CA 123.313 0.482 . . . . 10.0 112.86 164.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -70.05 163.87 25.26 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 118.104 0.952 . . . . 10.0 111.296 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 88.1 m -76.25 -99.68 0.02 OUTLIER 'General case' 0 N--CA 1.423 -1.824 0 C-N-CA 125.91 1.684 . . . . 10.0 107.672 159.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 165.03 49.51 0.0 OUTLIER 'General case' 0 C--N 1.344 0.35 0 CA-C-N 120.121 1.328 . . . . 10.0 110.541 -158.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -148.44 -87.61 0.09 Allowed 'General case' 0 CA--C 1.518 -0.273 0 O-C-N 120.581 -1.325 . . . . 10.0 108.809 176.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.12 -47.77 67.22 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 107.622 -1.251 . . . . 10.0 107.622 -178.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 13.1 m -57.11 -57.36 12.91 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.745 -1.116 . . . . 10.0 110.471 177.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -45.29 -53.9 7.8 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.007 0.923 . . . . 10.0 110.578 172.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -59.89 -25.1 64.82 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.403 -0.817 . . . . 10.0 112.213 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -74.61 -54.14 8.02 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 121.294 -0.879 . . . . 10.0 108.9 173.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.6 mt -48.22 -47.47 13.59 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.445 0 CA-C-O 117.964 -1.017 . . . . 10.0 111.277 -176.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -34.86 -61.88 0.39 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.517 0.727 . . . . 10.0 111.747 174.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.98 -42.25 69.93 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.492 1.117 . . . . 10.0 110.679 -177.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.96 -28.79 62.62 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.651 0.611 . . . . 10.0 112.651 175.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.5 mt -85.3 -42.97 14.13 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 126.188 1.795 . . . . 10.0 109.787 174.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -55.51 -23.95 29.0 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.898 0.879 . . . . 10.0 110.279 177.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -52.85 -41.6 64.41 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 113.794 1.035 . . . . 10.0 113.794 171.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.2 mp -54.58 133.38 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 109.563 -0.532 . . . . 10.0 109.563 176.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -77.98 -42.73 31.79 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 119.505 -0.284 . . . . 10.0 110.483 -178.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -80.63 39.6 2.37 Favored Glycine 0 CA--C 1.527 0.816 0 O-C-N 120.549 -1.344 . . . . 10.0 111.94 178.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.4 p -101.57 149.78 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 C-N-CA 124.973 1.309 . . . . 10.0 108.575 -178.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -109.5 -61.51 1.63 Allowed 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 107.934 -1.136 . . . . 10.0 107.934 170.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 57.8 m-80 -140.54 154.66 46.62 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 107.952 -1.129 . . . . 10.0 107.952 -174.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.47 58.01 2.58 Favored Pre-proline 0 CA--C 1.535 0.371 0 O-C-N 121.965 -0.459 . . . . 10.0 112.113 170.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -75.11 78.23 2.98 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 122.715 2.277 . . . . 10.0 108.756 177.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.4 m -59.12 152.45 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 109.851 -0.426 . . . . 10.0 109.851 174.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 74.3 m-80 -81.07 151.32 28.41 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 118.756 -1.178 . . . . 10.0 109.962 -176.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -123.23 42.91 3.09 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.412 1.485 . . . . 10.0 109.747 -175.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -175.13 -40.22 0.01 OUTLIER 'General case' 0 C--O 1.226 -0.163 0 C-N-CA 125.385 1.474 . . . . 10.0 109.736 170.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.2 mt -75.2 -17.04 60.44 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.884 0.874 . . . . 10.0 112.442 -167.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 65.3 48.69 2.08 Favored 'General case' 0 N--CA 1.46 0.072 0 C-N-CA 125.281 1.432 . . . . 10.0 110.32 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 8.0 p -142.85 133.24 24.81 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.324 1.45 . . . . 10.0 107.969 176.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.0 t -97.63 134.21 36.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 106.869 -1.53 . . . . 10.0 106.869 172.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 85.9 m -121.26 126.22 49.02 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 106.552 -1.647 . . . . 10.0 106.552 178.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.4 t -122.89 149.29 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 C-N-CA 124.323 1.049 . . . . 10.0 108.648 177.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -123.59 107.81 11.93 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 106.054 -1.832 . . . . 10.0 106.054 164.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -145.04 170.67 15.74 Favored 'General case' 0 C--O 1.225 -0.223 0 C-N-CA 124.142 0.977 . . . . 10.0 108.834 -177.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 14.6 p30 -111.85 134.77 21.27 Favored Pre-proline 0 CA--C 1.53 0.196 0 C-N-CA 122.806 0.443 . . . . 10.0 110.397 177.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -77.37 62.47 7.64 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 122.504 2.136 . . . . 10.0 109.867 174.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.1 pttt -123.73 -45.85 2.02 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 123.147 0.579 . . . . 10.0 109.951 172.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -91.49 -60.95 1.75 Allowed 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.385 1.074 . . . . 10.0 108.72 -176.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -119.08 174.34 6.37 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 125.671 1.588 . . . . 10.0 109.321 -175.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 53.3 p -131.66 -177.3 4.36 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.875 1.27 . . . . 10.0 110.167 176.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 35.3 m -48.64 -38.72 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-N 115.03 -0.986 . . . . 10.0 111.946 164.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 68.9 m -62.32 -43.31 99.13 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 122.761 0.424 . . . . 10.0 111.142 -174.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -65.28 -52.97 50.79 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.284 1.034 . . . . 10.0 109.136 -174.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.1 pp -66.97 -43.91 81.82 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 121.983 -0.448 . . . . 10.0 111.274 -178.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -41.66 -51.04 4.14 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-O 118.125 -0.94 . . . . 10.0 112.053 160.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -57.1 -43.92 82.72 Favored 'General case' 0 C--O 1.226 -0.157 0 CA-C-N 119.742 1.155 . . . . 10.0 110.386 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -52.88 -51.82 59.75 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.077 0.465 . . . . 10.0 110.392 176.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 53.9 t -61.85 -46.23 96.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 N-CA-C 112.39 0.515 . . . . 10.0 112.39 176.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -51.45 -51.11 57.74 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.856 1.263 . . . . 10.0 108.428 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.25 -44.26 92.38 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.611 1.565 . . . . 10.0 111.191 177.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -48.35 -39.45 22.16 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.79 0.836 . . . . 10.0 111.308 173.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 125.14 14.25 3.38 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-O 119.575 -0.57 . . . . 10.0 113.273 169.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -138.94 162.52 34.67 Favored 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 107.927 -1.138 . . . . 10.0 107.927 177.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 29.0 mmtt -95.98 151.04 19.8 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.776 0.798 . . . . 10.0 111.328 -172.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.5 tp -132.35 146.33 51.9 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 126.487 1.915 . . . . 10.0 107.886 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 16.5 mmtm -151.64 154.67 36.84 Favored 'General case' 0 N--CA 1.44 -0.947 0 C-N-CA 123.993 0.917 . . . . 10.0 109.011 163.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.6 tp -61.32 159.46 12.39 Favored 'General case' 0 N--CA 1.453 -0.301 0 O-C-N 124.321 1.013 . . . . 10.0 109.393 175.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 32.9 tttt -118.82 -66.34 1.08 Allowed 'General case' 0 N--CA 1.435 -1.216 0 C-N-CA 125.464 1.506 . . . . 10.0 108.276 177.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 161.7 43.63 0.02 OUTLIER Glycine 0 CA--C 1.528 0.865 0 CA-C-O 118.852 -0.971 . . . . 10.0 113.668 175.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 72.51 146.22 0.08 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.976 1.311 . . . . 10.0 112.941 167.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.05 136.38 55.14 Favored 'General case' 0 N--CA 1.443 -0.784 0 O-C-N 121.588 -0.695 . . . . 10.0 111.488 -177.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.4 t0 75.25 130.68 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 127.671 2.388 . . . . 10.0 109.812 -168.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 10.8 t -66.04 -32.33 73.74 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.209 1.003 . . . . 10.0 110.985 177.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 9.8 pt -122.63 -123.17 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 124.804 1.242 . . . . 10.0 109.633 -178.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -136.56 -68.73 0.49 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.179 0.992 . . . . 10.0 108.932 -176.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.67 122.09 0.38 Allowed Glycine 0 CA--C 1.532 1.148 0 C-N-CA 123.406 0.527 . . . . 10.0 112.165 174.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 29.9 mtp180 . . . . . 0 C--O 1.251 1.175 0 CA-C-O 116.947 -1.502 . . . . 10.0 108.595 161.406 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 95.9 t . . . . . 0 N--CA 1.472 0.647 0 N-CA-C 107.35 -1.352 . . . . 10.0 107.35 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.0 p -124.8 169.94 11.53 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 125.605 1.562 . . . . 10.0 109.293 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -131.66 150.21 52.23 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 127.472 2.309 . . . . 10.0 107.324 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -109.63 123.46 49.5 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.343 -0.984 . . . . 10.0 108.343 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -130.2 153.55 48.45 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.634 0.774 . . . . 10.0 110.676 176.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -118.7 148.56 42.63 Favored 'General case' 0 CA--C 1.507 -0.7 0 C-N-CA 124.62 1.168 . . . . 10.0 109.481 177.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -135.12 141.0 45.9 Favored 'General case' 0 N--CA 1.447 -0.605 0 O-C-N 124.792 1.308 . . . . 10.0 109.063 -174.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -103.45 131.78 50.26 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.525 1.53 . . . . 10.0 108.827 -174.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -115.44 137.13 50.0 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 C-N-CA 126.111 1.764 . . . . 10.0 110.023 -164.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -127.41 102.5 6.91 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.21 -1.033 . . . . 10.0 108.21 176.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 114.3 42.73 0.81 Allowed Glycine 0 CA--C 1.529 0.954 0 CA-C-O 119.263 -0.743 . . . . 10.0 114.185 166.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 9.0 ptp -101.08 -166.32 1.3 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.651 1.226 . . . . 10.0 111.051 173.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.5 t -123.45 -7.75 8.09 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.734 1.214 . . . . 10.0 112.024 177.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 58.2 m 62.14 48.96 4.68 Favored 'General case' 0 C--N 1.343 0.315 0 C-N-CA 123.547 0.739 . . . . 10.0 110.815 179.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -167.34 -90.32 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 108.733 -0.84 . . . . 10.0 108.733 171.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.39 -33.41 48.84 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 121.518 -0.739 . . . . 10.0 109.722 -171.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 59.2 m -62.66 -56.38 18.27 Favored 'General case' 0 C--N 1.339 0.143 0 N-CA-C 108.65 -0.87 . . . . 10.0 108.65 174.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -44.8 -45.03 9.86 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.397 1.079 . . . . 10.0 110.316 172.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -66.69 -32.45 73.78 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.945 1.091 . . . . 10.0 113.945 178.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.79 -45.89 87.65 Favored 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 120.757 -1.214 . . . . 10.0 108.413 177.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.8 mm -47.4 -48.85 9.47 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.231 0 O-C-N 123.94 0.775 . . . . 10.0 109.856 -177.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -44.03 -54.4 5.49 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.043 0.937 . . . . 10.0 111.526 178.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt -70.73 -45.7 64.4 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.954 0.902 . . . . 10.0 109.459 -177.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 51.7 mmt-85 -55.57 -32.24 62.85 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.147 0.425 . . . . 10.0 112.147 177.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.1 mt -84.39 -35.56 23.06 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.178 1.391 . . . . 10.0 112.26 174.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 32.7 t-20 -55.29 -31.78 61.9 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.685 0.675 . . . . 10.0 110.081 176.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -50.64 -28.89 9.72 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 114.996 1.48 . . . . 10.0 114.996 169.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 6.9 mm -61.71 104.93 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-O 121.71 0.766 . . . . 10.0 109.663 171.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -58.24 -26.08 62.48 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.451 0.537 . . . . 10.0 112.451 -179.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -90.79 18.02 52.34 Favored Glycine 0 CA--C 1.528 0.898 0 O-C-N 121.359 -0.838 . . . . 10.0 112.945 178.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.1 p -79.36 153.98 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 CA-C-N 118.595 1.198 . . . . 10.0 109.514 -179.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -112.94 -59.86 1.96 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.539 -0.912 . . . . 10.0 108.539 163.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 -134.63 155.43 50.5 Favored 'General case' 0 C--N 1.341 0.208 0 N-CA-C 109.254 -0.647 . . . . 10.0 109.254 -178.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -140.36 65.39 27.32 Favored Pre-proline 0 CA--C 1.534 0.355 0 C-N-CA 123.454 0.701 . . . . 10.0 109.825 172.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -78.64 68.7 8.03 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 123.044 2.496 . . . . 10.0 109.539 -176.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.1 m -68.85 155.37 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 O-C-N 122.099 -0.375 . . . . 10.0 111.727 -175.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -97.49 139.04 34.0 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 121.002 0.429 . . . . 10.0 111.407 -177.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -118.24 47.66 1.56 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.702 1.601 . . . . 10.0 110.451 -172.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -176.11 -41.61 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 125.449 1.5 . . . . 10.0 109.557 -177.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 16.6 mt -81.7 -19.02 42.4 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.625 1.17 . . . . 10.0 111.648 -170.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 61.16 50.64 4.8 Favored 'General case' 0 C--N 1.339 0.112 0 C-N-CA 125.892 1.677 . . . . 10.0 109.942 -175.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.4 p -140.07 126.99 20.74 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 107.646 -1.242 . . . . 10.0 107.646 174.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.1 t -97.15 130.62 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 106.769 -1.567 . . . . 10.0 106.769 172.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 58.2 m -110.85 128.38 55.76 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.95 1.7 . . . . 10.0 107.139 176.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.7 t -127.36 137.4 57.87 Favored 'Isoleucine or valine' 0 C--N 1.342 0.253 0 CA-C-N 119.161 0.891 . . . . 10.0 110.709 174.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -107.29 104.6 14.24 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.392 1.477 . . . . 10.0 107.088 164.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 14.7 p90 -143.32 167.02 23.13 Favored 'General case' 0 CA--C 1.52 -0.177 0 C-N-CA 123.936 0.895 . . . . 10.0 109.329 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -107.99 134.05 20.26 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-O 119.109 -0.472 . . . . 10.0 110.804 178.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -77.85 62.29 7.83 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.779 2.319 . . . . 10.0 110.613 176.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.0 pttt -124.42 -47.67 1.85 Allowed 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.706 0.802 . . . . 10.0 109.346 169.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -90.33 -51.84 5.23 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.961 0.905 . . . . 10.0 110.007 -169.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -132.17 174.73 9.9 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.631 1.172 . . . . 10.0 108.333 178.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 82.6 p -137.06 177.49 7.82 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 118.569 0.622 . . . . 10.0 110.757 176.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 49.1 t -42.24 -50.75 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 124.632 1.173 . . . . 10.0 110.902 172.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.1 m -51.56 -38.77 55.9 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.094 0.958 . . . . 10.0 112.414 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -70.11 -58.51 3.72 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.632 0.773 . . . . 10.0 109.178 -174.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.4 pp -63.56 -41.09 98.43 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 121.741 -0.6 . . . . 10.0 111.297 -178.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -43.51 -47.6 7.26 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 118.349 -0.834 . . . . 10.0 111.817 163.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.87 -42.21 98.79 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 119.571 1.078 . . . . 10.0 110.39 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -56.19 -48.59 76.09 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 109.65 -0.5 . . . . 10.0 109.65 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 82.8 t -62.56 -47.45 92.89 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 N-CA-C 112.909 0.707 . . . . 10.0 112.909 173.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -56.13 -37.7 69.81 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.044 -1.035 . . . . 10.0 109.025 -178.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.9 tttp -79.57 -31.51 41.89 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 124.343 1.057 . . . . 10.0 112.011 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 15.3 mt -51.69 -45.19 63.41 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.68 1.127 . . . . 10.0 110.783 163.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 147.89 -39.87 0.99 Allowed Glycine 0 CA--C 1.525 0.713 0 CA-C-N 117.964 0.347 . . . . 10.0 112.78 171.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -89.79 159.55 16.97 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 124.032 0.933 . . . . 10.0 108.738 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 19.7 tttt -91.87 161.23 14.92 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-O 121.137 0.494 . . . . 10.0 110.656 -171.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 23.9 tp -136.13 148.1 48.06 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.189 1.396 . . . . 10.0 108.248 177.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 16.9 mmtm -154.18 159.46 41.4 Favored 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 124.19 0.996 . . . . 10.0 108.587 164.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.8 tp -67.07 152.06 46.48 Favored 'General case' 0 N--CA 1.451 -0.423 0 O-C-N 123.735 0.647 . . . . 10.0 109.351 176.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 13.3 tptm -107.48 -55.2 2.38 Favored 'General case' 0 N--CA 1.438 -1.072 0 C-N-CA 127.168 2.187 . . . . 10.0 105.881 169.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 170.97 -95.96 0.11 Allowed Glycine 0 N--CA 1.444 -0.819 0 N-CA-C 106.204 -2.759 . . . . 10.0 106.204 -179.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -157.76 148.84 21.29 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.284 0.634 . . . . 10.0 110.447 -165.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.14 -47.31 58.66 Favored 'General case' 0 C--O 1.228 -0.068 0 C-N-CA 123.595 0.758 . . . . 10.0 111.279 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -172.78 150.4 2.11 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.414 1.885 . . . . 10.0 105.969 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 11.7 t -126.63 75.21 1.53 Allowed 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.809 1.243 . . . . 10.0 108.149 -178.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 28.6 pt -78.38 -16.86 13.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 114.654 -1.157 . . . . 10.0 113.311 -177.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 47.11 72.42 0.25 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.105 1.762 . . . . 10.0 110.807 -176.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -166.7 -162.82 19.2 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 109.955 -1.258 . . . . 10.0 109.955 -177.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.9 ptp180 . . . . . 0 C--O 1.251 1.157 0 CA-C-O 118.072 -0.966 . . . . 10.0 110.479 171.83 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.0 p . . . . . 0 N--CA 1.472 0.635 0 N-CA-C 109.399 -0.593 . . . . 10.0 109.399 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.2 p -148.64 171.16 16.61 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 125.982 1.713 . . . . 10.0 106.713 -176.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -143.49 143.02 31.39 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 126.858 2.063 . . . . 10.0 106.752 -170.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 45.1 mmtt -85.33 145.39 27.53 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.143 -0.688 . . . . 10.0 109.143 175.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -147.06 138.14 23.9 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 107.463 -1.31 . . . . 10.0 107.463 174.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -122.03 149.07 44.02 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 123.796 0.838 . . . . 10.0 110.022 174.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -142.95 141.22 31.38 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 124.804 1.315 . . . . 10.0 110.653 -168.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.44 132.18 43.39 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.985 1.714 . . . . 10.0 108.771 -170.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.7 mm -106.21 121.02 58.17 Favored 'Isoleucine or valine' 0 C--N 1.339 0.145 0 C-N-CA 124.842 1.257 . . . . 10.0 110.821 -170.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -101.52 83.27 2.41 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 106.267 -1.753 . . . . 10.0 106.267 175.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 108.65 100.54 2.65 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 122.991 0.329 . . . . 10.0 112.836 175.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 24.2 ptm -158.5 164.82 35.8 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 108.101 -1.074 . . . . 10.0 108.101 169.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.8 t -88.06 -18.34 29.12 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.149 0.426 . . . . 10.0 112.149 178.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 m 65.36 54.5 1.16 Allowed 'General case' 0 C--N 1.343 0.303 0 CA-C-O 121.872 0.844 . . . . 10.0 111.077 -178.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -170.57 -86.25 0.01 OUTLIER 'General case' 0 C--O 1.233 0.23 0 C-N-CA 124.333 1.053 . . . . 10.0 108.82 169.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.06 -42.14 76.67 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 108.484 -0.932 . . . . 10.0 108.484 -177.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 98.9 m -62.31 -55.11 31.35 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 118.555 -0.736 . . . . 10.0 109.81 -178.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -38.84 -57.33 1.24 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.658 1.183 . . . . 10.0 110.598 169.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -58.67 -34.73 71.57 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.765 -0.652 . . . . 10.0 112.71 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.7 ttm105 -68.58 -43.45 76.49 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 108.528 -0.916 . . . . 10.0 108.528 177.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -56.22 -46.31 81.3 Favored 'Isoleucine or valine' 0 C--N 1.342 0.255 0 CA-C-O 118.772 -0.632 . . . . 10.0 110.211 177.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -44.1 -54.91 5.14 Favored 'General case' 0 C--N 1.342 0.247 0 CA-C-O 121.098 0.475 . . . . 10.0 111.075 178.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.6 mttm -69.53 -42.88 74.07 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 124.298 1.039 . . . . 10.0 110.433 -177.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.23 -36.95 61.62 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 111.893 0.331 . . . . 10.0 111.893 173.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.5 -41.6 32.0 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.727 0.811 . . . . 10.0 110.856 175.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -61.28 -22.13 64.57 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 121.511 -0.743 . . . . 10.0 110.65 -177.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.4 mmpt? -53.68 -39.72 65.37 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 114.202 1.186 . . . . 10.0 114.202 168.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.8 mt -62.86 128.99 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 CA-C-N 118.965 0.802 . . . . 10.0 109.087 -175.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -56.48 -51.16 69.49 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 122.913 0.485 . . . . 10.0 111.824 -177.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -87.26 42.31 3.14 Favored Glycine 0 C--N 1.339 0.71 0 O-C-N 120.916 -1.115 . . . . 10.0 111.666 -172.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.8 p -105.7 151.91 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 C-N-CA 124.506 1.122 . . . . 10.0 108.628 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -117.61 -50.78 2.51 Favored 'General case' 0 C--N 1.334 -0.096 0 C-N-CA 122.946 0.499 . . . . 10.0 110.185 173.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -143.74 145.99 32.81 Favored 'General case' 0 N--CA 1.461 0.087 0 N-CA-C 109.082 -0.71 . . . . 10.0 109.082 -176.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -139.11 56.98 9.79 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 123.537 0.735 . . . . 10.0 112.461 177.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -75.3 78.87 2.87 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 123.321 2.681 . . . . 10.0 111.067 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 43.0 t -65.94 143.78 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 C-N-CA 124.786 1.234 . . . . 10.0 112.039 178.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 -91.01 97.83 11.41 Favored 'General case' 0 C--N 1.341 0.215 0 O-C-N 121.874 -0.516 . . . . 10.0 111.718 -167.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -76.45 53.25 0.84 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.785 1.634 . . . . 10.0 112.86 -177.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 179.19 -33.34 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 125.77 1.628 . . . . 10.0 110.51 168.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.2 mt -88.08 1.53 54.06 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.43 1.092 . . . . 10.0 112.155 -172.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 60.75 39.08 17.73 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 125.543 1.537 . . . . 10.0 110.91 169.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.48 133.97 26.51 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.919 1.287 . . . . 10.0 107.979 -175.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 17.1 t -90.88 142.66 12.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 107.1 -1.444 . . . . 10.0 107.1 167.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 91.6 m -133.98 114.96 13.8 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 125.585 1.554 . . . . 10.0 107.749 -177.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 50.4 t -122.0 156.14 26.55 Favored 'Isoleucine or valine' 0 C--N 1.341 0.235 0 C-N-CA 123.785 0.834 . . . . 10.0 110.607 -177.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.22 107.62 11.4 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 127.764 2.426 . . . . 10.0 105.659 170.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -136.63 165.96 24.66 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 123.395 0.678 . . . . 10.0 111.13 -176.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -99.94 126.84 35.36 Favored Pre-proline 0 CA--C 1.532 0.251 0 C-N-CA 123.73 0.812 . . . . 10.0 110.179 173.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -75.46 65.11 6.48 Favored 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 122.561 2.174 . . . . 10.0 108.569 175.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.32 -50.16 0.25 Allowed 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 107.487 -1.301 . . . . 10.0 107.487 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -106.31 -40.31 5.65 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 123.484 0.714 . . . . 10.0 110.715 173.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.24 150.63 26.06 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 121.539 -0.725 . . . . 10.0 109.993 177.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 44.9 p -147.22 149.31 32.67 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.885 0.85 . . . . 10.0 110.741 171.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 48.9 t -48.62 -51.2 11.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 125.544 1.538 . . . . 10.0 111.559 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.9 m -51.75 -43.01 62.76 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 118.943 -0.551 . . . . 10.0 111.742 178.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -67.71 -54.25 20.94 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.124 -0.695 . . . . 10.0 109.124 -173.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.0 pp -61.66 -45.36 94.36 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 120.695 -0.402 . . . . 10.0 110.212 -178.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.55 -51.93 8.49 Favored 'General case' 0 N--CA 1.45 -0.445 0 O-C-N 121.911 -0.493 . . . . 10.0 111.555 168.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.25 -40.26 95.64 Favored 'General case' 0 C--O 1.226 -0.174 0 CA-C-N 118.53 0.604 . . . . 10.0 110.293 -178.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -52.64 -49.21 65.61 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.393 0.677 . . . . 10.0 109.708 177.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 17.9 t -69.38 -43.83 80.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 116.493 -0.321 . . . . 10.0 111.183 177.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -50.45 -55.31 16.45 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.851 0.86 . . . . 10.0 109.566 178.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.5 ttmt -53.73 -42.45 68.11 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 126.151 1.78 . . . . 10.0 111.035 175.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.9 tp -53.0 -27.12 17.76 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 113.601 0.963 . . . . 10.0 113.601 174.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 140.21 -30.24 2.35 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-N 118.567 0.622 . . . . 10.0 112.671 169.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -127.8 157.97 38.97 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 124.695 1.198 . . . . 10.0 109.03 -173.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.4 ptpt -92.06 155.55 18.0 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 123.101 0.56 . . . . 10.0 111.574 -166.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 11.7 tp -134.37 146.06 49.55 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 126.393 1.877 . . . . 10.0 107.32 -176.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.3 tptp -147.31 137.18 23.02 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 119.232 -0.413 . . . . 10.0 110.602 168.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.5 tt -64.83 154.06 38.24 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.05 -0.722 . . . . 10.0 109.05 178.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 18.8 tttm -119.0 -63.7 1.37 Allowed 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 126.165 1.786 . . . . 10.0 108.371 -178.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.06 -78.75 0.03 OUTLIER Glycine 0 CA--C 1.521 0.452 0 N-CA-C 109.274 -1.53 . . . . 10.0 109.274 173.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -179.31 165.97 1.46 Allowed 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 108.443 -0.947 . . . . 10.0 108.443 -167.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.28 128.07 35.3 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.447 1.499 . . . . 10.0 110.739 178.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -39.94 -51.81 2.47 Favored 'General case' 0 C--N 1.339 0.151 0 C-N-CA 126.114 1.766 . . . . 10.0 110.539 175.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.5 m -95.22 115.79 27.89 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.013 -0.994 . . . . 10.0 109.585 174.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 22.8 mt -77.75 -124.99 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 N-CA-C 107.298 -1.371 . . . . 10.0 107.298 172.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -143.86 127.41 16.99 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 105.791 -1.929 . . . . 10.0 105.791 177.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -111.78 -59.98 0.46 Allowed Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.864 -0.895 . . . . 10.0 110.864 -172.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 2.9 mtt180 . . . . . 0 C--O 1.254 1.324 0 C-N-CA 127.887 2.475 . . . . 10.0 104.469 -171.834 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 51.5 t . . . . . 0 N--CA 1.468 0.459 0 N-CA-C 107.312 -1.366 . . . . 10.0 107.312 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.0 p -116.02 162.25 17.66 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.915 1.286 . . . . 10.0 110.216 178.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -116.69 162.83 17.05 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 126.863 2.065 . . . . 10.0 108.112 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.81 125.64 52.95 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.061 -1.459 . . . . 10.0 107.061 178.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -131.47 145.95 52.01 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.956 1.303 . . . . 10.0 108.474 -178.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -126.19 150.36 48.37 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 118.615 0.643 . . . . 10.0 111.578 177.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -139.74 139.05 36.42 Favored 'General case' 0 C--O 1.234 0.269 0 O-C-N 125.006 1.441 . . . . 10.0 110.079 -166.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.425 ' CG ' ' HZ3' ' A' ' 71' ' ' LYS . 5.3 m-20 -102.79 132.51 48.92 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.491 -0.929 . . . . 10.0 108.491 -171.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 8.7 mm -101.09 122.9 53.73 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 124.143 0.977 . . . . 10.0 109.839 -165.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -118.29 95.68 4.99 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 106.861 -1.533 . . . . 10.0 106.861 177.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 161.28 -88.42 0.11 Allowed Glycine 0 CA--C 1.527 0.792 0 C-N-CA 123.343 0.496 . . . . 10.0 112.455 178.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.11 160.74 20.54 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.04 0.936 . . . . 10.0 110.683 -172.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 13.9 t -151.23 87.04 1.37 Allowed 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 107.327 -1.36 . . . . 10.0 107.327 169.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 41.9 t -147.84 139.92 24.2 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 108.545 -0.909 . . . . 10.0 108.545 -178.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -46.38 -55.69 6.98 Favored 'General case' 0 C--O 1.223 -0.306 0 C-N-CA 125.449 1.499 . . . . 10.0 113.899 -168.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.24 -38.57 50.87 Favored 'General case' 0 C--N 1.333 -0.127 0 O-C-N 121.694 -0.629 . . . . 10.0 109.783 -168.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 57.3 m -61.82 -50.48 72.13 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 108.943 -0.762 . . . . 10.0 108.943 176.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -52.13 -43.34 63.97 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.817 0.847 . . . . 10.0 110.298 170.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -58.48 -38.27 77.28 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 121.493 -0.755 . . . . 10.0 110.953 -178.034 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.73 -40.07 75.05 Favored 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 121.645 -0.66 . . . . 10.0 109.752 177.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 9.0 mm -46.15 -50.38 4.61 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.249 0 CA-C-O 117.224 -1.37 . . . . 10.0 112.452 170.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -47.78 -53.41 15.44 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 120.34 1.427 . . . . 10.0 110.838 -176.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.2 tppt? -70.22 -43.59 70.33 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 123.612 0.765 . . . . 10.0 108.951 -176.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 14.2 tpp180 -63.4 -33.94 76.64 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-O 119.658 -0.21 . . . . 10.0 110.81 -175.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -78.68 -38.19 39.89 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 124.71 1.204 . . . . 10.0 110.529 173.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -59.95 -19.06 49.97 Favored 'General case' 0 C--O 1.225 -0.199 0 O-C-N 121.256 -0.903 . . . . 10.0 110.8 177.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.6 ptpt -51.84 -43.63 63.27 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 113.123 0.786 . . . . 10.0 113.123 169.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 5.2 mt -55.97 134.15 19.83 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 N-CA-C 108.635 -0.876 . . . . 10.0 108.635 -176.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -70.85 -47.1 61.13 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 108.705 -0.85 . . . . 10.0 108.705 -177.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -80.84 43.81 2.88 Favored Glycine 0 C--N 1.342 0.875 0 O-C-N 121.068 -1.02 . . . . 10.0 112.111 -176.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.8 p -105.92 152.05 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 C-N-CA 125.298 1.439 . . . . 10.0 109.058 -177.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -115.81 -57.91 2.17 Favored 'General case' 0 CA--C 1.522 -0.127 0 C-N-CA 123.796 0.838 . . . . 10.0 108.873 169.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 64.6 m-80 -143.62 159.24 42.81 Favored 'General case' 0 CA--C 1.526 0.057 0 N-CA-C 109.496 -0.557 . . . . 10.0 109.496 -176.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -141.32 61.34 13.67 Favored Pre-proline 0 CA--C 1.537 0.452 0 C-N-CA 123.884 0.874 . . . . 10.0 111.585 174.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -77.35 71.39 6.4 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 123.09 2.526 . . . . 10.0 110.03 -176.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.5 m -67.02 155.02 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 O-C-N 121.744 -0.598 . . . . 10.0 111.028 -178.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -95.69 155.24 16.83 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 120.98 0.419 . . . . 10.0 109.934 172.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -135.28 48.47 2.25 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 124.954 1.301 . . . . 10.0 109.695 -171.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -175.26 -42.44 0.01 OUTLIER 'General case' 0 C--O 1.224 -0.251 0 C-N-CA 126.09 1.756 . . . . 10.0 108.708 178.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.4 mt -80.66 -15.48 56.46 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 125.436 1.494 . . . . 10.0 112.012 -170.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 71.86 40.29 0.77 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.275 1.43 . . . . 10.0 110.721 174.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.5 p -140.76 123.38 16.12 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.64 1.576 . . . . 10.0 108.969 -178.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.3 t -92.86 145.91 7.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 107.322 -1.362 . . . . 10.0 107.322 168.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 88.3 m -133.75 122.13 22.89 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 105.997 -1.853 . . . . 10.0 105.997 -176.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 29.3 t -122.98 134.42 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-N 118.74 0.7 . . . . 10.0 109.408 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -96.15 104.41 16.37 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 106.833 -1.543 . . . . 10.0 106.833 161.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -145.42 163.72 33.75 Favored 'General case' 0 CA--C 1.521 -0.166 0 C-N-CA 123.558 0.743 . . . . 10.0 109.798 178.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 13.3 p30 -98.5 130.64 27.62 Favored Pre-proline 0 C--N 1.329 -0.307 0 C-N-CA 123.419 0.687 . . . . 10.0 109.492 175.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -79.02 57.56 6.53 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 121.86 1.707 . . . . 10.0 108.967 171.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.34 -46.79 2.03 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.144 -0.687 . . . . 10.0 109.144 174.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -85.75 -61.06 1.84 Allowed 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 109.696 -0.483 . . . . 10.0 109.696 -178.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -107.71 -176.61 3.11 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 124.105 0.962 . . . . 10.0 110.017 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 93.6 p -140.1 169.73 17.15 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.696 1.198 . . . . 10.0 109.622 176.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 84.0 t -48.43 -52.6 8.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 124.408 1.083 . . . . 10.0 109.83 168.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.1 m -55.5 -35.95 66.14 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.631 1.173 . . . . 10.0 112.394 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -71.84 -60.62 2.14 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.703 -0.48 . . . . 10.0 109.703 174.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.0 pp -61.54 -43.72 98.36 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 121.85 -0.531 . . . . 10.0 110.636 -167.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -51.37 -35.49 38.93 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 114.09 1.144 . . . . 10.0 114.09 171.065 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.88 -33.72 67.15 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 119.56 1.073 . . . . 10.0 110.088 176.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.38 -51.1 68.92 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 109.235 -0.654 . . . . 10.0 109.235 -177.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 43.3 t -59.54 -48.0 88.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 124.032 0.933 . . . . 10.0 111.477 173.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -53.09 -47.97 68.15 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 122.209 1.004 . . . . 10.0 109.435 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 32.8 tttp -70.56 -39.8 73.74 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 125.526 1.53 . . . . 10.0 110.897 -177.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 11.8 mt -51.57 -39.34 57.68 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 118.647 -0.692 . . . . 10.0 111.906 169.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 149.64 -21.2 1.17 Allowed Glycine 0 CA--C 1.527 0.798 0 CA-C-N 118.786 0.721 . . . . 10.0 114.698 167.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -118.82 155.43 31.19 Favored 'General case' 0 C--O 1.224 -0.276 0 C-N-CA 124.831 1.253 . . . . 10.0 107.955 -175.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.75 144.75 25.37 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 118.756 0.707 . . . . 10.0 110.331 -168.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 20.2 tp -123.36 145.18 48.96 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 126.157 1.783 . . . . 10.0 107.646 178.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.2 tptp -152.15 151.74 31.42 Favored 'General case' 0 CA--C 1.512 -0.499 0 C-N-CA 124.619 1.168 . . . . 10.0 108.488 171.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.9 tp -66.28 151.51 46.9 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 123.662 0.601 . . . . 10.0 109.66 177.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.425 ' HZ3' ' CG ' ' A' ' 8' ' ' ASP . 0.5 OUTLIER -105.07 -59.01 1.81 Allowed 'General case' 0 N--CA 1.437 -1.087 0 C-N-CA 127.492 2.317 . . . . 10.0 105.674 164.396 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 176.59 -93.65 0.09 OUTLIER Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 108.035 -2.026 . . . . 10.0 108.035 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -158.93 169.02 25.26 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.601 0.76 . . . . 10.0 109.608 -163.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -65.3 149.54 49.79 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.411 1.084 . . . . 10.0 111.36 -173.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -79.81 58.68 2.9 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.376 1.07 . . . . 10.0 109.785 -177.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 48.1 m -87.06 159.33 18.98 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.089 0.955 . . . . 10.0 110.435 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 41.7 pt -101.91 -163.85 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 N-CA-C 106.059 -1.83 . . . . 10.0 106.059 166.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -117.09 159.67 22.2 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 125.472 1.509 . . . . 10.0 107.183 164.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -142.59 -81.33 0.06 OUTLIER Glycine 0 CA--C 1.522 0.501 0 N-CA-C 108.169 -1.972 . . . . 10.0 108.169 175.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 20.0 ttp180 . . . . . 0 C--O 1.251 1.184 0 N-CA-C 105.922 -1.881 . . . . 10.0 105.922 171.599 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 4.0 p . . . . . 0 N--CA 1.471 0.591 0 N-CA-C 109.795 -0.446 . . . . 10.0 109.795 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.6 p -139.07 161.99 36.04 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 106.609 -1.626 . . . . 10.0 106.609 176.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -126.2 149.91 48.71 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 126.439 1.895 . . . . 10.0 107.478 -168.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.51 131.75 49.02 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 107.883 -1.155 . . . . 10.0 107.883 -176.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -140.27 157.24 45.89 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 123.656 0.782 . . . . 10.0 109.926 178.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -128.31 151.57 49.16 Favored 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 123.542 0.737 . . . . 10.0 110.353 178.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -140.35 146.64 38.69 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.845 1.658 . . . . 10.0 109.184 -170.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -110.15 125.82 53.42 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.311 1.044 . . . . 10.0 109.0 -165.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 8.6 mm -100.36 109.47 25.14 Favored 'Isoleucine or valine' 0 C--N 1.343 0.314 0 CA-C-N 118.907 0.776 . . . . 10.0 112.449 -159.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.499 ' OE1' ' NZ ' ' A' ' 67' ' ' LYS . 52.4 mt-10 -92.58 73.76 5.1 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 107.934 -1.135 . . . . 10.0 107.934 178.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 158.41 -109.32 0.4 Allowed Glycine 0 CA--C 1.526 0.758 0 N-CA-C 112.267 -0.333 . . . . 10.0 112.267 173.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.53 130.08 41.47 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 123.325 0.65 . . . . 10.0 110.933 -167.006 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.8 t -146.59 70.29 1.21 Allowed 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 107.675 -1.231 . . . . 10.0 107.675 -169.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 72.1 m -140.87 -116.35 0.12 Allowed 'General case' 0 C--N 1.339 0.15 0 N-CA-C 106.906 -1.516 . . . . 10.0 106.906 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -147.39 -49.09 0.18 Allowed 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.248 0.619 . . . . 10.0 110.249 178.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.51 -38.97 81.4 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.263 -0.643 . . . . 10.0 109.263 -175.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 52.5 m -64.06 -55.28 23.31 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 108.934 -0.765 . . . . 10.0 108.934 175.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -51.0 -39.08 54.94 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.835 1.254 . . . . 10.0 111.102 179.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -57.51 -30.49 65.18 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.038 0.755 . . . . 10.0 113.038 177.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 18.1 ttm180 -72.31 -36.46 68.92 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 120.641 -1.287 . . . . 10.0 109.392 -178.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 9.1 mt -43.95 -53.41 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.44 0 CA-C-O 118.654 -0.689 . . . . 10.0 109.492 168.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -48.98 -47.22 44.3 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.4 0.546 . . . . 10.0 111.811 -175.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.21 -48.45 65.14 Favored 'General case' 0 CA--C 1.531 0.222 0 O-C-N 121.585 -0.697 . . . . 10.0 110.014 177.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.9 mmt180 -56.72 -35.47 68.58 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 112.093 0.405 . . . . 10.0 112.093 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.3 mt -80.3 -44.8 18.97 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.752 1.621 . . . . 10.0 110.896 177.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -54.28 -24.98 21.07 Favored 'General case' 0 C--O 1.227 -0.113 0 CA-C-N 118.319 0.508 . . . . 10.0 111.077 174.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.8 ttmt -58.34 -35.37 71.8 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 112.984 0.735 . . . . 10.0 112.984 173.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.7 mm -60.02 135.13 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 C-N-CA 123.755 0.822 . . . . 10.0 109.85 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -69.05 -54.82 13.1 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 111.998 0.369 . . . . 10.0 111.998 -173.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.67 41.03 2.66 Favored Glycine 0 C--N 1.339 0.711 0 O-C-N 120.916 -1.115 . . . . 10.0 111.928 -173.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.4 p -100.95 150.61 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 C-N-CA 124.562 1.145 . . . . 10.0 108.542 -175.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -111.93 -58.16 2.16 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 108.483 -0.932 . . . . 10.0 108.483 171.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 60.0 m-80 -147.58 156.08 42.46 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.659 -0.867 . . . . 10.0 108.659 -173.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -141.72 56.81 6.3 Favored Pre-proline 0 CA--C 1.536 0.404 0 C-N-CA 123.626 0.771 . . . . 10.0 112.641 175.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -75.43 77.65 3.22 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 122.758 2.306 . . . . 10.0 110.152 -177.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.4 m -57.49 154.04 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 O-C-N 121.83 -0.543 . . . . 10.0 111.632 176.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -93.31 138.2 31.9 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.458 -0.571 . . . . 10.0 109.458 -179.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -117.7 54.56 0.9 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.99 1.316 . . . . 10.0 110.25 -171.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 171.14 -34.12 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 127.039 2.136 . . . . 10.0 109.997 176.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.5 mt -91.3 -1.67 57.59 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.14 1.376 . . . . 10.0 111.978 -171.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 65.44 35.19 7.52 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 124.918 1.287 . . . . 10.0 111.052 165.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -140.44 133.77 29.79 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 125.403 1.481 . . . . 10.0 107.857 -172.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.9 t -94.88 140.65 16.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 106.792 -1.558 . . . . 10.0 106.792 168.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 60.4 m -125.8 119.29 27.49 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 106.108 -1.812 . . . . 10.0 106.108 -178.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.8 t -120.57 142.51 36.15 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.207 0 C-N-CA 122.992 0.517 . . . . 10.0 109.629 -178.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 59.2 tt0 -109.51 110.44 21.54 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 107.184 -1.413 . . . . 10.0 107.184 162.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -151.72 164.93 35.9 Favored 'General case' 0 C--O 1.227 -0.129 0 C-N-CA 123.876 0.871 . . . . 10.0 109.405 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 20.7 p30 -95.53 134.69 23.9 Favored Pre-proline 0 C--N 1.328 -0.365 0 C-N-CA 123.437 0.695 . . . . 10.0 110.681 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -80.77 56.39 6.07 Favored 'Trans proline' 0 N--CA 1.45 -1.077 0 C-N-CA 121.603 1.536 . . . . 10.0 109.193 170.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.55 -39.54 0.51 Allowed 'General case' 0 C--N 1.346 0.439 0 CA-C-N 118.631 0.651 . . . . 10.0 112.54 175.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -95.23 -26.63 15.88 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 122.992 0.517 . . . . 10.0 110.321 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.51 173.22 15.42 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.183 0.993 . . . . 10.0 109.14 -179.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 91.0 p -131.59 169.35 16.25 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.565 1.146 . . . . 10.0 112.258 -177.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 26.4 m -48.75 -43.52 14.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 124.01 0.924 . . . . 10.0 110.679 166.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.85 -36.43 79.1 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.964 1.706 . . . . 10.0 111.642 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -71.55 -61.2 1.86 Allowed 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 108.472 -0.936 . . . . 10.0 108.472 175.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.3 pp -60.19 -42.31 94.8 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 120.042 -0.663 . . . . 10.0 111.545 -169.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -51.24 -37.68 48.36 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 117.305 -1.331 . . . . 10.0 113.879 170.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -51.55 -39.08 57.09 Favored 'General case' 0 C--N 1.346 0.417 0 CA-C-N 120.735 1.607 . . . . 10.0 110.298 173.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.18 -46.14 90.27 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 109.429 -0.582 . . . . 10.0 109.429 -174.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 68.9 t -66.83 -45.87 86.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 123.327 0.651 . . . . 10.0 111.755 172.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -49.9 -54.13 21.54 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 124.67 1.188 . . . . 10.0 108.821 -178.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 46.4 tptt -57.67 -34.78 69.75 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.549 1.54 . . . . 10.0 111.644 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.85 -34.45 65.44 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 124.255 1.022 . . . . 10.0 111.248 174.064 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 125.95 -11.45 7.36 Favored Glycine 0 CA--C 1.529 0.968 0 CA-C-O 119.474 -0.626 . . . . 10.0 113.4 174.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -116.35 151.46 35.87 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 107.149 -1.426 . . . . 10.0 107.149 173.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.499 ' NZ ' ' OE1' ' A' ' 10' ' ' GLU . 13.3 ttpp -95.47 156.4 16.34 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.246 0.546 . . . . 10.0 110.364 -171.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 29.7 tp -128.98 150.44 50.4 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.622 1.569 . . . . 10.0 107.882 -179.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 11.0 tptp -155.14 151.56 28.4 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 108.803 -0.814 . . . . 10.0 108.803 169.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.5 tp -62.74 154.78 28.48 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 121.303 0.573 . . . . 10.0 109.573 177.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 45.6 tttp -117.23 -53.44 2.45 Favored 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 127.769 2.428 . . . . 10.0 107.08 170.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 170.57 -84.38 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.515 0 N-CA-C 109.081 -1.608 . . . . 10.0 109.081 176.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -160.6 163.31 32.74 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 108.224 -1.028 . . . . 10.0 108.224 -164.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -84.83 123.9 30.98 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.302 -0.999 . . . . 10.0 108.302 175.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 53.2 t0 46.64 83.0 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.914 1.686 . . . . 10.0 112.934 172.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 35.1 m -61.19 70.06 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.297 1.839 . . . . 10.0 114.375 -176.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.7 pt -74.79 71.62 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 123.958 0.903 . . . . 10.0 111.736 176.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -79.39 -70.65 0.49 Allowed 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.285 1.034 . . . . 10.0 108.741 174.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.02 -66.14 3.46 Favored Glycine 0 CA--C 1.53 0.974 0 O-C-N 121.75 -0.594 . . . . 10.0 111.686 178.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 14.1 ttm180 . . . . . 0 C--O 1.251 1.182 0 CA-C-O 116.218 -1.848 . . . . 10.0 106.755 -178.651 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.41 ' CG1' ' H ' ' A' ' 2' ' ' THR . 18.0 t . . . . . 0 N--CA 1.466 0.348 0 N-CA-C 105.847 -1.908 . . . . 10.0 105.847 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.41 ' H ' ' CG1' ' A' ' 1' ' ' VAL . 21.7 p -113.75 137.44 51.63 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.765 1.226 . . . . 10.0 110.103 -178.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -116.47 151.95 35.02 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 125.186 1.394 . . . . 10.0 109.136 -165.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -86.58 129.67 34.78 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.857 1.263 . . . . 10.0 107.719 -171.275 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -134.28 136.34 43.48 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.527 1.131 . . . . 10.0 109.362 174.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -116.11 150.8 36.79 Favored 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 124.622 1.169 . . . . 10.0 108.067 174.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -138.95 138.17 37.07 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 124.493 1.121 . . . . 10.0 109.327 -174.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -102.12 130.59 48.77 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.727 1.611 . . . . 10.0 108.197 -176.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -114.95 153.86 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.068 0 C-N-CA 125.789 1.636 . . . . 10.0 110.895 -165.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -128.27 86.04 2.41 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 124.387 1.075 . . . . 10.0 108.23 168.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 114.16 61.99 0.4 Allowed Glycine 0 CA--C 1.525 0.671 0 CA-C-O 119.493 -0.615 . . . . 10.0 113.206 160.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 16.5 ptt? -128.23 40.92 3.59 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 122.527 1.156 . . . . 10.0 111.949 169.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 70.2 p -90.37 52.95 2.34 Favored 'General case' 0 C--N 1.33 -0.274 0 O-C-N 120.306 -1.496 . . . . 10.0 109.546 -172.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 12.6 t -137.5 5.03 2.67 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 112.031 0.382 . . . . 10.0 112.031 179.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 67.09 -57.12 0.43 Allowed 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 126.123 1.769 . . . . 10.0 112.995 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.7 -36.47 81.01 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.396 1.478 . . . . 10.0 109.463 -179.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 26.6 p -68.02 -51.83 42.59 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 109.424 -0.584 . . . . 10.0 109.424 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.4 -46.68 69.8 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.392 0.677 . . . . 10.0 110.053 173.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -61.31 -19.92 62.34 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.631 0.604 . . . . 10.0 112.631 178.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.1 ttm180 -78.7 -36.88 42.9 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.307 1.043 . . . . 10.0 108.805 178.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 19.1 mm -43.7 -54.31 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.399 0 CA-C-O 118.462 -0.78 . . . . 10.0 109.854 171.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -44.63 -46.79 10.31 Favored 'General case' 0 C--O 1.224 -0.277 0 C-N-CA 122.998 0.519 . . . . 10.0 111.841 -179.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.54 -46.25 63.95 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 122.971 0.508 . . . . 10.0 110.076 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.09 -33.68 74.9 Favored 'General case' 0 C--O 1.222 -0.342 0 O-C-N 121.987 -0.445 . . . . 10.0 111.808 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.12 -34.84 26.0 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.524 1.53 . . . . 10.0 111.431 177.328 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -58.68 -24.59 61.62 Favored 'General case' 0 C--O 1.226 -0.171 0 O-C-N 121.761 -0.587 . . . . 10.0 109.89 172.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -52.03 -40.12 60.58 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 120.879 -0.328 . . . . 10.0 111.348 171.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 15.9 mm -56.16 127.2 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 C-N-CA 123.203 0.601 . . . . 10.0 109.623 -176.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -70.42 -48.67 54.98 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 121.081 -0.248 . . . . 10.0 110.759 -176.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -84.31 43.43 3.21 Favored Glycine 0 C--N 1.34 0.75 0 O-C-N 120.802 -1.186 . . . . 10.0 111.549 -177.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.3 p -99.4 148.46 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 124.287 1.035 . . . . 10.0 108.582 -178.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -111.02 -57.51 2.23 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 124.106 0.962 . . . . 10.0 108.545 175.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 -143.39 152.46 41.62 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.307 -0.997 . . . . 10.0 108.307 -175.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -138.94 61.57 22.52 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 123.602 0.761 . . . . 10.0 111.072 173.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -78.48 67.76 8.22 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 123.004 2.469 . . . . 10.0 110.018 -175.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.2 m -65.0 155.15 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 O-C-N 121.859 -0.526 . . . . 10.0 110.61 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 75.4 m-80 -93.57 148.98 21.6 Favored 'General case' 0 C--O 1.224 -0.287 0 N-CA-C 108.497 -0.927 . . . . 10.0 108.497 175.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -126.3 47.95 2.2 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 123.643 0.777 . . . . 10.0 110.38 -173.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -174.22 -43.03 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 125.948 1.699 . . . . 10.0 109.614 178.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.0 mt -76.38 -18.47 58.85 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.803 1.241 . . . . 10.0 111.971 -169.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 63.2 54.72 2.01 Favored 'General case' 0 C--N 1.338 0.079 0 C-N-CA 125.752 1.621 . . . . 10.0 110.126 -174.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.2 p -142.29 130.74 22.41 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 107.481 -1.303 . . . . 10.0 107.481 172.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.2 t -105.28 145.41 13.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 106.759 -1.571 . . . . 10.0 106.759 173.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 69.8 m -139.83 123.57 17.42 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 106.25 -1.759 . . . . 10.0 106.25 -169.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 22.2 t -127.42 149.36 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 C-N-CA 123.692 0.797 . . . . 10.0 109.271 179.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 -115.78 112.02 21.38 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 105.895 -1.891 . . . . 10.0 105.895 159.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -146.44 162.81 37.46 Favored 'General case' 0 CA--C 1.52 -0.202 0 C-N-CA 123.403 0.681 . . . . 10.0 109.553 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 20.5 p30 -92.47 130.6 36.78 Favored Pre-proline 0 C--N 1.329 -0.306 0 C-N-CA 122.524 0.33 . . . . 10.0 110.237 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -76.47 61.6 6.82 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 121.554 1.503 . . . . 10.0 108.486 170.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.24 -43.88 0.33 Allowed 'General case' 0 C--N 1.341 0.223 0 O-C-N 122.085 -0.384 . . . . 10.0 109.979 177.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -87.02 -41.96 13.46 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 117.92 0.327 . . . . 10.0 110.865 177.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -133.04 -178.06 4.79 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 124.52 1.128 . . . . 10.0 109.952 -177.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 81.7 p -146.24 167.46 23.45 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.549 0.74 . . . . 10.0 109.579 177.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 64.9 t -43.01 -49.07 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.113 0 C-N-CA 124.836 1.254 . . . . 10.0 111.02 172.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 43.9 m -50.54 -43.4 56.07 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.486 0.714 . . . . 10.0 112.583 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -65.77 -60.21 3.12 Favored 'General case' 0 C--N 1.338 0.09 0 C-N-CA 123.808 0.843 . . . . 10.0 109.055 -177.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.0 pp -61.65 -42.84 99.47 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 120.06 -0.656 . . . . 10.0 110.533 -176.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.11 -53.2 6.63 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 117.823 -1.084 . . . . 10.0 112.16 163.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.32 -48.63 73.86 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 119.96 1.255 . . . . 10.0 110.38 178.398 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -48.28 -54.62 13.05 Favored 'General case' 0 N--CA 1.453 -0.309 0 O-C-N 123.349 0.405 . . . . 10.0 110.642 177.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.1 t -62.9 -44.6 99.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 N-CA-C 112.578 0.585 . . . . 10.0 112.578 176.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.63 -57.49 8.09 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.013 1.325 . . . . 10.0 108.431 178.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.0 tptm -55.6 -38.84 69.96 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 126.455 1.902 . . . . 10.0 111.216 176.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.1 tp -55.05 -27.46 44.8 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.186 0.995 . . . . 10.0 113.047 174.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 131.21 -11.14 5.58 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-O 119.169 -0.795 . . . . 10.0 114.258 168.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -137.91 160.55 38.99 Favored 'General case' 0 CA--C 1.527 0.058 0 CA-C-N 118.667 1.234 . . . . 10.0 108.37 -176.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 41.4 mmtt -88.94 153.62 20.89 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.148 0.499 . . . . 10.0 112.041 -165.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.9 tp -135.23 148.69 49.69 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 125.579 1.552 . . . . 10.0 107.104 176.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.8 mmtt -149.17 154.18 38.77 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 124.523 1.129 . . . . 10.0 108.233 165.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.9 tp -59.76 158.52 10.23 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 109.752 -0.462 . . . . 10.0 109.752 171.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 7.8 tptt -110.38 -74.19 0.66 Allowed 'General case' 0 N--CA 1.434 -1.255 0 C-N-CA 126.832 2.053 . . . . 10.0 106.892 173.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 163.87 44.79 0.02 OUTLIER Glycine 0 CA--C 1.53 0.992 0 CA-C-O 119.491 -0.616 . . . . 10.0 112.537 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 70.64 156.84 0.16 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.059 1.344 . . . . 10.0 113.893 169.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 8.1 mp0 -71.83 94.77 1.45 Allowed 'General case' 0 C--O 1.237 0.41 0 C-N-CA 124.175 0.99 . . . . 10.0 111.008 -173.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -59.29 78.3 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.072 1.349 . . . . 10.0 111.061 171.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 30.5 m -64.46 -28.83 69.94 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.438 1.095 . . . . 10.0 110.77 177.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 5.3 pt -142.44 87.85 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 C-N-CA 125.319 1.448 . . . . 10.0 109.065 178.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -72.24 -76.98 0.1 Allowed 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 108.665 -0.865 . . . . 10.0 108.665 175.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -101.01 -77.29 1.26 Allowed Glycine 0 CA--C 1.526 0.766 0 N-CA-C 109.647 -1.381 . . . . 10.0 109.647 178.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? . . . . . 0 C--O 1.251 1.153 0 C-N-CA 125.39 1.476 . . . . 10.0 110.999 -171.972 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.5 p . . . . . 0 N--CA 1.472 0.673 0 N-CA-C 109.604 -0.517 . . . . 10.0 109.604 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.2 p -144.03 169.56 17.6 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.431 1.492 . . . . 10.0 107.275 171.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -135.75 146.13 47.33 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 126.543 1.937 . . . . 10.0 106.708 -172.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 28.8 mmtm -81.54 145.73 30.52 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.77 -0.826 . . . . 10.0 108.77 177.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -145.12 141.58 28.92 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.721 1.208 . . . . 10.0 108.212 174.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -122.63 148.82 44.81 Favored 'General case' 0 CA--C 1.51 -0.595 0 C-N-CA 124.413 1.085 . . . . 10.0 108.601 174.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -140.43 138.05 34.42 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 125.101 1.5 . . . . 10.0 109.404 -171.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -103.98 127.82 51.53 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.964 -1.124 . . . . 10.0 107.964 -168.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 10.7 mm -103.56 136.11 38.0 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.114 0 C-N-CA 124.424 1.09 . . . . 10.0 110.804 -160.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -125.23 99.68 6.19 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.478 -1.305 . . . . 10.0 107.478 169.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 156.46 -103.89 0.24 Allowed Glycine 0 CA--C 1.527 0.804 0 CA-C-O 120.034 -0.314 . . . . 10.0 112.565 173.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.22 157.11 38.33 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 117.628 0.714 . . . . 10.0 110.892 -174.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.0 t -150.15 62.95 0.97 Allowed 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.87 -1.159 . . . . 10.0 107.87 175.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.6 t -160.91 140.59 10.76 Favored 'General case' 0 N--CA 1.454 -0.239 0 O-C-N 121.109 -0.994 . . . . 10.0 109.939 -177.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.53 -46.82 70.3 Favored 'General case' 0 C--O 1.222 -0.344 0 C-N-CA 124.104 0.962 . . . . 10.0 113.406 -170.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.08 -35.01 71.71 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 119.02 0.827 . . . . 10.0 109.917 -172.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 13.8 m -67.87 -54.29 20.02 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.717 -0.846 . . . . 10.0 108.717 177.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -51.41 -37.87 50.59 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.543 -0.753 . . . . 10.0 110.616 174.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -53.49 -34.43 57.99 Favored 'General case' 0 CA--C 1.531 0.235 0 O-C-N 121.606 -0.684 . . . . 10.0 112.064 -179.061 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -60.31 -38.4 83.56 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 121.056 -1.027 . . . . 10.0 109.135 -179.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 13.1 mm -52.57 -49.1 46.14 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.477 0 CA-C-O 118.053 -0.975 . . . . 10.0 110.323 176.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -46.42 -50.66 16.42 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.909 0.777 . . . . 10.0 110.56 -177.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.64 -46.37 63.41 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.106 0.562 . . . . 10.0 111.264 178.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.1 mmt180 -58.8 -27.34 64.95 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.743 0.645 . . . . 10.0 112.743 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.0 -39.3 13.04 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.943 1.697 . . . . 10.0 111.404 174.341 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 24.8 t30 -57.47 -25.82 60.3 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 118.703 0.683 . . . . 10.0 110.627 174.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.1 mmpt? -54.4 -37.33 64.94 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 114.3 1.222 . . . . 10.0 114.3 169.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 11.6 mm -54.53 128.82 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 109.084 -0.71 . . . . 10.0 109.084 175.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -68.39 -49.62 58.78 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 109.469 -0.567 . . . . 10.0 109.469 -177.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -82.39 47.31 3.72 Favored Glycine 0 C--N 1.34 0.783 0 O-C-N 120.651 -1.28 . . . . 10.0 112.181 -175.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.5 p -110.23 153.57 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 C-N-CA 125.223 1.409 . . . . 10.0 109.568 -177.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -118.0 -52.01 2.43 Favored 'General case' 0 C--O 1.228 -0.029 0 C-N-CA 122.714 0.406 . . . . 10.0 110.127 169.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -144.57 149.92 36.62 Favored 'General case' 0 CA--C 1.527 0.087 0 N-CA-C 109.075 -0.713 . . . . 10.0 109.075 -173.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -137.58 58.48 16.86 Favored Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 123.691 0.796 . . . . 10.0 112.432 174.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -77.04 77.2 3.87 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 123.125 2.55 . . . . 10.0 110.495 -176.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.7 m -59.71 153.43 4.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 O-C-N 121.741 -0.599 . . . . 10.0 111.398 176.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -97.84 143.6 28.28 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.829 -0.804 . . . . 10.0 108.829 175.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -125.34 43.01 3.15 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.278 1.031 . . . . 10.0 110.953 -166.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -175.6 -40.06 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 125.924 1.69 . . . . 10.0 108.942 -178.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 12.6 mt -76.38 -21.26 56.27 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.346 1.058 . . . . 10.0 111.414 -176.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 63.7 49.48 2.96 Favored 'General case' 0 CA--C 1.527 0.093 0 C-N-CA 125.547 1.539 . . . . 10.0 109.959 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.6 p -137.86 131.67 31.39 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 126.131 1.772 . . . . 10.0 106.854 174.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 17.5 t -93.26 144.21 9.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 106.174 -1.787 . . . . 10.0 106.174 167.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 92.4 m -130.4 123.1 29.09 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 105.453 -2.054 . . . . 10.0 105.453 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 44.5 t -122.26 149.79 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 N-CA-C 108.668 -0.864 . . . . 10.0 108.668 176.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -116.06 108.66 16.48 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 107.113 -1.44 . . . . 10.0 107.113 161.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -146.63 164.63 32.04 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 108.915 -0.772 . . . . 10.0 108.915 -178.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 17.3 p30 -94.81 128.44 39.47 Favored Pre-proline 0 C--N 1.326 -0.421 0 N-CA-C 109.983 -0.377 . . . . 10.0 109.983 174.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -77.55 57.2 5.87 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 121.787 1.658 . . . . 10.0 108.7 168.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.17 -45.66 1.97 Allowed 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.113 -0.699 . . . . 10.0 109.113 177.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -90.11 -58.88 2.35 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 123.2 0.6 . . . . 10.0 109.68 -178.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -111.32 175.13 5.55 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 125.187 1.395 . . . . 10.0 109.565 178.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 59.4 p -129.14 176.65 7.74 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.66 1.184 . . . . 10.0 110.226 175.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 92.3 t -52.43 -39.88 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-N 115.234 -0.893 . . . . 10.0 110.691 168.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.1 m -58.13 -37.34 74.44 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 123.083 0.553 . . . . 10.0 111.882 -177.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -69.36 -58.49 3.94 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 123.999 0.92 . . . . 10.0 109.137 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.1 pp -63.08 -41.22 99.38 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 120.381 -0.528 . . . . 10.0 111.118 -175.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -40.48 -57.93 1.69 Allowed 'General case' 0 C--O 1.22 -0.48 0 O-C-N 121.575 -0.703 . . . . 10.0 111.69 161.024 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.47 -42.3 77.97 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 118.851 0.75 . . . . 10.0 110.35 -177.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -55.35 -47.28 75.98 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.395 -0.82 . . . . 10.0 110.432 179.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 48.0 t -66.02 -41.84 90.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 N-CA-C 111.481 0.178 . . . . 10.0 111.481 171.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -58.21 -45.36 87.79 Favored 'General case' 0 C--N 1.331 -0.201 0 O-C-N 121.181 -0.949 . . . . 10.0 109.181 -172.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 56.5 tttm -64.39 -27.91 69.33 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.32 1.048 . . . . 10.0 112.459 178.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.63 -28.51 60.67 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 119.246 0.93 . . . . 10.0 110.756 168.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 131.26 -48.6 0.96 Allowed Glycine 0 C--N 1.337 0.635 0 N-CA-C 109.477 -1.449 . . . . 10.0 109.477 175.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -86.32 162.62 18.13 Favored 'General case' 0 C--O 1.224 -0.286 0 C-N-CA 125.422 1.489 . . . . 10.0 109.778 -177.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.87 163.7 12.53 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.38 0.609 . . . . 10.0 110.813 -167.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 18.4 tp -139.82 148.6 42.4 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 126.408 1.883 . . . . 10.0 107.561 -175.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.2 tptp -148.18 155.34 41.27 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 118.408 -0.806 . . . . 10.0 108.9 163.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.9 tp -63.83 158.4 22.06 Favored 'General case' 0 C--N 1.339 0.143 0 N-CA-C 108.992 -0.744 . . . . 10.0 108.992 174.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 14.8 tttp -113.77 -69.23 0.87 Allowed 'General case' 0 N--CA 1.436 -1.166 0 C-N-CA 125.739 1.616 . . . . 10.0 107.389 172.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 162.38 49.41 0.02 OUTLIER Glycine 0 CA--C 1.526 0.78 0 CA-C-O 119.666 -0.519 . . . . 10.0 112.35 175.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 66.76 168.56 0.23 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.996 1.319 . . . . 10.0 111.947 178.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -75.81 177.75 6.68 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.664 0.745 . . . . 10.0 110.293 176.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -38.18 -47.65 1.18 Allowed 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 125.531 1.532 . . . . 10.0 112.006 167.013 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 75.1 m 53.37 66.11 1.32 Allowed 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.474 1.11 . . . . 10.0 111.493 172.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 92.6 mt -64.02 -21.6 29.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 124.636 1.174 . . . . 10.0 112.692 -173.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -140.57 150.23 43.39 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.707 1.603 . . . . 10.0 107.484 179.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 157.3 105.05 0.22 Allowed Glycine 0 CA--C 1.53 1.031 0 CA-C-O 118.834 -0.981 . . . . 10.0 112.196 178.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 3.3 tpm_? . . . . . 0 C--O 1.247 0.945 0 C-N-CA 127.876 2.471 . . . . 10.0 111.363 170.035 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 86.1 t . . . . . 0 N--CA 1.473 0.68 0 N-CA-C 107.771 -1.196 . . . . 10.0 107.771 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.4 p -134.39 167.71 20.24 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 126.303 1.841 . . . . 10.0 107.309 177.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -137.75 146.76 44.05 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.414 1.486 . . . . 10.0 108.35 -166.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -91.71 140.14 30.0 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.036 0.534 . . . . 10.0 109.733 -177.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -142.84 148.23 36.72 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.051 1.34 . . . . 10.0 109.315 179.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -123.27 149.37 44.86 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.612 1.165 . . . . 10.0 108.372 174.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -141.04 144.12 34.8 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 124.976 1.422 . . . . 10.0 109.18 -174.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -106.92 132.03 53.32 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.4 1.08 . . . . 10.0 109.801 -169.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.7 mm -110.65 113.93 45.65 Favored 'Isoleucine or valine' 0 C--N 1.34 0.18 0 C-N-CA 125.096 1.358 . . . . 10.0 112.011 -160.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -106.91 98.39 8.06 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.397 -0.964 . . . . 10.0 108.397 169.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 162.77 -84.94 0.11 Allowed Glycine 0 CA--C 1.525 0.705 0 CA-C-O 119.751 -0.472 . . . . 10.0 112.845 168.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 16.4 ptp -131.21 134.73 46.75 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.729 0.812 . . . . 10.0 109.488 -174.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 58.7 p -147.23 71.15 1.2 Allowed 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 107.475 -1.305 . . . . 10.0 107.475 -164.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -147.9 162.25 39.66 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 124.02 0.928 . . . . 10.0 109.672 -171.016 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -52.42 -51.25 60.09 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.99 0.916 . . . . 10.0 113.464 -171.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.95 -30.47 69.77 Favored 'General case' 0 N--CA 1.456 -0.16 0 O-C-N 121.542 -0.723 . . . . 10.0 109.883 -178.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.1 m -69.65 -58.64 3.68 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.338 -1.356 . . . . 10.0 107.338 -177.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -39.17 -50.85 1.93 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 127.427 2.291 . . . . 10.0 111.057 168.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -61.62 -33.21 73.53 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 113.115 0.783 . . . . 10.0 113.115 -179.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.15 -48.44 57.38 Favored 'General case' 0 N--CA 1.451 -0.386 0 O-C-N 120.747 -1.221 . . . . 10.0 108.337 176.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -45.83 -51.55 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 CA-C-O 118.163 -0.922 . . . . 10.0 110.663 175.094 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -43.31 -48.8 6.89 Favored 'General case' 0 C--N 1.341 0.225 0 CA-C-N 118.626 0.648 . . . . 10.0 111.421 178.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.65 -47.04 61.98 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.779 -0.822 . . . . 10.0 108.779 -176.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.56 -38.67 75.17 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.275 -0.42 . . . . 10.0 111.894 -179.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.1 mt -78.96 -41.96 27.95 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.141 1.376 . . . . 10.0 110.576 178.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 15.7 t30 -54.8 -25.05 25.7 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.137 0.575 . . . . 10.0 111.226 173.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.2 ttmt -55.57 -38.38 69.29 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 112.393 0.516 . . . . 10.0 112.393 171.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 21.4 mm -60.01 132.14 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 C-N-CA 124.079 0.951 . . . . 10.0 109.831 -179.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -71.5 -52.63 17.33 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 111.47 0.174 . . . . 10.0 111.47 -174.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -82.95 42.83 3.02 Favored Glycine 0 C--N 1.339 0.71 0 O-C-N 120.753 -1.217 . . . . 10.0 112.026 -176.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.7 p -103.22 148.72 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 C-N-CA 124.385 1.074 . . . . 10.0 108.537 -177.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -110.94 -56.55 2.35 Favored 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 108.965 -0.754 . . . . 10.0 108.965 175.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -147.96 151.53 35.96 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 108.216 -1.031 . . . . 10.0 108.216 -172.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -136.61 65.16 53.96 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 123.77 0.828 . . . . 10.0 110.93 172.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -78.36 68.17 8.05 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.01 2.474 . . . . 10.0 109.447 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.6 m -71.27 158.95 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 C-N-CA 123.058 0.543 . . . . 10.0 111.36 -177.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -100.64 145.6 28.2 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-O 120.936 0.398 . . . . 10.0 110.894 -175.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -121.99 38.78 4.04 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.304 1.442 . . . . 10.0 111.102 -170.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -176.57 -36.68 0.01 OUTLIER 'General case' 0 C--O 1.224 -0.249 0 C-N-CA 125.06 1.344 . . . . 10.0 110.531 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 12.8 mt -82.18 -10.89 59.0 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.9 1.28 . . . . 10.0 112.036 -173.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 71.67 40.45 0.78 Allowed 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 125.661 1.584 . . . . 10.0 110.885 171.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 7.5 p -142.51 133.4 25.65 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.546 1.138 . . . . 10.0 108.975 -175.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.4 t -99.78 139.4 21.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 N-CA-C 106.187 -1.783 . . . . 10.0 106.187 168.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 57.7 m -131.66 118.17 19.66 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 105.218 -2.142 . . . . 10.0 105.218 -174.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.5 t -124.49 140.16 48.59 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.183 0 C-N-CA 122.964 0.506 . . . . 10.0 109.707 -175.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 49.4 tt0 -103.23 111.42 23.8 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 107.39 -1.337 . . . . 10.0 107.39 161.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -145.6 164.46 31.65 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 123.68 0.792 . . . . 10.0 109.782 176.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -96.75 131.56 27.81 Favored Pre-proline 0 C--N 1.33 -0.25 0 C-N-CA 123.067 0.547 . . . . 10.0 110.03 177.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -77.2 61.34 7.25 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 121.302 1.335 . . . . 10.0 108.68 168.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.14 -43.95 0.38 Allowed 'General case' 0 C--N 1.343 0.311 0 O-C-N 121.894 -0.504 . . . . 10.0 110.981 177.082 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.77 -41.12 14.36 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.797 0.839 . . . . 10.0 110.031 178.108 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -144.42 170.06 16.74 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 126.223 1.809 . . . . 10.0 108.772 -170.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 33.0 p -128.71 -179.49 5.1 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 122.608 1.194 . . . . 10.0 110.817 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 99.3 t -46.54 -41.46 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 114.413 -1.267 . . . . 10.0 111.292 163.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 70.6 m -62.0 -40.05 94.33 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 118.46 0.573 . . . . 10.0 111.301 -173.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -68.48 -54.57 16.07 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.814 1.245 . . . . 10.0 108.999 -175.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.0 pp -63.87 -44.07 94.18 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 119.664 -0.814 . . . . 10.0 110.485 -179.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.9 -49.66 10.88 Favored 'General case' 0 C--O 1.221 -0.438 0 CA-C-O 117.823 -1.084 . . . . 10.0 113.212 163.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 14.2 tm-20 -54.82 -46.2 74.52 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 120.715 1.598 . . . . 10.0 109.618 179.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -50.69 -55.37 16.86 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.377 -0.829 . . . . 10.0 109.372 178.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 66.8 t -60.98 -49.97 82.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 112.841 0.682 . . . . 10.0 112.841 177.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -58.34 -33.38 69.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.749 0.785 . . . . 10.0 109.285 -176.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.6 tttp -77.7 -34.11 52.94 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 123.451 0.701 . . . . 10.0 111.583 178.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 67.9 mt -53.09 -42.22 65.71 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.347 0.976 . . . . 10.0 111.148 164.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 143.51 -37.48 1.46 Allowed Glycine 0 C--N 1.337 0.636 0 CA-C-N 118.155 0.434 . . . . 10.0 112.439 168.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 22.3 p90 -85.71 158.55 20.02 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 108.494 -0.928 . . . . 10.0 108.494 176.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 33.6 mttp -100.94 160.84 14.04 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.544 0.688 . . . . 10.0 111.422 -173.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 21.6 tp -136.68 149.49 47.95 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.253 1.821 . . . . 10.0 107.549 -171.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -153.38 152.36 30.97 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 109.011 -0.737 . . . . 10.0 109.011 162.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.7 tp -60.02 156.61 14.43 Favored 'General case' 0 C--O 1.231 0.129 0 O-C-N 123.595 0.56 . . . . 10.0 109.683 175.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -112.1 -70.44 0.81 Allowed 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 125.672 1.589 . . . . 10.0 107.201 172.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 157.4 59.08 0.01 OUTLIER Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.191 -0.763 . . . . 10.0 111.191 -179.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . 0.272 12.4 pt-20 54.11 171.29 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 128.098 2.559 . . . . 10.0 114.737 176.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -97.33 149.69 21.81 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.576 -0.898 . . . . 10.0 108.576 -178.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -59.66 122.5 14.26 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 107.656 -1.239 . . . . 10.0 107.656 174.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -141.82 129.65 21.75 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.562 -1.273 . . . . 10.0 107.562 -173.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 5.6 pt -127.19 89.69 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 124.371 1.068 . . . . 10.0 109.279 -175.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -74.11 110.7 8.61 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.684 -0.858 . . . . 10.0 108.684 177.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -66.13 116.47 8.51 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 108.791 -1.723 . . . . 10.0 108.791 170.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 4.6 mmm180 . . . . . 0 C--O 1.251 1.132 0 CA-C-O 117.246 -1.359 . . . . 10.0 107.847 179.332 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 15.0 p . . . . . 0 N--CA 1.466 0.341 0 N-CA-C 105.954 -1.869 . . . . 10.0 105.954 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 11.8 p -112.21 153.85 26.46 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 126.447 1.899 . . . . 10.0 109.642 -177.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.7 mp0 -101.02 138.33 38.21 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.244 1.817 . . . . 10.0 109.212 177.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.7 tptt -81.87 119.86 24.46 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 108.105 -1.072 . . . . 10.0 108.105 171.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -128.09 153.55 46.69 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.537 1.135 . . . . 10.0 109.575 173.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -128.1 145.24 51.06 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.632 0.773 . . . . 10.0 110.215 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -130.22 133.57 46.64 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 125.236 1.585 . . . . 10.0 111.749 -167.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -85.1 136.11 33.69 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 125.28 1.432 . . . . 10.0 109.781 176.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 5.2 mm -109.42 134.58 51.03 Favored 'Isoleucine or valine' 0 C--N 1.34 0.176 0 C-N-CA 126.543 1.937 . . . . 10.0 109.756 -173.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -124.8 108.07 11.57 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 108.28 -1.007 . . . . 10.0 108.28 159.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 150.79 -98.08 0.18 Allowed Glycine 0 CA--C 1.529 0.911 0 C-N-CA 124.342 0.972 . . . . 10.0 111.739 169.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 36.6 mmt -76.04 139.5 41.46 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 117.642 0.721 . . . . 10.0 111.506 -175.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.2 t -148.19 66.05 1.09 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.902 1.281 . . . . 10.0 107.909 -178.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 37.3 m -153.39 143.86 22.48 Favored 'General case' 0 C--N 1.34 0.183 0 N-CA-C 108.359 -0.978 . . . . 10.0 108.359 -174.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -55.06 -46.61 75.38 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 114.037 1.125 . . . . 10.0 114.037 -174.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.3 -27.88 61.79 Favored 'General case' 0 C--N 1.332 -0.156 0 O-C-N 121.251 -0.906 . . . . 10.0 109.973 -176.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 91.2 m -74.33 -50.74 17.54 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.436 -0.95 . . . . 10.0 108.436 178.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -45.09 -46.3 11.6 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.564 1.545 . . . . 10.0 110.359 168.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -58.66 -34.49 71.29 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 121.268 -0.895 . . . . 10.0 112.491 178.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 34.5 ttt85 -66.38 -35.41 80.26 Favored 'General case' 0 N--CA 1.45 -0.425 0 O-C-N 120.813 -1.18 . . . . 10.0 109.77 178.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 4.6 mt -52.04 -57.98 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.498 0 N-CA-C 108.861 -0.792 . . . . 10.0 108.861 172.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -45.25 -48.18 12.8 Favored 'General case' 0 C--O 1.221 -0.427 0 O-C-N 123.856 0.723 . . . . 10.0 110.882 -177.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.2 mtmt -68.14 -46.98 69.34 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.934 0.893 . . . . 10.0 110.414 -178.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.3 tpm_? -63.32 -36.59 84.19 Favored 'General case' 0 N--CA 1.45 -0.425 0 O-C-N 121.858 -0.526 . . . . 10.0 110.184 -178.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.06 -34.57 50.34 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.901 1.681 . . . . 10.0 111.457 176.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -64.15 -20.5 66.03 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 118.633 0.651 . . . . 10.0 109.421 175.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -53.97 -41.24 67.64 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 119.941 -0.704 . . . . 10.0 111.156 168.014 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 28.2 mm -58.97 129.96 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 123.667 0.787 . . . . 10.0 109.757 -174.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -73.03 -48.95 31.7 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 116.631 -0.259 . . . . 10.0 110.399 -172.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -82.88 40.9 2.83 Favored Glycine 0 C--N 1.339 0.746 0 O-C-N 120.887 -1.133 . . . . 10.0 111.767 -176.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -104.89 144.73 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 N-CA-C 107.743 -1.206 . . . . 10.0 107.743 179.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -106.67 -55.19 2.36 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.26 -0.644 . . . . 10.0 109.26 171.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -142.89 143.01 31.88 Favored 'General case' 0 C--O 1.226 -0.154 0 N-CA-C 108.824 -0.806 . . . . 10.0 108.824 -174.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -133.68 55.64 16.83 Favored Pre-proline 0 CA--C 1.54 0.585 0 N-CA-C 113.552 0.945 . . . . 10.0 113.552 175.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -77.9 75.58 4.73 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 123.392 2.728 . . . . 10.0 110.39 -177.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.1 m -62.32 153.09 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 123.138 0.575 . . . . 10.0 111.719 178.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -94.35 138.53 32.21 Favored 'General case' 0 N--CA 1.457 -0.116 0 O-C-N 122.082 -0.386 . . . . 10.0 110.06 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -116.01 45.64 1.7 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.676 1.19 . . . . 10.0 111.557 -169.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -175.92 -39.99 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.207 0 C-N-CA 125.232 1.413 . . . . 10.0 109.354 178.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.7 mt -74.92 -20.21 59.8 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.491 1.117 . . . . 10.0 111.427 -174.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 63.39 49.93 3.04 Favored 'General case' 0 C--N 1.339 0.132 0 C-N-CA 125.466 1.506 . . . . 10.0 109.761 -178.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.1 p -140.06 125.85 19.43 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 125.507 1.523 . . . . 10.0 107.446 174.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 32.1 t -91.69 136.46 24.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 107.263 -1.384 . . . . 10.0 107.263 167.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 26.0 m -120.05 124.88 46.94 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 125.592 1.557 . . . . 10.0 107.079 178.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 98.1 t -134.94 146.52 30.43 Favored 'Isoleucine or valine' 0 C--N 1.341 0.232 0 CA-C-N 119.154 0.888 . . . . 10.0 110.524 175.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -105.03 106.64 17.23 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 126.99 2.116 . . . . 10.0 106.162 169.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 26.5 p90 -139.6 154.44 47.59 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 118.926 0.785 . . . . 10.0 110.766 179.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -94.69 128.28 40.36 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 118.589 -0.719 . . . . 10.0 110.079 175.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -76.07 57.87 5.36 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.553 2.169 . . . . 10.0 108.862 169.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.413 ' NZ ' ' OE1' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -124.51 -53.0 1.7 Allowed 'General case' 0 C--N 1.338 0.102 0 N-CA-C 106.508 -1.664 . . . . 10.0 106.508 176.195 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.413 ' OE1' ' NZ ' ' A' ' 50' ' ' LYS . 1.8 tp10 -89.45 -42.49 11.46 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.031 0.532 . . . . 10.0 110.712 -178.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.27 147.63 29.55 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 124.833 1.253 . . . . 10.0 107.965 -172.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 54.1 p -105.81 -171.98 2.01 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.104 0.962 . . . . 10.0 109.864 -179.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.5 p -61.37 -32.72 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 120.323 -0.551 . . . . 10.0 111.006 166.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.2 t -54.76 -43.54 72.84 Favored 'General case' 0 C--O 1.235 0.335 0 O-C-N 121.822 -0.549 . . . . 10.0 109.703 -175.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -64.32 -54.49 32.32 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 125.72 1.608 . . . . 10.0 108.839 -175.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.0 pp -67.78 -42.59 81.45 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.959 -0.463 . . . . 10.0 111.25 -178.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -44.64 -50.62 9.72 Favored 'General case' 0 N--CA 1.449 -0.477 0 O-C-N 121.162 -0.961 . . . . 10.0 111.709 163.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.45 -45.14 92.45 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 118.92 0.782 . . . . 10.0 109.87 179.411 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -51.45 -49.82 60.99 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.031 -0.531 . . . . 10.0 110.182 178.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 58.0 t -68.2 -43.71 84.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 112.209 0.448 . . . . 10.0 112.209 177.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -53.5 -40.99 65.82 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 108.973 -0.751 . . . . 10.0 108.973 176.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.8 tptt -75.01 -36.75 61.92 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.899 1.28 . . . . 10.0 111.324 -179.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 15.5 mt -51.93 -35.03 44.38 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.817 0.735 . . . . 10.0 112.023 167.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.79 24.29 4.99 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 123.192 0.425 . . . . 10.0 112.888 169.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -141.75 160.56 39.93 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 105.276 -2.12 . . . . 10.0 105.276 168.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 62.7 tttt -106.82 144.34 33.61 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 119.548 1.067 . . . . 10.0 111.774 -168.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.0 tp -121.47 147.99 45.03 Favored 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 127.883 2.473 . . . . 10.0 107.622 -176.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.0 mmtt -143.22 170.04 16.5 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 124.407 1.083 . . . . 10.0 108.445 161.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.6 tt -93.31 151.4 19.81 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 123.505 0.722 . . . . 10.0 109.195 178.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 56.9 tttp -116.08 -62.36 1.6 Allowed 'General case' 0 N--CA 1.441 -0.904 0 C-N-CA 125.94 1.696 . . . . 10.0 108.089 -177.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -175.52 -87.93 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 108.455 -1.858 . . . . 10.0 108.455 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -170.04 173.5 5.93 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.154 0.981 . . . . 10.0 109.177 -171.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -49.99 112.91 0.74 Allowed 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.761 1.224 . . . . 10.0 111.396 -179.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -81.29 67.84 7.37 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.139 0.495 . . . . 10.0 109.788 -175.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 17.5 t -144.93 105.42 4.1 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 123.418 0.687 . . . . 10.0 110.528 -179.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 16.3 pt -104.41 -19.74 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 C-N-CA 124.87 1.268 . . . . 10.0 113.21 176.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -75.42 157.96 33.39 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.484 0.714 . . . . 10.0 109.917 177.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -172.65 -95.42 0.1 OUTLIER Glycine 0 CA--C 1.528 0.875 0 N-CA-C 111.599 -0.601 . . . . 10.0 111.599 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 23.1 ttt180 . . . . . 0 C--O 1.249 1.053 0 N-CA-C 105.17 -2.159 . . . . 10.0 105.17 -179.165 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 86.2 t . . . . . 0 N--CA 1.473 0.698 0 N-CA-C 108.449 -0.945 . . . . 10.0 108.449 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.3 p -130.55 175.75 8.73 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.443 1.497 . . . . 10.0 107.337 170.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -139.16 147.74 42.26 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 127.525 2.33 . . . . 10.0 106.747 -167.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 59.7 mmtt -91.93 135.72 33.72 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 123.264 0.625 . . . . 10.0 109.636 -175.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -138.34 140.62 39.57 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.888 -1.152 . . . . 10.0 107.888 173.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -122.3 150.57 42.18 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.631 0.772 . . . . 10.0 110.368 175.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.483 ' CE2' HD11 ' A' ' 57' ' ' LEU . 0.8 OUTLIER -141.95 136.47 30.41 Favored 'General case' 0 N--CA 1.448 -0.566 0 O-C-N 124.925 1.39 . . . . 10.0 110.212 -169.903 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -95.91 135.74 37.26 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.933 1.693 . . . . 10.0 108.993 -175.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 7.2 mm -106.74 116.34 50.26 Favored 'Isoleucine or valine' 0 C--N 1.339 0.15 0 C-N-CA 125.851 1.66 . . . . 10.0 111.463 -165.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -102.03 97.56 7.88 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 107.595 -1.261 . . . . 10.0 107.595 170.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 150.43 -103.13 0.24 Allowed Glycine 0 CA--C 1.528 0.866 0 C-N-CA 123.457 0.551 . . . . 10.0 112.258 169.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 36.3 mmt -80.03 146.43 31.98 Favored 'General case' 0 N--CA 1.457 -0.096 0 CA-C-N 117.746 0.773 . . . . 10.0 111.711 -172.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.3 t -144.49 70.48 1.28 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.776 1.63 . . . . 10.0 106.724 -177.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -159.73 140.65 12.39 Favored 'General case' 0 C--N 1.343 0.303 0 O-C-N 120.823 -1.173 . . . . 10.0 109.331 -173.254 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.68 -45.06 81.96 Favored 'General case' 0 C--O 1.227 -0.118 0 C-N-CA 123.963 0.905 . . . . 10.0 113.419 -168.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.19 -43.14 96.14 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.753 -0.832 . . . . 10.0 108.753 -178.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -72.91 -49.48 29.39 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.305 -0.862 . . . . 10.0 109.586 -173.208 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -46.37 -51.98 13.81 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.088 1.355 . . . . 10.0 110.98 170.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -53.97 -28.82 40.0 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 112.59 0.589 . . . . 10.0 112.59 178.075 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.17 -36.97 66.68 Favored 'General case' 0 N--CA 1.447 -0.619 0 O-C-N 121.005 -1.059 . . . . 10.0 108.795 -178.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 11.6 mm -51.38 -58.2 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 N-CA-C 108.425 -0.954 . . . . 10.0 108.425 168.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -45.75 -41.41 10.71 Favored 'General case' 0 C--O 1.223 -0.311 0 O-C-N 123.604 0.565 . . . . 10.0 111.216 -178.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.29 -54.81 12.76 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 121.634 -0.666 . . . . 10.0 111.735 178.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.428 ' CZ ' ' HA ' ' A' ' 60' ' ' ALA . 4.8 mtp180 -60.99 -39.5 89.91 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 119.454 -0.899 . . . . 10.0 110.81 -178.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.89 -41.79 70.85 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 123.698 0.799 . . . . 10.0 110.74 179.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 44.4 m-20 -54.55 -30.78 55.08 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 118.454 0.57 . . . . 10.0 110.608 171.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -59.19 -31.7 69.24 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 118.377 -0.821 . . . . 10.0 112.776 176.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 18.6 mm -57.89 121.16 4.95 Favored 'Isoleucine or valine' 0 C--N 1.34 0.187 0 CA-C-N 118.933 0.788 . . . . 10.0 109.858 -178.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 50.1 mp0 -57.32 -46.13 83.55 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 123.658 0.783 . . . . 10.0 112.085 -175.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.95 32.61 3.2 Favored Glycine 0 C--N 1.341 0.816 0 CA-C-N 120.323 1.419 . . . . 10.0 112.772 -174.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.7 p -99.41 150.74 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 119.204 1.502 . . . . 10.0 109.327 -176.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -108.79 -59.12 1.92 Allowed 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 108.454 -0.943 . . . . 10.0 108.454 168.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 66.3 m-20 -139.64 152.96 47.19 Favored 'General case' 0 C--N 1.337 0.026 0 N-CA-C 108.775 -0.824 . . . . 10.0 108.775 -174.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -137.1 62.85 41.27 Favored Pre-proline 0 CA--C 1.537 0.462 0 C-N-CA 124.17 0.988 . . . . 10.0 111.687 174.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -75.68 77.1 3.44 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 123.061 2.508 . . . . 10.0 111.511 -177.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 70.6 t -61.96 135.65 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 C-N-CA 125.889 1.676 . . . . 10.0 111.391 176.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -94.85 94.91 8.33 Favored 'General case' 0 C--N 1.346 0.419 0 O-C-N 121.296 -0.878 . . . . 10.0 111.552 -175.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -75.35 49.47 0.47 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.781 2.032 . . . . 10.0 114.055 -173.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -176.84 -37.15 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 124.916 1.287 . . . . 10.0 110.452 176.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.5 mt -84.68 -13.38 51.61 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.057 0.943 . . . . 10.0 111.261 -173.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 74.17 40.54 0.43 Allowed 'General case' 0 C--O 1.228 -0.071 0 C-N-CA 125.213 1.405 . . . . 10.0 110.25 170.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 35.4 p -140.08 131.11 26.25 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 125.028 1.331 . . . . 10.0 107.828 179.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 28.5 t -91.99 144.14 9.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 107.026 -1.472 . . . . 10.0 107.026 165.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 91.3 m -131.67 124.1 29.16 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 105.879 -1.897 . . . . 10.0 105.879 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 42.2 t -126.36 145.21 34.25 Favored 'Isoleucine or valine' 0 C--N 1.339 0.145 0 C-N-CA 123.289 0.635 . . . . 10.0 109.371 177.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -112.85 103.36 11.35 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 105.601 -2.0 . . . . 10.0 105.601 171.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -136.58 159.54 41.51 Favored 'General case' 0 C--O 1.225 -0.218 0 C-N-CA 123.883 0.873 . . . . 10.0 110.755 -175.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 21.2 p30 -94.8 125.78 49.79 Favored Pre-proline 0 C--N 1.331 -0.197 0 C-N-CA 123.481 0.712 . . . . 10.0 109.953 175.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -74.56 65.63 5.63 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 121.766 1.644 . . . . 10.0 108.304 172.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.7 pttt -138.86 -49.77 0.52 Allowed 'General case' 0 C--O 1.227 -0.105 0 N-CA-C 106.967 -1.494 . . . . 10.0 106.967 178.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -106.15 -56.54 2.17 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 124.656 1.182 . . . . 10.0 108.069 174.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.24 139.45 50.06 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 123.391 0.677 . . . . 10.0 109.738 -176.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 20.6 p -130.78 143.51 50.79 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 122.047 0.927 . . . . 10.0 110.518 174.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 30.3 m -45.39 -43.58 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 C-N-CA 125.157 1.383 . . . . 10.0 111.609 176.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.0 m -58.2 -43.13 87.45 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.501 1.121 . . . . 10.0 112.517 -177.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -63.08 -53.19 57.52 Favored 'General case' 0 C--O 1.224 -0.263 0 CA-C-O 122.072 0.939 . . . . 10.0 108.875 -173.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.483 HD11 ' CE2' ' A' ' 7' ' ' PHE 0.267 1.2 pp -65.62 -36.39 83.57 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.082 -1.011 . . . . 10.0 112.621 -177.225 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.93 -64.59 0.48 Allowed 'General case' 0 CA--C 1.534 0.348 0 O-C-N 120.962 -1.087 . . . . 10.0 112.881 156.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.8 tm-20 -52.23 -39.76 60.73 Favored 'General case' 0 CA--C 1.517 -0.301 0 C-N-CA 123.455 0.702 . . . . 10.0 109.572 178.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.428 ' HA ' ' CZ ' ' A' ' 24' ' ' ARG . . . -59.68 -55.01 39.76 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 115.747 -0.661 . . . . 10.0 110.696 -174.275 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 80.4 t -62.46 -42.31 95.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-N 115.666 -0.697 . . . . 10.0 110.909 174.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -55.35 -51.25 67.4 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 121.575 0.702 . . . . 10.0 110.311 -176.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 40.6 tptt -56.65 -39.7 74.17 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 125.765 1.626 . . . . 10.0 111.007 177.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.74 -22.38 35.04 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 113.056 0.762 . . . . 10.0 113.056 174.066 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 108.73 14.71 14.86 Favored Glycine 0 CA--C 1.529 0.952 0 CA-C-N 118.78 0.718 . . . . 10.0 113.161 170.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -143.37 160.27 40.85 Favored 'General case' 0 C--O 1.225 -0.23 0 N-CA-C 106.603 -1.629 . . . . 10.0 106.603 172.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -111.6 144.59 40.6 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 119.064 0.847 . . . . 10.0 111.141 -162.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 23.3 tp -121.38 148.27 44.61 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 125.097 1.359 . . . . 10.0 108.289 -172.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 20.8 mmtt -149.0 139.51 22.52 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 125.446 1.498 . . . . 10.0 110.288 169.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.5 tt -72.1 157.38 37.88 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.633 -0.877 . . . . 10.0 108.633 177.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 64.1 tttt -120.86 -65.26 1.16 Allowed 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 125.585 1.554 . . . . 10.0 108.169 177.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.53 -74.01 0.03 OUTLIER Glycine 0 CA--C 1.522 0.518 0 N-CA-C 110.051 -1.22 . . . . 10.0 110.051 173.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -174.61 167.19 3.84 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 106.557 -1.646 . . . . 10.0 106.557 -165.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -81.31 153.27 27.14 Favored 'General case' 0 N--CA 1.457 -0.116 0 O-C-N 123.456 0.472 . . . . 10.0 110.513 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.3 t70 67.64 -158.7 0.22 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.025 1.33 . . . . 10.0 108.841 177.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.6 t -151.95 73.35 1.05 Allowed 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 124.901 1.281 . . . . 10.0 107.822 176.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 6.6 pt -103.47 -145.26 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 124.306 1.042 . . . . 10.0 108.836 179.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -151.04 -54.31 0.14 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.235 1.014 . . . . 10.0 109.379 -177.451 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -168.25 -156.47 10.3 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 109.136 -1.586 . . . . 10.0 109.136 -178.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 51.0 tpt85 . . . . . 0 C--O 1.249 1.036 0 CA-C-O 116.891 -1.528 . . . . 10.0 110.127 -172.444 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 53.0 t . . . . . 0 N--CA 1.47 0.549 0 N-CA-C 107.793 -1.188 . . . . 10.0 107.793 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 7.7 p -125.44 159.57 31.59 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 124.649 1.179 . . . . 10.0 110.33 179.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -124.51 151.16 44.99 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 127.475 2.31 . . . . 10.0 107.575 -171.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.1 mppt? -93.69 142.67 27.09 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 123.975 0.91 . . . . 10.0 109.6 -176.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -148.19 140.95 24.62 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.027 0.931 . . . . 10.0 109.336 -177.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -117.97 148.75 41.9 Favored 'General case' 0 CA--C 1.508 -0.638 0 C-N-CA 123.361 0.665 . . . . 10.0 110.415 173.577 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -134.47 144.39 48.07 Favored 'General case' 0 N--CA 1.446 -0.632 0 O-C-N 125.407 1.692 . . . . 10.0 108.781 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -109.97 132.42 54.17 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 108.475 -0.935 . . . . 10.0 108.475 -172.028 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.8 mm -113.43 144.16 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 C-N-CA 124.092 0.957 . . . . 10.0 111.811 -157.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -128.73 100.98 5.92 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 124.524 1.13 . . . . 10.0 108.123 169.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 145.36 -71.86 0.35 Allowed Glycine 0 CA--C 1.526 0.759 0 CA-C-N 117.958 0.345 . . . . 10.0 112.943 166.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 9.7 ptt? -65.86 115.08 5.58 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 122.368 -0.489 . . . . 10.0 110.202 -173.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.1 t -146.66 59.39 1.2 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.554 0.692 . . . . 10.0 109.548 -176.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.2 m -142.01 -82.27 0.21 Allowed 'General case' 0 C--N 1.345 0.392 0 O-C-N 121.439 -0.788 . . . . 10.0 109.135 173.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 176.92 -47.97 0.01 OUTLIER 'General case' 0 C--O 1.221 -0.428 0 C-N-CA 124.372 1.069 . . . . 10.0 109.956 -173.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.81 -49.35 47.38 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 122.315 1.055 . . . . 10.0 108.687 -177.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 22.4 p -59.3 -34.76 72.69 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 114.139 -1.391 . . . . 10.0 111.567 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.61 -57.55 4.29 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.297 1.039 . . . . 10.0 110.708 171.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -43.29 -44.96 5.68 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.181 1.392 . . . . 10.0 112.001 178.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 27.1 ttt180 -52.8 -38.14 60.78 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.253 1.021 . . . . 10.0 110.029 -178.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 27.5 mm -59.14 -45.98 92.31 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.538 0 CA-C-O 117.572 -1.204 . . . . 10.0 110.905 174.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -50.12 -50.5 48.35 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 119.606 1.094 . . . . 10.0 109.788 -176.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.7 tmmt? -67.9 -47.81 67.77 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.324 1.05 . . . . 10.0 110.11 179.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.04 -28.95 64.96 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.53 0.567 . . . . 10.0 112.53 177.539 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.09 -43.38 21.86 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.989 1.315 . . . . 10.0 109.347 175.084 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -56.89 -24.59 53.05 Favored 'General case' 0 C--O 1.226 -0.154 0 C-N-CA 123.964 0.905 . . . . 10.0 110.342 178.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.78 -36.51 81.3 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 114.775 1.398 . . . . 10.0 114.775 172.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.9 mp -62.39 129.19 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 120.067 1.303 . . . . 10.0 109.767 176.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -54.5 -51.16 65.98 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 112.433 0.531 . . . . 10.0 112.433 -177.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.85 37.3 2.82 Favored Glycine 0 C--N 1.34 0.774 0 O-C-N 120.563 -1.336 . . . . 10.0 112.317 -171.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.8 p -103.79 155.5 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 CA-C-N 118.362 1.081 . . . . 10.0 108.928 -177.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -120.52 -58.54 1.83 Allowed 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 109.006 -0.739 . . . . 10.0 109.006 170.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 62.2 m-80 -139.08 155.66 47.76 Favored 'General case' 0 CA--C 1.521 -0.172 0 N-CA-C 108.835 -0.802 . . . . 10.0 108.835 -173.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -153.38 58.6 2.37 Favored Pre-proline 0 CA--C 1.533 0.318 0 N-CA-C 112.668 0.618 . . . . 10.0 112.668 173.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -74.45 79.05 2.57 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.659 2.24 . . . . 10.0 109.935 -178.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.5 m -63.47 156.72 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 O-C-N 121.695 -0.628 . . . . 10.0 112.168 -179.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 73.9 m-80 -98.39 122.17 41.24 Favored 'General case' 0 N--CA 1.457 -0.102 0 O-C-N 122.144 -0.348 . . . . 10.0 110.585 -178.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -102.51 42.9 1.11 Allowed 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.954 1.301 . . . . 10.0 111.236 -176.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -163.1 -43.56 0.03 OUTLIER 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 124.176 0.99 . . . . 10.0 109.05 176.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 12.3 mt -76.24 -22.48 55.11 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.827 0.851 . . . . 10.0 111.213 -177.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 62.08 53.83 2.87 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 125.554 1.541 . . . . 10.0 109.509 -175.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 16.9 p -138.1 133.1 33.01 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.955 1.702 . . . . 10.0 107.458 173.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.9 t -100.1 125.46 53.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 107.188 -1.412 . . . . 10.0 107.188 173.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 37.4 m -109.54 115.25 29.57 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 126.397 1.879 . . . . 10.0 107.572 -178.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.7 t -117.1 145.92 22.23 Favored 'Isoleucine or valine' 0 C--N 1.34 0.166 0 CA-C-N 118.971 0.805 . . . . 10.0 110.857 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -115.11 108.07 16.16 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 125.283 1.433 . . . . 10.0 107.748 161.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 26.9 p90 -139.34 162.02 36.02 Favored 'General case' 0 C--O 1.226 -0.134 0 C-N-CA 123.808 0.843 . . . . 10.0 110.253 -178.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 25.1 p30 -95.97 128.48 37.17 Favored Pre-proline 0 C--N 1.332 -0.18 0 C-N-CA 123.397 0.679 . . . . 10.0 110.142 176.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -75.48 61.69 6.09 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 N-CA-C 108.468 -1.397 . . . . 10.0 108.468 171.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.84 -47.14 0.32 Allowed 'General case' 0 C--N 1.346 0.416 0 CA-C-N 118.584 0.629 . . . . 10.0 110.195 176.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -104.59 -40.23 6.1 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.067 0.547 . . . . 10.0 109.898 170.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.32 158.35 17.84 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.377 0.671 . . . . 10.0 110.366 -177.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 97.7 p -148.83 158.74 44.38 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.643 0.735 . . . . 10.0 111.776 172.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.0 m -53.41 -45.78 57.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 124.267 1.027 . . . . 10.0 110.937 173.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 16.0 m -57.66 -43.48 84.99 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.4 1.08 . . . . 10.0 111.722 -178.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -64.2 -57.5 9.33 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.283 1.033 . . . . 10.0 109.262 -178.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.3 pp -65.42 -41.34 93.66 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.123 -0.985 . . . . 10.0 111.058 -176.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -43.03 -52.05 5.45 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-O 118.244 -0.884 . . . . 10.0 112.562 160.595 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.76 -45.95 77.97 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 119.772 1.169 . . . . 10.0 110.082 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -52.7 -54.2 36.85 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.977 -0.556 . . . . 10.0 110.321 178.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 40.6 t -57.85 -47.23 86.68 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 N-CA-C 112.597 0.592 . . . . 10.0 112.597 174.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -53.48 -55.6 23.98 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.754 1.222 . . . . 10.0 109.257 -177.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -59.72 -33.62 71.86 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 126.997 2.119 . . . . 10.0 111.711 178.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.87 -38.0 61.06 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.24 0.616 . . . . 10.0 111.908 168.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 119.25 9.7 8.52 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 124.187 0.898 . . . . 10.0 113.344 176.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -135.76 172.74 12.57 Favored 'General case' 0 C--O 1.225 -0.221 0 N-CA-C 107.076 -1.453 . . . . 10.0 107.076 172.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 33.1 mttt -114.94 157.84 22.83 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 118.853 0.752 . . . . 10.0 111.994 -166.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.2 tp -143.82 145.3 32.25 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.206 1.802 . . . . 10.0 107.254 -170.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 32.2 mmtt -148.84 150.09 32.42 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 124.291 1.036 . . . . 10.0 109.044 164.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.6 tp -63.01 158.62 18.95 Favored 'General case' 0 N--CA 1.456 -0.172 0 O-C-N 123.919 0.762 . . . . 10.0 109.236 175.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 19.1 tttt -124.59 -53.81 1.67 Allowed 'General case' 0 N--CA 1.439 -1.023 0 C-N-CA 127.811 2.444 . . . . 10.0 107.559 -178.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 174.03 -85.56 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 108.098 -2.001 . . . . 10.0 108.098 175.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -160.25 159.86 31.95 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.38 1.072 . . . . 10.0 108.287 -169.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.25 147.3 23.03 Favored 'General case' 0 N--CA 1.454 -0.273 0 O-C-N 123.619 0.575 . . . . 10.0 109.643 174.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -115.25 164.31 14.42 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 107.48 -1.304 . . . . 10.0 107.48 165.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.3 t -166.33 84.6 0.3 Allowed 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.749 1.22 . . . . 10.0 108.175 -177.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 11.5 pt -104.58 -144.05 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 124.87 1.268 . . . . 10.0 108.006 177.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 68.36 84.81 0.15 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.749 1.619 . . . . 10.0 110.608 175.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 158.35 -109.2 0.39 Allowed Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.076 -1.21 . . . . 10.0 110.076 178.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 48.1 mtp180 . . . . . 0 C--O 1.252 1.196 0 CA-C-O 117.121 -1.419 . . . . 10.0 108.786 172.694 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 57.8 t . . . . . 0 N--CA 1.469 0.515 0 N-CA-C 106.633 -1.618 . . . . 10.0 106.633 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.9 p -115.19 172.38 7.11 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.133 1.773 . . . . 10.0 108.821 178.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -141.61 140.78 33.41 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 126.981 2.112 . . . . 10.0 106.833 -170.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -90.84 130.76 36.77 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 123.675 0.79 . . . . 10.0 109.063 177.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -133.12 146.93 52.05 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 125.915 1.686 . . . . 10.0 107.947 -177.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -123.69 150.28 44.47 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.227 0.611 . . . . 10.0 110.249 176.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.403 ' CE2' HD11 ' A' ' 70' ' ' LEU . 2.7 m-85 -138.56 140.9 39.21 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.897 1.279 . . . . 10.0 109.621 -171.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -101.13 134.77 43.65 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 124.836 1.254 . . . . 10.0 108.596 -175.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 6.1 mm -107.6 119.45 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 C-N-CA 124.751 1.221 . . . . 10.0 110.223 -161.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -111.33 95.95 5.82 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 108.329 -0.989 . . . . 10.0 108.329 174.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 151.54 -94.06 0.15 Allowed Glycine 0 CA--C 1.526 0.735 0 C-N-CA 123.951 0.786 . . . . 10.0 111.526 170.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 23.4 mmt -84.84 156.63 21.22 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 122.984 0.514 . . . . 10.0 111.772 -174.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -157.26 74.32 0.77 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.43 1.092 . . . . 10.0 109.31 -177.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.3 p -164.57 160.11 19.87 Favored 'General case' 0 C--N 1.342 0.26 0 O-C-N 120.92 -1.112 . . . . 10.0 109.779 176.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -55.38 -38.28 68.66 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.749 0.82 . . . . 10.0 111.326 179.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.96 -23.77 63.23 Favored 'General case' 0 N--CA 1.45 -0.434 0 O-C-N 121.848 -0.532 . . . . 10.0 110.221 -177.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 3.7 t -80.74 -60.21 2.39 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 108.958 -0.756 . . . . 10.0 108.958 173.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -39.27 -51.28 2.01 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 126.13 1.772 . . . . 10.0 111.191 176.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -55.88 -31.83 63.16 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 113.393 0.886 . . . . 10.0 113.393 -179.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.39 -53.56 18.82 Favored 'General case' 0 C--O 1.234 0.242 0 O-C-N 121.37 -0.831 . . . . 10.0 109.005 171.337 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.4 mm -44.07 -54.85 0.99 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.339 0 O-C-N 123.915 0.759 . . . . 10.0 110.093 179.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -42.53 -50.86 5.26 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.994 0.918 . . . . 10.0 111.702 178.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.39 -47.56 60.29 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 121.453 -0.779 . . . . 10.0 110.794 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -57.64 -36.91 72.47 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.952 0.901 . . . . 10.0 110.765 -177.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.83 -43.97 28.8 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 126.151 1.781 . . . . 10.0 110.741 175.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -52.55 -28.55 21.26 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 118.915 0.779 . . . . 10.0 111.606 172.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.7 tmmt? -62.11 -26.91 68.57 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 112.402 0.519 . . . . 10.0 112.402 177.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 10.0 mm -66.85 133.51 31.3 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.131 0 N-CA-C 108.874 -0.787 . . . . 10.0 108.874 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -64.8 -56.16 15.26 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 120.608 0.242 . . . . 10.0 110.67 -173.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.96 44.71 3.36 Favored Glycine 0 C--N 1.34 0.784 0 O-C-N 120.755 -1.215 . . . . 10.0 112.039 -171.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.6 p -108.15 150.59 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 C-N-CA 124.649 1.18 . . . . 10.0 108.846 -176.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -122.3 -52.29 1.95 Allowed 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.078 0.551 . . . . 10.0 110.285 174.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -138.68 153.89 48.57 Favored 'General case' 0 C--N 1.338 0.097 0 N-CA-C 109.378 -0.601 . . . . 10.0 109.378 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -146.29 61.85 7.45 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 123.484 0.714 . . . . 10.0 111.548 173.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -77.46 73.22 5.66 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.972 2.448 . . . . 10.0 109.599 -179.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.6 m -66.57 151.72 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 O-C-N 121.96 -0.462 . . . . 10.0 111.075 -179.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 -97.68 125.91 42.72 Favored 'General case' 0 N--CA 1.458 -0.068 0 O-C-N 122.193 -0.317 . . . . 10.0 110.413 -175.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -105.4 41.69 1.33 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.074 1.349 . . . . 10.0 111.65 -170.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -171.62 -38.81 0.02 OUTLIER 'General case' 0 C--O 1.225 -0.207 0 C-N-CA 124.958 1.303 . . . . 10.0 110.125 178.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.2 mt -77.37 -17.56 58.11 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.219 1.008 . . . . 10.0 111.616 -175.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 68.56 46.62 0.97 Allowed 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 125.64 1.576 . . . . 10.0 110.136 177.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 12.0 p -141.89 128.86 20.72 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.692 1.197 . . . . 10.0 108.378 177.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.3 t -93.72 135.04 29.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 106.361 -1.718 . . . . 10.0 106.361 169.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 60.6 m -121.05 123.48 42.47 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 105.9 -1.889 . . . . 10.0 105.9 178.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 19.3 t -124.23 149.97 28.66 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.115 0 C-N-CA 123.472 0.709 . . . . 10.0 109.211 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -124.92 102.33 7.49 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 126.647 1.979 . . . . 10.0 105.728 175.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -138.75 166.35 24.63 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 123.883 0.873 . . . . 10.0 110.675 -172.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 19.0 p30 -104.53 127.39 29.09 Favored Pre-proline 0 CA--C 1.532 0.254 0 C-N-CA 123.092 0.557 . . . . 10.0 110.094 177.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -75.59 63.66 6.49 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 122.52 2.147 . . . . 10.0 109.568 176.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 22.3 ttmt -142.74 -58.47 0.44 Allowed 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 106.3 -1.741 . . . . 10.0 106.3 175.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -114.08 1.16 14.53 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.34 1.456 . . . . 10.0 112.632 -173.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -133.23 154.5 50.6 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 125.276 1.43 . . . . 10.0 110.096 171.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 90.8 p -146.74 160.32 42.38 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.363 0.601 . . . . 10.0 111.391 175.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 59.4 t -52.79 -49.87 45.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 124.995 1.318 . . . . 10.0 109.408 173.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -51.11 -47.92 61.85 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 126.37 1.868 . . . . 10.0 111.758 178.337 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -67.83 -54.9 15.37 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.954 0.901 . . . . 10.0 109.899 -174.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.1 pp -66.0 -40.55 91.25 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 120.935 -1.103 . . . . 10.0 111.149 -178.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -43.87 -49.32 8.32 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 120.905 -1.122 . . . . 10.0 112.257 161.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.5 -43.49 79.78 Favored 'General case' 0 C--N 1.339 0.133 0 CA-C-N 119.824 1.193 . . . . 10.0 111.022 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -53.77 -53.26 54.77 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.126 -0.488 . . . . 10.0 110.335 176.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 47.4 t -63.07 -37.35 79.14 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 N-CA-C 112.321 0.489 . . . . 10.0 112.321 177.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -60.53 -55.13 37.1 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 125.091 1.356 . . . . 10.0 108.858 -177.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? -55.12 -41.21 71.41 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.893 0.877 . . . . 10.0 110.611 175.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -49.65 -33.14 14.7 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.33 0.652 . . . . 10.0 112.326 173.342 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 113.82 17.62 7.33 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 124.044 0.83 . . . . 10.0 113.117 169.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.07 167.43 22.1 Favored 'General case' 0 N--CA 1.458 -0.041 0 N-CA-C 107.366 -1.346 . . . . 10.0 107.366 175.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -105.43 144.12 32.65 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 121.536 0.684 . . . . 10.0 111.351 -164.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.4 tp -130.13 145.5 51.71 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.102 1.761 . . . . 10.0 107.9 -178.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 26.0 mmtt -151.77 154.43 36.24 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 124.673 1.189 . . . . 10.0 108.659 167.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.403 HD11 ' CE2' ' A' ' 7' ' ' PHE . 8.7 tp -63.41 155.21 29.66 Favored 'General case' 0 CA--C 1.529 0.167 0 O-C-N 123.702 0.626 . . . . 10.0 110.33 176.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -111.89 -60.01 1.91 Allowed 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 127.508 2.323 . . . . 10.0 106.418 172.315 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -179.07 -84.88 0.06 OUTLIER Glycine 0 CA--C 1.523 0.539 0 N-CA-C 109.625 -1.39 . . . . 10.0 109.625 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -163.56 174.78 11.37 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.475 1.11 . . . . 10.0 108.116 -169.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -47.97 113.46 0.73 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.19 0.996 . . . . 10.0 112.164 178.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -71.65 85.62 0.9 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.468 0.651 . . . . 10.0 109.653 178.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 67.2 m -129.24 159.65 35.44 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.8 1.64 . . . . 10.0 109.872 -174.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 10.1 pt -127.87 122.06 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 N-CA-C 104.653 -2.351 . . . . 10.0 104.653 175.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 39.13 72.79 0.13 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 127.96 2.504 . . . . 10.0 113.6 179.191 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -142.78 142.71 11.77 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 107.349 -2.3 . . . . 10.0 107.349 167.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 34.5 ttp180 . . . . . 0 C--O 1.249 1.037 0 CA-C-O 117.448 -1.263 . . . . 10.0 109.385 179.574 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 24.4 t . . . . . 0 N--CA 1.465 0.309 0 N-CA-C 105.825 -1.917 . . . . 10.0 105.825 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 13.4 p -126.39 153.29 45.17 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.004 1.322 . . . . 10.0 109.065 178.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -129.96 149.73 51.56 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 125.901 1.68 . . . . 10.0 109.49 -173.082 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.62 88.69 2.82 Favored 'General case' 0 C--N 1.341 0.215 0 C-N-CA 124.582 1.153 . . . . 10.0 109.606 -167.61 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -86.45 152.47 22.66 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.143 1.377 . . . . 10.0 110.523 -179.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -125.01 149.43 47.76 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.471 1.108 . . . . 10.0 109.341 174.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -140.86 143.64 34.84 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 124.947 1.404 . . . . 10.0 110.794 -172.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -104.91 129.81 53.2 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.677 1.591 . . . . 10.0 108.849 -171.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 6.5 mm -103.62 111.29 32.76 Favored 'Isoleucine or valine' 0 C--N 1.342 0.252 0 C-N-CA 123.852 0.861 . . . . 10.0 111.289 -163.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -102.56 94.55 5.71 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 107.704 -1.221 . . . . 10.0 107.704 175.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 155.03 -77.03 0.21 Allowed Glycine 0 CA--C 1.527 0.821 0 CA-C-N 116.013 -0.54 . . . . 10.0 112.678 168.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 4.2 mmt -102.12 150.97 22.72 Favored 'General case' 0 N--CA 1.461 0.078 0 C-N-CA 123.432 0.693 . . . . 10.0 109.962 -176.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.3 m -68.56 -60.94 2.06 Favored 'General case' 0 N--CA 1.433 -1.312 0 C-N-CA 124.156 0.982 . . . . 10.0 110.921 -171.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 11.2 m 133.26 78.11 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 127.431 2.293 . . . . 10.0 106.005 -177.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -138.88 -92.3 0.19 Allowed 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 106.701 -1.592 . . . . 10.0 106.701 165.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.06 -43.65 98.02 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.274 -1.01 . . . . 10.0 108.274 178.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -68.57 -49.2 61.24 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 114.991 -1.004 . . . . 10.0 110.798 -176.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -46.13 -48.27 17.32 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.85 0.86 . . . . 10.0 111.109 167.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -58.84 -23.66 60.93 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 114.885 -1.052 . . . . 10.0 112.112 -179.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.9 tpt180 -80.86 -48.05 12.94 Favored 'General case' 0 N--CA 1.452 -0.352 0 O-C-N 121.314 -0.866 . . . . 10.0 110.02 168.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 29.0 mm -39.35 -57.65 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.433 0 CA-C-O 118.545 -0.74 . . . . 10.0 110.844 177.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -44.75 -49.23 10.72 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 123.598 0.561 . . . . 10.0 111.499 -175.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.2 ttmt -72.7 -45.44 58.8 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.539 0.736 . . . . 10.0 110.379 -176.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -60.58 -36.36 78.33 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 122.805 0.442 . . . . 10.0 111.673 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.96 -49.01 40.96 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.41 1.084 . . . . 10.0 109.324 171.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -54.51 -19.47 5.87 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.542 -0.723 . . . . 10.0 112.704 177.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -56.25 -35.3 67.26 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.718 1.007 . . . . 10.0 113.718 171.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 11.2 mt -58.22 139.03 18.43 Favored 'Isoleucine or valine' 0 C--N 1.339 0.132 0 CA-C-N 118.59 0.632 . . . . 10.0 109.593 179.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -69.45 -52.66 24.64 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 111.665 0.246 . . . . 10.0 111.665 -176.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -85.07 44.29 3.36 Favored Glycine 0 C--N 1.339 0.749 0 O-C-N 120.705 -1.247 . . . . 10.0 111.224 -175.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.4 p -99.76 152.4 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 C-N-CA 124.62 1.168 . . . . 10.0 108.366 -179.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -112.92 -57.63 2.26 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 108.562 -0.903 . . . . 10.0 108.562 171.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 -148.71 158.13 43.93 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.217 -1.401 . . . . 10.0 107.217 -173.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -148.28 61.15 5.61 Favored Pre-proline 0 CA--C 1.531 0.245 0 O-C-N 121.902 -0.499 . . . . 10.0 111.568 168.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -75.03 83.79 1.77 Allowed 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 122.915 2.41 . . . . 10.0 108.225 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.6 m -54.48 157.3 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 C-N-CA 123.236 0.614 . . . . 10.0 110.527 173.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 -84.52 161.06 20.37 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 107.591 -1.263 . . . . 10.0 107.591 171.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -122.79 29.37 6.86 Favored 'General case' 0 C--N 1.335 -0.051 0 N-CA-C 112.21 0.448 . . . . 10.0 112.21 -169.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -174.55 -37.94 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 122.657 0.383 . . . . 10.0 111.227 -171.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 16.6 mt -72.18 -19.68 61.71 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.327 1.051 . . . . 10.0 111.66 -177.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 67.13 43.65 2.07 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.041 1.336 . . . . 10.0 109.557 -178.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 17.4 p -140.39 123.55 16.71 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.855 1.662 . . . . 10.0 109.167 178.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.6 t -89.76 149.08 4.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 108.226 -1.028 . . . . 10.0 108.226 173.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 85.3 m -130.07 125.94 36.43 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 106.787 -1.56 . . . . 10.0 106.787 179.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 42.1 t -120.13 128.45 75.96 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 C-N-CA 123.452 0.701 . . . . 10.0 109.196 177.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 72.2 tt0 -94.43 106.82 18.8 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 108.085 -1.08 . . . . 10.0 108.085 160.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -144.01 164.79 29.61 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 109.605 -0.517 . . . . 10.0 109.605 175.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 22.3 p30 -93.72 141.41 23.75 Favored Pre-proline 0 C--N 1.328 -0.334 0 N-CA-C 109.522 -0.547 . . . . 10.0 109.522 175.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -85.29 47.92 2.13 Favored 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 121.594 1.529 . . . . 10.0 109.485 170.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.9 -9.64 6.63 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.247 0.93 . . . . 10.0 113.127 177.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -128.56 -51.65 1.26 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.923 1.289 . . . . 10.0 108.68 -167.521 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -122.52 -172.22 2.43 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.767 1.227 . . . . 10.0 109.736 173.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 99.3 p -141.12 169.53 17.44 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.924 1.289 . . . . 10.0 110.959 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 70.0 t -50.1 -49.75 21.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 124.172 0.989 . . . . 10.0 110.491 165.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.2 m -58.47 -36.19 73.33 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 123.841 0.856 . . . . 10.0 111.991 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -69.09 -60.42 2.37 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 109.69 -0.485 . . . . 10.0 109.69 173.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.3 pp -60.07 -47.23 86.75 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 121.051 0.453 . . . . 10.0 110.822 -165.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -48.74 -36.45 16.41 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 114.004 1.113 . . . . 10.0 114.004 172.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -57.35 -33.49 67.81 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 119.08 0.854 . . . . 10.0 110.599 178.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.92 -51.82 66.58 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.544 -0.91 . . . . 10.0 108.544 -178.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 25.1 t -61.15 -45.84 97.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 124.89 1.276 . . . . 10.0 110.484 178.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -56.49 -55.4 34.2 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 124.196 0.998 . . . . 10.0 108.499 -178.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.78 -35.28 74.33 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.083 0.953 . . . . 10.0 111.62 177.01 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.4 mp -55.15 -32.82 62.41 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 118.626 -0.702 . . . . 10.0 112.383 171.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 134.76 -7.06 4.51 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-O 119.394 -0.67 . . . . 10.0 114.366 169.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -135.17 151.26 50.5 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 106.769 -1.567 . . . . 10.0 106.769 -177.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.79 142.28 35.0 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 121.46 0.648 . . . . 10.0 111.09 -161.552 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 16.0 tp -118.34 144.03 46.18 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.583 1.953 . . . . 10.0 107.842 -173.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 4.0 tptp -147.81 154.76 40.89 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.124 0.97 . . . . 10.0 108.669 171.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.7 tp -63.75 157.51 24.11 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 109.267 -0.642 . . . . 10.0 109.267 176.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 30.8 tttp -111.27 -67.19 1.01 Allowed 'General case' 0 N--CA 1.441 -0.89 0 C-N-CA 124.974 1.31 . . . . 10.0 107.932 170.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 162.1 49.75 0.02 OUTLIER Glycine 0 CA--C 1.526 0.762 0 CA-C-N 118.383 0.538 . . . . 10.0 112.914 174.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 64.16 170.61 0.18 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.823 1.249 . . . . 10.0 112.564 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -86.06 141.25 29.58 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.928 -0.578 . . . . 10.0 111.092 -177.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -69.78 69.74 0.31 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.478 1.111 . . . . 10.0 111.735 178.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 71.1 m -88.22 106.26 18.08 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 123.942 0.897 . . . . 10.0 111.013 175.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 48.0 mt -79.9 -23.04 11.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 123.771 0.828 . . . . 10.0 111.156 175.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -60.89 141.09 57.47 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.613 1.165 . . . . 10.0 110.621 -178.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 177.51 -166.93 37.66 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 109.326 -1.509 . . . . 10.0 109.326 179.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 66.1 ttt180 . . . . . 0 C--O 1.252 1.22 0 N-CA-C 104.984 -2.228 . . . . 10.0 104.984 165.055 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.8 p . . . . . 0 N--CA 1.47 0.558 0 N-CA-C 106.056 -1.831 . . . . 10.0 106.056 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 12.8 p -94.24 155.75 16.88 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.363 1.465 . . . . 10.0 109.824 -177.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -128.86 145.73 51.13 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 126.899 2.08 . . . . 10.0 108.528 -171.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -110.46 100.27 9.13 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.423 1.089 . . . . 10.0 112.559 -163.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -111.7 154.03 25.57 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.054 1.741 . . . . 10.0 110.241 -168.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -129.09 148.28 51.02 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 109.153 -0.684 . . . . 10.0 109.153 -177.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -138.68 138.24 37.58 Favored 'General case' 0 N--CA 1.452 -0.361 0 O-C-N 124.92 1.388 . . . . 10.0 109.281 -171.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -100.89 126.29 47.5 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.399 1.08 . . . . 10.0 108.223 -171.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 6.7 mm -104.62 126.85 59.39 Favored 'Isoleucine or valine' 0 C--N 1.343 0.307 0 C-N-CA 124.654 1.182 . . . . 10.0 111.875 -164.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -112.66 98.68 7.39 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.459 -0.941 . . . . 10.0 108.459 168.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 153.88 -106.32 0.29 Allowed Glycine 0 CA--C 1.53 0.973 0 C-N-CA 123.149 0.404 . . . . 10.0 112.749 171.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 59.3 mtt -90.46 89.8 7.74 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 117.509 0.654 . . . . 10.0 111.416 -169.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.4 p -118.95 56.94 0.89 Allowed 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 125.414 1.486 . . . . 10.0 109.736 -171.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 96.2 m -111.87 -87.61 0.54 Allowed 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 123.468 0.707 . . . . 10.0 109.555 -172.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -170.45 -58.26 0.02 OUTLIER 'General case' 0 C--N 1.338 0.091 0 C-N-CA 124.161 0.985 . . . . 10.0 109.879 -178.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.42 -40.25 93.11 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.568 -0.901 . . . . 10.0 108.568 -177.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 99.1 m -74.07 -45.54 48.71 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.509 -0.769 . . . . 10.0 110.153 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -45.05 -51.62 9.87 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.68 0.792 . . . . 10.0 111.229 170.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -52.86 -30.47 34.03 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.923 0.712 . . . . 10.0 112.923 176.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.3 ttm180 -72.32 -36.8 68.98 Favored 'General case' 0 N--CA 1.447 -0.61 0 O-C-N 121.009 -1.057 . . . . 10.0 109.371 -178.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.6 mt -57.49 -48.17 83.51 Favored 'Isoleucine or valine' 0 C--N 1.344 0.344 0 CA-C-O 118.324 -0.846 . . . . 10.0 108.967 172.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -47.73 -47.04 30.37 Favored 'General case' 0 C--O 1.225 -0.187 0 CA-C-N 118.59 0.632 . . . . 10.0 111.517 -178.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 27.6 ttmt -72.56 -48.87 36.57 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.156 0.582 . . . . 10.0 110.298 -177.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -54.31 -41.19 68.69 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.629 0.603 . . . . 10.0 112.629 176.489 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.5 mt -68.84 -52.4 30.29 Favored 'General case' 0 C--O 1.221 -0.421 0 C-N-CA 124.95 1.3 . . . . 10.0 109.521 173.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 45.9 m-20 -54.02 -19.85 5.44 Favored 'General case' 0 C--O 1.227 -0.118 0 CA-C-N 118.63 0.65 . . . . 10.0 111.964 179.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.6 ttmt -58.74 -26.59 64.12 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 113.72 1.007 . . . . 10.0 113.72 172.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 10.8 mt -54.26 133.93 17.27 Favored 'Isoleucine or valine' 0 C--N 1.341 0.232 0 CA-C-N 119.572 1.078 . . . . 10.0 108.706 173.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -69.56 -47.44 63.65 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.919 -0.488 . . . . 10.0 111.418 179.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -86.61 45.71 3.48 Favored Glycine 0 C--N 1.339 0.714 0 O-C-N 120.637 -1.289 . . . . 10.0 111.2 -174.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -99.32 149.59 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 108.389 -0.967 . . . . 10.0 108.389 -176.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -104.2 -57.43 2.03 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 107.769 -1.197 . . . . 10.0 107.769 165.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 55.4 m-80 -149.28 156.18 41.7 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.409 -0.96 . . . . 10.0 108.409 -171.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -146.45 61.94 7.41 Favored Pre-proline 0 CA--C 1.538 0.517 0 N-CA-C 112.86 0.689 . . . . 10.0 112.86 169.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -79.05 85.74 1.81 Allowed 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 123.23 2.62 . . . . 10.0 109.746 -178.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.0 m -71.84 153.56 7.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 O-C-N 121.495 -0.753 . . . . 10.0 110.901 -178.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -94.02 127.34 39.76 Favored 'General case' 0 C--N 1.339 0.11 0 O-C-N 121.996 -0.44 . . . . 10.0 110.771 -175.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -105.16 59.56 0.68 Allowed 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.437 1.495 . . . . 10.0 110.772 -173.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 173.47 -35.97 0.0 OUTLIER 'General case' 0 C--O 1.226 -0.176 0 C-N-CA 125.411 1.485 . . . . 10.0 109.794 171.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.6 mt -83.33 -14.22 53.4 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.913 0.885 . . . . 10.0 111.087 -172.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 75.92 38.31 0.35 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.735 1.614 . . . . 10.0 110.785 170.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 38.3 p -137.18 131.66 32.83 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.136 1.374 . . . . 10.0 109.327 -177.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.6 t -91.8 142.72 12.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 107.625 -1.25 . . . . 10.0 107.625 167.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 44.7 m -127.2 124.61 39.39 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 106.828 -1.545 . . . . 10.0 106.828 177.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.8 t -124.6 141.24 45.36 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 N-CA-C 109.183 -0.673 . . . . 10.0 109.183 -179.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 55.1 tt0 -115.22 106.82 14.5 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 106.985 -1.487 . . . . 10.0 106.985 166.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -149.96 158.64 44.36 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 123.062 0.545 . . . . 10.0 109.667 -179.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -88.64 128.26 53.3 Favored Pre-proline 0 C--N 1.326 -0.421 0 N-CA-C 109.952 -0.388 . . . . 10.0 109.952 178.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -75.69 60.4 5.92 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.479 2.119 . . . . 10.0 108.939 171.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.5 tttt -130.91 -52.62 1.05 Allowed 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 106.472 -1.677 . . . . 10.0 106.472 173.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -83.85 -43.51 15.28 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.077 0.551 . . . . 10.0 110.475 -170.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -134.12 -173.61 3.31 Favored 'General case' 0 C--N 1.339 0.128 0 C-N-CA 124.904 1.282 . . . . 10.0 109.093 178.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 79.8 p -145.78 166.8 24.84 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.676 0.75 . . . . 10.0 109.864 -177.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 26.8 m -49.79 -41.53 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 115.064 -0.971 . . . . 10.0 111.428 167.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.3 m -56.37 -44.2 79.95 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 123.914 0.885 . . . . 10.0 112.178 177.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -63.22 -56.89 12.83 Favored 'General case' 0 C--N 1.337 0.064 0 N-CA-C 109.203 -0.666 . . . . 10.0 109.203 179.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.2 pp -67.63 -41.22 84.23 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 119.675 -0.81 . . . . 10.0 110.81 -171.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -39.63 -52.47 2.22 Favored 'General case' 0 C--O 1.224 -0.238 0 O-C-N 121.683 -0.635 . . . . 10.0 112.473 159.333 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.45 -43.24 93.2 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 118.62 0.645 . . . . 10.0 109.873 179.4 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -51.87 -46.97 64.69 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 116.062 -0.517 . . . . 10.0 110.224 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 40.6 t -68.34 -47.44 77.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 124.266 1.026 . . . . 10.0 112.58 175.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -58.25 -35.37 71.64 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.406 -0.809 . . . . 10.0 109.126 -176.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.1 -28.79 39.0 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 118.538 -0.744 . . . . 10.0 112.179 179.315 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.2 mt -53.83 -42.65 68.7 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 120.036 1.289 . . . . 10.0 110.797 165.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 139.95 -14.3 3.09 Favored Glycine 0 CA--C 1.527 0.794 0 CA-C-O 119.974 -0.348 . . . . 10.0 113.787 170.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -114.83 159.19 20.92 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 125.54 1.536 . . . . 10.0 107.271 179.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 25.8 mttp -97.24 159.56 14.84 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 121.731 0.777 . . . . 10.0 111.782 -171.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 20.5 tp -137.24 147.28 45.65 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.929 1.691 . . . . 10.0 107.433 -177.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 22.9 tptt -154.41 153.41 31.52 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 108.624 -0.88 . . . . 10.0 108.624 164.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 22.5 mt -61.04 160.21 10.36 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 121.936 0.874 . . . . 10.0 110.856 175.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 12.3 tptt -113.12 -58.0 2.21 Favored 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 128.061 2.544 . . . . 10.0 106.419 173.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -179.88 -84.13 0.06 OUTLIER Glycine 0 CA--C 1.523 0.544 0 N-CA-C 109.617 -1.393 . . . . 10.0 109.617 178.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -165.39 160.8 18.43 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.304 -0.998 . . . . 10.0 108.304 -169.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.53 139.24 58.6 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 113.124 0.787 . . . . 10.0 113.124 -178.034 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -42.64 -51.04 5.36 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.13 1.772 . . . . 10.0 110.929 177.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.6 t 68.23 -171.53 0.19 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.696 1.198 . . . . 10.0 111.605 174.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.4 mt -145.29 25.28 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 125.098 1.359 . . . . 10.0 109.262 176.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 63.45 -167.74 0.21 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.427 1.091 . . . . 10.0 110.568 -172.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -161.17 -103.86 0.19 Allowed Glycine 0 CA--C 1.53 0.977 0 O-C-N 121.471 -0.768 . . . . 10.0 112.658 -173.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 11.1 mtt180 . . . . . 0 C--O 1.25 1.086 0 CA-C-O 116.82 -1.562 . . . . 10.0 107.043 164.754 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 8.7 p . . . . . 0 N--CA 1.469 0.51 0 N-CA-C 106.974 -1.491 . . . . 10.0 106.974 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.4 p -150.19 165.82 31.73 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 125.61 1.564 . . . . 10.0 107.263 -179.052 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -108.68 144.45 36.43 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 126.339 1.855 . . . . 10.0 110.28 179.484 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.0 mmtm -88.47 113.83 24.47 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.701 1.2 . . . . 10.0 109.801 174.034 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -116.64 149.87 39.04 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.678 1.191 . . . . 10.0 110.494 170.922 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -117.03 151.05 37.59 Favored 'General case' 0 CA--C 1.518 -0.257 0 C-N-CA 124.564 1.146 . . . . 10.0 111.423 171.237 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -140.99 137.47 33.04 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.549 1.14 . . . . 10.0 110.143 -175.333 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.513 ' CG ' ' HZ3' ' A' ' 71' ' ' LYS . 6.9 m-20 -95.0 137.84 33.52 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 125.165 1.386 . . . . 10.0 109.11 -176.952 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 7.5 mm -109.47 132.41 57.7 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 C-N-CA 124.84 1.256 . . . . 10.0 110.639 -164.822 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -121.68 88.18 2.89 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.377 -0.971 . . . . 10.0 108.377 173.197 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 150.46 -94.62 0.15 Allowed Glycine 0 CA--C 1.528 0.895 0 C-N-CA 123.394 0.521 . . . . 10.0 112.034 169.905 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 42.8 mtt -69.95 134.82 48.77 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 117.907 0.854 . . . . 10.0 111.235 -174.878 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.3 t -153.02 73.7 1.01 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.33 1.052 . . . . 10.0 108.531 -177.426 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 9.9 t -164.24 147.16 9.23 Favored 'General case' 0 C--N 1.339 0.122 0 O-C-N 120.939 -1.101 . . . . 10.0 109.762 -179.732 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -46.41 -46.04 18.37 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.043 1.337 . . . . 10.0 113.762 -174.768 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.34 -36.48 83.0 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 121.827 -0.545 . . . . 10.0 109.69 -177.634 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 91.2 m -72.81 -53.3 11.88 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 108.377 -0.972 . . . . 10.0 108.377 -176.4 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -39.18 -57.29 1.35 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 126.067 1.747 . . . . 10.0 110.948 168.237 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -49.43 -36.64 22.98 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.643 0.777 . . . . 10.0 112.44 175.682 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 15.6 ttt180 -73.49 -47.86 37.85 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 121.65 -0.656 . . . . 10.0 109.291 -179.61 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.3 mt -42.46 -52.51 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 123.1 0.56 . . . . 10.0 110.769 171.125 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -42.83 -58.54 2.32 Favored 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 123.01 0.524 . . . . 10.0 111.025 179.616 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -70.18 -39.59 75.15 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.859 0.863 . . . . 10.0 109.87 -173.885 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.24 -36.46 66.06 Favored 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 122.705 0.402 . . . . 10.0 110.685 175.611 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.49 -36.63 26.27 Favored 'General case' 0 C--O 1.222 -0.376 0 C-N-CA 123.571 0.749 . . . . 10.0 112.554 173.191 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -57.69 -25.73 60.72 Favored 'General case' 0 C--N 1.328 -0.326 0 O-C-N 120.715 -1.24 . . . . 10.0 109.821 179.291 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.5 mmpt? -51.82 -38.45 55.82 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 114.336 1.235 . . . . 10.0 114.336 168.975 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 11.5 mt -57.19 129.43 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 CA-C-N 118.838 0.745 . . . . 10.0 109.253 178.925 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -64.8 -49.53 70.29 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 120.968 -0.293 . . . . 10.0 110.991 -179.942 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -82.91 46.51 3.63 Favored Glycine 0 C--N 1.339 0.717 0 O-C-N 120.998 -1.064 . . . . 10.0 111.5 -175.008 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.3 p -106.7 152.9 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 C-N-CA 124.588 1.155 . . . . 10.0 109.003 -177.716 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -115.23 -51.95 2.69 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.989 -0.745 . . . . 10.0 108.989 168.499 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -151.58 158.86 44.09 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 109.234 -0.654 . . . . 10.0 109.234 -176.68 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -143.18 64.11 13.76 Favored Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 123.918 0.887 . . . . 10.0 111.861 173.088 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -79.22 77.68 4.0 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.178 2.585 . . . . 10.0 109.8 -177.252 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.4 m -71.3 153.16 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 O-C-N 121.775 -0.578 . . . . 10.0 111.385 -176.927 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 74.1 m-80 -87.46 148.05 25.12 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 120.817 -0.353 . . . . 10.0 110.298 177.241 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -124.02 44.8 2.63 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.904 1.281 . . . . 10.0 111.104 -172.306 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -175.8 -40.63 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.216 0 C-N-CA 125.292 1.437 . . . . 10.0 109.596 178.005 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.6 mt -78.15 -18.29 55.77 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.381 1.072 . . . . 10.0 111.834 -172.034 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 66.87 46.38 1.66 Allowed 'General case' 0 C--O 1.231 0.091 0 C-N-CA 125.377 1.471 . . . . 10.0 110.398 179.144 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.9 p -139.03 121.72 16.38 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 125.153 1.381 . . . . 10.0 108.538 176.349 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 17.9 t -88.55 137.56 20.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 107.227 -1.398 . . . . 10.0 107.227 168.505 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 88.8 m -120.09 124.02 44.8 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 106.445 -1.687 . . . . 10.0 106.445 176.659 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 24.7 t -121.56 140.1 46.64 Favored 'Isoleucine or valine' 0 C--N 1.339 0.139 0 CA-C-N 119.114 0.87 . . . . 10.0 110.073 178.755 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -105.19 101.47 11.02 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.458 1.503 . . . . 10.0 107.078 164.389 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -143.19 158.47 43.59 Favored 'General case' 0 CA--C 1.52 -0.21 0 C-N-CA 123.0 0.52 . . . . 10.0 110.627 178.421 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -93.06 129.45 39.46 Favored Pre-proline 0 CA--C 1.531 0.247 0 C-N-CA 123.393 0.677 . . . . 10.0 110.043 176.309 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -78.04 57.15 6.01 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 122.244 1.962 . . . . 10.0 108.86 169.768 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.74 -62.67 1.12 Allowed 'General case' 0 CA--C 1.521 -0.149 0 N-CA-C 106.533 -1.655 . . . . 10.0 106.533 175.822 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -81.84 -32.32 31.24 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 122.468 0.307 . . . . 10.0 110.87 -173.196 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -135.22 -176.48 4.27 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.14 0.976 . . . . 10.0 109.606 177.214 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 86.7 p -140.71 169.73 17.09 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.842 0.857 . . . . 10.0 111.501 -179.853 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 59.4 t -42.53 -48.71 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 125.43 1.492 . . . . 10.0 111.571 160.786 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.5 t -66.82 -34.25 77.4 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.356 -0.384 . . . . 10.0 110.553 -176.0 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -65.77 -60.71 2.61 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.682 -0.859 . . . . 10.0 108.682 173.382 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.9 pp -63.68 -44.91 92.34 Favored 'General case' 0 N--CA 1.447 -0.583 0 O-C-N 121.982 -0.449 . . . . 10.0 111.036 -164.774 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -48.64 -39.56 24.58 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 113.319 0.859 . . . . 10.0 113.319 170.094 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -57.25 -32.94 67.08 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 119.235 0.925 . . . . 10.0 110.646 178.939 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.41 -48.24 81.31 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.792 0.805 . . . . 10.0 109.338 -178.562 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 57.6 t -64.94 -50.57 74.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 124.947 1.299 . . . . 10.0 111.043 174.49 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -50.27 -39.18 44.4 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.354 1.462 . . . . 10.0 109.167 -179.292 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 33.1 tptt -76.59 -40.96 47.98 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 125.303 1.441 . . . . 10.0 110.595 -178.063 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 28.3 mt -53.19 -41.09 64.93 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.712 0.687 . . . . 10.0 111.402 169.056 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 140.4 -30.78 2.3 Favored Glycine 0 C--N 1.338 0.69 0 CA-C-N 118.225 0.466 . . . . 10.0 113.428 166.722 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 15.6 p90 -86.86 160.2 18.82 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 107.797 -1.186 . . . . 10.0 107.797 172.711 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -105.42 150.67 25.05 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 120.859 0.361 . . . . 10.0 110.549 -170.546 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 21.8 tp -123.2 150.47 43.33 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 126.643 1.977 . . . . 10.0 108.234 -176.897 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 19.5 tptt -154.26 140.01 18.05 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 123.145 0.578 . . . . 10.0 110.683 166.018 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.4 tt -70.8 158.27 36.63 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 123.524 0.729 . . . . 10.0 109.786 -178.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.513 ' HZ3' ' CG ' ' A' ' 8' ' ' ASP . 11.8 ttpt -121.74 -67.17 0.98 Allowed 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 126.894 2.078 . . . . 10.0 108.759 178.815 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -165.54 -81.31 0.04 OUTLIER Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.025 -1.23 . . . . 10.0 110.025 176.627 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -163.45 165.02 24.26 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 124.578 1.151 . . . . 10.0 107.937 -169.154 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.19 57.72 1.9 Allowed 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 117.829 0.286 . . . . 10.0 110.418 174.756 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 24.6 t0 37.13 59.93 1.06 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.858 1.663 . . . . 10.0 111.226 -178.646 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.9 t -79.86 -49.47 11.91 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.734 0.814 . . . . 10.0 109.018 -171.068 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 27.9 mt 66.66 2.89 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 C-N-CA 124.2 1.0 . . . . 10.0 112.342 176.418 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -120.5 156.16 32.09 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 124.793 1.237 . . . . 10.0 109.755 175.909 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -150.24 95.96 0.16 Allowed Glycine 0 CA--C 1.523 0.571 0 N-CA-C 105.537 -3.025 . . . . 10.0 105.537 170.927 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 13.3 tpt85 . . . . . 0 C--O 1.252 1.22 0 CA-C-O 117.027 -1.463 . . . . 10.0 110.863 -164.35 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 2.7 p . . . . . 0 N--CA 1.474 0.764 0 N-CA-C 109.146 -0.687 . . . . 10.0 109.146 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.1 p -144.13 170.89 15.11 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 105.908 -1.886 . . . . 10.0 105.908 171.789 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -133.98 143.24 48.03 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 126.83 2.052 . . . . 10.0 106.723 -168.345 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 18.3 tptm -89.25 143.33 26.91 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 107.546 -1.279 . . . . 10.0 107.546 -176.273 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -147.44 148.13 30.95 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.416 0.686 . . . . 10.0 109.441 177.66 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -128.09 152.41 48.01 Favored 'General case' 0 CA--C 1.507 -0.675 0 C-N-CA 124.494 1.118 . . . . 10.0 109.156 173.014 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -143.4 131.44 21.75 Favored 'General case' 0 N--CA 1.447 -0.623 0 O-C-N 125.607 1.817 . . . . 10.0 108.638 -170.826 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -93.59 138.41 31.87 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 106.811 -1.551 . . . . 10.0 106.811 -179.57 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 5.3 mm -105.44 141.23 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 124.289 1.036 . . . . 10.0 109.415 -166.251 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -107.21 81.14 1.5 Allowed 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 106.845 -1.539 . . . . 10.0 106.845 172.847 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.02 135.03 6.23 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.083 -0.962 . . . . 10.0 111.107 178.362 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 8.9 ptp -145.76 161.04 40.83 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 122.179 -0.6 . . . . 10.0 111.768 163.4 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.8 m -70.12 -40.38 74.9 Favored 'General case' 0 N--CA 1.438 -1.026 0 C-N-CA 125.516 1.526 . . . . 10.0 110.803 172.77 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 45.5 t 89.95 135.79 0.03 OUTLIER 'General case' 0 C--N 1.346 0.415 0 C-N-CA 126.508 1.923 . . . . 10.0 108.996 -178.551 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 59.39 -75.5 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.649 1.58 . . . . 10.0 111.848 -172.668 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.52 -28.67 67.28 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.185 0.994 . . . . 10.0 109.486 177.935 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.4 t -54.82 -69.32 0.13 Allowed 'General case' 0 C--N 1.343 0.291 0 C-N-CA 120.463 -0.495 . . . . 10.0 109.979 168.516 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -49.57 -38.09 29.88 Favored 'General case' 0 CA--C 1.522 -0.124 0 C-N-CA 123.473 0.709 . . . . 10.0 110.615 -177.526 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -58.81 -43.88 90.67 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 119.963 -0.695 . . . . 10.0 110.658 179.415 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.8 tpp85 -75.09 -44.36 47.75 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 109.098 -0.704 . . . . 10.0 109.098 -178.95 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.4 mm -44.49 -62.08 0.33 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.466 0 C-N-CA 124.063 0.945 . . . . 10.0 108.898 173.663 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -54.61 -34.83 62.67 Favored 'General case' 0 C--O 1.22 -0.483 0 CA-C-N 118.497 0.59 . . . . 10.0 112.203 -175.172 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.04 -43.43 78.74 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 120.715 -1.24 . . . . 10.0 109.376 176.595 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.53 -39.67 85.05 Favored 'General case' 0 C--O 1.224 -0.261 0 O-C-N 122.12 -0.362 . . . . 10.0 111.598 177.997 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.56 -34.62 58.48 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.693 1.197 . . . . 10.0 110.337 -179.426 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -71.14 -7.51 47.14 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 121.671 -0.643 . . . . 10.0 109.537 173.865 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.5 -37.94 82.71 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 118.368 -1.333 . . . . 10.0 109.422 165.92 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 25.6 mm -60.16 123.59 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 123.647 0.779 . . . . 10.0 109.711 -173.729 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -68.32 -48.84 63.81 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 110.001 -0.37 . . . . 10.0 110.001 -179.169 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -82.54 41.06 2.79 Favored Glycine 0 CA--C 1.526 0.747 0 O-C-N 121.326 -0.859 . . . . 10.0 111.937 -175.42 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.3 p -104.46 146.82 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 C-N-CA 124.864 1.266 . . . . 10.0 108.73 -178.266 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -115.94 -52.44 2.61 Favored 'General case' 0 C--N 1.333 -0.109 0 C-N-CA 122.848 0.459 . . . . 10.0 109.838 172.085 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -139.52 143.03 37.25 Favored 'General case' 0 C--N 1.341 0.212 0 N-CA-C 108.803 -0.814 . . . . 10.0 108.803 -176.797 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -130.85 62.74 67.12 Favored Pre-proline 0 CA--C 1.536 0.435 0 C-N-CA 123.39 0.676 . . . . 10.0 110.48 173.188 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -76.26 66.37 7.08 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 123.448 2.765 . . . . 10.0 110.633 -175.931 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.5 t -68.47 145.16 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 C-N-CA 126.123 1.769 . . . . 10.0 110.98 -176.805 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -90.98 145.07 25.02 Favored 'General case' 0 C--N 1.341 0.239 0 C-N-CA 120.315 -0.554 . . . . 10.0 110.582 -179.828 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -122.82 65.47 0.96 Allowed 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 125.309 1.444 . . . . 10.0 109.819 -172.861 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 157.55 -30.9 0.0 OUTLIER 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 127.627 2.371 . . . . 10.0 109.621 169.405 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.6 mt -75.56 -17.62 60.0 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.799 0.839 . . . . 10.0 110.846 -173.821 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 67.07 48.39 1.24 Allowed 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 126.005 1.722 . . . . 10.0 110.653 177.205 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.4 p -143.1 124.77 14.94 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.49 1.516 . . . . 10.0 108.283 176.422 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.0 t -94.2 141.58 14.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 106.884 -1.525 . . . . 10.0 106.884 169.602 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.6 m -129.98 126.05 36.85 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 105.491 -2.04 . . . . 10.0 105.491 -177.889 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 23.9 t -128.37 152.93 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 CA-C-N 118.657 0.662 . . . . 10.0 109.402 178.886 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -130.41 96.94 4.26 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 105.021 -2.215 . . . . 10.0 105.021 176.213 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -148.77 164.66 33.76 Favored 'General case' 0 C--O 1.226 -0.152 0 C-N-CA 123.956 0.903 . . . . 10.0 110.343 -171.569 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -96.09 132.63 26.51 Favored Pre-proline 0 C--N 1.33 -0.24 0 C-N-CA 122.858 0.463 . . . . 10.0 110.501 179.577 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -79.68 55.62 5.71 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 121.721 1.614 . . . . 10.0 109.136 166.991 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.52 -41.49 1.7 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 118.234 0.47 . . . . 10.0 110.364 177.73 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.89 -32.28 11.76 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.688 0.795 . . . . 10.0 111.091 178.332 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -138.22 -174.83 3.91 Favored 'General case' 0 CA--C 1.523 -0.065 0 C-N-CA 124.644 1.178 . . . . 10.0 109.67 -175.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.7 p -148.42 163.25 37.71 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 123.058 0.543 . . . . 10.0 109.896 -178.936 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 55.8 t -38.55 -50.39 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 C-N-CA 125.345 1.458 . . . . 10.0 110.07 163.698 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.3 m -51.4 -44.07 62.1 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 124.552 1.141 . . . . 10.0 113.056 -179.762 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -72.37 -53.59 11.86 Favored 'General case' 0 C--O 1.224 -0.289 0 N-CA-C 109.78 -0.452 . . . . 10.0 109.78 -178.625 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.0 pp -61.05 -39.95 91.79 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 118.247 -1.381 . . . . 10.0 110.738 -177.97 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.86 -57.48 3.74 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-O 117.854 -1.069 . . . . 10.0 112.309 161.54 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 14.6 tm-20 -50.22 -48.49 54.36 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-N 120.332 1.424 . . . . 10.0 110.298 176.392 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -51.63 -54.07 31.76 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 123.555 0.742 . . . . 10.0 109.602 -178.044 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 91.6 t -63.03 -45.12 99.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 115.986 -0.552 . . . . 10.0 111.155 177.818 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.45 -56.86 10.98 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.99 0.9 . . . . 10.0 109.836 178.942 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.9 tptp -49.35 -36.97 23.0 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 127.287 2.235 . . . . 10.0 111.602 175.273 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.4 tp -60.89 -34.38 74.55 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 125.055 1.342 . . . . 10.0 111.705 179.17 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 146.83 -53.0 0.55 Allowed Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.754 -0.538 . . . . 10.0 111.754 176.962 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -98.86 158.83 15.37 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 123.939 0.896 . . . . 10.0 109.859 -176.832 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 8.5 ttpt -92.16 153.18 19.5 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.217 0.532 . . . . 10.0 110.232 -170.46 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 23.9 tp -125.74 151.69 46.33 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.981 1.713 . . . . 10.0 107.932 179.734 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.9 tptp -153.92 147.63 25.29 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 122.775 0.43 . . . . 10.0 110.275 162.919 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.3 tp -59.14 158.48 8.77 Favored 'General case' 0 C--N 1.34 0.155 0 O-C-N 123.485 0.491 . . . . 10.0 109.963 176.561 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.6 tttt -116.26 -71.26 0.75 Allowed 'General case' 0 N--CA 1.436 -1.136 0 C-N-CA 126.849 2.059 . . . . 10.0 108.205 179.472 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 158.88 43.89 0.02 OUTLIER Glycine 0 CA--C 1.529 0.956 0 C-N-CA 123.952 0.787 . . . . 10.0 111.609 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 67.58 163.17 0.2 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.995 1.318 . . . . 10.0 111.962 171.6 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -79.26 -57.47 3.7 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 108.506 -0.924 . . . . 10.0 108.506 176.033 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -73.71 67.96 1.2 Allowed 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 126.814 2.046 . . . . 10.0 109.119 -172.961 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 29.6 t -52.09 -33.28 38.71 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 127.386 2.274 . . . . 10.0 112.341 -173.078 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 23.7 pt -131.84 164.88 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.409 0 N-CA-C 104.808 -2.293 . . . . 10.0 104.808 168.276 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -106.15 174.65 5.79 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 125.287 1.435 . . . . 10.0 109.799 169.971 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -160.17 -179.04 34.69 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 106.432 -2.667 . . . . 10.0 106.432 172.245 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 66.0 ttt180 . . . . . 0 C--O 1.254 1.33 0 N-CA-C 105.113 -2.181 . . . . 10.0 105.113 176.195 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 11.4 t . . . . . 0 N--CA 1.464 0.247 0 N-CA-C 106.528 -1.656 . . . . 10.0 106.528 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.6 p -116.27 132.25 56.72 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 122.606 1.194 . . . . 10.0 112.506 -168.723 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -82.62 164.19 20.94 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 107.791 -1.188 . . . . 10.0 107.791 176.352 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.65 144.73 31.99 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 106.737 -1.579 . . . . 10.0 106.737 176.611 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -148.24 139.23 23.18 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.424 -0.954 . . . . 10.0 108.424 179.294 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -120.71 148.21 44.26 Favored 'General case' 0 CA--C 1.513 -0.466 0 C-N-CA 123.964 0.906 . . . . 10.0 109.187 175.866 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -139.11 144.2 38.59 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.131 1.372 . . . . 10.0 109.144 -174.834 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -110.14 127.33 54.84 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.67 1.188 . . . . 10.0 107.878 -172.213 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.5 mm -107.25 137.16 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 124.004 0.922 . . . . 10.0 111.301 -160.691 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -123.37 91.35 3.46 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.554 1.141 . . . . 10.0 108.239 179.816 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 115.15 43.71 0.71 Allowed Glycine 0 CA--C 1.529 0.969 0 CA-C-O 119.459 -0.634 . . . . 10.0 114.243 165.737 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 28.2 ptm -104.6 153.56 21.04 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.351 1.076 . . . . 10.0 110.422 176.311 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -97.26 -4.29 39.11 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.61 0.764 . . . . 10.0 112.126 177.466 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER 72.72 -179.88 0.22 Allowed 'General case' 0 C--N 1.344 0.341 0 CA-C-N 119.485 1.039 . . . . 10.0 110.755 -173.129 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 50.17 -91.92 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 125.83 1.652 . . . . 10.0 111.578 -179.563 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.71 -42.93 94.9 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 123.883 0.873 . . . . 10.0 109.34 -178.167 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.6 m -64.69 -55.41 20.22 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.259 -0.645 . . . . 10.0 109.259 -177.395 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -46.15 -48.38 17.41 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.446 1.098 . . . . 10.0 110.752 173.757 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -61.9 -41.42 97.89 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.167 0.508 . . . . 10.0 111.212 179.016 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.65 -41.0 94.08 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 118.077 -0.964 . . . . 10.0 110.383 176.66 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 14.9 mm -47.62 -62.54 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.371 0 N-CA-C 108.367 -0.975 . . . . 10.0 108.367 169.682 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -54.56 -35.82 63.67 Favored 'General case' 0 C--O 1.22 -0.462 0 N-CA-C 112.177 0.436 . . . . 10.0 112.177 -176.281 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.65 -53.56 32.67 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 119.198 0.908 . . . . 10.0 109.783 179.233 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.7 tpt180 -64.27 -35.34 80.51 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 122.225 -0.297 . . . . 10.0 111.253 -178.987 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.51 -44.9 56.63 Favored 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 123.402 0.681 . . . . 10.0 111.319 178.134 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -51.25 -31.27 20.39 Favored 'General case' 0 C--O 1.225 -0.184 0 C-N-CA 123.81 0.844 . . . . 10.0 110.654 172.292 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -60.84 -34.6 74.83 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 118.703 -0.665 . . . . 10.0 112.239 176.956 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 22.4 mm -55.0 133.37 18.54 Favored 'Isoleucine or valine' 0 C--N 1.342 0.261 0 C-N-CA 124.077 0.951 . . . . 10.0 110.854 177.924 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 51.1 mp0 -73.73 -47.03 42.33 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 119.242 -0.408 . . . . 10.0 110.869 -172.955 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.99 36.75 2.52 Favored Glycine 0 C--N 1.343 0.937 0 O-C-N 120.298 -1.501 . . . . 10.0 113.0 -177.669 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.2 p -101.68 149.76 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 124.61 1.164 . . . . 10.0 108.343 -178.042 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -108.15 -57.84 2.06 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 106.572 -1.64 . . . . 10.0 106.572 165.366 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -154.3 167.17 30.84 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 115.644 -0.707 . . . . 10.0 109.371 -169.376 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -157.0 77.05 4.08 Favored Pre-proline 0 N--CA 1.454 -0.24 0 C-N-CA 123.592 0.757 . . . . 10.0 110.841 -179.393 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -75.47 69.53 5.87 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.547 2.164 . . . . 10.0 110.124 -179.13 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.8 m -64.6 157.24 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 C-N-CA 123.518 0.727 . . . . 10.0 110.383 178.056 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -102.35 159.93 14.99 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 119.603 -0.839 . . . . 10.0 111.954 172.218 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -129.76 59.22 1.62 Allowed 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 125.474 1.51 . . . . 10.0 108.743 -172.339 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 171.72 -29.44 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 125.304 1.442 . . . . 10.0 111.335 165.894 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.7 mt -81.86 -7.72 59.63 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 122.714 0.406 . . . . 10.0 111.063 -176.106 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 67.06 41.27 2.68 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 126.025 1.73 . . . . 10.0 110.557 173.895 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -136.86 140.85 42.68 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.928 0.871 . . . . 10.0 109.774 173.579 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.5 t -110.99 138.97 36.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 107.569 -1.271 . . . . 10.0 107.569 174.156 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 90.6 m -124.29 121.56 35.35 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 126.193 1.797 . . . . 10.0 106.293 -176.07 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.4 t -120.02 143.49 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 C-N-CA 124.597 1.159 . . . . 10.0 109.171 -179.944 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -120.66 96.68 5.22 Favored 'General case' 0 N--CA 1.429 -1.519 0 C-N-CA 126.255 1.822 . . . . 10.0 107.067 173.606 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 11.9 p90 -139.35 161.74 36.72 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 124.079 0.952 . . . . 10.0 109.986 -174.806 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -93.7 123.5 59.68 Favored Pre-proline 0 CA--C 1.534 0.358 0 C-N-CA 123.278 0.631 . . . . 10.0 111.011 175.214 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -75.14 67.33 6.07 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.708 2.272 . . . . 10.0 109.039 172.723 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.45 -49.56 0.49 Allowed 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 107.893 -1.151 . . . . 10.0 107.893 177.919 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -82.54 -62.57 1.58 Allowed 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 108.643 -0.873 . . . . 10.0 108.643 177.101 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -110.27 171.79 7.25 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 125.196 1.398 . . . . 10.0 109.701 -176.701 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 24.8 p -125.32 179.61 5.02 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.886 1.274 . . . . 10.0 110.663 172.994 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 26.8 m -51.36 -37.68 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-N 114.846 -1.07 . . . . 10.0 111.93 166.64 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.8 t -69.86 -39.19 76.49 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 119.032 -0.509 . . . . 10.0 110.811 -174.657 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -60.0 -52.58 64.77 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 119.241 0.928 . . . . 10.0 109.261 -176.341 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.2 pp -66.45 -42.91 86.9 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.144 -0.48 . . . . 10.0 110.692 -179.658 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.65 -50.34 13.51 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 121.125 -0.985 . . . . 10.0 112.901 164.255 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -60.71 -43.79 97.38 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 119.748 1.158 . . . . 10.0 109.251 -179.366 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -53.1 -52.08 59.79 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.327 -0.851 . . . . 10.0 109.887 178.718 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 98.3 t -64.22 -43.39 97.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 123.04 0.536 . . . . 10.0 112.287 175.115 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -52.26 -51.76 56.59 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 121.995 0.903 . . . . 10.0 109.262 179.181 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 45.0 tptt -57.89 -30.92 66.24 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.812 1.645 . . . . 10.0 112.273 176.837 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.3 mp -61.54 -30.37 70.6 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.657 0.783 . . . . 10.0 110.812 173.977 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 141.16 -45.7 0.95 Allowed Glycine 0 CA--C 1.526 0.772 0 CA-C-N 118.448 0.567 . . . . 10.0 111.716 171.82 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -99.47 156.2 17.16 Favored 'General case' 0 C--O 1.226 -0.145 0 C-N-CA 124.973 1.309 . . . . 10.0 109.017 -178.67 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 24.1 mtpp -87.97 165.34 15.28 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-O 121.719 0.771 . . . . 10.0 111.191 -173.17 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 11.5 tp -136.04 149.46 48.78 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.141 1.776 . . . . 10.0 107.057 -179.831 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 8.7 mmtp -149.42 153.35 37.2 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 108.857 -0.794 . . . . 10.0 108.857 163.797 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.4 tp -62.04 158.51 16.36 Favored 'General case' 0 N--CA 1.453 -0.291 0 O-C-N 124.25 0.969 . . . . 10.0 109.084 174.905 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 12.1 tttt -114.83 -69.86 0.83 Allowed 'General case' 0 N--CA 1.436 -1.175 0 C-N-CA 126.674 1.989 . . . . 10.0 107.28 177.161 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 162.73 47.21 0.02 OUTLIER Glycine 0 CA--C 1.527 0.808 0 CA-C-O 119.291 -0.727 . . . . 10.0 112.87 175.491 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 68.5 156.98 0.13 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.105 1.362 . . . . 10.0 113.165 171.853 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -64.58 142.86 58.28 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 121.859 -0.526 . . . . 10.0 110.654 175.359 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -73.54 72.56 1.41 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.884 0.874 . . . . 10.0 110.487 -179.429 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 53.0 m -116.06 156.26 26.68 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.624 1.569 . . . . 10.0 110.76 -177.698 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 8.8 mt -103.7 -117.92 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 124.16 0.984 . . . . 10.0 108.405 -176.701 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 60.51 179.61 0.1 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.863 1.665 . . . . 10.0 111.197 -170.94 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 179.07 -64.68 0.08 OUTLIER Glycine 0 CA--C 1.527 0.818 0 O-C-N 120.999 -1.063 . . . . 10.0 112.834 -179.075 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 4.8 ttm-85 . . . . . 0 C--O 1.254 1.339 0 N-CA-C 105.273 -2.121 . . . . 10.0 105.273 165.333 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 58.0 t . . . . . 0 N--CA 1.468 0.453 0 N-CA-C 106.287 -1.746 . . . . 10.0 106.287 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 20.7 p -127.87 122.45 32.58 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 107.059 -1.46 . . . . 10.0 107.059 168.485 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -114.27 149.51 35.8 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.943 1.297 . . . . 10.0 110.379 -170.247 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.2 mtmm -98.96 77.18 2.17 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 126.266 1.826 . . . . 10.0 110.816 -160.254 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -79.17 153.57 29.95 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.806 1.643 . . . . 10.0 110.586 -173.724 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -129.52 151.51 50.05 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 124.05 0.94 . . . . 10.0 109.155 176.374 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -140.77 133.75 29.22 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 125.262 1.601 . . . . 10.0 109.776 -174.731 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -87.45 134.68 33.56 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 125.953 1.701 . . . . 10.0 107.883 -179.254 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 12.8 mm -106.03 138.71 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 C-N-CA 125.474 1.51 . . . . 10.0 110.636 -166.523 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -126.31 105.15 8.6 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 108.546 -0.909 . . . . 10.0 108.546 165.749 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 135.13 -77.96 0.36 Allowed Glycine 0 CA--C 1.528 0.868 0 C-N-CA 124.219 0.914 . . . . 10.0 112.663 165.125 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 6.9 ptt? -65.61 126.87 29.71 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 122.192 -0.593 . . . . 10.0 110.641 -173.575 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.6 t -152.61 65.26 0.8 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.66 0.743 . . . . 10.0 110.122 -178.912 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 95.2 m -139.67 -99.02 0.16 Allowed 'General case' 0 C--O 1.225 -0.188 0 N-CA-C 107.823 -1.177 . . . . 10.0 107.823 170.096 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -167.93 -46.53 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.76 0.824 . . . . 10.0 109.608 -177.103 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.39 -40.48 77.34 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.543 0.737 . . . . 10.0 109.184 -179.26 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 18.2 p -65.82 -50.24 65.36 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 109.551 -0.536 . . . . 10.0 109.551 178.187 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.15 -41.8 72.27 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.436 1.095 . . . . 10.0 110.159 174.599 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -55.35 -31.09 61.45 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 121.385 -0.822 . . . . 10.0 112.758 179.568 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.7 ttt180 -70.03 -30.04 67.23 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 121.283 -0.886 . . . . 10.0 109.329 -179.099 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 25.8 mm -55.68 -54.56 24.63 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 CA-C-O 118.431 -0.795 . . . . 10.0 108.972 173.532 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -43.8 -49.72 8.02 Favored 'General case' 0 C--O 1.223 -0.297 0 C-N-CA 123.352 0.661 . . . . 10.0 110.576 -177.895 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.4 mppt? -65.19 -52.24 56.1 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 123.196 0.599 . . . . 10.0 109.818 179.597 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.75 -21.92 66.55 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 112.527 0.566 . . . . 10.0 112.527 -175.506 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.74 -41.28 14.26 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 126.735 2.014 . . . . 10.0 111.44 172.336 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -57.73 -29.07 64.44 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.899 0.88 . . . . 10.0 110.216 175.792 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.2 mmpt? -53.47 -36.03 61.18 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 113.968 1.099 . . . . 10.0 113.968 169.597 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.5 mm -61.08 125.13 16.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 119.108 0.867 . . . . 10.0 109.219 178.576 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 64.2 mt-10 -59.34 -52.9 63.65 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.962 0.727 . . . . 10.0 112.962 -176.547 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.41 43.12 2.85 Favored Glycine 0 C--N 1.339 0.745 0 CA-C-N 120.053 1.297 . . . . 10.0 112.12 -172.78 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.7 p -107.75 153.16 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 C-N-CA 124.783 1.233 . . . . 10.0 108.805 -176.826 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -116.76 -55.13 2.39 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.12 -0.696 . . . . 10.0 109.12 174.615 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -147.32 160.21 42.78 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 108.882 -0.784 . . . . 10.0 108.882 179.596 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.39 61.31 3.9 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 123.647 0.779 . . . . 10.0 112.214 174.29 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -79.42 78.71 3.61 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.826 2.351 . . . . 10.0 109.595 -177.248 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.3 m -58.75 149.65 5.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 123.381 0.672 . . . . 10.0 111.855 -178.276 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -93.59 94.65 8.75 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.979 0.419 . . . . 10.0 111.538 -172.855 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -73.96 53.79 0.49 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 127.084 2.154 . . . . 10.0 112.769 -178.588 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -172.27 -42.88 0.02 OUTLIER 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 125.271 1.428 . . . . 10.0 109.217 170.317 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.3 mt -79.83 -19.69 47.8 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 115.691 -0.686 . . . . 10.0 111.144 -170.996 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 64.54 53.28 1.63 Allowed 'General case' 0 N--CA 1.457 -0.085 0 C-N-CA 124.751 1.22 . . . . 10.0 109.002 -177.199 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 30.3 p -138.04 125.66 22.2 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 106.632 -1.618 . . . . 10.0 106.632 169.849 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.9 t -87.92 145.54 7.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 106.267 -1.753 . . . . 10.0 106.267 166.89 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 96.7 m -128.23 133.49 48.84 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 105.826 -1.916 . . . . 10.0 105.826 178.444 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 26.4 t -136.46 129.31 45.76 Favored 'Isoleucine or valine' 0 C--N 1.339 0.114 0 CA-C-N 118.477 0.581 . . . . 10.0 111.081 176.925 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -92.98 101.02 13.35 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 126.444 1.897 . . . . 10.0 106.265 169.06 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -138.18 159.14 42.83 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 118.411 0.55 . . . . 10.0 111.995 -178.711 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 16.8 p30 -94.87 128.46 39.28 Favored Pre-proline 0 CA--C 1.527 0.06 0 C-N-CA 123.995 0.918 . . . . 10.0 110.656 178.583 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -76.07 56.46 4.87 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 122.425 2.083 . . . . 10.0 109.946 175.511 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.5 ttpt -131.87 -66.34 0.71 Allowed 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 106.628 -1.619 . . . . 10.0 106.628 173.501 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -99.11 -14.86 19.2 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.523 1.129 . . . . 10.0 110.735 -175.378 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -122.06 144.75 48.72 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.24 1.016 . . . . 10.0 110.348 -178.784 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -149.42 147.78 28.68 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.494 0.664 . . . . 10.0 111.291 -173.785 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.4 m -52.41 -42.44 38.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 124.546 1.139 . . . . 10.0 111.314 -178.304 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.2 m -52.72 -44.92 66.68 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.093 1.357 . . . . 10.0 111.974 177.964 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -76.21 -47.3 24.52 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.844 1.258 . . . . 10.0 109.444 -170.636 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.2 pp -65.72 -42.65 90.83 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 119.253 -0.979 . . . . 10.0 109.871 176.455 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.85 -53.17 10.16 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 117.48 -1.248 . . . . 10.0 112.247 163.548 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -50.94 -45.7 60.74 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 120.687 1.585 . . . . 10.0 110.252 178.121 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -55.52 -51.33 67.39 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.135 -0.939 . . . . 10.0 110.211 -178.038 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 21.9 t -65.16 -43.71 95.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-N 116.475 -0.33 . . . . 10.0 111.653 177.021 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.41 -54.25 47.81 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 108.188 -1.041 . . . . 10.0 108.188 -175.884 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -58.09 -38.92 77.32 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.733 1.213 . . . . 10.0 111.107 178.419 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -50.92 -34.09 27.05 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.333 0.653 . . . . 10.0 112.067 172.61 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.75 20.78 6.7 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 123.65 0.643 . . . . 10.0 113.281 172.127 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -142.22 175.05 10.06 Favored 'General case' 0 CA--C 1.522 -0.12 0 N-CA-C 105.627 -1.99 . . . . 10.0 105.627 167.406 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 31.4 tttt -123.08 152.87 40.62 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 119.244 0.929 . . . . 10.0 113.182 -164.867 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 12.7 tp -134.74 148.86 50.35 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 126.815 2.046 . . . . 10.0 107.907 -168.808 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 12.6 tptp -149.94 151.28 33.13 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-O 118.713 -0.661 . . . . 10.0 109.536 161.843 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 11.4 tp -60.45 155.15 18.93 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 109.13 -0.693 . . . . 10.0 109.13 175.617 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 35.8 tttp -112.7 -68.35 0.94 Allowed 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 126.443 1.897 . . . . 10.0 107.815 178.912 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 154.75 51.68 0.01 OUTLIER Glycine 0 CA--C 1.529 0.929 0 CA-C-O 119.527 -0.596 . . . . 10.0 112.726 175.095 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 65.68 157.68 0.1 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.735 1.614 . . . . 10.0 113.584 178.22 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -83.68 150.4 25.89 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.42 -0.354 . . . . 10.0 111.348 -178.915 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -144.84 164.98 29.41 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 126.307 1.843 . . . . 10.0 106.588 167.89 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 7.8 t -151.98 77.95 1.23 Allowed 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 106.309 -1.737 . . . . 10.0 106.309 166.451 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.7 pt 41.6 61.11 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 C-N-CA 127.078 2.151 . . . . 10.0 115.022 -175.925 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -61.17 129.85 43.35 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.943 -0.571 . . . . 10.0 109.775 171.341 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 168.38 -179.75 41.23 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 108.368 -1.893 . . . . 10.0 108.368 -177.533 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 43.2 ttt180 . . . . . 0 C--O 1.253 1.289 0 N-CA-C 105.475 -2.046 . . . . 10.0 105.475 172.559 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 56.2 t . . . . . 0 N--CA 1.468 0.474 0 N-CA-C 106.505 -1.665 . . . . 10.0 106.505 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 21.0 p -103.81 170.51 7.88 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.462 0.705 . . . . 10.0 110.533 171.061 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -136.83 149.69 47.87 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 127.505 2.322 . . . . 10.0 106.423 -175.689 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.9 mmtm -97.81 132.52 43.35 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 124.43 1.092 . . . . 10.0 110.555 -176.84 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -134.43 140.24 46.12 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.866 1.267 . . . . 10.0 108.88 177.901 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -119.73 145.83 46.18 Favored 'General case' 0 CA--C 1.513 -0.446 0 C-N-CA 123.817 0.847 . . . . 10.0 109.645 173.071 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -137.09 143.33 42.52 Favored 'General case' 0 N--CA 1.448 -0.544 0 O-C-N 125.084 1.49 . . . . 10.0 109.81 -173.221 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -106.63 135.75 47.61 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.273 1.429 . . . . 10.0 108.701 -174.646 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.9 mm -114.86 134.68 57.13 Favored 'Isoleucine or valine' 0 C--N 1.34 0.164 0 C-N-CA 125.203 1.401 . . . . 10.0 110.415 -161.772 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -125.85 111.27 14.64 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.379 -0.6 . . . . 10.0 109.379 171.911 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 143.33 -60.69 0.52 Allowed Glycine 0 C--N 1.341 0.819 0 C-N-CA 123.818 0.723 . . . . 10.0 112.535 165.193 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.68 158.39 34.79 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.469 0.708 . . . . 10.0 111.612 -176.238 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -67.4 -86.52 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 124.503 1.121 . . . . 10.0 110.394 175.706 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 23.3 p 150.81 55.34 0.0 OUTLIER 'General case' 0 C--N 1.345 0.407 0 C-N-CA 125.21 1.404 . . . . 10.0 110.658 -165.524 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -161.29 -82.06 0.04 OUTLIER 'General case' 0 CA--C 1.519 -0.22 0 O-C-N 121.102 -0.999 . . . . 10.0 109.04 174.168 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.5 -46.63 25.88 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.25 -1.019 . . . . 10.0 108.25 -172.622 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 7.2 m -55.54 -58.52 7.45 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 114.695 -1.139 . . . . 10.0 109.644 173.225 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -44.63 -53.76 6.85 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.46 1.104 . . . . 10.0 111.131 173.828 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -56.98 -31.63 65.26 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.135 0.493 . . . . 10.0 112.0 178.897 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 11.9 ttm180 -74.6 -40.91 61.28 Favored 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 120.994 -1.066 . . . . 10.0 109.389 178.12 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 39.1 mm -46.23 -52.91 2.9 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 CA-C-O 117.796 -1.097 . . . . 10.0 110.012 170.504 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -43.99 -46.57 8.38 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 119.071 0.85 . . . . 10.0 111.955 -177.016 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -76.79 -39.66 50.75 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 123.737 0.815 . . . . 10.0 110.638 -178.279 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.91 -35.8 77.62 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 122.38 -0.2 . . . . 10.0 111.268 176.847 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.59 -36.28 29.16 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.293 1.837 . . . . 10.0 111.152 176.91 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -53.53 -31.63 47.07 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.265 -0.897 . . . . 10.0 110.88 173.232 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.5 mptt -54.15 -24.9 19.71 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 115.298 1.592 . . . . 10.0 115.298 172.349 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 11.4 mm -61.23 108.2 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 118.708 0.685 . . . . 10.0 109.966 172.381 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -55.37 -33.81 63.75 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.239 0.616 . . . . 10.0 111.945 -177.085 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.85 15.49 57.47 Favored Glycine 0 CA--C 1.528 0.883 0 O-C-N 121.497 -0.752 . . . . 10.0 113.19 -179.058 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.7 p -79.33 154.45 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-N 118.867 1.334 . . . . 10.0 109.943 -179.75 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -114.27 -46.62 2.97 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.541 -0.754 . . . . 10.0 109.716 161.019 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 -144.37 147.91 34.02 Favored 'General case' 0 C--N 1.339 0.12 0 N-CA-C 108.666 -0.864 . . . . 10.0 108.666 -173.389 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -148.48 56.3 2.52 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 118.721 0.692 . . . . 10.0 112.581 172.181 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -74.89 80.62 2.36 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.121 2.547 . . . . 10.0 109.797 178.523 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.6 m -62.3 157.73 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 123.823 0.849 . . . . 10.0 111.47 176.889 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 75.5 m-80 -92.12 116.92 29.36 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 120.23 -0.588 . . . . 10.0 112.18 -173.841 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -90.34 48.28 1.54 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.431 1.492 . . . . 10.0 111.249 -179.335 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -171.99 -39.01 0.02 OUTLIER 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 123.719 0.808 . . . . 10.0 110.579 165.272 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 16.4 mt -77.4 -15.03 59.57 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.794 0.838 . . . . 10.0 111.964 -167.666 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 65.52 47.25 2.28 Favored 'General case' 0 C--O 1.227 -0.081 0 C-N-CA 125.353 1.461 . . . . 10.0 109.824 -179.161 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 17.0 p -140.69 130.84 24.84 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 107.976 -1.12 . . . . 10.0 107.976 176.969 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.8 t -95.81 137.55 23.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 107.021 -1.474 . . . . 10.0 107.021 171.605 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 86.1 m -129.7 115.06 16.78 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 106.357 -1.72 . . . . 10.0 106.357 -174.776 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 32.3 t -115.69 144.05 24.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 C-N-CA 123.379 0.672 . . . . 10.0 109.799 -178.141 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -114.79 107.68 15.76 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 125.499 1.52 . . . . 10.0 107.873 164.836 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -149.13 164.18 35.45 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.736 -0.468 . . . . 10.0 109.736 -178.653 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -94.05 131.31 31.94 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 116.25 -0.432 . . . . 10.0 110.172 175.264 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -77.1 62.17 7.42 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.199 1.933 . . . . 10.0 109.488 169.336 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.83 -48.91 1.13 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.649 0.78 . . . . 10.0 108.994 174.685 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.29 -29.29 18.22 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 122.991 0.516 . . . . 10.0 111.841 -171.766 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.67 169.91 23.62 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.984 1.714 . . . . 10.0 106.82 -169.648 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 59.9 p -135.6 169.88 16.83 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 122.445 1.116 . . . . 10.0 112.649 -178.305 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 35.4 m -48.52 -40.87 11.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 125.189 1.395 . . . . 10.0 111.508 170.997 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 49.8 m -66.57 -35.87 81.26 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 123.509 0.723 . . . . 10.0 111.691 -179.746 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -70.2 -53.05 18.77 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 107.722 -1.214 . . . . 10.0 107.722 179.26 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.7 pp -65.87 -35.82 81.71 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 122.001 -0.437 . . . . 10.0 111.819 -173.317 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.7 ttpp -39.44 -54.63 1.9 Allowed 'General case' 0 C--N 1.341 0.222 0 O-C-N 121.216 -0.928 . . . . 10.0 112.559 159.952 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -54.42 -33.8 60.14 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 121.51 0.671 . . . . 10.0 110.54 -174.239 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.25 -52.33 66.05 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 121.778 0.799 . . . . 10.0 108.86 179.292 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 40.0 t -63.27 -43.11 98.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 115.331 -0.85 . . . . 10.0 110.716 176.617 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -56.88 -51.08 70.47 Favored 'General case' 0 CA--C 1.528 0.114 0 N-CA-C 109.28 -0.637 . . . . 10.0 109.28 -177.201 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -59.32 -35.84 74.55 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.241 1.016 . . . . 10.0 111.77 176.646 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -52.63 -31.21 35.54 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.621 0.769 . . . . 10.0 111.885 171.088 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 119.48 12.92 6.49 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 124.192 0.901 . . . . 10.0 113.124 171.401 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -149.9 161.67 41.83 Favored 'General case' 0 C--O 1.224 -0.245 0 N-CA-C 107.009 -1.478 . . . . 10.0 107.009 179.649 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.8 mttt -104.29 153.7 20.7 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 121.798 0.809 . . . . 10.0 112.002 -165.249 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.1 tp -129.72 145.76 51.52 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 127.298 2.239 . . . . 10.0 107.197 -176.474 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 33.3 mmtt -145.76 151.72 38.42 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 108.379 -0.971 . . . . 10.0 108.379 165.065 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 11.7 tp -63.25 156.46 25.4 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 108.419 -0.956 . . . . 10.0 108.419 173.48 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 24.3 ttpt -113.81 -52.85 2.72 Favored 'General case' 0 N--CA 1.437 -1.119 0 C-N-CA 126.433 1.893 . . . . 10.0 107.199 170.994 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 179.82 -78.95 0.06 OUTLIER Glycine 0 C--N 1.336 0.533 0 N-CA-C 109.736 -1.346 . . . . 10.0 109.736 174.486 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -170.6 176.14 4.41 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 107.45 -1.315 . . . . 10.0 107.45 -168.1 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -67.94 165.41 17.81 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.228 0.537 . . . . 10.0 112.37 -178.016 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -69.81 98.81 1.27 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.072 0.549 . . . . 10.0 110.025 170.586 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.0 t -82.64 134.74 35.16 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.213 0.605 . . . . 10.0 110.482 179.827 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 22.7 pt -98.04 -140.32 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 C-N-CA 124.718 1.207 . . . . 10.0 109.668 -177.225 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 76.86 -158.67 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.93 2.092 . . . . 10.0 110.875 179.682 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 153.19 -26.32 0.79 Allowed Glycine 0 CA--C 1.535 1.307 0 CA-C-O 118.705 -1.053 . . . . 10.0 115.164 -178.056 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.252 1.235 0 N-CA-C 106.925 -1.509 . . . . 10.0 106.925 -171.102 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 56.2 t . . . . . 0 N--CA 1.471 0.591 0 N-CA-C 108.631 -0.877 . . . . 10.0 108.631 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.1 p -134.93 164.35 27.81 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.368 1.467 . . . . 10.0 108.384 178.597 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -129.02 145.82 51.16 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 126.364 1.865 . . . . 10.0 109.628 -175.393 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 20.8 mtmt -106.82 92.16 3.97 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.383 1.473 . . . . 10.0 110.282 -165.706 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -97.61 151.67 19.84 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.906 1.682 . . . . 10.0 110.352 -171.822 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -124.43 148.04 47.89 Favored 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 124.24 1.016 . . . . 10.0 109.374 174.765 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -137.7 140.73 40.91 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 124.581 1.176 . . . . 10.0 109.266 -169.773 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -103.37 129.95 50.56 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 125.742 1.617 . . . . 10.0 108.587 -171.661 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.4 mm -110.52 127.16 67.73 Favored 'Isoleucine or valine' 0 C--N 1.34 0.164 0 C-N-CA 123.8 0.84 . . . . 10.0 110.71 -163.711 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -116.31 102.38 9.5 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.805 -0.813 . . . . 10.0 108.805 169.751 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 156.07 -82.6 0.16 Allowed Glycine 0 C--N 1.338 0.649 0 CA-C-O 119.827 -0.43 . . . . 10.0 112.193 167.65 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 13.0 ptt? -163.43 122.01 2.0 Allowed 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.79 -0.448 . . . . 10.0 109.79 -171.288 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.6 t -159.0 56.14 0.42 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.015 0.926 . . . . 10.0 109.497 178.403 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 37.5 t -148.15 51.08 1.02 Allowed 'General case' 0 C--O 1.227 -0.125 0 O-C-N 122.152 -0.343 . . . . 10.0 110.845 -172.347 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 165.55 -114.82 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 127.528 2.331 . . . . 10.0 107.629 173.824 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.86 -37.65 76.19 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 124.183 0.993 . . . . 10.0 109.31 -171.187 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 63.7 m -54.18 -56.91 13.66 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.879 1.671 . . . . 10.0 110.131 177.836 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -51.02 -54.02 28.26 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 121.796 0.808 . . . . 10.0 110.644 177.921 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -56.15 -40.21 73.51 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.25 -0.886 . . . . 10.0 110.908 178.125 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.04 -52.47 65.62 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 107.708 -1.219 . . . . 10.0 107.708 178.657 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.7 mt -46.25 -50.9 4.43 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.435 0 CA-C-O 117.652 -1.166 . . . . 10.0 111.011 -179.51 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -41.56 -57.65 2.18 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 119.147 0.885 . . . . 10.0 111.215 -178.316 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -67.43 -48.07 68.36 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 124.47 1.108 . . . . 10.0 110.566 -179.925 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.1 mmt180 -59.19 -21.7 59.85 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.326 0.861 . . . . 10.0 113.326 179.603 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.1 mt -92.55 -41.12 10.42 Favored 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 126.303 1.841 . . . . 10.0 110.693 171.973 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -52.06 -28.54 17.72 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.703 1.201 . . . . 10.0 110.167 174.6 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -44.81 -44.65 9.6 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 113.72 1.007 . . . . 10.0 113.72 168.411 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 7.3 mm -55.06 128.05 14.68 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 C-N-CA 123.125 0.57 . . . . 10.0 110.573 -179.316 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 20.0 mp0 -65.16 -51.86 58.59 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 122.17 -0.332 . . . . 10.0 111.066 -177.113 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.59 40.41 2.87 Favored Glycine 0 C--N 1.339 0.726 0 O-C-N 120.835 -1.165 . . . . 10.0 111.835 -173.411 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.2 p -99.3 148.64 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 C-N-CA 124.504 1.122 . . . . 10.0 108.571 -176.512 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -111.75 -56.96 2.32 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.1 0.96 . . . . 10.0 108.566 171.67 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -142.55 156.65 45.14 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 109.621 -0.511 . . . . 10.0 109.621 179.437 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -143.36 61.34 9.92 Favored Pre-proline 0 CA--C 1.535 0.4 0 C-N-CA 124.0 0.92 . . . . 10.0 110.721 174.605 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -78.68 71.54 6.86 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 122.76 2.306 . . . . 10.0 109.332 -176.724 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.6 m -64.09 153.51 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 O-C-N 121.728 -0.608 . . . . 10.0 111.002 -178.906 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 -88.23 140.71 29.2 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 120.577 -0.449 . . . . 10.0 110.532 177.256 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -114.89 39.25 2.92 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.277 1.431 . . . . 10.0 111.034 -173.376 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -173.17 -40.94 0.01 OUTLIER 'General case' 0 C--O 1.226 -0.135 0 C-N-CA 124.907 1.283 . . . . 10.0 110.339 178.529 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.5 mt -74.9 -19.43 60.15 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.98 0.912 . . . . 10.0 111.56 -172.434 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 64.44 52.43 1.83 Allowed 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 125.704 1.602 . . . . 10.0 110.343 -178.477 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.8 p -143.94 130.36 19.93 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 125.51 1.524 . . . . 10.0 107.476 175.14 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.9 t -100.47 148.59 6.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 106.829 -1.545 . . . . 10.0 106.829 173.323 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 59.0 m -136.55 126.53 25.97 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 106.403 -1.702 . . . . 10.0 106.403 -176.029 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.4 t -131.83 122.93 50.6 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 CA-C-N 118.48 0.582 . . . . 10.0 111.13 -179.538 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.0 mp0 -89.24 98.17 11.62 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 106.538 -1.652 . . . . 10.0 106.538 165.579 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -141.51 161.77 37.1 Favored 'General case' 0 CA--C 1.516 -0.332 0 C-N-CA 122.979 0.512 . . . . 10.0 110.089 175.661 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 31.3 p30 -92.14 136.26 26.08 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.238 -0.437 . . . . 10.0 110.556 178.439 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -79.85 53.0 4.54 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 121.234 1.289 . . . . 10.0 109.229 170.42 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.84 1.16 2.75 Favored 'General case' 0 C--N 1.347 0.49 0 CA-C-N 118.722 0.692 . . . . 10.0 112.801 177.94 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -138.28 -53.03 0.61 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.374 1.07 . . . . 10.0 108.502 -168.02 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -125.2 -176.41 3.56 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.01 1.324 . . . . 10.0 109.401 173.873 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 85.8 p -135.34 171.44 14.43 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.219 1.008 . . . . 10.0 110.875 174.495 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 77.8 t -48.39 -50.38 12.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 123.45 0.7 . . . . 10.0 110.533 166.787 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 72.2 m -59.78 -33.13 71.3 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.382 0.673 . . . . 10.0 111.526 -178.208 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -70.87 -59.55 2.73 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 108.607 -0.886 . . . . 10.0 108.607 175.482 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.0 pp -61.65 -47.04 87.17 Favored 'General case' 0 N--CA 1.452 -0.374 0 O-C-N 121.607 -0.683 . . . . 10.0 112.058 -170.579 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.3 -29.92 6.68 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 114.588 1.329 . . . . 10.0 114.588 170.428 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.61 -36.29 69.26 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 120.185 1.357 . . . . 10.0 109.993 177.586 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.29 -50.15 75.09 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.595 -0.52 . . . . 10.0 109.595 179.566 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 53.2 t -62.28 -50.17 81.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 123.34 0.656 . . . . 10.0 111.732 175.12 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -53.1 -40.77 64.38 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.684 0.794 . . . . 10.0 109.915 179.906 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.3 tptm -74.01 -38.6 64.02 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 124.498 1.119 . . . . 10.0 110.44 -178.41 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 34.3 mt -54.69 -41.46 70.25 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.278 0.49 . . . . 10.0 111.186 166.849 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 151.24 -51.19 0.52 Allowed Glycine 0 CA--C 1.525 0.68 0 CA-C-N 118.567 0.621 . . . . 10.0 112.445 166.755 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -76.07 157.22 33.18 Favored 'General case' 0 C--O 1.224 -0.25 0 N-CA-C 108.811 -0.811 . . . . 10.0 108.811 177.153 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 31.8 mtpt -103.02 157.75 16.77 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.352 0.596 . . . . 10.0 111.0 -172.663 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 34.2 tp -134.26 147.41 50.65 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.749 1.619 . . . . 10.0 108.419 -174.839 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 10.5 mmtp -152.46 156.01 38.62 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.771 1.628 . . . . 10.0 107.903 174.088 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.8 tp -66.5 159.05 28.07 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 109.771 -0.455 . . . . 10.0 109.771 176.029 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 6.0 tttp -113.76 -57.25 2.31 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 125.458 1.503 . . . . 10.0 108.409 169.651 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -172.72 -79.69 0.05 OUTLIER Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.273 -1.131 . . . . 10.0 110.273 179.962 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -166.61 174.96 8.32 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.378 1.071 . . . . 10.0 108.435 -176.226 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.81 123.11 4.8 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 124.296 0.998 . . . . 10.0 111.364 171.231 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -122.9 149.21 44.52 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 107.759 -1.2 . . . . 10.0 107.759 160.212 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.6 t -141.67 141.03 33.36 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 107.022 -1.473 . . . . 10.0 107.022 175.527 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.5 mt 67.8 7.2 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 C-N-CA 124.067 0.947 . . . . 10.0 111.068 -177.361 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 58.1 63.63 1.71 Allowed 'General case' 0 C--N 1.343 0.298 0 C-N-CA 125.38 1.472 . . . . 10.0 108.822 -178.734 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -164.67 -83.95 0.05 OUTLIER Glycine 0 CA--C 1.526 0.75 0 CA-C-O 119.231 -0.761 . . . . 10.0 113.638 -172.435 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 6.1 mtp85 . . . . . 0 C--O 1.252 1.204 0 C-N-CA 126.769 2.028 . . . . 10.0 105.886 -167.548 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 98.8 t . . . . . 0 N--CA 1.471 0.594 0 N-CA-C 107.556 -1.275 . . . . 10.0 107.556 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.5 p -126.21 162.57 25.12 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.883 1.673 . . . . 10.0 108.407 -178.848 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -134.85 136.53 42.52 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 126.101 1.76 . . . . 10.0 108.03 -170.228 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -102.86 113.63 27.23 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.005 0.922 . . . . 10.0 111.625 -168.415 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -115.64 149.95 37.5 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 127.306 2.243 . . . . 10.0 109.215 -172.32 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -124.24 146.97 48.41 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.493 1.117 . . . . 10.0 108.872 174.086 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -140.57 137.61 33.84 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 124.889 1.368 . . . . 10.0 110.467 -168.168 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.403 ' OD2' ' NZ ' ' A' ' 71' ' ' LYS . 1.2 m-20 -91.27 133.67 35.21 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 126.011 1.724 . . . . 10.0 109.421 -175.915 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.3 mm -113.1 134.38 55.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 125.611 1.565 . . . . 10.0 110.491 -173.959 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -126.89 103.41 7.48 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.059 0.943 . . . . 10.0 108.645 171.252 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 116.48 39.87 0.83 Allowed Glycine 0 CA--C 1.531 1.091 0 C-N-CA 123.833 0.73 . . . . 10.0 114.017 167.934 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -98.09 177.03 5.54 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.746 1.218 . . . . 10.0 110.996 -179.363 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 41.0 p -113.77 -7.16 13.27 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 123.763 0.825 . . . . 10.0 112.365 172.793 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 23.6 m 57.55 44.65 20.7 Favored 'General case' 0 C--N 1.342 0.242 0 C-N-CA 124.037 0.935 . . . . 10.0 110.69 178.19 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -162.23 -94.58 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.879 -0.786 . . . . 10.0 108.879 176.758 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.23 -38.27 43.4 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 109.134 -0.691 . . . . 10.0 109.134 -173.421 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 23.2 m -59.59 -54.78 42.54 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 109.488 -0.56 . . . . 10.0 109.488 175.226 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -48.28 -50.18 30.86 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.383 1.073 . . . . 10.0 110.567 172.742 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -59.09 -42.19 89.84 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 121.312 -0.868 . . . . 10.0 112.422 177.971 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.29 -45.96 79.96 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.085 0.954 . . . . 10.0 108.931 179.305 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.0 mt -43.7 -52.48 1.25 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.346 0 CA-C-O 118.362 -0.827 . . . . 10.0 110.532 175.572 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -48.0 -49.02 32.25 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 118.531 0.605 . . . . 10.0 110.873 -177.23 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.61 -47.69 58.85 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 121.627 -0.671 . . . . 10.0 110.533 -179.677 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -54.63 -33.8 61.11 Favored 'General case' 0 C--O 1.225 -0.235 0 C-N-CA 124.008 0.923 . . . . 10.0 112.181 178.305 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.99 -33.63 17.13 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 125.621 1.569 . . . . 10.0 111.392 177.605 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -60.06 -27.17 66.73 Favored 'General case' 0 C--O 1.225 -0.202 0 O-C-N 121.486 -0.759 . . . . 10.0 110.258 174.4 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.2 mmpt? -53.68 -34.26 58.13 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 113.736 1.013 . . . . 10.0 113.736 168.847 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 12.5 mm -56.4 127.92 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 119.126 0.875 . . . . 10.0 109.504 177.354 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -63.59 -56.93 12.07 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.515 -0.311 . . . . 10.0 110.486 -175.836 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.54 49.83 3.72 Favored Glycine 0 C--N 1.341 0.845 0 O-C-N 120.692 -1.255 . . . . 10.0 110.919 -173.042 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -105.71 146.06 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 C-N-CA 124.296 1.039 . . . . 10.0 108.244 -178.151 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -102.17 -52.22 3.2 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 108.375 -0.972 . . . . 10.0 108.375 176.004 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.0 p30 -160.23 149.37 17.41 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.449 -0.945 . . . . 10.0 108.449 -174.905 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -136.26 59.2 25.38 Favored Pre-proline 0 CA--C 1.536 0.424 0 C-N-CA 124.186 0.994 . . . . 10.0 111.54 178.077 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -77.0 74.84 4.82 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.031 2.487 . . . . 10.0 109.626 -178.964 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.0 m -65.28 158.42 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 C-N-CA 123.402 0.681 . . . . 10.0 111.428 179.988 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -96.35 121.71 38.44 Favored 'General case' 0 C--N 1.339 0.136 0 CA-C-O 120.83 0.347 . . . . 10.0 111.71 -176.861 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -96.15 50.16 1.16 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.303 1.441 . . . . 10.0 111.231 179.785 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -175.0 -40.72 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.228 0 C-N-CA 124.162 0.985 . . . . 10.0 109.928 172.533 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.1 mt -81.79 -11.6 58.91 Favored 'General case' 0 C--O 1.226 -0.146 0 C-N-CA 124.294 1.038 . . . . 10.0 112.214 -167.74 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 71.77 36.13 1.27 Allowed 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 125.403 1.481 . . . . 10.0 110.897 173.296 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.8 p -138.95 131.04 28.04 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.019 1.328 . . . . 10.0 108.312 -178.096 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 18.9 t -91.52 149.14 4.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 107.112 -1.44 . . . . 10.0 107.112 167.746 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 68.4 m -137.12 124.3 21.72 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 105.667 -1.975 . . . . 10.0 105.667 -179.553 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 47.9 t -135.98 138.44 47.46 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 CA-C-N 118.454 0.57 . . . . 10.0 109.712 179.278 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -101.95 112.71 25.44 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 107.226 -1.398 . . . . 10.0 107.226 165.145 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -146.99 165.92 28.38 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 123.361 0.664 . . . . 10.0 109.34 179.295 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 31.0 p30 -95.71 128.16 38.8 Favored Pre-proline 0 C--N 1.328 -0.341 0 N-CA-C 110.508 -0.182 . . . . 10.0 110.508 178.494 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -75.65 61.51 6.18 Favored 'Trans proline' 0 N--CA 1.45 -1.032 0 N-CA-C 108.507 -1.382 . . . . 10.0 108.507 169.205 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.31 -44.51 0.37 Allowed 'General case' 0 C--N 1.343 0.295 0 O-C-N 122.122 -0.361 . . . . 10.0 110.379 177.523 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -90.49 -36.61 14.41 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 122.378 0.271 . . . . 10.0 110.333 178.637 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -137.36 -175.58 4.11 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.542 1.137 . . . . 10.0 110.066 -179.707 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 91.5 p -147.05 172.44 13.74 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.295 0.638 . . . . 10.0 111.49 179.872 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 92.0 t -48.79 -45.4 15.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 124.051 0.94 . . . . 10.0 111.081 171.12 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.5 m -60.54 -37.22 80.51 Favored 'General case' 0 C--O 1.234 0.259 0 O-C-N 121.976 -0.452 . . . . 10.0 112.154 -179.689 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -65.71 -60.1 3.24 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 108.091 -1.078 . . . . 10.0 108.091 179.816 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.1 pp -63.48 -40.03 96.02 Favored 'General case' 0 N--CA 1.454 -0.24 0 O-C-N 121.55 -0.719 . . . . 10.0 111.477 -175.774 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.8 ttpp -39.16 -59.14 1.05 Allowed 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 117.627 -1.178 . . . . 10.0 111.004 162.653 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -47.85 -37.84 14.75 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-O 122.064 0.935 . . . . 10.0 110.755 -174.797 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.28 -49.76 76.61 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.041 -0.981 . . . . 10.0 109.784 -178.114 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 77.0 t -68.34 -45.65 82.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 124.536 1.134 . . . . 10.0 111.748 175.487 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -46.18 -44.67 16.2 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 126.576 1.95 . . . . 10.0 108.349 176.11 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -80.63 -34.63 34.84 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.238 1.415 . . . . 10.0 111.349 -176.887 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 18.7 mt -51.97 -43.43 63.56 Favored 'General case' 0 C--N 1.34 0.196 0 CA-C-N 118.871 0.759 . . . . 10.0 111.869 169.033 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 150.81 -35.18 0.93 Allowed Glycine 0 CA--C 1.525 0.666 0 C-N-CA 121.277 -0.487 . . . . 10.0 113.057 172.717 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -99.63 159.13 15.27 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.687 1.195 . . . . 10.0 107.888 -178.52 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.3 ttpt -94.8 155.16 16.93 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.194 0.521 . . . . 10.0 109.871 -176.984 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 24.8 tp -124.9 149.85 47.13 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 126.439 1.896 . . . . 10.0 107.528 179.756 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 34.0 mmtt -149.18 156.88 42.82 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 124.803 1.241 . . . . 10.0 108.332 162.905 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.7 tp -66.09 158.79 27.59 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 109.083 -0.71 . . . . 10.0 109.083 173.963 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.403 ' NZ ' ' OD2' ' A' ' 8' ' ' ASP . 0.0 OUTLIER -113.56 -56.45 2.4 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 125.551 1.54 . . . . 10.0 107.159 166.461 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -176.35 -83.01 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 109.609 -1.396 . . . . 10.0 109.609 179.13 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -168.9 173.49 7.01 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.544 0.738 . . . . 10.0 109.379 -167.923 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.4 pp0? -58.81 109.26 0.78 Allowed 'General case' 0 CA--C 1.534 0.341 0 O-C-N 124.567 1.167 . . . . 10.0 111.823 -174.979 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -82.43 95.91 7.82 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 108.551 -0.907 . . . . 10.0 108.551 179.052 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.7 t -154.55 163.65 39.89 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 108.837 -0.801 . . . . 10.0 108.837 170.093 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.1 pt -128.19 90.96 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 125.35 1.46 . . . . 10.0 109.755 177.287 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -121.43 138.87 54.09 Favored 'General case' 0 CA--C 1.527 0.095 0 N-CA-C 108.044 -1.095 . . . . 10.0 108.044 175.697 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -171.76 -174.06 39.05 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 109.752 -1.339 . . . . 10.0 109.752 -175.034 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.255 1.348 0 C-N-CA 125.488 1.515 . . . . 10.0 107.49 -177.889 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 60.1 t . . . . . 0 N--CA 1.469 0.505 0 N-CA-C 107.162 -1.421 . . . . 10.0 107.162 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.0 p -96.76 171.21 8.66 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.768 1.227 . . . . 10.0 111.02 175.958 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -136.57 151.67 49.63 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 128.434 2.694 . . . . 10.0 107.8 179.548 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 17.0 mmtt -96.86 118.13 32.61 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 108.491 -0.929 . . . . 10.0 108.491 175.796 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -113.68 138.54 50.07 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 124.253 1.021 . . . . 10.0 109.749 172.5 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -113.82 145.79 40.91 Favored 'General case' 0 CA--C 1.51 -0.591 0 C-N-CA 124.589 1.156 . . . . 10.0 110.246 174.97 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -139.17 142.52 37.96 Favored 'General case' 0 N--CA 1.448 -0.575 0 O-C-N 125.036 1.46 . . . . 10.0 110.056 -177.077 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -103.59 134.38 47.02 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 125.882 1.673 . . . . 10.0 108.604 -174.371 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.3 mm -109.58 125.25 66.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 C-N-CA 123.711 0.804 . . . . 10.0 110.422 -162.886 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -119.22 108.46 14.67 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.476 -0.935 . . . . 10.0 108.476 173.005 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 148.86 -87.34 0.15 Allowed Glycine 0 C--N 1.337 0.598 0 N-CA-C 111.511 -0.636 . . . . 10.0 111.511 170.196 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.4 mmt -81.18 159.88 24.5 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 122.675 0.39 . . . . 10.0 110.127 178.483 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 m -59.7 -88.31 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 126.677 1.991 . . . . 10.0 109.562 179.387 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.5 p 146.02 60.08 0.0 OUTLIER 'General case' 0 C--N 1.341 0.232 0 C-N-CA 125.029 1.332 . . . . 10.0 107.882 -159.385 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -153.12 -78.23 0.11 Allowed 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 107.039 -1.467 . . . . 10.0 107.039 172.799 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.65 -50.83 63.55 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 107.109 -1.441 . . . . 10.0 107.109 176.156 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 7.6 t -52.12 -65.86 0.49 Allowed 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 114.071 -1.422 . . . . 10.0 110.462 172.456 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -39.96 -55.04 2.11 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.248 1.019 . . . . 10.0 111.628 177.956 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -52.72 -36.62 57.83 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.961 0.726 . . . . 10.0 112.961 179.122 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.0 ttt180 -84.93 -42.02 15.37 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 126.058 1.743 . . . . 10.0 109.604 -172.653 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 18.4 mm -41.66 -57.05 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.323 0 C-N-CA 124.368 1.067 . . . . 10.0 108.66 166.756 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -42.53 -50.62 5.27 Favored 'General case' 0 C--O 1.221 -0.4 0 O-C-N 123.576 0.548 . . . . 10.0 111.399 179.389 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.7 -49.79 56.13 Favored 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 121.875 -0.516 . . . . 10.0 109.631 -176.289 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.9 mmt85 -57.65 -38.65 75.44 Favored 'General case' 0 C--O 1.226 -0.149 0 O-C-N 121.94 -0.475 . . . . 10.0 112.036 -179.437 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.36 -46.35 41.15 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.194 0.997 . . . . 10.0 110.147 177.396 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 53.0 m-20 -54.95 -24.08 22.12 Favored 'General case' 0 C--O 1.226 -0.135 0 C-N-CA 123.319 0.648 . . . . 10.0 111.503 174.941 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.3 ttmt -56.19 -39.53 72.56 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 118.372 0.533 . . . . 10.0 112.225 175.665 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.7 mp -56.74 135.87 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 C-N-CA 123.873 0.869 . . . . 10.0 110.436 179.09 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 55.9 mp0 -70.78 -49.46 46.33 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 116.274 -0.421 . . . . 10.0 110.091 -174.119 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.22 49.01 4.15 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.973 -0.851 . . . . 10.0 110.973 -177.836 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.4 p -110.74 155.54 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 126.009 1.724 . . . . 10.0 109.073 178.03 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -120.34 -56.78 1.97 Allowed 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 110.235 -0.283 . . . . 10.0 110.235 168.648 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -144.97 149.04 34.48 Favored 'General case' 0 C--O 1.226 -0.172 0 N-CA-C 107.992 -1.114 . . . . 10.0 107.992 -171.484 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -142.85 63.73 13.97 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 118.708 0.685 . . . . 10.0 111.201 172.4 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -76.71 74.32 4.91 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.926 2.417 . . . . 10.0 109.38 178.135 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.4 m -66.02 158.27 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 C-N-CA 123.624 0.77 . . . . 10.0 112.082 179.702 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -90.72 101.69 14.44 Favored 'General case' 0 N--CA 1.46 0.069 0 C-N-CA 120.441 -0.504 . . . . 10.0 111.706 -165.982 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -75.55 42.22 0.21 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.249 1.82 . . . . 10.0 113.938 -173.302 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -177.07 -36.3 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.288 1.435 . . . . 10.0 110.64 176.513 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.2 mt -88.67 0.99 55.88 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.635 1.174 . . . . 10.0 112.667 -169.156 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 58.26 45.5 17.11 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 124.789 1.235 . . . . 10.0 110.402 170.955 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -145.39 129.12 17.22 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.694 -1.224 . . . . 10.0 107.694 -178.124 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.5 t -97.55 126.79 50.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 108.277 -1.008 . . . . 10.0 108.277 175.575 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 84.0 m -113.8 112.26 23.1 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.982 1.713 . . . . 10.0 107.457 178.687 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 41.3 t -106.09 141.59 21.01 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.044 0 CA-C-N 118.359 0.527 . . . . 10.0 110.183 177.49 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -108.12 109.77 21.27 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 125.376 1.47 . . . . 10.0 108.016 160.227 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -143.2 169.57 17.37 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.905 -0.776 . . . . 10.0 108.905 177.288 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 7.3 p-10 -115.46 115.34 42.22 Favored Pre-proline 0 CA--C 1.531 0.238 0 C-N-CA 123.722 0.809 . . . . 10.0 110.021 -178.708 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -74.56 72.1 4.46 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.376 2.717 . . . . 10.0 111.015 -175.832 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.88 -39.16 0.63 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.075 0.55 . . . . 10.0 110.934 168.548 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -86.94 -51.07 6.25 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.193 0.451 . . . . 10.0 110.107 176.756 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -123.76 -175.0 3.11 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.784 1.234 . . . . 10.0 110.742 -171.653 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 83.2 p -144.46 167.94 21.3 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.575 0.75 . . . . 10.0 112.677 177.762 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 23.5 m -47.0 -43.19 6.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 124.57 1.148 . . . . 10.0 111.515 164.312 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 68.3 m -68.78 -40.89 79.42 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 122.782 0.433 . . . . 10.0 110.731 -177.095 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -57.78 -59.48 5.15 Favored 'General case' 0 N--CA 1.455 -0.199 0 O-C-N 123.916 0.76 . . . . 10.0 109.297 176.396 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.2 pp -65.05 -39.38 93.23 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 122.165 -0.334 . . . . 10.0 110.933 -171.536 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -43.46 -45.64 6.44 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 118.254 -0.879 . . . . 10.0 113.194 163.812 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -59.92 -40.56 89.25 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 120.236 1.38 . . . . 10.0 111.024 179.802 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -55.44 -49.41 72.49 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 122.106 -0.371 . . . . 10.0 110.104 178.366 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 24.8 t -66.08 -43.44 92.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 N-CA-C 112.815 0.672 . . . . 10.0 112.815 176.207 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -53.19 -44.0 67.59 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.841 0.829 . . . . 10.0 109.081 177.841 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.0 tttp -80.21 -30.59 38.69 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 124.722 1.209 . . . . 10.0 111.591 -175.246 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 15.1 mt -51.38 -35.49 39.01 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.407 1.003 . . . . 10.0 111.507 162.36 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 115.78 28.35 2.73 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 123.041 0.353 . . . . 10.0 112.822 169.066 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -145.67 158.24 43.87 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 107.251 -1.388 . . . . 10.0 107.251 168.443 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.24 130.96 37.82 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.69 -0.485 . . . . 10.0 109.69 -166.146 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 12.1 tp -114.9 146.98 40.55 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 106.265 -1.754 . . . . 10.0 106.265 173.261 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 17.6 tptt -153.09 150.14 28.82 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 109.053 -0.721 . . . . 10.0 109.053 168.458 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.9 tp -62.39 156.6 22.09 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 109.316 -0.624 . . . . 10.0 109.316 178.04 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 42.1 tttt -117.22 -64.24 1.33 Allowed 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 126.326 1.85 . . . . 10.0 107.742 178.905 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 154.06 50.71 0.01 OUTLIER Glycine 0 CA--C 1.527 0.8 0 CA-C-O 119.661 -0.522 . . . . 10.0 112.337 174.967 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 66.99 160.03 0.15 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.267 1.427 . . . . 10.0 111.989 175.014 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -80.26 -41.46 24.99 Favored 'General case' 0 CA--C 1.529 0.165 0 O-C-N 121.609 -0.682 . . . . 10.0 110.268 172.786 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 39.9 t0 53.99 64.19 1.92 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.318 1.447 . . . . 10.0 110.759 -171.304 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 17.3 m -128.75 41.9 3.41 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.753 1.221 . . . . 10.0 110.008 -177.058 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 15.9 mm -103.86 -135.98 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 N-CA-C 108.177 -1.045 . . . . 10.0 108.177 -179.908 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -159.22 177.5 10.98 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.83 2.052 . . . . 10.0 106.37 -178.533 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -80.46 -157.26 14.91 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 123.454 0.55 . . . . 10.0 111.979 179.366 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 . . . . . 0 C--O 1.249 1.078 0 N-CA-C 106.954 -1.499 . . . . 10.0 106.954 159.653 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 2.7 p . . . . . 0 N--CA 1.474 0.751 0 N-CA-C 109.931 -0.396 . . . . 10.0 109.931 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.8 p -133.36 173.94 10.93 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.844 1.658 . . . . 10.0 107.195 176.041 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -138.39 142.81 39.6 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 129.12 2.968 . . . . 10.0 106.989 -174.227 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 28.9 tttt -111.32 98.69 7.67 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.373 1.069 . . . . 10.0 110.09 -171.504 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -99.92 150.15 22.69 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.834 -1.075 . . . . 10.0 108.844 -175.641 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -122.36 150.17 42.77 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 123.221 0.608 . . . . 10.0 109.919 172.286 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -138.26 137.14 37.2 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 125.452 1.72 . . . . 10.0 108.335 -169.477 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -99.45 139.64 34.81 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 106.328 -1.731 . . . . 10.0 106.328 178.874 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.0 mm -114.32 141.39 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 C-N-CA 124.995 1.318 . . . . 10.0 109.913 -162.779 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -130.82 102.52 6.11 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 108.155 -1.054 . . . . 10.0 108.155 176.702 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 110.59 18.17 8.69 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 123.97 0.795 . . . . 10.0 114.018 170.043 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 28.3 ptm -79.85 165.35 22.8 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 118.724 1.262 . . . . 10.0 109.533 168.149 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 30.0 m -87.56 -59.31 2.28 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 126.147 1.779 . . . . 10.0 107.842 179.946 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 13.5 p 162.66 -121.23 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 128.187 2.595 . . . . 10.0 104.159 -177.51 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.36 -40.1 96.33 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.604 1.161 . . . . 10.0 112.704 -174.042 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.83 -44.09 97.06 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.207 -1.034 . . . . 10.0 108.207 -173.214 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 3.6 m -65.33 -55.73 16.58 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 114.996 -1.002 . . . . 10.0 109.951 177.554 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -41.55 -47.92 3.87 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.733 1.213 . . . . 10.0 111.883 176.282 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -54.89 -38.75 67.95 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.392 -0.367 . . . . 10.0 111.274 179.677 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.92 -42.04 41.0 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 118.306 -0.854 . . . . 10.0 111.033 176.202 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 27.2 mm -43.15 -55.1 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.411 0 CA-C-N 118.65 0.659 . . . . 10.0 109.573 174.028 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -43.17 -57.41 2.96 Favored 'General case' 0 C--O 1.222 -0.377 0 C-N-CA 123.244 0.618 . . . . 10.0 111.607 -179.48 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.06 -41.88 63.68 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.392 1.077 . . . . 10.0 109.794 -170.601 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 25.6 tpt180 -53.81 -45.65 70.86 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.328 0.651 . . . . 10.0 109.958 175.358 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.03 -37.72 64.25 Favored 'General case' 0 C--O 1.224 -0.284 0 C-N-CA 123.2 0.6 . . . . 10.0 111.858 176.046 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -51.98 -32.39 33.36 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 123.723 0.809 . . . . 10.0 109.788 175.317 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.7 -33.42 70.16 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.947 1.091 . . . . 10.0 113.947 175.478 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 17.0 mm -57.48 133.21 22.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 108.314 -0.995 . . . . 10.0 108.314 177.465 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -80.29 -41.88 24.12 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 118.486 0.585 . . . . 10.0 110.757 -172.039 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -78.91 39.92 2.05 Favored Glycine 0 C--N 1.339 0.738 0 O-C-N 120.117 -1.614 . . . . 10.0 112.491 176.1 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.4 p -105.68 148.22 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 C-N-CA 124.179 0.991 . . . . 10.0 108.363 -176.594 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -115.54 -56.36 2.35 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.92 -0.77 . . . . 10.0 108.92 174.876 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 64.2 m-80 -147.32 152.76 38.77 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 109.264 -0.643 . . . . 10.0 109.264 -178.546 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -134.81 65.85 67.26 Favored Pre-proline 0 CA--C 1.534 0.341 0 C-N-CA 123.639 0.776 . . . . 10.0 110.015 173.667 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -78.92 67.33 8.57 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.825 2.35 . . . . 10.0 109.078 -178.946 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.0 m -69.59 157.58 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 C-N-CA 122.889 0.476 . . . . 10.0 111.339 -175.89 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -91.51 126.36 36.57 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 121.276 0.56 . . . . 10.0 110.82 -178.675 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -99.61 33.07 2.61 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.962 1.705 . . . . 10.0 112.015 -168.522 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -171.12 -40.71 0.02 OUTLIER 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 124.542 1.137 . . . . 10.0 110.661 179.986 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.1 mt -72.57 -20.06 61.38 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.089 0.956 . . . . 10.0 111.477 -173.31 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 65.17 51.59 1.62 Allowed 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 125.664 1.586 . . . . 10.0 110.424 -178.018 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.1 p -140.1 124.37 17.82 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 125.457 1.503 . . . . 10.0 107.066 173.606 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.9 t -97.2 135.3 31.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 107.773 -1.195 . . . . 10.0 107.773 175.581 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.6 m -120.85 127.84 52.28 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 126.161 1.785 . . . . 10.0 107.418 178.708 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 36.6 t -131.9 128.18 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.123 0 CA-C-N 118.678 0.672 . . . . 10.0 110.093 178.94 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -93.13 102.11 14.41 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 105.314 -2.106 . . . . 10.0 105.314 165.968 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -135.7 176.78 8.37 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.536 1.134 . . . . 10.0 108.612 178.812 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 27.7 p30 -116.96 135.78 23.12 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 118.879 0.763 . . . . 10.0 110.986 175.682 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -79.7 56.84 6.22 Favored 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 121.435 1.424 . . . . 10.0 108.85 167.307 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.8 ptpt -123.88 -39.51 2.38 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 118.133 0.424 . . . . 10.0 111.344 172.828 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -97.99 -61.68 1.35 Allowed 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 107.425 -1.324 . . . . 10.0 107.425 177.48 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -105.62 -174.96 2.66 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 125.047 1.339 . . . . 10.0 111.102 -171.718 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 87.7 p -144.68 164.9 29.59 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 121.673 0.749 . . . . 10.0 109.985 173.692 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.2 m -52.58 -37.47 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 C-N-CA 124.384 1.073 . . . . 10.0 111.154 172.228 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.2 t -62.72 -40.45 97.24 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 122.47 0.308 . . . . 10.0 110.708 177.058 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -65.67 -52.79 48.81 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.891 -0.781 . . . . 10.0 108.891 -175.97 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.0 pp -64.77 -42.47 95.08 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 121.762 -0.586 . . . . 10.0 111.218 -178.482 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -41.54 -55.22 2.94 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-O 117.737 -1.125 . . . . 10.0 111.751 162.345 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 -56.58 -48.28 77.73 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 119.939 1.245 . . . . 10.0 110.353 178.669 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -51.29 -45.31 62.1 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 109.59 -0.522 . . . . 10.0 109.59 -178.665 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 99.5 t -69.39 -46.98 75.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 112.401 0.519 . . . . 10.0 112.401 174.017 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.518 ' CG ' ' HZ2' ' A' ' 67' ' ' LYS . 2.0 t0 -45.59 -42.35 11.04 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.482 1.513 . . . . 10.0 109.522 177.556 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -79.96 -26.2 40.09 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 125.104 1.362 . . . . 10.0 111.329 -173.879 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 67.9 mt -55.96 -41.23 74.39 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 119.489 1.041 . . . . 10.0 110.91 164.559 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 149.03 -40.79 0.88 Allowed Glycine 0 CA--C 1.526 0.755 0 CA-C-N 118.088 0.404 . . . . 10.0 112.531 173.227 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -96.02 157.51 15.86 Favored 'General case' 0 C--N 1.334 -0.099 0 C-N-CA 124.204 1.002 . . . . 10.0 109.351 -177.749 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.518 ' HZ2' ' CG ' ' A' ' 62' ' ' ASP . 63.5 mmtt -92.12 148.61 22.04 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 121.506 0.67 . . . . 10.0 110.341 -170.426 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 10.5 tp -124.46 148.73 47.47 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.115 1.766 . . . . 10.0 106.608 176.675 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.0 tptm -151.48 145.14 24.99 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 117.956 0.344 . . . . 10.0 110.711 165.478 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.4 tt -64.9 159.41 22.81 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-O 121.462 0.649 . . . . 10.0 109.684 178.36 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 27.5 tttt -127.38 -55.54 1.34 Allowed 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 127.701 2.4 . . . . 10.0 107.829 -175.979 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 176.34 -89.91 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 107.92 -2.072 . . . . 10.0 107.92 177.522 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -167.42 169.31 12.35 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.788 0.835 . . . . 10.0 108.795 -164.295 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -58.84 140.03 55.7 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 123.745 0.653 . . . . 10.0 112.043 -176.034 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -71.12 73.31 0.64 Allowed 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 108.393 -0.966 . . . . 10.0 108.393 167.844 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 11.5 t -152.97 127.29 9.21 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.166 -0.679 . . . . 10.0 109.166 175.878 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.4 pt -129.91 88.45 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 124.946 1.298 . . . . 10.0 109.096 179.702 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -108.68 140.94 41.36 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 107.646 -1.242 . . . . 10.0 107.646 173.986 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -101.93 -137.15 9.53 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 123.966 0.793 . . . . 10.0 111.649 -173.953 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.448 ' HE ' ' C ' ' A' ' 80' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.255 1.346 0 N-CA-C 105.085 -2.191 . . . . 10.0 105.085 170.503 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 8.9 p . . . . . 0 N--CA 1.468 0.426 0 N-CA-C 105.929 -1.878 . . . . 10.0 105.929 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.7 p -92.14 160.19 15.31 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 126.695 1.998 . . . . 10.0 109.786 -178.044 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -125.33 145.35 50.07 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 126.581 1.952 . . . . 10.0 108.273 -169.98 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.8 mmtm -87.15 124.45 33.28 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 124.096 0.959 . . . . 10.0 109.675 -175.166 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -125.35 143.11 51.13 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.16 1.784 . . . . 10.0 109.349 176.95 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -121.31 146.75 46.51 Favored 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 123.518 0.727 . . . . 10.0 109.096 172.881 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -133.39 140.27 47.26 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 125.194 1.559 . . . . 10.0 108.522 -173.443 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -96.99 141.79 29.72 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.687 1.995 . . . . 10.0 107.618 -177.471 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.401 ' CD1' ' H ' ' A' ' 43' ' ' VAL . 3.3 mp -132.41 148.5 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 125.236 1.415 . . . . 10.0 110.531 -167.407 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -133.56 89.93 2.65 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 112.286 -2.234 . . . . 10.0 106.229 175.613 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 154.35 -74.76 0.24 Allowed Glycine 0 C--N 1.341 0.822 0 C-N-CA 119.601 -1.285 . . . . 10.0 113.904 167.779 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.5 103.35 4.1 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 122.697 1.237 . . . . 10.0 111.118 -169.382 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.9 t -135.18 61.15 1.67 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.116 -1.402 . . . . 10.0 108.371 -165.561 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.3 m -146.44 -89.72 0.09 Allowed 'General case' 0 C--N 1.341 0.216 0 N-CA-C 107.78 -1.193 . . . . 10.0 107.78 175.747 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 179.36 -42.96 0.01 OUTLIER 'General case' 0 C--O 1.223 -0.294 0 C-N-CA 124.493 1.117 . . . . 10.0 109.674 -174.682 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.07 -50.93 17.44 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.649 -0.871 . . . . 10.0 108.649 -175.337 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 12.9 m -58.95 -52.43 65.8 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 109.358 -0.608 . . . . 10.0 109.358 177.21 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -44.84 -51.39 9.6 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.894 1.278 . . . . 10.0 111.431 170.862 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -56.87 -34.96 68.37 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 121.198 -0.939 . . . . 10.0 112.334 177.925 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.81 -40.88 89.9 Favored 'General case' 0 N--CA 1.455 -0.219 0 O-C-N 120.904 -1.122 . . . . 10.0 109.301 176.298 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 20.8 mm -54.13 -49.4 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 108.772 -0.825 . . . . 10.0 108.772 -177.945 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -45.8 -56.42 5.37 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.568 0.747 . . . . 10.0 110.967 -179.895 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.8 mtmt -66.29 -44.6 83.06 Favored 'General case' 0 N--CA 1.453 -0.291 0 O-C-N 121.845 -0.534 . . . . 10.0 111.084 179.583 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.0 tpt85 -56.88 -30.74 64.17 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 111.487 0.18 . . . . 10.0 111.487 178.829 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -84.0 -38.34 21.05 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 125.469 1.508 . . . . 10.0 111.46 174.894 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -60.67 -26.75 67.32 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.779 0.832 . . . . 10.0 109.785 178.845 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.0 mmpt? -50.69 -35.88 33.18 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 114.058 1.133 . . . . 10.0 114.058 168.397 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 13.4 mm -62.84 126.89 22.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 118.63 0.65 . . . . 10.0 109.388 -178.784 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -56.19 -57.53 11.81 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.13 0.419 . . . . 10.0 112.13 -179.673 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -82.57 43.9 3.13 Favored Glycine 0 C--N 1.341 0.838 0 O-C-N 120.259 -1.526 . . . . 10.0 111.988 -170.717 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.5 p -108.07 150.03 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 C-N-CA 124.645 1.178 . . . . 10.0 108.643 -176.965 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -106.86 -58.54 1.92 Allowed 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 109.039 -0.726 . . . . 10.0 109.039 171.81 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -144.97 141.31 28.86 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 106.837 -1.542 . . . . 10.0 106.837 -166.732 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -133.83 59.71 40.94 Favored Pre-proline 0 CA--C 1.535 0.388 0 CA-C-N 118.488 0.586 . . . . 10.0 111.719 172.297 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -77.0 82.26 2.4 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 123.248 2.632 . . . . 10.0 109.215 -178.62 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.9 m -71.53 151.44 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 O-C-N 121.746 -0.596 . . . . 10.0 110.705 -177.793 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -86.32 142.58 28.4 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 120.638 -0.425 . . . . 10.0 110.131 177.345 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -120.88 52.98 1.15 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.269 1.427 . . . . 10.0 110.067 -174.979 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -176.0 -42.7 0.01 OUTLIER 'General case' 0 C--O 1.226 -0.158 0 C-N-CA 125.481 1.512 . . . . 10.0 108.698 178.287 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.8 mt -80.13 -20.96 43.73 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.028 0.931 . . . . 10.0 111.459 -172.599 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 59.04 49.74 9.09 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 126.31 1.844 . . . . 10.0 110.129 -172.336 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 20.7 p -134.74 117.35 15.9 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 125.064 1.345 . . . . 10.0 108.631 173.362 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.401 ' H ' ' CD1' ' A' ' 9' ' ' ILE . 14.4 t -85.34 131.33 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 106.282 -1.747 . . . . 10.0 106.282 171.636 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.2 m -110.81 123.88 50.94 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 105.991 -1.855 . . . . 10.0 105.991 172.295 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 33.6 t -121.92 146.24 27.36 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.274 0 N-CA-C 107.961 -1.126 . . . . 10.0 107.961 171.277 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -112.47 113.35 25.48 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 106.303 -1.74 . . . . 10.0 106.303 166.569 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -142.08 156.82 45.41 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.062 0.545 . . . . 10.0 110.715 -177.099 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 19.6 p30 -93.37 126.05 51.9 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 118.813 -0.613 . . . . 10.0 109.47 177.225 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -74.71 63.42 5.72 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 122.401 2.067 . . . . 10.0 108.922 174.717 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.3 tttt -135.33 -57.03 0.8 Allowed 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 105.331 -2.1 . . . . 10.0 105.331 174.662 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -101.38 -51.12 3.56 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 108.638 -0.875 . . . . 10.0 108.638 -177.797 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -81.59 137.72 35.46 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 123.627 0.771 . . . . 10.0 110.717 -176.851 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.6 p -131.38 145.5 51.85 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.417 1.087 . . . . 10.0 110.945 177.112 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 97.0 t -48.39 -48.05 14.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 C-N-CA 125.243 1.417 . . . . 10.0 110.355 174.776 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.01 -43.79 78.06 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 124.914 1.285 . . . . 10.0 111.432 -179.858 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -64.97 -55.86 16.6 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 121.695 0.76 . . . . 10.0 109.3 -177.249 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.2 pp -65.56 -41.62 92.74 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.162 -0.961 . . . . 10.0 111.307 -176.423 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -43.88 -48.61 8.41 Favored 'General case' 0 N--CA 1.451 -0.4 0 O-C-N 121.51 -0.744 . . . . 10.0 112.291 161.701 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.63 -43.17 84.62 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 119.224 0.92 . . . . 10.0 109.695 -179.377 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -49.67 -56.81 8.75 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 122.741 0.417 . . . . 10.0 110.556 177.057 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 47.4 t -58.45 -50.19 79.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 N-CA-C 113.184 0.809 . . . . 10.0 113.184 174.185 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -59.21 -35.74 74.15 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.317 1.047 . . . . 10.0 109.5 -174.132 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.8 tptt -77.4 -43.83 31.33 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 125.301 1.441 . . . . 10.0 110.52 178.083 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 19.4 mt -51.25 -39.01 55.75 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-N 118.938 0.79 . . . . 10.0 111.569 172.358 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 128.8 3.08 5.56 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-O 119.41 -0.661 . . . . 10.0 113.58 169.29 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -99.45 -160.44 0.8 Allowed 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 107.57 -1.27 . . . . 10.0 107.57 175.768 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 35.0 tttt -139.06 149.12 44.23 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 118.458 0.572 . . . . 10.0 111.238 167.638 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.9 tp -135.62 150.84 49.77 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 127.419 2.288 . . . . 10.0 106.475 -176.046 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.7 tptm -149.76 152.89 35.98 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 108.446 -0.946 . . . . 10.0 108.446 163.642 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.6 tp -63.91 157.46 24.76 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 119.341 0.973 . . . . 10.0 108.883 172.338 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 34.5 tttp -117.03 -56.14 2.28 Favored 'General case' 0 N--CA 1.436 -1.152 0 C-N-CA 126.51 1.924 . . . . 10.0 107.783 170.133 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -179.47 -89.25 0.08 OUTLIER Glycine 0 CA--C 1.523 0.535 0 N-CA-C 109.158 -1.577 . . . . 10.0 109.158 -177.864 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -168.84 164.6 11.8 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.865 0.866 . . . . 10.0 109.189 -166.666 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -64.22 116.48 6.03 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.929 1.292 . . . . 10.0 112.476 -173.931 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -72.41 70.39 0.87 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.514 0.726 . . . . 10.0 111.54 -179.193 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 45.8 m -107.03 108.83 20.52 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 125.046 1.339 . . . . 10.0 109.633 176.052 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.5 mp -78.07 -27.58 14.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 123.452 0.701 . . . . 10.0 111.186 176.208 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -76.45 143.62 40.42 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.229 1.012 . . . . 10.0 109.051 176.737 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -133.41 167.57 23.43 Favored Glycine 0 CA--C 1.529 0.906 0 N-CA-C 109.823 -1.311 . . . . 10.0 109.823 176.143 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 59.8 mtt180 . . . . . 0 C--O 1.253 1.285 0 N-CA-C 104.721 -2.326 . . . . 10.0 104.721 172.854 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.441 HG21 ' HB2' ' A' ' 32' ' ' ALA . 5.9 p . . . . . 0 CA--C 1.532 0.271 0 N-CA-C 109.838 -0.431 . . . . 10.0 109.838 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -119.2 139.55 51.67 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 127.045 2.138 . . . . 10.0 109.321 -172.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.9 mtmm -104.87 88.75 2.97 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.844 1.658 . . . . 10.0 110.63 -165.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -104.59 152.35 22.53 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.299 1.44 . . . . 10.0 110.497 -168.063 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -123.54 148.89 45.88 Favored 'General case' 0 CA--C 1.511 -0.545 0 C-N-CA 123.791 0.836 . . . . 10.0 110.199 178.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.755 ' CE2' HD11 ' A' ' 57' ' ' LEU . 3.8 m-85 -138.72 142.3 38.9 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 125.241 1.416 . . . . 10.0 108.205 -175.731 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -108.86 137.41 46.84 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 107.698 -1.223 . . . . 10.0 107.698 -173.38 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 5.1 mm -110.22 124.86 67.33 Favored 'Isoleucine or valine' 0 C--N 1.338 0.096 0 C-N-CA 124.52 1.128 . . . . 10.0 110.715 -159.221 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 . . . . . 0 N--CA 1.45 -0.433 0 N-CA-C 108.942 -0.762 . . . . 10.0 108.942 173.92 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.531 0.236 0 N-CA-C 111.897 0.332 . . . . 10.0 111.897 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.59 -38.26 89.43 Favored 'General case' 0 N--CA 1.446 -0.655 0 O-C-N 121.265 -0.897 . . . . 10.0 110.154 178.727 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.429 HG22 HD12 ' A' ' 25' ' ' LEU . 19.3 mm -41.45 -54.04 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.305 0 C-N-CA 124.349 1.06 . . . . 10.0 111.495 170.5 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -49.56 -50.28 42.89 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-N 118.355 0.525 . . . . 10.0 110.476 -176.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.53 -46.22 67.01 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.787 -0.57 . . . . 10.0 110.187 -178.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.515 ' HG3' HD11 ' A' ' 64' ' ' LEU . 7.6 mmt180 -55.75 -32.27 63.28 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 113.284 0.846 . . . . 10.0 113.284 177.567 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.475 HD21 HD13 ' A' ' 57' ' ' LEU . 0.5 OUTLIER -84.92 -42.58 14.85 Favored 'General case' 0 C--O 1.22 -0.499 0 C-N-CA 123.419 0.688 . . . . 10.0 111.21 172.421 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -60.28 -18.65 50.69 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 120.933 -1.105 . . . . 10.0 111.359 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.1 mmpt? -51.19 -41.03 59.94 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 113.863 1.06 . . . . 10.0 113.863 164.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.686 HD11 ' HB3' ' A' ' 57' ' ' LEU . 10.8 mt -54.5 129.43 15.61 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.068 0 CA-C-N 119.216 0.916 . . . . 10.0 108.909 175.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 58.0 mp0 -66.94 -46.23 75.38 Favored 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 122.132 -0.355 . . . . 10.0 110.129 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.18 43.91 3.2 Favored Glycine 0 C--N 1.339 0.699 0 O-C-N 121.266 -0.896 . . . . 10.0 111.998 -173.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.4 p -103.8 152.47 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 C-N-CA 124.894 1.278 . . . . 10.0 108.811 -176.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.441 ' HB2' HG21 ' A' ' 2' ' ' THR . . . -117.69 -59.75 1.89 Allowed 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.677 -0.861 . . . . 10.0 108.677 168.031 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 -140.13 160.15 40.59 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 109.29 -0.633 . . . . 10.0 109.29 -178.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -149.2 63.72 6.88 Favored Pre-proline 0 CA--C 1.535 0.374 0 C-N-CA 123.191 0.596 . . . . 10.0 110.804 173.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -78.12 75.58 4.78 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.89 2.393 . . . . 10.0 109.698 -176.308 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.498 HG12 HG13 ' A' ' 43' ' ' VAL . 6.3 m -70.98 157.41 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 O-C-N 121.744 -0.597 . . . . 10.0 112.024 -177.427 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -100.93 138.07 38.47 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 110.084 -0.339 . . . . 10.0 110.084 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -120.98 53.66 1.12 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.976 1.31 . . . . 10.0 110.603 -172.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -176.26 -41.31 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 125.727 1.611 . . . . 10.0 108.805 178.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.3 mt -82.24 -15.2 53.94 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.021 1.328 . . . . 10.0 111.44 -172.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 72.91 44.15 0.37 Allowed 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 125.762 1.625 . . . . 10.0 110.377 173.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 39.7 p -140.91 131.71 25.83 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.189 1.396 . . . . 10.0 109.067 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.498 HG13 HG12 ' A' ' 36' ' ' VAL . 4.0 t -99.97 141.94 16.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 107.746 -1.205 . . . . 10.0 107.746 167.442 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 62.5 m -130.12 124.12 31.97 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 106.576 -1.639 . . . . 10.0 106.576 -176.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 16.5 t -126.63 134.54 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 C-N-CA 123.091 0.556 . . . . 10.0 110.681 -175.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -108.98 94.22 4.93 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 127.043 2.137 . . . . 10.0 106.914 171.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -140.14 163.38 32.89 Favored 'General case' 0 CA--C 1.521 -0.15 0 C-N-CA 123.29 0.636 . . . . 10.0 109.46 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -95.92 132.48 27.01 Favored Pre-proline 0 C--N 1.329 -0.306 0 C-N-CA 123.57 0.748 . . . . 10.0 110.186 177.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -78.81 56.43 5.96 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.081 1.854 . . . . 10.0 109.926 171.16 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.0 pttt -118.53 -45.74 2.6 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 108.965 -0.754 . . . . 10.0 108.965 170.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.08 -46.29 5.63 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.2 1.0 . . . . 10.0 110.605 -167.175 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.405 ' CB ' HG23 ' A' ' 28' ' ' ILE . . . -122.92 -171.34 2.27 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.287 1.035 . . . . 10.0 109.6 175.418 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 97.2 p -149.46 170.8 17.76 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.297 0.639 . . . . 10.0 110.466 177.164 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 31.4 m -49.42 -42.11 16.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 123.679 0.792 . . . . 10.0 111.293 172.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 66.9 m -61.23 -42.36 98.47 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 123.454 0.702 . . . . 10.0 111.699 -178.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -62.28 -57.39 11.59 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.265 0.626 . . . . 10.0 109.501 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.755 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.1 pp -65.85 -40.87 92.14 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 121.512 0.672 . . . . 10.0 110.373 -173.134 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.488 ' HA ' HD23 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -44.32 -47.19 9.54 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 112.675 0.62 . . . . 10.0 112.675 163.305 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.11 -44.54 96.43 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-N 119.02 0.827 . . . . 10.0 109.512 178.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -52.12 -47.76 65.16 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 110.382 -0.229 . . . . 10.0 110.382 178.03 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.555 ' HA ' HD12 ' A' ' 64' ' ' LEU . 38.7 t -65.73 -46.17 89.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 N-CA-C 112.776 0.658 . . . . 10.0 112.776 174.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -56.48 -38.67 72.04 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 120.544 -1.347 . . . . 10.0 110.268 178.284 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.2 tptm -66.65 -35.52 80.36 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.051 1.34 . . . . 10.0 109.83 -178.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.555 HD12 ' HA ' ' A' ' 61' ' ' VAL . 26.4 mt -58.65 -30.15 67.09 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 118.98 -0.533 . . . . 10.0 112.068 169.534 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 137.39 -39.79 1.58 Allowed Glycine 0 CA--C 1.527 0.804 0 C-N-CA 123.701 0.667 . . . . 10.0 111.716 171.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.406 ' CE2' HD11 ' A' ' 21' ' ' ILE . 8.1 p90 -97.7 152.44 19.1 Favored 'General case' 0 C--O 1.226 -0.175 0 C-N-CA 125.148 1.379 . . . . 10.0 109.527 -172.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -89.35 153.34 20.94 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.648 0.737 . . . . 10.0 110.849 -170.148 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.537 HD11 ' HB2' ' A' ' 7' ' ' PHE . 29.1 tp -130.3 148.29 52.11 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.233 1.813 . . . . 10.0 107.383 177.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 9.4 tptp -154.7 152.81 30.37 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 108.912 -0.773 . . . . 10.0 108.912 165.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.6 tp -62.46 154.7 27.64 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 109.488 -0.56 . . . . 10.0 109.488 178.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -108.34 -60.94 1.66 Allowed 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 125.462 1.505 . . . . 10.0 106.961 168.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -174.44 -79.4 0.05 OUTLIER Glycine 0 CA--C 1.521 0.455 0 N-CA-C 110.003 -1.239 . . . . 10.0 110.003 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 . . . . . 0 N--CA 1.452 -0.328 0 C-N-CA 124.384 1.074 . . . . 10.0 108.128 -170.664 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.441 HG21 ' HB2' ' A' ' 32' ' ' ALA . 5.9 p . . . . . 0 CA--C 1.532 0.271 0 N-CA-C 109.838 -0.431 . . . . 10.0 109.838 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -119.2 139.55 51.67 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 127.045 2.138 . . . . 10.0 109.321 -172.363 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.9 mtmm -104.87 88.75 2.97 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.844 1.658 . . . . 10.0 110.63 -165.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -104.59 152.35 22.53 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.299 1.44 . . . . 10.0 110.497 -168.063 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -123.54 148.89 45.88 Favored 'General case' 0 CA--C 1.511 -0.545 0 C-N-CA 123.791 0.836 . . . . 10.0 110.199 178.289 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.755 ' CE2' HD11 ' A' ' 57' ' ' LEU . 3.8 m-85 -138.72 142.3 38.9 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 125.241 1.416 . . . . 10.0 108.205 -175.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -108.86 137.41 46.84 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 107.698 -1.223 . . . . 10.0 107.698 -173.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 5.1 mm -110.22 124.86 67.33 Favored 'Isoleucine or valine' 0 C--N 1.338 0.096 0 C-N-CA 124.52 1.128 . . . . 10.0 110.715 -159.221 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 . . . . . 0 N--CA 1.45 -0.433 0 N-CA-C 108.942 -0.762 . . . . 10.0 108.942 173.92 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.531 0.236 0 N-CA-C 111.897 0.332 . . . . 10.0 111.897 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.59 -38.26 89.43 Favored 'General case' 0 N--CA 1.446 -0.655 0 O-C-N 121.265 -0.897 . . . . 10.0 110.154 178.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.429 HG22 HD12 ' A' ' 25' ' ' LEU . 19.3 mm -41.45 -54.04 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.305 0 C-N-CA 124.349 1.06 . . . . 10.0 111.495 170.5 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -49.56 -50.28 42.89 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-N 118.355 0.525 . . . . 10.0 110.476 -176.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.53 -46.22 67.01 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.787 -0.57 . . . . 10.0 110.187 -178.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.515 ' HG3' HD11 ' A' ' 64' ' ' LEU . 7.6 mmt180 -55.75 -32.27 63.28 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 113.284 0.846 . . . . 10.0 113.284 177.567 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.475 HD21 HD13 ' A' ' 57' ' ' LEU . 0.5 OUTLIER -84.92 -42.58 14.85 Favored 'General case' 0 C--O 1.22 -0.499 0 C-N-CA 123.419 0.688 . . . . 10.0 111.21 172.421 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -60.28 -18.65 50.69 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 120.933 -1.105 . . . . 10.0 111.359 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.1 mmpt? -51.19 -41.03 59.94 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 113.863 1.06 . . . . 10.0 113.863 164.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.686 HD11 ' HB3' ' A' ' 57' ' ' LEU . 10.8 mt -54.5 129.43 15.61 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.068 0 CA-C-N 119.216 0.916 . . . . 10.0 108.909 175.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 58.0 mp0 -66.94 -46.23 75.38 Favored 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 122.132 -0.355 . . . . 10.0 110.129 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.18 43.91 3.2 Favored Glycine 0 C--N 1.339 0.699 0 O-C-N 121.266 -0.896 . . . . 10.0 111.998 -173.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.4 p -103.8 152.47 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 C-N-CA 124.894 1.278 . . . . 10.0 108.811 -176.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.441 ' HB2' HG21 ' A' ' 2' ' ' THR . . . -117.69 -59.75 1.89 Allowed 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.677 -0.861 . . . . 10.0 108.677 168.031 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 -140.13 160.15 40.59 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 109.29 -0.633 . . . . 10.0 109.29 -178.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -149.2 63.72 6.88 Favored Pre-proline 0 CA--C 1.535 0.374 0 C-N-CA 123.191 0.596 . . . . 10.0 110.804 173.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -78.12 75.58 4.78 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.89 2.393 . . . . 10.0 109.698 -176.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.498 HG12 HG13 ' A' ' 43' ' ' VAL . 6.3 m -70.98 157.41 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 O-C-N 121.744 -0.597 . . . . 10.0 112.024 -177.427 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -100.93 138.07 38.47 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 110.084 -0.339 . . . . 10.0 110.084 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -120.98 53.66 1.12 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.976 1.31 . . . . 10.0 110.603 -172.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -176.26 -41.31 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 125.727 1.611 . . . . 10.0 108.805 178.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.3 mt -82.24 -15.2 53.94 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.021 1.328 . . . . 10.0 111.44 -172.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 72.91 44.15 0.37 Allowed 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 125.762 1.625 . . . . 10.0 110.377 173.334 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 39.7 p -140.91 131.71 25.83 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.189 1.396 . . . . 10.0 109.067 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.498 HG13 HG12 ' A' ' 36' ' ' VAL . 4.0 t -99.97 141.94 16.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 107.746 -1.205 . . . . 10.0 107.746 167.442 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 62.5 m -130.12 124.12 31.97 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 106.576 -1.639 . . . . 10.0 106.576 -176.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 16.5 t -126.63 134.54 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 C-N-CA 123.091 0.556 . . . . 10.0 110.681 -175.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -108.98 94.22 4.93 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 127.043 2.137 . . . . 10.0 106.914 171.408 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -140.14 163.38 32.89 Favored 'General case' 0 CA--C 1.521 -0.15 0 C-N-CA 123.29 0.636 . . . . 10.0 109.46 179.102 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -95.92 132.48 27.01 Favored Pre-proline 0 C--N 1.329 -0.306 0 C-N-CA 123.57 0.748 . . . . 10.0 110.186 177.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -78.81 56.43 5.96 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.081 1.854 . . . . 10.0 109.926 171.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.0 pttt -118.53 -45.74 2.6 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 108.965 -0.754 . . . . 10.0 108.965 170.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.08 -46.29 5.63 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.2 1.0 . . . . 10.0 110.605 -167.175 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.405 ' CB ' HG23 ' A' ' 28' ' ' ILE . . . -122.92 -171.34 2.27 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.287 1.035 . . . . 10.0 109.6 175.418 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 97.2 p -149.46 170.8 17.76 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.297 0.639 . . . . 10.0 110.466 177.164 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 31.4 m -49.42 -42.11 16.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 123.679 0.792 . . . . 10.0 111.293 172.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 66.9 m -61.23 -42.36 98.47 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 123.454 0.702 . . . . 10.0 111.699 -178.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -62.28 -57.39 11.59 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.265 0.626 . . . . 10.0 109.501 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.755 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.1 pp -65.85 -40.87 92.14 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 121.512 0.672 . . . . 10.0 110.373 -173.134 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.488 ' HA ' HD23 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -44.32 -47.19 9.54 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 112.675 0.62 . . . . 10.0 112.675 163.305 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.11 -44.54 96.43 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-N 119.02 0.827 . . . . 10.0 109.512 178.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -52.12 -47.76 65.16 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 110.382 -0.229 . . . . 10.0 110.382 178.03 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.555 ' HA ' HD12 ' A' ' 64' ' ' LEU . 38.7 t -65.73 -46.17 89.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 N-CA-C 112.776 0.658 . . . . 10.0 112.776 174.711 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -56.48 -38.67 72.04 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 120.544 -1.347 . . . . 10.0 110.268 178.284 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.2 tptm -66.65 -35.52 80.36 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.051 1.34 . . . . 10.0 109.83 -178.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.555 HD12 ' HA ' ' A' ' 61' ' ' VAL . 26.4 mt -58.65 -30.15 67.09 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 118.98 -0.533 . . . . 10.0 112.068 169.534 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 137.39 -39.79 1.58 Allowed Glycine 0 CA--C 1.527 0.804 0 C-N-CA 123.701 0.667 . . . . 10.0 111.716 171.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.406 ' CE2' HD11 ' A' ' 21' ' ' ILE . 8.1 p90 -97.7 152.44 19.1 Favored 'General case' 0 C--O 1.226 -0.175 0 C-N-CA 125.148 1.379 . . . . 10.0 109.527 -172.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -89.35 153.34 20.94 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.648 0.737 . . . . 10.0 110.849 -170.148 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.537 HD11 ' HB2' ' A' ' 7' ' ' PHE . 29.1 tp -130.3 148.29 52.11 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.233 1.813 . . . . 10.0 107.383 177.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 9.4 tptp -154.7 152.81 30.37 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 108.912 -0.773 . . . . 10.0 108.912 165.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.6 tp -62.46 154.7 27.64 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 109.488 -0.56 . . . . 10.0 109.488 178.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -108.34 -60.94 1.66 Allowed 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 125.462 1.505 . . . . 10.0 106.961 168.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -174.44 -79.4 0.05 OUTLIER Glycine 0 CA--C 1.521 0.455 0 N-CA-C 110.003 -1.239 . . . . 10.0 110.003 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 . . . . . 0 N--CA 1.452 -0.328 0 C-N-CA 124.384 1.074 . . . . 10.0 108.128 -170.664 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.458 HG21 ' HB2' ' A' ' 32' ' ' ALA . 1.8 p . . . . . 0 N--CA 1.451 -0.388 0 N-CA-C 107.555 -1.276 . . . . 10.0 107.555 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -121.7 147.69 45.57 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 126.51 1.924 . . . . 10.0 108.143 -166.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -88.69 130.91 35.21 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 107.983 -1.117 . . . . 10.0 107.983 -178.399 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -145.35 135.9 24.27 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.251 -0.648 . . . . 10.0 109.251 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -122.23 149.42 43.69 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 123.449 0.7 . . . . 10.0 111.614 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.784 ' CE2' HD11 ' A' ' 57' ' ' LEU . 13.1 m-85 -136.28 137.97 41.27 Favored 'General case' 0 N--CA 1.451 -0.409 0 O-C-N 125.134 1.521 . . . . 10.0 110.037 -170.545 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -93.9 138.09 32.41 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 106.926 -1.509 . . . . 10.0 106.926 178.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.447 ' CD1' HD12 ' A' ' 68' ' ' LEU . 6.9 mm -109.93 132.39 58.3 Favored 'Isoleucine or valine' 0 C--N 1.34 0.168 0 C-N-CA 125.018 1.327 . . . . 10.0 111.496 -165.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 . . . . . 0 N--CA 1.447 -0.618 0 C-N-CA 124.098 0.959 . . . . 10.0 109.649 176.77 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 33.7 t-20 . . . . . 0 CA--C 1.53 0.178 0 CA-C-O 120.436 0.16 . . . . 10.0 110.976 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 20.7 ttt180 -58.92 -34.8 72.12 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.717 0.807 . . . . 10.0 109.29 -177.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.572 HD12 HG22 ' A' ' 61' ' ' VAL . 14.9 mm -52.04 -41.92 33.25 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.466 0 CA-C-O 117.381 -1.295 . . . . 10.0 111.349 171.559 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 75.0 mt-10 -51.68 -50.11 61.08 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-N 120.78 1.627 . . . . 10.0 110.766 -178.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.2 mtmt -69.64 -45.7 67.87 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.103 0.561 . . . . 10.0 109.789 178.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.479 ' HB3' ' HB1' ' A' ' 60' ' ' ALA . 2.4 mmt180 -62.19 -30.92 71.41 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 120.316 -0.554 . . . . 10.0 112.195 -176.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.4 mt -79.07 -50.34 11.21 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 125.238 1.415 . . . . 10.0 110.369 172.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -48.0 -27.3 2.16 Favored 'General case' 0 C--O 1.226 -0.164 0 C-N-CA 124.297 1.039 . . . . 10.0 111.867 178.06 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -53.06 -47.52 68.39 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 112.337 0.495 . . . . 10.0 112.337 174.518 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.462 HG23 ' HB2' ' A' ' 52' ' ' ALA . 3.1 mp -52.83 131.91 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 C-N-CA 124.838 1.255 . . . . 10.0 110.803 -179.022 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 50.9 mp0 -70.11 -48.05 59.25 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 116.306 -0.406 . . . . 10.0 110.364 -171.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -84.89 39.76 2.97 Favored Glycine 0 CA--C 1.525 0.686 0 O-C-N 121.064 -1.022 . . . . 10.0 111.937 -175.147 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.6 p -99.92 149.57 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 C-N-CA 124.411 1.084 . . . . 10.0 108.313 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.458 ' HB2' HG21 ' A' ' 2' ' ' THR . . . -119.11 -53.69 2.25 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 122.969 0.507 . . . . 10.0 109.819 171.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.1 m-80 -142.6 154.75 44.69 Favored 'General case' 0 C--N 1.339 0.125 0 CA-C-N 118.298 0.499 . . . . 10.0 109.7 -177.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -146.92 62.8 7.77 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 124.101 0.961 . . . . 10.0 111.968 174.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -77.22 73.42 5.5 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.652 2.235 . . . . 10.0 110.048 -178.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.459 HG12 HG13 ' A' ' 43' ' ' VAL . 5.0 m -68.68 155.77 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 O-C-N 121.507 -0.745 . . . . 10.0 111.858 -177.503 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -99.03 131.51 45.02 Favored 'General case' 0 N--CA 1.458 -0.07 0 N-CA-C 110.204 -0.295 . . . . 10.0 110.204 -176.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -115.38 60.86 0.7 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.919 1.288 . . . . 10.0 110.424 -173.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 168.83 -32.63 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 127.118 2.167 . . . . 10.0 108.708 171.372 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.0 mt -86.89 -2.74 58.83 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.071 1.349 . . . . 10.0 112.103 -176.159 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 61.22 43.7 10.66 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 125.303 1.441 . . . . 10.0 111.107 166.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -142.5 129.79 21.05 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.297 1.439 . . . . 10.0 107.983 -176.565 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.459 HG13 HG12 ' A' ' 36' ' ' VAL . 3.4 t -101.49 132.37 47.47 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 N-CA-C 106.509 -1.663 . . . . 10.0 106.509 172.012 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 29.2 m -121.63 121.68 37.93 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 125.587 1.555 . . . . 10.0 106.817 -174.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.2 t -125.03 147.63 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 C-N-CA 123.271 0.628 . . . . 10.0 110.27 -176.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -125.24 95.69 4.57 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 127.723 2.409 . . . . 10.0 104.693 174.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -147.95 163.54 36.53 Favored 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 123.448 0.699 . . . . 10.0 109.568 -174.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 18.8 p30 -95.12 131.61 29.72 Favored Pre-proline 0 C--N 1.329 -0.317 0 C-N-CA 122.67 0.388 . . . . 10.0 110.551 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -78.2 60.82 7.57 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 121.537 1.491 . . . . 10.0 108.414 168.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.35 -45.55 0.46 Allowed 'General case' 0 C--N 1.344 0.343 0 O-C-N 121.859 -0.526 . . . . 10.0 110.554 176.232 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -87.66 -36.81 17.23 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 122.896 0.479 . . . . 10.0 110.442 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.462 ' HB2' HG23 ' A' ' 28' ' ' ILE . . . -137.2 174.88 10.14 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 125.914 1.686 . . . . 10.0 108.275 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 59.5 p -131.66 176.14 8.58 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.503 1.121 . . . . 10.0 110.186 174.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 29.7 m -48.99 -39.18 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-N 115.184 -0.916 . . . . 10.0 111.749 168.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 17.6 m -58.48 -40.6 83.19 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.707 0.803 . . . . 10.0 111.648 -178.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -71.32 -52.19 20.16 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.049 0.939 . . . . 10.0 109.686 -175.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.784 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.3 pp -64.64 -41.87 95.83 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 120.532 -1.355 . . . . 10.0 110.568 179.066 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.413 ' N ' HD12 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -45.81 -49.58 15.01 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-O 117.821 -1.085 . . . . 10.0 113.046 163.225 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -52.99 -46.56 68.36 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 120.712 1.597 . . . . 10.0 109.164 176.101 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.479 ' HB1' ' HB3' ' A' ' 24' ' ' ARG . . . -54.14 -50.04 67.85 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 114.789 -1.096 . . . . 10.0 110.874 -177.031 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.572 HG22 HD12 ' A' ' 21' ' ' ILE . 95.8 t -65.28 -44.73 94.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 112.309 0.485 . . . . 10.0 112.309 173.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -58.79 -47.29 85.26 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 121.107 -0.995 . . . . 10.0 109.952 -175.169 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.4 tmtm? -56.54 -35.6 68.3 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.899 1.28 . . . . 10.0 111.227 175.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.422 HD13 ' HA ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -54.71 -38.8 67.52 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.612 0.765 . . . . 10.0 110.702 173.364 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 135.21 -33.05 2.49 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 124.076 0.846 . . . . 10.0 111.767 175.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -94.12 157.84 15.89 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.954 0.902 . . . . 10.0 109.628 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.1 mtmp? -98.14 154.29 17.85 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.677 0.751 . . . . 10.0 110.989 -175.167 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.447 HD12 ' CD1' ' A' ' 9' ' ' ILE . 13.8 tp -129.22 148.62 51.17 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.555 1.942 . . . . 10.0 107.219 -177.098 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.2 tptm -151.67 148.67 28.21 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 119.27 -0.395 . . . . 10.0 111.089 159.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 11.8 tp -63.73 155.15 30.98 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 121.775 0.797 . . . . 10.0 109.702 178.096 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.5 tttt -119.45 -56.47 2.06 Favored 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 129.282 3.033 . . . . 10.0 107.655 177.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 172.37 -100.07 0.15 Allowed Glycine 0 N--CA 1.442 -0.935 0 N-CA-C 107.152 -2.379 . . . . 10.0 107.152 -176.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 . . . . . 0 N--CA 1.452 -0.327 0 C-N-CA 124.967 1.307 . . . . 10.0 107.94 -165.714 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.502 HG21 ' HB2' ' A' ' 32' ' ' ALA . 19.3 p . . . . . 0 CA--C 1.535 0.382 0 N-CA-C 109.146 -0.687 . . . . 10.0 109.146 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -127.09 135.67 51.08 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 127.524 2.33 . . . . 10.0 108.29 -175.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 58.6 mmtt -83.56 114.56 21.6 Favored 'General case' 0 N--CA 1.448 -0.559 0 O-C-N 124.06 0.85 . . . . 10.0 109.07 171.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -114.98 145.23 42.46 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.807 1.243 . . . . 10.0 109.545 169.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -119.46 150.78 39.65 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.046 0.939 . . . . 10.0 110.639 173.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.741 ' CE2' HD11 ' A' ' 57' ' ' LEU . 6.2 m-85 -140.14 136.68 33.77 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.899 1.28 . . . . 10.0 109.377 -171.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -97.44 134.98 39.97 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 106.981 -1.489 . . . . 10.0 106.981 -177.141 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.2 mm -108.35 142.01 22.1 Favored 'Isoleucine or valine' 0 C--N 1.342 0.259 0 C-N-CA 124.297 1.039 . . . . 10.0 111.192 -165.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 . . . . . 0 CA--C 1.531 0.25 0 C-N-CA 124.032 0.933 . . . . 10.0 109.375 171.596 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 . . . . . 0 CA--C 1.541 0.63 0 N-CA-C 112.511 0.56 . . . . 10.0 112.511 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.82 -40.7 83.78 Favored 'General case' 0 N--CA 1.45 -0.439 0 O-C-N 120.611 -1.306 . . . . 10.0 109.953 176.483 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 8.1 mm -41.17 -57.94 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.39 0 N-CA-C 108.993 -0.743 . . . . 10.0 108.993 170.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -49.44 -45.58 46.74 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.075 0.95 . . . . 10.0 111.931 -172.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.6 mmpt? -71.92 -45.26 61.79 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 123.208 0.603 . . . . 10.0 110.272 179.219 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -62.94 -32.44 73.74 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 120.498 -0.481 . . . . 10.0 111.533 -178.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.4 -39.59 28.07 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.016 1.727 . . . . 10.0 111.668 175.719 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -49.28 -33.56 13.29 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 119.077 0.853 . . . . 10.0 110.468 171.195 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -53.83 -37.58 63.74 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 113.178 0.807 . . . . 10.0 113.178 176.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 22.4 mm -60.87 129.46 23.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 123.458 0.703 . . . . 10.0 109.135 178.149 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -79.64 -37.32 36.29 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 118.623 0.647 . . . . 10.0 111.441 -175.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -77.39 30.24 1.67 Allowed Glycine 0 C--N 1.339 0.718 0 O-C-N 120.391 -1.443 . . . . 10.0 112.619 178.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -102.9 147.22 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 C-N-CA 124.576 1.15 . . . . 10.0 107.96 -176.604 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.502 ' HB2' HG21 ' A' ' 2' ' ' THR . . . -118.19 -47.66 2.56 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 122.661 0.384 . . . . 10.0 110.348 175.519 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -146.48 144.2 29.49 Favored 'General case' 0 C--O 1.226 -0.181 0 N-CA-C 108.308 -0.997 . . . . 10.0 108.308 -173.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -136.23 60.78 35.49 Favored Pre-proline 0 CA--C 1.539 0.522 0 C-N-CA 123.584 0.753 . . . . 10.0 111.978 176.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -76.34 74.69 4.57 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.948 2.432 . . . . 10.0 110.213 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.466 HG12 HG13 ' A' ' 43' ' ' VAL . 4.3 m -69.11 155.49 7.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 123.36 0.664 . . . . 10.0 112.05 -179.09 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -94.92 92.07 6.72 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.035 0.445 . . . . 10.0 110.469 -174.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -71.77 43.3 0.09 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 127.364 2.266 . . . . 10.0 114.141 -175.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -176.86 -36.32 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 126.388 1.875 . . . . 10.0 110.577 177.009 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.6 mt -90.25 3.54 53.26 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 124.519 1.128 . . . . 10.0 112.684 -171.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 64.61 38.31 7.26 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.5 1.12 . . . . 10.0 110.371 165.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -142.22 130.21 21.9 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.278 1.431 . . . . 10.0 107.829 -176.481 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.466 HG13 HG12 ' A' ' 36' ' ' VAL . 11.4 t -100.46 139.03 22.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 107.578 -1.268 . . . . 10.0 107.578 173.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 27.1 m -127.76 119.4 25.67 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 106.803 -1.554 . . . . 10.0 106.803 -177.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 40.1 t -123.3 138.98 51.39 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 N-CA-C 109.201 -0.666 . . . . 10.0 109.201 -178.251 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -100.6 109.08 21.13 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 106.485 -1.672 . . . . 10.0 106.485 162.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 14.4 p90 -138.71 165.27 27.41 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 109.465 -0.568 . . . . 10.0 109.465 176.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 15.2 p30 -108.58 128.77 24.97 Favored Pre-proline 0 C--N 1.331 -0.237 0 C-N-CA 123.587 0.755 . . . . 10.0 109.301 177.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -75.59 64.16 6.53 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.449 2.1 . . . . 10.0 109.129 174.293 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.8 pttt -130.48 -47.54 1.07 Allowed 'General case' 0 CA--C 1.527 0.076 0 N-CA-C 108.967 -0.753 . . . . 10.0 108.967 177.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -89.13 -62.15 1.55 Allowed 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.43 -0.952 . . . . 10.0 108.43 178.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -119.67 163.93 16.66 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 125.9 1.68 . . . . 10.0 109.332 -173.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 34.7 p -118.38 -179.1 3.68 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 122.855 1.312 . . . . 10.0 110.482 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.9 m -44.9 -40.99 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 113.697 -1.592 . . . . 10.0 111.966 163.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.0 t -69.86 -40.16 75.93 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 118.889 -0.577 . . . . 10.0 110.743 -172.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -62.66 -50.68 70.25 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.619 0.723 . . . . 10.0 109.331 -172.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.741 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.2 pp -64.33 -46.73 82.21 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.895 -0.503 . . . . 10.0 110.846 178.042 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.04 -45.88 16.33 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.099 -1.0 . . . . 10.0 113.46 166.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 15.5 tm-20 -62.66 -47.97 81.38 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 119.647 1.112 . . . . 10.0 109.408 177.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -52.73 -47.5 67.33 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 121.372 0.606 . . . . 10.0 109.725 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.416 ' HA ' HD12 ' A' ' 64' ' ' LEU . 80.5 t -66.01 -44.22 92.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 N-CA-C 112.746 0.647 . . . . 10.0 112.746 175.671 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -54.76 -39.72 68.64 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 120.942 -1.098 . . . . 10.0 110.071 175.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 40.2 tptt -70.73 -37.81 73.53 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 125.431 1.492 . . . . 10.0 110.832 -178.17 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.416 HD12 ' HA ' ' A' ' 61' ' ' VAL . 12.2 mt -51.36 -26.15 7.23 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 118.792 -0.623 . . . . 10.0 112.49 163.36 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 129.62 -25.41 4.48 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 124.127 0.87 . . . . 10.0 112.684 165.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.41 ' CE2' ' HB3' ' A' ' 64' ' ' LEU . 16.8 p90 -115.63 154.58 29.2 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 125.628 1.571 . . . . 10.0 108.437 -172.638 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.6 156.0 18.45 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.946 0.879 . . . . 10.0 111.545 -167.753 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 9.9 tp -132.45 146.81 52.22 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 127.033 2.133 . . . . 10.0 106.954 -178.361 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 9.5 mmtp -146.44 139.45 25.55 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 123.011 0.524 . . . . 10.0 110.616 163.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.717 HD23 ' H ' ' A' ' 71' ' ' LYS . 2.8 tt -65.65 157.03 31.07 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 124.32 1.012 . . . . 10.0 109.383 173.427 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.717 ' H ' HD23 ' A' ' 70' ' ' LEU . 55.1 tttt -127.44 -65.91 0.91 Allowed 'General case' 0 N--CA 1.437 -1.082 0 C-N-CA 127.445 2.298 . . . . 10.0 108.918 -172.324 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.35 -86.24 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 107.943 -2.063 . . . . 10.0 107.943 175.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 . . . . . 0 N--CA 1.453 -0.297 0 C-N-CA 124.469 1.108 . . . . 10.0 108.156 -168.13 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 7.2 p . . . . . 0 CA--C 1.53 0.201 0 N-CA-C 108.403 -0.962 . . . . 10.0 108.403 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -117.09 140.9 48.94 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 126.909 2.084 . . . . 10.0 109.089 -174.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 8.3 tptm -97.26 108.69 21.46 Favored 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 124.332 1.053 . . . . 10.0 109.089 -177.362 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.625 ' HB1' HD11 ' A' ' 70' ' ' LEU . . . -117.65 151.26 37.58 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 124.903 1.281 . . . . 10.0 109.88 -177.321 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -126.38 150.45 48.58 Favored 'General case' 0 CA--C 1.515 -0.377 0 C-N-CA 123.468 0.707 . . . . 10.0 111.264 177.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.831 ' CE2' HD11 ' A' ' 57' ' ' LEU . 2.2 m-85 -136.39 140.72 43.42 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.661 1.584 . . . . 10.0 108.553 -169.301 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -110.32 133.25 53.43 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 108.177 -1.045 . . . . 10.0 108.177 -172.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.8 mm -111.81 136.35 48.22 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.085 0 C-N-CA 124.154 0.982 . . . . 10.0 111.706 -155.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 . . . . . 0 N--CA 1.448 -0.528 0 N-CA-C 108.907 -0.775 . . . . 10.0 108.907 170.363 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 . . . . . 0 N--CA 1.468 0.441 0 N-CA-C 112.394 0.516 . . . . 10.0 112.394 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 23.0 ttm180 -75.67 -39.56 57.36 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 121.188 -0.945 . . . . 10.0 109.018 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 11.0 mm -45.97 -53.02 2.57 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.286 0 CA-C-O 118.523 -0.751 . . . . 10.0 110.037 170.201 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -44.94 -50.13 10.71 Favored 'General case' 0 C--O 1.224 -0.251 0 C-N-CA 122.918 0.487 . . . . 10.0 111.196 -178.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.5 mptt -68.51 -46.8 68.66 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.419 0.688 . . . . 10.0 110.159 -179.014 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.45 -36.14 75.39 Favored 'General case' 0 N--CA 1.451 -0.376 0 O-C-N 121.975 -0.453 . . . . 10.0 110.803 -178.281 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.38 -34.72 36.16 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.902 1.281 . . . . 10.0 111.221 175.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -60.86 -24.1 65.66 Favored 'General case' 0 C--N 1.332 -0.154 0 O-C-N 121.514 -0.741 . . . . 10.0 110.114 174.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -52.0 -40.64 61.29 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 117.893 0.315 . . . . 10.0 111.321 170.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 25.1 mm -57.77 128.67 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 123.585 0.754 . . . . 10.0 109.939 -173.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -69.08 -48.25 63.13 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 120.697 -0.401 . . . . 10.0 110.43 -177.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -80.67 37.85 2.3 Favored Glycine 0 CA--C 1.523 0.579 0 O-C-N 121.186 -0.946 . . . . 10.0 112.759 -174.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.4 p -103.86 147.4 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 C-N-CA 124.289 1.035 . . . . 10.0 108.657 -175.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -104.63 -50.27 3.34 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 107.998 -1.112 . . . . 10.0 107.998 171.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -164.06 160.64 21.87 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.263 -0.643 . . . . 10.0 109.263 -178.231 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -142.13 65.49 18.85 Favored Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 124.589 1.156 . . . . 10.0 111.358 178.458 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -75.36 75.54 3.82 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.184 2.589 . . . . 10.0 109.751 178.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.51 HG12 HG13 ' A' ' 43' ' ' VAL . 3.5 m -66.8 156.36 6.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 123.637 0.775 . . . . 10.0 111.808 -178.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -96.07 115.24 27.13 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 121.112 0.482 . . . . 10.0 111.3 -176.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 11.0 p90 -95.0 43.25 1.09 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.351 1.46 . . . . 10.0 112.447 -171.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -172.55 -39.76 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 124.841 1.257 . . . . 10.0 109.562 176.357 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 12.3 mt -79.04 -12.17 60.02 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.18 0.992 . . . . 10.0 112.019 -175.098 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 60.34 51.06 5.62 Favored 'General case' 0 C--N 1.334 -0.069 0 C-N-CA 124.915 1.286 . . . . 10.0 109.692 176.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -140.77 133.29 28.55 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 106.514 -1.661 . . . . 10.0 106.514 175.587 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.51 HG13 HG12 ' A' ' 36' ' ' VAL . 15.0 t -101.85 142.35 16.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 106.533 -1.655 . . . . 10.0 106.533 172.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 29.6 m -130.34 124.02 31.3 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 106.433 -1.692 . . . . 10.0 106.433 -177.055 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 29.0 t -128.62 137.52 57.09 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 N-CA-C 109.127 -0.694 . . . . 10.0 109.127 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -105.61 105.58 15.69 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 105.668 -1.975 . . . . 10.0 105.668 167.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -145.78 159.91 42.5 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 123.645 0.778 . . . . 10.0 110.541 -176.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -95.98 134.74 23.44 Favored Pre-proline 0 C--N 1.33 -0.263 0 C-N-CA 123.869 0.868 . . . . 10.0 110.813 178.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -80.44 56.27 6.01 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.259 1.973 . . . . 10.0 109.626 170.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.54 -49.95 1.76 Allowed 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 108.411 -0.959 . . . . 10.0 108.411 175.607 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -87.75 -42.52 12.55 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.525 0.73 . . . . 10.0 110.394 -175.656 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -137.81 -176.19 4.34 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.848 1.259 . . . . 10.0 109.327 -171.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 78.2 p -151.73 171.86 17.02 Favored 'General case' 0 N--CA 1.455 -0.193 0 O-C-N 122.043 -0.411 . . . . 10.0 110.38 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 88.3 t -42.93 -48.37 1.21 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.166 0 C-N-CA 124.511 1.124 . . . . 10.0 110.582 169.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.9 m -51.01 -42.88 60.68 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.583 1.153 . . . . 10.0 112.73 178.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -70.42 -56.9 5.52 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 124.114 0.965 . . . . 10.0 109.314 -176.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.831 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.1 pp -63.83 -40.49 96.73 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 120.786 -1.197 . . . . 10.0 110.816 -177.626 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -43.84 -52.7 6.56 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-O 118.049 -0.977 . . . . 10.0 112.386 161.106 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.8 -45.38 70.74 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 120.127 1.331 . . . . 10.0 110.573 178.415 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -53.63 -53.39 52.52 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.134 0.492 . . . . 10.0 110.414 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 59.3 t -64.77 -41.19 91.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-N 116.115 -0.493 . . . . 10.0 112.003 178.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -58.59 -45.99 87.9 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 108.825 -0.806 . . . . 10.0 108.825 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -70.23 -36.22 74.38 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.528 1.131 . . . . 10.0 111.03 -177.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 12.9 mt -52.24 -28.82 20.09 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 112.803 0.668 . . . . 10.0 112.803 165.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 108.22 31.29 3.59 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-N 118.502 0.592 . . . . 10.0 112.741 169.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -152.33 160.33 43.33 Favored 'General case' 0 C--O 1.227 -0.104 0 N-CA-C 106.987 -1.486 . . . . 10.0 106.987 169.009 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -98.99 152.61 19.62 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.581 0.705 . . . . 10.0 110.84 -163.224 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.5 tp -134.07 146.74 50.59 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 125.7 1.6 . . . . 10.0 108.316 -176.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 12.1 tptp -152.21 154.01 34.95 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 109.445 -0.576 . . . . 10.0 109.445 164.364 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.625 HD11 ' HB1' ' A' ' 5' ' ' ALA . 8.3 tp -65.78 155.84 34.97 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 121.401 0.619 . . . . 10.0 109.809 176.119 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 54.6 tttt -118.16 -55.71 2.22 Favored 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 128.633 2.773 . . . . 10.0 107.242 175.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 173.93 -91.22 0.09 OUTLIER Glycine 0 N--CA 1.444 -0.822 0 N-CA-C 108.175 -1.97 . . . . 10.0 108.175 178.137 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 . . . . . 0 N--CA 1.45 -0.425 0 C-N-CA 124.506 1.122 . . . . 10.0 108.472 -162.835 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.625 HG21 ' HB2' ' A' ' 32' ' ' ALA . 2.6 p . . . . . 0 CA--C 1.534 0.331 0 N-CA-C 108.851 -0.796 . . . . 10.0 108.851 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -137.71 140.41 40.72 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 126.465 1.906 . . . . 10.0 107.795 -168.024 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 18.4 mmtp -82.46 128.34 34.17 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.192 0.597 . . . . 10.0 109.419 178.612 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -128.99 136.8 50.81 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 125.698 1.599 . . . . 10.0 109.119 176.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -117.28 147.0 42.95 Favored 'General case' 0 CA--C 1.51 -0.587 0 C-N-CA 124.0 0.92 . . . . 10.0 110.198 177.262 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.76 ' CE2' HD11 ' A' ' 57' ' ' LEU . 3.1 m-85 -141.19 137.26 32.53 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 124.623 1.202 . . . . 10.0 111.241 -172.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -93.65 133.17 37.27 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.737 1.615 . . . . 10.0 108.741 -176.123 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.6 HD11 HG23 ' A' ' 43' ' ' VAL . 7.0 mm -103.56 114.15 42.38 Favored 'Isoleucine or valine' 0 C--N 1.34 0.185 0 C-N-CA 124.038 0.935 . . . . 10.0 110.621 -171.14 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 . . . . . 0 C--O 1.236 0.361 0 N-CA-C 107.833 -1.173 . . . . 10.0 107.833 170.94 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 . . . . . 0 N--CA 1.468 0.465 0 N-CA-C 112.311 0.486 . . . . 10.0 112.311 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -64.39 -45.25 88.49 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 120.759 -1.213 . . . . 10.0 108.209 179.032 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.625 HG22 HD12 ' A' ' 25' ' ' LEU . 9.8 mm -44.68 -47.55 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 C-N-CA 124.328 1.051 . . . . 10.0 111.625 177.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -48.21 -50.63 28.59 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 122.824 0.45 . . . . 10.0 110.868 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -72.77 -46.26 54.29 Favored 'General case' 0 N--CA 1.445 -0.713 0 O-C-N 121.757 -0.589 . . . . 10.0 110.933 -179.53 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.1 mmp_? -48.92 -42.66 37.87 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.122 0.416 . . . . 10.0 112.122 175.408 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.93 HD22 HG21 ' A' ' 45' ' ' VAL . 0.5 OUTLIER -79.4 -42.35 25.69 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.472 0.709 . . . . 10.0 111.05 178.741 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -55.0 -18.53 5.2 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.406 1.003 . . . . 10.0 112.22 172.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -59.69 -29.07 67.83 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 114.223 1.194 . . . . 10.0 114.223 171.058 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.539 HD11 ' HB3' ' A' ' 57' ' ' LEU . 11.1 mt -60.58 138.46 21.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 108.227 -1.027 . . . . 10.0 108.227 173.227 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.38 -49.58 32.84 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 109.554 -0.535 . . . . 10.0 109.554 179.104 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -80.29 42.25 2.55 Favored Glycine 0 CA--C 1.526 0.737 0 O-C-N 120.778 -1.201 . . . . 10.0 112.311 -175.056 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.6 p -102.05 153.2 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 C-N-CA 125.159 1.383 . . . . 10.0 109.677 -174.021 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.625 ' HB2' HG21 ' A' ' 2' ' ' THR . . . -111.54 -54.62 2.59 Favored 'General case' 0 C--N 1.334 -0.089 0 C-N-CA 123.877 0.871 . . . . 10.0 109.069 171.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 23.1 p30 -162.44 151.71 15.54 Favored 'General case' 0 C--O 1.227 -0.129 0 N-CA-C 108.732 -0.84 . . . . 10.0 108.732 -173.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -133.94 55.94 17.52 Favored Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 124.42 1.088 . . . . 10.0 112.34 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -75.05 79.2 2.73 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 122.884 2.39 . . . . 10.0 110.558 -177.355 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.526 HG12 HG13 ' A' ' 43' ' ' VAL . 2.4 m -67.47 151.16 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 O-C-N 121.622 -0.674 . . . . 10.0 111.801 -178.749 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -95.39 88.66 5.18 Favored 'General case' 0 C--O 1.234 0.256 0 O-C-N 122.179 -0.326 . . . . 10.0 110.23 -175.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -72.48 53.52 0.31 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 127.171 2.189 . . . . 10.0 112.727 -178.092 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -174.65 -40.72 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 126.281 1.832 . . . . 10.0 109.734 174.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 12.4 mt -86.62 -12.39 48.66 Favored 'General case' 0 C--N 1.338 0.093 0 C-N-CA 124.084 0.954 . . . . 10.0 111.797 -171.001 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 75.4 37.35 0.45 Allowed 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.884 1.274 . . . . 10.0 110.333 170.484 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 33.3 p -138.35 129.81 27.62 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.242 1.417 . . . . 10.0 108.127 178.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.6 HG23 HD11 ' A' ' 9' ' ' ILE . 21.8 t -90.33 131.39 37.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 107.515 -1.291 . . . . 10.0 107.515 167.328 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 85.6 m -110.54 117.93 34.87 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 106.303 -1.74 . . . . 10.0 106.303 171.221 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.93 HG21 HD22 ' A' ' 25' ' ' LEU . 82.6 t -122.46 141.28 43.48 Favored 'Isoleucine or valine' 0 C--N 1.342 0.248 0 CA-C-N 120.177 1.353 . . . . 10.0 109.79 168.284 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.438 ' HB3' ' HB3' ' A' ' 32' ' ' ALA . 18.3 tt0 -100.32 117.02 33.66 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 107.552 -1.277 . . . . 10.0 107.552 164.563 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -147.87 167.91 23.57 Favored 'General case' 0 C--O 1.226 -0.163 0 N-CA-C 108.861 -0.792 . . . . 10.0 108.861 177.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 24.7 p30 -100.54 135.96 20.05 Favored Pre-proline 0 C--N 1.329 -0.284 0 C-N-CA 123.273 0.629 . . . . 10.0 109.758 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -80.36 54.0 5.02 Favored 'Trans proline' 0 N--CA 1.448 -1.167 0 N-CA-C 108.883 -1.237 . . . . 10.0 108.883 171.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.16 10.19 3.27 Favored 'General case' 0 C--N 1.346 0.443 0 CA-C-N 118.623 0.647 . . . . 10.0 111.834 176.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -142.02 -65.15 0.42 Allowed 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.788 -1.189 . . . . 10.0 107.788 -173.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -114.52 175.51 5.45 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 124.071 0.948 . . . . 10.0 109.359 178.364 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 92.0 p -127.72 167.57 16.29 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.028 0.931 . . . . 10.0 110.065 177.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 74.2 t -49.06 -52.8 9.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 115.791 -0.641 . . . . 10.0 109.796 167.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.0 m -52.36 -37.13 55.43 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 125.185 1.394 . . . . 10.0 112.579 178.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -71.25 -60.4 2.25 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 109.603 -0.517 . . . . 10.0 109.603 174.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.76 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.4 pp -58.81 -46.81 86.76 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 118.348 0.522 . . . . 10.0 111.368 -168.429 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.455 ' N ' HD12 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -48.18 -35.63 12.11 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 114.549 1.315 . . . . 10.0 114.549 171.819 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.1 tm-20 -52.54 -35.49 53.61 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 120.466 1.485 . . . . 10.0 110.924 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.63 -52.51 60.53 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 120.057 -0.657 . . . . 10.0 109.922 -178.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.575 HG22 HD12 ' A' ' 21' ' ' ILE . 72.7 t -55.24 -47.96 77.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 122.905 0.482 . . . . 10.0 110.884 172.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.88 -55.91 19.76 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 124.906 1.282 . . . . 10.0 109.195 -177.726 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.8 tptm -57.06 -38.97 74.01 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 126.137 1.775 . . . . 10.0 111.322 177.234 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.4 mp -60.52 -19.74 58.02 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 113.075 0.768 . . . . 10.0 113.075 172.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 104.74 16.34 17.7 Favored Glycine 0 CA--C 1.528 0.863 0 CA-C-N 118.849 0.749 . . . . 10.0 113.263 168.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.405 ' O ' HG12 ' A' ' 61' ' ' VAL . 1.5 p90 -136.0 160.94 37.07 Favored 'General case' 0 C--O 1.227 -0.121 0 N-CA-C 106.776 -1.564 . . . . 10.0 106.776 169.002 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 10.5 ttmm -105.98 141.16 37.84 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 119.265 0.939 . . . . 10.0 111.405 -168.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.581 HD11 ' HB2' ' A' ' 7' ' ' PHE . 22.9 tp -117.93 145.04 44.95 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 126.117 1.767 . . . . 10.0 107.974 177.587 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 26.0 mmtt -152.99 153.44 32.93 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 125.721 1.608 . . . . 10.0 108.058 170.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.3 tp -68.34 152.41 45.47 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.398 0.618 . . . . 10.0 109.397 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.94 -57.44 2.04 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 127.51 2.324 . . . . 10.0 105.586 164.246 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 170.82 -92.56 0.1 OUTLIER Glycine 0 N--CA 1.442 -0.947 0 N-CA-C 105.833 -2.907 . . . . 10.0 105.833 177.446 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 . . . . . 0 N--CA 1.453 -0.293 0 C-N-CA 122.993 0.517 . . . . 10.0 109.829 -160.756 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.52 HG21 ' HB2' ' A' ' 32' ' ' ALA . 14.9 p . . . . . 0 CA--C 1.536 0.418 0 N-CA-C 108.02 -1.104 . . . . 10.0 108.02 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -140.65 142.25 34.98 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 127.427 2.291 . . . . 10.0 107.917 -167.152 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -104.91 110.09 22.32 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.54 0.736 . . . . 10.0 109.954 -168.618 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -108.9 146.14 34.24 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 124.976 1.31 . . . . 10.0 109.833 -175.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -122.63 147.25 46.65 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 123.749 0.82 . . . . 10.0 109.246 173.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.704 ' CE2' HD11 ' A' ' 57' ' ' LEU . 9.9 m-85 -137.0 140.85 42.44 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 125.222 1.576 . . . . 10.0 109.237 -173.68 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -105.46 133.9 49.45 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.358 1.063 . . . . 10.0 108.261 -175.195 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.9 mm -109.33 132.33 57.75 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 C-N-CA 123.667 0.787 . . . . 10.0 111.18 -157.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 . . . . . 0 N--CA 1.449 -0.506 0 C-N-CA 123.22 0.608 . . . . 10.0 109.36 172.569 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 . . . . . 0 N--CA 1.468 0.445 0 N-CA-C 112.213 0.449 . . . . 10.0 112.213 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -74.61 -54.14 8.02 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 121.294 -0.879 . . . . 10.0 108.9 173.175 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.661 HG22 HD12 ' A' ' 25' ' ' LEU . 1.6 mt -48.22 -47.47 13.59 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.445 0 CA-C-O 117.964 -1.017 . . . . 10.0 111.277 -176.112 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -34.86 -61.88 0.39 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.517 0.727 . . . . 10.0 111.747 174.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.98 -42.25 69.93 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.492 1.117 . . . . 10.0 110.679 -177.565 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.96 -28.79 62.62 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.651 0.611 . . . . 10.0 112.651 175.586 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.661 HD12 HG22 ' A' ' 21' ' ' ILE . 1.5 mt -85.3 -42.97 14.13 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 126.188 1.795 . . . . 10.0 109.787 174.09 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -55.51 -23.95 29.0 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.898 0.879 . . . . 10.0 110.279 177.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -52.85 -41.6 64.41 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 113.794 1.035 . . . . 10.0 113.794 171.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.2 mp -54.58 133.38 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 109.563 -0.532 . . . . 10.0 109.563 176.273 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -77.98 -42.73 31.79 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 119.505 -0.284 . . . . 10.0 110.483 -178.15 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -80.63 39.6 2.37 Favored Glycine 0 CA--C 1.527 0.816 0 O-C-N 120.549 -1.344 . . . . 10.0 111.94 178.276 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.4 p -101.57 149.78 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 C-N-CA 124.973 1.309 . . . . 10.0 108.575 -178.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.52 ' HB2' HG21 ' A' ' 2' ' ' THR . . . -109.5 -61.51 1.63 Allowed 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 107.934 -1.136 . . . . 10.0 107.934 170.59 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 57.8 m-80 -140.54 154.66 46.62 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 107.952 -1.129 . . . . 10.0 107.952 -174.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.47 58.01 2.58 Favored Pre-proline 0 CA--C 1.535 0.371 0 O-C-N 121.965 -0.459 . . . . 10.0 112.113 170.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -75.11 78.23 2.98 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 122.715 2.277 . . . . 10.0 108.756 177.013 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.478 HG12 HG13 ' A' ' 43' ' ' VAL . 3.4 m -59.12 152.45 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 109.851 -0.426 . . . . 10.0 109.851 174.642 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -81.07 151.32 28.41 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 118.756 -1.178 . . . . 10.0 109.962 -176.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -123.23 42.91 3.09 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.412 1.485 . . . . 10.0 109.747 -175.04 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -175.13 -40.22 0.01 OUTLIER 'General case' 0 C--O 1.226 -0.163 0 C-N-CA 125.385 1.474 . . . . 10.0 109.736 170.02 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.2 mt -75.2 -17.04 60.44 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.884 0.874 . . . . 10.0 112.442 -167.204 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 65.3 48.69 2.08 Favored 'General case' 0 N--CA 1.46 0.072 0 C-N-CA 125.281 1.432 . . . . 10.0 110.32 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 8.0 p -142.85 133.24 24.81 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.324 1.45 . . . . 10.0 107.969 176.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.478 HG13 HG12 ' A' ' 36' ' ' VAL . 7.0 t -97.63 134.21 36.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 106.869 -1.53 . . . . 10.0 106.869 172.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 85.9 m -121.26 126.22 49.02 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 106.552 -1.647 . . . . 10.0 106.552 178.317 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.4 t -122.89 149.29 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 C-N-CA 124.323 1.049 . . . . 10.0 108.648 177.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -123.59 107.81 11.93 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 106.054 -1.832 . . . . 10.0 106.054 164.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -145.04 170.67 15.74 Favored 'General case' 0 C--O 1.225 -0.223 0 C-N-CA 124.142 0.977 . . . . 10.0 108.834 -177.089 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 14.6 p30 -111.85 134.77 21.27 Favored Pre-proline 0 CA--C 1.53 0.196 0 C-N-CA 122.806 0.443 . . . . 10.0 110.397 177.162 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -77.37 62.47 7.64 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 122.504 2.136 . . . . 10.0 109.867 174.212 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.1 pttt -123.73 -45.85 2.02 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 123.147 0.579 . . . . 10.0 109.951 172.052 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -91.49 -60.95 1.75 Allowed 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.385 1.074 . . . . 10.0 108.72 -176.148 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -119.08 174.34 6.37 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 125.671 1.588 . . . . 10.0 109.321 -175.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 53.3 p -131.66 -177.3 4.36 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.875 1.27 . . . . 10.0 110.167 176.051 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 35.3 m -48.64 -38.72 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-N 115.03 -0.986 . . . . 10.0 111.946 164.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 68.9 m -62.32 -43.31 99.13 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 122.761 0.424 . . . . 10.0 111.142 -174.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -65.28 -52.97 50.79 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.284 1.034 . . . . 10.0 109.136 -174.185 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.704 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.1 pp -66.97 -43.91 81.82 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 121.983 -0.448 . . . . 10.0 111.274 -178.57 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.403 ' N ' HD12 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -41.66 -51.04 4.14 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-O 118.125 -0.94 . . . . 10.0 112.053 160.467 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -57.1 -43.92 82.72 Favored 'General case' 0 C--O 1.226 -0.157 0 CA-C-N 119.742 1.155 . . . . 10.0 110.386 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -52.88 -51.82 59.75 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.077 0.465 . . . . 10.0 110.392 176.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.476 HG11 ' HB2' ' A' ' 68' ' ' LEU . 53.9 t -61.85 -46.23 96.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 N-CA-C 112.39 0.515 . . . . 10.0 112.39 176.131 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -51.45 -51.11 57.74 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.856 1.263 . . . . 10.0 108.428 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.25 -44.26 92.38 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.611 1.565 . . . . 10.0 111.191 177.417 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -48.35 -39.45 22.16 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.79 0.836 . . . . 10.0 111.308 173.51 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 125.14 14.25 3.38 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-O 119.575 -0.57 . . . . 10.0 113.273 169.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -138.94 162.52 34.67 Favored 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 107.927 -1.138 . . . . 10.0 107.927 177.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 29.0 mmtt -95.98 151.04 19.8 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.776 0.798 . . . . 10.0 111.328 -172.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.476 ' HB2' HG11 ' A' ' 61' ' ' VAL . 14.5 tp -132.35 146.33 51.9 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 126.487 1.915 . . . . 10.0 107.886 -179.261 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 16.5 mmtm -151.64 154.67 36.84 Favored 'General case' 0 N--CA 1.44 -0.947 0 C-N-CA 123.993 0.917 . . . . 10.0 109.011 163.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.6 tp -61.32 159.46 12.39 Favored 'General case' 0 N--CA 1.453 -0.301 0 O-C-N 124.321 1.013 . . . . 10.0 109.393 175.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 32.9 tttt -118.82 -66.34 1.08 Allowed 'General case' 0 N--CA 1.435 -1.216 0 C-N-CA 125.464 1.506 . . . . 10.0 108.276 177.356 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 161.7 43.63 0.02 OUTLIER Glycine 0 CA--C 1.528 0.865 0 CA-C-O 118.852 -0.971 . . . . 10.0 113.668 175.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 . . . . . 0 CA--C 1.535 0.369 0 C-N-CA 124.976 1.311 . . . . 10.0 112.941 167.662 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.627 HG21 ' HB2' ' A' ' 32' ' ' ALA . 10.0 p . . . . . 0 N--CA 1.453 -0.285 0 N-CA-C 109.293 -0.632 . . . . 10.0 109.293 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -131.66 150.21 52.23 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 127.472 2.309 . . . . 10.0 107.324 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -109.63 123.46 49.5 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.343 -0.984 . . . . 10.0 108.343 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.647 ' HB1' HD11 ' A' ' 70' ' ' LEU . . . -130.2 153.55 48.45 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.634 0.774 . . . . 10.0 110.676 176.111 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -118.7 148.56 42.63 Favored 'General case' 0 CA--C 1.507 -0.7 0 C-N-CA 124.62 1.168 . . . . 10.0 109.481 177.234 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.817 ' CE2' HD11 ' A' ' 57' ' ' LEU . 2.2 m-85 -135.12 141.0 45.9 Favored 'General case' 0 N--CA 1.447 -0.605 0 O-C-N 124.792 1.308 . . . . 10.0 109.063 -174.572 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -103.45 131.78 50.26 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.525 1.53 . . . . 10.0 108.827 -174.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -115.44 137.13 50.0 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 C-N-CA 126.111 1.764 . . . . 10.0 110.023 -164.729 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 . . . . . 0 N--CA 1.454 -0.259 0 N-CA-C 108.21 -1.033 . . . . 10.0 108.21 176.038 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 . . . . . 0 CA--C 1.538 0.51 0 N-CA-C 113.945 1.091 . . . . 10.0 113.945 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.79 -45.89 87.65 Favored 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 120.757 -1.214 . . . . 10.0 108.413 177.586 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.846 HG22 HD12 ' A' ' 25' ' ' LEU . 2.8 mm -47.4 -48.85 9.47 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.231 0 O-C-N 123.94 0.775 . . . . 10.0 109.856 -177.376 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -44.03 -54.4 5.49 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.043 0.937 . . . . 10.0 111.526 178.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt -70.73 -45.7 64.4 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.954 0.902 . . . . 10.0 109.459 -177.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.626 ' HG3' HD11 ' A' ' 64' ' ' LEU . 51.7 mmt-85 -55.57 -32.24 62.85 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.147 0.425 . . . . 10.0 112.147 177.689 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.846 HD12 HG22 ' A' ' 21' ' ' ILE . 2.1 mt -84.39 -35.56 23.06 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.178 1.391 . . . . 10.0 112.26 174.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 32.7 t-20 -55.29 -31.78 61.9 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.685 0.675 . . . . 10.0 110.081 176.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -50.64 -28.89 9.72 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 114.996 1.48 . . . . 10.0 114.996 169.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.82 HG23 ' HB3' ' A' ' 52' ' ' ALA . 6.9 mm -61.71 104.93 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-O 121.71 0.766 . . . . 10.0 109.663 171.326 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -58.24 -26.08 62.48 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.451 0.537 . . . . 10.0 112.451 -179.053 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -90.79 18.02 52.34 Favored Glycine 0 CA--C 1.528 0.898 0 O-C-N 121.359 -0.838 . . . . 10.0 112.945 178.148 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.1 p -79.36 153.98 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 CA-C-N 118.595 1.198 . . . . 10.0 109.514 -179.052 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.627 ' HB2' HG21 ' A' ' 2' ' ' THR . . . -112.94 -59.86 1.96 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.539 -0.912 . . . . 10.0 108.539 163.135 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 -134.63 155.43 50.5 Favored 'General case' 0 C--N 1.341 0.208 0 N-CA-C 109.254 -0.647 . . . . 10.0 109.254 -178.381 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -140.36 65.39 27.32 Favored Pre-proline 0 CA--C 1.534 0.355 0 C-N-CA 123.454 0.701 . . . . 10.0 109.825 172.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -78.64 68.7 8.03 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 123.044 2.496 . . . . 10.0 109.539 -176.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.415 HG12 HG13 ' A' ' 43' ' ' VAL . 4.1 m -68.85 155.37 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 O-C-N 122.099 -0.375 . . . . 10.0 111.727 -175.644 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -97.49 139.04 34.0 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 121.002 0.429 . . . . 10.0 111.407 -177.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -118.24 47.66 1.56 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.702 1.601 . . . . 10.0 110.451 -172.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -176.11 -41.61 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 125.449 1.5 . . . . 10.0 109.557 -177.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 16.6 mt -81.7 -19.02 42.4 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.625 1.17 . . . . 10.0 111.648 -170.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 61.16 50.64 4.8 Favored 'General case' 0 C--N 1.339 0.112 0 C-N-CA 125.892 1.677 . . . . 10.0 109.942 -175.174 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.4 p -140.07 126.99 20.74 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 107.646 -1.242 . . . . 10.0 107.646 174.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.569 HG21 HG21 ' A' ' 21' ' ' ILE . 5.1 t -97.15 130.62 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 106.769 -1.567 . . . . 10.0 106.769 172.419 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 58.2 m -110.85 128.38 55.76 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.95 1.7 . . . . 10.0 107.139 176.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.7 t -127.36 137.4 57.87 Favored 'Isoleucine or valine' 0 C--N 1.342 0.253 0 CA-C-N 119.161 0.891 . . . . 10.0 110.709 174.465 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -107.29 104.6 14.24 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.392 1.477 . . . . 10.0 107.088 164.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 14.7 p90 -143.32 167.02 23.13 Favored 'General case' 0 CA--C 1.52 -0.177 0 C-N-CA 123.936 0.895 . . . . 10.0 109.329 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -107.99 134.05 20.26 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-O 119.109 -0.472 . . . . 10.0 110.804 178.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -77.85 62.29 7.83 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.779 2.319 . . . . 10.0 110.613 176.33 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.0 pttt -124.42 -47.67 1.85 Allowed 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.706 0.802 . . . . 10.0 109.346 169.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -90.33 -51.84 5.23 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.961 0.905 . . . . 10.0 110.007 -169.135 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.82 ' HB3' HG23 ' A' ' 28' ' ' ILE . . . -132.17 174.73 9.9 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.631 1.172 . . . . 10.0 108.333 178.585 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 82.6 p -137.06 177.49 7.82 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 118.569 0.622 . . . . 10.0 110.757 176.091 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 49.1 t -42.24 -50.75 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 124.632 1.173 . . . . 10.0 110.902 172.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.1 m -51.56 -38.77 55.9 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.094 0.958 . . . . 10.0 112.414 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -70.11 -58.51 3.72 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.632 0.773 . . . . 10.0 109.178 -174.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.817 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.4 pp -63.56 -41.09 98.43 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 121.741 -0.6 . . . . 10.0 111.297 -178.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.417 ' HA ' HD23 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -43.51 -47.6 7.26 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 118.349 -0.834 . . . . 10.0 111.817 163.289 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.87 -42.21 98.79 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 119.571 1.078 . . . . 10.0 110.39 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -56.19 -48.59 76.09 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 109.65 -0.5 . . . . 10.0 109.65 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.639 ' HA ' HD12 ' A' ' 64' ' ' LEU . 82.8 t -62.56 -47.45 92.89 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 N-CA-C 112.909 0.707 . . . . 10.0 112.909 173.346 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -56.13 -37.7 69.81 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.044 -1.035 . . . . 10.0 109.025 -178.228 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.9 tttp -79.57 -31.51 41.89 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 124.343 1.057 . . . . 10.0 112.011 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.639 HD12 ' HA ' ' A' ' 61' ' ' VAL . 15.3 mt -51.69 -45.19 63.41 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.68 1.127 . . . . 10.0 110.783 163.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 147.89 -39.87 0.99 Allowed Glycine 0 CA--C 1.525 0.713 0 CA-C-N 117.964 0.347 . . . . 10.0 112.78 171.245 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -89.79 159.55 16.97 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 124.032 0.933 . . . . 10.0 108.738 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 19.7 tttt -91.87 161.23 14.92 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-O 121.137 0.494 . . . . 10.0 110.656 -171.008 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.469 HD11 ' HB2' ' A' ' 7' ' ' PHE . 23.9 tp -136.13 148.1 48.06 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.189 1.396 . . . . 10.0 108.248 177.419 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 16.9 mmtm -154.18 159.46 41.4 Favored 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 124.19 0.996 . . . . 10.0 108.587 164.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.647 HD11 ' HB1' ' A' ' 5' ' ' ALA . 5.8 tp -67.07 152.06 46.48 Favored 'General case' 0 N--CA 1.451 -0.423 0 O-C-N 123.735 0.647 . . . . 10.0 109.351 176.166 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 13.3 tptm -107.48 -55.2 2.38 Favored 'General case' 0 N--CA 1.438 -1.072 0 C-N-CA 127.168 2.187 . . . . 10.0 105.881 169.403 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 170.97 -95.96 0.11 Allowed Glycine 0 N--CA 1.444 -0.819 0 N-CA-C 106.204 -2.759 . . . . 10.0 106.204 -179.282 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 . . . . . 0 N--CA 1.454 -0.253 0 C-N-CA 123.284 0.634 . . . . 10.0 110.447 -165.799 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.448 -0.557 0 N-CA-C 106.713 -1.588 . . . . 10.0 106.713 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -143.49 143.02 31.39 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 126.858 2.063 . . . . 10.0 106.752 -170.522 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 45.1 mmtt -85.33 145.39 27.53 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.143 -0.688 . . . . 10.0 109.143 175.232 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -147.06 138.14 23.9 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 107.463 -1.31 . . . . 10.0 107.463 174.115 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -122.03 149.07 44.02 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 123.796 0.838 . . . . 10.0 110.022 174.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.694 ' CE2' HD11 ' A' ' 57' ' ' LEU . 0.2 OUTLIER -142.95 141.22 31.38 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 124.804 1.315 . . . . 10.0 110.653 -168.387 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.44 132.18 43.39 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.985 1.714 . . . . 10.0 108.771 -170.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.63 HD11 HG23 ' A' ' 43' ' ' VAL . 3.7 mm -106.21 121.02 58.17 Favored 'Isoleucine or valine' 0 C--N 1.339 0.145 0 C-N-CA 124.842 1.257 . . . . 10.0 110.821 -170.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 . . . . . 0 N--CA 1.449 -0.505 0 N-CA-C 106.267 -1.753 . . . . 10.0 106.267 175.841 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 . . . . . 0 N--CA 1.466 0.36 0 N-CA-C 112.71 0.633 . . . . 10.0 112.71 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.7 ttm105 -68.58 -43.45 76.49 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 108.528 -0.916 . . . . 10.0 108.528 177.216 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.569 HG23 HG22 ' A' ' 61' ' ' VAL . 0.9 OUTLIER -56.22 -46.31 81.3 Favored 'Isoleucine or valine' 0 C--N 1.342 0.255 0 CA-C-O 118.772 -0.632 . . . . 10.0 110.211 177.922 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -44.1 -54.91 5.14 Favored 'General case' 0 C--N 1.342 0.247 0 CA-C-O 121.098 0.475 . . . . 10.0 111.075 178.486 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.6 mttm -69.53 -42.88 74.07 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 124.298 1.039 . . . . 10.0 110.433 -177.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.477 ' HG3' HD13 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -53.23 -36.95 61.62 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 111.893 0.331 . . . . 10.0 111.893 173.719 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.421 ' CD2' HG21 ' A' ' 45' ' ' VAL . 0.4 OUTLIER -78.5 -41.6 32.0 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.727 0.811 . . . . 10.0 110.856 175.799 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -61.28 -22.13 64.57 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 121.511 -0.743 . . . . 10.0 110.65 -177.017 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.4 mmpt? -53.68 -39.72 65.37 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 114.202 1.186 . . . . 10.0 114.202 168.234 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.8 mt -62.86 128.99 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 CA-C-N 118.965 0.802 . . . . 10.0 109.087 -175.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -56.48 -51.16 69.49 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 122.913 0.485 . . . . 10.0 111.824 -177.211 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -87.26 42.31 3.14 Favored Glycine 0 C--N 1.339 0.71 0 O-C-N 120.916 -1.115 . . . . 10.0 111.666 -172.205 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.8 p -105.7 151.91 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 C-N-CA 124.506 1.122 . . . . 10.0 108.628 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -117.61 -50.78 2.51 Favored 'General case' 0 C--N 1.334 -0.096 0 C-N-CA 122.946 0.499 . . . . 10.0 110.185 173.107 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -143.74 145.99 32.81 Favored 'General case' 0 N--CA 1.461 0.087 0 N-CA-C 109.082 -0.71 . . . . 10.0 109.082 -176.222 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -139.11 56.98 9.79 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 123.537 0.735 . . . . 10.0 112.461 177.546 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -75.3 78.87 2.87 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 123.321 2.681 . . . . 10.0 111.067 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.633 HG22 HG13 ' A' ' 43' ' ' VAL . 43.0 t -65.94 143.78 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 C-N-CA 124.786 1.234 . . . . 10.0 112.039 178.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 -91.01 97.83 11.41 Favored 'General case' 0 C--N 1.341 0.215 0 O-C-N 121.874 -0.516 . . . . 10.0 111.718 -167.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -76.45 53.25 0.84 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.785 1.634 . . . . 10.0 112.86 -177.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 179.19 -33.34 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 125.77 1.628 . . . . 10.0 110.51 168.083 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.2 mt -88.08 1.53 54.06 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.43 1.092 . . . . 10.0 112.155 -172.089 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 60.75 39.08 17.73 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 125.543 1.537 . . . . 10.0 110.91 169.26 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.48 133.97 26.51 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.919 1.287 . . . . 10.0 107.979 -175.353 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.633 HG13 HG22 ' A' ' 36' ' ' VAL . 17.1 t -90.88 142.66 12.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 107.1 -1.444 . . . . 10.0 107.1 167.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 91.6 m -133.98 114.96 13.8 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 125.585 1.554 . . . . 10.0 107.749 -177.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.421 HG21 ' CD2' ' A' ' 25' ' ' LEU . 50.4 t -122.0 156.14 26.55 Favored 'Isoleucine or valine' 0 C--N 1.341 0.235 0 C-N-CA 123.785 0.834 . . . . 10.0 110.607 -177.392 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.22 107.62 11.4 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 127.764 2.426 . . . . 10.0 105.659 170.725 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -136.63 165.96 24.66 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 123.395 0.678 . . . . 10.0 111.13 -176.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -99.94 126.84 35.36 Favored Pre-proline 0 CA--C 1.532 0.251 0 C-N-CA 123.73 0.812 . . . . 10.0 110.179 173.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -75.46 65.11 6.48 Favored 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 122.561 2.174 . . . . 10.0 108.569 175.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.32 -50.16 0.25 Allowed 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 107.487 -1.301 . . . . 10.0 107.487 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -106.31 -40.31 5.65 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 123.484 0.714 . . . . 10.0 110.715 173.185 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.24 150.63 26.06 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 121.539 -0.725 . . . . 10.0 109.993 177.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 44.9 p -147.22 149.31 32.67 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.885 0.85 . . . . 10.0 110.741 171.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 48.9 t -48.62 -51.2 11.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 125.544 1.538 . . . . 10.0 111.559 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.9 m -51.75 -43.01 62.76 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 118.943 -0.551 . . . . 10.0 111.742 178.366 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -67.71 -54.25 20.94 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.124 -0.695 . . . . 10.0 109.124 -173.047 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.694 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.0 pp -61.66 -45.36 94.36 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 120.695 -0.402 . . . . 10.0 110.212 -178.696 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.55 -51.93 8.49 Favored 'General case' 0 N--CA 1.45 -0.445 0 O-C-N 121.911 -0.493 . . . . 10.0 111.555 168.243 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.25 -40.26 95.64 Favored 'General case' 0 C--O 1.226 -0.174 0 CA-C-N 118.53 0.604 . . . . 10.0 110.293 -178.403 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -52.64 -49.21 65.61 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.393 0.677 . . . . 10.0 109.708 177.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.569 HG22 HG23 ' A' ' 21' ' ' ILE . 17.9 t -69.38 -43.83 80.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 116.493 -0.321 . . . . 10.0 111.183 177.786 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -50.45 -55.31 16.45 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.851 0.86 . . . . 10.0 109.566 178.444 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.5 ttmt -53.73 -42.45 68.11 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 126.151 1.78 . . . . 10.0 111.035 175.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.477 HD13 ' HG3' ' A' ' 24' ' ' ARG . 7.9 tp -53.0 -27.12 17.76 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 113.601 0.963 . . . . 10.0 113.601 174.32 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 140.21 -30.24 2.35 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-N 118.567 0.622 . . . . 10.0 112.671 169.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -127.8 157.97 38.97 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 124.695 1.198 . . . . 10.0 109.03 -173.081 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.4 ptpt -92.06 155.55 18.0 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 123.101 0.56 . . . . 10.0 111.574 -166.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.664 HD11 ' HB2' ' A' ' 7' ' ' PHE . 11.7 tp -134.37 146.06 49.55 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 126.393 1.877 . . . . 10.0 107.32 -176.087 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.3 tptp -147.31 137.18 23.02 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 119.232 -0.413 . . . . 10.0 110.602 168.158 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.598 HD23 ' N ' ' A' ' 71' ' ' LYS . 2.5 tt -64.83 154.06 38.24 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.05 -0.722 . . . . 10.0 109.05 178.181 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.598 ' N ' HD23 ' A' ' 70' ' ' LEU . 18.8 tttm -119.0 -63.7 1.37 Allowed 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 126.165 1.786 . . . . 10.0 108.371 -178.347 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.06 -78.75 0.03 OUTLIER Glycine 0 CA--C 1.521 0.452 0 N-CA-C 109.274 -1.53 . . . . 10.0 109.274 173.083 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 . . . . . 0 N--CA 1.455 -0.218 0 N-CA-C 108.443 -0.947 . . . . 10.0 108.443 -167.32 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.578 HG21 ' HB2' ' A' ' 32' ' ' ALA . 3.0 p . . . . . 0 N--CA 1.454 -0.26 0 CA-C-O 120.984 0.421 . . . . 10.0 110.216 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -116.69 162.83 17.05 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 126.863 2.065 . . . . 10.0 108.112 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.81 125.64 52.95 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.061 -1.459 . . . . 10.0 107.061 178.354 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.521 ' HB1' HD11 ' A' ' 70' ' ' LEU . . . -131.47 145.95 52.01 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.956 1.303 . . . . 10.0 108.474 -178.377 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -126.19 150.36 48.37 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 118.615 0.643 . . . . 10.0 111.578 177.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.784 ' CE2' HD11 ' A' ' 57' ' ' LEU . 2.1 m-85 -139.74 139.05 36.42 Favored 'General case' 0 C--O 1.234 0.269 0 O-C-N 125.006 1.441 . . . . 10.0 110.079 -166.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -102.79 132.51 48.92 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.491 -0.929 . . . . 10.0 108.491 -171.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.415 HD11 HG23 ' A' ' 43' ' ' VAL . 8.7 mm -101.09 122.9 53.73 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 124.143 0.977 . . . . 10.0 109.839 -165.009 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 . . . . . 0 N--CA 1.451 -0.395 0 N-CA-C 106.861 -1.533 . . . . 10.0 106.861 177.439 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.453 -0.292 0 CA-C-O 120.373 0.13 . . . . 10.0 110.953 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.73 -40.07 75.05 Favored 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 121.645 -0.66 . . . . 10.0 109.752 177.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.512 HD12 HG22 ' A' ' 61' ' ' VAL . 9.0 mm -46.15 -50.38 4.61 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.249 0 CA-C-O 117.224 -1.37 . . . . 10.0 112.452 170.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -47.78 -53.41 15.44 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 120.34 1.427 . . . . 10.0 110.838 -176.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.2 tppt? -70.22 -43.59 70.33 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 123.612 0.765 . . . . 10.0 108.951 -176.275 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 14.2 tpp180 -63.4 -33.94 76.64 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-O 119.658 -0.21 . . . . 10.0 110.81 -175.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.488 HD12 HG22 ' A' ' 21' ' ' ILE . 0.3 OUTLIER -78.68 -38.19 39.89 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 124.71 1.204 . . . . 10.0 110.529 173.01 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -59.95 -19.06 49.97 Favored 'General case' 0 C--O 1.225 -0.199 0 O-C-N 121.256 -0.903 . . . . 10.0 110.8 177.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.6 ptpt -51.84 -43.63 63.27 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 113.123 0.786 . . . . 10.0 113.123 169.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 5.2 mt -55.97 134.15 19.83 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 N-CA-C 108.635 -0.876 . . . . 10.0 108.635 -176.143 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -70.85 -47.1 61.13 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 108.705 -0.85 . . . . 10.0 108.705 -177.277 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -80.84 43.81 2.88 Favored Glycine 0 C--N 1.342 0.875 0 O-C-N 121.068 -1.02 . . . . 10.0 112.111 -176.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.8 p -105.92 152.05 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 C-N-CA 125.298 1.439 . . . . 10.0 109.058 -177.296 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.578 ' HB2' HG21 ' A' ' 2' ' ' THR . . . -115.81 -57.91 2.17 Favored 'General case' 0 CA--C 1.522 -0.127 0 C-N-CA 123.796 0.838 . . . . 10.0 108.873 169.219 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 64.6 m-80 -143.62 159.24 42.81 Favored 'General case' 0 CA--C 1.526 0.057 0 N-CA-C 109.496 -0.557 . . . . 10.0 109.496 -176.286 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -141.32 61.34 13.67 Favored Pre-proline 0 CA--C 1.537 0.452 0 C-N-CA 123.884 0.874 . . . . 10.0 111.585 174.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -77.35 71.39 6.4 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 123.09 2.526 . . . . 10.0 110.03 -176.305 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.543 HG12 HG13 ' A' ' 43' ' ' VAL . 3.5 m -67.02 155.02 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 O-C-N 121.744 -0.598 . . . . 10.0 111.028 -178.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -95.69 155.24 16.83 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 120.98 0.419 . . . . 10.0 109.934 172.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -135.28 48.47 2.25 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 124.954 1.301 . . . . 10.0 109.695 -171.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -175.26 -42.44 0.01 OUTLIER 'General case' 0 C--O 1.224 -0.251 0 C-N-CA 126.09 1.756 . . . . 10.0 108.708 178.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.4 mt -80.66 -15.48 56.46 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 125.436 1.494 . . . . 10.0 112.012 -170.395 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 71.86 40.29 0.77 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.275 1.43 . . . . 10.0 110.721 174.159 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.5 p -140.76 123.38 16.12 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.64 1.576 . . . . 10.0 108.969 -178.25 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.543 HG13 HG12 ' A' ' 36' ' ' VAL . 9.3 t -92.86 145.91 7.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 107.322 -1.362 . . . . 10.0 107.322 168.559 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 88.3 m -133.75 122.13 22.89 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 105.997 -1.853 . . . . 10.0 105.997 -176.065 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 29.3 t -122.98 134.42 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-N 118.74 0.7 . . . . 10.0 109.408 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -96.15 104.41 16.37 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 106.833 -1.543 . . . . 10.0 106.833 161.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -145.42 163.72 33.75 Favored 'General case' 0 CA--C 1.521 -0.166 0 C-N-CA 123.558 0.743 . . . . 10.0 109.798 178.583 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 13.3 p30 -98.5 130.64 27.62 Favored Pre-proline 0 C--N 1.329 -0.307 0 C-N-CA 123.419 0.687 . . . . 10.0 109.492 175.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -79.02 57.56 6.53 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 121.86 1.707 . . . . 10.0 108.967 171.399 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.34 -46.79 2.03 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.144 -0.687 . . . . 10.0 109.144 174.389 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -85.75 -61.06 1.84 Allowed 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 109.696 -0.483 . . . . 10.0 109.696 -178.263 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -107.71 -176.61 3.11 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 124.105 0.962 . . . . 10.0 110.017 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 93.6 p -140.1 169.73 17.15 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.696 1.198 . . . . 10.0 109.622 176.121 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 84.0 t -48.43 -52.6 8.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 124.408 1.083 . . . . 10.0 109.83 168.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.1 m -55.5 -35.95 66.14 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.631 1.173 . . . . 10.0 112.394 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -71.84 -60.62 2.14 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.703 -0.48 . . . . 10.0 109.703 174.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.784 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.0 pp -61.54 -43.72 98.36 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 121.85 -0.531 . . . . 10.0 110.636 -167.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.478 ' HA ' HD23 ' A' ' 68' ' ' LEU . 0.4 OUTLIER -51.37 -35.49 38.93 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 114.09 1.144 . . . . 10.0 114.09 171.065 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.88 -33.72 67.15 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 119.56 1.073 . . . . 10.0 110.088 176.652 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.38 -51.1 68.92 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 109.235 -0.654 . . . . 10.0 109.235 -177.265 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.512 HG22 HD12 ' A' ' 21' ' ' ILE . 43.3 t -59.54 -48.0 88.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 124.032 0.933 . . . . 10.0 111.477 173.744 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -53.09 -47.97 68.15 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 122.209 1.004 . . . . 10.0 109.435 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 32.8 tttp -70.56 -39.8 73.74 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 125.526 1.53 . . . . 10.0 110.897 -177.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 11.8 mt -51.57 -39.34 57.68 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 118.647 -0.692 . . . . 10.0 111.906 169.33 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 149.64 -21.2 1.17 Allowed Glycine 0 CA--C 1.527 0.798 0 CA-C-N 118.786 0.721 . . . . 10.0 114.698 167.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.42 ' OH ' HD11 ' A' ' 21' ' ' ILE . 1.9 p90 -118.82 155.43 31.19 Favored 'General case' 0 C--O 1.224 -0.276 0 C-N-CA 124.831 1.253 . . . . 10.0 107.955 -175.515 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.75 144.75 25.37 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 118.756 0.707 . . . . 10.0 110.331 -168.075 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.599 HD11 ' HB2' ' A' ' 7' ' ' PHE . 20.2 tp -123.36 145.18 48.96 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 126.157 1.783 . . . . 10.0 107.646 178.068 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.2 tptp -152.15 151.74 31.42 Favored 'General case' 0 CA--C 1.512 -0.499 0 C-N-CA 124.619 1.168 . . . . 10.0 108.488 171.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.521 HD11 ' HB1' ' A' ' 5' ' ' ALA . 7.9 tp -66.28 151.51 46.9 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 123.662 0.601 . . . . 10.0 109.66 177.527 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -105.07 -59.01 1.81 Allowed 'General case' 0 N--CA 1.437 -1.087 0 C-N-CA 127.492 2.317 . . . . 10.0 105.674 164.396 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 176.59 -93.65 0.09 OUTLIER Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 108.035 -2.026 . . . . 10.0 108.035 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 . . . . . 0 N--CA 1.453 -0.29 0 C-N-CA 123.601 0.76 . . . . 10.0 109.608 -163.548 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.6 p . . . . . 0 N--CA 1.452 -0.34 0 N-CA-C 106.609 -1.626 . . . . 10.0 106.609 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -126.2 149.91 48.71 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 126.439 1.895 . . . . 10.0 107.478 -168.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.51 131.75 49.02 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 107.883 -1.155 . . . . 10.0 107.883 -176.048 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.523 ' HB1' HD11 ' A' ' 70' ' ' LEU . . . -140.27 157.24 45.89 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 123.656 0.782 . . . . 10.0 109.926 178.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -128.31 151.57 49.16 Favored 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 123.542 0.737 . . . . 10.0 110.353 178.192 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.711 ' CE2' HD11 ' A' ' 57' ' ' LEU . 7.0 m-85 -140.35 146.64 38.69 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.845 1.658 . . . . 10.0 109.184 -170.037 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -110.15 125.82 53.42 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.311 1.044 . . . . 10.0 109.0 -165.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.418 HD11 HG23 ' A' ' 43' ' ' VAL . 8.6 mm -100.36 109.47 25.14 Favored 'Isoleucine or valine' 0 C--N 1.343 0.314 0 CA-C-N 118.907 0.776 . . . . 10.0 112.449 -159.173 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.407 ' OE1' ' NZ ' ' A' ' 67' ' ' LYS . 52.4 mt-10 . . . . . 0 N--CA 1.45 -0.458 0 N-CA-C 107.934 -1.135 . . . . 10.0 107.934 178.434 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 . . . . . 0 CA--C 1.534 0.352 0 N-CA-C 113.038 0.755 . . . . 10.0 113.038 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 18.1 ttm180 -72.31 -36.46 68.92 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 120.641 -1.287 . . . . 10.0 109.392 -178.46 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 9.1 mt -43.95 -53.41 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.44 0 CA-C-O 118.654 -0.689 . . . . 10.0 109.492 168.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -48.98 -47.22 44.3 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.4 0.546 . . . . 10.0 111.811 -175.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.21 -48.45 65.14 Favored 'General case' 0 CA--C 1.531 0.222 0 O-C-N 121.585 -0.697 . . . . 10.0 110.014 177.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.508 ' HB3' ' HB1' ' A' ' 60' ' ' ALA . 5.9 mmt180 -56.72 -35.47 68.58 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 112.093 0.405 . . . . 10.0 112.093 -179.473 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.489 HD21 ' HB2' ' A' ' 57' ' ' LEU . 1.3 mt -80.3 -44.8 18.97 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.752 1.621 . . . . 10.0 110.896 177.235 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -54.28 -24.98 21.07 Favored 'General case' 0 C--O 1.227 -0.113 0 CA-C-N 118.319 0.508 . . . . 10.0 111.077 174.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.8 ttmt -58.34 -35.37 71.8 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 112.984 0.735 . . . . 10.0 112.984 173.098 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.7 mm -60.02 135.13 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 C-N-CA 123.755 0.822 . . . . 10.0 109.85 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -69.05 -54.82 13.1 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 111.998 0.369 . . . . 10.0 111.998 -173.403 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.67 41.03 2.66 Favored Glycine 0 C--N 1.339 0.711 0 O-C-N 120.916 -1.115 . . . . 10.0 111.928 -173.3 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.4 p -100.95 150.61 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 C-N-CA 124.562 1.145 . . . . 10.0 108.542 -175.23 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -111.93 -58.16 2.16 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 108.483 -0.932 . . . . 10.0 108.483 171.668 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 60.0 m-80 -147.58 156.08 42.46 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.659 -0.867 . . . . 10.0 108.659 -173.289 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -141.72 56.81 6.3 Favored Pre-proline 0 CA--C 1.536 0.404 0 C-N-CA 123.626 0.771 . . . . 10.0 112.641 175.163 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -75.43 77.65 3.22 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 122.758 2.306 . . . . 10.0 110.152 -177.357 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.428 HG12 HG13 ' A' ' 43' ' ' VAL . 3.4 m -57.49 154.04 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 O-C-N 121.83 -0.543 . . . . 10.0 111.632 176.001 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -93.31 138.2 31.9 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.458 -0.571 . . . . 10.0 109.458 -179.443 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -117.7 54.56 0.9 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.99 1.316 . . . . 10.0 110.25 -171.388 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 171.14 -34.12 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 127.039 2.136 . . . . 10.0 109.997 176.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.5 mt -91.3 -1.67 57.59 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.14 1.376 . . . . 10.0 111.978 -171.088 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 65.44 35.19 7.52 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 124.918 1.287 . . . . 10.0 111.052 165.272 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -140.44 133.77 29.79 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 125.403 1.481 . . . . 10.0 107.857 -172.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.428 HG13 HG12 ' A' ' 36' ' ' VAL . 7.9 t -94.88 140.65 16.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 106.792 -1.558 . . . . 10.0 106.792 168.525 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 60.4 m -125.8 119.29 27.49 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 106.108 -1.812 . . . . 10.0 106.108 -178.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.8 t -120.57 142.51 36.15 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.207 0 C-N-CA 122.992 0.517 . . . . 10.0 109.629 -178.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 59.2 tt0 -109.51 110.44 21.54 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 107.184 -1.413 . . . . 10.0 107.184 162.38 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -151.72 164.93 35.9 Favored 'General case' 0 C--O 1.227 -0.129 0 C-N-CA 123.876 0.871 . . . . 10.0 109.405 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 20.7 p30 -95.53 134.69 23.9 Favored Pre-proline 0 C--N 1.328 -0.365 0 C-N-CA 123.437 0.695 . . . . 10.0 110.681 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -80.77 56.39 6.07 Favored 'Trans proline' 0 N--CA 1.45 -1.077 0 C-N-CA 121.603 1.536 . . . . 10.0 109.193 170.118 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.55 -39.54 0.51 Allowed 'General case' 0 C--N 1.346 0.439 0 CA-C-N 118.631 0.651 . . . . 10.0 112.54 175.642 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -95.23 -26.63 15.88 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 122.992 0.517 . . . . 10.0 110.321 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.51 173.22 15.42 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.183 0.993 . . . . 10.0 109.14 -179.221 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 91.0 p -131.59 169.35 16.25 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.565 1.146 . . . . 10.0 112.258 -177.124 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 26.4 m -48.75 -43.52 14.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 124.01 0.924 . . . . 10.0 110.679 166.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.85 -36.43 79.1 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.964 1.706 . . . . 10.0 111.642 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -71.55 -61.2 1.86 Allowed 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 108.472 -0.936 . . . . 10.0 108.472 175.253 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.711 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.3 pp -60.19 -42.31 94.8 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 120.042 -0.663 . . . . 10.0 111.545 -169.75 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.45 ' HA ' HD23 ' A' ' 68' ' ' LEU . 0.4 OUTLIER -51.24 -37.68 48.36 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 117.305 -1.331 . . . . 10.0 113.879 170.718 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -51.55 -39.08 57.09 Favored 'General case' 0 C--N 1.346 0.417 0 CA-C-N 120.735 1.607 . . . . 10.0 110.298 173.55 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.508 ' HB1' ' HB3' ' A' ' 24' ' ' ARG . . . -62.18 -46.14 90.27 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 109.429 -0.582 . . . . 10.0 109.429 -174.21 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 68.9 t -66.83 -45.87 86.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 123.327 0.651 . . . . 10.0 111.755 172.592 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -49.9 -54.13 21.54 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 124.67 1.188 . . . . 10.0 108.821 -178.794 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 46.4 tptt -57.67 -34.78 69.75 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.549 1.54 . . . . 10.0 111.644 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.458 HD13 ' HA ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -55.85 -34.45 65.44 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 124.255 1.022 . . . . 10.0 111.248 174.064 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 125.95 -11.45 7.36 Favored Glycine 0 CA--C 1.529 0.968 0 CA-C-O 119.474 -0.626 . . . . 10.0 113.4 174.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -116.35 151.46 35.87 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 107.149 -1.426 . . . . 10.0 107.149 173.643 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.407 ' NZ ' ' OE1' ' A' ' 10' ' ' GLU . 13.3 ttpp -95.47 156.4 16.34 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.246 0.546 . . . . 10.0 110.364 -171.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.519 HD11 ' HB2' ' A' ' 7' ' ' PHE . 29.7 tp -128.98 150.44 50.4 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.622 1.569 . . . . 10.0 107.882 -179.045 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 11.0 tptp -155.14 151.56 28.4 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 108.803 -0.814 . . . . 10.0 108.803 169.293 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.523 HD11 ' HB1' ' A' ' 5' ' ' ALA . 7.5 tp -62.74 154.78 28.48 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 121.303 0.573 . . . . 10.0 109.573 177.532 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 45.6 tttp -117.23 -53.44 2.45 Favored 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 127.769 2.428 . . . . 10.0 107.08 170.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 170.57 -84.38 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.515 0 N-CA-C 109.081 -1.608 . . . . 10.0 109.081 176.607 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 . . . . . 0 N--CA 1.448 -0.525 0 N-CA-C 108.224 -1.028 . . . . 10.0 108.224 -164.578 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.549 HG21 ' HB2' ' A' ' 32' ' ' ALA . 21.7 p . . . . . 0 N--CA 1.451 -0.393 0 CA-C-O 121.71 0.767 . . . . 10.0 110.103 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -116.47 151.95 35.02 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 125.186 1.394 . . . . 10.0 109.136 -165.442 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -86.58 129.67 34.78 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.857 1.263 . . . . 10.0 107.719 -171.275 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -134.28 136.34 43.48 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.527 1.131 . . . . 10.0 109.362 174.576 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -116.11 150.8 36.79 Favored 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 124.622 1.169 . . . . 10.0 108.067 174.201 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.821 ' CE2' HD11 ' A' ' 57' ' ' LEU . 7.0 m-85 -138.95 138.17 37.07 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 124.493 1.121 . . . . 10.0 109.327 -174.617 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -102.12 130.59 48.77 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.727 1.611 . . . . 10.0 108.197 -176.386 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.408 HD12 HD12 ' A' ' 68' ' ' LEU . 0.9 OUTLIER -114.95 153.86 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.068 0 C-N-CA 125.789 1.636 . . . . 10.0 110.895 -165.86 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 . . . . . 0 N--CA 1.443 -0.811 0 C-N-CA 124.387 1.075 . . . . 10.0 108.23 168.656 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 . . . . . 0 CA--C 1.539 0.523 0 N-CA-C 112.631 0.604 . . . . 10.0 112.631 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.1 ttm180 -78.7 -36.88 42.9 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.307 1.043 . . . . 10.0 108.805 178.032 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 19.1 mm -43.7 -54.31 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.399 0 CA-C-O 118.462 -0.78 . . . . 10.0 109.854 171.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -44.63 -46.79 10.31 Favored 'General case' 0 C--O 1.224 -0.277 0 C-N-CA 122.998 0.519 . . . . 10.0 111.841 -179.401 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.54 -46.25 63.95 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 122.971 0.508 . . . . 10.0 110.076 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.09 -33.68 74.9 Favored 'General case' 0 C--O 1.222 -0.342 0 O-C-N 121.987 -0.445 . . . . 10.0 111.808 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.12 -34.84 26.0 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.524 1.53 . . . . 10.0 111.431 177.328 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -58.68 -24.59 61.62 Favored 'General case' 0 C--O 1.226 -0.171 0 O-C-N 121.761 -0.587 . . . . 10.0 109.89 172.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -52.03 -40.12 60.58 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 120.879 -0.328 . . . . 10.0 111.348 171.635 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 15.9 mm -56.16 127.2 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 C-N-CA 123.203 0.601 . . . . 10.0 109.623 -176.187 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -70.42 -48.67 54.98 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 121.081 -0.248 . . . . 10.0 110.759 -176.592 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -84.31 43.43 3.21 Favored Glycine 0 C--N 1.34 0.75 0 O-C-N 120.802 -1.186 . . . . 10.0 111.549 -177.185 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.3 p -99.4 148.46 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 124.287 1.035 . . . . 10.0 108.582 -178.052 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.549 ' HB2' HG21 ' A' ' 2' ' ' THR . . . -111.02 -57.51 2.23 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 124.106 0.962 . . . . 10.0 108.545 175.349 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 -143.39 152.46 41.62 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.307 -0.997 . . . . 10.0 108.307 -175.422 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -138.94 61.57 22.52 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 123.602 0.761 . . . . 10.0 111.072 173.232 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -78.48 67.76 8.22 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 123.004 2.469 . . . . 10.0 110.018 -175.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.456 HG12 HG13 ' A' ' 43' ' ' VAL . 4.2 m -65.0 155.15 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 O-C-N 121.859 -0.526 . . . . 10.0 110.61 179.509 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 34.4 m120 -93.57 148.98 21.6 Favored 'General case' 0 C--O 1.224 -0.287 0 N-CA-C 108.497 -0.927 . . . . 10.0 108.497 175.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -126.3 47.95 2.2 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 123.643 0.777 . . . . 10.0 110.38 -173.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -174.22 -43.03 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 125.948 1.699 . . . . 10.0 109.614 178.465 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.0 mt -76.38 -18.47 58.85 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.803 1.241 . . . . 10.0 111.971 -169.334 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 63.2 54.72 2.01 Favored 'General case' 0 C--N 1.338 0.079 0 C-N-CA 125.752 1.621 . . . . 10.0 110.126 -174.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.2 p -142.29 130.74 22.41 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 107.481 -1.303 . . . . 10.0 107.481 172.222 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.456 HG13 HG12 ' A' ' 36' ' ' VAL . 9.2 t -105.28 145.41 13.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 106.759 -1.571 . . . . 10.0 106.759 173.033 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 69.8 m -139.83 123.57 17.42 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 106.25 -1.759 . . . . 10.0 106.25 -169.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 22.2 t -127.42 149.36 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 C-N-CA 123.692 0.797 . . . . 10.0 109.271 179.403 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 -115.78 112.02 21.38 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 105.895 -1.891 . . . . 10.0 105.895 159.684 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -146.44 162.81 37.46 Favored 'General case' 0 CA--C 1.52 -0.202 0 C-N-CA 123.403 0.681 . . . . 10.0 109.553 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 20.5 p30 -92.47 130.6 36.78 Favored Pre-proline 0 C--N 1.329 -0.306 0 C-N-CA 122.524 0.33 . . . . 10.0 110.237 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -76.47 61.6 6.82 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 121.554 1.503 . . . . 10.0 108.486 170.146 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.24 -43.88 0.33 Allowed 'General case' 0 C--N 1.341 0.223 0 O-C-N 122.085 -0.384 . . . . 10.0 109.979 177.795 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -87.02 -41.96 13.46 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 117.92 0.327 . . . . 10.0 110.865 177.052 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -133.04 -178.06 4.79 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 124.52 1.128 . . . . 10.0 109.952 -177.7 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 81.7 p -146.24 167.46 23.45 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.549 0.74 . . . . 10.0 109.579 177.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 64.9 t -43.01 -49.07 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.113 0 C-N-CA 124.836 1.254 . . . . 10.0 111.02 172.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 43.9 m -50.54 -43.4 56.07 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.486 0.714 . . . . 10.0 112.583 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -65.77 -60.21 3.12 Favored 'General case' 0 C--N 1.338 0.09 0 C-N-CA 123.808 0.843 . . . . 10.0 109.055 -177.483 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.821 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.0 pp -61.65 -42.84 99.47 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 120.06 -0.656 . . . . 10.0 110.533 -176.051 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.11 -53.2 6.63 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 117.823 -1.084 . . . . 10.0 112.16 163.514 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.32 -48.63 73.86 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 119.96 1.255 . . . . 10.0 110.38 178.398 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -48.28 -54.62 13.05 Favored 'General case' 0 N--CA 1.453 -0.309 0 O-C-N 123.349 0.405 . . . . 10.0 110.642 177.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.1 t -62.9 -44.6 99.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 N-CA-C 112.578 0.585 . . . . 10.0 112.578 176.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.63 -57.49 8.09 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.013 1.325 . . . . 10.0 108.431 178.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.0 tptm -55.6 -38.84 69.96 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 126.455 1.902 . . . . 10.0 111.216 176.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.403 HD12 ' HA ' ' A' ' 64' ' ' LEU . 6.1 tp -55.05 -27.46 44.8 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.186 0.995 . . . . 10.0 113.047 174.423 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 131.21 -11.14 5.58 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-O 119.169 -0.795 . . . . 10.0 114.258 168.496 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -137.91 160.55 38.99 Favored 'General case' 0 CA--C 1.527 0.058 0 CA-C-N 118.667 1.234 . . . . 10.0 108.37 -176.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 41.4 mmtt -88.94 153.62 20.89 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.148 0.499 . . . . 10.0 112.041 -165.363 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.408 HD12 HD12 ' A' ' 9' ' ' ILE . 8.9 tp -135.23 148.69 49.69 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 125.579 1.552 . . . . 10.0 107.104 176.294 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.8 mmtt -149.17 154.18 38.77 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 124.523 1.129 . . . . 10.0 108.233 165.108 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.9 tp -59.76 158.52 10.23 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 109.752 -0.462 . . . . 10.0 109.752 171.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 7.8 tptt -110.38 -74.19 0.66 Allowed 'General case' 0 N--CA 1.434 -1.255 0 C-N-CA 126.832 2.053 . . . . 10.0 106.892 173.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 163.87 44.79 0.02 OUTLIER Glycine 0 CA--C 1.53 0.992 0 CA-C-O 119.491 -0.616 . . . . 10.0 112.537 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 . . . . . 0 CA--C 1.542 0.657 0 C-N-CA 125.059 1.344 . . . . 10.0 113.893 169.255 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.685 HG21 ' HB2' ' A' ' 32' ' ' ALA . 2.2 p . . . . . 0 N--CA 1.449 -0.489 0 N-CA-C 107.275 -1.38 . . . . 10.0 107.275 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -135.75 146.13 47.33 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 126.543 1.937 . . . . 10.0 106.708 -172.224 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 28.8 mmtm -81.54 145.73 30.52 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.77 -0.826 . . . . 10.0 108.77 177.167 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -145.12 141.58 28.92 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.721 1.208 . . . . 10.0 108.212 174.392 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -122.63 148.82 44.81 Favored 'General case' 0 CA--C 1.51 -0.595 0 C-N-CA 124.413 1.085 . . . . 10.0 108.601 174.626 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.774 ' CE2' HD11 ' A' ' 57' ' ' LEU . 2.7 m-85 -140.43 138.05 34.42 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 125.101 1.5 . . . . 10.0 109.404 -171.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -103.98 127.82 51.53 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.964 -1.124 . . . . 10.0 107.964 -168.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 10.7 mm -103.56 136.11 38.0 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.114 0 C-N-CA 124.424 1.09 . . . . 10.0 110.804 -160.466 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 . . . . . 0 N--CA 1.45 -0.473 0 N-CA-C 107.478 -1.305 . . . . 10.0 107.478 169.651 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 . . . . . 0 CA--C 1.531 0.235 0 N-CA-C 112.064 0.394 . . . . 10.0 112.064 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -60.31 -38.4 83.56 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 121.056 -1.027 . . . . 10.0 109.135 -179.643 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.428 HD12 HG22 ' A' ' 61' ' ' VAL . 13.1 mm -52.57 -49.1 46.14 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.477 0 CA-C-O 118.053 -0.975 . . . . 10.0 110.323 176.12 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -46.42 -50.66 16.42 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.909 0.777 . . . . 10.0 110.56 -177.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.64 -46.37 63.41 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.106 0.562 . . . . 10.0 111.264 178.763 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.1 mmt180 -58.8 -27.34 64.95 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.743 0.645 . . . . 10.0 112.743 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.0 -39.3 13.04 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.943 1.697 . . . . 10.0 111.404 174.341 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 24.8 t30 -57.47 -25.82 60.3 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 118.703 0.683 . . . . 10.0 110.627 174.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.1 mmpt? -54.4 -37.33 64.94 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 114.3 1.222 . . . . 10.0 114.3 169.09 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 11.6 mm -54.53 128.82 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 109.084 -0.71 . . . . 10.0 109.084 175.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -68.39 -49.62 58.78 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 109.469 -0.567 . . . . 10.0 109.469 -177.217 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -82.39 47.31 3.72 Favored Glycine 0 C--N 1.34 0.783 0 O-C-N 120.651 -1.28 . . . . 10.0 112.181 -175.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.5 p -110.23 153.57 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 C-N-CA 125.223 1.409 . . . . 10.0 109.568 -177.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.685 ' HB2' HG21 ' A' ' 2' ' ' THR . . . -118.0 -52.01 2.43 Favored 'General case' 0 C--O 1.228 -0.029 0 C-N-CA 122.714 0.406 . . . . 10.0 110.127 169.227 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -144.57 149.92 36.62 Favored 'General case' 0 CA--C 1.527 0.087 0 N-CA-C 109.075 -0.713 . . . . 10.0 109.075 -173.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -137.58 58.48 16.86 Favored Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 123.691 0.796 . . . . 10.0 112.432 174.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -77.04 77.2 3.87 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 123.125 2.55 . . . . 10.0 110.495 -176.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.45 HG12 HG13 ' A' ' 43' ' ' VAL . 3.7 m -59.71 153.43 4.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 O-C-N 121.741 -0.599 . . . . 10.0 111.398 176.009 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -97.84 143.6 28.28 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.829 -0.804 . . . . 10.0 108.829 175.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -125.34 43.01 3.15 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.278 1.031 . . . . 10.0 110.953 -166.182 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -175.6 -40.06 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 125.924 1.69 . . . . 10.0 108.942 -178.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 12.6 mt -76.38 -21.26 56.27 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.346 1.058 . . . . 10.0 111.414 -176.612 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 63.7 49.48 2.96 Favored 'General case' 0 CA--C 1.527 0.093 0 C-N-CA 125.547 1.539 . . . . 10.0 109.959 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.6 p -137.86 131.67 31.39 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 126.131 1.772 . . . . 10.0 106.854 174.164 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.45 HG13 HG12 ' A' ' 36' ' ' VAL . 17.5 t -93.26 144.21 9.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 106.174 -1.787 . . . . 10.0 106.174 167.122 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 92.4 m -130.4 123.1 29.09 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 105.453 -2.054 . . . . 10.0 105.453 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 44.5 t -122.26 149.79 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 N-CA-C 108.668 -0.864 . . . . 10.0 108.668 176.122 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -116.06 108.66 16.48 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 107.113 -1.44 . . . . 10.0 107.113 161.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -146.63 164.63 32.04 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 108.915 -0.772 . . . . 10.0 108.915 -178.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 17.3 p30 -94.81 128.44 39.47 Favored Pre-proline 0 C--N 1.326 -0.421 0 N-CA-C 109.983 -0.377 . . . . 10.0 109.983 174.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -77.55 57.2 5.87 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 121.787 1.658 . . . . 10.0 108.7 168.355 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.17 -45.66 1.97 Allowed 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.113 -0.699 . . . . 10.0 109.113 177.138 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -90.11 -58.88 2.35 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 123.2 0.6 . . . . 10.0 109.68 -178.209 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -111.32 175.13 5.55 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 125.187 1.395 . . . . 10.0 109.565 178.431 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 59.4 p -129.14 176.65 7.74 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.66 1.184 . . . . 10.0 110.226 175.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 92.3 t -52.43 -39.88 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-N 115.234 -0.893 . . . . 10.0 110.691 168.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.1 m -58.13 -37.34 74.44 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 123.083 0.553 . . . . 10.0 111.882 -177.301 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -69.36 -58.49 3.94 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 123.999 0.92 . . . . 10.0 109.137 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.774 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.1 pp -63.08 -41.22 99.38 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 120.381 -0.528 . . . . 10.0 111.118 -175.518 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -40.48 -57.93 1.69 Allowed 'General case' 0 C--O 1.22 -0.48 0 O-C-N 121.575 -0.703 . . . . 10.0 111.69 161.024 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.47 -42.3 77.97 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 118.851 0.75 . . . . 10.0 110.35 -177.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -55.35 -47.28 75.98 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.395 -0.82 . . . . 10.0 110.432 179.059 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.428 HG22 HD12 ' A' ' 21' ' ' ILE . 48.0 t -66.02 -41.84 90.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 N-CA-C 111.481 0.178 . . . . 10.0 111.481 171.784 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -58.21 -45.36 87.79 Favored 'General case' 0 C--N 1.331 -0.201 0 O-C-N 121.181 -0.949 . . . . 10.0 109.181 -172.236 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 56.5 tttm -64.39 -27.91 69.33 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.32 1.048 . . . . 10.0 112.459 178.201 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.466 HD13 ' HA ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -56.63 -28.51 60.67 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 119.246 0.93 . . . . 10.0 110.756 168.959 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 131.26 -48.6 0.96 Allowed Glycine 0 C--N 1.337 0.635 0 N-CA-C 109.477 -1.449 . . . . 10.0 109.477 175.359 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -86.32 162.62 18.13 Favored 'General case' 0 C--O 1.224 -0.286 0 C-N-CA 125.422 1.489 . . . . 10.0 109.778 -177.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.87 163.7 12.53 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.38 0.609 . . . . 10.0 110.813 -167.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.548 HD11 ' HB2' ' A' ' 7' ' ' PHE . 18.4 tp -139.82 148.6 42.4 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 126.408 1.883 . . . . 10.0 107.561 -175.494 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.2 tptp -148.18 155.34 41.27 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 118.408 -0.806 . . . . 10.0 108.9 163.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.9 tp -63.83 158.4 22.06 Favored 'General case' 0 C--N 1.339 0.143 0 N-CA-C 108.992 -0.744 . . . . 10.0 108.992 174.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 14.8 tttp -113.77 -69.23 0.87 Allowed 'General case' 0 N--CA 1.436 -1.166 0 C-N-CA 125.739 1.616 . . . . 10.0 107.389 172.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 162.38 49.41 0.02 OUTLIER Glycine 0 CA--C 1.526 0.78 0 CA-C-O 119.666 -0.519 . . . . 10.0 112.35 175.349 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 . . . . . 0 CA--C 1.53 0.188 0 C-N-CA 124.996 1.319 . . . . 10.0 111.947 178.162 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.609 HG21 ' HB2' ' A' ' 32' ' ' ALA . 2.4 p . . . . . 0 N--CA 1.45 -0.43 0 N-CA-C 107.309 -1.367 . . . . 10.0 107.309 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -137.75 146.76 44.05 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.414 1.486 . . . . 10.0 108.35 -166.509 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -91.71 140.14 30.0 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.036 0.534 . . . . 10.0 109.733 -177.486 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -142.84 148.23 36.72 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.051 1.34 . . . . 10.0 109.315 179.147 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -123.27 149.37 44.86 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.612 1.165 . . . . 10.0 108.372 174.248 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.786 ' CE2' HD11 ' A' ' 57' ' ' LEU . 3.1 m-85 -141.04 144.12 34.8 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 124.976 1.422 . . . . 10.0 109.18 -174.095 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -106.92 132.03 53.32 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.4 1.08 . . . . 10.0 109.801 -169.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.426 HD11 ' HB ' ' A' ' 43' ' ' VAL . 4.7 mm -110.65 113.93 45.65 Favored 'Isoleucine or valine' 0 C--N 1.34 0.18 0 C-N-CA 125.096 1.358 . . . . 10.0 112.011 -160.541 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 . . . . . 0 N--CA 1.451 -0.407 0 N-CA-C 108.397 -0.964 . . . . 10.0 108.397 169.686 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 . . . . . 0 N--CA 1.448 -0.558 0 N-CA-C 113.115 0.783 . . . . 10.0 113.115 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.15 -48.44 57.38 Favored 'General case' 0 N--CA 1.451 -0.386 0 O-C-N 120.747 -1.221 . . . . 10.0 108.337 176.686 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -45.83 -51.55 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 CA-C-O 118.163 -0.922 . . . . 10.0 110.663 175.094 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -43.31 -48.8 6.89 Favored 'General case' 0 C--N 1.341 0.225 0 CA-C-N 118.626 0.648 . . . . 10.0 111.421 178.007 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.65 -47.04 61.98 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.779 -0.822 . . . . 10.0 108.779 -176.352 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.56 -38.67 75.17 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.275 -0.42 . . . . 10.0 111.894 -179.296 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.1 mt -78.96 -41.96 27.95 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.141 1.376 . . . . 10.0 110.576 178.275 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 15.7 t30 -54.8 -25.05 25.7 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.137 0.575 . . . . 10.0 111.226 173.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.2 ttmt -55.57 -38.38 69.29 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 112.393 0.516 . . . . 10.0 112.393 171.136 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 21.4 mm -60.01 132.14 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 C-N-CA 124.079 0.951 . . . . 10.0 109.831 -179.113 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -71.5 -52.63 17.33 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 111.47 0.174 . . . . 10.0 111.47 -174.807 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -82.95 42.83 3.02 Favored Glycine 0 C--N 1.339 0.71 0 O-C-N 120.753 -1.217 . . . . 10.0 112.026 -176.125 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.7 p -103.22 148.72 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 C-N-CA 124.385 1.074 . . . . 10.0 108.537 -177.138 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.609 ' HB2' HG21 ' A' ' 2' ' ' THR . . . -110.94 -56.55 2.35 Favored 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 108.965 -0.754 . . . . 10.0 108.965 175.063 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -147.96 151.53 35.96 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 108.216 -1.031 . . . . 10.0 108.216 -172.343 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -136.61 65.16 53.96 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 123.77 0.828 . . . . 10.0 110.93 172.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -78.36 68.17 8.05 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.01 2.474 . . . . 10.0 109.447 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.457 HG12 HG13 ' A' ' 43' ' ' VAL . 13.6 m -71.27 158.95 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 C-N-CA 123.058 0.543 . . . . 10.0 111.36 -177.236 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -100.64 145.6 28.2 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-O 120.936 0.398 . . . . 10.0 110.894 -175.529 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -121.99 38.78 4.04 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.304 1.442 . . . . 10.0 111.102 -170.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -176.57 -36.68 0.01 OUTLIER 'General case' 0 C--O 1.224 -0.249 0 C-N-CA 125.06 1.344 . . . . 10.0 110.531 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 12.8 mt -82.18 -10.89 59.0 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.9 1.28 . . . . 10.0 112.036 -173.019 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 71.67 40.45 0.78 Allowed 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 125.661 1.584 . . . . 10.0 110.885 171.445 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 7.5 p -142.51 133.4 25.65 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.546 1.138 . . . . 10.0 108.975 -175.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.457 HG13 HG12 ' A' ' 36' ' ' VAL . 3.4 t -99.78 139.4 21.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 N-CA-C 106.187 -1.783 . . . . 10.0 106.187 168.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 57.7 m -131.66 118.17 19.66 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 105.218 -2.142 . . . . 10.0 105.218 -174.136 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.5 t -124.49 140.16 48.59 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.183 0 C-N-CA 122.964 0.506 . . . . 10.0 109.707 -175.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 49.4 tt0 -103.23 111.42 23.8 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 107.39 -1.337 . . . . 10.0 107.39 161.061 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -145.6 164.46 31.65 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 123.68 0.792 . . . . 10.0 109.782 176.595 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -96.75 131.56 27.81 Favored Pre-proline 0 C--N 1.33 -0.25 0 C-N-CA 123.067 0.547 . . . . 10.0 110.03 177.59 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -77.2 61.34 7.25 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 121.302 1.335 . . . . 10.0 108.68 168.539 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.14 -43.95 0.38 Allowed 'General case' 0 C--N 1.343 0.311 0 O-C-N 121.894 -0.504 . . . . 10.0 110.981 177.082 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.77 -41.12 14.36 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.797 0.839 . . . . 10.0 110.031 178.108 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -144.42 170.06 16.74 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 126.223 1.809 . . . . 10.0 108.772 -170.511 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 33.0 p -128.71 -179.49 5.1 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 122.608 1.194 . . . . 10.0 110.817 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 99.3 t -46.54 -41.46 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 114.413 -1.267 . . . . 10.0 111.292 163.174 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 70.6 m -62.0 -40.05 94.33 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 118.46 0.573 . . . . 10.0 111.301 -173.655 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -68.48 -54.57 16.07 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.814 1.245 . . . . 10.0 108.999 -175.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.786 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.0 pp -63.87 -44.07 94.18 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 119.664 -0.814 . . . . 10.0 110.485 -179.555 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.9 -49.66 10.88 Favored 'General case' 0 C--O 1.221 -0.438 0 CA-C-O 117.823 -1.084 . . . . 10.0 113.212 163.739 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 14.2 tm-20 -54.82 -46.2 74.52 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 120.715 1.598 . . . . 10.0 109.618 179.426 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -50.69 -55.37 16.86 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.377 -0.829 . . . . 10.0 109.372 178.229 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.516 HG13 ' CE2' ' A' ' 66' ' ' TYR . 66.8 t -60.98 -49.97 82.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 112.841 0.682 . . . . 10.0 112.841 177.297 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -58.34 -33.38 69.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.749 0.785 . . . . 10.0 109.285 -176.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.6 tttp -77.7 -34.11 52.94 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 123.451 0.701 . . . . 10.0 111.583 178.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 67.9 mt -53.09 -42.22 65.71 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.347 0.976 . . . . 10.0 111.148 164.329 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 143.51 -37.48 1.46 Allowed Glycine 0 C--N 1.337 0.636 0 CA-C-N 118.155 0.434 . . . . 10.0 112.439 168.511 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.516 ' CE2' HG13 ' A' ' 61' ' ' VAL . 22.3 p90 -85.71 158.55 20.02 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 108.494 -0.928 . . . . 10.0 108.494 176.226 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 33.6 mttp -100.94 160.84 14.04 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.544 0.688 . . . . 10.0 111.422 -173.697 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.508 HD11 ' HB2' ' A' ' 7' ' ' PHE . 21.6 tp -136.68 149.49 47.95 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.253 1.821 . . . . 10.0 107.549 -171.821 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -153.38 152.36 30.97 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 109.011 -0.737 . . . . 10.0 109.011 162.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.7 tp -60.02 156.61 14.43 Favored 'General case' 0 C--O 1.231 0.129 0 O-C-N 123.595 0.56 . . . . 10.0 109.683 175.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -112.1 -70.44 0.81 Allowed 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 125.672 1.589 . . . . 10.0 107.201 172.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 157.4 59.08 0.01 OUTLIER Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.191 -0.763 . . . . 10.0 111.191 -179.07 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . 0.272 12.4 pt-20 . . . . . 0 CA--C 1.533 0.309 0 C-N-CA 128.098 2.559 . . . . 10.0 114.737 176.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.648 HG21 ' HB2' ' A' ' 32' ' ' ALA . 11.8 p . . . . . 0 N--CA 1.445 -0.687 0 N-CA-C 109.642 -0.503 . . . . 10.0 109.642 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.7 mp0 -101.02 138.33 38.21 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.244 1.817 . . . . 10.0 109.212 177.326 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.7 tptt -81.87 119.86 24.46 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 108.105 -1.072 . . . . 10.0 108.105 171.549 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -128.09 153.55 46.69 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.537 1.135 . . . . 10.0 109.575 173.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -128.1 145.24 51.06 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.632 0.773 . . . . 10.0 110.215 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.537 ' HB2' HD11 ' A' ' 68' ' ' LEU . 2.1 m-85 -130.22 133.57 46.64 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 125.236 1.585 . . . . 10.0 111.749 -167.484 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -85.1 136.11 33.69 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 125.28 1.432 . . . . 10.0 109.781 176.101 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.541 HD11 HG23 ' A' ' 43' ' ' VAL . 5.2 mm -109.42 134.58 51.03 Favored 'Isoleucine or valine' 0 C--N 1.34 0.176 0 C-N-CA 126.543 1.937 . . . . 10.0 109.756 -173.649 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 . . . . . 0 N--CA 1.446 -0.658 0 N-CA-C 108.28 -1.007 . . . . 10.0 108.28 159.841 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 . . . . . 0 CA--C 1.537 0.443 0 CA-C-O 121.915 0.864 . . . . 10.0 112.491 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 34.5 ttt85 -66.38 -35.41 80.26 Favored 'General case' 0 N--CA 1.45 -0.425 0 O-C-N 120.813 -1.18 . . . . 10.0 109.77 178.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 4.6 mt -52.04 -57.98 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.498 0 N-CA-C 108.861 -0.792 . . . . 10.0 108.861 172.066 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -45.25 -48.18 12.8 Favored 'General case' 0 C--O 1.221 -0.427 0 O-C-N 123.856 0.723 . . . . 10.0 110.882 -177.021 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.2 mtmt -68.14 -46.98 69.34 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.934 0.893 . . . . 10.0 110.414 -178.136 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.3 tpm_? -63.32 -36.59 84.19 Favored 'General case' 0 N--CA 1.45 -0.425 0 O-C-N 121.858 -0.526 . . . . 10.0 110.184 -178.066 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.06 -34.57 50.34 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.901 1.681 . . . . 10.0 111.457 176.644 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -64.15 -20.5 66.03 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 118.633 0.651 . . . . 10.0 109.421 175.086 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -53.97 -41.24 67.64 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 119.941 -0.704 . . . . 10.0 111.156 168.014 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 28.2 mm -58.97 129.96 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 123.667 0.787 . . . . 10.0 109.757 -174.356 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -73.03 -48.95 31.7 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 116.631 -0.259 . . . . 10.0 110.399 -172.618 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -82.88 40.9 2.83 Favored Glycine 0 C--N 1.339 0.746 0 O-C-N 120.887 -1.133 . . . . 10.0 111.767 -176.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -104.89 144.73 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 N-CA-C 107.743 -1.206 . . . . 10.0 107.743 179.424 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.648 ' HB2' HG21 ' A' ' 2' ' ' THR . . . -106.67 -55.19 2.36 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.26 -0.644 . . . . 10.0 109.26 171.594 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -142.89 143.01 31.88 Favored 'General case' 0 C--O 1.226 -0.154 0 N-CA-C 108.824 -0.806 . . . . 10.0 108.824 -174.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -133.68 55.64 16.83 Favored Pre-proline 0 CA--C 1.54 0.585 0 N-CA-C 113.552 0.945 . . . . 10.0 113.552 175.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -77.9 75.58 4.73 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 123.392 2.728 . . . . 10.0 110.39 -177.022 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.644 HG12 HG13 ' A' ' 43' ' ' VAL . 2.1 m -62.32 153.09 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 123.138 0.575 . . . . 10.0 111.719 178.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -94.35 138.53 32.21 Favored 'General case' 0 N--CA 1.457 -0.116 0 O-C-N 122.082 -0.386 . . . . 10.0 110.06 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -116.01 45.64 1.7 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.676 1.19 . . . . 10.0 111.557 -169.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -175.92 -39.99 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.207 0 C-N-CA 125.232 1.413 . . . . 10.0 109.354 178.515 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.7 mt -74.92 -20.21 59.8 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.491 1.117 . . . . 10.0 111.427 -174.606 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 63.39 49.93 3.04 Favored 'General case' 0 C--N 1.339 0.132 0 C-N-CA 125.466 1.506 . . . . 10.0 109.761 -178.193 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.1 p -140.06 125.85 19.43 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 125.507 1.523 . . . . 10.0 107.446 174.537 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.644 HG13 HG12 ' A' ' 36' ' ' VAL . 32.1 t -91.69 136.46 24.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 107.263 -1.384 . . . . 10.0 107.263 167.863 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 26.0 m -120.05 124.88 46.94 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 125.592 1.557 . . . . 10.0 107.079 178.39 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 98.1 t -134.94 146.52 30.43 Favored 'Isoleucine or valine' 0 C--N 1.341 0.232 0 CA-C-N 119.154 0.888 . . . . 10.0 110.524 175.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -105.03 106.64 17.23 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 126.99 2.116 . . . . 10.0 106.162 169.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 26.5 p90 -139.6 154.44 47.59 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 118.926 0.785 . . . . 10.0 110.766 179.196 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -94.69 128.28 40.36 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 118.589 -0.719 . . . . 10.0 110.079 175.595 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -76.07 57.87 5.36 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.553 2.169 . . . . 10.0 108.862 169.168 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.413 ' NZ ' ' OE1' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -124.51 -53.0 1.7 Allowed 'General case' 0 C--N 1.338 0.102 0 N-CA-C 106.508 -1.664 . . . . 10.0 106.508 176.195 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.413 ' OE1' ' NZ ' ' A' ' 50' ' ' LYS . 1.8 tp10 -89.45 -42.49 11.46 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.031 0.532 . . . . 10.0 110.712 -178.269 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.27 147.63 29.55 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 124.833 1.253 . . . . 10.0 107.965 -172.077 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 54.1 p -105.81 -171.98 2.01 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.104 0.962 . . . . 10.0 109.864 -179.253 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.51 HG21 HD12 ' A' ' 70' ' ' LEU . 3.5 p -61.37 -32.72 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 120.323 -0.551 . . . . 10.0 111.006 166.402 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.2 t -54.76 -43.54 72.84 Favored 'General case' 0 C--O 1.235 0.335 0 O-C-N 121.822 -0.549 . . . . 10.0 109.703 -175.673 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -64.32 -54.49 32.32 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 125.72 1.608 . . . . 10.0 108.839 -175.402 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.435 HD13 ' CE2' ' A' ' 7' ' ' PHE . 4.0 pp -67.78 -42.59 81.45 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.959 -0.463 . . . . 10.0 111.25 -178.116 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -44.64 -50.62 9.72 Favored 'General case' 0 N--CA 1.449 -0.477 0 O-C-N 121.162 -0.961 . . . . 10.0 111.709 163.549 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.45 -45.14 92.45 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 118.92 0.782 . . . . 10.0 109.87 179.411 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -51.45 -49.82 60.99 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.031 -0.531 . . . . 10.0 110.182 178.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.502 ' HA ' HD12 ' A' ' 64' ' ' LEU . 58.0 t -68.2 -43.71 84.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 112.209 0.448 . . . . 10.0 112.209 177.696 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -53.5 -40.99 65.82 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 108.973 -0.751 . . . . 10.0 108.973 176.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.8 tptt -75.01 -36.75 61.92 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.899 1.28 . . . . 10.0 111.324 -179.555 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.502 HD12 ' HA ' ' A' ' 61' ' ' VAL . 15.5 mt -51.93 -35.03 44.38 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.817 0.735 . . . . 10.0 112.023 167.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.79 24.29 4.99 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 123.192 0.425 . . . . 10.0 112.888 169.58 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -141.75 160.56 39.93 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 105.276 -2.12 . . . . 10.0 105.276 168.463 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 62.7 tttt -106.82 144.34 33.61 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 119.548 1.067 . . . . 10.0 111.774 -168.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.537 HD11 ' HB2' ' A' ' 7' ' ' PHE . 14.0 tp -121.47 147.99 45.03 Favored 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 127.883 2.473 . . . . 10.0 107.622 -176.813 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.0 mmtt -143.22 170.04 16.5 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 124.407 1.083 . . . . 10.0 108.445 161.273 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.516 HD23 ' H ' ' A' ' 71' ' ' LYS . 1.6 tt -93.31 151.4 19.81 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 123.505 0.722 . . . . 10.0 109.195 178.645 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.516 ' H ' HD23 ' A' ' 70' ' ' LEU . 56.9 tttp -116.08 -62.36 1.6 Allowed 'General case' 0 N--CA 1.441 -0.904 0 C-N-CA 125.94 1.696 . . . . 10.0 108.089 -177.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -175.52 -87.93 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 108.455 -1.858 . . . . 10.0 108.455 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 . . . . . 0 N--CA 1.452 -0.353 0 C-N-CA 124.154 0.981 . . . . 10.0 109.177 -171.313 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.57 HG21 ' HB2' ' A' ' 32' ' ' ALA . 6.3 p . . . . . 0 CA--C 1.534 0.33 0 N-CA-C 107.337 -1.357 . . . . 10.0 107.337 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -139.16 147.74 42.26 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 127.525 2.33 . . . . 10.0 106.747 -167.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 59.7 mmtt -91.93 135.72 33.72 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 123.264 0.625 . . . . 10.0 109.636 -175.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -138.34 140.62 39.57 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.888 -1.152 . . . . 10.0 107.888 173.51 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -122.3 150.57 42.18 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.631 0.772 . . . . 10.0 110.368 175.466 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.724 ' HB2' HD11 ' A' ' 68' ' ' LEU . 0.8 OUTLIER -141.95 136.47 30.41 Favored 'General case' 0 N--CA 1.448 -0.566 0 O-C-N 124.925 1.39 . . . . 10.0 110.212 -169.903 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -95.91 135.74 37.26 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.933 1.693 . . . . 10.0 108.993 -175.693 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.554 HD11 HG23 ' A' ' 43' ' ' VAL . 7.2 mm -106.74 116.34 50.26 Favored 'Isoleucine or valine' 0 C--N 1.339 0.15 0 C-N-CA 125.851 1.66 . . . . 10.0 111.463 -165.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 . . . . . 0 N--CA 1.448 -0.548 0 N-CA-C 107.595 -1.261 . . . . 10.0 107.595 170.912 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.539 0.524 0 N-CA-C 112.59 0.589 . . . . 10.0 112.59 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.17 -36.97 66.68 Favored 'General case' 0 N--CA 1.447 -0.619 0 O-C-N 121.005 -1.059 . . . . 10.0 108.795 -178.605 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.568 HD12 HG22 ' A' ' 61' ' ' VAL . 11.6 mm -51.38 -58.2 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 N-CA-C 108.425 -0.954 . . . . 10.0 108.425 168.418 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -45.75 -41.41 10.71 Favored 'General case' 0 C--O 1.223 -0.311 0 O-C-N 123.604 0.565 . . . . 10.0 111.216 -178.152 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.29 -54.81 12.76 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 121.634 -0.666 . . . . 10.0 111.735 178.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.48 ' CZ ' ' HA ' ' A' ' 60' ' ' ALA . 4.8 mtp180 -60.99 -39.5 89.91 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 119.454 -0.899 . . . . 10.0 110.81 -178.768 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.89 -41.79 70.85 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 123.698 0.799 . . . . 10.0 110.74 179.553 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 44.4 m-20 -54.55 -30.78 55.08 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 118.454 0.57 . . . . 10.0 110.608 171.39 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -59.19 -31.7 69.24 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 118.377 -0.821 . . . . 10.0 112.776 176.086 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 18.6 mm -57.89 121.16 4.95 Favored 'Isoleucine or valine' 0 C--N 1.34 0.187 0 CA-C-N 118.933 0.788 . . . . 10.0 109.858 -178.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 50.1 mp0 -57.32 -46.13 83.55 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 123.658 0.783 . . . . 10.0 112.085 -175.351 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.95 32.61 3.2 Favored Glycine 0 C--N 1.341 0.816 0 CA-C-N 120.323 1.419 . . . . 10.0 112.772 -174.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.7 p -99.41 150.74 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 119.204 1.502 . . . . 10.0 109.327 -176.133 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.57 ' HB2' HG21 ' A' ' 2' ' ' THR . . . -108.79 -59.12 1.92 Allowed 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 108.454 -0.943 . . . . 10.0 108.454 168.613 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 66.3 m-20 -139.64 152.96 47.19 Favored 'General case' 0 C--N 1.337 0.026 0 N-CA-C 108.775 -0.824 . . . . 10.0 108.775 -174.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -137.1 62.85 41.27 Favored Pre-proline 0 CA--C 1.537 0.462 0 C-N-CA 124.17 0.988 . . . . 10.0 111.687 174.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -75.68 77.1 3.44 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 123.061 2.508 . . . . 10.0 111.511 -177.595 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.528 HG13 HG22 ' A' ' 43' ' ' VAL . 70.6 t -61.96 135.65 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 C-N-CA 125.889 1.676 . . . . 10.0 111.391 176.738 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -94.85 94.91 8.33 Favored 'General case' 0 C--N 1.346 0.419 0 O-C-N 121.296 -0.878 . . . . 10.0 111.552 -175.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -75.35 49.47 0.47 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.781 2.032 . . . . 10.0 114.055 -173.612 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -176.84 -37.15 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 124.916 1.287 . . . . 10.0 110.452 176.719 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.5 mt -84.68 -13.38 51.61 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.057 0.943 . . . . 10.0 111.261 -173.007 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 74.17 40.54 0.43 Allowed 'General case' 0 C--O 1.228 -0.071 0 C-N-CA 125.213 1.405 . . . . 10.0 110.25 170.686 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 35.4 p -140.08 131.11 26.25 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 125.028 1.331 . . . . 10.0 107.828 179.013 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.554 HG23 HD11 ' A' ' 9' ' ' ILE . 28.5 t -91.99 144.14 9.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 107.026 -1.472 . . . . 10.0 107.026 165.481 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 91.3 m -131.67 124.1 29.16 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 105.879 -1.897 . . . . 10.0 105.879 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 42.2 t -126.36 145.21 34.25 Favored 'Isoleucine or valine' 0 C--N 1.339 0.145 0 C-N-CA 123.289 0.635 . . . . 10.0 109.371 177.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -112.85 103.36 11.35 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 105.601 -2.0 . . . . 10.0 105.601 171.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -136.58 159.54 41.51 Favored 'General case' 0 C--O 1.225 -0.218 0 C-N-CA 123.883 0.873 . . . . 10.0 110.755 -175.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 21.2 p30 -94.8 125.78 49.79 Favored Pre-proline 0 C--N 1.331 -0.197 0 C-N-CA 123.481 0.712 . . . . 10.0 109.953 175.255 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -74.56 65.63 5.63 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 121.766 1.644 . . . . 10.0 108.304 172.065 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.7 pttt -138.86 -49.77 0.52 Allowed 'General case' 0 C--O 1.227 -0.105 0 N-CA-C 106.967 -1.494 . . . . 10.0 106.967 178.51 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -106.15 -56.54 2.17 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 124.656 1.182 . . . . 10.0 108.069 174.68 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.24 139.45 50.06 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 123.391 0.677 . . . . 10.0 109.738 -176.708 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 20.6 p -130.78 143.51 50.79 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 122.047 0.927 . . . . 10.0 110.518 174.045 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 30.3 m -45.39 -43.58 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 C-N-CA 125.157 1.383 . . . . 10.0 111.609 176.704 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.0 m -58.2 -43.13 87.45 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.501 1.121 . . . . 10.0 112.517 -177.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -63.08 -53.19 57.52 Favored 'General case' 0 C--O 1.224 -0.263 0 CA-C-O 122.072 0.939 . . . . 10.0 108.875 -173.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.567 HD11 ' CE2' ' A' ' 7' ' ' PHE 0.267 1.2 pp -65.62 -36.39 83.57 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.082 -1.011 . . . . 10.0 112.621 -177.225 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.405 ' HZ2' HD23 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -39.93 -64.59 0.48 Allowed 'General case' 0 CA--C 1.534 0.348 0 O-C-N 120.962 -1.087 . . . . 10.0 112.881 156.525 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.8 tm-20 -52.23 -39.76 60.73 Favored 'General case' 0 CA--C 1.517 -0.301 0 C-N-CA 123.455 0.702 . . . . 10.0 109.572 178.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.48 ' HA ' ' CZ ' ' A' ' 24' ' ' ARG . . . -59.68 -55.01 39.76 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 115.747 -0.661 . . . . 10.0 110.696 -174.275 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.568 HG22 HD12 ' A' ' 21' ' ' ILE . 80.4 t -62.46 -42.31 95.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-N 115.666 -0.697 . . . . 10.0 110.909 174.228 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -55.35 -51.25 67.4 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 121.575 0.702 . . . . 10.0 110.311 -176.731 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 40.6 tptt -56.65 -39.7 74.17 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 125.765 1.626 . . . . 10.0 111.007 177.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.74 -22.38 35.04 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 113.056 0.762 . . . . 10.0 113.056 174.066 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 108.73 14.71 14.86 Favored Glycine 0 CA--C 1.529 0.952 0 CA-C-N 118.78 0.718 . . . . 10.0 113.161 170.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.427 ' CZ ' HD11 ' A' ' 21' ' ' ILE . 2.2 p90 -143.37 160.27 40.85 Favored 'General case' 0 C--O 1.225 -0.23 0 N-CA-C 106.603 -1.629 . . . . 10.0 106.603 172.13 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -111.6 144.59 40.6 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 119.064 0.847 . . . . 10.0 111.141 -162.423 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.724 HD11 ' HB2' ' A' ' 7' ' ' PHE . 23.3 tp -121.38 148.27 44.61 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 125.097 1.359 . . . . 10.0 108.289 -172.188 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 20.8 mmtt -149.0 139.51 22.52 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 125.446 1.498 . . . . 10.0 110.288 169.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.563 HD23 ' N ' ' A' ' 71' ' ' LYS . 2.5 tt -72.1 157.38 37.88 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.633 -0.877 . . . . 10.0 108.633 177.758 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.563 ' N ' HD23 ' A' ' 70' ' ' LEU . 64.1 tttt -120.86 -65.26 1.16 Allowed 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 125.585 1.554 . . . . 10.0 108.169 177.548 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.53 -74.01 0.03 OUTLIER Glycine 0 CA--C 1.522 0.518 0 N-CA-C 110.051 -1.22 . . . . 10.0 110.051 173.378 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 . . . . . 0 N--CA 1.454 -0.251 0 N-CA-C 106.557 -1.646 . . . . 10.0 106.557 -165.567 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.508 HG21 ' HB2' ' A' ' 32' ' ' ALA . 7.7 p . . . . . 0 N--CA 1.455 -0.195 0 CA-C-O 120.87 0.367 . . . . 10.0 110.33 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -124.51 151.16 44.99 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 127.475 2.31 . . . . 10.0 107.575 -171.549 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.1 mppt? -93.69 142.67 27.09 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 123.975 0.91 . . . . 10.0 109.6 -176.149 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -148.19 140.95 24.62 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.027 0.931 . . . . 10.0 109.336 -177.381 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -117.97 148.75 41.9 Favored 'General case' 0 CA--C 1.508 -0.638 0 C-N-CA 123.361 0.665 . . . . 10.0 110.415 173.577 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.75 ' CE2' HD11 ' A' ' 57' ' ' LEU . 15.2 m-85 -134.47 144.39 48.07 Favored 'General case' 0 N--CA 1.446 -0.632 0 O-C-N 125.407 1.692 . . . . 10.0 108.781 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -109.97 132.42 54.17 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 108.475 -0.935 . . . . 10.0 108.475 -172.028 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.8 mm -113.43 144.16 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 C-N-CA 124.092 0.957 . . . . 10.0 111.811 -157.005 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 . . . . . 0 N--CA 1.444 -0.76 0 C-N-CA 124.524 1.13 . . . . 10.0 108.123 169.438 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 . . . . . 0 N--CA 1.468 0.43 0 CA-C-O 121.572 0.701 . . . . 10.0 112.001 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 27.1 ttt180 -52.8 -38.14 60.78 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.253 1.021 . . . . 10.0 110.029 -178.33 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.64 HG22 HD12 ' A' ' 25' ' ' LEU . 27.5 mm -59.14 -45.98 92.31 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.538 0 CA-C-O 117.572 -1.204 . . . . 10.0 110.905 174.708 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -50.12 -50.5 48.35 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 119.606 1.094 . . . . 10.0 109.788 -176.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.7 tmmt? -67.9 -47.81 67.77 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.324 1.05 . . . . 10.0 110.11 179.08 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.04 -28.95 64.96 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.53 0.567 . . . . 10.0 112.53 177.539 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.64 HD12 HG22 ' A' ' 21' ' ' ILE . 1.0 OUTLIER -80.09 -43.38 21.86 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.989 1.315 . . . . 10.0 109.347 175.084 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.457 ' HA ' HG11 ' A' ' 31' ' ' VAL . 0.3 OUTLIER -56.89 -24.59 53.05 Favored 'General case' 0 C--O 1.226 -0.154 0 C-N-CA 123.964 0.905 . . . . 10.0 110.342 178.583 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.78 -36.51 81.3 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 114.775 1.398 . . . . 10.0 114.775 172.642 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.9 mp -62.39 129.19 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 120.067 1.303 . . . . 10.0 109.767 176.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -54.5 -51.16 65.98 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 112.433 0.531 . . . . 10.0 112.433 -177.55 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.85 37.3 2.82 Favored Glycine 0 C--N 1.34 0.774 0 O-C-N 120.563 -1.336 . . . . 10.0 112.317 -171.047 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.457 HG11 ' HA ' ' A' ' 26' ' ' ASN . 2.8 p -103.79 155.5 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 CA-C-N 118.362 1.081 . . . . 10.0 108.928 -177.154 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.508 ' HB2' HG21 ' A' ' 2' ' ' THR . . . -120.52 -58.54 1.83 Allowed 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 109.006 -0.739 . . . . 10.0 109.006 170.489 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 62.2 m-80 -139.08 155.66 47.76 Favored 'General case' 0 CA--C 1.521 -0.172 0 N-CA-C 108.835 -0.802 . . . . 10.0 108.835 -173.647 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -153.38 58.6 2.37 Favored Pre-proline 0 CA--C 1.533 0.318 0 N-CA-C 112.668 0.618 . . . . 10.0 112.668 173.223 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -74.45 79.05 2.57 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.659 2.24 . . . . 10.0 109.935 -178.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.535 HG12 HG13 ' A' ' 43' ' ' VAL . 4.5 m -63.47 156.72 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 O-C-N 121.695 -0.628 . . . . 10.0 112.168 -179.219 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -98.39 122.17 41.24 Favored 'General case' 0 N--CA 1.457 -0.102 0 O-C-N 122.144 -0.348 . . . . 10.0 110.585 -178.093 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -102.51 42.9 1.11 Allowed 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.954 1.301 . . . . 10.0 111.236 -176.373 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -163.1 -43.56 0.03 OUTLIER 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 124.176 0.99 . . . . 10.0 109.05 176.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 12.3 mt -76.24 -22.48 55.11 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.827 0.851 . . . . 10.0 111.213 -177.604 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 62.08 53.83 2.87 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 125.554 1.541 . . . . 10.0 109.509 -175.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 16.9 p -138.1 133.1 33.01 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.955 1.702 . . . . 10.0 107.458 173.152 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.535 HG13 HG12 ' A' ' 36' ' ' VAL . 5.9 t -100.1 125.46 53.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 107.188 -1.412 . . . . 10.0 107.188 173.071 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 37.4 m -109.54 115.25 29.57 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 126.397 1.879 . . . . 10.0 107.572 -178.036 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.7 t -117.1 145.92 22.23 Favored 'Isoleucine or valine' 0 C--N 1.34 0.166 0 CA-C-N 118.971 0.805 . . . . 10.0 110.857 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -115.11 108.07 16.16 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 125.283 1.433 . . . . 10.0 107.748 161.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 26.9 p90 -139.34 162.02 36.02 Favored 'General case' 0 C--O 1.226 -0.134 0 C-N-CA 123.808 0.843 . . . . 10.0 110.253 -178.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 25.1 p30 -95.97 128.48 37.17 Favored Pre-proline 0 C--N 1.332 -0.18 0 C-N-CA 123.397 0.679 . . . . 10.0 110.142 176.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -75.48 61.69 6.09 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 N-CA-C 108.468 -1.397 . . . . 10.0 108.468 171.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.84 -47.14 0.32 Allowed 'General case' 0 C--N 1.346 0.416 0 CA-C-N 118.584 0.629 . . . . 10.0 110.195 176.381 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -104.59 -40.23 6.1 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.067 0.547 . . . . 10.0 109.898 170.82 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.32 158.35 17.84 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.377 0.671 . . . . 10.0 110.366 -177.566 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 97.7 p -148.83 158.74 44.38 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.643 0.735 . . . . 10.0 111.776 172.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.0 m -53.41 -45.78 57.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 124.267 1.027 . . . . 10.0 110.937 173.08 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 16.0 m -57.66 -43.48 84.99 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.4 1.08 . . . . 10.0 111.722 -178.549 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -64.2 -57.5 9.33 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.283 1.033 . . . . 10.0 109.262 -178.316 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.75 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.3 pp -65.42 -41.34 93.66 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.123 -0.985 . . . . 10.0 111.058 -176.259 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -43.03 -52.05 5.45 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-O 118.244 -0.884 . . . . 10.0 112.562 160.595 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.76 -45.95 77.97 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 119.772 1.169 . . . . 10.0 110.082 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -52.7 -54.2 36.85 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.977 -0.556 . . . . 10.0 110.321 178.024 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.498 HG22 HD12 ' A' ' 21' ' ' ILE . 40.6 t -57.85 -47.23 86.68 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 N-CA-C 112.597 0.592 . . . . 10.0 112.597 174.656 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -53.48 -55.6 23.98 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.754 1.222 . . . . 10.0 109.257 -177.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -59.72 -33.62 71.86 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 126.997 2.119 . . . . 10.0 111.711 178.041 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.87 -38.0 61.06 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.24 0.616 . . . . 10.0 111.908 168.68 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 119.25 9.7 8.52 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 124.187 0.898 . . . . 10.0 113.344 176.423 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -135.76 172.74 12.57 Favored 'General case' 0 C--O 1.225 -0.221 0 N-CA-C 107.076 -1.453 . . . . 10.0 107.076 172.618 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 33.1 mttt -114.94 157.84 22.83 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 118.853 0.752 . . . . 10.0 111.994 -166.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.2 tp -143.82 145.3 32.25 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.206 1.802 . . . . 10.0 107.254 -170.5 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 32.2 mmtt -148.84 150.09 32.42 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 124.291 1.036 . . . . 10.0 109.044 164.296 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.6 tp -63.01 158.62 18.95 Favored 'General case' 0 N--CA 1.456 -0.172 0 O-C-N 123.919 0.762 . . . . 10.0 109.236 175.061 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 19.1 tttt -124.59 -53.81 1.67 Allowed 'General case' 0 N--CA 1.439 -1.023 0 C-N-CA 127.811 2.444 . . . . 10.0 107.559 -178.76 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 174.03 -85.56 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 108.098 -2.001 . . . . 10.0 108.098 175.467 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 . . . . . 0 N--CA 1.453 -0.322 0 C-N-CA 124.38 1.072 . . . . 10.0 108.287 -169.259 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.474 HG21 ' HB2' ' A' ' 32' ' ' ALA . 4.9 p . . . . . 0 N--CA 1.449 -0.502 0 N-CA-C 108.821 -0.807 . . . . 10.0 108.821 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -141.61 140.78 33.41 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 126.981 2.112 . . . . 10.0 106.833 -170.432 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -90.84 130.76 36.77 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 123.675 0.79 . . . . 10.0 109.063 177.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -133.12 146.93 52.05 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 125.915 1.686 . . . . 10.0 107.947 -177.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -123.69 150.28 44.47 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.227 0.611 . . . . 10.0 110.249 176.113 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.869 ' CE2' HD11 ' A' ' 57' ' ' LEU . 2.7 m-85 -138.56 140.9 39.21 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.897 1.279 . . . . 10.0 109.621 -171.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -101.13 134.77 43.65 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 124.836 1.254 . . . . 10.0 108.596 -175.044 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 6.1 mm -107.6 119.45 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 C-N-CA 124.751 1.221 . . . . 10.0 110.223 -161.326 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 . . . . . 0 N--CA 1.449 -0.486 0 N-CA-C 108.329 -0.989 . . . . 10.0 108.329 174.025 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.6 m120 . . . . . 0 N--CA 1.464 0.269 0 N-CA-C 113.393 0.886 . . . . 10.0 113.393 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.4 ' HG2' HD11 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -69.39 -53.56 18.82 Favored 'General case' 0 C--O 1.234 0.242 0 O-C-N 121.37 -0.831 . . . . 10.0 109.005 171.337 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.533 HG22 HD12 ' A' ' 25' ' ' LEU . 6.4 mm -44.07 -54.85 0.99 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.339 0 O-C-N 123.915 0.759 . . . . 10.0 110.093 179.379 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -42.53 -50.86 5.26 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.994 0.918 . . . . 10.0 111.702 178.718 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.39 -47.56 60.29 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 121.453 -0.779 . . . . 10.0 110.794 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.428 ' CG ' ' HB1' ' A' ' 60' ' ' ALA . 0.5 OUTLIER -57.64 -36.91 72.47 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.952 0.901 . . . . 10.0 110.765 -177.606 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.533 HD12 HG22 ' A' ' 21' ' ' ILE . 0.4 OUTLIER -77.83 -43.97 28.8 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 126.151 1.781 . . . . 10.0 110.741 175.829 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -52.55 -28.55 21.26 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 118.915 0.779 . . . . 10.0 111.606 172.283 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.7 tmmt? -62.11 -26.91 68.57 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 112.402 0.519 . . . . 10.0 112.402 177.473 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 10.0 mm -66.85 133.51 31.3 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.131 0 N-CA-C 108.874 -0.787 . . . . 10.0 108.874 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -64.8 -56.16 15.26 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 120.608 0.242 . . . . 10.0 110.67 -173.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.96 44.71 3.36 Favored Glycine 0 C--N 1.34 0.784 0 O-C-N 120.755 -1.215 . . . . 10.0 112.039 -171.729 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.6 p -108.15 150.59 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 C-N-CA 124.649 1.18 . . . . 10.0 108.846 -176.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.474 ' HB2' HG21 ' A' ' 2' ' ' THR . . . -122.3 -52.29 1.95 Allowed 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.078 0.551 . . . . 10.0 110.285 174.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -138.68 153.89 48.57 Favored 'General case' 0 C--N 1.338 0.097 0 N-CA-C 109.378 -0.601 . . . . 10.0 109.378 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -146.29 61.85 7.45 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 123.484 0.714 . . . . 10.0 111.548 173.097 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -77.46 73.22 5.66 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.972 2.448 . . . . 10.0 109.599 -179.082 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.507 HG12 HG13 ' A' ' 43' ' ' VAL . 2.6 m -66.57 151.72 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 O-C-N 121.96 -0.462 . . . . 10.0 111.075 -179.125 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 -97.68 125.91 42.72 Favored 'General case' 0 N--CA 1.458 -0.068 0 O-C-N 122.193 -0.317 . . . . 10.0 110.413 -175.688 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -105.4 41.69 1.33 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.074 1.349 . . . . 10.0 111.65 -170.696 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -171.62 -38.81 0.02 OUTLIER 'General case' 0 C--O 1.225 -0.207 0 C-N-CA 124.958 1.303 . . . . 10.0 110.125 178.46 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.2 mt -77.37 -17.56 58.11 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.219 1.008 . . . . 10.0 111.616 -175.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 68.56 46.62 0.97 Allowed 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 125.64 1.576 . . . . 10.0 110.136 177.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 12.0 p -141.89 128.86 20.72 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.692 1.197 . . . . 10.0 108.378 177.532 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.507 HG13 HG12 ' A' ' 36' ' ' VAL . 10.3 t -93.72 135.04 29.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 106.361 -1.718 . . . . 10.0 106.361 169.488 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 60.6 m -121.05 123.48 42.47 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 105.9 -1.889 . . . . 10.0 105.9 178.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 19.3 t -124.23 149.97 28.66 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.115 0 C-N-CA 123.472 0.709 . . . . 10.0 109.211 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -124.92 102.33 7.49 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 126.647 1.979 . . . . 10.0 105.728 175.275 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -138.75 166.35 24.63 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 123.883 0.873 . . . . 10.0 110.675 -172.042 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 19.0 p30 -104.53 127.39 29.09 Favored Pre-proline 0 CA--C 1.532 0.254 0 C-N-CA 123.092 0.557 . . . . 10.0 110.094 177.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -75.59 63.66 6.49 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 122.52 2.147 . . . . 10.0 109.568 176.349 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 22.3 ttmt -142.74 -58.47 0.44 Allowed 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 106.3 -1.741 . . . . 10.0 106.3 175.72 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -114.08 1.16 14.53 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.34 1.456 . . . . 10.0 112.632 -173.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -133.23 154.5 50.6 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 125.276 1.43 . . . . 10.0 110.096 171.383 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 90.8 p -146.74 160.32 42.38 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.363 0.601 . . . . 10.0 111.391 175.013 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 59.4 t -52.79 -49.87 45.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 124.995 1.318 . . . . 10.0 109.408 173.056 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -51.11 -47.92 61.85 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 126.37 1.868 . . . . 10.0 111.758 178.337 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -67.83 -54.9 15.37 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.954 0.901 . . . . 10.0 109.899 -174.023 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.869 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.1 pp -66.0 -40.55 91.25 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 120.935 -1.103 . . . . 10.0 111.149 -178.576 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -43.87 -49.32 8.32 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 120.905 -1.122 . . . . 10.0 112.257 161.516 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.5 -43.49 79.78 Favored 'General case' 0 C--N 1.339 0.133 0 CA-C-N 119.824 1.193 . . . . 10.0 111.022 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.428 ' HB1' ' CG ' ' A' ' 24' ' ' ARG . . . -53.77 -53.26 54.77 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.126 -0.488 . . . . 10.0 110.335 176.146 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 47.4 t -63.07 -37.35 79.14 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 N-CA-C 112.321 0.489 . . . . 10.0 112.321 177.292 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -60.53 -55.13 37.1 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 125.091 1.356 . . . . 10.0 108.858 -177.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? -55.12 -41.21 71.41 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.893 0.877 . . . . 10.0 110.611 175.185 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.4 HD11 ' HG2' ' A' ' 20' ' ' ARG . 0.1 OUTLIER -49.65 -33.14 14.7 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.33 0.652 . . . . 10.0 112.326 173.342 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 113.82 17.62 7.33 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 124.044 0.83 . . . . 10.0 113.117 169.185 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.07 167.43 22.1 Favored 'General case' 0 N--CA 1.458 -0.041 0 N-CA-C 107.366 -1.346 . . . . 10.0 107.366 175.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -105.43 144.12 32.65 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 121.536 0.684 . . . . 10.0 111.351 -164.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.4 tp -130.13 145.5 51.71 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.102 1.761 . . . . 10.0 107.9 -178.414 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 26.0 mmtt -151.77 154.43 36.24 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 124.673 1.189 . . . . 10.0 108.659 167.478 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.7 tp -63.41 155.21 29.66 Favored 'General case' 0 CA--C 1.529 0.167 0 O-C-N 123.702 0.626 . . . . 10.0 110.33 176.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -111.89 -60.01 1.91 Allowed 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 127.508 2.323 . . . . 10.0 106.418 172.315 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -179.07 -84.88 0.06 OUTLIER Glycine 0 CA--C 1.523 0.539 0 N-CA-C 109.625 -1.39 . . . . 10.0 109.625 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 . . . . . 0 N--CA 1.451 -0.385 0 C-N-CA 124.475 1.11 . . . . 10.0 108.116 -169.497 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 13.4 p . . . . . 0 CA--C 1.535 0.375 0 N-CA-C 109.065 -0.716 . . . . 10.0 109.065 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -129.96 149.73 51.56 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 125.901 1.68 . . . . 10.0 109.49 -173.082 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.62 88.69 2.82 Favored 'General case' 0 C--N 1.341 0.215 0 C-N-CA 124.582 1.153 . . . . 10.0 109.606 -167.61 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -86.45 152.47 22.66 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.143 1.377 . . . . 10.0 110.523 -179.615 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -125.01 149.43 47.76 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.471 1.108 . . . . 10.0 109.341 174.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.716 ' CE2' HD11 ' A' ' 57' ' ' LEU . 4.7 m-85 -140.86 143.64 34.84 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 124.947 1.404 . . . . 10.0 110.794 -172.119 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -104.91 129.81 53.2 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.677 1.591 . . . . 10.0 108.849 -171.204 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 6.5 mm -103.62 111.29 32.76 Favored 'Isoleucine or valine' 0 C--N 1.342 0.252 0 C-N-CA 123.852 0.861 . . . . 10.0 111.289 -163.207 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 . . . . . 0 C--O 1.236 0.346 0 N-CA-C 107.704 -1.221 . . . . 10.0 107.704 175.573 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 . . . . . 0 CA--C 1.536 0.419 0 N-CA-C 112.112 0.412 . . . . 10.0 112.112 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.9 tpt180 -80.86 -48.05 12.94 Favored 'General case' 0 N--CA 1.452 -0.352 0 O-C-N 121.314 -0.866 . . . . 10.0 110.02 168.659 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.464 ' CG2' HD12 ' A' ' 25' ' ' LEU . 29.0 mm -39.35 -57.65 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.433 0 CA-C-O 118.545 -0.74 . . . . 10.0 110.844 177.104 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -44.75 -49.23 10.72 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 123.598 0.561 . . . . 10.0 111.499 -175.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.2 ttmt -72.7 -45.44 58.8 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.539 0.736 . . . . 10.0 110.379 -176.454 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -60.58 -36.36 78.33 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 122.805 0.442 . . . . 10.0 111.673 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.464 HD12 ' CG2' ' A' ' 21' ' ' ILE . 0.9 OUTLIER -71.96 -49.01 40.96 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.41 1.084 . . . . 10.0 109.324 171.975 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -54.51 -19.47 5.87 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.542 -0.723 . . . . 10.0 112.704 177.487 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -56.25 -35.3 67.26 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.718 1.007 . . . . 10.0 113.718 171.076 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.46 HD11 ' CB ' ' A' ' 57' ' ' LEU . 11.2 mt -58.22 139.03 18.43 Favored 'Isoleucine or valine' 0 C--N 1.339 0.132 0 CA-C-N 118.59 0.632 . . . . 10.0 109.593 179.415 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -69.45 -52.66 24.64 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 111.665 0.246 . . . . 10.0 111.665 -176.07 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -85.07 44.29 3.36 Favored Glycine 0 C--N 1.339 0.749 0 O-C-N 120.705 -1.247 . . . . 10.0 111.224 -175.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.4 p -99.76 152.4 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 C-N-CA 124.62 1.168 . . . . 10.0 108.366 -179.091 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -112.92 -57.63 2.26 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 108.562 -0.903 . . . . 10.0 108.562 171.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 -148.71 158.13 43.93 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.217 -1.401 . . . . 10.0 107.217 -173.41 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -148.28 61.15 5.61 Favored Pre-proline 0 CA--C 1.531 0.245 0 O-C-N 121.902 -0.499 . . . . 10.0 111.568 168.291 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -75.03 83.79 1.77 Allowed 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 122.915 2.41 . . . . 10.0 108.225 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.549 HG12 HG13 ' A' ' 43' ' ' VAL . 3.6 m -54.48 157.3 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 C-N-CA 123.236 0.614 . . . . 10.0 110.527 173.154 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 -84.52 161.06 20.37 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 107.591 -1.263 . . . . 10.0 107.591 171.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -122.79 29.37 6.86 Favored 'General case' 0 C--N 1.335 -0.051 0 N-CA-C 112.21 0.448 . . . . 10.0 112.21 -169.393 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -174.55 -37.94 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 122.657 0.383 . . . . 10.0 111.227 -171.033 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 16.6 mt -72.18 -19.68 61.71 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.327 1.051 . . . . 10.0 111.66 -177.036 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 67.13 43.65 2.07 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.041 1.336 . . . . 10.0 109.557 -178.038 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 17.4 p -140.39 123.55 16.71 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.855 1.662 . . . . 10.0 109.167 178.202 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.549 HG13 HG12 ' A' ' 36' ' ' VAL . 8.6 t -89.76 149.08 4.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 108.226 -1.028 . . . . 10.0 108.226 173.526 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 85.3 m -130.07 125.94 36.43 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 106.787 -1.56 . . . . 10.0 106.787 179.239 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.418 HG22 HD13 ' A' ' 25' ' ' LEU . 42.1 t -120.13 128.45 75.96 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 C-N-CA 123.452 0.701 . . . . 10.0 109.196 177.366 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 72.2 tt0 -94.43 106.82 18.8 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 108.085 -1.08 . . . . 10.0 108.085 160.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -144.01 164.79 29.61 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 109.605 -0.517 . . . . 10.0 109.605 175.455 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 22.3 p30 -93.72 141.41 23.75 Favored Pre-proline 0 C--N 1.328 -0.334 0 N-CA-C 109.522 -0.547 . . . . 10.0 109.522 175.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -85.29 47.92 2.13 Favored 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 121.594 1.529 . . . . 10.0 109.485 170.586 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.9 -9.64 6.63 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.247 0.93 . . . . 10.0 113.127 177.59 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -128.56 -51.65 1.26 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.923 1.289 . . . . 10.0 108.68 -167.521 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -122.52 -172.22 2.43 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.767 1.227 . . . . 10.0 109.736 173.171 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 99.3 p -141.12 169.53 17.44 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.924 1.289 . . . . 10.0 110.959 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 70.0 t -50.1 -49.75 21.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 124.172 0.989 . . . . 10.0 110.491 165.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.2 m -58.47 -36.19 73.33 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 123.841 0.856 . . . . 10.0 111.991 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -69.09 -60.42 2.37 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 109.69 -0.485 . . . . 10.0 109.69 173.479 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.716 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.3 pp -60.07 -47.23 86.75 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 121.051 0.453 . . . . 10.0 110.822 -165.266 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.468 ' N ' HD12 ' A' ' 57' ' ' LEU . 0.9 OUTLIER -48.74 -36.45 16.41 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 114.004 1.113 . . . . 10.0 114.004 172.196 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -57.35 -33.49 67.81 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 119.08 0.854 . . . . 10.0 110.599 178.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.92 -51.82 66.58 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.544 -0.91 . . . . 10.0 108.544 -178.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 25.1 t -61.15 -45.84 97.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 124.89 1.276 . . . . 10.0 110.484 178.079 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -56.49 -55.4 34.2 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 124.196 0.998 . . . . 10.0 108.499 -178.123 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.78 -35.28 74.33 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.083 0.953 . . . . 10.0 111.62 177.01 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.4 mp -55.15 -32.82 62.41 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 118.626 -0.702 . . . . 10.0 112.383 171.368 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 134.76 -7.06 4.51 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-O 119.394 -0.67 . . . . 10.0 114.366 169.472 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -135.17 151.26 50.5 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 106.769 -1.567 . . . . 10.0 106.769 -177.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.79 142.28 35.0 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 121.46 0.648 . . . . 10.0 111.09 -161.552 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.568 HD11 ' HB2' ' A' ' 7' ' ' PHE . 16.0 tp -118.34 144.03 46.18 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.583 1.953 . . . . 10.0 107.842 -173.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 4.0 tptp -147.81 154.76 40.89 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.124 0.97 . . . . 10.0 108.669 171.383 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.7 tp -63.75 157.51 24.11 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 109.267 -0.642 . . . . 10.0 109.267 176.734 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 30.8 tttp -111.27 -67.19 1.01 Allowed 'General case' 0 N--CA 1.441 -0.89 0 C-N-CA 124.974 1.31 . . . . 10.0 107.932 170.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 162.1 49.75 0.02 OUTLIER Glycine 0 CA--C 1.526 0.762 0 CA-C-N 118.383 0.538 . . . . 10.0 112.914 174.593 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 . . . . . 0 CA--C 1.532 0.272 0 C-N-CA 124.823 1.249 . . . . 10.0 112.564 -179.329 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 12.8 p . . . . . 0 N--CA 1.448 -0.537 0 N-CA-C 109.824 -0.436 . . . . 10.0 109.824 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -128.86 145.73 51.13 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 126.899 2.08 . . . . 10.0 108.528 -171.1 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -110.46 100.27 9.13 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.423 1.089 . . . . 10.0 112.559 -163.53 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -111.7 154.03 25.57 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.054 1.741 . . . . 10.0 110.241 -168.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -129.09 148.28 51.02 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 109.153 -0.684 . . . . 10.0 109.153 -177.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.753 ' CE2' HD11 ' A' ' 57' ' ' LEU . 4.3 m-85 -138.68 138.24 37.58 Favored 'General case' 0 N--CA 1.452 -0.361 0 O-C-N 124.92 1.388 . . . . 10.0 109.281 -171.31 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -100.89 126.29 47.5 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.399 1.08 . . . . 10.0 108.223 -171.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.411 HD11 HG23 ' A' ' 43' ' ' VAL . 6.7 mm -104.62 126.85 59.39 Favored 'Isoleucine or valine' 0 C--N 1.343 0.307 0 C-N-CA 124.654 1.182 . . . . 10.0 111.875 -164.132 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 . . . . . 0 N--CA 1.449 -0.495 0 N-CA-C 108.459 -0.941 . . . . 10.0 108.459 168.023 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.582 0 N-CA-C 112.923 0.712 . . . . 10.0 112.923 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.3 ttm180 -72.32 -36.8 68.98 Favored 'General case' 0 N--CA 1.447 -0.61 0 O-C-N 121.009 -1.057 . . . . 10.0 109.371 -178.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.677 HG22 HD12 ' A' ' 25' ' ' LEU . 1.6 mt -57.49 -48.17 83.51 Favored 'Isoleucine or valine' 0 C--N 1.344 0.344 0 CA-C-O 118.324 -0.846 . . . . 10.0 108.967 172.424 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -47.73 -47.04 30.37 Favored 'General case' 0 C--O 1.225 -0.187 0 CA-C-N 118.59 0.632 . . . . 10.0 111.517 -178.514 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 27.6 ttmt -72.56 -48.87 36.57 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.156 0.582 . . . . 10.0 110.298 -177.267 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -54.31 -41.19 68.69 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.629 0.603 . . . . 10.0 112.629 176.489 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.677 HD12 HG22 ' A' ' 21' ' ' ILE . 1.5 mt -68.84 -52.4 30.29 Favored 'General case' 0 C--O 1.221 -0.421 0 C-N-CA 124.95 1.3 . . . . 10.0 109.521 173.806 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 45.9 m-20 -54.02 -19.85 5.44 Favored 'General case' 0 C--O 1.227 -0.118 0 CA-C-N 118.63 0.65 . . . . 10.0 111.964 179.416 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.6 ttmt -58.74 -26.59 64.12 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 113.72 1.007 . . . . 10.0 113.72 172.326 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.69 HD11 ' HB3' ' A' ' 57' ' ' LEU . 10.8 mt -54.26 133.93 17.27 Favored 'Isoleucine or valine' 0 C--N 1.341 0.232 0 CA-C-N 119.572 1.078 . . . . 10.0 108.706 173.835 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -69.56 -47.44 63.65 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.919 -0.488 . . . . 10.0 111.418 179.511 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -86.61 45.71 3.48 Favored Glycine 0 C--N 1.339 0.714 0 O-C-N 120.637 -1.289 . . . . 10.0 111.2 -174.061 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -99.32 149.59 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 108.389 -0.967 . . . . 10.0 108.389 -176.629 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -104.2 -57.43 2.03 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 107.769 -1.197 . . . . 10.0 107.769 165.441 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 55.4 m-80 -149.28 156.18 41.7 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.409 -0.96 . . . . 10.0 108.409 -171.751 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -146.45 61.94 7.41 Favored Pre-proline 0 CA--C 1.538 0.517 0 N-CA-C 112.86 0.689 . . . . 10.0 112.86 169.549 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -79.05 85.74 1.81 Allowed 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 123.23 2.62 . . . . 10.0 109.746 -178.15 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.416 HG12 HG13 ' A' ' 43' ' ' VAL . 3.0 m -71.84 153.56 7.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 O-C-N 121.495 -0.753 . . . . 10.0 110.901 -178.819 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -94.02 127.34 39.76 Favored 'General case' 0 C--N 1.339 0.11 0 O-C-N 121.996 -0.44 . . . . 10.0 110.771 -175.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -105.16 59.56 0.68 Allowed 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.437 1.495 . . . . 10.0 110.772 -173.361 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 173.47 -35.97 0.0 OUTLIER 'General case' 0 C--O 1.226 -0.176 0 C-N-CA 125.411 1.485 . . . . 10.0 109.794 171.299 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.6 mt -83.33 -14.22 53.4 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.913 0.885 . . . . 10.0 111.087 -172.134 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 75.92 38.31 0.35 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.735 1.614 . . . . 10.0 110.785 170.138 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 38.3 p -137.18 131.66 32.83 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.136 1.374 . . . . 10.0 109.327 -177.52 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.416 HG13 HG12 ' A' ' 36' ' ' VAL . 3.6 t -91.8 142.72 12.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 107.625 -1.25 . . . . 10.0 107.625 167.121 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 44.7 m -127.2 124.61 39.39 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 106.828 -1.545 . . . . 10.0 106.828 177.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.8 t -124.6 141.24 45.36 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 N-CA-C 109.183 -0.673 . . . . 10.0 109.183 -179.257 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 55.1 tt0 -115.22 106.82 14.5 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 106.985 -1.487 . . . . 10.0 106.985 166.077 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -149.96 158.64 44.36 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 123.062 0.545 . . . . 10.0 109.667 -179.3 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -88.64 128.26 53.3 Favored Pre-proline 0 C--N 1.326 -0.421 0 N-CA-C 109.952 -0.388 . . . . 10.0 109.952 178.089 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -75.69 60.4 5.92 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.479 2.119 . . . . 10.0 108.939 171.457 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.5 tttt -130.91 -52.62 1.05 Allowed 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 106.472 -1.677 . . . . 10.0 106.472 173.051 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -83.85 -43.51 15.28 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.077 0.551 . . . . 10.0 110.475 -170.411 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -134.12 -173.61 3.31 Favored 'General case' 0 C--N 1.339 0.128 0 C-N-CA 124.904 1.282 . . . . 10.0 109.093 178.749 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 79.8 p -145.78 166.8 24.84 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.676 0.75 . . . . 10.0 109.864 -177.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.64 HG11 HD11 ' A' ' 70' ' ' LEU . 26.8 m -49.79 -41.53 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 115.064 -0.971 . . . . 10.0 111.428 167.877 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.3 m -56.37 -44.2 79.95 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 123.914 0.885 . . . . 10.0 112.178 177.151 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -63.22 -56.89 12.83 Favored 'General case' 0 C--N 1.337 0.064 0 N-CA-C 109.203 -0.666 . . . . 10.0 109.203 179.153 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.753 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.2 pp -67.63 -41.22 84.23 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 119.675 -0.81 . . . . 10.0 110.81 -171.765 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.458 ' HA ' HD23 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -39.63 -52.47 2.22 Favored 'General case' 0 C--O 1.224 -0.238 0 O-C-N 121.683 -0.635 . . . . 10.0 112.473 159.333 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.45 -43.24 93.2 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 118.62 0.645 . . . . 10.0 109.873 179.4 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -51.87 -46.97 64.69 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 116.062 -0.517 . . . . 10.0 110.224 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.403 ' HA ' HD12 ' A' ' 64' ' ' LEU . 40.6 t -68.34 -47.44 77.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 124.266 1.026 . . . . 10.0 112.58 175.587 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -58.25 -35.37 71.64 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.406 -0.809 . . . . 10.0 109.126 -176.358 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.1 -28.79 39.0 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 118.538 -0.744 . . . . 10.0 112.179 179.315 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.403 HD12 ' HA ' ' A' ' 61' ' ' VAL . 10.2 mt -53.83 -42.65 68.7 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 120.036 1.289 . . . . 10.0 110.797 165.14 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 139.95 -14.3 3.09 Favored Glycine 0 CA--C 1.527 0.794 0 CA-C-O 119.974 -0.348 . . . . 10.0 113.787 170.846 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -114.83 159.19 20.92 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 125.54 1.536 . . . . 10.0 107.271 179.39 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 25.8 mttp -97.24 159.56 14.84 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 121.731 0.777 . . . . 10.0 111.782 -171.461 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.458 HD23 ' HA ' ' A' ' 58' ' ' LYS . 20.5 tp -137.24 147.28 45.65 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.929 1.691 . . . . 10.0 107.433 -177.535 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 22.9 tptt -154.41 153.41 31.52 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 108.624 -0.88 . . . . 10.0 108.624 164.489 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.64 HD11 HG11 ' A' ' 54' ' ' VAL . 22.5 mt -61.04 160.21 10.36 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 121.936 0.874 . . . . 10.0 110.856 175.743 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 12.3 tptt -113.12 -58.0 2.21 Favored 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 128.061 2.544 . . . . 10.0 106.419 173.706 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -179.88 -84.13 0.06 OUTLIER Glycine 0 CA--C 1.523 0.544 0 N-CA-C 109.617 -1.393 . . . . 10.0 109.617 178.715 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 . . . . . 0 N--CA 1.45 -0.446 0 N-CA-C 108.304 -0.998 . . . . 10.0 108.304 -169.915 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.426 HG21 ' HB2' ' A' ' 32' ' ' ALA . 3.4 p . . . . . 0 N--CA 1.451 -0.387 0 N-CA-C 107.263 -1.384 . . . . 10.0 107.263 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -108.68 144.45 36.43 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 126.339 1.855 . . . . 10.0 110.28 179.484 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.0 mmtm -88.47 113.83 24.47 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.701 1.2 . . . . 10.0 109.801 174.034 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -116.64 149.87 39.04 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.678 1.191 . . . . 10.0 110.494 170.922 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -117.03 151.05 37.59 Favored 'General case' 0 CA--C 1.518 -0.257 0 C-N-CA 124.564 1.146 . . . . 10.0 111.423 171.237 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.736 ' CE2' HD11 ' A' ' 57' ' ' LEU . 1.8 m-85 -140.99 137.47 33.04 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.549 1.14 . . . . 10.0 110.143 -175.333 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.537 ' CG ' ' HZ3' ' A' ' 71' ' ' LYS . 6.9 m-20 -95.0 137.84 33.52 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 125.165 1.386 . . . . 10.0 109.11 -176.952 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.468 HD11 HG23 ' A' ' 43' ' ' VAL . 7.5 mm -109.47 132.41 57.7 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 C-N-CA 124.84 1.256 . . . . 10.0 110.639 -164.822 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 . . . . . 0 N--CA 1.452 -0.369 0 N-CA-C 108.377 -0.971 . . . . 10.0 108.377 173.197 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.535 0.377 0 N-CA-C 112.44 0.533 . . . . 10.0 112.44 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 15.6 ttt180 -73.49 -47.86 37.85 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 121.65 -0.656 . . . . 10.0 109.291 -179.61 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.3 mt -42.46 -52.51 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 123.1 0.56 . . . . 10.0 110.769 171.125 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -42.83 -58.54 2.32 Favored 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 123.01 0.524 . . . . 10.0 111.025 179.616 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -70.18 -39.59 75.15 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.859 0.863 . . . . 10.0 109.87 -173.885 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.24 -36.46 66.06 Favored 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 122.705 0.402 . . . . 10.0 110.685 175.611 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.49 -36.63 26.27 Favored 'General case' 0 C--O 1.222 -0.376 0 C-N-CA 123.571 0.749 . . . . 10.0 112.554 173.191 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -57.69 -25.73 60.72 Favored 'General case' 0 C--N 1.328 -0.326 0 O-C-N 120.715 -1.24 . . . . 10.0 109.821 179.291 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.5 mmpt? -51.82 -38.45 55.82 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 114.336 1.235 . . . . 10.0 114.336 168.975 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.423 HG23 ' CB ' ' A' ' 52' ' ' ALA . 11.5 mt -57.19 129.43 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 CA-C-N 118.838 0.745 . . . . 10.0 109.253 178.925 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -64.8 -49.53 70.29 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 120.968 -0.293 . . . . 10.0 110.991 -179.942 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -82.91 46.51 3.63 Favored Glycine 0 C--N 1.339 0.717 0 O-C-N 120.998 -1.064 . . . . 10.0 111.5 -175.008 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.3 p -106.7 152.9 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 C-N-CA 124.588 1.155 . . . . 10.0 109.003 -177.716 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.426 ' HB2' HG21 ' A' ' 2' ' ' THR . . . -115.23 -51.95 2.69 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.989 -0.745 . . . . 10.0 108.989 168.499 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -151.58 158.86 44.09 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 109.234 -0.654 . . . . 10.0 109.234 -176.68 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -143.18 64.11 13.76 Favored Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 123.918 0.887 . . . . 10.0 111.861 173.088 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -79.22 77.68 4.0 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.178 2.585 . . . . 10.0 109.8 -177.252 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.519 HG12 HG13 ' A' ' 43' ' ' VAL . 2.4 m -71.3 153.16 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 O-C-N 121.775 -0.578 . . . . 10.0 111.385 -176.927 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 34.2 m120 -87.46 148.05 25.12 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 120.817 -0.353 . . . . 10.0 110.298 177.241 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -124.02 44.8 2.63 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.904 1.281 . . . . 10.0 111.104 -172.306 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -175.8 -40.63 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.216 0 C-N-CA 125.292 1.437 . . . . 10.0 109.596 178.005 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.6 mt -78.15 -18.29 55.77 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.381 1.072 . . . . 10.0 111.834 -172.034 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 66.87 46.38 1.66 Allowed 'General case' 0 C--O 1.231 0.091 0 C-N-CA 125.377 1.471 . . . . 10.0 110.398 179.144 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.9 p -139.03 121.72 16.38 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 125.153 1.381 . . . . 10.0 108.538 176.349 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.519 HG13 HG12 ' A' ' 36' ' ' VAL . 17.9 t -88.55 137.56 20.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 107.227 -1.398 . . . . 10.0 107.227 168.505 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 88.8 m -120.09 124.02 44.8 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 106.445 -1.687 . . . . 10.0 106.445 176.659 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 24.7 t -121.56 140.1 46.64 Favored 'Isoleucine or valine' 0 C--N 1.339 0.139 0 CA-C-N 119.114 0.87 . . . . 10.0 110.073 178.755 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -105.19 101.47 11.02 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.458 1.503 . . . . 10.0 107.078 164.389 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -143.19 158.47 43.59 Favored 'General case' 0 CA--C 1.52 -0.21 0 C-N-CA 123.0 0.52 . . . . 10.0 110.627 178.421 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -93.06 129.45 39.46 Favored Pre-proline 0 CA--C 1.531 0.247 0 C-N-CA 123.393 0.677 . . . . 10.0 110.043 176.309 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -78.04 57.15 6.01 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 122.244 1.962 . . . . 10.0 108.86 169.768 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.74 -62.67 1.12 Allowed 'General case' 0 CA--C 1.521 -0.149 0 N-CA-C 106.533 -1.655 . . . . 10.0 106.533 175.822 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -81.84 -32.32 31.24 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 122.468 0.307 . . . . 10.0 110.87 -173.196 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.423 ' CB ' HG23 ' A' ' 28' ' ' ILE . . . -135.22 -176.48 4.27 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.14 0.976 . . . . 10.0 109.606 177.214 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 86.7 p -140.71 169.73 17.09 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.842 0.857 . . . . 10.0 111.501 -179.853 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 59.4 t -42.53 -48.71 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 125.43 1.492 . . . . 10.0 111.571 160.786 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.5 t -66.82 -34.25 77.4 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.356 -0.384 . . . . 10.0 110.553 -176.0 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -65.77 -60.71 2.61 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.682 -0.859 . . . . 10.0 108.682 173.382 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.736 HD11 ' CE2' ' A' ' 7' ' ' PHE . 3.9 pp -63.68 -44.91 92.34 Favored 'General case' 0 N--CA 1.447 -0.583 0 O-C-N 121.982 -0.449 . . . . 10.0 111.036 -164.774 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.418 ' N ' HD12 ' A' ' 57' ' ' LEU . 1.0 OUTLIER -48.64 -39.56 24.58 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 113.319 0.859 . . . . 10.0 113.319 170.094 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -57.25 -32.94 67.08 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 119.235 0.925 . . . . 10.0 110.646 178.939 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.41 -48.24 81.31 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.792 0.805 . . . . 10.0 109.338 -178.562 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.613 HG13 ' CE2' ' A' ' 66' ' ' TYR . 57.6 t -64.94 -50.57 74.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 124.947 1.299 . . . . 10.0 111.043 174.49 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -50.27 -39.18 44.4 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.354 1.462 . . . . 10.0 109.167 -179.292 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 33.1 tptt -76.59 -40.96 47.98 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 125.303 1.441 . . . . 10.0 110.595 -178.063 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 28.3 mt -53.19 -41.09 64.93 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.712 0.687 . . . . 10.0 111.402 169.056 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 140.4 -30.78 2.3 Favored Glycine 0 C--N 1.338 0.69 0 CA-C-N 118.225 0.466 . . . . 10.0 113.428 166.722 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.613 ' CE2' HG13 ' A' ' 61' ' ' VAL . 15.6 p90 -86.86 160.2 18.82 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 107.797 -1.186 . . . . 10.0 107.797 172.711 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -105.42 150.67 25.05 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 120.859 0.361 . . . . 10.0 110.549 -170.546 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.532 HD11 ' HB2' ' A' ' 7' ' ' PHE . 21.8 tp -123.2 150.47 43.33 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 126.643 1.977 . . . . 10.0 108.234 -176.897 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 19.5 tptt -154.26 140.01 18.05 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 123.145 0.578 . . . . 10.0 110.683 166.018 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.607 HD23 ' N ' ' A' ' 71' ' ' LYS . 2.4 tt -70.8 158.27 36.63 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 123.524 0.729 . . . . 10.0 109.786 -178.966 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.607 ' N ' HD23 ' A' ' 70' ' ' LEU . 11.8 ttpt -121.74 -67.17 0.98 Allowed 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 126.894 2.078 . . . . 10.0 108.759 178.815 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -165.54 -81.31 0.04 OUTLIER Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.025 -1.23 . . . . 10.0 110.025 176.627 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 . . . . . 0 C--O 1.232 0.151 0 C-N-CA 124.578 1.151 . . . . 10.0 107.937 -169.154 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.491 HG21 ' HB2' ' A' ' 32' ' ' ALA . 1.1 p . . . . . 0 N--CA 1.447 -0.591 0 N-CA-C 105.908 -1.886 . . . . 10.0 105.908 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -133.98 143.24 48.03 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 126.83 2.052 . . . . 10.0 106.723 -168.345 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 18.3 tptm -89.25 143.33 26.91 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 107.546 -1.279 . . . . 10.0 107.546 -176.273 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -147.44 148.13 30.95 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.416 0.686 . . . . 10.0 109.441 177.66 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -128.09 152.41 48.01 Favored 'General case' 0 CA--C 1.507 -0.675 0 C-N-CA 124.494 1.118 . . . . 10.0 109.156 173.014 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.793 ' CE2' HD11 ' A' ' 57' ' ' LEU . 2.7 m-85 -143.4 131.44 21.75 Favored 'General case' 0 N--CA 1.447 -0.623 0 O-C-N 125.607 1.817 . . . . 10.0 108.638 -170.826 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -93.59 138.41 31.87 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 106.811 -1.551 . . . . 10.0 106.811 -179.57 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 5.3 mm -105.44 141.23 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 124.289 1.036 . . . . 10.0 109.415 -166.251 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 . . . . . 0 N--CA 1.446 -0.662 0 N-CA-C 106.845 -1.539 . . . . 10.0 106.845 172.847 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 . . . . . 0 N--CA 1.464 0.247 0 CA-C-O 120.866 0.365 . . . . 10.0 110.658 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.488 ' CG ' HD11 ' A' ' 64' ' ' LEU . 3.8 tpp85 -75.09 -44.36 47.75 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 109.098 -0.704 . . . . 10.0 109.098 -178.95 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.4 mm -44.49 -62.08 0.33 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.466 0 C-N-CA 124.063 0.945 . . . . 10.0 108.898 173.663 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -54.61 -34.83 62.67 Favored 'General case' 0 C--O 1.22 -0.483 0 CA-C-N 118.497 0.59 . . . . 10.0 112.203 -175.172 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.04 -43.43 78.74 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 120.715 -1.24 . . . . 10.0 109.376 176.595 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.459 ' HB3' ' HB1' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -67.53 -39.67 85.05 Favored 'General case' 0 C--O 1.224 -0.261 0 O-C-N 122.12 -0.362 . . . . 10.0 111.598 177.997 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.56 -34.62 58.48 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.693 1.197 . . . . 10.0 110.337 -179.426 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -71.14 -7.51 47.14 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 121.671 -0.643 . . . . 10.0 109.537 173.865 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.491 ' HE3' ' HB2' ' A' ' 60' ' ' ALA . 0.5 OUTLIER -60.5 -37.94 82.71 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 118.368 -1.333 . . . . 10.0 109.422 165.92 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.464 HG23 ' CB ' ' A' ' 52' ' ' ALA . 25.6 mm -60.16 123.59 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 123.647 0.779 . . . . 10.0 109.711 -173.729 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -68.32 -48.84 63.81 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 110.001 -0.37 . . . . 10.0 110.001 -179.169 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -82.54 41.06 2.79 Favored Glycine 0 CA--C 1.526 0.747 0 O-C-N 121.326 -0.859 . . . . 10.0 111.937 -175.42 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.3 p -104.46 146.82 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 C-N-CA 124.864 1.266 . . . . 10.0 108.73 -178.266 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.491 ' HB2' HG21 ' A' ' 2' ' ' THR . . . -115.94 -52.44 2.61 Favored 'General case' 0 C--N 1.333 -0.109 0 C-N-CA 122.848 0.459 . . . . 10.0 109.838 172.085 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -139.52 143.03 37.25 Favored 'General case' 0 C--N 1.341 0.212 0 N-CA-C 108.803 -0.814 . . . . 10.0 108.803 -176.797 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -130.85 62.74 67.12 Favored Pre-proline 0 CA--C 1.536 0.435 0 C-N-CA 123.39 0.676 . . . . 10.0 110.48 173.188 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -76.26 66.37 7.08 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 123.448 2.765 . . . . 10.0 110.633 -175.931 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.627 HG22 HG13 ' A' ' 43' ' ' VAL . 41.5 t -68.47 145.16 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 C-N-CA 126.123 1.769 . . . . 10.0 110.98 -176.805 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -90.98 145.07 25.02 Favored 'General case' 0 C--N 1.341 0.239 0 C-N-CA 120.315 -0.554 . . . . 10.0 110.582 -179.828 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -122.82 65.47 0.96 Allowed 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 125.309 1.444 . . . . 10.0 109.819 -172.861 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 157.55 -30.9 0.0 OUTLIER 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 127.627 2.371 . . . . 10.0 109.621 169.405 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.6 mt -75.56 -17.62 60.0 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.799 0.839 . . . . 10.0 110.846 -173.821 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 67.07 48.39 1.24 Allowed 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 126.005 1.722 . . . . 10.0 110.653 177.205 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.4 p -143.1 124.77 14.94 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.49 1.516 . . . . 10.0 108.283 176.422 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.627 HG13 HG22 ' A' ' 36' ' ' VAL . 12.0 t -94.2 141.58 14.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 106.884 -1.525 . . . . 10.0 106.884 169.602 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.6 m -129.98 126.05 36.85 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 105.491 -2.04 . . . . 10.0 105.491 -177.889 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 23.9 t -128.37 152.93 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 CA-C-N 118.657 0.662 . . . . 10.0 109.402 178.886 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -130.41 96.94 4.26 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 105.021 -2.215 . . . . 10.0 105.021 176.213 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -148.77 164.66 33.76 Favored 'General case' 0 C--O 1.226 -0.152 0 C-N-CA 123.956 0.903 . . . . 10.0 110.343 -171.569 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -96.09 132.63 26.51 Favored Pre-proline 0 C--N 1.33 -0.24 0 C-N-CA 122.858 0.463 . . . . 10.0 110.501 179.577 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -79.68 55.62 5.71 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 121.721 1.614 . . . . 10.0 109.136 166.991 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.52 -41.49 1.7 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 118.234 0.47 . . . . 10.0 110.364 177.73 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.89 -32.28 11.76 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.688 0.795 . . . . 10.0 111.091 178.332 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.464 ' CB ' HG23 ' A' ' 28' ' ' ILE . . . -138.22 -174.83 3.91 Favored 'General case' 0 CA--C 1.523 -0.065 0 C-N-CA 124.644 1.178 . . . . 10.0 109.67 -175.996 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.7 p -148.42 163.25 37.71 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 123.058 0.543 . . . . 10.0 109.896 -178.936 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 55.8 t -38.55 -50.39 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 C-N-CA 125.345 1.458 . . . . 10.0 110.07 163.698 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.3 m -51.4 -44.07 62.1 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 124.552 1.141 . . . . 10.0 113.056 -179.762 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -72.37 -53.59 11.86 Favored 'General case' 0 C--O 1.224 -0.289 0 N-CA-C 109.78 -0.452 . . . . 10.0 109.78 -178.625 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.793 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.0 pp -61.05 -39.95 91.79 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 118.247 -1.381 . . . . 10.0 110.738 -177.97 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.442 ' HA ' HD23 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -44.86 -57.48 3.74 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-O 117.854 -1.069 . . . . 10.0 112.309 161.54 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 14.6 tm-20 -50.22 -48.49 54.36 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-N 120.332 1.424 . . . . 10.0 110.298 176.392 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.491 ' HB2' ' HE3' ' A' ' 27' ' ' LYS . . . -51.63 -54.07 31.76 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 123.555 0.742 . . . . 10.0 109.602 -178.044 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 91.6 t -63.03 -45.12 99.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 115.986 -0.552 . . . . 10.0 111.155 177.818 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.45 -56.86 10.98 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.99 0.9 . . . . 10.0 109.836 178.942 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.9 tptp -49.35 -36.97 23.0 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 127.287 2.235 . . . . 10.0 111.602 175.273 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.488 HD11 ' CG ' ' A' ' 20' ' ' ARG . 5.4 tp -60.89 -34.38 74.55 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 125.055 1.342 . . . . 10.0 111.705 179.17 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 146.83 -53.0 0.55 Allowed Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.754 -0.538 . . . . 10.0 111.754 176.962 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -98.86 158.83 15.37 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 123.939 0.896 . . . . 10.0 109.859 -176.832 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 8.5 ttpt -92.16 153.18 19.5 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.217 0.532 . . . . 10.0 110.232 -170.46 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.479 HD11 ' HB2' ' A' ' 7' ' ' PHE . 23.9 tp -125.74 151.69 46.33 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.981 1.713 . . . . 10.0 107.932 179.734 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.9 tptp -153.92 147.63 25.29 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 122.775 0.43 . . . . 10.0 110.275 162.919 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.3 tp -59.14 158.48 8.77 Favored 'General case' 0 C--N 1.34 0.155 0 O-C-N 123.485 0.491 . . . . 10.0 109.963 176.561 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.6 tttt -116.26 -71.26 0.75 Allowed 'General case' 0 N--CA 1.436 -1.136 0 C-N-CA 126.849 2.059 . . . . 10.0 108.205 179.472 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 158.88 43.89 0.02 OUTLIER Glycine 0 CA--C 1.529 0.956 0 C-N-CA 123.952 0.787 . . . . 10.0 111.609 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 . . . . . 0 CA--C 1.537 0.452 0 C-N-CA 124.995 1.318 . . . . 10.0 111.962 171.6 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.535 HG21 ' HB2' ' A' ' 32' ' ' ALA . 4.6 p . . . . . 0 C--O 1.238 0.472 0 CA-C-O 122.606 1.194 . . . . 10.0 112.506 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -82.62 164.19 20.94 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 107.791 -1.188 . . . . 10.0 107.791 176.352 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.65 144.73 31.99 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 106.737 -1.579 . . . . 10.0 106.737 176.611 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -148.24 139.23 23.18 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.424 -0.954 . . . . 10.0 108.424 179.294 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -120.71 148.21 44.26 Favored 'General case' 0 CA--C 1.513 -0.466 0 C-N-CA 123.964 0.906 . . . . 10.0 109.187 175.866 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.746 ' CE2' HD11 ' A' ' 57' ' ' LEU . 12.8 m-85 -139.11 144.2 38.59 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.131 1.372 . . . . 10.0 109.144 -174.834 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -110.14 127.33 54.84 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.67 1.188 . . . . 10.0 107.878 -172.213 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.535 HD11 ' HB ' ' A' ' 43' ' ' VAL . 2.5 mm -107.25 137.16 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 124.004 0.922 . . . . 10.0 111.301 -160.691 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 . . . . . 0 N--CA 1.455 -0.176 0 C-N-CA 124.554 1.141 . . . . 10.0 108.239 179.816 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 . . . . . 0 N--CA 1.467 0.405 0 CA-C-O 121.167 0.508 . . . . 10.0 111.212 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.65 -41.0 94.08 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 118.077 -0.964 . . . . 10.0 110.383 176.66 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.411 HG22 HD12 ' A' ' 25' ' ' LEU . 14.9 mm -47.62 -62.54 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.371 0 N-CA-C 108.367 -0.975 . . . . 10.0 108.367 169.682 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -54.56 -35.82 63.67 Favored 'General case' 0 C--O 1.22 -0.462 0 N-CA-C 112.177 0.436 . . . . 10.0 112.177 -176.281 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.65 -53.56 32.67 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 119.198 0.908 . . . . 10.0 109.783 179.233 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.7 tpt180 -64.27 -35.34 80.51 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 122.225 -0.297 . . . . 10.0 111.253 -178.987 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.411 HD12 HG22 ' A' ' 21' ' ' ILE . 0.3 OUTLIER -73.51 -44.9 56.63 Favored 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 123.402 0.681 . . . . 10.0 111.319 178.134 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -51.25 -31.27 20.39 Favored 'General case' 0 C--O 1.225 -0.184 0 C-N-CA 123.81 0.844 . . . . 10.0 110.654 172.292 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -60.84 -34.6 74.83 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 118.703 -0.665 . . . . 10.0 112.239 176.956 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 22.4 mm -55.0 133.37 18.54 Favored 'Isoleucine or valine' 0 C--N 1.342 0.261 0 C-N-CA 124.077 0.951 . . . . 10.0 110.854 177.924 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 51.1 mp0 -73.73 -47.03 42.33 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 119.242 -0.408 . . . . 10.0 110.869 -172.955 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.99 36.75 2.52 Favored Glycine 0 C--N 1.343 0.937 0 O-C-N 120.298 -1.501 . . . . 10.0 113.0 -177.669 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.2 p -101.68 149.76 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 124.61 1.164 . . . . 10.0 108.343 -178.042 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.535 ' HB2' HG21 ' A' ' 2' ' ' THR . . . -108.15 -57.84 2.06 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 106.572 -1.64 . . . . 10.0 106.572 165.366 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -154.3 167.17 30.84 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 115.644 -0.707 . . . . 10.0 109.371 -169.376 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -157.0 77.05 4.08 Favored Pre-proline 0 N--CA 1.454 -0.24 0 C-N-CA 123.592 0.757 . . . . 10.0 110.841 -179.393 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -75.47 69.53 5.87 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.547 2.164 . . . . 10.0 110.124 -179.13 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.487 HG12 HG13 ' A' ' 43' ' ' VAL . 3.8 m -64.6 157.24 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 C-N-CA 123.518 0.727 . . . . 10.0 110.383 178.056 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -102.35 159.93 14.99 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 119.603 -0.839 . . . . 10.0 111.954 172.218 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -129.76 59.22 1.62 Allowed 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 125.474 1.51 . . . . 10.0 108.743 -172.339 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 171.72 -29.44 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 125.304 1.442 . . . . 10.0 111.335 165.894 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.7 mt -81.86 -7.72 59.63 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 122.714 0.406 . . . . 10.0 111.063 -176.106 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 67.06 41.27 2.68 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 126.025 1.73 . . . . 10.0 110.557 173.895 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -136.86 140.85 42.68 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.928 0.871 . . . . 10.0 109.774 173.579 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.535 ' HB ' HD11 ' A' ' 9' ' ' ILE . 2.5 t -110.99 138.97 36.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 107.569 -1.271 . . . . 10.0 107.569 174.156 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 90.6 m -124.29 121.56 35.35 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 126.193 1.797 . . . . 10.0 106.293 -176.07 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.4 t -120.02 143.49 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 C-N-CA 124.597 1.159 . . . . 10.0 109.171 -179.944 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -120.66 96.68 5.22 Favored 'General case' 0 N--CA 1.429 -1.519 0 C-N-CA 126.255 1.822 . . . . 10.0 107.067 173.606 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 11.9 p90 -139.35 161.74 36.72 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 124.079 0.952 . . . . 10.0 109.986 -174.806 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -93.7 123.5 59.68 Favored Pre-proline 0 CA--C 1.534 0.358 0 C-N-CA 123.278 0.631 . . . . 10.0 111.011 175.214 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -75.14 67.33 6.07 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.708 2.272 . . . . 10.0 109.039 172.723 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.45 -49.56 0.49 Allowed 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 107.893 -1.151 . . . . 10.0 107.893 177.919 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -82.54 -62.57 1.58 Allowed 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 108.643 -0.873 . . . . 10.0 108.643 177.101 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -110.27 171.79 7.25 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 125.196 1.398 . . . . 10.0 109.701 -176.701 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 24.8 p -125.32 179.61 5.02 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.886 1.274 . . . . 10.0 110.663 172.994 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 26.8 m -51.36 -37.68 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-N 114.846 -1.07 . . . . 10.0 111.93 166.64 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.8 t -69.86 -39.19 76.49 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 119.032 -0.509 . . . . 10.0 110.811 -174.657 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -60.0 -52.58 64.77 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 119.241 0.928 . . . . 10.0 109.261 -176.341 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.746 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.2 pp -66.45 -42.91 86.9 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.144 -0.48 . . . . 10.0 110.692 -179.658 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.407 ' N ' HD12 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -45.65 -50.34 13.51 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 121.125 -0.985 . . . . 10.0 112.901 164.255 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -60.71 -43.79 97.38 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 119.748 1.158 . . . . 10.0 109.251 -179.366 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -53.1 -52.08 59.79 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.327 -0.851 . . . . 10.0 109.887 178.718 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 98.3 t -64.22 -43.39 97.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 123.04 0.536 . . . . 10.0 112.287 175.115 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -52.26 -51.76 56.59 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 121.995 0.903 . . . . 10.0 109.262 179.181 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 45.0 tptt -57.89 -30.92 66.24 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.812 1.645 . . . . 10.0 112.273 176.837 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.3 mp -61.54 -30.37 70.6 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.657 0.783 . . . . 10.0 110.812 173.977 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 141.16 -45.7 0.95 Allowed Glycine 0 CA--C 1.526 0.772 0 CA-C-N 118.448 0.567 . . . . 10.0 111.716 171.82 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -99.47 156.2 17.16 Favored 'General case' 0 C--O 1.226 -0.145 0 C-N-CA 124.973 1.309 . . . . 10.0 109.017 -178.67 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 24.1 mtpp -87.97 165.34 15.28 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-O 121.719 0.771 . . . . 10.0 111.191 -173.17 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 11.5 tp -136.04 149.46 48.78 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.141 1.776 . . . . 10.0 107.057 -179.831 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 8.7 mmtp -149.42 153.35 37.2 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 108.857 -0.794 . . . . 10.0 108.857 163.797 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.4 tp -62.04 158.51 16.36 Favored 'General case' 0 N--CA 1.453 -0.291 0 O-C-N 124.25 0.969 . . . . 10.0 109.084 174.905 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 12.1 tttt -114.83 -69.86 0.83 Allowed 'General case' 0 N--CA 1.436 -1.175 0 C-N-CA 126.674 1.989 . . . . 10.0 107.28 177.161 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 162.73 47.21 0.02 OUTLIER Glycine 0 CA--C 1.527 0.808 0 CA-C-O 119.291 -0.727 . . . . 10.0 112.87 175.491 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 . . . . . 0 CA--C 1.536 0.412 0 C-N-CA 125.105 1.362 . . . . 10.0 113.165 171.853 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 20.7 p . . . . . 0 N--CA 1.447 -0.584 0 N-CA-C 107.059 -1.46 . . . . 10.0 107.059 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -114.27 149.51 35.8 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.943 1.297 . . . . 10.0 110.379 -170.247 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.2 mtmm -98.96 77.18 2.17 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 126.266 1.826 . . . . 10.0 110.816 -160.254 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -79.17 153.57 29.95 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.806 1.643 . . . . 10.0 110.586 -173.724 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -129.52 151.51 50.05 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 124.05 0.94 . . . . 10.0 109.155 176.374 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.801 ' CE2' HD11 ' A' ' 57' ' ' LEU . 4.6 m-85 -140.77 133.75 29.22 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 125.262 1.601 . . . . 10.0 109.776 -174.731 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -87.45 134.68 33.56 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 125.953 1.701 . . . . 10.0 107.883 -179.254 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 12.8 mm -106.03 138.71 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 C-N-CA 125.474 1.51 . . . . 10.0 110.636 -166.523 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 . . . . . 0 N--CA 1.443 -0.785 0 N-CA-C 108.546 -0.909 . . . . 10.0 108.546 165.749 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 . . . . . 0 N--CA 1.463 0.182 0 N-CA-C 112.758 0.651 . . . . 10.0 112.758 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.7 ttt180 -70.03 -30.04 67.23 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 121.283 -0.886 . . . . 10.0 109.329 -179.099 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 25.8 mm -55.68 -54.56 24.63 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 CA-C-O 118.431 -0.795 . . . . 10.0 108.972 173.532 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -43.8 -49.72 8.02 Favored 'General case' 0 C--O 1.223 -0.297 0 C-N-CA 123.352 0.661 . . . . 10.0 110.576 -177.895 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.4 mppt? -65.19 -52.24 56.1 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 123.196 0.599 . . . . 10.0 109.818 179.597 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.75 -21.92 66.55 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 112.527 0.566 . . . . 10.0 112.527 -175.506 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.74 -41.28 14.26 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 126.735 2.014 . . . . 10.0 111.44 172.336 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -57.73 -29.07 64.44 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.899 0.88 . . . . 10.0 110.216 175.792 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.2 mmpt? -53.47 -36.03 61.18 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 113.968 1.099 . . . . 10.0 113.968 169.597 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.5 mm -61.08 125.13 16.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 119.108 0.867 . . . . 10.0 109.219 178.576 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 64.2 mt-10 -59.34 -52.9 63.65 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.962 0.727 . . . . 10.0 112.962 -176.547 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.41 43.12 2.85 Favored Glycine 0 C--N 1.339 0.745 0 CA-C-N 120.053 1.297 . . . . 10.0 112.12 -172.78 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.7 p -107.75 153.16 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 C-N-CA 124.783 1.233 . . . . 10.0 108.805 -176.826 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -116.76 -55.13 2.39 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.12 -0.696 . . . . 10.0 109.12 174.615 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -147.32 160.21 42.78 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 108.882 -0.784 . . . . 10.0 108.882 179.596 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.39 61.31 3.9 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 123.647 0.779 . . . . 10.0 112.214 174.29 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -79.42 78.71 3.61 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.826 2.351 . . . . 10.0 109.595 -177.248 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.449 HG12 HG13 ' A' ' 43' ' ' VAL . 2.3 m -58.75 149.65 5.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 123.381 0.672 . . . . 10.0 111.855 -178.276 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -93.59 94.65 8.75 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.979 0.419 . . . . 10.0 111.538 -172.855 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -73.96 53.79 0.49 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 127.084 2.154 . . . . 10.0 112.769 -178.588 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -172.27 -42.88 0.02 OUTLIER 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 125.271 1.428 . . . . 10.0 109.217 170.317 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.3 mt -79.83 -19.69 47.8 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 115.691 -0.686 . . . . 10.0 111.144 -170.996 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 64.54 53.28 1.63 Allowed 'General case' 0 N--CA 1.457 -0.085 0 C-N-CA 124.751 1.22 . . . . 10.0 109.002 -177.199 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 30.3 p -138.04 125.66 22.2 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 106.632 -1.618 . . . . 10.0 106.632 169.849 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.449 HG13 HG12 ' A' ' 36' ' ' VAL . 13.9 t -87.92 145.54 7.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 106.267 -1.753 . . . . 10.0 106.267 166.89 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 96.7 m -128.23 133.49 48.84 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 105.826 -1.916 . . . . 10.0 105.826 178.444 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 26.4 t -136.46 129.31 45.76 Favored 'Isoleucine or valine' 0 C--N 1.339 0.114 0 CA-C-N 118.477 0.581 . . . . 10.0 111.081 176.925 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -92.98 101.02 13.35 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 126.444 1.897 . . . . 10.0 106.265 169.06 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -138.18 159.14 42.83 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 118.411 0.55 . . . . 10.0 111.995 -178.711 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 16.8 p30 -94.87 128.46 39.28 Favored Pre-proline 0 CA--C 1.527 0.06 0 C-N-CA 123.995 0.918 . . . . 10.0 110.656 178.583 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -76.07 56.46 4.87 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 122.425 2.083 . . . . 10.0 109.946 175.511 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.5 ttpt -131.87 -66.34 0.71 Allowed 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 106.628 -1.619 . . . . 10.0 106.628 173.501 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -99.11 -14.86 19.2 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.523 1.129 . . . . 10.0 110.735 -175.378 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -122.06 144.75 48.72 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.24 1.016 . . . . 10.0 110.348 -178.784 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -149.42 147.78 28.68 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.494 0.664 . . . . 10.0 111.291 -173.785 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.4 m -52.41 -42.44 38.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 124.546 1.139 . . . . 10.0 111.314 -178.304 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.2 m -52.72 -44.92 66.68 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.093 1.357 . . . . 10.0 111.974 177.964 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -76.21 -47.3 24.52 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.844 1.258 . . . . 10.0 109.444 -170.636 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.801 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.2 pp -65.72 -42.65 90.83 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 119.253 -0.979 . . . . 10.0 109.871 176.455 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.85 -53.17 10.16 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 117.48 -1.248 . . . . 10.0 112.247 163.548 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -50.94 -45.7 60.74 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 120.687 1.585 . . . . 10.0 110.252 178.121 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -55.52 -51.33 67.39 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.135 -0.939 . . . . 10.0 110.211 -178.038 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 21.9 t -65.16 -43.71 95.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-N 116.475 -0.33 . . . . 10.0 111.653 177.021 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.41 -54.25 47.81 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 108.188 -1.041 . . . . 10.0 108.188 -175.884 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -58.09 -38.92 77.32 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.733 1.213 . . . . 10.0 111.107 178.419 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.442 HD13 ' HA ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -50.92 -34.09 27.05 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.333 0.653 . . . . 10.0 112.067 172.61 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.75 20.78 6.7 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 123.65 0.643 . . . . 10.0 113.281 172.127 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -142.22 175.05 10.06 Favored 'General case' 0 CA--C 1.522 -0.12 0 N-CA-C 105.627 -1.99 . . . . 10.0 105.627 167.406 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 31.4 tttt -123.08 152.87 40.62 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 119.244 0.929 . . . . 10.0 113.182 -164.867 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 12.7 tp -134.74 148.86 50.35 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 126.815 2.046 . . . . 10.0 107.907 -168.808 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 12.6 tptp -149.94 151.28 33.13 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-O 118.713 -0.661 . . . . 10.0 109.536 161.843 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 11.4 tp -60.45 155.15 18.93 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 109.13 -0.693 . . . . 10.0 109.13 175.617 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 35.8 tttp -112.7 -68.35 0.94 Allowed 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 126.443 1.897 . . . . 10.0 107.815 178.912 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 154.75 51.68 0.01 OUTLIER Glycine 0 CA--C 1.529 0.929 0 CA-C-O 119.527 -0.596 . . . . 10.0 112.726 175.095 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 . . . . . 0 CA--C 1.532 0.282 0 C-N-CA 125.735 1.614 . . . . 10.0 113.584 178.22 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.672 HG21 ' HB2' ' A' ' 32' ' ' ALA . 21.0 p . . . . . 0 N--CA 1.454 -0.253 0 CA-C-O 120.757 0.313 . . . . 10.0 110.533 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -136.83 149.69 47.87 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 127.505 2.322 . . . . 10.0 106.423 -175.689 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.9 mmtm -97.81 132.52 43.35 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 124.43 1.092 . . . . 10.0 110.555 -176.84 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -134.43 140.24 46.12 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.866 1.267 . . . . 10.0 108.88 177.901 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -119.73 145.83 46.18 Favored 'General case' 0 CA--C 1.513 -0.446 0 C-N-CA 123.817 0.847 . . . . 10.0 109.645 173.071 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.709 ' CE2' HD11 ' A' ' 57' ' ' LEU . 3.7 m-85 -137.09 143.33 42.52 Favored 'General case' 0 N--CA 1.448 -0.544 0 O-C-N 125.084 1.49 . . . . 10.0 109.81 -173.221 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -106.63 135.75 47.61 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.273 1.429 . . . . 10.0 108.701 -174.646 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.9 mm -114.86 134.68 57.13 Favored 'Isoleucine or valine' 0 C--N 1.34 0.164 0 C-N-CA 125.203 1.401 . . . . 10.0 110.415 -161.772 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 . . . . . 0 N--CA 1.451 -0.407 0 N-CA-C 109.379 -0.6 . . . . 10.0 109.379 171.911 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 . . . . . 0 CA--C 1.537 0.46 0 CA-C-O 121.135 0.493 . . . . 10.0 112.0 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 11.9 ttm180 -74.6 -40.91 61.28 Favored 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 120.994 -1.066 . . . . 10.0 109.389 178.12 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.597 HD11 ' HE2' ' A' ' 66' ' ' TYR . 39.1 mm -46.23 -52.91 2.9 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 CA-C-O 117.796 -1.097 . . . . 10.0 110.012 170.504 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -43.99 -46.57 8.38 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 119.071 0.85 . . . . 10.0 111.955 -177.016 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -76.79 -39.66 50.75 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 123.737 0.815 . . . . 10.0 110.638 -178.279 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.91 -35.8 77.62 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 122.38 -0.2 . . . . 10.0 111.268 176.847 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.59 -36.28 29.16 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.293 1.837 . . . . 10.0 111.152 176.91 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -53.53 -31.63 47.07 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.265 -0.897 . . . . 10.0 110.88 173.232 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.5 mptt -54.15 -24.9 19.71 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 115.298 1.592 . . . . 10.0 115.298 172.349 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.475 HG23 ' HB3' ' A' ' 52' ' ' ALA . 11.4 mm -61.23 108.2 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 118.708 0.685 . . . . 10.0 109.966 172.381 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -55.37 -33.81 63.75 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.239 0.616 . . . . 10.0 111.945 -177.085 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.85 15.49 57.47 Favored Glycine 0 CA--C 1.528 0.883 0 O-C-N 121.497 -0.752 . . . . 10.0 113.19 -179.058 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.7 p -79.33 154.45 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-N 118.867 1.334 . . . . 10.0 109.943 -179.75 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.672 ' HB2' HG21 ' A' ' 2' ' ' THR . . . -114.27 -46.62 2.97 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.541 -0.754 . . . . 10.0 109.716 161.019 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 -144.37 147.91 34.02 Favored 'General case' 0 C--N 1.339 0.12 0 N-CA-C 108.666 -0.864 . . . . 10.0 108.666 -173.389 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -148.48 56.3 2.52 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 118.721 0.692 . . . . 10.0 112.581 172.181 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -74.89 80.62 2.36 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.121 2.547 . . . . 10.0 109.797 178.523 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.486 HG12 HG13 ' A' ' 43' ' ' VAL . 3.6 m -62.3 157.73 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 123.823 0.849 . . . . 10.0 111.47 176.889 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 35.3 m120 -92.12 116.92 29.36 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 120.23 -0.588 . . . . 10.0 112.18 -173.841 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -90.34 48.28 1.54 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.431 1.492 . . . . 10.0 111.249 -179.335 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -171.99 -39.01 0.02 OUTLIER 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 123.719 0.808 . . . . 10.0 110.579 165.272 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 16.4 mt -77.4 -15.03 59.57 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.794 0.838 . . . . 10.0 111.964 -167.666 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 65.52 47.25 2.28 Favored 'General case' 0 C--O 1.227 -0.081 0 C-N-CA 125.353 1.461 . . . . 10.0 109.824 -179.161 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 17.0 p -140.69 130.84 24.84 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 107.976 -1.12 . . . . 10.0 107.976 176.969 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.486 HG13 HG12 ' A' ' 36' ' ' VAL . 12.8 t -95.81 137.55 23.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 107.021 -1.474 . . . . 10.0 107.021 171.605 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 86.1 m -129.7 115.06 16.78 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 106.357 -1.72 . . . . 10.0 106.357 -174.776 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 32.3 t -115.69 144.05 24.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 C-N-CA 123.379 0.672 . . . . 10.0 109.799 -178.141 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -114.79 107.68 15.76 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 125.499 1.52 . . . . 10.0 107.873 164.836 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -149.13 164.18 35.45 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.736 -0.468 . . . . 10.0 109.736 -178.653 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -94.05 131.31 31.94 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 116.25 -0.432 . . . . 10.0 110.172 175.264 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -77.1 62.17 7.42 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.199 1.933 . . . . 10.0 109.488 169.336 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.83 -48.91 1.13 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.649 0.78 . . . . 10.0 108.994 174.685 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.29 -29.29 18.22 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 122.991 0.516 . . . . 10.0 111.841 -171.766 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.475 ' HB3' HG23 ' A' ' 28' ' ' ILE . . . -156.67 169.91 23.62 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.984 1.714 . . . . 10.0 106.82 -169.648 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 59.9 p -135.6 169.88 16.83 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 122.445 1.116 . . . . 10.0 112.649 -178.305 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 35.4 m -48.52 -40.87 11.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 125.189 1.395 . . . . 10.0 111.508 170.997 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 49.8 m -66.57 -35.87 81.26 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 123.509 0.723 . . . . 10.0 111.691 -179.746 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -70.2 -53.05 18.77 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 107.722 -1.214 . . . . 10.0 107.722 179.26 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.709 HD11 ' CE2' ' A' ' 7' ' ' PHE . 3.7 pp -65.87 -35.82 81.71 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 122.001 -0.437 . . . . 10.0 111.819 -173.317 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.7 ttpp -39.44 -54.63 1.9 Allowed 'General case' 0 C--N 1.341 0.222 0 O-C-N 121.216 -0.928 . . . . 10.0 112.559 159.952 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -54.42 -33.8 60.14 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 121.51 0.671 . . . . 10.0 110.54 -174.239 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -58.25 -52.33 66.05 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 121.778 0.799 . . . . 10.0 108.86 179.292 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.564 HG22 HD12 ' A' ' 21' ' ' ILE . 40.0 t -63.27 -43.11 98.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 115.331 -0.85 . . . . 10.0 110.716 176.617 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -56.88 -51.08 70.47 Favored 'General case' 0 CA--C 1.528 0.114 0 N-CA-C 109.28 -0.637 . . . . 10.0 109.28 -177.201 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -59.32 -35.84 74.55 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.241 1.016 . . . . 10.0 111.77 176.646 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.429 ' HA ' HD13 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -52.63 -31.21 35.54 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.621 0.769 . . . . 10.0 111.885 171.088 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 119.48 12.92 6.49 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 124.192 0.901 . . . . 10.0 113.124 171.401 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.597 ' HE2' HD11 ' A' ' 21' ' ' ILE . 1.0 OUTLIER -149.9 161.67 41.83 Favored 'General case' 0 C--O 1.224 -0.245 0 N-CA-C 107.009 -1.478 . . . . 10.0 107.009 179.649 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.8 mttt -104.29 153.7 20.7 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 121.798 0.809 . . . . 10.0 112.002 -165.249 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.427 HD11 ' HB2' ' A' ' 7' ' ' PHE . 13.1 tp -129.72 145.76 51.52 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 127.298 2.239 . . . . 10.0 107.197 -176.474 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 33.3 mmtt -145.76 151.72 38.42 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 108.379 -0.971 . . . . 10.0 108.379 165.065 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 11.7 tp -63.25 156.46 25.4 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 108.419 -0.956 . . . . 10.0 108.419 173.48 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 24.3 ttpt -113.81 -52.85 2.72 Favored 'General case' 0 N--CA 1.437 -1.119 0 C-N-CA 126.433 1.893 . . . . 10.0 107.199 170.994 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 179.82 -78.95 0.06 OUTLIER Glycine 0 C--N 1.336 0.533 0 N-CA-C 109.736 -1.346 . . . . 10.0 109.736 174.486 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 . . . . . 0 N--CA 1.453 -0.3 0 N-CA-C 107.45 -1.315 . . . . 10.0 107.45 -168.1 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.1 p . . . . . 0 CA--C 1.533 0.309 0 N-CA-C 108.384 -0.969 . . . . 10.0 108.384 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -129.02 145.82 51.16 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 126.364 1.865 . . . . 10.0 109.628 -175.393 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 20.8 mtmt -106.82 92.16 3.97 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.383 1.473 . . . . 10.0 110.282 -165.706 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.602 ' HB1' HD11 ' A' ' 70' ' ' LEU . . . -97.61 151.67 19.84 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.906 1.682 . . . . 10.0 110.352 -171.822 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -124.43 148.04 47.89 Favored 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 124.24 1.016 . . . . 10.0 109.374 174.765 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.703 ' CE2' HD11 ' A' ' 57' ' ' LEU . 4.9 m-85 -137.7 140.73 40.91 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 124.581 1.176 . . . . 10.0 109.266 -169.773 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -103.37 129.95 50.56 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 125.742 1.617 . . . . 10.0 108.587 -171.661 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.4 mm -110.52 127.16 67.73 Favored 'Isoleucine or valine' 0 C--N 1.34 0.164 0 C-N-CA 123.8 0.84 . . . . 10.0 110.71 -163.711 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 . . . . . 0 N--CA 1.449 -0.483 0 N-CA-C 108.805 -0.813 . . . . 10.0 108.805 169.751 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 . . . . . 0 CA--C 1.534 0.331 0 CA-C-O 121.099 0.476 . . . . 10.0 110.908 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.04 -52.47 65.62 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 107.708 -1.219 . . . . 10.0 107.708 178.657 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.541 HG22 HD12 ' A' ' 25' ' ' LEU . 1.7 mt -46.25 -50.9 4.43 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.435 0 CA-C-O 117.652 -1.166 . . . . 10.0 111.011 -179.51 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -41.56 -57.65 2.18 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 119.147 0.885 . . . . 10.0 111.215 -178.316 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -67.43 -48.07 68.36 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 124.47 1.108 . . . . 10.0 110.566 -179.925 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.1 mmt180 -59.19 -21.7 59.85 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.326 0.861 . . . . 10.0 113.326 179.603 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.541 HD12 HG22 ' A' ' 21' ' ' ILE . 3.1 mt -92.55 -41.12 10.42 Favored 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 126.303 1.841 . . . . 10.0 110.693 171.973 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -52.06 -28.54 17.72 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.703 1.201 . . . . 10.0 110.167 174.6 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -44.81 -44.65 9.6 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 113.72 1.007 . . . . 10.0 113.72 168.411 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 7.3 mm -55.06 128.05 14.68 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 C-N-CA 123.125 0.57 . . . . 10.0 110.573 -179.316 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 20.0 mp0 -65.16 -51.86 58.59 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 122.17 -0.332 . . . . 10.0 111.066 -177.113 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.59 40.41 2.87 Favored Glycine 0 C--N 1.339 0.726 0 O-C-N 120.835 -1.165 . . . . 10.0 111.835 -173.411 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.2 p -99.3 148.64 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 C-N-CA 124.504 1.122 . . . . 10.0 108.571 -176.512 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -111.75 -56.96 2.32 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.1 0.96 . . . . 10.0 108.566 171.67 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -142.55 156.65 45.14 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 109.621 -0.511 . . . . 10.0 109.621 179.437 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -143.36 61.34 9.92 Favored Pre-proline 0 CA--C 1.535 0.4 0 C-N-CA 124.0 0.92 . . . . 10.0 110.721 174.605 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -78.68 71.54 6.86 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 122.76 2.306 . . . . 10.0 109.332 -176.724 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.449 HG12 HG13 ' A' ' 43' ' ' VAL . 3.6 m -64.09 153.51 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 O-C-N 121.728 -0.608 . . . . 10.0 111.002 -178.906 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 33.8 m120 -88.23 140.71 29.2 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 120.577 -0.449 . . . . 10.0 110.532 177.256 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -114.89 39.25 2.92 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.277 1.431 . . . . 10.0 111.034 -173.376 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -173.17 -40.94 0.01 OUTLIER 'General case' 0 C--O 1.226 -0.135 0 C-N-CA 124.907 1.283 . . . . 10.0 110.339 178.529 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.5 mt -74.9 -19.43 60.15 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.98 0.912 . . . . 10.0 111.56 -172.434 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 64.44 52.43 1.83 Allowed 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 125.704 1.602 . . . . 10.0 110.343 -178.477 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.8 p -143.94 130.36 19.93 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 125.51 1.524 . . . . 10.0 107.476 175.14 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.449 HG13 HG12 ' A' ' 36' ' ' VAL . 4.9 t -100.47 148.59 6.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 106.829 -1.545 . . . . 10.0 106.829 173.323 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 59.0 m -136.55 126.53 25.97 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 106.403 -1.702 . . . . 10.0 106.403 -176.029 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.424 HG22 HD13 ' A' ' 25' ' ' LEU . 14.4 t -131.83 122.93 50.6 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 CA-C-N 118.48 0.582 . . . . 10.0 111.13 -179.538 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.0 mp0 -89.24 98.17 11.62 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 106.538 -1.652 . . . . 10.0 106.538 165.579 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -141.51 161.77 37.1 Favored 'General case' 0 CA--C 1.516 -0.332 0 C-N-CA 122.979 0.512 . . . . 10.0 110.089 175.661 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 31.3 p30 -92.14 136.26 26.08 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.238 -0.437 . . . . 10.0 110.556 178.439 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -79.85 53.0 4.54 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 121.234 1.289 . . . . 10.0 109.229 170.42 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.84 1.16 2.75 Favored 'General case' 0 C--N 1.347 0.49 0 CA-C-N 118.722 0.692 . . . . 10.0 112.801 177.94 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -138.28 -53.03 0.61 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.374 1.07 . . . . 10.0 108.502 -168.02 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -125.2 -176.41 3.56 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.01 1.324 . . . . 10.0 109.401 173.873 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 85.8 p -135.34 171.44 14.43 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.219 1.008 . . . . 10.0 110.875 174.495 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 77.8 t -48.39 -50.38 12.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 123.45 0.7 . . . . 10.0 110.533 166.787 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 72.2 m -59.78 -33.13 71.3 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.382 0.673 . . . . 10.0 111.526 -178.208 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -70.87 -59.55 2.73 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 108.607 -0.886 . . . . 10.0 108.607 175.482 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.703 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.0 pp -61.65 -47.04 87.17 Favored 'General case' 0 N--CA 1.452 -0.374 0 O-C-N 121.607 -0.683 . . . . 10.0 112.058 -170.579 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.451 ' N ' HD12 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -49.3 -29.92 6.68 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 114.588 1.329 . . . . 10.0 114.588 170.428 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.61 -36.29 69.26 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 120.185 1.357 . . . . 10.0 109.993 177.586 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.29 -50.15 75.09 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.595 -0.52 . . . . 10.0 109.595 179.566 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.472 HG12 ' O ' ' A' ' 66' ' ' TYR . 53.2 t -62.28 -50.17 81.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 123.34 0.656 . . . . 10.0 111.732 175.12 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -53.1 -40.77 64.38 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.684 0.794 . . . . 10.0 109.915 179.906 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.3 tptm -74.01 -38.6 64.02 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 124.498 1.119 . . . . 10.0 110.44 -178.41 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 34.3 mt -54.69 -41.46 70.25 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.278 0.49 . . . . 10.0 111.186 166.849 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 151.24 -51.19 0.52 Allowed Glycine 0 CA--C 1.525 0.68 0 CA-C-N 118.567 0.621 . . . . 10.0 112.445 166.755 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.472 ' O ' HG12 ' A' ' 61' ' ' VAL . 10.2 p90 -76.07 157.22 33.18 Favored 'General case' 0 C--O 1.224 -0.25 0 N-CA-C 108.811 -0.811 . . . . 10.0 108.811 177.153 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 31.8 mtpt -103.02 157.75 16.77 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.352 0.596 . . . . 10.0 111.0 -172.663 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.484 HD11 ' HB2' ' A' ' 7' ' ' PHE . 34.2 tp -134.26 147.41 50.65 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.749 1.619 . . . . 10.0 108.419 -174.839 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 10.5 mmtp -152.46 156.01 38.62 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.771 1.628 . . . . 10.0 107.903 174.088 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.602 HD11 ' HB1' ' A' ' 5' ' ' ALA . 6.8 tp -66.5 159.05 28.07 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 109.771 -0.455 . . . . 10.0 109.771 176.029 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 6.0 tttp -113.76 -57.25 2.31 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 125.458 1.503 . . . . 10.0 108.409 169.651 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -172.72 -79.69 0.05 OUTLIER Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.273 -1.131 . . . . 10.0 110.273 179.962 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 . . . . . 0 N--CA 1.455 -0.2 0 C-N-CA 124.378 1.071 . . . . 10.0 108.435 -176.226 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.558 HG21 ' HB2' ' A' ' 32' ' ' ALA . 4.5 p . . . . . 0 CA--C 1.533 0.317 0 N-CA-C 108.407 -0.96 . . . . 10.0 108.407 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -134.85 136.53 42.52 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 126.101 1.76 . . . . 10.0 108.03 -170.228 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -102.86 113.63 27.23 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.005 0.922 . . . . 10.0 111.625 -168.415 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.549 ' HB1' HD11 ' A' ' 70' ' ' LEU . . . -115.64 149.95 37.5 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 127.306 2.243 . . . . 10.0 109.215 -172.32 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -124.24 146.97 48.41 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.493 1.117 . . . . 10.0 108.872 174.086 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.727 ' CE2' HD11 ' A' ' 57' ' ' LEU . 1.9 m-85 -140.57 137.61 33.84 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 124.889 1.368 . . . . 10.0 110.467 -168.168 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -91.27 133.67 35.21 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 126.011 1.724 . . . . 10.0 109.421 -175.915 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.462 HD11 HG23 ' A' ' 43' ' ' VAL . 3.3 mm -113.1 134.38 55.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 125.611 1.565 . . . . 10.0 110.491 -173.959 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 . . . . . 0 N--CA 1.45 -0.441 0 C-N-CA 124.059 0.943 . . . . 10.0 108.645 171.252 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 . . . . . 0 CA--C 1.538 0.506 0 CA-C-O 121.454 0.645 . . . . 10.0 112.422 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.29 -45.96 79.96 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.085 0.954 . . . . 10.0 108.931 179.305 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.453 HG22 HD12 ' A' ' 25' ' ' LEU . 3.0 mt -43.7 -52.48 1.25 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.346 0 CA-C-O 118.362 -0.827 . . . . 10.0 110.532 175.572 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -48.0 -49.02 32.25 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 118.531 0.605 . . . . 10.0 110.873 -177.23 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.61 -47.69 58.85 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 121.627 -0.671 . . . . 10.0 110.533 -179.677 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.487 ' HB3' ' HB1' ' A' ' 60' ' ' ALA . 1.2 mmp_? -54.63 -33.8 61.11 Favored 'General case' 0 C--O 1.225 -0.235 0 C-N-CA 124.008 0.923 . . . . 10.0 112.181 178.305 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.565 HD21 ' HB2' ' A' ' 57' ' ' LEU . 0.3 OUTLIER -88.99 -33.63 17.13 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 125.621 1.569 . . . . 10.0 111.392 177.605 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -60.06 -27.17 66.73 Favored 'General case' 0 C--O 1.225 -0.202 0 O-C-N 121.486 -0.759 . . . . 10.0 110.258 174.4 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.2 mmpt? -53.68 -34.26 58.13 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 113.736 1.013 . . . . 10.0 113.736 168.847 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 12.5 mm -56.4 127.92 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 119.126 0.875 . . . . 10.0 109.504 177.354 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -63.59 -56.93 12.07 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.515 -0.311 . . . . 10.0 110.486 -175.836 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.54 49.83 3.72 Favored Glycine 0 C--N 1.341 0.845 0 O-C-N 120.692 -1.255 . . . . 10.0 110.919 -173.042 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -105.71 146.06 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 C-N-CA 124.296 1.039 . . . . 10.0 108.244 -178.151 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.558 ' HB2' HG21 ' A' ' 2' ' ' THR . . . -102.17 -52.22 3.2 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 108.375 -0.972 . . . . 10.0 108.375 176.004 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.0 p30 -160.23 149.37 17.41 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.449 -0.945 . . . . 10.0 108.449 -174.905 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -136.26 59.2 25.38 Favored Pre-proline 0 CA--C 1.536 0.424 0 C-N-CA 124.186 0.994 . . . . 10.0 111.54 178.077 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -77.0 74.84 4.82 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.031 2.487 . . . . 10.0 109.626 -178.964 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.574 HG12 HG13 ' A' ' 43' ' ' VAL . 3.0 m -65.28 158.42 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 C-N-CA 123.402 0.681 . . . . 10.0 111.428 179.988 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -96.35 121.71 38.44 Favored 'General case' 0 C--N 1.339 0.136 0 CA-C-O 120.83 0.347 . . . . 10.0 111.71 -176.861 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -96.15 50.16 1.16 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.303 1.441 . . . . 10.0 111.231 179.785 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -175.0 -40.72 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.228 0 C-N-CA 124.162 0.985 . . . . 10.0 109.928 172.533 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.1 mt -81.79 -11.6 58.91 Favored 'General case' 0 C--O 1.226 -0.146 0 C-N-CA 124.294 1.038 . . . . 10.0 112.214 -167.74 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 71.77 36.13 1.27 Allowed 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 125.403 1.481 . . . . 10.0 110.897 173.296 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.8 p -138.95 131.04 28.04 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.019 1.328 . . . . 10.0 108.312 -178.096 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.574 HG13 HG12 ' A' ' 36' ' ' VAL . 18.9 t -91.52 149.14 4.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 107.112 -1.44 . . . . 10.0 107.112 167.746 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 68.4 m -137.12 124.3 21.72 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 105.667 -1.975 . . . . 10.0 105.667 -179.553 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 47.9 t -135.98 138.44 47.46 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 CA-C-N 118.454 0.57 . . . . 10.0 109.712 179.278 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -101.95 112.71 25.44 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 107.226 -1.398 . . . . 10.0 107.226 165.145 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -146.99 165.92 28.38 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 123.361 0.664 . . . . 10.0 109.34 179.295 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 31.0 p30 -95.71 128.16 38.8 Favored Pre-proline 0 C--N 1.328 -0.341 0 N-CA-C 110.508 -0.182 . . . . 10.0 110.508 178.494 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -75.65 61.51 6.18 Favored 'Trans proline' 0 N--CA 1.45 -1.032 0 N-CA-C 108.507 -1.382 . . . . 10.0 108.507 169.205 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.31 -44.51 0.37 Allowed 'General case' 0 C--N 1.343 0.295 0 O-C-N 122.122 -0.361 . . . . 10.0 110.379 177.523 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -90.49 -36.61 14.41 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 122.378 0.271 . . . . 10.0 110.333 178.637 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -137.36 -175.58 4.11 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.542 1.137 . . . . 10.0 110.066 -179.707 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 91.5 p -147.05 172.44 13.74 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.295 0.638 . . . . 10.0 111.49 179.872 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 92.0 t -48.79 -45.4 15.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 124.051 0.94 . . . . 10.0 111.081 171.12 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.5 m -60.54 -37.22 80.51 Favored 'General case' 0 C--O 1.234 0.259 0 O-C-N 121.976 -0.452 . . . . 10.0 112.154 -179.689 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -65.71 -60.1 3.24 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 108.091 -1.078 . . . . 10.0 108.091 179.816 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.727 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.1 pp -63.48 -40.03 96.02 Favored 'General case' 0 N--CA 1.454 -0.24 0 O-C-N 121.55 -0.719 . . . . 10.0 111.477 -175.774 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.8 ttpp -39.16 -59.14 1.05 Allowed 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 117.627 -1.178 . . . . 10.0 111.004 162.653 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -47.85 -37.84 14.75 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-O 122.064 0.935 . . . . 10.0 110.755 -174.797 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.487 ' HB1' ' HB3' ' A' ' 24' ' ' ARG . . . -59.28 -49.76 76.61 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.041 -0.981 . . . . 10.0 109.784 -178.114 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.536 ' HA ' HD12 ' A' ' 64' ' ' LEU . 77.0 t -68.34 -45.65 82.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 124.536 1.134 . . . . 10.0 111.748 175.487 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -46.18 -44.67 16.2 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 126.576 1.95 . . . . 10.0 108.349 176.11 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -80.63 -34.63 34.84 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.238 1.415 . . . . 10.0 111.349 -176.887 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.536 HD12 ' HA ' ' A' ' 61' ' ' VAL . 18.7 mt -51.97 -43.43 63.56 Favored 'General case' 0 C--N 1.34 0.196 0 CA-C-N 118.871 0.759 . . . . 10.0 111.869 169.033 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 150.81 -35.18 0.93 Allowed Glycine 0 CA--C 1.525 0.666 0 C-N-CA 121.277 -0.487 . . . . 10.0 113.057 172.717 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -99.63 159.13 15.27 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.687 1.195 . . . . 10.0 107.888 -178.52 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.3 ttpt -94.8 155.16 16.93 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.194 0.521 . . . . 10.0 109.871 -176.984 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.583 HD11 ' HB2' ' A' ' 7' ' ' PHE . 24.8 tp -124.9 149.85 47.13 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 126.439 1.896 . . . . 10.0 107.528 179.756 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 34.0 mmtt -149.18 156.88 42.82 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 124.803 1.241 . . . . 10.0 108.332 162.905 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.549 HD11 ' HB1' ' A' ' 5' ' ' ALA . 8.7 tp -66.09 158.79 27.59 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 109.083 -0.71 . . . . 10.0 109.083 173.963 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.56 -56.45 2.4 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 125.551 1.54 . . . . 10.0 107.159 166.461 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -176.35 -83.01 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 109.609 -1.396 . . . . 10.0 109.609 179.13 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 . . . . . 0 N--CA 1.454 -0.272 0 C-N-CA 123.544 0.738 . . . . 10.0 109.379 -167.923 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.481 HG21 ' HB2' ' A' ' 32' ' ' ALA . 5.0 p . . . . . 0 N--CA 1.452 -0.353 0 CA-C-O 120.61 0.243 . . . . 10.0 111.02 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -136.57 151.67 49.63 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 128.434 2.694 . . . . 10.0 107.8 179.548 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 17.0 mmtt -96.86 118.13 32.61 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 108.491 -0.929 . . . . 10.0 108.491 175.796 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -113.68 138.54 50.07 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 124.253 1.021 . . . . 10.0 109.749 172.5 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -113.82 145.79 40.91 Favored 'General case' 0 CA--C 1.51 -0.591 0 C-N-CA 124.589 1.156 . . . . 10.0 110.246 174.97 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.648 ' CE2' HD11 ' A' ' 57' ' ' LEU . 3.9 m-85 -139.17 142.52 37.96 Favored 'General case' 0 N--CA 1.448 -0.575 0 O-C-N 125.036 1.46 . . . . 10.0 110.056 -177.077 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -103.59 134.38 47.02 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 125.882 1.673 . . . . 10.0 108.604 -174.371 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.3 mm -109.58 125.25 66.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 C-N-CA 123.711 0.804 . . . . 10.0 110.422 -162.886 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 . . . . . 0 N--CA 1.452 -0.335 0 N-CA-C 108.476 -0.935 . . . . 10.0 108.476 173.005 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.542 0.642 0 N-CA-C 112.961 0.726 . . . . 10.0 112.961 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.0 ttt180 -84.93 -42.02 15.37 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 126.058 1.743 . . . . 10.0 109.604 -172.653 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.424 ' CG2' HD12 ' A' ' 25' ' ' LEU . 18.4 mm -41.66 -57.05 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.323 0 C-N-CA 124.368 1.067 . . . . 10.0 108.66 166.756 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -42.53 -50.62 5.27 Favored 'General case' 0 C--O 1.221 -0.4 0 O-C-N 123.576 0.548 . . . . 10.0 111.399 179.389 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.7 -49.79 56.13 Favored 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 121.875 -0.516 . . . . 10.0 109.631 -176.289 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.432 ' HG3' HD11 ' A' ' 64' ' ' LEU . 6.9 mmt85 -57.65 -38.65 75.44 Favored 'General case' 0 C--O 1.226 -0.149 0 O-C-N 121.94 -0.475 . . . . 10.0 112.036 -179.437 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.424 HD12 ' CG2' ' A' ' 21' ' ' ILE . 0.5 OUTLIER -74.36 -46.35 41.15 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.194 0.997 . . . . 10.0 110.147 177.396 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 53.0 m-20 -54.95 -24.08 22.12 Favored 'General case' 0 C--O 1.226 -0.135 0 C-N-CA 123.319 0.648 . . . . 10.0 111.503 174.941 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.3 ttmt -56.19 -39.53 72.56 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 118.372 0.533 . . . . 10.0 112.225 175.665 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.7 mp -56.74 135.87 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 C-N-CA 123.873 0.869 . . . . 10.0 110.436 179.09 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 55.9 mp0 -70.78 -49.46 46.33 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 116.274 -0.421 . . . . 10.0 110.091 -174.119 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.22 49.01 4.15 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.973 -0.851 . . . . 10.0 110.973 -177.836 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.4 p -110.74 155.54 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 126.009 1.724 . . . . 10.0 109.073 178.03 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.481 ' HB2' HG21 ' A' ' 2' ' ' THR . . . -120.34 -56.78 1.97 Allowed 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 110.235 -0.283 . . . . 10.0 110.235 168.648 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -144.97 149.04 34.48 Favored 'General case' 0 C--O 1.226 -0.172 0 N-CA-C 107.992 -1.114 . . . . 10.0 107.992 -171.484 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -142.85 63.73 13.97 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 118.708 0.685 . . . . 10.0 111.201 172.4 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -76.71 74.32 4.91 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.926 2.417 . . . . 10.0 109.38 178.135 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.494 HG12 HG13 ' A' ' 43' ' ' VAL . 11.4 m -66.02 158.27 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 C-N-CA 123.624 0.77 . . . . 10.0 112.082 179.702 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -90.72 101.69 14.44 Favored 'General case' 0 N--CA 1.46 0.069 0 C-N-CA 120.441 -0.504 . . . . 10.0 111.706 -165.982 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -75.55 42.22 0.21 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.249 1.82 . . . . 10.0 113.938 -173.302 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -177.07 -36.3 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.288 1.435 . . . . 10.0 110.64 176.513 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.2 mt -88.67 0.99 55.88 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.635 1.174 . . . . 10.0 112.667 -169.156 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 58.26 45.5 17.11 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 124.789 1.235 . . . . 10.0 110.402 170.955 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -145.39 129.12 17.22 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.694 -1.224 . . . . 10.0 107.694 -178.124 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.494 HG13 HG12 ' A' ' 36' ' ' VAL . 5.5 t -97.55 126.79 50.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 108.277 -1.008 . . . . 10.0 108.277 175.575 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 84.0 m -113.8 112.26 23.1 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.982 1.713 . . . . 10.0 107.457 178.687 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 41.3 t -106.09 141.59 21.01 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.044 0 CA-C-N 118.359 0.527 . . . . 10.0 110.183 177.49 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -108.12 109.77 21.27 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 125.376 1.47 . . . . 10.0 108.016 160.227 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -143.2 169.57 17.37 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.905 -0.776 . . . . 10.0 108.905 177.288 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 7.3 p-10 -115.46 115.34 42.22 Favored Pre-proline 0 CA--C 1.531 0.238 0 C-N-CA 123.722 0.809 . . . . 10.0 110.021 -178.708 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -74.56 72.1 4.46 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.376 2.717 . . . . 10.0 111.015 -175.832 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.88 -39.16 0.63 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.075 0.55 . . . . 10.0 110.934 168.548 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -86.94 -51.07 6.25 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.193 0.451 . . . . 10.0 110.107 176.756 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -123.76 -175.0 3.11 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.784 1.234 . . . . 10.0 110.742 -171.653 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 83.2 p -144.46 167.94 21.3 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.575 0.75 . . . . 10.0 112.677 177.762 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 23.5 m -47.0 -43.19 6.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 124.57 1.148 . . . . 10.0 111.515 164.312 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 68.3 m -68.78 -40.89 79.42 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 122.782 0.433 . . . . 10.0 110.731 -177.095 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -57.78 -59.48 5.15 Favored 'General case' 0 N--CA 1.455 -0.199 0 O-C-N 123.916 0.76 . . . . 10.0 109.297 176.396 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.648 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.2 pp -65.05 -39.38 93.23 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 122.165 -0.334 . . . . 10.0 110.933 -171.536 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.408 ' HA ' HD23 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -43.46 -45.64 6.44 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 118.254 -0.879 . . . . 10.0 113.194 163.812 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -59.92 -40.56 89.25 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 120.236 1.38 . . . . 10.0 111.024 179.802 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -55.44 -49.41 72.49 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 122.106 -0.371 . . . . 10.0 110.104 178.366 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.519 ' HA ' HD12 ' A' ' 64' ' ' LEU . 24.8 t -66.08 -43.44 92.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 N-CA-C 112.815 0.672 . . . . 10.0 112.815 176.207 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -53.19 -44.0 67.59 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.841 0.829 . . . . 10.0 109.081 177.841 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.0 tttp -80.21 -30.59 38.69 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 124.722 1.209 . . . . 10.0 111.591 -175.246 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.519 HD12 ' HA ' ' A' ' 61' ' ' VAL . 15.1 mt -51.38 -35.49 39.01 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.407 1.003 . . . . 10.0 111.507 162.36 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 115.78 28.35 2.73 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 123.041 0.353 . . . . 10.0 112.822 169.066 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -145.67 158.24 43.87 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 107.251 -1.388 . . . . 10.0 107.251 168.443 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.24 130.96 37.82 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.69 -0.485 . . . . 10.0 109.69 -166.146 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.468 HD11 ' HB2' ' A' ' 7' ' ' PHE . 12.1 tp -114.9 146.98 40.55 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 106.265 -1.754 . . . . 10.0 106.265 173.261 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 17.6 tptt -153.09 150.14 28.82 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 109.053 -0.721 . . . . 10.0 109.053 168.458 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.9 tp -62.39 156.6 22.09 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 109.316 -0.624 . . . . 10.0 109.316 178.04 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 42.1 tttt -117.22 -64.24 1.33 Allowed 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 126.326 1.85 . . . . 10.0 107.742 178.905 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 154.06 50.71 0.01 OUTLIER Glycine 0 CA--C 1.527 0.8 0 CA-C-O 119.661 -0.522 . . . . 10.0 112.337 174.967 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 . . . . . 0 CA--C 1.537 0.472 0 C-N-CA 125.267 1.427 . . . . 10.0 111.989 175.014 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.512 HG21 ' HB2' ' A' ' 32' ' ' ALA . 9.8 p . . . . . 0 CA--C 1.534 0.351 0 N-CA-C 107.195 -1.409 . . . . 10.0 107.195 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -138.39 142.81 39.6 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 129.12 2.968 . . . . 10.0 106.989 -174.227 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 28.9 tttt -111.32 98.69 7.67 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.373 1.069 . . . . 10.0 110.09 -171.504 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -99.92 150.15 22.69 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.834 -1.075 . . . . 10.0 108.844 -175.641 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -122.36 150.17 42.77 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 123.221 0.608 . . . . 10.0 109.919 172.286 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.646 ' CE2' HD11 ' A' ' 57' ' ' LEU . 7.8 m-85 -138.26 137.14 37.2 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 125.452 1.72 . . . . 10.0 108.335 -169.477 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -99.45 139.64 34.81 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 106.328 -1.731 . . . . 10.0 106.328 178.874 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.0 mm -114.32 141.39 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 C-N-CA 124.995 1.318 . . . . 10.0 109.913 -162.779 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 . . . . . 0 N--CA 1.444 -0.729 0 N-CA-C 108.155 -1.054 . . . . 10.0 108.155 176.702 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 . . . . . 0 N--CA 1.464 0.27 0 CA-C-O 120.575 0.226 . . . . 10.0 111.274 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.92 -42.04 41.0 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 118.306 -0.854 . . . . 10.0 111.033 176.202 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 27.2 mm -43.15 -55.1 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.411 0 CA-C-N 118.65 0.659 . . . . 10.0 109.573 174.028 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -43.17 -57.41 2.96 Favored 'General case' 0 C--O 1.222 -0.377 0 C-N-CA 123.244 0.618 . . . . 10.0 111.607 -179.48 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.06 -41.88 63.68 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.392 1.077 . . . . 10.0 109.794 -170.601 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.416 ' HG3' ' HB1' ' A' ' 60' ' ' ALA . 25.6 tpt180 -53.81 -45.65 70.86 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.328 0.651 . . . . 10.0 109.958 175.358 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.03 -37.72 64.25 Favored 'General case' 0 C--O 1.224 -0.284 0 C-N-CA 123.2 0.6 . . . . 10.0 111.858 176.046 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -51.98 -32.39 33.36 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 123.723 0.809 . . . . 10.0 109.788 175.317 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.7 -33.42 70.16 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.947 1.091 . . . . 10.0 113.947 175.478 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 17.0 mm -57.48 133.21 22.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 108.314 -0.995 . . . . 10.0 108.314 177.465 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -80.29 -41.88 24.12 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 118.486 0.585 . . . . 10.0 110.757 -172.039 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -78.91 39.92 2.05 Favored Glycine 0 C--N 1.339 0.738 0 O-C-N 120.117 -1.614 . . . . 10.0 112.491 176.1 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.4 p -105.68 148.22 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 C-N-CA 124.179 0.991 . . . . 10.0 108.363 -176.594 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.512 ' HB2' HG21 ' A' ' 2' ' ' THR . . . -115.54 -56.36 2.35 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.92 -0.77 . . . . 10.0 108.92 174.876 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 64.2 m-80 -147.32 152.76 38.77 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 109.264 -0.643 . . . . 10.0 109.264 -178.546 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -134.81 65.85 67.26 Favored Pre-proline 0 CA--C 1.534 0.341 0 C-N-CA 123.639 0.776 . . . . 10.0 110.015 173.667 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -78.92 67.33 8.57 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.825 2.35 . . . . 10.0 109.078 -178.946 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.473 HG12 HG13 ' A' ' 43' ' ' VAL . 5.0 m -69.59 157.58 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 C-N-CA 122.889 0.476 . . . . 10.0 111.339 -175.89 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -91.51 126.36 36.57 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 121.276 0.56 . . . . 10.0 110.82 -178.675 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -99.61 33.07 2.61 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.962 1.705 . . . . 10.0 112.015 -168.522 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -171.12 -40.71 0.02 OUTLIER 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 124.542 1.137 . . . . 10.0 110.661 179.986 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.1 mt -72.57 -20.06 61.38 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.089 0.956 . . . . 10.0 111.477 -173.31 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 65.17 51.59 1.62 Allowed 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 125.664 1.586 . . . . 10.0 110.424 -178.018 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.1 p -140.1 124.37 17.82 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 125.457 1.503 . . . . 10.0 107.066 173.606 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.473 HG13 HG12 ' A' ' 36' ' ' VAL . 7.9 t -97.2 135.3 31.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 107.773 -1.195 . . . . 10.0 107.773 175.581 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.6 m -120.85 127.84 52.28 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 126.161 1.785 . . . . 10.0 107.418 178.708 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 36.6 t -131.9 128.18 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.123 0 CA-C-N 118.678 0.672 . . . . 10.0 110.093 178.94 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -93.13 102.11 14.41 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 105.314 -2.106 . . . . 10.0 105.314 165.968 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -135.7 176.78 8.37 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.536 1.134 . . . . 10.0 108.612 178.812 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 27.7 p30 -116.96 135.78 23.12 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 118.879 0.763 . . . . 10.0 110.986 175.682 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -79.7 56.84 6.22 Favored 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 121.435 1.424 . . . . 10.0 108.85 167.307 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.8 ptpt -123.88 -39.51 2.38 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 118.133 0.424 . . . . 10.0 111.344 172.828 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -97.99 -61.68 1.35 Allowed 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 107.425 -1.324 . . . . 10.0 107.425 177.48 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -105.62 -174.96 2.66 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 125.047 1.339 . . . . 10.0 111.102 -171.718 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 87.7 p -144.68 164.9 29.59 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 121.673 0.749 . . . . 10.0 109.985 173.692 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.2 m -52.58 -37.47 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 C-N-CA 124.384 1.073 . . . . 10.0 111.154 172.228 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.2 t -62.72 -40.45 97.24 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 122.47 0.308 . . . . 10.0 110.708 177.058 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -65.67 -52.79 48.81 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.891 -0.781 . . . . 10.0 108.891 -175.97 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.646 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.0 pp -64.77 -42.47 95.08 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 121.762 -0.586 . . . . 10.0 111.218 -178.482 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -41.54 -55.22 2.94 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-O 117.737 -1.125 . . . . 10.0 111.751 162.345 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 -56.58 -48.28 77.73 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 119.939 1.245 . . . . 10.0 110.353 178.669 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.416 ' HB1' ' HG3' ' A' ' 24' ' ' ARG . . . -51.29 -45.31 62.1 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 109.59 -0.522 . . . . 10.0 109.59 -178.665 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 99.5 t -69.39 -46.98 75.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 112.401 0.519 . . . . 10.0 112.401 174.017 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -45.59 -42.35 11.04 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.482 1.513 . . . . 10.0 109.522 177.556 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -79.96 -26.2 40.09 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 125.104 1.362 . . . . 10.0 111.329 -173.879 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 67.9 mt -55.96 -41.23 74.39 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 119.489 1.041 . . . . 10.0 110.91 164.559 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 149.03 -40.79 0.88 Allowed Glycine 0 CA--C 1.526 0.755 0 CA-C-N 118.088 0.404 . . . . 10.0 112.531 173.227 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -96.02 157.51 15.86 Favored 'General case' 0 C--N 1.334 -0.099 0 C-N-CA 124.204 1.002 . . . . 10.0 109.351 -177.749 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 63.5 mmtt -92.12 148.61 22.04 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 121.506 0.67 . . . . 10.0 110.341 -170.426 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 10.5 tp -124.46 148.73 47.47 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.115 1.766 . . . . 10.0 106.608 176.675 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.0 tptm -151.48 145.14 24.99 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 117.956 0.344 . . . . 10.0 110.711 165.478 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.4 tt -64.9 159.41 22.81 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-O 121.462 0.649 . . . . 10.0 109.684 178.36 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 27.5 tttt -127.38 -55.54 1.34 Allowed 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 127.701 2.4 . . . . 10.0 107.829 -175.979 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 176.34 -89.91 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 107.92 -2.072 . . . . 10.0 107.92 177.522 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 . . . . . 0 N--CA 1.451 -0.38 0 C-N-CA 123.788 0.835 . . . . 10.0 108.795 -164.295 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.7 p . . . . . 0 N--CA 1.445 -0.694 0 N-CA-C 109.786 -0.45 . . . . 10.0 109.786 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -125.33 145.35 50.07 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 126.581 1.952 . . . . 10.0 108.273 -169.98 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.8 mmtm -87.15 124.45 33.28 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 124.096 0.959 . . . . 10.0 109.675 -175.166 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.474 ' HB1' HD11 ' A' ' 70' ' ' LEU . . . -125.35 143.11 51.13 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.16 1.784 . . . . 10.0 109.349 176.95 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -121.31 146.75 46.51 Favored 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 123.518 0.727 . . . . 10.0 109.096 172.881 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.823 ' CE2' HD11 ' A' ' 57' ' ' LEU . 3.8 m-85 -133.39 140.27 47.26 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 125.194 1.559 . . . . 10.0 108.522 -173.443 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -96.99 141.79 29.72 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.687 1.995 . . . . 10.0 107.618 -177.471 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.548 HG13 HD12 ' A' ' 68' ' ' LEU . 3.3 mp -132.41 148.5 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 125.236 1.415 . . . . 10.0 110.531 -167.407 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 . . . . . 0 N--CA 1.441 -0.877 0 CA-C-N 112.286 -2.234 . . . . 10.0 106.229 175.613 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 . . . . . 0 N--CA 1.472 0.642 0 N-CA-C 112.334 0.494 . . . . 10.0 112.334 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.81 -40.88 89.9 Favored 'General case' 0 N--CA 1.455 -0.219 0 O-C-N 120.904 -1.122 . . . . 10.0 109.301 176.298 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.53 HG22 HD12 ' A' ' 25' ' ' LEU . 20.8 mm -54.13 -49.4 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 108.772 -0.825 . . . . 10.0 108.772 -177.945 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -45.8 -56.42 5.37 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.568 0.747 . . . . 10.0 110.967 -179.895 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.8 mtmt -66.29 -44.6 83.06 Favored 'General case' 0 N--CA 1.453 -0.291 0 O-C-N 121.845 -0.534 . . . . 10.0 111.084 179.583 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.0 tpt85 -56.88 -30.74 64.17 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 111.487 0.18 . . . . 10.0 111.487 178.829 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.53 HD12 HG22 ' A' ' 21' ' ' ILE . 0.3 OUTLIER -84.0 -38.34 21.05 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 125.469 1.508 . . . . 10.0 111.46 174.894 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -60.67 -26.75 67.32 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.779 0.832 . . . . 10.0 109.785 178.845 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.0 mmpt? -50.69 -35.88 33.18 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 114.058 1.133 . . . . 10.0 114.058 168.397 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 13.4 mm -62.84 126.89 22.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 118.63 0.65 . . . . 10.0 109.388 -178.784 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -56.19 -57.53 11.81 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.13 0.419 . . . . 10.0 112.13 -179.673 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -82.57 43.9 3.13 Favored Glycine 0 C--N 1.341 0.838 0 O-C-N 120.259 -1.526 . . . . 10.0 111.988 -170.717 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.5 p -108.07 150.03 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 C-N-CA 124.645 1.178 . . . . 10.0 108.643 -176.965 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -106.86 -58.54 1.92 Allowed 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 109.039 -0.726 . . . . 10.0 109.039 171.81 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -144.97 141.31 28.86 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 106.837 -1.542 . . . . 10.0 106.837 -166.732 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -133.83 59.71 40.94 Favored Pre-proline 0 CA--C 1.535 0.388 0 CA-C-N 118.488 0.586 . . . . 10.0 111.719 172.297 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -77.0 82.26 2.4 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 123.248 2.632 . . . . 10.0 109.215 -178.62 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.515 HG12 HG13 ' A' ' 43' ' ' VAL . 2.9 m -71.53 151.44 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 O-C-N 121.746 -0.596 . . . . 10.0 110.705 -177.793 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -86.32 142.58 28.4 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 120.638 -0.425 . . . . 10.0 110.131 177.345 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -120.88 52.98 1.15 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.269 1.427 . . . . 10.0 110.067 -174.979 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -176.0 -42.7 0.01 OUTLIER 'General case' 0 C--O 1.226 -0.158 0 C-N-CA 125.481 1.512 . . . . 10.0 108.698 178.287 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.8 mt -80.13 -20.96 43.73 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.028 0.931 . . . . 10.0 111.459 -172.599 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 59.04 49.74 9.09 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 126.31 1.844 . . . . 10.0 110.129 -172.336 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 20.7 p -134.74 117.35 15.9 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 125.064 1.345 . . . . 10.0 108.631 173.362 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.518 ' H ' ' CD1' ' A' ' 9' ' ' ILE . 14.4 t -85.34 131.33 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 106.282 -1.747 . . . . 10.0 106.282 171.636 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.2 m -110.81 123.88 50.94 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 105.991 -1.855 . . . . 10.0 105.991 172.295 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 33.6 t -121.92 146.24 27.36 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.274 0 N-CA-C 107.961 -1.126 . . . . 10.0 107.961 171.277 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -112.47 113.35 25.48 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 106.303 -1.74 . . . . 10.0 106.303 166.569 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -142.08 156.82 45.41 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.062 0.545 . . . . 10.0 110.715 -177.099 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 19.6 p30 -93.37 126.05 51.9 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 118.813 -0.613 . . . . 10.0 109.47 177.225 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -74.71 63.42 5.72 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 122.401 2.067 . . . . 10.0 108.922 174.717 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.3 tttt -135.33 -57.03 0.8 Allowed 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 105.331 -2.1 . . . . 10.0 105.331 174.662 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -101.38 -51.12 3.56 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 108.638 -0.875 . . . . 10.0 108.638 -177.797 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -81.59 137.72 35.46 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 123.627 0.771 . . . . 10.0 110.717 -176.851 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.6 p -131.38 145.5 51.85 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.417 1.087 . . . . 10.0 110.945 177.112 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 97.0 t -48.39 -48.05 14.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 C-N-CA 125.243 1.417 . . . . 10.0 110.355 174.776 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.01 -43.79 78.06 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 124.914 1.285 . . . . 10.0 111.432 -179.858 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -64.97 -55.86 16.6 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 121.695 0.76 . . . . 10.0 109.3 -177.249 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.823 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.2 pp -65.56 -41.62 92.74 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.162 -0.961 . . . . 10.0 111.307 -176.423 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -43.88 -48.61 8.41 Favored 'General case' 0 N--CA 1.451 -0.4 0 O-C-N 121.51 -0.744 . . . . 10.0 112.291 161.701 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.63 -43.17 84.62 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 119.224 0.92 . . . . 10.0 109.695 -179.377 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -49.67 -56.81 8.75 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 122.741 0.417 . . . . 10.0 110.556 177.057 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.552 HG11 ' HB2' ' A' ' 68' ' ' LEU . 47.4 t -58.45 -50.19 79.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 N-CA-C 113.184 0.809 . . . . 10.0 113.184 174.185 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -59.21 -35.74 74.15 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.317 1.047 . . . . 10.0 109.5 -174.132 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.8 tptt -77.4 -43.83 31.33 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 125.301 1.441 . . . . 10.0 110.52 178.083 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 19.4 mt -51.25 -39.01 55.75 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-N 118.938 0.79 . . . . 10.0 111.569 172.358 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 128.8 3.08 5.56 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-O 119.41 -0.661 . . . . 10.0 113.58 169.29 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -99.45 -160.44 0.8 Allowed 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 107.57 -1.27 . . . . 10.0 107.57 175.768 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 35.0 tttt -139.06 149.12 44.23 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 118.458 0.572 . . . . 10.0 111.238 167.638 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.552 ' HB2' HG11 ' A' ' 61' ' ' VAL . 13.9 tp -135.62 150.84 49.77 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 127.419 2.288 . . . . 10.0 106.475 -176.046 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.7 tptm -149.76 152.89 35.98 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 108.446 -0.946 . . . . 10.0 108.446 163.642 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.474 HD11 ' HB1' ' A' ' 5' ' ' ALA . 10.6 tp -63.91 157.46 24.76 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 119.341 0.973 . . . . 10.0 108.883 172.338 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 34.5 tttp -117.03 -56.14 2.28 Favored 'General case' 0 N--CA 1.436 -1.152 0 C-N-CA 126.51 1.924 . . . . 10.0 107.783 170.133 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -179.47 -89.25 0.08 OUTLIER Glycine 0 CA--C 1.523 0.535 0 N-CA-C 109.158 -1.577 . . . . 10.0 109.158 -177.864 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 . . . . . 0 N--CA 1.454 -0.251 0 C-N-CA 123.865 0.866 . . . . 10.0 109.189 -166.666 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 47.6 t . . . . . 0 N--CA 1.469 0.497 0 N-CA-C 107.825 -1.176 . . . . 10.0 107.825 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.441 HG21 ' HB2' ' A' ' 32' ' ' ALA . 5.9 p -130.62 154.5 47.82 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.826 1.25 . . . . 10.0 109.838 -176.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -119.2 139.55 51.67 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 127.045 2.138 . . . . 10.0 109.321 -172.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.9 mtmm -104.87 88.75 2.97 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.844 1.658 . . . . 10.0 110.63 -165.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -104.59 152.35 22.53 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.299 1.44 . . . . 10.0 110.497 -168.063 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -123.54 148.89 45.88 Favored 'General case' 0 CA--C 1.511 -0.545 0 C-N-CA 123.791 0.836 . . . . 10.0 110.199 178.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.755 ' CE2' HD11 ' A' ' 57' ' ' LEU . 3.8 m-85 -138.72 142.3 38.9 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 125.241 1.416 . . . . 10.0 108.205 -175.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -108.86 137.41 46.84 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 107.698 -1.223 . . . . 10.0 107.698 -173.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 5.1 mm -110.22 124.86 67.33 Favored 'Isoleucine or valine' 0 C--N 1.338 0.096 0 C-N-CA 124.52 1.128 . . . . 10.0 110.715 -159.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -117.58 102.67 9.36 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.942 -0.762 . . . . 10.0 108.942 173.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 160.15 -84.75 0.12 Allowed Glycine 0 CA--C 1.527 0.792 0 C-N-CA 123.887 0.756 . . . . 10.0 111.858 170.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.14 160.95 15.19 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.441 0.697 . . . . 10.0 110.772 -176.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.6 t -153.02 86.18 1.24 Allowed 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 107.485 -1.302 . . . . 10.0 107.485 170.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 31.6 t -152.48 138.26 17.95 Favored 'General case' 0 C--O 1.227 -0.131 0 N-CA-C 108.564 -0.902 . . . . 10.0 108.564 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -48.73 -53.4 19.09 Favored 'General case' 0 C--O 1.226 -0.173 0 C-N-CA 125.192 1.397 . . . . 10.0 113.738 -172.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.58 -40.76 48.6 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.336 -0.616 . . . . 10.0 109.336 -168.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.2 m -61.7 -52.38 64.53 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.336 -0.616 . . . . 10.0 109.336 176.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -52.33 -40.0 61.36 Favored 'General case' 0 C--O 1.221 -0.428 0 C-N-CA 123.693 0.797 . . . . 10.0 110.205 173.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -51.69 -31.2 25.02 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 121.497 -0.752 . . . . 10.0 111.897 179.481 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.59 -38.26 89.43 Favored 'General case' 0 N--CA 1.446 -0.655 0 O-C-N 121.265 -0.897 . . . . 10.0 110.154 178.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.429 HG22 HD12 ' A' ' 25' ' ' LEU . 19.3 mm -41.45 -54.04 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.305 0 C-N-CA 124.349 1.06 . . . . 10.0 111.495 170.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -49.56 -50.28 42.89 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-N 118.355 0.525 . . . . 10.0 110.476 -176.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.53 -46.22 67.01 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.787 -0.57 . . . . 10.0 110.187 -178.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.515 ' HG3' HD11 ' A' ' 64' ' ' LEU . 7.6 mmt180 -55.75 -32.27 63.28 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 113.284 0.846 . . . . 10.0 113.284 177.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.475 HD21 HD13 ' A' ' 57' ' ' LEU . 0.5 OUTLIER -84.92 -42.58 14.85 Favored 'General case' 0 C--O 1.22 -0.499 0 C-N-CA 123.419 0.688 . . . . 10.0 111.21 172.421 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -60.28 -18.65 50.69 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 120.933 -1.105 . . . . 10.0 111.359 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.1 mmpt? -51.19 -41.03 59.94 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 113.863 1.06 . . . . 10.0 113.863 164.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.686 HD11 ' HB3' ' A' ' 57' ' ' LEU . 10.8 mt -54.5 129.43 15.61 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.068 0 CA-C-N 119.216 0.916 . . . . 10.0 108.909 175.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 58.0 mp0 -66.94 -46.23 75.38 Favored 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 122.132 -0.355 . . . . 10.0 110.129 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.18 43.91 3.2 Favored Glycine 0 C--N 1.339 0.699 0 O-C-N 121.266 -0.896 . . . . 10.0 111.998 -173.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.4 p -103.8 152.47 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 C-N-CA 124.894 1.278 . . . . 10.0 108.811 -176.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.441 ' HB2' HG21 ' A' ' 2' ' ' THR . . . -117.69 -59.75 1.89 Allowed 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.677 -0.861 . . . . 10.0 108.677 168.031 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 -140.13 160.15 40.59 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 109.29 -0.633 . . . . 10.0 109.29 -178.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -149.2 63.72 6.88 Favored Pre-proline 0 CA--C 1.535 0.374 0 C-N-CA 123.191 0.596 . . . . 10.0 110.804 173.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -78.12 75.58 4.78 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.89 2.393 . . . . 10.0 109.698 -176.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.498 HG12 HG13 ' A' ' 43' ' ' VAL . 6.3 m -70.98 157.41 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 O-C-N 121.744 -0.597 . . . . 10.0 112.024 -177.427 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -100.93 138.07 38.47 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 110.084 -0.339 . . . . 10.0 110.084 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -120.98 53.66 1.12 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.976 1.31 . . . . 10.0 110.603 -172.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -176.26 -41.31 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 125.727 1.611 . . . . 10.0 108.805 178.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.3 mt -82.24 -15.2 53.94 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.021 1.328 . . . . 10.0 111.44 -172.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 72.91 44.15 0.37 Allowed 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 125.762 1.625 . . . . 10.0 110.377 173.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 39.7 p -140.91 131.71 25.83 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.189 1.396 . . . . 10.0 109.067 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.498 HG13 HG12 ' A' ' 36' ' ' VAL . 4.0 t -99.97 141.94 16.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 107.746 -1.205 . . . . 10.0 107.746 167.442 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 62.5 m -130.12 124.12 31.97 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 106.576 -1.639 . . . . 10.0 106.576 -176.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 16.5 t -126.63 134.54 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 C-N-CA 123.091 0.556 . . . . 10.0 110.681 -175.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -108.98 94.22 4.93 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 127.043 2.137 . . . . 10.0 106.914 171.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -140.14 163.38 32.89 Favored 'General case' 0 CA--C 1.521 -0.15 0 C-N-CA 123.29 0.636 . . . . 10.0 109.46 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -95.92 132.48 27.01 Favored Pre-proline 0 C--N 1.329 -0.306 0 C-N-CA 123.57 0.748 . . . . 10.0 110.186 177.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -78.81 56.43 5.96 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.081 1.854 . . . . 10.0 109.926 171.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.0 pttt -118.53 -45.74 2.6 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 108.965 -0.754 . . . . 10.0 108.965 170.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.08 -46.29 5.63 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.2 1.0 . . . . 10.0 110.605 -167.175 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.405 ' CB ' HG23 ' A' ' 28' ' ' ILE . . . -122.92 -171.34 2.27 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.287 1.035 . . . . 10.0 109.6 175.418 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 97.2 p -149.46 170.8 17.76 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.297 0.639 . . . . 10.0 110.466 177.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 31.4 m -49.42 -42.11 16.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 123.679 0.792 . . . . 10.0 111.293 172.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 66.9 m -61.23 -42.36 98.47 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 123.454 0.702 . . . . 10.0 111.699 -178.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -62.28 -57.39 11.59 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.265 0.626 . . . . 10.0 109.501 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.755 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.1 pp -65.85 -40.87 92.14 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 121.512 0.672 . . . . 10.0 110.373 -173.134 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.488 ' HA ' HD23 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -44.32 -47.19 9.54 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 112.675 0.62 . . . . 10.0 112.675 163.305 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.11 -44.54 96.43 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-N 119.02 0.827 . . . . 10.0 109.512 178.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -52.12 -47.76 65.16 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 110.382 -0.229 . . . . 10.0 110.382 178.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.555 ' HA ' HD12 ' A' ' 64' ' ' LEU . 38.7 t -65.73 -46.17 89.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 N-CA-C 112.776 0.658 . . . . 10.0 112.776 174.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -56.48 -38.67 72.04 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 120.544 -1.347 . . . . 10.0 110.268 178.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.2 tptm -66.65 -35.52 80.36 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.051 1.34 . . . . 10.0 109.83 -178.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.555 HD12 ' HA ' ' A' ' 61' ' ' VAL . 26.4 mt -58.65 -30.15 67.09 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 118.98 -0.533 . . . . 10.0 112.068 169.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 137.39 -39.79 1.58 Allowed Glycine 0 CA--C 1.527 0.804 0 C-N-CA 123.701 0.667 . . . . 10.0 111.716 171.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.406 ' CE2' HD11 ' A' ' 21' ' ' ILE . 8.1 p90 -97.7 152.44 19.1 Favored 'General case' 0 C--O 1.226 -0.175 0 C-N-CA 125.148 1.379 . . . . 10.0 109.527 -172.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -89.35 153.34 20.94 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.648 0.737 . . . . 10.0 110.849 -170.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.537 HD11 ' HB2' ' A' ' 7' ' ' PHE . 29.1 tp -130.3 148.29 52.11 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.233 1.813 . . . . 10.0 107.383 177.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 9.4 tptp -154.7 152.81 30.37 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 108.912 -0.773 . . . . 10.0 108.912 165.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.6 tp -62.46 154.7 27.64 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 109.488 -0.56 . . . . 10.0 109.488 178.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -108.34 -60.94 1.66 Allowed 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 125.462 1.505 . . . . 10.0 106.961 168.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -174.44 -79.4 0.05 OUTLIER Glycine 0 CA--C 1.521 0.455 0 N-CA-C 110.003 -1.239 . . . . 10.0 110.003 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -162.49 174.38 12.76 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.384 1.074 . . . . 10.0 108.128 -170.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 23.8 pt20 -45.25 129.95 8.03 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 123.863 0.727 . . . . 10.0 112.123 178.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.6 t70 67.27 -176.3 0.2 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.109 1.364 . . . . 10.0 110.69 174.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 40.3 m -96.47 -23.26 16.66 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.08 1.352 . . . . 10.0 110.975 171.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 15.3 mt -128.24 -119.39 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 123.2 0.6 . . . . 10.0 109.571 -178.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 33.09 64.74 0.27 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 127.259 2.224 . . . . 10.0 113.942 -175.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -65.18 109.91 3.17 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 109.503 -1.439 . . . . 10.0 109.503 171.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.144 0 CA-C-O 116.499 -1.715 . . . . 10.0 107.204 -172.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 47.6 t . . . . . 0 N--CA 1.469 0.497 0 N-CA-C 107.825 -1.176 . . . . 10.0 107.825 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.441 HG21 ' HB2' ' A' ' 32' ' ' ALA . 5.9 p -130.62 154.5 47.82 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.826 1.25 . . . . 10.0 109.838 -176.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -119.2 139.55 51.67 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 127.045 2.138 . . . . 10.0 109.321 -172.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.9 mtmm -104.87 88.75 2.97 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.844 1.658 . . . . 10.0 110.63 -165.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -104.59 152.35 22.53 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.299 1.44 . . . . 10.0 110.497 -168.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -123.54 148.89 45.88 Favored 'General case' 0 CA--C 1.511 -0.545 0 C-N-CA 123.791 0.836 . . . . 10.0 110.199 178.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.755 ' CE2' HD11 ' A' ' 57' ' ' LEU . 3.8 m-85 -138.72 142.3 38.9 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 125.241 1.416 . . . . 10.0 108.205 -175.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -108.86 137.41 46.84 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 107.698 -1.223 . . . . 10.0 107.698 -173.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 5.1 mm -110.22 124.86 67.33 Favored 'Isoleucine or valine' 0 C--N 1.338 0.096 0 C-N-CA 124.52 1.128 . . . . 10.0 110.715 -159.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -117.58 102.67 9.36 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.942 -0.762 . . . . 10.0 108.942 173.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 160.15 -84.75 0.12 Allowed Glycine 0 CA--C 1.527 0.792 0 C-N-CA 123.887 0.756 . . . . 10.0 111.858 170.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.14 160.95 15.19 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.441 0.697 . . . . 10.0 110.772 -176.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.6 t -153.02 86.18 1.24 Allowed 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 107.485 -1.302 . . . . 10.0 107.485 170.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 31.6 t -152.48 138.26 17.95 Favored 'General case' 0 C--O 1.227 -0.131 0 N-CA-C 108.564 -0.902 . . . . 10.0 108.564 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -48.73 -53.4 19.09 Favored 'General case' 0 C--O 1.226 -0.173 0 C-N-CA 125.192 1.397 . . . . 10.0 113.738 -172.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.58 -40.76 48.6 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.336 -0.616 . . . . 10.0 109.336 -168.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.2 m -61.7 -52.38 64.53 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.336 -0.616 . . . . 10.0 109.336 176.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -52.33 -40.0 61.36 Favored 'General case' 0 C--O 1.221 -0.428 0 C-N-CA 123.693 0.797 . . . . 10.0 110.205 173.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -51.69 -31.2 25.02 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 121.497 -0.752 . . . . 10.0 111.897 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.59 -38.26 89.43 Favored 'General case' 0 N--CA 1.446 -0.655 0 O-C-N 121.265 -0.897 . . . . 10.0 110.154 178.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.429 HG22 HD12 ' A' ' 25' ' ' LEU . 19.3 mm -41.45 -54.04 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.305 0 C-N-CA 124.349 1.06 . . . . 10.0 111.495 170.5 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -49.56 -50.28 42.89 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-N 118.355 0.525 . . . . 10.0 110.476 -176.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.53 -46.22 67.01 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.787 -0.57 . . . . 10.0 110.187 -178.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.515 ' HG3' HD11 ' A' ' 64' ' ' LEU . 7.6 mmt180 -55.75 -32.27 63.28 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 113.284 0.846 . . . . 10.0 113.284 177.567 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.475 HD21 HD13 ' A' ' 57' ' ' LEU . 0.5 OUTLIER -84.92 -42.58 14.85 Favored 'General case' 0 C--O 1.22 -0.499 0 C-N-CA 123.419 0.688 . . . . 10.0 111.21 172.421 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -60.28 -18.65 50.69 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 120.933 -1.105 . . . . 10.0 111.359 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.1 mmpt? -51.19 -41.03 59.94 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 113.863 1.06 . . . . 10.0 113.863 164.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.686 HD11 ' HB3' ' A' ' 57' ' ' LEU . 10.8 mt -54.5 129.43 15.61 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.068 0 CA-C-N 119.216 0.916 . . . . 10.0 108.909 175.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 58.0 mp0 -66.94 -46.23 75.38 Favored 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 122.132 -0.355 . . . . 10.0 110.129 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.18 43.91 3.2 Favored Glycine 0 C--N 1.339 0.699 0 O-C-N 121.266 -0.896 . . . . 10.0 111.998 -173.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.4 p -103.8 152.47 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 C-N-CA 124.894 1.278 . . . . 10.0 108.811 -176.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.441 ' HB2' HG21 ' A' ' 2' ' ' THR . . . -117.69 -59.75 1.89 Allowed 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.677 -0.861 . . . . 10.0 108.677 168.031 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 -140.13 160.15 40.59 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 109.29 -0.633 . . . . 10.0 109.29 -178.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -149.2 63.72 6.88 Favored Pre-proline 0 CA--C 1.535 0.374 0 C-N-CA 123.191 0.596 . . . . 10.0 110.804 173.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -78.12 75.58 4.78 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.89 2.393 . . . . 10.0 109.698 -176.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.498 HG12 HG13 ' A' ' 43' ' ' VAL . 6.3 m -70.98 157.41 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 O-C-N 121.744 -0.597 . . . . 10.0 112.024 -177.427 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -100.93 138.07 38.47 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 110.084 -0.339 . . . . 10.0 110.084 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -120.98 53.66 1.12 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.976 1.31 . . . . 10.0 110.603 -172.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -176.26 -41.31 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 125.727 1.611 . . . . 10.0 108.805 178.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.3 mt -82.24 -15.2 53.94 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.021 1.328 . . . . 10.0 111.44 -172.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 72.91 44.15 0.37 Allowed 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 125.762 1.625 . . . . 10.0 110.377 173.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 39.7 p -140.91 131.71 25.83 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.189 1.396 . . . . 10.0 109.067 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.498 HG13 HG12 ' A' ' 36' ' ' VAL . 4.0 t -99.97 141.94 16.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 107.746 -1.205 . . . . 10.0 107.746 167.442 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 62.5 m -130.12 124.12 31.97 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 106.576 -1.639 . . . . 10.0 106.576 -176.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 16.5 t -126.63 134.54 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 C-N-CA 123.091 0.556 . . . . 10.0 110.681 -175.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -108.98 94.22 4.93 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 127.043 2.137 . . . . 10.0 106.914 171.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -140.14 163.38 32.89 Favored 'General case' 0 CA--C 1.521 -0.15 0 C-N-CA 123.29 0.636 . . . . 10.0 109.46 179.102 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -95.92 132.48 27.01 Favored Pre-proline 0 C--N 1.329 -0.306 0 C-N-CA 123.57 0.748 . . . . 10.0 110.186 177.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -78.81 56.43 5.96 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.081 1.854 . . . . 10.0 109.926 171.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.0 pttt -118.53 -45.74 2.6 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 108.965 -0.754 . . . . 10.0 108.965 170.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.08 -46.29 5.63 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.2 1.0 . . . . 10.0 110.605 -167.175 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.405 ' CB ' HG23 ' A' ' 28' ' ' ILE . . . -122.92 -171.34 2.27 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.287 1.035 . . . . 10.0 109.6 175.418 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 97.2 p -149.46 170.8 17.76 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.297 0.639 . . . . 10.0 110.466 177.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 31.4 m -49.42 -42.11 16.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 123.679 0.792 . . . . 10.0 111.293 172.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 66.9 m -61.23 -42.36 98.47 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 123.454 0.702 . . . . 10.0 111.699 -178.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -62.28 -57.39 11.59 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.265 0.626 . . . . 10.0 109.501 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.755 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.1 pp -65.85 -40.87 92.14 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 121.512 0.672 . . . . 10.0 110.373 -173.134 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.488 ' HA ' HD23 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -44.32 -47.19 9.54 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 112.675 0.62 . . . . 10.0 112.675 163.305 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.11 -44.54 96.43 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-N 119.02 0.827 . . . . 10.0 109.512 178.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -52.12 -47.76 65.16 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 110.382 -0.229 . . . . 10.0 110.382 178.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.555 ' HA ' HD12 ' A' ' 64' ' ' LEU . 38.7 t -65.73 -46.17 89.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 N-CA-C 112.776 0.658 . . . . 10.0 112.776 174.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -56.48 -38.67 72.04 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 120.544 -1.347 . . . . 10.0 110.268 178.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.2 tptm -66.65 -35.52 80.36 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.051 1.34 . . . . 10.0 109.83 -178.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.555 HD12 ' HA ' ' A' ' 61' ' ' VAL . 26.4 mt -58.65 -30.15 67.09 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 118.98 -0.533 . . . . 10.0 112.068 169.534 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 137.39 -39.79 1.58 Allowed Glycine 0 CA--C 1.527 0.804 0 C-N-CA 123.701 0.667 . . . . 10.0 111.716 171.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.406 ' CE2' HD11 ' A' ' 21' ' ' ILE . 8.1 p90 -97.7 152.44 19.1 Favored 'General case' 0 C--O 1.226 -0.175 0 C-N-CA 125.148 1.379 . . . . 10.0 109.527 -172.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -89.35 153.34 20.94 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.648 0.737 . . . . 10.0 110.849 -170.148 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.537 HD11 ' HB2' ' A' ' 7' ' ' PHE . 29.1 tp -130.3 148.29 52.11 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.233 1.813 . . . . 10.0 107.383 177.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 9.4 tptp -154.7 152.81 30.37 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 108.912 -0.773 . . . . 10.0 108.912 165.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.6 tp -62.46 154.7 27.64 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 109.488 -0.56 . . . . 10.0 109.488 178.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -108.34 -60.94 1.66 Allowed 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 125.462 1.505 . . . . 10.0 106.961 168.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -174.44 -79.4 0.05 OUTLIER Glycine 0 CA--C 1.521 0.455 0 N-CA-C 110.003 -1.239 . . . . 10.0 110.003 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -162.49 174.38 12.76 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.384 1.074 . . . . 10.0 108.128 -170.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 23.8 pt20 -45.25 129.95 8.03 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 123.863 0.727 . . . . 10.0 112.123 178.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.6 t70 67.27 -176.3 0.2 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.109 1.364 . . . . 10.0 110.69 174.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 40.3 m -96.47 -23.26 16.66 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.08 1.352 . . . . 10.0 110.975 171.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 15.3 mt -128.24 -119.39 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 123.2 0.6 . . . . 10.0 109.571 -178.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 33.09 64.74 0.27 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 127.259 2.224 . . . . 10.0 113.942 -175.003 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -65.18 109.91 3.17 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 109.503 -1.439 . . . . 10.0 109.503 171.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.144 0 CA-C-O 116.499 -1.715 . . . . 10.0 107.204 -172.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.2 p . . . . . 0 N--CA 1.472 0.652 0 N-CA-C 109.807 -0.442 . . . . 10.0 109.807 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.458 HG21 ' HB2' ' A' ' 32' ' ' ALA . 1.8 p -142.48 159.09 42.91 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.238 1.415 . . . . 10.0 107.555 178.321 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -121.7 147.69 45.57 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 126.51 1.924 . . . . 10.0 108.143 -166.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -88.69 130.91 35.21 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 107.983 -1.117 . . . . 10.0 107.983 -178.399 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -145.35 135.9 24.27 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.251 -0.648 . . . . 10.0 109.251 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -122.23 149.42 43.69 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 123.449 0.7 . . . . 10.0 111.614 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.784 ' CE2' HD11 ' A' ' 57' ' ' LEU . 13.1 m-85 -136.28 137.97 41.27 Favored 'General case' 0 N--CA 1.451 -0.409 0 O-C-N 125.134 1.521 . . . . 10.0 110.037 -170.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -93.9 138.09 32.41 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 106.926 -1.509 . . . . 10.0 106.926 178.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.447 ' CD1' HD12 ' A' ' 68' ' ' LEU . 6.9 mm -109.93 132.39 58.3 Favored 'Isoleucine or valine' 0 C--N 1.34 0.168 0 C-N-CA 125.018 1.327 . . . . 10.0 111.496 -165.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 -124.23 94.18 4.14 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 124.098 0.959 . . . . 10.0 109.649 176.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 162.43 -70.15 0.22 Allowed Glycine 0 CA--C 1.53 0.987 0 CA-C-O 119.33 -0.706 . . . . 10.0 113.089 164.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 23.7 ptp -149.99 136.97 19.46 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.18 0.99 . . . . 10.0 109.72 -173.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.2 p -149.16 30.06 0.78 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.222 1.009 . . . . 10.0 111.066 -156.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 94.6 m -90.4 -65.39 1.02 Allowed 'General case' 0 C--O 1.224 -0.24 0 O-C-N 121.728 -0.607 . . . . 10.0 110.944 -157.006 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -172.19 -67.92 0.02 OUTLIER 'General case' 0 C--O 1.222 -0.388 0 C-N-CA 123.956 0.902 . . . . 10.0 109.568 -177.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.99 -39.48 66.02 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 109.501 -0.555 . . . . 10.0 109.501 -173.04 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 13.8 p -60.32 -49.08 79.01 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.776 -0.453 . . . . 10.0 109.776 177.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.26 -43.66 83.2 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.185 0.994 . . . . 10.0 109.445 173.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 33.7 t-20 -55.79 -43.05 76.46 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 122.102 -0.374 . . . . 10.0 110.976 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 20.7 ttt180 -58.92 -34.8 72.12 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.717 0.807 . . . . 10.0 109.29 -177.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.572 HD12 HG22 ' A' ' 61' ' ' VAL . 14.9 mm -52.04 -41.92 33.25 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.466 0 CA-C-O 117.381 -1.295 . . . . 10.0 111.349 171.559 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 75.0 mt-10 -51.68 -50.11 61.08 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-N 120.78 1.627 . . . . 10.0 110.766 -178.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.2 mtmt -69.64 -45.7 67.87 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.103 0.561 . . . . 10.0 109.789 178.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.479 ' HB3' ' HB1' ' A' ' 60' ' ' ALA . 2.4 mmt180 -62.19 -30.92 71.41 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 120.316 -0.554 . . . . 10.0 112.195 -176.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.4 mt -79.07 -50.34 11.21 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 125.238 1.415 . . . . 10.0 110.369 172.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -48.0 -27.3 2.16 Favored 'General case' 0 C--O 1.226 -0.164 0 C-N-CA 124.297 1.039 . . . . 10.0 111.867 178.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -53.06 -47.52 68.39 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 112.337 0.495 . . . . 10.0 112.337 174.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.462 HG23 ' HB2' ' A' ' 52' ' ' ALA . 3.1 mp -52.83 131.91 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 C-N-CA 124.838 1.255 . . . . 10.0 110.803 -179.022 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 50.9 mp0 -70.11 -48.05 59.25 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 116.306 -0.406 . . . . 10.0 110.364 -171.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -84.89 39.76 2.97 Favored Glycine 0 CA--C 1.525 0.686 0 O-C-N 121.064 -1.022 . . . . 10.0 111.937 -175.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.6 p -99.92 149.57 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 C-N-CA 124.411 1.084 . . . . 10.0 108.313 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.458 ' HB2' HG21 ' A' ' 2' ' ' THR . . . -119.11 -53.69 2.25 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 122.969 0.507 . . . . 10.0 109.819 171.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.1 m-80 -142.6 154.75 44.69 Favored 'General case' 0 C--N 1.339 0.125 0 CA-C-N 118.298 0.499 . . . . 10.0 109.7 -177.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -146.92 62.8 7.77 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 124.101 0.961 . . . . 10.0 111.968 174.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -77.22 73.42 5.5 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.652 2.235 . . . . 10.0 110.048 -178.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.459 HG12 HG13 ' A' ' 43' ' ' VAL . 5.0 m -68.68 155.77 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 O-C-N 121.507 -0.745 . . . . 10.0 111.858 -177.503 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -99.03 131.51 45.02 Favored 'General case' 0 N--CA 1.458 -0.07 0 N-CA-C 110.204 -0.295 . . . . 10.0 110.204 -176.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -115.38 60.86 0.7 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.919 1.288 . . . . 10.0 110.424 -173.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 168.83 -32.63 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 127.118 2.167 . . . . 10.0 108.708 171.372 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.0 mt -86.89 -2.74 58.83 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.071 1.349 . . . . 10.0 112.103 -176.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 61.22 43.7 10.66 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 125.303 1.441 . . . . 10.0 111.107 166.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -142.5 129.79 21.05 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.297 1.439 . . . . 10.0 107.983 -176.565 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.459 HG13 HG12 ' A' ' 36' ' ' VAL . 3.4 t -101.49 132.37 47.47 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 N-CA-C 106.509 -1.663 . . . . 10.0 106.509 172.012 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 29.2 m -121.63 121.68 37.93 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 125.587 1.555 . . . . 10.0 106.817 -174.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.2 t -125.03 147.63 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 C-N-CA 123.271 0.628 . . . . 10.0 110.27 -176.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -125.24 95.69 4.57 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 127.723 2.409 . . . . 10.0 104.693 174.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -147.95 163.54 36.53 Favored 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 123.448 0.699 . . . . 10.0 109.568 -174.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 18.8 p30 -95.12 131.61 29.72 Favored Pre-proline 0 C--N 1.329 -0.317 0 C-N-CA 122.67 0.388 . . . . 10.0 110.551 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -78.2 60.82 7.57 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 121.537 1.491 . . . . 10.0 108.414 168.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.35 -45.55 0.46 Allowed 'General case' 0 C--N 1.344 0.343 0 O-C-N 121.859 -0.526 . . . . 10.0 110.554 176.232 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -87.66 -36.81 17.23 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 122.896 0.479 . . . . 10.0 110.442 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.462 ' HB2' HG23 ' A' ' 28' ' ' ILE . . . -137.2 174.88 10.14 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 125.914 1.686 . . . . 10.0 108.275 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 59.5 p -131.66 176.14 8.58 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.503 1.121 . . . . 10.0 110.186 174.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 29.7 m -48.99 -39.18 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-N 115.184 -0.916 . . . . 10.0 111.749 168.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 17.6 m -58.48 -40.6 83.19 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.707 0.803 . . . . 10.0 111.648 -178.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -71.32 -52.19 20.16 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.049 0.939 . . . . 10.0 109.686 -175.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.784 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.3 pp -64.64 -41.87 95.83 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 120.532 -1.355 . . . . 10.0 110.568 179.066 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.413 ' N ' HD12 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -45.81 -49.58 15.01 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-O 117.821 -1.085 . . . . 10.0 113.046 163.225 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -52.99 -46.56 68.36 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 120.712 1.597 . . . . 10.0 109.164 176.101 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.479 ' HB1' ' HB3' ' A' ' 24' ' ' ARG . . . -54.14 -50.04 67.85 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 114.789 -1.096 . . . . 10.0 110.874 -177.031 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.572 HG22 HD12 ' A' ' 21' ' ' ILE . 95.8 t -65.28 -44.73 94.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 112.309 0.485 . . . . 10.0 112.309 173.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -58.79 -47.29 85.26 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 121.107 -0.995 . . . . 10.0 109.952 -175.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.4 tmtm? -56.54 -35.6 68.3 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.899 1.28 . . . . 10.0 111.227 175.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.422 HD13 ' HA ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -54.71 -38.8 67.52 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.612 0.765 . . . . 10.0 110.702 173.364 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 135.21 -33.05 2.49 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 124.076 0.846 . . . . 10.0 111.767 175.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -94.12 157.84 15.89 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.954 0.902 . . . . 10.0 109.628 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.1 mtmp? -98.14 154.29 17.85 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.677 0.751 . . . . 10.0 110.989 -175.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.447 HD12 ' CD1' ' A' ' 9' ' ' ILE . 13.8 tp -129.22 148.62 51.17 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.555 1.942 . . . . 10.0 107.219 -177.098 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.2 tptm -151.67 148.67 28.21 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 119.27 -0.395 . . . . 10.0 111.089 159.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 11.8 tp -63.73 155.15 30.98 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 121.775 0.797 . . . . 10.0 109.702 178.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.5 tttt -119.45 -56.47 2.06 Favored 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 129.282 3.033 . . . . 10.0 107.655 177.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 172.37 -100.07 0.15 Allowed Glycine 0 N--CA 1.442 -0.935 0 N-CA-C 107.152 -2.379 . . . . 10.0 107.152 -176.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -157.1 166.4 33.39 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.967 1.307 . . . . 10.0 107.94 -165.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -90.32 156.96 17.9 Favored 'General case' 0 N--CA 1.453 -0.299 0 O-C-N 123.768 0.668 . . . . 10.0 110.265 -175.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -54.06 -33.6 57.89 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.162 0.985 . . . . 10.0 111.478 175.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 13.4 t 73.0 -175.48 0.16 Allowed 'General case' 0 C--N 1.34 0.166 0 C-N-CA 125.735 1.614 . . . . 10.0 110.917 177.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 13.1 pt -127.11 -176.73 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.358 0 N-CA-C 105.417 -2.068 . . . . 10.0 105.417 161.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -78.3 173.79 11.92 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.613 1.965 . . . . 10.0 110.712 175.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -147.52 -84.9 0.05 OUTLIER Glycine 0 CA--C 1.528 0.893 0 C-N-CA 123.701 0.667 . . . . 10.0 112.928 -176.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.235 0 CA-C-O 115.881 -2.009 . . . . 10.0 106.651 -169.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 2.3 p . . . . . 0 N--CA 1.469 0.522 0 CA-C-O 117.384 -1.293 . . . . 10.0 107.614 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.502 HG21 ' HB2' ' A' ' 32' ' ' ALA . 19.3 p -113.35 167.72 10.33 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.921 1.289 . . . . 10.0 109.146 177.217 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -127.09 135.67 51.08 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 127.524 2.33 . . . . 10.0 108.29 -175.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 58.6 mmtt -83.56 114.56 21.6 Favored 'General case' 0 N--CA 1.448 -0.559 0 O-C-N 124.06 0.85 . . . . 10.0 109.07 171.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -114.98 145.23 42.46 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.807 1.243 . . . . 10.0 109.545 169.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -119.46 150.78 39.65 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.046 0.939 . . . . 10.0 110.639 173.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.741 ' CE2' HD11 ' A' ' 57' ' ' LEU . 6.2 m-85 -140.14 136.68 33.77 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.899 1.28 . . . . 10.0 109.377 -171.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -97.44 134.98 39.97 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 106.981 -1.489 . . . . 10.0 106.981 -177.141 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.2 mm -108.35 142.01 22.1 Favored 'Isoleucine or valine' 0 C--N 1.342 0.259 0 C-N-CA 124.297 1.039 . . . . 10.0 111.192 -165.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -125.74 84.02 2.23 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.032 0.933 . . . . 10.0 109.375 171.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 160.16 -96.27 0.15 Allowed Glycine 0 CA--C 1.53 0.983 0 CA-C-O 119.892 -0.393 . . . . 10.0 112.753 171.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 5.0 mtt -66.78 74.73 0.11 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.167 1.387 . . . . 10.0 113.082 -172.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.8 p -105.14 45.68 0.95 Allowed 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 126.268 1.827 . . . . 10.0 109.539 -173.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 45.9 t -146.33 59.52 1.22 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.569 0.7 . . . . 10.0 111.099 -173.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 47.54 -77.62 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 127.481 2.313 . . . . 10.0 116.297 167.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.21 -28.62 70.16 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 121.865 0.84 . . . . 10.0 109.596 176.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 20.6 m -60.27 -59.59 5.17 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 123.569 0.747 . . . . 10.0 109.633 168.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -50.69 -38.87 49.41 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.795 1.238 . . . . 10.0 112.203 176.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -55.22 -22.8 19.26 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.406 -0.809 . . . . 10.0 112.511 177.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.82 -40.7 83.78 Favored 'General case' 0 N--CA 1.45 -0.439 0 O-C-N 120.611 -1.306 . . . . 10.0 109.953 176.483 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 8.1 mm -41.17 -57.94 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.39 0 N-CA-C 108.993 -0.743 . . . . 10.0 108.993 170.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -49.44 -45.58 46.74 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.075 0.95 . . . . 10.0 111.931 -172.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.6 mmpt? -71.92 -45.26 61.79 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 123.208 0.603 . . . . 10.0 110.272 179.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -62.94 -32.44 73.74 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 120.498 -0.481 . . . . 10.0 111.533 -178.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.4 -39.59 28.07 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.016 1.727 . . . . 10.0 111.668 175.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -49.28 -33.56 13.29 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 119.077 0.853 . . . . 10.0 110.468 171.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -53.83 -37.58 63.74 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 113.178 0.807 . . . . 10.0 113.178 176.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 22.4 mm -60.87 129.46 23.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 123.458 0.703 . . . . 10.0 109.135 178.149 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -79.64 -37.32 36.29 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 118.623 0.647 . . . . 10.0 111.441 -175.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -77.39 30.24 1.67 Allowed Glycine 0 C--N 1.339 0.718 0 O-C-N 120.391 -1.443 . . . . 10.0 112.619 178.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -102.9 147.22 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 C-N-CA 124.576 1.15 . . . . 10.0 107.96 -176.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.502 ' HB2' HG21 ' A' ' 2' ' ' THR . . . -118.19 -47.66 2.56 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 122.661 0.384 . . . . 10.0 110.348 175.519 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -146.48 144.2 29.49 Favored 'General case' 0 C--O 1.226 -0.181 0 N-CA-C 108.308 -0.997 . . . . 10.0 108.308 -173.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -136.23 60.78 35.49 Favored Pre-proline 0 CA--C 1.539 0.522 0 C-N-CA 123.584 0.753 . . . . 10.0 111.978 176.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -76.34 74.69 4.57 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.948 2.432 . . . . 10.0 110.213 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.466 HG12 HG13 ' A' ' 43' ' ' VAL . 4.3 m -69.11 155.49 7.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 123.36 0.664 . . . . 10.0 112.05 -179.09 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -94.92 92.07 6.72 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.035 0.445 . . . . 10.0 110.469 -174.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -71.77 43.3 0.09 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 127.364 2.266 . . . . 10.0 114.141 -175.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -176.86 -36.32 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 126.388 1.875 . . . . 10.0 110.577 177.009 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.6 mt -90.25 3.54 53.26 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 124.519 1.128 . . . . 10.0 112.684 -171.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 64.61 38.31 7.26 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.5 1.12 . . . . 10.0 110.371 165.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -142.22 130.21 21.9 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.278 1.431 . . . . 10.0 107.829 -176.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.466 HG13 HG12 ' A' ' 36' ' ' VAL . 11.4 t -100.46 139.03 22.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 107.578 -1.268 . . . . 10.0 107.578 173.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 27.1 m -127.76 119.4 25.67 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 106.803 -1.554 . . . . 10.0 106.803 -177.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 40.1 t -123.3 138.98 51.39 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 N-CA-C 109.201 -0.666 . . . . 10.0 109.201 -178.251 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -100.6 109.08 21.13 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 106.485 -1.672 . . . . 10.0 106.485 162.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 14.4 p90 -138.71 165.27 27.41 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 109.465 -0.568 . . . . 10.0 109.465 176.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 15.2 p30 -108.58 128.77 24.97 Favored Pre-proline 0 C--N 1.331 -0.237 0 C-N-CA 123.587 0.755 . . . . 10.0 109.301 177.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -75.59 64.16 6.53 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.449 2.1 . . . . 10.0 109.129 174.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.8 pttt -130.48 -47.54 1.07 Allowed 'General case' 0 CA--C 1.527 0.076 0 N-CA-C 108.967 -0.753 . . . . 10.0 108.967 177.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -89.13 -62.15 1.55 Allowed 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.43 -0.952 . . . . 10.0 108.43 178.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -119.67 163.93 16.66 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 125.9 1.68 . . . . 10.0 109.332 -173.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 34.7 p -118.38 -179.1 3.68 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 122.855 1.312 . . . . 10.0 110.482 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.9 m -44.9 -40.99 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 113.697 -1.592 . . . . 10.0 111.966 163.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.0 t -69.86 -40.16 75.93 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 118.889 -0.577 . . . . 10.0 110.743 -172.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -62.66 -50.68 70.25 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.619 0.723 . . . . 10.0 109.331 -172.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.741 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.2 pp -64.33 -46.73 82.21 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.895 -0.503 . . . . 10.0 110.846 178.042 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.04 -45.88 16.33 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.099 -1.0 . . . . 10.0 113.46 166.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 15.5 tm-20 -62.66 -47.97 81.38 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 119.647 1.112 . . . . 10.0 109.408 177.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -52.73 -47.5 67.33 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 121.372 0.606 . . . . 10.0 109.725 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.416 ' HA ' HD12 ' A' ' 64' ' ' LEU . 80.5 t -66.01 -44.22 92.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 N-CA-C 112.746 0.647 . . . . 10.0 112.746 175.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -54.76 -39.72 68.64 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 120.942 -1.098 . . . . 10.0 110.071 175.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 40.2 tptt -70.73 -37.81 73.53 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 125.431 1.492 . . . . 10.0 110.832 -178.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.416 HD12 ' HA ' ' A' ' 61' ' ' VAL . 12.2 mt -51.36 -26.15 7.23 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 118.792 -0.623 . . . . 10.0 112.49 163.36 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 129.62 -25.41 4.48 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 124.127 0.87 . . . . 10.0 112.684 165.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.41 ' CE2' ' HB3' ' A' ' 64' ' ' LEU . 16.8 p90 -115.63 154.58 29.2 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 125.628 1.571 . . . . 10.0 108.437 -172.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.6 156.0 18.45 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.946 0.879 . . . . 10.0 111.545 -167.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 9.9 tp -132.45 146.81 52.22 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 127.033 2.133 . . . . 10.0 106.954 -178.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 9.5 mmtp -146.44 139.45 25.55 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 123.011 0.524 . . . . 10.0 110.616 163.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.717 HD23 ' H ' ' A' ' 71' ' ' LYS . 2.8 tt -65.65 157.03 31.07 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 124.32 1.012 . . . . 10.0 109.383 173.427 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.717 ' H ' HD23 ' A' ' 70' ' ' LEU . 55.1 tttt -127.44 -65.91 0.91 Allowed 'General case' 0 N--CA 1.437 -1.082 0 C-N-CA 127.445 2.298 . . . . 10.0 108.918 -172.324 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.35 -86.24 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 107.943 -2.063 . . . . 10.0 107.943 175.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -172.89 167.05 5.17 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.469 1.108 . . . . 10.0 108.156 -168.13 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.13 95.75 4.32 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.601 0.76 . . . . 10.0 110.846 -179.329 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 51.5 t0 71.32 74.18 0.18 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.116 1.766 . . . . 10.0 110.379 173.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 26.2 p -72.11 92.5 1.34 Allowed 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.672 1.189 . . . . 10.0 110.581 -175.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 9.0 pt -72.83 71.71 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 121.923 0.868 . . . . 10.0 112.978 178.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -56.31 113.78 1.71 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.206 -1.035 . . . . 10.0 108.206 164.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -177.31 -41.76 0.06 OUTLIER Glycine 0 CA--C 1.528 0.882 0 CA-C-N 118.38 0.536 . . . . 10.0 112.858 -174.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 89.3 mtm-85 . . . . . 0 C--O 1.249 1.042 0 N-CA-C 105.184 -2.154 . . . . 10.0 105.184 164.604 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 62.2 t . . . . . 0 N--CA 1.471 0.602 0 N-CA-C 107.914 -1.143 . . . . 10.0 107.914 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 7.2 p -130.11 153.92 48.01 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 125.121 1.368 . . . . 10.0 108.403 -178.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -117.09 140.9 48.94 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 126.909 2.084 . . . . 10.0 109.089 -174.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 8.3 tptm -97.26 108.69 21.46 Favored 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 124.332 1.053 . . . . 10.0 109.089 -177.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.625 ' HB1' HD11 ' A' ' 70' ' ' LEU . . . -117.65 151.26 37.58 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 124.903 1.281 . . . . 10.0 109.88 -177.321 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -126.38 150.45 48.58 Favored 'General case' 0 CA--C 1.515 -0.377 0 C-N-CA 123.468 0.707 . . . . 10.0 111.264 177.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.831 ' CE2' HD11 ' A' ' 57' ' ' LEU . 2.2 m-85 -136.39 140.72 43.42 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.661 1.584 . . . . 10.0 108.553 -169.301 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -110.32 133.25 53.43 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 108.177 -1.045 . . . . 10.0 108.177 -172.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.8 mm -111.81 136.35 48.22 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.085 0 C-N-CA 124.154 0.982 . . . . 10.0 111.706 -155.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -123.41 102.33 7.84 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.907 -0.775 . . . . 10.0 108.907 170.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 147.16 -67.09 0.4 Allowed Glycine 0 C--N 1.341 0.816 0 C-N-CA 123.431 0.538 . . . . 10.0 112.632 165.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 13.3 ptt? -65.13 148.91 50.82 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 117.835 0.817 . . . . 10.0 109.8 -178.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.3 t -160.06 50.48 0.3 Allowed 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 109.435 -0.579 . . . . 10.0 109.435 176.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 35.2 t -162.13 143.23 10.6 Favored 'General case' 0 C--N 1.344 0.347 0 O-C-N 120.387 -1.446 . . . . 10.0 109.404 -179.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.1 -38.72 71.12 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.465 0.706 . . . . 10.0 112.48 -172.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.91 -31.69 72.46 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.429 0.692 . . . . 10.0 109.984 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 88.6 m -76.02 -51.37 12.47 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 108.32 -0.993 . . . . 10.0 108.32 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -46.69 -47.89 20.3 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.567 1.147 . . . . 10.0 110.568 171.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -59.77 -27.55 66.64 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.394 0.516 . . . . 10.0 112.394 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 23.0 ttm180 -75.67 -39.56 57.36 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 121.188 -0.945 . . . . 10.0 109.018 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 11.0 mm -45.97 -53.02 2.57 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.286 0 CA-C-O 118.523 -0.751 . . . . 10.0 110.037 170.201 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -44.94 -50.13 10.71 Favored 'General case' 0 C--O 1.224 -0.251 0 C-N-CA 122.918 0.487 . . . . 10.0 111.196 -178.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.5 mptt -68.51 -46.8 68.66 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.419 0.688 . . . . 10.0 110.159 -179.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.45 -36.14 75.39 Favored 'General case' 0 N--CA 1.451 -0.376 0 O-C-N 121.975 -0.453 . . . . 10.0 110.803 -178.281 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.38 -34.72 36.16 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.902 1.281 . . . . 10.0 111.221 175.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -60.86 -24.1 65.66 Favored 'General case' 0 C--N 1.332 -0.154 0 O-C-N 121.514 -0.741 . . . . 10.0 110.114 174.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -52.0 -40.64 61.29 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 117.893 0.315 . . . . 10.0 111.321 170.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 25.1 mm -57.77 128.67 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 123.585 0.754 . . . . 10.0 109.939 -173.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -69.08 -48.25 63.13 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 120.697 -0.401 . . . . 10.0 110.43 -177.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -80.67 37.85 2.3 Favored Glycine 0 CA--C 1.523 0.579 0 O-C-N 121.186 -0.946 . . . . 10.0 112.759 -174.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.4 p -103.86 147.4 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 C-N-CA 124.289 1.035 . . . . 10.0 108.657 -175.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -104.63 -50.27 3.34 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 107.998 -1.112 . . . . 10.0 107.998 171.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -164.06 160.64 21.87 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.263 -0.643 . . . . 10.0 109.263 -178.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -142.13 65.49 18.85 Favored Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 124.589 1.156 . . . . 10.0 111.358 178.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -75.36 75.54 3.82 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.184 2.589 . . . . 10.0 109.751 178.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.51 HG12 HG13 ' A' ' 43' ' ' VAL . 3.5 m -66.8 156.36 6.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 123.637 0.775 . . . . 10.0 111.808 -178.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -96.07 115.24 27.13 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 121.112 0.482 . . . . 10.0 111.3 -176.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 11.0 p90 -95.0 43.25 1.09 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.351 1.46 . . . . 10.0 112.447 -171.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -172.55 -39.76 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 124.841 1.257 . . . . 10.0 109.562 176.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 12.3 mt -79.04 -12.17 60.02 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.18 0.992 . . . . 10.0 112.019 -175.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 60.34 51.06 5.62 Favored 'General case' 0 C--N 1.334 -0.069 0 C-N-CA 124.915 1.286 . . . . 10.0 109.692 176.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -140.77 133.29 28.55 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 106.514 -1.661 . . . . 10.0 106.514 175.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.51 HG13 HG12 ' A' ' 36' ' ' VAL . 15.0 t -101.85 142.35 16.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 106.533 -1.655 . . . . 10.0 106.533 172.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 29.6 m -130.34 124.02 31.3 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 106.433 -1.692 . . . . 10.0 106.433 -177.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 29.0 t -128.62 137.52 57.09 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 N-CA-C 109.127 -0.694 . . . . 10.0 109.127 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -105.61 105.58 15.69 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 105.668 -1.975 . . . . 10.0 105.668 167.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -145.78 159.91 42.5 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 123.645 0.778 . . . . 10.0 110.541 -176.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -95.98 134.74 23.44 Favored Pre-proline 0 C--N 1.33 -0.263 0 C-N-CA 123.869 0.868 . . . . 10.0 110.813 178.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -80.44 56.27 6.01 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.259 1.973 . . . . 10.0 109.626 170.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.54 -49.95 1.76 Allowed 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 108.411 -0.959 . . . . 10.0 108.411 175.607 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -87.75 -42.52 12.55 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.525 0.73 . . . . 10.0 110.394 -175.656 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -137.81 -176.19 4.34 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.848 1.259 . . . . 10.0 109.327 -171.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 78.2 p -151.73 171.86 17.02 Favored 'General case' 0 N--CA 1.455 -0.193 0 O-C-N 122.043 -0.411 . . . . 10.0 110.38 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 88.3 t -42.93 -48.37 1.21 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.166 0 C-N-CA 124.511 1.124 . . . . 10.0 110.582 169.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.9 m -51.01 -42.88 60.68 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.583 1.153 . . . . 10.0 112.73 178.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -70.42 -56.9 5.52 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 124.114 0.965 . . . . 10.0 109.314 -176.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.831 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.1 pp -63.83 -40.49 96.73 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 120.786 -1.197 . . . . 10.0 110.816 -177.626 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -43.84 -52.7 6.56 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-O 118.049 -0.977 . . . . 10.0 112.386 161.106 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.8 -45.38 70.74 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 120.127 1.331 . . . . 10.0 110.573 178.415 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -53.63 -53.39 52.52 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.134 0.492 . . . . 10.0 110.414 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 59.3 t -64.77 -41.19 91.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-N 116.115 -0.493 . . . . 10.0 112.003 178.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -58.59 -45.99 87.9 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 108.825 -0.806 . . . . 10.0 108.825 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -70.23 -36.22 74.38 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.528 1.131 . . . . 10.0 111.03 -177.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 12.9 mt -52.24 -28.82 20.09 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 112.803 0.668 . . . . 10.0 112.803 165.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 108.22 31.29 3.59 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-N 118.502 0.592 . . . . 10.0 112.741 169.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -152.33 160.33 43.33 Favored 'General case' 0 C--O 1.227 -0.104 0 N-CA-C 106.987 -1.486 . . . . 10.0 106.987 169.009 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -98.99 152.61 19.62 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.581 0.705 . . . . 10.0 110.84 -163.224 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.5 tp -134.07 146.74 50.59 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 125.7 1.6 . . . . 10.0 108.316 -176.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 12.1 tptp -152.21 154.01 34.95 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 109.445 -0.576 . . . . 10.0 109.445 164.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.625 HD11 ' HB1' ' A' ' 5' ' ' ALA . 8.3 tp -65.78 155.84 34.97 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 121.401 0.619 . . . . 10.0 109.809 176.119 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 54.6 tttt -118.16 -55.71 2.22 Favored 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 128.633 2.773 . . . . 10.0 107.242 175.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 173.93 -91.22 0.09 OUTLIER Glycine 0 N--CA 1.444 -0.822 0 N-CA-C 108.175 -1.97 . . . . 10.0 108.175 178.137 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -160.51 170.34 21.12 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 124.506 1.122 . . . . 10.0 108.472 -162.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -54.37 136.1 44.22 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 123.8 0.688 . . . . 10.0 111.355 -177.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -46.61 -58.51 3.75 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.858 0.863 . . . . 10.0 109.413 170.075 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 67.08 170.52 0.25 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.642 1.177 . . . . 10.0 110.873 -176.118 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 6.1 pt -137.73 -146.38 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 N-CA-C 107.622 -1.251 . . . . 10.0 107.622 174.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 70.56 172.08 0.31 Allowed 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.26 1.424 . . . . 10.0 111.207 -177.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -179.22 166.77 36.47 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 106.185 -2.766 . . . . 10.0 106.185 178.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.253 1.279 0 CA-C-O 115.803 -2.046 . . . . 10.0 105.702 173.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 92.1 t . . . . . 0 N--CA 1.471 0.622 0 N-CA-C 107.641 -1.244 . . . . 10.0 107.641 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.625 HG21 ' HB2' ' A' ' 32' ' ' ALA . 2.6 p -123.52 169.32 11.53 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.045 1.738 . . . . 10.0 108.851 177.654 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -137.71 140.41 40.72 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 126.465 1.906 . . . . 10.0 107.795 -168.024 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 18.4 mmtp -82.46 128.34 34.17 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.192 0.597 . . . . 10.0 109.419 178.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -128.99 136.8 50.81 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 125.698 1.599 . . . . 10.0 109.119 176.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -117.28 147.0 42.95 Favored 'General case' 0 CA--C 1.51 -0.587 0 C-N-CA 124.0 0.92 . . . . 10.0 110.198 177.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.76 ' CE2' HD11 ' A' ' 57' ' ' LEU . 3.1 m-85 -141.19 137.26 32.53 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 124.623 1.202 . . . . 10.0 111.241 -172.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -93.65 133.17 37.27 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.737 1.615 . . . . 10.0 108.741 -176.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.6 HD11 HG23 ' A' ' 43' ' ' VAL . 7.0 mm -103.56 114.15 42.38 Favored 'Isoleucine or valine' 0 C--N 1.34 0.185 0 C-N-CA 124.038 0.935 . . . . 10.0 110.621 -171.14 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -103.87 97.36 7.37 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.833 -1.173 . . . . 10.0 107.833 170.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 149.35 -103.49 0.26 Allowed Glycine 0 CA--C 1.526 0.741 0 C-N-CA 124.202 0.906 . . . . 10.0 111.317 172.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 6.4 mmt -81.94 123.51 28.92 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 118.174 0.987 . . . . 10.0 111.69 -172.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 21.7 p -132.9 58.41 1.77 Allowed 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.263 1.425 . . . . 10.0 108.391 -173.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 97.9 m -129.48 -132.81 0.22 Allowed 'General case' 0 C--N 1.339 0.118 0 N-CA-C 106.665 -1.606 . . . . 10.0 106.665 -175.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -131.02 -49.19 1.02 Allowed 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.282 0.633 . . . . 10.0 111.265 -174.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.63 -45.67 67.97 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 108.683 -0.858 . . . . 10.0 108.683 -174.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 10.0 m -61.56 -53.79 51.63 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.614 -0.721 . . . . 10.0 109.604 177.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -49.05 -46.27 44.06 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.856 0.863 . . . . 10.0 111.106 175.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -58.94 -29.83 67.42 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 121.596 -0.69 . . . . 10.0 112.311 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -64.39 -45.25 88.49 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 120.759 -1.213 . . . . 10.0 108.209 179.032 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.625 HG22 HD12 ' A' ' 25' ' ' LEU . 9.8 mm -44.68 -47.55 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 C-N-CA 124.328 1.051 . . . . 10.0 111.625 177.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -48.21 -50.63 28.59 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 122.824 0.45 . . . . 10.0 110.868 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -72.77 -46.26 54.29 Favored 'General case' 0 N--CA 1.445 -0.713 0 O-C-N 121.757 -0.589 . . . . 10.0 110.933 -179.53 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.1 mmp_? -48.92 -42.66 37.87 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.122 0.416 . . . . 10.0 112.122 175.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.93 HD22 HG21 ' A' ' 45' ' ' VAL . 0.5 OUTLIER -79.4 -42.35 25.69 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.472 0.709 . . . . 10.0 111.05 178.741 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -55.0 -18.53 5.2 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.406 1.003 . . . . 10.0 112.22 172.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -59.69 -29.07 67.83 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 114.223 1.194 . . . . 10.0 114.223 171.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.539 HD11 ' HB3' ' A' ' 57' ' ' LEU . 11.1 mt -60.58 138.46 21.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 108.227 -1.027 . . . . 10.0 108.227 173.227 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.38 -49.58 32.84 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 109.554 -0.535 . . . . 10.0 109.554 179.104 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -80.29 42.25 2.55 Favored Glycine 0 CA--C 1.526 0.737 0 O-C-N 120.778 -1.201 . . . . 10.0 112.311 -175.056 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.6 p -102.05 153.2 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 C-N-CA 125.159 1.383 . . . . 10.0 109.677 -174.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.625 ' HB2' HG21 ' A' ' 2' ' ' THR . . . -111.54 -54.62 2.59 Favored 'General case' 0 C--N 1.334 -0.089 0 C-N-CA 123.877 0.871 . . . . 10.0 109.069 171.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 23.1 p30 -162.44 151.71 15.54 Favored 'General case' 0 C--O 1.227 -0.129 0 N-CA-C 108.732 -0.84 . . . . 10.0 108.732 -173.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -133.94 55.94 17.52 Favored Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 124.42 1.088 . . . . 10.0 112.34 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -75.05 79.2 2.73 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 122.884 2.39 . . . . 10.0 110.558 -177.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.526 HG12 HG13 ' A' ' 43' ' ' VAL . 2.4 m -67.47 151.16 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 O-C-N 121.622 -0.674 . . . . 10.0 111.801 -178.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -95.39 88.66 5.18 Favored 'General case' 0 C--O 1.234 0.256 0 O-C-N 122.179 -0.326 . . . . 10.0 110.23 -175.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -72.48 53.52 0.31 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 127.171 2.189 . . . . 10.0 112.727 -178.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -174.65 -40.72 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 126.281 1.832 . . . . 10.0 109.734 174.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 12.4 mt -86.62 -12.39 48.66 Favored 'General case' 0 C--N 1.338 0.093 0 C-N-CA 124.084 0.954 . . . . 10.0 111.797 -171.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 75.4 37.35 0.45 Allowed 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.884 1.274 . . . . 10.0 110.333 170.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 33.3 p -138.35 129.81 27.62 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.242 1.417 . . . . 10.0 108.127 178.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.6 HG23 HD11 ' A' ' 9' ' ' ILE . 21.8 t -90.33 131.39 37.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 107.515 -1.291 . . . . 10.0 107.515 167.328 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 85.6 m -110.54 117.93 34.87 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 106.303 -1.74 . . . . 10.0 106.303 171.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.93 HG21 HD22 ' A' ' 25' ' ' LEU . 82.6 t -122.46 141.28 43.48 Favored 'Isoleucine or valine' 0 C--N 1.342 0.248 0 CA-C-N 120.177 1.353 . . . . 10.0 109.79 168.284 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.438 ' HB3' ' HB3' ' A' ' 32' ' ' ALA . 18.3 tt0 -100.32 117.02 33.66 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 107.552 -1.277 . . . . 10.0 107.552 164.563 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -147.87 167.91 23.57 Favored 'General case' 0 C--O 1.226 -0.163 0 N-CA-C 108.861 -0.792 . . . . 10.0 108.861 177.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 24.7 p30 -100.54 135.96 20.05 Favored Pre-proline 0 C--N 1.329 -0.284 0 C-N-CA 123.273 0.629 . . . . 10.0 109.758 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -80.36 54.0 5.02 Favored 'Trans proline' 0 N--CA 1.448 -1.167 0 N-CA-C 108.883 -1.237 . . . . 10.0 108.883 171.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.16 10.19 3.27 Favored 'General case' 0 C--N 1.346 0.443 0 CA-C-N 118.623 0.647 . . . . 10.0 111.834 176.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -142.02 -65.15 0.42 Allowed 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.788 -1.189 . . . . 10.0 107.788 -173.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -114.52 175.51 5.45 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 124.071 0.948 . . . . 10.0 109.359 178.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 92.0 p -127.72 167.57 16.29 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.028 0.931 . . . . 10.0 110.065 177.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 74.2 t -49.06 -52.8 9.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 115.791 -0.641 . . . . 10.0 109.796 167.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.0 m -52.36 -37.13 55.43 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 125.185 1.394 . . . . 10.0 112.579 178.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -71.25 -60.4 2.25 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 109.603 -0.517 . . . . 10.0 109.603 174.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.76 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.4 pp -58.81 -46.81 86.76 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 118.348 0.522 . . . . 10.0 111.368 -168.429 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.455 ' N ' HD12 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -48.18 -35.63 12.11 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 114.549 1.315 . . . . 10.0 114.549 171.819 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.1 tm-20 -52.54 -35.49 53.61 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 120.466 1.485 . . . . 10.0 110.924 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.63 -52.51 60.53 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 120.057 -0.657 . . . . 10.0 109.922 -178.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.575 HG22 HD12 ' A' ' 21' ' ' ILE . 72.7 t -55.24 -47.96 77.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 122.905 0.482 . . . . 10.0 110.884 172.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.88 -55.91 19.76 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 124.906 1.282 . . . . 10.0 109.195 -177.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.8 tptm -57.06 -38.97 74.01 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 126.137 1.775 . . . . 10.0 111.322 177.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.4 mp -60.52 -19.74 58.02 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 113.075 0.768 . . . . 10.0 113.075 172.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 104.74 16.34 17.7 Favored Glycine 0 CA--C 1.528 0.863 0 CA-C-N 118.849 0.749 . . . . 10.0 113.263 168.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.405 ' O ' HG12 ' A' ' 61' ' ' VAL . 1.5 p90 -136.0 160.94 37.07 Favored 'General case' 0 C--O 1.227 -0.121 0 N-CA-C 106.776 -1.564 . . . . 10.0 106.776 169.002 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 10.5 ttmm -105.98 141.16 37.84 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 119.265 0.939 . . . . 10.0 111.405 -168.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.581 HD11 ' HB2' ' A' ' 7' ' ' PHE . 22.9 tp -117.93 145.04 44.95 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 126.117 1.767 . . . . 10.0 107.974 177.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 26.0 mmtt -152.99 153.44 32.93 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 125.721 1.608 . . . . 10.0 108.058 170.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.3 tp -68.34 152.41 45.47 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.398 0.618 . . . . 10.0 109.397 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.94 -57.44 2.04 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 127.51 2.324 . . . . 10.0 105.586 164.246 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 170.82 -92.56 0.1 OUTLIER Glycine 0 N--CA 1.442 -0.947 0 N-CA-C 105.833 -2.907 . . . . 10.0 105.833 177.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -166.02 139.7 4.31 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 122.993 0.517 . . . . 10.0 109.829 -160.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -72.52 -47.29 49.62 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.64 1.176 . . . . 10.0 112.596 -177.344 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 41.4 t0 42.18 78.34 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.769 2.028 . . . . 10.0 113.501 -168.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 6.2 t -77.07 72.65 3.63 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 121.333 -0.854 . . . . 10.0 110.891 -174.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 11.1 pt -71.76 80.21 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-O 121.809 0.814 . . . . 10.0 112.508 179.238 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -70.63 165.94 21.78 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.657 0.783 . . . . 10.0 111.172 173.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -102.51 97.53 1.56 Allowed Glycine 0 CA--C 1.529 0.927 0 CA-C-O 118.391 -1.227 . . . . 10.0 112.857 -170.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 6.3 tpm_? . . . . . 0 C--O 1.259 1.558 0 C-N-CA 129.552 3.141 . . . . 10.0 109.169 165.539 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 59.5 t . . . . . 0 N--CA 1.47 0.568 0 N-CA-C 108.141 -1.059 . . . . 10.0 108.141 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.52 HG21 ' HB2' ' A' ' 32' ' ' ALA . 14.9 p -133.04 172.4 12.68 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.57 1.548 . . . . 10.0 108.02 179.109 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -140.65 142.25 34.98 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 127.427 2.291 . . . . 10.0 107.917 -167.152 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -104.91 110.09 22.32 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.54 0.736 . . . . 10.0 109.954 -168.618 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -108.9 146.14 34.24 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 124.976 1.31 . . . . 10.0 109.833 -175.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -122.63 147.25 46.65 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 123.749 0.82 . . . . 10.0 109.246 173.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.704 ' CE2' HD11 ' A' ' 57' ' ' LEU . 9.9 m-85 -137.0 140.85 42.44 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 125.222 1.576 . . . . 10.0 109.237 -173.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -105.46 133.9 49.45 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.358 1.063 . . . . 10.0 108.261 -175.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.9 mm -109.33 132.33 57.75 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 C-N-CA 123.667 0.787 . . . . 10.0 111.18 -157.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -123.67 99.73 6.44 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.22 0.608 . . . . 10.0 109.36 172.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 151.49 -61.09 0.4 Allowed Glycine 0 CA--C 1.529 0.922 0 C-N-CA 123.313 0.482 . . . . 10.0 112.86 164.101 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -70.05 163.87 25.26 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 118.104 0.952 . . . . 10.0 111.296 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 88.1 m -76.25 -99.68 0.02 OUTLIER 'General case' 0 N--CA 1.423 -1.824 0 C-N-CA 125.91 1.684 . . . . 10.0 107.672 159.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 165.03 49.51 0.0 OUTLIER 'General case' 0 C--N 1.344 0.35 0 CA-C-N 120.121 1.328 . . . . 10.0 110.541 -158.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -148.44 -87.61 0.09 Allowed 'General case' 0 CA--C 1.518 -0.273 0 O-C-N 120.581 -1.325 . . . . 10.0 108.809 176.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.12 -47.77 67.22 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 107.622 -1.251 . . . . 10.0 107.622 -178.299 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 13.1 m -57.11 -57.36 12.91 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.745 -1.116 . . . . 10.0 110.471 177.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -45.29 -53.9 7.8 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.007 0.923 . . . . 10.0 110.578 172.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -59.89 -25.1 64.82 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.403 -0.817 . . . . 10.0 112.213 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -74.61 -54.14 8.02 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 121.294 -0.879 . . . . 10.0 108.9 173.175 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.661 HG22 HD12 ' A' ' 25' ' ' LEU . 1.6 mt -48.22 -47.47 13.59 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.445 0 CA-C-O 117.964 -1.017 . . . . 10.0 111.277 -176.112 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -34.86 -61.88 0.39 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.517 0.727 . . . . 10.0 111.747 174.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.98 -42.25 69.93 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.492 1.117 . . . . 10.0 110.679 -177.565 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.96 -28.79 62.62 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.651 0.611 . . . . 10.0 112.651 175.586 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.661 HD12 HG22 ' A' ' 21' ' ' ILE . 1.5 mt -85.3 -42.97 14.13 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 126.188 1.795 . . . . 10.0 109.787 174.09 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -55.51 -23.95 29.0 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.898 0.879 . . . . 10.0 110.279 177.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -52.85 -41.6 64.41 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 113.794 1.035 . . . . 10.0 113.794 171.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.2 mp -54.58 133.38 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 109.563 -0.532 . . . . 10.0 109.563 176.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -77.98 -42.73 31.79 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 119.505 -0.284 . . . . 10.0 110.483 -178.15 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -80.63 39.6 2.37 Favored Glycine 0 CA--C 1.527 0.816 0 O-C-N 120.549 -1.344 . . . . 10.0 111.94 178.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.4 p -101.57 149.78 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 C-N-CA 124.973 1.309 . . . . 10.0 108.575 -178.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.52 ' HB2' HG21 ' A' ' 2' ' ' THR . . . -109.5 -61.51 1.63 Allowed 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 107.934 -1.136 . . . . 10.0 107.934 170.59 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 57.8 m-80 -140.54 154.66 46.62 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 107.952 -1.129 . . . . 10.0 107.952 -174.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.47 58.01 2.58 Favored Pre-proline 0 CA--C 1.535 0.371 0 O-C-N 121.965 -0.459 . . . . 10.0 112.113 170.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -75.11 78.23 2.98 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 122.715 2.277 . . . . 10.0 108.756 177.013 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.478 HG12 HG13 ' A' ' 43' ' ' VAL . 3.4 m -59.12 152.45 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 109.851 -0.426 . . . . 10.0 109.851 174.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -81.07 151.32 28.41 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 118.756 -1.178 . . . . 10.0 109.962 -176.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -123.23 42.91 3.09 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.412 1.485 . . . . 10.0 109.747 -175.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -175.13 -40.22 0.01 OUTLIER 'General case' 0 C--O 1.226 -0.163 0 C-N-CA 125.385 1.474 . . . . 10.0 109.736 170.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.2 mt -75.2 -17.04 60.44 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.884 0.874 . . . . 10.0 112.442 -167.204 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 65.3 48.69 2.08 Favored 'General case' 0 N--CA 1.46 0.072 0 C-N-CA 125.281 1.432 . . . . 10.0 110.32 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 8.0 p -142.85 133.24 24.81 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.324 1.45 . . . . 10.0 107.969 176.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.478 HG13 HG12 ' A' ' 36' ' ' VAL . 7.0 t -97.63 134.21 36.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 106.869 -1.53 . . . . 10.0 106.869 172.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 85.9 m -121.26 126.22 49.02 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 106.552 -1.647 . . . . 10.0 106.552 178.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.4 t -122.89 149.29 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 C-N-CA 124.323 1.049 . . . . 10.0 108.648 177.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -123.59 107.81 11.93 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 106.054 -1.832 . . . . 10.0 106.054 164.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -145.04 170.67 15.74 Favored 'General case' 0 C--O 1.225 -0.223 0 C-N-CA 124.142 0.977 . . . . 10.0 108.834 -177.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 14.6 p30 -111.85 134.77 21.27 Favored Pre-proline 0 CA--C 1.53 0.196 0 C-N-CA 122.806 0.443 . . . . 10.0 110.397 177.162 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -77.37 62.47 7.64 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 122.504 2.136 . . . . 10.0 109.867 174.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.1 pttt -123.73 -45.85 2.02 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 123.147 0.579 . . . . 10.0 109.951 172.052 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -91.49 -60.95 1.75 Allowed 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.385 1.074 . . . . 10.0 108.72 -176.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -119.08 174.34 6.37 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 125.671 1.588 . . . . 10.0 109.321 -175.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 53.3 p -131.66 -177.3 4.36 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.875 1.27 . . . . 10.0 110.167 176.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 35.3 m -48.64 -38.72 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-N 115.03 -0.986 . . . . 10.0 111.946 164.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 68.9 m -62.32 -43.31 99.13 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 122.761 0.424 . . . . 10.0 111.142 -174.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -65.28 -52.97 50.79 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.284 1.034 . . . . 10.0 109.136 -174.185 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.704 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.1 pp -66.97 -43.91 81.82 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 121.983 -0.448 . . . . 10.0 111.274 -178.57 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.403 ' N ' HD12 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -41.66 -51.04 4.14 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-O 118.125 -0.94 . . . . 10.0 112.053 160.467 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -57.1 -43.92 82.72 Favored 'General case' 0 C--O 1.226 -0.157 0 CA-C-N 119.742 1.155 . . . . 10.0 110.386 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -52.88 -51.82 59.75 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.077 0.465 . . . . 10.0 110.392 176.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.476 HG11 ' HB2' ' A' ' 68' ' ' LEU . 53.9 t -61.85 -46.23 96.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 N-CA-C 112.39 0.515 . . . . 10.0 112.39 176.131 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -51.45 -51.11 57.74 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.856 1.263 . . . . 10.0 108.428 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.25 -44.26 92.38 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.611 1.565 . . . . 10.0 111.191 177.417 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -48.35 -39.45 22.16 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.79 0.836 . . . . 10.0 111.308 173.51 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 125.14 14.25 3.38 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-O 119.575 -0.57 . . . . 10.0 113.273 169.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -138.94 162.52 34.67 Favored 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 107.927 -1.138 . . . . 10.0 107.927 177.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 29.0 mmtt -95.98 151.04 19.8 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.776 0.798 . . . . 10.0 111.328 -172.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.476 ' HB2' HG11 ' A' ' 61' ' ' VAL . 14.5 tp -132.35 146.33 51.9 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 126.487 1.915 . . . . 10.0 107.886 -179.261 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 16.5 mmtm -151.64 154.67 36.84 Favored 'General case' 0 N--CA 1.44 -0.947 0 C-N-CA 123.993 0.917 . . . . 10.0 109.011 163.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.6 tp -61.32 159.46 12.39 Favored 'General case' 0 N--CA 1.453 -0.301 0 O-C-N 124.321 1.013 . . . . 10.0 109.393 175.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 32.9 tttt -118.82 -66.34 1.08 Allowed 'General case' 0 N--CA 1.435 -1.216 0 C-N-CA 125.464 1.506 . . . . 10.0 108.276 177.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 161.7 43.63 0.02 OUTLIER Glycine 0 CA--C 1.528 0.865 0 CA-C-O 118.852 -0.971 . . . . 10.0 113.668 175.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 72.51 146.22 0.08 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.976 1.311 . . . . 10.0 112.941 167.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.05 136.38 55.14 Favored 'General case' 0 N--CA 1.443 -0.784 0 O-C-N 121.588 -0.695 . . . . 10.0 111.488 -177.45 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.4 t0 75.25 130.68 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 127.671 2.388 . . . . 10.0 109.812 -168.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 10.8 t -66.04 -32.33 73.74 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.209 1.003 . . . . 10.0 110.985 177.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 9.8 pt -122.63 -123.17 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 124.804 1.242 . . . . 10.0 109.633 -178.111 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -136.56 -68.73 0.49 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.179 0.992 . . . . 10.0 108.932 -176.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.67 122.09 0.38 Allowed Glycine 0 CA--C 1.532 1.148 0 C-N-CA 123.406 0.527 . . . . 10.0 112.165 174.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 29.9 mtp180 . . . . . 0 C--O 1.251 1.175 0 CA-C-O 116.947 -1.502 . . . . 10.0 108.595 161.406 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 95.9 t . . . . . 0 N--CA 1.472 0.647 0 N-CA-C 107.35 -1.352 . . . . 10.0 107.35 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.627 HG21 ' HB2' ' A' ' 32' ' ' ALA . 10.0 p -124.8 169.94 11.53 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 125.605 1.562 . . . . 10.0 109.293 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -131.66 150.21 52.23 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 127.472 2.309 . . . . 10.0 107.324 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -109.63 123.46 49.5 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.343 -0.984 . . . . 10.0 108.343 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.647 ' HB1' HD11 ' A' ' 70' ' ' LEU . . . -130.2 153.55 48.45 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.634 0.774 . . . . 10.0 110.676 176.111 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -118.7 148.56 42.63 Favored 'General case' 0 CA--C 1.507 -0.7 0 C-N-CA 124.62 1.168 . . . . 10.0 109.481 177.234 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.817 ' CE2' HD11 ' A' ' 57' ' ' LEU . 2.2 m-85 -135.12 141.0 45.9 Favored 'General case' 0 N--CA 1.447 -0.605 0 O-C-N 124.792 1.308 . . . . 10.0 109.063 -174.572 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -103.45 131.78 50.26 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.525 1.53 . . . . 10.0 108.827 -174.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -115.44 137.13 50.0 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 C-N-CA 126.111 1.764 . . . . 10.0 110.023 -164.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -127.41 102.5 6.91 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.21 -1.033 . . . . 10.0 108.21 176.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 114.3 42.73 0.81 Allowed Glycine 0 CA--C 1.529 0.954 0 CA-C-O 119.263 -0.743 . . . . 10.0 114.185 166.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 9.0 ptp -101.08 -166.32 1.3 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.651 1.226 . . . . 10.0 111.051 173.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.5 t -123.45 -7.75 8.09 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.734 1.214 . . . . 10.0 112.024 177.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 58.2 m 62.14 48.96 4.68 Favored 'General case' 0 C--N 1.343 0.315 0 C-N-CA 123.547 0.739 . . . . 10.0 110.815 179.228 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -167.34 -90.32 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 108.733 -0.84 . . . . 10.0 108.733 171.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.39 -33.41 48.84 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 121.518 -0.739 . . . . 10.0 109.722 -171.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 59.2 m -62.66 -56.38 18.27 Favored 'General case' 0 C--N 1.339 0.143 0 N-CA-C 108.65 -0.87 . . . . 10.0 108.65 174.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -44.8 -45.03 9.86 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.397 1.079 . . . . 10.0 110.316 172.134 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -66.69 -32.45 73.78 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.945 1.091 . . . . 10.0 113.945 178.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.79 -45.89 87.65 Favored 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 120.757 -1.214 . . . . 10.0 108.413 177.586 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.846 HG22 HD12 ' A' ' 25' ' ' LEU . 2.8 mm -47.4 -48.85 9.47 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.231 0 O-C-N 123.94 0.775 . . . . 10.0 109.856 -177.376 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -44.03 -54.4 5.49 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.043 0.937 . . . . 10.0 111.526 178.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt -70.73 -45.7 64.4 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.954 0.902 . . . . 10.0 109.459 -177.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.626 ' HG3' HD11 ' A' ' 64' ' ' LEU . 51.7 mmt-85 -55.57 -32.24 62.85 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.147 0.425 . . . . 10.0 112.147 177.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.846 HD12 HG22 ' A' ' 21' ' ' ILE . 2.1 mt -84.39 -35.56 23.06 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.178 1.391 . . . . 10.0 112.26 174.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 32.7 t-20 -55.29 -31.78 61.9 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.685 0.675 . . . . 10.0 110.081 176.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -50.64 -28.89 9.72 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 114.996 1.48 . . . . 10.0 114.996 169.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.82 HG23 ' HB3' ' A' ' 52' ' ' ALA . 6.9 mm -61.71 104.93 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-O 121.71 0.766 . . . . 10.0 109.663 171.326 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -58.24 -26.08 62.48 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.451 0.537 . . . . 10.0 112.451 -179.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -90.79 18.02 52.34 Favored Glycine 0 CA--C 1.528 0.898 0 O-C-N 121.359 -0.838 . . . . 10.0 112.945 178.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.1 p -79.36 153.98 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 CA-C-N 118.595 1.198 . . . . 10.0 109.514 -179.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.627 ' HB2' HG21 ' A' ' 2' ' ' THR . . . -112.94 -59.86 1.96 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.539 -0.912 . . . . 10.0 108.539 163.135 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 -134.63 155.43 50.5 Favored 'General case' 0 C--N 1.341 0.208 0 N-CA-C 109.254 -0.647 . . . . 10.0 109.254 -178.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -140.36 65.39 27.32 Favored Pre-proline 0 CA--C 1.534 0.355 0 C-N-CA 123.454 0.701 . . . . 10.0 109.825 172.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -78.64 68.7 8.03 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 123.044 2.496 . . . . 10.0 109.539 -176.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.415 HG12 HG13 ' A' ' 43' ' ' VAL . 4.1 m -68.85 155.37 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 O-C-N 122.099 -0.375 . . . . 10.0 111.727 -175.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -97.49 139.04 34.0 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 121.002 0.429 . . . . 10.0 111.407 -177.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -118.24 47.66 1.56 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.702 1.601 . . . . 10.0 110.451 -172.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -176.11 -41.61 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 125.449 1.5 . . . . 10.0 109.557 -177.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 16.6 mt -81.7 -19.02 42.4 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.625 1.17 . . . . 10.0 111.648 -170.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 61.16 50.64 4.8 Favored 'General case' 0 C--N 1.339 0.112 0 C-N-CA 125.892 1.677 . . . . 10.0 109.942 -175.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.4 p -140.07 126.99 20.74 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 107.646 -1.242 . . . . 10.0 107.646 174.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.569 HG21 HG21 ' A' ' 21' ' ' ILE . 5.1 t -97.15 130.62 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 106.769 -1.567 . . . . 10.0 106.769 172.419 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 58.2 m -110.85 128.38 55.76 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.95 1.7 . . . . 10.0 107.139 176.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.7 t -127.36 137.4 57.87 Favored 'Isoleucine or valine' 0 C--N 1.342 0.253 0 CA-C-N 119.161 0.891 . . . . 10.0 110.709 174.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -107.29 104.6 14.24 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.392 1.477 . . . . 10.0 107.088 164.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 14.7 p90 -143.32 167.02 23.13 Favored 'General case' 0 CA--C 1.52 -0.177 0 C-N-CA 123.936 0.895 . . . . 10.0 109.329 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -107.99 134.05 20.26 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-O 119.109 -0.472 . . . . 10.0 110.804 178.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -77.85 62.29 7.83 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.779 2.319 . . . . 10.0 110.613 176.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.0 pttt -124.42 -47.67 1.85 Allowed 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.706 0.802 . . . . 10.0 109.346 169.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -90.33 -51.84 5.23 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.961 0.905 . . . . 10.0 110.007 -169.135 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.82 ' HB3' HG23 ' A' ' 28' ' ' ILE . . . -132.17 174.73 9.9 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.631 1.172 . . . . 10.0 108.333 178.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 82.6 p -137.06 177.49 7.82 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 118.569 0.622 . . . . 10.0 110.757 176.091 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 49.1 t -42.24 -50.75 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 124.632 1.173 . . . . 10.0 110.902 172.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.1 m -51.56 -38.77 55.9 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.094 0.958 . . . . 10.0 112.414 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -70.11 -58.51 3.72 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.632 0.773 . . . . 10.0 109.178 -174.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.817 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.4 pp -63.56 -41.09 98.43 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 121.741 -0.6 . . . . 10.0 111.297 -178.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.417 ' HA ' HD23 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -43.51 -47.6 7.26 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 118.349 -0.834 . . . . 10.0 111.817 163.289 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.87 -42.21 98.79 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 119.571 1.078 . . . . 10.0 110.39 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -56.19 -48.59 76.09 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 109.65 -0.5 . . . . 10.0 109.65 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.639 ' HA ' HD12 ' A' ' 64' ' ' LEU . 82.8 t -62.56 -47.45 92.89 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 N-CA-C 112.909 0.707 . . . . 10.0 112.909 173.346 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -56.13 -37.7 69.81 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.044 -1.035 . . . . 10.0 109.025 -178.228 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.9 tttp -79.57 -31.51 41.89 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 124.343 1.057 . . . . 10.0 112.011 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.639 HD12 ' HA ' ' A' ' 61' ' ' VAL . 15.3 mt -51.69 -45.19 63.41 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.68 1.127 . . . . 10.0 110.783 163.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 147.89 -39.87 0.99 Allowed Glycine 0 CA--C 1.525 0.713 0 CA-C-N 117.964 0.347 . . . . 10.0 112.78 171.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -89.79 159.55 16.97 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 124.032 0.933 . . . . 10.0 108.738 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 19.7 tttt -91.87 161.23 14.92 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-O 121.137 0.494 . . . . 10.0 110.656 -171.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.469 HD11 ' HB2' ' A' ' 7' ' ' PHE . 23.9 tp -136.13 148.1 48.06 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.189 1.396 . . . . 10.0 108.248 177.419 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 16.9 mmtm -154.18 159.46 41.4 Favored 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 124.19 0.996 . . . . 10.0 108.587 164.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.647 HD11 ' HB1' ' A' ' 5' ' ' ALA . 5.8 tp -67.07 152.06 46.48 Favored 'General case' 0 N--CA 1.451 -0.423 0 O-C-N 123.735 0.647 . . . . 10.0 109.351 176.166 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 13.3 tptm -107.48 -55.2 2.38 Favored 'General case' 0 N--CA 1.438 -1.072 0 C-N-CA 127.168 2.187 . . . . 10.0 105.881 169.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 170.97 -95.96 0.11 Allowed Glycine 0 N--CA 1.444 -0.819 0 N-CA-C 106.204 -2.759 . . . . 10.0 106.204 -179.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -157.76 148.84 21.29 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.284 0.634 . . . . 10.0 110.447 -165.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.14 -47.31 58.66 Favored 'General case' 0 C--O 1.228 -0.068 0 C-N-CA 123.595 0.758 . . . . 10.0 111.279 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -172.78 150.4 2.11 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.414 1.885 . . . . 10.0 105.969 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 11.7 t -126.63 75.21 1.53 Allowed 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.809 1.243 . . . . 10.0 108.149 -178.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 28.6 pt -78.38 -16.86 13.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 114.654 -1.157 . . . . 10.0 113.311 -177.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 47.11 72.42 0.25 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.105 1.762 . . . . 10.0 110.807 -176.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -166.7 -162.82 19.2 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 109.955 -1.258 . . . . 10.0 109.955 -177.102 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.9 ptp180 . . . . . 0 C--O 1.251 1.157 0 CA-C-O 118.072 -0.966 . . . . 10.0 110.479 171.83 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.0 p . . . . . 0 N--CA 1.472 0.635 0 N-CA-C 109.399 -0.593 . . . . 10.0 109.399 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.2 p -148.64 171.16 16.61 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 125.982 1.713 . . . . 10.0 106.713 -176.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -143.49 143.02 31.39 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 126.858 2.063 . . . . 10.0 106.752 -170.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 45.1 mmtt -85.33 145.39 27.53 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.143 -0.688 . . . . 10.0 109.143 175.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -147.06 138.14 23.9 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 107.463 -1.31 . . . . 10.0 107.463 174.115 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -122.03 149.07 44.02 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 123.796 0.838 . . . . 10.0 110.022 174.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.694 ' CE2' HD11 ' A' ' 57' ' ' LEU . 0.2 OUTLIER -142.95 141.22 31.38 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 124.804 1.315 . . . . 10.0 110.653 -168.387 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.44 132.18 43.39 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.985 1.714 . . . . 10.0 108.771 -170.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.63 HD11 HG23 ' A' ' 43' ' ' VAL . 3.7 mm -106.21 121.02 58.17 Favored 'Isoleucine or valine' 0 C--N 1.339 0.145 0 C-N-CA 124.842 1.257 . . . . 10.0 110.821 -170.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -101.52 83.27 2.41 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 106.267 -1.753 . . . . 10.0 106.267 175.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 108.65 100.54 2.65 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 122.991 0.329 . . . . 10.0 112.836 175.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 24.2 ptm -158.5 164.82 35.8 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 108.101 -1.074 . . . . 10.0 108.101 169.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.8 t -88.06 -18.34 29.12 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.149 0.426 . . . . 10.0 112.149 178.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 m 65.36 54.5 1.16 Allowed 'General case' 0 C--N 1.343 0.303 0 CA-C-O 121.872 0.844 . . . . 10.0 111.077 -178.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -170.57 -86.25 0.01 OUTLIER 'General case' 0 C--O 1.233 0.23 0 C-N-CA 124.333 1.053 . . . . 10.0 108.82 169.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.06 -42.14 76.67 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 108.484 -0.932 . . . . 10.0 108.484 -177.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 98.9 m -62.31 -55.11 31.35 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 118.555 -0.736 . . . . 10.0 109.81 -178.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -38.84 -57.33 1.24 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.658 1.183 . . . . 10.0 110.598 169.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -58.67 -34.73 71.57 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.765 -0.652 . . . . 10.0 112.71 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.7 ttm105 -68.58 -43.45 76.49 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 108.528 -0.916 . . . . 10.0 108.528 177.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.569 HG23 HG22 ' A' ' 61' ' ' VAL . 0.9 OUTLIER -56.22 -46.31 81.3 Favored 'Isoleucine or valine' 0 C--N 1.342 0.255 0 CA-C-O 118.772 -0.632 . . . . 10.0 110.211 177.922 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -44.1 -54.91 5.14 Favored 'General case' 0 C--N 1.342 0.247 0 CA-C-O 121.098 0.475 . . . . 10.0 111.075 178.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.6 mttm -69.53 -42.88 74.07 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 124.298 1.039 . . . . 10.0 110.433 -177.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.477 ' HG3' HD13 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -53.23 -36.95 61.62 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 111.893 0.331 . . . . 10.0 111.893 173.719 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.421 ' CD2' HG21 ' A' ' 45' ' ' VAL . 0.4 OUTLIER -78.5 -41.6 32.0 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.727 0.811 . . . . 10.0 110.856 175.799 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -61.28 -22.13 64.57 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 121.511 -0.743 . . . . 10.0 110.65 -177.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.4 mmpt? -53.68 -39.72 65.37 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 114.202 1.186 . . . . 10.0 114.202 168.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.8 mt -62.86 128.99 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 CA-C-N 118.965 0.802 . . . . 10.0 109.087 -175.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -56.48 -51.16 69.49 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 122.913 0.485 . . . . 10.0 111.824 -177.211 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -87.26 42.31 3.14 Favored Glycine 0 C--N 1.339 0.71 0 O-C-N 120.916 -1.115 . . . . 10.0 111.666 -172.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.8 p -105.7 151.91 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 C-N-CA 124.506 1.122 . . . . 10.0 108.628 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -117.61 -50.78 2.51 Favored 'General case' 0 C--N 1.334 -0.096 0 C-N-CA 122.946 0.499 . . . . 10.0 110.185 173.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -143.74 145.99 32.81 Favored 'General case' 0 N--CA 1.461 0.087 0 N-CA-C 109.082 -0.71 . . . . 10.0 109.082 -176.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -139.11 56.98 9.79 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 123.537 0.735 . . . . 10.0 112.461 177.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -75.3 78.87 2.87 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 123.321 2.681 . . . . 10.0 111.067 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.633 HG22 HG13 ' A' ' 43' ' ' VAL . 43.0 t -65.94 143.78 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 C-N-CA 124.786 1.234 . . . . 10.0 112.039 178.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 -91.01 97.83 11.41 Favored 'General case' 0 C--N 1.341 0.215 0 O-C-N 121.874 -0.516 . . . . 10.0 111.718 -167.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -76.45 53.25 0.84 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.785 1.634 . . . . 10.0 112.86 -177.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 179.19 -33.34 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 125.77 1.628 . . . . 10.0 110.51 168.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.2 mt -88.08 1.53 54.06 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.43 1.092 . . . . 10.0 112.155 -172.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 60.75 39.08 17.73 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 125.543 1.537 . . . . 10.0 110.91 169.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.48 133.97 26.51 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.919 1.287 . . . . 10.0 107.979 -175.353 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.633 HG13 HG22 ' A' ' 36' ' ' VAL . 17.1 t -90.88 142.66 12.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 107.1 -1.444 . . . . 10.0 107.1 167.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 91.6 m -133.98 114.96 13.8 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 125.585 1.554 . . . . 10.0 107.749 -177.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.421 HG21 ' CD2' ' A' ' 25' ' ' LEU . 50.4 t -122.0 156.14 26.55 Favored 'Isoleucine or valine' 0 C--N 1.341 0.235 0 C-N-CA 123.785 0.834 . . . . 10.0 110.607 -177.392 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.22 107.62 11.4 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 127.764 2.426 . . . . 10.0 105.659 170.725 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -136.63 165.96 24.66 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 123.395 0.678 . . . . 10.0 111.13 -176.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -99.94 126.84 35.36 Favored Pre-proline 0 CA--C 1.532 0.251 0 C-N-CA 123.73 0.812 . . . . 10.0 110.179 173.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -75.46 65.11 6.48 Favored 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 122.561 2.174 . . . . 10.0 108.569 175.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.32 -50.16 0.25 Allowed 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 107.487 -1.301 . . . . 10.0 107.487 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -106.31 -40.31 5.65 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 123.484 0.714 . . . . 10.0 110.715 173.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.24 150.63 26.06 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 121.539 -0.725 . . . . 10.0 109.993 177.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 44.9 p -147.22 149.31 32.67 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.885 0.85 . . . . 10.0 110.741 171.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 48.9 t -48.62 -51.2 11.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 125.544 1.538 . . . . 10.0 111.559 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.9 m -51.75 -43.01 62.76 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 118.943 -0.551 . . . . 10.0 111.742 178.366 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -67.71 -54.25 20.94 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.124 -0.695 . . . . 10.0 109.124 -173.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.694 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.0 pp -61.66 -45.36 94.36 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 120.695 -0.402 . . . . 10.0 110.212 -178.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.55 -51.93 8.49 Favored 'General case' 0 N--CA 1.45 -0.445 0 O-C-N 121.911 -0.493 . . . . 10.0 111.555 168.243 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.25 -40.26 95.64 Favored 'General case' 0 C--O 1.226 -0.174 0 CA-C-N 118.53 0.604 . . . . 10.0 110.293 -178.403 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -52.64 -49.21 65.61 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.393 0.677 . . . . 10.0 109.708 177.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.569 HG22 HG23 ' A' ' 21' ' ' ILE . 17.9 t -69.38 -43.83 80.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 116.493 -0.321 . . . . 10.0 111.183 177.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -50.45 -55.31 16.45 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.851 0.86 . . . . 10.0 109.566 178.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.5 ttmt -53.73 -42.45 68.11 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 126.151 1.78 . . . . 10.0 111.035 175.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.477 HD13 ' HG3' ' A' ' 24' ' ' ARG . 7.9 tp -53.0 -27.12 17.76 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 113.601 0.963 . . . . 10.0 113.601 174.32 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 140.21 -30.24 2.35 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-N 118.567 0.622 . . . . 10.0 112.671 169.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -127.8 157.97 38.97 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 124.695 1.198 . . . . 10.0 109.03 -173.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.4 ptpt -92.06 155.55 18.0 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 123.101 0.56 . . . . 10.0 111.574 -166.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.664 HD11 ' HB2' ' A' ' 7' ' ' PHE . 11.7 tp -134.37 146.06 49.55 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 126.393 1.877 . . . . 10.0 107.32 -176.087 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.3 tptp -147.31 137.18 23.02 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 119.232 -0.413 . . . . 10.0 110.602 168.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.598 HD23 ' N ' ' A' ' 71' ' ' LYS . 2.5 tt -64.83 154.06 38.24 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.05 -0.722 . . . . 10.0 109.05 178.181 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.598 ' N ' HD23 ' A' ' 70' ' ' LEU . 18.8 tttm -119.0 -63.7 1.37 Allowed 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 126.165 1.786 . . . . 10.0 108.371 -178.347 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.06 -78.75 0.03 OUTLIER Glycine 0 CA--C 1.521 0.452 0 N-CA-C 109.274 -1.53 . . . . 10.0 109.274 173.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -179.31 165.97 1.46 Allowed 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 108.443 -0.947 . . . . 10.0 108.443 -167.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.28 128.07 35.3 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.447 1.499 . . . . 10.0 110.739 178.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -39.94 -51.81 2.47 Favored 'General case' 0 C--N 1.339 0.151 0 C-N-CA 126.114 1.766 . . . . 10.0 110.539 175.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.5 m -95.22 115.79 27.89 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.013 -0.994 . . . . 10.0 109.585 174.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 22.8 mt -77.75 -124.99 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 N-CA-C 107.298 -1.371 . . . . 10.0 107.298 172.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -143.86 127.41 16.99 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 105.791 -1.929 . . . . 10.0 105.791 177.04 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -111.78 -59.98 0.46 Allowed Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.864 -0.895 . . . . 10.0 110.864 -172.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 2.9 mtt180 . . . . . 0 C--O 1.254 1.324 0 C-N-CA 127.887 2.475 . . . . 10.0 104.469 -171.834 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 51.5 t . . . . . 0 N--CA 1.468 0.459 0 N-CA-C 107.312 -1.366 . . . . 10.0 107.312 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.578 HG21 ' HB2' ' A' ' 32' ' ' ALA . 3.0 p -116.02 162.25 17.66 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.915 1.286 . . . . 10.0 110.216 178.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -116.69 162.83 17.05 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 126.863 2.065 . . . . 10.0 108.112 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.81 125.64 52.95 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.061 -1.459 . . . . 10.0 107.061 178.354 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.521 ' HB1' HD11 ' A' ' 70' ' ' LEU . . . -131.47 145.95 52.01 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.956 1.303 . . . . 10.0 108.474 -178.377 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -126.19 150.36 48.37 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 118.615 0.643 . . . . 10.0 111.578 177.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.784 ' CE2' HD11 ' A' ' 57' ' ' LEU . 2.1 m-85 -139.74 139.05 36.42 Favored 'General case' 0 C--O 1.234 0.269 0 O-C-N 125.006 1.441 . . . . 10.0 110.079 -166.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -102.79 132.51 48.92 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.491 -0.929 . . . . 10.0 108.491 -171.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.415 HD11 HG23 ' A' ' 43' ' ' VAL . 8.7 mm -101.09 122.9 53.73 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 124.143 0.977 . . . . 10.0 109.839 -165.009 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -118.29 95.68 4.99 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 106.861 -1.533 . . . . 10.0 106.861 177.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 161.28 -88.42 0.11 Allowed Glycine 0 CA--C 1.527 0.792 0 C-N-CA 123.343 0.496 . . . . 10.0 112.455 178.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.11 160.74 20.54 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.04 0.936 . . . . 10.0 110.683 -172.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 13.9 t -151.23 87.04 1.37 Allowed 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 107.327 -1.36 . . . . 10.0 107.327 169.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 41.9 t -147.84 139.92 24.2 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 108.545 -0.909 . . . . 10.0 108.545 -178.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -46.38 -55.69 6.98 Favored 'General case' 0 C--O 1.223 -0.306 0 C-N-CA 125.449 1.499 . . . . 10.0 113.899 -168.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.24 -38.57 50.87 Favored 'General case' 0 C--N 1.333 -0.127 0 O-C-N 121.694 -0.629 . . . . 10.0 109.783 -168.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 57.3 m -61.82 -50.48 72.13 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 108.943 -0.762 . . . . 10.0 108.943 176.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -52.13 -43.34 63.97 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.817 0.847 . . . . 10.0 110.298 170.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -58.48 -38.27 77.28 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 121.493 -0.755 . . . . 10.0 110.953 -178.034 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.73 -40.07 75.05 Favored 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 121.645 -0.66 . . . . 10.0 109.752 177.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.512 HD12 HG22 ' A' ' 61' ' ' VAL . 9.0 mm -46.15 -50.38 4.61 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.249 0 CA-C-O 117.224 -1.37 . . . . 10.0 112.452 170.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -47.78 -53.41 15.44 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 120.34 1.427 . . . . 10.0 110.838 -176.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.2 tppt? -70.22 -43.59 70.33 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 123.612 0.765 . . . . 10.0 108.951 -176.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 14.2 tpp180 -63.4 -33.94 76.64 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-O 119.658 -0.21 . . . . 10.0 110.81 -175.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.488 HD12 HG22 ' A' ' 21' ' ' ILE . 0.3 OUTLIER -78.68 -38.19 39.89 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 124.71 1.204 . . . . 10.0 110.529 173.01 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -59.95 -19.06 49.97 Favored 'General case' 0 C--O 1.225 -0.199 0 O-C-N 121.256 -0.903 . . . . 10.0 110.8 177.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.6 ptpt -51.84 -43.63 63.27 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 113.123 0.786 . . . . 10.0 113.123 169.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 5.2 mt -55.97 134.15 19.83 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 N-CA-C 108.635 -0.876 . . . . 10.0 108.635 -176.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -70.85 -47.1 61.13 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 108.705 -0.85 . . . . 10.0 108.705 -177.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -80.84 43.81 2.88 Favored Glycine 0 C--N 1.342 0.875 0 O-C-N 121.068 -1.02 . . . . 10.0 112.111 -176.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.8 p -105.92 152.05 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 C-N-CA 125.298 1.439 . . . . 10.0 109.058 -177.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.578 ' HB2' HG21 ' A' ' 2' ' ' THR . . . -115.81 -57.91 2.17 Favored 'General case' 0 CA--C 1.522 -0.127 0 C-N-CA 123.796 0.838 . . . . 10.0 108.873 169.219 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 64.6 m-80 -143.62 159.24 42.81 Favored 'General case' 0 CA--C 1.526 0.057 0 N-CA-C 109.496 -0.557 . . . . 10.0 109.496 -176.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -141.32 61.34 13.67 Favored Pre-proline 0 CA--C 1.537 0.452 0 C-N-CA 123.884 0.874 . . . . 10.0 111.585 174.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -77.35 71.39 6.4 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 123.09 2.526 . . . . 10.0 110.03 -176.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.543 HG12 HG13 ' A' ' 43' ' ' VAL . 3.5 m -67.02 155.02 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 O-C-N 121.744 -0.598 . . . . 10.0 111.028 -178.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -95.69 155.24 16.83 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 120.98 0.419 . . . . 10.0 109.934 172.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -135.28 48.47 2.25 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 124.954 1.301 . . . . 10.0 109.695 -171.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -175.26 -42.44 0.01 OUTLIER 'General case' 0 C--O 1.224 -0.251 0 C-N-CA 126.09 1.756 . . . . 10.0 108.708 178.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.4 mt -80.66 -15.48 56.46 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 125.436 1.494 . . . . 10.0 112.012 -170.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 71.86 40.29 0.77 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.275 1.43 . . . . 10.0 110.721 174.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.5 p -140.76 123.38 16.12 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.64 1.576 . . . . 10.0 108.969 -178.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.543 HG13 HG12 ' A' ' 36' ' ' VAL . 9.3 t -92.86 145.91 7.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 107.322 -1.362 . . . . 10.0 107.322 168.559 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 88.3 m -133.75 122.13 22.89 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 105.997 -1.853 . . . . 10.0 105.997 -176.065 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 29.3 t -122.98 134.42 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-N 118.74 0.7 . . . . 10.0 109.408 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -96.15 104.41 16.37 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 106.833 -1.543 . . . . 10.0 106.833 161.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -145.42 163.72 33.75 Favored 'General case' 0 CA--C 1.521 -0.166 0 C-N-CA 123.558 0.743 . . . . 10.0 109.798 178.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 13.3 p30 -98.5 130.64 27.62 Favored Pre-proline 0 C--N 1.329 -0.307 0 C-N-CA 123.419 0.687 . . . . 10.0 109.492 175.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -79.02 57.56 6.53 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 121.86 1.707 . . . . 10.0 108.967 171.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.34 -46.79 2.03 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.144 -0.687 . . . . 10.0 109.144 174.389 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -85.75 -61.06 1.84 Allowed 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 109.696 -0.483 . . . . 10.0 109.696 -178.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -107.71 -176.61 3.11 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 124.105 0.962 . . . . 10.0 110.017 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 93.6 p -140.1 169.73 17.15 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.696 1.198 . . . . 10.0 109.622 176.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 84.0 t -48.43 -52.6 8.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 124.408 1.083 . . . . 10.0 109.83 168.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.1 m -55.5 -35.95 66.14 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.631 1.173 . . . . 10.0 112.394 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -71.84 -60.62 2.14 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.703 -0.48 . . . . 10.0 109.703 174.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.784 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.0 pp -61.54 -43.72 98.36 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 121.85 -0.531 . . . . 10.0 110.636 -167.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.478 ' HA ' HD23 ' A' ' 68' ' ' LEU . 0.4 OUTLIER -51.37 -35.49 38.93 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 114.09 1.144 . . . . 10.0 114.09 171.065 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.88 -33.72 67.15 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 119.56 1.073 . . . . 10.0 110.088 176.652 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.38 -51.1 68.92 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 109.235 -0.654 . . . . 10.0 109.235 -177.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.512 HG22 HD12 ' A' ' 21' ' ' ILE . 43.3 t -59.54 -48.0 88.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 124.032 0.933 . . . . 10.0 111.477 173.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -53.09 -47.97 68.15 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 122.209 1.004 . . . . 10.0 109.435 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 32.8 tttp -70.56 -39.8 73.74 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 125.526 1.53 . . . . 10.0 110.897 -177.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 11.8 mt -51.57 -39.34 57.68 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 118.647 -0.692 . . . . 10.0 111.906 169.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 149.64 -21.2 1.17 Allowed Glycine 0 CA--C 1.527 0.798 0 CA-C-N 118.786 0.721 . . . . 10.0 114.698 167.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.42 ' OH ' HD11 ' A' ' 21' ' ' ILE . 1.9 p90 -118.82 155.43 31.19 Favored 'General case' 0 C--O 1.224 -0.276 0 C-N-CA 124.831 1.253 . . . . 10.0 107.955 -175.515 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.75 144.75 25.37 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 118.756 0.707 . . . . 10.0 110.331 -168.075 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.599 HD11 ' HB2' ' A' ' 7' ' ' PHE . 20.2 tp -123.36 145.18 48.96 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 126.157 1.783 . . . . 10.0 107.646 178.068 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.2 tptp -152.15 151.74 31.42 Favored 'General case' 0 CA--C 1.512 -0.499 0 C-N-CA 124.619 1.168 . . . . 10.0 108.488 171.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.521 HD11 ' HB1' ' A' ' 5' ' ' ALA . 7.9 tp -66.28 151.51 46.9 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 123.662 0.601 . . . . 10.0 109.66 177.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -105.07 -59.01 1.81 Allowed 'General case' 0 N--CA 1.437 -1.087 0 C-N-CA 127.492 2.317 . . . . 10.0 105.674 164.396 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 176.59 -93.65 0.09 OUTLIER Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 108.035 -2.026 . . . . 10.0 108.035 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -158.93 169.02 25.26 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.601 0.76 . . . . 10.0 109.608 -163.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -65.3 149.54 49.79 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.411 1.084 . . . . 10.0 111.36 -173.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -79.81 58.68 2.9 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.376 1.07 . . . . 10.0 109.785 -177.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 48.1 m -87.06 159.33 18.98 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.089 0.955 . . . . 10.0 110.435 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 41.7 pt -101.91 -163.85 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 N-CA-C 106.059 -1.83 . . . . 10.0 106.059 166.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -117.09 159.67 22.2 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 125.472 1.509 . . . . 10.0 107.183 164.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -142.59 -81.33 0.06 OUTLIER Glycine 0 CA--C 1.522 0.501 0 N-CA-C 108.169 -1.972 . . . . 10.0 108.169 175.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 20.0 ttp180 . . . . . 0 C--O 1.251 1.184 0 N-CA-C 105.922 -1.881 . . . . 10.0 105.922 171.599 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.503 HG13 ' H ' ' A' ' 2' ' ' THR . 4.0 p . . . . . 0 N--CA 1.471 0.591 0 N-CA-C 109.795 -0.446 . . . . 10.0 109.795 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.503 ' H ' HG13 ' A' ' 1' ' ' VAL . 5.6 p -139.07 161.99 36.04 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 106.609 -1.626 . . . . 10.0 106.609 176.062 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -126.2 149.91 48.71 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 126.439 1.895 . . . . 10.0 107.478 -168.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.51 131.75 49.02 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 107.883 -1.155 . . . . 10.0 107.883 -176.048 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.523 ' HB1' HD11 ' A' ' 70' ' ' LEU . . . -140.27 157.24 45.89 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 123.656 0.782 . . . . 10.0 109.926 178.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -128.31 151.57 49.16 Favored 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 123.542 0.737 . . . . 10.0 110.353 178.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.711 ' CE2' HD11 ' A' ' 57' ' ' LEU . 7.0 m-85 -140.35 146.64 38.69 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.845 1.658 . . . . 10.0 109.184 -170.037 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -110.15 125.82 53.42 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.311 1.044 . . . . 10.0 109.0 -165.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.418 HD11 HG23 ' A' ' 43' ' ' VAL . 8.6 mm -100.36 109.47 25.14 Favored 'Isoleucine or valine' 0 C--N 1.343 0.314 0 CA-C-N 118.907 0.776 . . . . 10.0 112.449 -159.173 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.407 ' OE1' ' NZ ' ' A' ' 67' ' ' LYS . 52.4 mt-10 -92.58 73.76 5.1 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 107.934 -1.135 . . . . 10.0 107.934 178.434 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 158.41 -109.32 0.4 Allowed Glycine 0 CA--C 1.526 0.758 0 N-CA-C 112.267 -0.333 . . . . 10.0 112.267 173.104 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.53 130.08 41.47 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 123.325 0.65 . . . . 10.0 110.933 -167.006 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.8 t -146.59 70.29 1.21 Allowed 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 107.675 -1.231 . . . . 10.0 107.675 -169.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 72.1 m -140.87 -116.35 0.12 Allowed 'General case' 0 C--N 1.339 0.15 0 N-CA-C 106.906 -1.516 . . . . 10.0 106.906 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -147.39 -49.09 0.18 Allowed 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.248 0.619 . . . . 10.0 110.249 178.616 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.51 -38.97 81.4 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.263 -0.643 . . . . 10.0 109.263 -175.187 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 52.5 m -64.06 -55.28 23.31 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 108.934 -0.765 . . . . 10.0 108.934 175.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -51.0 -39.08 54.94 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.835 1.254 . . . . 10.0 111.102 179.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -57.51 -30.49 65.18 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.038 0.755 . . . . 10.0 113.038 177.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 18.1 ttm180 -72.31 -36.46 68.92 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 120.641 -1.287 . . . . 10.0 109.392 -178.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 9.1 mt -43.95 -53.41 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.44 0 CA-C-O 118.654 -0.689 . . . . 10.0 109.492 168.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -48.98 -47.22 44.3 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.4 0.546 . . . . 10.0 111.811 -175.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.21 -48.45 65.14 Favored 'General case' 0 CA--C 1.531 0.222 0 O-C-N 121.585 -0.697 . . . . 10.0 110.014 177.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.508 ' HB3' ' HB1' ' A' ' 60' ' ' ALA . 5.9 mmt180 -56.72 -35.47 68.58 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 112.093 0.405 . . . . 10.0 112.093 -179.473 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.489 HD21 ' HB2' ' A' ' 57' ' ' LEU . 1.3 mt -80.3 -44.8 18.97 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.752 1.621 . . . . 10.0 110.896 177.235 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -54.28 -24.98 21.07 Favored 'General case' 0 C--O 1.227 -0.113 0 CA-C-N 118.319 0.508 . . . . 10.0 111.077 174.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.8 ttmt -58.34 -35.37 71.8 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 112.984 0.735 . . . . 10.0 112.984 173.098 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.7 mm -60.02 135.13 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 C-N-CA 123.755 0.822 . . . . 10.0 109.85 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -69.05 -54.82 13.1 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 111.998 0.369 . . . . 10.0 111.998 -173.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.67 41.03 2.66 Favored Glycine 0 C--N 1.339 0.711 0 O-C-N 120.916 -1.115 . . . . 10.0 111.928 -173.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.4 p -100.95 150.61 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 C-N-CA 124.562 1.145 . . . . 10.0 108.542 -175.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -111.93 -58.16 2.16 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 108.483 -0.932 . . . . 10.0 108.483 171.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 60.0 m-80 -147.58 156.08 42.46 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.659 -0.867 . . . . 10.0 108.659 -173.289 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -141.72 56.81 6.3 Favored Pre-proline 0 CA--C 1.536 0.404 0 C-N-CA 123.626 0.771 . . . . 10.0 112.641 175.163 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -75.43 77.65 3.22 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 122.758 2.306 . . . . 10.0 110.152 -177.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.428 HG12 HG13 ' A' ' 43' ' ' VAL . 3.4 m -57.49 154.04 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 O-C-N 121.83 -0.543 . . . . 10.0 111.632 176.001 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -93.31 138.2 31.9 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.458 -0.571 . . . . 10.0 109.458 -179.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -117.7 54.56 0.9 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.99 1.316 . . . . 10.0 110.25 -171.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 171.14 -34.12 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 127.039 2.136 . . . . 10.0 109.997 176.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.5 mt -91.3 -1.67 57.59 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.14 1.376 . . . . 10.0 111.978 -171.088 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 65.44 35.19 7.52 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 124.918 1.287 . . . . 10.0 111.052 165.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -140.44 133.77 29.79 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 125.403 1.481 . . . . 10.0 107.857 -172.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.428 HG13 HG12 ' A' ' 36' ' ' VAL . 7.9 t -94.88 140.65 16.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 106.792 -1.558 . . . . 10.0 106.792 168.525 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 60.4 m -125.8 119.29 27.49 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 106.108 -1.812 . . . . 10.0 106.108 -178.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.8 t -120.57 142.51 36.15 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.207 0 C-N-CA 122.992 0.517 . . . . 10.0 109.629 -178.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 59.2 tt0 -109.51 110.44 21.54 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 107.184 -1.413 . . . . 10.0 107.184 162.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -151.72 164.93 35.9 Favored 'General case' 0 C--O 1.227 -0.129 0 C-N-CA 123.876 0.871 . . . . 10.0 109.405 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 20.7 p30 -95.53 134.69 23.9 Favored Pre-proline 0 C--N 1.328 -0.365 0 C-N-CA 123.437 0.695 . . . . 10.0 110.681 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -80.77 56.39 6.07 Favored 'Trans proline' 0 N--CA 1.45 -1.077 0 C-N-CA 121.603 1.536 . . . . 10.0 109.193 170.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.55 -39.54 0.51 Allowed 'General case' 0 C--N 1.346 0.439 0 CA-C-N 118.631 0.651 . . . . 10.0 112.54 175.642 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -95.23 -26.63 15.88 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 122.992 0.517 . . . . 10.0 110.321 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.51 173.22 15.42 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.183 0.993 . . . . 10.0 109.14 -179.221 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 91.0 p -131.59 169.35 16.25 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.565 1.146 . . . . 10.0 112.258 -177.124 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 26.4 m -48.75 -43.52 14.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 124.01 0.924 . . . . 10.0 110.679 166.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.85 -36.43 79.1 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.964 1.706 . . . . 10.0 111.642 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -71.55 -61.2 1.86 Allowed 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 108.472 -0.936 . . . . 10.0 108.472 175.253 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.711 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.3 pp -60.19 -42.31 94.8 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 120.042 -0.663 . . . . 10.0 111.545 -169.75 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.45 ' HA ' HD23 ' A' ' 68' ' ' LEU . 0.4 OUTLIER -51.24 -37.68 48.36 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 117.305 -1.331 . . . . 10.0 113.879 170.718 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -51.55 -39.08 57.09 Favored 'General case' 0 C--N 1.346 0.417 0 CA-C-N 120.735 1.607 . . . . 10.0 110.298 173.55 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.508 ' HB1' ' HB3' ' A' ' 24' ' ' ARG . . . -62.18 -46.14 90.27 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 109.429 -0.582 . . . . 10.0 109.429 -174.21 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 68.9 t -66.83 -45.87 86.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 123.327 0.651 . . . . 10.0 111.755 172.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -49.9 -54.13 21.54 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 124.67 1.188 . . . . 10.0 108.821 -178.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 46.4 tptt -57.67 -34.78 69.75 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.549 1.54 . . . . 10.0 111.644 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.458 HD13 ' HA ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -55.85 -34.45 65.44 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 124.255 1.022 . . . . 10.0 111.248 174.064 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 125.95 -11.45 7.36 Favored Glycine 0 CA--C 1.529 0.968 0 CA-C-O 119.474 -0.626 . . . . 10.0 113.4 174.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -116.35 151.46 35.87 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 107.149 -1.426 . . . . 10.0 107.149 173.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.407 ' NZ ' ' OE1' ' A' ' 10' ' ' GLU . 13.3 ttpp -95.47 156.4 16.34 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.246 0.546 . . . . 10.0 110.364 -171.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.519 HD11 ' HB2' ' A' ' 7' ' ' PHE . 29.7 tp -128.98 150.44 50.4 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.622 1.569 . . . . 10.0 107.882 -179.045 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 11.0 tptp -155.14 151.56 28.4 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 108.803 -0.814 . . . . 10.0 108.803 169.293 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.523 HD11 ' HB1' ' A' ' 5' ' ' ALA . 7.5 tp -62.74 154.78 28.48 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 121.303 0.573 . . . . 10.0 109.573 177.532 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 45.6 tttp -117.23 -53.44 2.45 Favored 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 127.769 2.428 . . . . 10.0 107.08 170.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 170.57 -84.38 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.515 0 N-CA-C 109.081 -1.608 . . . . 10.0 109.081 176.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -160.6 163.31 32.74 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 108.224 -1.028 . . . . 10.0 108.224 -164.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -84.83 123.9 30.98 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.302 -0.999 . . . . 10.0 108.302 175.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 53.2 t0 46.64 83.0 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.914 1.686 . . . . 10.0 112.934 172.42 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 35.1 m -61.19 70.06 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.297 1.839 . . . . 10.0 114.375 -176.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.7 pt -74.79 71.62 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 123.958 0.903 . . . . 10.0 111.736 176.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -79.39 -70.65 0.49 Allowed 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.285 1.034 . . . . 10.0 108.741 174.075 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.02 -66.14 3.46 Favored Glycine 0 CA--C 1.53 0.974 0 O-C-N 121.75 -0.594 . . . . 10.0 111.686 178.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 14.1 ttm180 . . . . . 0 C--O 1.251 1.182 0 CA-C-O 116.218 -1.848 . . . . 10.0 106.755 -178.651 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.622 HG12 ' H ' ' A' ' 2' ' ' THR . 18.0 t . . . . . 0 N--CA 1.466 0.348 0 N-CA-C 105.847 -1.908 . . . . 10.0 105.847 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.622 ' H ' HG12 ' A' ' 1' ' ' VAL . 21.7 p -113.75 137.44 51.63 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.765 1.226 . . . . 10.0 110.103 -178.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -116.47 151.95 35.02 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 125.186 1.394 . . . . 10.0 109.136 -165.442 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -86.58 129.67 34.78 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.857 1.263 . . . . 10.0 107.719 -171.275 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -134.28 136.34 43.48 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.527 1.131 . . . . 10.0 109.362 174.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -116.11 150.8 36.79 Favored 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 124.622 1.169 . . . . 10.0 108.067 174.201 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.821 ' CE2' HD11 ' A' ' 57' ' ' LEU . 7.0 m-85 -138.95 138.17 37.07 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 124.493 1.121 . . . . 10.0 109.327 -174.617 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -102.12 130.59 48.77 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.727 1.611 . . . . 10.0 108.197 -176.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.408 HD12 HD12 ' A' ' 68' ' ' LEU . 0.9 OUTLIER -114.95 153.86 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.068 0 C-N-CA 125.789 1.636 . . . . 10.0 110.895 -165.86 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -128.27 86.04 2.41 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 124.387 1.075 . . . . 10.0 108.23 168.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 114.16 61.99 0.4 Allowed Glycine 0 CA--C 1.525 0.671 0 CA-C-O 119.493 -0.615 . . . . 10.0 113.206 160.361 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 16.5 ptt? -128.23 40.92 3.59 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 122.527 1.156 . . . . 10.0 111.949 169.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 70.2 p -90.37 52.95 2.34 Favored 'General case' 0 C--N 1.33 -0.274 0 O-C-N 120.306 -1.496 . . . . 10.0 109.546 -172.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 12.6 t -137.5 5.03 2.67 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 112.031 0.382 . . . . 10.0 112.031 179.367 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 67.09 -57.12 0.43 Allowed 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 126.123 1.769 . . . . 10.0 112.995 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.7 -36.47 81.01 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.396 1.478 . . . . 10.0 109.463 -179.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 26.6 p -68.02 -51.83 42.59 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 109.424 -0.584 . . . . 10.0 109.424 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.4 -46.68 69.8 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.392 0.677 . . . . 10.0 110.053 173.407 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -61.31 -19.92 62.34 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.631 0.604 . . . . 10.0 112.631 178.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.1 ttm180 -78.7 -36.88 42.9 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.307 1.043 . . . . 10.0 108.805 178.032 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 19.1 mm -43.7 -54.31 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.399 0 CA-C-O 118.462 -0.78 . . . . 10.0 109.854 171.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -44.63 -46.79 10.31 Favored 'General case' 0 C--O 1.224 -0.277 0 C-N-CA 122.998 0.519 . . . . 10.0 111.841 -179.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.54 -46.25 63.95 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 122.971 0.508 . . . . 10.0 110.076 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.09 -33.68 74.9 Favored 'General case' 0 C--O 1.222 -0.342 0 O-C-N 121.987 -0.445 . . . . 10.0 111.808 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.12 -34.84 26.0 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.524 1.53 . . . . 10.0 111.431 177.328 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -58.68 -24.59 61.62 Favored 'General case' 0 C--O 1.226 -0.171 0 O-C-N 121.761 -0.587 . . . . 10.0 109.89 172.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -52.03 -40.12 60.58 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 120.879 -0.328 . . . . 10.0 111.348 171.635 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 15.9 mm -56.16 127.2 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 C-N-CA 123.203 0.601 . . . . 10.0 109.623 -176.187 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -70.42 -48.67 54.98 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 121.081 -0.248 . . . . 10.0 110.759 -176.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -84.31 43.43 3.21 Favored Glycine 0 C--N 1.34 0.75 0 O-C-N 120.802 -1.186 . . . . 10.0 111.549 -177.185 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.3 p -99.4 148.46 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 124.287 1.035 . . . . 10.0 108.582 -178.052 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.549 ' HB2' HG21 ' A' ' 2' ' ' THR . . . -111.02 -57.51 2.23 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 124.106 0.962 . . . . 10.0 108.545 175.349 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 -143.39 152.46 41.62 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.307 -0.997 . . . . 10.0 108.307 -175.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -138.94 61.57 22.52 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 123.602 0.761 . . . . 10.0 111.072 173.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -78.48 67.76 8.22 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 123.004 2.469 . . . . 10.0 110.018 -175.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.456 HG12 HG13 ' A' ' 43' ' ' VAL . 4.2 m -65.0 155.15 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 O-C-N 121.859 -0.526 . . . . 10.0 110.61 179.509 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 34.4 m120 -93.57 148.98 21.6 Favored 'General case' 0 C--O 1.224 -0.287 0 N-CA-C 108.497 -0.927 . . . . 10.0 108.497 175.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -126.3 47.95 2.2 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 123.643 0.777 . . . . 10.0 110.38 -173.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -174.22 -43.03 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 125.948 1.699 . . . . 10.0 109.614 178.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.0 mt -76.38 -18.47 58.85 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.803 1.241 . . . . 10.0 111.971 -169.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 63.2 54.72 2.01 Favored 'General case' 0 C--N 1.338 0.079 0 C-N-CA 125.752 1.621 . . . . 10.0 110.126 -174.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.2 p -142.29 130.74 22.41 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 107.481 -1.303 . . . . 10.0 107.481 172.222 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.456 HG13 HG12 ' A' ' 36' ' ' VAL . 9.2 t -105.28 145.41 13.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 106.759 -1.571 . . . . 10.0 106.759 173.033 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 69.8 m -139.83 123.57 17.42 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 106.25 -1.759 . . . . 10.0 106.25 -169.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 22.2 t -127.42 149.36 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 C-N-CA 123.692 0.797 . . . . 10.0 109.271 179.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 -115.78 112.02 21.38 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 105.895 -1.891 . . . . 10.0 105.895 159.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -146.44 162.81 37.46 Favored 'General case' 0 CA--C 1.52 -0.202 0 C-N-CA 123.403 0.681 . . . . 10.0 109.553 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 20.5 p30 -92.47 130.6 36.78 Favored Pre-proline 0 C--N 1.329 -0.306 0 C-N-CA 122.524 0.33 . . . . 10.0 110.237 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -76.47 61.6 6.82 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 121.554 1.503 . . . . 10.0 108.486 170.146 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.24 -43.88 0.33 Allowed 'General case' 0 C--N 1.341 0.223 0 O-C-N 122.085 -0.384 . . . . 10.0 109.979 177.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -87.02 -41.96 13.46 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 117.92 0.327 . . . . 10.0 110.865 177.052 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -133.04 -178.06 4.79 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 124.52 1.128 . . . . 10.0 109.952 -177.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 81.7 p -146.24 167.46 23.45 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.549 0.74 . . . . 10.0 109.579 177.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 64.9 t -43.01 -49.07 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.113 0 C-N-CA 124.836 1.254 . . . . 10.0 111.02 172.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 43.9 m -50.54 -43.4 56.07 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.486 0.714 . . . . 10.0 112.583 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -65.77 -60.21 3.12 Favored 'General case' 0 C--N 1.338 0.09 0 C-N-CA 123.808 0.843 . . . . 10.0 109.055 -177.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.821 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.0 pp -61.65 -42.84 99.47 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 120.06 -0.656 . . . . 10.0 110.533 -176.051 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.11 -53.2 6.63 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 117.823 -1.084 . . . . 10.0 112.16 163.514 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.32 -48.63 73.86 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 119.96 1.255 . . . . 10.0 110.38 178.398 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -48.28 -54.62 13.05 Favored 'General case' 0 N--CA 1.453 -0.309 0 O-C-N 123.349 0.405 . . . . 10.0 110.642 177.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.1 t -62.9 -44.6 99.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 N-CA-C 112.578 0.585 . . . . 10.0 112.578 176.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.63 -57.49 8.09 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.013 1.325 . . . . 10.0 108.431 178.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.0 tptm -55.6 -38.84 69.96 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 126.455 1.902 . . . . 10.0 111.216 176.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.403 HD12 ' HA ' ' A' ' 64' ' ' LEU . 6.1 tp -55.05 -27.46 44.8 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.186 0.995 . . . . 10.0 113.047 174.423 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 131.21 -11.14 5.58 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-O 119.169 -0.795 . . . . 10.0 114.258 168.496 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -137.91 160.55 38.99 Favored 'General case' 0 CA--C 1.527 0.058 0 CA-C-N 118.667 1.234 . . . . 10.0 108.37 -176.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 41.4 mmtt -88.94 153.62 20.89 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.148 0.499 . . . . 10.0 112.041 -165.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.408 HD12 HD12 ' A' ' 9' ' ' ILE . 8.9 tp -135.23 148.69 49.69 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 125.579 1.552 . . . . 10.0 107.104 176.294 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.8 mmtt -149.17 154.18 38.77 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 124.523 1.129 . . . . 10.0 108.233 165.108 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.9 tp -59.76 158.52 10.23 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 109.752 -0.462 . . . . 10.0 109.752 171.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 7.8 tptt -110.38 -74.19 0.66 Allowed 'General case' 0 N--CA 1.434 -1.255 0 C-N-CA 126.832 2.053 . . . . 10.0 106.892 173.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 163.87 44.79 0.02 OUTLIER Glycine 0 CA--C 1.53 0.992 0 CA-C-O 119.491 -0.616 . . . . 10.0 112.537 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 70.64 156.84 0.16 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.059 1.344 . . . . 10.0 113.893 169.255 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 8.1 mp0 -71.83 94.77 1.45 Allowed 'General case' 0 C--O 1.237 0.41 0 C-N-CA 124.175 0.99 . . . . 10.0 111.008 -173.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -59.29 78.3 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.072 1.349 . . . . 10.0 111.061 171.089 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 30.5 m -64.46 -28.83 69.94 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.438 1.095 . . . . 10.0 110.77 177.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 5.3 pt -142.44 87.85 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 C-N-CA 125.319 1.448 . . . . 10.0 109.065 178.28 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -72.24 -76.98 0.1 Allowed 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 108.665 -0.865 . . . . 10.0 108.665 175.019 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -101.01 -77.29 1.26 Allowed Glycine 0 CA--C 1.526 0.766 0 N-CA-C 109.647 -1.381 . . . . 10.0 109.647 178.269 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? . . . . . 0 C--O 1.251 1.153 0 C-N-CA 125.39 1.476 . . . . 10.0 110.999 -171.972 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.5 p . . . . . 0 N--CA 1.472 0.673 0 N-CA-C 109.604 -0.517 . . . . 10.0 109.604 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.685 HG21 ' HB2' ' A' ' 32' ' ' ALA . 2.2 p -144.03 169.56 17.6 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.431 1.492 . . . . 10.0 107.275 171.58 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -135.75 146.13 47.33 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 126.543 1.937 . . . . 10.0 106.708 -172.224 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 28.8 mmtm -81.54 145.73 30.52 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.77 -0.826 . . . . 10.0 108.77 177.167 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -145.12 141.58 28.92 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.721 1.208 . . . . 10.0 108.212 174.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -122.63 148.82 44.81 Favored 'General case' 0 CA--C 1.51 -0.595 0 C-N-CA 124.413 1.085 . . . . 10.0 108.601 174.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.774 ' CE2' HD11 ' A' ' 57' ' ' LEU . 2.7 m-85 -140.43 138.05 34.42 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 125.101 1.5 . . . . 10.0 109.404 -171.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -103.98 127.82 51.53 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.964 -1.124 . . . . 10.0 107.964 -168.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 10.7 mm -103.56 136.11 38.0 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.114 0 C-N-CA 124.424 1.09 . . . . 10.0 110.804 -160.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -125.23 99.68 6.19 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.478 -1.305 . . . . 10.0 107.478 169.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 156.46 -103.89 0.24 Allowed Glycine 0 CA--C 1.527 0.804 0 CA-C-O 120.034 -0.314 . . . . 10.0 112.565 173.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.22 157.11 38.33 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 117.628 0.714 . . . . 10.0 110.892 -174.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.0 t -150.15 62.95 0.97 Allowed 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.87 -1.159 . . . . 10.0 107.87 175.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.6 t -160.91 140.59 10.76 Favored 'General case' 0 N--CA 1.454 -0.239 0 O-C-N 121.109 -0.994 . . . . 10.0 109.939 -177.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.53 -46.82 70.3 Favored 'General case' 0 C--O 1.222 -0.344 0 C-N-CA 124.104 0.962 . . . . 10.0 113.406 -170.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.08 -35.01 71.71 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 119.02 0.827 . . . . 10.0 109.917 -172.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 13.8 m -67.87 -54.29 20.02 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.717 -0.846 . . . . 10.0 108.717 177.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -51.41 -37.87 50.59 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.543 -0.753 . . . . 10.0 110.616 174.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -53.49 -34.43 57.99 Favored 'General case' 0 CA--C 1.531 0.235 0 O-C-N 121.606 -0.684 . . . . 10.0 112.064 -179.061 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -60.31 -38.4 83.56 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 121.056 -1.027 . . . . 10.0 109.135 -179.643 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.428 HD12 HG22 ' A' ' 61' ' ' VAL . 13.1 mm -52.57 -49.1 46.14 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.477 0 CA-C-O 118.053 -0.975 . . . . 10.0 110.323 176.12 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -46.42 -50.66 16.42 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.909 0.777 . . . . 10.0 110.56 -177.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.64 -46.37 63.41 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.106 0.562 . . . . 10.0 111.264 178.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.1 mmt180 -58.8 -27.34 64.95 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.743 0.645 . . . . 10.0 112.743 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.0 -39.3 13.04 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.943 1.697 . . . . 10.0 111.404 174.341 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 24.8 t30 -57.47 -25.82 60.3 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 118.703 0.683 . . . . 10.0 110.627 174.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.1 mmpt? -54.4 -37.33 64.94 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 114.3 1.222 . . . . 10.0 114.3 169.09 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 11.6 mm -54.53 128.82 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 109.084 -0.71 . . . . 10.0 109.084 175.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -68.39 -49.62 58.78 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 109.469 -0.567 . . . . 10.0 109.469 -177.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -82.39 47.31 3.72 Favored Glycine 0 C--N 1.34 0.783 0 O-C-N 120.651 -1.28 . . . . 10.0 112.181 -175.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.5 p -110.23 153.57 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 C-N-CA 125.223 1.409 . . . . 10.0 109.568 -177.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.685 ' HB2' HG21 ' A' ' 2' ' ' THR . . . -118.0 -52.01 2.43 Favored 'General case' 0 C--O 1.228 -0.029 0 C-N-CA 122.714 0.406 . . . . 10.0 110.127 169.227 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -144.57 149.92 36.62 Favored 'General case' 0 CA--C 1.527 0.087 0 N-CA-C 109.075 -0.713 . . . . 10.0 109.075 -173.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -137.58 58.48 16.86 Favored Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 123.691 0.796 . . . . 10.0 112.432 174.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -77.04 77.2 3.87 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 123.125 2.55 . . . . 10.0 110.495 -176.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.45 HG12 HG13 ' A' ' 43' ' ' VAL . 3.7 m -59.71 153.43 4.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 O-C-N 121.741 -0.599 . . . . 10.0 111.398 176.009 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -97.84 143.6 28.28 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.829 -0.804 . . . . 10.0 108.829 175.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -125.34 43.01 3.15 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.278 1.031 . . . . 10.0 110.953 -166.182 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -175.6 -40.06 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 125.924 1.69 . . . . 10.0 108.942 -178.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 12.6 mt -76.38 -21.26 56.27 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.346 1.058 . . . . 10.0 111.414 -176.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 63.7 49.48 2.96 Favored 'General case' 0 CA--C 1.527 0.093 0 C-N-CA 125.547 1.539 . . . . 10.0 109.959 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.6 p -137.86 131.67 31.39 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 126.131 1.772 . . . . 10.0 106.854 174.164 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.45 HG13 HG12 ' A' ' 36' ' ' VAL . 17.5 t -93.26 144.21 9.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 106.174 -1.787 . . . . 10.0 106.174 167.122 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 92.4 m -130.4 123.1 29.09 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 105.453 -2.054 . . . . 10.0 105.453 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 44.5 t -122.26 149.79 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 N-CA-C 108.668 -0.864 . . . . 10.0 108.668 176.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -116.06 108.66 16.48 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 107.113 -1.44 . . . . 10.0 107.113 161.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -146.63 164.63 32.04 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 108.915 -0.772 . . . . 10.0 108.915 -178.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 17.3 p30 -94.81 128.44 39.47 Favored Pre-proline 0 C--N 1.326 -0.421 0 N-CA-C 109.983 -0.377 . . . . 10.0 109.983 174.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -77.55 57.2 5.87 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 121.787 1.658 . . . . 10.0 108.7 168.355 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.17 -45.66 1.97 Allowed 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.113 -0.699 . . . . 10.0 109.113 177.138 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -90.11 -58.88 2.35 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 123.2 0.6 . . . . 10.0 109.68 -178.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -111.32 175.13 5.55 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 125.187 1.395 . . . . 10.0 109.565 178.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 59.4 p -129.14 176.65 7.74 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.66 1.184 . . . . 10.0 110.226 175.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 92.3 t -52.43 -39.88 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-N 115.234 -0.893 . . . . 10.0 110.691 168.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.1 m -58.13 -37.34 74.44 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 123.083 0.553 . . . . 10.0 111.882 -177.301 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -69.36 -58.49 3.94 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 123.999 0.92 . . . . 10.0 109.137 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.774 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.1 pp -63.08 -41.22 99.38 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 120.381 -0.528 . . . . 10.0 111.118 -175.518 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -40.48 -57.93 1.69 Allowed 'General case' 0 C--O 1.22 -0.48 0 O-C-N 121.575 -0.703 . . . . 10.0 111.69 161.024 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.47 -42.3 77.97 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 118.851 0.75 . . . . 10.0 110.35 -177.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -55.35 -47.28 75.98 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.395 -0.82 . . . . 10.0 110.432 179.059 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.428 HG22 HD12 ' A' ' 21' ' ' ILE . 48.0 t -66.02 -41.84 90.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 N-CA-C 111.481 0.178 . . . . 10.0 111.481 171.784 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -58.21 -45.36 87.79 Favored 'General case' 0 C--N 1.331 -0.201 0 O-C-N 121.181 -0.949 . . . . 10.0 109.181 -172.236 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 56.5 tttm -64.39 -27.91 69.33 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.32 1.048 . . . . 10.0 112.459 178.201 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.466 HD13 ' HA ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -56.63 -28.51 60.67 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 119.246 0.93 . . . . 10.0 110.756 168.959 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 131.26 -48.6 0.96 Allowed Glycine 0 C--N 1.337 0.635 0 N-CA-C 109.477 -1.449 . . . . 10.0 109.477 175.359 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -86.32 162.62 18.13 Favored 'General case' 0 C--O 1.224 -0.286 0 C-N-CA 125.422 1.489 . . . . 10.0 109.778 -177.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.87 163.7 12.53 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.38 0.609 . . . . 10.0 110.813 -167.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.548 HD11 ' HB2' ' A' ' 7' ' ' PHE . 18.4 tp -139.82 148.6 42.4 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 126.408 1.883 . . . . 10.0 107.561 -175.494 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.2 tptp -148.18 155.34 41.27 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 118.408 -0.806 . . . . 10.0 108.9 163.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.9 tp -63.83 158.4 22.06 Favored 'General case' 0 C--N 1.339 0.143 0 N-CA-C 108.992 -0.744 . . . . 10.0 108.992 174.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 14.8 tttp -113.77 -69.23 0.87 Allowed 'General case' 0 N--CA 1.436 -1.166 0 C-N-CA 125.739 1.616 . . . . 10.0 107.389 172.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 162.38 49.41 0.02 OUTLIER Glycine 0 CA--C 1.526 0.78 0 CA-C-O 119.666 -0.519 . . . . 10.0 112.35 175.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 66.76 168.56 0.23 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.996 1.319 . . . . 10.0 111.947 178.162 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -75.81 177.75 6.68 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.664 0.745 . . . . 10.0 110.293 176.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -38.18 -47.65 1.18 Allowed 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 125.531 1.532 . . . . 10.0 112.006 167.013 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 75.1 m 53.37 66.11 1.32 Allowed 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.474 1.11 . . . . 10.0 111.493 172.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 92.6 mt -64.02 -21.6 29.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 124.636 1.174 . . . . 10.0 112.692 -173.083 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -140.57 150.23 43.39 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.707 1.603 . . . . 10.0 107.484 179.082 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 157.3 105.05 0.22 Allowed Glycine 0 CA--C 1.53 1.031 0 CA-C-O 118.834 -0.981 . . . . 10.0 112.196 178.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 3.3 tpm_? . . . . . 0 C--O 1.247 0.945 0 C-N-CA 127.876 2.471 . . . . 10.0 111.363 170.035 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 86.1 t . . . . . 0 N--CA 1.473 0.68 0 N-CA-C 107.771 -1.196 . . . . 10.0 107.771 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.609 HG21 ' HB2' ' A' ' 32' ' ' ALA . 2.4 p -134.39 167.71 20.24 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 126.303 1.841 . . . . 10.0 107.309 177.477 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -137.75 146.76 44.05 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.414 1.486 . . . . 10.0 108.35 -166.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -91.71 140.14 30.0 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.036 0.534 . . . . 10.0 109.733 -177.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -142.84 148.23 36.72 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.051 1.34 . . . . 10.0 109.315 179.147 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -123.27 149.37 44.86 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.612 1.165 . . . . 10.0 108.372 174.248 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.786 ' CE2' HD11 ' A' ' 57' ' ' LEU . 3.1 m-85 -141.04 144.12 34.8 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 124.976 1.422 . . . . 10.0 109.18 -174.095 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -106.92 132.03 53.32 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.4 1.08 . . . . 10.0 109.801 -169.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.426 HD11 ' HB ' ' A' ' 43' ' ' VAL . 4.7 mm -110.65 113.93 45.65 Favored 'Isoleucine or valine' 0 C--N 1.34 0.18 0 C-N-CA 125.096 1.358 . . . . 10.0 112.011 -160.541 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -106.91 98.39 8.06 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.397 -0.964 . . . . 10.0 108.397 169.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 162.77 -84.94 0.11 Allowed Glycine 0 CA--C 1.525 0.705 0 CA-C-O 119.751 -0.472 . . . . 10.0 112.845 168.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 16.4 ptp -131.21 134.73 46.75 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.729 0.812 . . . . 10.0 109.488 -174.275 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 58.7 p -147.23 71.15 1.2 Allowed 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 107.475 -1.305 . . . . 10.0 107.475 -164.066 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -147.9 162.25 39.66 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 124.02 0.928 . . . . 10.0 109.672 -171.016 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -52.42 -51.25 60.09 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.99 0.916 . . . . 10.0 113.464 -171.071 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.95 -30.47 69.77 Favored 'General case' 0 N--CA 1.456 -0.16 0 O-C-N 121.542 -0.723 . . . . 10.0 109.883 -178.359 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.1 m -69.65 -58.64 3.68 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.338 -1.356 . . . . 10.0 107.338 -177.522 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -39.17 -50.85 1.93 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 127.427 2.291 . . . . 10.0 111.057 168.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -61.62 -33.21 73.53 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 113.115 0.783 . . . . 10.0 113.115 -179.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.15 -48.44 57.38 Favored 'General case' 0 N--CA 1.451 -0.386 0 O-C-N 120.747 -1.221 . . . . 10.0 108.337 176.686 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -45.83 -51.55 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 CA-C-O 118.163 -0.922 . . . . 10.0 110.663 175.094 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -43.31 -48.8 6.89 Favored 'General case' 0 C--N 1.341 0.225 0 CA-C-N 118.626 0.648 . . . . 10.0 111.421 178.007 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.65 -47.04 61.98 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.779 -0.822 . . . . 10.0 108.779 -176.352 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.56 -38.67 75.17 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.275 -0.42 . . . . 10.0 111.894 -179.296 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.1 mt -78.96 -41.96 27.95 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.141 1.376 . . . . 10.0 110.576 178.275 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 15.7 t30 -54.8 -25.05 25.7 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.137 0.575 . . . . 10.0 111.226 173.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.2 ttmt -55.57 -38.38 69.29 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 112.393 0.516 . . . . 10.0 112.393 171.136 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 21.4 mm -60.01 132.14 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 C-N-CA 124.079 0.951 . . . . 10.0 109.831 -179.113 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -71.5 -52.63 17.33 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 111.47 0.174 . . . . 10.0 111.47 -174.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -82.95 42.83 3.02 Favored Glycine 0 C--N 1.339 0.71 0 O-C-N 120.753 -1.217 . . . . 10.0 112.026 -176.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.7 p -103.22 148.72 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 C-N-CA 124.385 1.074 . . . . 10.0 108.537 -177.138 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.609 ' HB2' HG21 ' A' ' 2' ' ' THR . . . -110.94 -56.55 2.35 Favored 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 108.965 -0.754 . . . . 10.0 108.965 175.063 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -147.96 151.53 35.96 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 108.216 -1.031 . . . . 10.0 108.216 -172.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -136.61 65.16 53.96 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 123.77 0.828 . . . . 10.0 110.93 172.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -78.36 68.17 8.05 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.01 2.474 . . . . 10.0 109.447 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.457 HG12 HG13 ' A' ' 43' ' ' VAL . 13.6 m -71.27 158.95 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 C-N-CA 123.058 0.543 . . . . 10.0 111.36 -177.236 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -100.64 145.6 28.2 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-O 120.936 0.398 . . . . 10.0 110.894 -175.529 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -121.99 38.78 4.04 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.304 1.442 . . . . 10.0 111.102 -170.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -176.57 -36.68 0.01 OUTLIER 'General case' 0 C--O 1.224 -0.249 0 C-N-CA 125.06 1.344 . . . . 10.0 110.531 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 12.8 mt -82.18 -10.89 59.0 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.9 1.28 . . . . 10.0 112.036 -173.019 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 71.67 40.45 0.78 Allowed 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 125.661 1.584 . . . . 10.0 110.885 171.445 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 7.5 p -142.51 133.4 25.65 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.546 1.138 . . . . 10.0 108.975 -175.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.457 HG13 HG12 ' A' ' 36' ' ' VAL . 3.4 t -99.78 139.4 21.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 N-CA-C 106.187 -1.783 . . . . 10.0 106.187 168.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 57.7 m -131.66 118.17 19.66 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 105.218 -2.142 . . . . 10.0 105.218 -174.136 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.5 t -124.49 140.16 48.59 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.183 0 C-N-CA 122.964 0.506 . . . . 10.0 109.707 -175.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 49.4 tt0 -103.23 111.42 23.8 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 107.39 -1.337 . . . . 10.0 107.39 161.061 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -145.6 164.46 31.65 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 123.68 0.792 . . . . 10.0 109.782 176.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -96.75 131.56 27.81 Favored Pre-proline 0 C--N 1.33 -0.25 0 C-N-CA 123.067 0.547 . . . . 10.0 110.03 177.59 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -77.2 61.34 7.25 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 121.302 1.335 . . . . 10.0 108.68 168.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.14 -43.95 0.38 Allowed 'General case' 0 C--N 1.343 0.311 0 O-C-N 121.894 -0.504 . . . . 10.0 110.981 177.082 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.77 -41.12 14.36 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.797 0.839 . . . . 10.0 110.031 178.108 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -144.42 170.06 16.74 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 126.223 1.809 . . . . 10.0 108.772 -170.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 33.0 p -128.71 -179.49 5.1 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 122.608 1.194 . . . . 10.0 110.817 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 99.3 t -46.54 -41.46 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 114.413 -1.267 . . . . 10.0 111.292 163.174 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 70.6 m -62.0 -40.05 94.33 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 118.46 0.573 . . . . 10.0 111.301 -173.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -68.48 -54.57 16.07 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.814 1.245 . . . . 10.0 108.999 -175.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.786 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.0 pp -63.87 -44.07 94.18 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 119.664 -0.814 . . . . 10.0 110.485 -179.555 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.9 -49.66 10.88 Favored 'General case' 0 C--O 1.221 -0.438 0 CA-C-O 117.823 -1.084 . . . . 10.0 113.212 163.739 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 14.2 tm-20 -54.82 -46.2 74.52 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 120.715 1.598 . . . . 10.0 109.618 179.426 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -50.69 -55.37 16.86 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.377 -0.829 . . . . 10.0 109.372 178.229 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.516 HG13 ' CE2' ' A' ' 66' ' ' TYR . 66.8 t -60.98 -49.97 82.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 112.841 0.682 . . . . 10.0 112.841 177.297 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -58.34 -33.38 69.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.749 0.785 . . . . 10.0 109.285 -176.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.6 tttp -77.7 -34.11 52.94 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 123.451 0.701 . . . . 10.0 111.583 178.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 67.9 mt -53.09 -42.22 65.71 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.347 0.976 . . . . 10.0 111.148 164.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 143.51 -37.48 1.46 Allowed Glycine 0 C--N 1.337 0.636 0 CA-C-N 118.155 0.434 . . . . 10.0 112.439 168.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.516 ' CE2' HG13 ' A' ' 61' ' ' VAL . 22.3 p90 -85.71 158.55 20.02 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 108.494 -0.928 . . . . 10.0 108.494 176.226 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 33.6 mttp -100.94 160.84 14.04 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.544 0.688 . . . . 10.0 111.422 -173.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.508 HD11 ' HB2' ' A' ' 7' ' ' PHE . 21.6 tp -136.68 149.49 47.95 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.253 1.821 . . . . 10.0 107.549 -171.821 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -153.38 152.36 30.97 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 109.011 -0.737 . . . . 10.0 109.011 162.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.7 tp -60.02 156.61 14.43 Favored 'General case' 0 C--O 1.231 0.129 0 O-C-N 123.595 0.56 . . . . 10.0 109.683 175.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -112.1 -70.44 0.81 Allowed 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 125.672 1.589 . . . . 10.0 107.201 172.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 157.4 59.08 0.01 OUTLIER Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.191 -0.763 . . . . 10.0 111.191 -179.07 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . 0.272 12.4 pt-20 54.11 171.29 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 128.098 2.559 . . . . 10.0 114.737 176.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -97.33 149.69 21.81 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.576 -0.898 . . . . 10.0 108.576 -178.285 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -59.66 122.5 14.26 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 107.656 -1.239 . . . . 10.0 107.656 174.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -141.82 129.65 21.75 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.562 -1.273 . . . . 10.0 107.562 -173.352 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 5.6 pt -127.19 89.69 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 124.371 1.068 . . . . 10.0 109.279 -175.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -74.11 110.7 8.61 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.684 -0.858 . . . . 10.0 108.684 177.246 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -66.13 116.47 8.51 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 108.791 -1.723 . . . . 10.0 108.791 170.364 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 4.6 mmm180 . . . . . 0 C--O 1.251 1.132 0 CA-C-O 117.246 -1.359 . . . . 10.0 107.847 179.332 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.669 HG22 ' H ' ' A' ' 2' ' ' THR . 15.0 p . . . . . 0 N--CA 1.466 0.341 0 N-CA-C 105.954 -1.869 . . . . 10.0 105.954 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.669 ' H ' HG22 ' A' ' 1' ' ' VAL . 11.8 p -112.21 153.85 26.46 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 126.447 1.899 . . . . 10.0 109.642 -177.028 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.7 mp0 -101.02 138.33 38.21 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.244 1.817 . . . . 10.0 109.212 177.326 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.7 tptt -81.87 119.86 24.46 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 108.105 -1.072 . . . . 10.0 108.105 171.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -128.09 153.55 46.69 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.537 1.135 . . . . 10.0 109.575 173.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -128.1 145.24 51.06 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.632 0.773 . . . . 10.0 110.215 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.537 ' HB2' HD11 ' A' ' 68' ' ' LEU . 2.1 m-85 -130.22 133.57 46.64 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 125.236 1.585 . . . . 10.0 111.749 -167.484 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -85.1 136.11 33.69 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 125.28 1.432 . . . . 10.0 109.781 176.101 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.541 HD11 HG23 ' A' ' 43' ' ' VAL . 5.2 mm -109.42 134.58 51.03 Favored 'Isoleucine or valine' 0 C--N 1.34 0.176 0 C-N-CA 126.543 1.937 . . . . 10.0 109.756 -173.649 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -124.8 108.07 11.57 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 108.28 -1.007 . . . . 10.0 108.28 159.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 150.79 -98.08 0.18 Allowed Glycine 0 CA--C 1.529 0.911 0 C-N-CA 124.342 0.972 . . . . 10.0 111.739 169.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 36.6 mmt -76.04 139.5 41.46 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 117.642 0.721 . . . . 10.0 111.506 -175.018 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.2 t -148.19 66.05 1.09 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.902 1.281 . . . . 10.0 107.909 -178.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 37.3 m -153.39 143.86 22.48 Favored 'General case' 0 C--N 1.34 0.183 0 N-CA-C 108.359 -0.978 . . . . 10.0 108.359 -174.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -55.06 -46.61 75.38 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 114.037 1.125 . . . . 10.0 114.037 -174.26 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.3 -27.88 61.79 Favored 'General case' 0 C--N 1.332 -0.156 0 O-C-N 121.251 -0.906 . . . . 10.0 109.973 -176.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 91.2 m -74.33 -50.74 17.54 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.436 -0.95 . . . . 10.0 108.436 178.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -45.09 -46.3 11.6 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.564 1.545 . . . . 10.0 110.359 168.405 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -58.66 -34.49 71.29 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 121.268 -0.895 . . . . 10.0 112.491 178.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 34.5 ttt85 -66.38 -35.41 80.26 Favored 'General case' 0 N--CA 1.45 -0.425 0 O-C-N 120.813 -1.18 . . . . 10.0 109.77 178.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 4.6 mt -52.04 -57.98 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.498 0 N-CA-C 108.861 -0.792 . . . . 10.0 108.861 172.066 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -45.25 -48.18 12.8 Favored 'General case' 0 C--O 1.221 -0.427 0 O-C-N 123.856 0.723 . . . . 10.0 110.882 -177.021 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.2 mtmt -68.14 -46.98 69.34 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.934 0.893 . . . . 10.0 110.414 -178.136 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.3 tpm_? -63.32 -36.59 84.19 Favored 'General case' 0 N--CA 1.45 -0.425 0 O-C-N 121.858 -0.526 . . . . 10.0 110.184 -178.066 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.06 -34.57 50.34 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.901 1.681 . . . . 10.0 111.457 176.644 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -64.15 -20.5 66.03 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 118.633 0.651 . . . . 10.0 109.421 175.086 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -53.97 -41.24 67.64 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 119.941 -0.704 . . . . 10.0 111.156 168.014 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 28.2 mm -58.97 129.96 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 123.667 0.787 . . . . 10.0 109.757 -174.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -73.03 -48.95 31.7 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 116.631 -0.259 . . . . 10.0 110.399 -172.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -82.88 40.9 2.83 Favored Glycine 0 C--N 1.339 0.746 0 O-C-N 120.887 -1.133 . . . . 10.0 111.767 -176.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -104.89 144.73 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 N-CA-C 107.743 -1.206 . . . . 10.0 107.743 179.424 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.648 ' HB2' HG21 ' A' ' 2' ' ' THR . . . -106.67 -55.19 2.36 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.26 -0.644 . . . . 10.0 109.26 171.594 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -142.89 143.01 31.88 Favored 'General case' 0 C--O 1.226 -0.154 0 N-CA-C 108.824 -0.806 . . . . 10.0 108.824 -174.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -133.68 55.64 16.83 Favored Pre-proline 0 CA--C 1.54 0.585 0 N-CA-C 113.552 0.945 . . . . 10.0 113.552 175.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -77.9 75.58 4.73 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 123.392 2.728 . . . . 10.0 110.39 -177.022 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.644 HG12 HG13 ' A' ' 43' ' ' VAL . 2.1 m -62.32 153.09 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 123.138 0.575 . . . . 10.0 111.719 178.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -94.35 138.53 32.21 Favored 'General case' 0 N--CA 1.457 -0.116 0 O-C-N 122.082 -0.386 . . . . 10.0 110.06 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -116.01 45.64 1.7 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.676 1.19 . . . . 10.0 111.557 -169.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -175.92 -39.99 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.207 0 C-N-CA 125.232 1.413 . . . . 10.0 109.354 178.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.7 mt -74.92 -20.21 59.8 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.491 1.117 . . . . 10.0 111.427 -174.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 63.39 49.93 3.04 Favored 'General case' 0 C--N 1.339 0.132 0 C-N-CA 125.466 1.506 . . . . 10.0 109.761 -178.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.1 p -140.06 125.85 19.43 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 125.507 1.523 . . . . 10.0 107.446 174.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.644 HG13 HG12 ' A' ' 36' ' ' VAL . 32.1 t -91.69 136.46 24.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 107.263 -1.384 . . . . 10.0 107.263 167.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 26.0 m -120.05 124.88 46.94 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 125.592 1.557 . . . . 10.0 107.079 178.39 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 98.1 t -134.94 146.52 30.43 Favored 'Isoleucine or valine' 0 C--N 1.341 0.232 0 CA-C-N 119.154 0.888 . . . . 10.0 110.524 175.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -105.03 106.64 17.23 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 126.99 2.116 . . . . 10.0 106.162 169.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 26.5 p90 -139.6 154.44 47.59 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 118.926 0.785 . . . . 10.0 110.766 179.196 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -94.69 128.28 40.36 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 118.589 -0.719 . . . . 10.0 110.079 175.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -76.07 57.87 5.36 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.553 2.169 . . . . 10.0 108.862 169.168 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.413 ' NZ ' ' OE1' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -124.51 -53.0 1.7 Allowed 'General case' 0 C--N 1.338 0.102 0 N-CA-C 106.508 -1.664 . . . . 10.0 106.508 176.195 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.413 ' OE1' ' NZ ' ' A' ' 50' ' ' LYS . 1.8 tp10 -89.45 -42.49 11.46 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.031 0.532 . . . . 10.0 110.712 -178.269 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.27 147.63 29.55 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 124.833 1.253 . . . . 10.0 107.965 -172.077 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 54.1 p -105.81 -171.98 2.01 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.104 0.962 . . . . 10.0 109.864 -179.253 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.51 HG21 HD12 ' A' ' 70' ' ' LEU . 3.5 p -61.37 -32.72 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 120.323 -0.551 . . . . 10.0 111.006 166.402 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.2 t -54.76 -43.54 72.84 Favored 'General case' 0 C--O 1.235 0.335 0 O-C-N 121.822 -0.549 . . . . 10.0 109.703 -175.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -64.32 -54.49 32.32 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 125.72 1.608 . . . . 10.0 108.839 -175.402 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.435 HD13 ' CE2' ' A' ' 7' ' ' PHE . 4.0 pp -67.78 -42.59 81.45 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.959 -0.463 . . . . 10.0 111.25 -178.116 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -44.64 -50.62 9.72 Favored 'General case' 0 N--CA 1.449 -0.477 0 O-C-N 121.162 -0.961 . . . . 10.0 111.709 163.549 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.45 -45.14 92.45 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 118.92 0.782 . . . . 10.0 109.87 179.411 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -51.45 -49.82 60.99 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.031 -0.531 . . . . 10.0 110.182 178.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.502 ' HA ' HD12 ' A' ' 64' ' ' LEU . 58.0 t -68.2 -43.71 84.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 112.209 0.448 . . . . 10.0 112.209 177.696 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -53.5 -40.99 65.82 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 108.973 -0.751 . . . . 10.0 108.973 176.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.8 tptt -75.01 -36.75 61.92 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.899 1.28 . . . . 10.0 111.324 -179.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.502 HD12 ' HA ' ' A' ' 61' ' ' VAL . 15.5 mt -51.93 -35.03 44.38 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.817 0.735 . . . . 10.0 112.023 167.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.79 24.29 4.99 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 123.192 0.425 . . . . 10.0 112.888 169.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -141.75 160.56 39.93 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 105.276 -2.12 . . . . 10.0 105.276 168.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 62.7 tttt -106.82 144.34 33.61 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 119.548 1.067 . . . . 10.0 111.774 -168.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.537 HD11 ' HB2' ' A' ' 7' ' ' PHE . 14.0 tp -121.47 147.99 45.03 Favored 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 127.883 2.473 . . . . 10.0 107.622 -176.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.0 mmtt -143.22 170.04 16.5 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 124.407 1.083 . . . . 10.0 108.445 161.273 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.516 HD23 ' H ' ' A' ' 71' ' ' LYS . 1.6 tt -93.31 151.4 19.81 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 123.505 0.722 . . . . 10.0 109.195 178.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.516 ' H ' HD23 ' A' ' 70' ' ' LEU . 56.9 tttp -116.08 -62.36 1.6 Allowed 'General case' 0 N--CA 1.441 -0.904 0 C-N-CA 125.94 1.696 . . . . 10.0 108.089 -177.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -175.52 -87.93 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 108.455 -1.858 . . . . 10.0 108.455 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -170.04 173.5 5.93 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.154 0.981 . . . . 10.0 109.177 -171.313 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -49.99 112.91 0.74 Allowed 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.761 1.224 . . . . 10.0 111.396 -179.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -81.29 67.84 7.37 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.139 0.495 . . . . 10.0 109.788 -175.101 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 17.5 t -144.93 105.42 4.1 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 123.418 0.687 . . . . 10.0 110.528 -179.31 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 16.3 pt -104.41 -19.74 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 C-N-CA 124.87 1.268 . . . . 10.0 113.21 176.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -75.42 157.96 33.39 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.484 0.714 . . . . 10.0 109.917 177.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -172.65 -95.42 0.1 OUTLIER Glycine 0 CA--C 1.528 0.875 0 N-CA-C 111.599 -0.601 . . . . 10.0 111.599 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 23.1 ttt180 . . . . . 0 C--O 1.249 1.053 0 N-CA-C 105.17 -2.159 . . . . 10.0 105.17 -179.165 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 86.2 t . . . . . 0 N--CA 1.473 0.698 0 N-CA-C 108.449 -0.945 . . . . 10.0 108.449 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.57 HG21 ' HB2' ' A' ' 32' ' ' ALA . 6.3 p -130.55 175.75 8.73 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.443 1.497 . . . . 10.0 107.337 170.54 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -139.16 147.74 42.26 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 127.525 2.33 . . . . 10.0 106.747 -167.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 59.7 mmtt -91.93 135.72 33.72 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 123.264 0.625 . . . . 10.0 109.636 -175.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -138.34 140.62 39.57 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.888 -1.152 . . . . 10.0 107.888 173.51 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -122.3 150.57 42.18 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.631 0.772 . . . . 10.0 110.368 175.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.724 ' HB2' HD11 ' A' ' 68' ' ' LEU . 0.8 OUTLIER -141.95 136.47 30.41 Favored 'General case' 0 N--CA 1.448 -0.566 0 O-C-N 124.925 1.39 . . . . 10.0 110.212 -169.903 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -95.91 135.74 37.26 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.933 1.693 . . . . 10.0 108.993 -175.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.554 HD11 HG23 ' A' ' 43' ' ' VAL . 7.2 mm -106.74 116.34 50.26 Favored 'Isoleucine or valine' 0 C--N 1.339 0.15 0 C-N-CA 125.851 1.66 . . . . 10.0 111.463 -165.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -102.03 97.56 7.88 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 107.595 -1.261 . . . . 10.0 107.595 170.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 150.43 -103.13 0.24 Allowed Glycine 0 CA--C 1.528 0.866 0 C-N-CA 123.457 0.551 . . . . 10.0 112.258 169.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 36.3 mmt -80.03 146.43 31.98 Favored 'General case' 0 N--CA 1.457 -0.096 0 CA-C-N 117.746 0.773 . . . . 10.0 111.711 -172.15 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.3 t -144.49 70.48 1.28 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.776 1.63 . . . . 10.0 106.724 -177.328 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -159.73 140.65 12.39 Favored 'General case' 0 C--N 1.343 0.303 0 O-C-N 120.823 -1.173 . . . . 10.0 109.331 -173.254 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.68 -45.06 81.96 Favored 'General case' 0 C--O 1.227 -0.118 0 C-N-CA 123.963 0.905 . . . . 10.0 113.419 -168.329 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.19 -43.14 96.14 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.753 -0.832 . . . . 10.0 108.753 -178.144 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -72.91 -49.48 29.39 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.305 -0.862 . . . . 10.0 109.586 -173.208 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -46.37 -51.98 13.81 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.088 1.355 . . . . 10.0 110.98 170.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -53.97 -28.82 40.0 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 112.59 0.589 . . . . 10.0 112.59 178.075 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.17 -36.97 66.68 Favored 'General case' 0 N--CA 1.447 -0.619 0 O-C-N 121.005 -1.059 . . . . 10.0 108.795 -178.605 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.568 HD12 HG22 ' A' ' 61' ' ' VAL . 11.6 mm -51.38 -58.2 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 N-CA-C 108.425 -0.954 . . . . 10.0 108.425 168.418 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -45.75 -41.41 10.71 Favored 'General case' 0 C--O 1.223 -0.311 0 O-C-N 123.604 0.565 . . . . 10.0 111.216 -178.152 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.29 -54.81 12.76 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 121.634 -0.666 . . . . 10.0 111.735 178.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.48 ' CZ ' ' HA ' ' A' ' 60' ' ' ALA . 4.8 mtp180 -60.99 -39.5 89.91 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 119.454 -0.899 . . . . 10.0 110.81 -178.768 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.89 -41.79 70.85 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 123.698 0.799 . . . . 10.0 110.74 179.553 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 44.4 m-20 -54.55 -30.78 55.08 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 118.454 0.57 . . . . 10.0 110.608 171.39 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -59.19 -31.7 69.24 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 118.377 -0.821 . . . . 10.0 112.776 176.086 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 18.6 mm -57.89 121.16 4.95 Favored 'Isoleucine or valine' 0 C--N 1.34 0.187 0 CA-C-N 118.933 0.788 . . . . 10.0 109.858 -178.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 50.1 mp0 -57.32 -46.13 83.55 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 123.658 0.783 . . . . 10.0 112.085 -175.351 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.95 32.61 3.2 Favored Glycine 0 C--N 1.341 0.816 0 CA-C-N 120.323 1.419 . . . . 10.0 112.772 -174.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.7 p -99.41 150.74 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 119.204 1.502 . . . . 10.0 109.327 -176.133 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.57 ' HB2' HG21 ' A' ' 2' ' ' THR . . . -108.79 -59.12 1.92 Allowed 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 108.454 -0.943 . . . . 10.0 108.454 168.613 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 66.3 m-20 -139.64 152.96 47.19 Favored 'General case' 0 C--N 1.337 0.026 0 N-CA-C 108.775 -0.824 . . . . 10.0 108.775 -174.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -137.1 62.85 41.27 Favored Pre-proline 0 CA--C 1.537 0.462 0 C-N-CA 124.17 0.988 . . . . 10.0 111.687 174.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -75.68 77.1 3.44 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 123.061 2.508 . . . . 10.0 111.511 -177.595 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.528 HG13 HG22 ' A' ' 43' ' ' VAL . 70.6 t -61.96 135.65 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 C-N-CA 125.889 1.676 . . . . 10.0 111.391 176.738 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -94.85 94.91 8.33 Favored 'General case' 0 C--N 1.346 0.419 0 O-C-N 121.296 -0.878 . . . . 10.0 111.552 -175.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -75.35 49.47 0.47 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.781 2.032 . . . . 10.0 114.055 -173.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -176.84 -37.15 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 124.916 1.287 . . . . 10.0 110.452 176.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.5 mt -84.68 -13.38 51.61 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.057 0.943 . . . . 10.0 111.261 -173.007 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 74.17 40.54 0.43 Allowed 'General case' 0 C--O 1.228 -0.071 0 C-N-CA 125.213 1.405 . . . . 10.0 110.25 170.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 35.4 p -140.08 131.11 26.25 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 125.028 1.331 . . . . 10.0 107.828 179.013 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.554 HG23 HD11 ' A' ' 9' ' ' ILE . 28.5 t -91.99 144.14 9.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 107.026 -1.472 . . . . 10.0 107.026 165.481 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 91.3 m -131.67 124.1 29.16 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 105.879 -1.897 . . . . 10.0 105.879 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 42.2 t -126.36 145.21 34.25 Favored 'Isoleucine or valine' 0 C--N 1.339 0.145 0 C-N-CA 123.289 0.635 . . . . 10.0 109.371 177.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -112.85 103.36 11.35 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 105.601 -2.0 . . . . 10.0 105.601 171.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -136.58 159.54 41.51 Favored 'General case' 0 C--O 1.225 -0.218 0 C-N-CA 123.883 0.873 . . . . 10.0 110.755 -175.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 21.2 p30 -94.8 125.78 49.79 Favored Pre-proline 0 C--N 1.331 -0.197 0 C-N-CA 123.481 0.712 . . . . 10.0 109.953 175.255 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -74.56 65.63 5.63 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 121.766 1.644 . . . . 10.0 108.304 172.065 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.7 pttt -138.86 -49.77 0.52 Allowed 'General case' 0 C--O 1.227 -0.105 0 N-CA-C 106.967 -1.494 . . . . 10.0 106.967 178.51 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -106.15 -56.54 2.17 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 124.656 1.182 . . . . 10.0 108.069 174.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.24 139.45 50.06 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 123.391 0.677 . . . . 10.0 109.738 -176.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 20.6 p -130.78 143.51 50.79 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 122.047 0.927 . . . . 10.0 110.518 174.045 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 30.3 m -45.39 -43.58 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 C-N-CA 125.157 1.383 . . . . 10.0 111.609 176.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.0 m -58.2 -43.13 87.45 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.501 1.121 . . . . 10.0 112.517 -177.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -63.08 -53.19 57.52 Favored 'General case' 0 C--O 1.224 -0.263 0 CA-C-O 122.072 0.939 . . . . 10.0 108.875 -173.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.567 HD11 ' CE2' ' A' ' 7' ' ' PHE 0.267 1.2 pp -65.62 -36.39 83.57 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.082 -1.011 . . . . 10.0 112.621 -177.225 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.405 ' HZ2' HD23 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -39.93 -64.59 0.48 Allowed 'General case' 0 CA--C 1.534 0.348 0 O-C-N 120.962 -1.087 . . . . 10.0 112.881 156.525 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.8 tm-20 -52.23 -39.76 60.73 Favored 'General case' 0 CA--C 1.517 -0.301 0 C-N-CA 123.455 0.702 . . . . 10.0 109.572 178.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.48 ' HA ' ' CZ ' ' A' ' 24' ' ' ARG . . . -59.68 -55.01 39.76 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 115.747 -0.661 . . . . 10.0 110.696 -174.275 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.568 HG22 HD12 ' A' ' 21' ' ' ILE . 80.4 t -62.46 -42.31 95.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-N 115.666 -0.697 . . . . 10.0 110.909 174.228 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -55.35 -51.25 67.4 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 121.575 0.702 . . . . 10.0 110.311 -176.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 40.6 tptt -56.65 -39.7 74.17 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 125.765 1.626 . . . . 10.0 111.007 177.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.74 -22.38 35.04 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 113.056 0.762 . . . . 10.0 113.056 174.066 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 108.73 14.71 14.86 Favored Glycine 0 CA--C 1.529 0.952 0 CA-C-N 118.78 0.718 . . . . 10.0 113.161 170.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.427 ' CZ ' HD11 ' A' ' 21' ' ' ILE . 2.2 p90 -143.37 160.27 40.85 Favored 'General case' 0 C--O 1.225 -0.23 0 N-CA-C 106.603 -1.629 . . . . 10.0 106.603 172.13 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -111.6 144.59 40.6 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 119.064 0.847 . . . . 10.0 111.141 -162.423 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.724 HD11 ' HB2' ' A' ' 7' ' ' PHE . 23.3 tp -121.38 148.27 44.61 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 125.097 1.359 . . . . 10.0 108.289 -172.188 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 20.8 mmtt -149.0 139.51 22.52 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 125.446 1.498 . . . . 10.0 110.288 169.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.563 HD23 ' N ' ' A' ' 71' ' ' LYS . 2.5 tt -72.1 157.38 37.88 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.633 -0.877 . . . . 10.0 108.633 177.758 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.563 ' N ' HD23 ' A' ' 70' ' ' LEU . 64.1 tttt -120.86 -65.26 1.16 Allowed 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 125.585 1.554 . . . . 10.0 108.169 177.548 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.53 -74.01 0.03 OUTLIER Glycine 0 CA--C 1.522 0.518 0 N-CA-C 110.051 -1.22 . . . . 10.0 110.051 173.378 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -174.61 167.19 3.84 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 106.557 -1.646 . . . . 10.0 106.557 -165.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -81.31 153.27 27.14 Favored 'General case' 0 N--CA 1.457 -0.116 0 O-C-N 123.456 0.472 . . . . 10.0 110.513 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.3 t70 67.64 -158.7 0.22 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.025 1.33 . . . . 10.0 108.841 177.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.6 t -151.95 73.35 1.05 Allowed 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 124.901 1.281 . . . . 10.0 107.822 176.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 6.6 pt -103.47 -145.26 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 124.306 1.042 . . . . 10.0 108.836 179.017 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -151.04 -54.31 0.14 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.235 1.014 . . . . 10.0 109.379 -177.451 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -168.25 -156.47 10.3 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 109.136 -1.586 . . . . 10.0 109.136 -178.254 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 51.0 tpt85 . . . . . 0 C--O 1.249 1.036 0 CA-C-O 116.891 -1.528 . . . . 10.0 110.127 -172.444 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 53.0 t . . . . . 0 N--CA 1.47 0.549 0 N-CA-C 107.793 -1.188 . . . . 10.0 107.793 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.508 HG21 ' HB2' ' A' ' 32' ' ' ALA . 7.7 p -125.44 159.57 31.59 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 124.649 1.179 . . . . 10.0 110.33 179.529 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -124.51 151.16 44.99 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 127.475 2.31 . . . . 10.0 107.575 -171.549 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.1 mppt? -93.69 142.67 27.09 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 123.975 0.91 . . . . 10.0 109.6 -176.149 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -148.19 140.95 24.62 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.027 0.931 . . . . 10.0 109.336 -177.381 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -117.97 148.75 41.9 Favored 'General case' 0 CA--C 1.508 -0.638 0 C-N-CA 123.361 0.665 . . . . 10.0 110.415 173.577 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.75 ' CE2' HD11 ' A' ' 57' ' ' LEU . 15.2 m-85 -134.47 144.39 48.07 Favored 'General case' 0 N--CA 1.446 -0.632 0 O-C-N 125.407 1.692 . . . . 10.0 108.781 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -109.97 132.42 54.17 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 108.475 -0.935 . . . . 10.0 108.475 -172.028 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.8 mm -113.43 144.16 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 C-N-CA 124.092 0.957 . . . . 10.0 111.811 -157.005 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -128.73 100.98 5.92 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 124.524 1.13 . . . . 10.0 108.123 169.438 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 145.36 -71.86 0.35 Allowed Glycine 0 CA--C 1.526 0.759 0 CA-C-N 117.958 0.345 . . . . 10.0 112.943 166.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 9.7 ptt? -65.86 115.08 5.58 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 122.368 -0.489 . . . . 10.0 110.202 -173.436 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.1 t -146.66 59.39 1.2 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.554 0.692 . . . . 10.0 109.548 -176.221 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.2 m -142.01 -82.27 0.21 Allowed 'General case' 0 C--N 1.345 0.392 0 O-C-N 121.439 -0.788 . . . . 10.0 109.135 173.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 176.92 -47.97 0.01 OUTLIER 'General case' 0 C--O 1.221 -0.428 0 C-N-CA 124.372 1.069 . . . . 10.0 109.956 -173.232 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.81 -49.35 47.38 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 122.315 1.055 . . . . 10.0 108.687 -177.506 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 22.4 p -59.3 -34.76 72.69 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 114.139 -1.391 . . . . 10.0 111.567 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.61 -57.55 4.29 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.297 1.039 . . . . 10.0 110.708 171.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -43.29 -44.96 5.68 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.181 1.392 . . . . 10.0 112.001 178.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 27.1 ttt180 -52.8 -38.14 60.78 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.253 1.021 . . . . 10.0 110.029 -178.33 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.64 HG22 HD12 ' A' ' 25' ' ' LEU . 27.5 mm -59.14 -45.98 92.31 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.538 0 CA-C-O 117.572 -1.204 . . . . 10.0 110.905 174.708 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -50.12 -50.5 48.35 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 119.606 1.094 . . . . 10.0 109.788 -176.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.7 tmmt? -67.9 -47.81 67.77 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.324 1.05 . . . . 10.0 110.11 179.08 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.04 -28.95 64.96 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.53 0.567 . . . . 10.0 112.53 177.539 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.64 HD12 HG22 ' A' ' 21' ' ' ILE . 1.0 OUTLIER -80.09 -43.38 21.86 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.989 1.315 . . . . 10.0 109.347 175.084 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.457 ' HA ' HG11 ' A' ' 31' ' ' VAL . 0.3 OUTLIER -56.89 -24.59 53.05 Favored 'General case' 0 C--O 1.226 -0.154 0 C-N-CA 123.964 0.905 . . . . 10.0 110.342 178.583 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.78 -36.51 81.3 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 114.775 1.398 . . . . 10.0 114.775 172.642 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.9 mp -62.39 129.19 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 120.067 1.303 . . . . 10.0 109.767 176.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -54.5 -51.16 65.98 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 112.433 0.531 . . . . 10.0 112.433 -177.55 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.85 37.3 2.82 Favored Glycine 0 C--N 1.34 0.774 0 O-C-N 120.563 -1.336 . . . . 10.0 112.317 -171.047 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.457 HG11 ' HA ' ' A' ' 26' ' ' ASN . 2.8 p -103.79 155.5 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 CA-C-N 118.362 1.081 . . . . 10.0 108.928 -177.154 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.508 ' HB2' HG21 ' A' ' 2' ' ' THR . . . -120.52 -58.54 1.83 Allowed 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 109.006 -0.739 . . . . 10.0 109.006 170.489 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 62.2 m-80 -139.08 155.66 47.76 Favored 'General case' 0 CA--C 1.521 -0.172 0 N-CA-C 108.835 -0.802 . . . . 10.0 108.835 -173.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -153.38 58.6 2.37 Favored Pre-proline 0 CA--C 1.533 0.318 0 N-CA-C 112.668 0.618 . . . . 10.0 112.668 173.223 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -74.45 79.05 2.57 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.659 2.24 . . . . 10.0 109.935 -178.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.535 HG12 HG13 ' A' ' 43' ' ' VAL . 4.5 m -63.47 156.72 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 O-C-N 121.695 -0.628 . . . . 10.0 112.168 -179.219 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -98.39 122.17 41.24 Favored 'General case' 0 N--CA 1.457 -0.102 0 O-C-N 122.144 -0.348 . . . . 10.0 110.585 -178.093 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -102.51 42.9 1.11 Allowed 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.954 1.301 . . . . 10.0 111.236 -176.373 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -163.1 -43.56 0.03 OUTLIER 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 124.176 0.99 . . . . 10.0 109.05 176.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 12.3 mt -76.24 -22.48 55.11 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.827 0.851 . . . . 10.0 111.213 -177.604 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 62.08 53.83 2.87 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 125.554 1.541 . . . . 10.0 109.509 -175.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 16.9 p -138.1 133.1 33.01 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.955 1.702 . . . . 10.0 107.458 173.152 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.535 HG13 HG12 ' A' ' 36' ' ' VAL . 5.9 t -100.1 125.46 53.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 107.188 -1.412 . . . . 10.0 107.188 173.071 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 37.4 m -109.54 115.25 29.57 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 126.397 1.879 . . . . 10.0 107.572 -178.036 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.7 t -117.1 145.92 22.23 Favored 'Isoleucine or valine' 0 C--N 1.34 0.166 0 CA-C-N 118.971 0.805 . . . . 10.0 110.857 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -115.11 108.07 16.16 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 125.283 1.433 . . . . 10.0 107.748 161.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 26.9 p90 -139.34 162.02 36.02 Favored 'General case' 0 C--O 1.226 -0.134 0 C-N-CA 123.808 0.843 . . . . 10.0 110.253 -178.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 25.1 p30 -95.97 128.48 37.17 Favored Pre-proline 0 C--N 1.332 -0.18 0 C-N-CA 123.397 0.679 . . . . 10.0 110.142 176.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -75.48 61.69 6.09 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 N-CA-C 108.468 -1.397 . . . . 10.0 108.468 171.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.84 -47.14 0.32 Allowed 'General case' 0 C--N 1.346 0.416 0 CA-C-N 118.584 0.629 . . . . 10.0 110.195 176.381 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -104.59 -40.23 6.1 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.067 0.547 . . . . 10.0 109.898 170.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.32 158.35 17.84 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.377 0.671 . . . . 10.0 110.366 -177.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 97.7 p -148.83 158.74 44.38 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.643 0.735 . . . . 10.0 111.776 172.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.0 m -53.41 -45.78 57.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 124.267 1.027 . . . . 10.0 110.937 173.08 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 16.0 m -57.66 -43.48 84.99 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.4 1.08 . . . . 10.0 111.722 -178.549 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -64.2 -57.5 9.33 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.283 1.033 . . . . 10.0 109.262 -178.316 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.75 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.3 pp -65.42 -41.34 93.66 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.123 -0.985 . . . . 10.0 111.058 -176.259 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -43.03 -52.05 5.45 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-O 118.244 -0.884 . . . . 10.0 112.562 160.595 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.76 -45.95 77.97 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 119.772 1.169 . . . . 10.0 110.082 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -52.7 -54.2 36.85 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.977 -0.556 . . . . 10.0 110.321 178.024 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.498 HG22 HD12 ' A' ' 21' ' ' ILE . 40.6 t -57.85 -47.23 86.68 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 N-CA-C 112.597 0.592 . . . . 10.0 112.597 174.656 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -53.48 -55.6 23.98 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.754 1.222 . . . . 10.0 109.257 -177.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -59.72 -33.62 71.86 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 126.997 2.119 . . . . 10.0 111.711 178.041 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.87 -38.0 61.06 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.24 0.616 . . . . 10.0 111.908 168.68 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 119.25 9.7 8.52 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 124.187 0.898 . . . . 10.0 113.344 176.423 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -135.76 172.74 12.57 Favored 'General case' 0 C--O 1.225 -0.221 0 N-CA-C 107.076 -1.453 . . . . 10.0 107.076 172.618 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 33.1 mttt -114.94 157.84 22.83 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 118.853 0.752 . . . . 10.0 111.994 -166.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.2 tp -143.82 145.3 32.25 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.206 1.802 . . . . 10.0 107.254 -170.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 32.2 mmtt -148.84 150.09 32.42 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 124.291 1.036 . . . . 10.0 109.044 164.296 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.6 tp -63.01 158.62 18.95 Favored 'General case' 0 N--CA 1.456 -0.172 0 O-C-N 123.919 0.762 . . . . 10.0 109.236 175.061 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 19.1 tttt -124.59 -53.81 1.67 Allowed 'General case' 0 N--CA 1.439 -1.023 0 C-N-CA 127.811 2.444 . . . . 10.0 107.559 -178.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 174.03 -85.56 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 108.098 -2.001 . . . . 10.0 108.098 175.467 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -160.25 159.86 31.95 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.38 1.072 . . . . 10.0 108.287 -169.259 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.25 147.3 23.03 Favored 'General case' 0 N--CA 1.454 -0.273 0 O-C-N 123.619 0.575 . . . . 10.0 109.643 174.5 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -115.25 164.31 14.42 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 107.48 -1.304 . . . . 10.0 107.48 165.568 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.3 t -166.33 84.6 0.3 Allowed 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.749 1.22 . . . . 10.0 108.175 -177.438 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 11.5 pt -104.58 -144.05 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 124.87 1.268 . . . . 10.0 108.006 177.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 68.36 84.81 0.15 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.749 1.619 . . . . 10.0 110.608 175.556 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 158.35 -109.2 0.39 Allowed Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.076 -1.21 . . . . 10.0 110.076 178.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 48.1 mtp180 . . . . . 0 C--O 1.252 1.196 0 CA-C-O 117.121 -1.419 . . . . 10.0 108.786 172.694 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 57.8 t . . . . . 0 N--CA 1.469 0.515 0 N-CA-C 106.633 -1.618 . . . . 10.0 106.633 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.474 HG21 ' HB2' ' A' ' 32' ' ' ALA . 4.9 p -115.19 172.38 7.11 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.133 1.773 . . . . 10.0 108.821 178.25 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -141.61 140.78 33.41 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 126.981 2.112 . . . . 10.0 106.833 -170.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -90.84 130.76 36.77 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 123.675 0.79 . . . . 10.0 109.063 177.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -133.12 146.93 52.05 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 125.915 1.686 . . . . 10.0 107.947 -177.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -123.69 150.28 44.47 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.227 0.611 . . . . 10.0 110.249 176.113 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.869 ' CE2' HD11 ' A' ' 57' ' ' LEU . 2.7 m-85 -138.56 140.9 39.21 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.897 1.279 . . . . 10.0 109.621 -171.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -101.13 134.77 43.65 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 124.836 1.254 . . . . 10.0 108.596 -175.044 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 6.1 mm -107.6 119.45 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 C-N-CA 124.751 1.221 . . . . 10.0 110.223 -161.326 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -111.33 95.95 5.82 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 108.329 -0.989 . . . . 10.0 108.329 174.025 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 151.54 -94.06 0.15 Allowed Glycine 0 CA--C 1.526 0.735 0 C-N-CA 123.951 0.786 . . . . 10.0 111.526 170.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 23.4 mmt -84.84 156.63 21.22 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 122.984 0.514 . . . . 10.0 111.772 -174.284 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -157.26 74.32 0.77 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.43 1.092 . . . . 10.0 109.31 -177.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.3 p -164.57 160.11 19.87 Favored 'General case' 0 C--N 1.342 0.26 0 O-C-N 120.92 -1.112 . . . . 10.0 109.779 176.193 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -55.38 -38.28 68.66 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.749 0.82 . . . . 10.0 111.326 179.328 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.96 -23.77 63.23 Favored 'General case' 0 N--CA 1.45 -0.434 0 O-C-N 121.848 -0.532 . . . . 10.0 110.221 -177.45 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 3.7 t -80.74 -60.21 2.39 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 108.958 -0.756 . . . . 10.0 108.958 173.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -39.27 -51.28 2.01 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 126.13 1.772 . . . . 10.0 111.191 176.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -55.88 -31.83 63.16 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 113.393 0.886 . . . . 10.0 113.393 -179.248 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.4 ' HG2' HD11 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -69.39 -53.56 18.82 Favored 'General case' 0 C--O 1.234 0.242 0 O-C-N 121.37 -0.831 . . . . 10.0 109.005 171.337 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.533 HG22 HD12 ' A' ' 25' ' ' LEU . 6.4 mm -44.07 -54.85 0.99 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.339 0 O-C-N 123.915 0.759 . . . . 10.0 110.093 179.379 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -42.53 -50.86 5.26 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.994 0.918 . . . . 10.0 111.702 178.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.39 -47.56 60.29 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 121.453 -0.779 . . . . 10.0 110.794 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.428 ' CG ' ' HB1' ' A' ' 60' ' ' ALA . 0.5 OUTLIER -57.64 -36.91 72.47 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.952 0.901 . . . . 10.0 110.765 -177.606 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.533 HD12 HG22 ' A' ' 21' ' ' ILE . 0.4 OUTLIER -77.83 -43.97 28.8 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 126.151 1.781 . . . . 10.0 110.741 175.829 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -52.55 -28.55 21.26 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 118.915 0.779 . . . . 10.0 111.606 172.283 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.7 tmmt? -62.11 -26.91 68.57 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 112.402 0.519 . . . . 10.0 112.402 177.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 10.0 mm -66.85 133.51 31.3 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.131 0 N-CA-C 108.874 -0.787 . . . . 10.0 108.874 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -64.8 -56.16 15.26 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 120.608 0.242 . . . . 10.0 110.67 -173.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.96 44.71 3.36 Favored Glycine 0 C--N 1.34 0.784 0 O-C-N 120.755 -1.215 . . . . 10.0 112.039 -171.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.6 p -108.15 150.59 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 C-N-CA 124.649 1.18 . . . . 10.0 108.846 -176.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.474 ' HB2' HG21 ' A' ' 2' ' ' THR . . . -122.3 -52.29 1.95 Allowed 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.078 0.551 . . . . 10.0 110.285 174.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -138.68 153.89 48.57 Favored 'General case' 0 C--N 1.338 0.097 0 N-CA-C 109.378 -0.601 . . . . 10.0 109.378 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -146.29 61.85 7.45 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 123.484 0.714 . . . . 10.0 111.548 173.097 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -77.46 73.22 5.66 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.972 2.448 . . . . 10.0 109.599 -179.082 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.507 HG12 HG13 ' A' ' 43' ' ' VAL . 2.6 m -66.57 151.72 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 O-C-N 121.96 -0.462 . . . . 10.0 111.075 -179.125 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 -97.68 125.91 42.72 Favored 'General case' 0 N--CA 1.458 -0.068 0 O-C-N 122.193 -0.317 . . . . 10.0 110.413 -175.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -105.4 41.69 1.33 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.074 1.349 . . . . 10.0 111.65 -170.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -171.62 -38.81 0.02 OUTLIER 'General case' 0 C--O 1.225 -0.207 0 C-N-CA 124.958 1.303 . . . . 10.0 110.125 178.46 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.2 mt -77.37 -17.56 58.11 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.219 1.008 . . . . 10.0 111.616 -175.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 68.56 46.62 0.97 Allowed 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 125.64 1.576 . . . . 10.0 110.136 177.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 12.0 p -141.89 128.86 20.72 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.692 1.197 . . . . 10.0 108.378 177.532 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.507 HG13 HG12 ' A' ' 36' ' ' VAL . 10.3 t -93.72 135.04 29.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 106.361 -1.718 . . . . 10.0 106.361 169.488 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 60.6 m -121.05 123.48 42.47 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 105.9 -1.889 . . . . 10.0 105.9 178.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 19.3 t -124.23 149.97 28.66 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.115 0 C-N-CA 123.472 0.709 . . . . 10.0 109.211 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -124.92 102.33 7.49 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 126.647 1.979 . . . . 10.0 105.728 175.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -138.75 166.35 24.63 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 123.883 0.873 . . . . 10.0 110.675 -172.042 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 19.0 p30 -104.53 127.39 29.09 Favored Pre-proline 0 CA--C 1.532 0.254 0 C-N-CA 123.092 0.557 . . . . 10.0 110.094 177.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -75.59 63.66 6.49 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 122.52 2.147 . . . . 10.0 109.568 176.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 22.3 ttmt -142.74 -58.47 0.44 Allowed 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 106.3 -1.741 . . . . 10.0 106.3 175.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -114.08 1.16 14.53 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.34 1.456 . . . . 10.0 112.632 -173.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -133.23 154.5 50.6 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 125.276 1.43 . . . . 10.0 110.096 171.383 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 90.8 p -146.74 160.32 42.38 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.363 0.601 . . . . 10.0 111.391 175.013 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 59.4 t -52.79 -49.87 45.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 124.995 1.318 . . . . 10.0 109.408 173.056 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -51.11 -47.92 61.85 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 126.37 1.868 . . . . 10.0 111.758 178.337 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -67.83 -54.9 15.37 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.954 0.901 . . . . 10.0 109.899 -174.023 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.869 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.1 pp -66.0 -40.55 91.25 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 120.935 -1.103 . . . . 10.0 111.149 -178.576 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -43.87 -49.32 8.32 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 120.905 -1.122 . . . . 10.0 112.257 161.516 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.5 -43.49 79.78 Favored 'General case' 0 C--N 1.339 0.133 0 CA-C-N 119.824 1.193 . . . . 10.0 111.022 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.428 ' HB1' ' CG ' ' A' ' 24' ' ' ARG . . . -53.77 -53.26 54.77 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.126 -0.488 . . . . 10.0 110.335 176.146 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 47.4 t -63.07 -37.35 79.14 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 N-CA-C 112.321 0.489 . . . . 10.0 112.321 177.292 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -60.53 -55.13 37.1 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 125.091 1.356 . . . . 10.0 108.858 -177.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? -55.12 -41.21 71.41 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.893 0.877 . . . . 10.0 110.611 175.185 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.4 HD11 ' HG2' ' A' ' 20' ' ' ARG . 0.1 OUTLIER -49.65 -33.14 14.7 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.33 0.652 . . . . 10.0 112.326 173.342 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 113.82 17.62 7.33 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 124.044 0.83 . . . . 10.0 113.117 169.185 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.07 167.43 22.1 Favored 'General case' 0 N--CA 1.458 -0.041 0 N-CA-C 107.366 -1.346 . . . . 10.0 107.366 175.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -105.43 144.12 32.65 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 121.536 0.684 . . . . 10.0 111.351 -164.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.4 tp -130.13 145.5 51.71 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.102 1.761 . . . . 10.0 107.9 -178.414 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 26.0 mmtt -151.77 154.43 36.24 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 124.673 1.189 . . . . 10.0 108.659 167.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.7 tp -63.41 155.21 29.66 Favored 'General case' 0 CA--C 1.529 0.167 0 O-C-N 123.702 0.626 . . . . 10.0 110.33 176.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -111.89 -60.01 1.91 Allowed 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 127.508 2.323 . . . . 10.0 106.418 172.315 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -179.07 -84.88 0.06 OUTLIER Glycine 0 CA--C 1.523 0.539 0 N-CA-C 109.625 -1.39 . . . . 10.0 109.625 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -163.56 174.78 11.37 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.475 1.11 . . . . 10.0 108.116 -169.497 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -47.97 113.46 0.73 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.19 0.996 . . . . 10.0 112.164 178.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -71.65 85.62 0.9 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.468 0.651 . . . . 10.0 109.653 178.247 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 67.2 m -129.24 159.65 35.44 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.8 1.64 . . . . 10.0 109.872 -174.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 10.1 pt -127.87 122.06 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 N-CA-C 104.653 -2.351 . . . . 10.0 104.653 175.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 39.13 72.79 0.13 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 127.96 2.504 . . . . 10.0 113.6 179.191 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -142.78 142.71 11.77 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 107.349 -2.3 . . . . 10.0 107.349 167.318 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 34.5 ttp180 . . . . . 0 C--O 1.249 1.037 0 CA-C-O 117.448 -1.263 . . . . 10.0 109.385 179.574 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 24.4 t . . . . . 0 N--CA 1.465 0.309 0 N-CA-C 105.825 -1.917 . . . . 10.0 105.825 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 13.4 p -126.39 153.29 45.17 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.004 1.322 . . . . 10.0 109.065 178.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -129.96 149.73 51.56 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 125.901 1.68 . . . . 10.0 109.49 -173.082 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.62 88.69 2.82 Favored 'General case' 0 C--N 1.341 0.215 0 C-N-CA 124.582 1.153 . . . . 10.0 109.606 -167.61 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -86.45 152.47 22.66 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.143 1.377 . . . . 10.0 110.523 -179.615 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -125.01 149.43 47.76 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.471 1.108 . . . . 10.0 109.341 174.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.716 ' CE2' HD11 ' A' ' 57' ' ' LEU . 4.7 m-85 -140.86 143.64 34.84 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 124.947 1.404 . . . . 10.0 110.794 -172.119 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -104.91 129.81 53.2 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.677 1.591 . . . . 10.0 108.849 -171.204 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 6.5 mm -103.62 111.29 32.76 Favored 'Isoleucine or valine' 0 C--N 1.342 0.252 0 C-N-CA 123.852 0.861 . . . . 10.0 111.289 -163.207 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -102.56 94.55 5.71 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 107.704 -1.221 . . . . 10.0 107.704 175.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 155.03 -77.03 0.21 Allowed Glycine 0 CA--C 1.527 0.821 0 CA-C-N 116.013 -0.54 . . . . 10.0 112.678 168.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 4.2 mmt -102.12 150.97 22.72 Favored 'General case' 0 N--CA 1.461 0.078 0 C-N-CA 123.432 0.693 . . . . 10.0 109.962 -176.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.3 m -68.56 -60.94 2.06 Favored 'General case' 0 N--CA 1.433 -1.312 0 C-N-CA 124.156 0.982 . . . . 10.0 110.921 -171.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.514 ' HA ' ' HB2' ' A' ' 18' ' ' ALA . 11.2 m 133.26 78.11 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 127.431 2.293 . . . . 10.0 106.005 -177.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -138.88 -92.3 0.19 Allowed 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 106.701 -1.592 . . . . 10.0 106.701 165.342 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.06 -43.65 98.02 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.274 -1.01 . . . . 10.0 108.274 178.358 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -68.57 -49.2 61.24 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 114.991 -1.004 . . . . 10.0 110.798 -176.544 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.602 ' HB1' HG21 ' A' ' 36' ' ' VAL . . . -46.13 -48.27 17.32 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.85 0.86 . . . . 10.0 111.109 167.725 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -58.84 -23.66 60.93 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 114.885 -1.052 . . . . 10.0 112.112 -179.345 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.9 tpt180 -80.86 -48.05 12.94 Favored 'General case' 0 N--CA 1.452 -0.352 0 O-C-N 121.314 -0.866 . . . . 10.0 110.02 168.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.464 ' CG2' HD12 ' A' ' 25' ' ' LEU . 29.0 mm -39.35 -57.65 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.433 0 CA-C-O 118.545 -0.74 . . . . 10.0 110.844 177.104 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -44.75 -49.23 10.72 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 123.598 0.561 . . . . 10.0 111.499 -175.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.2 ttmt -72.7 -45.44 58.8 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.539 0.736 . . . . 10.0 110.379 -176.454 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -60.58 -36.36 78.33 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 122.805 0.442 . . . . 10.0 111.673 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.464 HD12 ' CG2' ' A' ' 21' ' ' ILE . 0.9 OUTLIER -71.96 -49.01 40.96 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.41 1.084 . . . . 10.0 109.324 171.975 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -54.51 -19.47 5.87 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.542 -0.723 . . . . 10.0 112.704 177.487 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -56.25 -35.3 67.26 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.718 1.007 . . . . 10.0 113.718 171.076 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.46 HD11 ' CB ' ' A' ' 57' ' ' LEU . 11.2 mt -58.22 139.03 18.43 Favored 'Isoleucine or valine' 0 C--N 1.339 0.132 0 CA-C-N 118.59 0.632 . . . . 10.0 109.593 179.415 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -69.45 -52.66 24.64 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 111.665 0.246 . . . . 10.0 111.665 -176.07 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -85.07 44.29 3.36 Favored Glycine 0 C--N 1.339 0.749 0 O-C-N 120.705 -1.247 . . . . 10.0 111.224 -175.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.4 p -99.76 152.4 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 C-N-CA 124.62 1.168 . . . . 10.0 108.366 -179.091 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -112.92 -57.63 2.26 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 108.562 -0.903 . . . . 10.0 108.562 171.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 -148.71 158.13 43.93 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.217 -1.401 . . . . 10.0 107.217 -173.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -148.28 61.15 5.61 Favored Pre-proline 0 CA--C 1.531 0.245 0 O-C-N 121.902 -0.499 . . . . 10.0 111.568 168.291 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -75.03 83.79 1.77 Allowed 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 122.915 2.41 . . . . 10.0 108.225 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.602 HG21 ' HB1' ' A' ' 18' ' ' ALA . 3.6 m -54.48 157.3 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 C-N-CA 123.236 0.614 . . . . 10.0 110.527 173.154 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 -84.52 161.06 20.37 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 107.591 -1.263 . . . . 10.0 107.591 171.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -122.79 29.37 6.86 Favored 'General case' 0 C--N 1.335 -0.051 0 N-CA-C 112.21 0.448 . . . . 10.0 112.21 -169.393 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -174.55 -37.94 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 122.657 0.383 . . . . 10.0 111.227 -171.033 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 16.6 mt -72.18 -19.68 61.71 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.327 1.051 . . . . 10.0 111.66 -177.036 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 67.13 43.65 2.07 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.041 1.336 . . . . 10.0 109.557 -178.038 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 17.4 p -140.39 123.55 16.71 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.855 1.662 . . . . 10.0 109.167 178.202 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.549 HG13 HG12 ' A' ' 36' ' ' VAL . 8.6 t -89.76 149.08 4.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 108.226 -1.028 . . . . 10.0 108.226 173.526 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 85.3 m -130.07 125.94 36.43 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 106.787 -1.56 . . . . 10.0 106.787 179.239 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.418 HG22 HD13 ' A' ' 25' ' ' LEU . 42.1 t -120.13 128.45 75.96 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 C-N-CA 123.452 0.701 . . . . 10.0 109.196 177.366 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 72.2 tt0 -94.43 106.82 18.8 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 108.085 -1.08 . . . . 10.0 108.085 160.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -144.01 164.79 29.61 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 109.605 -0.517 . . . . 10.0 109.605 175.455 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 22.3 p30 -93.72 141.41 23.75 Favored Pre-proline 0 C--N 1.328 -0.334 0 N-CA-C 109.522 -0.547 . . . . 10.0 109.522 175.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -85.29 47.92 2.13 Favored 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 121.594 1.529 . . . . 10.0 109.485 170.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.9 -9.64 6.63 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.247 0.93 . . . . 10.0 113.127 177.59 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -128.56 -51.65 1.26 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.923 1.289 . . . . 10.0 108.68 -167.521 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -122.52 -172.22 2.43 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.767 1.227 . . . . 10.0 109.736 173.171 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 99.3 p -141.12 169.53 17.44 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.924 1.289 . . . . 10.0 110.959 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 70.0 t -50.1 -49.75 21.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 124.172 0.989 . . . . 10.0 110.491 165.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.2 m -58.47 -36.19 73.33 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 123.841 0.856 . . . . 10.0 111.991 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -69.09 -60.42 2.37 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 109.69 -0.485 . . . . 10.0 109.69 173.479 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.716 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.3 pp -60.07 -47.23 86.75 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 121.051 0.453 . . . . 10.0 110.822 -165.266 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.468 ' N ' HD12 ' A' ' 57' ' ' LEU . 0.9 OUTLIER -48.74 -36.45 16.41 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 114.004 1.113 . . . . 10.0 114.004 172.196 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -57.35 -33.49 67.81 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 119.08 0.854 . . . . 10.0 110.599 178.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.92 -51.82 66.58 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.544 -0.91 . . . . 10.0 108.544 -178.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 25.1 t -61.15 -45.84 97.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 124.89 1.276 . . . . 10.0 110.484 178.079 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -56.49 -55.4 34.2 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 124.196 0.998 . . . . 10.0 108.499 -178.123 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.78 -35.28 74.33 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.083 0.953 . . . . 10.0 111.62 177.01 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.4 mp -55.15 -32.82 62.41 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 118.626 -0.702 . . . . 10.0 112.383 171.368 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 134.76 -7.06 4.51 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-O 119.394 -0.67 . . . . 10.0 114.366 169.472 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -135.17 151.26 50.5 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 106.769 -1.567 . . . . 10.0 106.769 -177.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.79 142.28 35.0 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 121.46 0.648 . . . . 10.0 111.09 -161.552 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.568 HD11 ' HB2' ' A' ' 7' ' ' PHE . 16.0 tp -118.34 144.03 46.18 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.583 1.953 . . . . 10.0 107.842 -173.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 4.0 tptp -147.81 154.76 40.89 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.124 0.97 . . . . 10.0 108.669 171.383 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.7 tp -63.75 157.51 24.11 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 109.267 -0.642 . . . . 10.0 109.267 176.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 30.8 tttp -111.27 -67.19 1.01 Allowed 'General case' 0 N--CA 1.441 -0.89 0 C-N-CA 124.974 1.31 . . . . 10.0 107.932 170.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 162.1 49.75 0.02 OUTLIER Glycine 0 CA--C 1.526 0.762 0 CA-C-N 118.383 0.538 . . . . 10.0 112.914 174.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 64.16 170.61 0.18 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.823 1.249 . . . . 10.0 112.564 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -86.06 141.25 29.58 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.928 -0.578 . . . . 10.0 111.092 -177.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -69.78 69.74 0.31 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.478 1.111 . . . . 10.0 111.735 178.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 71.1 m -88.22 106.26 18.08 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 123.942 0.897 . . . . 10.0 111.013 175.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 48.0 mt -79.9 -23.04 11.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 123.771 0.828 . . . . 10.0 111.156 175.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -60.89 141.09 57.47 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.613 1.165 . . . . 10.0 110.621 -178.272 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 177.51 -166.93 37.66 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 109.326 -1.509 . . . . 10.0 109.326 179.312 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 66.1 ttt180 . . . . . 0 C--O 1.252 1.22 0 N-CA-C 104.984 -2.228 . . . . 10.0 104.984 165.055 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.8 p . . . . . 0 N--CA 1.47 0.558 0 N-CA-C 106.056 -1.831 . . . . 10.0 106.056 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 12.8 p -94.24 155.75 16.88 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.363 1.465 . . . . 10.0 109.824 -177.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -128.86 145.73 51.13 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 126.899 2.08 . . . . 10.0 108.528 -171.1 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -110.46 100.27 9.13 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.423 1.089 . . . . 10.0 112.559 -163.53 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -111.7 154.03 25.57 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.054 1.741 . . . . 10.0 110.241 -168.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -129.09 148.28 51.02 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 109.153 -0.684 . . . . 10.0 109.153 -177.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.753 ' CE2' HD11 ' A' ' 57' ' ' LEU . 4.3 m-85 -138.68 138.24 37.58 Favored 'General case' 0 N--CA 1.452 -0.361 0 O-C-N 124.92 1.388 . . . . 10.0 109.281 -171.31 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -100.89 126.29 47.5 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.399 1.08 . . . . 10.0 108.223 -171.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.411 HD11 HG23 ' A' ' 43' ' ' VAL . 6.7 mm -104.62 126.85 59.39 Favored 'Isoleucine or valine' 0 C--N 1.343 0.307 0 C-N-CA 124.654 1.182 . . . . 10.0 111.875 -164.132 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -112.66 98.68 7.39 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.459 -0.941 . . . . 10.0 108.459 168.023 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 153.88 -106.32 0.29 Allowed Glycine 0 CA--C 1.53 0.973 0 C-N-CA 123.149 0.404 . . . . 10.0 112.749 171.058 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 59.3 mtt -90.46 89.8 7.74 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 117.509 0.654 . . . . 10.0 111.416 -169.205 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.4 p -118.95 56.94 0.89 Allowed 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 125.414 1.486 . . . . 10.0 109.736 -171.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 96.2 m -111.87 -87.61 0.54 Allowed 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 123.468 0.707 . . . . 10.0 109.555 -172.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -170.45 -58.26 0.02 OUTLIER 'General case' 0 C--N 1.338 0.091 0 C-N-CA 124.161 0.985 . . . . 10.0 109.879 -178.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.42 -40.25 93.11 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.568 -0.901 . . . . 10.0 108.568 -177.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 99.1 m -74.07 -45.54 48.71 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.509 -0.769 . . . . 10.0 110.153 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -45.05 -51.62 9.87 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.68 0.792 . . . . 10.0 111.229 170.055 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -52.86 -30.47 34.03 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.923 0.712 . . . . 10.0 112.923 176.279 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.3 ttm180 -72.32 -36.8 68.98 Favored 'General case' 0 N--CA 1.447 -0.61 0 O-C-N 121.009 -1.057 . . . . 10.0 109.371 -178.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.677 HG22 HD12 ' A' ' 25' ' ' LEU . 1.6 mt -57.49 -48.17 83.51 Favored 'Isoleucine or valine' 0 C--N 1.344 0.344 0 CA-C-O 118.324 -0.846 . . . . 10.0 108.967 172.424 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -47.73 -47.04 30.37 Favored 'General case' 0 C--O 1.225 -0.187 0 CA-C-N 118.59 0.632 . . . . 10.0 111.517 -178.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 27.6 ttmt -72.56 -48.87 36.57 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.156 0.582 . . . . 10.0 110.298 -177.267 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -54.31 -41.19 68.69 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.629 0.603 . . . . 10.0 112.629 176.489 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.677 HD12 HG22 ' A' ' 21' ' ' ILE . 1.5 mt -68.84 -52.4 30.29 Favored 'General case' 0 C--O 1.221 -0.421 0 C-N-CA 124.95 1.3 . . . . 10.0 109.521 173.806 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 45.9 m-20 -54.02 -19.85 5.44 Favored 'General case' 0 C--O 1.227 -0.118 0 CA-C-N 118.63 0.65 . . . . 10.0 111.964 179.416 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.6 ttmt -58.74 -26.59 64.12 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 113.72 1.007 . . . . 10.0 113.72 172.326 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.69 HD11 ' HB3' ' A' ' 57' ' ' LEU . 10.8 mt -54.26 133.93 17.27 Favored 'Isoleucine or valine' 0 C--N 1.341 0.232 0 CA-C-N 119.572 1.078 . . . . 10.0 108.706 173.835 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -69.56 -47.44 63.65 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.919 -0.488 . . . . 10.0 111.418 179.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -86.61 45.71 3.48 Favored Glycine 0 C--N 1.339 0.714 0 O-C-N 120.637 -1.289 . . . . 10.0 111.2 -174.061 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -99.32 149.59 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 108.389 -0.967 . . . . 10.0 108.389 -176.629 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -104.2 -57.43 2.03 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 107.769 -1.197 . . . . 10.0 107.769 165.441 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 55.4 m-80 -149.28 156.18 41.7 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.409 -0.96 . . . . 10.0 108.409 -171.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -146.45 61.94 7.41 Favored Pre-proline 0 CA--C 1.538 0.517 0 N-CA-C 112.86 0.689 . . . . 10.0 112.86 169.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -79.05 85.74 1.81 Allowed 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 123.23 2.62 . . . . 10.0 109.746 -178.15 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.416 HG12 HG13 ' A' ' 43' ' ' VAL . 3.0 m -71.84 153.56 7.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 O-C-N 121.495 -0.753 . . . . 10.0 110.901 -178.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -94.02 127.34 39.76 Favored 'General case' 0 C--N 1.339 0.11 0 O-C-N 121.996 -0.44 . . . . 10.0 110.771 -175.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -105.16 59.56 0.68 Allowed 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.437 1.495 . . . . 10.0 110.772 -173.361 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 173.47 -35.97 0.0 OUTLIER 'General case' 0 C--O 1.226 -0.176 0 C-N-CA 125.411 1.485 . . . . 10.0 109.794 171.299 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.6 mt -83.33 -14.22 53.4 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.913 0.885 . . . . 10.0 111.087 -172.134 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 75.92 38.31 0.35 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.735 1.614 . . . . 10.0 110.785 170.138 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 38.3 p -137.18 131.66 32.83 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.136 1.374 . . . . 10.0 109.327 -177.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.416 HG13 HG12 ' A' ' 36' ' ' VAL . 3.6 t -91.8 142.72 12.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 107.625 -1.25 . . . . 10.0 107.625 167.121 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 44.7 m -127.2 124.61 39.39 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 106.828 -1.545 . . . . 10.0 106.828 177.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.8 t -124.6 141.24 45.36 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 N-CA-C 109.183 -0.673 . . . . 10.0 109.183 -179.257 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 55.1 tt0 -115.22 106.82 14.5 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 106.985 -1.487 . . . . 10.0 106.985 166.077 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -149.96 158.64 44.36 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 123.062 0.545 . . . . 10.0 109.667 -179.3 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -88.64 128.26 53.3 Favored Pre-proline 0 C--N 1.326 -0.421 0 N-CA-C 109.952 -0.388 . . . . 10.0 109.952 178.089 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -75.69 60.4 5.92 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.479 2.119 . . . . 10.0 108.939 171.457 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.5 tttt -130.91 -52.62 1.05 Allowed 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 106.472 -1.677 . . . . 10.0 106.472 173.051 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -83.85 -43.51 15.28 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.077 0.551 . . . . 10.0 110.475 -170.411 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -134.12 -173.61 3.31 Favored 'General case' 0 C--N 1.339 0.128 0 C-N-CA 124.904 1.282 . . . . 10.0 109.093 178.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 79.8 p -145.78 166.8 24.84 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.676 0.75 . . . . 10.0 109.864 -177.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.64 HG11 HD11 ' A' ' 70' ' ' LEU . 26.8 m -49.79 -41.53 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 115.064 -0.971 . . . . 10.0 111.428 167.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.3 m -56.37 -44.2 79.95 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 123.914 0.885 . . . . 10.0 112.178 177.151 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -63.22 -56.89 12.83 Favored 'General case' 0 C--N 1.337 0.064 0 N-CA-C 109.203 -0.666 . . . . 10.0 109.203 179.153 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.753 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.2 pp -67.63 -41.22 84.23 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 119.675 -0.81 . . . . 10.0 110.81 -171.765 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.458 ' HA ' HD23 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -39.63 -52.47 2.22 Favored 'General case' 0 C--O 1.224 -0.238 0 O-C-N 121.683 -0.635 . . . . 10.0 112.473 159.333 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.45 -43.24 93.2 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 118.62 0.645 . . . . 10.0 109.873 179.4 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -51.87 -46.97 64.69 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 116.062 -0.517 . . . . 10.0 110.224 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.403 ' HA ' HD12 ' A' ' 64' ' ' LEU . 40.6 t -68.34 -47.44 77.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 124.266 1.026 . . . . 10.0 112.58 175.587 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -58.25 -35.37 71.64 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.406 -0.809 . . . . 10.0 109.126 -176.358 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.1 -28.79 39.0 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 118.538 -0.744 . . . . 10.0 112.179 179.315 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.403 HD12 ' HA ' ' A' ' 61' ' ' VAL . 10.2 mt -53.83 -42.65 68.7 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 120.036 1.289 . . . . 10.0 110.797 165.14 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 139.95 -14.3 3.09 Favored Glycine 0 CA--C 1.527 0.794 0 CA-C-O 119.974 -0.348 . . . . 10.0 113.787 170.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -114.83 159.19 20.92 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 125.54 1.536 . . . . 10.0 107.271 179.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 25.8 mttp -97.24 159.56 14.84 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 121.731 0.777 . . . . 10.0 111.782 -171.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.458 HD23 ' HA ' ' A' ' 58' ' ' LYS . 20.5 tp -137.24 147.28 45.65 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.929 1.691 . . . . 10.0 107.433 -177.535 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 22.9 tptt -154.41 153.41 31.52 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 108.624 -0.88 . . . . 10.0 108.624 164.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.64 HD11 HG11 ' A' ' 54' ' ' VAL . 22.5 mt -61.04 160.21 10.36 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 121.936 0.874 . . . . 10.0 110.856 175.743 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 12.3 tptt -113.12 -58.0 2.21 Favored 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 128.061 2.544 . . . . 10.0 106.419 173.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -179.88 -84.13 0.06 OUTLIER Glycine 0 CA--C 1.523 0.544 0 N-CA-C 109.617 -1.393 . . . . 10.0 109.617 178.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -165.39 160.8 18.43 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.304 -0.998 . . . . 10.0 108.304 -169.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.53 139.24 58.6 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 113.124 0.787 . . . . 10.0 113.124 -178.034 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -42.64 -51.04 5.36 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.13 1.772 . . . . 10.0 110.929 177.164 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.6 t 68.23 -171.53 0.19 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.696 1.198 . . . . 10.0 111.605 174.073 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.4 mt -145.29 25.28 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 125.098 1.359 . . . . 10.0 109.262 176.025 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 63.45 -167.74 0.21 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.427 1.091 . . . . 10.0 110.568 -172.472 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -161.17 -103.86 0.19 Allowed Glycine 0 CA--C 1.53 0.977 0 O-C-N 121.471 -0.768 . . . . 10.0 112.658 -173.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 11.1 mtt180 . . . . . 0 C--O 1.25 1.086 0 CA-C-O 116.82 -1.562 . . . . 10.0 107.043 164.754 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 8.7 p . . . . . 0 N--CA 1.469 0.51 0 N-CA-C 106.974 -1.491 . . . . 10.0 106.974 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.426 HG21 ' HB2' ' A' ' 32' ' ' ALA . 3.4 p -150.19 165.82 31.73 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 125.61 1.564 . . . . 10.0 107.263 -179.052 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -108.68 144.45 36.43 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 126.339 1.855 . . . . 10.0 110.28 179.484 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.0 mmtm -88.47 113.83 24.47 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.701 1.2 . . . . 10.0 109.801 174.034 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -116.64 149.87 39.04 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.678 1.191 . . . . 10.0 110.494 170.922 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -117.03 151.05 37.59 Favored 'General case' 0 CA--C 1.518 -0.257 0 C-N-CA 124.564 1.146 . . . . 10.0 111.423 171.237 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.736 ' CE2' HD11 ' A' ' 57' ' ' LEU . 1.8 m-85 -140.99 137.47 33.04 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.549 1.14 . . . . 10.0 110.143 -175.333 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.537 ' CG ' ' HZ3' ' A' ' 71' ' ' LYS . 6.9 m-20 -95.0 137.84 33.52 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 125.165 1.386 . . . . 10.0 109.11 -176.952 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.468 HD11 HG23 ' A' ' 43' ' ' VAL . 7.5 mm -109.47 132.41 57.7 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 C-N-CA 124.84 1.256 . . . . 10.0 110.639 -164.822 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -121.68 88.18 2.89 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.377 -0.971 . . . . 10.0 108.377 173.197 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 150.46 -94.62 0.15 Allowed Glycine 0 CA--C 1.528 0.895 0 C-N-CA 123.394 0.521 . . . . 10.0 112.034 169.905 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 42.8 mtt -69.95 134.82 48.77 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 117.907 0.854 . . . . 10.0 111.235 -174.878 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.3 t -153.02 73.7 1.01 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.33 1.052 . . . . 10.0 108.531 -177.426 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 9.9 t -164.24 147.16 9.23 Favored 'General case' 0 C--N 1.339 0.122 0 O-C-N 120.939 -1.101 . . . . 10.0 109.762 -179.732 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -46.41 -46.04 18.37 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.043 1.337 . . . . 10.0 113.762 -174.768 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.34 -36.48 83.0 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 121.827 -0.545 . . . . 10.0 109.69 -177.634 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 91.2 m -72.81 -53.3 11.88 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 108.377 -0.972 . . . . 10.0 108.377 -176.4 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -39.18 -57.29 1.35 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 126.067 1.747 . . . . 10.0 110.948 168.237 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -49.43 -36.64 22.98 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.643 0.777 . . . . 10.0 112.44 175.682 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 15.6 ttt180 -73.49 -47.86 37.85 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 121.65 -0.656 . . . . 10.0 109.291 -179.61 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.3 mt -42.46 -52.51 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 123.1 0.56 . . . . 10.0 110.769 171.125 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -42.83 -58.54 2.32 Favored 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 123.01 0.524 . . . . 10.0 111.025 179.616 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -70.18 -39.59 75.15 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.859 0.863 . . . . 10.0 109.87 -173.885 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.24 -36.46 66.06 Favored 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 122.705 0.402 . . . . 10.0 110.685 175.611 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.49 -36.63 26.27 Favored 'General case' 0 C--O 1.222 -0.376 0 C-N-CA 123.571 0.749 . . . . 10.0 112.554 173.191 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -57.69 -25.73 60.72 Favored 'General case' 0 C--N 1.328 -0.326 0 O-C-N 120.715 -1.24 . . . . 10.0 109.821 179.291 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.5 mmpt? -51.82 -38.45 55.82 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 114.336 1.235 . . . . 10.0 114.336 168.975 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.423 HG23 ' CB ' ' A' ' 52' ' ' ALA . 11.5 mt -57.19 129.43 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 CA-C-N 118.838 0.745 . . . . 10.0 109.253 178.925 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -64.8 -49.53 70.29 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 120.968 -0.293 . . . . 10.0 110.991 -179.942 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -82.91 46.51 3.63 Favored Glycine 0 C--N 1.339 0.717 0 O-C-N 120.998 -1.064 . . . . 10.0 111.5 -175.008 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.3 p -106.7 152.9 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 C-N-CA 124.588 1.155 . . . . 10.0 109.003 -177.716 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.426 ' HB2' HG21 ' A' ' 2' ' ' THR . . . -115.23 -51.95 2.69 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.989 -0.745 . . . . 10.0 108.989 168.499 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -151.58 158.86 44.09 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 109.234 -0.654 . . . . 10.0 109.234 -176.68 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -143.18 64.11 13.76 Favored Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 123.918 0.887 . . . . 10.0 111.861 173.088 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -79.22 77.68 4.0 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.178 2.585 . . . . 10.0 109.8 -177.252 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.519 HG12 HG13 ' A' ' 43' ' ' VAL . 2.4 m -71.3 153.16 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 O-C-N 121.775 -0.578 . . . . 10.0 111.385 -176.927 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 34.2 m120 -87.46 148.05 25.12 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 120.817 -0.353 . . . . 10.0 110.298 177.241 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -124.02 44.8 2.63 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.904 1.281 . . . . 10.0 111.104 -172.306 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -175.8 -40.63 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.216 0 C-N-CA 125.292 1.437 . . . . 10.0 109.596 178.005 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.6 mt -78.15 -18.29 55.77 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.381 1.072 . . . . 10.0 111.834 -172.034 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 66.87 46.38 1.66 Allowed 'General case' 0 C--O 1.231 0.091 0 C-N-CA 125.377 1.471 . . . . 10.0 110.398 179.144 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.9 p -139.03 121.72 16.38 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 125.153 1.381 . . . . 10.0 108.538 176.349 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.519 HG13 HG12 ' A' ' 36' ' ' VAL . 17.9 t -88.55 137.56 20.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 107.227 -1.398 . . . . 10.0 107.227 168.505 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 88.8 m -120.09 124.02 44.8 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 106.445 -1.687 . . . . 10.0 106.445 176.659 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 24.7 t -121.56 140.1 46.64 Favored 'Isoleucine or valine' 0 C--N 1.339 0.139 0 CA-C-N 119.114 0.87 . . . . 10.0 110.073 178.755 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -105.19 101.47 11.02 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.458 1.503 . . . . 10.0 107.078 164.389 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -143.19 158.47 43.59 Favored 'General case' 0 CA--C 1.52 -0.21 0 C-N-CA 123.0 0.52 . . . . 10.0 110.627 178.421 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -93.06 129.45 39.46 Favored Pre-proline 0 CA--C 1.531 0.247 0 C-N-CA 123.393 0.677 . . . . 10.0 110.043 176.309 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -78.04 57.15 6.01 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 122.244 1.962 . . . . 10.0 108.86 169.768 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.74 -62.67 1.12 Allowed 'General case' 0 CA--C 1.521 -0.149 0 N-CA-C 106.533 -1.655 . . . . 10.0 106.533 175.822 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -81.84 -32.32 31.24 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 122.468 0.307 . . . . 10.0 110.87 -173.196 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.423 ' CB ' HG23 ' A' ' 28' ' ' ILE . . . -135.22 -176.48 4.27 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.14 0.976 . . . . 10.0 109.606 177.214 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 86.7 p -140.71 169.73 17.09 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.842 0.857 . . . . 10.0 111.501 -179.853 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 59.4 t -42.53 -48.71 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 125.43 1.492 . . . . 10.0 111.571 160.786 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.5 t -66.82 -34.25 77.4 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.356 -0.384 . . . . 10.0 110.553 -176.0 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -65.77 -60.71 2.61 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.682 -0.859 . . . . 10.0 108.682 173.382 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.736 HD11 ' CE2' ' A' ' 7' ' ' PHE . 3.9 pp -63.68 -44.91 92.34 Favored 'General case' 0 N--CA 1.447 -0.583 0 O-C-N 121.982 -0.449 . . . . 10.0 111.036 -164.774 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.418 ' N ' HD12 ' A' ' 57' ' ' LEU . 1.0 OUTLIER -48.64 -39.56 24.58 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 113.319 0.859 . . . . 10.0 113.319 170.094 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -57.25 -32.94 67.08 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 119.235 0.925 . . . . 10.0 110.646 178.939 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.41 -48.24 81.31 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.792 0.805 . . . . 10.0 109.338 -178.562 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.613 HG13 ' CE2' ' A' ' 66' ' ' TYR . 57.6 t -64.94 -50.57 74.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 124.947 1.299 . . . . 10.0 111.043 174.49 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -50.27 -39.18 44.4 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.354 1.462 . . . . 10.0 109.167 -179.292 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 33.1 tptt -76.59 -40.96 47.98 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 125.303 1.441 . . . . 10.0 110.595 -178.063 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 28.3 mt -53.19 -41.09 64.93 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.712 0.687 . . . . 10.0 111.402 169.056 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 140.4 -30.78 2.3 Favored Glycine 0 C--N 1.338 0.69 0 CA-C-N 118.225 0.466 . . . . 10.0 113.428 166.722 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.613 ' CE2' HG13 ' A' ' 61' ' ' VAL . 15.6 p90 -86.86 160.2 18.82 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 107.797 -1.186 . . . . 10.0 107.797 172.711 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -105.42 150.67 25.05 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 120.859 0.361 . . . . 10.0 110.549 -170.546 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.532 HD11 ' HB2' ' A' ' 7' ' ' PHE . 21.8 tp -123.2 150.47 43.33 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 126.643 1.977 . . . . 10.0 108.234 -176.897 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 19.5 tptt -154.26 140.01 18.05 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 123.145 0.578 . . . . 10.0 110.683 166.018 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.607 HD23 ' N ' ' A' ' 71' ' ' LYS . 2.4 tt -70.8 158.27 36.63 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 123.524 0.729 . . . . 10.0 109.786 -178.966 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.607 ' N ' HD23 ' A' ' 70' ' ' LEU . 11.8 ttpt -121.74 -67.17 0.98 Allowed 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 126.894 2.078 . . . . 10.0 108.759 178.815 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -165.54 -81.31 0.04 OUTLIER Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.025 -1.23 . . . . 10.0 110.025 176.627 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -163.45 165.02 24.26 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 124.578 1.151 . . . . 10.0 107.937 -169.154 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.19 57.72 1.9 Allowed 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 117.829 0.286 . . . . 10.0 110.418 174.756 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 24.6 t0 37.13 59.93 1.06 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.858 1.663 . . . . 10.0 111.226 -178.646 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.9 t -79.86 -49.47 11.91 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.734 0.814 . . . . 10.0 109.018 -171.068 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.41 HG22 ' O ' ' A' ' 77' ' ' ILE . 27.9 mt 66.66 2.89 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 C-N-CA 124.2 1.0 . . . . 10.0 112.342 176.418 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -120.5 156.16 32.09 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 124.793 1.237 . . . . 10.0 109.755 175.909 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -150.24 95.96 0.16 Allowed Glycine 0 CA--C 1.523 0.571 0 N-CA-C 105.537 -3.025 . . . . 10.0 105.537 170.927 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 13.3 tpt85 . . . . . 0 C--O 1.252 1.22 0 CA-C-O 117.027 -1.463 . . . . 10.0 110.863 -164.35 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.463 HG13 ' H ' ' A' ' 2' ' ' THR . 2.7 p . . . . . 0 N--CA 1.474 0.764 0 N-CA-C 109.146 -0.687 . . . . 10.0 109.146 . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.491 HG21 ' HB2' ' A' ' 32' ' ' ALA . 1.1 p -144.13 170.89 15.11 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 105.908 -1.886 . . . . 10.0 105.908 171.789 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -133.98 143.24 48.03 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 126.83 2.052 . . . . 10.0 106.723 -168.345 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 18.3 tptm -89.25 143.33 26.91 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 107.546 -1.279 . . . . 10.0 107.546 -176.273 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -147.44 148.13 30.95 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.416 0.686 . . . . 10.0 109.441 177.66 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -128.09 152.41 48.01 Favored 'General case' 0 CA--C 1.507 -0.675 0 C-N-CA 124.494 1.118 . . . . 10.0 109.156 173.014 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.793 ' CE2' HD11 ' A' ' 57' ' ' LEU . 2.7 m-85 -143.4 131.44 21.75 Favored 'General case' 0 N--CA 1.447 -0.623 0 O-C-N 125.607 1.817 . . . . 10.0 108.638 -170.826 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -93.59 138.41 31.87 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 106.811 -1.551 . . . . 10.0 106.811 -179.57 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 5.3 mm -105.44 141.23 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 124.289 1.036 . . . . 10.0 109.415 -166.251 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -107.21 81.14 1.5 Allowed 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 106.845 -1.539 . . . . 10.0 106.845 172.847 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.02 135.03 6.23 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.083 -0.962 . . . . 10.0 111.107 178.362 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 8.9 ptp -145.76 161.04 40.83 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 122.179 -0.6 . . . . 10.0 111.768 163.4 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.8 m -70.12 -40.38 74.9 Favored 'General case' 0 N--CA 1.438 -1.026 0 C-N-CA 125.516 1.526 . . . . 10.0 110.803 172.77 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 45.5 t 89.95 135.79 0.03 OUTLIER 'General case' 0 C--N 1.346 0.415 0 C-N-CA 126.508 1.923 . . . . 10.0 108.996 -178.551 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 59.39 -75.5 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.649 1.58 . . . . 10.0 111.848 -172.668 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.52 -28.67 67.28 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.185 0.994 . . . . 10.0 109.486 177.935 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.4 t -54.82 -69.32 0.13 Allowed 'General case' 0 C--N 1.343 0.291 0 C-N-CA 120.463 -0.495 . . . . 10.0 109.979 168.516 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -49.57 -38.09 29.88 Favored 'General case' 0 CA--C 1.522 -0.124 0 C-N-CA 123.473 0.709 . . . . 10.0 110.615 -177.526 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -58.81 -43.88 90.67 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 119.963 -0.695 . . . . 10.0 110.658 179.415 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.488 ' CG ' HD11 ' A' ' 64' ' ' LEU . 3.8 tpp85 -75.09 -44.36 47.75 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 109.098 -0.704 . . . . 10.0 109.098 -178.95 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.4 mm -44.49 -62.08 0.33 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.466 0 C-N-CA 124.063 0.945 . . . . 10.0 108.898 173.663 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -54.61 -34.83 62.67 Favored 'General case' 0 C--O 1.22 -0.483 0 CA-C-N 118.497 0.59 . . . . 10.0 112.203 -175.172 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.04 -43.43 78.74 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 120.715 -1.24 . . . . 10.0 109.376 176.595 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.459 ' HB3' ' HB1' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -67.53 -39.67 85.05 Favored 'General case' 0 C--O 1.224 -0.261 0 O-C-N 122.12 -0.362 . . . . 10.0 111.598 177.997 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.56 -34.62 58.48 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.693 1.197 . . . . 10.0 110.337 -179.426 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -71.14 -7.51 47.14 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 121.671 -0.643 . . . . 10.0 109.537 173.865 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.491 ' HE3' ' HB2' ' A' ' 60' ' ' ALA . 0.5 OUTLIER -60.5 -37.94 82.71 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 118.368 -1.333 . . . . 10.0 109.422 165.92 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.464 HG23 ' CB ' ' A' ' 52' ' ' ALA . 25.6 mm -60.16 123.59 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 123.647 0.779 . . . . 10.0 109.711 -173.729 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -68.32 -48.84 63.81 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 110.001 -0.37 . . . . 10.0 110.001 -179.169 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -82.54 41.06 2.79 Favored Glycine 0 CA--C 1.526 0.747 0 O-C-N 121.326 -0.859 . . . . 10.0 111.937 -175.42 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.3 p -104.46 146.82 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 C-N-CA 124.864 1.266 . . . . 10.0 108.73 -178.266 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.491 ' HB2' HG21 ' A' ' 2' ' ' THR . . . -115.94 -52.44 2.61 Favored 'General case' 0 C--N 1.333 -0.109 0 C-N-CA 122.848 0.459 . . . . 10.0 109.838 172.085 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -139.52 143.03 37.25 Favored 'General case' 0 C--N 1.341 0.212 0 N-CA-C 108.803 -0.814 . . . . 10.0 108.803 -176.797 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -130.85 62.74 67.12 Favored Pre-proline 0 CA--C 1.536 0.435 0 C-N-CA 123.39 0.676 . . . . 10.0 110.48 173.188 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -76.26 66.37 7.08 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 123.448 2.765 . . . . 10.0 110.633 -175.931 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.627 HG22 HG13 ' A' ' 43' ' ' VAL . 41.5 t -68.47 145.16 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 C-N-CA 126.123 1.769 . . . . 10.0 110.98 -176.805 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -90.98 145.07 25.02 Favored 'General case' 0 C--N 1.341 0.239 0 C-N-CA 120.315 -0.554 . . . . 10.0 110.582 -179.828 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -122.82 65.47 0.96 Allowed 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 125.309 1.444 . . . . 10.0 109.819 -172.861 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 157.55 -30.9 0.0 OUTLIER 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 127.627 2.371 . . . . 10.0 109.621 169.405 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.6 mt -75.56 -17.62 60.0 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.799 0.839 . . . . 10.0 110.846 -173.821 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 67.07 48.39 1.24 Allowed 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 126.005 1.722 . . . . 10.0 110.653 177.205 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.4 p -143.1 124.77 14.94 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.49 1.516 . . . . 10.0 108.283 176.422 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.627 HG13 HG22 ' A' ' 36' ' ' VAL . 12.0 t -94.2 141.58 14.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 106.884 -1.525 . . . . 10.0 106.884 169.602 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.6 m -129.98 126.05 36.85 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 105.491 -2.04 . . . . 10.0 105.491 -177.889 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 23.9 t -128.37 152.93 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 CA-C-N 118.657 0.662 . . . . 10.0 109.402 178.886 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -130.41 96.94 4.26 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 105.021 -2.215 . . . . 10.0 105.021 176.213 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -148.77 164.66 33.76 Favored 'General case' 0 C--O 1.226 -0.152 0 C-N-CA 123.956 0.903 . . . . 10.0 110.343 -171.569 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -96.09 132.63 26.51 Favored Pre-proline 0 C--N 1.33 -0.24 0 C-N-CA 122.858 0.463 . . . . 10.0 110.501 179.577 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -79.68 55.62 5.71 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 121.721 1.614 . . . . 10.0 109.136 166.991 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.52 -41.49 1.7 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 118.234 0.47 . . . . 10.0 110.364 177.73 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.89 -32.28 11.76 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.688 0.795 . . . . 10.0 111.091 178.332 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.464 ' CB ' HG23 ' A' ' 28' ' ' ILE . . . -138.22 -174.83 3.91 Favored 'General case' 0 CA--C 1.523 -0.065 0 C-N-CA 124.644 1.178 . . . . 10.0 109.67 -175.996 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.7 p -148.42 163.25 37.71 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 123.058 0.543 . . . . 10.0 109.896 -178.936 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 55.8 t -38.55 -50.39 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 C-N-CA 125.345 1.458 . . . . 10.0 110.07 163.698 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.3 m -51.4 -44.07 62.1 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 124.552 1.141 . . . . 10.0 113.056 -179.762 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -72.37 -53.59 11.86 Favored 'General case' 0 C--O 1.224 -0.289 0 N-CA-C 109.78 -0.452 . . . . 10.0 109.78 -178.625 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.793 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.0 pp -61.05 -39.95 91.79 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 118.247 -1.381 . . . . 10.0 110.738 -177.97 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.442 ' HA ' HD23 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -44.86 -57.48 3.74 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-O 117.854 -1.069 . . . . 10.0 112.309 161.54 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 14.6 tm-20 -50.22 -48.49 54.36 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-N 120.332 1.424 . . . . 10.0 110.298 176.392 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.491 ' HB2' ' HE3' ' A' ' 27' ' ' LYS . . . -51.63 -54.07 31.76 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 123.555 0.742 . . . . 10.0 109.602 -178.044 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 91.6 t -63.03 -45.12 99.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 115.986 -0.552 . . . . 10.0 111.155 177.818 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.45 -56.86 10.98 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.99 0.9 . . . . 10.0 109.836 178.942 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.9 tptp -49.35 -36.97 23.0 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 127.287 2.235 . . . . 10.0 111.602 175.273 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.488 HD11 ' CG ' ' A' ' 20' ' ' ARG . 5.4 tp -60.89 -34.38 74.55 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 125.055 1.342 . . . . 10.0 111.705 179.17 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 146.83 -53.0 0.55 Allowed Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.754 -0.538 . . . . 10.0 111.754 176.962 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -98.86 158.83 15.37 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 123.939 0.896 . . . . 10.0 109.859 -176.832 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 8.5 ttpt -92.16 153.18 19.5 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.217 0.532 . . . . 10.0 110.232 -170.46 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.479 HD11 ' HB2' ' A' ' 7' ' ' PHE . 23.9 tp -125.74 151.69 46.33 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.981 1.713 . . . . 10.0 107.932 179.734 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.9 tptp -153.92 147.63 25.29 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 122.775 0.43 . . . . 10.0 110.275 162.919 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.3 tp -59.14 158.48 8.77 Favored 'General case' 0 C--N 1.34 0.155 0 O-C-N 123.485 0.491 . . . . 10.0 109.963 176.561 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.6 tttt -116.26 -71.26 0.75 Allowed 'General case' 0 N--CA 1.436 -1.136 0 C-N-CA 126.849 2.059 . . . . 10.0 108.205 179.472 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 158.88 43.89 0.02 OUTLIER Glycine 0 CA--C 1.529 0.956 0 C-N-CA 123.952 0.787 . . . . 10.0 111.609 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 67.58 163.17 0.2 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.995 1.318 . . . . 10.0 111.962 171.6 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -79.26 -57.47 3.7 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 108.506 -0.924 . . . . 10.0 108.506 176.033 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -73.71 67.96 1.2 Allowed 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 126.814 2.046 . . . . 10.0 109.119 -172.961 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 29.6 t -52.09 -33.28 38.71 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 127.386 2.274 . . . . 10.0 112.341 -173.078 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 23.7 pt -131.84 164.88 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.409 0 N-CA-C 104.808 -2.293 . . . . 10.0 104.808 168.276 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -106.15 174.65 5.79 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 125.287 1.435 . . . . 10.0 109.799 169.971 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -160.17 -179.04 34.69 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 106.432 -2.667 . . . . 10.0 106.432 172.245 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 66.0 ttt180 . . . . . 0 C--O 1.254 1.33 0 N-CA-C 105.113 -2.181 . . . . 10.0 105.113 176.195 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 11.4 t . . . . . 0 N--CA 1.464 0.247 0 N-CA-C 106.528 -1.656 . . . . 10.0 106.528 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.535 HG21 ' HB2' ' A' ' 32' ' ' ALA . 4.6 p -116.27 132.25 56.72 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 122.606 1.194 . . . . 10.0 112.506 -168.723 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -82.62 164.19 20.94 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 107.791 -1.188 . . . . 10.0 107.791 176.352 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.65 144.73 31.99 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 106.737 -1.579 . . . . 10.0 106.737 176.611 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -148.24 139.23 23.18 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.424 -0.954 . . . . 10.0 108.424 179.294 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -120.71 148.21 44.26 Favored 'General case' 0 CA--C 1.513 -0.466 0 C-N-CA 123.964 0.906 . . . . 10.0 109.187 175.866 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.746 ' CE2' HD11 ' A' ' 57' ' ' LEU . 12.8 m-85 -139.11 144.2 38.59 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.131 1.372 . . . . 10.0 109.144 -174.834 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -110.14 127.33 54.84 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.67 1.188 . . . . 10.0 107.878 -172.213 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.535 HD11 ' HB ' ' A' ' 43' ' ' VAL . 2.5 mm -107.25 137.16 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 124.004 0.922 . . . . 10.0 111.301 -160.691 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -123.37 91.35 3.46 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.554 1.141 . . . . 10.0 108.239 179.816 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 115.15 43.71 0.71 Allowed Glycine 0 CA--C 1.529 0.969 0 CA-C-O 119.459 -0.634 . . . . 10.0 114.243 165.737 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 28.2 ptm -104.6 153.56 21.04 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.351 1.076 . . . . 10.0 110.422 176.311 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -97.26 -4.29 39.11 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.61 0.764 . . . . 10.0 112.126 177.466 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER 72.72 -179.88 0.22 Allowed 'General case' 0 C--N 1.344 0.341 0 CA-C-N 119.485 1.039 . . . . 10.0 110.755 -173.129 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 50.17 -91.92 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 125.83 1.652 . . . . 10.0 111.578 -179.563 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.71 -42.93 94.9 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 123.883 0.873 . . . . 10.0 109.34 -178.167 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.6 m -64.69 -55.41 20.22 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.259 -0.645 . . . . 10.0 109.259 -177.395 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -46.15 -48.38 17.41 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.446 1.098 . . . . 10.0 110.752 173.757 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -61.9 -41.42 97.89 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.167 0.508 . . . . 10.0 111.212 179.016 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.65 -41.0 94.08 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 118.077 -0.964 . . . . 10.0 110.383 176.66 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.411 HG22 HD12 ' A' ' 25' ' ' LEU . 14.9 mm -47.62 -62.54 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.371 0 N-CA-C 108.367 -0.975 . . . . 10.0 108.367 169.682 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -54.56 -35.82 63.67 Favored 'General case' 0 C--O 1.22 -0.462 0 N-CA-C 112.177 0.436 . . . . 10.0 112.177 -176.281 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.65 -53.56 32.67 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 119.198 0.908 . . . . 10.0 109.783 179.233 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.7 tpt180 -64.27 -35.34 80.51 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 122.225 -0.297 . . . . 10.0 111.253 -178.987 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.411 HD12 HG22 ' A' ' 21' ' ' ILE . 0.3 OUTLIER -73.51 -44.9 56.63 Favored 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 123.402 0.681 . . . . 10.0 111.319 178.134 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -51.25 -31.27 20.39 Favored 'General case' 0 C--O 1.225 -0.184 0 C-N-CA 123.81 0.844 . . . . 10.0 110.654 172.292 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -60.84 -34.6 74.83 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 118.703 -0.665 . . . . 10.0 112.239 176.956 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 22.4 mm -55.0 133.37 18.54 Favored 'Isoleucine or valine' 0 C--N 1.342 0.261 0 C-N-CA 124.077 0.951 . . . . 10.0 110.854 177.924 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 51.1 mp0 -73.73 -47.03 42.33 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 119.242 -0.408 . . . . 10.0 110.869 -172.955 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.99 36.75 2.52 Favored Glycine 0 C--N 1.343 0.937 0 O-C-N 120.298 -1.501 . . . . 10.0 113.0 -177.669 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.2 p -101.68 149.76 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 124.61 1.164 . . . . 10.0 108.343 -178.042 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.535 ' HB2' HG21 ' A' ' 2' ' ' THR . . . -108.15 -57.84 2.06 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 106.572 -1.64 . . . . 10.0 106.572 165.366 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -154.3 167.17 30.84 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 115.644 -0.707 . . . . 10.0 109.371 -169.376 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -157.0 77.05 4.08 Favored Pre-proline 0 N--CA 1.454 -0.24 0 C-N-CA 123.592 0.757 . . . . 10.0 110.841 -179.393 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -75.47 69.53 5.87 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.547 2.164 . . . . 10.0 110.124 -179.13 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.487 HG12 HG13 ' A' ' 43' ' ' VAL . 3.8 m -64.6 157.24 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 C-N-CA 123.518 0.727 . . . . 10.0 110.383 178.056 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -102.35 159.93 14.99 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 119.603 -0.839 . . . . 10.0 111.954 172.218 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -129.76 59.22 1.62 Allowed 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 125.474 1.51 . . . . 10.0 108.743 -172.339 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 171.72 -29.44 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 125.304 1.442 . . . . 10.0 111.335 165.894 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.7 mt -81.86 -7.72 59.63 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 122.714 0.406 . . . . 10.0 111.063 -176.106 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 67.06 41.27 2.68 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 126.025 1.73 . . . . 10.0 110.557 173.895 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -136.86 140.85 42.68 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.928 0.871 . . . . 10.0 109.774 173.579 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.535 ' HB ' HD11 ' A' ' 9' ' ' ILE . 2.5 t -110.99 138.97 36.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 107.569 -1.271 . . . . 10.0 107.569 174.156 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 90.6 m -124.29 121.56 35.35 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 126.193 1.797 . . . . 10.0 106.293 -176.07 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.4 t -120.02 143.49 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 C-N-CA 124.597 1.159 . . . . 10.0 109.171 -179.944 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -120.66 96.68 5.22 Favored 'General case' 0 N--CA 1.429 -1.519 0 C-N-CA 126.255 1.822 . . . . 10.0 107.067 173.606 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 11.9 p90 -139.35 161.74 36.72 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 124.079 0.952 . . . . 10.0 109.986 -174.806 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -93.7 123.5 59.68 Favored Pre-proline 0 CA--C 1.534 0.358 0 C-N-CA 123.278 0.631 . . . . 10.0 111.011 175.214 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -75.14 67.33 6.07 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.708 2.272 . . . . 10.0 109.039 172.723 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.45 -49.56 0.49 Allowed 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 107.893 -1.151 . . . . 10.0 107.893 177.919 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -82.54 -62.57 1.58 Allowed 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 108.643 -0.873 . . . . 10.0 108.643 177.101 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -110.27 171.79 7.25 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 125.196 1.398 . . . . 10.0 109.701 -176.701 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 24.8 p -125.32 179.61 5.02 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.886 1.274 . . . . 10.0 110.663 172.994 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 26.8 m -51.36 -37.68 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-N 114.846 -1.07 . . . . 10.0 111.93 166.64 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.8 t -69.86 -39.19 76.49 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 119.032 -0.509 . . . . 10.0 110.811 -174.657 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -60.0 -52.58 64.77 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 119.241 0.928 . . . . 10.0 109.261 -176.341 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.746 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.2 pp -66.45 -42.91 86.9 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.144 -0.48 . . . . 10.0 110.692 -179.658 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.407 ' N ' HD12 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -45.65 -50.34 13.51 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 121.125 -0.985 . . . . 10.0 112.901 164.255 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -60.71 -43.79 97.38 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 119.748 1.158 . . . . 10.0 109.251 -179.366 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -53.1 -52.08 59.79 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.327 -0.851 . . . . 10.0 109.887 178.718 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 98.3 t -64.22 -43.39 97.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 123.04 0.536 . . . . 10.0 112.287 175.115 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -52.26 -51.76 56.59 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 121.995 0.903 . . . . 10.0 109.262 179.181 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 45.0 tptt -57.89 -30.92 66.24 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.812 1.645 . . . . 10.0 112.273 176.837 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.3 mp -61.54 -30.37 70.6 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.657 0.783 . . . . 10.0 110.812 173.977 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 141.16 -45.7 0.95 Allowed Glycine 0 CA--C 1.526 0.772 0 CA-C-N 118.448 0.567 . . . . 10.0 111.716 171.82 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -99.47 156.2 17.16 Favored 'General case' 0 C--O 1.226 -0.145 0 C-N-CA 124.973 1.309 . . . . 10.0 109.017 -178.67 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 24.1 mtpp -87.97 165.34 15.28 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-O 121.719 0.771 . . . . 10.0 111.191 -173.17 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 11.5 tp -136.04 149.46 48.78 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.141 1.776 . . . . 10.0 107.057 -179.831 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 8.7 mmtp -149.42 153.35 37.2 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 108.857 -0.794 . . . . 10.0 108.857 163.797 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.4 tp -62.04 158.51 16.36 Favored 'General case' 0 N--CA 1.453 -0.291 0 O-C-N 124.25 0.969 . . . . 10.0 109.084 174.905 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 12.1 tttt -114.83 -69.86 0.83 Allowed 'General case' 0 N--CA 1.436 -1.175 0 C-N-CA 126.674 1.989 . . . . 10.0 107.28 177.161 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 162.73 47.21 0.02 OUTLIER Glycine 0 CA--C 1.527 0.808 0 CA-C-O 119.291 -0.727 . . . . 10.0 112.87 175.491 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 68.5 156.98 0.13 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.105 1.362 . . . . 10.0 113.165 171.853 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -64.58 142.86 58.28 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 121.859 -0.526 . . . . 10.0 110.654 175.359 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -73.54 72.56 1.41 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.884 0.874 . . . . 10.0 110.487 -179.429 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 53.0 m -116.06 156.26 26.68 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.624 1.569 . . . . 10.0 110.76 -177.698 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 8.8 mt -103.7 -117.92 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 124.16 0.984 . . . . 10.0 108.405 -176.701 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 60.51 179.61 0.1 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.863 1.665 . . . . 10.0 111.197 -170.94 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 179.07 -64.68 0.08 OUTLIER Glycine 0 CA--C 1.527 0.818 0 O-C-N 120.999 -1.063 . . . . 10.0 112.834 -179.075 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 4.8 ttm-85 . . . . . 0 C--O 1.254 1.339 0 N-CA-C 105.273 -2.121 . . . . 10.0 105.273 165.333 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 58.0 t . . . . . 0 N--CA 1.468 0.453 0 N-CA-C 106.287 -1.746 . . . . 10.0 106.287 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 20.7 p -127.87 122.45 32.58 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 107.059 -1.46 . . . . 10.0 107.059 168.485 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -114.27 149.51 35.8 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.943 1.297 . . . . 10.0 110.379 -170.247 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.2 mtmm -98.96 77.18 2.17 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 126.266 1.826 . . . . 10.0 110.816 -160.254 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -79.17 153.57 29.95 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.806 1.643 . . . . 10.0 110.586 -173.724 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -129.52 151.51 50.05 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 124.05 0.94 . . . . 10.0 109.155 176.374 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.801 ' CE2' HD11 ' A' ' 57' ' ' LEU . 4.6 m-85 -140.77 133.75 29.22 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 125.262 1.601 . . . . 10.0 109.776 -174.731 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -87.45 134.68 33.56 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 125.953 1.701 . . . . 10.0 107.883 -179.254 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 12.8 mm -106.03 138.71 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 C-N-CA 125.474 1.51 . . . . 10.0 110.636 -166.523 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -126.31 105.15 8.6 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 108.546 -0.909 . . . . 10.0 108.546 165.749 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 135.13 -77.96 0.36 Allowed Glycine 0 CA--C 1.528 0.868 0 C-N-CA 124.219 0.914 . . . . 10.0 112.663 165.125 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 6.9 ptt? -65.61 126.87 29.71 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 122.192 -0.593 . . . . 10.0 110.641 -173.575 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.6 t -152.61 65.26 0.8 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.66 0.743 . . . . 10.0 110.122 -178.912 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 95.2 m -139.67 -99.02 0.16 Allowed 'General case' 0 C--O 1.225 -0.188 0 N-CA-C 107.823 -1.177 . . . . 10.0 107.823 170.096 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -167.93 -46.53 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.76 0.824 . . . . 10.0 109.608 -177.103 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.39 -40.48 77.34 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.543 0.737 . . . . 10.0 109.184 -179.26 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 18.2 p -65.82 -50.24 65.36 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 109.551 -0.536 . . . . 10.0 109.551 178.187 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.15 -41.8 72.27 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.436 1.095 . . . . 10.0 110.159 174.599 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -55.35 -31.09 61.45 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 121.385 -0.822 . . . . 10.0 112.758 179.568 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.7 ttt180 -70.03 -30.04 67.23 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 121.283 -0.886 . . . . 10.0 109.329 -179.099 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 25.8 mm -55.68 -54.56 24.63 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 CA-C-O 118.431 -0.795 . . . . 10.0 108.972 173.532 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -43.8 -49.72 8.02 Favored 'General case' 0 C--O 1.223 -0.297 0 C-N-CA 123.352 0.661 . . . . 10.0 110.576 -177.895 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.4 mppt? -65.19 -52.24 56.1 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 123.196 0.599 . . . . 10.0 109.818 179.597 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.75 -21.92 66.55 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 112.527 0.566 . . . . 10.0 112.527 -175.506 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.74 -41.28 14.26 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 126.735 2.014 . . . . 10.0 111.44 172.336 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -57.73 -29.07 64.44 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.899 0.88 . . . . 10.0 110.216 175.792 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.2 mmpt? -53.47 -36.03 61.18 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 113.968 1.099 . . . . 10.0 113.968 169.597 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.5 mm -61.08 125.13 16.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 119.108 0.867 . . . . 10.0 109.219 178.576 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 64.2 mt-10 -59.34 -52.9 63.65 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.962 0.727 . . . . 10.0 112.962 -176.547 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.41 43.12 2.85 Favored Glycine 0 C--N 1.339 0.745 0 CA-C-N 120.053 1.297 . . . . 10.0 112.12 -172.78 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.7 p -107.75 153.16 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 C-N-CA 124.783 1.233 . . . . 10.0 108.805 -176.826 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -116.76 -55.13 2.39 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.12 -0.696 . . . . 10.0 109.12 174.615 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -147.32 160.21 42.78 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 108.882 -0.784 . . . . 10.0 108.882 179.596 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.39 61.31 3.9 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 123.647 0.779 . . . . 10.0 112.214 174.29 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -79.42 78.71 3.61 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.826 2.351 . . . . 10.0 109.595 -177.248 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.449 HG12 HG13 ' A' ' 43' ' ' VAL . 2.3 m -58.75 149.65 5.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 123.381 0.672 . . . . 10.0 111.855 -178.276 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -93.59 94.65 8.75 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.979 0.419 . . . . 10.0 111.538 -172.855 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -73.96 53.79 0.49 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 127.084 2.154 . . . . 10.0 112.769 -178.588 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -172.27 -42.88 0.02 OUTLIER 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 125.271 1.428 . . . . 10.0 109.217 170.317 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.3 mt -79.83 -19.69 47.8 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 115.691 -0.686 . . . . 10.0 111.144 -170.996 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 64.54 53.28 1.63 Allowed 'General case' 0 N--CA 1.457 -0.085 0 C-N-CA 124.751 1.22 . . . . 10.0 109.002 -177.199 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 30.3 p -138.04 125.66 22.2 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 106.632 -1.618 . . . . 10.0 106.632 169.849 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.449 HG13 HG12 ' A' ' 36' ' ' VAL . 13.9 t -87.92 145.54 7.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 106.267 -1.753 . . . . 10.0 106.267 166.89 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 96.7 m -128.23 133.49 48.84 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 105.826 -1.916 . . . . 10.0 105.826 178.444 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 26.4 t -136.46 129.31 45.76 Favored 'Isoleucine or valine' 0 C--N 1.339 0.114 0 CA-C-N 118.477 0.581 . . . . 10.0 111.081 176.925 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -92.98 101.02 13.35 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 126.444 1.897 . . . . 10.0 106.265 169.06 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -138.18 159.14 42.83 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 118.411 0.55 . . . . 10.0 111.995 -178.711 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 16.8 p30 -94.87 128.46 39.28 Favored Pre-proline 0 CA--C 1.527 0.06 0 C-N-CA 123.995 0.918 . . . . 10.0 110.656 178.583 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -76.07 56.46 4.87 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 122.425 2.083 . . . . 10.0 109.946 175.511 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.5 ttpt -131.87 -66.34 0.71 Allowed 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 106.628 -1.619 . . . . 10.0 106.628 173.501 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -99.11 -14.86 19.2 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.523 1.129 . . . . 10.0 110.735 -175.378 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -122.06 144.75 48.72 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.24 1.016 . . . . 10.0 110.348 -178.784 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -149.42 147.78 28.68 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.494 0.664 . . . . 10.0 111.291 -173.785 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.4 m -52.41 -42.44 38.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 124.546 1.139 . . . . 10.0 111.314 -178.304 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.2 m -52.72 -44.92 66.68 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.093 1.357 . . . . 10.0 111.974 177.964 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -76.21 -47.3 24.52 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.844 1.258 . . . . 10.0 109.444 -170.636 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.801 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.2 pp -65.72 -42.65 90.83 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 119.253 -0.979 . . . . 10.0 109.871 176.455 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.85 -53.17 10.16 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 117.48 -1.248 . . . . 10.0 112.247 163.548 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -50.94 -45.7 60.74 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 120.687 1.585 . . . . 10.0 110.252 178.121 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -55.52 -51.33 67.39 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.135 -0.939 . . . . 10.0 110.211 -178.038 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 21.9 t -65.16 -43.71 95.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-N 116.475 -0.33 . . . . 10.0 111.653 177.021 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.41 -54.25 47.81 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 108.188 -1.041 . . . . 10.0 108.188 -175.884 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -58.09 -38.92 77.32 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.733 1.213 . . . . 10.0 111.107 178.419 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.442 HD13 ' HA ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -50.92 -34.09 27.05 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.333 0.653 . . . . 10.0 112.067 172.61 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.75 20.78 6.7 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 123.65 0.643 . . . . 10.0 113.281 172.127 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -142.22 175.05 10.06 Favored 'General case' 0 CA--C 1.522 -0.12 0 N-CA-C 105.627 -1.99 . . . . 10.0 105.627 167.406 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 31.4 tttt -123.08 152.87 40.62 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 119.244 0.929 . . . . 10.0 113.182 -164.867 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 12.7 tp -134.74 148.86 50.35 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 126.815 2.046 . . . . 10.0 107.907 -168.808 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 12.6 tptp -149.94 151.28 33.13 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-O 118.713 -0.661 . . . . 10.0 109.536 161.843 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 11.4 tp -60.45 155.15 18.93 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 109.13 -0.693 . . . . 10.0 109.13 175.617 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 35.8 tttp -112.7 -68.35 0.94 Allowed 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 126.443 1.897 . . . . 10.0 107.815 178.912 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 154.75 51.68 0.01 OUTLIER Glycine 0 CA--C 1.529 0.929 0 CA-C-O 119.527 -0.596 . . . . 10.0 112.726 175.095 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 65.68 157.68 0.1 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.735 1.614 . . . . 10.0 113.584 178.22 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -83.68 150.4 25.89 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.42 -0.354 . . . . 10.0 111.348 -178.915 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -144.84 164.98 29.41 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 126.307 1.843 . . . . 10.0 106.588 167.89 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 7.8 t -151.98 77.95 1.23 Allowed 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 106.309 -1.737 . . . . 10.0 106.309 166.451 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.7 pt 41.6 61.11 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 C-N-CA 127.078 2.151 . . . . 10.0 115.022 -175.925 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -61.17 129.85 43.35 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.943 -0.571 . . . . 10.0 109.775 171.341 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 168.38 -179.75 41.23 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 108.368 -1.893 . . . . 10.0 108.368 -177.533 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 43.2 ttt180 . . . . . 0 C--O 1.253 1.289 0 N-CA-C 105.475 -2.046 . . . . 10.0 105.475 172.559 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 56.2 t . . . . . 0 N--CA 1.468 0.474 0 N-CA-C 106.505 -1.665 . . . . 10.0 106.505 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.672 HG21 ' HB2' ' A' ' 32' ' ' ALA . 21.0 p -103.81 170.51 7.88 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.462 0.705 . . . . 10.0 110.533 171.061 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -136.83 149.69 47.87 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 127.505 2.322 . . . . 10.0 106.423 -175.689 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.9 mmtm -97.81 132.52 43.35 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 124.43 1.092 . . . . 10.0 110.555 -176.84 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -134.43 140.24 46.12 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.866 1.267 . . . . 10.0 108.88 177.901 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -119.73 145.83 46.18 Favored 'General case' 0 CA--C 1.513 -0.446 0 C-N-CA 123.817 0.847 . . . . 10.0 109.645 173.071 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.709 ' CE2' HD11 ' A' ' 57' ' ' LEU . 3.7 m-85 -137.09 143.33 42.52 Favored 'General case' 0 N--CA 1.448 -0.544 0 O-C-N 125.084 1.49 . . . . 10.0 109.81 -173.221 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -106.63 135.75 47.61 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.273 1.429 . . . . 10.0 108.701 -174.646 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.9 mm -114.86 134.68 57.13 Favored 'Isoleucine or valine' 0 C--N 1.34 0.164 0 C-N-CA 125.203 1.401 . . . . 10.0 110.415 -161.772 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -125.85 111.27 14.64 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.379 -0.6 . . . . 10.0 109.379 171.911 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 143.33 -60.69 0.52 Allowed Glycine 0 C--N 1.341 0.819 0 C-N-CA 123.818 0.723 . . . . 10.0 112.535 165.193 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.68 158.39 34.79 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.469 0.708 . . . . 10.0 111.612 -176.238 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -67.4 -86.52 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 124.503 1.121 . . . . 10.0 110.394 175.706 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 23.3 p 150.81 55.34 0.0 OUTLIER 'General case' 0 C--N 1.345 0.407 0 C-N-CA 125.21 1.404 . . . . 10.0 110.658 -165.524 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -161.29 -82.06 0.04 OUTLIER 'General case' 0 CA--C 1.519 -0.22 0 O-C-N 121.102 -0.999 . . . . 10.0 109.04 174.168 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.5 -46.63 25.88 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.25 -1.019 . . . . 10.0 108.25 -172.622 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 7.2 m -55.54 -58.52 7.45 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 114.695 -1.139 . . . . 10.0 109.644 173.225 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -44.63 -53.76 6.85 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.46 1.104 . . . . 10.0 111.131 173.828 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -56.98 -31.63 65.26 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.135 0.493 . . . . 10.0 112.0 178.897 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 11.9 ttm180 -74.6 -40.91 61.28 Favored 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 120.994 -1.066 . . . . 10.0 109.389 178.12 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.597 HD11 ' HE2' ' A' ' 66' ' ' TYR . 39.1 mm -46.23 -52.91 2.9 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 CA-C-O 117.796 -1.097 . . . . 10.0 110.012 170.504 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -43.99 -46.57 8.38 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 119.071 0.85 . . . . 10.0 111.955 -177.016 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -76.79 -39.66 50.75 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 123.737 0.815 . . . . 10.0 110.638 -178.279 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.91 -35.8 77.62 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 122.38 -0.2 . . . . 10.0 111.268 176.847 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.59 -36.28 29.16 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.293 1.837 . . . . 10.0 111.152 176.91 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -53.53 -31.63 47.07 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.265 -0.897 . . . . 10.0 110.88 173.232 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.5 mptt -54.15 -24.9 19.71 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 115.298 1.592 . . . . 10.0 115.298 172.349 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.475 HG23 ' HB3' ' A' ' 52' ' ' ALA . 11.4 mm -61.23 108.2 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 118.708 0.685 . . . . 10.0 109.966 172.381 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -55.37 -33.81 63.75 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.239 0.616 . . . . 10.0 111.945 -177.085 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.85 15.49 57.47 Favored Glycine 0 CA--C 1.528 0.883 0 O-C-N 121.497 -0.752 . . . . 10.0 113.19 -179.058 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.7 p -79.33 154.45 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-N 118.867 1.334 . . . . 10.0 109.943 -179.75 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.672 ' HB2' HG21 ' A' ' 2' ' ' THR . . . -114.27 -46.62 2.97 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.541 -0.754 . . . . 10.0 109.716 161.019 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 -144.37 147.91 34.02 Favored 'General case' 0 C--N 1.339 0.12 0 N-CA-C 108.666 -0.864 . . . . 10.0 108.666 -173.389 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -148.48 56.3 2.52 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 118.721 0.692 . . . . 10.0 112.581 172.181 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -74.89 80.62 2.36 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.121 2.547 . . . . 10.0 109.797 178.523 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.486 HG12 HG13 ' A' ' 43' ' ' VAL . 3.6 m -62.3 157.73 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 123.823 0.849 . . . . 10.0 111.47 176.889 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 35.3 m120 -92.12 116.92 29.36 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 120.23 -0.588 . . . . 10.0 112.18 -173.841 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -90.34 48.28 1.54 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.431 1.492 . . . . 10.0 111.249 -179.335 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -171.99 -39.01 0.02 OUTLIER 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 123.719 0.808 . . . . 10.0 110.579 165.272 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 16.4 mt -77.4 -15.03 59.57 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.794 0.838 . . . . 10.0 111.964 -167.666 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 65.52 47.25 2.28 Favored 'General case' 0 C--O 1.227 -0.081 0 C-N-CA 125.353 1.461 . . . . 10.0 109.824 -179.161 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 17.0 p -140.69 130.84 24.84 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 107.976 -1.12 . . . . 10.0 107.976 176.969 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.486 HG13 HG12 ' A' ' 36' ' ' VAL . 12.8 t -95.81 137.55 23.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 107.021 -1.474 . . . . 10.0 107.021 171.605 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 86.1 m -129.7 115.06 16.78 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 106.357 -1.72 . . . . 10.0 106.357 -174.776 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 32.3 t -115.69 144.05 24.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 C-N-CA 123.379 0.672 . . . . 10.0 109.799 -178.141 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -114.79 107.68 15.76 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 125.499 1.52 . . . . 10.0 107.873 164.836 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -149.13 164.18 35.45 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.736 -0.468 . . . . 10.0 109.736 -178.653 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -94.05 131.31 31.94 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 116.25 -0.432 . . . . 10.0 110.172 175.264 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -77.1 62.17 7.42 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.199 1.933 . . . . 10.0 109.488 169.336 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.83 -48.91 1.13 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.649 0.78 . . . . 10.0 108.994 174.685 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.29 -29.29 18.22 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 122.991 0.516 . . . . 10.0 111.841 -171.766 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.475 ' HB3' HG23 ' A' ' 28' ' ' ILE . . . -156.67 169.91 23.62 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.984 1.714 . . . . 10.0 106.82 -169.648 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 59.9 p -135.6 169.88 16.83 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 122.445 1.116 . . . . 10.0 112.649 -178.305 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 35.4 m -48.52 -40.87 11.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 125.189 1.395 . . . . 10.0 111.508 170.997 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 49.8 m -66.57 -35.87 81.26 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 123.509 0.723 . . . . 10.0 111.691 -179.746 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -70.2 -53.05 18.77 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 107.722 -1.214 . . . . 10.0 107.722 179.26 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.709 HD11 ' CE2' ' A' ' 7' ' ' PHE . 3.7 pp -65.87 -35.82 81.71 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 122.001 -0.437 . . . . 10.0 111.819 -173.317 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.7 ttpp -39.44 -54.63 1.9 Allowed 'General case' 0 C--N 1.341 0.222 0 O-C-N 121.216 -0.928 . . . . 10.0 112.559 159.952 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -54.42 -33.8 60.14 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 121.51 0.671 . . . . 10.0 110.54 -174.239 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -58.25 -52.33 66.05 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 121.778 0.799 . . . . 10.0 108.86 179.292 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.564 HG22 HD12 ' A' ' 21' ' ' ILE . 40.0 t -63.27 -43.11 98.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 115.331 -0.85 . . . . 10.0 110.716 176.617 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -56.88 -51.08 70.47 Favored 'General case' 0 CA--C 1.528 0.114 0 N-CA-C 109.28 -0.637 . . . . 10.0 109.28 -177.201 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -59.32 -35.84 74.55 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.241 1.016 . . . . 10.0 111.77 176.646 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.429 ' HA ' HD13 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -52.63 -31.21 35.54 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.621 0.769 . . . . 10.0 111.885 171.088 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 119.48 12.92 6.49 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 124.192 0.901 . . . . 10.0 113.124 171.401 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.597 ' HE2' HD11 ' A' ' 21' ' ' ILE . 1.0 OUTLIER -149.9 161.67 41.83 Favored 'General case' 0 C--O 1.224 -0.245 0 N-CA-C 107.009 -1.478 . . . . 10.0 107.009 179.649 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.8 mttt -104.29 153.7 20.7 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 121.798 0.809 . . . . 10.0 112.002 -165.249 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.427 HD11 ' HB2' ' A' ' 7' ' ' PHE . 13.1 tp -129.72 145.76 51.52 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 127.298 2.239 . . . . 10.0 107.197 -176.474 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 33.3 mmtt -145.76 151.72 38.42 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 108.379 -0.971 . . . . 10.0 108.379 165.065 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 11.7 tp -63.25 156.46 25.4 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 108.419 -0.956 . . . . 10.0 108.419 173.48 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 24.3 ttpt -113.81 -52.85 2.72 Favored 'General case' 0 N--CA 1.437 -1.119 0 C-N-CA 126.433 1.893 . . . . 10.0 107.199 170.994 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 179.82 -78.95 0.06 OUTLIER Glycine 0 C--N 1.336 0.533 0 N-CA-C 109.736 -1.346 . . . . 10.0 109.736 174.486 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -170.6 176.14 4.41 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 107.45 -1.315 . . . . 10.0 107.45 -168.1 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -67.94 165.41 17.81 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.228 0.537 . . . . 10.0 112.37 -178.016 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -69.81 98.81 1.27 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.072 0.549 . . . . 10.0 110.025 170.586 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.0 t -82.64 134.74 35.16 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.213 0.605 . . . . 10.0 110.482 179.827 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 22.7 pt -98.04 -140.32 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 C-N-CA 124.718 1.207 . . . . 10.0 109.668 -177.225 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 76.86 -158.67 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.93 2.092 . . . . 10.0 110.875 179.682 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 153.19 -26.32 0.79 Allowed Glycine 0 CA--C 1.535 1.307 0 CA-C-O 118.705 -1.053 . . . . 10.0 115.164 -178.056 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.252 1.235 0 N-CA-C 106.925 -1.509 . . . . 10.0 106.925 -171.102 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 56.2 t . . . . . 0 N--CA 1.471 0.591 0 N-CA-C 108.631 -0.877 . . . . 10.0 108.631 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.1 p -134.93 164.35 27.81 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.368 1.467 . . . . 10.0 108.384 178.597 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -129.02 145.82 51.16 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 126.364 1.865 . . . . 10.0 109.628 -175.393 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 20.8 mtmt -106.82 92.16 3.97 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.383 1.473 . . . . 10.0 110.282 -165.706 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.602 ' HB1' HD11 ' A' ' 70' ' ' LEU . . . -97.61 151.67 19.84 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.906 1.682 . . . . 10.0 110.352 -171.822 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -124.43 148.04 47.89 Favored 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 124.24 1.016 . . . . 10.0 109.374 174.765 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.703 ' CE2' HD11 ' A' ' 57' ' ' LEU . 4.9 m-85 -137.7 140.73 40.91 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 124.581 1.176 . . . . 10.0 109.266 -169.773 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -103.37 129.95 50.56 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 125.742 1.617 . . . . 10.0 108.587 -171.661 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.4 mm -110.52 127.16 67.73 Favored 'Isoleucine or valine' 0 C--N 1.34 0.164 0 C-N-CA 123.8 0.84 . . . . 10.0 110.71 -163.711 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -116.31 102.38 9.5 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.805 -0.813 . . . . 10.0 108.805 169.751 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 156.07 -82.6 0.16 Allowed Glycine 0 C--N 1.338 0.649 0 CA-C-O 119.827 -0.43 . . . . 10.0 112.193 167.65 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 13.0 ptt? -163.43 122.01 2.0 Allowed 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.79 -0.448 . . . . 10.0 109.79 -171.288 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.6 t -159.0 56.14 0.42 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.015 0.926 . . . . 10.0 109.497 178.403 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.404 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 37.5 t -148.15 51.08 1.02 Allowed 'General case' 0 C--O 1.227 -0.125 0 O-C-N 122.152 -0.343 . . . . 10.0 110.845 -172.347 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.404 ' HB2' ' O ' ' A' ' 14' ' ' CYS . . . 165.55 -114.82 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 127.528 2.331 . . . . 10.0 107.629 173.824 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.86 -37.65 76.19 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 124.183 0.993 . . . . 10.0 109.31 -171.187 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 63.7 m -54.18 -56.91 13.66 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.879 1.671 . . . . 10.0 110.131 177.836 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -51.02 -54.02 28.26 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 121.796 0.808 . . . . 10.0 110.644 177.921 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -56.15 -40.21 73.51 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.25 -0.886 . . . . 10.0 110.908 178.125 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.04 -52.47 65.62 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 107.708 -1.219 . . . . 10.0 107.708 178.657 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.541 HG22 HD12 ' A' ' 25' ' ' LEU . 1.7 mt -46.25 -50.9 4.43 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.435 0 CA-C-O 117.652 -1.166 . . . . 10.0 111.011 -179.51 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -41.56 -57.65 2.18 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 119.147 0.885 . . . . 10.0 111.215 -178.316 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -67.43 -48.07 68.36 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 124.47 1.108 . . . . 10.0 110.566 -179.925 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.1 mmt180 -59.19 -21.7 59.85 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.326 0.861 . . . . 10.0 113.326 179.603 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.541 HD12 HG22 ' A' ' 21' ' ' ILE . 3.1 mt -92.55 -41.12 10.42 Favored 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 126.303 1.841 . . . . 10.0 110.693 171.973 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -52.06 -28.54 17.72 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.703 1.201 . . . . 10.0 110.167 174.6 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -44.81 -44.65 9.6 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 113.72 1.007 . . . . 10.0 113.72 168.411 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 7.3 mm -55.06 128.05 14.68 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 C-N-CA 123.125 0.57 . . . . 10.0 110.573 -179.316 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 20.0 mp0 -65.16 -51.86 58.59 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 122.17 -0.332 . . . . 10.0 111.066 -177.113 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.59 40.41 2.87 Favored Glycine 0 C--N 1.339 0.726 0 O-C-N 120.835 -1.165 . . . . 10.0 111.835 -173.411 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.2 p -99.3 148.64 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 C-N-CA 124.504 1.122 . . . . 10.0 108.571 -176.512 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -111.75 -56.96 2.32 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.1 0.96 . . . . 10.0 108.566 171.67 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -142.55 156.65 45.14 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 109.621 -0.511 . . . . 10.0 109.621 179.437 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -143.36 61.34 9.92 Favored Pre-proline 0 CA--C 1.535 0.4 0 C-N-CA 124.0 0.92 . . . . 10.0 110.721 174.605 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -78.68 71.54 6.86 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 122.76 2.306 . . . . 10.0 109.332 -176.724 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.449 HG12 HG13 ' A' ' 43' ' ' VAL . 3.6 m -64.09 153.51 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 O-C-N 121.728 -0.608 . . . . 10.0 111.002 -178.906 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 33.8 m120 -88.23 140.71 29.2 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 120.577 -0.449 . . . . 10.0 110.532 177.256 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -114.89 39.25 2.92 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.277 1.431 . . . . 10.0 111.034 -173.376 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -173.17 -40.94 0.01 OUTLIER 'General case' 0 C--O 1.226 -0.135 0 C-N-CA 124.907 1.283 . . . . 10.0 110.339 178.529 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.5 mt -74.9 -19.43 60.15 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.98 0.912 . . . . 10.0 111.56 -172.434 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 64.44 52.43 1.83 Allowed 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 125.704 1.602 . . . . 10.0 110.343 -178.477 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.8 p -143.94 130.36 19.93 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 125.51 1.524 . . . . 10.0 107.476 175.14 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.449 HG13 HG12 ' A' ' 36' ' ' VAL . 4.9 t -100.47 148.59 6.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 106.829 -1.545 . . . . 10.0 106.829 173.323 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 59.0 m -136.55 126.53 25.97 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 106.403 -1.702 . . . . 10.0 106.403 -176.029 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.424 HG22 HD13 ' A' ' 25' ' ' LEU . 14.4 t -131.83 122.93 50.6 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 CA-C-N 118.48 0.582 . . . . 10.0 111.13 -179.538 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.0 mp0 -89.24 98.17 11.62 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 106.538 -1.652 . . . . 10.0 106.538 165.579 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -141.51 161.77 37.1 Favored 'General case' 0 CA--C 1.516 -0.332 0 C-N-CA 122.979 0.512 . . . . 10.0 110.089 175.661 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 31.3 p30 -92.14 136.26 26.08 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.238 -0.437 . . . . 10.0 110.556 178.439 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -79.85 53.0 4.54 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 121.234 1.289 . . . . 10.0 109.229 170.42 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.84 1.16 2.75 Favored 'General case' 0 C--N 1.347 0.49 0 CA-C-N 118.722 0.692 . . . . 10.0 112.801 177.94 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -138.28 -53.03 0.61 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.374 1.07 . . . . 10.0 108.502 -168.02 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -125.2 -176.41 3.56 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.01 1.324 . . . . 10.0 109.401 173.873 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 85.8 p -135.34 171.44 14.43 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.219 1.008 . . . . 10.0 110.875 174.495 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 77.8 t -48.39 -50.38 12.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 123.45 0.7 . . . . 10.0 110.533 166.787 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 72.2 m -59.78 -33.13 71.3 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.382 0.673 . . . . 10.0 111.526 -178.208 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -70.87 -59.55 2.73 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 108.607 -0.886 . . . . 10.0 108.607 175.482 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.703 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.0 pp -61.65 -47.04 87.17 Favored 'General case' 0 N--CA 1.452 -0.374 0 O-C-N 121.607 -0.683 . . . . 10.0 112.058 -170.579 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.451 ' N ' HD12 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -49.3 -29.92 6.68 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 114.588 1.329 . . . . 10.0 114.588 170.428 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.61 -36.29 69.26 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 120.185 1.357 . . . . 10.0 109.993 177.586 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.29 -50.15 75.09 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.595 -0.52 . . . . 10.0 109.595 179.566 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.472 HG12 ' O ' ' A' ' 66' ' ' TYR . 53.2 t -62.28 -50.17 81.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 123.34 0.656 . . . . 10.0 111.732 175.12 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -53.1 -40.77 64.38 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.684 0.794 . . . . 10.0 109.915 179.906 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.3 tptm -74.01 -38.6 64.02 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 124.498 1.119 . . . . 10.0 110.44 -178.41 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 34.3 mt -54.69 -41.46 70.25 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.278 0.49 . . . . 10.0 111.186 166.849 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 151.24 -51.19 0.52 Allowed Glycine 0 CA--C 1.525 0.68 0 CA-C-N 118.567 0.621 . . . . 10.0 112.445 166.755 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.472 ' O ' HG12 ' A' ' 61' ' ' VAL . 10.2 p90 -76.07 157.22 33.18 Favored 'General case' 0 C--O 1.224 -0.25 0 N-CA-C 108.811 -0.811 . . . . 10.0 108.811 177.153 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 31.8 mtpt -103.02 157.75 16.77 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.352 0.596 . . . . 10.0 111.0 -172.663 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.484 HD11 ' HB2' ' A' ' 7' ' ' PHE . 34.2 tp -134.26 147.41 50.65 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.749 1.619 . . . . 10.0 108.419 -174.839 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 10.5 mmtp -152.46 156.01 38.62 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.771 1.628 . . . . 10.0 107.903 174.088 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.602 HD11 ' HB1' ' A' ' 5' ' ' ALA . 6.8 tp -66.5 159.05 28.07 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 109.771 -0.455 . . . . 10.0 109.771 176.029 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 6.0 tttp -113.76 -57.25 2.31 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 125.458 1.503 . . . . 10.0 108.409 169.651 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -172.72 -79.69 0.05 OUTLIER Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.273 -1.131 . . . . 10.0 110.273 179.962 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -166.61 174.96 8.32 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.378 1.071 . . . . 10.0 108.435 -176.226 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.81 123.11 4.8 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 124.296 0.998 . . . . 10.0 111.364 171.231 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -122.9 149.21 44.52 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 107.759 -1.2 . . . . 10.0 107.759 160.212 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.6 t -141.67 141.03 33.36 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 107.022 -1.473 . . . . 10.0 107.022 175.527 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.5 mt 67.8 7.2 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 C-N-CA 124.067 0.947 . . . . 10.0 111.068 -177.361 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 58.1 63.63 1.71 Allowed 'General case' 0 C--N 1.343 0.298 0 C-N-CA 125.38 1.472 . . . . 10.0 108.822 -178.734 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -164.67 -83.95 0.05 OUTLIER Glycine 0 CA--C 1.526 0.75 0 CA-C-O 119.231 -0.761 . . . . 10.0 113.638 -172.435 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 6.1 mtp85 . . . . . 0 C--O 1.252 1.204 0 C-N-CA 126.769 2.028 . . . . 10.0 105.886 -167.548 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 98.8 t . . . . . 0 N--CA 1.471 0.594 0 N-CA-C 107.556 -1.275 . . . . 10.0 107.556 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.558 HG21 ' HB2' ' A' ' 32' ' ' ALA . 4.5 p -126.21 162.57 25.12 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.883 1.673 . . . . 10.0 108.407 -178.848 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -134.85 136.53 42.52 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 126.101 1.76 . . . . 10.0 108.03 -170.228 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -102.86 113.63 27.23 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.005 0.922 . . . . 10.0 111.625 -168.415 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.549 ' HB1' HD11 ' A' ' 70' ' ' LEU . . . -115.64 149.95 37.5 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 127.306 2.243 . . . . 10.0 109.215 -172.32 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -124.24 146.97 48.41 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.493 1.117 . . . . 10.0 108.872 174.086 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.727 ' CE2' HD11 ' A' ' 57' ' ' LEU . 1.9 m-85 -140.57 137.61 33.84 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 124.889 1.368 . . . . 10.0 110.467 -168.168 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -91.27 133.67 35.21 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 126.011 1.724 . . . . 10.0 109.421 -175.915 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.462 HD11 HG23 ' A' ' 43' ' ' VAL . 3.3 mm -113.1 134.38 55.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 125.611 1.565 . . . . 10.0 110.491 -173.959 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -126.89 103.41 7.48 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.059 0.943 . . . . 10.0 108.645 171.252 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 116.48 39.87 0.83 Allowed Glycine 0 CA--C 1.531 1.091 0 C-N-CA 123.833 0.73 . . . . 10.0 114.017 167.934 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -98.09 177.03 5.54 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.746 1.218 . . . . 10.0 110.996 -179.363 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 41.0 p -113.77 -7.16 13.27 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 123.763 0.825 . . . . 10.0 112.365 172.793 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 23.6 m 57.55 44.65 20.7 Favored 'General case' 0 C--N 1.342 0.242 0 C-N-CA 124.037 0.935 . . . . 10.0 110.69 178.19 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -162.23 -94.58 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.879 -0.786 . . . . 10.0 108.879 176.758 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.23 -38.27 43.4 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 109.134 -0.691 . . . . 10.0 109.134 -173.421 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 23.2 m -59.59 -54.78 42.54 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 109.488 -0.56 . . . . 10.0 109.488 175.226 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -48.28 -50.18 30.86 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.383 1.073 . . . . 10.0 110.567 172.742 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -59.09 -42.19 89.84 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 121.312 -0.868 . . . . 10.0 112.422 177.971 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.29 -45.96 79.96 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.085 0.954 . . . . 10.0 108.931 179.305 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.453 HG22 HD12 ' A' ' 25' ' ' LEU . 3.0 mt -43.7 -52.48 1.25 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.346 0 CA-C-O 118.362 -0.827 . . . . 10.0 110.532 175.572 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -48.0 -49.02 32.25 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 118.531 0.605 . . . . 10.0 110.873 -177.23 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.61 -47.69 58.85 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 121.627 -0.671 . . . . 10.0 110.533 -179.677 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.487 ' HB3' ' HB1' ' A' ' 60' ' ' ALA . 1.2 mmp_? -54.63 -33.8 61.11 Favored 'General case' 0 C--O 1.225 -0.235 0 C-N-CA 124.008 0.923 . . . . 10.0 112.181 178.305 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.565 HD21 ' HB2' ' A' ' 57' ' ' LEU . 0.3 OUTLIER -88.99 -33.63 17.13 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 125.621 1.569 . . . . 10.0 111.392 177.605 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -60.06 -27.17 66.73 Favored 'General case' 0 C--O 1.225 -0.202 0 O-C-N 121.486 -0.759 . . . . 10.0 110.258 174.4 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.2 mmpt? -53.68 -34.26 58.13 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 113.736 1.013 . . . . 10.0 113.736 168.847 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 12.5 mm -56.4 127.92 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 119.126 0.875 . . . . 10.0 109.504 177.354 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -63.59 -56.93 12.07 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.515 -0.311 . . . . 10.0 110.486 -175.836 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.54 49.83 3.72 Favored Glycine 0 C--N 1.341 0.845 0 O-C-N 120.692 -1.255 . . . . 10.0 110.919 -173.042 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -105.71 146.06 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 C-N-CA 124.296 1.039 . . . . 10.0 108.244 -178.151 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.558 ' HB2' HG21 ' A' ' 2' ' ' THR . . . -102.17 -52.22 3.2 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 108.375 -0.972 . . . . 10.0 108.375 176.004 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.0 p30 -160.23 149.37 17.41 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.449 -0.945 . . . . 10.0 108.449 -174.905 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -136.26 59.2 25.38 Favored Pre-proline 0 CA--C 1.536 0.424 0 C-N-CA 124.186 0.994 . . . . 10.0 111.54 178.077 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -77.0 74.84 4.82 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.031 2.487 . . . . 10.0 109.626 -178.964 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.574 HG12 HG13 ' A' ' 43' ' ' VAL . 3.0 m -65.28 158.42 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 C-N-CA 123.402 0.681 . . . . 10.0 111.428 179.988 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -96.35 121.71 38.44 Favored 'General case' 0 C--N 1.339 0.136 0 CA-C-O 120.83 0.347 . . . . 10.0 111.71 -176.861 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -96.15 50.16 1.16 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.303 1.441 . . . . 10.0 111.231 179.785 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -175.0 -40.72 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.228 0 C-N-CA 124.162 0.985 . . . . 10.0 109.928 172.533 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.1 mt -81.79 -11.6 58.91 Favored 'General case' 0 C--O 1.226 -0.146 0 C-N-CA 124.294 1.038 . . . . 10.0 112.214 -167.74 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 71.77 36.13 1.27 Allowed 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 125.403 1.481 . . . . 10.0 110.897 173.296 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.8 p -138.95 131.04 28.04 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.019 1.328 . . . . 10.0 108.312 -178.096 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.574 HG13 HG12 ' A' ' 36' ' ' VAL . 18.9 t -91.52 149.14 4.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 107.112 -1.44 . . . . 10.0 107.112 167.746 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 68.4 m -137.12 124.3 21.72 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 105.667 -1.975 . . . . 10.0 105.667 -179.553 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 47.9 t -135.98 138.44 47.46 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 CA-C-N 118.454 0.57 . . . . 10.0 109.712 179.278 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -101.95 112.71 25.44 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 107.226 -1.398 . . . . 10.0 107.226 165.145 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -146.99 165.92 28.38 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 123.361 0.664 . . . . 10.0 109.34 179.295 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 31.0 p30 -95.71 128.16 38.8 Favored Pre-proline 0 C--N 1.328 -0.341 0 N-CA-C 110.508 -0.182 . . . . 10.0 110.508 178.494 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -75.65 61.51 6.18 Favored 'Trans proline' 0 N--CA 1.45 -1.032 0 N-CA-C 108.507 -1.382 . . . . 10.0 108.507 169.205 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.31 -44.51 0.37 Allowed 'General case' 0 C--N 1.343 0.295 0 O-C-N 122.122 -0.361 . . . . 10.0 110.379 177.523 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -90.49 -36.61 14.41 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 122.378 0.271 . . . . 10.0 110.333 178.637 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -137.36 -175.58 4.11 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.542 1.137 . . . . 10.0 110.066 -179.707 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 91.5 p -147.05 172.44 13.74 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.295 0.638 . . . . 10.0 111.49 179.872 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 92.0 t -48.79 -45.4 15.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 124.051 0.94 . . . . 10.0 111.081 171.12 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.5 m -60.54 -37.22 80.51 Favored 'General case' 0 C--O 1.234 0.259 0 O-C-N 121.976 -0.452 . . . . 10.0 112.154 -179.689 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -65.71 -60.1 3.24 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 108.091 -1.078 . . . . 10.0 108.091 179.816 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.727 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.1 pp -63.48 -40.03 96.02 Favored 'General case' 0 N--CA 1.454 -0.24 0 O-C-N 121.55 -0.719 . . . . 10.0 111.477 -175.774 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.8 ttpp -39.16 -59.14 1.05 Allowed 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 117.627 -1.178 . . . . 10.0 111.004 162.653 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -47.85 -37.84 14.75 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-O 122.064 0.935 . . . . 10.0 110.755 -174.797 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.487 ' HB1' ' HB3' ' A' ' 24' ' ' ARG . . . -59.28 -49.76 76.61 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.041 -0.981 . . . . 10.0 109.784 -178.114 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.536 ' HA ' HD12 ' A' ' 64' ' ' LEU . 77.0 t -68.34 -45.65 82.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 124.536 1.134 . . . . 10.0 111.748 175.487 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -46.18 -44.67 16.2 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 126.576 1.95 . . . . 10.0 108.349 176.11 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -80.63 -34.63 34.84 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.238 1.415 . . . . 10.0 111.349 -176.887 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.536 HD12 ' HA ' ' A' ' 61' ' ' VAL . 18.7 mt -51.97 -43.43 63.56 Favored 'General case' 0 C--N 1.34 0.196 0 CA-C-N 118.871 0.759 . . . . 10.0 111.869 169.033 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 150.81 -35.18 0.93 Allowed Glycine 0 CA--C 1.525 0.666 0 C-N-CA 121.277 -0.487 . . . . 10.0 113.057 172.717 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -99.63 159.13 15.27 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.687 1.195 . . . . 10.0 107.888 -178.52 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.3 ttpt -94.8 155.16 16.93 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.194 0.521 . . . . 10.0 109.871 -176.984 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.583 HD11 ' HB2' ' A' ' 7' ' ' PHE . 24.8 tp -124.9 149.85 47.13 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 126.439 1.896 . . . . 10.0 107.528 179.756 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 34.0 mmtt -149.18 156.88 42.82 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 124.803 1.241 . . . . 10.0 108.332 162.905 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.549 HD11 ' HB1' ' A' ' 5' ' ' ALA . 8.7 tp -66.09 158.79 27.59 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 109.083 -0.71 . . . . 10.0 109.083 173.963 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.56 -56.45 2.4 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 125.551 1.54 . . . . 10.0 107.159 166.461 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -176.35 -83.01 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 109.609 -1.396 . . . . 10.0 109.609 179.13 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -168.9 173.49 7.01 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.544 0.738 . . . . 10.0 109.379 -167.923 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.4 pp0? -58.81 109.26 0.78 Allowed 'General case' 0 CA--C 1.534 0.341 0 O-C-N 124.567 1.167 . . . . 10.0 111.823 -174.979 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -82.43 95.91 7.82 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 108.551 -0.907 . . . . 10.0 108.551 179.052 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.7 t -154.55 163.65 39.89 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 108.837 -0.801 . . . . 10.0 108.837 170.093 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.1 pt -128.19 90.96 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 125.35 1.46 . . . . 10.0 109.755 177.287 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -121.43 138.87 54.09 Favored 'General case' 0 CA--C 1.527 0.095 0 N-CA-C 108.044 -1.095 . . . . 10.0 108.044 175.697 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -171.76 -174.06 39.05 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 109.752 -1.339 . . . . 10.0 109.752 -175.034 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.255 1.348 0 C-N-CA 125.488 1.515 . . . . 10.0 107.49 -177.889 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 60.1 t . . . . . 0 N--CA 1.469 0.505 0 N-CA-C 107.162 -1.421 . . . . 10.0 107.162 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.481 HG21 ' HB2' ' A' ' 32' ' ' ALA . 5.0 p -96.76 171.21 8.66 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.768 1.227 . . . . 10.0 111.02 175.958 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -136.57 151.67 49.63 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 128.434 2.694 . . . . 10.0 107.8 179.548 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 17.0 mmtt -96.86 118.13 32.61 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 108.491 -0.929 . . . . 10.0 108.491 175.796 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -113.68 138.54 50.07 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 124.253 1.021 . . . . 10.0 109.749 172.5 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -113.82 145.79 40.91 Favored 'General case' 0 CA--C 1.51 -0.591 0 C-N-CA 124.589 1.156 . . . . 10.0 110.246 174.97 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.648 ' CE2' HD11 ' A' ' 57' ' ' LEU . 3.9 m-85 -139.17 142.52 37.96 Favored 'General case' 0 N--CA 1.448 -0.575 0 O-C-N 125.036 1.46 . . . . 10.0 110.056 -177.077 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -103.59 134.38 47.02 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 125.882 1.673 . . . . 10.0 108.604 -174.371 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.3 mm -109.58 125.25 66.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 C-N-CA 123.711 0.804 . . . . 10.0 110.422 -162.886 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -119.22 108.46 14.67 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.476 -0.935 . . . . 10.0 108.476 173.005 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 148.86 -87.34 0.15 Allowed Glycine 0 C--N 1.337 0.598 0 N-CA-C 111.511 -0.636 . . . . 10.0 111.511 170.196 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.4 mmt -81.18 159.88 24.5 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 122.675 0.39 . . . . 10.0 110.127 178.483 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 m -59.7 -88.31 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 126.677 1.991 . . . . 10.0 109.562 179.387 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.5 p 146.02 60.08 0.0 OUTLIER 'General case' 0 C--N 1.341 0.232 0 C-N-CA 125.029 1.332 . . . . 10.0 107.882 -159.385 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -153.12 -78.23 0.11 Allowed 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 107.039 -1.467 . . . . 10.0 107.039 172.799 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.65 -50.83 63.55 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 107.109 -1.441 . . . . 10.0 107.109 176.156 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 7.6 t -52.12 -65.86 0.49 Allowed 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 114.071 -1.422 . . . . 10.0 110.462 172.456 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -39.96 -55.04 2.11 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.248 1.019 . . . . 10.0 111.628 177.956 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -52.72 -36.62 57.83 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.961 0.726 . . . . 10.0 112.961 179.122 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.0 ttt180 -84.93 -42.02 15.37 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 126.058 1.743 . . . . 10.0 109.604 -172.653 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.424 ' CG2' HD12 ' A' ' 25' ' ' LEU . 18.4 mm -41.66 -57.05 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.323 0 C-N-CA 124.368 1.067 . . . . 10.0 108.66 166.756 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -42.53 -50.62 5.27 Favored 'General case' 0 C--O 1.221 -0.4 0 O-C-N 123.576 0.548 . . . . 10.0 111.399 179.389 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.7 -49.79 56.13 Favored 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 121.875 -0.516 . . . . 10.0 109.631 -176.289 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.432 ' HG3' HD11 ' A' ' 64' ' ' LEU . 6.9 mmt85 -57.65 -38.65 75.44 Favored 'General case' 0 C--O 1.226 -0.149 0 O-C-N 121.94 -0.475 . . . . 10.0 112.036 -179.437 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.424 HD12 ' CG2' ' A' ' 21' ' ' ILE . 0.5 OUTLIER -74.36 -46.35 41.15 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.194 0.997 . . . . 10.0 110.147 177.396 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 53.0 m-20 -54.95 -24.08 22.12 Favored 'General case' 0 C--O 1.226 -0.135 0 C-N-CA 123.319 0.648 . . . . 10.0 111.503 174.941 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.3 ttmt -56.19 -39.53 72.56 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 118.372 0.533 . . . . 10.0 112.225 175.665 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.7 mp -56.74 135.87 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 C-N-CA 123.873 0.869 . . . . 10.0 110.436 179.09 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 55.9 mp0 -70.78 -49.46 46.33 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 116.274 -0.421 . . . . 10.0 110.091 -174.119 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.22 49.01 4.15 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.973 -0.851 . . . . 10.0 110.973 -177.836 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.4 p -110.74 155.54 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 126.009 1.724 . . . . 10.0 109.073 178.03 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.481 ' HB2' HG21 ' A' ' 2' ' ' THR . . . -120.34 -56.78 1.97 Allowed 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 110.235 -0.283 . . . . 10.0 110.235 168.648 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -144.97 149.04 34.48 Favored 'General case' 0 C--O 1.226 -0.172 0 N-CA-C 107.992 -1.114 . . . . 10.0 107.992 -171.484 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -142.85 63.73 13.97 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 118.708 0.685 . . . . 10.0 111.201 172.4 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -76.71 74.32 4.91 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.926 2.417 . . . . 10.0 109.38 178.135 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.494 HG12 HG13 ' A' ' 43' ' ' VAL . 11.4 m -66.02 158.27 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 C-N-CA 123.624 0.77 . . . . 10.0 112.082 179.702 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -90.72 101.69 14.44 Favored 'General case' 0 N--CA 1.46 0.069 0 C-N-CA 120.441 -0.504 . . . . 10.0 111.706 -165.982 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -75.55 42.22 0.21 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.249 1.82 . . . . 10.0 113.938 -173.302 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -177.07 -36.3 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.288 1.435 . . . . 10.0 110.64 176.513 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.2 mt -88.67 0.99 55.88 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.635 1.174 . . . . 10.0 112.667 -169.156 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 58.26 45.5 17.11 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 124.789 1.235 . . . . 10.0 110.402 170.955 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -145.39 129.12 17.22 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.694 -1.224 . . . . 10.0 107.694 -178.124 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.494 HG13 HG12 ' A' ' 36' ' ' VAL . 5.5 t -97.55 126.79 50.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 108.277 -1.008 . . . . 10.0 108.277 175.575 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 84.0 m -113.8 112.26 23.1 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.982 1.713 . . . . 10.0 107.457 178.687 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 41.3 t -106.09 141.59 21.01 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.044 0 CA-C-N 118.359 0.527 . . . . 10.0 110.183 177.49 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -108.12 109.77 21.27 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 125.376 1.47 . . . . 10.0 108.016 160.227 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -143.2 169.57 17.37 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.905 -0.776 . . . . 10.0 108.905 177.288 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 7.3 p-10 -115.46 115.34 42.22 Favored Pre-proline 0 CA--C 1.531 0.238 0 C-N-CA 123.722 0.809 . . . . 10.0 110.021 -178.708 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -74.56 72.1 4.46 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.376 2.717 . . . . 10.0 111.015 -175.832 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.88 -39.16 0.63 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.075 0.55 . . . . 10.0 110.934 168.548 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -86.94 -51.07 6.25 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.193 0.451 . . . . 10.0 110.107 176.756 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -123.76 -175.0 3.11 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.784 1.234 . . . . 10.0 110.742 -171.653 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 83.2 p -144.46 167.94 21.3 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.575 0.75 . . . . 10.0 112.677 177.762 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 23.5 m -47.0 -43.19 6.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 124.57 1.148 . . . . 10.0 111.515 164.312 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 68.3 m -68.78 -40.89 79.42 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 122.782 0.433 . . . . 10.0 110.731 -177.095 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -57.78 -59.48 5.15 Favored 'General case' 0 N--CA 1.455 -0.199 0 O-C-N 123.916 0.76 . . . . 10.0 109.297 176.396 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.648 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.2 pp -65.05 -39.38 93.23 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 122.165 -0.334 . . . . 10.0 110.933 -171.536 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.408 ' HA ' HD23 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -43.46 -45.64 6.44 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 118.254 -0.879 . . . . 10.0 113.194 163.812 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -59.92 -40.56 89.25 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 120.236 1.38 . . . . 10.0 111.024 179.802 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -55.44 -49.41 72.49 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 122.106 -0.371 . . . . 10.0 110.104 178.366 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.519 ' HA ' HD12 ' A' ' 64' ' ' LEU . 24.8 t -66.08 -43.44 92.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 N-CA-C 112.815 0.672 . . . . 10.0 112.815 176.207 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -53.19 -44.0 67.59 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.841 0.829 . . . . 10.0 109.081 177.841 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.0 tttp -80.21 -30.59 38.69 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 124.722 1.209 . . . . 10.0 111.591 -175.246 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.519 HD12 ' HA ' ' A' ' 61' ' ' VAL . 15.1 mt -51.38 -35.49 39.01 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.407 1.003 . . . . 10.0 111.507 162.36 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 115.78 28.35 2.73 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 123.041 0.353 . . . . 10.0 112.822 169.066 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -145.67 158.24 43.87 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 107.251 -1.388 . . . . 10.0 107.251 168.443 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.24 130.96 37.82 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.69 -0.485 . . . . 10.0 109.69 -166.146 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.468 HD11 ' HB2' ' A' ' 7' ' ' PHE . 12.1 tp -114.9 146.98 40.55 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 106.265 -1.754 . . . . 10.0 106.265 173.261 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 17.6 tptt -153.09 150.14 28.82 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 109.053 -0.721 . . . . 10.0 109.053 168.458 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.9 tp -62.39 156.6 22.09 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 109.316 -0.624 . . . . 10.0 109.316 178.04 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 42.1 tttt -117.22 -64.24 1.33 Allowed 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 126.326 1.85 . . . . 10.0 107.742 178.905 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 154.06 50.71 0.01 OUTLIER Glycine 0 CA--C 1.527 0.8 0 CA-C-O 119.661 -0.522 . . . . 10.0 112.337 174.967 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 66.99 160.03 0.15 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.267 1.427 . . . . 10.0 111.989 175.014 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -80.26 -41.46 24.99 Favored 'General case' 0 CA--C 1.529 0.165 0 O-C-N 121.609 -0.682 . . . . 10.0 110.268 172.786 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 39.9 t0 53.99 64.19 1.92 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.318 1.447 . . . . 10.0 110.759 -171.304 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 17.3 m -128.75 41.9 3.41 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.753 1.221 . . . . 10.0 110.008 -177.058 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.536 HG22 ' H ' ' A' ' 78' ' ' GLU . 15.9 mm -103.86 -135.98 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 N-CA-C 108.177 -1.045 . . . . 10.0 108.177 -179.908 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.536 ' H ' HG22 ' A' ' 77' ' ' ILE . 2.9 mt-10 -159.22 177.5 10.98 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.83 2.052 . . . . 10.0 106.37 -178.533 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -80.46 -157.26 14.91 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 123.454 0.55 . . . . 10.0 111.979 179.366 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 . . . . . 0 C--O 1.249 1.078 0 N-CA-C 106.954 -1.499 . . . . 10.0 106.954 159.653 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 2.7 p . . . . . 0 N--CA 1.474 0.751 0 N-CA-C 109.931 -0.396 . . . . 10.0 109.931 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.512 HG21 ' HB2' ' A' ' 32' ' ' ALA . 9.8 p -133.36 173.94 10.93 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.844 1.658 . . . . 10.0 107.195 176.041 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -138.39 142.81 39.6 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 129.12 2.968 . . . . 10.0 106.989 -174.227 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 28.9 tttt -111.32 98.69 7.67 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.373 1.069 . . . . 10.0 110.09 -171.504 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -99.92 150.15 22.69 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.834 -1.075 . . . . 10.0 108.844 -175.641 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -122.36 150.17 42.77 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 123.221 0.608 . . . . 10.0 109.919 172.286 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.646 ' CE2' HD11 ' A' ' 57' ' ' LEU . 7.8 m-85 -138.26 137.14 37.2 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 125.452 1.72 . . . . 10.0 108.335 -169.477 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -99.45 139.64 34.81 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 106.328 -1.731 . . . . 10.0 106.328 178.874 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.0 mm -114.32 141.39 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 C-N-CA 124.995 1.318 . . . . 10.0 109.913 -162.779 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -130.82 102.52 6.11 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 108.155 -1.054 . . . . 10.0 108.155 176.702 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 110.59 18.17 8.69 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 123.97 0.795 . . . . 10.0 114.018 170.043 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 28.3 ptm -79.85 165.35 22.8 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 118.724 1.262 . . . . 10.0 109.533 168.149 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 30.0 m -87.56 -59.31 2.28 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 126.147 1.779 . . . . 10.0 107.842 179.946 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 13.5 p 162.66 -121.23 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 128.187 2.595 . . . . 10.0 104.159 -177.51 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.36 -40.1 96.33 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.604 1.161 . . . . 10.0 112.704 -174.042 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.83 -44.09 97.06 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.207 -1.034 . . . . 10.0 108.207 -173.214 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 3.6 m -65.33 -55.73 16.58 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 114.996 -1.002 . . . . 10.0 109.951 177.554 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -41.55 -47.92 3.87 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.733 1.213 . . . . 10.0 111.883 176.282 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -54.89 -38.75 67.95 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.392 -0.367 . . . . 10.0 111.274 179.677 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.92 -42.04 41.0 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 118.306 -0.854 . . . . 10.0 111.033 176.202 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 27.2 mm -43.15 -55.1 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.411 0 CA-C-N 118.65 0.659 . . . . 10.0 109.573 174.028 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -43.17 -57.41 2.96 Favored 'General case' 0 C--O 1.222 -0.377 0 C-N-CA 123.244 0.618 . . . . 10.0 111.607 -179.48 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.06 -41.88 63.68 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.392 1.077 . . . . 10.0 109.794 -170.601 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.416 ' HG3' ' HB1' ' A' ' 60' ' ' ALA . 25.6 tpt180 -53.81 -45.65 70.86 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.328 0.651 . . . . 10.0 109.958 175.358 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.03 -37.72 64.25 Favored 'General case' 0 C--O 1.224 -0.284 0 C-N-CA 123.2 0.6 . . . . 10.0 111.858 176.046 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -51.98 -32.39 33.36 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 123.723 0.809 . . . . 10.0 109.788 175.317 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.7 -33.42 70.16 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.947 1.091 . . . . 10.0 113.947 175.478 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 17.0 mm -57.48 133.21 22.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 108.314 -0.995 . . . . 10.0 108.314 177.465 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -80.29 -41.88 24.12 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 118.486 0.585 . . . . 10.0 110.757 -172.039 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -78.91 39.92 2.05 Favored Glycine 0 C--N 1.339 0.738 0 O-C-N 120.117 -1.614 . . . . 10.0 112.491 176.1 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.4 p -105.68 148.22 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 C-N-CA 124.179 0.991 . . . . 10.0 108.363 -176.594 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.512 ' HB2' HG21 ' A' ' 2' ' ' THR . . . -115.54 -56.36 2.35 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.92 -0.77 . . . . 10.0 108.92 174.876 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 64.2 m-80 -147.32 152.76 38.77 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 109.264 -0.643 . . . . 10.0 109.264 -178.546 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -134.81 65.85 67.26 Favored Pre-proline 0 CA--C 1.534 0.341 0 C-N-CA 123.639 0.776 . . . . 10.0 110.015 173.667 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -78.92 67.33 8.57 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.825 2.35 . . . . 10.0 109.078 -178.946 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.473 HG12 HG13 ' A' ' 43' ' ' VAL . 5.0 m -69.59 157.58 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 C-N-CA 122.889 0.476 . . . . 10.0 111.339 -175.89 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -91.51 126.36 36.57 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 121.276 0.56 . . . . 10.0 110.82 -178.675 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -99.61 33.07 2.61 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.962 1.705 . . . . 10.0 112.015 -168.522 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -171.12 -40.71 0.02 OUTLIER 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 124.542 1.137 . . . . 10.0 110.661 179.986 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.1 mt -72.57 -20.06 61.38 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.089 0.956 . . . . 10.0 111.477 -173.31 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 65.17 51.59 1.62 Allowed 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 125.664 1.586 . . . . 10.0 110.424 -178.018 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.1 p -140.1 124.37 17.82 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 125.457 1.503 . . . . 10.0 107.066 173.606 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.473 HG13 HG12 ' A' ' 36' ' ' VAL . 7.9 t -97.2 135.3 31.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 107.773 -1.195 . . . . 10.0 107.773 175.581 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.6 m -120.85 127.84 52.28 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 126.161 1.785 . . . . 10.0 107.418 178.708 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 36.6 t -131.9 128.18 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.123 0 CA-C-N 118.678 0.672 . . . . 10.0 110.093 178.94 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -93.13 102.11 14.41 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 105.314 -2.106 . . . . 10.0 105.314 165.968 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -135.7 176.78 8.37 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.536 1.134 . . . . 10.0 108.612 178.812 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 27.7 p30 -116.96 135.78 23.12 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 118.879 0.763 . . . . 10.0 110.986 175.682 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -79.7 56.84 6.22 Favored 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 121.435 1.424 . . . . 10.0 108.85 167.307 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.8 ptpt -123.88 -39.51 2.38 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 118.133 0.424 . . . . 10.0 111.344 172.828 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -97.99 -61.68 1.35 Allowed 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 107.425 -1.324 . . . . 10.0 107.425 177.48 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -105.62 -174.96 2.66 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 125.047 1.339 . . . . 10.0 111.102 -171.718 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 87.7 p -144.68 164.9 29.59 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 121.673 0.749 . . . . 10.0 109.985 173.692 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.2 m -52.58 -37.47 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 C-N-CA 124.384 1.073 . . . . 10.0 111.154 172.228 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.2 t -62.72 -40.45 97.24 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 122.47 0.308 . . . . 10.0 110.708 177.058 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -65.67 -52.79 48.81 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.891 -0.781 . . . . 10.0 108.891 -175.97 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.646 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.0 pp -64.77 -42.47 95.08 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 121.762 -0.586 . . . . 10.0 111.218 -178.482 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -41.54 -55.22 2.94 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-O 117.737 -1.125 . . . . 10.0 111.751 162.345 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 -56.58 -48.28 77.73 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 119.939 1.245 . . . . 10.0 110.353 178.669 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.416 ' HB1' ' HG3' ' A' ' 24' ' ' ARG . . . -51.29 -45.31 62.1 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 109.59 -0.522 . . . . 10.0 109.59 -178.665 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 99.5 t -69.39 -46.98 75.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 112.401 0.519 . . . . 10.0 112.401 174.017 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -45.59 -42.35 11.04 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.482 1.513 . . . . 10.0 109.522 177.556 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -79.96 -26.2 40.09 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 125.104 1.362 . . . . 10.0 111.329 -173.879 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 67.9 mt -55.96 -41.23 74.39 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 119.489 1.041 . . . . 10.0 110.91 164.559 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 149.03 -40.79 0.88 Allowed Glycine 0 CA--C 1.526 0.755 0 CA-C-N 118.088 0.404 . . . . 10.0 112.531 173.227 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -96.02 157.51 15.86 Favored 'General case' 0 C--N 1.334 -0.099 0 C-N-CA 124.204 1.002 . . . . 10.0 109.351 -177.749 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 63.5 mmtt -92.12 148.61 22.04 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 121.506 0.67 . . . . 10.0 110.341 -170.426 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 10.5 tp -124.46 148.73 47.47 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.115 1.766 . . . . 10.0 106.608 176.675 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.0 tptm -151.48 145.14 24.99 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 117.956 0.344 . . . . 10.0 110.711 165.478 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.4 tt -64.9 159.41 22.81 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-O 121.462 0.649 . . . . 10.0 109.684 178.36 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 27.5 tttt -127.38 -55.54 1.34 Allowed 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 127.701 2.4 . . . . 10.0 107.829 -175.979 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 176.34 -89.91 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 107.92 -2.072 . . . . 10.0 107.92 177.522 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -167.42 169.31 12.35 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.788 0.835 . . . . 10.0 108.795 -164.295 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -58.84 140.03 55.7 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 123.745 0.653 . . . . 10.0 112.043 -176.034 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -71.12 73.31 0.64 Allowed 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 108.393 -0.966 . . . . 10.0 108.393 167.844 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 11.5 t -152.97 127.29 9.21 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.166 -0.679 . . . . 10.0 109.166 175.878 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.4 pt -129.91 88.45 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 124.946 1.298 . . . . 10.0 109.096 179.702 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -108.68 140.94 41.36 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 107.646 -1.242 . . . . 10.0 107.646 173.986 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -101.93 -137.15 9.53 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 123.966 0.793 . . . . 10.0 111.649 -173.953 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.255 1.346 0 N-CA-C 105.085 -2.191 . . . . 10.0 105.085 170.503 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.726 HG22 ' H ' ' A' ' 2' ' ' THR . 8.9 p . . . . . 0 N--CA 1.468 0.426 0 N-CA-C 105.929 -1.878 . . . . 10.0 105.929 . . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.726 ' H ' HG22 ' A' ' 1' ' ' VAL . 2.7 p -92.14 160.19 15.31 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 126.695 1.998 . . . . 10.0 109.786 -178.044 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -125.33 145.35 50.07 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 126.581 1.952 . . . . 10.0 108.273 -169.98 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.8 mmtm -87.15 124.45 33.28 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 124.096 0.959 . . . . 10.0 109.675 -175.166 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.474 ' HB1' HD11 ' A' ' 70' ' ' LEU . . . -125.35 143.11 51.13 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.16 1.784 . . . . 10.0 109.349 176.95 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -121.31 146.75 46.51 Favored 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 123.518 0.727 . . . . 10.0 109.096 172.881 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.823 ' CE2' HD11 ' A' ' 57' ' ' LEU . 3.8 m-85 -133.39 140.27 47.26 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 125.194 1.559 . . . . 10.0 108.522 -173.443 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -96.99 141.79 29.72 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.687 1.995 . . . . 10.0 107.618 -177.471 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.548 HG13 HD12 ' A' ' 68' ' ' LEU . 3.3 mp -132.41 148.5 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 125.236 1.415 . . . . 10.0 110.531 -167.407 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -133.56 89.93 2.65 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 112.286 -2.234 . . . . 10.0 106.229 175.613 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 154.35 -74.76 0.24 Allowed Glycine 0 C--N 1.341 0.822 0 C-N-CA 119.601 -1.285 . . . . 10.0 113.904 167.779 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.5 103.35 4.1 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 122.697 1.237 . . . . 10.0 111.118 -169.382 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.9 t -135.18 61.15 1.67 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.116 -1.402 . . . . 10.0 108.371 -165.561 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.3 m -146.44 -89.72 0.09 Allowed 'General case' 0 C--N 1.341 0.216 0 N-CA-C 107.78 -1.193 . . . . 10.0 107.78 175.747 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 179.36 -42.96 0.01 OUTLIER 'General case' 0 C--O 1.223 -0.294 0 C-N-CA 124.493 1.117 . . . . 10.0 109.674 -174.682 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.07 -50.93 17.44 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.649 -0.871 . . . . 10.0 108.649 -175.337 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 12.9 m -58.95 -52.43 65.8 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 109.358 -0.608 . . . . 10.0 109.358 177.21 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -44.84 -51.39 9.6 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.894 1.278 . . . . 10.0 111.431 170.862 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -56.87 -34.96 68.37 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 121.198 -0.939 . . . . 10.0 112.334 177.925 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.81 -40.88 89.9 Favored 'General case' 0 N--CA 1.455 -0.219 0 O-C-N 120.904 -1.122 . . . . 10.0 109.301 176.298 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.53 HG22 HD12 ' A' ' 25' ' ' LEU . 20.8 mm -54.13 -49.4 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 108.772 -0.825 . . . . 10.0 108.772 -177.945 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -45.8 -56.42 5.37 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.568 0.747 . . . . 10.0 110.967 -179.895 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.8 mtmt -66.29 -44.6 83.06 Favored 'General case' 0 N--CA 1.453 -0.291 0 O-C-N 121.845 -0.534 . . . . 10.0 111.084 179.583 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.0 tpt85 -56.88 -30.74 64.17 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 111.487 0.18 . . . . 10.0 111.487 178.829 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.53 HD12 HG22 ' A' ' 21' ' ' ILE . 0.3 OUTLIER -84.0 -38.34 21.05 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 125.469 1.508 . . . . 10.0 111.46 174.894 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -60.67 -26.75 67.32 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.779 0.832 . . . . 10.0 109.785 178.845 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.0 mmpt? -50.69 -35.88 33.18 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 114.058 1.133 . . . . 10.0 114.058 168.397 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 13.4 mm -62.84 126.89 22.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 118.63 0.65 . . . . 10.0 109.388 -178.784 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -56.19 -57.53 11.81 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.13 0.419 . . . . 10.0 112.13 -179.673 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -82.57 43.9 3.13 Favored Glycine 0 C--N 1.341 0.838 0 O-C-N 120.259 -1.526 . . . . 10.0 111.988 -170.717 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.5 p -108.07 150.03 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 C-N-CA 124.645 1.178 . . . . 10.0 108.643 -176.965 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -106.86 -58.54 1.92 Allowed 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 109.039 -0.726 . . . . 10.0 109.039 171.81 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -144.97 141.31 28.86 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 106.837 -1.542 . . . . 10.0 106.837 -166.732 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -133.83 59.71 40.94 Favored Pre-proline 0 CA--C 1.535 0.388 0 CA-C-N 118.488 0.586 . . . . 10.0 111.719 172.297 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -77.0 82.26 2.4 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 123.248 2.632 . . . . 10.0 109.215 -178.62 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.515 HG12 HG13 ' A' ' 43' ' ' VAL . 2.9 m -71.53 151.44 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 O-C-N 121.746 -0.596 . . . . 10.0 110.705 -177.793 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -86.32 142.58 28.4 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 120.638 -0.425 . . . . 10.0 110.131 177.345 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -120.88 52.98 1.15 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.269 1.427 . . . . 10.0 110.067 -174.979 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -176.0 -42.7 0.01 OUTLIER 'General case' 0 C--O 1.226 -0.158 0 C-N-CA 125.481 1.512 . . . . 10.0 108.698 178.287 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.8 mt -80.13 -20.96 43.73 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.028 0.931 . . . . 10.0 111.459 -172.599 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 59.04 49.74 9.09 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 126.31 1.844 . . . . 10.0 110.129 -172.336 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 20.7 p -134.74 117.35 15.9 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 125.064 1.345 . . . . 10.0 108.631 173.362 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.518 ' H ' ' CD1' ' A' ' 9' ' ' ILE . 14.4 t -85.34 131.33 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 106.282 -1.747 . . . . 10.0 106.282 171.636 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.2 m -110.81 123.88 50.94 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 105.991 -1.855 . . . . 10.0 105.991 172.295 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 33.6 t -121.92 146.24 27.36 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.274 0 N-CA-C 107.961 -1.126 . . . . 10.0 107.961 171.277 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -112.47 113.35 25.48 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 106.303 -1.74 . . . . 10.0 106.303 166.569 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -142.08 156.82 45.41 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.062 0.545 . . . . 10.0 110.715 -177.099 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 19.6 p30 -93.37 126.05 51.9 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 118.813 -0.613 . . . . 10.0 109.47 177.225 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -74.71 63.42 5.72 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 122.401 2.067 . . . . 10.0 108.922 174.717 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.3 tttt -135.33 -57.03 0.8 Allowed 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 105.331 -2.1 . . . . 10.0 105.331 174.662 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -101.38 -51.12 3.56 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 108.638 -0.875 . . . . 10.0 108.638 -177.797 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -81.59 137.72 35.46 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 123.627 0.771 . . . . 10.0 110.717 -176.851 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.6 p -131.38 145.5 51.85 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.417 1.087 . . . . 10.0 110.945 177.112 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 97.0 t -48.39 -48.05 14.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 C-N-CA 125.243 1.417 . . . . 10.0 110.355 174.776 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.01 -43.79 78.06 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 124.914 1.285 . . . . 10.0 111.432 -179.858 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -64.97 -55.86 16.6 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 121.695 0.76 . . . . 10.0 109.3 -177.249 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.823 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.2 pp -65.56 -41.62 92.74 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.162 -0.961 . . . . 10.0 111.307 -176.423 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -43.88 -48.61 8.41 Favored 'General case' 0 N--CA 1.451 -0.4 0 O-C-N 121.51 -0.744 . . . . 10.0 112.291 161.701 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.63 -43.17 84.62 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 119.224 0.92 . . . . 10.0 109.695 -179.377 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -49.67 -56.81 8.75 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 122.741 0.417 . . . . 10.0 110.556 177.057 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.552 HG11 ' HB2' ' A' ' 68' ' ' LEU . 47.4 t -58.45 -50.19 79.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 N-CA-C 113.184 0.809 . . . . 10.0 113.184 174.185 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -59.21 -35.74 74.15 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.317 1.047 . . . . 10.0 109.5 -174.132 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.8 tptt -77.4 -43.83 31.33 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 125.301 1.441 . . . . 10.0 110.52 178.083 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 19.4 mt -51.25 -39.01 55.75 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-N 118.938 0.79 . . . . 10.0 111.569 172.358 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 128.8 3.08 5.56 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-O 119.41 -0.661 . . . . 10.0 113.58 169.29 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -99.45 -160.44 0.8 Allowed 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 107.57 -1.27 . . . . 10.0 107.57 175.768 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 35.0 tttt -139.06 149.12 44.23 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 118.458 0.572 . . . . 10.0 111.238 167.638 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.552 ' HB2' HG11 ' A' ' 61' ' ' VAL . 13.9 tp -135.62 150.84 49.77 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 127.419 2.288 . . . . 10.0 106.475 -176.046 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.7 tptm -149.76 152.89 35.98 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 108.446 -0.946 . . . . 10.0 108.446 163.642 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.474 HD11 ' HB1' ' A' ' 5' ' ' ALA . 10.6 tp -63.91 157.46 24.76 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 119.341 0.973 . . . . 10.0 108.883 172.338 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 34.5 tttp -117.03 -56.14 2.28 Favored 'General case' 0 N--CA 1.436 -1.152 0 C-N-CA 126.51 1.924 . . . . 10.0 107.783 170.133 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -179.47 -89.25 0.08 OUTLIER Glycine 0 CA--C 1.523 0.535 0 N-CA-C 109.158 -1.577 . . . . 10.0 109.158 -177.864 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -168.84 164.6 11.8 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.865 0.866 . . . . 10.0 109.189 -166.666 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -64.22 116.48 6.03 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.929 1.292 . . . . 10.0 112.476 -173.931 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -72.41 70.39 0.87 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.514 0.726 . . . . 10.0 111.54 -179.193 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 45.8 m -107.03 108.83 20.52 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 125.046 1.339 . . . . 10.0 109.633 176.052 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.5 mp -78.07 -27.58 14.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 123.452 0.701 . . . . 10.0 111.186 176.208 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -76.45 143.62 40.42 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.229 1.012 . . . . 10.0 109.051 176.737 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -133.41 167.57 23.43 Favored Glycine 0 CA--C 1.529 0.906 0 N-CA-C 109.823 -1.311 . . . . 10.0 109.823 176.143 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 59.8 mtt180 . . . . . 0 C--O 1.253 1.285 0 N-CA-C 104.721 -2.326 . . . . 10.0 104.721 172.854 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.441 HG21 ' HB2' ' A' ' 32' ' ' ALA . 5.9 p . . . . . 0 CA--C 1.532 0.271 0 N-CA-C 109.838 -0.431 . . . . 10.0 109.838 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -119.2 139.55 51.67 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 127.045 2.138 . . . . 10.0 109.321 -172.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.9 mtmm -104.87 88.75 2.97 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.844 1.658 . . . . 10.0 110.63 -165.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -104.59 152.35 22.53 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.299 1.44 . . . . 10.0 110.497 -168.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -123.54 148.89 45.88 Favored 'General case' 0 CA--C 1.511 -0.545 0 C-N-CA 123.791 0.836 . . . . 10.0 110.199 178.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.755 ' CE2' HD11 ' A' ' 57' ' ' LEU . 3.8 m-85 -138.72 142.3 38.9 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 125.241 1.416 . . . . 10.0 108.205 -175.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -108.86 137.41 46.84 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 107.698 -1.223 . . . . 10.0 107.698 -173.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 5.1 mm -110.22 124.86 67.33 Favored 'Isoleucine or valine' 0 C--N 1.338 0.096 0 C-N-CA 124.52 1.128 . . . . 10.0 110.715 -159.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 . . . . . 0 N--CA 1.45 -0.433 0 N-CA-C 108.942 -0.762 . . . . 10.0 108.942 173.92 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.531 0.236 0 N-CA-C 111.897 0.332 . . . . 10.0 111.897 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.59 -38.26 89.43 Favored 'General case' 0 N--CA 1.446 -0.655 0 O-C-N 121.265 -0.897 . . . . 10.0 110.154 178.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.429 HG22 HD12 ' A' ' 25' ' ' LEU . 19.3 mm -41.45 -54.04 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.305 0 C-N-CA 124.349 1.06 . . . . 10.0 111.495 170.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -49.56 -50.28 42.89 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-N 118.355 0.525 . . . . 10.0 110.476 -176.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.53 -46.22 67.01 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.787 -0.57 . . . . 10.0 110.187 -178.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.515 ' HG3' HD11 ' A' ' 64' ' ' LEU . 7.6 mmt180 -55.75 -32.27 63.28 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 113.284 0.846 . . . . 10.0 113.284 177.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.475 HD21 HD13 ' A' ' 57' ' ' LEU . 0.5 OUTLIER -84.92 -42.58 14.85 Favored 'General case' 0 C--O 1.22 -0.499 0 C-N-CA 123.419 0.688 . . . . 10.0 111.21 172.421 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -60.28 -18.65 50.69 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 120.933 -1.105 . . . . 10.0 111.359 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.1 mmpt? -51.19 -41.03 59.94 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 113.863 1.06 . . . . 10.0 113.863 164.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.686 HD11 ' HB3' ' A' ' 57' ' ' LEU . 10.8 mt -54.5 129.43 15.61 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.068 0 CA-C-N 119.216 0.916 . . . . 10.0 108.909 175.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 58.0 mp0 -66.94 -46.23 75.38 Favored 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 122.132 -0.355 . . . . 10.0 110.129 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.18 43.91 3.2 Favored Glycine 0 C--N 1.339 0.699 0 O-C-N 121.266 -0.896 . . . . 10.0 111.998 -173.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.4 p -103.8 152.47 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 C-N-CA 124.894 1.278 . . . . 10.0 108.811 -176.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.441 ' HB2' HG21 ' A' ' 2' ' ' THR . . . -117.69 -59.75 1.89 Allowed 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.677 -0.861 . . . . 10.0 108.677 168.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 -140.13 160.15 40.59 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 109.29 -0.633 . . . . 10.0 109.29 -178.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -149.2 63.72 6.88 Favored Pre-proline 0 CA--C 1.535 0.374 0 C-N-CA 123.191 0.596 . . . . 10.0 110.804 173.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -78.12 75.58 4.78 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.89 2.393 . . . . 10.0 109.698 -176.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.498 HG12 HG13 ' A' ' 43' ' ' VAL . 6.3 m -70.98 157.41 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 O-C-N 121.744 -0.597 . . . . 10.0 112.024 -177.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -100.93 138.07 38.47 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 110.084 -0.339 . . . . 10.0 110.084 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -120.98 53.66 1.12 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.976 1.31 . . . . 10.0 110.603 -172.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -176.26 -41.31 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 125.727 1.611 . . . . 10.0 108.805 178.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.3 mt -82.24 -15.2 53.94 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.021 1.328 . . . . 10.0 111.44 -172.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 72.91 44.15 0.37 Allowed 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 125.762 1.625 . . . . 10.0 110.377 173.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 39.7 p -140.91 131.71 25.83 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.189 1.396 . . . . 10.0 109.067 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.498 HG13 HG12 ' A' ' 36' ' ' VAL . 4.0 t -99.97 141.94 16.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 107.746 -1.205 . . . . 10.0 107.746 167.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 62.5 m -130.12 124.12 31.97 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 106.576 -1.639 . . . . 10.0 106.576 -176.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 16.5 t -126.63 134.54 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 C-N-CA 123.091 0.556 . . . . 10.0 110.681 -175.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -108.98 94.22 4.93 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 127.043 2.137 . . . . 10.0 106.914 171.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -140.14 163.38 32.89 Favored 'General case' 0 CA--C 1.521 -0.15 0 C-N-CA 123.29 0.636 . . . . 10.0 109.46 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -95.92 132.48 27.01 Favored Pre-proline 0 C--N 1.329 -0.306 0 C-N-CA 123.57 0.748 . . . . 10.0 110.186 177.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -78.81 56.43 5.96 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.081 1.854 . . . . 10.0 109.926 171.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.0 pttt -118.53 -45.74 2.6 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 108.965 -0.754 . . . . 10.0 108.965 170.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.08 -46.29 5.63 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.2 1.0 . . . . 10.0 110.605 -167.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.405 ' CB ' HG23 ' A' ' 28' ' ' ILE . . . -122.92 -171.34 2.27 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.287 1.035 . . . . 10.0 109.6 175.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 97.2 p -149.46 170.8 17.76 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.297 0.639 . . . . 10.0 110.466 177.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 31.4 m -49.42 -42.11 16.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 123.679 0.792 . . . . 10.0 111.293 172.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 66.9 m -61.23 -42.36 98.47 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 123.454 0.702 . . . . 10.0 111.699 -178.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -62.28 -57.39 11.59 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.265 0.626 . . . . 10.0 109.501 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.755 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.1 pp -65.85 -40.87 92.14 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 121.512 0.672 . . . . 10.0 110.373 -173.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.488 ' HA ' HD23 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -44.32 -47.19 9.54 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 112.675 0.62 . . . . 10.0 112.675 163.305 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.11 -44.54 96.43 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-N 119.02 0.827 . . . . 10.0 109.512 178.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -52.12 -47.76 65.16 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 110.382 -0.229 . . . . 10.0 110.382 178.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.555 ' HA ' HD12 ' A' ' 64' ' ' LEU . 38.7 t -65.73 -46.17 89.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 N-CA-C 112.776 0.658 . . . . 10.0 112.776 174.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -56.48 -38.67 72.04 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 120.544 -1.347 . . . . 10.0 110.268 178.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.2 tptm -66.65 -35.52 80.36 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.051 1.34 . . . . 10.0 109.83 -178.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.555 HD12 ' HA ' ' A' ' 61' ' ' VAL . 26.4 mt -58.65 -30.15 67.09 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 118.98 -0.533 . . . . 10.0 112.068 169.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 137.39 -39.79 1.58 Allowed Glycine 0 CA--C 1.527 0.804 0 C-N-CA 123.701 0.667 . . . . 10.0 111.716 171.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.406 ' CE2' HD11 ' A' ' 21' ' ' ILE . 8.1 p90 -97.7 152.44 19.1 Favored 'General case' 0 C--O 1.226 -0.175 0 C-N-CA 125.148 1.379 . . . . 10.0 109.527 -172.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -89.35 153.34 20.94 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.648 0.737 . . . . 10.0 110.849 -170.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.537 HD11 ' HB2' ' A' ' 7' ' ' PHE . 29.1 tp -130.3 148.29 52.11 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.233 1.813 . . . . 10.0 107.383 177.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 9.4 tptp -154.7 152.81 30.37 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 108.912 -0.773 . . . . 10.0 108.912 165.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.6 tp -62.46 154.7 27.64 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 109.488 -0.56 . . . . 10.0 109.488 178.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -108.34 -60.94 1.66 Allowed 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 125.462 1.505 . . . . 10.0 106.961 168.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -174.44 -79.4 0.05 OUTLIER Glycine 0 CA--C 1.521 0.455 0 N-CA-C 110.003 -1.239 . . . . 10.0 110.003 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 . . . . . 0 N--CA 1.452 -0.328 0 C-N-CA 124.384 1.074 . . . . 10.0 108.128 -170.664 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.441 HG21 ' HB2' ' A' ' 32' ' ' ALA . 5.9 p . . . . . 0 CA--C 1.532 0.271 0 N-CA-C 109.838 -0.431 . . . . 10.0 109.838 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -119.2 139.55 51.67 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 127.045 2.138 . . . . 10.0 109.321 -172.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.9 mtmm -104.87 88.75 2.97 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.844 1.658 . . . . 10.0 110.63 -165.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -104.59 152.35 22.53 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.299 1.44 . . . . 10.0 110.497 -168.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -123.54 148.89 45.88 Favored 'General case' 0 CA--C 1.511 -0.545 0 C-N-CA 123.791 0.836 . . . . 10.0 110.199 178.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.755 ' CE2' HD11 ' A' ' 57' ' ' LEU . 3.8 m-85 -138.72 142.3 38.9 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 125.241 1.416 . . . . 10.0 108.205 -175.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -108.86 137.41 46.84 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 107.698 -1.223 . . . . 10.0 107.698 -173.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 5.1 mm -110.22 124.86 67.33 Favored 'Isoleucine or valine' 0 C--N 1.338 0.096 0 C-N-CA 124.52 1.128 . . . . 10.0 110.715 -159.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 . . . . . 0 N--CA 1.45 -0.433 0 N-CA-C 108.942 -0.762 . . . . 10.0 108.942 173.92 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.531 0.236 0 N-CA-C 111.897 0.332 . . . . 10.0 111.897 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.59 -38.26 89.43 Favored 'General case' 0 N--CA 1.446 -0.655 0 O-C-N 121.265 -0.897 . . . . 10.0 110.154 178.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.429 HG22 HD12 ' A' ' 25' ' ' LEU . 19.3 mm -41.45 -54.04 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.305 0 C-N-CA 124.349 1.06 . . . . 10.0 111.495 170.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -49.56 -50.28 42.89 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-N 118.355 0.525 . . . . 10.0 110.476 -176.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.53 -46.22 67.01 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.787 -0.57 . . . . 10.0 110.187 -178.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.515 ' HG3' HD11 ' A' ' 64' ' ' LEU . 7.6 mmt180 -55.75 -32.27 63.28 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 113.284 0.846 . . . . 10.0 113.284 177.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.475 HD21 HD13 ' A' ' 57' ' ' LEU . 0.5 OUTLIER -84.92 -42.58 14.85 Favored 'General case' 0 C--O 1.22 -0.499 0 C-N-CA 123.419 0.688 . . . . 10.0 111.21 172.421 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -60.28 -18.65 50.69 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 120.933 -1.105 . . . . 10.0 111.359 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.1 mmpt? -51.19 -41.03 59.94 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 113.863 1.06 . . . . 10.0 113.863 164.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.686 HD11 ' HB3' ' A' ' 57' ' ' LEU . 10.8 mt -54.5 129.43 15.61 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.068 0 CA-C-N 119.216 0.916 . . . . 10.0 108.909 175.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 58.0 mp0 -66.94 -46.23 75.38 Favored 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 122.132 -0.355 . . . . 10.0 110.129 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.18 43.91 3.2 Favored Glycine 0 C--N 1.339 0.699 0 O-C-N 121.266 -0.896 . . . . 10.0 111.998 -173.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.4 p -103.8 152.47 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 C-N-CA 124.894 1.278 . . . . 10.0 108.811 -176.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.441 ' HB2' HG21 ' A' ' 2' ' ' THR . . . -117.69 -59.75 1.89 Allowed 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.677 -0.861 . . . . 10.0 108.677 168.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 -140.13 160.15 40.59 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 109.29 -0.633 . . . . 10.0 109.29 -178.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -149.2 63.72 6.88 Favored Pre-proline 0 CA--C 1.535 0.374 0 C-N-CA 123.191 0.596 . . . . 10.0 110.804 173.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -78.12 75.58 4.78 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.89 2.393 . . . . 10.0 109.698 -176.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.498 HG12 HG13 ' A' ' 43' ' ' VAL . 6.3 m -70.98 157.41 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 O-C-N 121.744 -0.597 . . . . 10.0 112.024 -177.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -100.93 138.07 38.47 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 110.084 -0.339 . . . . 10.0 110.084 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -120.98 53.66 1.12 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.976 1.31 . . . . 10.0 110.603 -172.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -176.26 -41.31 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 125.727 1.611 . . . . 10.0 108.805 178.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.3 mt -82.24 -15.2 53.94 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.021 1.328 . . . . 10.0 111.44 -172.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 72.91 44.15 0.37 Allowed 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 125.762 1.625 . . . . 10.0 110.377 173.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 39.7 p -140.91 131.71 25.83 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.189 1.396 . . . . 10.0 109.067 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.498 HG13 HG12 ' A' ' 36' ' ' VAL . 4.0 t -99.97 141.94 16.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 107.746 -1.205 . . . . 10.0 107.746 167.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 62.5 m -130.12 124.12 31.97 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 106.576 -1.639 . . . . 10.0 106.576 -176.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 16.5 t -126.63 134.54 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 C-N-CA 123.091 0.556 . . . . 10.0 110.681 -175.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -108.98 94.22 4.93 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 127.043 2.137 . . . . 10.0 106.914 171.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -140.14 163.38 32.89 Favored 'General case' 0 CA--C 1.521 -0.15 0 C-N-CA 123.29 0.636 . . . . 10.0 109.46 179.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -95.92 132.48 27.01 Favored Pre-proline 0 C--N 1.329 -0.306 0 C-N-CA 123.57 0.748 . . . . 10.0 110.186 177.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -78.81 56.43 5.96 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.081 1.854 . . . . 10.0 109.926 171.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.0 pttt -118.53 -45.74 2.6 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 108.965 -0.754 . . . . 10.0 108.965 170.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.08 -46.29 5.63 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.2 1.0 . . . . 10.0 110.605 -167.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.405 ' CB ' HG23 ' A' ' 28' ' ' ILE . . . -122.92 -171.34 2.27 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.287 1.035 . . . . 10.0 109.6 175.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 97.2 p -149.46 170.8 17.76 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.297 0.639 . . . . 10.0 110.466 177.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 31.4 m -49.42 -42.11 16.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 123.679 0.792 . . . . 10.0 111.293 172.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 66.9 m -61.23 -42.36 98.47 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 123.454 0.702 . . . . 10.0 111.699 -178.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -62.28 -57.39 11.59 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.265 0.626 . . . . 10.0 109.501 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.755 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.1 pp -65.85 -40.87 92.14 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 121.512 0.672 . . . . 10.0 110.373 -173.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.488 ' HA ' HD23 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -44.32 -47.19 9.54 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 112.675 0.62 . . . . 10.0 112.675 163.305 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.11 -44.54 96.43 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-N 119.02 0.827 . . . . 10.0 109.512 178.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -52.12 -47.76 65.16 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 110.382 -0.229 . . . . 10.0 110.382 178.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.555 ' HA ' HD12 ' A' ' 64' ' ' LEU . 38.7 t -65.73 -46.17 89.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 N-CA-C 112.776 0.658 . . . . 10.0 112.776 174.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -56.48 -38.67 72.04 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 120.544 -1.347 . . . . 10.0 110.268 178.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.2 tptm -66.65 -35.52 80.36 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.051 1.34 . . . . 10.0 109.83 -178.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.555 HD12 ' HA ' ' A' ' 61' ' ' VAL . 26.4 mt -58.65 -30.15 67.09 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 118.98 -0.533 . . . . 10.0 112.068 169.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 137.39 -39.79 1.58 Allowed Glycine 0 CA--C 1.527 0.804 0 C-N-CA 123.701 0.667 . . . . 10.0 111.716 171.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.406 ' CE2' HD11 ' A' ' 21' ' ' ILE . 8.1 p90 -97.7 152.44 19.1 Favored 'General case' 0 C--O 1.226 -0.175 0 C-N-CA 125.148 1.379 . . . . 10.0 109.527 -172.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -89.35 153.34 20.94 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.648 0.737 . . . . 10.0 110.849 -170.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.537 HD11 ' HB2' ' A' ' 7' ' ' PHE . 29.1 tp -130.3 148.29 52.11 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.233 1.813 . . . . 10.0 107.383 177.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 9.4 tptp -154.7 152.81 30.37 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 108.912 -0.773 . . . . 10.0 108.912 165.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.6 tp -62.46 154.7 27.64 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 109.488 -0.56 . . . . 10.0 109.488 178.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -108.34 -60.94 1.66 Allowed 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 125.462 1.505 . . . . 10.0 106.961 168.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -174.44 -79.4 0.05 OUTLIER Glycine 0 CA--C 1.521 0.455 0 N-CA-C 110.003 -1.239 . . . . 10.0 110.003 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 . . . . . 0 N--CA 1.452 -0.328 0 C-N-CA 124.384 1.074 . . . . 10.0 108.128 -170.664 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.458 HG21 ' HB2' ' A' ' 32' ' ' ALA . 1.8 p . . . . . 0 N--CA 1.451 -0.388 0 N-CA-C 107.555 -1.276 . . . . 10.0 107.555 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -121.7 147.69 45.57 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 126.51 1.924 . . . . 10.0 108.143 -166.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -88.69 130.91 35.21 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 107.983 -1.117 . . . . 10.0 107.983 -178.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -145.35 135.9 24.27 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.251 -0.648 . . . . 10.0 109.251 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -122.23 149.42 43.69 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 123.449 0.7 . . . . 10.0 111.614 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.784 ' CE2' HD11 ' A' ' 57' ' ' LEU . 13.1 m-85 -136.28 137.97 41.27 Favored 'General case' 0 N--CA 1.451 -0.409 0 O-C-N 125.134 1.521 . . . . 10.0 110.037 -170.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -93.9 138.09 32.41 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 106.926 -1.509 . . . . 10.0 106.926 178.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.447 ' CD1' HD12 ' A' ' 68' ' ' LEU . 6.9 mm -109.93 132.39 58.3 Favored 'Isoleucine or valine' 0 C--N 1.34 0.168 0 C-N-CA 125.018 1.327 . . . . 10.0 111.496 -165.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 . . . . . 0 N--CA 1.447 -0.618 0 C-N-CA 124.098 0.959 . . . . 10.0 109.649 176.77 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.53 0.178 0 CA-C-O 120.436 0.16 . . . . 10.0 110.976 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 20.7 ttt180 -58.92 -34.8 72.12 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.717 0.807 . . . . 10.0 109.29 -177.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.572 HD12 HG22 ' A' ' 61' ' ' VAL . 14.9 mm -52.04 -41.92 33.25 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.466 0 CA-C-O 117.381 -1.295 . . . . 10.0 111.349 171.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 75.0 mt-10 -51.68 -50.11 61.08 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-N 120.78 1.627 . . . . 10.0 110.766 -178.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.2 mtmt -69.64 -45.7 67.87 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.103 0.561 . . . . 10.0 109.789 178.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.479 ' HB3' ' HB1' ' A' ' 60' ' ' ALA . 2.4 mmt180 -62.19 -30.92 71.41 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 120.316 -0.554 . . . . 10.0 112.195 -176.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.4 mt -79.07 -50.34 11.21 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 125.238 1.415 . . . . 10.0 110.369 172.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -48.0 -27.3 2.16 Favored 'General case' 0 C--O 1.226 -0.164 0 C-N-CA 124.297 1.039 . . . . 10.0 111.867 178.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -53.06 -47.52 68.39 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 112.337 0.495 . . . . 10.0 112.337 174.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.462 HG23 ' HB2' ' A' ' 52' ' ' ALA . 3.1 mp -52.83 131.91 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 C-N-CA 124.838 1.255 . . . . 10.0 110.803 -179.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 50.9 mp0 -70.11 -48.05 59.25 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 116.306 -0.406 . . . . 10.0 110.364 -171.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -84.89 39.76 2.97 Favored Glycine 0 CA--C 1.525 0.686 0 O-C-N 121.064 -1.022 . . . . 10.0 111.937 -175.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.6 p -99.92 149.57 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 C-N-CA 124.411 1.084 . . . . 10.0 108.313 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.458 ' HB2' HG21 ' A' ' 2' ' ' THR . . . -119.11 -53.69 2.25 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 122.969 0.507 . . . . 10.0 109.819 171.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.1 m-80 -142.6 154.75 44.69 Favored 'General case' 0 C--N 1.339 0.125 0 CA-C-N 118.298 0.499 . . . . 10.0 109.7 -177.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -146.92 62.8 7.77 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 124.101 0.961 . . . . 10.0 111.968 174.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -77.22 73.42 5.5 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.652 2.235 . . . . 10.0 110.048 -178.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.459 HG12 HG13 ' A' ' 43' ' ' VAL . 5.0 m -68.68 155.77 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 O-C-N 121.507 -0.745 . . . . 10.0 111.858 -177.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -99.03 131.51 45.02 Favored 'General case' 0 N--CA 1.458 -0.07 0 N-CA-C 110.204 -0.295 . . . . 10.0 110.204 -176.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -115.38 60.86 0.7 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.919 1.288 . . . . 10.0 110.424 -173.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 168.83 -32.63 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 127.118 2.167 . . . . 10.0 108.708 171.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.0 mt -86.89 -2.74 58.83 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.071 1.349 . . . . 10.0 112.103 -176.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 61.22 43.7 10.66 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 125.303 1.441 . . . . 10.0 111.107 166.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -142.5 129.79 21.05 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.297 1.439 . . . . 10.0 107.983 -176.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.459 HG13 HG12 ' A' ' 36' ' ' VAL . 3.4 t -101.49 132.37 47.47 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 N-CA-C 106.509 -1.663 . . . . 10.0 106.509 172.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 29.2 m -121.63 121.68 37.93 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 125.587 1.555 . . . . 10.0 106.817 -174.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.2 t -125.03 147.63 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 C-N-CA 123.271 0.628 . . . . 10.0 110.27 -176.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -125.24 95.69 4.57 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 127.723 2.409 . . . . 10.0 104.693 174.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -147.95 163.54 36.53 Favored 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 123.448 0.699 . . . . 10.0 109.568 -174.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 18.8 p30 -95.12 131.61 29.72 Favored Pre-proline 0 C--N 1.329 -0.317 0 C-N-CA 122.67 0.388 . . . . 10.0 110.551 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -78.2 60.82 7.57 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 121.537 1.491 . . . . 10.0 108.414 168.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.35 -45.55 0.46 Allowed 'General case' 0 C--N 1.344 0.343 0 O-C-N 121.859 -0.526 . . . . 10.0 110.554 176.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -87.66 -36.81 17.23 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 122.896 0.479 . . . . 10.0 110.442 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.462 ' HB2' HG23 ' A' ' 28' ' ' ILE . . . -137.2 174.88 10.14 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 125.914 1.686 . . . . 10.0 108.275 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 59.5 p -131.66 176.14 8.58 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.503 1.121 . . . . 10.0 110.186 174.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 29.7 m -48.99 -39.18 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-N 115.184 -0.916 . . . . 10.0 111.749 168.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 17.6 m -58.48 -40.6 83.19 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.707 0.803 . . . . 10.0 111.648 -178.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -71.32 -52.19 20.16 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.049 0.939 . . . . 10.0 109.686 -175.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.784 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.3 pp -64.64 -41.87 95.83 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 120.532 -1.355 . . . . 10.0 110.568 179.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.413 ' N ' HD12 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -45.81 -49.58 15.01 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-O 117.821 -1.085 . . . . 10.0 113.046 163.225 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -52.99 -46.56 68.36 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 120.712 1.597 . . . . 10.0 109.164 176.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.479 ' HB1' ' HB3' ' A' ' 24' ' ' ARG . . . -54.14 -50.04 67.85 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 114.789 -1.096 . . . . 10.0 110.874 -177.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.572 HG22 HD12 ' A' ' 21' ' ' ILE . 95.8 t -65.28 -44.73 94.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 112.309 0.485 . . . . 10.0 112.309 173.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -58.79 -47.29 85.26 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 121.107 -0.995 . . . . 10.0 109.952 -175.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.4 tmtm? -56.54 -35.6 68.3 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.899 1.28 . . . . 10.0 111.227 175.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.422 HD13 ' HA ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -54.71 -38.8 67.52 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.612 0.765 . . . . 10.0 110.702 173.364 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 135.21 -33.05 2.49 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 124.076 0.846 . . . . 10.0 111.767 175.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -94.12 157.84 15.89 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.954 0.902 . . . . 10.0 109.628 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.1 mtmp? -98.14 154.29 17.85 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.677 0.751 . . . . 10.0 110.989 -175.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.447 HD12 ' CD1' ' A' ' 9' ' ' ILE . 13.8 tp -129.22 148.62 51.17 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.555 1.942 . . . . 10.0 107.219 -177.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.2 tptm -151.67 148.67 28.21 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 119.27 -0.395 . . . . 10.0 111.089 159.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 11.8 tp -63.73 155.15 30.98 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 121.775 0.797 . . . . 10.0 109.702 178.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.5 tttt -119.45 -56.47 2.06 Favored 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 129.282 3.033 . . . . 10.0 107.655 177.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 172.37 -100.07 0.15 Allowed Glycine 0 N--CA 1.442 -0.935 0 N-CA-C 107.152 -2.379 . . . . 10.0 107.152 -176.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 . . . . . 0 N--CA 1.452 -0.327 0 C-N-CA 124.967 1.307 . . . . 10.0 107.94 -165.714 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.502 HG21 ' HB2' ' A' ' 32' ' ' ALA . 19.3 p . . . . . 0 CA--C 1.535 0.382 0 N-CA-C 109.146 -0.687 . . . . 10.0 109.146 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -127.09 135.67 51.08 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 127.524 2.33 . . . . 10.0 108.29 -175.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 58.6 mmtt -83.56 114.56 21.6 Favored 'General case' 0 N--CA 1.448 -0.559 0 O-C-N 124.06 0.85 . . . . 10.0 109.07 171.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -114.98 145.23 42.46 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.807 1.243 . . . . 10.0 109.545 169.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -119.46 150.78 39.65 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.046 0.939 . . . . 10.0 110.639 173.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.741 ' CE2' HD11 ' A' ' 57' ' ' LEU . 6.2 m-85 -140.14 136.68 33.77 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.899 1.28 . . . . 10.0 109.377 -171.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -97.44 134.98 39.97 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 106.981 -1.489 . . . . 10.0 106.981 -177.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.2 mm -108.35 142.01 22.1 Favored 'Isoleucine or valine' 0 C--N 1.342 0.259 0 C-N-CA 124.297 1.039 . . . . 10.0 111.192 -165.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 . . . . . 0 CA--C 1.531 0.25 0 C-N-CA 124.032 0.933 . . . . 10.0 109.375 171.596 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 . . . . . 0 CA--C 1.541 0.63 0 N-CA-C 112.511 0.56 . . . . 10.0 112.511 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.82 -40.7 83.78 Favored 'General case' 0 N--CA 1.45 -0.439 0 O-C-N 120.611 -1.306 . . . . 10.0 109.953 176.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 8.1 mm -41.17 -57.94 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.39 0 N-CA-C 108.993 -0.743 . . . . 10.0 108.993 170.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -49.44 -45.58 46.74 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.075 0.95 . . . . 10.0 111.931 -172.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.6 mmpt? -71.92 -45.26 61.79 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 123.208 0.603 . . . . 10.0 110.272 179.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -62.94 -32.44 73.74 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 120.498 -0.481 . . . . 10.0 111.533 -178.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.4 -39.59 28.07 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.016 1.727 . . . . 10.0 111.668 175.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -49.28 -33.56 13.29 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 119.077 0.853 . . . . 10.0 110.468 171.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -53.83 -37.58 63.74 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 113.178 0.807 . . . . 10.0 113.178 176.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 22.4 mm -60.87 129.46 23.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 123.458 0.703 . . . . 10.0 109.135 178.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -79.64 -37.32 36.29 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 118.623 0.647 . . . . 10.0 111.441 -175.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -77.39 30.24 1.67 Allowed Glycine 0 C--N 1.339 0.718 0 O-C-N 120.391 -1.443 . . . . 10.0 112.619 178.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -102.9 147.22 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 C-N-CA 124.576 1.15 . . . . 10.0 107.96 -176.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.502 ' HB2' HG21 ' A' ' 2' ' ' THR . . . -118.19 -47.66 2.56 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 122.661 0.384 . . . . 10.0 110.348 175.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -146.48 144.2 29.49 Favored 'General case' 0 C--O 1.226 -0.181 0 N-CA-C 108.308 -0.997 . . . . 10.0 108.308 -173.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -136.23 60.78 35.49 Favored Pre-proline 0 CA--C 1.539 0.522 0 C-N-CA 123.584 0.753 . . . . 10.0 111.978 176.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -76.34 74.69 4.57 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.948 2.432 . . . . 10.0 110.213 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.466 HG12 HG13 ' A' ' 43' ' ' VAL . 4.3 m -69.11 155.49 7.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 123.36 0.664 . . . . 10.0 112.05 -179.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -94.92 92.07 6.72 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.035 0.445 . . . . 10.0 110.469 -174.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -71.77 43.3 0.09 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 127.364 2.266 . . . . 10.0 114.141 -175.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -176.86 -36.32 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 126.388 1.875 . . . . 10.0 110.577 177.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.6 mt -90.25 3.54 53.26 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 124.519 1.128 . . . . 10.0 112.684 -171.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 64.61 38.31 7.26 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.5 1.12 . . . . 10.0 110.371 165.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -142.22 130.21 21.9 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.278 1.431 . . . . 10.0 107.829 -176.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.466 HG13 HG12 ' A' ' 36' ' ' VAL . 11.4 t -100.46 139.03 22.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 107.578 -1.268 . . . . 10.0 107.578 173.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 27.1 m -127.76 119.4 25.67 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 106.803 -1.554 . . . . 10.0 106.803 -177.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 40.1 t -123.3 138.98 51.39 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 N-CA-C 109.201 -0.666 . . . . 10.0 109.201 -178.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -100.6 109.08 21.13 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 106.485 -1.672 . . . . 10.0 106.485 162.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 14.4 p90 -138.71 165.27 27.41 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 109.465 -0.568 . . . . 10.0 109.465 176.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 15.2 p30 -108.58 128.77 24.97 Favored Pre-proline 0 C--N 1.331 -0.237 0 C-N-CA 123.587 0.755 . . . . 10.0 109.301 177.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -75.59 64.16 6.53 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.449 2.1 . . . . 10.0 109.129 174.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.8 pttt -130.48 -47.54 1.07 Allowed 'General case' 0 CA--C 1.527 0.076 0 N-CA-C 108.967 -0.753 . . . . 10.0 108.967 177.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -89.13 -62.15 1.55 Allowed 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.43 -0.952 . . . . 10.0 108.43 178.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -119.67 163.93 16.66 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 125.9 1.68 . . . . 10.0 109.332 -173.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 34.7 p -118.38 -179.1 3.68 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 122.855 1.312 . . . . 10.0 110.482 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.9 m -44.9 -40.99 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 113.697 -1.592 . . . . 10.0 111.966 163.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.0 t -69.86 -40.16 75.93 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 118.889 -0.577 . . . . 10.0 110.743 -172.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -62.66 -50.68 70.25 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.619 0.723 . . . . 10.0 109.331 -172.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.741 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.2 pp -64.33 -46.73 82.21 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.895 -0.503 . . . . 10.0 110.846 178.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.04 -45.88 16.33 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.099 -1.0 . . . . 10.0 113.46 166.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 15.5 tm-20 -62.66 -47.97 81.38 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 119.647 1.112 . . . . 10.0 109.408 177.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -52.73 -47.5 67.33 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 121.372 0.606 . . . . 10.0 109.725 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.416 ' HA ' HD12 ' A' ' 64' ' ' LEU . 80.5 t -66.01 -44.22 92.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 N-CA-C 112.746 0.647 . . . . 10.0 112.746 175.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -54.76 -39.72 68.64 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 120.942 -1.098 . . . . 10.0 110.071 175.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 40.2 tptt -70.73 -37.81 73.53 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 125.431 1.492 . . . . 10.0 110.832 -178.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.416 HD12 ' HA ' ' A' ' 61' ' ' VAL . 12.2 mt -51.36 -26.15 7.23 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 118.792 -0.623 . . . . 10.0 112.49 163.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 129.62 -25.41 4.48 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 124.127 0.87 . . . . 10.0 112.684 165.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.41 ' CE2' ' HB3' ' A' ' 64' ' ' LEU . 16.8 p90 -115.63 154.58 29.2 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 125.628 1.571 . . . . 10.0 108.437 -172.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.6 156.0 18.45 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.946 0.879 . . . . 10.0 111.545 -167.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 9.9 tp -132.45 146.81 52.22 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 127.033 2.133 . . . . 10.0 106.954 -178.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 9.5 mmtp -146.44 139.45 25.55 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 123.011 0.524 . . . . 10.0 110.616 163.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.717 HD23 ' H ' ' A' ' 71' ' ' LYS . 2.8 tt -65.65 157.03 31.07 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 124.32 1.012 . . . . 10.0 109.383 173.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.717 ' H ' HD23 ' A' ' 70' ' ' LEU . 55.1 tttt -127.44 -65.91 0.91 Allowed 'General case' 0 N--CA 1.437 -1.082 0 C-N-CA 127.445 2.298 . . . . 10.0 108.918 -172.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.35 -86.24 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 107.943 -2.063 . . . . 10.0 107.943 175.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 . . . . . 0 N--CA 1.453 -0.297 0 C-N-CA 124.469 1.108 . . . . 10.0 108.156 -168.13 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 7.2 p . . . . . 0 CA--C 1.53 0.201 0 N-CA-C 108.403 -0.962 . . . . 10.0 108.403 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -117.09 140.9 48.94 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 126.909 2.084 . . . . 10.0 109.089 -174.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 8.3 tptm -97.26 108.69 21.46 Favored 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 124.332 1.053 . . . . 10.0 109.089 -177.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.625 ' HB1' HD11 ' A' ' 70' ' ' LEU . . . -117.65 151.26 37.58 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 124.903 1.281 . . . . 10.0 109.88 -177.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -126.38 150.45 48.58 Favored 'General case' 0 CA--C 1.515 -0.377 0 C-N-CA 123.468 0.707 . . . . 10.0 111.264 177.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.831 ' CE2' HD11 ' A' ' 57' ' ' LEU . 2.2 m-85 -136.39 140.72 43.42 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.661 1.584 . . . . 10.0 108.553 -169.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -110.32 133.25 53.43 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 108.177 -1.045 . . . . 10.0 108.177 -172.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.8 mm -111.81 136.35 48.22 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.085 0 C-N-CA 124.154 0.982 . . . . 10.0 111.706 -155.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 . . . . . 0 N--CA 1.448 -0.528 0 N-CA-C 108.907 -0.775 . . . . 10.0 108.907 170.363 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 . . . . . 0 N--CA 1.468 0.441 0 N-CA-C 112.394 0.516 . . . . 10.0 112.394 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 23.0 ttm180 -75.67 -39.56 57.36 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 121.188 -0.945 . . . . 10.0 109.018 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 11.0 mm -45.97 -53.02 2.57 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.286 0 CA-C-O 118.523 -0.751 . . . . 10.0 110.037 170.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -44.94 -50.13 10.71 Favored 'General case' 0 C--O 1.224 -0.251 0 C-N-CA 122.918 0.487 . . . . 10.0 111.196 -178.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.5 mptt -68.51 -46.8 68.66 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.419 0.688 . . . . 10.0 110.159 -179.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.45 -36.14 75.39 Favored 'General case' 0 N--CA 1.451 -0.376 0 O-C-N 121.975 -0.453 . . . . 10.0 110.803 -178.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.38 -34.72 36.16 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.902 1.281 . . . . 10.0 111.221 175.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -60.86 -24.1 65.66 Favored 'General case' 0 C--N 1.332 -0.154 0 O-C-N 121.514 -0.741 . . . . 10.0 110.114 174.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -52.0 -40.64 61.29 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 117.893 0.315 . . . . 10.0 111.321 170.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 25.1 mm -57.77 128.67 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 123.585 0.754 . . . . 10.0 109.939 -173.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -69.08 -48.25 63.13 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 120.697 -0.401 . . . . 10.0 110.43 -177.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -80.67 37.85 2.3 Favored Glycine 0 CA--C 1.523 0.579 0 O-C-N 121.186 -0.946 . . . . 10.0 112.759 -174.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.4 p -103.86 147.4 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 C-N-CA 124.289 1.035 . . . . 10.0 108.657 -175.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -104.63 -50.27 3.34 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 107.998 -1.112 . . . . 10.0 107.998 171.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -164.06 160.64 21.87 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.263 -0.643 . . . . 10.0 109.263 -178.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -142.13 65.49 18.85 Favored Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 124.589 1.156 . . . . 10.0 111.358 178.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -75.36 75.54 3.82 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.184 2.589 . . . . 10.0 109.751 178.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.51 HG12 HG13 ' A' ' 43' ' ' VAL . 3.5 m -66.8 156.36 6.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 123.637 0.775 . . . . 10.0 111.808 -178.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -96.07 115.24 27.13 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 121.112 0.482 . . . . 10.0 111.3 -176.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 11.0 p90 -95.0 43.25 1.09 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.351 1.46 . . . . 10.0 112.447 -171.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -172.55 -39.76 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 124.841 1.257 . . . . 10.0 109.562 176.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 12.3 mt -79.04 -12.17 60.02 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.18 0.992 . . . . 10.0 112.019 -175.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 60.34 51.06 5.62 Favored 'General case' 0 C--N 1.334 -0.069 0 C-N-CA 124.915 1.286 . . . . 10.0 109.692 176.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -140.77 133.29 28.55 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 106.514 -1.661 . . . . 10.0 106.514 175.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.51 HG13 HG12 ' A' ' 36' ' ' VAL . 15.0 t -101.85 142.35 16.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 106.533 -1.655 . . . . 10.0 106.533 172.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 29.6 m -130.34 124.02 31.3 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 106.433 -1.692 . . . . 10.0 106.433 -177.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 29.0 t -128.62 137.52 57.09 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 N-CA-C 109.127 -0.694 . . . . 10.0 109.127 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -105.61 105.58 15.69 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 105.668 -1.975 . . . . 10.0 105.668 167.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -145.78 159.91 42.5 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 123.645 0.778 . . . . 10.0 110.541 -176.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -95.98 134.74 23.44 Favored Pre-proline 0 C--N 1.33 -0.263 0 C-N-CA 123.869 0.868 . . . . 10.0 110.813 178.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -80.44 56.27 6.01 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.259 1.973 . . . . 10.0 109.626 170.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.54 -49.95 1.76 Allowed 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 108.411 -0.959 . . . . 10.0 108.411 175.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -87.75 -42.52 12.55 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.525 0.73 . . . . 10.0 110.394 -175.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -137.81 -176.19 4.34 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.848 1.259 . . . . 10.0 109.327 -171.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 78.2 p -151.73 171.86 17.02 Favored 'General case' 0 N--CA 1.455 -0.193 0 O-C-N 122.043 -0.411 . . . . 10.0 110.38 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 88.3 t -42.93 -48.37 1.21 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.166 0 C-N-CA 124.511 1.124 . . . . 10.0 110.582 169.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.9 m -51.01 -42.88 60.68 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.583 1.153 . . . . 10.0 112.73 178.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -70.42 -56.9 5.52 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 124.114 0.965 . . . . 10.0 109.314 -176.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.831 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.1 pp -63.83 -40.49 96.73 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 120.786 -1.197 . . . . 10.0 110.816 -177.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -43.84 -52.7 6.56 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-O 118.049 -0.977 . . . . 10.0 112.386 161.106 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.8 -45.38 70.74 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 120.127 1.331 . . . . 10.0 110.573 178.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -53.63 -53.39 52.52 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.134 0.492 . . . . 10.0 110.414 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 59.3 t -64.77 -41.19 91.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-N 116.115 -0.493 . . . . 10.0 112.003 178.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -58.59 -45.99 87.9 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 108.825 -0.806 . . . . 10.0 108.825 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -70.23 -36.22 74.38 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.528 1.131 . . . . 10.0 111.03 -177.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 12.9 mt -52.24 -28.82 20.09 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 112.803 0.668 . . . . 10.0 112.803 165.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 108.22 31.29 3.59 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-N 118.502 0.592 . . . . 10.0 112.741 169.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -152.33 160.33 43.33 Favored 'General case' 0 C--O 1.227 -0.104 0 N-CA-C 106.987 -1.486 . . . . 10.0 106.987 169.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -98.99 152.61 19.62 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.581 0.705 . . . . 10.0 110.84 -163.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.5 tp -134.07 146.74 50.59 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 125.7 1.6 . . . . 10.0 108.316 -176.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 12.1 tptp -152.21 154.01 34.95 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 109.445 -0.576 . . . . 10.0 109.445 164.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.625 HD11 ' HB1' ' A' ' 5' ' ' ALA . 8.3 tp -65.78 155.84 34.97 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 121.401 0.619 . . . . 10.0 109.809 176.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 54.6 tttt -118.16 -55.71 2.22 Favored 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 128.633 2.773 . . . . 10.0 107.242 175.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 173.93 -91.22 0.09 OUTLIER Glycine 0 N--CA 1.444 -0.822 0 N-CA-C 108.175 -1.97 . . . . 10.0 108.175 178.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 . . . . . 0 N--CA 1.45 -0.425 0 C-N-CA 124.506 1.122 . . . . 10.0 108.472 -162.835 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.625 HG21 ' HB2' ' A' ' 32' ' ' ALA . 2.6 p . . . . . 0 CA--C 1.534 0.331 0 N-CA-C 108.851 -0.796 . . . . 10.0 108.851 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -137.71 140.41 40.72 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 126.465 1.906 . . . . 10.0 107.795 -168.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 18.4 mmtp -82.46 128.34 34.17 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.192 0.597 . . . . 10.0 109.419 178.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -128.99 136.8 50.81 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 125.698 1.599 . . . . 10.0 109.119 176.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -117.28 147.0 42.95 Favored 'General case' 0 CA--C 1.51 -0.587 0 C-N-CA 124.0 0.92 . . . . 10.0 110.198 177.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.76 ' CE2' HD11 ' A' ' 57' ' ' LEU . 3.1 m-85 -141.19 137.26 32.53 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 124.623 1.202 . . . . 10.0 111.241 -172.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -93.65 133.17 37.27 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.737 1.615 . . . . 10.0 108.741 -176.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.6 HD11 HG23 ' A' ' 43' ' ' VAL . 7.0 mm -103.56 114.15 42.38 Favored 'Isoleucine or valine' 0 C--N 1.34 0.185 0 C-N-CA 124.038 0.935 . . . . 10.0 110.621 -171.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 . . . . . 0 C--O 1.236 0.361 0 N-CA-C 107.833 -1.173 . . . . 10.0 107.833 170.94 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 . . . . . 0 N--CA 1.468 0.465 0 N-CA-C 112.311 0.486 . . . . 10.0 112.311 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -64.39 -45.25 88.49 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 120.759 -1.213 . . . . 10.0 108.209 179.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.625 HG22 HD12 ' A' ' 25' ' ' LEU . 9.8 mm -44.68 -47.55 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 C-N-CA 124.328 1.051 . . . . 10.0 111.625 177.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -48.21 -50.63 28.59 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 122.824 0.45 . . . . 10.0 110.868 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -72.77 -46.26 54.29 Favored 'General case' 0 N--CA 1.445 -0.713 0 O-C-N 121.757 -0.589 . . . . 10.0 110.933 -179.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.1 mmp_? -48.92 -42.66 37.87 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.122 0.416 . . . . 10.0 112.122 175.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.93 HD22 HG21 ' A' ' 45' ' ' VAL . 0.5 OUTLIER -79.4 -42.35 25.69 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.472 0.709 . . . . 10.0 111.05 178.741 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -55.0 -18.53 5.2 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.406 1.003 . . . . 10.0 112.22 172.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -59.69 -29.07 67.83 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 114.223 1.194 . . . . 10.0 114.223 171.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.539 HD11 ' HB3' ' A' ' 57' ' ' LEU . 11.1 mt -60.58 138.46 21.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 108.227 -1.027 . . . . 10.0 108.227 173.227 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.38 -49.58 32.84 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 109.554 -0.535 . . . . 10.0 109.554 179.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -80.29 42.25 2.55 Favored Glycine 0 CA--C 1.526 0.737 0 O-C-N 120.778 -1.201 . . . . 10.0 112.311 -175.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.6 p -102.05 153.2 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 C-N-CA 125.159 1.383 . . . . 10.0 109.677 -174.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.625 ' HB2' HG21 ' A' ' 2' ' ' THR . . . -111.54 -54.62 2.59 Favored 'General case' 0 C--N 1.334 -0.089 0 C-N-CA 123.877 0.871 . . . . 10.0 109.069 171.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 23.1 p30 -162.44 151.71 15.54 Favored 'General case' 0 C--O 1.227 -0.129 0 N-CA-C 108.732 -0.84 . . . . 10.0 108.732 -173.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -133.94 55.94 17.52 Favored Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 124.42 1.088 . . . . 10.0 112.34 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -75.05 79.2 2.73 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 122.884 2.39 . . . . 10.0 110.558 -177.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.526 HG12 HG13 ' A' ' 43' ' ' VAL . 2.4 m -67.47 151.16 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 O-C-N 121.622 -0.674 . . . . 10.0 111.801 -178.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -95.39 88.66 5.18 Favored 'General case' 0 C--O 1.234 0.256 0 O-C-N 122.179 -0.326 . . . . 10.0 110.23 -175.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -72.48 53.52 0.31 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 127.171 2.189 . . . . 10.0 112.727 -178.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -174.65 -40.72 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 126.281 1.832 . . . . 10.0 109.734 174.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 12.4 mt -86.62 -12.39 48.66 Favored 'General case' 0 C--N 1.338 0.093 0 C-N-CA 124.084 0.954 . . . . 10.0 111.797 -171.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 75.4 37.35 0.45 Allowed 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.884 1.274 . . . . 10.0 110.333 170.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 33.3 p -138.35 129.81 27.62 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.242 1.417 . . . . 10.0 108.127 178.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.6 HG23 HD11 ' A' ' 9' ' ' ILE . 21.8 t -90.33 131.39 37.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 107.515 -1.291 . . . . 10.0 107.515 167.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 85.6 m -110.54 117.93 34.87 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 106.303 -1.74 . . . . 10.0 106.303 171.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.93 HG21 HD22 ' A' ' 25' ' ' LEU . 82.6 t -122.46 141.28 43.48 Favored 'Isoleucine or valine' 0 C--N 1.342 0.248 0 CA-C-N 120.177 1.353 . . . . 10.0 109.79 168.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.438 ' HB3' ' HB3' ' A' ' 32' ' ' ALA . 18.3 tt0 -100.32 117.02 33.66 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 107.552 -1.277 . . . . 10.0 107.552 164.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -147.87 167.91 23.57 Favored 'General case' 0 C--O 1.226 -0.163 0 N-CA-C 108.861 -0.792 . . . . 10.0 108.861 177.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 24.7 p30 -100.54 135.96 20.05 Favored Pre-proline 0 C--N 1.329 -0.284 0 C-N-CA 123.273 0.629 . . . . 10.0 109.758 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -80.36 54.0 5.02 Favored 'Trans proline' 0 N--CA 1.448 -1.167 0 N-CA-C 108.883 -1.237 . . . . 10.0 108.883 171.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.16 10.19 3.27 Favored 'General case' 0 C--N 1.346 0.443 0 CA-C-N 118.623 0.647 . . . . 10.0 111.834 176.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -142.02 -65.15 0.42 Allowed 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.788 -1.189 . . . . 10.0 107.788 -173.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -114.52 175.51 5.45 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 124.071 0.948 . . . . 10.0 109.359 178.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 92.0 p -127.72 167.57 16.29 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.028 0.931 . . . . 10.0 110.065 177.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 74.2 t -49.06 -52.8 9.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 115.791 -0.641 . . . . 10.0 109.796 167.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.0 m -52.36 -37.13 55.43 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 125.185 1.394 . . . . 10.0 112.579 178.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -71.25 -60.4 2.25 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 109.603 -0.517 . . . . 10.0 109.603 174.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.76 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.4 pp -58.81 -46.81 86.76 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 118.348 0.522 . . . . 10.0 111.368 -168.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.455 ' N ' HD12 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -48.18 -35.63 12.11 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 114.549 1.315 . . . . 10.0 114.549 171.819 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.1 tm-20 -52.54 -35.49 53.61 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 120.466 1.485 . . . . 10.0 110.924 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.63 -52.51 60.53 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 120.057 -0.657 . . . . 10.0 109.922 -178.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.575 HG22 HD12 ' A' ' 21' ' ' ILE . 72.7 t -55.24 -47.96 77.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 122.905 0.482 . . . . 10.0 110.884 172.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.88 -55.91 19.76 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 124.906 1.282 . . . . 10.0 109.195 -177.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.8 tptm -57.06 -38.97 74.01 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 126.137 1.775 . . . . 10.0 111.322 177.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.4 mp -60.52 -19.74 58.02 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 113.075 0.768 . . . . 10.0 113.075 172.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 104.74 16.34 17.7 Favored Glycine 0 CA--C 1.528 0.863 0 CA-C-N 118.849 0.749 . . . . 10.0 113.263 168.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.405 ' O ' HG12 ' A' ' 61' ' ' VAL . 1.5 p90 -136.0 160.94 37.07 Favored 'General case' 0 C--O 1.227 -0.121 0 N-CA-C 106.776 -1.564 . . . . 10.0 106.776 169.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 10.5 ttmm -105.98 141.16 37.84 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 119.265 0.939 . . . . 10.0 111.405 -168.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.581 HD11 ' HB2' ' A' ' 7' ' ' PHE . 22.9 tp -117.93 145.04 44.95 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 126.117 1.767 . . . . 10.0 107.974 177.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 26.0 mmtt -152.99 153.44 32.93 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 125.721 1.608 . . . . 10.0 108.058 170.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.3 tp -68.34 152.41 45.47 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.398 0.618 . . . . 10.0 109.397 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.94 -57.44 2.04 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 127.51 2.324 . . . . 10.0 105.586 164.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 170.82 -92.56 0.1 OUTLIER Glycine 0 N--CA 1.442 -0.947 0 N-CA-C 105.833 -2.907 . . . . 10.0 105.833 177.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 . . . . . 0 N--CA 1.453 -0.293 0 C-N-CA 122.993 0.517 . . . . 10.0 109.829 -160.756 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.52 HG21 ' HB2' ' A' ' 32' ' ' ALA . 14.9 p . . . . . 0 CA--C 1.536 0.418 0 N-CA-C 108.02 -1.104 . . . . 10.0 108.02 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -140.65 142.25 34.98 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 127.427 2.291 . . . . 10.0 107.917 -167.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -104.91 110.09 22.32 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.54 0.736 . . . . 10.0 109.954 -168.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -108.9 146.14 34.24 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 124.976 1.31 . . . . 10.0 109.833 -175.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -122.63 147.25 46.65 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 123.749 0.82 . . . . 10.0 109.246 173.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.704 ' CE2' HD11 ' A' ' 57' ' ' LEU . 9.9 m-85 -137.0 140.85 42.44 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 125.222 1.576 . . . . 10.0 109.237 -173.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -105.46 133.9 49.45 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.358 1.063 . . . . 10.0 108.261 -175.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.9 mm -109.33 132.33 57.75 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 C-N-CA 123.667 0.787 . . . . 10.0 111.18 -157.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 . . . . . 0 N--CA 1.449 -0.506 0 C-N-CA 123.22 0.608 . . . . 10.0 109.36 172.569 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 . . . . . 0 N--CA 1.468 0.445 0 N-CA-C 112.213 0.449 . . . . 10.0 112.213 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -74.61 -54.14 8.02 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 121.294 -0.879 . . . . 10.0 108.9 173.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.661 HG22 HD12 ' A' ' 25' ' ' LEU . 1.6 mt -48.22 -47.47 13.59 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.445 0 CA-C-O 117.964 -1.017 . . . . 10.0 111.277 -176.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -34.86 -61.88 0.39 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.517 0.727 . . . . 10.0 111.747 174.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.98 -42.25 69.93 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.492 1.117 . . . . 10.0 110.679 -177.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.96 -28.79 62.62 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.651 0.611 . . . . 10.0 112.651 175.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.661 HD12 HG22 ' A' ' 21' ' ' ILE . 1.5 mt -85.3 -42.97 14.13 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 126.188 1.795 . . . . 10.0 109.787 174.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -55.51 -23.95 29.0 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.898 0.879 . . . . 10.0 110.279 177.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -52.85 -41.6 64.41 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 113.794 1.035 . . . . 10.0 113.794 171.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.2 mp -54.58 133.38 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 109.563 -0.532 . . . . 10.0 109.563 176.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -77.98 -42.73 31.79 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 119.505 -0.284 . . . . 10.0 110.483 -178.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -80.63 39.6 2.37 Favored Glycine 0 CA--C 1.527 0.816 0 O-C-N 120.549 -1.344 . . . . 10.0 111.94 178.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.4 p -101.57 149.78 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 C-N-CA 124.973 1.309 . . . . 10.0 108.575 -178.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.52 ' HB2' HG21 ' A' ' 2' ' ' THR . . . -109.5 -61.51 1.63 Allowed 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 107.934 -1.136 . . . . 10.0 107.934 170.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 57.8 m-80 -140.54 154.66 46.62 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 107.952 -1.129 . . . . 10.0 107.952 -174.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.47 58.01 2.58 Favored Pre-proline 0 CA--C 1.535 0.371 0 O-C-N 121.965 -0.459 . . . . 10.0 112.113 170.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -75.11 78.23 2.98 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 122.715 2.277 . . . . 10.0 108.756 177.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.478 HG12 HG13 ' A' ' 43' ' ' VAL . 3.4 m -59.12 152.45 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 109.851 -0.426 . . . . 10.0 109.851 174.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 74.3 m-80 -81.07 151.32 28.41 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 118.756 -1.178 . . . . 10.0 109.962 -176.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -123.23 42.91 3.09 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.412 1.485 . . . . 10.0 109.747 -175.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -175.13 -40.22 0.01 OUTLIER 'General case' 0 C--O 1.226 -0.163 0 C-N-CA 125.385 1.474 . . . . 10.0 109.736 170.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.2 mt -75.2 -17.04 60.44 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.884 0.874 . . . . 10.0 112.442 -167.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 65.3 48.69 2.08 Favored 'General case' 0 N--CA 1.46 0.072 0 C-N-CA 125.281 1.432 . . . . 10.0 110.32 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 8.0 p -142.85 133.24 24.81 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.324 1.45 . . . . 10.0 107.969 176.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.478 HG13 HG12 ' A' ' 36' ' ' VAL . 7.0 t -97.63 134.21 36.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 106.869 -1.53 . . . . 10.0 106.869 172.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 85.9 m -121.26 126.22 49.02 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 106.552 -1.647 . . . . 10.0 106.552 178.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.4 t -122.89 149.29 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 C-N-CA 124.323 1.049 . . . . 10.0 108.648 177.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -123.59 107.81 11.93 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 106.054 -1.832 . . . . 10.0 106.054 164.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -145.04 170.67 15.74 Favored 'General case' 0 C--O 1.225 -0.223 0 C-N-CA 124.142 0.977 . . . . 10.0 108.834 -177.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 14.6 p30 -111.85 134.77 21.27 Favored Pre-proline 0 CA--C 1.53 0.196 0 C-N-CA 122.806 0.443 . . . . 10.0 110.397 177.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -77.37 62.47 7.64 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 122.504 2.136 . . . . 10.0 109.867 174.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.1 pttt -123.73 -45.85 2.02 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 123.147 0.579 . . . . 10.0 109.951 172.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -91.49 -60.95 1.75 Allowed 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.385 1.074 . . . . 10.0 108.72 -176.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -119.08 174.34 6.37 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 125.671 1.588 . . . . 10.0 109.321 -175.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 53.3 p -131.66 -177.3 4.36 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.875 1.27 . . . . 10.0 110.167 176.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 35.3 m -48.64 -38.72 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-N 115.03 -0.986 . . . . 10.0 111.946 164.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 68.9 m -62.32 -43.31 99.13 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 122.761 0.424 . . . . 10.0 111.142 -174.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -65.28 -52.97 50.79 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.284 1.034 . . . . 10.0 109.136 -174.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.704 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.1 pp -66.97 -43.91 81.82 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 121.983 -0.448 . . . . 10.0 111.274 -178.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.403 ' N ' HD12 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -41.66 -51.04 4.14 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-O 118.125 -0.94 . . . . 10.0 112.053 160.467 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -57.1 -43.92 82.72 Favored 'General case' 0 C--O 1.226 -0.157 0 CA-C-N 119.742 1.155 . . . . 10.0 110.386 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -52.88 -51.82 59.75 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.077 0.465 . . . . 10.0 110.392 176.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.476 HG11 ' HB2' ' A' ' 68' ' ' LEU . 53.9 t -61.85 -46.23 96.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 N-CA-C 112.39 0.515 . . . . 10.0 112.39 176.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -51.45 -51.11 57.74 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.856 1.263 . . . . 10.0 108.428 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.25 -44.26 92.38 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.611 1.565 . . . . 10.0 111.191 177.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -48.35 -39.45 22.16 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.79 0.836 . . . . 10.0 111.308 173.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 125.14 14.25 3.38 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-O 119.575 -0.57 . . . . 10.0 113.273 169.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -138.94 162.52 34.67 Favored 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 107.927 -1.138 . . . . 10.0 107.927 177.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 29.0 mmtt -95.98 151.04 19.8 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.776 0.798 . . . . 10.0 111.328 -172.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.476 ' HB2' HG11 ' A' ' 61' ' ' VAL . 14.5 tp -132.35 146.33 51.9 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 126.487 1.915 . . . . 10.0 107.886 -179.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 16.5 mmtm -151.64 154.67 36.84 Favored 'General case' 0 N--CA 1.44 -0.947 0 C-N-CA 123.993 0.917 . . . . 10.0 109.011 163.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.6 tp -61.32 159.46 12.39 Favored 'General case' 0 N--CA 1.453 -0.301 0 O-C-N 124.321 1.013 . . . . 10.0 109.393 175.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 32.9 tttt -118.82 -66.34 1.08 Allowed 'General case' 0 N--CA 1.435 -1.216 0 C-N-CA 125.464 1.506 . . . . 10.0 108.276 177.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 161.7 43.63 0.02 OUTLIER Glycine 0 CA--C 1.528 0.865 0 CA-C-O 118.852 -0.971 . . . . 10.0 113.668 175.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 . . . . . 0 CA--C 1.535 0.369 0 C-N-CA 124.976 1.311 . . . . 10.0 112.941 167.662 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.627 HG21 ' HB2' ' A' ' 32' ' ' ALA . 10.0 p . . . . . 0 N--CA 1.453 -0.285 0 N-CA-C 109.293 -0.632 . . . . 10.0 109.293 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -131.66 150.21 52.23 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 127.472 2.309 . . . . 10.0 107.324 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -109.63 123.46 49.5 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.343 -0.984 . . . . 10.0 108.343 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.647 ' HB1' HD11 ' A' ' 70' ' ' LEU . . . -130.2 153.55 48.45 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.634 0.774 . . . . 10.0 110.676 176.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -118.7 148.56 42.63 Favored 'General case' 0 CA--C 1.507 -0.7 0 C-N-CA 124.62 1.168 . . . . 10.0 109.481 177.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.817 ' CE2' HD11 ' A' ' 57' ' ' LEU . 2.2 m-85 -135.12 141.0 45.9 Favored 'General case' 0 N--CA 1.447 -0.605 0 O-C-N 124.792 1.308 . . . . 10.0 109.063 -174.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -103.45 131.78 50.26 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.525 1.53 . . . . 10.0 108.827 -174.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -115.44 137.13 50.0 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 C-N-CA 126.111 1.764 . . . . 10.0 110.023 -164.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 . . . . . 0 N--CA 1.454 -0.259 0 N-CA-C 108.21 -1.033 . . . . 10.0 108.21 176.038 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 . . . . . 0 CA--C 1.538 0.51 0 N-CA-C 113.945 1.091 . . . . 10.0 113.945 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.79 -45.89 87.65 Favored 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 120.757 -1.214 . . . . 10.0 108.413 177.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.846 HG22 HD12 ' A' ' 25' ' ' LEU . 2.8 mm -47.4 -48.85 9.47 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.231 0 O-C-N 123.94 0.775 . . . . 10.0 109.856 -177.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -44.03 -54.4 5.49 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.043 0.937 . . . . 10.0 111.526 178.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt -70.73 -45.7 64.4 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.954 0.902 . . . . 10.0 109.459 -177.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.626 ' HG3' HD11 ' A' ' 64' ' ' LEU . 51.7 mmt-85 -55.57 -32.24 62.85 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.147 0.425 . . . . 10.0 112.147 177.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.846 HD12 HG22 ' A' ' 21' ' ' ILE . 2.1 mt -84.39 -35.56 23.06 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.178 1.391 . . . . 10.0 112.26 174.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 32.7 t-20 -55.29 -31.78 61.9 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.685 0.675 . . . . 10.0 110.081 176.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -50.64 -28.89 9.72 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 114.996 1.48 . . . . 10.0 114.996 169.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.82 HG23 ' HB3' ' A' ' 52' ' ' ALA . 6.9 mm -61.71 104.93 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-O 121.71 0.766 . . . . 10.0 109.663 171.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -58.24 -26.08 62.48 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.451 0.537 . . . . 10.0 112.451 -179.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -90.79 18.02 52.34 Favored Glycine 0 CA--C 1.528 0.898 0 O-C-N 121.359 -0.838 . . . . 10.0 112.945 178.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.1 p -79.36 153.98 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 CA-C-N 118.595 1.198 . . . . 10.0 109.514 -179.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.627 ' HB2' HG21 ' A' ' 2' ' ' THR . . . -112.94 -59.86 1.96 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.539 -0.912 . . . . 10.0 108.539 163.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 -134.63 155.43 50.5 Favored 'General case' 0 C--N 1.341 0.208 0 N-CA-C 109.254 -0.647 . . . . 10.0 109.254 -178.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -140.36 65.39 27.32 Favored Pre-proline 0 CA--C 1.534 0.355 0 C-N-CA 123.454 0.701 . . . . 10.0 109.825 172.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -78.64 68.7 8.03 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 123.044 2.496 . . . . 10.0 109.539 -176.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.415 HG12 HG13 ' A' ' 43' ' ' VAL . 4.1 m -68.85 155.37 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 O-C-N 122.099 -0.375 . . . . 10.0 111.727 -175.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -97.49 139.04 34.0 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 121.002 0.429 . . . . 10.0 111.407 -177.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -118.24 47.66 1.56 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.702 1.601 . . . . 10.0 110.451 -172.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -176.11 -41.61 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 125.449 1.5 . . . . 10.0 109.557 -177.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 16.6 mt -81.7 -19.02 42.4 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.625 1.17 . . . . 10.0 111.648 -170.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 61.16 50.64 4.8 Favored 'General case' 0 C--N 1.339 0.112 0 C-N-CA 125.892 1.677 . . . . 10.0 109.942 -175.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.4 p -140.07 126.99 20.74 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 107.646 -1.242 . . . . 10.0 107.646 174.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.569 HG21 HG21 ' A' ' 21' ' ' ILE . 5.1 t -97.15 130.62 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 106.769 -1.567 . . . . 10.0 106.769 172.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 58.2 m -110.85 128.38 55.76 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.95 1.7 . . . . 10.0 107.139 176.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.7 t -127.36 137.4 57.87 Favored 'Isoleucine or valine' 0 C--N 1.342 0.253 0 CA-C-N 119.161 0.891 . . . . 10.0 110.709 174.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -107.29 104.6 14.24 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.392 1.477 . . . . 10.0 107.088 164.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 14.7 p90 -143.32 167.02 23.13 Favored 'General case' 0 CA--C 1.52 -0.177 0 C-N-CA 123.936 0.895 . . . . 10.0 109.329 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -107.99 134.05 20.26 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-O 119.109 -0.472 . . . . 10.0 110.804 178.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -77.85 62.29 7.83 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.779 2.319 . . . . 10.0 110.613 176.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.0 pttt -124.42 -47.67 1.85 Allowed 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.706 0.802 . . . . 10.0 109.346 169.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -90.33 -51.84 5.23 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.961 0.905 . . . . 10.0 110.007 -169.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.82 ' HB3' HG23 ' A' ' 28' ' ' ILE . . . -132.17 174.73 9.9 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.631 1.172 . . . . 10.0 108.333 178.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 82.6 p -137.06 177.49 7.82 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 118.569 0.622 . . . . 10.0 110.757 176.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 49.1 t -42.24 -50.75 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 124.632 1.173 . . . . 10.0 110.902 172.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.1 m -51.56 -38.77 55.9 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.094 0.958 . . . . 10.0 112.414 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -70.11 -58.51 3.72 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.632 0.773 . . . . 10.0 109.178 -174.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.817 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.4 pp -63.56 -41.09 98.43 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 121.741 -0.6 . . . . 10.0 111.297 -178.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.417 ' HA ' HD23 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -43.51 -47.6 7.26 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 118.349 -0.834 . . . . 10.0 111.817 163.289 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.87 -42.21 98.79 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 119.571 1.078 . . . . 10.0 110.39 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -56.19 -48.59 76.09 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 109.65 -0.5 . . . . 10.0 109.65 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.639 ' HA ' HD12 ' A' ' 64' ' ' LEU . 82.8 t -62.56 -47.45 92.89 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 N-CA-C 112.909 0.707 . . . . 10.0 112.909 173.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -56.13 -37.7 69.81 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.044 -1.035 . . . . 10.0 109.025 -178.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.9 tttp -79.57 -31.51 41.89 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 124.343 1.057 . . . . 10.0 112.011 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.639 HD12 ' HA ' ' A' ' 61' ' ' VAL . 15.3 mt -51.69 -45.19 63.41 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.68 1.127 . . . . 10.0 110.783 163.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 147.89 -39.87 0.99 Allowed Glycine 0 CA--C 1.525 0.713 0 CA-C-N 117.964 0.347 . . . . 10.0 112.78 171.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -89.79 159.55 16.97 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 124.032 0.933 . . . . 10.0 108.738 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 19.7 tttt -91.87 161.23 14.92 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-O 121.137 0.494 . . . . 10.0 110.656 -171.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.469 HD11 ' HB2' ' A' ' 7' ' ' PHE . 23.9 tp -136.13 148.1 48.06 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.189 1.396 . . . . 10.0 108.248 177.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 16.9 mmtm -154.18 159.46 41.4 Favored 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 124.19 0.996 . . . . 10.0 108.587 164.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.647 HD11 ' HB1' ' A' ' 5' ' ' ALA . 5.8 tp -67.07 152.06 46.48 Favored 'General case' 0 N--CA 1.451 -0.423 0 O-C-N 123.735 0.647 . . . . 10.0 109.351 176.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 13.3 tptm -107.48 -55.2 2.38 Favored 'General case' 0 N--CA 1.438 -1.072 0 C-N-CA 127.168 2.187 . . . . 10.0 105.881 169.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 170.97 -95.96 0.11 Allowed Glycine 0 N--CA 1.444 -0.819 0 N-CA-C 106.204 -2.759 . . . . 10.0 106.204 -179.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 . . . . . 0 N--CA 1.454 -0.253 0 C-N-CA 123.284 0.634 . . . . 10.0 110.447 -165.799 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.448 -0.557 0 N-CA-C 106.713 -1.588 . . . . 10.0 106.713 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -143.49 143.02 31.39 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 126.858 2.063 . . . . 10.0 106.752 -170.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 45.1 mmtt -85.33 145.39 27.53 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.143 -0.688 . . . . 10.0 109.143 175.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -147.06 138.14 23.9 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 107.463 -1.31 . . . . 10.0 107.463 174.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -122.03 149.07 44.02 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 123.796 0.838 . . . . 10.0 110.022 174.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.694 ' CE2' HD11 ' A' ' 57' ' ' LEU . 0.2 OUTLIER -142.95 141.22 31.38 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 124.804 1.315 . . . . 10.0 110.653 -168.387 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.44 132.18 43.39 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.985 1.714 . . . . 10.0 108.771 -170.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.63 HD11 HG23 ' A' ' 43' ' ' VAL . 3.7 mm -106.21 121.02 58.17 Favored 'Isoleucine or valine' 0 C--N 1.339 0.145 0 C-N-CA 124.842 1.257 . . . . 10.0 110.821 -170.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 . . . . . 0 N--CA 1.449 -0.505 0 N-CA-C 106.267 -1.753 . . . . 10.0 106.267 175.841 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 . . . . . 0 N--CA 1.466 0.36 0 N-CA-C 112.71 0.633 . . . . 10.0 112.71 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.7 ttm105 -68.58 -43.45 76.49 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 108.528 -0.916 . . . . 10.0 108.528 177.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.569 HG23 HG22 ' A' ' 61' ' ' VAL . 0.9 OUTLIER -56.22 -46.31 81.3 Favored 'Isoleucine or valine' 0 C--N 1.342 0.255 0 CA-C-O 118.772 -0.632 . . . . 10.0 110.211 177.922 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -44.1 -54.91 5.14 Favored 'General case' 0 C--N 1.342 0.247 0 CA-C-O 121.098 0.475 . . . . 10.0 111.075 178.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.6 mttm -69.53 -42.88 74.07 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 124.298 1.039 . . . . 10.0 110.433 -177.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.477 ' HG3' HD13 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -53.23 -36.95 61.62 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 111.893 0.331 . . . . 10.0 111.893 173.719 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.421 ' CD2' HG21 ' A' ' 45' ' ' VAL . 0.4 OUTLIER -78.5 -41.6 32.0 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.727 0.811 . . . . 10.0 110.856 175.799 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -61.28 -22.13 64.57 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 121.511 -0.743 . . . . 10.0 110.65 -177.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.4 mmpt? -53.68 -39.72 65.37 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 114.202 1.186 . . . . 10.0 114.202 168.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.8 mt -62.86 128.99 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 CA-C-N 118.965 0.802 . . . . 10.0 109.087 -175.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -56.48 -51.16 69.49 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 122.913 0.485 . . . . 10.0 111.824 -177.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -87.26 42.31 3.14 Favored Glycine 0 C--N 1.339 0.71 0 O-C-N 120.916 -1.115 . . . . 10.0 111.666 -172.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.8 p -105.7 151.91 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 C-N-CA 124.506 1.122 . . . . 10.0 108.628 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -117.61 -50.78 2.51 Favored 'General case' 0 C--N 1.334 -0.096 0 C-N-CA 122.946 0.499 . . . . 10.0 110.185 173.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -143.74 145.99 32.81 Favored 'General case' 0 N--CA 1.461 0.087 0 N-CA-C 109.082 -0.71 . . . . 10.0 109.082 -176.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -139.11 56.98 9.79 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 123.537 0.735 . . . . 10.0 112.461 177.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -75.3 78.87 2.87 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 123.321 2.681 . . . . 10.0 111.067 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.633 HG22 HG13 ' A' ' 43' ' ' VAL . 43.0 t -65.94 143.78 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 C-N-CA 124.786 1.234 . . . . 10.0 112.039 178.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 -91.01 97.83 11.41 Favored 'General case' 0 C--N 1.341 0.215 0 O-C-N 121.874 -0.516 . . . . 10.0 111.718 -167.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -76.45 53.25 0.84 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.785 1.634 . . . . 10.0 112.86 -177.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 179.19 -33.34 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 125.77 1.628 . . . . 10.0 110.51 168.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.2 mt -88.08 1.53 54.06 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.43 1.092 . . . . 10.0 112.155 -172.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 60.75 39.08 17.73 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 125.543 1.537 . . . . 10.0 110.91 169.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.48 133.97 26.51 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.919 1.287 . . . . 10.0 107.979 -175.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.633 HG13 HG22 ' A' ' 36' ' ' VAL . 17.1 t -90.88 142.66 12.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 107.1 -1.444 . . . . 10.0 107.1 167.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 91.6 m -133.98 114.96 13.8 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 125.585 1.554 . . . . 10.0 107.749 -177.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.421 HG21 ' CD2' ' A' ' 25' ' ' LEU . 50.4 t -122.0 156.14 26.55 Favored 'Isoleucine or valine' 0 C--N 1.341 0.235 0 C-N-CA 123.785 0.834 . . . . 10.0 110.607 -177.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.22 107.62 11.4 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 127.764 2.426 . . . . 10.0 105.659 170.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -136.63 165.96 24.66 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 123.395 0.678 . . . . 10.0 111.13 -176.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -99.94 126.84 35.36 Favored Pre-proline 0 CA--C 1.532 0.251 0 C-N-CA 123.73 0.812 . . . . 10.0 110.179 173.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -75.46 65.11 6.48 Favored 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 122.561 2.174 . . . . 10.0 108.569 175.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.32 -50.16 0.25 Allowed 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 107.487 -1.301 . . . . 10.0 107.487 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -106.31 -40.31 5.65 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 123.484 0.714 . . . . 10.0 110.715 173.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.24 150.63 26.06 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 121.539 -0.725 . . . . 10.0 109.993 177.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 44.9 p -147.22 149.31 32.67 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.885 0.85 . . . . 10.0 110.741 171.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 48.9 t -48.62 -51.2 11.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 125.544 1.538 . . . . 10.0 111.559 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.9 m -51.75 -43.01 62.76 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 118.943 -0.551 . . . . 10.0 111.742 178.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -67.71 -54.25 20.94 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.124 -0.695 . . . . 10.0 109.124 -173.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.694 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.0 pp -61.66 -45.36 94.36 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 120.695 -0.402 . . . . 10.0 110.212 -178.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.55 -51.93 8.49 Favored 'General case' 0 N--CA 1.45 -0.445 0 O-C-N 121.911 -0.493 . . . . 10.0 111.555 168.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.25 -40.26 95.64 Favored 'General case' 0 C--O 1.226 -0.174 0 CA-C-N 118.53 0.604 . . . . 10.0 110.293 -178.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -52.64 -49.21 65.61 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.393 0.677 . . . . 10.0 109.708 177.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.569 HG22 HG23 ' A' ' 21' ' ' ILE . 17.9 t -69.38 -43.83 80.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 116.493 -0.321 . . . . 10.0 111.183 177.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -50.45 -55.31 16.45 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.851 0.86 . . . . 10.0 109.566 178.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.5 ttmt -53.73 -42.45 68.11 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 126.151 1.78 . . . . 10.0 111.035 175.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.477 HD13 ' HG3' ' A' ' 24' ' ' ARG . 7.9 tp -53.0 -27.12 17.76 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 113.601 0.963 . . . . 10.0 113.601 174.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 140.21 -30.24 2.35 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-N 118.567 0.622 . . . . 10.0 112.671 169.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -127.8 157.97 38.97 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 124.695 1.198 . . . . 10.0 109.03 -173.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.4 ptpt -92.06 155.55 18.0 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 123.101 0.56 . . . . 10.0 111.574 -166.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.664 HD11 ' HB2' ' A' ' 7' ' ' PHE . 11.7 tp -134.37 146.06 49.55 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 126.393 1.877 . . . . 10.0 107.32 -176.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.3 tptp -147.31 137.18 23.02 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 119.232 -0.413 . . . . 10.0 110.602 168.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.598 HD23 ' N ' ' A' ' 71' ' ' LYS . 2.5 tt -64.83 154.06 38.24 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.05 -0.722 . . . . 10.0 109.05 178.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.598 ' N ' HD23 ' A' ' 70' ' ' LEU . 18.8 tttm -119.0 -63.7 1.37 Allowed 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 126.165 1.786 . . . . 10.0 108.371 -178.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.06 -78.75 0.03 OUTLIER Glycine 0 CA--C 1.521 0.452 0 N-CA-C 109.274 -1.53 . . . . 10.0 109.274 173.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 . . . . . 0 N--CA 1.455 -0.218 0 N-CA-C 108.443 -0.947 . . . . 10.0 108.443 -167.32 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.578 HG21 ' HB2' ' A' ' 32' ' ' ALA . 3.0 p . . . . . 0 N--CA 1.454 -0.26 0 CA-C-O 120.984 0.421 . . . . 10.0 110.216 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -116.69 162.83 17.05 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 126.863 2.065 . . . . 10.0 108.112 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.81 125.64 52.95 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.061 -1.459 . . . . 10.0 107.061 178.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.521 ' HB1' HD11 ' A' ' 70' ' ' LEU . . . -131.47 145.95 52.01 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.956 1.303 . . . . 10.0 108.474 -178.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -126.19 150.36 48.37 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 118.615 0.643 . . . . 10.0 111.578 177.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.784 ' CE2' HD11 ' A' ' 57' ' ' LEU . 2.1 m-85 -139.74 139.05 36.42 Favored 'General case' 0 C--O 1.234 0.269 0 O-C-N 125.006 1.441 . . . . 10.0 110.079 -166.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -102.79 132.51 48.92 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.491 -0.929 . . . . 10.0 108.491 -171.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.415 HD11 HG23 ' A' ' 43' ' ' VAL . 8.7 mm -101.09 122.9 53.73 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 124.143 0.977 . . . . 10.0 109.839 -165.009 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 . . . . . 0 N--CA 1.451 -0.395 0 N-CA-C 106.861 -1.533 . . . . 10.0 106.861 177.439 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.453 -0.292 0 CA-C-O 120.373 0.13 . . . . 10.0 110.953 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.73 -40.07 75.05 Favored 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 121.645 -0.66 . . . . 10.0 109.752 177.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.512 HD12 HG22 ' A' ' 61' ' ' VAL . 9.0 mm -46.15 -50.38 4.61 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.249 0 CA-C-O 117.224 -1.37 . . . . 10.0 112.452 170.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -47.78 -53.41 15.44 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 120.34 1.427 . . . . 10.0 110.838 -176.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.2 tppt? -70.22 -43.59 70.33 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 123.612 0.765 . . . . 10.0 108.951 -176.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 14.2 tpp180 -63.4 -33.94 76.64 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-O 119.658 -0.21 . . . . 10.0 110.81 -175.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.488 HD12 HG22 ' A' ' 21' ' ' ILE . 0.3 OUTLIER -78.68 -38.19 39.89 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 124.71 1.204 . . . . 10.0 110.529 173.01 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -59.95 -19.06 49.97 Favored 'General case' 0 C--O 1.225 -0.199 0 O-C-N 121.256 -0.903 . . . . 10.0 110.8 177.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.6 ptpt -51.84 -43.63 63.27 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 113.123 0.786 . . . . 10.0 113.123 169.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 5.2 mt -55.97 134.15 19.83 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 N-CA-C 108.635 -0.876 . . . . 10.0 108.635 -176.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -70.85 -47.1 61.13 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 108.705 -0.85 . . . . 10.0 108.705 -177.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -80.84 43.81 2.88 Favored Glycine 0 C--N 1.342 0.875 0 O-C-N 121.068 -1.02 . . . . 10.0 112.111 -176.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.8 p -105.92 152.05 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 C-N-CA 125.298 1.439 . . . . 10.0 109.058 -177.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.578 ' HB2' HG21 ' A' ' 2' ' ' THR . . . -115.81 -57.91 2.17 Favored 'General case' 0 CA--C 1.522 -0.127 0 C-N-CA 123.796 0.838 . . . . 10.0 108.873 169.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 64.6 m-80 -143.62 159.24 42.81 Favored 'General case' 0 CA--C 1.526 0.057 0 N-CA-C 109.496 -0.557 . . . . 10.0 109.496 -176.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -141.32 61.34 13.67 Favored Pre-proline 0 CA--C 1.537 0.452 0 C-N-CA 123.884 0.874 . . . . 10.0 111.585 174.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -77.35 71.39 6.4 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 123.09 2.526 . . . . 10.0 110.03 -176.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.543 HG12 HG13 ' A' ' 43' ' ' VAL . 3.5 m -67.02 155.02 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 O-C-N 121.744 -0.598 . . . . 10.0 111.028 -178.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -95.69 155.24 16.83 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 120.98 0.419 . . . . 10.0 109.934 172.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -135.28 48.47 2.25 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 124.954 1.301 . . . . 10.0 109.695 -171.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -175.26 -42.44 0.01 OUTLIER 'General case' 0 C--O 1.224 -0.251 0 C-N-CA 126.09 1.756 . . . . 10.0 108.708 178.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.4 mt -80.66 -15.48 56.46 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 125.436 1.494 . . . . 10.0 112.012 -170.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 71.86 40.29 0.77 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.275 1.43 . . . . 10.0 110.721 174.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.5 p -140.76 123.38 16.12 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.64 1.576 . . . . 10.0 108.969 -178.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.543 HG13 HG12 ' A' ' 36' ' ' VAL . 9.3 t -92.86 145.91 7.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 107.322 -1.362 . . . . 10.0 107.322 168.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 88.3 m -133.75 122.13 22.89 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 105.997 -1.853 . . . . 10.0 105.997 -176.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 29.3 t -122.98 134.42 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-N 118.74 0.7 . . . . 10.0 109.408 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -96.15 104.41 16.37 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 106.833 -1.543 . . . . 10.0 106.833 161.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -145.42 163.72 33.75 Favored 'General case' 0 CA--C 1.521 -0.166 0 C-N-CA 123.558 0.743 . . . . 10.0 109.798 178.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 13.3 p30 -98.5 130.64 27.62 Favored Pre-proline 0 C--N 1.329 -0.307 0 C-N-CA 123.419 0.687 . . . . 10.0 109.492 175.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -79.02 57.56 6.53 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 121.86 1.707 . . . . 10.0 108.967 171.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.34 -46.79 2.03 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.144 -0.687 . . . . 10.0 109.144 174.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -85.75 -61.06 1.84 Allowed 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 109.696 -0.483 . . . . 10.0 109.696 -178.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -107.71 -176.61 3.11 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 124.105 0.962 . . . . 10.0 110.017 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 93.6 p -140.1 169.73 17.15 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.696 1.198 . . . . 10.0 109.622 176.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 84.0 t -48.43 -52.6 8.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 124.408 1.083 . . . . 10.0 109.83 168.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.1 m -55.5 -35.95 66.14 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.631 1.173 . . . . 10.0 112.394 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -71.84 -60.62 2.14 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.703 -0.48 . . . . 10.0 109.703 174.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.784 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.0 pp -61.54 -43.72 98.36 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 121.85 -0.531 . . . . 10.0 110.636 -167.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.478 ' HA ' HD23 ' A' ' 68' ' ' LEU . 0.4 OUTLIER -51.37 -35.49 38.93 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 114.09 1.144 . . . . 10.0 114.09 171.065 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.88 -33.72 67.15 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 119.56 1.073 . . . . 10.0 110.088 176.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.38 -51.1 68.92 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 109.235 -0.654 . . . . 10.0 109.235 -177.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.512 HG22 HD12 ' A' ' 21' ' ' ILE . 43.3 t -59.54 -48.0 88.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 124.032 0.933 . . . . 10.0 111.477 173.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -53.09 -47.97 68.15 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 122.209 1.004 . . . . 10.0 109.435 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 32.8 tttp -70.56 -39.8 73.74 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 125.526 1.53 . . . . 10.0 110.897 -177.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 11.8 mt -51.57 -39.34 57.68 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 118.647 -0.692 . . . . 10.0 111.906 169.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 149.64 -21.2 1.17 Allowed Glycine 0 CA--C 1.527 0.798 0 CA-C-N 118.786 0.721 . . . . 10.0 114.698 167.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.42 ' OH ' HD11 ' A' ' 21' ' ' ILE . 1.9 p90 -118.82 155.43 31.19 Favored 'General case' 0 C--O 1.224 -0.276 0 C-N-CA 124.831 1.253 . . . . 10.0 107.955 -175.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.75 144.75 25.37 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 118.756 0.707 . . . . 10.0 110.331 -168.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.599 HD11 ' HB2' ' A' ' 7' ' ' PHE . 20.2 tp -123.36 145.18 48.96 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 126.157 1.783 . . . . 10.0 107.646 178.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.2 tptp -152.15 151.74 31.42 Favored 'General case' 0 CA--C 1.512 -0.499 0 C-N-CA 124.619 1.168 . . . . 10.0 108.488 171.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.521 HD11 ' HB1' ' A' ' 5' ' ' ALA . 7.9 tp -66.28 151.51 46.9 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 123.662 0.601 . . . . 10.0 109.66 177.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -105.07 -59.01 1.81 Allowed 'General case' 0 N--CA 1.437 -1.087 0 C-N-CA 127.492 2.317 . . . . 10.0 105.674 164.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 176.59 -93.65 0.09 OUTLIER Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 108.035 -2.026 . . . . 10.0 108.035 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 . . . . . 0 N--CA 1.453 -0.29 0 C-N-CA 123.601 0.76 . . . . 10.0 109.608 -163.548 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.6 p . . . . . 0 N--CA 1.452 -0.34 0 N-CA-C 106.609 -1.626 . . . . 10.0 106.609 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -126.2 149.91 48.71 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 126.439 1.895 . . . . 10.0 107.478 -168.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.51 131.75 49.02 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 107.883 -1.155 . . . . 10.0 107.883 -176.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.523 ' HB1' HD11 ' A' ' 70' ' ' LEU . . . -140.27 157.24 45.89 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 123.656 0.782 . . . . 10.0 109.926 178.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -128.31 151.57 49.16 Favored 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 123.542 0.737 . . . . 10.0 110.353 178.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.711 ' CE2' HD11 ' A' ' 57' ' ' LEU . 7.0 m-85 -140.35 146.64 38.69 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.845 1.658 . . . . 10.0 109.184 -170.037 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -110.15 125.82 53.42 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.311 1.044 . . . . 10.0 109.0 -165.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.418 HD11 HG23 ' A' ' 43' ' ' VAL . 8.6 mm -100.36 109.47 25.14 Favored 'Isoleucine or valine' 0 C--N 1.343 0.314 0 CA-C-N 118.907 0.776 . . . . 10.0 112.449 -159.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.407 ' OE1' ' NZ ' ' A' ' 67' ' ' LYS . 52.4 mt-10 . . . . . 0 N--CA 1.45 -0.458 0 N-CA-C 107.934 -1.135 . . . . 10.0 107.934 178.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 . . . . . 0 CA--C 1.534 0.352 0 N-CA-C 113.038 0.755 . . . . 10.0 113.038 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 18.1 ttm180 -72.31 -36.46 68.92 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 120.641 -1.287 . . . . 10.0 109.392 -178.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 9.1 mt -43.95 -53.41 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.44 0 CA-C-O 118.654 -0.689 . . . . 10.0 109.492 168.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -48.98 -47.22 44.3 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.4 0.546 . . . . 10.0 111.811 -175.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.21 -48.45 65.14 Favored 'General case' 0 CA--C 1.531 0.222 0 O-C-N 121.585 -0.697 . . . . 10.0 110.014 177.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.508 ' HB3' ' HB1' ' A' ' 60' ' ' ALA . 5.9 mmt180 -56.72 -35.47 68.58 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 112.093 0.405 . . . . 10.0 112.093 -179.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.489 HD21 ' HB2' ' A' ' 57' ' ' LEU . 1.3 mt -80.3 -44.8 18.97 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.752 1.621 . . . . 10.0 110.896 177.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -54.28 -24.98 21.07 Favored 'General case' 0 C--O 1.227 -0.113 0 CA-C-N 118.319 0.508 . . . . 10.0 111.077 174.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.8 ttmt -58.34 -35.37 71.8 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 112.984 0.735 . . . . 10.0 112.984 173.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.7 mm -60.02 135.13 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 C-N-CA 123.755 0.822 . . . . 10.0 109.85 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -69.05 -54.82 13.1 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 111.998 0.369 . . . . 10.0 111.998 -173.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.67 41.03 2.66 Favored Glycine 0 C--N 1.339 0.711 0 O-C-N 120.916 -1.115 . . . . 10.0 111.928 -173.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.4 p -100.95 150.61 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 C-N-CA 124.562 1.145 . . . . 10.0 108.542 -175.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -111.93 -58.16 2.16 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 108.483 -0.932 . . . . 10.0 108.483 171.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 60.0 m-80 -147.58 156.08 42.46 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.659 -0.867 . . . . 10.0 108.659 -173.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -141.72 56.81 6.3 Favored Pre-proline 0 CA--C 1.536 0.404 0 C-N-CA 123.626 0.771 . . . . 10.0 112.641 175.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -75.43 77.65 3.22 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 122.758 2.306 . . . . 10.0 110.152 -177.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.428 HG12 HG13 ' A' ' 43' ' ' VAL . 3.4 m -57.49 154.04 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 O-C-N 121.83 -0.543 . . . . 10.0 111.632 176.001 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -93.31 138.2 31.9 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.458 -0.571 . . . . 10.0 109.458 -179.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -117.7 54.56 0.9 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.99 1.316 . . . . 10.0 110.25 -171.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 171.14 -34.12 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 127.039 2.136 . . . . 10.0 109.997 176.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.5 mt -91.3 -1.67 57.59 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.14 1.376 . . . . 10.0 111.978 -171.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 65.44 35.19 7.52 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 124.918 1.287 . . . . 10.0 111.052 165.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -140.44 133.77 29.79 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 125.403 1.481 . . . . 10.0 107.857 -172.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.428 HG13 HG12 ' A' ' 36' ' ' VAL . 7.9 t -94.88 140.65 16.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 106.792 -1.558 . . . . 10.0 106.792 168.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 60.4 m -125.8 119.29 27.49 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 106.108 -1.812 . . . . 10.0 106.108 -178.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.8 t -120.57 142.51 36.15 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.207 0 C-N-CA 122.992 0.517 . . . . 10.0 109.629 -178.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 59.2 tt0 -109.51 110.44 21.54 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 107.184 -1.413 . . . . 10.0 107.184 162.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -151.72 164.93 35.9 Favored 'General case' 0 C--O 1.227 -0.129 0 C-N-CA 123.876 0.871 . . . . 10.0 109.405 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 20.7 p30 -95.53 134.69 23.9 Favored Pre-proline 0 C--N 1.328 -0.365 0 C-N-CA 123.437 0.695 . . . . 10.0 110.681 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -80.77 56.39 6.07 Favored 'Trans proline' 0 N--CA 1.45 -1.077 0 C-N-CA 121.603 1.536 . . . . 10.0 109.193 170.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.55 -39.54 0.51 Allowed 'General case' 0 C--N 1.346 0.439 0 CA-C-N 118.631 0.651 . . . . 10.0 112.54 175.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -95.23 -26.63 15.88 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 122.992 0.517 . . . . 10.0 110.321 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.51 173.22 15.42 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.183 0.993 . . . . 10.0 109.14 -179.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 91.0 p -131.59 169.35 16.25 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.565 1.146 . . . . 10.0 112.258 -177.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 26.4 m -48.75 -43.52 14.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 124.01 0.924 . . . . 10.0 110.679 166.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.85 -36.43 79.1 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.964 1.706 . . . . 10.0 111.642 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -71.55 -61.2 1.86 Allowed 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 108.472 -0.936 . . . . 10.0 108.472 175.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.711 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.3 pp -60.19 -42.31 94.8 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 120.042 -0.663 . . . . 10.0 111.545 -169.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.45 ' HA ' HD23 ' A' ' 68' ' ' LEU . 0.4 OUTLIER -51.24 -37.68 48.36 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 117.305 -1.331 . . . . 10.0 113.879 170.718 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -51.55 -39.08 57.09 Favored 'General case' 0 C--N 1.346 0.417 0 CA-C-N 120.735 1.607 . . . . 10.0 110.298 173.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.508 ' HB1' ' HB3' ' A' ' 24' ' ' ARG . . . -62.18 -46.14 90.27 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 109.429 -0.582 . . . . 10.0 109.429 -174.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 68.9 t -66.83 -45.87 86.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 123.327 0.651 . . . . 10.0 111.755 172.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -49.9 -54.13 21.54 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 124.67 1.188 . . . . 10.0 108.821 -178.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 46.4 tptt -57.67 -34.78 69.75 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.549 1.54 . . . . 10.0 111.644 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.458 HD13 ' HA ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -55.85 -34.45 65.44 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 124.255 1.022 . . . . 10.0 111.248 174.064 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 125.95 -11.45 7.36 Favored Glycine 0 CA--C 1.529 0.968 0 CA-C-O 119.474 -0.626 . . . . 10.0 113.4 174.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -116.35 151.46 35.87 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 107.149 -1.426 . . . . 10.0 107.149 173.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.407 ' NZ ' ' OE1' ' A' ' 10' ' ' GLU . 13.3 ttpp -95.47 156.4 16.34 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.246 0.546 . . . . 10.0 110.364 -171.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.519 HD11 ' HB2' ' A' ' 7' ' ' PHE . 29.7 tp -128.98 150.44 50.4 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.622 1.569 . . . . 10.0 107.882 -179.045 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 11.0 tptp -155.14 151.56 28.4 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 108.803 -0.814 . . . . 10.0 108.803 169.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.523 HD11 ' HB1' ' A' ' 5' ' ' ALA . 7.5 tp -62.74 154.78 28.48 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 121.303 0.573 . . . . 10.0 109.573 177.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 45.6 tttp -117.23 -53.44 2.45 Favored 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 127.769 2.428 . . . . 10.0 107.08 170.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 170.57 -84.38 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.515 0 N-CA-C 109.081 -1.608 . . . . 10.0 109.081 176.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 . . . . . 0 N--CA 1.448 -0.525 0 N-CA-C 108.224 -1.028 . . . . 10.0 108.224 -164.578 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.549 HG21 ' HB2' ' A' ' 32' ' ' ALA . 21.7 p . . . . . 0 N--CA 1.451 -0.393 0 CA-C-O 121.71 0.767 . . . . 10.0 110.103 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -116.47 151.95 35.02 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 125.186 1.394 . . . . 10.0 109.136 -165.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -86.58 129.67 34.78 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.857 1.263 . . . . 10.0 107.719 -171.275 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -134.28 136.34 43.48 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.527 1.131 . . . . 10.0 109.362 174.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -116.11 150.8 36.79 Favored 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 124.622 1.169 . . . . 10.0 108.067 174.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.821 ' CE2' HD11 ' A' ' 57' ' ' LEU . 7.0 m-85 -138.95 138.17 37.07 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 124.493 1.121 . . . . 10.0 109.327 -174.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -102.12 130.59 48.77 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.727 1.611 . . . . 10.0 108.197 -176.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.408 HD12 HD12 ' A' ' 68' ' ' LEU . 0.9 OUTLIER -114.95 153.86 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.068 0 C-N-CA 125.789 1.636 . . . . 10.0 110.895 -165.86 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 . . . . . 0 N--CA 1.443 -0.811 0 C-N-CA 124.387 1.075 . . . . 10.0 108.23 168.656 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 . . . . . 0 CA--C 1.539 0.523 0 N-CA-C 112.631 0.604 . . . . 10.0 112.631 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.1 ttm180 -78.7 -36.88 42.9 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.307 1.043 . . . . 10.0 108.805 178.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 19.1 mm -43.7 -54.31 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.399 0 CA-C-O 118.462 -0.78 . . . . 10.0 109.854 171.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -44.63 -46.79 10.31 Favored 'General case' 0 C--O 1.224 -0.277 0 C-N-CA 122.998 0.519 . . . . 10.0 111.841 -179.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.54 -46.25 63.95 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 122.971 0.508 . . . . 10.0 110.076 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.09 -33.68 74.9 Favored 'General case' 0 C--O 1.222 -0.342 0 O-C-N 121.987 -0.445 . . . . 10.0 111.808 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.12 -34.84 26.0 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.524 1.53 . . . . 10.0 111.431 177.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -58.68 -24.59 61.62 Favored 'General case' 0 C--O 1.226 -0.171 0 O-C-N 121.761 -0.587 . . . . 10.0 109.89 172.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -52.03 -40.12 60.58 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 120.879 -0.328 . . . . 10.0 111.348 171.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 15.9 mm -56.16 127.2 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 C-N-CA 123.203 0.601 . . . . 10.0 109.623 -176.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -70.42 -48.67 54.98 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 121.081 -0.248 . . . . 10.0 110.759 -176.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -84.31 43.43 3.21 Favored Glycine 0 C--N 1.34 0.75 0 O-C-N 120.802 -1.186 . . . . 10.0 111.549 -177.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.3 p -99.4 148.46 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 124.287 1.035 . . . . 10.0 108.582 -178.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.549 ' HB2' HG21 ' A' ' 2' ' ' THR . . . -111.02 -57.51 2.23 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 124.106 0.962 . . . . 10.0 108.545 175.349 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 -143.39 152.46 41.62 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.307 -0.997 . . . . 10.0 108.307 -175.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -138.94 61.57 22.52 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 123.602 0.761 . . . . 10.0 111.072 173.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -78.48 67.76 8.22 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 123.004 2.469 . . . . 10.0 110.018 -175.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.456 HG12 HG13 ' A' ' 43' ' ' VAL . 4.2 m -65.0 155.15 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 O-C-N 121.859 -0.526 . . . . 10.0 110.61 179.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 75.4 m-80 -93.57 148.98 21.6 Favored 'General case' 0 C--O 1.224 -0.287 0 N-CA-C 108.497 -0.927 . . . . 10.0 108.497 175.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -126.3 47.95 2.2 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 123.643 0.777 . . . . 10.0 110.38 -173.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -174.22 -43.03 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 125.948 1.699 . . . . 10.0 109.614 178.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.0 mt -76.38 -18.47 58.85 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.803 1.241 . . . . 10.0 111.971 -169.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 63.2 54.72 2.01 Favored 'General case' 0 C--N 1.338 0.079 0 C-N-CA 125.752 1.621 . . . . 10.0 110.126 -174.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.2 p -142.29 130.74 22.41 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 107.481 -1.303 . . . . 10.0 107.481 172.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.456 HG13 HG12 ' A' ' 36' ' ' VAL . 9.2 t -105.28 145.41 13.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 106.759 -1.571 . . . . 10.0 106.759 173.033 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 69.8 m -139.83 123.57 17.42 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 106.25 -1.759 . . . . 10.0 106.25 -169.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 22.2 t -127.42 149.36 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 C-N-CA 123.692 0.797 . . . . 10.0 109.271 179.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 -115.78 112.02 21.38 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 105.895 -1.891 . . . . 10.0 105.895 159.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -146.44 162.81 37.46 Favored 'General case' 0 CA--C 1.52 -0.202 0 C-N-CA 123.403 0.681 . . . . 10.0 109.553 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 20.5 p30 -92.47 130.6 36.78 Favored Pre-proline 0 C--N 1.329 -0.306 0 C-N-CA 122.524 0.33 . . . . 10.0 110.237 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -76.47 61.6 6.82 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 121.554 1.503 . . . . 10.0 108.486 170.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.24 -43.88 0.33 Allowed 'General case' 0 C--N 1.341 0.223 0 O-C-N 122.085 -0.384 . . . . 10.0 109.979 177.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -87.02 -41.96 13.46 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 117.92 0.327 . . . . 10.0 110.865 177.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -133.04 -178.06 4.79 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 124.52 1.128 . . . . 10.0 109.952 -177.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 81.7 p -146.24 167.46 23.45 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.549 0.74 . . . . 10.0 109.579 177.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 64.9 t -43.01 -49.07 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.113 0 C-N-CA 124.836 1.254 . . . . 10.0 111.02 172.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 43.9 m -50.54 -43.4 56.07 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.486 0.714 . . . . 10.0 112.583 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -65.77 -60.21 3.12 Favored 'General case' 0 C--N 1.338 0.09 0 C-N-CA 123.808 0.843 . . . . 10.0 109.055 -177.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.821 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.0 pp -61.65 -42.84 99.47 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 120.06 -0.656 . . . . 10.0 110.533 -176.051 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.11 -53.2 6.63 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 117.823 -1.084 . . . . 10.0 112.16 163.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.32 -48.63 73.86 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 119.96 1.255 . . . . 10.0 110.38 178.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -48.28 -54.62 13.05 Favored 'General case' 0 N--CA 1.453 -0.309 0 O-C-N 123.349 0.405 . . . . 10.0 110.642 177.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.1 t -62.9 -44.6 99.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 N-CA-C 112.578 0.585 . . . . 10.0 112.578 176.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.63 -57.49 8.09 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.013 1.325 . . . . 10.0 108.431 178.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.0 tptm -55.6 -38.84 69.96 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 126.455 1.902 . . . . 10.0 111.216 176.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.403 HD12 ' HA ' ' A' ' 64' ' ' LEU . 6.1 tp -55.05 -27.46 44.8 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.186 0.995 . . . . 10.0 113.047 174.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 131.21 -11.14 5.58 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-O 119.169 -0.795 . . . . 10.0 114.258 168.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -137.91 160.55 38.99 Favored 'General case' 0 CA--C 1.527 0.058 0 CA-C-N 118.667 1.234 . . . . 10.0 108.37 -176.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 41.4 mmtt -88.94 153.62 20.89 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.148 0.499 . . . . 10.0 112.041 -165.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.408 HD12 HD12 ' A' ' 9' ' ' ILE . 8.9 tp -135.23 148.69 49.69 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 125.579 1.552 . . . . 10.0 107.104 176.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.8 mmtt -149.17 154.18 38.77 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 124.523 1.129 . . . . 10.0 108.233 165.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.9 tp -59.76 158.52 10.23 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 109.752 -0.462 . . . . 10.0 109.752 171.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 7.8 tptt -110.38 -74.19 0.66 Allowed 'General case' 0 N--CA 1.434 -1.255 0 C-N-CA 126.832 2.053 . . . . 10.0 106.892 173.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 163.87 44.79 0.02 OUTLIER Glycine 0 CA--C 1.53 0.992 0 CA-C-O 119.491 -0.616 . . . . 10.0 112.537 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 . . . . . 0 CA--C 1.542 0.657 0 C-N-CA 125.059 1.344 . . . . 10.0 113.893 169.255 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.685 HG21 ' HB2' ' A' ' 32' ' ' ALA . 2.2 p . . . . . 0 N--CA 1.449 -0.489 0 N-CA-C 107.275 -1.38 . . . . 10.0 107.275 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -135.75 146.13 47.33 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 126.543 1.937 . . . . 10.0 106.708 -172.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 28.8 mmtm -81.54 145.73 30.52 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.77 -0.826 . . . . 10.0 108.77 177.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -145.12 141.58 28.92 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.721 1.208 . . . . 10.0 108.212 174.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -122.63 148.82 44.81 Favored 'General case' 0 CA--C 1.51 -0.595 0 C-N-CA 124.413 1.085 . . . . 10.0 108.601 174.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.774 ' CE2' HD11 ' A' ' 57' ' ' LEU . 2.7 m-85 -140.43 138.05 34.42 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 125.101 1.5 . . . . 10.0 109.404 -171.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -103.98 127.82 51.53 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.964 -1.124 . . . . 10.0 107.964 -168.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 10.7 mm -103.56 136.11 38.0 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.114 0 C-N-CA 124.424 1.09 . . . . 10.0 110.804 -160.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 . . . . . 0 N--CA 1.45 -0.473 0 N-CA-C 107.478 -1.305 . . . . 10.0 107.478 169.651 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.531 0.235 0 N-CA-C 112.064 0.394 . . . . 10.0 112.064 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -60.31 -38.4 83.56 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 121.056 -1.027 . . . . 10.0 109.135 -179.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.428 HD12 HG22 ' A' ' 61' ' ' VAL . 13.1 mm -52.57 -49.1 46.14 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.477 0 CA-C-O 118.053 -0.975 . . . . 10.0 110.323 176.12 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -46.42 -50.66 16.42 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.909 0.777 . . . . 10.0 110.56 -177.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.64 -46.37 63.41 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.106 0.562 . . . . 10.0 111.264 178.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.1 mmt180 -58.8 -27.34 64.95 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.743 0.645 . . . . 10.0 112.743 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.0 -39.3 13.04 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.943 1.697 . . . . 10.0 111.404 174.341 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 24.8 t30 -57.47 -25.82 60.3 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 118.703 0.683 . . . . 10.0 110.627 174.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.1 mmpt? -54.4 -37.33 64.94 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 114.3 1.222 . . . . 10.0 114.3 169.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 11.6 mm -54.53 128.82 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 109.084 -0.71 . . . . 10.0 109.084 175.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -68.39 -49.62 58.78 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 109.469 -0.567 . . . . 10.0 109.469 -177.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -82.39 47.31 3.72 Favored Glycine 0 C--N 1.34 0.783 0 O-C-N 120.651 -1.28 . . . . 10.0 112.181 -175.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.5 p -110.23 153.57 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 C-N-CA 125.223 1.409 . . . . 10.0 109.568 -177.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.685 ' HB2' HG21 ' A' ' 2' ' ' THR . . . -118.0 -52.01 2.43 Favored 'General case' 0 C--O 1.228 -0.029 0 C-N-CA 122.714 0.406 . . . . 10.0 110.127 169.227 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -144.57 149.92 36.62 Favored 'General case' 0 CA--C 1.527 0.087 0 N-CA-C 109.075 -0.713 . . . . 10.0 109.075 -173.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -137.58 58.48 16.86 Favored Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 123.691 0.796 . . . . 10.0 112.432 174.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -77.04 77.2 3.87 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 123.125 2.55 . . . . 10.0 110.495 -176.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.45 HG12 HG13 ' A' ' 43' ' ' VAL . 3.7 m -59.71 153.43 4.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 O-C-N 121.741 -0.599 . . . . 10.0 111.398 176.009 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -97.84 143.6 28.28 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.829 -0.804 . . . . 10.0 108.829 175.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -125.34 43.01 3.15 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.278 1.031 . . . . 10.0 110.953 -166.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -175.6 -40.06 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 125.924 1.69 . . . . 10.0 108.942 -178.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 12.6 mt -76.38 -21.26 56.27 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.346 1.058 . . . . 10.0 111.414 -176.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 63.7 49.48 2.96 Favored 'General case' 0 CA--C 1.527 0.093 0 C-N-CA 125.547 1.539 . . . . 10.0 109.959 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.6 p -137.86 131.67 31.39 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 126.131 1.772 . . . . 10.0 106.854 174.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.45 HG13 HG12 ' A' ' 36' ' ' VAL . 17.5 t -93.26 144.21 9.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 106.174 -1.787 . . . . 10.0 106.174 167.122 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 92.4 m -130.4 123.1 29.09 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 105.453 -2.054 . . . . 10.0 105.453 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 44.5 t -122.26 149.79 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 N-CA-C 108.668 -0.864 . . . . 10.0 108.668 176.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -116.06 108.66 16.48 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 107.113 -1.44 . . . . 10.0 107.113 161.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -146.63 164.63 32.04 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 108.915 -0.772 . . . . 10.0 108.915 -178.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 17.3 p30 -94.81 128.44 39.47 Favored Pre-proline 0 C--N 1.326 -0.421 0 N-CA-C 109.983 -0.377 . . . . 10.0 109.983 174.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -77.55 57.2 5.87 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 121.787 1.658 . . . . 10.0 108.7 168.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.17 -45.66 1.97 Allowed 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.113 -0.699 . . . . 10.0 109.113 177.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -90.11 -58.88 2.35 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 123.2 0.6 . . . . 10.0 109.68 -178.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -111.32 175.13 5.55 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 125.187 1.395 . . . . 10.0 109.565 178.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 59.4 p -129.14 176.65 7.74 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.66 1.184 . . . . 10.0 110.226 175.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 92.3 t -52.43 -39.88 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-N 115.234 -0.893 . . . . 10.0 110.691 168.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.1 m -58.13 -37.34 74.44 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 123.083 0.553 . . . . 10.0 111.882 -177.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -69.36 -58.49 3.94 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 123.999 0.92 . . . . 10.0 109.137 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.774 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.1 pp -63.08 -41.22 99.38 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 120.381 -0.528 . . . . 10.0 111.118 -175.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -40.48 -57.93 1.69 Allowed 'General case' 0 C--O 1.22 -0.48 0 O-C-N 121.575 -0.703 . . . . 10.0 111.69 161.024 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.47 -42.3 77.97 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 118.851 0.75 . . . . 10.0 110.35 -177.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -55.35 -47.28 75.98 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.395 -0.82 . . . . 10.0 110.432 179.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.428 HG22 HD12 ' A' ' 21' ' ' ILE . 48.0 t -66.02 -41.84 90.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 N-CA-C 111.481 0.178 . . . . 10.0 111.481 171.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -58.21 -45.36 87.79 Favored 'General case' 0 C--N 1.331 -0.201 0 O-C-N 121.181 -0.949 . . . . 10.0 109.181 -172.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 56.5 tttm -64.39 -27.91 69.33 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.32 1.048 . . . . 10.0 112.459 178.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.466 HD13 ' HA ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -56.63 -28.51 60.67 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 119.246 0.93 . . . . 10.0 110.756 168.959 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 131.26 -48.6 0.96 Allowed Glycine 0 C--N 1.337 0.635 0 N-CA-C 109.477 -1.449 . . . . 10.0 109.477 175.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -86.32 162.62 18.13 Favored 'General case' 0 C--O 1.224 -0.286 0 C-N-CA 125.422 1.489 . . . . 10.0 109.778 -177.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.87 163.7 12.53 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.38 0.609 . . . . 10.0 110.813 -167.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.548 HD11 ' HB2' ' A' ' 7' ' ' PHE . 18.4 tp -139.82 148.6 42.4 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 126.408 1.883 . . . . 10.0 107.561 -175.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.2 tptp -148.18 155.34 41.27 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 118.408 -0.806 . . . . 10.0 108.9 163.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.9 tp -63.83 158.4 22.06 Favored 'General case' 0 C--N 1.339 0.143 0 N-CA-C 108.992 -0.744 . . . . 10.0 108.992 174.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 14.8 tttp -113.77 -69.23 0.87 Allowed 'General case' 0 N--CA 1.436 -1.166 0 C-N-CA 125.739 1.616 . . . . 10.0 107.389 172.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 162.38 49.41 0.02 OUTLIER Glycine 0 CA--C 1.526 0.78 0 CA-C-O 119.666 -0.519 . . . . 10.0 112.35 175.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 . . . . . 0 CA--C 1.53 0.188 0 C-N-CA 124.996 1.319 . . . . 10.0 111.947 178.162 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.609 HG21 ' HB2' ' A' ' 32' ' ' ALA . 2.4 p . . . . . 0 N--CA 1.45 -0.43 0 N-CA-C 107.309 -1.367 . . . . 10.0 107.309 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -137.75 146.76 44.05 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.414 1.486 . . . . 10.0 108.35 -166.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -91.71 140.14 30.0 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.036 0.534 . . . . 10.0 109.733 -177.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -142.84 148.23 36.72 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.051 1.34 . . . . 10.0 109.315 179.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -123.27 149.37 44.86 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.612 1.165 . . . . 10.0 108.372 174.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.786 ' CE2' HD11 ' A' ' 57' ' ' LEU . 3.1 m-85 -141.04 144.12 34.8 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 124.976 1.422 . . . . 10.0 109.18 -174.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -106.92 132.03 53.32 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.4 1.08 . . . . 10.0 109.801 -169.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.426 HD11 ' HB ' ' A' ' 43' ' ' VAL . 4.7 mm -110.65 113.93 45.65 Favored 'Isoleucine or valine' 0 C--N 1.34 0.18 0 C-N-CA 125.096 1.358 . . . . 10.0 112.011 -160.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 . . . . . 0 N--CA 1.451 -0.407 0 N-CA-C 108.397 -0.964 . . . . 10.0 108.397 169.686 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 . . . . . 0 N--CA 1.448 -0.558 0 N-CA-C 113.115 0.783 . . . . 10.0 113.115 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.15 -48.44 57.38 Favored 'General case' 0 N--CA 1.451 -0.386 0 O-C-N 120.747 -1.221 . . . . 10.0 108.337 176.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -45.83 -51.55 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 CA-C-O 118.163 -0.922 . . . . 10.0 110.663 175.094 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -43.31 -48.8 6.89 Favored 'General case' 0 C--N 1.341 0.225 0 CA-C-N 118.626 0.648 . . . . 10.0 111.421 178.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.65 -47.04 61.98 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.779 -0.822 . . . . 10.0 108.779 -176.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.56 -38.67 75.17 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.275 -0.42 . . . . 10.0 111.894 -179.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.1 mt -78.96 -41.96 27.95 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.141 1.376 . . . . 10.0 110.576 178.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 15.7 t30 -54.8 -25.05 25.7 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.137 0.575 . . . . 10.0 111.226 173.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.2 ttmt -55.57 -38.38 69.29 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 112.393 0.516 . . . . 10.0 112.393 171.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 21.4 mm -60.01 132.14 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 C-N-CA 124.079 0.951 . . . . 10.0 109.831 -179.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -71.5 -52.63 17.33 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 111.47 0.174 . . . . 10.0 111.47 -174.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -82.95 42.83 3.02 Favored Glycine 0 C--N 1.339 0.71 0 O-C-N 120.753 -1.217 . . . . 10.0 112.026 -176.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.7 p -103.22 148.72 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 C-N-CA 124.385 1.074 . . . . 10.0 108.537 -177.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.609 ' HB2' HG21 ' A' ' 2' ' ' THR . . . -110.94 -56.55 2.35 Favored 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 108.965 -0.754 . . . . 10.0 108.965 175.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -147.96 151.53 35.96 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 108.216 -1.031 . . . . 10.0 108.216 -172.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -136.61 65.16 53.96 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 123.77 0.828 . . . . 10.0 110.93 172.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -78.36 68.17 8.05 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.01 2.474 . . . . 10.0 109.447 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.457 HG12 HG13 ' A' ' 43' ' ' VAL . 13.6 m -71.27 158.95 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 C-N-CA 123.058 0.543 . . . . 10.0 111.36 -177.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -100.64 145.6 28.2 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-O 120.936 0.398 . . . . 10.0 110.894 -175.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -121.99 38.78 4.04 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.304 1.442 . . . . 10.0 111.102 -170.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -176.57 -36.68 0.01 OUTLIER 'General case' 0 C--O 1.224 -0.249 0 C-N-CA 125.06 1.344 . . . . 10.0 110.531 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 12.8 mt -82.18 -10.89 59.0 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.9 1.28 . . . . 10.0 112.036 -173.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 71.67 40.45 0.78 Allowed 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 125.661 1.584 . . . . 10.0 110.885 171.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 7.5 p -142.51 133.4 25.65 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.546 1.138 . . . . 10.0 108.975 -175.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.457 HG13 HG12 ' A' ' 36' ' ' VAL . 3.4 t -99.78 139.4 21.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 N-CA-C 106.187 -1.783 . . . . 10.0 106.187 168.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 57.7 m -131.66 118.17 19.66 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 105.218 -2.142 . . . . 10.0 105.218 -174.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.5 t -124.49 140.16 48.59 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.183 0 C-N-CA 122.964 0.506 . . . . 10.0 109.707 -175.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 49.4 tt0 -103.23 111.42 23.8 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 107.39 -1.337 . . . . 10.0 107.39 161.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -145.6 164.46 31.65 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 123.68 0.792 . . . . 10.0 109.782 176.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -96.75 131.56 27.81 Favored Pre-proline 0 C--N 1.33 -0.25 0 C-N-CA 123.067 0.547 . . . . 10.0 110.03 177.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -77.2 61.34 7.25 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 121.302 1.335 . . . . 10.0 108.68 168.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.14 -43.95 0.38 Allowed 'General case' 0 C--N 1.343 0.311 0 O-C-N 121.894 -0.504 . . . . 10.0 110.981 177.082 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.77 -41.12 14.36 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.797 0.839 . . . . 10.0 110.031 178.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -144.42 170.06 16.74 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 126.223 1.809 . . . . 10.0 108.772 -170.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 33.0 p -128.71 -179.49 5.1 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 122.608 1.194 . . . . 10.0 110.817 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 99.3 t -46.54 -41.46 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 114.413 -1.267 . . . . 10.0 111.292 163.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 70.6 m -62.0 -40.05 94.33 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 118.46 0.573 . . . . 10.0 111.301 -173.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -68.48 -54.57 16.07 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.814 1.245 . . . . 10.0 108.999 -175.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.786 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.0 pp -63.87 -44.07 94.18 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 119.664 -0.814 . . . . 10.0 110.485 -179.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.9 -49.66 10.88 Favored 'General case' 0 C--O 1.221 -0.438 0 CA-C-O 117.823 -1.084 . . . . 10.0 113.212 163.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 14.2 tm-20 -54.82 -46.2 74.52 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 120.715 1.598 . . . . 10.0 109.618 179.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -50.69 -55.37 16.86 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.377 -0.829 . . . . 10.0 109.372 178.229 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.516 HG13 ' CE2' ' A' ' 66' ' ' TYR . 66.8 t -60.98 -49.97 82.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 112.841 0.682 . . . . 10.0 112.841 177.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -58.34 -33.38 69.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.749 0.785 . . . . 10.0 109.285 -176.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.6 tttp -77.7 -34.11 52.94 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 123.451 0.701 . . . . 10.0 111.583 178.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 67.9 mt -53.09 -42.22 65.71 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.347 0.976 . . . . 10.0 111.148 164.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 143.51 -37.48 1.46 Allowed Glycine 0 C--N 1.337 0.636 0 CA-C-N 118.155 0.434 . . . . 10.0 112.439 168.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.516 ' CE2' HG13 ' A' ' 61' ' ' VAL . 22.3 p90 -85.71 158.55 20.02 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 108.494 -0.928 . . . . 10.0 108.494 176.226 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 33.6 mttp -100.94 160.84 14.04 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.544 0.688 . . . . 10.0 111.422 -173.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.508 HD11 ' HB2' ' A' ' 7' ' ' PHE . 21.6 tp -136.68 149.49 47.95 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.253 1.821 . . . . 10.0 107.549 -171.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -153.38 152.36 30.97 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 109.011 -0.737 . . . . 10.0 109.011 162.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.7 tp -60.02 156.61 14.43 Favored 'General case' 0 C--O 1.231 0.129 0 O-C-N 123.595 0.56 . . . . 10.0 109.683 175.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -112.1 -70.44 0.81 Allowed 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 125.672 1.589 . . . . 10.0 107.201 172.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 157.4 59.08 0.01 OUTLIER Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.191 -0.763 . . . . 10.0 111.191 -179.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . 0.272 12.4 pt-20 . . . . . 0 CA--C 1.533 0.309 0 C-N-CA 128.098 2.559 . . . . 10.0 114.737 176.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.648 HG21 ' HB2' ' A' ' 32' ' ' ALA . 11.8 p . . . . . 0 N--CA 1.445 -0.687 0 N-CA-C 109.642 -0.503 . . . . 10.0 109.642 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.7 mp0 -101.02 138.33 38.21 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.244 1.817 . . . . 10.0 109.212 177.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.7 tptt -81.87 119.86 24.46 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 108.105 -1.072 . . . . 10.0 108.105 171.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -128.09 153.55 46.69 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.537 1.135 . . . . 10.0 109.575 173.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -128.1 145.24 51.06 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.632 0.773 . . . . 10.0 110.215 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.537 ' HB2' HD11 ' A' ' 68' ' ' LEU . 2.1 m-85 -130.22 133.57 46.64 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 125.236 1.585 . . . . 10.0 111.749 -167.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -85.1 136.11 33.69 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 125.28 1.432 . . . . 10.0 109.781 176.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.541 HD11 HG23 ' A' ' 43' ' ' VAL . 5.2 mm -109.42 134.58 51.03 Favored 'Isoleucine or valine' 0 C--N 1.34 0.176 0 C-N-CA 126.543 1.937 . . . . 10.0 109.756 -173.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 . . . . . 0 N--CA 1.446 -0.658 0 N-CA-C 108.28 -1.007 . . . . 10.0 108.28 159.841 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 . . . . . 0 CA--C 1.537 0.443 0 CA-C-O 121.915 0.864 . . . . 10.0 112.491 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 34.5 ttt85 -66.38 -35.41 80.26 Favored 'General case' 0 N--CA 1.45 -0.425 0 O-C-N 120.813 -1.18 . . . . 10.0 109.77 178.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 4.6 mt -52.04 -57.98 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.498 0 N-CA-C 108.861 -0.792 . . . . 10.0 108.861 172.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -45.25 -48.18 12.8 Favored 'General case' 0 C--O 1.221 -0.427 0 O-C-N 123.856 0.723 . . . . 10.0 110.882 -177.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.2 mtmt -68.14 -46.98 69.34 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.934 0.893 . . . . 10.0 110.414 -178.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.3 tpm_? -63.32 -36.59 84.19 Favored 'General case' 0 N--CA 1.45 -0.425 0 O-C-N 121.858 -0.526 . . . . 10.0 110.184 -178.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.06 -34.57 50.34 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.901 1.681 . . . . 10.0 111.457 176.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -64.15 -20.5 66.03 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 118.633 0.651 . . . . 10.0 109.421 175.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -53.97 -41.24 67.64 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 119.941 -0.704 . . . . 10.0 111.156 168.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 28.2 mm -58.97 129.96 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 123.667 0.787 . . . . 10.0 109.757 -174.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -73.03 -48.95 31.7 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 116.631 -0.259 . . . . 10.0 110.399 -172.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -82.88 40.9 2.83 Favored Glycine 0 C--N 1.339 0.746 0 O-C-N 120.887 -1.133 . . . . 10.0 111.767 -176.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -104.89 144.73 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 N-CA-C 107.743 -1.206 . . . . 10.0 107.743 179.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.648 ' HB2' HG21 ' A' ' 2' ' ' THR . . . -106.67 -55.19 2.36 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.26 -0.644 . . . . 10.0 109.26 171.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -142.89 143.01 31.88 Favored 'General case' 0 C--O 1.226 -0.154 0 N-CA-C 108.824 -0.806 . . . . 10.0 108.824 -174.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -133.68 55.64 16.83 Favored Pre-proline 0 CA--C 1.54 0.585 0 N-CA-C 113.552 0.945 . . . . 10.0 113.552 175.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -77.9 75.58 4.73 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 123.392 2.728 . . . . 10.0 110.39 -177.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.644 HG12 HG13 ' A' ' 43' ' ' VAL . 2.1 m -62.32 153.09 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 123.138 0.575 . . . . 10.0 111.719 178.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -94.35 138.53 32.21 Favored 'General case' 0 N--CA 1.457 -0.116 0 O-C-N 122.082 -0.386 . . . . 10.0 110.06 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -116.01 45.64 1.7 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.676 1.19 . . . . 10.0 111.557 -169.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -175.92 -39.99 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.207 0 C-N-CA 125.232 1.413 . . . . 10.0 109.354 178.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.7 mt -74.92 -20.21 59.8 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.491 1.117 . . . . 10.0 111.427 -174.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 63.39 49.93 3.04 Favored 'General case' 0 C--N 1.339 0.132 0 C-N-CA 125.466 1.506 . . . . 10.0 109.761 -178.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.1 p -140.06 125.85 19.43 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 125.507 1.523 . . . . 10.0 107.446 174.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.644 HG13 HG12 ' A' ' 36' ' ' VAL . 32.1 t -91.69 136.46 24.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 107.263 -1.384 . . . . 10.0 107.263 167.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 26.0 m -120.05 124.88 46.94 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 125.592 1.557 . . . . 10.0 107.079 178.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 98.1 t -134.94 146.52 30.43 Favored 'Isoleucine or valine' 0 C--N 1.341 0.232 0 CA-C-N 119.154 0.888 . . . . 10.0 110.524 175.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -105.03 106.64 17.23 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 126.99 2.116 . . . . 10.0 106.162 169.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 26.5 p90 -139.6 154.44 47.59 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 118.926 0.785 . . . . 10.0 110.766 179.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -94.69 128.28 40.36 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 118.589 -0.719 . . . . 10.0 110.079 175.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -76.07 57.87 5.36 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.553 2.169 . . . . 10.0 108.862 169.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.413 ' NZ ' ' OE1' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -124.51 -53.0 1.7 Allowed 'General case' 0 C--N 1.338 0.102 0 N-CA-C 106.508 -1.664 . . . . 10.0 106.508 176.195 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.413 ' OE1' ' NZ ' ' A' ' 50' ' ' LYS . 1.8 tp10 -89.45 -42.49 11.46 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.031 0.532 . . . . 10.0 110.712 -178.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.27 147.63 29.55 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 124.833 1.253 . . . . 10.0 107.965 -172.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 54.1 p -105.81 -171.98 2.01 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.104 0.962 . . . . 10.0 109.864 -179.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.51 HG21 HD12 ' A' ' 70' ' ' LEU . 3.5 p -61.37 -32.72 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 120.323 -0.551 . . . . 10.0 111.006 166.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.2 t -54.76 -43.54 72.84 Favored 'General case' 0 C--O 1.235 0.335 0 O-C-N 121.822 -0.549 . . . . 10.0 109.703 -175.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -64.32 -54.49 32.32 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 125.72 1.608 . . . . 10.0 108.839 -175.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.435 HD13 ' CE2' ' A' ' 7' ' ' PHE . 4.0 pp -67.78 -42.59 81.45 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.959 -0.463 . . . . 10.0 111.25 -178.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -44.64 -50.62 9.72 Favored 'General case' 0 N--CA 1.449 -0.477 0 O-C-N 121.162 -0.961 . . . . 10.0 111.709 163.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.45 -45.14 92.45 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 118.92 0.782 . . . . 10.0 109.87 179.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -51.45 -49.82 60.99 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.031 -0.531 . . . . 10.0 110.182 178.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.502 ' HA ' HD12 ' A' ' 64' ' ' LEU . 58.0 t -68.2 -43.71 84.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 112.209 0.448 . . . . 10.0 112.209 177.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -53.5 -40.99 65.82 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 108.973 -0.751 . . . . 10.0 108.973 176.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.8 tptt -75.01 -36.75 61.92 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.899 1.28 . . . . 10.0 111.324 -179.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.502 HD12 ' HA ' ' A' ' 61' ' ' VAL . 15.5 mt -51.93 -35.03 44.38 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.817 0.735 . . . . 10.0 112.023 167.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.79 24.29 4.99 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 123.192 0.425 . . . . 10.0 112.888 169.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -141.75 160.56 39.93 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 105.276 -2.12 . . . . 10.0 105.276 168.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 62.7 tttt -106.82 144.34 33.61 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 119.548 1.067 . . . . 10.0 111.774 -168.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.537 HD11 ' HB2' ' A' ' 7' ' ' PHE . 14.0 tp -121.47 147.99 45.03 Favored 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 127.883 2.473 . . . . 10.0 107.622 -176.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.0 mmtt -143.22 170.04 16.5 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 124.407 1.083 . . . . 10.0 108.445 161.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.516 HD23 ' H ' ' A' ' 71' ' ' LYS . 1.6 tt -93.31 151.4 19.81 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 123.505 0.722 . . . . 10.0 109.195 178.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.516 ' H ' HD23 ' A' ' 70' ' ' LEU . 56.9 tttp -116.08 -62.36 1.6 Allowed 'General case' 0 N--CA 1.441 -0.904 0 C-N-CA 125.94 1.696 . . . . 10.0 108.089 -177.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -175.52 -87.93 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 108.455 -1.858 . . . . 10.0 108.455 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 . . . . . 0 N--CA 1.452 -0.353 0 C-N-CA 124.154 0.981 . . . . 10.0 109.177 -171.313 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.57 HG21 ' HB2' ' A' ' 32' ' ' ALA . 6.3 p . . . . . 0 CA--C 1.534 0.33 0 N-CA-C 107.337 -1.357 . . . . 10.0 107.337 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -139.16 147.74 42.26 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 127.525 2.33 . . . . 10.0 106.747 -167.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 59.7 mmtt -91.93 135.72 33.72 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 123.264 0.625 . . . . 10.0 109.636 -175.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -138.34 140.62 39.57 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.888 -1.152 . . . . 10.0 107.888 173.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -122.3 150.57 42.18 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.631 0.772 . . . . 10.0 110.368 175.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.724 ' HB2' HD11 ' A' ' 68' ' ' LEU . 0.8 OUTLIER -141.95 136.47 30.41 Favored 'General case' 0 N--CA 1.448 -0.566 0 O-C-N 124.925 1.39 . . . . 10.0 110.212 -169.903 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -95.91 135.74 37.26 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.933 1.693 . . . . 10.0 108.993 -175.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.554 HD11 HG23 ' A' ' 43' ' ' VAL . 7.2 mm -106.74 116.34 50.26 Favored 'Isoleucine or valine' 0 C--N 1.339 0.15 0 C-N-CA 125.851 1.66 . . . . 10.0 111.463 -165.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 . . . . . 0 N--CA 1.448 -0.548 0 N-CA-C 107.595 -1.261 . . . . 10.0 107.595 170.912 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.539 0.524 0 N-CA-C 112.59 0.589 . . . . 10.0 112.59 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.17 -36.97 66.68 Favored 'General case' 0 N--CA 1.447 -0.619 0 O-C-N 121.005 -1.059 . . . . 10.0 108.795 -178.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.568 HD12 HG22 ' A' ' 61' ' ' VAL . 11.6 mm -51.38 -58.2 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 N-CA-C 108.425 -0.954 . . . . 10.0 108.425 168.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -45.75 -41.41 10.71 Favored 'General case' 0 C--O 1.223 -0.311 0 O-C-N 123.604 0.565 . . . . 10.0 111.216 -178.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.29 -54.81 12.76 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 121.634 -0.666 . . . . 10.0 111.735 178.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.48 ' CZ ' ' HA ' ' A' ' 60' ' ' ALA . 4.8 mtp180 -60.99 -39.5 89.91 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 119.454 -0.899 . . . . 10.0 110.81 -178.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.89 -41.79 70.85 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 123.698 0.799 . . . . 10.0 110.74 179.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 44.4 m-20 -54.55 -30.78 55.08 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 118.454 0.57 . . . . 10.0 110.608 171.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -59.19 -31.7 69.24 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 118.377 -0.821 . . . . 10.0 112.776 176.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 18.6 mm -57.89 121.16 4.95 Favored 'Isoleucine or valine' 0 C--N 1.34 0.187 0 CA-C-N 118.933 0.788 . . . . 10.0 109.858 -178.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 50.1 mp0 -57.32 -46.13 83.55 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 123.658 0.783 . . . . 10.0 112.085 -175.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.95 32.61 3.2 Favored Glycine 0 C--N 1.341 0.816 0 CA-C-N 120.323 1.419 . . . . 10.0 112.772 -174.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.7 p -99.41 150.74 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 119.204 1.502 . . . . 10.0 109.327 -176.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.57 ' HB2' HG21 ' A' ' 2' ' ' THR . . . -108.79 -59.12 1.92 Allowed 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 108.454 -0.943 . . . . 10.0 108.454 168.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 66.3 m-20 -139.64 152.96 47.19 Favored 'General case' 0 C--N 1.337 0.026 0 N-CA-C 108.775 -0.824 . . . . 10.0 108.775 -174.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -137.1 62.85 41.27 Favored Pre-proline 0 CA--C 1.537 0.462 0 C-N-CA 124.17 0.988 . . . . 10.0 111.687 174.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -75.68 77.1 3.44 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 123.061 2.508 . . . . 10.0 111.511 -177.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.528 HG13 HG22 ' A' ' 43' ' ' VAL . 70.6 t -61.96 135.65 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 C-N-CA 125.889 1.676 . . . . 10.0 111.391 176.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -94.85 94.91 8.33 Favored 'General case' 0 C--N 1.346 0.419 0 O-C-N 121.296 -0.878 . . . . 10.0 111.552 -175.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -75.35 49.47 0.47 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.781 2.032 . . . . 10.0 114.055 -173.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -176.84 -37.15 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 124.916 1.287 . . . . 10.0 110.452 176.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.5 mt -84.68 -13.38 51.61 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.057 0.943 . . . . 10.0 111.261 -173.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 74.17 40.54 0.43 Allowed 'General case' 0 C--O 1.228 -0.071 0 C-N-CA 125.213 1.405 . . . . 10.0 110.25 170.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 35.4 p -140.08 131.11 26.25 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 125.028 1.331 . . . . 10.0 107.828 179.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.554 HG23 HD11 ' A' ' 9' ' ' ILE . 28.5 t -91.99 144.14 9.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 107.026 -1.472 . . . . 10.0 107.026 165.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 91.3 m -131.67 124.1 29.16 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 105.879 -1.897 . . . . 10.0 105.879 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 42.2 t -126.36 145.21 34.25 Favored 'Isoleucine or valine' 0 C--N 1.339 0.145 0 C-N-CA 123.289 0.635 . . . . 10.0 109.371 177.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -112.85 103.36 11.35 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 105.601 -2.0 . . . . 10.0 105.601 171.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -136.58 159.54 41.51 Favored 'General case' 0 C--O 1.225 -0.218 0 C-N-CA 123.883 0.873 . . . . 10.0 110.755 -175.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 21.2 p30 -94.8 125.78 49.79 Favored Pre-proline 0 C--N 1.331 -0.197 0 C-N-CA 123.481 0.712 . . . . 10.0 109.953 175.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -74.56 65.63 5.63 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 121.766 1.644 . . . . 10.0 108.304 172.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.7 pttt -138.86 -49.77 0.52 Allowed 'General case' 0 C--O 1.227 -0.105 0 N-CA-C 106.967 -1.494 . . . . 10.0 106.967 178.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -106.15 -56.54 2.17 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 124.656 1.182 . . . . 10.0 108.069 174.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.24 139.45 50.06 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 123.391 0.677 . . . . 10.0 109.738 -176.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 20.6 p -130.78 143.51 50.79 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 122.047 0.927 . . . . 10.0 110.518 174.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 30.3 m -45.39 -43.58 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 C-N-CA 125.157 1.383 . . . . 10.0 111.609 176.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.0 m -58.2 -43.13 87.45 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.501 1.121 . . . . 10.0 112.517 -177.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -63.08 -53.19 57.52 Favored 'General case' 0 C--O 1.224 -0.263 0 CA-C-O 122.072 0.939 . . . . 10.0 108.875 -173.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.567 HD11 ' CE2' ' A' ' 7' ' ' PHE 0.267 1.2 pp -65.62 -36.39 83.57 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.082 -1.011 . . . . 10.0 112.621 -177.225 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.405 ' HZ2' HD23 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -39.93 -64.59 0.48 Allowed 'General case' 0 CA--C 1.534 0.348 0 O-C-N 120.962 -1.087 . . . . 10.0 112.881 156.525 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.8 tm-20 -52.23 -39.76 60.73 Favored 'General case' 0 CA--C 1.517 -0.301 0 C-N-CA 123.455 0.702 . . . . 10.0 109.572 178.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.48 ' HA ' ' CZ ' ' A' ' 24' ' ' ARG . . . -59.68 -55.01 39.76 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 115.747 -0.661 . . . . 10.0 110.696 -174.275 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.568 HG22 HD12 ' A' ' 21' ' ' ILE . 80.4 t -62.46 -42.31 95.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-N 115.666 -0.697 . . . . 10.0 110.909 174.228 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -55.35 -51.25 67.4 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 121.575 0.702 . . . . 10.0 110.311 -176.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 40.6 tptt -56.65 -39.7 74.17 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 125.765 1.626 . . . . 10.0 111.007 177.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.74 -22.38 35.04 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 113.056 0.762 . . . . 10.0 113.056 174.066 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 108.73 14.71 14.86 Favored Glycine 0 CA--C 1.529 0.952 0 CA-C-N 118.78 0.718 . . . . 10.0 113.161 170.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.427 ' CZ ' HD11 ' A' ' 21' ' ' ILE . 2.2 p90 -143.37 160.27 40.85 Favored 'General case' 0 C--O 1.225 -0.23 0 N-CA-C 106.603 -1.629 . . . . 10.0 106.603 172.13 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -111.6 144.59 40.6 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 119.064 0.847 . . . . 10.0 111.141 -162.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.724 HD11 ' HB2' ' A' ' 7' ' ' PHE . 23.3 tp -121.38 148.27 44.61 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 125.097 1.359 . . . . 10.0 108.289 -172.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 20.8 mmtt -149.0 139.51 22.52 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 125.446 1.498 . . . . 10.0 110.288 169.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.563 HD23 ' N ' ' A' ' 71' ' ' LYS . 2.5 tt -72.1 157.38 37.88 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.633 -0.877 . . . . 10.0 108.633 177.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.563 ' N ' HD23 ' A' ' 70' ' ' LEU . 64.1 tttt -120.86 -65.26 1.16 Allowed 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 125.585 1.554 . . . . 10.0 108.169 177.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.53 -74.01 0.03 OUTLIER Glycine 0 CA--C 1.522 0.518 0 N-CA-C 110.051 -1.22 . . . . 10.0 110.051 173.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 . . . . . 0 N--CA 1.454 -0.251 0 N-CA-C 106.557 -1.646 . . . . 10.0 106.557 -165.567 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.508 HG21 ' HB2' ' A' ' 32' ' ' ALA . 7.7 p . . . . . 0 N--CA 1.455 -0.195 0 CA-C-O 120.87 0.367 . . . . 10.0 110.33 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -124.51 151.16 44.99 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 127.475 2.31 . . . . 10.0 107.575 -171.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.1 mppt? -93.69 142.67 27.09 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 123.975 0.91 . . . . 10.0 109.6 -176.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -148.19 140.95 24.62 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.027 0.931 . . . . 10.0 109.336 -177.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -117.97 148.75 41.9 Favored 'General case' 0 CA--C 1.508 -0.638 0 C-N-CA 123.361 0.665 . . . . 10.0 110.415 173.577 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.75 ' CE2' HD11 ' A' ' 57' ' ' LEU . 15.2 m-85 -134.47 144.39 48.07 Favored 'General case' 0 N--CA 1.446 -0.632 0 O-C-N 125.407 1.692 . . . . 10.0 108.781 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -109.97 132.42 54.17 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 108.475 -0.935 . . . . 10.0 108.475 -172.028 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.8 mm -113.43 144.16 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 C-N-CA 124.092 0.957 . . . . 10.0 111.811 -157.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 . . . . . 0 N--CA 1.444 -0.76 0 C-N-CA 124.524 1.13 . . . . 10.0 108.123 169.438 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.468 0.43 0 CA-C-O 121.572 0.701 . . . . 10.0 112.001 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 27.1 ttt180 -52.8 -38.14 60.78 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.253 1.021 . . . . 10.0 110.029 -178.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.64 HG22 HD12 ' A' ' 25' ' ' LEU . 27.5 mm -59.14 -45.98 92.31 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.538 0 CA-C-O 117.572 -1.204 . . . . 10.0 110.905 174.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -50.12 -50.5 48.35 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 119.606 1.094 . . . . 10.0 109.788 -176.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.7 tmmt? -67.9 -47.81 67.77 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.324 1.05 . . . . 10.0 110.11 179.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.04 -28.95 64.96 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.53 0.567 . . . . 10.0 112.53 177.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.64 HD12 HG22 ' A' ' 21' ' ' ILE . 1.0 OUTLIER -80.09 -43.38 21.86 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.989 1.315 . . . . 10.0 109.347 175.084 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.457 ' HA ' HG11 ' A' ' 31' ' ' VAL . 0.3 OUTLIER -56.89 -24.59 53.05 Favored 'General case' 0 C--O 1.226 -0.154 0 C-N-CA 123.964 0.905 . . . . 10.0 110.342 178.583 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.78 -36.51 81.3 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 114.775 1.398 . . . . 10.0 114.775 172.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.9 mp -62.39 129.19 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 120.067 1.303 . . . . 10.0 109.767 176.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -54.5 -51.16 65.98 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 112.433 0.531 . . . . 10.0 112.433 -177.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.85 37.3 2.82 Favored Glycine 0 C--N 1.34 0.774 0 O-C-N 120.563 -1.336 . . . . 10.0 112.317 -171.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.457 HG11 ' HA ' ' A' ' 26' ' ' ASN . 2.8 p -103.79 155.5 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 CA-C-N 118.362 1.081 . . . . 10.0 108.928 -177.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.508 ' HB2' HG21 ' A' ' 2' ' ' THR . . . -120.52 -58.54 1.83 Allowed 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 109.006 -0.739 . . . . 10.0 109.006 170.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 62.2 m-80 -139.08 155.66 47.76 Favored 'General case' 0 CA--C 1.521 -0.172 0 N-CA-C 108.835 -0.802 . . . . 10.0 108.835 -173.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -153.38 58.6 2.37 Favored Pre-proline 0 CA--C 1.533 0.318 0 N-CA-C 112.668 0.618 . . . . 10.0 112.668 173.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -74.45 79.05 2.57 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.659 2.24 . . . . 10.0 109.935 -178.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.535 HG12 HG13 ' A' ' 43' ' ' VAL . 4.5 m -63.47 156.72 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 O-C-N 121.695 -0.628 . . . . 10.0 112.168 -179.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 73.9 m-80 -98.39 122.17 41.24 Favored 'General case' 0 N--CA 1.457 -0.102 0 O-C-N 122.144 -0.348 . . . . 10.0 110.585 -178.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -102.51 42.9 1.11 Allowed 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.954 1.301 . . . . 10.0 111.236 -176.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -163.1 -43.56 0.03 OUTLIER 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 124.176 0.99 . . . . 10.0 109.05 176.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 12.3 mt -76.24 -22.48 55.11 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.827 0.851 . . . . 10.0 111.213 -177.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 62.08 53.83 2.87 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 125.554 1.541 . . . . 10.0 109.509 -175.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 16.9 p -138.1 133.1 33.01 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.955 1.702 . . . . 10.0 107.458 173.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.535 HG13 HG12 ' A' ' 36' ' ' VAL . 5.9 t -100.1 125.46 53.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 107.188 -1.412 . . . . 10.0 107.188 173.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 37.4 m -109.54 115.25 29.57 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 126.397 1.879 . . . . 10.0 107.572 -178.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.7 t -117.1 145.92 22.23 Favored 'Isoleucine or valine' 0 C--N 1.34 0.166 0 CA-C-N 118.971 0.805 . . . . 10.0 110.857 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -115.11 108.07 16.16 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 125.283 1.433 . . . . 10.0 107.748 161.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 26.9 p90 -139.34 162.02 36.02 Favored 'General case' 0 C--O 1.226 -0.134 0 C-N-CA 123.808 0.843 . . . . 10.0 110.253 -178.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 25.1 p30 -95.97 128.48 37.17 Favored Pre-proline 0 C--N 1.332 -0.18 0 C-N-CA 123.397 0.679 . . . . 10.0 110.142 176.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -75.48 61.69 6.09 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 N-CA-C 108.468 -1.397 . . . . 10.0 108.468 171.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.84 -47.14 0.32 Allowed 'General case' 0 C--N 1.346 0.416 0 CA-C-N 118.584 0.629 . . . . 10.0 110.195 176.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -104.59 -40.23 6.1 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.067 0.547 . . . . 10.0 109.898 170.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.32 158.35 17.84 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.377 0.671 . . . . 10.0 110.366 -177.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 97.7 p -148.83 158.74 44.38 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.643 0.735 . . . . 10.0 111.776 172.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.0 m -53.41 -45.78 57.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 124.267 1.027 . . . . 10.0 110.937 173.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 16.0 m -57.66 -43.48 84.99 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.4 1.08 . . . . 10.0 111.722 -178.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -64.2 -57.5 9.33 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.283 1.033 . . . . 10.0 109.262 -178.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.75 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.3 pp -65.42 -41.34 93.66 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.123 -0.985 . . . . 10.0 111.058 -176.259 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -43.03 -52.05 5.45 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-O 118.244 -0.884 . . . . 10.0 112.562 160.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.76 -45.95 77.97 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 119.772 1.169 . . . . 10.0 110.082 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -52.7 -54.2 36.85 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.977 -0.556 . . . . 10.0 110.321 178.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.498 HG22 HD12 ' A' ' 21' ' ' ILE . 40.6 t -57.85 -47.23 86.68 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 N-CA-C 112.597 0.592 . . . . 10.0 112.597 174.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -53.48 -55.6 23.98 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.754 1.222 . . . . 10.0 109.257 -177.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -59.72 -33.62 71.86 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 126.997 2.119 . . . . 10.0 111.711 178.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.87 -38.0 61.06 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.24 0.616 . . . . 10.0 111.908 168.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 119.25 9.7 8.52 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 124.187 0.898 . . . . 10.0 113.344 176.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -135.76 172.74 12.57 Favored 'General case' 0 C--O 1.225 -0.221 0 N-CA-C 107.076 -1.453 . . . . 10.0 107.076 172.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 33.1 mttt -114.94 157.84 22.83 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 118.853 0.752 . . . . 10.0 111.994 -166.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.2 tp -143.82 145.3 32.25 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.206 1.802 . . . . 10.0 107.254 -170.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 32.2 mmtt -148.84 150.09 32.42 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 124.291 1.036 . . . . 10.0 109.044 164.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.6 tp -63.01 158.62 18.95 Favored 'General case' 0 N--CA 1.456 -0.172 0 O-C-N 123.919 0.762 . . . . 10.0 109.236 175.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 19.1 tttt -124.59 -53.81 1.67 Allowed 'General case' 0 N--CA 1.439 -1.023 0 C-N-CA 127.811 2.444 . . . . 10.0 107.559 -178.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 174.03 -85.56 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 108.098 -2.001 . . . . 10.0 108.098 175.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 . . . . . 0 N--CA 1.453 -0.322 0 C-N-CA 124.38 1.072 . . . . 10.0 108.287 -169.259 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.474 HG21 ' HB2' ' A' ' 32' ' ' ALA . 4.9 p . . . . . 0 N--CA 1.449 -0.502 0 N-CA-C 108.821 -0.807 . . . . 10.0 108.821 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -141.61 140.78 33.41 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 126.981 2.112 . . . . 10.0 106.833 -170.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -90.84 130.76 36.77 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 123.675 0.79 . . . . 10.0 109.063 177.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -133.12 146.93 52.05 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 125.915 1.686 . . . . 10.0 107.947 -177.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -123.69 150.28 44.47 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.227 0.611 . . . . 10.0 110.249 176.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.869 ' CE2' HD11 ' A' ' 57' ' ' LEU . 2.7 m-85 -138.56 140.9 39.21 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.897 1.279 . . . . 10.0 109.621 -171.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -101.13 134.77 43.65 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 124.836 1.254 . . . . 10.0 108.596 -175.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 6.1 mm -107.6 119.45 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 C-N-CA 124.751 1.221 . . . . 10.0 110.223 -161.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 . . . . . 0 N--CA 1.449 -0.486 0 N-CA-C 108.329 -0.989 . . . . 10.0 108.329 174.025 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.6 m120 . . . . . 0 N--CA 1.464 0.269 0 N-CA-C 113.393 0.886 . . . . 10.0 113.393 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.4 ' HG2' HD11 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -69.39 -53.56 18.82 Favored 'General case' 0 C--O 1.234 0.242 0 O-C-N 121.37 -0.831 . . . . 10.0 109.005 171.337 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.533 HG22 HD12 ' A' ' 25' ' ' LEU . 6.4 mm -44.07 -54.85 0.99 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.339 0 O-C-N 123.915 0.759 . . . . 10.0 110.093 179.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -42.53 -50.86 5.26 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.994 0.918 . . . . 10.0 111.702 178.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.39 -47.56 60.29 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 121.453 -0.779 . . . . 10.0 110.794 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.428 ' CG ' ' HB1' ' A' ' 60' ' ' ALA . 0.5 OUTLIER -57.64 -36.91 72.47 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.952 0.901 . . . . 10.0 110.765 -177.606 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.533 HD12 HG22 ' A' ' 21' ' ' ILE . 0.4 OUTLIER -77.83 -43.97 28.8 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 126.151 1.781 . . . . 10.0 110.741 175.829 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -52.55 -28.55 21.26 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 118.915 0.779 . . . . 10.0 111.606 172.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.7 tmmt? -62.11 -26.91 68.57 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 112.402 0.519 . . . . 10.0 112.402 177.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 10.0 mm -66.85 133.51 31.3 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.131 0 N-CA-C 108.874 -0.787 . . . . 10.0 108.874 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -64.8 -56.16 15.26 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 120.608 0.242 . . . . 10.0 110.67 -173.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.96 44.71 3.36 Favored Glycine 0 C--N 1.34 0.784 0 O-C-N 120.755 -1.215 . . . . 10.0 112.039 -171.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.6 p -108.15 150.59 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 C-N-CA 124.649 1.18 . . . . 10.0 108.846 -176.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.474 ' HB2' HG21 ' A' ' 2' ' ' THR . . . -122.3 -52.29 1.95 Allowed 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.078 0.551 . . . . 10.0 110.285 174.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -138.68 153.89 48.57 Favored 'General case' 0 C--N 1.338 0.097 0 N-CA-C 109.378 -0.601 . . . . 10.0 109.378 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -146.29 61.85 7.45 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 123.484 0.714 . . . . 10.0 111.548 173.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -77.46 73.22 5.66 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.972 2.448 . . . . 10.0 109.599 -179.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.507 HG12 HG13 ' A' ' 43' ' ' VAL . 2.6 m -66.57 151.72 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 O-C-N 121.96 -0.462 . . . . 10.0 111.075 -179.125 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 -97.68 125.91 42.72 Favored 'General case' 0 N--CA 1.458 -0.068 0 O-C-N 122.193 -0.317 . . . . 10.0 110.413 -175.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -105.4 41.69 1.33 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.074 1.349 . . . . 10.0 111.65 -170.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -171.62 -38.81 0.02 OUTLIER 'General case' 0 C--O 1.225 -0.207 0 C-N-CA 124.958 1.303 . . . . 10.0 110.125 178.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.2 mt -77.37 -17.56 58.11 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.219 1.008 . . . . 10.0 111.616 -175.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 68.56 46.62 0.97 Allowed 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 125.64 1.576 . . . . 10.0 110.136 177.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 12.0 p -141.89 128.86 20.72 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.692 1.197 . . . . 10.0 108.378 177.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.507 HG13 HG12 ' A' ' 36' ' ' VAL . 10.3 t -93.72 135.04 29.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 106.361 -1.718 . . . . 10.0 106.361 169.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 60.6 m -121.05 123.48 42.47 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 105.9 -1.889 . . . . 10.0 105.9 178.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 19.3 t -124.23 149.97 28.66 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.115 0 C-N-CA 123.472 0.709 . . . . 10.0 109.211 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -124.92 102.33 7.49 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 126.647 1.979 . . . . 10.0 105.728 175.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -138.75 166.35 24.63 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 123.883 0.873 . . . . 10.0 110.675 -172.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 19.0 p30 -104.53 127.39 29.09 Favored Pre-proline 0 CA--C 1.532 0.254 0 C-N-CA 123.092 0.557 . . . . 10.0 110.094 177.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -75.59 63.66 6.49 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 122.52 2.147 . . . . 10.0 109.568 176.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 22.3 ttmt -142.74 -58.47 0.44 Allowed 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 106.3 -1.741 . . . . 10.0 106.3 175.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -114.08 1.16 14.53 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.34 1.456 . . . . 10.0 112.632 -173.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -133.23 154.5 50.6 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 125.276 1.43 . . . . 10.0 110.096 171.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 90.8 p -146.74 160.32 42.38 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.363 0.601 . . . . 10.0 111.391 175.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 59.4 t -52.79 -49.87 45.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 124.995 1.318 . . . . 10.0 109.408 173.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -51.11 -47.92 61.85 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 126.37 1.868 . . . . 10.0 111.758 178.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -67.83 -54.9 15.37 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.954 0.901 . . . . 10.0 109.899 -174.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.869 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.1 pp -66.0 -40.55 91.25 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 120.935 -1.103 . . . . 10.0 111.149 -178.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -43.87 -49.32 8.32 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 120.905 -1.122 . . . . 10.0 112.257 161.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.5 -43.49 79.78 Favored 'General case' 0 C--N 1.339 0.133 0 CA-C-N 119.824 1.193 . . . . 10.0 111.022 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.428 ' HB1' ' CG ' ' A' ' 24' ' ' ARG . . . -53.77 -53.26 54.77 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.126 -0.488 . . . . 10.0 110.335 176.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 47.4 t -63.07 -37.35 79.14 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 N-CA-C 112.321 0.489 . . . . 10.0 112.321 177.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -60.53 -55.13 37.1 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 125.091 1.356 . . . . 10.0 108.858 -177.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? -55.12 -41.21 71.41 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.893 0.877 . . . . 10.0 110.611 175.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.4 HD11 ' HG2' ' A' ' 20' ' ' ARG . 0.1 OUTLIER -49.65 -33.14 14.7 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.33 0.652 . . . . 10.0 112.326 173.342 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 113.82 17.62 7.33 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 124.044 0.83 . . . . 10.0 113.117 169.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.07 167.43 22.1 Favored 'General case' 0 N--CA 1.458 -0.041 0 N-CA-C 107.366 -1.346 . . . . 10.0 107.366 175.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -105.43 144.12 32.65 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 121.536 0.684 . . . . 10.0 111.351 -164.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.4 tp -130.13 145.5 51.71 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.102 1.761 . . . . 10.0 107.9 -178.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 26.0 mmtt -151.77 154.43 36.24 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 124.673 1.189 . . . . 10.0 108.659 167.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.7 tp -63.41 155.21 29.66 Favored 'General case' 0 CA--C 1.529 0.167 0 O-C-N 123.702 0.626 . . . . 10.0 110.33 176.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -111.89 -60.01 1.91 Allowed 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 127.508 2.323 . . . . 10.0 106.418 172.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -179.07 -84.88 0.06 OUTLIER Glycine 0 CA--C 1.523 0.539 0 N-CA-C 109.625 -1.39 . . . . 10.0 109.625 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 . . . . . 0 N--CA 1.451 -0.385 0 C-N-CA 124.475 1.11 . . . . 10.0 108.116 -169.497 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 13.4 p . . . . . 0 CA--C 1.535 0.375 0 N-CA-C 109.065 -0.716 . . . . 10.0 109.065 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -129.96 149.73 51.56 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 125.901 1.68 . . . . 10.0 109.49 -173.082 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.62 88.69 2.82 Favored 'General case' 0 C--N 1.341 0.215 0 C-N-CA 124.582 1.153 . . . . 10.0 109.606 -167.61 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -86.45 152.47 22.66 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.143 1.377 . . . . 10.0 110.523 -179.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -125.01 149.43 47.76 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.471 1.108 . . . . 10.0 109.341 174.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.716 ' CE2' HD11 ' A' ' 57' ' ' LEU . 4.7 m-85 -140.86 143.64 34.84 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 124.947 1.404 . . . . 10.0 110.794 -172.119 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -104.91 129.81 53.2 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.677 1.591 . . . . 10.0 108.849 -171.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 6.5 mm -103.62 111.29 32.76 Favored 'Isoleucine or valine' 0 C--N 1.342 0.252 0 C-N-CA 123.852 0.861 . . . . 10.0 111.289 -163.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 . . . . . 0 C--O 1.236 0.346 0 N-CA-C 107.704 -1.221 . . . . 10.0 107.704 175.573 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 . . . . . 0 CA--C 1.536 0.419 0 N-CA-C 112.112 0.412 . . . . 10.0 112.112 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.9 tpt180 -80.86 -48.05 12.94 Favored 'General case' 0 N--CA 1.452 -0.352 0 O-C-N 121.314 -0.866 . . . . 10.0 110.02 168.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.464 ' CG2' HD12 ' A' ' 25' ' ' LEU . 29.0 mm -39.35 -57.65 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.433 0 CA-C-O 118.545 -0.74 . . . . 10.0 110.844 177.104 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -44.75 -49.23 10.72 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 123.598 0.561 . . . . 10.0 111.499 -175.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.2 ttmt -72.7 -45.44 58.8 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.539 0.736 . . . . 10.0 110.379 -176.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -60.58 -36.36 78.33 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 122.805 0.442 . . . . 10.0 111.673 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.464 HD12 ' CG2' ' A' ' 21' ' ' ILE . 0.9 OUTLIER -71.96 -49.01 40.96 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.41 1.084 . . . . 10.0 109.324 171.975 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -54.51 -19.47 5.87 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.542 -0.723 . . . . 10.0 112.704 177.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -56.25 -35.3 67.26 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.718 1.007 . . . . 10.0 113.718 171.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.46 HD11 ' CB ' ' A' ' 57' ' ' LEU . 11.2 mt -58.22 139.03 18.43 Favored 'Isoleucine or valine' 0 C--N 1.339 0.132 0 CA-C-N 118.59 0.632 . . . . 10.0 109.593 179.415 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -69.45 -52.66 24.64 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 111.665 0.246 . . . . 10.0 111.665 -176.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -85.07 44.29 3.36 Favored Glycine 0 C--N 1.339 0.749 0 O-C-N 120.705 -1.247 . . . . 10.0 111.224 -175.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.4 p -99.76 152.4 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 C-N-CA 124.62 1.168 . . . . 10.0 108.366 -179.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -112.92 -57.63 2.26 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 108.562 -0.903 . . . . 10.0 108.562 171.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 -148.71 158.13 43.93 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.217 -1.401 . . . . 10.0 107.217 -173.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -148.28 61.15 5.61 Favored Pre-proline 0 CA--C 1.531 0.245 0 O-C-N 121.902 -0.499 . . . . 10.0 111.568 168.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -75.03 83.79 1.77 Allowed 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 122.915 2.41 . . . . 10.0 108.225 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.549 HG12 HG13 ' A' ' 43' ' ' VAL . 3.6 m -54.48 157.3 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 C-N-CA 123.236 0.614 . . . . 10.0 110.527 173.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 -84.52 161.06 20.37 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 107.591 -1.263 . . . . 10.0 107.591 171.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -122.79 29.37 6.86 Favored 'General case' 0 C--N 1.335 -0.051 0 N-CA-C 112.21 0.448 . . . . 10.0 112.21 -169.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -174.55 -37.94 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 122.657 0.383 . . . . 10.0 111.227 -171.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 16.6 mt -72.18 -19.68 61.71 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.327 1.051 . . . . 10.0 111.66 -177.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 67.13 43.65 2.07 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.041 1.336 . . . . 10.0 109.557 -178.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 17.4 p -140.39 123.55 16.71 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.855 1.662 . . . . 10.0 109.167 178.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.549 HG13 HG12 ' A' ' 36' ' ' VAL . 8.6 t -89.76 149.08 4.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 108.226 -1.028 . . . . 10.0 108.226 173.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 85.3 m -130.07 125.94 36.43 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 106.787 -1.56 . . . . 10.0 106.787 179.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.418 HG22 HD13 ' A' ' 25' ' ' LEU . 42.1 t -120.13 128.45 75.96 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 C-N-CA 123.452 0.701 . . . . 10.0 109.196 177.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 72.2 tt0 -94.43 106.82 18.8 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 108.085 -1.08 . . . . 10.0 108.085 160.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -144.01 164.79 29.61 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 109.605 -0.517 . . . . 10.0 109.605 175.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 22.3 p30 -93.72 141.41 23.75 Favored Pre-proline 0 C--N 1.328 -0.334 0 N-CA-C 109.522 -0.547 . . . . 10.0 109.522 175.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -85.29 47.92 2.13 Favored 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 121.594 1.529 . . . . 10.0 109.485 170.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.9 -9.64 6.63 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.247 0.93 . . . . 10.0 113.127 177.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -128.56 -51.65 1.26 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.923 1.289 . . . . 10.0 108.68 -167.521 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -122.52 -172.22 2.43 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.767 1.227 . . . . 10.0 109.736 173.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 99.3 p -141.12 169.53 17.44 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.924 1.289 . . . . 10.0 110.959 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 70.0 t -50.1 -49.75 21.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 124.172 0.989 . . . . 10.0 110.491 165.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.2 m -58.47 -36.19 73.33 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 123.841 0.856 . . . . 10.0 111.991 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -69.09 -60.42 2.37 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 109.69 -0.485 . . . . 10.0 109.69 173.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.716 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.3 pp -60.07 -47.23 86.75 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 121.051 0.453 . . . . 10.0 110.822 -165.266 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.468 ' N ' HD12 ' A' ' 57' ' ' LEU . 0.9 OUTLIER -48.74 -36.45 16.41 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 114.004 1.113 . . . . 10.0 114.004 172.196 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -57.35 -33.49 67.81 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 119.08 0.854 . . . . 10.0 110.599 178.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.92 -51.82 66.58 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.544 -0.91 . . . . 10.0 108.544 -178.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 25.1 t -61.15 -45.84 97.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 124.89 1.276 . . . . 10.0 110.484 178.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -56.49 -55.4 34.2 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 124.196 0.998 . . . . 10.0 108.499 -178.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.78 -35.28 74.33 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.083 0.953 . . . . 10.0 111.62 177.01 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.4 mp -55.15 -32.82 62.41 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 118.626 -0.702 . . . . 10.0 112.383 171.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 134.76 -7.06 4.51 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-O 119.394 -0.67 . . . . 10.0 114.366 169.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -135.17 151.26 50.5 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 106.769 -1.567 . . . . 10.0 106.769 -177.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.79 142.28 35.0 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 121.46 0.648 . . . . 10.0 111.09 -161.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.568 HD11 ' HB2' ' A' ' 7' ' ' PHE . 16.0 tp -118.34 144.03 46.18 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.583 1.953 . . . . 10.0 107.842 -173.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 4.0 tptp -147.81 154.76 40.89 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.124 0.97 . . . . 10.0 108.669 171.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.7 tp -63.75 157.51 24.11 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 109.267 -0.642 . . . . 10.0 109.267 176.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 30.8 tttp -111.27 -67.19 1.01 Allowed 'General case' 0 N--CA 1.441 -0.89 0 C-N-CA 124.974 1.31 . . . . 10.0 107.932 170.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 162.1 49.75 0.02 OUTLIER Glycine 0 CA--C 1.526 0.762 0 CA-C-N 118.383 0.538 . . . . 10.0 112.914 174.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 . . . . . 0 CA--C 1.532 0.272 0 C-N-CA 124.823 1.249 . . . . 10.0 112.564 -179.329 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 12.8 p . . . . . 0 N--CA 1.448 -0.537 0 N-CA-C 109.824 -0.436 . . . . 10.0 109.824 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -128.86 145.73 51.13 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 126.899 2.08 . . . . 10.0 108.528 -171.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -110.46 100.27 9.13 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.423 1.089 . . . . 10.0 112.559 -163.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -111.7 154.03 25.57 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.054 1.741 . . . . 10.0 110.241 -168.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -129.09 148.28 51.02 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 109.153 -0.684 . . . . 10.0 109.153 -177.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.753 ' CE2' HD11 ' A' ' 57' ' ' LEU . 4.3 m-85 -138.68 138.24 37.58 Favored 'General case' 0 N--CA 1.452 -0.361 0 O-C-N 124.92 1.388 . . . . 10.0 109.281 -171.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -100.89 126.29 47.5 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.399 1.08 . . . . 10.0 108.223 -171.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.411 HD11 HG23 ' A' ' 43' ' ' VAL . 6.7 mm -104.62 126.85 59.39 Favored 'Isoleucine or valine' 0 C--N 1.343 0.307 0 C-N-CA 124.654 1.182 . . . . 10.0 111.875 -164.132 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 . . . . . 0 N--CA 1.449 -0.495 0 N-CA-C 108.459 -0.941 . . . . 10.0 108.459 168.023 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.582 0 N-CA-C 112.923 0.712 . . . . 10.0 112.923 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.3 ttm180 -72.32 -36.8 68.98 Favored 'General case' 0 N--CA 1.447 -0.61 0 O-C-N 121.009 -1.057 . . . . 10.0 109.371 -178.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.677 HG22 HD12 ' A' ' 25' ' ' LEU . 1.6 mt -57.49 -48.17 83.51 Favored 'Isoleucine or valine' 0 C--N 1.344 0.344 0 CA-C-O 118.324 -0.846 . . . . 10.0 108.967 172.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -47.73 -47.04 30.37 Favored 'General case' 0 C--O 1.225 -0.187 0 CA-C-N 118.59 0.632 . . . . 10.0 111.517 -178.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 27.6 ttmt -72.56 -48.87 36.57 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.156 0.582 . . . . 10.0 110.298 -177.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -54.31 -41.19 68.69 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.629 0.603 . . . . 10.0 112.629 176.489 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.677 HD12 HG22 ' A' ' 21' ' ' ILE . 1.5 mt -68.84 -52.4 30.29 Favored 'General case' 0 C--O 1.221 -0.421 0 C-N-CA 124.95 1.3 . . . . 10.0 109.521 173.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 45.9 m-20 -54.02 -19.85 5.44 Favored 'General case' 0 C--O 1.227 -0.118 0 CA-C-N 118.63 0.65 . . . . 10.0 111.964 179.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.6 ttmt -58.74 -26.59 64.12 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 113.72 1.007 . . . . 10.0 113.72 172.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.69 HD11 ' HB3' ' A' ' 57' ' ' LEU . 10.8 mt -54.26 133.93 17.27 Favored 'Isoleucine or valine' 0 C--N 1.341 0.232 0 CA-C-N 119.572 1.078 . . . . 10.0 108.706 173.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -69.56 -47.44 63.65 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.919 -0.488 . . . . 10.0 111.418 179.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -86.61 45.71 3.48 Favored Glycine 0 C--N 1.339 0.714 0 O-C-N 120.637 -1.289 . . . . 10.0 111.2 -174.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -99.32 149.59 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 108.389 -0.967 . . . . 10.0 108.389 -176.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -104.2 -57.43 2.03 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 107.769 -1.197 . . . . 10.0 107.769 165.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 55.4 m-80 -149.28 156.18 41.7 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.409 -0.96 . . . . 10.0 108.409 -171.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -146.45 61.94 7.41 Favored Pre-proline 0 CA--C 1.538 0.517 0 N-CA-C 112.86 0.689 . . . . 10.0 112.86 169.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -79.05 85.74 1.81 Allowed 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 123.23 2.62 . . . . 10.0 109.746 -178.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.416 HG12 HG13 ' A' ' 43' ' ' VAL . 3.0 m -71.84 153.56 7.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 O-C-N 121.495 -0.753 . . . . 10.0 110.901 -178.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -94.02 127.34 39.76 Favored 'General case' 0 C--N 1.339 0.11 0 O-C-N 121.996 -0.44 . . . . 10.0 110.771 -175.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -105.16 59.56 0.68 Allowed 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.437 1.495 . . . . 10.0 110.772 -173.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 173.47 -35.97 0.0 OUTLIER 'General case' 0 C--O 1.226 -0.176 0 C-N-CA 125.411 1.485 . . . . 10.0 109.794 171.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.6 mt -83.33 -14.22 53.4 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.913 0.885 . . . . 10.0 111.087 -172.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 75.92 38.31 0.35 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.735 1.614 . . . . 10.0 110.785 170.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 38.3 p -137.18 131.66 32.83 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.136 1.374 . . . . 10.0 109.327 -177.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.416 HG13 HG12 ' A' ' 36' ' ' VAL . 3.6 t -91.8 142.72 12.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 107.625 -1.25 . . . . 10.0 107.625 167.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 44.7 m -127.2 124.61 39.39 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 106.828 -1.545 . . . . 10.0 106.828 177.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.8 t -124.6 141.24 45.36 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 N-CA-C 109.183 -0.673 . . . . 10.0 109.183 -179.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 55.1 tt0 -115.22 106.82 14.5 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 106.985 -1.487 . . . . 10.0 106.985 166.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -149.96 158.64 44.36 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 123.062 0.545 . . . . 10.0 109.667 -179.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -88.64 128.26 53.3 Favored Pre-proline 0 C--N 1.326 -0.421 0 N-CA-C 109.952 -0.388 . . . . 10.0 109.952 178.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -75.69 60.4 5.92 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.479 2.119 . . . . 10.0 108.939 171.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.5 tttt -130.91 -52.62 1.05 Allowed 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 106.472 -1.677 . . . . 10.0 106.472 173.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -83.85 -43.51 15.28 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.077 0.551 . . . . 10.0 110.475 -170.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -134.12 -173.61 3.31 Favored 'General case' 0 C--N 1.339 0.128 0 C-N-CA 124.904 1.282 . . . . 10.0 109.093 178.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 79.8 p -145.78 166.8 24.84 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.676 0.75 . . . . 10.0 109.864 -177.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.64 HG11 HD11 ' A' ' 70' ' ' LEU . 26.8 m -49.79 -41.53 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 115.064 -0.971 . . . . 10.0 111.428 167.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.3 m -56.37 -44.2 79.95 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 123.914 0.885 . . . . 10.0 112.178 177.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -63.22 -56.89 12.83 Favored 'General case' 0 C--N 1.337 0.064 0 N-CA-C 109.203 -0.666 . . . . 10.0 109.203 179.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.753 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.2 pp -67.63 -41.22 84.23 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 119.675 -0.81 . . . . 10.0 110.81 -171.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.458 ' HA ' HD23 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -39.63 -52.47 2.22 Favored 'General case' 0 C--O 1.224 -0.238 0 O-C-N 121.683 -0.635 . . . . 10.0 112.473 159.333 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.45 -43.24 93.2 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 118.62 0.645 . . . . 10.0 109.873 179.4 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -51.87 -46.97 64.69 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 116.062 -0.517 . . . . 10.0 110.224 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.403 ' HA ' HD12 ' A' ' 64' ' ' LEU . 40.6 t -68.34 -47.44 77.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 124.266 1.026 . . . . 10.0 112.58 175.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -58.25 -35.37 71.64 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.406 -0.809 . . . . 10.0 109.126 -176.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.1 -28.79 39.0 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 118.538 -0.744 . . . . 10.0 112.179 179.315 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.403 HD12 ' HA ' ' A' ' 61' ' ' VAL . 10.2 mt -53.83 -42.65 68.7 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 120.036 1.289 . . . . 10.0 110.797 165.14 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 139.95 -14.3 3.09 Favored Glycine 0 CA--C 1.527 0.794 0 CA-C-O 119.974 -0.348 . . . . 10.0 113.787 170.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -114.83 159.19 20.92 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 125.54 1.536 . . . . 10.0 107.271 179.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 25.8 mttp -97.24 159.56 14.84 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 121.731 0.777 . . . . 10.0 111.782 -171.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.458 HD23 ' HA ' ' A' ' 58' ' ' LYS . 20.5 tp -137.24 147.28 45.65 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.929 1.691 . . . . 10.0 107.433 -177.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 22.9 tptt -154.41 153.41 31.52 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 108.624 -0.88 . . . . 10.0 108.624 164.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.64 HD11 HG11 ' A' ' 54' ' ' VAL . 22.5 mt -61.04 160.21 10.36 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 121.936 0.874 . . . . 10.0 110.856 175.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 12.3 tptt -113.12 -58.0 2.21 Favored 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 128.061 2.544 . . . . 10.0 106.419 173.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -179.88 -84.13 0.06 OUTLIER Glycine 0 CA--C 1.523 0.544 0 N-CA-C 109.617 -1.393 . . . . 10.0 109.617 178.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 . . . . . 0 N--CA 1.45 -0.446 0 N-CA-C 108.304 -0.998 . . . . 10.0 108.304 -169.915 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.426 HG21 ' HB2' ' A' ' 32' ' ' ALA . 3.4 p . . . . . 0 N--CA 1.451 -0.387 0 N-CA-C 107.263 -1.384 . . . . 10.0 107.263 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -108.68 144.45 36.43 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 126.339 1.855 . . . . 10.0 110.28 179.484 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.0 mmtm -88.47 113.83 24.47 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.701 1.2 . . . . 10.0 109.801 174.034 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -116.64 149.87 39.04 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.678 1.191 . . . . 10.0 110.494 170.922 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -117.03 151.05 37.59 Favored 'General case' 0 CA--C 1.518 -0.257 0 C-N-CA 124.564 1.146 . . . . 10.0 111.423 171.237 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.736 ' CE2' HD11 ' A' ' 57' ' ' LEU . 1.8 m-85 -140.99 137.47 33.04 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.549 1.14 . . . . 10.0 110.143 -175.333 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.537 ' CG ' ' HZ3' ' A' ' 71' ' ' LYS . 6.9 m-20 -95.0 137.84 33.52 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 125.165 1.386 . . . . 10.0 109.11 -176.952 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.468 HD11 HG23 ' A' ' 43' ' ' VAL . 7.5 mm -109.47 132.41 57.7 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 C-N-CA 124.84 1.256 . . . . 10.0 110.639 -164.822 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 . . . . . 0 N--CA 1.452 -0.369 0 N-CA-C 108.377 -0.971 . . . . 10.0 108.377 173.197 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.535 0.377 0 N-CA-C 112.44 0.533 . . . . 10.0 112.44 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 15.6 ttt180 -73.49 -47.86 37.85 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 121.65 -0.656 . . . . 10.0 109.291 -179.61 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.3 mt -42.46 -52.51 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 123.1 0.56 . . . . 10.0 110.769 171.125 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -42.83 -58.54 2.32 Favored 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 123.01 0.524 . . . . 10.0 111.025 179.616 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -70.18 -39.59 75.15 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.859 0.863 . . . . 10.0 109.87 -173.885 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.24 -36.46 66.06 Favored 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 122.705 0.402 . . . . 10.0 110.685 175.611 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.49 -36.63 26.27 Favored 'General case' 0 C--O 1.222 -0.376 0 C-N-CA 123.571 0.749 . . . . 10.0 112.554 173.191 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -57.69 -25.73 60.72 Favored 'General case' 0 C--N 1.328 -0.326 0 O-C-N 120.715 -1.24 . . . . 10.0 109.821 179.291 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.5 mmpt? -51.82 -38.45 55.82 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 114.336 1.235 . . . . 10.0 114.336 168.975 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.423 HG23 ' CB ' ' A' ' 52' ' ' ALA . 11.5 mt -57.19 129.43 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 CA-C-N 118.838 0.745 . . . . 10.0 109.253 178.925 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -64.8 -49.53 70.29 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 120.968 -0.293 . . . . 10.0 110.991 -179.942 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -82.91 46.51 3.63 Favored Glycine 0 C--N 1.339 0.717 0 O-C-N 120.998 -1.064 . . . . 10.0 111.5 -175.008 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.3 p -106.7 152.9 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 C-N-CA 124.588 1.155 . . . . 10.0 109.003 -177.716 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.426 ' HB2' HG21 ' A' ' 2' ' ' THR . . . -115.23 -51.95 2.69 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.989 -0.745 . . . . 10.0 108.989 168.499 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -151.58 158.86 44.09 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 109.234 -0.654 . . . . 10.0 109.234 -176.68 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -143.18 64.11 13.76 Favored Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 123.918 0.887 . . . . 10.0 111.861 173.088 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -79.22 77.68 4.0 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.178 2.585 . . . . 10.0 109.8 -177.252 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.519 HG12 HG13 ' A' ' 43' ' ' VAL . 2.4 m -71.3 153.16 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 O-C-N 121.775 -0.578 . . . . 10.0 111.385 -176.927 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 74.1 m-80 -87.46 148.05 25.12 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 120.817 -0.353 . . . . 10.0 110.298 177.241 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -124.02 44.8 2.63 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.904 1.281 . . . . 10.0 111.104 -172.306 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -175.8 -40.63 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.216 0 C-N-CA 125.292 1.437 . . . . 10.0 109.596 178.005 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.6 mt -78.15 -18.29 55.77 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.381 1.072 . . . . 10.0 111.834 -172.034 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 66.87 46.38 1.66 Allowed 'General case' 0 C--O 1.231 0.091 0 C-N-CA 125.377 1.471 . . . . 10.0 110.398 179.144 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.9 p -139.03 121.72 16.38 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 125.153 1.381 . . . . 10.0 108.538 176.349 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.519 HG13 HG12 ' A' ' 36' ' ' VAL . 17.9 t -88.55 137.56 20.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 107.227 -1.398 . . . . 10.0 107.227 168.505 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 88.8 m -120.09 124.02 44.8 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 106.445 -1.687 . . . . 10.0 106.445 176.659 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 24.7 t -121.56 140.1 46.64 Favored 'Isoleucine or valine' 0 C--N 1.339 0.139 0 CA-C-N 119.114 0.87 . . . . 10.0 110.073 178.755 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -105.19 101.47 11.02 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.458 1.503 . . . . 10.0 107.078 164.389 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -143.19 158.47 43.59 Favored 'General case' 0 CA--C 1.52 -0.21 0 C-N-CA 123.0 0.52 . . . . 10.0 110.627 178.421 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -93.06 129.45 39.46 Favored Pre-proline 0 CA--C 1.531 0.247 0 C-N-CA 123.393 0.677 . . . . 10.0 110.043 176.309 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -78.04 57.15 6.01 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 122.244 1.962 . . . . 10.0 108.86 169.768 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.74 -62.67 1.12 Allowed 'General case' 0 CA--C 1.521 -0.149 0 N-CA-C 106.533 -1.655 . . . . 10.0 106.533 175.822 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -81.84 -32.32 31.24 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 122.468 0.307 . . . . 10.0 110.87 -173.196 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.423 ' CB ' HG23 ' A' ' 28' ' ' ILE . . . -135.22 -176.48 4.27 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.14 0.976 . . . . 10.0 109.606 177.214 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 86.7 p -140.71 169.73 17.09 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.842 0.857 . . . . 10.0 111.501 -179.853 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 59.4 t -42.53 -48.71 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 125.43 1.492 . . . . 10.0 111.571 160.786 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.5 t -66.82 -34.25 77.4 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.356 -0.384 . . . . 10.0 110.553 -176.0 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -65.77 -60.71 2.61 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.682 -0.859 . . . . 10.0 108.682 173.382 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.736 HD11 ' CE2' ' A' ' 7' ' ' PHE . 3.9 pp -63.68 -44.91 92.34 Favored 'General case' 0 N--CA 1.447 -0.583 0 O-C-N 121.982 -0.449 . . . . 10.0 111.036 -164.774 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.418 ' N ' HD12 ' A' ' 57' ' ' LEU . 1.0 OUTLIER -48.64 -39.56 24.58 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 113.319 0.859 . . . . 10.0 113.319 170.094 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -57.25 -32.94 67.08 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 119.235 0.925 . . . . 10.0 110.646 178.939 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.41 -48.24 81.31 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.792 0.805 . . . . 10.0 109.338 -178.562 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.613 HG13 ' CE2' ' A' ' 66' ' ' TYR . 57.6 t -64.94 -50.57 74.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 124.947 1.299 . . . . 10.0 111.043 174.49 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -50.27 -39.18 44.4 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.354 1.462 . . . . 10.0 109.167 -179.292 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 33.1 tptt -76.59 -40.96 47.98 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 125.303 1.441 . . . . 10.0 110.595 -178.063 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 28.3 mt -53.19 -41.09 64.93 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.712 0.687 . . . . 10.0 111.402 169.056 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 140.4 -30.78 2.3 Favored Glycine 0 C--N 1.338 0.69 0 CA-C-N 118.225 0.466 . . . . 10.0 113.428 166.722 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.613 ' CE2' HG13 ' A' ' 61' ' ' VAL . 15.6 p90 -86.86 160.2 18.82 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 107.797 -1.186 . . . . 10.0 107.797 172.711 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -105.42 150.67 25.05 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 120.859 0.361 . . . . 10.0 110.549 -170.546 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.532 HD11 ' HB2' ' A' ' 7' ' ' PHE . 21.8 tp -123.2 150.47 43.33 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 126.643 1.977 . . . . 10.0 108.234 -176.897 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 19.5 tptt -154.26 140.01 18.05 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 123.145 0.578 . . . . 10.0 110.683 166.018 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.607 HD23 ' N ' ' A' ' 71' ' ' LYS . 2.4 tt -70.8 158.27 36.63 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 123.524 0.729 . . . . 10.0 109.786 -178.966 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.607 ' N ' HD23 ' A' ' 70' ' ' LEU . 11.8 ttpt -121.74 -67.17 0.98 Allowed 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 126.894 2.078 . . . . 10.0 108.759 178.815 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -165.54 -81.31 0.04 OUTLIER Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.025 -1.23 . . . . 10.0 110.025 176.627 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 . . . . . 0 C--O 1.232 0.151 0 C-N-CA 124.578 1.151 . . . . 10.0 107.937 -169.154 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.491 HG21 ' HB2' ' A' ' 32' ' ' ALA . 1.1 p . . . . . 0 N--CA 1.447 -0.591 0 N-CA-C 105.908 -1.886 . . . . 10.0 105.908 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -133.98 143.24 48.03 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 126.83 2.052 . . . . 10.0 106.723 -168.345 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 18.3 tptm -89.25 143.33 26.91 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 107.546 -1.279 . . . . 10.0 107.546 -176.273 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -147.44 148.13 30.95 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.416 0.686 . . . . 10.0 109.441 177.66 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -128.09 152.41 48.01 Favored 'General case' 0 CA--C 1.507 -0.675 0 C-N-CA 124.494 1.118 . . . . 10.0 109.156 173.014 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.793 ' CE2' HD11 ' A' ' 57' ' ' LEU . 2.7 m-85 -143.4 131.44 21.75 Favored 'General case' 0 N--CA 1.447 -0.623 0 O-C-N 125.607 1.817 . . . . 10.0 108.638 -170.826 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -93.59 138.41 31.87 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 106.811 -1.551 . . . . 10.0 106.811 -179.57 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 5.3 mm -105.44 141.23 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 124.289 1.036 . . . . 10.0 109.415 -166.251 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 . . . . . 0 N--CA 1.446 -0.662 0 N-CA-C 106.845 -1.539 . . . . 10.0 106.845 172.847 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 . . . . . 0 N--CA 1.464 0.247 0 CA-C-O 120.866 0.365 . . . . 10.0 110.658 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.488 ' CG ' HD11 ' A' ' 64' ' ' LEU . 3.8 tpp85 -75.09 -44.36 47.75 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 109.098 -0.704 . . . . 10.0 109.098 -178.95 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.4 mm -44.49 -62.08 0.33 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.466 0 C-N-CA 124.063 0.945 . . . . 10.0 108.898 173.663 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -54.61 -34.83 62.67 Favored 'General case' 0 C--O 1.22 -0.483 0 CA-C-N 118.497 0.59 . . . . 10.0 112.203 -175.172 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.04 -43.43 78.74 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 120.715 -1.24 . . . . 10.0 109.376 176.595 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.459 ' HB3' ' HB1' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -67.53 -39.67 85.05 Favored 'General case' 0 C--O 1.224 -0.261 0 O-C-N 122.12 -0.362 . . . . 10.0 111.598 177.997 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.56 -34.62 58.48 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.693 1.197 . . . . 10.0 110.337 -179.426 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -71.14 -7.51 47.14 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 121.671 -0.643 . . . . 10.0 109.537 173.865 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.491 ' HE3' ' HB2' ' A' ' 60' ' ' ALA . 0.5 OUTLIER -60.5 -37.94 82.71 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 118.368 -1.333 . . . . 10.0 109.422 165.92 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.464 HG23 ' CB ' ' A' ' 52' ' ' ALA . 25.6 mm -60.16 123.59 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 123.647 0.779 . . . . 10.0 109.711 -173.729 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -68.32 -48.84 63.81 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 110.001 -0.37 . . . . 10.0 110.001 -179.169 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -82.54 41.06 2.79 Favored Glycine 0 CA--C 1.526 0.747 0 O-C-N 121.326 -0.859 . . . . 10.0 111.937 -175.42 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.3 p -104.46 146.82 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 C-N-CA 124.864 1.266 . . . . 10.0 108.73 -178.266 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.491 ' HB2' HG21 ' A' ' 2' ' ' THR . . . -115.94 -52.44 2.61 Favored 'General case' 0 C--N 1.333 -0.109 0 C-N-CA 122.848 0.459 . . . . 10.0 109.838 172.085 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -139.52 143.03 37.25 Favored 'General case' 0 C--N 1.341 0.212 0 N-CA-C 108.803 -0.814 . . . . 10.0 108.803 -176.797 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -130.85 62.74 67.12 Favored Pre-proline 0 CA--C 1.536 0.435 0 C-N-CA 123.39 0.676 . . . . 10.0 110.48 173.188 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -76.26 66.37 7.08 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 123.448 2.765 . . . . 10.0 110.633 -175.931 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.627 HG22 HG13 ' A' ' 43' ' ' VAL . 41.5 t -68.47 145.16 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 C-N-CA 126.123 1.769 . . . . 10.0 110.98 -176.805 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -90.98 145.07 25.02 Favored 'General case' 0 C--N 1.341 0.239 0 C-N-CA 120.315 -0.554 . . . . 10.0 110.582 -179.828 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -122.82 65.47 0.96 Allowed 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 125.309 1.444 . . . . 10.0 109.819 -172.861 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 157.55 -30.9 0.0 OUTLIER 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 127.627 2.371 . . . . 10.0 109.621 169.405 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.6 mt -75.56 -17.62 60.0 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.799 0.839 . . . . 10.0 110.846 -173.821 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 67.07 48.39 1.24 Allowed 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 126.005 1.722 . . . . 10.0 110.653 177.205 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.4 p -143.1 124.77 14.94 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.49 1.516 . . . . 10.0 108.283 176.422 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.627 HG13 HG22 ' A' ' 36' ' ' VAL . 12.0 t -94.2 141.58 14.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 106.884 -1.525 . . . . 10.0 106.884 169.602 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.6 m -129.98 126.05 36.85 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 105.491 -2.04 . . . . 10.0 105.491 -177.889 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 23.9 t -128.37 152.93 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 CA-C-N 118.657 0.662 . . . . 10.0 109.402 178.886 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -130.41 96.94 4.26 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 105.021 -2.215 . . . . 10.0 105.021 176.213 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -148.77 164.66 33.76 Favored 'General case' 0 C--O 1.226 -0.152 0 C-N-CA 123.956 0.903 . . . . 10.0 110.343 -171.569 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -96.09 132.63 26.51 Favored Pre-proline 0 C--N 1.33 -0.24 0 C-N-CA 122.858 0.463 . . . . 10.0 110.501 179.577 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -79.68 55.62 5.71 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 121.721 1.614 . . . . 10.0 109.136 166.991 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.52 -41.49 1.7 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 118.234 0.47 . . . . 10.0 110.364 177.73 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.89 -32.28 11.76 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.688 0.795 . . . . 10.0 111.091 178.332 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.464 ' CB ' HG23 ' A' ' 28' ' ' ILE . . . -138.22 -174.83 3.91 Favored 'General case' 0 CA--C 1.523 -0.065 0 C-N-CA 124.644 1.178 . . . . 10.0 109.67 -175.996 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.7 p -148.42 163.25 37.71 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 123.058 0.543 . . . . 10.0 109.896 -178.936 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 55.8 t -38.55 -50.39 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 C-N-CA 125.345 1.458 . . . . 10.0 110.07 163.698 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.3 m -51.4 -44.07 62.1 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 124.552 1.141 . . . . 10.0 113.056 -179.762 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -72.37 -53.59 11.86 Favored 'General case' 0 C--O 1.224 -0.289 0 N-CA-C 109.78 -0.452 . . . . 10.0 109.78 -178.625 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.793 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.0 pp -61.05 -39.95 91.79 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 118.247 -1.381 . . . . 10.0 110.738 -177.97 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.442 ' HA ' HD23 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -44.86 -57.48 3.74 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-O 117.854 -1.069 . . . . 10.0 112.309 161.54 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 14.6 tm-20 -50.22 -48.49 54.36 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-N 120.332 1.424 . . . . 10.0 110.298 176.392 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.491 ' HB2' ' HE3' ' A' ' 27' ' ' LYS . . . -51.63 -54.07 31.76 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 123.555 0.742 . . . . 10.0 109.602 -178.044 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 91.6 t -63.03 -45.12 99.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 115.986 -0.552 . . . . 10.0 111.155 177.818 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.45 -56.86 10.98 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.99 0.9 . . . . 10.0 109.836 178.942 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.9 tptp -49.35 -36.97 23.0 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 127.287 2.235 . . . . 10.0 111.602 175.273 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.488 HD11 ' CG ' ' A' ' 20' ' ' ARG . 5.4 tp -60.89 -34.38 74.55 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 125.055 1.342 . . . . 10.0 111.705 179.17 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 146.83 -53.0 0.55 Allowed Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.754 -0.538 . . . . 10.0 111.754 176.962 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -98.86 158.83 15.37 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 123.939 0.896 . . . . 10.0 109.859 -176.832 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 8.5 ttpt -92.16 153.18 19.5 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.217 0.532 . . . . 10.0 110.232 -170.46 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.479 HD11 ' HB2' ' A' ' 7' ' ' PHE . 23.9 tp -125.74 151.69 46.33 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.981 1.713 . . . . 10.0 107.932 179.734 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.9 tptp -153.92 147.63 25.29 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 122.775 0.43 . . . . 10.0 110.275 162.919 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.3 tp -59.14 158.48 8.77 Favored 'General case' 0 C--N 1.34 0.155 0 O-C-N 123.485 0.491 . . . . 10.0 109.963 176.561 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.6 tttt -116.26 -71.26 0.75 Allowed 'General case' 0 N--CA 1.436 -1.136 0 C-N-CA 126.849 2.059 . . . . 10.0 108.205 179.472 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 158.88 43.89 0.02 OUTLIER Glycine 0 CA--C 1.529 0.956 0 C-N-CA 123.952 0.787 . . . . 10.0 111.609 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 . . . . . 0 CA--C 1.537 0.452 0 C-N-CA 124.995 1.318 . . . . 10.0 111.962 171.6 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.535 HG21 ' HB2' ' A' ' 32' ' ' ALA . 4.6 p . . . . . 0 C--O 1.238 0.472 0 CA-C-O 122.606 1.194 . . . . 10.0 112.506 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -82.62 164.19 20.94 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 107.791 -1.188 . . . . 10.0 107.791 176.352 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.65 144.73 31.99 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 106.737 -1.579 . . . . 10.0 106.737 176.611 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -148.24 139.23 23.18 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.424 -0.954 . . . . 10.0 108.424 179.294 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -120.71 148.21 44.26 Favored 'General case' 0 CA--C 1.513 -0.466 0 C-N-CA 123.964 0.906 . . . . 10.0 109.187 175.866 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.746 ' CE2' HD11 ' A' ' 57' ' ' LEU . 12.8 m-85 -139.11 144.2 38.59 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.131 1.372 . . . . 10.0 109.144 -174.834 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -110.14 127.33 54.84 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.67 1.188 . . . . 10.0 107.878 -172.213 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.535 HD11 ' HB ' ' A' ' 43' ' ' VAL . 2.5 mm -107.25 137.16 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 124.004 0.922 . . . . 10.0 111.301 -160.691 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 . . . . . 0 N--CA 1.455 -0.176 0 C-N-CA 124.554 1.141 . . . . 10.0 108.239 179.816 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 . . . . . 0 N--CA 1.467 0.405 0 CA-C-O 121.167 0.508 . . . . 10.0 111.212 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.65 -41.0 94.08 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 118.077 -0.964 . . . . 10.0 110.383 176.66 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.411 HG22 HD12 ' A' ' 25' ' ' LEU . 14.9 mm -47.62 -62.54 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.371 0 N-CA-C 108.367 -0.975 . . . . 10.0 108.367 169.682 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -54.56 -35.82 63.67 Favored 'General case' 0 C--O 1.22 -0.462 0 N-CA-C 112.177 0.436 . . . . 10.0 112.177 -176.281 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.65 -53.56 32.67 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 119.198 0.908 . . . . 10.0 109.783 179.233 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.7 tpt180 -64.27 -35.34 80.51 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 122.225 -0.297 . . . . 10.0 111.253 -178.987 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.411 HD12 HG22 ' A' ' 21' ' ' ILE . 0.3 OUTLIER -73.51 -44.9 56.63 Favored 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 123.402 0.681 . . . . 10.0 111.319 178.134 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -51.25 -31.27 20.39 Favored 'General case' 0 C--O 1.225 -0.184 0 C-N-CA 123.81 0.844 . . . . 10.0 110.654 172.292 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -60.84 -34.6 74.83 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 118.703 -0.665 . . . . 10.0 112.239 176.956 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 22.4 mm -55.0 133.37 18.54 Favored 'Isoleucine or valine' 0 C--N 1.342 0.261 0 C-N-CA 124.077 0.951 . . . . 10.0 110.854 177.924 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 51.1 mp0 -73.73 -47.03 42.33 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 119.242 -0.408 . . . . 10.0 110.869 -172.955 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.99 36.75 2.52 Favored Glycine 0 C--N 1.343 0.937 0 O-C-N 120.298 -1.501 . . . . 10.0 113.0 -177.669 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.2 p -101.68 149.76 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 124.61 1.164 . . . . 10.0 108.343 -178.042 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.535 ' HB2' HG21 ' A' ' 2' ' ' THR . . . -108.15 -57.84 2.06 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 106.572 -1.64 . . . . 10.0 106.572 165.366 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -154.3 167.17 30.84 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 115.644 -0.707 . . . . 10.0 109.371 -169.376 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -157.0 77.05 4.08 Favored Pre-proline 0 N--CA 1.454 -0.24 0 C-N-CA 123.592 0.757 . . . . 10.0 110.841 -179.393 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -75.47 69.53 5.87 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.547 2.164 . . . . 10.0 110.124 -179.13 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.487 HG12 HG13 ' A' ' 43' ' ' VAL . 3.8 m -64.6 157.24 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 C-N-CA 123.518 0.727 . . . . 10.0 110.383 178.056 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -102.35 159.93 14.99 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 119.603 -0.839 . . . . 10.0 111.954 172.218 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -129.76 59.22 1.62 Allowed 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 125.474 1.51 . . . . 10.0 108.743 -172.339 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 171.72 -29.44 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 125.304 1.442 . . . . 10.0 111.335 165.894 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.7 mt -81.86 -7.72 59.63 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 122.714 0.406 . . . . 10.0 111.063 -176.106 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 67.06 41.27 2.68 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 126.025 1.73 . . . . 10.0 110.557 173.895 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -136.86 140.85 42.68 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.928 0.871 . . . . 10.0 109.774 173.579 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.535 ' HB ' HD11 ' A' ' 9' ' ' ILE . 2.5 t -110.99 138.97 36.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 107.569 -1.271 . . . . 10.0 107.569 174.156 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 90.6 m -124.29 121.56 35.35 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 126.193 1.797 . . . . 10.0 106.293 -176.07 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.4 t -120.02 143.49 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 C-N-CA 124.597 1.159 . . . . 10.0 109.171 -179.944 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -120.66 96.68 5.22 Favored 'General case' 0 N--CA 1.429 -1.519 0 C-N-CA 126.255 1.822 . . . . 10.0 107.067 173.606 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 11.9 p90 -139.35 161.74 36.72 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 124.079 0.952 . . . . 10.0 109.986 -174.806 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -93.7 123.5 59.68 Favored Pre-proline 0 CA--C 1.534 0.358 0 C-N-CA 123.278 0.631 . . . . 10.0 111.011 175.214 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -75.14 67.33 6.07 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.708 2.272 . . . . 10.0 109.039 172.723 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.45 -49.56 0.49 Allowed 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 107.893 -1.151 . . . . 10.0 107.893 177.919 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -82.54 -62.57 1.58 Allowed 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 108.643 -0.873 . . . . 10.0 108.643 177.101 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -110.27 171.79 7.25 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 125.196 1.398 . . . . 10.0 109.701 -176.701 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 24.8 p -125.32 179.61 5.02 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.886 1.274 . . . . 10.0 110.663 172.994 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 26.8 m -51.36 -37.68 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-N 114.846 -1.07 . . . . 10.0 111.93 166.64 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.8 t -69.86 -39.19 76.49 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 119.032 -0.509 . . . . 10.0 110.811 -174.657 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -60.0 -52.58 64.77 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 119.241 0.928 . . . . 10.0 109.261 -176.341 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.746 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.2 pp -66.45 -42.91 86.9 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.144 -0.48 . . . . 10.0 110.692 -179.658 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.407 ' N ' HD12 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -45.65 -50.34 13.51 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 121.125 -0.985 . . . . 10.0 112.901 164.255 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -60.71 -43.79 97.38 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 119.748 1.158 . . . . 10.0 109.251 -179.366 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -53.1 -52.08 59.79 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.327 -0.851 . . . . 10.0 109.887 178.718 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 98.3 t -64.22 -43.39 97.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 123.04 0.536 . . . . 10.0 112.287 175.115 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -52.26 -51.76 56.59 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 121.995 0.903 . . . . 10.0 109.262 179.181 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 45.0 tptt -57.89 -30.92 66.24 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.812 1.645 . . . . 10.0 112.273 176.837 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.3 mp -61.54 -30.37 70.6 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.657 0.783 . . . . 10.0 110.812 173.977 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 141.16 -45.7 0.95 Allowed Glycine 0 CA--C 1.526 0.772 0 CA-C-N 118.448 0.567 . . . . 10.0 111.716 171.82 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -99.47 156.2 17.16 Favored 'General case' 0 C--O 1.226 -0.145 0 C-N-CA 124.973 1.309 . . . . 10.0 109.017 -178.67 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 24.1 mtpp -87.97 165.34 15.28 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-O 121.719 0.771 . . . . 10.0 111.191 -173.17 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 11.5 tp -136.04 149.46 48.78 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.141 1.776 . . . . 10.0 107.057 -179.831 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 8.7 mmtp -149.42 153.35 37.2 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 108.857 -0.794 . . . . 10.0 108.857 163.797 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.4 tp -62.04 158.51 16.36 Favored 'General case' 0 N--CA 1.453 -0.291 0 O-C-N 124.25 0.969 . . . . 10.0 109.084 174.905 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 12.1 tttt -114.83 -69.86 0.83 Allowed 'General case' 0 N--CA 1.436 -1.175 0 C-N-CA 126.674 1.989 . . . . 10.0 107.28 177.161 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 162.73 47.21 0.02 OUTLIER Glycine 0 CA--C 1.527 0.808 0 CA-C-O 119.291 -0.727 . . . . 10.0 112.87 175.491 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 . . . . . 0 CA--C 1.536 0.412 0 C-N-CA 125.105 1.362 . . . . 10.0 113.165 171.853 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 20.7 p . . . . . 0 N--CA 1.447 -0.584 0 N-CA-C 107.059 -1.46 . . . . 10.0 107.059 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -114.27 149.51 35.8 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.943 1.297 . . . . 10.0 110.379 -170.247 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.2 mtmm -98.96 77.18 2.17 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 126.266 1.826 . . . . 10.0 110.816 -160.254 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -79.17 153.57 29.95 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.806 1.643 . . . . 10.0 110.586 -173.724 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -129.52 151.51 50.05 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 124.05 0.94 . . . . 10.0 109.155 176.374 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.801 ' CE2' HD11 ' A' ' 57' ' ' LEU . 4.6 m-85 -140.77 133.75 29.22 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 125.262 1.601 . . . . 10.0 109.776 -174.731 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -87.45 134.68 33.56 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 125.953 1.701 . . . . 10.0 107.883 -179.254 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 12.8 mm -106.03 138.71 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 C-N-CA 125.474 1.51 . . . . 10.0 110.636 -166.523 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 . . . . . 0 N--CA 1.443 -0.785 0 N-CA-C 108.546 -0.909 . . . . 10.0 108.546 165.749 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 . . . . . 0 N--CA 1.463 0.182 0 N-CA-C 112.758 0.651 . . . . 10.0 112.758 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.7 ttt180 -70.03 -30.04 67.23 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 121.283 -0.886 . . . . 10.0 109.329 -179.099 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 25.8 mm -55.68 -54.56 24.63 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 CA-C-O 118.431 -0.795 . . . . 10.0 108.972 173.532 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -43.8 -49.72 8.02 Favored 'General case' 0 C--O 1.223 -0.297 0 C-N-CA 123.352 0.661 . . . . 10.0 110.576 -177.895 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.4 mppt? -65.19 -52.24 56.1 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 123.196 0.599 . . . . 10.0 109.818 179.597 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.75 -21.92 66.55 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 112.527 0.566 . . . . 10.0 112.527 -175.506 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.74 -41.28 14.26 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 126.735 2.014 . . . . 10.0 111.44 172.336 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -57.73 -29.07 64.44 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.899 0.88 . . . . 10.0 110.216 175.792 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.2 mmpt? -53.47 -36.03 61.18 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 113.968 1.099 . . . . 10.0 113.968 169.597 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.5 mm -61.08 125.13 16.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 119.108 0.867 . . . . 10.0 109.219 178.576 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 64.2 mt-10 -59.34 -52.9 63.65 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.962 0.727 . . . . 10.0 112.962 -176.547 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.41 43.12 2.85 Favored Glycine 0 C--N 1.339 0.745 0 CA-C-N 120.053 1.297 . . . . 10.0 112.12 -172.78 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.7 p -107.75 153.16 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 C-N-CA 124.783 1.233 . . . . 10.0 108.805 -176.826 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -116.76 -55.13 2.39 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.12 -0.696 . . . . 10.0 109.12 174.615 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -147.32 160.21 42.78 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 108.882 -0.784 . . . . 10.0 108.882 179.596 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.39 61.31 3.9 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 123.647 0.779 . . . . 10.0 112.214 174.29 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -79.42 78.71 3.61 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.826 2.351 . . . . 10.0 109.595 -177.248 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.449 HG12 HG13 ' A' ' 43' ' ' VAL . 2.3 m -58.75 149.65 5.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 123.381 0.672 . . . . 10.0 111.855 -178.276 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -93.59 94.65 8.75 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.979 0.419 . . . . 10.0 111.538 -172.855 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -73.96 53.79 0.49 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 127.084 2.154 . . . . 10.0 112.769 -178.588 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -172.27 -42.88 0.02 OUTLIER 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 125.271 1.428 . . . . 10.0 109.217 170.317 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.3 mt -79.83 -19.69 47.8 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 115.691 -0.686 . . . . 10.0 111.144 -170.996 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 64.54 53.28 1.63 Allowed 'General case' 0 N--CA 1.457 -0.085 0 C-N-CA 124.751 1.22 . . . . 10.0 109.002 -177.199 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 30.3 p -138.04 125.66 22.2 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 106.632 -1.618 . . . . 10.0 106.632 169.849 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.449 HG13 HG12 ' A' ' 36' ' ' VAL . 13.9 t -87.92 145.54 7.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 106.267 -1.753 . . . . 10.0 106.267 166.89 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 96.7 m -128.23 133.49 48.84 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 105.826 -1.916 . . . . 10.0 105.826 178.444 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 26.4 t -136.46 129.31 45.76 Favored 'Isoleucine or valine' 0 C--N 1.339 0.114 0 CA-C-N 118.477 0.581 . . . . 10.0 111.081 176.925 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -92.98 101.02 13.35 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 126.444 1.897 . . . . 10.0 106.265 169.06 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -138.18 159.14 42.83 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 118.411 0.55 . . . . 10.0 111.995 -178.711 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 16.8 p30 -94.87 128.46 39.28 Favored Pre-proline 0 CA--C 1.527 0.06 0 C-N-CA 123.995 0.918 . . . . 10.0 110.656 178.583 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -76.07 56.46 4.87 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 122.425 2.083 . . . . 10.0 109.946 175.511 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.5 ttpt -131.87 -66.34 0.71 Allowed 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 106.628 -1.619 . . . . 10.0 106.628 173.501 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -99.11 -14.86 19.2 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.523 1.129 . . . . 10.0 110.735 -175.378 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -122.06 144.75 48.72 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.24 1.016 . . . . 10.0 110.348 -178.784 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -149.42 147.78 28.68 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.494 0.664 . . . . 10.0 111.291 -173.785 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.4 m -52.41 -42.44 38.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 124.546 1.139 . . . . 10.0 111.314 -178.304 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.2 m -52.72 -44.92 66.68 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.093 1.357 . . . . 10.0 111.974 177.964 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -76.21 -47.3 24.52 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.844 1.258 . . . . 10.0 109.444 -170.636 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.801 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.2 pp -65.72 -42.65 90.83 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 119.253 -0.979 . . . . 10.0 109.871 176.455 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.85 -53.17 10.16 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 117.48 -1.248 . . . . 10.0 112.247 163.548 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -50.94 -45.7 60.74 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 120.687 1.585 . . . . 10.0 110.252 178.121 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -55.52 -51.33 67.39 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.135 -0.939 . . . . 10.0 110.211 -178.038 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 21.9 t -65.16 -43.71 95.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-N 116.475 -0.33 . . . . 10.0 111.653 177.021 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.41 -54.25 47.81 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 108.188 -1.041 . . . . 10.0 108.188 -175.884 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -58.09 -38.92 77.32 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.733 1.213 . . . . 10.0 111.107 178.419 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.442 HD13 ' HA ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -50.92 -34.09 27.05 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.333 0.653 . . . . 10.0 112.067 172.61 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.75 20.78 6.7 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 123.65 0.643 . . . . 10.0 113.281 172.127 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -142.22 175.05 10.06 Favored 'General case' 0 CA--C 1.522 -0.12 0 N-CA-C 105.627 -1.99 . . . . 10.0 105.627 167.406 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 31.4 tttt -123.08 152.87 40.62 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 119.244 0.929 . . . . 10.0 113.182 -164.867 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 12.7 tp -134.74 148.86 50.35 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 126.815 2.046 . . . . 10.0 107.907 -168.808 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 12.6 tptp -149.94 151.28 33.13 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-O 118.713 -0.661 . . . . 10.0 109.536 161.843 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 11.4 tp -60.45 155.15 18.93 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 109.13 -0.693 . . . . 10.0 109.13 175.617 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 35.8 tttp -112.7 -68.35 0.94 Allowed 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 126.443 1.897 . . . . 10.0 107.815 178.912 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 154.75 51.68 0.01 OUTLIER Glycine 0 CA--C 1.529 0.929 0 CA-C-O 119.527 -0.596 . . . . 10.0 112.726 175.095 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 . . . . . 0 CA--C 1.532 0.282 0 C-N-CA 125.735 1.614 . . . . 10.0 113.584 178.22 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.672 HG21 ' HB2' ' A' ' 32' ' ' ALA . 21.0 p . . . . . 0 N--CA 1.454 -0.253 0 CA-C-O 120.757 0.313 . . . . 10.0 110.533 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -136.83 149.69 47.87 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 127.505 2.322 . . . . 10.0 106.423 -175.689 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.9 mmtm -97.81 132.52 43.35 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 124.43 1.092 . . . . 10.0 110.555 -176.84 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -134.43 140.24 46.12 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.866 1.267 . . . . 10.0 108.88 177.901 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -119.73 145.83 46.18 Favored 'General case' 0 CA--C 1.513 -0.446 0 C-N-CA 123.817 0.847 . . . . 10.0 109.645 173.071 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.709 ' CE2' HD11 ' A' ' 57' ' ' LEU . 3.7 m-85 -137.09 143.33 42.52 Favored 'General case' 0 N--CA 1.448 -0.544 0 O-C-N 125.084 1.49 . . . . 10.0 109.81 -173.221 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -106.63 135.75 47.61 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.273 1.429 . . . . 10.0 108.701 -174.646 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.9 mm -114.86 134.68 57.13 Favored 'Isoleucine or valine' 0 C--N 1.34 0.164 0 C-N-CA 125.203 1.401 . . . . 10.0 110.415 -161.772 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 . . . . . 0 N--CA 1.451 -0.407 0 N-CA-C 109.379 -0.6 . . . . 10.0 109.379 171.911 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 . . . . . 0 CA--C 1.537 0.46 0 CA-C-O 121.135 0.493 . . . . 10.0 112.0 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 11.9 ttm180 -74.6 -40.91 61.28 Favored 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 120.994 -1.066 . . . . 10.0 109.389 178.12 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.597 HD11 ' HE2' ' A' ' 66' ' ' TYR . 39.1 mm -46.23 -52.91 2.9 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 CA-C-O 117.796 -1.097 . . . . 10.0 110.012 170.504 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -43.99 -46.57 8.38 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 119.071 0.85 . . . . 10.0 111.955 -177.016 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -76.79 -39.66 50.75 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 123.737 0.815 . . . . 10.0 110.638 -178.279 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.91 -35.8 77.62 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 122.38 -0.2 . . . . 10.0 111.268 176.847 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.59 -36.28 29.16 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.293 1.837 . . . . 10.0 111.152 176.91 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -53.53 -31.63 47.07 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.265 -0.897 . . . . 10.0 110.88 173.232 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.5 mptt -54.15 -24.9 19.71 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 115.298 1.592 . . . . 10.0 115.298 172.349 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.475 HG23 ' HB3' ' A' ' 52' ' ' ALA . 11.4 mm -61.23 108.2 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 118.708 0.685 . . . . 10.0 109.966 172.381 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -55.37 -33.81 63.75 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.239 0.616 . . . . 10.0 111.945 -177.085 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.85 15.49 57.47 Favored Glycine 0 CA--C 1.528 0.883 0 O-C-N 121.497 -0.752 . . . . 10.0 113.19 -179.058 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.7 p -79.33 154.45 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-N 118.867 1.334 . . . . 10.0 109.943 -179.75 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.672 ' HB2' HG21 ' A' ' 2' ' ' THR . . . -114.27 -46.62 2.97 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.541 -0.754 . . . . 10.0 109.716 161.019 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 -144.37 147.91 34.02 Favored 'General case' 0 C--N 1.339 0.12 0 N-CA-C 108.666 -0.864 . . . . 10.0 108.666 -173.389 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -148.48 56.3 2.52 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 118.721 0.692 . . . . 10.0 112.581 172.181 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -74.89 80.62 2.36 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.121 2.547 . . . . 10.0 109.797 178.523 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.486 HG12 HG13 ' A' ' 43' ' ' VAL . 3.6 m -62.3 157.73 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 123.823 0.849 . . . . 10.0 111.47 176.889 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 75.5 m-80 -92.12 116.92 29.36 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 120.23 -0.588 . . . . 10.0 112.18 -173.841 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -90.34 48.28 1.54 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.431 1.492 . . . . 10.0 111.249 -179.335 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -171.99 -39.01 0.02 OUTLIER 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 123.719 0.808 . . . . 10.0 110.579 165.272 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 16.4 mt -77.4 -15.03 59.57 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.794 0.838 . . . . 10.0 111.964 -167.666 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 65.52 47.25 2.28 Favored 'General case' 0 C--O 1.227 -0.081 0 C-N-CA 125.353 1.461 . . . . 10.0 109.824 -179.161 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 17.0 p -140.69 130.84 24.84 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 107.976 -1.12 . . . . 10.0 107.976 176.969 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.486 HG13 HG12 ' A' ' 36' ' ' VAL . 12.8 t -95.81 137.55 23.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 107.021 -1.474 . . . . 10.0 107.021 171.605 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 86.1 m -129.7 115.06 16.78 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 106.357 -1.72 . . . . 10.0 106.357 -174.776 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 32.3 t -115.69 144.05 24.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 C-N-CA 123.379 0.672 . . . . 10.0 109.799 -178.141 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -114.79 107.68 15.76 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 125.499 1.52 . . . . 10.0 107.873 164.836 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -149.13 164.18 35.45 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.736 -0.468 . . . . 10.0 109.736 -178.653 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -94.05 131.31 31.94 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 116.25 -0.432 . . . . 10.0 110.172 175.264 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -77.1 62.17 7.42 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.199 1.933 . . . . 10.0 109.488 169.336 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.83 -48.91 1.13 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.649 0.78 . . . . 10.0 108.994 174.685 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.29 -29.29 18.22 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 122.991 0.516 . . . . 10.0 111.841 -171.766 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.475 ' HB3' HG23 ' A' ' 28' ' ' ILE . . . -156.67 169.91 23.62 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.984 1.714 . . . . 10.0 106.82 -169.648 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 59.9 p -135.6 169.88 16.83 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 122.445 1.116 . . . . 10.0 112.649 -178.305 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 35.4 m -48.52 -40.87 11.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 125.189 1.395 . . . . 10.0 111.508 170.997 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 49.8 m -66.57 -35.87 81.26 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 123.509 0.723 . . . . 10.0 111.691 -179.746 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -70.2 -53.05 18.77 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 107.722 -1.214 . . . . 10.0 107.722 179.26 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.709 HD11 ' CE2' ' A' ' 7' ' ' PHE . 3.7 pp -65.87 -35.82 81.71 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 122.001 -0.437 . . . . 10.0 111.819 -173.317 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.7 ttpp -39.44 -54.63 1.9 Allowed 'General case' 0 C--N 1.341 0.222 0 O-C-N 121.216 -0.928 . . . . 10.0 112.559 159.952 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -54.42 -33.8 60.14 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 121.51 0.671 . . . . 10.0 110.54 -174.239 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -58.25 -52.33 66.05 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 121.778 0.799 . . . . 10.0 108.86 179.292 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.564 HG22 HD12 ' A' ' 21' ' ' ILE . 40.0 t -63.27 -43.11 98.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 115.331 -0.85 . . . . 10.0 110.716 176.617 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -56.88 -51.08 70.47 Favored 'General case' 0 CA--C 1.528 0.114 0 N-CA-C 109.28 -0.637 . . . . 10.0 109.28 -177.201 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -59.32 -35.84 74.55 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.241 1.016 . . . . 10.0 111.77 176.646 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.429 ' HA ' HD13 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -52.63 -31.21 35.54 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.621 0.769 . . . . 10.0 111.885 171.088 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 119.48 12.92 6.49 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 124.192 0.901 . . . . 10.0 113.124 171.401 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.597 ' HE2' HD11 ' A' ' 21' ' ' ILE . 1.0 OUTLIER -149.9 161.67 41.83 Favored 'General case' 0 C--O 1.224 -0.245 0 N-CA-C 107.009 -1.478 . . . . 10.0 107.009 179.649 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.8 mttt -104.29 153.7 20.7 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 121.798 0.809 . . . . 10.0 112.002 -165.249 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.427 HD11 ' HB2' ' A' ' 7' ' ' PHE . 13.1 tp -129.72 145.76 51.52 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 127.298 2.239 . . . . 10.0 107.197 -176.474 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 33.3 mmtt -145.76 151.72 38.42 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 108.379 -0.971 . . . . 10.0 108.379 165.065 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 11.7 tp -63.25 156.46 25.4 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 108.419 -0.956 . . . . 10.0 108.419 173.48 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 24.3 ttpt -113.81 -52.85 2.72 Favored 'General case' 0 N--CA 1.437 -1.119 0 C-N-CA 126.433 1.893 . . . . 10.0 107.199 170.994 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 179.82 -78.95 0.06 OUTLIER Glycine 0 C--N 1.336 0.533 0 N-CA-C 109.736 -1.346 . . . . 10.0 109.736 174.486 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 . . . . . 0 N--CA 1.453 -0.3 0 N-CA-C 107.45 -1.315 . . . . 10.0 107.45 -168.1 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.1 p . . . . . 0 CA--C 1.533 0.309 0 N-CA-C 108.384 -0.969 . . . . 10.0 108.384 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -129.02 145.82 51.16 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 126.364 1.865 . . . . 10.0 109.628 -175.393 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 20.8 mtmt -106.82 92.16 3.97 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.383 1.473 . . . . 10.0 110.282 -165.706 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.602 ' HB1' HD11 ' A' ' 70' ' ' LEU . . . -97.61 151.67 19.84 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.906 1.682 . . . . 10.0 110.352 -171.822 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -124.43 148.04 47.89 Favored 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 124.24 1.016 . . . . 10.0 109.374 174.765 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.703 ' CE2' HD11 ' A' ' 57' ' ' LEU . 4.9 m-85 -137.7 140.73 40.91 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 124.581 1.176 . . . . 10.0 109.266 -169.773 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -103.37 129.95 50.56 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 125.742 1.617 . . . . 10.0 108.587 -171.661 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.4 mm -110.52 127.16 67.73 Favored 'Isoleucine or valine' 0 C--N 1.34 0.164 0 C-N-CA 123.8 0.84 . . . . 10.0 110.71 -163.711 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 . . . . . 0 N--CA 1.449 -0.483 0 N-CA-C 108.805 -0.813 . . . . 10.0 108.805 169.751 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.534 0.331 0 CA-C-O 121.099 0.476 . . . . 10.0 110.908 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.04 -52.47 65.62 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 107.708 -1.219 . . . . 10.0 107.708 178.657 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.541 HG22 HD12 ' A' ' 25' ' ' LEU . 1.7 mt -46.25 -50.9 4.43 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.435 0 CA-C-O 117.652 -1.166 . . . . 10.0 111.011 -179.51 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -41.56 -57.65 2.18 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 119.147 0.885 . . . . 10.0 111.215 -178.316 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -67.43 -48.07 68.36 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 124.47 1.108 . . . . 10.0 110.566 -179.925 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.1 mmt180 -59.19 -21.7 59.85 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.326 0.861 . . . . 10.0 113.326 179.603 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.541 HD12 HG22 ' A' ' 21' ' ' ILE . 3.1 mt -92.55 -41.12 10.42 Favored 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 126.303 1.841 . . . . 10.0 110.693 171.973 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -52.06 -28.54 17.72 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.703 1.201 . . . . 10.0 110.167 174.6 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -44.81 -44.65 9.6 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 113.72 1.007 . . . . 10.0 113.72 168.411 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 7.3 mm -55.06 128.05 14.68 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 C-N-CA 123.125 0.57 . . . . 10.0 110.573 -179.316 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 20.0 mp0 -65.16 -51.86 58.59 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 122.17 -0.332 . . . . 10.0 111.066 -177.113 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.59 40.41 2.87 Favored Glycine 0 C--N 1.339 0.726 0 O-C-N 120.835 -1.165 . . . . 10.0 111.835 -173.411 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.2 p -99.3 148.64 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 C-N-CA 124.504 1.122 . . . . 10.0 108.571 -176.512 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -111.75 -56.96 2.32 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.1 0.96 . . . . 10.0 108.566 171.67 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -142.55 156.65 45.14 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 109.621 -0.511 . . . . 10.0 109.621 179.437 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -143.36 61.34 9.92 Favored Pre-proline 0 CA--C 1.535 0.4 0 C-N-CA 124.0 0.92 . . . . 10.0 110.721 174.605 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -78.68 71.54 6.86 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 122.76 2.306 . . . . 10.0 109.332 -176.724 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.449 HG12 HG13 ' A' ' 43' ' ' VAL . 3.6 m -64.09 153.51 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 O-C-N 121.728 -0.608 . . . . 10.0 111.002 -178.906 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 -88.23 140.71 29.2 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 120.577 -0.449 . . . . 10.0 110.532 177.256 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -114.89 39.25 2.92 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.277 1.431 . . . . 10.0 111.034 -173.376 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -173.17 -40.94 0.01 OUTLIER 'General case' 0 C--O 1.226 -0.135 0 C-N-CA 124.907 1.283 . . . . 10.0 110.339 178.529 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.5 mt -74.9 -19.43 60.15 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.98 0.912 . . . . 10.0 111.56 -172.434 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 64.44 52.43 1.83 Allowed 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 125.704 1.602 . . . . 10.0 110.343 -178.477 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.8 p -143.94 130.36 19.93 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 125.51 1.524 . . . . 10.0 107.476 175.14 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.449 HG13 HG12 ' A' ' 36' ' ' VAL . 4.9 t -100.47 148.59 6.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 106.829 -1.545 . . . . 10.0 106.829 173.323 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 59.0 m -136.55 126.53 25.97 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 106.403 -1.702 . . . . 10.0 106.403 -176.029 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.424 HG22 HD13 ' A' ' 25' ' ' LEU . 14.4 t -131.83 122.93 50.6 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 CA-C-N 118.48 0.582 . . . . 10.0 111.13 -179.538 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.0 mp0 -89.24 98.17 11.62 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 106.538 -1.652 . . . . 10.0 106.538 165.579 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -141.51 161.77 37.1 Favored 'General case' 0 CA--C 1.516 -0.332 0 C-N-CA 122.979 0.512 . . . . 10.0 110.089 175.661 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 31.3 p30 -92.14 136.26 26.08 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.238 -0.437 . . . . 10.0 110.556 178.439 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -79.85 53.0 4.54 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 121.234 1.289 . . . . 10.0 109.229 170.42 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.84 1.16 2.75 Favored 'General case' 0 C--N 1.347 0.49 0 CA-C-N 118.722 0.692 . . . . 10.0 112.801 177.94 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -138.28 -53.03 0.61 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.374 1.07 . . . . 10.0 108.502 -168.02 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -125.2 -176.41 3.56 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.01 1.324 . . . . 10.0 109.401 173.873 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 85.8 p -135.34 171.44 14.43 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.219 1.008 . . . . 10.0 110.875 174.495 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 77.8 t -48.39 -50.38 12.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 123.45 0.7 . . . . 10.0 110.533 166.787 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 72.2 m -59.78 -33.13 71.3 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.382 0.673 . . . . 10.0 111.526 -178.208 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -70.87 -59.55 2.73 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 108.607 -0.886 . . . . 10.0 108.607 175.482 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.703 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.0 pp -61.65 -47.04 87.17 Favored 'General case' 0 N--CA 1.452 -0.374 0 O-C-N 121.607 -0.683 . . . . 10.0 112.058 -170.579 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.451 ' N ' HD12 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -49.3 -29.92 6.68 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 114.588 1.329 . . . . 10.0 114.588 170.428 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.61 -36.29 69.26 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 120.185 1.357 . . . . 10.0 109.993 177.586 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.29 -50.15 75.09 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.595 -0.52 . . . . 10.0 109.595 179.566 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.472 HG12 ' O ' ' A' ' 66' ' ' TYR . 53.2 t -62.28 -50.17 81.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 123.34 0.656 . . . . 10.0 111.732 175.12 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -53.1 -40.77 64.38 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.684 0.794 . . . . 10.0 109.915 179.906 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.3 tptm -74.01 -38.6 64.02 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 124.498 1.119 . . . . 10.0 110.44 -178.41 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 34.3 mt -54.69 -41.46 70.25 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.278 0.49 . . . . 10.0 111.186 166.849 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 151.24 -51.19 0.52 Allowed Glycine 0 CA--C 1.525 0.68 0 CA-C-N 118.567 0.621 . . . . 10.0 112.445 166.755 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.472 ' O ' HG12 ' A' ' 61' ' ' VAL . 10.2 p90 -76.07 157.22 33.18 Favored 'General case' 0 C--O 1.224 -0.25 0 N-CA-C 108.811 -0.811 . . . . 10.0 108.811 177.153 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 31.8 mtpt -103.02 157.75 16.77 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.352 0.596 . . . . 10.0 111.0 -172.663 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.484 HD11 ' HB2' ' A' ' 7' ' ' PHE . 34.2 tp -134.26 147.41 50.65 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.749 1.619 . . . . 10.0 108.419 -174.839 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 10.5 mmtp -152.46 156.01 38.62 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.771 1.628 . . . . 10.0 107.903 174.088 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.602 HD11 ' HB1' ' A' ' 5' ' ' ALA . 6.8 tp -66.5 159.05 28.07 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 109.771 -0.455 . . . . 10.0 109.771 176.029 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 6.0 tttp -113.76 -57.25 2.31 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 125.458 1.503 . . . . 10.0 108.409 169.651 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -172.72 -79.69 0.05 OUTLIER Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.273 -1.131 . . . . 10.0 110.273 179.962 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 . . . . . 0 N--CA 1.455 -0.2 0 C-N-CA 124.378 1.071 . . . . 10.0 108.435 -176.226 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.558 HG21 ' HB2' ' A' ' 32' ' ' ALA . 4.5 p . . . . . 0 CA--C 1.533 0.317 0 N-CA-C 108.407 -0.96 . . . . 10.0 108.407 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -134.85 136.53 42.52 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 126.101 1.76 . . . . 10.0 108.03 -170.228 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -102.86 113.63 27.23 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.005 0.922 . . . . 10.0 111.625 -168.415 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.549 ' HB1' HD11 ' A' ' 70' ' ' LEU . . . -115.64 149.95 37.5 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 127.306 2.243 . . . . 10.0 109.215 -172.32 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -124.24 146.97 48.41 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.493 1.117 . . . . 10.0 108.872 174.086 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.727 ' CE2' HD11 ' A' ' 57' ' ' LEU . 1.9 m-85 -140.57 137.61 33.84 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 124.889 1.368 . . . . 10.0 110.467 -168.168 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -91.27 133.67 35.21 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 126.011 1.724 . . . . 10.0 109.421 -175.915 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.462 HD11 HG23 ' A' ' 43' ' ' VAL . 3.3 mm -113.1 134.38 55.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 125.611 1.565 . . . . 10.0 110.491 -173.959 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 . . . . . 0 N--CA 1.45 -0.441 0 C-N-CA 124.059 0.943 . . . . 10.0 108.645 171.252 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 . . . . . 0 CA--C 1.538 0.506 0 CA-C-O 121.454 0.645 . . . . 10.0 112.422 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.29 -45.96 79.96 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.085 0.954 . . . . 10.0 108.931 179.305 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.453 HG22 HD12 ' A' ' 25' ' ' LEU . 3.0 mt -43.7 -52.48 1.25 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.346 0 CA-C-O 118.362 -0.827 . . . . 10.0 110.532 175.572 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -48.0 -49.02 32.25 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 118.531 0.605 . . . . 10.0 110.873 -177.23 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.61 -47.69 58.85 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 121.627 -0.671 . . . . 10.0 110.533 -179.677 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.487 ' HB3' ' HB1' ' A' ' 60' ' ' ALA . 1.2 mmp_? -54.63 -33.8 61.11 Favored 'General case' 0 C--O 1.225 -0.235 0 C-N-CA 124.008 0.923 . . . . 10.0 112.181 178.305 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.565 HD21 ' HB2' ' A' ' 57' ' ' LEU . 0.3 OUTLIER -88.99 -33.63 17.13 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 125.621 1.569 . . . . 10.0 111.392 177.605 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -60.06 -27.17 66.73 Favored 'General case' 0 C--O 1.225 -0.202 0 O-C-N 121.486 -0.759 . . . . 10.0 110.258 174.4 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.2 mmpt? -53.68 -34.26 58.13 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 113.736 1.013 . . . . 10.0 113.736 168.847 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 12.5 mm -56.4 127.92 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 119.126 0.875 . . . . 10.0 109.504 177.354 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -63.59 -56.93 12.07 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.515 -0.311 . . . . 10.0 110.486 -175.836 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.54 49.83 3.72 Favored Glycine 0 C--N 1.341 0.845 0 O-C-N 120.692 -1.255 . . . . 10.0 110.919 -173.042 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -105.71 146.06 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 C-N-CA 124.296 1.039 . . . . 10.0 108.244 -178.151 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.558 ' HB2' HG21 ' A' ' 2' ' ' THR . . . -102.17 -52.22 3.2 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 108.375 -0.972 . . . . 10.0 108.375 176.004 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.0 p30 -160.23 149.37 17.41 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.449 -0.945 . . . . 10.0 108.449 -174.905 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -136.26 59.2 25.38 Favored Pre-proline 0 CA--C 1.536 0.424 0 C-N-CA 124.186 0.994 . . . . 10.0 111.54 178.077 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -77.0 74.84 4.82 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.031 2.487 . . . . 10.0 109.626 -178.964 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.574 HG12 HG13 ' A' ' 43' ' ' VAL . 3.0 m -65.28 158.42 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 C-N-CA 123.402 0.681 . . . . 10.0 111.428 179.988 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -96.35 121.71 38.44 Favored 'General case' 0 C--N 1.339 0.136 0 CA-C-O 120.83 0.347 . . . . 10.0 111.71 -176.861 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -96.15 50.16 1.16 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.303 1.441 . . . . 10.0 111.231 179.785 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -175.0 -40.72 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.228 0 C-N-CA 124.162 0.985 . . . . 10.0 109.928 172.533 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.1 mt -81.79 -11.6 58.91 Favored 'General case' 0 C--O 1.226 -0.146 0 C-N-CA 124.294 1.038 . . . . 10.0 112.214 -167.74 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 71.77 36.13 1.27 Allowed 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 125.403 1.481 . . . . 10.0 110.897 173.296 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.8 p -138.95 131.04 28.04 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.019 1.328 . . . . 10.0 108.312 -178.096 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.574 HG13 HG12 ' A' ' 36' ' ' VAL . 18.9 t -91.52 149.14 4.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 107.112 -1.44 . . . . 10.0 107.112 167.746 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 68.4 m -137.12 124.3 21.72 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 105.667 -1.975 . . . . 10.0 105.667 -179.553 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 47.9 t -135.98 138.44 47.46 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 CA-C-N 118.454 0.57 . . . . 10.0 109.712 179.278 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -101.95 112.71 25.44 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 107.226 -1.398 . . . . 10.0 107.226 165.145 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -146.99 165.92 28.38 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 123.361 0.664 . . . . 10.0 109.34 179.295 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 31.0 p30 -95.71 128.16 38.8 Favored Pre-proline 0 C--N 1.328 -0.341 0 N-CA-C 110.508 -0.182 . . . . 10.0 110.508 178.494 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -75.65 61.51 6.18 Favored 'Trans proline' 0 N--CA 1.45 -1.032 0 N-CA-C 108.507 -1.382 . . . . 10.0 108.507 169.205 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.31 -44.51 0.37 Allowed 'General case' 0 C--N 1.343 0.295 0 O-C-N 122.122 -0.361 . . . . 10.0 110.379 177.523 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -90.49 -36.61 14.41 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 122.378 0.271 . . . . 10.0 110.333 178.637 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -137.36 -175.58 4.11 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.542 1.137 . . . . 10.0 110.066 -179.707 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 91.5 p -147.05 172.44 13.74 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.295 0.638 . . . . 10.0 111.49 179.872 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 92.0 t -48.79 -45.4 15.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 124.051 0.94 . . . . 10.0 111.081 171.12 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.5 m -60.54 -37.22 80.51 Favored 'General case' 0 C--O 1.234 0.259 0 O-C-N 121.976 -0.452 . . . . 10.0 112.154 -179.689 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -65.71 -60.1 3.24 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 108.091 -1.078 . . . . 10.0 108.091 179.816 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.727 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.1 pp -63.48 -40.03 96.02 Favored 'General case' 0 N--CA 1.454 -0.24 0 O-C-N 121.55 -0.719 . . . . 10.0 111.477 -175.774 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.8 ttpp -39.16 -59.14 1.05 Allowed 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 117.627 -1.178 . . . . 10.0 111.004 162.653 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -47.85 -37.84 14.75 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-O 122.064 0.935 . . . . 10.0 110.755 -174.797 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.487 ' HB1' ' HB3' ' A' ' 24' ' ' ARG . . . -59.28 -49.76 76.61 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.041 -0.981 . . . . 10.0 109.784 -178.114 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.536 ' HA ' HD12 ' A' ' 64' ' ' LEU . 77.0 t -68.34 -45.65 82.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 124.536 1.134 . . . . 10.0 111.748 175.487 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -46.18 -44.67 16.2 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 126.576 1.95 . . . . 10.0 108.349 176.11 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -80.63 -34.63 34.84 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.238 1.415 . . . . 10.0 111.349 -176.887 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.536 HD12 ' HA ' ' A' ' 61' ' ' VAL . 18.7 mt -51.97 -43.43 63.56 Favored 'General case' 0 C--N 1.34 0.196 0 CA-C-N 118.871 0.759 . . . . 10.0 111.869 169.033 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 150.81 -35.18 0.93 Allowed Glycine 0 CA--C 1.525 0.666 0 C-N-CA 121.277 -0.487 . . . . 10.0 113.057 172.717 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -99.63 159.13 15.27 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.687 1.195 . . . . 10.0 107.888 -178.52 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.3 ttpt -94.8 155.16 16.93 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.194 0.521 . . . . 10.0 109.871 -176.984 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.583 HD11 ' HB2' ' A' ' 7' ' ' PHE . 24.8 tp -124.9 149.85 47.13 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 126.439 1.896 . . . . 10.0 107.528 179.756 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 34.0 mmtt -149.18 156.88 42.82 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 124.803 1.241 . . . . 10.0 108.332 162.905 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.549 HD11 ' HB1' ' A' ' 5' ' ' ALA . 8.7 tp -66.09 158.79 27.59 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 109.083 -0.71 . . . . 10.0 109.083 173.963 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.56 -56.45 2.4 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 125.551 1.54 . . . . 10.0 107.159 166.461 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -176.35 -83.01 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 109.609 -1.396 . . . . 10.0 109.609 179.13 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 . . . . . 0 N--CA 1.454 -0.272 0 C-N-CA 123.544 0.738 . . . . 10.0 109.379 -167.923 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.481 HG21 ' HB2' ' A' ' 32' ' ' ALA . 5.0 p . . . . . 0 N--CA 1.452 -0.353 0 CA-C-O 120.61 0.243 . . . . 10.0 111.02 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -136.57 151.67 49.63 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 128.434 2.694 . . . . 10.0 107.8 179.548 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 17.0 mmtt -96.86 118.13 32.61 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 108.491 -0.929 . . . . 10.0 108.491 175.796 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -113.68 138.54 50.07 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 124.253 1.021 . . . . 10.0 109.749 172.5 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -113.82 145.79 40.91 Favored 'General case' 0 CA--C 1.51 -0.591 0 C-N-CA 124.589 1.156 . . . . 10.0 110.246 174.97 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.648 ' CE2' HD11 ' A' ' 57' ' ' LEU . 3.9 m-85 -139.17 142.52 37.96 Favored 'General case' 0 N--CA 1.448 -0.575 0 O-C-N 125.036 1.46 . . . . 10.0 110.056 -177.077 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -103.59 134.38 47.02 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 125.882 1.673 . . . . 10.0 108.604 -174.371 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.3 mm -109.58 125.25 66.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 C-N-CA 123.711 0.804 . . . . 10.0 110.422 -162.886 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 . . . . . 0 N--CA 1.452 -0.335 0 N-CA-C 108.476 -0.935 . . . . 10.0 108.476 173.005 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.542 0.642 0 N-CA-C 112.961 0.726 . . . . 10.0 112.961 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.0 ttt180 -84.93 -42.02 15.37 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 126.058 1.743 . . . . 10.0 109.604 -172.653 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.424 ' CG2' HD12 ' A' ' 25' ' ' LEU . 18.4 mm -41.66 -57.05 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.323 0 C-N-CA 124.368 1.067 . . . . 10.0 108.66 166.756 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -42.53 -50.62 5.27 Favored 'General case' 0 C--O 1.221 -0.4 0 O-C-N 123.576 0.548 . . . . 10.0 111.399 179.389 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.7 -49.79 56.13 Favored 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 121.875 -0.516 . . . . 10.0 109.631 -176.289 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.432 ' HG3' HD11 ' A' ' 64' ' ' LEU . 6.9 mmt85 -57.65 -38.65 75.44 Favored 'General case' 0 C--O 1.226 -0.149 0 O-C-N 121.94 -0.475 . . . . 10.0 112.036 -179.437 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.424 HD12 ' CG2' ' A' ' 21' ' ' ILE . 0.5 OUTLIER -74.36 -46.35 41.15 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.194 0.997 . . . . 10.0 110.147 177.396 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 53.0 m-20 -54.95 -24.08 22.12 Favored 'General case' 0 C--O 1.226 -0.135 0 C-N-CA 123.319 0.648 . . . . 10.0 111.503 174.941 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.3 ttmt -56.19 -39.53 72.56 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 118.372 0.533 . . . . 10.0 112.225 175.665 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.7 mp -56.74 135.87 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 C-N-CA 123.873 0.869 . . . . 10.0 110.436 179.09 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 55.9 mp0 -70.78 -49.46 46.33 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 116.274 -0.421 . . . . 10.0 110.091 -174.119 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.22 49.01 4.15 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.973 -0.851 . . . . 10.0 110.973 -177.836 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.4 p -110.74 155.54 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 126.009 1.724 . . . . 10.0 109.073 178.03 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.481 ' HB2' HG21 ' A' ' 2' ' ' THR . . . -120.34 -56.78 1.97 Allowed 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 110.235 -0.283 . . . . 10.0 110.235 168.648 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -144.97 149.04 34.48 Favored 'General case' 0 C--O 1.226 -0.172 0 N-CA-C 107.992 -1.114 . . . . 10.0 107.992 -171.484 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -142.85 63.73 13.97 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 118.708 0.685 . . . . 10.0 111.201 172.4 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -76.71 74.32 4.91 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.926 2.417 . . . . 10.0 109.38 178.135 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.494 HG12 HG13 ' A' ' 43' ' ' VAL . 11.4 m -66.02 158.27 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 C-N-CA 123.624 0.77 . . . . 10.0 112.082 179.702 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -90.72 101.69 14.44 Favored 'General case' 0 N--CA 1.46 0.069 0 C-N-CA 120.441 -0.504 . . . . 10.0 111.706 -165.982 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -75.55 42.22 0.21 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.249 1.82 . . . . 10.0 113.938 -173.302 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -177.07 -36.3 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.288 1.435 . . . . 10.0 110.64 176.513 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.2 mt -88.67 0.99 55.88 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.635 1.174 . . . . 10.0 112.667 -169.156 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 58.26 45.5 17.11 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 124.789 1.235 . . . . 10.0 110.402 170.955 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -145.39 129.12 17.22 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.694 -1.224 . . . . 10.0 107.694 -178.124 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.494 HG13 HG12 ' A' ' 36' ' ' VAL . 5.5 t -97.55 126.79 50.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 108.277 -1.008 . . . . 10.0 108.277 175.575 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 84.0 m -113.8 112.26 23.1 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.982 1.713 . . . . 10.0 107.457 178.687 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 41.3 t -106.09 141.59 21.01 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.044 0 CA-C-N 118.359 0.527 . . . . 10.0 110.183 177.49 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -108.12 109.77 21.27 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 125.376 1.47 . . . . 10.0 108.016 160.227 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -143.2 169.57 17.37 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.905 -0.776 . . . . 10.0 108.905 177.288 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 7.3 p-10 -115.46 115.34 42.22 Favored Pre-proline 0 CA--C 1.531 0.238 0 C-N-CA 123.722 0.809 . . . . 10.0 110.021 -178.708 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -74.56 72.1 4.46 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.376 2.717 . . . . 10.0 111.015 -175.832 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.88 -39.16 0.63 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.075 0.55 . . . . 10.0 110.934 168.548 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -86.94 -51.07 6.25 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.193 0.451 . . . . 10.0 110.107 176.756 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -123.76 -175.0 3.11 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.784 1.234 . . . . 10.0 110.742 -171.653 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 83.2 p -144.46 167.94 21.3 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.575 0.75 . . . . 10.0 112.677 177.762 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 23.5 m -47.0 -43.19 6.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 124.57 1.148 . . . . 10.0 111.515 164.312 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 68.3 m -68.78 -40.89 79.42 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 122.782 0.433 . . . . 10.0 110.731 -177.095 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -57.78 -59.48 5.15 Favored 'General case' 0 N--CA 1.455 -0.199 0 O-C-N 123.916 0.76 . . . . 10.0 109.297 176.396 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.648 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.2 pp -65.05 -39.38 93.23 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 122.165 -0.334 . . . . 10.0 110.933 -171.536 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.408 ' HA ' HD23 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -43.46 -45.64 6.44 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 118.254 -0.879 . . . . 10.0 113.194 163.812 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -59.92 -40.56 89.25 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 120.236 1.38 . . . . 10.0 111.024 179.802 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -55.44 -49.41 72.49 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 122.106 -0.371 . . . . 10.0 110.104 178.366 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.519 ' HA ' HD12 ' A' ' 64' ' ' LEU . 24.8 t -66.08 -43.44 92.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 N-CA-C 112.815 0.672 . . . . 10.0 112.815 176.207 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -53.19 -44.0 67.59 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.841 0.829 . . . . 10.0 109.081 177.841 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.0 tttp -80.21 -30.59 38.69 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 124.722 1.209 . . . . 10.0 111.591 -175.246 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.519 HD12 ' HA ' ' A' ' 61' ' ' VAL . 15.1 mt -51.38 -35.49 39.01 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.407 1.003 . . . . 10.0 111.507 162.36 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 115.78 28.35 2.73 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 123.041 0.353 . . . . 10.0 112.822 169.066 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -145.67 158.24 43.87 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 107.251 -1.388 . . . . 10.0 107.251 168.443 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.24 130.96 37.82 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.69 -0.485 . . . . 10.0 109.69 -166.146 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.468 HD11 ' HB2' ' A' ' 7' ' ' PHE . 12.1 tp -114.9 146.98 40.55 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 106.265 -1.754 . . . . 10.0 106.265 173.261 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 17.6 tptt -153.09 150.14 28.82 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 109.053 -0.721 . . . . 10.0 109.053 168.458 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.9 tp -62.39 156.6 22.09 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 109.316 -0.624 . . . . 10.0 109.316 178.04 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 42.1 tttt -117.22 -64.24 1.33 Allowed 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 126.326 1.85 . . . . 10.0 107.742 178.905 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 154.06 50.71 0.01 OUTLIER Glycine 0 CA--C 1.527 0.8 0 CA-C-O 119.661 -0.522 . . . . 10.0 112.337 174.967 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 . . . . . 0 CA--C 1.537 0.472 0 C-N-CA 125.267 1.427 . . . . 10.0 111.989 175.014 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.512 HG21 ' HB2' ' A' ' 32' ' ' ALA . 9.8 p . . . . . 0 CA--C 1.534 0.351 0 N-CA-C 107.195 -1.409 . . . . 10.0 107.195 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -138.39 142.81 39.6 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 129.12 2.968 . . . . 10.0 106.989 -174.227 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 28.9 tttt -111.32 98.69 7.67 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.373 1.069 . . . . 10.0 110.09 -171.504 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -99.92 150.15 22.69 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.834 -1.075 . . . . 10.0 108.844 -175.641 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -122.36 150.17 42.77 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 123.221 0.608 . . . . 10.0 109.919 172.286 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.646 ' CE2' HD11 ' A' ' 57' ' ' LEU . 7.8 m-85 -138.26 137.14 37.2 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 125.452 1.72 . . . . 10.0 108.335 -169.477 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -99.45 139.64 34.81 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 106.328 -1.731 . . . . 10.0 106.328 178.874 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.0 mm -114.32 141.39 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 C-N-CA 124.995 1.318 . . . . 10.0 109.913 -162.779 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 . . . . . 0 N--CA 1.444 -0.729 0 N-CA-C 108.155 -1.054 . . . . 10.0 108.155 176.702 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 . . . . . 0 N--CA 1.464 0.27 0 CA-C-O 120.575 0.226 . . . . 10.0 111.274 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.92 -42.04 41.0 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 118.306 -0.854 . . . . 10.0 111.033 176.202 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 27.2 mm -43.15 -55.1 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.411 0 CA-C-N 118.65 0.659 . . . . 10.0 109.573 174.028 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -43.17 -57.41 2.96 Favored 'General case' 0 C--O 1.222 -0.377 0 C-N-CA 123.244 0.618 . . . . 10.0 111.607 -179.48 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.06 -41.88 63.68 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.392 1.077 . . . . 10.0 109.794 -170.601 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.416 ' HG3' ' HB1' ' A' ' 60' ' ' ALA . 25.6 tpt180 -53.81 -45.65 70.86 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.328 0.651 . . . . 10.0 109.958 175.358 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.03 -37.72 64.25 Favored 'General case' 0 C--O 1.224 -0.284 0 C-N-CA 123.2 0.6 . . . . 10.0 111.858 176.046 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -51.98 -32.39 33.36 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 123.723 0.809 . . . . 10.0 109.788 175.317 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.7 -33.42 70.16 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.947 1.091 . . . . 10.0 113.947 175.478 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 17.0 mm -57.48 133.21 22.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 108.314 -0.995 . . . . 10.0 108.314 177.465 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -80.29 -41.88 24.12 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 118.486 0.585 . . . . 10.0 110.757 -172.039 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -78.91 39.92 2.05 Favored Glycine 0 C--N 1.339 0.738 0 O-C-N 120.117 -1.614 . . . . 10.0 112.491 176.1 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.4 p -105.68 148.22 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 C-N-CA 124.179 0.991 . . . . 10.0 108.363 -176.594 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.512 ' HB2' HG21 ' A' ' 2' ' ' THR . . . -115.54 -56.36 2.35 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.92 -0.77 . . . . 10.0 108.92 174.876 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 64.2 m-80 -147.32 152.76 38.77 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 109.264 -0.643 . . . . 10.0 109.264 -178.546 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -134.81 65.85 67.26 Favored Pre-proline 0 CA--C 1.534 0.341 0 C-N-CA 123.639 0.776 . . . . 10.0 110.015 173.667 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -78.92 67.33 8.57 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.825 2.35 . . . . 10.0 109.078 -178.946 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.473 HG12 HG13 ' A' ' 43' ' ' VAL . 5.0 m -69.59 157.58 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 C-N-CA 122.889 0.476 . . . . 10.0 111.339 -175.89 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -91.51 126.36 36.57 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 121.276 0.56 . . . . 10.0 110.82 -178.675 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -99.61 33.07 2.61 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.962 1.705 . . . . 10.0 112.015 -168.522 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -171.12 -40.71 0.02 OUTLIER 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 124.542 1.137 . . . . 10.0 110.661 179.986 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.1 mt -72.57 -20.06 61.38 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.089 0.956 . . . . 10.0 111.477 -173.31 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 65.17 51.59 1.62 Allowed 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 125.664 1.586 . . . . 10.0 110.424 -178.018 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.1 p -140.1 124.37 17.82 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 125.457 1.503 . . . . 10.0 107.066 173.606 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.473 HG13 HG12 ' A' ' 36' ' ' VAL . 7.9 t -97.2 135.3 31.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 107.773 -1.195 . . . . 10.0 107.773 175.581 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.6 m -120.85 127.84 52.28 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 126.161 1.785 . . . . 10.0 107.418 178.708 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 36.6 t -131.9 128.18 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.123 0 CA-C-N 118.678 0.672 . . . . 10.0 110.093 178.94 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -93.13 102.11 14.41 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 105.314 -2.106 . . . . 10.0 105.314 165.968 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -135.7 176.78 8.37 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.536 1.134 . . . . 10.0 108.612 178.812 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 27.7 p30 -116.96 135.78 23.12 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 118.879 0.763 . . . . 10.0 110.986 175.682 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -79.7 56.84 6.22 Favored 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 121.435 1.424 . . . . 10.0 108.85 167.307 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.8 ptpt -123.88 -39.51 2.38 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 118.133 0.424 . . . . 10.0 111.344 172.828 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -97.99 -61.68 1.35 Allowed 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 107.425 -1.324 . . . . 10.0 107.425 177.48 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -105.62 -174.96 2.66 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 125.047 1.339 . . . . 10.0 111.102 -171.718 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 87.7 p -144.68 164.9 29.59 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 121.673 0.749 . . . . 10.0 109.985 173.692 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.2 m -52.58 -37.47 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 C-N-CA 124.384 1.073 . . . . 10.0 111.154 172.228 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.2 t -62.72 -40.45 97.24 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 122.47 0.308 . . . . 10.0 110.708 177.058 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -65.67 -52.79 48.81 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.891 -0.781 . . . . 10.0 108.891 -175.97 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.646 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.0 pp -64.77 -42.47 95.08 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 121.762 -0.586 . . . . 10.0 111.218 -178.482 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -41.54 -55.22 2.94 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-O 117.737 -1.125 . . . . 10.0 111.751 162.345 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 -56.58 -48.28 77.73 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 119.939 1.245 . . . . 10.0 110.353 178.669 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.416 ' HB1' ' HG3' ' A' ' 24' ' ' ARG . . . -51.29 -45.31 62.1 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 109.59 -0.522 . . . . 10.0 109.59 -178.665 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 99.5 t -69.39 -46.98 75.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 112.401 0.519 . . . . 10.0 112.401 174.017 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -45.59 -42.35 11.04 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.482 1.513 . . . . 10.0 109.522 177.556 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -79.96 -26.2 40.09 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 125.104 1.362 . . . . 10.0 111.329 -173.879 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 67.9 mt -55.96 -41.23 74.39 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 119.489 1.041 . . . . 10.0 110.91 164.559 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 149.03 -40.79 0.88 Allowed Glycine 0 CA--C 1.526 0.755 0 CA-C-N 118.088 0.404 . . . . 10.0 112.531 173.227 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -96.02 157.51 15.86 Favored 'General case' 0 C--N 1.334 -0.099 0 C-N-CA 124.204 1.002 . . . . 10.0 109.351 -177.749 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 63.5 mmtt -92.12 148.61 22.04 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 121.506 0.67 . . . . 10.0 110.341 -170.426 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 10.5 tp -124.46 148.73 47.47 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.115 1.766 . . . . 10.0 106.608 176.675 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.0 tptm -151.48 145.14 24.99 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 117.956 0.344 . . . . 10.0 110.711 165.478 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.4 tt -64.9 159.41 22.81 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-O 121.462 0.649 . . . . 10.0 109.684 178.36 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 27.5 tttt -127.38 -55.54 1.34 Allowed 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 127.701 2.4 . . . . 10.0 107.829 -175.979 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 176.34 -89.91 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 107.92 -2.072 . . . . 10.0 107.92 177.522 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 . . . . . 0 N--CA 1.451 -0.38 0 C-N-CA 123.788 0.835 . . . . 10.0 108.795 -164.295 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.7 p . . . . . 0 N--CA 1.445 -0.694 0 N-CA-C 109.786 -0.45 . . . . 10.0 109.786 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -125.33 145.35 50.07 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 126.581 1.952 . . . . 10.0 108.273 -169.98 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.8 mmtm -87.15 124.45 33.28 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 124.096 0.959 . . . . 10.0 109.675 -175.166 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.474 ' HB1' HD11 ' A' ' 70' ' ' LEU . . . -125.35 143.11 51.13 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.16 1.784 . . . . 10.0 109.349 176.95 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -121.31 146.75 46.51 Favored 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 123.518 0.727 . . . . 10.0 109.096 172.881 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.823 ' CE2' HD11 ' A' ' 57' ' ' LEU . 3.8 m-85 -133.39 140.27 47.26 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 125.194 1.559 . . . . 10.0 108.522 -173.443 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -96.99 141.79 29.72 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.687 1.995 . . . . 10.0 107.618 -177.471 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.548 HG13 HD12 ' A' ' 68' ' ' LEU . 3.3 mp -132.41 148.5 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 125.236 1.415 . . . . 10.0 110.531 -167.407 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 . . . . . 0 N--CA 1.441 -0.877 0 CA-C-N 112.286 -2.234 . . . . 10.0 106.229 175.613 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 . . . . . 0 N--CA 1.472 0.642 0 N-CA-C 112.334 0.494 . . . . 10.0 112.334 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.81 -40.88 89.9 Favored 'General case' 0 N--CA 1.455 -0.219 0 O-C-N 120.904 -1.122 . . . . 10.0 109.301 176.298 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.53 HG22 HD12 ' A' ' 25' ' ' LEU . 20.8 mm -54.13 -49.4 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 108.772 -0.825 . . . . 10.0 108.772 -177.945 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -45.8 -56.42 5.37 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.568 0.747 . . . . 10.0 110.967 -179.895 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.8 mtmt -66.29 -44.6 83.06 Favored 'General case' 0 N--CA 1.453 -0.291 0 O-C-N 121.845 -0.534 . . . . 10.0 111.084 179.583 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.0 tpt85 -56.88 -30.74 64.17 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 111.487 0.18 . . . . 10.0 111.487 178.829 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.53 HD12 HG22 ' A' ' 21' ' ' ILE . 0.3 OUTLIER -84.0 -38.34 21.05 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 125.469 1.508 . . . . 10.0 111.46 174.894 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -60.67 -26.75 67.32 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.779 0.832 . . . . 10.0 109.785 178.845 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.0 mmpt? -50.69 -35.88 33.18 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 114.058 1.133 . . . . 10.0 114.058 168.397 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 13.4 mm -62.84 126.89 22.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 118.63 0.65 . . . . 10.0 109.388 -178.784 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -56.19 -57.53 11.81 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.13 0.419 . . . . 10.0 112.13 -179.673 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -82.57 43.9 3.13 Favored Glycine 0 C--N 1.341 0.838 0 O-C-N 120.259 -1.526 . . . . 10.0 111.988 -170.717 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.5 p -108.07 150.03 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 C-N-CA 124.645 1.178 . . . . 10.0 108.643 -176.965 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -106.86 -58.54 1.92 Allowed 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 109.039 -0.726 . . . . 10.0 109.039 171.81 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -144.97 141.31 28.86 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 106.837 -1.542 . . . . 10.0 106.837 -166.732 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -133.83 59.71 40.94 Favored Pre-proline 0 CA--C 1.535 0.388 0 CA-C-N 118.488 0.586 . . . . 10.0 111.719 172.297 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -77.0 82.26 2.4 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 123.248 2.632 . . . . 10.0 109.215 -178.62 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.515 HG12 HG13 ' A' ' 43' ' ' VAL . 2.9 m -71.53 151.44 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 O-C-N 121.746 -0.596 . . . . 10.0 110.705 -177.793 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -86.32 142.58 28.4 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 120.638 -0.425 . . . . 10.0 110.131 177.345 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -120.88 52.98 1.15 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.269 1.427 . . . . 10.0 110.067 -174.979 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -176.0 -42.7 0.01 OUTLIER 'General case' 0 C--O 1.226 -0.158 0 C-N-CA 125.481 1.512 . . . . 10.0 108.698 178.287 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.8 mt -80.13 -20.96 43.73 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.028 0.931 . . . . 10.0 111.459 -172.599 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 59.04 49.74 9.09 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 126.31 1.844 . . . . 10.0 110.129 -172.336 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 20.7 p -134.74 117.35 15.9 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 125.064 1.345 . . . . 10.0 108.631 173.362 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.518 ' H ' ' CD1' ' A' ' 9' ' ' ILE . 14.4 t -85.34 131.33 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 106.282 -1.747 . . . . 10.0 106.282 171.636 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.2 m -110.81 123.88 50.94 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 105.991 -1.855 . . . . 10.0 105.991 172.295 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 33.6 t -121.92 146.24 27.36 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.274 0 N-CA-C 107.961 -1.126 . . . . 10.0 107.961 171.277 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -112.47 113.35 25.48 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 106.303 -1.74 . . . . 10.0 106.303 166.569 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -142.08 156.82 45.41 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.062 0.545 . . . . 10.0 110.715 -177.099 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 19.6 p30 -93.37 126.05 51.9 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 118.813 -0.613 . . . . 10.0 109.47 177.225 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -74.71 63.42 5.72 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 122.401 2.067 . . . . 10.0 108.922 174.717 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.3 tttt -135.33 -57.03 0.8 Allowed 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 105.331 -2.1 . . . . 10.0 105.331 174.662 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -101.38 -51.12 3.56 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 108.638 -0.875 . . . . 10.0 108.638 -177.797 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -81.59 137.72 35.46 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 123.627 0.771 . . . . 10.0 110.717 -176.851 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.6 p -131.38 145.5 51.85 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.417 1.087 . . . . 10.0 110.945 177.112 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 97.0 t -48.39 -48.05 14.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 C-N-CA 125.243 1.417 . . . . 10.0 110.355 174.776 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.01 -43.79 78.06 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 124.914 1.285 . . . . 10.0 111.432 -179.858 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -64.97 -55.86 16.6 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 121.695 0.76 . . . . 10.0 109.3 -177.249 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.823 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.2 pp -65.56 -41.62 92.74 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.162 -0.961 . . . . 10.0 111.307 -176.423 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -43.88 -48.61 8.41 Favored 'General case' 0 N--CA 1.451 -0.4 0 O-C-N 121.51 -0.744 . . . . 10.0 112.291 161.701 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.63 -43.17 84.62 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 119.224 0.92 . . . . 10.0 109.695 -179.377 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -49.67 -56.81 8.75 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 122.741 0.417 . . . . 10.0 110.556 177.057 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.552 HG11 ' HB2' ' A' ' 68' ' ' LEU . 47.4 t -58.45 -50.19 79.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 N-CA-C 113.184 0.809 . . . . 10.0 113.184 174.185 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -59.21 -35.74 74.15 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.317 1.047 . . . . 10.0 109.5 -174.132 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.8 tptt -77.4 -43.83 31.33 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 125.301 1.441 . . . . 10.0 110.52 178.083 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 19.4 mt -51.25 -39.01 55.75 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-N 118.938 0.79 . . . . 10.0 111.569 172.358 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 128.8 3.08 5.56 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-O 119.41 -0.661 . . . . 10.0 113.58 169.29 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -99.45 -160.44 0.8 Allowed 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 107.57 -1.27 . . . . 10.0 107.57 175.768 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 35.0 tttt -139.06 149.12 44.23 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 118.458 0.572 . . . . 10.0 111.238 167.638 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.552 ' HB2' HG11 ' A' ' 61' ' ' VAL . 13.9 tp -135.62 150.84 49.77 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 127.419 2.288 . . . . 10.0 106.475 -176.046 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.7 tptm -149.76 152.89 35.98 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 108.446 -0.946 . . . . 10.0 108.446 163.642 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.474 HD11 ' HB1' ' A' ' 5' ' ' ALA . 10.6 tp -63.91 157.46 24.76 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 119.341 0.973 . . . . 10.0 108.883 172.338 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 34.5 tttp -117.03 -56.14 2.28 Favored 'General case' 0 N--CA 1.436 -1.152 0 C-N-CA 126.51 1.924 . . . . 10.0 107.783 170.133 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -179.47 -89.25 0.08 OUTLIER Glycine 0 CA--C 1.523 0.535 0 N-CA-C 109.158 -1.577 . . . . 10.0 109.158 -177.864 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 . . . . . 0 N--CA 1.454 -0.251 0 C-N-CA 123.865 0.866 . . . . 10.0 109.189 -166.666 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 47.6 t . . . . . 0 N--CA 1.469 0.497 0 N-CA-C 107.825 -1.176 . . . . 10.0 107.825 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.441 HG21 ' HB2' ' A' ' 32' ' ' ALA . 5.9 p -130.62 154.5 47.82 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.826 1.25 . . . . 10.0 109.838 -176.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -119.2 139.55 51.67 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 127.045 2.138 . . . . 10.0 109.321 -172.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.9 mtmm -104.87 88.75 2.97 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.844 1.658 . . . . 10.0 110.63 -165.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -104.59 152.35 22.53 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.299 1.44 . . . . 10.0 110.497 -168.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -123.54 148.89 45.88 Favored 'General case' 0 CA--C 1.511 -0.545 0 C-N-CA 123.791 0.836 . . . . 10.0 110.199 178.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.755 ' CE2' HD11 ' A' ' 57' ' ' LEU . 3.8 m-85 -138.72 142.3 38.9 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 125.241 1.416 . . . . 10.0 108.205 -175.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -108.86 137.41 46.84 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 107.698 -1.223 . . . . 10.0 107.698 -173.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 5.1 mm -110.22 124.86 67.33 Favored 'Isoleucine or valine' 0 C--N 1.338 0.096 0 C-N-CA 124.52 1.128 . . . . 10.0 110.715 -159.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -117.58 102.67 9.36 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.942 -0.762 . . . . 10.0 108.942 173.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 160.15 -84.75 0.12 Allowed Glycine 0 CA--C 1.527 0.792 0 C-N-CA 123.887 0.756 . . . . 10.0 111.858 170.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.14 160.95 15.19 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.441 0.697 . . . . 10.0 110.772 -176.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.6 t -153.02 86.18 1.24 Allowed 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 107.485 -1.302 . . . . 10.0 107.485 170.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 31.6 t -152.48 138.26 17.95 Favored 'General case' 0 C--O 1.227 -0.131 0 N-CA-C 108.564 -0.902 . . . . 10.0 108.564 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -48.73 -53.4 19.09 Favored 'General case' 0 C--O 1.226 -0.173 0 C-N-CA 125.192 1.397 . . . . 10.0 113.738 -172.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.58 -40.76 48.6 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.336 -0.616 . . . . 10.0 109.336 -168.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.2 m -61.7 -52.38 64.53 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.336 -0.616 . . . . 10.0 109.336 176.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -52.33 -40.0 61.36 Favored 'General case' 0 C--O 1.221 -0.428 0 C-N-CA 123.693 0.797 . . . . 10.0 110.205 173.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -51.69 -31.2 25.02 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 121.497 -0.752 . . . . 10.0 111.897 179.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.59 -38.26 89.43 Favored 'General case' 0 N--CA 1.446 -0.655 0 O-C-N 121.265 -0.897 . . . . 10.0 110.154 178.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.429 HG22 HD12 ' A' ' 25' ' ' LEU . 19.3 mm -41.45 -54.04 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.305 0 C-N-CA 124.349 1.06 . . . . 10.0 111.495 170.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -49.56 -50.28 42.89 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-N 118.355 0.525 . . . . 10.0 110.476 -176.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.53 -46.22 67.01 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.787 -0.57 . . . . 10.0 110.187 -178.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.515 ' HG3' HD11 ' A' ' 64' ' ' LEU . 7.6 mmt180 -55.75 -32.27 63.28 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 113.284 0.846 . . . . 10.0 113.284 177.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.475 HD21 HD13 ' A' ' 57' ' ' LEU . 0.5 OUTLIER -84.92 -42.58 14.85 Favored 'General case' 0 C--O 1.22 -0.499 0 C-N-CA 123.419 0.688 . . . . 10.0 111.21 172.421 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -60.28 -18.65 50.69 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 120.933 -1.105 . . . . 10.0 111.359 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.1 mmpt? -51.19 -41.03 59.94 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 113.863 1.06 . . . . 10.0 113.863 164.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.686 HD11 ' HB3' ' A' ' 57' ' ' LEU . 10.8 mt -54.5 129.43 15.61 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.068 0 CA-C-N 119.216 0.916 . . . . 10.0 108.909 175.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 58.0 mp0 -66.94 -46.23 75.38 Favored 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 122.132 -0.355 . . . . 10.0 110.129 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.18 43.91 3.2 Favored Glycine 0 C--N 1.339 0.699 0 O-C-N 121.266 -0.896 . . . . 10.0 111.998 -173.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.4 p -103.8 152.47 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 C-N-CA 124.894 1.278 . . . . 10.0 108.811 -176.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.441 ' HB2' HG21 ' A' ' 2' ' ' THR . . . -117.69 -59.75 1.89 Allowed 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.677 -0.861 . . . . 10.0 108.677 168.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 -140.13 160.15 40.59 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 109.29 -0.633 . . . . 10.0 109.29 -178.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -149.2 63.72 6.88 Favored Pre-proline 0 CA--C 1.535 0.374 0 C-N-CA 123.191 0.596 . . . . 10.0 110.804 173.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -78.12 75.58 4.78 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.89 2.393 . . . . 10.0 109.698 -176.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.498 HG12 HG13 ' A' ' 43' ' ' VAL . 6.3 m -70.98 157.41 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 O-C-N 121.744 -0.597 . . . . 10.0 112.024 -177.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -100.93 138.07 38.47 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 110.084 -0.339 . . . . 10.0 110.084 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -120.98 53.66 1.12 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.976 1.31 . . . . 10.0 110.603 -172.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -176.26 -41.31 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 125.727 1.611 . . . . 10.0 108.805 178.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.3 mt -82.24 -15.2 53.94 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.021 1.328 . . . . 10.0 111.44 -172.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 72.91 44.15 0.37 Allowed 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 125.762 1.625 . . . . 10.0 110.377 173.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 39.7 p -140.91 131.71 25.83 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.189 1.396 . . . . 10.0 109.067 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.498 HG13 HG12 ' A' ' 36' ' ' VAL . 4.0 t -99.97 141.94 16.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 107.746 -1.205 . . . . 10.0 107.746 167.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 62.5 m -130.12 124.12 31.97 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 106.576 -1.639 . . . . 10.0 106.576 -176.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 16.5 t -126.63 134.54 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 C-N-CA 123.091 0.556 . . . . 10.0 110.681 -175.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -108.98 94.22 4.93 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 127.043 2.137 . . . . 10.0 106.914 171.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -140.14 163.38 32.89 Favored 'General case' 0 CA--C 1.521 -0.15 0 C-N-CA 123.29 0.636 . . . . 10.0 109.46 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -95.92 132.48 27.01 Favored Pre-proline 0 C--N 1.329 -0.306 0 C-N-CA 123.57 0.748 . . . . 10.0 110.186 177.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -78.81 56.43 5.96 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.081 1.854 . . . . 10.0 109.926 171.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.0 pttt -118.53 -45.74 2.6 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 108.965 -0.754 . . . . 10.0 108.965 170.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.08 -46.29 5.63 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.2 1.0 . . . . 10.0 110.605 -167.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.405 ' CB ' HG23 ' A' ' 28' ' ' ILE . . . -122.92 -171.34 2.27 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.287 1.035 . . . . 10.0 109.6 175.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 97.2 p -149.46 170.8 17.76 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.297 0.639 . . . . 10.0 110.466 177.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 31.4 m -49.42 -42.11 16.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 123.679 0.792 . . . . 10.0 111.293 172.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 66.9 m -61.23 -42.36 98.47 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 123.454 0.702 . . . . 10.0 111.699 -178.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -62.28 -57.39 11.59 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.265 0.626 . . . . 10.0 109.501 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.755 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.1 pp -65.85 -40.87 92.14 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 121.512 0.672 . . . . 10.0 110.373 -173.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.488 ' HA ' HD23 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -44.32 -47.19 9.54 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 112.675 0.62 . . . . 10.0 112.675 163.305 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.11 -44.54 96.43 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-N 119.02 0.827 . . . . 10.0 109.512 178.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -52.12 -47.76 65.16 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 110.382 -0.229 . . . . 10.0 110.382 178.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.555 ' HA ' HD12 ' A' ' 64' ' ' LEU . 38.7 t -65.73 -46.17 89.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 N-CA-C 112.776 0.658 . . . . 10.0 112.776 174.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -56.48 -38.67 72.04 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 120.544 -1.347 . . . . 10.0 110.268 178.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.2 tptm -66.65 -35.52 80.36 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.051 1.34 . . . . 10.0 109.83 -178.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.555 HD12 ' HA ' ' A' ' 61' ' ' VAL . 26.4 mt -58.65 -30.15 67.09 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 118.98 -0.533 . . . . 10.0 112.068 169.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 137.39 -39.79 1.58 Allowed Glycine 0 CA--C 1.527 0.804 0 C-N-CA 123.701 0.667 . . . . 10.0 111.716 171.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.406 ' CE2' HD11 ' A' ' 21' ' ' ILE . 8.1 p90 -97.7 152.44 19.1 Favored 'General case' 0 C--O 1.226 -0.175 0 C-N-CA 125.148 1.379 . . . . 10.0 109.527 -172.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -89.35 153.34 20.94 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.648 0.737 . . . . 10.0 110.849 -170.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.537 HD11 ' HB2' ' A' ' 7' ' ' PHE . 29.1 tp -130.3 148.29 52.11 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.233 1.813 . . . . 10.0 107.383 177.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 9.4 tptp -154.7 152.81 30.37 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 108.912 -0.773 . . . . 10.0 108.912 165.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.6 tp -62.46 154.7 27.64 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 109.488 -0.56 . . . . 10.0 109.488 178.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -108.34 -60.94 1.66 Allowed 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 125.462 1.505 . . . . 10.0 106.961 168.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -174.44 -79.4 0.05 OUTLIER Glycine 0 CA--C 1.521 0.455 0 N-CA-C 110.003 -1.239 . . . . 10.0 110.003 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -162.49 174.38 12.76 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.384 1.074 . . . . 10.0 108.128 -170.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 23.8 pt20 -45.25 129.95 8.03 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 123.863 0.727 . . . . 10.0 112.123 178.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.6 t70 67.27 -176.3 0.2 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.109 1.364 . . . . 10.0 110.69 174.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 40.3 m -96.47 -23.26 16.66 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.08 1.352 . . . . 10.0 110.975 171.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 15.3 mt -128.24 -119.39 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 123.2 0.6 . . . . 10.0 109.571 -178.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 33.09 64.74 0.27 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 127.259 2.224 . . . . 10.0 113.942 -175.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -65.18 109.91 3.17 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 109.503 -1.439 . . . . 10.0 109.503 171.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.144 0 CA-C-O 116.499 -1.715 . . . . 10.0 107.204 -172.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 47.6 t . . . . . 0 N--CA 1.469 0.497 0 N-CA-C 107.825 -1.176 . . . . 10.0 107.825 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.441 HG21 ' HB2' ' A' ' 32' ' ' ALA . 5.9 p -130.62 154.5 47.82 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.826 1.25 . . . . 10.0 109.838 -176.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -119.2 139.55 51.67 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 127.045 2.138 . . . . 10.0 109.321 -172.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.9 mtmm -104.87 88.75 2.97 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.844 1.658 . . . . 10.0 110.63 -165.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -104.59 152.35 22.53 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.299 1.44 . . . . 10.0 110.497 -168.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -123.54 148.89 45.88 Favored 'General case' 0 CA--C 1.511 -0.545 0 C-N-CA 123.791 0.836 . . . . 10.0 110.199 178.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.755 ' CE2' HD11 ' A' ' 57' ' ' LEU . 3.8 m-85 -138.72 142.3 38.9 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 125.241 1.416 . . . . 10.0 108.205 -175.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -108.86 137.41 46.84 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 107.698 -1.223 . . . . 10.0 107.698 -173.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 5.1 mm -110.22 124.86 67.33 Favored 'Isoleucine or valine' 0 C--N 1.338 0.096 0 C-N-CA 124.52 1.128 . . . . 10.0 110.715 -159.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -117.58 102.67 9.36 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.942 -0.762 . . . . 10.0 108.942 173.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 160.15 -84.75 0.12 Allowed Glycine 0 CA--C 1.527 0.792 0 C-N-CA 123.887 0.756 . . . . 10.0 111.858 170.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.14 160.95 15.19 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.441 0.697 . . . . 10.0 110.772 -176.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.6 t -153.02 86.18 1.24 Allowed 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 107.485 -1.302 . . . . 10.0 107.485 170.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 31.6 t -152.48 138.26 17.95 Favored 'General case' 0 C--O 1.227 -0.131 0 N-CA-C 108.564 -0.902 . . . . 10.0 108.564 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -48.73 -53.4 19.09 Favored 'General case' 0 C--O 1.226 -0.173 0 C-N-CA 125.192 1.397 . . . . 10.0 113.738 -172.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.58 -40.76 48.6 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.336 -0.616 . . . . 10.0 109.336 -168.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.2 m -61.7 -52.38 64.53 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.336 -0.616 . . . . 10.0 109.336 176.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -52.33 -40.0 61.36 Favored 'General case' 0 C--O 1.221 -0.428 0 C-N-CA 123.693 0.797 . . . . 10.0 110.205 173.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -51.69 -31.2 25.02 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 121.497 -0.752 . . . . 10.0 111.897 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.59 -38.26 89.43 Favored 'General case' 0 N--CA 1.446 -0.655 0 O-C-N 121.265 -0.897 . . . . 10.0 110.154 178.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.429 HG22 HD12 ' A' ' 25' ' ' LEU . 19.3 mm -41.45 -54.04 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.305 0 C-N-CA 124.349 1.06 . . . . 10.0 111.495 170.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -49.56 -50.28 42.89 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-N 118.355 0.525 . . . . 10.0 110.476 -176.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.53 -46.22 67.01 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.787 -0.57 . . . . 10.0 110.187 -178.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.515 ' HG3' HD11 ' A' ' 64' ' ' LEU . 7.6 mmt180 -55.75 -32.27 63.28 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 113.284 0.846 . . . . 10.0 113.284 177.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.475 HD21 HD13 ' A' ' 57' ' ' LEU . 0.5 OUTLIER -84.92 -42.58 14.85 Favored 'General case' 0 C--O 1.22 -0.499 0 C-N-CA 123.419 0.688 . . . . 10.0 111.21 172.421 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -60.28 -18.65 50.69 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 120.933 -1.105 . . . . 10.0 111.359 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.1 mmpt? -51.19 -41.03 59.94 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 113.863 1.06 . . . . 10.0 113.863 164.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.686 HD11 ' HB3' ' A' ' 57' ' ' LEU . 10.8 mt -54.5 129.43 15.61 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.068 0 CA-C-N 119.216 0.916 . . . . 10.0 108.909 175.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 58.0 mp0 -66.94 -46.23 75.38 Favored 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 122.132 -0.355 . . . . 10.0 110.129 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.18 43.91 3.2 Favored Glycine 0 C--N 1.339 0.699 0 O-C-N 121.266 -0.896 . . . . 10.0 111.998 -173.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.4 p -103.8 152.47 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 C-N-CA 124.894 1.278 . . . . 10.0 108.811 -176.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.441 ' HB2' HG21 ' A' ' 2' ' ' THR . . . -117.69 -59.75 1.89 Allowed 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.677 -0.861 . . . . 10.0 108.677 168.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 -140.13 160.15 40.59 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 109.29 -0.633 . . . . 10.0 109.29 -178.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -149.2 63.72 6.88 Favored Pre-proline 0 CA--C 1.535 0.374 0 C-N-CA 123.191 0.596 . . . . 10.0 110.804 173.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -78.12 75.58 4.78 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.89 2.393 . . . . 10.0 109.698 -176.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.498 HG12 HG13 ' A' ' 43' ' ' VAL . 6.3 m -70.98 157.41 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 O-C-N 121.744 -0.597 . . . . 10.0 112.024 -177.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -100.93 138.07 38.47 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 110.084 -0.339 . . . . 10.0 110.084 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -120.98 53.66 1.12 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.976 1.31 . . . . 10.0 110.603 -172.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -176.26 -41.31 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 125.727 1.611 . . . . 10.0 108.805 178.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.3 mt -82.24 -15.2 53.94 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.021 1.328 . . . . 10.0 111.44 -172.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 72.91 44.15 0.37 Allowed 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 125.762 1.625 . . . . 10.0 110.377 173.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 39.7 p -140.91 131.71 25.83 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.189 1.396 . . . . 10.0 109.067 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.498 HG13 HG12 ' A' ' 36' ' ' VAL . 4.0 t -99.97 141.94 16.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 107.746 -1.205 . . . . 10.0 107.746 167.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 62.5 m -130.12 124.12 31.97 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 106.576 -1.639 . . . . 10.0 106.576 -176.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 16.5 t -126.63 134.54 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 C-N-CA 123.091 0.556 . . . . 10.0 110.681 -175.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -108.98 94.22 4.93 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 127.043 2.137 . . . . 10.0 106.914 171.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -140.14 163.38 32.89 Favored 'General case' 0 CA--C 1.521 -0.15 0 C-N-CA 123.29 0.636 . . . . 10.0 109.46 179.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -95.92 132.48 27.01 Favored Pre-proline 0 C--N 1.329 -0.306 0 C-N-CA 123.57 0.748 . . . . 10.0 110.186 177.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -78.81 56.43 5.96 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.081 1.854 . . . . 10.0 109.926 171.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.0 pttt -118.53 -45.74 2.6 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 108.965 -0.754 . . . . 10.0 108.965 170.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.08 -46.29 5.63 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.2 1.0 . . . . 10.0 110.605 -167.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.405 ' CB ' HG23 ' A' ' 28' ' ' ILE . . . -122.92 -171.34 2.27 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.287 1.035 . . . . 10.0 109.6 175.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 97.2 p -149.46 170.8 17.76 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.297 0.639 . . . . 10.0 110.466 177.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 31.4 m -49.42 -42.11 16.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 123.679 0.792 . . . . 10.0 111.293 172.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 66.9 m -61.23 -42.36 98.47 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 123.454 0.702 . . . . 10.0 111.699 -178.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -62.28 -57.39 11.59 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.265 0.626 . . . . 10.0 109.501 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.755 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.1 pp -65.85 -40.87 92.14 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 121.512 0.672 . . . . 10.0 110.373 -173.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.488 ' HA ' HD23 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -44.32 -47.19 9.54 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 112.675 0.62 . . . . 10.0 112.675 163.305 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.11 -44.54 96.43 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-N 119.02 0.827 . . . . 10.0 109.512 178.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -52.12 -47.76 65.16 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 110.382 -0.229 . . . . 10.0 110.382 178.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.555 ' HA ' HD12 ' A' ' 64' ' ' LEU . 38.7 t -65.73 -46.17 89.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 N-CA-C 112.776 0.658 . . . . 10.0 112.776 174.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -56.48 -38.67 72.04 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 120.544 -1.347 . . . . 10.0 110.268 178.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.2 tptm -66.65 -35.52 80.36 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.051 1.34 . . . . 10.0 109.83 -178.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.555 HD12 ' HA ' ' A' ' 61' ' ' VAL . 26.4 mt -58.65 -30.15 67.09 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 118.98 -0.533 . . . . 10.0 112.068 169.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 137.39 -39.79 1.58 Allowed Glycine 0 CA--C 1.527 0.804 0 C-N-CA 123.701 0.667 . . . . 10.0 111.716 171.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.406 ' CE2' HD11 ' A' ' 21' ' ' ILE . 8.1 p90 -97.7 152.44 19.1 Favored 'General case' 0 C--O 1.226 -0.175 0 C-N-CA 125.148 1.379 . . . . 10.0 109.527 -172.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -89.35 153.34 20.94 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.648 0.737 . . . . 10.0 110.849 -170.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.537 HD11 ' HB2' ' A' ' 7' ' ' PHE . 29.1 tp -130.3 148.29 52.11 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.233 1.813 . . . . 10.0 107.383 177.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 9.4 tptp -154.7 152.81 30.37 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 108.912 -0.773 . . . . 10.0 108.912 165.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.6 tp -62.46 154.7 27.64 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 109.488 -0.56 . . . . 10.0 109.488 178.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -108.34 -60.94 1.66 Allowed 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 125.462 1.505 . . . . 10.0 106.961 168.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -174.44 -79.4 0.05 OUTLIER Glycine 0 CA--C 1.521 0.455 0 N-CA-C 110.003 -1.239 . . . . 10.0 110.003 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -162.49 174.38 12.76 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.384 1.074 . . . . 10.0 108.128 -170.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 23.8 pt20 -45.25 129.95 8.03 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 123.863 0.727 . . . . 10.0 112.123 178.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.6 t70 67.27 -176.3 0.2 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.109 1.364 . . . . 10.0 110.69 174.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 40.3 m -96.47 -23.26 16.66 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.08 1.352 . . . . 10.0 110.975 171.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 15.3 mt -128.24 -119.39 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 123.2 0.6 . . . . 10.0 109.571 -178.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 33.09 64.74 0.27 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 127.259 2.224 . . . . 10.0 113.942 -175.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -65.18 109.91 3.17 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 109.503 -1.439 . . . . 10.0 109.503 171.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.144 0 CA-C-O 116.499 -1.715 . . . . 10.0 107.204 -172.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.2 p . . . . . 0 N--CA 1.472 0.652 0 N-CA-C 109.807 -0.442 . . . . 10.0 109.807 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.458 HG21 ' HB2' ' A' ' 32' ' ' ALA . 1.8 p -142.48 159.09 42.91 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.238 1.415 . . . . 10.0 107.555 178.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -121.7 147.69 45.57 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 126.51 1.924 . . . . 10.0 108.143 -166.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -88.69 130.91 35.21 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 107.983 -1.117 . . . . 10.0 107.983 -178.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -145.35 135.9 24.27 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.251 -0.648 . . . . 10.0 109.251 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -122.23 149.42 43.69 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 123.449 0.7 . . . . 10.0 111.614 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.784 ' CE2' HD11 ' A' ' 57' ' ' LEU . 13.1 m-85 -136.28 137.97 41.27 Favored 'General case' 0 N--CA 1.451 -0.409 0 O-C-N 125.134 1.521 . . . . 10.0 110.037 -170.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -93.9 138.09 32.41 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 106.926 -1.509 . . . . 10.0 106.926 178.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.447 ' CD1' HD12 ' A' ' 68' ' ' LEU . 6.9 mm -109.93 132.39 58.3 Favored 'Isoleucine or valine' 0 C--N 1.34 0.168 0 C-N-CA 125.018 1.327 . . . . 10.0 111.496 -165.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 -124.23 94.18 4.14 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 124.098 0.959 . . . . 10.0 109.649 176.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 162.43 -70.15 0.22 Allowed Glycine 0 CA--C 1.53 0.987 0 CA-C-O 119.33 -0.706 . . . . 10.0 113.089 164.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 23.7 ptp -149.99 136.97 19.46 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.18 0.99 . . . . 10.0 109.72 -173.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.2 p -149.16 30.06 0.78 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.222 1.009 . . . . 10.0 111.066 -156.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 94.6 m -90.4 -65.39 1.02 Allowed 'General case' 0 C--O 1.224 -0.24 0 O-C-N 121.728 -0.607 . . . . 10.0 110.944 -157.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -172.19 -67.92 0.02 OUTLIER 'General case' 0 C--O 1.222 -0.388 0 C-N-CA 123.956 0.902 . . . . 10.0 109.568 -177.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.99 -39.48 66.02 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 109.501 -0.555 . . . . 10.0 109.501 -173.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 13.8 p -60.32 -49.08 79.01 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.776 -0.453 . . . . 10.0 109.776 177.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.26 -43.66 83.2 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.185 0.994 . . . . 10.0 109.445 173.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -55.79 -43.05 76.46 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 122.102 -0.374 . . . . 10.0 110.976 -179.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 20.7 ttt180 -58.92 -34.8 72.12 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.717 0.807 . . . . 10.0 109.29 -177.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.572 HD12 HG22 ' A' ' 61' ' ' VAL . 14.9 mm -52.04 -41.92 33.25 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.466 0 CA-C-O 117.381 -1.295 . . . . 10.0 111.349 171.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 75.0 mt-10 -51.68 -50.11 61.08 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-N 120.78 1.627 . . . . 10.0 110.766 -178.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.2 mtmt -69.64 -45.7 67.87 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.103 0.561 . . . . 10.0 109.789 178.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.479 ' HB3' ' HB1' ' A' ' 60' ' ' ALA . 2.4 mmt180 -62.19 -30.92 71.41 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 120.316 -0.554 . . . . 10.0 112.195 -176.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.4 mt -79.07 -50.34 11.21 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 125.238 1.415 . . . . 10.0 110.369 172.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -48.0 -27.3 2.16 Favored 'General case' 0 C--O 1.226 -0.164 0 C-N-CA 124.297 1.039 . . . . 10.0 111.867 178.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -53.06 -47.52 68.39 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 112.337 0.495 . . . . 10.0 112.337 174.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.462 HG23 ' HB2' ' A' ' 52' ' ' ALA . 3.1 mp -52.83 131.91 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 C-N-CA 124.838 1.255 . . . . 10.0 110.803 -179.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 50.9 mp0 -70.11 -48.05 59.25 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 116.306 -0.406 . . . . 10.0 110.364 -171.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -84.89 39.76 2.97 Favored Glycine 0 CA--C 1.525 0.686 0 O-C-N 121.064 -1.022 . . . . 10.0 111.937 -175.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.6 p -99.92 149.57 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 C-N-CA 124.411 1.084 . . . . 10.0 108.313 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.458 ' HB2' HG21 ' A' ' 2' ' ' THR . . . -119.11 -53.69 2.25 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 122.969 0.507 . . . . 10.0 109.819 171.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.1 m-80 -142.6 154.75 44.69 Favored 'General case' 0 C--N 1.339 0.125 0 CA-C-N 118.298 0.499 . . . . 10.0 109.7 -177.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -146.92 62.8 7.77 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 124.101 0.961 . . . . 10.0 111.968 174.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -77.22 73.42 5.5 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.652 2.235 . . . . 10.0 110.048 -178.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.459 HG12 HG13 ' A' ' 43' ' ' VAL . 5.0 m -68.68 155.77 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 O-C-N 121.507 -0.745 . . . . 10.0 111.858 -177.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -99.03 131.51 45.02 Favored 'General case' 0 N--CA 1.458 -0.07 0 N-CA-C 110.204 -0.295 . . . . 10.0 110.204 -176.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -115.38 60.86 0.7 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.919 1.288 . . . . 10.0 110.424 -173.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 168.83 -32.63 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 127.118 2.167 . . . . 10.0 108.708 171.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.0 mt -86.89 -2.74 58.83 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.071 1.349 . . . . 10.0 112.103 -176.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 61.22 43.7 10.66 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 125.303 1.441 . . . . 10.0 111.107 166.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -142.5 129.79 21.05 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.297 1.439 . . . . 10.0 107.983 -176.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.459 HG13 HG12 ' A' ' 36' ' ' VAL . 3.4 t -101.49 132.37 47.47 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 N-CA-C 106.509 -1.663 . . . . 10.0 106.509 172.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 29.2 m -121.63 121.68 37.93 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 125.587 1.555 . . . . 10.0 106.817 -174.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.2 t -125.03 147.63 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 C-N-CA 123.271 0.628 . . . . 10.0 110.27 -176.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -125.24 95.69 4.57 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 127.723 2.409 . . . . 10.0 104.693 174.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -147.95 163.54 36.53 Favored 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 123.448 0.699 . . . . 10.0 109.568 -174.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 18.8 p30 -95.12 131.61 29.72 Favored Pre-proline 0 C--N 1.329 -0.317 0 C-N-CA 122.67 0.388 . . . . 10.0 110.551 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -78.2 60.82 7.57 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 121.537 1.491 . . . . 10.0 108.414 168.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.35 -45.55 0.46 Allowed 'General case' 0 C--N 1.344 0.343 0 O-C-N 121.859 -0.526 . . . . 10.0 110.554 176.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -87.66 -36.81 17.23 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 122.896 0.479 . . . . 10.0 110.442 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.462 ' HB2' HG23 ' A' ' 28' ' ' ILE . . . -137.2 174.88 10.14 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 125.914 1.686 . . . . 10.0 108.275 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 59.5 p -131.66 176.14 8.58 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.503 1.121 . . . . 10.0 110.186 174.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 29.7 m -48.99 -39.18 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-N 115.184 -0.916 . . . . 10.0 111.749 168.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 17.6 m -58.48 -40.6 83.19 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.707 0.803 . . . . 10.0 111.648 -178.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -71.32 -52.19 20.16 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.049 0.939 . . . . 10.0 109.686 -175.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.784 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.3 pp -64.64 -41.87 95.83 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 120.532 -1.355 . . . . 10.0 110.568 179.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.413 ' N ' HD12 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -45.81 -49.58 15.01 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-O 117.821 -1.085 . . . . 10.0 113.046 163.225 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -52.99 -46.56 68.36 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 120.712 1.597 . . . . 10.0 109.164 176.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.479 ' HB1' ' HB3' ' A' ' 24' ' ' ARG . . . -54.14 -50.04 67.85 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 114.789 -1.096 . . . . 10.0 110.874 -177.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.572 HG22 HD12 ' A' ' 21' ' ' ILE . 95.8 t -65.28 -44.73 94.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 112.309 0.485 . . . . 10.0 112.309 173.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -58.79 -47.29 85.26 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 121.107 -0.995 . . . . 10.0 109.952 -175.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.4 tmtm? -56.54 -35.6 68.3 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.899 1.28 . . . . 10.0 111.227 175.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.422 HD13 ' HA ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -54.71 -38.8 67.52 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.612 0.765 . . . . 10.0 110.702 173.364 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 135.21 -33.05 2.49 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 124.076 0.846 . . . . 10.0 111.767 175.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -94.12 157.84 15.89 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.954 0.902 . . . . 10.0 109.628 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.1 mtmp? -98.14 154.29 17.85 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.677 0.751 . . . . 10.0 110.989 -175.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.447 HD12 ' CD1' ' A' ' 9' ' ' ILE . 13.8 tp -129.22 148.62 51.17 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.555 1.942 . . . . 10.0 107.219 -177.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.2 tptm -151.67 148.67 28.21 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 119.27 -0.395 . . . . 10.0 111.089 159.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 11.8 tp -63.73 155.15 30.98 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 121.775 0.797 . . . . 10.0 109.702 178.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.5 tttt -119.45 -56.47 2.06 Favored 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 129.282 3.033 . . . . 10.0 107.655 177.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 172.37 -100.07 0.15 Allowed Glycine 0 N--CA 1.442 -0.935 0 N-CA-C 107.152 -2.379 . . . . 10.0 107.152 -176.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -157.1 166.4 33.39 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.967 1.307 . . . . 10.0 107.94 -165.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -90.32 156.96 17.9 Favored 'General case' 0 N--CA 1.453 -0.299 0 O-C-N 123.768 0.668 . . . . 10.0 110.265 -175.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -54.06 -33.6 57.89 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.162 0.985 . . . . 10.0 111.478 175.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 13.4 t 73.0 -175.48 0.16 Allowed 'General case' 0 C--N 1.34 0.166 0 C-N-CA 125.735 1.614 . . . . 10.0 110.917 177.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 13.1 pt -127.11 -176.73 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.358 0 N-CA-C 105.417 -2.068 . . . . 10.0 105.417 161.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -78.3 173.79 11.92 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.613 1.965 . . . . 10.0 110.712 175.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -147.52 -84.9 0.05 OUTLIER Glycine 0 CA--C 1.528 0.893 0 C-N-CA 123.701 0.667 . . . . 10.0 112.928 -176.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.235 0 CA-C-O 115.881 -2.009 . . . . 10.0 106.651 -169.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 2.3 p . . . . . 0 N--CA 1.469 0.522 0 CA-C-O 117.384 -1.293 . . . . 10.0 107.614 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.502 HG21 ' HB2' ' A' ' 32' ' ' ALA . 19.3 p -113.35 167.72 10.33 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.921 1.289 . . . . 10.0 109.146 177.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -127.09 135.67 51.08 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 127.524 2.33 . . . . 10.0 108.29 -175.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 58.6 mmtt -83.56 114.56 21.6 Favored 'General case' 0 N--CA 1.448 -0.559 0 O-C-N 124.06 0.85 . . . . 10.0 109.07 171.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -114.98 145.23 42.46 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.807 1.243 . . . . 10.0 109.545 169.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -119.46 150.78 39.65 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.046 0.939 . . . . 10.0 110.639 173.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.741 ' CE2' HD11 ' A' ' 57' ' ' LEU . 6.2 m-85 -140.14 136.68 33.77 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.899 1.28 . . . . 10.0 109.377 -171.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -97.44 134.98 39.97 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 106.981 -1.489 . . . . 10.0 106.981 -177.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.2 mm -108.35 142.01 22.1 Favored 'Isoleucine or valine' 0 C--N 1.342 0.259 0 C-N-CA 124.297 1.039 . . . . 10.0 111.192 -165.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -125.74 84.02 2.23 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.032 0.933 . . . . 10.0 109.375 171.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 160.16 -96.27 0.15 Allowed Glycine 0 CA--C 1.53 0.983 0 CA-C-O 119.892 -0.393 . . . . 10.0 112.753 171.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 5.0 mtt -66.78 74.73 0.11 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.167 1.387 . . . . 10.0 113.082 -172.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.8 p -105.14 45.68 0.95 Allowed 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 126.268 1.827 . . . . 10.0 109.539 -173.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 45.9 t -146.33 59.52 1.22 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.569 0.7 . . . . 10.0 111.099 -173.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 47.54 -77.62 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 127.481 2.313 . . . . 10.0 116.297 167.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.21 -28.62 70.16 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 121.865 0.84 . . . . 10.0 109.596 176.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 20.6 m -60.27 -59.59 5.17 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 123.569 0.747 . . . . 10.0 109.633 168.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -50.69 -38.87 49.41 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.795 1.238 . . . . 10.0 112.203 176.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -55.22 -22.8 19.26 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.406 -0.809 . . . . 10.0 112.511 177.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.82 -40.7 83.78 Favored 'General case' 0 N--CA 1.45 -0.439 0 O-C-N 120.611 -1.306 . . . . 10.0 109.953 176.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 8.1 mm -41.17 -57.94 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.39 0 N-CA-C 108.993 -0.743 . . . . 10.0 108.993 170.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -49.44 -45.58 46.74 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.075 0.95 . . . . 10.0 111.931 -172.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.6 mmpt? -71.92 -45.26 61.79 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 123.208 0.603 . . . . 10.0 110.272 179.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -62.94 -32.44 73.74 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 120.498 -0.481 . . . . 10.0 111.533 -178.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.4 -39.59 28.07 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.016 1.727 . . . . 10.0 111.668 175.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -49.28 -33.56 13.29 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 119.077 0.853 . . . . 10.0 110.468 171.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -53.83 -37.58 63.74 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 113.178 0.807 . . . . 10.0 113.178 176.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 22.4 mm -60.87 129.46 23.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 123.458 0.703 . . . . 10.0 109.135 178.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -79.64 -37.32 36.29 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 118.623 0.647 . . . . 10.0 111.441 -175.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -77.39 30.24 1.67 Allowed Glycine 0 C--N 1.339 0.718 0 O-C-N 120.391 -1.443 . . . . 10.0 112.619 178.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -102.9 147.22 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 C-N-CA 124.576 1.15 . . . . 10.0 107.96 -176.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.502 ' HB2' HG21 ' A' ' 2' ' ' THR . . . -118.19 -47.66 2.56 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 122.661 0.384 . . . . 10.0 110.348 175.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -146.48 144.2 29.49 Favored 'General case' 0 C--O 1.226 -0.181 0 N-CA-C 108.308 -0.997 . . . . 10.0 108.308 -173.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -136.23 60.78 35.49 Favored Pre-proline 0 CA--C 1.539 0.522 0 C-N-CA 123.584 0.753 . . . . 10.0 111.978 176.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -76.34 74.69 4.57 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.948 2.432 . . . . 10.0 110.213 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.466 HG12 HG13 ' A' ' 43' ' ' VAL . 4.3 m -69.11 155.49 7.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 123.36 0.664 . . . . 10.0 112.05 -179.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -94.92 92.07 6.72 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.035 0.445 . . . . 10.0 110.469 -174.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -71.77 43.3 0.09 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 127.364 2.266 . . . . 10.0 114.141 -175.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -176.86 -36.32 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 126.388 1.875 . . . . 10.0 110.577 177.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.6 mt -90.25 3.54 53.26 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 124.519 1.128 . . . . 10.0 112.684 -171.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 64.61 38.31 7.26 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.5 1.12 . . . . 10.0 110.371 165.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -142.22 130.21 21.9 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.278 1.431 . . . . 10.0 107.829 -176.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.466 HG13 HG12 ' A' ' 36' ' ' VAL . 11.4 t -100.46 139.03 22.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 107.578 -1.268 . . . . 10.0 107.578 173.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 27.1 m -127.76 119.4 25.67 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 106.803 -1.554 . . . . 10.0 106.803 -177.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 40.1 t -123.3 138.98 51.39 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 N-CA-C 109.201 -0.666 . . . . 10.0 109.201 -178.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -100.6 109.08 21.13 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 106.485 -1.672 . . . . 10.0 106.485 162.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 14.4 p90 -138.71 165.27 27.41 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 109.465 -0.568 . . . . 10.0 109.465 176.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 15.2 p30 -108.58 128.77 24.97 Favored Pre-proline 0 C--N 1.331 -0.237 0 C-N-CA 123.587 0.755 . . . . 10.0 109.301 177.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -75.59 64.16 6.53 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.449 2.1 . . . . 10.0 109.129 174.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.8 pttt -130.48 -47.54 1.07 Allowed 'General case' 0 CA--C 1.527 0.076 0 N-CA-C 108.967 -0.753 . . . . 10.0 108.967 177.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -89.13 -62.15 1.55 Allowed 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.43 -0.952 . . . . 10.0 108.43 178.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -119.67 163.93 16.66 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 125.9 1.68 . . . . 10.0 109.332 -173.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 34.7 p -118.38 -179.1 3.68 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 122.855 1.312 . . . . 10.0 110.482 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.9 m -44.9 -40.99 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 113.697 -1.592 . . . . 10.0 111.966 163.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.0 t -69.86 -40.16 75.93 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 118.889 -0.577 . . . . 10.0 110.743 -172.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -62.66 -50.68 70.25 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.619 0.723 . . . . 10.0 109.331 -172.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.741 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.2 pp -64.33 -46.73 82.21 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.895 -0.503 . . . . 10.0 110.846 178.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.04 -45.88 16.33 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.099 -1.0 . . . . 10.0 113.46 166.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 15.5 tm-20 -62.66 -47.97 81.38 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 119.647 1.112 . . . . 10.0 109.408 177.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -52.73 -47.5 67.33 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 121.372 0.606 . . . . 10.0 109.725 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.416 ' HA ' HD12 ' A' ' 64' ' ' LEU . 80.5 t -66.01 -44.22 92.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 N-CA-C 112.746 0.647 . . . . 10.0 112.746 175.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -54.76 -39.72 68.64 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 120.942 -1.098 . . . . 10.0 110.071 175.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 40.2 tptt -70.73 -37.81 73.53 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 125.431 1.492 . . . . 10.0 110.832 -178.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.416 HD12 ' HA ' ' A' ' 61' ' ' VAL . 12.2 mt -51.36 -26.15 7.23 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 118.792 -0.623 . . . . 10.0 112.49 163.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 129.62 -25.41 4.48 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 124.127 0.87 . . . . 10.0 112.684 165.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.41 ' CE2' ' HB3' ' A' ' 64' ' ' LEU . 16.8 p90 -115.63 154.58 29.2 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 125.628 1.571 . . . . 10.0 108.437 -172.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.6 156.0 18.45 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.946 0.879 . . . . 10.0 111.545 -167.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 9.9 tp -132.45 146.81 52.22 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 127.033 2.133 . . . . 10.0 106.954 -178.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 9.5 mmtp -146.44 139.45 25.55 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 123.011 0.524 . . . . 10.0 110.616 163.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.717 HD23 ' H ' ' A' ' 71' ' ' LYS . 2.8 tt -65.65 157.03 31.07 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 124.32 1.012 . . . . 10.0 109.383 173.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.717 ' H ' HD23 ' A' ' 70' ' ' LEU . 55.1 tttt -127.44 -65.91 0.91 Allowed 'General case' 0 N--CA 1.437 -1.082 0 C-N-CA 127.445 2.298 . . . . 10.0 108.918 -172.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.35 -86.24 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 107.943 -2.063 . . . . 10.0 107.943 175.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -172.89 167.05 5.17 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.469 1.108 . . . . 10.0 108.156 -168.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.13 95.75 4.32 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.601 0.76 . . . . 10.0 110.846 -179.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 51.5 t0 71.32 74.18 0.18 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.116 1.766 . . . . 10.0 110.379 173.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 26.2 p -72.11 92.5 1.34 Allowed 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.672 1.189 . . . . 10.0 110.581 -175.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 9.0 pt -72.83 71.71 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 121.923 0.868 . . . . 10.0 112.978 178.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -56.31 113.78 1.71 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.206 -1.035 . . . . 10.0 108.206 164.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -177.31 -41.76 0.06 OUTLIER Glycine 0 CA--C 1.528 0.882 0 CA-C-N 118.38 0.536 . . . . 10.0 112.858 -174.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 89.3 mtm-85 . . . . . 0 C--O 1.249 1.042 0 N-CA-C 105.184 -2.154 . . . . 10.0 105.184 164.604 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 62.2 t . . . . . 0 N--CA 1.471 0.602 0 N-CA-C 107.914 -1.143 . . . . 10.0 107.914 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 7.2 p -130.11 153.92 48.01 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 125.121 1.368 . . . . 10.0 108.403 -178.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -117.09 140.9 48.94 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 126.909 2.084 . . . . 10.0 109.089 -174.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 8.3 tptm -97.26 108.69 21.46 Favored 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 124.332 1.053 . . . . 10.0 109.089 -177.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.625 ' HB1' HD11 ' A' ' 70' ' ' LEU . . . -117.65 151.26 37.58 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 124.903 1.281 . . . . 10.0 109.88 -177.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -126.38 150.45 48.58 Favored 'General case' 0 CA--C 1.515 -0.377 0 C-N-CA 123.468 0.707 . . . . 10.0 111.264 177.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.831 ' CE2' HD11 ' A' ' 57' ' ' LEU . 2.2 m-85 -136.39 140.72 43.42 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.661 1.584 . . . . 10.0 108.553 -169.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -110.32 133.25 53.43 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 108.177 -1.045 . . . . 10.0 108.177 -172.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.8 mm -111.81 136.35 48.22 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.085 0 C-N-CA 124.154 0.982 . . . . 10.0 111.706 -155.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -123.41 102.33 7.84 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.907 -0.775 . . . . 10.0 108.907 170.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 147.16 -67.09 0.4 Allowed Glycine 0 C--N 1.341 0.816 0 C-N-CA 123.431 0.538 . . . . 10.0 112.632 165.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 13.3 ptt? -65.13 148.91 50.82 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 117.835 0.817 . . . . 10.0 109.8 -178.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.3 t -160.06 50.48 0.3 Allowed 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 109.435 -0.579 . . . . 10.0 109.435 176.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 35.2 t -162.13 143.23 10.6 Favored 'General case' 0 C--N 1.344 0.347 0 O-C-N 120.387 -1.446 . . . . 10.0 109.404 -179.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.1 -38.72 71.12 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.465 0.706 . . . . 10.0 112.48 -172.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.91 -31.69 72.46 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.429 0.692 . . . . 10.0 109.984 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 88.6 m -76.02 -51.37 12.47 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 108.32 -0.993 . . . . 10.0 108.32 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -46.69 -47.89 20.3 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.567 1.147 . . . . 10.0 110.568 171.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -59.77 -27.55 66.64 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.394 0.516 . . . . 10.0 112.394 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 23.0 ttm180 -75.67 -39.56 57.36 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 121.188 -0.945 . . . . 10.0 109.018 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 11.0 mm -45.97 -53.02 2.57 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.286 0 CA-C-O 118.523 -0.751 . . . . 10.0 110.037 170.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -44.94 -50.13 10.71 Favored 'General case' 0 C--O 1.224 -0.251 0 C-N-CA 122.918 0.487 . . . . 10.0 111.196 -178.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.5 mptt -68.51 -46.8 68.66 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.419 0.688 . . . . 10.0 110.159 -179.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.45 -36.14 75.39 Favored 'General case' 0 N--CA 1.451 -0.376 0 O-C-N 121.975 -0.453 . . . . 10.0 110.803 -178.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.38 -34.72 36.16 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.902 1.281 . . . . 10.0 111.221 175.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -60.86 -24.1 65.66 Favored 'General case' 0 C--N 1.332 -0.154 0 O-C-N 121.514 -0.741 . . . . 10.0 110.114 174.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -52.0 -40.64 61.29 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 117.893 0.315 . . . . 10.0 111.321 170.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 25.1 mm -57.77 128.67 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 123.585 0.754 . . . . 10.0 109.939 -173.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -69.08 -48.25 63.13 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 120.697 -0.401 . . . . 10.0 110.43 -177.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -80.67 37.85 2.3 Favored Glycine 0 CA--C 1.523 0.579 0 O-C-N 121.186 -0.946 . . . . 10.0 112.759 -174.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.4 p -103.86 147.4 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 C-N-CA 124.289 1.035 . . . . 10.0 108.657 -175.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -104.63 -50.27 3.34 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 107.998 -1.112 . . . . 10.0 107.998 171.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -164.06 160.64 21.87 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.263 -0.643 . . . . 10.0 109.263 -178.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -142.13 65.49 18.85 Favored Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 124.589 1.156 . . . . 10.0 111.358 178.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -75.36 75.54 3.82 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.184 2.589 . . . . 10.0 109.751 178.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.51 HG12 HG13 ' A' ' 43' ' ' VAL . 3.5 m -66.8 156.36 6.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 123.637 0.775 . . . . 10.0 111.808 -178.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -96.07 115.24 27.13 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 121.112 0.482 . . . . 10.0 111.3 -176.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 11.0 p90 -95.0 43.25 1.09 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.351 1.46 . . . . 10.0 112.447 -171.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -172.55 -39.76 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 124.841 1.257 . . . . 10.0 109.562 176.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 12.3 mt -79.04 -12.17 60.02 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.18 0.992 . . . . 10.0 112.019 -175.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 60.34 51.06 5.62 Favored 'General case' 0 C--N 1.334 -0.069 0 C-N-CA 124.915 1.286 . . . . 10.0 109.692 176.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -140.77 133.29 28.55 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 106.514 -1.661 . . . . 10.0 106.514 175.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.51 HG13 HG12 ' A' ' 36' ' ' VAL . 15.0 t -101.85 142.35 16.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 106.533 -1.655 . . . . 10.0 106.533 172.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 29.6 m -130.34 124.02 31.3 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 106.433 -1.692 . . . . 10.0 106.433 -177.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 29.0 t -128.62 137.52 57.09 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 N-CA-C 109.127 -0.694 . . . . 10.0 109.127 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -105.61 105.58 15.69 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 105.668 -1.975 . . . . 10.0 105.668 167.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -145.78 159.91 42.5 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 123.645 0.778 . . . . 10.0 110.541 -176.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -95.98 134.74 23.44 Favored Pre-proline 0 C--N 1.33 -0.263 0 C-N-CA 123.869 0.868 . . . . 10.0 110.813 178.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -80.44 56.27 6.01 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.259 1.973 . . . . 10.0 109.626 170.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.54 -49.95 1.76 Allowed 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 108.411 -0.959 . . . . 10.0 108.411 175.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -87.75 -42.52 12.55 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.525 0.73 . . . . 10.0 110.394 -175.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -137.81 -176.19 4.34 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.848 1.259 . . . . 10.0 109.327 -171.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 78.2 p -151.73 171.86 17.02 Favored 'General case' 0 N--CA 1.455 -0.193 0 O-C-N 122.043 -0.411 . . . . 10.0 110.38 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 88.3 t -42.93 -48.37 1.21 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.166 0 C-N-CA 124.511 1.124 . . . . 10.0 110.582 169.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.9 m -51.01 -42.88 60.68 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.583 1.153 . . . . 10.0 112.73 178.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -70.42 -56.9 5.52 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 124.114 0.965 . . . . 10.0 109.314 -176.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.831 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.1 pp -63.83 -40.49 96.73 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 120.786 -1.197 . . . . 10.0 110.816 -177.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -43.84 -52.7 6.56 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-O 118.049 -0.977 . . . . 10.0 112.386 161.106 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.8 -45.38 70.74 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 120.127 1.331 . . . . 10.0 110.573 178.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -53.63 -53.39 52.52 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.134 0.492 . . . . 10.0 110.414 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 59.3 t -64.77 -41.19 91.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-N 116.115 -0.493 . . . . 10.0 112.003 178.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -58.59 -45.99 87.9 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 108.825 -0.806 . . . . 10.0 108.825 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -70.23 -36.22 74.38 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.528 1.131 . . . . 10.0 111.03 -177.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 12.9 mt -52.24 -28.82 20.09 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 112.803 0.668 . . . . 10.0 112.803 165.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 108.22 31.29 3.59 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-N 118.502 0.592 . . . . 10.0 112.741 169.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -152.33 160.33 43.33 Favored 'General case' 0 C--O 1.227 -0.104 0 N-CA-C 106.987 -1.486 . . . . 10.0 106.987 169.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -98.99 152.61 19.62 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.581 0.705 . . . . 10.0 110.84 -163.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.5 tp -134.07 146.74 50.59 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 125.7 1.6 . . . . 10.0 108.316 -176.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 12.1 tptp -152.21 154.01 34.95 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 109.445 -0.576 . . . . 10.0 109.445 164.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.625 HD11 ' HB1' ' A' ' 5' ' ' ALA . 8.3 tp -65.78 155.84 34.97 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 121.401 0.619 . . . . 10.0 109.809 176.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 54.6 tttt -118.16 -55.71 2.22 Favored 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 128.633 2.773 . . . . 10.0 107.242 175.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 173.93 -91.22 0.09 OUTLIER Glycine 0 N--CA 1.444 -0.822 0 N-CA-C 108.175 -1.97 . . . . 10.0 108.175 178.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -160.51 170.34 21.12 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 124.506 1.122 . . . . 10.0 108.472 -162.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -54.37 136.1 44.22 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 123.8 0.688 . . . . 10.0 111.355 -177.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -46.61 -58.51 3.75 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.858 0.863 . . . . 10.0 109.413 170.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 67.08 170.52 0.25 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.642 1.177 . . . . 10.0 110.873 -176.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 6.1 pt -137.73 -146.38 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 N-CA-C 107.622 -1.251 . . . . 10.0 107.622 174.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 70.56 172.08 0.31 Allowed 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.26 1.424 . . . . 10.0 111.207 -177.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -179.22 166.77 36.47 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 106.185 -2.766 . . . . 10.0 106.185 178.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.253 1.279 0 CA-C-O 115.803 -2.046 . . . . 10.0 105.702 173.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 92.1 t . . . . . 0 N--CA 1.471 0.622 0 N-CA-C 107.641 -1.244 . . . . 10.0 107.641 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.625 HG21 ' HB2' ' A' ' 32' ' ' ALA . 2.6 p -123.52 169.32 11.53 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.045 1.738 . . . . 10.0 108.851 177.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -137.71 140.41 40.72 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 126.465 1.906 . . . . 10.0 107.795 -168.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 18.4 mmtp -82.46 128.34 34.17 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.192 0.597 . . . . 10.0 109.419 178.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -128.99 136.8 50.81 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 125.698 1.599 . . . . 10.0 109.119 176.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -117.28 147.0 42.95 Favored 'General case' 0 CA--C 1.51 -0.587 0 C-N-CA 124.0 0.92 . . . . 10.0 110.198 177.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.76 ' CE2' HD11 ' A' ' 57' ' ' LEU . 3.1 m-85 -141.19 137.26 32.53 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 124.623 1.202 . . . . 10.0 111.241 -172.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -93.65 133.17 37.27 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.737 1.615 . . . . 10.0 108.741 -176.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.6 HD11 HG23 ' A' ' 43' ' ' VAL . 7.0 mm -103.56 114.15 42.38 Favored 'Isoleucine or valine' 0 C--N 1.34 0.185 0 C-N-CA 124.038 0.935 . . . . 10.0 110.621 -171.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -103.87 97.36 7.37 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.833 -1.173 . . . . 10.0 107.833 170.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 149.35 -103.49 0.26 Allowed Glycine 0 CA--C 1.526 0.741 0 C-N-CA 124.202 0.906 . . . . 10.0 111.317 172.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 6.4 mmt -81.94 123.51 28.92 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 118.174 0.987 . . . . 10.0 111.69 -172.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 21.7 p -132.9 58.41 1.77 Allowed 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.263 1.425 . . . . 10.0 108.391 -173.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 97.9 m -129.48 -132.81 0.22 Allowed 'General case' 0 C--N 1.339 0.118 0 N-CA-C 106.665 -1.606 . . . . 10.0 106.665 -175.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -131.02 -49.19 1.02 Allowed 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.282 0.633 . . . . 10.0 111.265 -174.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.63 -45.67 67.97 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 108.683 -0.858 . . . . 10.0 108.683 -174.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 10.0 m -61.56 -53.79 51.63 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.614 -0.721 . . . . 10.0 109.604 177.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -49.05 -46.27 44.06 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.856 0.863 . . . . 10.0 111.106 175.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -58.94 -29.83 67.42 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 121.596 -0.69 . . . . 10.0 112.311 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -64.39 -45.25 88.49 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 120.759 -1.213 . . . . 10.0 108.209 179.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.625 HG22 HD12 ' A' ' 25' ' ' LEU . 9.8 mm -44.68 -47.55 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 C-N-CA 124.328 1.051 . . . . 10.0 111.625 177.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -48.21 -50.63 28.59 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 122.824 0.45 . . . . 10.0 110.868 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -72.77 -46.26 54.29 Favored 'General case' 0 N--CA 1.445 -0.713 0 O-C-N 121.757 -0.589 . . . . 10.0 110.933 -179.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.1 mmp_? -48.92 -42.66 37.87 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.122 0.416 . . . . 10.0 112.122 175.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.93 HD22 HG21 ' A' ' 45' ' ' VAL . 0.5 OUTLIER -79.4 -42.35 25.69 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.472 0.709 . . . . 10.0 111.05 178.741 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -55.0 -18.53 5.2 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.406 1.003 . . . . 10.0 112.22 172.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -59.69 -29.07 67.83 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 114.223 1.194 . . . . 10.0 114.223 171.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.539 HD11 ' HB3' ' A' ' 57' ' ' LEU . 11.1 mt -60.58 138.46 21.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 108.227 -1.027 . . . . 10.0 108.227 173.227 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.38 -49.58 32.84 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 109.554 -0.535 . . . . 10.0 109.554 179.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -80.29 42.25 2.55 Favored Glycine 0 CA--C 1.526 0.737 0 O-C-N 120.778 -1.201 . . . . 10.0 112.311 -175.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.6 p -102.05 153.2 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 C-N-CA 125.159 1.383 . . . . 10.0 109.677 -174.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.625 ' HB2' HG21 ' A' ' 2' ' ' THR . . . -111.54 -54.62 2.59 Favored 'General case' 0 C--N 1.334 -0.089 0 C-N-CA 123.877 0.871 . . . . 10.0 109.069 171.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 23.1 p30 -162.44 151.71 15.54 Favored 'General case' 0 C--O 1.227 -0.129 0 N-CA-C 108.732 -0.84 . . . . 10.0 108.732 -173.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -133.94 55.94 17.52 Favored Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 124.42 1.088 . . . . 10.0 112.34 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -75.05 79.2 2.73 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 122.884 2.39 . . . . 10.0 110.558 -177.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.526 HG12 HG13 ' A' ' 43' ' ' VAL . 2.4 m -67.47 151.16 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 O-C-N 121.622 -0.674 . . . . 10.0 111.801 -178.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -95.39 88.66 5.18 Favored 'General case' 0 C--O 1.234 0.256 0 O-C-N 122.179 -0.326 . . . . 10.0 110.23 -175.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -72.48 53.52 0.31 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 127.171 2.189 . . . . 10.0 112.727 -178.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -174.65 -40.72 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 126.281 1.832 . . . . 10.0 109.734 174.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 12.4 mt -86.62 -12.39 48.66 Favored 'General case' 0 C--N 1.338 0.093 0 C-N-CA 124.084 0.954 . . . . 10.0 111.797 -171.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 75.4 37.35 0.45 Allowed 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.884 1.274 . . . . 10.0 110.333 170.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 33.3 p -138.35 129.81 27.62 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.242 1.417 . . . . 10.0 108.127 178.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.6 HG23 HD11 ' A' ' 9' ' ' ILE . 21.8 t -90.33 131.39 37.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 107.515 -1.291 . . . . 10.0 107.515 167.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 85.6 m -110.54 117.93 34.87 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 106.303 -1.74 . . . . 10.0 106.303 171.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.93 HG21 HD22 ' A' ' 25' ' ' LEU . 82.6 t -122.46 141.28 43.48 Favored 'Isoleucine or valine' 0 C--N 1.342 0.248 0 CA-C-N 120.177 1.353 . . . . 10.0 109.79 168.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.438 ' HB3' ' HB3' ' A' ' 32' ' ' ALA . 18.3 tt0 -100.32 117.02 33.66 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 107.552 -1.277 . . . . 10.0 107.552 164.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -147.87 167.91 23.57 Favored 'General case' 0 C--O 1.226 -0.163 0 N-CA-C 108.861 -0.792 . . . . 10.0 108.861 177.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 24.7 p30 -100.54 135.96 20.05 Favored Pre-proline 0 C--N 1.329 -0.284 0 C-N-CA 123.273 0.629 . . . . 10.0 109.758 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -80.36 54.0 5.02 Favored 'Trans proline' 0 N--CA 1.448 -1.167 0 N-CA-C 108.883 -1.237 . . . . 10.0 108.883 171.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.16 10.19 3.27 Favored 'General case' 0 C--N 1.346 0.443 0 CA-C-N 118.623 0.647 . . . . 10.0 111.834 176.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -142.02 -65.15 0.42 Allowed 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.788 -1.189 . . . . 10.0 107.788 -173.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -114.52 175.51 5.45 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 124.071 0.948 . . . . 10.0 109.359 178.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 92.0 p -127.72 167.57 16.29 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.028 0.931 . . . . 10.0 110.065 177.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 74.2 t -49.06 -52.8 9.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 115.791 -0.641 . . . . 10.0 109.796 167.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.0 m -52.36 -37.13 55.43 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 125.185 1.394 . . . . 10.0 112.579 178.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -71.25 -60.4 2.25 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 109.603 -0.517 . . . . 10.0 109.603 174.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.76 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.4 pp -58.81 -46.81 86.76 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 118.348 0.522 . . . . 10.0 111.368 -168.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.455 ' N ' HD12 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -48.18 -35.63 12.11 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 114.549 1.315 . . . . 10.0 114.549 171.819 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.1 tm-20 -52.54 -35.49 53.61 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 120.466 1.485 . . . . 10.0 110.924 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.63 -52.51 60.53 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 120.057 -0.657 . . . . 10.0 109.922 -178.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.575 HG22 HD12 ' A' ' 21' ' ' ILE . 72.7 t -55.24 -47.96 77.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 122.905 0.482 . . . . 10.0 110.884 172.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.88 -55.91 19.76 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 124.906 1.282 . . . . 10.0 109.195 -177.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.8 tptm -57.06 -38.97 74.01 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 126.137 1.775 . . . . 10.0 111.322 177.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.4 mp -60.52 -19.74 58.02 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 113.075 0.768 . . . . 10.0 113.075 172.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 104.74 16.34 17.7 Favored Glycine 0 CA--C 1.528 0.863 0 CA-C-N 118.849 0.749 . . . . 10.0 113.263 168.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.405 ' O ' HG12 ' A' ' 61' ' ' VAL . 1.5 p90 -136.0 160.94 37.07 Favored 'General case' 0 C--O 1.227 -0.121 0 N-CA-C 106.776 -1.564 . . . . 10.0 106.776 169.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 10.5 ttmm -105.98 141.16 37.84 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 119.265 0.939 . . . . 10.0 111.405 -168.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.581 HD11 ' HB2' ' A' ' 7' ' ' PHE . 22.9 tp -117.93 145.04 44.95 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 126.117 1.767 . . . . 10.0 107.974 177.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 26.0 mmtt -152.99 153.44 32.93 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 125.721 1.608 . . . . 10.0 108.058 170.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.3 tp -68.34 152.41 45.47 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.398 0.618 . . . . 10.0 109.397 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.94 -57.44 2.04 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 127.51 2.324 . . . . 10.0 105.586 164.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 170.82 -92.56 0.1 OUTLIER Glycine 0 N--CA 1.442 -0.947 0 N-CA-C 105.833 -2.907 . . . . 10.0 105.833 177.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -166.02 139.7 4.31 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 122.993 0.517 . . . . 10.0 109.829 -160.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -72.52 -47.29 49.62 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.64 1.176 . . . . 10.0 112.596 -177.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 41.4 t0 42.18 78.34 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.769 2.028 . . . . 10.0 113.501 -168.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 6.2 t -77.07 72.65 3.63 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 121.333 -0.854 . . . . 10.0 110.891 -174.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 11.1 pt -71.76 80.21 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-O 121.809 0.814 . . . . 10.0 112.508 179.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -70.63 165.94 21.78 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.657 0.783 . . . . 10.0 111.172 173.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -102.51 97.53 1.56 Allowed Glycine 0 CA--C 1.529 0.927 0 CA-C-O 118.391 -1.227 . . . . 10.0 112.857 -170.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 6.3 tpm_? . . . . . 0 C--O 1.259 1.558 0 C-N-CA 129.552 3.141 . . . . 10.0 109.169 165.539 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 59.5 t . . . . . 0 N--CA 1.47 0.568 0 N-CA-C 108.141 -1.059 . . . . 10.0 108.141 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.52 HG21 ' HB2' ' A' ' 32' ' ' ALA . 14.9 p -133.04 172.4 12.68 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.57 1.548 . . . . 10.0 108.02 179.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -140.65 142.25 34.98 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 127.427 2.291 . . . . 10.0 107.917 -167.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -104.91 110.09 22.32 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.54 0.736 . . . . 10.0 109.954 -168.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -108.9 146.14 34.24 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 124.976 1.31 . . . . 10.0 109.833 -175.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -122.63 147.25 46.65 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 123.749 0.82 . . . . 10.0 109.246 173.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.704 ' CE2' HD11 ' A' ' 57' ' ' LEU . 9.9 m-85 -137.0 140.85 42.44 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 125.222 1.576 . . . . 10.0 109.237 -173.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -105.46 133.9 49.45 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.358 1.063 . . . . 10.0 108.261 -175.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.9 mm -109.33 132.33 57.75 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 C-N-CA 123.667 0.787 . . . . 10.0 111.18 -157.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -123.67 99.73 6.44 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.22 0.608 . . . . 10.0 109.36 172.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 151.49 -61.09 0.4 Allowed Glycine 0 CA--C 1.529 0.922 0 C-N-CA 123.313 0.482 . . . . 10.0 112.86 164.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -70.05 163.87 25.26 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 118.104 0.952 . . . . 10.0 111.296 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 88.1 m -76.25 -99.68 0.02 OUTLIER 'General case' 0 N--CA 1.423 -1.824 0 C-N-CA 125.91 1.684 . . . . 10.0 107.672 159.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 165.03 49.51 0.0 OUTLIER 'General case' 0 C--N 1.344 0.35 0 CA-C-N 120.121 1.328 . . . . 10.0 110.541 -158.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -148.44 -87.61 0.09 Allowed 'General case' 0 CA--C 1.518 -0.273 0 O-C-N 120.581 -1.325 . . . . 10.0 108.809 176.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.12 -47.77 67.22 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 107.622 -1.251 . . . . 10.0 107.622 -178.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 13.1 m -57.11 -57.36 12.91 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.745 -1.116 . . . . 10.0 110.471 177.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -45.29 -53.9 7.8 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.007 0.923 . . . . 10.0 110.578 172.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -59.89 -25.1 64.82 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.403 -0.817 . . . . 10.0 112.213 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -74.61 -54.14 8.02 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 121.294 -0.879 . . . . 10.0 108.9 173.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.661 HG22 HD12 ' A' ' 25' ' ' LEU . 1.6 mt -48.22 -47.47 13.59 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.445 0 CA-C-O 117.964 -1.017 . . . . 10.0 111.277 -176.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -34.86 -61.88 0.39 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.517 0.727 . . . . 10.0 111.747 174.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.98 -42.25 69.93 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.492 1.117 . . . . 10.0 110.679 -177.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.96 -28.79 62.62 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.651 0.611 . . . . 10.0 112.651 175.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.661 HD12 HG22 ' A' ' 21' ' ' ILE . 1.5 mt -85.3 -42.97 14.13 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 126.188 1.795 . . . . 10.0 109.787 174.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -55.51 -23.95 29.0 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.898 0.879 . . . . 10.0 110.279 177.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -52.85 -41.6 64.41 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 113.794 1.035 . . . . 10.0 113.794 171.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.2 mp -54.58 133.38 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 109.563 -0.532 . . . . 10.0 109.563 176.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -77.98 -42.73 31.79 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 119.505 -0.284 . . . . 10.0 110.483 -178.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -80.63 39.6 2.37 Favored Glycine 0 CA--C 1.527 0.816 0 O-C-N 120.549 -1.344 . . . . 10.0 111.94 178.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.4 p -101.57 149.78 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 C-N-CA 124.973 1.309 . . . . 10.0 108.575 -178.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.52 ' HB2' HG21 ' A' ' 2' ' ' THR . . . -109.5 -61.51 1.63 Allowed 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 107.934 -1.136 . . . . 10.0 107.934 170.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 57.8 m-80 -140.54 154.66 46.62 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 107.952 -1.129 . . . . 10.0 107.952 -174.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.47 58.01 2.58 Favored Pre-proline 0 CA--C 1.535 0.371 0 O-C-N 121.965 -0.459 . . . . 10.0 112.113 170.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -75.11 78.23 2.98 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 122.715 2.277 . . . . 10.0 108.756 177.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.478 HG12 HG13 ' A' ' 43' ' ' VAL . 3.4 m -59.12 152.45 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 109.851 -0.426 . . . . 10.0 109.851 174.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 74.3 m-80 -81.07 151.32 28.41 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 118.756 -1.178 . . . . 10.0 109.962 -176.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -123.23 42.91 3.09 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.412 1.485 . . . . 10.0 109.747 -175.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -175.13 -40.22 0.01 OUTLIER 'General case' 0 C--O 1.226 -0.163 0 C-N-CA 125.385 1.474 . . . . 10.0 109.736 170.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.2 mt -75.2 -17.04 60.44 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.884 0.874 . . . . 10.0 112.442 -167.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 65.3 48.69 2.08 Favored 'General case' 0 N--CA 1.46 0.072 0 C-N-CA 125.281 1.432 . . . . 10.0 110.32 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 8.0 p -142.85 133.24 24.81 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.324 1.45 . . . . 10.0 107.969 176.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.478 HG13 HG12 ' A' ' 36' ' ' VAL . 7.0 t -97.63 134.21 36.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 106.869 -1.53 . . . . 10.0 106.869 172.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 85.9 m -121.26 126.22 49.02 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 106.552 -1.647 . . . . 10.0 106.552 178.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.4 t -122.89 149.29 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 C-N-CA 124.323 1.049 . . . . 10.0 108.648 177.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -123.59 107.81 11.93 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 106.054 -1.832 . . . . 10.0 106.054 164.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -145.04 170.67 15.74 Favored 'General case' 0 C--O 1.225 -0.223 0 C-N-CA 124.142 0.977 . . . . 10.0 108.834 -177.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 14.6 p30 -111.85 134.77 21.27 Favored Pre-proline 0 CA--C 1.53 0.196 0 C-N-CA 122.806 0.443 . . . . 10.0 110.397 177.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -77.37 62.47 7.64 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 122.504 2.136 . . . . 10.0 109.867 174.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.1 pttt -123.73 -45.85 2.02 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 123.147 0.579 . . . . 10.0 109.951 172.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -91.49 -60.95 1.75 Allowed 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.385 1.074 . . . . 10.0 108.72 -176.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -119.08 174.34 6.37 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 125.671 1.588 . . . . 10.0 109.321 -175.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 53.3 p -131.66 -177.3 4.36 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.875 1.27 . . . . 10.0 110.167 176.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 35.3 m -48.64 -38.72 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-N 115.03 -0.986 . . . . 10.0 111.946 164.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 68.9 m -62.32 -43.31 99.13 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 122.761 0.424 . . . . 10.0 111.142 -174.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -65.28 -52.97 50.79 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.284 1.034 . . . . 10.0 109.136 -174.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.704 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.1 pp -66.97 -43.91 81.82 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 121.983 -0.448 . . . . 10.0 111.274 -178.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.403 ' N ' HD12 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -41.66 -51.04 4.14 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-O 118.125 -0.94 . . . . 10.0 112.053 160.467 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -57.1 -43.92 82.72 Favored 'General case' 0 C--O 1.226 -0.157 0 CA-C-N 119.742 1.155 . . . . 10.0 110.386 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -52.88 -51.82 59.75 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.077 0.465 . . . . 10.0 110.392 176.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.476 HG11 ' HB2' ' A' ' 68' ' ' LEU . 53.9 t -61.85 -46.23 96.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 N-CA-C 112.39 0.515 . . . . 10.0 112.39 176.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -51.45 -51.11 57.74 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.856 1.263 . . . . 10.0 108.428 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.25 -44.26 92.38 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.611 1.565 . . . . 10.0 111.191 177.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -48.35 -39.45 22.16 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.79 0.836 . . . . 10.0 111.308 173.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 125.14 14.25 3.38 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-O 119.575 -0.57 . . . . 10.0 113.273 169.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -138.94 162.52 34.67 Favored 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 107.927 -1.138 . . . . 10.0 107.927 177.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 29.0 mmtt -95.98 151.04 19.8 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.776 0.798 . . . . 10.0 111.328 -172.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.476 ' HB2' HG11 ' A' ' 61' ' ' VAL . 14.5 tp -132.35 146.33 51.9 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 126.487 1.915 . . . . 10.0 107.886 -179.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 16.5 mmtm -151.64 154.67 36.84 Favored 'General case' 0 N--CA 1.44 -0.947 0 C-N-CA 123.993 0.917 . . . . 10.0 109.011 163.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.6 tp -61.32 159.46 12.39 Favored 'General case' 0 N--CA 1.453 -0.301 0 O-C-N 124.321 1.013 . . . . 10.0 109.393 175.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 32.9 tttt -118.82 -66.34 1.08 Allowed 'General case' 0 N--CA 1.435 -1.216 0 C-N-CA 125.464 1.506 . . . . 10.0 108.276 177.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 161.7 43.63 0.02 OUTLIER Glycine 0 CA--C 1.528 0.865 0 CA-C-O 118.852 -0.971 . . . . 10.0 113.668 175.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 72.51 146.22 0.08 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.976 1.311 . . . . 10.0 112.941 167.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.05 136.38 55.14 Favored 'General case' 0 N--CA 1.443 -0.784 0 O-C-N 121.588 -0.695 . . . . 10.0 111.488 -177.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.4 t0 75.25 130.68 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 127.671 2.388 . . . . 10.0 109.812 -168.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 10.8 t -66.04 -32.33 73.74 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.209 1.003 . . . . 10.0 110.985 177.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 9.8 pt -122.63 -123.17 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 124.804 1.242 . . . . 10.0 109.633 -178.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -136.56 -68.73 0.49 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.179 0.992 . . . . 10.0 108.932 -176.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.67 122.09 0.38 Allowed Glycine 0 CA--C 1.532 1.148 0 C-N-CA 123.406 0.527 . . . . 10.0 112.165 174.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 29.9 mtp180 . . . . . 0 C--O 1.251 1.175 0 CA-C-O 116.947 -1.502 . . . . 10.0 108.595 161.406 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 95.9 t . . . . . 0 N--CA 1.472 0.647 0 N-CA-C 107.35 -1.352 . . . . 10.0 107.35 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.627 HG21 ' HB2' ' A' ' 32' ' ' ALA . 10.0 p -124.8 169.94 11.53 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 125.605 1.562 . . . . 10.0 109.293 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -131.66 150.21 52.23 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 127.472 2.309 . . . . 10.0 107.324 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -109.63 123.46 49.5 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.343 -0.984 . . . . 10.0 108.343 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.647 ' HB1' HD11 ' A' ' 70' ' ' LEU . . . -130.2 153.55 48.45 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.634 0.774 . . . . 10.0 110.676 176.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -118.7 148.56 42.63 Favored 'General case' 0 CA--C 1.507 -0.7 0 C-N-CA 124.62 1.168 . . . . 10.0 109.481 177.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.817 ' CE2' HD11 ' A' ' 57' ' ' LEU . 2.2 m-85 -135.12 141.0 45.9 Favored 'General case' 0 N--CA 1.447 -0.605 0 O-C-N 124.792 1.308 . . . . 10.0 109.063 -174.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -103.45 131.78 50.26 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.525 1.53 . . . . 10.0 108.827 -174.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -115.44 137.13 50.0 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 C-N-CA 126.111 1.764 . . . . 10.0 110.023 -164.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -127.41 102.5 6.91 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.21 -1.033 . . . . 10.0 108.21 176.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 114.3 42.73 0.81 Allowed Glycine 0 CA--C 1.529 0.954 0 CA-C-O 119.263 -0.743 . . . . 10.0 114.185 166.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 9.0 ptp -101.08 -166.32 1.3 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.651 1.226 . . . . 10.0 111.051 173.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.5 t -123.45 -7.75 8.09 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.734 1.214 . . . . 10.0 112.024 177.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 58.2 m 62.14 48.96 4.68 Favored 'General case' 0 C--N 1.343 0.315 0 C-N-CA 123.547 0.739 . . . . 10.0 110.815 179.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -167.34 -90.32 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 108.733 -0.84 . . . . 10.0 108.733 171.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.39 -33.41 48.84 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 121.518 -0.739 . . . . 10.0 109.722 -171.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 59.2 m -62.66 -56.38 18.27 Favored 'General case' 0 C--N 1.339 0.143 0 N-CA-C 108.65 -0.87 . . . . 10.0 108.65 174.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -44.8 -45.03 9.86 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.397 1.079 . . . . 10.0 110.316 172.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -66.69 -32.45 73.78 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.945 1.091 . . . . 10.0 113.945 178.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.79 -45.89 87.65 Favored 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 120.757 -1.214 . . . . 10.0 108.413 177.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.846 HG22 HD12 ' A' ' 25' ' ' LEU . 2.8 mm -47.4 -48.85 9.47 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.231 0 O-C-N 123.94 0.775 . . . . 10.0 109.856 -177.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -44.03 -54.4 5.49 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.043 0.937 . . . . 10.0 111.526 178.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt -70.73 -45.7 64.4 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.954 0.902 . . . . 10.0 109.459 -177.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.626 ' HG3' HD11 ' A' ' 64' ' ' LEU . 51.7 mmt-85 -55.57 -32.24 62.85 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.147 0.425 . . . . 10.0 112.147 177.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.846 HD12 HG22 ' A' ' 21' ' ' ILE . 2.1 mt -84.39 -35.56 23.06 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.178 1.391 . . . . 10.0 112.26 174.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 32.7 t-20 -55.29 -31.78 61.9 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.685 0.675 . . . . 10.0 110.081 176.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -50.64 -28.89 9.72 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 114.996 1.48 . . . . 10.0 114.996 169.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.82 HG23 ' HB3' ' A' ' 52' ' ' ALA . 6.9 mm -61.71 104.93 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-O 121.71 0.766 . . . . 10.0 109.663 171.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -58.24 -26.08 62.48 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.451 0.537 . . . . 10.0 112.451 -179.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -90.79 18.02 52.34 Favored Glycine 0 CA--C 1.528 0.898 0 O-C-N 121.359 -0.838 . . . . 10.0 112.945 178.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.1 p -79.36 153.98 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 CA-C-N 118.595 1.198 . . . . 10.0 109.514 -179.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.627 ' HB2' HG21 ' A' ' 2' ' ' THR . . . -112.94 -59.86 1.96 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.539 -0.912 . . . . 10.0 108.539 163.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 -134.63 155.43 50.5 Favored 'General case' 0 C--N 1.341 0.208 0 N-CA-C 109.254 -0.647 . . . . 10.0 109.254 -178.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -140.36 65.39 27.32 Favored Pre-proline 0 CA--C 1.534 0.355 0 C-N-CA 123.454 0.701 . . . . 10.0 109.825 172.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -78.64 68.7 8.03 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 123.044 2.496 . . . . 10.0 109.539 -176.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.415 HG12 HG13 ' A' ' 43' ' ' VAL . 4.1 m -68.85 155.37 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 O-C-N 122.099 -0.375 . . . . 10.0 111.727 -175.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -97.49 139.04 34.0 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 121.002 0.429 . . . . 10.0 111.407 -177.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -118.24 47.66 1.56 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.702 1.601 . . . . 10.0 110.451 -172.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -176.11 -41.61 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 125.449 1.5 . . . . 10.0 109.557 -177.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 16.6 mt -81.7 -19.02 42.4 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.625 1.17 . . . . 10.0 111.648 -170.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 61.16 50.64 4.8 Favored 'General case' 0 C--N 1.339 0.112 0 C-N-CA 125.892 1.677 . . . . 10.0 109.942 -175.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.4 p -140.07 126.99 20.74 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 107.646 -1.242 . . . . 10.0 107.646 174.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.569 HG21 HG21 ' A' ' 21' ' ' ILE . 5.1 t -97.15 130.62 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 106.769 -1.567 . . . . 10.0 106.769 172.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 58.2 m -110.85 128.38 55.76 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.95 1.7 . . . . 10.0 107.139 176.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.7 t -127.36 137.4 57.87 Favored 'Isoleucine or valine' 0 C--N 1.342 0.253 0 CA-C-N 119.161 0.891 . . . . 10.0 110.709 174.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -107.29 104.6 14.24 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.392 1.477 . . . . 10.0 107.088 164.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 14.7 p90 -143.32 167.02 23.13 Favored 'General case' 0 CA--C 1.52 -0.177 0 C-N-CA 123.936 0.895 . . . . 10.0 109.329 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -107.99 134.05 20.26 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-O 119.109 -0.472 . . . . 10.0 110.804 178.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -77.85 62.29 7.83 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.779 2.319 . . . . 10.0 110.613 176.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.0 pttt -124.42 -47.67 1.85 Allowed 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.706 0.802 . . . . 10.0 109.346 169.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -90.33 -51.84 5.23 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.961 0.905 . . . . 10.0 110.007 -169.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.82 ' HB3' HG23 ' A' ' 28' ' ' ILE . . . -132.17 174.73 9.9 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.631 1.172 . . . . 10.0 108.333 178.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 82.6 p -137.06 177.49 7.82 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 118.569 0.622 . . . . 10.0 110.757 176.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 49.1 t -42.24 -50.75 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 124.632 1.173 . . . . 10.0 110.902 172.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.1 m -51.56 -38.77 55.9 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.094 0.958 . . . . 10.0 112.414 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -70.11 -58.51 3.72 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.632 0.773 . . . . 10.0 109.178 -174.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.817 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.4 pp -63.56 -41.09 98.43 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 121.741 -0.6 . . . . 10.0 111.297 -178.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.417 ' HA ' HD23 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -43.51 -47.6 7.26 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 118.349 -0.834 . . . . 10.0 111.817 163.289 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.87 -42.21 98.79 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 119.571 1.078 . . . . 10.0 110.39 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -56.19 -48.59 76.09 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 109.65 -0.5 . . . . 10.0 109.65 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.639 ' HA ' HD12 ' A' ' 64' ' ' LEU . 82.8 t -62.56 -47.45 92.89 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 N-CA-C 112.909 0.707 . . . . 10.0 112.909 173.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -56.13 -37.7 69.81 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.044 -1.035 . . . . 10.0 109.025 -178.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.9 tttp -79.57 -31.51 41.89 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 124.343 1.057 . . . . 10.0 112.011 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.639 HD12 ' HA ' ' A' ' 61' ' ' VAL . 15.3 mt -51.69 -45.19 63.41 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.68 1.127 . . . . 10.0 110.783 163.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 147.89 -39.87 0.99 Allowed Glycine 0 CA--C 1.525 0.713 0 CA-C-N 117.964 0.347 . . . . 10.0 112.78 171.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -89.79 159.55 16.97 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 124.032 0.933 . . . . 10.0 108.738 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 19.7 tttt -91.87 161.23 14.92 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-O 121.137 0.494 . . . . 10.0 110.656 -171.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.469 HD11 ' HB2' ' A' ' 7' ' ' PHE . 23.9 tp -136.13 148.1 48.06 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.189 1.396 . . . . 10.0 108.248 177.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 16.9 mmtm -154.18 159.46 41.4 Favored 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 124.19 0.996 . . . . 10.0 108.587 164.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.647 HD11 ' HB1' ' A' ' 5' ' ' ALA . 5.8 tp -67.07 152.06 46.48 Favored 'General case' 0 N--CA 1.451 -0.423 0 O-C-N 123.735 0.647 . . . . 10.0 109.351 176.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 13.3 tptm -107.48 -55.2 2.38 Favored 'General case' 0 N--CA 1.438 -1.072 0 C-N-CA 127.168 2.187 . . . . 10.0 105.881 169.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 170.97 -95.96 0.11 Allowed Glycine 0 N--CA 1.444 -0.819 0 N-CA-C 106.204 -2.759 . . . . 10.0 106.204 -179.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -157.76 148.84 21.29 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.284 0.634 . . . . 10.0 110.447 -165.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.14 -47.31 58.66 Favored 'General case' 0 C--O 1.228 -0.068 0 C-N-CA 123.595 0.758 . . . . 10.0 111.279 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -172.78 150.4 2.11 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.414 1.885 . . . . 10.0 105.969 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 11.7 t -126.63 75.21 1.53 Allowed 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.809 1.243 . . . . 10.0 108.149 -178.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 28.6 pt -78.38 -16.86 13.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 114.654 -1.157 . . . . 10.0 113.311 -177.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 47.11 72.42 0.25 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.105 1.762 . . . . 10.0 110.807 -176.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -166.7 -162.82 19.2 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 109.955 -1.258 . . . . 10.0 109.955 -177.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.9 ptp180 . . . . . 0 C--O 1.251 1.157 0 CA-C-O 118.072 -0.966 . . . . 10.0 110.479 171.83 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.0 p . . . . . 0 N--CA 1.472 0.635 0 N-CA-C 109.399 -0.593 . . . . 10.0 109.399 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.2 p -148.64 171.16 16.61 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 125.982 1.713 . . . . 10.0 106.713 -176.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -143.49 143.02 31.39 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 126.858 2.063 . . . . 10.0 106.752 -170.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 45.1 mmtt -85.33 145.39 27.53 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.143 -0.688 . . . . 10.0 109.143 175.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -147.06 138.14 23.9 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 107.463 -1.31 . . . . 10.0 107.463 174.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -122.03 149.07 44.02 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 123.796 0.838 . . . . 10.0 110.022 174.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.694 ' CE2' HD11 ' A' ' 57' ' ' LEU . 0.2 OUTLIER -142.95 141.22 31.38 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 124.804 1.315 . . . . 10.0 110.653 -168.387 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.44 132.18 43.39 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.985 1.714 . . . . 10.0 108.771 -170.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.63 HD11 HG23 ' A' ' 43' ' ' VAL . 3.7 mm -106.21 121.02 58.17 Favored 'Isoleucine or valine' 0 C--N 1.339 0.145 0 C-N-CA 124.842 1.257 . . . . 10.0 110.821 -170.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -101.52 83.27 2.41 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 106.267 -1.753 . . . . 10.0 106.267 175.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 108.65 100.54 2.65 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 122.991 0.329 . . . . 10.0 112.836 175.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 24.2 ptm -158.5 164.82 35.8 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 108.101 -1.074 . . . . 10.0 108.101 169.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.8 t -88.06 -18.34 29.12 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.149 0.426 . . . . 10.0 112.149 178.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 m 65.36 54.5 1.16 Allowed 'General case' 0 C--N 1.343 0.303 0 CA-C-O 121.872 0.844 . . . . 10.0 111.077 -178.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -170.57 -86.25 0.01 OUTLIER 'General case' 0 C--O 1.233 0.23 0 C-N-CA 124.333 1.053 . . . . 10.0 108.82 169.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.06 -42.14 76.67 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 108.484 -0.932 . . . . 10.0 108.484 -177.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 98.9 m -62.31 -55.11 31.35 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 118.555 -0.736 . . . . 10.0 109.81 -178.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -38.84 -57.33 1.24 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.658 1.183 . . . . 10.0 110.598 169.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -58.67 -34.73 71.57 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.765 -0.652 . . . . 10.0 112.71 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.7 ttm105 -68.58 -43.45 76.49 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 108.528 -0.916 . . . . 10.0 108.528 177.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.569 HG23 HG22 ' A' ' 61' ' ' VAL . 0.9 OUTLIER -56.22 -46.31 81.3 Favored 'Isoleucine or valine' 0 C--N 1.342 0.255 0 CA-C-O 118.772 -0.632 . . . . 10.0 110.211 177.922 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -44.1 -54.91 5.14 Favored 'General case' 0 C--N 1.342 0.247 0 CA-C-O 121.098 0.475 . . . . 10.0 111.075 178.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.6 mttm -69.53 -42.88 74.07 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 124.298 1.039 . . . . 10.0 110.433 -177.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.477 ' HG3' HD13 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -53.23 -36.95 61.62 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 111.893 0.331 . . . . 10.0 111.893 173.719 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.421 ' CD2' HG21 ' A' ' 45' ' ' VAL . 0.4 OUTLIER -78.5 -41.6 32.0 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.727 0.811 . . . . 10.0 110.856 175.799 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -61.28 -22.13 64.57 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 121.511 -0.743 . . . . 10.0 110.65 -177.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.4 mmpt? -53.68 -39.72 65.37 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 114.202 1.186 . . . . 10.0 114.202 168.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.8 mt -62.86 128.99 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 CA-C-N 118.965 0.802 . . . . 10.0 109.087 -175.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -56.48 -51.16 69.49 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 122.913 0.485 . . . . 10.0 111.824 -177.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -87.26 42.31 3.14 Favored Glycine 0 C--N 1.339 0.71 0 O-C-N 120.916 -1.115 . . . . 10.0 111.666 -172.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.8 p -105.7 151.91 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 C-N-CA 124.506 1.122 . . . . 10.0 108.628 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -117.61 -50.78 2.51 Favored 'General case' 0 C--N 1.334 -0.096 0 C-N-CA 122.946 0.499 . . . . 10.0 110.185 173.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -143.74 145.99 32.81 Favored 'General case' 0 N--CA 1.461 0.087 0 N-CA-C 109.082 -0.71 . . . . 10.0 109.082 -176.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -139.11 56.98 9.79 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 123.537 0.735 . . . . 10.0 112.461 177.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -75.3 78.87 2.87 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 123.321 2.681 . . . . 10.0 111.067 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.633 HG22 HG13 ' A' ' 43' ' ' VAL . 43.0 t -65.94 143.78 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 C-N-CA 124.786 1.234 . . . . 10.0 112.039 178.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 -91.01 97.83 11.41 Favored 'General case' 0 C--N 1.341 0.215 0 O-C-N 121.874 -0.516 . . . . 10.0 111.718 -167.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -76.45 53.25 0.84 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.785 1.634 . . . . 10.0 112.86 -177.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 179.19 -33.34 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 125.77 1.628 . . . . 10.0 110.51 168.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.2 mt -88.08 1.53 54.06 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.43 1.092 . . . . 10.0 112.155 -172.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 60.75 39.08 17.73 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 125.543 1.537 . . . . 10.0 110.91 169.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.48 133.97 26.51 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.919 1.287 . . . . 10.0 107.979 -175.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.633 HG13 HG22 ' A' ' 36' ' ' VAL . 17.1 t -90.88 142.66 12.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 107.1 -1.444 . . . . 10.0 107.1 167.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 91.6 m -133.98 114.96 13.8 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 125.585 1.554 . . . . 10.0 107.749 -177.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.421 HG21 ' CD2' ' A' ' 25' ' ' LEU . 50.4 t -122.0 156.14 26.55 Favored 'Isoleucine or valine' 0 C--N 1.341 0.235 0 C-N-CA 123.785 0.834 . . . . 10.0 110.607 -177.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.22 107.62 11.4 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 127.764 2.426 . . . . 10.0 105.659 170.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -136.63 165.96 24.66 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 123.395 0.678 . . . . 10.0 111.13 -176.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -99.94 126.84 35.36 Favored Pre-proline 0 CA--C 1.532 0.251 0 C-N-CA 123.73 0.812 . . . . 10.0 110.179 173.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -75.46 65.11 6.48 Favored 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 122.561 2.174 . . . . 10.0 108.569 175.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.32 -50.16 0.25 Allowed 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 107.487 -1.301 . . . . 10.0 107.487 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -106.31 -40.31 5.65 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 123.484 0.714 . . . . 10.0 110.715 173.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.24 150.63 26.06 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 121.539 -0.725 . . . . 10.0 109.993 177.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 44.9 p -147.22 149.31 32.67 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.885 0.85 . . . . 10.0 110.741 171.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 48.9 t -48.62 -51.2 11.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 125.544 1.538 . . . . 10.0 111.559 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.9 m -51.75 -43.01 62.76 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 118.943 -0.551 . . . . 10.0 111.742 178.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -67.71 -54.25 20.94 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.124 -0.695 . . . . 10.0 109.124 -173.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.694 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.0 pp -61.66 -45.36 94.36 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 120.695 -0.402 . . . . 10.0 110.212 -178.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.55 -51.93 8.49 Favored 'General case' 0 N--CA 1.45 -0.445 0 O-C-N 121.911 -0.493 . . . . 10.0 111.555 168.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.25 -40.26 95.64 Favored 'General case' 0 C--O 1.226 -0.174 0 CA-C-N 118.53 0.604 . . . . 10.0 110.293 -178.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -52.64 -49.21 65.61 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.393 0.677 . . . . 10.0 109.708 177.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.569 HG22 HG23 ' A' ' 21' ' ' ILE . 17.9 t -69.38 -43.83 80.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 116.493 -0.321 . . . . 10.0 111.183 177.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -50.45 -55.31 16.45 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.851 0.86 . . . . 10.0 109.566 178.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.5 ttmt -53.73 -42.45 68.11 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 126.151 1.78 . . . . 10.0 111.035 175.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.477 HD13 ' HG3' ' A' ' 24' ' ' ARG . 7.9 tp -53.0 -27.12 17.76 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 113.601 0.963 . . . . 10.0 113.601 174.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 140.21 -30.24 2.35 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-N 118.567 0.622 . . . . 10.0 112.671 169.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -127.8 157.97 38.97 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 124.695 1.198 . . . . 10.0 109.03 -173.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.4 ptpt -92.06 155.55 18.0 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 123.101 0.56 . . . . 10.0 111.574 -166.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.664 HD11 ' HB2' ' A' ' 7' ' ' PHE . 11.7 tp -134.37 146.06 49.55 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 126.393 1.877 . . . . 10.0 107.32 -176.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.3 tptp -147.31 137.18 23.02 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 119.232 -0.413 . . . . 10.0 110.602 168.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.598 HD23 ' N ' ' A' ' 71' ' ' LYS . 2.5 tt -64.83 154.06 38.24 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.05 -0.722 . . . . 10.0 109.05 178.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.598 ' N ' HD23 ' A' ' 70' ' ' LEU . 18.8 tttm -119.0 -63.7 1.37 Allowed 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 126.165 1.786 . . . . 10.0 108.371 -178.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.06 -78.75 0.03 OUTLIER Glycine 0 CA--C 1.521 0.452 0 N-CA-C 109.274 -1.53 . . . . 10.0 109.274 173.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -179.31 165.97 1.46 Allowed 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 108.443 -0.947 . . . . 10.0 108.443 -167.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.28 128.07 35.3 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.447 1.499 . . . . 10.0 110.739 178.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -39.94 -51.81 2.47 Favored 'General case' 0 C--N 1.339 0.151 0 C-N-CA 126.114 1.766 . . . . 10.0 110.539 175.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.5 m -95.22 115.79 27.89 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.013 -0.994 . . . . 10.0 109.585 174.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 22.8 mt -77.75 -124.99 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 N-CA-C 107.298 -1.371 . . . . 10.0 107.298 172.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -143.86 127.41 16.99 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 105.791 -1.929 . . . . 10.0 105.791 177.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -111.78 -59.98 0.46 Allowed Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.864 -0.895 . . . . 10.0 110.864 -172.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 2.9 mtt180 . . . . . 0 C--O 1.254 1.324 0 C-N-CA 127.887 2.475 . . . . 10.0 104.469 -171.834 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 51.5 t . . . . . 0 N--CA 1.468 0.459 0 N-CA-C 107.312 -1.366 . . . . 10.0 107.312 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.578 HG21 ' HB2' ' A' ' 32' ' ' ALA . 3.0 p -116.02 162.25 17.66 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.915 1.286 . . . . 10.0 110.216 178.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -116.69 162.83 17.05 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 126.863 2.065 . . . . 10.0 108.112 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.81 125.64 52.95 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.061 -1.459 . . . . 10.0 107.061 178.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.521 ' HB1' HD11 ' A' ' 70' ' ' LEU . . . -131.47 145.95 52.01 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.956 1.303 . . . . 10.0 108.474 -178.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -126.19 150.36 48.37 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 118.615 0.643 . . . . 10.0 111.578 177.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.784 ' CE2' HD11 ' A' ' 57' ' ' LEU . 2.1 m-85 -139.74 139.05 36.42 Favored 'General case' 0 C--O 1.234 0.269 0 O-C-N 125.006 1.441 . . . . 10.0 110.079 -166.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -102.79 132.51 48.92 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.491 -0.929 . . . . 10.0 108.491 -171.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.415 HD11 HG23 ' A' ' 43' ' ' VAL . 8.7 mm -101.09 122.9 53.73 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 124.143 0.977 . . . . 10.0 109.839 -165.009 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -118.29 95.68 4.99 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 106.861 -1.533 . . . . 10.0 106.861 177.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 161.28 -88.42 0.11 Allowed Glycine 0 CA--C 1.527 0.792 0 C-N-CA 123.343 0.496 . . . . 10.0 112.455 178.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.11 160.74 20.54 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.04 0.936 . . . . 10.0 110.683 -172.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 13.9 t -151.23 87.04 1.37 Allowed 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 107.327 -1.36 . . . . 10.0 107.327 169.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 41.9 t -147.84 139.92 24.2 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 108.545 -0.909 . . . . 10.0 108.545 -178.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -46.38 -55.69 6.98 Favored 'General case' 0 C--O 1.223 -0.306 0 C-N-CA 125.449 1.499 . . . . 10.0 113.899 -168.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.24 -38.57 50.87 Favored 'General case' 0 C--N 1.333 -0.127 0 O-C-N 121.694 -0.629 . . . . 10.0 109.783 -168.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 57.3 m -61.82 -50.48 72.13 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 108.943 -0.762 . . . . 10.0 108.943 176.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -52.13 -43.34 63.97 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.817 0.847 . . . . 10.0 110.298 170.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -58.48 -38.27 77.28 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 121.493 -0.755 . . . . 10.0 110.953 -178.034 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.73 -40.07 75.05 Favored 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 121.645 -0.66 . . . . 10.0 109.752 177.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.512 HD12 HG22 ' A' ' 61' ' ' VAL . 9.0 mm -46.15 -50.38 4.61 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.249 0 CA-C-O 117.224 -1.37 . . . . 10.0 112.452 170.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -47.78 -53.41 15.44 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 120.34 1.427 . . . . 10.0 110.838 -176.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.2 tppt? -70.22 -43.59 70.33 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 123.612 0.765 . . . . 10.0 108.951 -176.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 14.2 tpp180 -63.4 -33.94 76.64 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-O 119.658 -0.21 . . . . 10.0 110.81 -175.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.488 HD12 HG22 ' A' ' 21' ' ' ILE . 0.3 OUTLIER -78.68 -38.19 39.89 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 124.71 1.204 . . . . 10.0 110.529 173.01 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -59.95 -19.06 49.97 Favored 'General case' 0 C--O 1.225 -0.199 0 O-C-N 121.256 -0.903 . . . . 10.0 110.8 177.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.6 ptpt -51.84 -43.63 63.27 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 113.123 0.786 . . . . 10.0 113.123 169.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 5.2 mt -55.97 134.15 19.83 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 N-CA-C 108.635 -0.876 . . . . 10.0 108.635 -176.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -70.85 -47.1 61.13 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 108.705 -0.85 . . . . 10.0 108.705 -177.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -80.84 43.81 2.88 Favored Glycine 0 C--N 1.342 0.875 0 O-C-N 121.068 -1.02 . . . . 10.0 112.111 -176.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.8 p -105.92 152.05 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 C-N-CA 125.298 1.439 . . . . 10.0 109.058 -177.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.578 ' HB2' HG21 ' A' ' 2' ' ' THR . . . -115.81 -57.91 2.17 Favored 'General case' 0 CA--C 1.522 -0.127 0 C-N-CA 123.796 0.838 . . . . 10.0 108.873 169.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 64.6 m-80 -143.62 159.24 42.81 Favored 'General case' 0 CA--C 1.526 0.057 0 N-CA-C 109.496 -0.557 . . . . 10.0 109.496 -176.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -141.32 61.34 13.67 Favored Pre-proline 0 CA--C 1.537 0.452 0 C-N-CA 123.884 0.874 . . . . 10.0 111.585 174.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -77.35 71.39 6.4 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 123.09 2.526 . . . . 10.0 110.03 -176.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.543 HG12 HG13 ' A' ' 43' ' ' VAL . 3.5 m -67.02 155.02 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 O-C-N 121.744 -0.598 . . . . 10.0 111.028 -178.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -95.69 155.24 16.83 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 120.98 0.419 . . . . 10.0 109.934 172.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -135.28 48.47 2.25 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 124.954 1.301 . . . . 10.0 109.695 -171.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -175.26 -42.44 0.01 OUTLIER 'General case' 0 C--O 1.224 -0.251 0 C-N-CA 126.09 1.756 . . . . 10.0 108.708 178.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.4 mt -80.66 -15.48 56.46 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 125.436 1.494 . . . . 10.0 112.012 -170.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 71.86 40.29 0.77 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.275 1.43 . . . . 10.0 110.721 174.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.5 p -140.76 123.38 16.12 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.64 1.576 . . . . 10.0 108.969 -178.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.543 HG13 HG12 ' A' ' 36' ' ' VAL . 9.3 t -92.86 145.91 7.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 107.322 -1.362 . . . . 10.0 107.322 168.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 88.3 m -133.75 122.13 22.89 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 105.997 -1.853 . . . . 10.0 105.997 -176.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 29.3 t -122.98 134.42 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-N 118.74 0.7 . . . . 10.0 109.408 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -96.15 104.41 16.37 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 106.833 -1.543 . . . . 10.0 106.833 161.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -145.42 163.72 33.75 Favored 'General case' 0 CA--C 1.521 -0.166 0 C-N-CA 123.558 0.743 . . . . 10.0 109.798 178.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 13.3 p30 -98.5 130.64 27.62 Favored Pre-proline 0 C--N 1.329 -0.307 0 C-N-CA 123.419 0.687 . . . . 10.0 109.492 175.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -79.02 57.56 6.53 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 121.86 1.707 . . . . 10.0 108.967 171.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.34 -46.79 2.03 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.144 -0.687 . . . . 10.0 109.144 174.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -85.75 -61.06 1.84 Allowed 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 109.696 -0.483 . . . . 10.0 109.696 -178.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -107.71 -176.61 3.11 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 124.105 0.962 . . . . 10.0 110.017 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 93.6 p -140.1 169.73 17.15 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.696 1.198 . . . . 10.0 109.622 176.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 84.0 t -48.43 -52.6 8.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 124.408 1.083 . . . . 10.0 109.83 168.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.1 m -55.5 -35.95 66.14 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.631 1.173 . . . . 10.0 112.394 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -71.84 -60.62 2.14 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.703 -0.48 . . . . 10.0 109.703 174.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.784 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.0 pp -61.54 -43.72 98.36 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 121.85 -0.531 . . . . 10.0 110.636 -167.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.478 ' HA ' HD23 ' A' ' 68' ' ' LEU . 0.4 OUTLIER -51.37 -35.49 38.93 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 114.09 1.144 . . . . 10.0 114.09 171.065 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.88 -33.72 67.15 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 119.56 1.073 . . . . 10.0 110.088 176.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.38 -51.1 68.92 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 109.235 -0.654 . . . . 10.0 109.235 -177.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.512 HG22 HD12 ' A' ' 21' ' ' ILE . 43.3 t -59.54 -48.0 88.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 124.032 0.933 . . . . 10.0 111.477 173.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -53.09 -47.97 68.15 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 122.209 1.004 . . . . 10.0 109.435 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 32.8 tttp -70.56 -39.8 73.74 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 125.526 1.53 . . . . 10.0 110.897 -177.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 11.8 mt -51.57 -39.34 57.68 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 118.647 -0.692 . . . . 10.0 111.906 169.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 149.64 -21.2 1.17 Allowed Glycine 0 CA--C 1.527 0.798 0 CA-C-N 118.786 0.721 . . . . 10.0 114.698 167.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.42 ' OH ' HD11 ' A' ' 21' ' ' ILE . 1.9 p90 -118.82 155.43 31.19 Favored 'General case' 0 C--O 1.224 -0.276 0 C-N-CA 124.831 1.253 . . . . 10.0 107.955 -175.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.75 144.75 25.37 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 118.756 0.707 . . . . 10.0 110.331 -168.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.599 HD11 ' HB2' ' A' ' 7' ' ' PHE . 20.2 tp -123.36 145.18 48.96 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 126.157 1.783 . . . . 10.0 107.646 178.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.2 tptp -152.15 151.74 31.42 Favored 'General case' 0 CA--C 1.512 -0.499 0 C-N-CA 124.619 1.168 . . . . 10.0 108.488 171.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.521 HD11 ' HB1' ' A' ' 5' ' ' ALA . 7.9 tp -66.28 151.51 46.9 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 123.662 0.601 . . . . 10.0 109.66 177.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -105.07 -59.01 1.81 Allowed 'General case' 0 N--CA 1.437 -1.087 0 C-N-CA 127.492 2.317 . . . . 10.0 105.674 164.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 176.59 -93.65 0.09 OUTLIER Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 108.035 -2.026 . . . . 10.0 108.035 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -158.93 169.02 25.26 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.601 0.76 . . . . 10.0 109.608 -163.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -65.3 149.54 49.79 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.411 1.084 . . . . 10.0 111.36 -173.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -79.81 58.68 2.9 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.376 1.07 . . . . 10.0 109.785 -177.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 48.1 m -87.06 159.33 18.98 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.089 0.955 . . . . 10.0 110.435 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 41.7 pt -101.91 -163.85 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 N-CA-C 106.059 -1.83 . . . . 10.0 106.059 166.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -117.09 159.67 22.2 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 125.472 1.509 . . . . 10.0 107.183 164.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -142.59 -81.33 0.06 OUTLIER Glycine 0 CA--C 1.522 0.501 0 N-CA-C 108.169 -1.972 . . . . 10.0 108.169 175.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 20.0 ttp180 . . . . . 0 C--O 1.251 1.184 0 N-CA-C 105.922 -1.881 . . . . 10.0 105.922 171.599 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.503 HG13 ' H ' ' A' ' 2' ' ' THR . 4.0 p . . . . . 0 N--CA 1.471 0.591 0 N-CA-C 109.795 -0.446 . . . . 10.0 109.795 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.503 ' H ' HG13 ' A' ' 1' ' ' VAL . 5.6 p -139.07 161.99 36.04 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 106.609 -1.626 . . . . 10.0 106.609 176.062 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -126.2 149.91 48.71 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 126.439 1.895 . . . . 10.0 107.478 -168.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.51 131.75 49.02 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 107.883 -1.155 . . . . 10.0 107.883 -176.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.523 ' HB1' HD11 ' A' ' 70' ' ' LEU . . . -140.27 157.24 45.89 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 123.656 0.782 . . . . 10.0 109.926 178.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -128.31 151.57 49.16 Favored 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 123.542 0.737 . . . . 10.0 110.353 178.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.711 ' CE2' HD11 ' A' ' 57' ' ' LEU . 7.0 m-85 -140.35 146.64 38.69 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.845 1.658 . . . . 10.0 109.184 -170.037 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -110.15 125.82 53.42 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.311 1.044 . . . . 10.0 109.0 -165.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.418 HD11 HG23 ' A' ' 43' ' ' VAL . 8.6 mm -100.36 109.47 25.14 Favored 'Isoleucine or valine' 0 C--N 1.343 0.314 0 CA-C-N 118.907 0.776 . . . . 10.0 112.449 -159.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.407 ' OE1' ' NZ ' ' A' ' 67' ' ' LYS . 52.4 mt-10 -92.58 73.76 5.1 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 107.934 -1.135 . . . . 10.0 107.934 178.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 158.41 -109.32 0.4 Allowed Glycine 0 CA--C 1.526 0.758 0 N-CA-C 112.267 -0.333 . . . . 10.0 112.267 173.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.53 130.08 41.47 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 123.325 0.65 . . . . 10.0 110.933 -167.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.8 t -146.59 70.29 1.21 Allowed 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 107.675 -1.231 . . . . 10.0 107.675 -169.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 72.1 m -140.87 -116.35 0.12 Allowed 'General case' 0 C--N 1.339 0.15 0 N-CA-C 106.906 -1.516 . . . . 10.0 106.906 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -147.39 -49.09 0.18 Allowed 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.248 0.619 . . . . 10.0 110.249 178.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.51 -38.97 81.4 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.263 -0.643 . . . . 10.0 109.263 -175.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 52.5 m -64.06 -55.28 23.31 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 108.934 -0.765 . . . . 10.0 108.934 175.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -51.0 -39.08 54.94 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.835 1.254 . . . . 10.0 111.102 179.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -57.51 -30.49 65.18 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.038 0.755 . . . . 10.0 113.038 177.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 18.1 ttm180 -72.31 -36.46 68.92 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 120.641 -1.287 . . . . 10.0 109.392 -178.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 9.1 mt -43.95 -53.41 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.44 0 CA-C-O 118.654 -0.689 . . . . 10.0 109.492 168.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -48.98 -47.22 44.3 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.4 0.546 . . . . 10.0 111.811 -175.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.21 -48.45 65.14 Favored 'General case' 0 CA--C 1.531 0.222 0 O-C-N 121.585 -0.697 . . . . 10.0 110.014 177.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.508 ' HB3' ' HB1' ' A' ' 60' ' ' ALA . 5.9 mmt180 -56.72 -35.47 68.58 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 112.093 0.405 . . . . 10.0 112.093 -179.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.489 HD21 ' HB2' ' A' ' 57' ' ' LEU . 1.3 mt -80.3 -44.8 18.97 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.752 1.621 . . . . 10.0 110.896 177.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -54.28 -24.98 21.07 Favored 'General case' 0 C--O 1.227 -0.113 0 CA-C-N 118.319 0.508 . . . . 10.0 111.077 174.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.8 ttmt -58.34 -35.37 71.8 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 112.984 0.735 . . . . 10.0 112.984 173.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.7 mm -60.02 135.13 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 C-N-CA 123.755 0.822 . . . . 10.0 109.85 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -69.05 -54.82 13.1 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 111.998 0.369 . . . . 10.0 111.998 -173.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.67 41.03 2.66 Favored Glycine 0 C--N 1.339 0.711 0 O-C-N 120.916 -1.115 . . . . 10.0 111.928 -173.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.4 p -100.95 150.61 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 C-N-CA 124.562 1.145 . . . . 10.0 108.542 -175.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -111.93 -58.16 2.16 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 108.483 -0.932 . . . . 10.0 108.483 171.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 60.0 m-80 -147.58 156.08 42.46 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.659 -0.867 . . . . 10.0 108.659 -173.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -141.72 56.81 6.3 Favored Pre-proline 0 CA--C 1.536 0.404 0 C-N-CA 123.626 0.771 . . . . 10.0 112.641 175.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -75.43 77.65 3.22 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 122.758 2.306 . . . . 10.0 110.152 -177.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.428 HG12 HG13 ' A' ' 43' ' ' VAL . 3.4 m -57.49 154.04 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 O-C-N 121.83 -0.543 . . . . 10.0 111.632 176.001 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -93.31 138.2 31.9 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.458 -0.571 . . . . 10.0 109.458 -179.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -117.7 54.56 0.9 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.99 1.316 . . . . 10.0 110.25 -171.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 171.14 -34.12 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 127.039 2.136 . . . . 10.0 109.997 176.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.5 mt -91.3 -1.67 57.59 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.14 1.376 . . . . 10.0 111.978 -171.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 65.44 35.19 7.52 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 124.918 1.287 . . . . 10.0 111.052 165.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -140.44 133.77 29.79 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 125.403 1.481 . . . . 10.0 107.857 -172.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.428 HG13 HG12 ' A' ' 36' ' ' VAL . 7.9 t -94.88 140.65 16.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 106.792 -1.558 . . . . 10.0 106.792 168.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 60.4 m -125.8 119.29 27.49 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 106.108 -1.812 . . . . 10.0 106.108 -178.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.8 t -120.57 142.51 36.15 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.207 0 C-N-CA 122.992 0.517 . . . . 10.0 109.629 -178.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 59.2 tt0 -109.51 110.44 21.54 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 107.184 -1.413 . . . . 10.0 107.184 162.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -151.72 164.93 35.9 Favored 'General case' 0 C--O 1.227 -0.129 0 C-N-CA 123.876 0.871 . . . . 10.0 109.405 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 20.7 p30 -95.53 134.69 23.9 Favored Pre-proline 0 C--N 1.328 -0.365 0 C-N-CA 123.437 0.695 . . . . 10.0 110.681 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -80.77 56.39 6.07 Favored 'Trans proline' 0 N--CA 1.45 -1.077 0 C-N-CA 121.603 1.536 . . . . 10.0 109.193 170.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.55 -39.54 0.51 Allowed 'General case' 0 C--N 1.346 0.439 0 CA-C-N 118.631 0.651 . . . . 10.0 112.54 175.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -95.23 -26.63 15.88 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 122.992 0.517 . . . . 10.0 110.321 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.51 173.22 15.42 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.183 0.993 . . . . 10.0 109.14 -179.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 91.0 p -131.59 169.35 16.25 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.565 1.146 . . . . 10.0 112.258 -177.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 26.4 m -48.75 -43.52 14.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 124.01 0.924 . . . . 10.0 110.679 166.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.85 -36.43 79.1 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.964 1.706 . . . . 10.0 111.642 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -71.55 -61.2 1.86 Allowed 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 108.472 -0.936 . . . . 10.0 108.472 175.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.711 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.3 pp -60.19 -42.31 94.8 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 120.042 -0.663 . . . . 10.0 111.545 -169.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.45 ' HA ' HD23 ' A' ' 68' ' ' LEU . 0.4 OUTLIER -51.24 -37.68 48.36 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 117.305 -1.331 . . . . 10.0 113.879 170.718 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -51.55 -39.08 57.09 Favored 'General case' 0 C--N 1.346 0.417 0 CA-C-N 120.735 1.607 . . . . 10.0 110.298 173.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.508 ' HB1' ' HB3' ' A' ' 24' ' ' ARG . . . -62.18 -46.14 90.27 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 109.429 -0.582 . . . . 10.0 109.429 -174.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 68.9 t -66.83 -45.87 86.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 123.327 0.651 . . . . 10.0 111.755 172.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -49.9 -54.13 21.54 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 124.67 1.188 . . . . 10.0 108.821 -178.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 46.4 tptt -57.67 -34.78 69.75 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.549 1.54 . . . . 10.0 111.644 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.458 HD13 ' HA ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -55.85 -34.45 65.44 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 124.255 1.022 . . . . 10.0 111.248 174.064 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 125.95 -11.45 7.36 Favored Glycine 0 CA--C 1.529 0.968 0 CA-C-O 119.474 -0.626 . . . . 10.0 113.4 174.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -116.35 151.46 35.87 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 107.149 -1.426 . . . . 10.0 107.149 173.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.407 ' NZ ' ' OE1' ' A' ' 10' ' ' GLU . 13.3 ttpp -95.47 156.4 16.34 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.246 0.546 . . . . 10.0 110.364 -171.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.519 HD11 ' HB2' ' A' ' 7' ' ' PHE . 29.7 tp -128.98 150.44 50.4 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.622 1.569 . . . . 10.0 107.882 -179.045 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 11.0 tptp -155.14 151.56 28.4 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 108.803 -0.814 . . . . 10.0 108.803 169.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.523 HD11 ' HB1' ' A' ' 5' ' ' ALA . 7.5 tp -62.74 154.78 28.48 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 121.303 0.573 . . . . 10.0 109.573 177.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 45.6 tttp -117.23 -53.44 2.45 Favored 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 127.769 2.428 . . . . 10.0 107.08 170.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 170.57 -84.38 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.515 0 N-CA-C 109.081 -1.608 . . . . 10.0 109.081 176.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -160.6 163.31 32.74 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 108.224 -1.028 . . . . 10.0 108.224 -164.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -84.83 123.9 30.98 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.302 -0.999 . . . . 10.0 108.302 175.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 53.2 t0 46.64 83.0 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.914 1.686 . . . . 10.0 112.934 172.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 35.1 m -61.19 70.06 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.297 1.839 . . . . 10.0 114.375 -176.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.7 pt -74.79 71.62 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 123.958 0.903 . . . . 10.0 111.736 176.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -79.39 -70.65 0.49 Allowed 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.285 1.034 . . . . 10.0 108.741 174.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.02 -66.14 3.46 Favored Glycine 0 CA--C 1.53 0.974 0 O-C-N 121.75 -0.594 . . . . 10.0 111.686 178.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 14.1 ttm180 . . . . . 0 C--O 1.251 1.182 0 CA-C-O 116.218 -1.848 . . . . 10.0 106.755 -178.651 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.622 HG12 ' H ' ' A' ' 2' ' ' THR . 18.0 t . . . . . 0 N--CA 1.466 0.348 0 N-CA-C 105.847 -1.908 . . . . 10.0 105.847 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.622 ' H ' HG12 ' A' ' 1' ' ' VAL . 21.7 p -113.75 137.44 51.63 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.765 1.226 . . . . 10.0 110.103 -178.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -116.47 151.95 35.02 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 125.186 1.394 . . . . 10.0 109.136 -165.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -86.58 129.67 34.78 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.857 1.263 . . . . 10.0 107.719 -171.275 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -134.28 136.34 43.48 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.527 1.131 . . . . 10.0 109.362 174.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -116.11 150.8 36.79 Favored 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 124.622 1.169 . . . . 10.0 108.067 174.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.821 ' CE2' HD11 ' A' ' 57' ' ' LEU . 7.0 m-85 -138.95 138.17 37.07 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 124.493 1.121 . . . . 10.0 109.327 -174.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -102.12 130.59 48.77 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.727 1.611 . . . . 10.0 108.197 -176.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.408 HD12 HD12 ' A' ' 68' ' ' LEU . 0.9 OUTLIER -114.95 153.86 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.068 0 C-N-CA 125.789 1.636 . . . . 10.0 110.895 -165.86 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -128.27 86.04 2.41 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 124.387 1.075 . . . . 10.0 108.23 168.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 114.16 61.99 0.4 Allowed Glycine 0 CA--C 1.525 0.671 0 CA-C-O 119.493 -0.615 . . . . 10.0 113.206 160.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 16.5 ptt? -128.23 40.92 3.59 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 122.527 1.156 . . . . 10.0 111.949 169.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 70.2 p -90.37 52.95 2.34 Favored 'General case' 0 C--N 1.33 -0.274 0 O-C-N 120.306 -1.496 . . . . 10.0 109.546 -172.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 12.6 t -137.5 5.03 2.67 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 112.031 0.382 . . . . 10.0 112.031 179.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 67.09 -57.12 0.43 Allowed 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 126.123 1.769 . . . . 10.0 112.995 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.7 -36.47 81.01 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.396 1.478 . . . . 10.0 109.463 -179.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 26.6 p -68.02 -51.83 42.59 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 109.424 -0.584 . . . . 10.0 109.424 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.4 -46.68 69.8 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.392 0.677 . . . . 10.0 110.053 173.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -61.31 -19.92 62.34 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.631 0.604 . . . . 10.0 112.631 178.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.1 ttm180 -78.7 -36.88 42.9 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.307 1.043 . . . . 10.0 108.805 178.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 19.1 mm -43.7 -54.31 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.399 0 CA-C-O 118.462 -0.78 . . . . 10.0 109.854 171.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -44.63 -46.79 10.31 Favored 'General case' 0 C--O 1.224 -0.277 0 C-N-CA 122.998 0.519 . . . . 10.0 111.841 -179.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.54 -46.25 63.95 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 122.971 0.508 . . . . 10.0 110.076 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.09 -33.68 74.9 Favored 'General case' 0 C--O 1.222 -0.342 0 O-C-N 121.987 -0.445 . . . . 10.0 111.808 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.12 -34.84 26.0 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.524 1.53 . . . . 10.0 111.431 177.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -58.68 -24.59 61.62 Favored 'General case' 0 C--O 1.226 -0.171 0 O-C-N 121.761 -0.587 . . . . 10.0 109.89 172.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -52.03 -40.12 60.58 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 120.879 -0.328 . . . . 10.0 111.348 171.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 15.9 mm -56.16 127.2 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 C-N-CA 123.203 0.601 . . . . 10.0 109.623 -176.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -70.42 -48.67 54.98 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 121.081 -0.248 . . . . 10.0 110.759 -176.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -84.31 43.43 3.21 Favored Glycine 0 C--N 1.34 0.75 0 O-C-N 120.802 -1.186 . . . . 10.0 111.549 -177.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.3 p -99.4 148.46 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 124.287 1.035 . . . . 10.0 108.582 -178.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.549 ' HB2' HG21 ' A' ' 2' ' ' THR . . . -111.02 -57.51 2.23 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 124.106 0.962 . . . . 10.0 108.545 175.349 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 -143.39 152.46 41.62 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.307 -0.997 . . . . 10.0 108.307 -175.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -138.94 61.57 22.52 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 123.602 0.761 . . . . 10.0 111.072 173.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -78.48 67.76 8.22 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 123.004 2.469 . . . . 10.0 110.018 -175.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.456 HG12 HG13 ' A' ' 43' ' ' VAL . 4.2 m -65.0 155.15 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 O-C-N 121.859 -0.526 . . . . 10.0 110.61 179.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 75.4 m-80 -93.57 148.98 21.6 Favored 'General case' 0 C--O 1.224 -0.287 0 N-CA-C 108.497 -0.927 . . . . 10.0 108.497 175.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -126.3 47.95 2.2 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 123.643 0.777 . . . . 10.0 110.38 -173.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -174.22 -43.03 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 125.948 1.699 . . . . 10.0 109.614 178.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.0 mt -76.38 -18.47 58.85 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.803 1.241 . . . . 10.0 111.971 -169.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 63.2 54.72 2.01 Favored 'General case' 0 C--N 1.338 0.079 0 C-N-CA 125.752 1.621 . . . . 10.0 110.126 -174.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.2 p -142.29 130.74 22.41 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 107.481 -1.303 . . . . 10.0 107.481 172.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.456 HG13 HG12 ' A' ' 36' ' ' VAL . 9.2 t -105.28 145.41 13.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 106.759 -1.571 . . . . 10.0 106.759 173.033 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 69.8 m -139.83 123.57 17.42 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 106.25 -1.759 . . . . 10.0 106.25 -169.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 22.2 t -127.42 149.36 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 C-N-CA 123.692 0.797 . . . . 10.0 109.271 179.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 -115.78 112.02 21.38 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 105.895 -1.891 . . . . 10.0 105.895 159.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -146.44 162.81 37.46 Favored 'General case' 0 CA--C 1.52 -0.202 0 C-N-CA 123.403 0.681 . . . . 10.0 109.553 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 20.5 p30 -92.47 130.6 36.78 Favored Pre-proline 0 C--N 1.329 -0.306 0 C-N-CA 122.524 0.33 . . . . 10.0 110.237 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -76.47 61.6 6.82 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 121.554 1.503 . . . . 10.0 108.486 170.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.24 -43.88 0.33 Allowed 'General case' 0 C--N 1.341 0.223 0 O-C-N 122.085 -0.384 . . . . 10.0 109.979 177.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -87.02 -41.96 13.46 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 117.92 0.327 . . . . 10.0 110.865 177.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -133.04 -178.06 4.79 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 124.52 1.128 . . . . 10.0 109.952 -177.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 81.7 p -146.24 167.46 23.45 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.549 0.74 . . . . 10.0 109.579 177.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 64.9 t -43.01 -49.07 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.113 0 C-N-CA 124.836 1.254 . . . . 10.0 111.02 172.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 43.9 m -50.54 -43.4 56.07 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.486 0.714 . . . . 10.0 112.583 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -65.77 -60.21 3.12 Favored 'General case' 0 C--N 1.338 0.09 0 C-N-CA 123.808 0.843 . . . . 10.0 109.055 -177.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.821 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.0 pp -61.65 -42.84 99.47 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 120.06 -0.656 . . . . 10.0 110.533 -176.051 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.11 -53.2 6.63 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 117.823 -1.084 . . . . 10.0 112.16 163.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.32 -48.63 73.86 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 119.96 1.255 . . . . 10.0 110.38 178.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -48.28 -54.62 13.05 Favored 'General case' 0 N--CA 1.453 -0.309 0 O-C-N 123.349 0.405 . . . . 10.0 110.642 177.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.1 t -62.9 -44.6 99.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 N-CA-C 112.578 0.585 . . . . 10.0 112.578 176.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.63 -57.49 8.09 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.013 1.325 . . . . 10.0 108.431 178.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.0 tptm -55.6 -38.84 69.96 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 126.455 1.902 . . . . 10.0 111.216 176.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.403 HD12 ' HA ' ' A' ' 64' ' ' LEU . 6.1 tp -55.05 -27.46 44.8 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.186 0.995 . . . . 10.0 113.047 174.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 131.21 -11.14 5.58 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-O 119.169 -0.795 . . . . 10.0 114.258 168.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -137.91 160.55 38.99 Favored 'General case' 0 CA--C 1.527 0.058 0 CA-C-N 118.667 1.234 . . . . 10.0 108.37 -176.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 41.4 mmtt -88.94 153.62 20.89 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.148 0.499 . . . . 10.0 112.041 -165.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.408 HD12 HD12 ' A' ' 9' ' ' ILE . 8.9 tp -135.23 148.69 49.69 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 125.579 1.552 . . . . 10.0 107.104 176.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.8 mmtt -149.17 154.18 38.77 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 124.523 1.129 . . . . 10.0 108.233 165.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.9 tp -59.76 158.52 10.23 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 109.752 -0.462 . . . . 10.0 109.752 171.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 7.8 tptt -110.38 -74.19 0.66 Allowed 'General case' 0 N--CA 1.434 -1.255 0 C-N-CA 126.832 2.053 . . . . 10.0 106.892 173.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 163.87 44.79 0.02 OUTLIER Glycine 0 CA--C 1.53 0.992 0 CA-C-O 119.491 -0.616 . . . . 10.0 112.537 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 70.64 156.84 0.16 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.059 1.344 . . . . 10.0 113.893 169.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 8.1 mp0 -71.83 94.77 1.45 Allowed 'General case' 0 C--O 1.237 0.41 0 C-N-CA 124.175 0.99 . . . . 10.0 111.008 -173.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -59.29 78.3 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.072 1.349 . . . . 10.0 111.061 171.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 30.5 m -64.46 -28.83 69.94 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.438 1.095 . . . . 10.0 110.77 177.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 5.3 pt -142.44 87.85 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 C-N-CA 125.319 1.448 . . . . 10.0 109.065 178.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -72.24 -76.98 0.1 Allowed 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 108.665 -0.865 . . . . 10.0 108.665 175.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -101.01 -77.29 1.26 Allowed Glycine 0 CA--C 1.526 0.766 0 N-CA-C 109.647 -1.381 . . . . 10.0 109.647 178.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? . . . . . 0 C--O 1.251 1.153 0 C-N-CA 125.39 1.476 . . . . 10.0 110.999 -171.972 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.5 p . . . . . 0 N--CA 1.472 0.673 0 N-CA-C 109.604 -0.517 . . . . 10.0 109.604 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.685 HG21 ' HB2' ' A' ' 32' ' ' ALA . 2.2 p -144.03 169.56 17.6 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.431 1.492 . . . . 10.0 107.275 171.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -135.75 146.13 47.33 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 126.543 1.937 . . . . 10.0 106.708 -172.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 28.8 mmtm -81.54 145.73 30.52 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.77 -0.826 . . . . 10.0 108.77 177.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -145.12 141.58 28.92 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.721 1.208 . . . . 10.0 108.212 174.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -122.63 148.82 44.81 Favored 'General case' 0 CA--C 1.51 -0.595 0 C-N-CA 124.413 1.085 . . . . 10.0 108.601 174.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.774 ' CE2' HD11 ' A' ' 57' ' ' LEU . 2.7 m-85 -140.43 138.05 34.42 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 125.101 1.5 . . . . 10.0 109.404 -171.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -103.98 127.82 51.53 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.964 -1.124 . . . . 10.0 107.964 -168.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 10.7 mm -103.56 136.11 38.0 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.114 0 C-N-CA 124.424 1.09 . . . . 10.0 110.804 -160.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -125.23 99.68 6.19 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.478 -1.305 . . . . 10.0 107.478 169.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 156.46 -103.89 0.24 Allowed Glycine 0 CA--C 1.527 0.804 0 CA-C-O 120.034 -0.314 . . . . 10.0 112.565 173.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.22 157.11 38.33 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 117.628 0.714 . . . . 10.0 110.892 -174.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.0 t -150.15 62.95 0.97 Allowed 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.87 -1.159 . . . . 10.0 107.87 175.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.6 t -160.91 140.59 10.76 Favored 'General case' 0 N--CA 1.454 -0.239 0 O-C-N 121.109 -0.994 . . . . 10.0 109.939 -177.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.53 -46.82 70.3 Favored 'General case' 0 C--O 1.222 -0.344 0 C-N-CA 124.104 0.962 . . . . 10.0 113.406 -170.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.08 -35.01 71.71 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 119.02 0.827 . . . . 10.0 109.917 -172.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 13.8 m -67.87 -54.29 20.02 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.717 -0.846 . . . . 10.0 108.717 177.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -51.41 -37.87 50.59 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.543 -0.753 . . . . 10.0 110.616 174.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -53.49 -34.43 57.99 Favored 'General case' 0 CA--C 1.531 0.235 0 O-C-N 121.606 -0.684 . . . . 10.0 112.064 -179.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -60.31 -38.4 83.56 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 121.056 -1.027 . . . . 10.0 109.135 -179.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.428 HD12 HG22 ' A' ' 61' ' ' VAL . 13.1 mm -52.57 -49.1 46.14 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.477 0 CA-C-O 118.053 -0.975 . . . . 10.0 110.323 176.12 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -46.42 -50.66 16.42 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.909 0.777 . . . . 10.0 110.56 -177.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.64 -46.37 63.41 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.106 0.562 . . . . 10.0 111.264 178.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.1 mmt180 -58.8 -27.34 64.95 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.743 0.645 . . . . 10.0 112.743 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.0 -39.3 13.04 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.943 1.697 . . . . 10.0 111.404 174.341 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 24.8 t30 -57.47 -25.82 60.3 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 118.703 0.683 . . . . 10.0 110.627 174.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.1 mmpt? -54.4 -37.33 64.94 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 114.3 1.222 . . . . 10.0 114.3 169.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 11.6 mm -54.53 128.82 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 109.084 -0.71 . . . . 10.0 109.084 175.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -68.39 -49.62 58.78 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 109.469 -0.567 . . . . 10.0 109.469 -177.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -82.39 47.31 3.72 Favored Glycine 0 C--N 1.34 0.783 0 O-C-N 120.651 -1.28 . . . . 10.0 112.181 -175.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.5 p -110.23 153.57 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 C-N-CA 125.223 1.409 . . . . 10.0 109.568 -177.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.685 ' HB2' HG21 ' A' ' 2' ' ' THR . . . -118.0 -52.01 2.43 Favored 'General case' 0 C--O 1.228 -0.029 0 C-N-CA 122.714 0.406 . . . . 10.0 110.127 169.227 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -144.57 149.92 36.62 Favored 'General case' 0 CA--C 1.527 0.087 0 N-CA-C 109.075 -0.713 . . . . 10.0 109.075 -173.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -137.58 58.48 16.86 Favored Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 123.691 0.796 . . . . 10.0 112.432 174.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -77.04 77.2 3.87 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 123.125 2.55 . . . . 10.0 110.495 -176.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.45 HG12 HG13 ' A' ' 43' ' ' VAL . 3.7 m -59.71 153.43 4.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 O-C-N 121.741 -0.599 . . . . 10.0 111.398 176.009 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -97.84 143.6 28.28 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.829 -0.804 . . . . 10.0 108.829 175.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -125.34 43.01 3.15 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.278 1.031 . . . . 10.0 110.953 -166.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -175.6 -40.06 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 125.924 1.69 . . . . 10.0 108.942 -178.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 12.6 mt -76.38 -21.26 56.27 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.346 1.058 . . . . 10.0 111.414 -176.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 63.7 49.48 2.96 Favored 'General case' 0 CA--C 1.527 0.093 0 C-N-CA 125.547 1.539 . . . . 10.0 109.959 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.6 p -137.86 131.67 31.39 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 126.131 1.772 . . . . 10.0 106.854 174.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.45 HG13 HG12 ' A' ' 36' ' ' VAL . 17.5 t -93.26 144.21 9.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 106.174 -1.787 . . . . 10.0 106.174 167.122 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 92.4 m -130.4 123.1 29.09 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 105.453 -2.054 . . . . 10.0 105.453 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 44.5 t -122.26 149.79 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 N-CA-C 108.668 -0.864 . . . . 10.0 108.668 176.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -116.06 108.66 16.48 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 107.113 -1.44 . . . . 10.0 107.113 161.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -146.63 164.63 32.04 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 108.915 -0.772 . . . . 10.0 108.915 -178.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 17.3 p30 -94.81 128.44 39.47 Favored Pre-proline 0 C--N 1.326 -0.421 0 N-CA-C 109.983 -0.377 . . . . 10.0 109.983 174.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -77.55 57.2 5.87 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 121.787 1.658 . . . . 10.0 108.7 168.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.17 -45.66 1.97 Allowed 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.113 -0.699 . . . . 10.0 109.113 177.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -90.11 -58.88 2.35 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 123.2 0.6 . . . . 10.0 109.68 -178.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -111.32 175.13 5.55 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 125.187 1.395 . . . . 10.0 109.565 178.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 59.4 p -129.14 176.65 7.74 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.66 1.184 . . . . 10.0 110.226 175.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 92.3 t -52.43 -39.88 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-N 115.234 -0.893 . . . . 10.0 110.691 168.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.1 m -58.13 -37.34 74.44 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 123.083 0.553 . . . . 10.0 111.882 -177.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -69.36 -58.49 3.94 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 123.999 0.92 . . . . 10.0 109.137 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.774 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.1 pp -63.08 -41.22 99.38 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 120.381 -0.528 . . . . 10.0 111.118 -175.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -40.48 -57.93 1.69 Allowed 'General case' 0 C--O 1.22 -0.48 0 O-C-N 121.575 -0.703 . . . . 10.0 111.69 161.024 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.47 -42.3 77.97 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 118.851 0.75 . . . . 10.0 110.35 -177.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -55.35 -47.28 75.98 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.395 -0.82 . . . . 10.0 110.432 179.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.428 HG22 HD12 ' A' ' 21' ' ' ILE . 48.0 t -66.02 -41.84 90.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 N-CA-C 111.481 0.178 . . . . 10.0 111.481 171.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -58.21 -45.36 87.79 Favored 'General case' 0 C--N 1.331 -0.201 0 O-C-N 121.181 -0.949 . . . . 10.0 109.181 -172.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 56.5 tttm -64.39 -27.91 69.33 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.32 1.048 . . . . 10.0 112.459 178.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.466 HD13 ' HA ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -56.63 -28.51 60.67 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 119.246 0.93 . . . . 10.0 110.756 168.959 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 131.26 -48.6 0.96 Allowed Glycine 0 C--N 1.337 0.635 0 N-CA-C 109.477 -1.449 . . . . 10.0 109.477 175.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -86.32 162.62 18.13 Favored 'General case' 0 C--O 1.224 -0.286 0 C-N-CA 125.422 1.489 . . . . 10.0 109.778 -177.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.87 163.7 12.53 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.38 0.609 . . . . 10.0 110.813 -167.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.548 HD11 ' HB2' ' A' ' 7' ' ' PHE . 18.4 tp -139.82 148.6 42.4 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 126.408 1.883 . . . . 10.0 107.561 -175.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.2 tptp -148.18 155.34 41.27 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 118.408 -0.806 . . . . 10.0 108.9 163.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.9 tp -63.83 158.4 22.06 Favored 'General case' 0 C--N 1.339 0.143 0 N-CA-C 108.992 -0.744 . . . . 10.0 108.992 174.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 14.8 tttp -113.77 -69.23 0.87 Allowed 'General case' 0 N--CA 1.436 -1.166 0 C-N-CA 125.739 1.616 . . . . 10.0 107.389 172.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 162.38 49.41 0.02 OUTLIER Glycine 0 CA--C 1.526 0.78 0 CA-C-O 119.666 -0.519 . . . . 10.0 112.35 175.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 66.76 168.56 0.23 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.996 1.319 . . . . 10.0 111.947 178.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -75.81 177.75 6.68 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.664 0.745 . . . . 10.0 110.293 176.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -38.18 -47.65 1.18 Allowed 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 125.531 1.532 . . . . 10.0 112.006 167.013 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 75.1 m 53.37 66.11 1.32 Allowed 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.474 1.11 . . . . 10.0 111.493 172.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 92.6 mt -64.02 -21.6 29.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 124.636 1.174 . . . . 10.0 112.692 -173.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -140.57 150.23 43.39 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.707 1.603 . . . . 10.0 107.484 179.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 157.3 105.05 0.22 Allowed Glycine 0 CA--C 1.53 1.031 0 CA-C-O 118.834 -0.981 . . . . 10.0 112.196 178.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 3.3 tpm_? . . . . . 0 C--O 1.247 0.945 0 C-N-CA 127.876 2.471 . . . . 10.0 111.363 170.035 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 86.1 t . . . . . 0 N--CA 1.473 0.68 0 N-CA-C 107.771 -1.196 . . . . 10.0 107.771 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.609 HG21 ' HB2' ' A' ' 32' ' ' ALA . 2.4 p -134.39 167.71 20.24 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 126.303 1.841 . . . . 10.0 107.309 177.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -137.75 146.76 44.05 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.414 1.486 . . . . 10.0 108.35 -166.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -91.71 140.14 30.0 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.036 0.534 . . . . 10.0 109.733 -177.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -142.84 148.23 36.72 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.051 1.34 . . . . 10.0 109.315 179.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -123.27 149.37 44.86 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.612 1.165 . . . . 10.0 108.372 174.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.786 ' CE2' HD11 ' A' ' 57' ' ' LEU . 3.1 m-85 -141.04 144.12 34.8 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 124.976 1.422 . . . . 10.0 109.18 -174.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -106.92 132.03 53.32 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.4 1.08 . . . . 10.0 109.801 -169.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.426 HD11 ' HB ' ' A' ' 43' ' ' VAL . 4.7 mm -110.65 113.93 45.65 Favored 'Isoleucine or valine' 0 C--N 1.34 0.18 0 C-N-CA 125.096 1.358 . . . . 10.0 112.011 -160.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -106.91 98.39 8.06 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.397 -0.964 . . . . 10.0 108.397 169.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 162.77 -84.94 0.11 Allowed Glycine 0 CA--C 1.525 0.705 0 CA-C-O 119.751 -0.472 . . . . 10.0 112.845 168.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 16.4 ptp -131.21 134.73 46.75 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.729 0.812 . . . . 10.0 109.488 -174.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 58.7 p -147.23 71.15 1.2 Allowed 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 107.475 -1.305 . . . . 10.0 107.475 -164.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -147.9 162.25 39.66 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 124.02 0.928 . . . . 10.0 109.672 -171.016 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -52.42 -51.25 60.09 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.99 0.916 . . . . 10.0 113.464 -171.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.95 -30.47 69.77 Favored 'General case' 0 N--CA 1.456 -0.16 0 O-C-N 121.542 -0.723 . . . . 10.0 109.883 -178.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.1 m -69.65 -58.64 3.68 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.338 -1.356 . . . . 10.0 107.338 -177.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -39.17 -50.85 1.93 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 127.427 2.291 . . . . 10.0 111.057 168.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -61.62 -33.21 73.53 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 113.115 0.783 . . . . 10.0 113.115 -179.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.15 -48.44 57.38 Favored 'General case' 0 N--CA 1.451 -0.386 0 O-C-N 120.747 -1.221 . . . . 10.0 108.337 176.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -45.83 -51.55 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 CA-C-O 118.163 -0.922 . . . . 10.0 110.663 175.094 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -43.31 -48.8 6.89 Favored 'General case' 0 C--N 1.341 0.225 0 CA-C-N 118.626 0.648 . . . . 10.0 111.421 178.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.65 -47.04 61.98 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.779 -0.822 . . . . 10.0 108.779 -176.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.56 -38.67 75.17 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.275 -0.42 . . . . 10.0 111.894 -179.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.1 mt -78.96 -41.96 27.95 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.141 1.376 . . . . 10.0 110.576 178.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 15.7 t30 -54.8 -25.05 25.7 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.137 0.575 . . . . 10.0 111.226 173.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.2 ttmt -55.57 -38.38 69.29 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 112.393 0.516 . . . . 10.0 112.393 171.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 21.4 mm -60.01 132.14 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 C-N-CA 124.079 0.951 . . . . 10.0 109.831 -179.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -71.5 -52.63 17.33 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 111.47 0.174 . . . . 10.0 111.47 -174.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -82.95 42.83 3.02 Favored Glycine 0 C--N 1.339 0.71 0 O-C-N 120.753 -1.217 . . . . 10.0 112.026 -176.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.7 p -103.22 148.72 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 C-N-CA 124.385 1.074 . . . . 10.0 108.537 -177.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.609 ' HB2' HG21 ' A' ' 2' ' ' THR . . . -110.94 -56.55 2.35 Favored 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 108.965 -0.754 . . . . 10.0 108.965 175.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -147.96 151.53 35.96 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 108.216 -1.031 . . . . 10.0 108.216 -172.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -136.61 65.16 53.96 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 123.77 0.828 . . . . 10.0 110.93 172.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -78.36 68.17 8.05 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.01 2.474 . . . . 10.0 109.447 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.457 HG12 HG13 ' A' ' 43' ' ' VAL . 13.6 m -71.27 158.95 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 C-N-CA 123.058 0.543 . . . . 10.0 111.36 -177.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -100.64 145.6 28.2 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-O 120.936 0.398 . . . . 10.0 110.894 -175.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -121.99 38.78 4.04 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.304 1.442 . . . . 10.0 111.102 -170.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -176.57 -36.68 0.01 OUTLIER 'General case' 0 C--O 1.224 -0.249 0 C-N-CA 125.06 1.344 . . . . 10.0 110.531 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 12.8 mt -82.18 -10.89 59.0 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.9 1.28 . . . . 10.0 112.036 -173.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 71.67 40.45 0.78 Allowed 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 125.661 1.584 . . . . 10.0 110.885 171.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 7.5 p -142.51 133.4 25.65 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.546 1.138 . . . . 10.0 108.975 -175.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.457 HG13 HG12 ' A' ' 36' ' ' VAL . 3.4 t -99.78 139.4 21.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 N-CA-C 106.187 -1.783 . . . . 10.0 106.187 168.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 57.7 m -131.66 118.17 19.66 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 105.218 -2.142 . . . . 10.0 105.218 -174.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.5 t -124.49 140.16 48.59 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.183 0 C-N-CA 122.964 0.506 . . . . 10.0 109.707 -175.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 49.4 tt0 -103.23 111.42 23.8 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 107.39 -1.337 . . . . 10.0 107.39 161.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -145.6 164.46 31.65 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 123.68 0.792 . . . . 10.0 109.782 176.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -96.75 131.56 27.81 Favored Pre-proline 0 C--N 1.33 -0.25 0 C-N-CA 123.067 0.547 . . . . 10.0 110.03 177.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -77.2 61.34 7.25 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 121.302 1.335 . . . . 10.0 108.68 168.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.14 -43.95 0.38 Allowed 'General case' 0 C--N 1.343 0.311 0 O-C-N 121.894 -0.504 . . . . 10.0 110.981 177.082 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.77 -41.12 14.36 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.797 0.839 . . . . 10.0 110.031 178.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -144.42 170.06 16.74 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 126.223 1.809 . . . . 10.0 108.772 -170.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 33.0 p -128.71 -179.49 5.1 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 122.608 1.194 . . . . 10.0 110.817 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 99.3 t -46.54 -41.46 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 114.413 -1.267 . . . . 10.0 111.292 163.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 70.6 m -62.0 -40.05 94.33 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 118.46 0.573 . . . . 10.0 111.301 -173.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -68.48 -54.57 16.07 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.814 1.245 . . . . 10.0 108.999 -175.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.786 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.0 pp -63.87 -44.07 94.18 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 119.664 -0.814 . . . . 10.0 110.485 -179.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.9 -49.66 10.88 Favored 'General case' 0 C--O 1.221 -0.438 0 CA-C-O 117.823 -1.084 . . . . 10.0 113.212 163.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 14.2 tm-20 -54.82 -46.2 74.52 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 120.715 1.598 . . . . 10.0 109.618 179.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -50.69 -55.37 16.86 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.377 -0.829 . . . . 10.0 109.372 178.229 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.516 HG13 ' CE2' ' A' ' 66' ' ' TYR . 66.8 t -60.98 -49.97 82.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 112.841 0.682 . . . . 10.0 112.841 177.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -58.34 -33.38 69.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.749 0.785 . . . . 10.0 109.285 -176.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.6 tttp -77.7 -34.11 52.94 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 123.451 0.701 . . . . 10.0 111.583 178.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 67.9 mt -53.09 -42.22 65.71 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.347 0.976 . . . . 10.0 111.148 164.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 143.51 -37.48 1.46 Allowed Glycine 0 C--N 1.337 0.636 0 CA-C-N 118.155 0.434 . . . . 10.0 112.439 168.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.516 ' CE2' HG13 ' A' ' 61' ' ' VAL . 22.3 p90 -85.71 158.55 20.02 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 108.494 -0.928 . . . . 10.0 108.494 176.226 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 33.6 mttp -100.94 160.84 14.04 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.544 0.688 . . . . 10.0 111.422 -173.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.508 HD11 ' HB2' ' A' ' 7' ' ' PHE . 21.6 tp -136.68 149.49 47.95 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.253 1.821 . . . . 10.0 107.549 -171.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -153.38 152.36 30.97 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 109.011 -0.737 . . . . 10.0 109.011 162.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.7 tp -60.02 156.61 14.43 Favored 'General case' 0 C--O 1.231 0.129 0 O-C-N 123.595 0.56 . . . . 10.0 109.683 175.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -112.1 -70.44 0.81 Allowed 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 125.672 1.589 . . . . 10.0 107.201 172.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 157.4 59.08 0.01 OUTLIER Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.191 -0.763 . . . . 10.0 111.191 -179.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . 0.272 12.4 pt-20 54.11 171.29 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 128.098 2.559 . . . . 10.0 114.737 176.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -97.33 149.69 21.81 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.576 -0.898 . . . . 10.0 108.576 -178.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -59.66 122.5 14.26 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 107.656 -1.239 . . . . 10.0 107.656 174.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -141.82 129.65 21.75 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.562 -1.273 . . . . 10.0 107.562 -173.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 5.6 pt -127.19 89.69 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 124.371 1.068 . . . . 10.0 109.279 -175.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -74.11 110.7 8.61 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.684 -0.858 . . . . 10.0 108.684 177.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -66.13 116.47 8.51 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 108.791 -1.723 . . . . 10.0 108.791 170.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 4.6 mmm180 . . . . . 0 C--O 1.251 1.132 0 CA-C-O 117.246 -1.359 . . . . 10.0 107.847 179.332 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.669 HG22 ' H ' ' A' ' 2' ' ' THR . 15.0 p . . . . . 0 N--CA 1.466 0.341 0 N-CA-C 105.954 -1.869 . . . . 10.0 105.954 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.669 ' H ' HG22 ' A' ' 1' ' ' VAL . 11.8 p -112.21 153.85 26.46 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 126.447 1.899 . . . . 10.0 109.642 -177.028 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.7 mp0 -101.02 138.33 38.21 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.244 1.817 . . . . 10.0 109.212 177.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.7 tptt -81.87 119.86 24.46 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 108.105 -1.072 . . . . 10.0 108.105 171.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -128.09 153.55 46.69 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.537 1.135 . . . . 10.0 109.575 173.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -128.1 145.24 51.06 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.632 0.773 . . . . 10.0 110.215 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.537 ' HB2' HD11 ' A' ' 68' ' ' LEU . 2.1 m-85 -130.22 133.57 46.64 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 125.236 1.585 . . . . 10.0 111.749 -167.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -85.1 136.11 33.69 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 125.28 1.432 . . . . 10.0 109.781 176.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.541 HD11 HG23 ' A' ' 43' ' ' VAL . 5.2 mm -109.42 134.58 51.03 Favored 'Isoleucine or valine' 0 C--N 1.34 0.176 0 C-N-CA 126.543 1.937 . . . . 10.0 109.756 -173.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -124.8 108.07 11.57 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 108.28 -1.007 . . . . 10.0 108.28 159.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 150.79 -98.08 0.18 Allowed Glycine 0 CA--C 1.529 0.911 0 C-N-CA 124.342 0.972 . . . . 10.0 111.739 169.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 36.6 mmt -76.04 139.5 41.46 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 117.642 0.721 . . . . 10.0 111.506 -175.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.2 t -148.19 66.05 1.09 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.902 1.281 . . . . 10.0 107.909 -178.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 37.3 m -153.39 143.86 22.48 Favored 'General case' 0 C--N 1.34 0.183 0 N-CA-C 108.359 -0.978 . . . . 10.0 108.359 -174.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -55.06 -46.61 75.38 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 114.037 1.125 . . . . 10.0 114.037 -174.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.3 -27.88 61.79 Favored 'General case' 0 C--N 1.332 -0.156 0 O-C-N 121.251 -0.906 . . . . 10.0 109.973 -176.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 91.2 m -74.33 -50.74 17.54 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.436 -0.95 . . . . 10.0 108.436 178.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -45.09 -46.3 11.6 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.564 1.545 . . . . 10.0 110.359 168.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -58.66 -34.49 71.29 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 121.268 -0.895 . . . . 10.0 112.491 178.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 34.5 ttt85 -66.38 -35.41 80.26 Favored 'General case' 0 N--CA 1.45 -0.425 0 O-C-N 120.813 -1.18 . . . . 10.0 109.77 178.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 4.6 mt -52.04 -57.98 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.498 0 N-CA-C 108.861 -0.792 . . . . 10.0 108.861 172.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -45.25 -48.18 12.8 Favored 'General case' 0 C--O 1.221 -0.427 0 O-C-N 123.856 0.723 . . . . 10.0 110.882 -177.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.2 mtmt -68.14 -46.98 69.34 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.934 0.893 . . . . 10.0 110.414 -178.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.3 tpm_? -63.32 -36.59 84.19 Favored 'General case' 0 N--CA 1.45 -0.425 0 O-C-N 121.858 -0.526 . . . . 10.0 110.184 -178.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.06 -34.57 50.34 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.901 1.681 . . . . 10.0 111.457 176.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -64.15 -20.5 66.03 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 118.633 0.651 . . . . 10.0 109.421 175.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -53.97 -41.24 67.64 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 119.941 -0.704 . . . . 10.0 111.156 168.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 28.2 mm -58.97 129.96 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 123.667 0.787 . . . . 10.0 109.757 -174.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -73.03 -48.95 31.7 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 116.631 -0.259 . . . . 10.0 110.399 -172.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -82.88 40.9 2.83 Favored Glycine 0 C--N 1.339 0.746 0 O-C-N 120.887 -1.133 . . . . 10.0 111.767 -176.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -104.89 144.73 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 N-CA-C 107.743 -1.206 . . . . 10.0 107.743 179.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.648 ' HB2' HG21 ' A' ' 2' ' ' THR . . . -106.67 -55.19 2.36 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.26 -0.644 . . . . 10.0 109.26 171.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -142.89 143.01 31.88 Favored 'General case' 0 C--O 1.226 -0.154 0 N-CA-C 108.824 -0.806 . . . . 10.0 108.824 -174.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -133.68 55.64 16.83 Favored Pre-proline 0 CA--C 1.54 0.585 0 N-CA-C 113.552 0.945 . . . . 10.0 113.552 175.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -77.9 75.58 4.73 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 123.392 2.728 . . . . 10.0 110.39 -177.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.644 HG12 HG13 ' A' ' 43' ' ' VAL . 2.1 m -62.32 153.09 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 123.138 0.575 . . . . 10.0 111.719 178.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -94.35 138.53 32.21 Favored 'General case' 0 N--CA 1.457 -0.116 0 O-C-N 122.082 -0.386 . . . . 10.0 110.06 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -116.01 45.64 1.7 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.676 1.19 . . . . 10.0 111.557 -169.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -175.92 -39.99 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.207 0 C-N-CA 125.232 1.413 . . . . 10.0 109.354 178.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.7 mt -74.92 -20.21 59.8 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.491 1.117 . . . . 10.0 111.427 -174.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 63.39 49.93 3.04 Favored 'General case' 0 C--N 1.339 0.132 0 C-N-CA 125.466 1.506 . . . . 10.0 109.761 -178.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.1 p -140.06 125.85 19.43 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 125.507 1.523 . . . . 10.0 107.446 174.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.644 HG13 HG12 ' A' ' 36' ' ' VAL . 32.1 t -91.69 136.46 24.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 107.263 -1.384 . . . . 10.0 107.263 167.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 26.0 m -120.05 124.88 46.94 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 125.592 1.557 . . . . 10.0 107.079 178.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 98.1 t -134.94 146.52 30.43 Favored 'Isoleucine or valine' 0 C--N 1.341 0.232 0 CA-C-N 119.154 0.888 . . . . 10.0 110.524 175.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -105.03 106.64 17.23 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 126.99 2.116 . . . . 10.0 106.162 169.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 26.5 p90 -139.6 154.44 47.59 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 118.926 0.785 . . . . 10.0 110.766 179.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -94.69 128.28 40.36 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 118.589 -0.719 . . . . 10.0 110.079 175.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -76.07 57.87 5.36 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.553 2.169 . . . . 10.0 108.862 169.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.413 ' NZ ' ' OE1' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -124.51 -53.0 1.7 Allowed 'General case' 0 C--N 1.338 0.102 0 N-CA-C 106.508 -1.664 . . . . 10.0 106.508 176.195 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.413 ' OE1' ' NZ ' ' A' ' 50' ' ' LYS . 1.8 tp10 -89.45 -42.49 11.46 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.031 0.532 . . . . 10.0 110.712 -178.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.27 147.63 29.55 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 124.833 1.253 . . . . 10.0 107.965 -172.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 54.1 p -105.81 -171.98 2.01 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.104 0.962 . . . . 10.0 109.864 -179.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.51 HG21 HD12 ' A' ' 70' ' ' LEU . 3.5 p -61.37 -32.72 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 120.323 -0.551 . . . . 10.0 111.006 166.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.2 t -54.76 -43.54 72.84 Favored 'General case' 0 C--O 1.235 0.335 0 O-C-N 121.822 -0.549 . . . . 10.0 109.703 -175.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -64.32 -54.49 32.32 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 125.72 1.608 . . . . 10.0 108.839 -175.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.435 HD13 ' CE2' ' A' ' 7' ' ' PHE . 4.0 pp -67.78 -42.59 81.45 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.959 -0.463 . . . . 10.0 111.25 -178.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -44.64 -50.62 9.72 Favored 'General case' 0 N--CA 1.449 -0.477 0 O-C-N 121.162 -0.961 . . . . 10.0 111.709 163.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.45 -45.14 92.45 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 118.92 0.782 . . . . 10.0 109.87 179.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -51.45 -49.82 60.99 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.031 -0.531 . . . . 10.0 110.182 178.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.502 ' HA ' HD12 ' A' ' 64' ' ' LEU . 58.0 t -68.2 -43.71 84.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 112.209 0.448 . . . . 10.0 112.209 177.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -53.5 -40.99 65.82 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 108.973 -0.751 . . . . 10.0 108.973 176.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.8 tptt -75.01 -36.75 61.92 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.899 1.28 . . . . 10.0 111.324 -179.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.502 HD12 ' HA ' ' A' ' 61' ' ' VAL . 15.5 mt -51.93 -35.03 44.38 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.817 0.735 . . . . 10.0 112.023 167.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.79 24.29 4.99 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 123.192 0.425 . . . . 10.0 112.888 169.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -141.75 160.56 39.93 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 105.276 -2.12 . . . . 10.0 105.276 168.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 62.7 tttt -106.82 144.34 33.61 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 119.548 1.067 . . . . 10.0 111.774 -168.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.537 HD11 ' HB2' ' A' ' 7' ' ' PHE . 14.0 tp -121.47 147.99 45.03 Favored 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 127.883 2.473 . . . . 10.0 107.622 -176.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.0 mmtt -143.22 170.04 16.5 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 124.407 1.083 . . . . 10.0 108.445 161.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.516 HD23 ' H ' ' A' ' 71' ' ' LYS . 1.6 tt -93.31 151.4 19.81 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 123.505 0.722 . . . . 10.0 109.195 178.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.516 ' H ' HD23 ' A' ' 70' ' ' LEU . 56.9 tttp -116.08 -62.36 1.6 Allowed 'General case' 0 N--CA 1.441 -0.904 0 C-N-CA 125.94 1.696 . . . . 10.0 108.089 -177.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -175.52 -87.93 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 108.455 -1.858 . . . . 10.0 108.455 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -170.04 173.5 5.93 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.154 0.981 . . . . 10.0 109.177 -171.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -49.99 112.91 0.74 Allowed 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.761 1.224 . . . . 10.0 111.396 -179.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -81.29 67.84 7.37 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.139 0.495 . . . . 10.0 109.788 -175.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 17.5 t -144.93 105.42 4.1 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 123.418 0.687 . . . . 10.0 110.528 -179.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 16.3 pt -104.41 -19.74 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 C-N-CA 124.87 1.268 . . . . 10.0 113.21 176.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -75.42 157.96 33.39 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.484 0.714 . . . . 10.0 109.917 177.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -172.65 -95.42 0.1 OUTLIER Glycine 0 CA--C 1.528 0.875 0 N-CA-C 111.599 -0.601 . . . . 10.0 111.599 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 23.1 ttt180 . . . . . 0 C--O 1.249 1.053 0 N-CA-C 105.17 -2.159 . . . . 10.0 105.17 -179.165 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 86.2 t . . . . . 0 N--CA 1.473 0.698 0 N-CA-C 108.449 -0.945 . . . . 10.0 108.449 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.57 HG21 ' HB2' ' A' ' 32' ' ' ALA . 6.3 p -130.55 175.75 8.73 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.443 1.497 . . . . 10.0 107.337 170.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -139.16 147.74 42.26 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 127.525 2.33 . . . . 10.0 106.747 -167.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 59.7 mmtt -91.93 135.72 33.72 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 123.264 0.625 . . . . 10.0 109.636 -175.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -138.34 140.62 39.57 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.888 -1.152 . . . . 10.0 107.888 173.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -122.3 150.57 42.18 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.631 0.772 . . . . 10.0 110.368 175.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.724 ' HB2' HD11 ' A' ' 68' ' ' LEU . 0.8 OUTLIER -141.95 136.47 30.41 Favored 'General case' 0 N--CA 1.448 -0.566 0 O-C-N 124.925 1.39 . . . . 10.0 110.212 -169.903 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -95.91 135.74 37.26 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.933 1.693 . . . . 10.0 108.993 -175.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.554 HD11 HG23 ' A' ' 43' ' ' VAL . 7.2 mm -106.74 116.34 50.26 Favored 'Isoleucine or valine' 0 C--N 1.339 0.15 0 C-N-CA 125.851 1.66 . . . . 10.0 111.463 -165.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -102.03 97.56 7.88 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 107.595 -1.261 . . . . 10.0 107.595 170.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 150.43 -103.13 0.24 Allowed Glycine 0 CA--C 1.528 0.866 0 C-N-CA 123.457 0.551 . . . . 10.0 112.258 169.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 36.3 mmt -80.03 146.43 31.98 Favored 'General case' 0 N--CA 1.457 -0.096 0 CA-C-N 117.746 0.773 . . . . 10.0 111.711 -172.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.3 t -144.49 70.48 1.28 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.776 1.63 . . . . 10.0 106.724 -177.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -159.73 140.65 12.39 Favored 'General case' 0 C--N 1.343 0.303 0 O-C-N 120.823 -1.173 . . . . 10.0 109.331 -173.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.68 -45.06 81.96 Favored 'General case' 0 C--O 1.227 -0.118 0 C-N-CA 123.963 0.905 . . . . 10.0 113.419 -168.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.19 -43.14 96.14 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.753 -0.832 . . . . 10.0 108.753 -178.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -72.91 -49.48 29.39 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.305 -0.862 . . . . 10.0 109.586 -173.208 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -46.37 -51.98 13.81 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.088 1.355 . . . . 10.0 110.98 170.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -53.97 -28.82 40.0 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 112.59 0.589 . . . . 10.0 112.59 178.075 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.17 -36.97 66.68 Favored 'General case' 0 N--CA 1.447 -0.619 0 O-C-N 121.005 -1.059 . . . . 10.0 108.795 -178.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.568 HD12 HG22 ' A' ' 61' ' ' VAL . 11.6 mm -51.38 -58.2 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 N-CA-C 108.425 -0.954 . . . . 10.0 108.425 168.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -45.75 -41.41 10.71 Favored 'General case' 0 C--O 1.223 -0.311 0 O-C-N 123.604 0.565 . . . . 10.0 111.216 -178.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.29 -54.81 12.76 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 121.634 -0.666 . . . . 10.0 111.735 178.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.48 ' CZ ' ' HA ' ' A' ' 60' ' ' ALA . 4.8 mtp180 -60.99 -39.5 89.91 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 119.454 -0.899 . . . . 10.0 110.81 -178.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.89 -41.79 70.85 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 123.698 0.799 . . . . 10.0 110.74 179.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 44.4 m-20 -54.55 -30.78 55.08 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 118.454 0.57 . . . . 10.0 110.608 171.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -59.19 -31.7 69.24 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 118.377 -0.821 . . . . 10.0 112.776 176.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 18.6 mm -57.89 121.16 4.95 Favored 'Isoleucine or valine' 0 C--N 1.34 0.187 0 CA-C-N 118.933 0.788 . . . . 10.0 109.858 -178.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 50.1 mp0 -57.32 -46.13 83.55 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 123.658 0.783 . . . . 10.0 112.085 -175.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.95 32.61 3.2 Favored Glycine 0 C--N 1.341 0.816 0 CA-C-N 120.323 1.419 . . . . 10.0 112.772 -174.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.7 p -99.41 150.74 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 119.204 1.502 . . . . 10.0 109.327 -176.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.57 ' HB2' HG21 ' A' ' 2' ' ' THR . . . -108.79 -59.12 1.92 Allowed 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 108.454 -0.943 . . . . 10.0 108.454 168.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 66.3 m-20 -139.64 152.96 47.19 Favored 'General case' 0 C--N 1.337 0.026 0 N-CA-C 108.775 -0.824 . . . . 10.0 108.775 -174.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -137.1 62.85 41.27 Favored Pre-proline 0 CA--C 1.537 0.462 0 C-N-CA 124.17 0.988 . . . . 10.0 111.687 174.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -75.68 77.1 3.44 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 123.061 2.508 . . . . 10.0 111.511 -177.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.528 HG13 HG22 ' A' ' 43' ' ' VAL . 70.6 t -61.96 135.65 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 C-N-CA 125.889 1.676 . . . . 10.0 111.391 176.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -94.85 94.91 8.33 Favored 'General case' 0 C--N 1.346 0.419 0 O-C-N 121.296 -0.878 . . . . 10.0 111.552 -175.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -75.35 49.47 0.47 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.781 2.032 . . . . 10.0 114.055 -173.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -176.84 -37.15 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 124.916 1.287 . . . . 10.0 110.452 176.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.5 mt -84.68 -13.38 51.61 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.057 0.943 . . . . 10.0 111.261 -173.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 74.17 40.54 0.43 Allowed 'General case' 0 C--O 1.228 -0.071 0 C-N-CA 125.213 1.405 . . . . 10.0 110.25 170.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 35.4 p -140.08 131.11 26.25 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 125.028 1.331 . . . . 10.0 107.828 179.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.554 HG23 HD11 ' A' ' 9' ' ' ILE . 28.5 t -91.99 144.14 9.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 107.026 -1.472 . . . . 10.0 107.026 165.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 91.3 m -131.67 124.1 29.16 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 105.879 -1.897 . . . . 10.0 105.879 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 42.2 t -126.36 145.21 34.25 Favored 'Isoleucine or valine' 0 C--N 1.339 0.145 0 C-N-CA 123.289 0.635 . . . . 10.0 109.371 177.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -112.85 103.36 11.35 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 105.601 -2.0 . . . . 10.0 105.601 171.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -136.58 159.54 41.51 Favored 'General case' 0 C--O 1.225 -0.218 0 C-N-CA 123.883 0.873 . . . . 10.0 110.755 -175.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 21.2 p30 -94.8 125.78 49.79 Favored Pre-proline 0 C--N 1.331 -0.197 0 C-N-CA 123.481 0.712 . . . . 10.0 109.953 175.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -74.56 65.63 5.63 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 121.766 1.644 . . . . 10.0 108.304 172.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.7 pttt -138.86 -49.77 0.52 Allowed 'General case' 0 C--O 1.227 -0.105 0 N-CA-C 106.967 -1.494 . . . . 10.0 106.967 178.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -106.15 -56.54 2.17 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 124.656 1.182 . . . . 10.0 108.069 174.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.24 139.45 50.06 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 123.391 0.677 . . . . 10.0 109.738 -176.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 20.6 p -130.78 143.51 50.79 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 122.047 0.927 . . . . 10.0 110.518 174.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 30.3 m -45.39 -43.58 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 C-N-CA 125.157 1.383 . . . . 10.0 111.609 176.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.0 m -58.2 -43.13 87.45 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.501 1.121 . . . . 10.0 112.517 -177.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -63.08 -53.19 57.52 Favored 'General case' 0 C--O 1.224 -0.263 0 CA-C-O 122.072 0.939 . . . . 10.0 108.875 -173.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.567 HD11 ' CE2' ' A' ' 7' ' ' PHE 0.267 1.2 pp -65.62 -36.39 83.57 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.082 -1.011 . . . . 10.0 112.621 -177.225 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.405 ' HZ2' HD23 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -39.93 -64.59 0.48 Allowed 'General case' 0 CA--C 1.534 0.348 0 O-C-N 120.962 -1.087 . . . . 10.0 112.881 156.525 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.8 tm-20 -52.23 -39.76 60.73 Favored 'General case' 0 CA--C 1.517 -0.301 0 C-N-CA 123.455 0.702 . . . . 10.0 109.572 178.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.48 ' HA ' ' CZ ' ' A' ' 24' ' ' ARG . . . -59.68 -55.01 39.76 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 115.747 -0.661 . . . . 10.0 110.696 -174.275 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.568 HG22 HD12 ' A' ' 21' ' ' ILE . 80.4 t -62.46 -42.31 95.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-N 115.666 -0.697 . . . . 10.0 110.909 174.228 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -55.35 -51.25 67.4 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 121.575 0.702 . . . . 10.0 110.311 -176.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 40.6 tptt -56.65 -39.7 74.17 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 125.765 1.626 . . . . 10.0 111.007 177.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.74 -22.38 35.04 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 113.056 0.762 . . . . 10.0 113.056 174.066 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 108.73 14.71 14.86 Favored Glycine 0 CA--C 1.529 0.952 0 CA-C-N 118.78 0.718 . . . . 10.0 113.161 170.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.427 ' CZ ' HD11 ' A' ' 21' ' ' ILE . 2.2 p90 -143.37 160.27 40.85 Favored 'General case' 0 C--O 1.225 -0.23 0 N-CA-C 106.603 -1.629 . . . . 10.0 106.603 172.13 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -111.6 144.59 40.6 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 119.064 0.847 . . . . 10.0 111.141 -162.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.724 HD11 ' HB2' ' A' ' 7' ' ' PHE . 23.3 tp -121.38 148.27 44.61 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 125.097 1.359 . . . . 10.0 108.289 -172.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 20.8 mmtt -149.0 139.51 22.52 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 125.446 1.498 . . . . 10.0 110.288 169.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.563 HD23 ' N ' ' A' ' 71' ' ' LYS . 2.5 tt -72.1 157.38 37.88 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.633 -0.877 . . . . 10.0 108.633 177.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.563 ' N ' HD23 ' A' ' 70' ' ' LEU . 64.1 tttt -120.86 -65.26 1.16 Allowed 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 125.585 1.554 . . . . 10.0 108.169 177.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.53 -74.01 0.03 OUTLIER Glycine 0 CA--C 1.522 0.518 0 N-CA-C 110.051 -1.22 . . . . 10.0 110.051 173.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -174.61 167.19 3.84 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 106.557 -1.646 . . . . 10.0 106.557 -165.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -81.31 153.27 27.14 Favored 'General case' 0 N--CA 1.457 -0.116 0 O-C-N 123.456 0.472 . . . . 10.0 110.513 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.3 t70 67.64 -158.7 0.22 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.025 1.33 . . . . 10.0 108.841 177.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.6 t -151.95 73.35 1.05 Allowed 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 124.901 1.281 . . . . 10.0 107.822 176.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 6.6 pt -103.47 -145.26 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 124.306 1.042 . . . . 10.0 108.836 179.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -151.04 -54.31 0.14 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.235 1.014 . . . . 10.0 109.379 -177.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -168.25 -156.47 10.3 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 109.136 -1.586 . . . . 10.0 109.136 -178.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 51.0 tpt85 . . . . . 0 C--O 1.249 1.036 0 CA-C-O 116.891 -1.528 . . . . 10.0 110.127 -172.444 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 53.0 t . . . . . 0 N--CA 1.47 0.549 0 N-CA-C 107.793 -1.188 . . . . 10.0 107.793 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.508 HG21 ' HB2' ' A' ' 32' ' ' ALA . 7.7 p -125.44 159.57 31.59 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 124.649 1.179 . . . . 10.0 110.33 179.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -124.51 151.16 44.99 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 127.475 2.31 . . . . 10.0 107.575 -171.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.1 mppt? -93.69 142.67 27.09 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 123.975 0.91 . . . . 10.0 109.6 -176.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -148.19 140.95 24.62 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.027 0.931 . . . . 10.0 109.336 -177.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -117.97 148.75 41.9 Favored 'General case' 0 CA--C 1.508 -0.638 0 C-N-CA 123.361 0.665 . . . . 10.0 110.415 173.577 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.75 ' CE2' HD11 ' A' ' 57' ' ' LEU . 15.2 m-85 -134.47 144.39 48.07 Favored 'General case' 0 N--CA 1.446 -0.632 0 O-C-N 125.407 1.692 . . . . 10.0 108.781 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -109.97 132.42 54.17 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 108.475 -0.935 . . . . 10.0 108.475 -172.028 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.8 mm -113.43 144.16 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 C-N-CA 124.092 0.957 . . . . 10.0 111.811 -157.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -128.73 100.98 5.92 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 124.524 1.13 . . . . 10.0 108.123 169.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 145.36 -71.86 0.35 Allowed Glycine 0 CA--C 1.526 0.759 0 CA-C-N 117.958 0.345 . . . . 10.0 112.943 166.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 9.7 ptt? -65.86 115.08 5.58 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 122.368 -0.489 . . . . 10.0 110.202 -173.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.1 t -146.66 59.39 1.2 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.554 0.692 . . . . 10.0 109.548 -176.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.2 m -142.01 -82.27 0.21 Allowed 'General case' 0 C--N 1.345 0.392 0 O-C-N 121.439 -0.788 . . . . 10.0 109.135 173.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 176.92 -47.97 0.01 OUTLIER 'General case' 0 C--O 1.221 -0.428 0 C-N-CA 124.372 1.069 . . . . 10.0 109.956 -173.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.81 -49.35 47.38 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 122.315 1.055 . . . . 10.0 108.687 -177.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 22.4 p -59.3 -34.76 72.69 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 114.139 -1.391 . . . . 10.0 111.567 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.61 -57.55 4.29 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.297 1.039 . . . . 10.0 110.708 171.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -43.29 -44.96 5.68 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.181 1.392 . . . . 10.0 112.001 178.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 27.1 ttt180 -52.8 -38.14 60.78 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.253 1.021 . . . . 10.0 110.029 -178.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.64 HG22 HD12 ' A' ' 25' ' ' LEU . 27.5 mm -59.14 -45.98 92.31 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.538 0 CA-C-O 117.572 -1.204 . . . . 10.0 110.905 174.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -50.12 -50.5 48.35 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 119.606 1.094 . . . . 10.0 109.788 -176.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.7 tmmt? -67.9 -47.81 67.77 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.324 1.05 . . . . 10.0 110.11 179.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.04 -28.95 64.96 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.53 0.567 . . . . 10.0 112.53 177.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.64 HD12 HG22 ' A' ' 21' ' ' ILE . 1.0 OUTLIER -80.09 -43.38 21.86 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.989 1.315 . . . . 10.0 109.347 175.084 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.457 ' HA ' HG11 ' A' ' 31' ' ' VAL . 0.3 OUTLIER -56.89 -24.59 53.05 Favored 'General case' 0 C--O 1.226 -0.154 0 C-N-CA 123.964 0.905 . . . . 10.0 110.342 178.583 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.78 -36.51 81.3 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 114.775 1.398 . . . . 10.0 114.775 172.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.9 mp -62.39 129.19 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 120.067 1.303 . . . . 10.0 109.767 176.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -54.5 -51.16 65.98 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 112.433 0.531 . . . . 10.0 112.433 -177.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.85 37.3 2.82 Favored Glycine 0 C--N 1.34 0.774 0 O-C-N 120.563 -1.336 . . . . 10.0 112.317 -171.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.457 HG11 ' HA ' ' A' ' 26' ' ' ASN . 2.8 p -103.79 155.5 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 CA-C-N 118.362 1.081 . . . . 10.0 108.928 -177.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.508 ' HB2' HG21 ' A' ' 2' ' ' THR . . . -120.52 -58.54 1.83 Allowed 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 109.006 -0.739 . . . . 10.0 109.006 170.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 62.2 m-80 -139.08 155.66 47.76 Favored 'General case' 0 CA--C 1.521 -0.172 0 N-CA-C 108.835 -0.802 . . . . 10.0 108.835 -173.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -153.38 58.6 2.37 Favored Pre-proline 0 CA--C 1.533 0.318 0 N-CA-C 112.668 0.618 . . . . 10.0 112.668 173.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -74.45 79.05 2.57 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.659 2.24 . . . . 10.0 109.935 -178.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.535 HG12 HG13 ' A' ' 43' ' ' VAL . 4.5 m -63.47 156.72 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 O-C-N 121.695 -0.628 . . . . 10.0 112.168 -179.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 73.9 m-80 -98.39 122.17 41.24 Favored 'General case' 0 N--CA 1.457 -0.102 0 O-C-N 122.144 -0.348 . . . . 10.0 110.585 -178.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -102.51 42.9 1.11 Allowed 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.954 1.301 . . . . 10.0 111.236 -176.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -163.1 -43.56 0.03 OUTLIER 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 124.176 0.99 . . . . 10.0 109.05 176.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 12.3 mt -76.24 -22.48 55.11 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.827 0.851 . . . . 10.0 111.213 -177.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 62.08 53.83 2.87 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 125.554 1.541 . . . . 10.0 109.509 -175.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 16.9 p -138.1 133.1 33.01 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.955 1.702 . . . . 10.0 107.458 173.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.535 HG13 HG12 ' A' ' 36' ' ' VAL . 5.9 t -100.1 125.46 53.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 107.188 -1.412 . . . . 10.0 107.188 173.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 37.4 m -109.54 115.25 29.57 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 126.397 1.879 . . . . 10.0 107.572 -178.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.7 t -117.1 145.92 22.23 Favored 'Isoleucine or valine' 0 C--N 1.34 0.166 0 CA-C-N 118.971 0.805 . . . . 10.0 110.857 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -115.11 108.07 16.16 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 125.283 1.433 . . . . 10.0 107.748 161.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 26.9 p90 -139.34 162.02 36.02 Favored 'General case' 0 C--O 1.226 -0.134 0 C-N-CA 123.808 0.843 . . . . 10.0 110.253 -178.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 25.1 p30 -95.97 128.48 37.17 Favored Pre-proline 0 C--N 1.332 -0.18 0 C-N-CA 123.397 0.679 . . . . 10.0 110.142 176.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -75.48 61.69 6.09 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 N-CA-C 108.468 -1.397 . . . . 10.0 108.468 171.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.84 -47.14 0.32 Allowed 'General case' 0 C--N 1.346 0.416 0 CA-C-N 118.584 0.629 . . . . 10.0 110.195 176.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -104.59 -40.23 6.1 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.067 0.547 . . . . 10.0 109.898 170.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.32 158.35 17.84 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.377 0.671 . . . . 10.0 110.366 -177.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 97.7 p -148.83 158.74 44.38 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.643 0.735 . . . . 10.0 111.776 172.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.0 m -53.41 -45.78 57.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 124.267 1.027 . . . . 10.0 110.937 173.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 16.0 m -57.66 -43.48 84.99 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.4 1.08 . . . . 10.0 111.722 -178.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -64.2 -57.5 9.33 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.283 1.033 . . . . 10.0 109.262 -178.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.75 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.3 pp -65.42 -41.34 93.66 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.123 -0.985 . . . . 10.0 111.058 -176.259 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -43.03 -52.05 5.45 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-O 118.244 -0.884 . . . . 10.0 112.562 160.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.76 -45.95 77.97 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 119.772 1.169 . . . . 10.0 110.082 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -52.7 -54.2 36.85 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.977 -0.556 . . . . 10.0 110.321 178.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.498 HG22 HD12 ' A' ' 21' ' ' ILE . 40.6 t -57.85 -47.23 86.68 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 N-CA-C 112.597 0.592 . . . . 10.0 112.597 174.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -53.48 -55.6 23.98 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.754 1.222 . . . . 10.0 109.257 -177.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -59.72 -33.62 71.86 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 126.997 2.119 . . . . 10.0 111.711 178.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.87 -38.0 61.06 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.24 0.616 . . . . 10.0 111.908 168.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 119.25 9.7 8.52 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 124.187 0.898 . . . . 10.0 113.344 176.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -135.76 172.74 12.57 Favored 'General case' 0 C--O 1.225 -0.221 0 N-CA-C 107.076 -1.453 . . . . 10.0 107.076 172.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 33.1 mttt -114.94 157.84 22.83 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 118.853 0.752 . . . . 10.0 111.994 -166.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.2 tp -143.82 145.3 32.25 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.206 1.802 . . . . 10.0 107.254 -170.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 32.2 mmtt -148.84 150.09 32.42 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 124.291 1.036 . . . . 10.0 109.044 164.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.6 tp -63.01 158.62 18.95 Favored 'General case' 0 N--CA 1.456 -0.172 0 O-C-N 123.919 0.762 . . . . 10.0 109.236 175.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 19.1 tttt -124.59 -53.81 1.67 Allowed 'General case' 0 N--CA 1.439 -1.023 0 C-N-CA 127.811 2.444 . . . . 10.0 107.559 -178.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 174.03 -85.56 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 108.098 -2.001 . . . . 10.0 108.098 175.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -160.25 159.86 31.95 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.38 1.072 . . . . 10.0 108.287 -169.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.25 147.3 23.03 Favored 'General case' 0 N--CA 1.454 -0.273 0 O-C-N 123.619 0.575 . . . . 10.0 109.643 174.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -115.25 164.31 14.42 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 107.48 -1.304 . . . . 10.0 107.48 165.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.3 t -166.33 84.6 0.3 Allowed 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.749 1.22 . . . . 10.0 108.175 -177.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 11.5 pt -104.58 -144.05 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 124.87 1.268 . . . . 10.0 108.006 177.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 68.36 84.81 0.15 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.749 1.619 . . . . 10.0 110.608 175.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 158.35 -109.2 0.39 Allowed Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.076 -1.21 . . . . 10.0 110.076 178.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 48.1 mtp180 . . . . . 0 C--O 1.252 1.196 0 CA-C-O 117.121 -1.419 . . . . 10.0 108.786 172.694 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 57.8 t . . . . . 0 N--CA 1.469 0.515 0 N-CA-C 106.633 -1.618 . . . . 10.0 106.633 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.474 HG21 ' HB2' ' A' ' 32' ' ' ALA . 4.9 p -115.19 172.38 7.11 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.133 1.773 . . . . 10.0 108.821 178.25 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -141.61 140.78 33.41 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 126.981 2.112 . . . . 10.0 106.833 -170.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -90.84 130.76 36.77 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 123.675 0.79 . . . . 10.0 109.063 177.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -133.12 146.93 52.05 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 125.915 1.686 . . . . 10.0 107.947 -177.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -123.69 150.28 44.47 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.227 0.611 . . . . 10.0 110.249 176.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.869 ' CE2' HD11 ' A' ' 57' ' ' LEU . 2.7 m-85 -138.56 140.9 39.21 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.897 1.279 . . . . 10.0 109.621 -171.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -101.13 134.77 43.65 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 124.836 1.254 . . . . 10.0 108.596 -175.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 6.1 mm -107.6 119.45 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 C-N-CA 124.751 1.221 . . . . 10.0 110.223 -161.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -111.33 95.95 5.82 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 108.329 -0.989 . . . . 10.0 108.329 174.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 151.54 -94.06 0.15 Allowed Glycine 0 CA--C 1.526 0.735 0 C-N-CA 123.951 0.786 . . . . 10.0 111.526 170.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 23.4 mmt -84.84 156.63 21.22 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 122.984 0.514 . . . . 10.0 111.772 -174.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -157.26 74.32 0.77 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.43 1.092 . . . . 10.0 109.31 -177.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.3 p -164.57 160.11 19.87 Favored 'General case' 0 C--N 1.342 0.26 0 O-C-N 120.92 -1.112 . . . . 10.0 109.779 176.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -55.38 -38.28 68.66 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.749 0.82 . . . . 10.0 111.326 179.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.96 -23.77 63.23 Favored 'General case' 0 N--CA 1.45 -0.434 0 O-C-N 121.848 -0.532 . . . . 10.0 110.221 -177.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 3.7 t -80.74 -60.21 2.39 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 108.958 -0.756 . . . . 10.0 108.958 173.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -39.27 -51.28 2.01 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 126.13 1.772 . . . . 10.0 111.191 176.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -55.88 -31.83 63.16 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 113.393 0.886 . . . . 10.0 113.393 -179.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.4 ' HG2' HD11 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -69.39 -53.56 18.82 Favored 'General case' 0 C--O 1.234 0.242 0 O-C-N 121.37 -0.831 . . . . 10.0 109.005 171.337 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.533 HG22 HD12 ' A' ' 25' ' ' LEU . 6.4 mm -44.07 -54.85 0.99 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.339 0 O-C-N 123.915 0.759 . . . . 10.0 110.093 179.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -42.53 -50.86 5.26 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.994 0.918 . . . . 10.0 111.702 178.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.39 -47.56 60.29 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 121.453 -0.779 . . . . 10.0 110.794 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.428 ' CG ' ' HB1' ' A' ' 60' ' ' ALA . 0.5 OUTLIER -57.64 -36.91 72.47 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.952 0.901 . . . . 10.0 110.765 -177.606 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.533 HD12 HG22 ' A' ' 21' ' ' ILE . 0.4 OUTLIER -77.83 -43.97 28.8 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 126.151 1.781 . . . . 10.0 110.741 175.829 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -52.55 -28.55 21.26 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 118.915 0.779 . . . . 10.0 111.606 172.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.7 tmmt? -62.11 -26.91 68.57 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 112.402 0.519 . . . . 10.0 112.402 177.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 10.0 mm -66.85 133.51 31.3 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.131 0 N-CA-C 108.874 -0.787 . . . . 10.0 108.874 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -64.8 -56.16 15.26 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 120.608 0.242 . . . . 10.0 110.67 -173.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.96 44.71 3.36 Favored Glycine 0 C--N 1.34 0.784 0 O-C-N 120.755 -1.215 . . . . 10.0 112.039 -171.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.6 p -108.15 150.59 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 C-N-CA 124.649 1.18 . . . . 10.0 108.846 -176.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.474 ' HB2' HG21 ' A' ' 2' ' ' THR . . . -122.3 -52.29 1.95 Allowed 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.078 0.551 . . . . 10.0 110.285 174.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -138.68 153.89 48.57 Favored 'General case' 0 C--N 1.338 0.097 0 N-CA-C 109.378 -0.601 . . . . 10.0 109.378 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -146.29 61.85 7.45 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 123.484 0.714 . . . . 10.0 111.548 173.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -77.46 73.22 5.66 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.972 2.448 . . . . 10.0 109.599 -179.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.507 HG12 HG13 ' A' ' 43' ' ' VAL . 2.6 m -66.57 151.72 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 O-C-N 121.96 -0.462 . . . . 10.0 111.075 -179.125 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 -97.68 125.91 42.72 Favored 'General case' 0 N--CA 1.458 -0.068 0 O-C-N 122.193 -0.317 . . . . 10.0 110.413 -175.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -105.4 41.69 1.33 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.074 1.349 . . . . 10.0 111.65 -170.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -171.62 -38.81 0.02 OUTLIER 'General case' 0 C--O 1.225 -0.207 0 C-N-CA 124.958 1.303 . . . . 10.0 110.125 178.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.2 mt -77.37 -17.56 58.11 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.219 1.008 . . . . 10.0 111.616 -175.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 68.56 46.62 0.97 Allowed 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 125.64 1.576 . . . . 10.0 110.136 177.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 12.0 p -141.89 128.86 20.72 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.692 1.197 . . . . 10.0 108.378 177.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.507 HG13 HG12 ' A' ' 36' ' ' VAL . 10.3 t -93.72 135.04 29.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 106.361 -1.718 . . . . 10.0 106.361 169.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 60.6 m -121.05 123.48 42.47 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 105.9 -1.889 . . . . 10.0 105.9 178.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 19.3 t -124.23 149.97 28.66 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.115 0 C-N-CA 123.472 0.709 . . . . 10.0 109.211 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -124.92 102.33 7.49 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 126.647 1.979 . . . . 10.0 105.728 175.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -138.75 166.35 24.63 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 123.883 0.873 . . . . 10.0 110.675 -172.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 19.0 p30 -104.53 127.39 29.09 Favored Pre-proline 0 CA--C 1.532 0.254 0 C-N-CA 123.092 0.557 . . . . 10.0 110.094 177.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -75.59 63.66 6.49 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 122.52 2.147 . . . . 10.0 109.568 176.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 22.3 ttmt -142.74 -58.47 0.44 Allowed 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 106.3 -1.741 . . . . 10.0 106.3 175.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -114.08 1.16 14.53 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.34 1.456 . . . . 10.0 112.632 -173.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -133.23 154.5 50.6 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 125.276 1.43 . . . . 10.0 110.096 171.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 90.8 p -146.74 160.32 42.38 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.363 0.601 . . . . 10.0 111.391 175.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 59.4 t -52.79 -49.87 45.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 124.995 1.318 . . . . 10.0 109.408 173.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -51.11 -47.92 61.85 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 126.37 1.868 . . . . 10.0 111.758 178.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -67.83 -54.9 15.37 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.954 0.901 . . . . 10.0 109.899 -174.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.869 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.1 pp -66.0 -40.55 91.25 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 120.935 -1.103 . . . . 10.0 111.149 -178.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -43.87 -49.32 8.32 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 120.905 -1.122 . . . . 10.0 112.257 161.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.5 -43.49 79.78 Favored 'General case' 0 C--N 1.339 0.133 0 CA-C-N 119.824 1.193 . . . . 10.0 111.022 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.428 ' HB1' ' CG ' ' A' ' 24' ' ' ARG . . . -53.77 -53.26 54.77 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.126 -0.488 . . . . 10.0 110.335 176.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 47.4 t -63.07 -37.35 79.14 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 N-CA-C 112.321 0.489 . . . . 10.0 112.321 177.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -60.53 -55.13 37.1 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 125.091 1.356 . . . . 10.0 108.858 -177.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? -55.12 -41.21 71.41 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.893 0.877 . . . . 10.0 110.611 175.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.4 HD11 ' HG2' ' A' ' 20' ' ' ARG . 0.1 OUTLIER -49.65 -33.14 14.7 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.33 0.652 . . . . 10.0 112.326 173.342 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 113.82 17.62 7.33 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 124.044 0.83 . . . . 10.0 113.117 169.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.07 167.43 22.1 Favored 'General case' 0 N--CA 1.458 -0.041 0 N-CA-C 107.366 -1.346 . . . . 10.0 107.366 175.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -105.43 144.12 32.65 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 121.536 0.684 . . . . 10.0 111.351 -164.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.4 tp -130.13 145.5 51.71 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.102 1.761 . . . . 10.0 107.9 -178.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 26.0 mmtt -151.77 154.43 36.24 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 124.673 1.189 . . . . 10.0 108.659 167.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.7 tp -63.41 155.21 29.66 Favored 'General case' 0 CA--C 1.529 0.167 0 O-C-N 123.702 0.626 . . . . 10.0 110.33 176.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -111.89 -60.01 1.91 Allowed 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 127.508 2.323 . . . . 10.0 106.418 172.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -179.07 -84.88 0.06 OUTLIER Glycine 0 CA--C 1.523 0.539 0 N-CA-C 109.625 -1.39 . . . . 10.0 109.625 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -163.56 174.78 11.37 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.475 1.11 . . . . 10.0 108.116 -169.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -47.97 113.46 0.73 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.19 0.996 . . . . 10.0 112.164 178.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -71.65 85.62 0.9 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.468 0.651 . . . . 10.0 109.653 178.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 67.2 m -129.24 159.65 35.44 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.8 1.64 . . . . 10.0 109.872 -174.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 10.1 pt -127.87 122.06 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 N-CA-C 104.653 -2.351 . . . . 10.0 104.653 175.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 39.13 72.79 0.13 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 127.96 2.504 . . . . 10.0 113.6 179.191 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -142.78 142.71 11.77 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 107.349 -2.3 . . . . 10.0 107.349 167.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 34.5 ttp180 . . . . . 0 C--O 1.249 1.037 0 CA-C-O 117.448 -1.263 . . . . 10.0 109.385 179.574 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 24.4 t . . . . . 0 N--CA 1.465 0.309 0 N-CA-C 105.825 -1.917 . . . . 10.0 105.825 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 13.4 p -126.39 153.29 45.17 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.004 1.322 . . . . 10.0 109.065 178.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -129.96 149.73 51.56 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 125.901 1.68 . . . . 10.0 109.49 -173.082 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.62 88.69 2.82 Favored 'General case' 0 C--N 1.341 0.215 0 C-N-CA 124.582 1.153 . . . . 10.0 109.606 -167.61 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -86.45 152.47 22.66 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.143 1.377 . . . . 10.0 110.523 -179.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -125.01 149.43 47.76 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.471 1.108 . . . . 10.0 109.341 174.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.716 ' CE2' HD11 ' A' ' 57' ' ' LEU . 4.7 m-85 -140.86 143.64 34.84 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 124.947 1.404 . . . . 10.0 110.794 -172.119 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -104.91 129.81 53.2 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.677 1.591 . . . . 10.0 108.849 -171.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 6.5 mm -103.62 111.29 32.76 Favored 'Isoleucine or valine' 0 C--N 1.342 0.252 0 C-N-CA 123.852 0.861 . . . . 10.0 111.289 -163.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -102.56 94.55 5.71 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 107.704 -1.221 . . . . 10.0 107.704 175.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 155.03 -77.03 0.21 Allowed Glycine 0 CA--C 1.527 0.821 0 CA-C-N 116.013 -0.54 . . . . 10.0 112.678 168.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 4.2 mmt -102.12 150.97 22.72 Favored 'General case' 0 N--CA 1.461 0.078 0 C-N-CA 123.432 0.693 . . . . 10.0 109.962 -176.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.3 m -68.56 -60.94 2.06 Favored 'General case' 0 N--CA 1.433 -1.312 0 C-N-CA 124.156 0.982 . . . . 10.0 110.921 -171.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.514 ' HA ' ' HB2' ' A' ' 18' ' ' ALA . 11.2 m 133.26 78.11 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 127.431 2.293 . . . . 10.0 106.005 -177.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -138.88 -92.3 0.19 Allowed 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 106.701 -1.592 . . . . 10.0 106.701 165.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.06 -43.65 98.02 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.274 -1.01 . . . . 10.0 108.274 178.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -68.57 -49.2 61.24 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 114.991 -1.004 . . . . 10.0 110.798 -176.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.602 ' HB1' HG21 ' A' ' 36' ' ' VAL . . . -46.13 -48.27 17.32 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.85 0.86 . . . . 10.0 111.109 167.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -58.84 -23.66 60.93 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 114.885 -1.052 . . . . 10.0 112.112 -179.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.9 tpt180 -80.86 -48.05 12.94 Favored 'General case' 0 N--CA 1.452 -0.352 0 O-C-N 121.314 -0.866 . . . . 10.0 110.02 168.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.464 ' CG2' HD12 ' A' ' 25' ' ' LEU . 29.0 mm -39.35 -57.65 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.433 0 CA-C-O 118.545 -0.74 . . . . 10.0 110.844 177.104 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -44.75 -49.23 10.72 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 123.598 0.561 . . . . 10.0 111.499 -175.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.2 ttmt -72.7 -45.44 58.8 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.539 0.736 . . . . 10.0 110.379 -176.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -60.58 -36.36 78.33 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 122.805 0.442 . . . . 10.0 111.673 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.464 HD12 ' CG2' ' A' ' 21' ' ' ILE . 0.9 OUTLIER -71.96 -49.01 40.96 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.41 1.084 . . . . 10.0 109.324 171.975 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -54.51 -19.47 5.87 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.542 -0.723 . . . . 10.0 112.704 177.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -56.25 -35.3 67.26 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.718 1.007 . . . . 10.0 113.718 171.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.46 HD11 ' CB ' ' A' ' 57' ' ' LEU . 11.2 mt -58.22 139.03 18.43 Favored 'Isoleucine or valine' 0 C--N 1.339 0.132 0 CA-C-N 118.59 0.632 . . . . 10.0 109.593 179.415 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -69.45 -52.66 24.64 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 111.665 0.246 . . . . 10.0 111.665 -176.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -85.07 44.29 3.36 Favored Glycine 0 C--N 1.339 0.749 0 O-C-N 120.705 -1.247 . . . . 10.0 111.224 -175.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.4 p -99.76 152.4 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 C-N-CA 124.62 1.168 . . . . 10.0 108.366 -179.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -112.92 -57.63 2.26 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 108.562 -0.903 . . . . 10.0 108.562 171.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 -148.71 158.13 43.93 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.217 -1.401 . . . . 10.0 107.217 -173.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -148.28 61.15 5.61 Favored Pre-proline 0 CA--C 1.531 0.245 0 O-C-N 121.902 -0.499 . . . . 10.0 111.568 168.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -75.03 83.79 1.77 Allowed 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 122.915 2.41 . . . . 10.0 108.225 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.602 HG21 ' HB1' ' A' ' 18' ' ' ALA . 3.6 m -54.48 157.3 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 C-N-CA 123.236 0.614 . . . . 10.0 110.527 173.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 -84.52 161.06 20.37 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 107.591 -1.263 . . . . 10.0 107.591 171.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -122.79 29.37 6.86 Favored 'General case' 0 C--N 1.335 -0.051 0 N-CA-C 112.21 0.448 . . . . 10.0 112.21 -169.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -174.55 -37.94 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 122.657 0.383 . . . . 10.0 111.227 -171.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 16.6 mt -72.18 -19.68 61.71 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.327 1.051 . . . . 10.0 111.66 -177.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 67.13 43.65 2.07 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.041 1.336 . . . . 10.0 109.557 -178.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 17.4 p -140.39 123.55 16.71 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.855 1.662 . . . . 10.0 109.167 178.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.549 HG13 HG12 ' A' ' 36' ' ' VAL . 8.6 t -89.76 149.08 4.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 108.226 -1.028 . . . . 10.0 108.226 173.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 85.3 m -130.07 125.94 36.43 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 106.787 -1.56 . . . . 10.0 106.787 179.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.418 HG22 HD13 ' A' ' 25' ' ' LEU . 42.1 t -120.13 128.45 75.96 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 C-N-CA 123.452 0.701 . . . . 10.0 109.196 177.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 72.2 tt0 -94.43 106.82 18.8 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 108.085 -1.08 . . . . 10.0 108.085 160.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -144.01 164.79 29.61 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 109.605 -0.517 . . . . 10.0 109.605 175.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 22.3 p30 -93.72 141.41 23.75 Favored Pre-proline 0 C--N 1.328 -0.334 0 N-CA-C 109.522 -0.547 . . . . 10.0 109.522 175.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -85.29 47.92 2.13 Favored 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 121.594 1.529 . . . . 10.0 109.485 170.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.9 -9.64 6.63 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.247 0.93 . . . . 10.0 113.127 177.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -128.56 -51.65 1.26 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.923 1.289 . . . . 10.0 108.68 -167.521 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -122.52 -172.22 2.43 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.767 1.227 . . . . 10.0 109.736 173.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 99.3 p -141.12 169.53 17.44 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.924 1.289 . . . . 10.0 110.959 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 70.0 t -50.1 -49.75 21.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 124.172 0.989 . . . . 10.0 110.491 165.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.2 m -58.47 -36.19 73.33 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 123.841 0.856 . . . . 10.0 111.991 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -69.09 -60.42 2.37 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 109.69 -0.485 . . . . 10.0 109.69 173.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.716 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.3 pp -60.07 -47.23 86.75 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 121.051 0.453 . . . . 10.0 110.822 -165.266 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.468 ' N ' HD12 ' A' ' 57' ' ' LEU . 0.9 OUTLIER -48.74 -36.45 16.41 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 114.004 1.113 . . . . 10.0 114.004 172.196 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -57.35 -33.49 67.81 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 119.08 0.854 . . . . 10.0 110.599 178.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.92 -51.82 66.58 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.544 -0.91 . . . . 10.0 108.544 -178.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 25.1 t -61.15 -45.84 97.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 124.89 1.276 . . . . 10.0 110.484 178.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -56.49 -55.4 34.2 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 124.196 0.998 . . . . 10.0 108.499 -178.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.78 -35.28 74.33 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.083 0.953 . . . . 10.0 111.62 177.01 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.4 mp -55.15 -32.82 62.41 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 118.626 -0.702 . . . . 10.0 112.383 171.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 134.76 -7.06 4.51 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-O 119.394 -0.67 . . . . 10.0 114.366 169.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -135.17 151.26 50.5 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 106.769 -1.567 . . . . 10.0 106.769 -177.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.79 142.28 35.0 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 121.46 0.648 . . . . 10.0 111.09 -161.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.568 HD11 ' HB2' ' A' ' 7' ' ' PHE . 16.0 tp -118.34 144.03 46.18 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.583 1.953 . . . . 10.0 107.842 -173.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 4.0 tptp -147.81 154.76 40.89 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.124 0.97 . . . . 10.0 108.669 171.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.7 tp -63.75 157.51 24.11 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 109.267 -0.642 . . . . 10.0 109.267 176.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 30.8 tttp -111.27 -67.19 1.01 Allowed 'General case' 0 N--CA 1.441 -0.89 0 C-N-CA 124.974 1.31 . . . . 10.0 107.932 170.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 162.1 49.75 0.02 OUTLIER Glycine 0 CA--C 1.526 0.762 0 CA-C-N 118.383 0.538 . . . . 10.0 112.914 174.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 64.16 170.61 0.18 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.823 1.249 . . . . 10.0 112.564 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -86.06 141.25 29.58 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.928 -0.578 . . . . 10.0 111.092 -177.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -69.78 69.74 0.31 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.478 1.111 . . . . 10.0 111.735 178.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 71.1 m -88.22 106.26 18.08 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 123.942 0.897 . . . . 10.0 111.013 175.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 48.0 mt -79.9 -23.04 11.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 123.771 0.828 . . . . 10.0 111.156 175.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -60.89 141.09 57.47 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.613 1.165 . . . . 10.0 110.621 -178.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 177.51 -166.93 37.66 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 109.326 -1.509 . . . . 10.0 109.326 179.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 66.1 ttt180 . . . . . 0 C--O 1.252 1.22 0 N-CA-C 104.984 -2.228 . . . . 10.0 104.984 165.055 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.8 p . . . . . 0 N--CA 1.47 0.558 0 N-CA-C 106.056 -1.831 . . . . 10.0 106.056 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 12.8 p -94.24 155.75 16.88 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.363 1.465 . . . . 10.0 109.824 -177.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -128.86 145.73 51.13 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 126.899 2.08 . . . . 10.0 108.528 -171.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -110.46 100.27 9.13 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.423 1.089 . . . . 10.0 112.559 -163.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -111.7 154.03 25.57 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.054 1.741 . . . . 10.0 110.241 -168.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -129.09 148.28 51.02 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 109.153 -0.684 . . . . 10.0 109.153 -177.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.753 ' CE2' HD11 ' A' ' 57' ' ' LEU . 4.3 m-85 -138.68 138.24 37.58 Favored 'General case' 0 N--CA 1.452 -0.361 0 O-C-N 124.92 1.388 . . . . 10.0 109.281 -171.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -100.89 126.29 47.5 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.399 1.08 . . . . 10.0 108.223 -171.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.411 HD11 HG23 ' A' ' 43' ' ' VAL . 6.7 mm -104.62 126.85 59.39 Favored 'Isoleucine or valine' 0 C--N 1.343 0.307 0 C-N-CA 124.654 1.182 . . . . 10.0 111.875 -164.132 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -112.66 98.68 7.39 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.459 -0.941 . . . . 10.0 108.459 168.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 153.88 -106.32 0.29 Allowed Glycine 0 CA--C 1.53 0.973 0 C-N-CA 123.149 0.404 . . . . 10.0 112.749 171.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 59.3 mtt -90.46 89.8 7.74 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 117.509 0.654 . . . . 10.0 111.416 -169.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.4 p -118.95 56.94 0.89 Allowed 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 125.414 1.486 . . . . 10.0 109.736 -171.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 96.2 m -111.87 -87.61 0.54 Allowed 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 123.468 0.707 . . . . 10.0 109.555 -172.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -170.45 -58.26 0.02 OUTLIER 'General case' 0 C--N 1.338 0.091 0 C-N-CA 124.161 0.985 . . . . 10.0 109.879 -178.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.42 -40.25 93.11 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.568 -0.901 . . . . 10.0 108.568 -177.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 99.1 m -74.07 -45.54 48.71 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.509 -0.769 . . . . 10.0 110.153 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -45.05 -51.62 9.87 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.68 0.792 . . . . 10.0 111.229 170.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -52.86 -30.47 34.03 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.923 0.712 . . . . 10.0 112.923 176.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.3 ttm180 -72.32 -36.8 68.98 Favored 'General case' 0 N--CA 1.447 -0.61 0 O-C-N 121.009 -1.057 . . . . 10.0 109.371 -178.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.677 HG22 HD12 ' A' ' 25' ' ' LEU . 1.6 mt -57.49 -48.17 83.51 Favored 'Isoleucine or valine' 0 C--N 1.344 0.344 0 CA-C-O 118.324 -0.846 . . . . 10.0 108.967 172.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -47.73 -47.04 30.37 Favored 'General case' 0 C--O 1.225 -0.187 0 CA-C-N 118.59 0.632 . . . . 10.0 111.517 -178.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 27.6 ttmt -72.56 -48.87 36.57 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.156 0.582 . . . . 10.0 110.298 -177.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -54.31 -41.19 68.69 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.629 0.603 . . . . 10.0 112.629 176.489 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.677 HD12 HG22 ' A' ' 21' ' ' ILE . 1.5 mt -68.84 -52.4 30.29 Favored 'General case' 0 C--O 1.221 -0.421 0 C-N-CA 124.95 1.3 . . . . 10.0 109.521 173.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 45.9 m-20 -54.02 -19.85 5.44 Favored 'General case' 0 C--O 1.227 -0.118 0 CA-C-N 118.63 0.65 . . . . 10.0 111.964 179.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.6 ttmt -58.74 -26.59 64.12 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 113.72 1.007 . . . . 10.0 113.72 172.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.69 HD11 ' HB3' ' A' ' 57' ' ' LEU . 10.8 mt -54.26 133.93 17.27 Favored 'Isoleucine or valine' 0 C--N 1.341 0.232 0 CA-C-N 119.572 1.078 . . . . 10.0 108.706 173.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -69.56 -47.44 63.65 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.919 -0.488 . . . . 10.0 111.418 179.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -86.61 45.71 3.48 Favored Glycine 0 C--N 1.339 0.714 0 O-C-N 120.637 -1.289 . . . . 10.0 111.2 -174.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -99.32 149.59 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 108.389 -0.967 . . . . 10.0 108.389 -176.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -104.2 -57.43 2.03 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 107.769 -1.197 . . . . 10.0 107.769 165.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 55.4 m-80 -149.28 156.18 41.7 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.409 -0.96 . . . . 10.0 108.409 -171.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -146.45 61.94 7.41 Favored Pre-proline 0 CA--C 1.538 0.517 0 N-CA-C 112.86 0.689 . . . . 10.0 112.86 169.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -79.05 85.74 1.81 Allowed 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 123.23 2.62 . . . . 10.0 109.746 -178.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.416 HG12 HG13 ' A' ' 43' ' ' VAL . 3.0 m -71.84 153.56 7.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 O-C-N 121.495 -0.753 . . . . 10.0 110.901 -178.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -94.02 127.34 39.76 Favored 'General case' 0 C--N 1.339 0.11 0 O-C-N 121.996 -0.44 . . . . 10.0 110.771 -175.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -105.16 59.56 0.68 Allowed 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.437 1.495 . . . . 10.0 110.772 -173.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 173.47 -35.97 0.0 OUTLIER 'General case' 0 C--O 1.226 -0.176 0 C-N-CA 125.411 1.485 . . . . 10.0 109.794 171.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.6 mt -83.33 -14.22 53.4 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.913 0.885 . . . . 10.0 111.087 -172.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 75.92 38.31 0.35 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.735 1.614 . . . . 10.0 110.785 170.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 38.3 p -137.18 131.66 32.83 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.136 1.374 . . . . 10.0 109.327 -177.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.416 HG13 HG12 ' A' ' 36' ' ' VAL . 3.6 t -91.8 142.72 12.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 107.625 -1.25 . . . . 10.0 107.625 167.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 44.7 m -127.2 124.61 39.39 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 106.828 -1.545 . . . . 10.0 106.828 177.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.8 t -124.6 141.24 45.36 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 N-CA-C 109.183 -0.673 . . . . 10.0 109.183 -179.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 55.1 tt0 -115.22 106.82 14.5 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 106.985 -1.487 . . . . 10.0 106.985 166.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -149.96 158.64 44.36 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 123.062 0.545 . . . . 10.0 109.667 -179.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -88.64 128.26 53.3 Favored Pre-proline 0 C--N 1.326 -0.421 0 N-CA-C 109.952 -0.388 . . . . 10.0 109.952 178.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -75.69 60.4 5.92 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.479 2.119 . . . . 10.0 108.939 171.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.5 tttt -130.91 -52.62 1.05 Allowed 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 106.472 -1.677 . . . . 10.0 106.472 173.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -83.85 -43.51 15.28 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.077 0.551 . . . . 10.0 110.475 -170.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -134.12 -173.61 3.31 Favored 'General case' 0 C--N 1.339 0.128 0 C-N-CA 124.904 1.282 . . . . 10.0 109.093 178.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 79.8 p -145.78 166.8 24.84 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.676 0.75 . . . . 10.0 109.864 -177.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.64 HG11 HD11 ' A' ' 70' ' ' LEU . 26.8 m -49.79 -41.53 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 115.064 -0.971 . . . . 10.0 111.428 167.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.3 m -56.37 -44.2 79.95 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 123.914 0.885 . . . . 10.0 112.178 177.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -63.22 -56.89 12.83 Favored 'General case' 0 C--N 1.337 0.064 0 N-CA-C 109.203 -0.666 . . . . 10.0 109.203 179.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.753 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.2 pp -67.63 -41.22 84.23 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 119.675 -0.81 . . . . 10.0 110.81 -171.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.458 ' HA ' HD23 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -39.63 -52.47 2.22 Favored 'General case' 0 C--O 1.224 -0.238 0 O-C-N 121.683 -0.635 . . . . 10.0 112.473 159.333 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.45 -43.24 93.2 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 118.62 0.645 . . . . 10.0 109.873 179.4 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -51.87 -46.97 64.69 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 116.062 -0.517 . . . . 10.0 110.224 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.403 ' HA ' HD12 ' A' ' 64' ' ' LEU . 40.6 t -68.34 -47.44 77.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 124.266 1.026 . . . . 10.0 112.58 175.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -58.25 -35.37 71.64 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.406 -0.809 . . . . 10.0 109.126 -176.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.1 -28.79 39.0 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 118.538 -0.744 . . . . 10.0 112.179 179.315 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.403 HD12 ' HA ' ' A' ' 61' ' ' VAL . 10.2 mt -53.83 -42.65 68.7 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 120.036 1.289 . . . . 10.0 110.797 165.14 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 139.95 -14.3 3.09 Favored Glycine 0 CA--C 1.527 0.794 0 CA-C-O 119.974 -0.348 . . . . 10.0 113.787 170.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -114.83 159.19 20.92 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 125.54 1.536 . . . . 10.0 107.271 179.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 25.8 mttp -97.24 159.56 14.84 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 121.731 0.777 . . . . 10.0 111.782 -171.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.458 HD23 ' HA ' ' A' ' 58' ' ' LYS . 20.5 tp -137.24 147.28 45.65 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.929 1.691 . . . . 10.0 107.433 -177.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 22.9 tptt -154.41 153.41 31.52 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 108.624 -0.88 . . . . 10.0 108.624 164.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.64 HD11 HG11 ' A' ' 54' ' ' VAL . 22.5 mt -61.04 160.21 10.36 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 121.936 0.874 . . . . 10.0 110.856 175.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 12.3 tptt -113.12 -58.0 2.21 Favored 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 128.061 2.544 . . . . 10.0 106.419 173.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -179.88 -84.13 0.06 OUTLIER Glycine 0 CA--C 1.523 0.544 0 N-CA-C 109.617 -1.393 . . . . 10.0 109.617 178.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -165.39 160.8 18.43 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.304 -0.998 . . . . 10.0 108.304 -169.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.53 139.24 58.6 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 113.124 0.787 . . . . 10.0 113.124 -178.034 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -42.64 -51.04 5.36 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.13 1.772 . . . . 10.0 110.929 177.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.6 t 68.23 -171.53 0.19 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.696 1.198 . . . . 10.0 111.605 174.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.4 mt -145.29 25.28 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 125.098 1.359 . . . . 10.0 109.262 176.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 63.45 -167.74 0.21 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.427 1.091 . . . . 10.0 110.568 -172.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -161.17 -103.86 0.19 Allowed Glycine 0 CA--C 1.53 0.977 0 O-C-N 121.471 -0.768 . . . . 10.0 112.658 -173.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 11.1 mtt180 . . . . . 0 C--O 1.25 1.086 0 CA-C-O 116.82 -1.562 . . . . 10.0 107.043 164.754 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 8.7 p . . . . . 0 N--CA 1.469 0.51 0 N-CA-C 106.974 -1.491 . . . . 10.0 106.974 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.426 HG21 ' HB2' ' A' ' 32' ' ' ALA . 3.4 p -150.19 165.82 31.73 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 125.61 1.564 . . . . 10.0 107.263 -179.052 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -108.68 144.45 36.43 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 126.339 1.855 . . . . 10.0 110.28 179.484 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.0 mmtm -88.47 113.83 24.47 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.701 1.2 . . . . 10.0 109.801 174.034 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -116.64 149.87 39.04 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.678 1.191 . . . . 10.0 110.494 170.922 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -117.03 151.05 37.59 Favored 'General case' 0 CA--C 1.518 -0.257 0 C-N-CA 124.564 1.146 . . . . 10.0 111.423 171.237 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.736 ' CE2' HD11 ' A' ' 57' ' ' LEU . 1.8 m-85 -140.99 137.47 33.04 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.549 1.14 . . . . 10.0 110.143 -175.333 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.537 ' CG ' ' HZ3' ' A' ' 71' ' ' LYS . 6.9 m-20 -95.0 137.84 33.52 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 125.165 1.386 . . . . 10.0 109.11 -176.952 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.468 HD11 HG23 ' A' ' 43' ' ' VAL . 7.5 mm -109.47 132.41 57.7 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 C-N-CA 124.84 1.256 . . . . 10.0 110.639 -164.822 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -121.68 88.18 2.89 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.377 -0.971 . . . . 10.0 108.377 173.197 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 150.46 -94.62 0.15 Allowed Glycine 0 CA--C 1.528 0.895 0 C-N-CA 123.394 0.521 . . . . 10.0 112.034 169.905 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 42.8 mtt -69.95 134.82 48.77 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 117.907 0.854 . . . . 10.0 111.235 -174.878 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.3 t -153.02 73.7 1.01 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.33 1.052 . . . . 10.0 108.531 -177.426 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 9.9 t -164.24 147.16 9.23 Favored 'General case' 0 C--N 1.339 0.122 0 O-C-N 120.939 -1.101 . . . . 10.0 109.762 -179.732 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -46.41 -46.04 18.37 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.043 1.337 . . . . 10.0 113.762 -174.768 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.34 -36.48 83.0 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 121.827 -0.545 . . . . 10.0 109.69 -177.634 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 91.2 m -72.81 -53.3 11.88 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 108.377 -0.972 . . . . 10.0 108.377 -176.4 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -39.18 -57.29 1.35 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 126.067 1.747 . . . . 10.0 110.948 168.237 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -49.43 -36.64 22.98 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.643 0.777 . . . . 10.0 112.44 175.682 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 15.6 ttt180 -73.49 -47.86 37.85 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 121.65 -0.656 . . . . 10.0 109.291 -179.61 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.3 mt -42.46 -52.51 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 123.1 0.56 . . . . 10.0 110.769 171.125 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -42.83 -58.54 2.32 Favored 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 123.01 0.524 . . . . 10.0 111.025 179.616 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -70.18 -39.59 75.15 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.859 0.863 . . . . 10.0 109.87 -173.885 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.24 -36.46 66.06 Favored 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 122.705 0.402 . . . . 10.0 110.685 175.611 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.49 -36.63 26.27 Favored 'General case' 0 C--O 1.222 -0.376 0 C-N-CA 123.571 0.749 . . . . 10.0 112.554 173.191 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -57.69 -25.73 60.72 Favored 'General case' 0 C--N 1.328 -0.326 0 O-C-N 120.715 -1.24 . . . . 10.0 109.821 179.291 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.5 mmpt? -51.82 -38.45 55.82 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 114.336 1.235 . . . . 10.0 114.336 168.975 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.423 HG23 ' CB ' ' A' ' 52' ' ' ALA . 11.5 mt -57.19 129.43 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 CA-C-N 118.838 0.745 . . . . 10.0 109.253 178.925 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -64.8 -49.53 70.29 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 120.968 -0.293 . . . . 10.0 110.991 -179.942 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -82.91 46.51 3.63 Favored Glycine 0 C--N 1.339 0.717 0 O-C-N 120.998 -1.064 . . . . 10.0 111.5 -175.008 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.3 p -106.7 152.9 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 C-N-CA 124.588 1.155 . . . . 10.0 109.003 -177.716 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.426 ' HB2' HG21 ' A' ' 2' ' ' THR . . . -115.23 -51.95 2.69 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.989 -0.745 . . . . 10.0 108.989 168.499 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -151.58 158.86 44.09 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 109.234 -0.654 . . . . 10.0 109.234 -176.68 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -143.18 64.11 13.76 Favored Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 123.918 0.887 . . . . 10.0 111.861 173.088 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -79.22 77.68 4.0 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.178 2.585 . . . . 10.0 109.8 -177.252 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.519 HG12 HG13 ' A' ' 43' ' ' VAL . 2.4 m -71.3 153.16 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 O-C-N 121.775 -0.578 . . . . 10.0 111.385 -176.927 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 74.1 m-80 -87.46 148.05 25.12 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 120.817 -0.353 . . . . 10.0 110.298 177.241 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -124.02 44.8 2.63 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.904 1.281 . . . . 10.0 111.104 -172.306 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -175.8 -40.63 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.216 0 C-N-CA 125.292 1.437 . . . . 10.0 109.596 178.005 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.6 mt -78.15 -18.29 55.77 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.381 1.072 . . . . 10.0 111.834 -172.034 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 66.87 46.38 1.66 Allowed 'General case' 0 C--O 1.231 0.091 0 C-N-CA 125.377 1.471 . . . . 10.0 110.398 179.144 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.9 p -139.03 121.72 16.38 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 125.153 1.381 . . . . 10.0 108.538 176.349 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.519 HG13 HG12 ' A' ' 36' ' ' VAL . 17.9 t -88.55 137.56 20.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 107.227 -1.398 . . . . 10.0 107.227 168.505 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 88.8 m -120.09 124.02 44.8 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 106.445 -1.687 . . . . 10.0 106.445 176.659 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 24.7 t -121.56 140.1 46.64 Favored 'Isoleucine or valine' 0 C--N 1.339 0.139 0 CA-C-N 119.114 0.87 . . . . 10.0 110.073 178.755 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -105.19 101.47 11.02 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.458 1.503 . . . . 10.0 107.078 164.389 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -143.19 158.47 43.59 Favored 'General case' 0 CA--C 1.52 -0.21 0 C-N-CA 123.0 0.52 . . . . 10.0 110.627 178.421 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -93.06 129.45 39.46 Favored Pre-proline 0 CA--C 1.531 0.247 0 C-N-CA 123.393 0.677 . . . . 10.0 110.043 176.309 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -78.04 57.15 6.01 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 122.244 1.962 . . . . 10.0 108.86 169.768 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.74 -62.67 1.12 Allowed 'General case' 0 CA--C 1.521 -0.149 0 N-CA-C 106.533 -1.655 . . . . 10.0 106.533 175.822 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -81.84 -32.32 31.24 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 122.468 0.307 . . . . 10.0 110.87 -173.196 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.423 ' CB ' HG23 ' A' ' 28' ' ' ILE . . . -135.22 -176.48 4.27 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.14 0.976 . . . . 10.0 109.606 177.214 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 86.7 p -140.71 169.73 17.09 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.842 0.857 . . . . 10.0 111.501 -179.853 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 59.4 t -42.53 -48.71 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 125.43 1.492 . . . . 10.0 111.571 160.786 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.5 t -66.82 -34.25 77.4 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.356 -0.384 . . . . 10.0 110.553 -176.0 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -65.77 -60.71 2.61 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.682 -0.859 . . . . 10.0 108.682 173.382 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.736 HD11 ' CE2' ' A' ' 7' ' ' PHE . 3.9 pp -63.68 -44.91 92.34 Favored 'General case' 0 N--CA 1.447 -0.583 0 O-C-N 121.982 -0.449 . . . . 10.0 111.036 -164.774 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.418 ' N ' HD12 ' A' ' 57' ' ' LEU . 1.0 OUTLIER -48.64 -39.56 24.58 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 113.319 0.859 . . . . 10.0 113.319 170.094 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -57.25 -32.94 67.08 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 119.235 0.925 . . . . 10.0 110.646 178.939 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.41 -48.24 81.31 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.792 0.805 . . . . 10.0 109.338 -178.562 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.613 HG13 ' CE2' ' A' ' 66' ' ' TYR . 57.6 t -64.94 -50.57 74.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 124.947 1.299 . . . . 10.0 111.043 174.49 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -50.27 -39.18 44.4 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.354 1.462 . . . . 10.0 109.167 -179.292 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 33.1 tptt -76.59 -40.96 47.98 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 125.303 1.441 . . . . 10.0 110.595 -178.063 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 28.3 mt -53.19 -41.09 64.93 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.712 0.687 . . . . 10.0 111.402 169.056 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 140.4 -30.78 2.3 Favored Glycine 0 C--N 1.338 0.69 0 CA-C-N 118.225 0.466 . . . . 10.0 113.428 166.722 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.613 ' CE2' HG13 ' A' ' 61' ' ' VAL . 15.6 p90 -86.86 160.2 18.82 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 107.797 -1.186 . . . . 10.0 107.797 172.711 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -105.42 150.67 25.05 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 120.859 0.361 . . . . 10.0 110.549 -170.546 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.532 HD11 ' HB2' ' A' ' 7' ' ' PHE . 21.8 tp -123.2 150.47 43.33 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 126.643 1.977 . . . . 10.0 108.234 -176.897 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 19.5 tptt -154.26 140.01 18.05 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 123.145 0.578 . . . . 10.0 110.683 166.018 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.607 HD23 ' N ' ' A' ' 71' ' ' LYS . 2.4 tt -70.8 158.27 36.63 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 123.524 0.729 . . . . 10.0 109.786 -178.966 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.607 ' N ' HD23 ' A' ' 70' ' ' LEU . 11.8 ttpt -121.74 -67.17 0.98 Allowed 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 126.894 2.078 . . . . 10.0 108.759 178.815 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -165.54 -81.31 0.04 OUTLIER Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.025 -1.23 . . . . 10.0 110.025 176.627 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -163.45 165.02 24.26 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 124.578 1.151 . . . . 10.0 107.937 -169.154 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.19 57.72 1.9 Allowed 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 117.829 0.286 . . . . 10.0 110.418 174.756 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 24.6 t0 37.13 59.93 1.06 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.858 1.663 . . . . 10.0 111.226 -178.646 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.9 t -79.86 -49.47 11.91 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.734 0.814 . . . . 10.0 109.018 -171.068 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.41 ' O ' HG22 ' A' ' 77' ' ' ILE . 27.9 mt 66.66 2.89 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 C-N-CA 124.2 1.0 . . . . 10.0 112.342 176.418 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -120.5 156.16 32.09 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 124.793 1.237 . . . . 10.0 109.755 175.909 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -150.24 95.96 0.16 Allowed Glycine 0 CA--C 1.523 0.571 0 N-CA-C 105.537 -3.025 . . . . 10.0 105.537 170.927 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 13.3 tpt85 . . . . . 0 C--O 1.252 1.22 0 CA-C-O 117.027 -1.463 . . . . 10.0 110.863 -164.35 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.463 HG13 ' H ' ' A' ' 2' ' ' THR . 2.7 p . . . . . 0 N--CA 1.474 0.764 0 N-CA-C 109.146 -0.687 . . . . 10.0 109.146 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.491 HG21 ' HB2' ' A' ' 32' ' ' ALA . 1.1 p -144.13 170.89 15.11 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 105.908 -1.886 . . . . 10.0 105.908 171.789 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -133.98 143.24 48.03 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 126.83 2.052 . . . . 10.0 106.723 -168.345 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 18.3 tptm -89.25 143.33 26.91 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 107.546 -1.279 . . . . 10.0 107.546 -176.273 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -147.44 148.13 30.95 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.416 0.686 . . . . 10.0 109.441 177.66 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -128.09 152.41 48.01 Favored 'General case' 0 CA--C 1.507 -0.675 0 C-N-CA 124.494 1.118 . . . . 10.0 109.156 173.014 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.793 ' CE2' HD11 ' A' ' 57' ' ' LEU . 2.7 m-85 -143.4 131.44 21.75 Favored 'General case' 0 N--CA 1.447 -0.623 0 O-C-N 125.607 1.817 . . . . 10.0 108.638 -170.826 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -93.59 138.41 31.87 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 106.811 -1.551 . . . . 10.0 106.811 -179.57 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 5.3 mm -105.44 141.23 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 124.289 1.036 . . . . 10.0 109.415 -166.251 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -107.21 81.14 1.5 Allowed 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 106.845 -1.539 . . . . 10.0 106.845 172.847 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.02 135.03 6.23 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.083 -0.962 . . . . 10.0 111.107 178.362 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 8.9 ptp -145.76 161.04 40.83 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 122.179 -0.6 . . . . 10.0 111.768 163.4 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.8 m -70.12 -40.38 74.9 Favored 'General case' 0 N--CA 1.438 -1.026 0 C-N-CA 125.516 1.526 . . . . 10.0 110.803 172.77 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 45.5 t 89.95 135.79 0.03 OUTLIER 'General case' 0 C--N 1.346 0.415 0 C-N-CA 126.508 1.923 . . . . 10.0 108.996 -178.551 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 59.39 -75.5 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.649 1.58 . . . . 10.0 111.848 -172.668 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.52 -28.67 67.28 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.185 0.994 . . . . 10.0 109.486 177.935 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.4 t -54.82 -69.32 0.13 Allowed 'General case' 0 C--N 1.343 0.291 0 C-N-CA 120.463 -0.495 . . . . 10.0 109.979 168.516 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -49.57 -38.09 29.88 Favored 'General case' 0 CA--C 1.522 -0.124 0 C-N-CA 123.473 0.709 . . . . 10.0 110.615 -177.526 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -58.81 -43.88 90.67 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 119.963 -0.695 . . . . 10.0 110.658 179.415 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.488 ' CG ' HD11 ' A' ' 64' ' ' LEU . 3.8 tpp85 -75.09 -44.36 47.75 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 109.098 -0.704 . . . . 10.0 109.098 -178.95 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.4 mm -44.49 -62.08 0.33 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.466 0 C-N-CA 124.063 0.945 . . . . 10.0 108.898 173.663 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -54.61 -34.83 62.67 Favored 'General case' 0 C--O 1.22 -0.483 0 CA-C-N 118.497 0.59 . . . . 10.0 112.203 -175.172 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.04 -43.43 78.74 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 120.715 -1.24 . . . . 10.0 109.376 176.595 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.459 ' HB3' ' HB1' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -67.53 -39.67 85.05 Favored 'General case' 0 C--O 1.224 -0.261 0 O-C-N 122.12 -0.362 . . . . 10.0 111.598 177.997 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.56 -34.62 58.48 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.693 1.197 . . . . 10.0 110.337 -179.426 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -71.14 -7.51 47.14 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 121.671 -0.643 . . . . 10.0 109.537 173.865 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.491 ' HE3' ' HB2' ' A' ' 60' ' ' ALA . 0.5 OUTLIER -60.5 -37.94 82.71 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 118.368 -1.333 . . . . 10.0 109.422 165.92 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.464 HG23 ' CB ' ' A' ' 52' ' ' ALA . 25.6 mm -60.16 123.59 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 123.647 0.779 . . . . 10.0 109.711 -173.729 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -68.32 -48.84 63.81 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 110.001 -0.37 . . . . 10.0 110.001 -179.169 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -82.54 41.06 2.79 Favored Glycine 0 CA--C 1.526 0.747 0 O-C-N 121.326 -0.859 . . . . 10.0 111.937 -175.42 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.3 p -104.46 146.82 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 C-N-CA 124.864 1.266 . . . . 10.0 108.73 -178.266 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.491 ' HB2' HG21 ' A' ' 2' ' ' THR . . . -115.94 -52.44 2.61 Favored 'General case' 0 C--N 1.333 -0.109 0 C-N-CA 122.848 0.459 . . . . 10.0 109.838 172.085 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -139.52 143.03 37.25 Favored 'General case' 0 C--N 1.341 0.212 0 N-CA-C 108.803 -0.814 . . . . 10.0 108.803 -176.797 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -130.85 62.74 67.12 Favored Pre-proline 0 CA--C 1.536 0.435 0 C-N-CA 123.39 0.676 . . . . 10.0 110.48 173.188 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -76.26 66.37 7.08 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 123.448 2.765 . . . . 10.0 110.633 -175.931 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.627 HG22 HG13 ' A' ' 43' ' ' VAL . 41.5 t -68.47 145.16 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 C-N-CA 126.123 1.769 . . . . 10.0 110.98 -176.805 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -90.98 145.07 25.02 Favored 'General case' 0 C--N 1.341 0.239 0 C-N-CA 120.315 -0.554 . . . . 10.0 110.582 -179.828 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -122.82 65.47 0.96 Allowed 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 125.309 1.444 . . . . 10.0 109.819 -172.861 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 157.55 -30.9 0.0 OUTLIER 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 127.627 2.371 . . . . 10.0 109.621 169.405 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.6 mt -75.56 -17.62 60.0 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.799 0.839 . . . . 10.0 110.846 -173.821 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 67.07 48.39 1.24 Allowed 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 126.005 1.722 . . . . 10.0 110.653 177.205 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.4 p -143.1 124.77 14.94 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.49 1.516 . . . . 10.0 108.283 176.422 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.627 HG13 HG22 ' A' ' 36' ' ' VAL . 12.0 t -94.2 141.58 14.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 106.884 -1.525 . . . . 10.0 106.884 169.602 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.6 m -129.98 126.05 36.85 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 105.491 -2.04 . . . . 10.0 105.491 -177.889 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 23.9 t -128.37 152.93 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 CA-C-N 118.657 0.662 . . . . 10.0 109.402 178.886 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -130.41 96.94 4.26 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 105.021 -2.215 . . . . 10.0 105.021 176.213 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -148.77 164.66 33.76 Favored 'General case' 0 C--O 1.226 -0.152 0 C-N-CA 123.956 0.903 . . . . 10.0 110.343 -171.569 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -96.09 132.63 26.51 Favored Pre-proline 0 C--N 1.33 -0.24 0 C-N-CA 122.858 0.463 . . . . 10.0 110.501 179.577 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -79.68 55.62 5.71 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 121.721 1.614 . . . . 10.0 109.136 166.991 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.52 -41.49 1.7 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 118.234 0.47 . . . . 10.0 110.364 177.73 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.89 -32.28 11.76 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.688 0.795 . . . . 10.0 111.091 178.332 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.464 ' CB ' HG23 ' A' ' 28' ' ' ILE . . . -138.22 -174.83 3.91 Favored 'General case' 0 CA--C 1.523 -0.065 0 C-N-CA 124.644 1.178 . . . . 10.0 109.67 -175.996 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.7 p -148.42 163.25 37.71 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 123.058 0.543 . . . . 10.0 109.896 -178.936 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 55.8 t -38.55 -50.39 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 C-N-CA 125.345 1.458 . . . . 10.0 110.07 163.698 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.3 m -51.4 -44.07 62.1 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 124.552 1.141 . . . . 10.0 113.056 -179.762 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -72.37 -53.59 11.86 Favored 'General case' 0 C--O 1.224 -0.289 0 N-CA-C 109.78 -0.452 . . . . 10.0 109.78 -178.625 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.793 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.0 pp -61.05 -39.95 91.79 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 118.247 -1.381 . . . . 10.0 110.738 -177.97 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.442 ' HA ' HD23 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -44.86 -57.48 3.74 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-O 117.854 -1.069 . . . . 10.0 112.309 161.54 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 14.6 tm-20 -50.22 -48.49 54.36 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-N 120.332 1.424 . . . . 10.0 110.298 176.392 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.491 ' HB2' ' HE3' ' A' ' 27' ' ' LYS . . . -51.63 -54.07 31.76 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 123.555 0.742 . . . . 10.0 109.602 -178.044 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 91.6 t -63.03 -45.12 99.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 115.986 -0.552 . . . . 10.0 111.155 177.818 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.45 -56.86 10.98 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.99 0.9 . . . . 10.0 109.836 178.942 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.9 tptp -49.35 -36.97 23.0 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 127.287 2.235 . . . . 10.0 111.602 175.273 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.488 HD11 ' CG ' ' A' ' 20' ' ' ARG . 5.4 tp -60.89 -34.38 74.55 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 125.055 1.342 . . . . 10.0 111.705 179.17 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 146.83 -53.0 0.55 Allowed Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.754 -0.538 . . . . 10.0 111.754 176.962 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -98.86 158.83 15.37 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 123.939 0.896 . . . . 10.0 109.859 -176.832 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 8.5 ttpt -92.16 153.18 19.5 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.217 0.532 . . . . 10.0 110.232 -170.46 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.479 HD11 ' HB2' ' A' ' 7' ' ' PHE . 23.9 tp -125.74 151.69 46.33 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.981 1.713 . . . . 10.0 107.932 179.734 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.9 tptp -153.92 147.63 25.29 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 122.775 0.43 . . . . 10.0 110.275 162.919 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.3 tp -59.14 158.48 8.77 Favored 'General case' 0 C--N 1.34 0.155 0 O-C-N 123.485 0.491 . . . . 10.0 109.963 176.561 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.6 tttt -116.26 -71.26 0.75 Allowed 'General case' 0 N--CA 1.436 -1.136 0 C-N-CA 126.849 2.059 . . . . 10.0 108.205 179.472 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 158.88 43.89 0.02 OUTLIER Glycine 0 CA--C 1.529 0.956 0 C-N-CA 123.952 0.787 . . . . 10.0 111.609 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 67.58 163.17 0.2 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.995 1.318 . . . . 10.0 111.962 171.6 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -79.26 -57.47 3.7 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 108.506 -0.924 . . . . 10.0 108.506 176.033 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -73.71 67.96 1.2 Allowed 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 126.814 2.046 . . . . 10.0 109.119 -172.961 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 29.6 t -52.09 -33.28 38.71 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 127.386 2.274 . . . . 10.0 112.341 -173.078 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 23.7 pt -131.84 164.88 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.409 0 N-CA-C 104.808 -2.293 . . . . 10.0 104.808 168.276 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -106.15 174.65 5.79 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 125.287 1.435 . . . . 10.0 109.799 169.971 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -160.17 -179.04 34.69 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 106.432 -2.667 . . . . 10.0 106.432 172.245 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 66.0 ttt180 . . . . . 0 C--O 1.254 1.33 0 N-CA-C 105.113 -2.181 . . . . 10.0 105.113 176.195 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 11.4 t . . . . . 0 N--CA 1.464 0.247 0 N-CA-C 106.528 -1.656 . . . . 10.0 106.528 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.535 HG21 ' HB2' ' A' ' 32' ' ' ALA . 4.6 p -116.27 132.25 56.72 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 122.606 1.194 . . . . 10.0 112.506 -168.723 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -82.62 164.19 20.94 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 107.791 -1.188 . . . . 10.0 107.791 176.352 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.65 144.73 31.99 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 106.737 -1.579 . . . . 10.0 106.737 176.611 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -148.24 139.23 23.18 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.424 -0.954 . . . . 10.0 108.424 179.294 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -120.71 148.21 44.26 Favored 'General case' 0 CA--C 1.513 -0.466 0 C-N-CA 123.964 0.906 . . . . 10.0 109.187 175.866 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.746 ' CE2' HD11 ' A' ' 57' ' ' LEU . 12.8 m-85 -139.11 144.2 38.59 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.131 1.372 . . . . 10.0 109.144 -174.834 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -110.14 127.33 54.84 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.67 1.188 . . . . 10.0 107.878 -172.213 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.535 HD11 ' HB ' ' A' ' 43' ' ' VAL . 2.5 mm -107.25 137.16 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 124.004 0.922 . . . . 10.0 111.301 -160.691 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -123.37 91.35 3.46 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.554 1.141 . . . . 10.0 108.239 179.816 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 115.15 43.71 0.71 Allowed Glycine 0 CA--C 1.529 0.969 0 CA-C-O 119.459 -0.634 . . . . 10.0 114.243 165.737 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 28.2 ptm -104.6 153.56 21.04 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.351 1.076 . . . . 10.0 110.422 176.311 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -97.26 -4.29 39.11 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.61 0.764 . . . . 10.0 112.126 177.466 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER 72.72 -179.88 0.22 Allowed 'General case' 0 C--N 1.344 0.341 0 CA-C-N 119.485 1.039 . . . . 10.0 110.755 -173.129 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 50.17 -91.92 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 125.83 1.652 . . . . 10.0 111.578 -179.563 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.71 -42.93 94.9 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 123.883 0.873 . . . . 10.0 109.34 -178.167 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.6 m -64.69 -55.41 20.22 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.259 -0.645 . . . . 10.0 109.259 -177.395 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -46.15 -48.38 17.41 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.446 1.098 . . . . 10.0 110.752 173.757 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -61.9 -41.42 97.89 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.167 0.508 . . . . 10.0 111.212 179.016 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.65 -41.0 94.08 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 118.077 -0.964 . . . . 10.0 110.383 176.66 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.411 HG22 HD12 ' A' ' 25' ' ' LEU . 14.9 mm -47.62 -62.54 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.371 0 N-CA-C 108.367 -0.975 . . . . 10.0 108.367 169.682 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -54.56 -35.82 63.67 Favored 'General case' 0 C--O 1.22 -0.462 0 N-CA-C 112.177 0.436 . . . . 10.0 112.177 -176.281 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.65 -53.56 32.67 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 119.198 0.908 . . . . 10.0 109.783 179.233 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.7 tpt180 -64.27 -35.34 80.51 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 122.225 -0.297 . . . . 10.0 111.253 -178.987 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.411 HD12 HG22 ' A' ' 21' ' ' ILE . 0.3 OUTLIER -73.51 -44.9 56.63 Favored 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 123.402 0.681 . . . . 10.0 111.319 178.134 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -51.25 -31.27 20.39 Favored 'General case' 0 C--O 1.225 -0.184 0 C-N-CA 123.81 0.844 . . . . 10.0 110.654 172.292 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -60.84 -34.6 74.83 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 118.703 -0.665 . . . . 10.0 112.239 176.956 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 22.4 mm -55.0 133.37 18.54 Favored 'Isoleucine or valine' 0 C--N 1.342 0.261 0 C-N-CA 124.077 0.951 . . . . 10.0 110.854 177.924 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 51.1 mp0 -73.73 -47.03 42.33 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 119.242 -0.408 . . . . 10.0 110.869 -172.955 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.99 36.75 2.52 Favored Glycine 0 C--N 1.343 0.937 0 O-C-N 120.298 -1.501 . . . . 10.0 113.0 -177.669 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.2 p -101.68 149.76 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 124.61 1.164 . . . . 10.0 108.343 -178.042 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.535 ' HB2' HG21 ' A' ' 2' ' ' THR . . . -108.15 -57.84 2.06 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 106.572 -1.64 . . . . 10.0 106.572 165.366 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -154.3 167.17 30.84 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 115.644 -0.707 . . . . 10.0 109.371 -169.376 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -157.0 77.05 4.08 Favored Pre-proline 0 N--CA 1.454 -0.24 0 C-N-CA 123.592 0.757 . . . . 10.0 110.841 -179.393 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -75.47 69.53 5.87 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.547 2.164 . . . . 10.0 110.124 -179.13 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.487 HG12 HG13 ' A' ' 43' ' ' VAL . 3.8 m -64.6 157.24 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 C-N-CA 123.518 0.727 . . . . 10.0 110.383 178.056 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -102.35 159.93 14.99 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 119.603 -0.839 . . . . 10.0 111.954 172.218 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -129.76 59.22 1.62 Allowed 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 125.474 1.51 . . . . 10.0 108.743 -172.339 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 171.72 -29.44 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 125.304 1.442 . . . . 10.0 111.335 165.894 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.7 mt -81.86 -7.72 59.63 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 122.714 0.406 . . . . 10.0 111.063 -176.106 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 67.06 41.27 2.68 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 126.025 1.73 . . . . 10.0 110.557 173.895 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -136.86 140.85 42.68 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.928 0.871 . . . . 10.0 109.774 173.579 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.535 ' HB ' HD11 ' A' ' 9' ' ' ILE . 2.5 t -110.99 138.97 36.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 107.569 -1.271 . . . . 10.0 107.569 174.156 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 90.6 m -124.29 121.56 35.35 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 126.193 1.797 . . . . 10.0 106.293 -176.07 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.4 t -120.02 143.49 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 C-N-CA 124.597 1.159 . . . . 10.0 109.171 -179.944 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -120.66 96.68 5.22 Favored 'General case' 0 N--CA 1.429 -1.519 0 C-N-CA 126.255 1.822 . . . . 10.0 107.067 173.606 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 11.9 p90 -139.35 161.74 36.72 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 124.079 0.952 . . . . 10.0 109.986 -174.806 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -93.7 123.5 59.68 Favored Pre-proline 0 CA--C 1.534 0.358 0 C-N-CA 123.278 0.631 . . . . 10.0 111.011 175.214 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -75.14 67.33 6.07 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.708 2.272 . . . . 10.0 109.039 172.723 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.45 -49.56 0.49 Allowed 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 107.893 -1.151 . . . . 10.0 107.893 177.919 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -82.54 -62.57 1.58 Allowed 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 108.643 -0.873 . . . . 10.0 108.643 177.101 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -110.27 171.79 7.25 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 125.196 1.398 . . . . 10.0 109.701 -176.701 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 24.8 p -125.32 179.61 5.02 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.886 1.274 . . . . 10.0 110.663 172.994 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 26.8 m -51.36 -37.68 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-N 114.846 -1.07 . . . . 10.0 111.93 166.64 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.8 t -69.86 -39.19 76.49 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 119.032 -0.509 . . . . 10.0 110.811 -174.657 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -60.0 -52.58 64.77 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 119.241 0.928 . . . . 10.0 109.261 -176.341 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.746 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.2 pp -66.45 -42.91 86.9 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.144 -0.48 . . . . 10.0 110.692 -179.658 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.407 ' N ' HD12 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -45.65 -50.34 13.51 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 121.125 -0.985 . . . . 10.0 112.901 164.255 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -60.71 -43.79 97.38 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 119.748 1.158 . . . . 10.0 109.251 -179.366 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -53.1 -52.08 59.79 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.327 -0.851 . . . . 10.0 109.887 178.718 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 98.3 t -64.22 -43.39 97.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 123.04 0.536 . . . . 10.0 112.287 175.115 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -52.26 -51.76 56.59 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 121.995 0.903 . . . . 10.0 109.262 179.181 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 45.0 tptt -57.89 -30.92 66.24 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.812 1.645 . . . . 10.0 112.273 176.837 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.3 mp -61.54 -30.37 70.6 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.657 0.783 . . . . 10.0 110.812 173.977 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 141.16 -45.7 0.95 Allowed Glycine 0 CA--C 1.526 0.772 0 CA-C-N 118.448 0.567 . . . . 10.0 111.716 171.82 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -99.47 156.2 17.16 Favored 'General case' 0 C--O 1.226 -0.145 0 C-N-CA 124.973 1.309 . . . . 10.0 109.017 -178.67 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 24.1 mtpp -87.97 165.34 15.28 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-O 121.719 0.771 . . . . 10.0 111.191 -173.17 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 11.5 tp -136.04 149.46 48.78 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.141 1.776 . . . . 10.0 107.057 -179.831 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 8.7 mmtp -149.42 153.35 37.2 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 108.857 -0.794 . . . . 10.0 108.857 163.797 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.4 tp -62.04 158.51 16.36 Favored 'General case' 0 N--CA 1.453 -0.291 0 O-C-N 124.25 0.969 . . . . 10.0 109.084 174.905 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 12.1 tttt -114.83 -69.86 0.83 Allowed 'General case' 0 N--CA 1.436 -1.175 0 C-N-CA 126.674 1.989 . . . . 10.0 107.28 177.161 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 162.73 47.21 0.02 OUTLIER Glycine 0 CA--C 1.527 0.808 0 CA-C-O 119.291 -0.727 . . . . 10.0 112.87 175.491 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 68.5 156.98 0.13 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.105 1.362 . . . . 10.0 113.165 171.853 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -64.58 142.86 58.28 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 121.859 -0.526 . . . . 10.0 110.654 175.359 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -73.54 72.56 1.41 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.884 0.874 . . . . 10.0 110.487 -179.429 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 53.0 m -116.06 156.26 26.68 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.624 1.569 . . . . 10.0 110.76 -177.698 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 8.8 mt -103.7 -117.92 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 124.16 0.984 . . . . 10.0 108.405 -176.701 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 60.51 179.61 0.1 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.863 1.665 . . . . 10.0 111.197 -170.94 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 179.07 -64.68 0.08 OUTLIER Glycine 0 CA--C 1.527 0.818 0 O-C-N 120.999 -1.063 . . . . 10.0 112.834 -179.075 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 4.8 ttm-85 . . . . . 0 C--O 1.254 1.339 0 N-CA-C 105.273 -2.121 . . . . 10.0 105.273 165.333 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 58.0 t . . . . . 0 N--CA 1.468 0.453 0 N-CA-C 106.287 -1.746 . . . . 10.0 106.287 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 20.7 p -127.87 122.45 32.58 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 107.059 -1.46 . . . . 10.0 107.059 168.485 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -114.27 149.51 35.8 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.943 1.297 . . . . 10.0 110.379 -170.247 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.2 mtmm -98.96 77.18 2.17 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 126.266 1.826 . . . . 10.0 110.816 -160.254 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -79.17 153.57 29.95 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.806 1.643 . . . . 10.0 110.586 -173.724 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -129.52 151.51 50.05 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 124.05 0.94 . . . . 10.0 109.155 176.374 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.801 ' CE2' HD11 ' A' ' 57' ' ' LEU . 4.6 m-85 -140.77 133.75 29.22 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 125.262 1.601 . . . . 10.0 109.776 -174.731 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -87.45 134.68 33.56 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 125.953 1.701 . . . . 10.0 107.883 -179.254 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 12.8 mm -106.03 138.71 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 C-N-CA 125.474 1.51 . . . . 10.0 110.636 -166.523 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -126.31 105.15 8.6 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 108.546 -0.909 . . . . 10.0 108.546 165.749 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 135.13 -77.96 0.36 Allowed Glycine 0 CA--C 1.528 0.868 0 C-N-CA 124.219 0.914 . . . . 10.0 112.663 165.125 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 6.9 ptt? -65.61 126.87 29.71 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 122.192 -0.593 . . . . 10.0 110.641 -173.575 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.6 t -152.61 65.26 0.8 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.66 0.743 . . . . 10.0 110.122 -178.912 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 95.2 m -139.67 -99.02 0.16 Allowed 'General case' 0 C--O 1.225 -0.188 0 N-CA-C 107.823 -1.177 . . . . 10.0 107.823 170.096 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -167.93 -46.53 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.76 0.824 . . . . 10.0 109.608 -177.103 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.39 -40.48 77.34 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.543 0.737 . . . . 10.0 109.184 -179.26 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 18.2 p -65.82 -50.24 65.36 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 109.551 -0.536 . . . . 10.0 109.551 178.187 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.15 -41.8 72.27 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.436 1.095 . . . . 10.0 110.159 174.599 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -55.35 -31.09 61.45 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 121.385 -0.822 . . . . 10.0 112.758 179.568 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.7 ttt180 -70.03 -30.04 67.23 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 121.283 -0.886 . . . . 10.0 109.329 -179.099 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 25.8 mm -55.68 -54.56 24.63 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 CA-C-O 118.431 -0.795 . . . . 10.0 108.972 173.532 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -43.8 -49.72 8.02 Favored 'General case' 0 C--O 1.223 -0.297 0 C-N-CA 123.352 0.661 . . . . 10.0 110.576 -177.895 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.4 mppt? -65.19 -52.24 56.1 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 123.196 0.599 . . . . 10.0 109.818 179.597 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.75 -21.92 66.55 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 112.527 0.566 . . . . 10.0 112.527 -175.506 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.74 -41.28 14.26 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 126.735 2.014 . . . . 10.0 111.44 172.336 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -57.73 -29.07 64.44 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.899 0.88 . . . . 10.0 110.216 175.792 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.2 mmpt? -53.47 -36.03 61.18 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 113.968 1.099 . . . . 10.0 113.968 169.597 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.5 mm -61.08 125.13 16.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 119.108 0.867 . . . . 10.0 109.219 178.576 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 64.2 mt-10 -59.34 -52.9 63.65 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.962 0.727 . . . . 10.0 112.962 -176.547 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.41 43.12 2.85 Favored Glycine 0 C--N 1.339 0.745 0 CA-C-N 120.053 1.297 . . . . 10.0 112.12 -172.78 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.7 p -107.75 153.16 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 C-N-CA 124.783 1.233 . . . . 10.0 108.805 -176.826 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -116.76 -55.13 2.39 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.12 -0.696 . . . . 10.0 109.12 174.615 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -147.32 160.21 42.78 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 108.882 -0.784 . . . . 10.0 108.882 179.596 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.39 61.31 3.9 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 123.647 0.779 . . . . 10.0 112.214 174.29 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -79.42 78.71 3.61 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.826 2.351 . . . . 10.0 109.595 -177.248 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.449 HG12 HG13 ' A' ' 43' ' ' VAL . 2.3 m -58.75 149.65 5.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 123.381 0.672 . . . . 10.0 111.855 -178.276 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -93.59 94.65 8.75 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.979 0.419 . . . . 10.0 111.538 -172.855 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -73.96 53.79 0.49 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 127.084 2.154 . . . . 10.0 112.769 -178.588 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -172.27 -42.88 0.02 OUTLIER 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 125.271 1.428 . . . . 10.0 109.217 170.317 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.3 mt -79.83 -19.69 47.8 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 115.691 -0.686 . . . . 10.0 111.144 -170.996 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 64.54 53.28 1.63 Allowed 'General case' 0 N--CA 1.457 -0.085 0 C-N-CA 124.751 1.22 . . . . 10.0 109.002 -177.199 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 30.3 p -138.04 125.66 22.2 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 106.632 -1.618 . . . . 10.0 106.632 169.849 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.449 HG13 HG12 ' A' ' 36' ' ' VAL . 13.9 t -87.92 145.54 7.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 106.267 -1.753 . . . . 10.0 106.267 166.89 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 96.7 m -128.23 133.49 48.84 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 105.826 -1.916 . . . . 10.0 105.826 178.444 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 26.4 t -136.46 129.31 45.76 Favored 'Isoleucine or valine' 0 C--N 1.339 0.114 0 CA-C-N 118.477 0.581 . . . . 10.0 111.081 176.925 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -92.98 101.02 13.35 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 126.444 1.897 . . . . 10.0 106.265 169.06 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -138.18 159.14 42.83 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 118.411 0.55 . . . . 10.0 111.995 -178.711 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 16.8 p30 -94.87 128.46 39.28 Favored Pre-proline 0 CA--C 1.527 0.06 0 C-N-CA 123.995 0.918 . . . . 10.0 110.656 178.583 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -76.07 56.46 4.87 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 122.425 2.083 . . . . 10.0 109.946 175.511 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.5 ttpt -131.87 -66.34 0.71 Allowed 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 106.628 -1.619 . . . . 10.0 106.628 173.501 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -99.11 -14.86 19.2 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.523 1.129 . . . . 10.0 110.735 -175.378 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -122.06 144.75 48.72 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.24 1.016 . . . . 10.0 110.348 -178.784 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -149.42 147.78 28.68 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.494 0.664 . . . . 10.0 111.291 -173.785 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.4 m -52.41 -42.44 38.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 124.546 1.139 . . . . 10.0 111.314 -178.304 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.2 m -52.72 -44.92 66.68 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.093 1.357 . . . . 10.0 111.974 177.964 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -76.21 -47.3 24.52 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.844 1.258 . . . . 10.0 109.444 -170.636 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.801 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.2 pp -65.72 -42.65 90.83 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 119.253 -0.979 . . . . 10.0 109.871 176.455 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.85 -53.17 10.16 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 117.48 -1.248 . . . . 10.0 112.247 163.548 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -50.94 -45.7 60.74 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 120.687 1.585 . . . . 10.0 110.252 178.121 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -55.52 -51.33 67.39 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.135 -0.939 . . . . 10.0 110.211 -178.038 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 21.9 t -65.16 -43.71 95.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-N 116.475 -0.33 . . . . 10.0 111.653 177.021 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.41 -54.25 47.81 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 108.188 -1.041 . . . . 10.0 108.188 -175.884 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -58.09 -38.92 77.32 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.733 1.213 . . . . 10.0 111.107 178.419 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.442 HD13 ' HA ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -50.92 -34.09 27.05 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.333 0.653 . . . . 10.0 112.067 172.61 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.75 20.78 6.7 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 123.65 0.643 . . . . 10.0 113.281 172.127 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -142.22 175.05 10.06 Favored 'General case' 0 CA--C 1.522 -0.12 0 N-CA-C 105.627 -1.99 . . . . 10.0 105.627 167.406 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 31.4 tttt -123.08 152.87 40.62 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 119.244 0.929 . . . . 10.0 113.182 -164.867 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 12.7 tp -134.74 148.86 50.35 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 126.815 2.046 . . . . 10.0 107.907 -168.808 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 12.6 tptp -149.94 151.28 33.13 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-O 118.713 -0.661 . . . . 10.0 109.536 161.843 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 11.4 tp -60.45 155.15 18.93 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 109.13 -0.693 . . . . 10.0 109.13 175.617 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 35.8 tttp -112.7 -68.35 0.94 Allowed 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 126.443 1.897 . . . . 10.0 107.815 178.912 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 154.75 51.68 0.01 OUTLIER Glycine 0 CA--C 1.529 0.929 0 CA-C-O 119.527 -0.596 . . . . 10.0 112.726 175.095 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 65.68 157.68 0.1 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.735 1.614 . . . . 10.0 113.584 178.22 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -83.68 150.4 25.89 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.42 -0.354 . . . . 10.0 111.348 -178.915 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -144.84 164.98 29.41 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 126.307 1.843 . . . . 10.0 106.588 167.89 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 7.8 t -151.98 77.95 1.23 Allowed 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 106.309 -1.737 . . . . 10.0 106.309 166.451 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.7 pt 41.6 61.11 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 C-N-CA 127.078 2.151 . . . . 10.0 115.022 -175.925 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -61.17 129.85 43.35 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.943 -0.571 . . . . 10.0 109.775 171.341 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 168.38 -179.75 41.23 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 108.368 -1.893 . . . . 10.0 108.368 -177.533 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 43.2 ttt180 . . . . . 0 C--O 1.253 1.289 0 N-CA-C 105.475 -2.046 . . . . 10.0 105.475 172.559 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 56.2 t . . . . . 0 N--CA 1.468 0.474 0 N-CA-C 106.505 -1.665 . . . . 10.0 106.505 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.672 HG21 ' HB2' ' A' ' 32' ' ' ALA . 21.0 p -103.81 170.51 7.88 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.462 0.705 . . . . 10.0 110.533 171.061 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -136.83 149.69 47.87 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 127.505 2.322 . . . . 10.0 106.423 -175.689 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.9 mmtm -97.81 132.52 43.35 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 124.43 1.092 . . . . 10.0 110.555 -176.84 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -134.43 140.24 46.12 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.866 1.267 . . . . 10.0 108.88 177.901 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -119.73 145.83 46.18 Favored 'General case' 0 CA--C 1.513 -0.446 0 C-N-CA 123.817 0.847 . . . . 10.0 109.645 173.071 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.709 ' CE2' HD11 ' A' ' 57' ' ' LEU . 3.7 m-85 -137.09 143.33 42.52 Favored 'General case' 0 N--CA 1.448 -0.544 0 O-C-N 125.084 1.49 . . . . 10.0 109.81 -173.221 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -106.63 135.75 47.61 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.273 1.429 . . . . 10.0 108.701 -174.646 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.9 mm -114.86 134.68 57.13 Favored 'Isoleucine or valine' 0 C--N 1.34 0.164 0 C-N-CA 125.203 1.401 . . . . 10.0 110.415 -161.772 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -125.85 111.27 14.64 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.379 -0.6 . . . . 10.0 109.379 171.911 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 143.33 -60.69 0.52 Allowed Glycine 0 C--N 1.341 0.819 0 C-N-CA 123.818 0.723 . . . . 10.0 112.535 165.193 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.68 158.39 34.79 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.469 0.708 . . . . 10.0 111.612 -176.238 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -67.4 -86.52 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 124.503 1.121 . . . . 10.0 110.394 175.706 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 23.3 p 150.81 55.34 0.0 OUTLIER 'General case' 0 C--N 1.345 0.407 0 C-N-CA 125.21 1.404 . . . . 10.0 110.658 -165.524 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -161.29 -82.06 0.04 OUTLIER 'General case' 0 CA--C 1.519 -0.22 0 O-C-N 121.102 -0.999 . . . . 10.0 109.04 174.168 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.5 -46.63 25.88 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.25 -1.019 . . . . 10.0 108.25 -172.622 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 7.2 m -55.54 -58.52 7.45 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 114.695 -1.139 . . . . 10.0 109.644 173.225 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -44.63 -53.76 6.85 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.46 1.104 . . . . 10.0 111.131 173.828 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -56.98 -31.63 65.26 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.135 0.493 . . . . 10.0 112.0 178.897 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 11.9 ttm180 -74.6 -40.91 61.28 Favored 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 120.994 -1.066 . . . . 10.0 109.389 178.12 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.597 HD11 ' HE2' ' A' ' 66' ' ' TYR . 39.1 mm -46.23 -52.91 2.9 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 CA-C-O 117.796 -1.097 . . . . 10.0 110.012 170.504 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -43.99 -46.57 8.38 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 119.071 0.85 . . . . 10.0 111.955 -177.016 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -76.79 -39.66 50.75 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 123.737 0.815 . . . . 10.0 110.638 -178.279 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.91 -35.8 77.62 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 122.38 -0.2 . . . . 10.0 111.268 176.847 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.59 -36.28 29.16 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.293 1.837 . . . . 10.0 111.152 176.91 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -53.53 -31.63 47.07 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.265 -0.897 . . . . 10.0 110.88 173.232 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.5 mptt -54.15 -24.9 19.71 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 115.298 1.592 . . . . 10.0 115.298 172.349 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.475 HG23 ' HB3' ' A' ' 52' ' ' ALA . 11.4 mm -61.23 108.2 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 118.708 0.685 . . . . 10.0 109.966 172.381 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -55.37 -33.81 63.75 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.239 0.616 . . . . 10.0 111.945 -177.085 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.85 15.49 57.47 Favored Glycine 0 CA--C 1.528 0.883 0 O-C-N 121.497 -0.752 . . . . 10.0 113.19 -179.058 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.7 p -79.33 154.45 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-N 118.867 1.334 . . . . 10.0 109.943 -179.75 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.672 ' HB2' HG21 ' A' ' 2' ' ' THR . . . -114.27 -46.62 2.97 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.541 -0.754 . . . . 10.0 109.716 161.019 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 -144.37 147.91 34.02 Favored 'General case' 0 C--N 1.339 0.12 0 N-CA-C 108.666 -0.864 . . . . 10.0 108.666 -173.389 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -148.48 56.3 2.52 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 118.721 0.692 . . . . 10.0 112.581 172.181 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -74.89 80.62 2.36 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.121 2.547 . . . . 10.0 109.797 178.523 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.486 HG12 HG13 ' A' ' 43' ' ' VAL . 3.6 m -62.3 157.73 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 123.823 0.849 . . . . 10.0 111.47 176.889 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 75.5 m-80 -92.12 116.92 29.36 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 120.23 -0.588 . . . . 10.0 112.18 -173.841 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -90.34 48.28 1.54 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.431 1.492 . . . . 10.0 111.249 -179.335 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -171.99 -39.01 0.02 OUTLIER 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 123.719 0.808 . . . . 10.0 110.579 165.272 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 16.4 mt -77.4 -15.03 59.57 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.794 0.838 . . . . 10.0 111.964 -167.666 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 65.52 47.25 2.28 Favored 'General case' 0 C--O 1.227 -0.081 0 C-N-CA 125.353 1.461 . . . . 10.0 109.824 -179.161 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 17.0 p -140.69 130.84 24.84 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 107.976 -1.12 . . . . 10.0 107.976 176.969 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.486 HG13 HG12 ' A' ' 36' ' ' VAL . 12.8 t -95.81 137.55 23.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 107.021 -1.474 . . . . 10.0 107.021 171.605 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 86.1 m -129.7 115.06 16.78 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 106.357 -1.72 . . . . 10.0 106.357 -174.776 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 32.3 t -115.69 144.05 24.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 C-N-CA 123.379 0.672 . . . . 10.0 109.799 -178.141 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -114.79 107.68 15.76 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 125.499 1.52 . . . . 10.0 107.873 164.836 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -149.13 164.18 35.45 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.736 -0.468 . . . . 10.0 109.736 -178.653 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -94.05 131.31 31.94 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 116.25 -0.432 . . . . 10.0 110.172 175.264 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -77.1 62.17 7.42 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.199 1.933 . . . . 10.0 109.488 169.336 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.83 -48.91 1.13 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.649 0.78 . . . . 10.0 108.994 174.685 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.29 -29.29 18.22 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 122.991 0.516 . . . . 10.0 111.841 -171.766 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.475 ' HB3' HG23 ' A' ' 28' ' ' ILE . . . -156.67 169.91 23.62 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.984 1.714 . . . . 10.0 106.82 -169.648 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 59.9 p -135.6 169.88 16.83 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 122.445 1.116 . . . . 10.0 112.649 -178.305 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 35.4 m -48.52 -40.87 11.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 125.189 1.395 . . . . 10.0 111.508 170.997 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 49.8 m -66.57 -35.87 81.26 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 123.509 0.723 . . . . 10.0 111.691 -179.746 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -70.2 -53.05 18.77 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 107.722 -1.214 . . . . 10.0 107.722 179.26 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.709 HD11 ' CE2' ' A' ' 7' ' ' PHE . 3.7 pp -65.87 -35.82 81.71 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 122.001 -0.437 . . . . 10.0 111.819 -173.317 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.7 ttpp -39.44 -54.63 1.9 Allowed 'General case' 0 C--N 1.341 0.222 0 O-C-N 121.216 -0.928 . . . . 10.0 112.559 159.952 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -54.42 -33.8 60.14 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 121.51 0.671 . . . . 10.0 110.54 -174.239 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -58.25 -52.33 66.05 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 121.778 0.799 . . . . 10.0 108.86 179.292 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.564 HG22 HD12 ' A' ' 21' ' ' ILE . 40.0 t -63.27 -43.11 98.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 115.331 -0.85 . . . . 10.0 110.716 176.617 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -56.88 -51.08 70.47 Favored 'General case' 0 CA--C 1.528 0.114 0 N-CA-C 109.28 -0.637 . . . . 10.0 109.28 -177.201 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -59.32 -35.84 74.55 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.241 1.016 . . . . 10.0 111.77 176.646 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.429 ' HA ' HD13 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -52.63 -31.21 35.54 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.621 0.769 . . . . 10.0 111.885 171.088 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 119.48 12.92 6.49 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 124.192 0.901 . . . . 10.0 113.124 171.401 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.597 ' HE2' HD11 ' A' ' 21' ' ' ILE . 1.0 OUTLIER -149.9 161.67 41.83 Favored 'General case' 0 C--O 1.224 -0.245 0 N-CA-C 107.009 -1.478 . . . . 10.0 107.009 179.649 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.8 mttt -104.29 153.7 20.7 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 121.798 0.809 . . . . 10.0 112.002 -165.249 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.427 HD11 ' HB2' ' A' ' 7' ' ' PHE . 13.1 tp -129.72 145.76 51.52 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 127.298 2.239 . . . . 10.0 107.197 -176.474 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 33.3 mmtt -145.76 151.72 38.42 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 108.379 -0.971 . . . . 10.0 108.379 165.065 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 11.7 tp -63.25 156.46 25.4 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 108.419 -0.956 . . . . 10.0 108.419 173.48 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 24.3 ttpt -113.81 -52.85 2.72 Favored 'General case' 0 N--CA 1.437 -1.119 0 C-N-CA 126.433 1.893 . . . . 10.0 107.199 170.994 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 179.82 -78.95 0.06 OUTLIER Glycine 0 C--N 1.336 0.533 0 N-CA-C 109.736 -1.346 . . . . 10.0 109.736 174.486 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -170.6 176.14 4.41 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 107.45 -1.315 . . . . 10.0 107.45 -168.1 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -67.94 165.41 17.81 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.228 0.537 . . . . 10.0 112.37 -178.016 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -69.81 98.81 1.27 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.072 0.549 . . . . 10.0 110.025 170.586 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.0 t -82.64 134.74 35.16 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.213 0.605 . . . . 10.0 110.482 179.827 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 22.7 pt -98.04 -140.32 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 C-N-CA 124.718 1.207 . . . . 10.0 109.668 -177.225 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 76.86 -158.67 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.93 2.092 . . . . 10.0 110.875 179.682 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 153.19 -26.32 0.79 Allowed Glycine 0 CA--C 1.535 1.307 0 CA-C-O 118.705 -1.053 . . . . 10.0 115.164 -178.056 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.252 1.235 0 N-CA-C 106.925 -1.509 . . . . 10.0 106.925 -171.102 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 56.2 t . . . . . 0 N--CA 1.471 0.591 0 N-CA-C 108.631 -0.877 . . . . 10.0 108.631 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.1 p -134.93 164.35 27.81 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.368 1.467 . . . . 10.0 108.384 178.597 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -129.02 145.82 51.16 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 126.364 1.865 . . . . 10.0 109.628 -175.393 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 20.8 mtmt -106.82 92.16 3.97 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.383 1.473 . . . . 10.0 110.282 -165.706 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.602 ' HB1' HD11 ' A' ' 70' ' ' LEU . . . -97.61 151.67 19.84 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.906 1.682 . . . . 10.0 110.352 -171.822 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -124.43 148.04 47.89 Favored 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 124.24 1.016 . . . . 10.0 109.374 174.765 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.703 ' CE2' HD11 ' A' ' 57' ' ' LEU . 4.9 m-85 -137.7 140.73 40.91 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 124.581 1.176 . . . . 10.0 109.266 -169.773 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -103.37 129.95 50.56 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 125.742 1.617 . . . . 10.0 108.587 -171.661 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.4 mm -110.52 127.16 67.73 Favored 'Isoleucine or valine' 0 C--N 1.34 0.164 0 C-N-CA 123.8 0.84 . . . . 10.0 110.71 -163.711 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -116.31 102.38 9.5 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.805 -0.813 . . . . 10.0 108.805 169.751 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 156.07 -82.6 0.16 Allowed Glycine 0 C--N 1.338 0.649 0 CA-C-O 119.827 -0.43 . . . . 10.0 112.193 167.65 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 13.0 ptt? -163.43 122.01 2.0 Allowed 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.79 -0.448 . . . . 10.0 109.79 -171.288 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.6 t -159.0 56.14 0.42 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.015 0.926 . . . . 10.0 109.497 178.403 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.404 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 37.5 t -148.15 51.08 1.02 Allowed 'General case' 0 C--O 1.227 -0.125 0 O-C-N 122.152 -0.343 . . . . 10.0 110.845 -172.347 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.404 ' HB2' ' O ' ' A' ' 14' ' ' CYS . . . 165.55 -114.82 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 127.528 2.331 . . . . 10.0 107.629 173.824 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.86 -37.65 76.19 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 124.183 0.993 . . . . 10.0 109.31 -171.187 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 63.7 m -54.18 -56.91 13.66 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.879 1.671 . . . . 10.0 110.131 177.836 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -51.02 -54.02 28.26 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 121.796 0.808 . . . . 10.0 110.644 177.921 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -56.15 -40.21 73.51 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.25 -0.886 . . . . 10.0 110.908 178.125 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.04 -52.47 65.62 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 107.708 -1.219 . . . . 10.0 107.708 178.657 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.541 HG22 HD12 ' A' ' 25' ' ' LEU . 1.7 mt -46.25 -50.9 4.43 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.435 0 CA-C-O 117.652 -1.166 . . . . 10.0 111.011 -179.51 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -41.56 -57.65 2.18 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 119.147 0.885 . . . . 10.0 111.215 -178.316 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -67.43 -48.07 68.36 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 124.47 1.108 . . . . 10.0 110.566 -179.925 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.1 mmt180 -59.19 -21.7 59.85 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.326 0.861 . . . . 10.0 113.326 179.603 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.541 HD12 HG22 ' A' ' 21' ' ' ILE . 3.1 mt -92.55 -41.12 10.42 Favored 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 126.303 1.841 . . . . 10.0 110.693 171.973 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -52.06 -28.54 17.72 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.703 1.201 . . . . 10.0 110.167 174.6 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -44.81 -44.65 9.6 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 113.72 1.007 . . . . 10.0 113.72 168.411 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 7.3 mm -55.06 128.05 14.68 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 C-N-CA 123.125 0.57 . . . . 10.0 110.573 -179.316 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 20.0 mp0 -65.16 -51.86 58.59 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 122.17 -0.332 . . . . 10.0 111.066 -177.113 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.59 40.41 2.87 Favored Glycine 0 C--N 1.339 0.726 0 O-C-N 120.835 -1.165 . . . . 10.0 111.835 -173.411 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.2 p -99.3 148.64 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 C-N-CA 124.504 1.122 . . . . 10.0 108.571 -176.512 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -111.75 -56.96 2.32 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.1 0.96 . . . . 10.0 108.566 171.67 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -142.55 156.65 45.14 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 109.621 -0.511 . . . . 10.0 109.621 179.437 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -143.36 61.34 9.92 Favored Pre-proline 0 CA--C 1.535 0.4 0 C-N-CA 124.0 0.92 . . . . 10.0 110.721 174.605 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -78.68 71.54 6.86 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 122.76 2.306 . . . . 10.0 109.332 -176.724 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.449 HG12 HG13 ' A' ' 43' ' ' VAL . 3.6 m -64.09 153.51 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 O-C-N 121.728 -0.608 . . . . 10.0 111.002 -178.906 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 -88.23 140.71 29.2 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 120.577 -0.449 . . . . 10.0 110.532 177.256 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -114.89 39.25 2.92 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.277 1.431 . . . . 10.0 111.034 -173.376 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -173.17 -40.94 0.01 OUTLIER 'General case' 0 C--O 1.226 -0.135 0 C-N-CA 124.907 1.283 . . . . 10.0 110.339 178.529 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.5 mt -74.9 -19.43 60.15 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.98 0.912 . . . . 10.0 111.56 -172.434 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 64.44 52.43 1.83 Allowed 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 125.704 1.602 . . . . 10.0 110.343 -178.477 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.8 p -143.94 130.36 19.93 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 125.51 1.524 . . . . 10.0 107.476 175.14 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.449 HG13 HG12 ' A' ' 36' ' ' VAL . 4.9 t -100.47 148.59 6.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 106.829 -1.545 . . . . 10.0 106.829 173.323 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 59.0 m -136.55 126.53 25.97 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 106.403 -1.702 . . . . 10.0 106.403 -176.029 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.424 HG22 HD13 ' A' ' 25' ' ' LEU . 14.4 t -131.83 122.93 50.6 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 CA-C-N 118.48 0.582 . . . . 10.0 111.13 -179.538 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.0 mp0 -89.24 98.17 11.62 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 106.538 -1.652 . . . . 10.0 106.538 165.579 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -141.51 161.77 37.1 Favored 'General case' 0 CA--C 1.516 -0.332 0 C-N-CA 122.979 0.512 . . . . 10.0 110.089 175.661 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 31.3 p30 -92.14 136.26 26.08 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.238 -0.437 . . . . 10.0 110.556 178.439 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -79.85 53.0 4.54 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 121.234 1.289 . . . . 10.0 109.229 170.42 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.84 1.16 2.75 Favored 'General case' 0 C--N 1.347 0.49 0 CA-C-N 118.722 0.692 . . . . 10.0 112.801 177.94 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -138.28 -53.03 0.61 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.374 1.07 . . . . 10.0 108.502 -168.02 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -125.2 -176.41 3.56 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.01 1.324 . . . . 10.0 109.401 173.873 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 85.8 p -135.34 171.44 14.43 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.219 1.008 . . . . 10.0 110.875 174.495 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 77.8 t -48.39 -50.38 12.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 123.45 0.7 . . . . 10.0 110.533 166.787 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 72.2 m -59.78 -33.13 71.3 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.382 0.673 . . . . 10.0 111.526 -178.208 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -70.87 -59.55 2.73 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 108.607 -0.886 . . . . 10.0 108.607 175.482 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.703 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.0 pp -61.65 -47.04 87.17 Favored 'General case' 0 N--CA 1.452 -0.374 0 O-C-N 121.607 -0.683 . . . . 10.0 112.058 -170.579 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.451 ' N ' HD12 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -49.3 -29.92 6.68 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 114.588 1.329 . . . . 10.0 114.588 170.428 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.61 -36.29 69.26 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 120.185 1.357 . . . . 10.0 109.993 177.586 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.29 -50.15 75.09 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.595 -0.52 . . . . 10.0 109.595 179.566 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.472 HG12 ' O ' ' A' ' 66' ' ' TYR . 53.2 t -62.28 -50.17 81.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 123.34 0.656 . . . . 10.0 111.732 175.12 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -53.1 -40.77 64.38 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.684 0.794 . . . . 10.0 109.915 179.906 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.3 tptm -74.01 -38.6 64.02 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 124.498 1.119 . . . . 10.0 110.44 -178.41 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 34.3 mt -54.69 -41.46 70.25 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.278 0.49 . . . . 10.0 111.186 166.849 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 151.24 -51.19 0.52 Allowed Glycine 0 CA--C 1.525 0.68 0 CA-C-N 118.567 0.621 . . . . 10.0 112.445 166.755 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.472 ' O ' HG12 ' A' ' 61' ' ' VAL . 10.2 p90 -76.07 157.22 33.18 Favored 'General case' 0 C--O 1.224 -0.25 0 N-CA-C 108.811 -0.811 . . . . 10.0 108.811 177.153 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 31.8 mtpt -103.02 157.75 16.77 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.352 0.596 . . . . 10.0 111.0 -172.663 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.484 HD11 ' HB2' ' A' ' 7' ' ' PHE . 34.2 tp -134.26 147.41 50.65 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.749 1.619 . . . . 10.0 108.419 -174.839 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 10.5 mmtp -152.46 156.01 38.62 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.771 1.628 . . . . 10.0 107.903 174.088 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.602 HD11 ' HB1' ' A' ' 5' ' ' ALA . 6.8 tp -66.5 159.05 28.07 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 109.771 -0.455 . . . . 10.0 109.771 176.029 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 6.0 tttp -113.76 -57.25 2.31 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 125.458 1.503 . . . . 10.0 108.409 169.651 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -172.72 -79.69 0.05 OUTLIER Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.273 -1.131 . . . . 10.0 110.273 179.962 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -166.61 174.96 8.32 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.378 1.071 . . . . 10.0 108.435 -176.226 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.81 123.11 4.8 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 124.296 0.998 . . . . 10.0 111.364 171.231 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -122.9 149.21 44.52 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 107.759 -1.2 . . . . 10.0 107.759 160.212 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.6 t -141.67 141.03 33.36 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 107.022 -1.473 . . . . 10.0 107.022 175.527 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.5 mt 67.8 7.2 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 C-N-CA 124.067 0.947 . . . . 10.0 111.068 -177.361 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 58.1 63.63 1.71 Allowed 'General case' 0 C--N 1.343 0.298 0 C-N-CA 125.38 1.472 . . . . 10.0 108.822 -178.734 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -164.67 -83.95 0.05 OUTLIER Glycine 0 CA--C 1.526 0.75 0 CA-C-O 119.231 -0.761 . . . . 10.0 113.638 -172.435 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 6.1 mtp85 . . . . . 0 C--O 1.252 1.204 0 C-N-CA 126.769 2.028 . . . . 10.0 105.886 -167.548 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 98.8 t . . . . . 0 N--CA 1.471 0.594 0 N-CA-C 107.556 -1.275 . . . . 10.0 107.556 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.558 HG21 ' HB2' ' A' ' 32' ' ' ALA . 4.5 p -126.21 162.57 25.12 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.883 1.673 . . . . 10.0 108.407 -178.848 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -134.85 136.53 42.52 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 126.101 1.76 . . . . 10.0 108.03 -170.228 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -102.86 113.63 27.23 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.005 0.922 . . . . 10.0 111.625 -168.415 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.549 ' HB1' HD11 ' A' ' 70' ' ' LEU . . . -115.64 149.95 37.5 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 127.306 2.243 . . . . 10.0 109.215 -172.32 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -124.24 146.97 48.41 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.493 1.117 . . . . 10.0 108.872 174.086 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.727 ' CE2' HD11 ' A' ' 57' ' ' LEU . 1.9 m-85 -140.57 137.61 33.84 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 124.889 1.368 . . . . 10.0 110.467 -168.168 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -91.27 133.67 35.21 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 126.011 1.724 . . . . 10.0 109.421 -175.915 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.462 HD11 HG23 ' A' ' 43' ' ' VAL . 3.3 mm -113.1 134.38 55.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 125.611 1.565 . . . . 10.0 110.491 -173.959 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -126.89 103.41 7.48 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.059 0.943 . . . . 10.0 108.645 171.252 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 116.48 39.87 0.83 Allowed Glycine 0 CA--C 1.531 1.091 0 C-N-CA 123.833 0.73 . . . . 10.0 114.017 167.934 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -98.09 177.03 5.54 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.746 1.218 . . . . 10.0 110.996 -179.363 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 41.0 p -113.77 -7.16 13.27 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 123.763 0.825 . . . . 10.0 112.365 172.793 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 23.6 m 57.55 44.65 20.7 Favored 'General case' 0 C--N 1.342 0.242 0 C-N-CA 124.037 0.935 . . . . 10.0 110.69 178.19 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -162.23 -94.58 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.879 -0.786 . . . . 10.0 108.879 176.758 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.23 -38.27 43.4 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 109.134 -0.691 . . . . 10.0 109.134 -173.421 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 23.2 m -59.59 -54.78 42.54 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 109.488 -0.56 . . . . 10.0 109.488 175.226 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -48.28 -50.18 30.86 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.383 1.073 . . . . 10.0 110.567 172.742 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -59.09 -42.19 89.84 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 121.312 -0.868 . . . . 10.0 112.422 177.971 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.29 -45.96 79.96 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.085 0.954 . . . . 10.0 108.931 179.305 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.453 HG22 HD12 ' A' ' 25' ' ' LEU . 3.0 mt -43.7 -52.48 1.25 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.346 0 CA-C-O 118.362 -0.827 . . . . 10.0 110.532 175.572 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -48.0 -49.02 32.25 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 118.531 0.605 . . . . 10.0 110.873 -177.23 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.61 -47.69 58.85 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 121.627 -0.671 . . . . 10.0 110.533 -179.677 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.487 ' HB3' ' HB1' ' A' ' 60' ' ' ALA . 1.2 mmp_? -54.63 -33.8 61.11 Favored 'General case' 0 C--O 1.225 -0.235 0 C-N-CA 124.008 0.923 . . . . 10.0 112.181 178.305 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.565 HD21 ' HB2' ' A' ' 57' ' ' LEU . 0.3 OUTLIER -88.99 -33.63 17.13 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 125.621 1.569 . . . . 10.0 111.392 177.605 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -60.06 -27.17 66.73 Favored 'General case' 0 C--O 1.225 -0.202 0 O-C-N 121.486 -0.759 . . . . 10.0 110.258 174.4 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.2 mmpt? -53.68 -34.26 58.13 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 113.736 1.013 . . . . 10.0 113.736 168.847 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 12.5 mm -56.4 127.92 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 119.126 0.875 . . . . 10.0 109.504 177.354 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -63.59 -56.93 12.07 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.515 -0.311 . . . . 10.0 110.486 -175.836 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.54 49.83 3.72 Favored Glycine 0 C--N 1.341 0.845 0 O-C-N 120.692 -1.255 . . . . 10.0 110.919 -173.042 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -105.71 146.06 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 C-N-CA 124.296 1.039 . . . . 10.0 108.244 -178.151 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.558 ' HB2' HG21 ' A' ' 2' ' ' THR . . . -102.17 -52.22 3.2 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 108.375 -0.972 . . . . 10.0 108.375 176.004 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.0 p30 -160.23 149.37 17.41 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.449 -0.945 . . . . 10.0 108.449 -174.905 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -136.26 59.2 25.38 Favored Pre-proline 0 CA--C 1.536 0.424 0 C-N-CA 124.186 0.994 . . . . 10.0 111.54 178.077 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -77.0 74.84 4.82 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.031 2.487 . . . . 10.0 109.626 -178.964 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.574 HG12 HG13 ' A' ' 43' ' ' VAL . 3.0 m -65.28 158.42 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 C-N-CA 123.402 0.681 . . . . 10.0 111.428 179.988 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -96.35 121.71 38.44 Favored 'General case' 0 C--N 1.339 0.136 0 CA-C-O 120.83 0.347 . . . . 10.0 111.71 -176.861 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -96.15 50.16 1.16 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.303 1.441 . . . . 10.0 111.231 179.785 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -175.0 -40.72 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.228 0 C-N-CA 124.162 0.985 . . . . 10.0 109.928 172.533 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.1 mt -81.79 -11.6 58.91 Favored 'General case' 0 C--O 1.226 -0.146 0 C-N-CA 124.294 1.038 . . . . 10.0 112.214 -167.74 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 71.77 36.13 1.27 Allowed 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 125.403 1.481 . . . . 10.0 110.897 173.296 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.8 p -138.95 131.04 28.04 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.019 1.328 . . . . 10.0 108.312 -178.096 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.574 HG13 HG12 ' A' ' 36' ' ' VAL . 18.9 t -91.52 149.14 4.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 107.112 -1.44 . . . . 10.0 107.112 167.746 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 68.4 m -137.12 124.3 21.72 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 105.667 -1.975 . . . . 10.0 105.667 -179.553 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 47.9 t -135.98 138.44 47.46 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 CA-C-N 118.454 0.57 . . . . 10.0 109.712 179.278 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -101.95 112.71 25.44 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 107.226 -1.398 . . . . 10.0 107.226 165.145 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -146.99 165.92 28.38 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 123.361 0.664 . . . . 10.0 109.34 179.295 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 31.0 p30 -95.71 128.16 38.8 Favored Pre-proline 0 C--N 1.328 -0.341 0 N-CA-C 110.508 -0.182 . . . . 10.0 110.508 178.494 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -75.65 61.51 6.18 Favored 'Trans proline' 0 N--CA 1.45 -1.032 0 N-CA-C 108.507 -1.382 . . . . 10.0 108.507 169.205 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.31 -44.51 0.37 Allowed 'General case' 0 C--N 1.343 0.295 0 O-C-N 122.122 -0.361 . . . . 10.0 110.379 177.523 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -90.49 -36.61 14.41 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 122.378 0.271 . . . . 10.0 110.333 178.637 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -137.36 -175.58 4.11 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.542 1.137 . . . . 10.0 110.066 -179.707 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 91.5 p -147.05 172.44 13.74 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.295 0.638 . . . . 10.0 111.49 179.872 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 92.0 t -48.79 -45.4 15.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 124.051 0.94 . . . . 10.0 111.081 171.12 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.5 m -60.54 -37.22 80.51 Favored 'General case' 0 C--O 1.234 0.259 0 O-C-N 121.976 -0.452 . . . . 10.0 112.154 -179.689 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -65.71 -60.1 3.24 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 108.091 -1.078 . . . . 10.0 108.091 179.816 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.727 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.1 pp -63.48 -40.03 96.02 Favored 'General case' 0 N--CA 1.454 -0.24 0 O-C-N 121.55 -0.719 . . . . 10.0 111.477 -175.774 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.8 ttpp -39.16 -59.14 1.05 Allowed 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 117.627 -1.178 . . . . 10.0 111.004 162.653 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -47.85 -37.84 14.75 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-O 122.064 0.935 . . . . 10.0 110.755 -174.797 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.487 ' HB1' ' HB3' ' A' ' 24' ' ' ARG . . . -59.28 -49.76 76.61 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.041 -0.981 . . . . 10.0 109.784 -178.114 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.536 ' HA ' HD12 ' A' ' 64' ' ' LEU . 77.0 t -68.34 -45.65 82.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 124.536 1.134 . . . . 10.0 111.748 175.487 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -46.18 -44.67 16.2 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 126.576 1.95 . . . . 10.0 108.349 176.11 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -80.63 -34.63 34.84 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.238 1.415 . . . . 10.0 111.349 -176.887 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.536 HD12 ' HA ' ' A' ' 61' ' ' VAL . 18.7 mt -51.97 -43.43 63.56 Favored 'General case' 0 C--N 1.34 0.196 0 CA-C-N 118.871 0.759 . . . . 10.0 111.869 169.033 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 150.81 -35.18 0.93 Allowed Glycine 0 CA--C 1.525 0.666 0 C-N-CA 121.277 -0.487 . . . . 10.0 113.057 172.717 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -99.63 159.13 15.27 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.687 1.195 . . . . 10.0 107.888 -178.52 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.3 ttpt -94.8 155.16 16.93 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.194 0.521 . . . . 10.0 109.871 -176.984 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.583 HD11 ' HB2' ' A' ' 7' ' ' PHE . 24.8 tp -124.9 149.85 47.13 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 126.439 1.896 . . . . 10.0 107.528 179.756 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 34.0 mmtt -149.18 156.88 42.82 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 124.803 1.241 . . . . 10.0 108.332 162.905 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.549 HD11 ' HB1' ' A' ' 5' ' ' ALA . 8.7 tp -66.09 158.79 27.59 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 109.083 -0.71 . . . . 10.0 109.083 173.963 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.56 -56.45 2.4 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 125.551 1.54 . . . . 10.0 107.159 166.461 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -176.35 -83.01 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 109.609 -1.396 . . . . 10.0 109.609 179.13 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -168.9 173.49 7.01 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.544 0.738 . . . . 10.0 109.379 -167.923 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.4 pp0? -58.81 109.26 0.78 Allowed 'General case' 0 CA--C 1.534 0.341 0 O-C-N 124.567 1.167 . . . . 10.0 111.823 -174.979 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -82.43 95.91 7.82 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 108.551 -0.907 . . . . 10.0 108.551 179.052 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.7 t -154.55 163.65 39.89 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 108.837 -0.801 . . . . 10.0 108.837 170.093 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.1 pt -128.19 90.96 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 125.35 1.46 . . . . 10.0 109.755 177.287 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -121.43 138.87 54.09 Favored 'General case' 0 CA--C 1.527 0.095 0 N-CA-C 108.044 -1.095 . . . . 10.0 108.044 175.697 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -171.76 -174.06 39.05 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 109.752 -1.339 . . . . 10.0 109.752 -175.034 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.255 1.348 0 C-N-CA 125.488 1.515 . . . . 10.0 107.49 -177.889 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 60.1 t . . . . . 0 N--CA 1.469 0.505 0 N-CA-C 107.162 -1.421 . . . . 10.0 107.162 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.481 HG21 ' HB2' ' A' ' 32' ' ' ALA . 5.0 p -96.76 171.21 8.66 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.768 1.227 . . . . 10.0 111.02 175.958 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -136.57 151.67 49.63 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 128.434 2.694 . . . . 10.0 107.8 179.548 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 17.0 mmtt -96.86 118.13 32.61 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 108.491 -0.929 . . . . 10.0 108.491 175.796 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -113.68 138.54 50.07 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 124.253 1.021 . . . . 10.0 109.749 172.5 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -113.82 145.79 40.91 Favored 'General case' 0 CA--C 1.51 -0.591 0 C-N-CA 124.589 1.156 . . . . 10.0 110.246 174.97 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.648 ' CE2' HD11 ' A' ' 57' ' ' LEU . 3.9 m-85 -139.17 142.52 37.96 Favored 'General case' 0 N--CA 1.448 -0.575 0 O-C-N 125.036 1.46 . . . . 10.0 110.056 -177.077 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -103.59 134.38 47.02 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 125.882 1.673 . . . . 10.0 108.604 -174.371 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.3 mm -109.58 125.25 66.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 C-N-CA 123.711 0.804 . . . . 10.0 110.422 -162.886 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -119.22 108.46 14.67 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.476 -0.935 . . . . 10.0 108.476 173.005 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 148.86 -87.34 0.15 Allowed Glycine 0 C--N 1.337 0.598 0 N-CA-C 111.511 -0.636 . . . . 10.0 111.511 170.196 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.4 mmt -81.18 159.88 24.5 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 122.675 0.39 . . . . 10.0 110.127 178.483 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 m -59.7 -88.31 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 126.677 1.991 . . . . 10.0 109.562 179.387 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.5 p 146.02 60.08 0.0 OUTLIER 'General case' 0 C--N 1.341 0.232 0 C-N-CA 125.029 1.332 . . . . 10.0 107.882 -159.385 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -153.12 -78.23 0.11 Allowed 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 107.039 -1.467 . . . . 10.0 107.039 172.799 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.65 -50.83 63.55 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 107.109 -1.441 . . . . 10.0 107.109 176.156 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 7.6 t -52.12 -65.86 0.49 Allowed 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 114.071 -1.422 . . . . 10.0 110.462 172.456 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -39.96 -55.04 2.11 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.248 1.019 . . . . 10.0 111.628 177.956 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -52.72 -36.62 57.83 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.961 0.726 . . . . 10.0 112.961 179.122 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.0 ttt180 -84.93 -42.02 15.37 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 126.058 1.743 . . . . 10.0 109.604 -172.653 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.424 ' CG2' HD12 ' A' ' 25' ' ' LEU . 18.4 mm -41.66 -57.05 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.323 0 C-N-CA 124.368 1.067 . . . . 10.0 108.66 166.756 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -42.53 -50.62 5.27 Favored 'General case' 0 C--O 1.221 -0.4 0 O-C-N 123.576 0.548 . . . . 10.0 111.399 179.389 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.7 -49.79 56.13 Favored 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 121.875 -0.516 . . . . 10.0 109.631 -176.289 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.432 ' HG3' HD11 ' A' ' 64' ' ' LEU . 6.9 mmt85 -57.65 -38.65 75.44 Favored 'General case' 0 C--O 1.226 -0.149 0 O-C-N 121.94 -0.475 . . . . 10.0 112.036 -179.437 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.424 HD12 ' CG2' ' A' ' 21' ' ' ILE . 0.5 OUTLIER -74.36 -46.35 41.15 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.194 0.997 . . . . 10.0 110.147 177.396 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 53.0 m-20 -54.95 -24.08 22.12 Favored 'General case' 0 C--O 1.226 -0.135 0 C-N-CA 123.319 0.648 . . . . 10.0 111.503 174.941 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.3 ttmt -56.19 -39.53 72.56 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 118.372 0.533 . . . . 10.0 112.225 175.665 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.7 mp -56.74 135.87 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 C-N-CA 123.873 0.869 . . . . 10.0 110.436 179.09 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 55.9 mp0 -70.78 -49.46 46.33 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 116.274 -0.421 . . . . 10.0 110.091 -174.119 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.22 49.01 4.15 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.973 -0.851 . . . . 10.0 110.973 -177.836 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.4 p -110.74 155.54 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 126.009 1.724 . . . . 10.0 109.073 178.03 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.481 ' HB2' HG21 ' A' ' 2' ' ' THR . . . -120.34 -56.78 1.97 Allowed 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 110.235 -0.283 . . . . 10.0 110.235 168.648 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -144.97 149.04 34.48 Favored 'General case' 0 C--O 1.226 -0.172 0 N-CA-C 107.992 -1.114 . . . . 10.0 107.992 -171.484 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -142.85 63.73 13.97 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 118.708 0.685 . . . . 10.0 111.201 172.4 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -76.71 74.32 4.91 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.926 2.417 . . . . 10.0 109.38 178.135 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.494 HG12 HG13 ' A' ' 43' ' ' VAL . 11.4 m -66.02 158.27 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 C-N-CA 123.624 0.77 . . . . 10.0 112.082 179.702 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -90.72 101.69 14.44 Favored 'General case' 0 N--CA 1.46 0.069 0 C-N-CA 120.441 -0.504 . . . . 10.0 111.706 -165.982 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -75.55 42.22 0.21 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.249 1.82 . . . . 10.0 113.938 -173.302 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -177.07 -36.3 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.288 1.435 . . . . 10.0 110.64 176.513 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.2 mt -88.67 0.99 55.88 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.635 1.174 . . . . 10.0 112.667 -169.156 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 58.26 45.5 17.11 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 124.789 1.235 . . . . 10.0 110.402 170.955 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -145.39 129.12 17.22 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.694 -1.224 . . . . 10.0 107.694 -178.124 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.494 HG13 HG12 ' A' ' 36' ' ' VAL . 5.5 t -97.55 126.79 50.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 108.277 -1.008 . . . . 10.0 108.277 175.575 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 84.0 m -113.8 112.26 23.1 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.982 1.713 . . . . 10.0 107.457 178.687 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 41.3 t -106.09 141.59 21.01 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.044 0 CA-C-N 118.359 0.527 . . . . 10.0 110.183 177.49 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -108.12 109.77 21.27 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 125.376 1.47 . . . . 10.0 108.016 160.227 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -143.2 169.57 17.37 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.905 -0.776 . . . . 10.0 108.905 177.288 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 7.3 p-10 -115.46 115.34 42.22 Favored Pre-proline 0 CA--C 1.531 0.238 0 C-N-CA 123.722 0.809 . . . . 10.0 110.021 -178.708 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -74.56 72.1 4.46 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.376 2.717 . . . . 10.0 111.015 -175.832 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.88 -39.16 0.63 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.075 0.55 . . . . 10.0 110.934 168.548 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -86.94 -51.07 6.25 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.193 0.451 . . . . 10.0 110.107 176.756 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -123.76 -175.0 3.11 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.784 1.234 . . . . 10.0 110.742 -171.653 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 83.2 p -144.46 167.94 21.3 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.575 0.75 . . . . 10.0 112.677 177.762 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 23.5 m -47.0 -43.19 6.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 124.57 1.148 . . . . 10.0 111.515 164.312 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 68.3 m -68.78 -40.89 79.42 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 122.782 0.433 . . . . 10.0 110.731 -177.095 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -57.78 -59.48 5.15 Favored 'General case' 0 N--CA 1.455 -0.199 0 O-C-N 123.916 0.76 . . . . 10.0 109.297 176.396 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.648 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.2 pp -65.05 -39.38 93.23 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 122.165 -0.334 . . . . 10.0 110.933 -171.536 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.408 ' HA ' HD23 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -43.46 -45.64 6.44 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 118.254 -0.879 . . . . 10.0 113.194 163.812 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -59.92 -40.56 89.25 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 120.236 1.38 . . . . 10.0 111.024 179.802 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -55.44 -49.41 72.49 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 122.106 -0.371 . . . . 10.0 110.104 178.366 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.519 ' HA ' HD12 ' A' ' 64' ' ' LEU . 24.8 t -66.08 -43.44 92.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 N-CA-C 112.815 0.672 . . . . 10.0 112.815 176.207 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -53.19 -44.0 67.59 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.841 0.829 . . . . 10.0 109.081 177.841 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.0 tttp -80.21 -30.59 38.69 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 124.722 1.209 . . . . 10.0 111.591 -175.246 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.519 HD12 ' HA ' ' A' ' 61' ' ' VAL . 15.1 mt -51.38 -35.49 39.01 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.407 1.003 . . . . 10.0 111.507 162.36 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 115.78 28.35 2.73 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 123.041 0.353 . . . . 10.0 112.822 169.066 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -145.67 158.24 43.87 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 107.251 -1.388 . . . . 10.0 107.251 168.443 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.24 130.96 37.82 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.69 -0.485 . . . . 10.0 109.69 -166.146 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.468 HD11 ' HB2' ' A' ' 7' ' ' PHE . 12.1 tp -114.9 146.98 40.55 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 106.265 -1.754 . . . . 10.0 106.265 173.261 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 17.6 tptt -153.09 150.14 28.82 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 109.053 -0.721 . . . . 10.0 109.053 168.458 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.9 tp -62.39 156.6 22.09 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 109.316 -0.624 . . . . 10.0 109.316 178.04 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 42.1 tttt -117.22 -64.24 1.33 Allowed 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 126.326 1.85 . . . . 10.0 107.742 178.905 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 154.06 50.71 0.01 OUTLIER Glycine 0 CA--C 1.527 0.8 0 CA-C-O 119.661 -0.522 . . . . 10.0 112.337 174.967 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 66.99 160.03 0.15 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.267 1.427 . . . . 10.0 111.989 175.014 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -80.26 -41.46 24.99 Favored 'General case' 0 CA--C 1.529 0.165 0 O-C-N 121.609 -0.682 . . . . 10.0 110.268 172.786 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 39.9 t0 53.99 64.19 1.92 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.318 1.447 . . . . 10.0 110.759 -171.304 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 17.3 m -128.75 41.9 3.41 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.753 1.221 . . . . 10.0 110.008 -177.058 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.536 HG22 ' H ' ' A' ' 78' ' ' GLU . 15.9 mm -103.86 -135.98 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 N-CA-C 108.177 -1.045 . . . . 10.0 108.177 -179.908 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.536 ' H ' HG22 ' A' ' 77' ' ' ILE . 2.9 mt-10 -159.22 177.5 10.98 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.83 2.052 . . . . 10.0 106.37 -178.533 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -80.46 -157.26 14.91 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 123.454 0.55 . . . . 10.0 111.979 179.366 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 . . . . . 0 C--O 1.249 1.078 0 N-CA-C 106.954 -1.499 . . . . 10.0 106.954 159.653 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 2.7 p . . . . . 0 N--CA 1.474 0.751 0 N-CA-C 109.931 -0.396 . . . . 10.0 109.931 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.512 HG21 ' HB2' ' A' ' 32' ' ' ALA . 9.8 p -133.36 173.94 10.93 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.844 1.658 . . . . 10.0 107.195 176.041 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -138.39 142.81 39.6 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 129.12 2.968 . . . . 10.0 106.989 -174.227 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 28.9 tttt -111.32 98.69 7.67 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.373 1.069 . . . . 10.0 110.09 -171.504 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -99.92 150.15 22.69 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.834 -1.075 . . . . 10.0 108.844 -175.641 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -122.36 150.17 42.77 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 123.221 0.608 . . . . 10.0 109.919 172.286 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.646 ' CE2' HD11 ' A' ' 57' ' ' LEU . 7.8 m-85 -138.26 137.14 37.2 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 125.452 1.72 . . . . 10.0 108.335 -169.477 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -99.45 139.64 34.81 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 106.328 -1.731 . . . . 10.0 106.328 178.874 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.0 mm -114.32 141.39 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 C-N-CA 124.995 1.318 . . . . 10.0 109.913 -162.779 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -130.82 102.52 6.11 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 108.155 -1.054 . . . . 10.0 108.155 176.702 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 110.59 18.17 8.69 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 123.97 0.795 . . . . 10.0 114.018 170.043 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 28.3 ptm -79.85 165.35 22.8 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 118.724 1.262 . . . . 10.0 109.533 168.149 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 30.0 m -87.56 -59.31 2.28 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 126.147 1.779 . . . . 10.0 107.842 179.946 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 13.5 p 162.66 -121.23 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 128.187 2.595 . . . . 10.0 104.159 -177.51 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.36 -40.1 96.33 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.604 1.161 . . . . 10.0 112.704 -174.042 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.83 -44.09 97.06 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.207 -1.034 . . . . 10.0 108.207 -173.214 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 3.6 m -65.33 -55.73 16.58 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 114.996 -1.002 . . . . 10.0 109.951 177.554 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -41.55 -47.92 3.87 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.733 1.213 . . . . 10.0 111.883 176.282 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -54.89 -38.75 67.95 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.392 -0.367 . . . . 10.0 111.274 179.677 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.92 -42.04 41.0 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 118.306 -0.854 . . . . 10.0 111.033 176.202 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 27.2 mm -43.15 -55.1 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.411 0 CA-C-N 118.65 0.659 . . . . 10.0 109.573 174.028 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -43.17 -57.41 2.96 Favored 'General case' 0 C--O 1.222 -0.377 0 C-N-CA 123.244 0.618 . . . . 10.0 111.607 -179.48 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.06 -41.88 63.68 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.392 1.077 . . . . 10.0 109.794 -170.601 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.416 ' HG3' ' HB1' ' A' ' 60' ' ' ALA . 25.6 tpt180 -53.81 -45.65 70.86 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.328 0.651 . . . . 10.0 109.958 175.358 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.03 -37.72 64.25 Favored 'General case' 0 C--O 1.224 -0.284 0 C-N-CA 123.2 0.6 . . . . 10.0 111.858 176.046 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -51.98 -32.39 33.36 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 123.723 0.809 . . . . 10.0 109.788 175.317 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.7 -33.42 70.16 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.947 1.091 . . . . 10.0 113.947 175.478 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 17.0 mm -57.48 133.21 22.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 108.314 -0.995 . . . . 10.0 108.314 177.465 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -80.29 -41.88 24.12 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 118.486 0.585 . . . . 10.0 110.757 -172.039 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -78.91 39.92 2.05 Favored Glycine 0 C--N 1.339 0.738 0 O-C-N 120.117 -1.614 . . . . 10.0 112.491 176.1 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.4 p -105.68 148.22 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 C-N-CA 124.179 0.991 . . . . 10.0 108.363 -176.594 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.512 ' HB2' HG21 ' A' ' 2' ' ' THR . . . -115.54 -56.36 2.35 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.92 -0.77 . . . . 10.0 108.92 174.876 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 64.2 m-80 -147.32 152.76 38.77 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 109.264 -0.643 . . . . 10.0 109.264 -178.546 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -134.81 65.85 67.26 Favored Pre-proline 0 CA--C 1.534 0.341 0 C-N-CA 123.639 0.776 . . . . 10.0 110.015 173.667 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -78.92 67.33 8.57 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.825 2.35 . . . . 10.0 109.078 -178.946 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.473 HG12 HG13 ' A' ' 43' ' ' VAL . 5.0 m -69.59 157.58 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 C-N-CA 122.889 0.476 . . . . 10.0 111.339 -175.89 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -91.51 126.36 36.57 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 121.276 0.56 . . . . 10.0 110.82 -178.675 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -99.61 33.07 2.61 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.962 1.705 . . . . 10.0 112.015 -168.522 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -171.12 -40.71 0.02 OUTLIER 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 124.542 1.137 . . . . 10.0 110.661 179.986 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.1 mt -72.57 -20.06 61.38 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.089 0.956 . . . . 10.0 111.477 -173.31 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 65.17 51.59 1.62 Allowed 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 125.664 1.586 . . . . 10.0 110.424 -178.018 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.1 p -140.1 124.37 17.82 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 125.457 1.503 . . . . 10.0 107.066 173.606 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.473 HG13 HG12 ' A' ' 36' ' ' VAL . 7.9 t -97.2 135.3 31.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 107.773 -1.195 . . . . 10.0 107.773 175.581 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.6 m -120.85 127.84 52.28 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 126.161 1.785 . . . . 10.0 107.418 178.708 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 36.6 t -131.9 128.18 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.123 0 CA-C-N 118.678 0.672 . . . . 10.0 110.093 178.94 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -93.13 102.11 14.41 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 105.314 -2.106 . . . . 10.0 105.314 165.968 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -135.7 176.78 8.37 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.536 1.134 . . . . 10.0 108.612 178.812 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 27.7 p30 -116.96 135.78 23.12 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 118.879 0.763 . . . . 10.0 110.986 175.682 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -79.7 56.84 6.22 Favored 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 121.435 1.424 . . . . 10.0 108.85 167.307 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.8 ptpt -123.88 -39.51 2.38 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 118.133 0.424 . . . . 10.0 111.344 172.828 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -97.99 -61.68 1.35 Allowed 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 107.425 -1.324 . . . . 10.0 107.425 177.48 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -105.62 -174.96 2.66 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 125.047 1.339 . . . . 10.0 111.102 -171.718 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 87.7 p -144.68 164.9 29.59 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 121.673 0.749 . . . . 10.0 109.985 173.692 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.2 m -52.58 -37.47 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 C-N-CA 124.384 1.073 . . . . 10.0 111.154 172.228 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.2 t -62.72 -40.45 97.24 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 122.47 0.308 . . . . 10.0 110.708 177.058 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -65.67 -52.79 48.81 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.891 -0.781 . . . . 10.0 108.891 -175.97 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.646 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.0 pp -64.77 -42.47 95.08 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 121.762 -0.586 . . . . 10.0 111.218 -178.482 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -41.54 -55.22 2.94 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-O 117.737 -1.125 . . . . 10.0 111.751 162.345 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 -56.58 -48.28 77.73 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 119.939 1.245 . . . . 10.0 110.353 178.669 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.416 ' HB1' ' HG3' ' A' ' 24' ' ' ARG . . . -51.29 -45.31 62.1 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 109.59 -0.522 . . . . 10.0 109.59 -178.665 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 99.5 t -69.39 -46.98 75.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 112.401 0.519 . . . . 10.0 112.401 174.017 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -45.59 -42.35 11.04 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.482 1.513 . . . . 10.0 109.522 177.556 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -79.96 -26.2 40.09 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 125.104 1.362 . . . . 10.0 111.329 -173.879 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 67.9 mt -55.96 -41.23 74.39 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 119.489 1.041 . . . . 10.0 110.91 164.559 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 149.03 -40.79 0.88 Allowed Glycine 0 CA--C 1.526 0.755 0 CA-C-N 118.088 0.404 . . . . 10.0 112.531 173.227 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -96.02 157.51 15.86 Favored 'General case' 0 C--N 1.334 -0.099 0 C-N-CA 124.204 1.002 . . . . 10.0 109.351 -177.749 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 63.5 mmtt -92.12 148.61 22.04 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 121.506 0.67 . . . . 10.0 110.341 -170.426 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 10.5 tp -124.46 148.73 47.47 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.115 1.766 . . . . 10.0 106.608 176.675 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.0 tptm -151.48 145.14 24.99 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 117.956 0.344 . . . . 10.0 110.711 165.478 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.4 tt -64.9 159.41 22.81 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-O 121.462 0.649 . . . . 10.0 109.684 178.36 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 27.5 tttt -127.38 -55.54 1.34 Allowed 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 127.701 2.4 . . . . 10.0 107.829 -175.979 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 176.34 -89.91 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 107.92 -2.072 . . . . 10.0 107.92 177.522 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -167.42 169.31 12.35 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.788 0.835 . . . . 10.0 108.795 -164.295 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -58.84 140.03 55.7 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 123.745 0.653 . . . . 10.0 112.043 -176.034 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -71.12 73.31 0.64 Allowed 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 108.393 -0.966 . . . . 10.0 108.393 167.844 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 11.5 t -152.97 127.29 9.21 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.166 -0.679 . . . . 10.0 109.166 175.878 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.4 pt -129.91 88.45 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 124.946 1.298 . . . . 10.0 109.096 179.702 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -108.68 140.94 41.36 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 107.646 -1.242 . . . . 10.0 107.646 173.986 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -101.93 -137.15 9.53 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 123.966 0.793 . . . . 10.0 111.649 -173.953 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.255 1.346 0 N-CA-C 105.085 -2.191 . . . . 10.0 105.085 170.503 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.726 HG22 ' H ' ' A' ' 2' ' ' THR . 8.9 p . . . . . 0 N--CA 1.468 0.426 0 N-CA-C 105.929 -1.878 . . . . 10.0 105.929 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.726 ' H ' HG22 ' A' ' 1' ' ' VAL . 2.7 p -92.14 160.19 15.31 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 126.695 1.998 . . . . 10.0 109.786 -178.044 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -125.33 145.35 50.07 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 126.581 1.952 . . . . 10.0 108.273 -169.98 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.8 mmtm -87.15 124.45 33.28 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 124.096 0.959 . . . . 10.0 109.675 -175.166 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.474 ' HB1' HD11 ' A' ' 70' ' ' LEU . . . -125.35 143.11 51.13 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.16 1.784 . . . . 10.0 109.349 176.95 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -121.31 146.75 46.51 Favored 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 123.518 0.727 . . . . 10.0 109.096 172.881 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.823 ' CE2' HD11 ' A' ' 57' ' ' LEU . 3.8 m-85 -133.39 140.27 47.26 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 125.194 1.559 . . . . 10.0 108.522 -173.443 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -96.99 141.79 29.72 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.687 1.995 . . . . 10.0 107.618 -177.471 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.548 HG13 HD12 ' A' ' 68' ' ' LEU . 3.3 mp -132.41 148.5 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 125.236 1.415 . . . . 10.0 110.531 -167.407 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -133.56 89.93 2.65 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 112.286 -2.234 . . . . 10.0 106.229 175.613 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 154.35 -74.76 0.24 Allowed Glycine 0 C--N 1.341 0.822 0 C-N-CA 119.601 -1.285 . . . . 10.0 113.904 167.779 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.5 103.35 4.1 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 122.697 1.237 . . . . 10.0 111.118 -169.382 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.9 t -135.18 61.15 1.67 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.116 -1.402 . . . . 10.0 108.371 -165.561 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.3 m -146.44 -89.72 0.09 Allowed 'General case' 0 C--N 1.341 0.216 0 N-CA-C 107.78 -1.193 . . . . 10.0 107.78 175.747 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 179.36 -42.96 0.01 OUTLIER 'General case' 0 C--O 1.223 -0.294 0 C-N-CA 124.493 1.117 . . . . 10.0 109.674 -174.682 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.07 -50.93 17.44 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.649 -0.871 . . . . 10.0 108.649 -175.337 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 12.9 m -58.95 -52.43 65.8 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 109.358 -0.608 . . . . 10.0 109.358 177.21 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -44.84 -51.39 9.6 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.894 1.278 . . . . 10.0 111.431 170.862 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -56.87 -34.96 68.37 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 121.198 -0.939 . . . . 10.0 112.334 177.925 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.81 -40.88 89.9 Favored 'General case' 0 N--CA 1.455 -0.219 0 O-C-N 120.904 -1.122 . . . . 10.0 109.301 176.298 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.53 HG22 HD12 ' A' ' 25' ' ' LEU . 20.8 mm -54.13 -49.4 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 108.772 -0.825 . . . . 10.0 108.772 -177.945 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -45.8 -56.42 5.37 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.568 0.747 . . . . 10.0 110.967 -179.895 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.8 mtmt -66.29 -44.6 83.06 Favored 'General case' 0 N--CA 1.453 -0.291 0 O-C-N 121.845 -0.534 . . . . 10.0 111.084 179.583 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.0 tpt85 -56.88 -30.74 64.17 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 111.487 0.18 . . . . 10.0 111.487 178.829 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.53 HD12 HG22 ' A' ' 21' ' ' ILE . 0.3 OUTLIER -84.0 -38.34 21.05 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 125.469 1.508 . . . . 10.0 111.46 174.894 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -60.67 -26.75 67.32 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.779 0.832 . . . . 10.0 109.785 178.845 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.0 mmpt? -50.69 -35.88 33.18 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 114.058 1.133 . . . . 10.0 114.058 168.397 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 13.4 mm -62.84 126.89 22.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 118.63 0.65 . . . . 10.0 109.388 -178.784 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -56.19 -57.53 11.81 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.13 0.419 . . . . 10.0 112.13 -179.673 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -82.57 43.9 3.13 Favored Glycine 0 C--N 1.341 0.838 0 O-C-N 120.259 -1.526 . . . . 10.0 111.988 -170.717 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.5 p -108.07 150.03 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 C-N-CA 124.645 1.178 . . . . 10.0 108.643 -176.965 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -106.86 -58.54 1.92 Allowed 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 109.039 -0.726 . . . . 10.0 109.039 171.81 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -144.97 141.31 28.86 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 106.837 -1.542 . . . . 10.0 106.837 -166.732 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -133.83 59.71 40.94 Favored Pre-proline 0 CA--C 1.535 0.388 0 CA-C-N 118.488 0.586 . . . . 10.0 111.719 172.297 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -77.0 82.26 2.4 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 123.248 2.632 . . . . 10.0 109.215 -178.62 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.515 HG12 HG13 ' A' ' 43' ' ' VAL . 2.9 m -71.53 151.44 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 O-C-N 121.746 -0.596 . . . . 10.0 110.705 -177.793 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -86.32 142.58 28.4 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 120.638 -0.425 . . . . 10.0 110.131 177.345 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -120.88 52.98 1.15 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.269 1.427 . . . . 10.0 110.067 -174.979 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -176.0 -42.7 0.01 OUTLIER 'General case' 0 C--O 1.226 -0.158 0 C-N-CA 125.481 1.512 . . . . 10.0 108.698 178.287 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.8 mt -80.13 -20.96 43.73 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.028 0.931 . . . . 10.0 111.459 -172.599 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 59.04 49.74 9.09 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 126.31 1.844 . . . . 10.0 110.129 -172.336 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 20.7 p -134.74 117.35 15.9 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 125.064 1.345 . . . . 10.0 108.631 173.362 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.518 ' H ' ' CD1' ' A' ' 9' ' ' ILE . 14.4 t -85.34 131.33 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 106.282 -1.747 . . . . 10.0 106.282 171.636 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.2 m -110.81 123.88 50.94 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 105.991 -1.855 . . . . 10.0 105.991 172.295 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 33.6 t -121.92 146.24 27.36 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.274 0 N-CA-C 107.961 -1.126 . . . . 10.0 107.961 171.277 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -112.47 113.35 25.48 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 106.303 -1.74 . . . . 10.0 106.303 166.569 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -142.08 156.82 45.41 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.062 0.545 . . . . 10.0 110.715 -177.099 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 19.6 p30 -93.37 126.05 51.9 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 118.813 -0.613 . . . . 10.0 109.47 177.225 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -74.71 63.42 5.72 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 122.401 2.067 . . . . 10.0 108.922 174.717 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.3 tttt -135.33 -57.03 0.8 Allowed 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 105.331 -2.1 . . . . 10.0 105.331 174.662 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -101.38 -51.12 3.56 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 108.638 -0.875 . . . . 10.0 108.638 -177.797 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -81.59 137.72 35.46 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 123.627 0.771 . . . . 10.0 110.717 -176.851 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.6 p -131.38 145.5 51.85 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.417 1.087 . . . . 10.0 110.945 177.112 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 97.0 t -48.39 -48.05 14.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 C-N-CA 125.243 1.417 . . . . 10.0 110.355 174.776 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.01 -43.79 78.06 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 124.914 1.285 . . . . 10.0 111.432 -179.858 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -64.97 -55.86 16.6 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 121.695 0.76 . . . . 10.0 109.3 -177.249 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.823 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.2 pp -65.56 -41.62 92.74 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.162 -0.961 . . . . 10.0 111.307 -176.423 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -43.88 -48.61 8.41 Favored 'General case' 0 N--CA 1.451 -0.4 0 O-C-N 121.51 -0.744 . . . . 10.0 112.291 161.701 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.63 -43.17 84.62 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 119.224 0.92 . . . . 10.0 109.695 -179.377 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . -49.67 -56.81 8.75 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 122.741 0.417 . . . . 10.0 110.556 177.057 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.552 HG11 ' HB2' ' A' ' 68' ' ' LEU . 47.4 t -58.45 -50.19 79.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 N-CA-C 113.184 0.809 . . . . 10.0 113.184 174.185 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -59.21 -35.74 74.15 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.317 1.047 . . . . 10.0 109.5 -174.132 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.8 tptt -77.4 -43.83 31.33 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 125.301 1.441 . . . . 10.0 110.52 178.083 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 19.4 mt -51.25 -39.01 55.75 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-N 118.938 0.79 . . . . 10.0 111.569 172.358 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 128.8 3.08 5.56 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-O 119.41 -0.661 . . . . 10.0 113.58 169.29 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -99.45 -160.44 0.8 Allowed 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 107.57 -1.27 . . . . 10.0 107.57 175.768 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 35.0 tttt -139.06 149.12 44.23 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 118.458 0.572 . . . . 10.0 111.238 167.638 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.552 ' HB2' HG11 ' A' ' 61' ' ' VAL . 13.9 tp -135.62 150.84 49.77 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 127.419 2.288 . . . . 10.0 106.475 -176.046 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.7 tptm -149.76 152.89 35.98 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 108.446 -0.946 . . . . 10.0 108.446 163.642 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.474 HD11 ' HB1' ' A' ' 5' ' ' ALA . 10.6 tp -63.91 157.46 24.76 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 119.341 0.973 . . . . 10.0 108.883 172.338 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 34.5 tttp -117.03 -56.14 2.28 Favored 'General case' 0 N--CA 1.436 -1.152 0 C-N-CA 126.51 1.924 . . . . 10.0 107.783 170.133 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -179.47 -89.25 0.08 OUTLIER Glycine 0 CA--C 1.523 0.535 0 N-CA-C 109.158 -1.577 . . . . 10.0 109.158 -177.864 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -168.84 164.6 11.8 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.865 0.866 . . . . 10.0 109.189 -166.666 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -64.22 116.48 6.03 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.929 1.292 . . . . 10.0 112.476 -173.931 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -72.41 70.39 0.87 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.514 0.726 . . . . 10.0 111.54 -179.193 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 45.8 m -107.03 108.83 20.52 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 125.046 1.339 . . . . 10.0 109.633 176.052 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.5 mp -78.07 -27.58 14.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 123.452 0.701 . . . . 10.0 111.186 176.208 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -76.45 143.62 40.42 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.229 1.012 . . . . 10.0 109.051 176.737 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -133.41 167.57 23.43 Favored Glycine 0 CA--C 1.529 0.906 0 N-CA-C 109.823 -1.311 . . . . 10.0 109.823 176.143 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 59.8 mtt180 . . . . . 0 C--O 1.253 1.285 0 N-CA-C 104.721 -2.326 . . . . 10.0 104.721 172.854 . . . . . . . . 0 0 . 1 stop_ save_